PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Helwig, K; Seeger, F; Holschermann, H; Lischke, V; Gerriets, T; Niessner, M; Foerch, C				Helwig, Kirsten; Seeger, Florian; Hoelschermann, Hans; Lischke, Volker; Gerriets, Tibo; Niessner, Marion; Foerch, Christian			Elevated Serum Glial Fibrillary Acidic Protein (GFAP) is Associated with Poor Functional Outcome After Cardiopulmonary Resuscitation	NEUROCRITICAL CARE			English	Article						Cardiac arrest; GFAP; NSE; Outcome; Biomarker	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; C-TERMINAL HYDROLASE-L1; CARDIAC-ARREST; INTRACEREBRAL HEMORRHAGE; ACUTE STROKE; THERAPEUTIC HYPOTHERMIA; COMPUTED-TOMOGRAPHY; COMATOSE SURVIVORS; ISCHEMIC-STROKE	Background The neurological prognosis of patients after cardiopulmonary resuscitation (CPR) is difficult to assess. GFAP is an astrocytic intermediate filament protein released into bloodstream in case of cell death. We performed a prospective study aiming to compare the predictive potential of GFAP after resuscitation to the more widely used biomarker neuron-specific enolase (NSE). Methods One hundred patients were included at 48 h (tolerance interval +/- 12 h) after cardiac arrest. A serum sample was collected immediately after study inclusion. We determined serum levels of GFAP and NSE by means of immunoassays. Primary outcome was the modified Glasgow outcome scale at 4 weeks. Values below four were considered as a poor functional outcome. Results Median GFAP levels in poor outcome (n = 61) and good outcome (n = 39) patients were 0.03 mu g/L (interquartile range 0.01-0.07 mu g/L) and 0.02 mu g/L (0.01-0.03 mu g/L; p = 0.014), respectively. GFAPrevealed a sensitivity of 60.7% and a specificity of 66.7% to predict a poor functional outcome. All patients having a GFAP level > 0.08 mu g/L had a poor functional outcome. For NSE, sensitivity was 44.3% and specificity was 100.0% for predicting a poor outcome. Multivariate regression analysis revealed GFAP, NSE, and the Karnofsky index to be independent predictors of outcome. Conclusions The release patterns of GFAP and NSE after CPR show differences. GFAP levels above 0.08 mu g/L were associated with a poor outcome in all cases, and patients with strongly elevated values (> 3 mu g/L) consistently had severe brain damage on brain imaging. Both biomarkers independently contribute to outcome prediction after CPR.	[Helwig, Kirsten; Foerch, Christian] Goethe Univ, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany; [Seeger, Florian] Goethe Univ, Dept Cardiol, Frankfurt, Germany; [Hoelschermann, Hans] Hochtaunus Kliniken, Dept Cardiol, Bad Homburg, Germany; [Lischke, Volker] Hochtaunus Kliniken, Dept Anesthesiol, Bad Homburg, Germany; [Gerriets, Tibo] Justus Liebig Univ, Dept Neurol, Giessen, Germany; [Gerriets, Tibo] Gesundheitszentrum Wetterau, Dept Neurol, Friedberg, Germany; [Niessner, Marion] Roche Diagnost, Penzberg, Germany	Foerch, C (corresponding author), Goethe Univ, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	foerch@em.uni-frankfurt.de					Ben-Hamouda N, 2014, CHEST, V146, P1375, DOI 10.1378/chest.14-0523; Brunkhorst R, 2010, TRANSL STROKE RES, V1, P246, DOI 10.1007/s12975-010-0040-6; Conlon N, 2008, BRIT J ANAESTH, V100, P219, DOI 10.1093/bja/aem372; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Fogel W, 1997, CRIT CARE MED, V25, P1133, DOI 10.1097/00003246-199707000-00012; Geocadin RG, 2006, NEUROLOGY, V67, P105, DOI 10.1212/01.wnl.0000223335.86166.b4; Hayashida H, 2010, NEUROCRIT CARE, V12, P252, DOI 10.1007/s12028-009-9318-5; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Horn J, 2014, CURR OPIN CRIT CARE, V20, P280, DOI 10.1097/MCC.0000000000000085; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Koenig MA, 2014, CRIT CARE CLIN, V30, P765, DOI 10.1016/j.ccc.2014.06.007; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Missler U, 1999, CLIN CHEM, V45, P138; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Rana OR, 2012, CLIN RES CARDIOL, V101, P533, DOI 10.1007/s00392-012-0423-7; Reisinger J, 2007, EUR HEART J, V28, P52, DOI 10.1093/eurheartj/ehl316; Sandroni C, 2013, RESUSCITATION, V84, P1324, DOI 10.1016/j.resuscitation.2013.06.020; Scolletta S, 2012, EXPERT REV CLIN PHAR, V5, P687, DOI [10.1586/ECP.12.64, 10.1586/ecp.12.64]; Steffen IG, 2010, CRIT CARE, V14, DOI 10.1186/cc8975; Tichy J, 2016, J NEURO-ONCOL, V126, P361, DOI 10.1007/s11060-015-1978-8; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x	31	15	16	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2017	27	1					68	74		10.1007/s12028-016-0371-6			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	FB7GX	WOS:000406310200010	28054291				2021-06-18	
J	Jang, JY; Kwon, HY; Choi, EH; Lee, WY; Shim, H; Bae, KS				Jang, Ji Young; Kwon, Hye Youn; Choi, Eun Hee; Lee, Won-Yeon; Shim, Hongjin; Bae, Keum Seok			Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii	JOURNAL OF CRITICAL CARE			English	Article						Colistin; Nebulizer; Inhalation; Ventilator-associated pneumonia; Acinetobacter baumannii	GRAM-NEGATIVE BACTERIA; AEROSOLIZED COLISTIN; INHALED COLISTIN; INTRAVENOUS COLISTIN; ADJUNCTIVE TREATMENT; ACQUIRED PNEUMONIA; RISK-FACTORS; TRIAL; TRACHEOBRONCHITIS; DEFINITIONS	Purpose: Few studies have compared nebulized and intravenous (IV) colistin for multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa pneumonia. This study compared the nephrotoxicity and clinical outcomes for these two delivery routes. Methods: This study retrospectively compared 95 critically ill surgical patients who were diagnosed with Acinetobacter baumannii ventilator associated pneumonia and received colistin between March 2013 and January 2016. Results: The most common diagnoses were brain hemorrhage (27.4%), traumatic brain injury (20%), traumatic thoracic injury (15.8%), and secondary peritonitis (11.6%). Compared to the IV group, the nebulizer group was significantly older (60.0 vs. 67.5 years, p = 0.010), had higher APACHE II scores (16.3 vs. 19.9, p = 0.001), and more frequently had diabetes mellitus (6.8% vs. 21.6%, p = 0.043). Nephrotoxicity was more common in the IV group (60.5% vs. 15.7%, p < 0.0001). Both groups had similar microbiological and clinical outcomes (p = 0.921 and p= 0.719, respectively). Patients with nephrotoxicity exhibited prolonged IV or nebulized colistin treatment and more frequent combination with vancomycin. Nephrotoxicity was independently associated with IV delivery (odds ratio: 8.48, 95% confidence interval: 2.95-24.39, p < 0.0001). Conclusions: Nebulized colistinmay have less nephrotoxicity and provide similar clinical results, compared to IV colistin. (C) 2017 Elsevier Inc. All rights reserved.	[Jang, Ji Young; Kwon, Hye Youn; Shim, Hongjin; Bae, Keum Seok] Yonsei Univ, Wonju Coll Med, Dept Surg, Trauma Ctr, Seoul, South Korea; [Choi, Eun Hee] Yonsei Univ, Wonju Coll Med, Inst Lifestyle Med, Seoul, South Korea; [Lee, Won-Yeon] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Seoul, South Korea	Shim, H (corresponding author), Yonsei Univ, Wonju Coll Med, Wonju Severance Christian Hosp, Trauma Ctr,Dept Surg, 220-701 Ilsan Ro, Wonju, Gangwon Do, South Korea.	simong3@yonsei.ac.kr		Choi, Eunhee/0000-0002-3449-0672; Jang, Ji Young/0000-0001-6372-4194			Abdellatif S, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0127-7; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bassetti M, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0140-x; Boisson M, 2013, MINERVA ANESTESIOL, V79, P200; Chaari A, 2013, INT J INFECT DIS, V17, pE1225, DOI 10.1016/j.ijid.2013.07.014; Choi HK, 2014, YONSEI MED J, V55, P118, DOI 10.3349/ymj.2014.55.1.118; Choi HS, 2008, TUBERC RESPIR DIS, V64, P8, DOI 10.4046/trd.2008.64.1.8; Cisneros JM, 2005, CLIN MICROBIOL INFEC, V11, P874, DOI 10.1111/j.1469-0691.2005.01256.x; Clinical and Laboratory Standard Institute, 2009, 2009M100S17 CLSI; Coelho JM, 2006, J CLIN MICROBIOL, V44, P3623, DOI 10.1128/JCM.00699-06; Doshi NM, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-45; Falagas ME, 2010, PEDIATR PULM, V45, P1135, DOI 10.1002/ppul.21302; Falagas ME, 2006, J MED MICROBIOL, V55, P1619, DOI 10.1099/jmm.0.46747-0; Ferrari F, 2009, INTENS CARE MED, V35, P1792, DOI 10.1007/s00134-009-1605-2; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Kalin G, 2012, J INFECT CHEMOTHER, V18, P872, DOI 10.1007/s10156-012-0430-7; Kofteridis DP, 2010, CLIN INFECT DIS, V51, P1238, DOI 10.1086/657242; Korbila IP, 2010, CLIN MICROBIOL INFEC, V16, P1230, DOI 10.1111/j.1469-0691.2009.03040.x; Lee SO, 2004, ANTIMICROB AGENTS CH, V48, P224, DOI 10.1128/AAC.48.1.224-228.2004; Lin CC, 2010, J MICROBIOL IMMUNOL, V43, P323, DOI 10.1016/S1684-1182(10)60050-3; Lu Q, 2012, ANESTHESIOLOGY, V117, P1335, DOI 10.1097/ALN.0b013e31827515de; Lu Q, 2010, INTENS CARE MED, V36, P1147, DOI 10.1007/s00134-010-1879-4; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; Michalopoulos A, 2008, RESP MED, V102, P407, DOI 10.1016/j.rmed.2007.10.011; Motaouakkil S, 2006, J INFECTION, V53, P274, DOI 10.1016/j.jinf.2005.11.019; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Naesens R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-317; Niederman MS, 2010, CLIN INFECT DIS, V51, pS12, DOI 10.1086/653035; Rattanaumpawan P, 2010, J ANTIMICROB CHEMOTH, V65, P2645, DOI 10.1093/jac/dkq360; Rello J, 2003, CRIT CARE MED, V31, P2544, DOI 10.1097/01.CCM.0000089928.84326.D2; Rouby JJ, 2012, ANESTHESIOLOGY, V117, P1364, DOI 10.1097/ALN.0b013e3182755d7a; Schurink CAM, 2004, INTENS CARE MED, V30, P217, DOI 10.1007/s00134-003-2018-2; Tumbarello M, 2013, CHEST, V144, P1768, DOI 10.1378/chest.13-1018; Valachis A, 2015, CRIT CARE MED, V43, P527, DOI 10.1097/CCM.0000000000000771	34	15	17	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	AUG	2017	40						251	256		10.1016/j.jcrc.2017.04.004			6	Critical Care Medicine	General & Internal Medicine	FM6XC	WOS:000415204800042	28458172				2021-06-18	
J	Varner, EL; Leong, CL; Jaquins-Gerstl, A; Nesbitt, KM; Boutelle, MG; Michael, AC				Varner, Erika L.; Leong, Chi Leng; Jaquins-Gerstl, Andrea; Nesbitt, Kathryn M.; Boutelle, Martyn G.; Michael, Adrian C.			Enhancing Continuous Online Microdialysis Using Dexamethasone: Measurement of Dynamic Neurometabolic Changes during Spreading Depolarization	ACS CHEMICAL NEUROSCIENCE			English	Article						Microdialysis; dexamethasone; biosensor; microfluidic; spreading depolarization	TRAUMATIC BRAIN-INJURY; STRIATAL DOPAMINE RELEASE; RAT STRIATUM; DEPRESSION; LACTATE; GLUCOSE; PROBES; IMPLANTATION; ISCHEMIA; RETRODIALYSIS	Microdialysis is well established in chemical neuroscience as a mainstay technology for real time intracranial chemical monitoring in both animal models and human patients. Evidence shows that microdialysis can be enhanced by mitigating the penetration injury caused during the insertion of microdialysis probes into brain tissue. Herein, we show that retrodialysis of dexamethasone in the rat cortex enhances the microdialysis detection of K+ and glucose transients induced by spreading depolarization. Without dexamethasone, quantification of glucose transients was unreliable by 5 days after probe insertion. With dexamethasone, robust K+ and glucose transients were readily quantified at 2 h, 5 days, and 10 days after probe insertion. The amplitudes of the K+ transients declined day-to-day following probe insertion, and the amplitudes of the glucose transients exhibited a decreasing trend that did not reach statistical significance. Immunohistochemistry and fluorescence microscopy confirm that dexamethasone is highly effective at preserving a healthy probe-brain interface for at least 10 days even though retrodialysis of dexamethasone ceased after 5 days.	[Varner, Erika L.; Jaquins-Gerstl, Andrea; Nesbitt, Kathryn M.; Michael, Adrian C.] Univ Pittsburgh, Dept Chem, 219 Parkman Ave, Pittsburgh, PA 15260 USA; [Leong, Chi Leng; Boutelle, Martyn G.] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England	Michael, AC (corresponding author), Univ Pittsburgh, Dept Chem, 219 Parkman Ave, Pittsburgh, PA 15260 USA.	amichael@pitt.edu		/0000-0002-0101-0249; Leong, Chi Leng/0000-0002-2654-1345	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS092245]; NSFNational Science Foundation (NSF) [1247842]; University of Pittsburgh's Center for Biologic Imaging [1S10RR028478-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR028478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS092245] Funding Source: NIH RePORTER	This work was funded by the NIH (NS092245), NSF Graduate Research Fellowship Program (E.L.V., 1247842), and University of Pittsburgh's Center for Biologic Imaging (1S10RR028478-01: for the use of the Olympus FluoView 1000)	[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; Bungay PM, 2003, J NEUROCHEM, V86, P932, DOI 10.1046/j.1471-4159.2003.01904.x; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Feuerstein D, 2009, ANAL CHEM, V81, P4987, DOI 10.1021/ac900161x; Groothuis J, 2014, BRAIN STIMUL, V7, P1, DOI 10.1016/j.brs.2013.07.001; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hascup ER, 2009, BRAIN RES, V1291, P12, DOI 10.1016/j.brainres.2009.06.084; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Holson RR, 1996, BRAIN RES, V739, P301, DOI 10.1016/S0006-8993(96)00837-2; Holson RR, 1998, BRAIN RES, V808, P182, DOI 10.1016/S0006-8993(98)00816-6; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; Jaquins-Gerstl A, 2009, J NEUROSCI METH, V183, P127, DOI 10.1016/j.jneumeth.2009.06.023; Jones DA, 2002, J ELECTROANAL CHEM, V538, P243, DOI 10.1016/S0022-0728(02)00839-2; Kozai TDY, 2016, BIOMATERIALS, V87, P157, DOI 10.1016/j.biomaterials.2016.02.013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Mitala CM, 2008, J NEUROSCI METH, V174, P177, DOI 10.1016/j.jneumeth.2008.06.034; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Nesbitt KM, 2015, ACS CHEM NEUROSCI, V6, P163, DOI 10.1021/cn500257x; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Papadimitriou KI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00212; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; ROBINSON TE, 1991, J NEUROSCI METH, V40, P211, DOI 10.1016/0165-0270(91)90070-G; Rogers ML, 2017, J CEREBR BLOOD F MET, V37, P1883, DOI 10.1177/0271678X16674486; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; SHARP T, 1986, PHARMACOL BIOCHEM BE, V24, P1755, DOI 10.1016/0091-3057(86)90516-2; Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Varner EL, 2016, ACS CHEM NEUROSCI, V7, P728, DOI 10.1021/acschemneuro.5b00331; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Watson CJ, 2006, ANAL CHEM, V78, P1391, DOI 10.1021/ac0693722; Westerink BH, 2007, HDB MICRODIALYSIS ME; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024; Zhou F, 2001, AM J PATHOL, V158, P2145, DOI 10.1016/S0002-9440(10)64686-X	49	15	15	2	20	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	AUG	2017	8	8					1779	1788		10.1021/acschemneuro.7b00148			10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	FE2WK	WOS:000408077700022	28482157	Green Accepted			2021-06-18	
J	Zhang, LM; Li, R; Zhao, XC; Zhang, Q; Luo, XL				Zhang, Li-Min; Li, Rui; Zhao, Xiao-Chun; Zhang, Qian; Luo, Xing-Liao			Increased Transfusion of Fresh Frozen Plasma is Associated with Mortality or Worse Functional Outcomes After Severe Traumatic Brain Injury: A Retrospective Study	WORLD NEUROSURGERY			English	Article						Fresh frozen plasma; Glasgow Outcome Scale; Traumatic brain injury	POSTTRAUMATIC CEREBRAL INFARCTION; RISK-FACTORS; RESUSCITATION; RECOVERY; MODERATE	BACKGROUND: The fresh frozen plasma (FFP) transfusion threshold and timing for traumatic brain injury (TBI)-associated coagulopathy are controversial. Thus, a multicenter retrospective study was conducted to determine whether or not FFP transfusion is associated with poor outcomes after severe TBI. METHODS: Data from decompressive craniotomy after blunt force trauma that took place between December 2013 and June 2016 were collected in a multicenter chart. The primary outcomes were mortality and survival, as well as worse outcomes (defined as a Glasgow Outcome Scale [GOS] score <= 3) and better outcomes (GOS score >= 4). Secondary outcomes included 90-day survival rates in all patients with or without FFP transfusion, as well as length of hospital stay in patients with a better prognosis (GOS score >= 4). Univariate analysis, bivariate logistic regression, Spearman rank correlation, and Kaplan-Meier analysis were performed to account for the association between perioperative FFP transfusion and different outcomes. RESULTS: Bivariate logistic analysis showed that mortality and worse outcomes were correlated with FFP transfusion and Glasgow Coma Scale score (P < 0.05). Kaplan-Meier analysis suggested that mortality was statistically higher in the FFP transfusion groups compared with the no FFP transfusion groups, regardless of the severity of TBI (P < 0.05). The overall complications, acute respiratory distress syndrome, and pneumonia rate were significantly higher for patients receiving FFP transfusion (P < 0.05). CONCLUSIONS: Increased perioperative FFP infusion was independently associated with mortality or worse outcomes across a spectrum of surgical risk profiles.	[Zhang, Li-Min; Li, Rui] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China; [Zhao, Xiao-Chun] Shengjing Hosp, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China; [Zhang, Qian] Cangzhou Second People Hosp, Dept Anesthesiol, Cangzhou, Peoples R China; [Luo, Xing-Liao] Huabei Petr Adm Bur, Gen Hosp, Dept Anesthesiol, Renqiu, Peoples R China	Zhang, LM (corresponding author), Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China.	azai2010@126.com					Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Beattie GW, 2014, INTERACT CARDIOV TH, V18, P117, DOI 10.1093/icvts/ivt327; Bochicchio GV, 2008, WORLD J SURG, V32, P2185, DOI 10.1007/s00268-008-9655-0; Carr KR, 2016, NEUROCRIT CARE, V25, P185, DOI 10.1007/s12028-016-0273-7; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Haagh W A J J M, 2006, Ned Tijdschr Geneeskd, V150, P2530; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC16, DOI 10.7860/JCDR/2016/16390.7294; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Liu SW, 2015, ACTA NEUROCHIR, V157, P1697, DOI 10.1007/s00701-015-2559-5; Marshall A, 2015, J THROMB, V14, P324; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nystrup KB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0097-z; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5	18	15	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2017	104						381	389		10.1016/j.wneu.2017.04.140			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FD7NP	WOS:000407713100053	28465266				2021-06-18	
J	Boone, DK; Weisz, HA; Bi, M; Falduto, MT; Torres, KEO; Willey, HE; Volsko, CM; Kumar, AM; Micci, MA; Dewitt, DS; Prough, DS; Hellmich, HL				Boone, Deborah Kennedy; Weisz, Harris A.; Bi, Min; Falduto, Michael T.; Torres, Karen E. O.; Willey, Hannah E.; Volsko, Christina M.; Kumar, Anjali M.; Micci, Maria-Adelaide; Dewitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.			Evidence linking microRNA suppression of essential prosurvival genes with hippocampal cell death after traumatic brain injury	SCIENTIFIC REPORTS			English	Article							NEURODEGENERATIVE DISEASES; NEURONAL VULNERABILITY; NETWORKS; NEUROPATHOLOGY; DISORDERS; CHANNELS; GENOME; TARGET	The underlying molecular mechanisms of how dysregulated microRNAs (miRNAs) cause neurodegeneration after traumatic brain injury (TBI) remain elusive. Here we analyzed the biological roles of approximately 600 genes - we previously found these dysregulated in dying and surviving rat hippocampal neurons - that are targeted by ten TBI-altered miRNAs. Bioinformatic analysis suggests that neurodegeneration results from a global miRNA-mediated suppression of genes essential for maintaining proteostasis; many are hub genes - involved in RNA processing, cytoskeletal metabolism, intracellular trafficking, cell cycle progression, repair/maintenance, bioenergetics and cell-cell signaling - whose disrupted expression is linked to human disease. Notably, dysregulation of these essential genes would significantly impair synaptic function and functional brain connectivity. In surviving neurons, upregulated miRNA target genes are co-regulated members of prosurvival pathways associated with cellular regeneration, neural plasticity, and development. This study captures the diversity of miRNA-regulated genes that may be essential for cell repair and survival responses after TBI.	[Boone, Deborah Kennedy; Weisz, Harris A.; Bi, Min; Willey, Hannah E.; Volsko, Christina M.; Kumar, Anjali M.; Micci, Maria-Adelaide; Dewitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Falduto, Michael T.; Torres, Karen E. O.] Genus Biosyst Inc, Northbrook, IL USA	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X; Willey, Hannah/0000-0002-5164-4127	department of Anesthesiology (UTMB); Moody Foundation;  [RO1 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052532] Funding Source: NIH RePORTER	Supported by RO1 NS052532 (HLH), and in part by the department of Anesthesiology (UTMB) and a Moody Foundation grant to the Moody Project for Translational Traumatic Brain Injury Research (DSP and DSD). We thank Laurie Bolding and Christine Courteau for editorial assistance, Dr. Stacy Sell for critical reading of the manuscript and Christy Perry for all illustrations and figures.	Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Becker L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033297; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chen LH, 2010, AGEING RES REV, V9, pS59, DOI 10.1016/j.arr.2010.08.002; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Fornito A, 2015, EUR NEUROPSYCHOPHARM, V25, P733, DOI 10.1016/j.euroneuro.2014.02.011; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hayden EC, 2016, NATURE, V538, P154; Hullinger TG, 2012, CIRC RES, V110, P71, DOI 10.1161/CIRCRESAHA.111.244442; Imbrici Paola, 2013, Frontiers in Genetics, V4, P76, DOI 10.3389/fgene.2013.00076; Jalles A., 2016, MOL SCI, V2, P259; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Messina A, 2016, NAT NEUROSCI, V19, P835, DOI 10.1038/nn.4298; O'Donovan MC, 2016, NAT MED, V22, P1214, DOI 10.1038/nm.4196; Puchta O, 2016, SCIENCE, V352, P840, DOI 10.1126/science.aaf0965; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Sin O, 2015, CELL MOL LIFE SCI, V72, P4027, DOI 10.1007/s00018-015-1985-0; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1; Xiong Y., 2015, EXPERT OPIN INV DRUG, V1, P1; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3; Zeltner N, 2016, NAT MED, V22, P1421, DOI 10.1038/nm.4220	47	15	15	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 27	2017	7								6645	10.1038/s41598-017-06341-6			11	Multidisciplinary Sciences	Science & Technology - Other Topics	FB8CH	WOS:000406366000003	28751711	DOAJ Gold, Green Published			2021-06-18	
J	MacManus, DB; Pierrat, B; Murphy, JG; Gilchrist, MD				MacManus, David B.; Pierrat, Baptiste; Murphy, Jeremiah G.; Gilchrist, Michael D.			Protection of cortex by overlying meninges tissue during dynamic indentation of the adolescent brain	ACTA BIOMATERIALIA			English	Article						Dura mater; Traumatic brain injury; Viscoelasticity; Indentation; Characterization	P56 MOUSE-BRAIN; MECHANICAL-PROPERTIES; DURA-MATER; INJURY; HEAD; VISCOELASTICITY; BIOMECHANICS	Traumatic brain injury (TBI) has become a recent focus of biomedical research with a growing international effort targeting material characterization of brain tissue and simulations of trauma using computer models of the head and brain to try to elucidate the mechanisms and pathogenesis of TBI. The meninges, a collagenous protective tri-layer, which encloses the entire brain and spinal cord has been largely overlooked in these material characterization studies. This has resulted in a lack of accurate constitutive data for the cranial meninges, particularly under dynamic conditions such as those experienced during head impacts. The work presented here addresses this lack of data by providing for the first time, in situ large deformation material properties of the porcine dura-arachnoid mater composite under dynamic indentation. It is demonstrated that this tissue is substantially stiffer (shear modulus, mu = 19.10 +/- 8.55 kPa) and relaxes at a slower rate (tau(1) = 0.034 +/- 0.008 s, tau(2) = 0.336 +/- 0.077 s) than the underlying brain tissue (mu = 6.97 +/- 2.26 kPa, tau(1) = 0.021 +/- 0.007 s, tau(2) = 0.199 +/- 0.036 s), reducing the magnitudes of stress by 250% and 65% for strains that arise during indentation-type deformations in adolescent brains. Statement of Significance We present the first mechanical analysis of the protective capacity of the cranial meninges using in situ micro-indentation techniques. Force-relaxation tests are performed on in situ meninges and cortex tissue, under large strain dynamic micro-indentation. A quasi-linear viscoelastic model is used subsequently, providing time-dependent mechanical properties of these neural tissues under loading conditions comparable to what is experienced in TBI. The reported data highlights the large differences in mechanical properties between these two tissues. Finite element simulations of the indentation experiments are also performed to investigate the protective capacity of the meninges. These simulations show that the meninges protect the underlying brain tissue by reducing the overall magnitude of stress by 250% and up to 65% for strains. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[MacManus, David B.; Pierrat, Baptiste; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Murphy, Jeremiah G.] Dublin City Univ, Dept Mech & Mfg Engn, Dublin, Ireland; [Pierrat, Baptiste] Ecole Natl Super Mines, CIS EMSE, SAINBIOSE, F-42023 St Etienne, France; [Pierrat, Baptiste] INSERM, U1059, F-42000 St Etienne, France	Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	david.mac-manus@ucdconnect.ie; pierrat@emse.fr; jeremiah.murphy@dcu.ie; michael.gilchrist@ucd.ie		Pierrat, Baptiste/0000-0001-8064-8496; MacManus, David/0000-0003-2959-698X	Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/IP/1732]	The authors would like to acknowledge Dawn Pork & Bacon, Waterford, for supplying the porcine specimens. This work was made possible by Science Foundation Ireland (Grant No. 12/IP/1732).	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Antona-Makoshi J, 2012, P 2012 INT IRCOBI C, V2012, P441; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00257; Budday S, 2014, J MECH PHYS SOLIDS, V72, P75, DOI 10.1016/j.jmps.2014.07.010; Budday S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05644; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin B S, 2010, J BIOMECHANICAL ENG, V132, P1; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; England M.A., 1996, COLOUR ATLAS BRAIN S; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fiford RJ, 2005, J BIOMECH, V38, P1509, DOI 10.1016/j.jbiomech.2004.07.009; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P10976, DOI 10.1073/pnas.1309690110; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Haimann MCJ, 1998, J ANAT, V192, P99; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P911, DOI 10.1007/s00401-016-1565-x; Lejeune E, 2016, SOFT MATTER, V12, P5613, DOI 10.1039/c6sm00526h; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Maas S., 2015, FEBIO THEORY MANUAL, P94; MacManus DB, 2015, J BIOMECH, V48, P3213, DOI 10.1016/j.jbiomech.2015.06.028; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Mao H., J BIOMECH ENG, P135; Menard HP., 2008, DYNAMIC MECH ANAL PR; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Olivero WC, 2016, PEDIATR NEUROSURG, V51, P257, DOI 10.1159/000445900; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; PATIN DJ, 1993, ANESTH ANALG, V76, P535; Persson C, 2010, ANN BIOMED ENG, V38, P975, DOI 10.1007/s10439-010-9924-6; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; REILAND S, 1978, ACTA RADIOL DIAGN, P15; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sacks MS, 1998, J BIOMECH ENG-T ASME, V120, P541, DOI 10.1115/1.2798027; Shearer T, 2015, J BIOMECH, V48, P3017, DOI 10.1016/j.jbiomech.2015.07.032; Shetye SS, 2014, J MECH BEHAV BIOMED, V34, P146, DOI 10.1016/j.jmbbm.2014.02.014; Sim A., 2012, J NEUROSURG, V116, P511; Streitberger K., 2016, EUR RADIOL; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; van Noort R, 1981, Clin Phys Physiol Meas, V2, P197, DOI 10.1088/0143-0815/2/3/003; Wadsworth JDF, 2011, ACTA NEUROPATHOL, V121, P69, DOI 10.1007/s00401-010-0735-5; Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192; Willinger R, 1999, CR ACAD SCI II B, V327, P125, DOI 10.1016/S1287-4620(99)80021-0; Zhang HT, 2016, C PROC SOC EXP MECH, P99, DOI 10.1007/978-3-319-21455-9_11; Zhang M, 1997, MED ENG PHYS, V19, P512, DOI 10.1016/S1350-4533(97)00017-9	60	15	16	1	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JUL 15	2017	57						384	394		10.1016/j.actbio.2017.05.022			11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	EZ9HY	WOS:000405041900033	28501711				2021-06-18	
J	Wolf, JA; Johnson, BN; Johnson, VE; Putt, ME; Browne, KD; Mietus, CJ; Brown, DP; Wofford, KL; Smith, DH; Grady, MS; Cohen, AS; Cullen, DK				Wolf, John A.; Johnson, Brian N.; Johnson, Victoria E.; Putt, Mary E.; Browne, Kevin D.; Mietus, Constance J.; Brown, Daniel P.; Wofford, Kathryn L.; Smith, Douglas H.; Grady, M. Sean; Cohen, Akiva S.; Cullen, D. Kacy			Concussion Induces Hippocampal Circuitry Disruption in Swine	JOURNAL OF NEUROTRAUMA			English	Article						axonal pathology; concussion; epileptogenesis; hippocampus; mild TBI; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; AMYLOID PRECURSOR PROTEIN; CLOSED-HEAD-INJURY; COGNITIVE IMPAIRMENT; PYRAMIDAL CELLS; SODIUM-CHANNELS; AREA CA1; NEURONS; MEMORY	Hippocampal-dependent deficits in learning and memory formation are a prominent feature of traumatic brain injury (TBI); however, the role of the hippocampus in cognitive dysfunction after concussion (mild TBI) is unknown. We therefore investigated functional and structural changes in the swine hippocampus following TBI using a model of head rotational acceleration that closely replicates the biomechanics and neuropathology of closed-head TBI in humans. We examined neurophysiological changes using a novel ex vivo hippocampal slice paradigm with extracellular stimulation and recording in the dentate gyrus and CA1 occurring at 7 days following non-impact inertial TBI in swine. Hippocampal neurophysiology post-injury revealed reduced axonal function, synaptic dysfunction, and regional hyperexcitability at one week following even mild injury levels. Moreover, these neurophysiological changes occurred in the apparent absence of intra-hippocampal neuronal or axonal degeneration. Input-output curves demonstrated an elevated excitatory post-synaptic potential (EPSP) output for a given fiber volley input in injured versus sham animals, suggesting a form of homeostatic plasticity that manifested as a compensatory response to decreased axonal function in post-synaptic regions. These data indicate that closed-head rotational acceleration-induced TBI, the common cause of concussion in humans, may induce significant alterations in hippocampal circuitry function that have not resolved at 7 days post-injury. This circuitry dysfunction may underlie some of the post-concussion symptomatology associated with the hippocampus, such as post-traumatic amnesia and ongoing cognitive deficits.	[Wolf, John A.; Johnson, Victoria E.; Browne, Kevin D.; Mietus, Constance J.; Brown, Daniel P.; Wofford, Kathryn L.; Smith, Douglas H.; Grady, M. Sean; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Putt, Mary E.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wolf, John A.; Browne, Kevin D.; Brown, Daniel P.; Wofford, Kathryn L.; Cullen, D. Kacy] Corporal Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA USA; [Johnson, Brian N.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA	Cullen, DK (corresponding author), Univ Penn, Dept Neurosurg, Room 105,Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	dkacy@mail.med.upenn.edu	Wolf, John A/A-1034-2007	Wolf, John A/0000-0002-6950-2303; Wofford, Kathryn/0000-0002-0391-2641	National Institutes of Health [NINDS]United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS-050598, R01-NS-069629, T32-NS043126]; National Institutes of Health [NICHD]United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37-HD-059288]; National Institutes of Health [NICH] [U54 HD086984]; Department of Veterans Affairs [Rehabilitation Research & Development (Merit Review Award) [B1097-I]; Department of Veterans Affairs [Rehabilitation Research & Development (Career Development Award) [IK2-RX001479]; CURE Taking Flight Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD086984, R37HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126, R01NS050598, R01NS069629, R01NS101108] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001097, IK2RX001479] Funding Source: NIH RePORTER	We wish to thank Dr. William Stewart of the Dept. of Neuropathology and Glasgow TBI Archive, Southern General Hospital, Glasgow, United Kingdom for helpful advice and provision of immunohistochemical protocols. We wish to thank Professor Max Morris of the Department of Statistics, Iowa State University, for consultation on the statistical analyses. This work was made possible due to financial support provided by the National Institutes of Health [NINDS (R01-NS-050598, R01-NS-069629, T32-NS043126), NICHD (R37-HD-059288) & NICH (U54 HD086984)], the Department of Veterans Affairs [Rehabilitation Research & Development (Merit Review Award #B1097-I & Career Development Award #IK2-RX001479)], and the CURE Taking Flight Award.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akam T, 2014, NAT REV NEUROSCI, V15, P111, DOI 10.1038/nrn3668; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BRAAK H, 1992, NEUROSCI RES, V15, P6, DOI 10.1016/0168-0102(92)90014-4; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; Cullen D. K., 2016, INJURY MODELS CENTRA; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Dinocourt C, 2011, EPILEPSIA, V52, P1656, DOI 10.1111/j.1528-1167.2011.03113.x; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GIBSON KL, 1991, MICROSURG, V12, P80, DOI 10.1002/micr.1920120205; Golarai G, 2001, J NEUROSCI, V21, P8523; Graham R., 2014, SPORTS RELATED CONCU; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kirkby DL, 1998, EUR J NEUROSCI, V10, P823, DOI 10.1046/j.1460-9568.1998.00087.x; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LOMO T, 1971, EXP BRAIN RES, V12, P46; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morris M.D., 2011, DESIGN EXPT INTRO BA; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; R Core Team, 2018, R LANG ENV STAT COMP; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.3.CO;2-2; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	73	15	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2303	2314		10.1089/neu.2016.4848			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000013	28298170	Green Published			2021-06-18	
J	Rajajee, V; Fontana, RJ; Courey, AJ; Patil, PG				Rajajee, Venkatakrishna; Fontana, Robert J.; Courey, Anthony J.; Patil, Parag G.			Protocol based invasive intracranial pressure monitoring in acute liver failure: feasibility, safety and impact on management	CRITICAL CARE			English	Article						Fulminant hepatic failure; Hepatic encephalopathy; Cerebral edema; Intracranial hypertension; Intracranial hemorrhage	FULMINANT HEPATIC-FAILURE; RECOMBINANT FACTOR VIIA; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; ACTIVATED FACTOR-VII; CEREBRAL PERFUSION; TRANSPLANTATION; HYPERTENSION; ENCEPHALOPATHY; COMPLICATIONS	Background: Acute liver failure (ALF) may result in elevated intracranial pressure (ICP). While invasive ICP monitoring (IICPM) may have a role in ALF management, these patients are typically coagulopathic and at risk for intracranial hemorrhage (ICH). Contemporary ICP monitoring techniques and coagulopathy reversal strategies may be associated with a lower risk of hemorrhage. Our objective was to evaluate the safety, feasibility, impact on clinical management and outcomes associated with protocol-directed use of IICPM in ALF. Methods: Adult patients admitted between June 2011 and October 2016, with ALF and grade-4 encephalopathy with a reasonable likelihood of survival, were eligible for IICPM. The coagulopathy reversal protocol included administration of recombinant Factor VIIa (rFVIIa) and desmopressin, a goal platelet count > 50,000/mm(3) and fibrinogen > 100 mg/dL. Monitor insertion was performed within an hour of the rFVIIa dose. Only intraparenchymal monitors were used. Computed tomography of the brain was performed prior to and within 24 hours of monitor placement. Outcomes of interest included ICH, sustained intracranial hypertension, therapeutic intensity level (TIL) for ICP management, mortality and functional outcome on the Glasgow Outcome Scale (GOS) at discharge and 6 months. Results: A total of 24/37 patients (65%) with ALF underwent IICPM. The most common reason for exclusion was encephalopathy grade <4. Four patients underwent liver transplantation. There was one asymptomatic ICH following IICPM, in a patient who had an excellent outcome. Sustained intracranial hypertension occurred in 13/24 monitored patients (54%), 5/24 (21%) required extreme measures (TIL-4) for ICP control, which were successful in 4 patients: 12/24 patients (50%) died but only 4 deaths (17%) were attributed to intracranial hypertension. Six of the 8 survivors with 6-month follow up had good functional outcome (GOS > 3). Conclusions: Protocol-directed use of IICPM in ALF is feasible, associated with a low incidence of serious complications and has a significant impact on clinical management.	[Rajajee, Venkatakrishna] Univ Michigan, Dept Neurosurg, 3552 Taubman Hlth Care Ctr,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA; [Rajajee, Venkatakrishna] Univ Michigan, Dept Neurol, 3552 Taubman Hlth Care Ctr,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA; [Fontana, Robert J.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Courey, Anthony J.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Patil, Parag G.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA	Rajajee, V (corresponding author), Univ Michigan, Dept Neurosurg, 3552 Taubman Hlth Care Ctr,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.; Rajajee, V (corresponding author), Univ Michigan, Dept Neurol, 3552 Taubman Hlth Care Ctr,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	vrajajee@yahoo.com		Rajajee, Venkatakrishna/0000-0002-7183-8324			Aggarwal S, 2005, LIVER TRANSPLANT, V11, P1353, DOI 10.1002/lt.20479; Aggarwal S, 2008, LIVER TRANSPLANT, V14, P1048, DOI 10.1002/lt.21499; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Poca MA, 2007, J NEUROSURG, V106, P548, DOI 10.3171/jns.2007.106.4.548; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Bacher A, 2006, TRANSPLANT P, V38, P783, DOI 10.1016/j.transproceed.2006.01.073; Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Bernal W, 2016, J HEPATOL, V65, P273, DOI 10.1016/j.jhep.2016.03.003; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Bindi M L, 2008, J Clin Monit Comput, V22, P449, DOI 10.1007/s10877-008-9156-6; BLEI AT, 1993, LANCET, V341, P157, DOI 10.1016/0140-6736(93)90016-A; CANALESE J, 1982, GUT, V23, P625, DOI 10.1136/gut.23.7.625; Chan G, 2009, LIVER TRANSPLANT, V15, P1696, DOI 10.1002/lt.21931; Chavez-Tapia NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022581; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clevenger B, 2014, WORLD J GASTROENTERO, V20, P6146, DOI 10.3748/wjg.v20.i20.6146; DAVIES MH, 1994, LANCET, V343, P1329, DOI 10.1016/S0140-6736(94)92471-6; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; FORBES A, 1989, HEPATOLOGY, V10, P306, DOI 10.1002/hep.1840100309; HANID MA, 1980, GUT, V21, P866, DOI 10.1136/gut.21.10.866; Helmke K, 2000, TRANSPLANTATION, V70, P392, DOI 10.1097/00007890-200007270-00029; Jeffers L, 2002, GASTROENTEROLOGY, V123, P118, DOI 10.1053/gast.2002.34164; JENNETT B, 1975, LANCET, V1, P480; Kamat P, 2012, PEDIATR CRIT CARE ME, V13, pE33, DOI 10.1097/PCC.0b013e31820ac08f; Karvellas CJ, 2014, CRIT CARE MED, V42, P1157, DOI 10.1097/CCM.0000000000000144; Kawakami M, 2010, CLIN IMAG, V34, P327, DOI 10.1016/j.clinimag.2009.09.006; KEAYS RT, 1993, J HEPATOL, V18, P205, DOI 10.1016/S0168-8278(05)80247-8; Krishnamoorthy V, 2013, LIVER TRANSPLANT, V19, P246, DOI 10.1002/lt.23591; Krisl JC, 2011, ANN PHARMACOTHER, V45, P1433, DOI 10.1345/aph.1Q207; Larsen FS, 2016, J HEPATOL, V64, P69, DOI 10.1016/j.jhep.2015.08.018; Le TV, 2010, NEUROSURGERY, V66, P455, DOI 10.1227/01.NEU.0000365517.52586.A2; LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508; LIDOFSKY SD, 1992, HEPATOLOGY, V16, P1, DOI 10.1002/hep.1840160102; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Maloney PR, 2016, NEUROCRIT CARE, V25, P86, DOI 10.1007/s12028-016-0261-y; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Munoz SJ, 2008, NEUROCRIT CARE, V9, P103, DOI 10.1007/s12028-008-9087-6; MUNOZ SJ, 1991, HEPATOLOGY, V13, P209, DOI 10.1002/hep.1840130202; Paschoal FM, 2016, WORLD J HEPATOL, V8, P915, DOI 10.4254/wjh.v8.i22.915; Pavese P, 2005, CAN J ANAESTH, V52, P26, DOI 10.1007/BF03018576; Pham HP, 2014, CLIN APPL THROMB-HEM, V20, P607, DOI 10.1177/1076029614524621; Porte RJ, 2005, LIVER TRANSPLANT, V11, P872, DOI 10.1002/lt.20447; Rabinowich L, 2016, WORLD J GASTROENTERO, V22, P7595, DOI 10.3748/wjg.v22.i33.7595; Raghavan M, 2006, NEUROCRIT CARE, V4, P179, DOI 10.1385/NCC:4:2:179; Rajajee V, 2012, CRITICAL CARE, V16, P79; Raschke RA, 2008, CRIT CARE MED, V36, P2244, DOI 10.1097/CCM.0b013e31818029a3; Riordan SM, 2008, SEMIN LIVER DIS, V28, P137, DOI 10.1055/s-2008-1073113; Ryan JM, 2013, METAB BRAIN DIS, V28, P7, DOI 10.1007/s11011-012-9363-1; Shami VM, 2003, LIVER TRANSPLANT, V9, P138, DOI 10.1053/jlts.2003.50017; Shawcross DL, 2012, NEUROCHEM INT, V60, P662, DOI 10.1016/j.neuint.2011.10.006; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Tan WF, 2012, TRANSPLANTATION, V94, P768, DOI 10.1097/TP.0b013e3182620596; Vaquero J, 2005, LIVER TRANSPLANT, V11, P1581, DOI 10.1002/lt.20625; WARE AJ, 1971, GASTROENTEROLOGY, V61, P877; Zheng YY, 2012, NEUROCRIT CARE, V17, P77, DOI 10.1007/s12028-012-9721-1; 1991, LANCET, V338, P156	56	15	15	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	JUL 11	2017	21								178	10.1186/s13054-017-1762-6			13	Critical Care Medicine	General & Internal Medicine	FA7AK	WOS:000405596300001	28693567	DOAJ Gold, Green Published			2021-06-18	
J	Feng, Y; Gao, Y; Wang, T; Tao, LY; Qiu, SH; Zhao, XF				Feng, Yuan; Gao, Yuan; Wang, Tao; Tao, Luyang; Qiu, Suhao; Zhao, Xuefeng			A longitudinal study of the mechanical properties of injured brain tissue in a mouse model	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Biomechanics; Traumatic brain injury; Indentation; Mouse model; Longitudinal effects	MAGNETIC-RESONANCE ELASTOGRAPHY; CONTROLLED CORTICAL IMPACT; IN-VIVO; WHITE-MATTER; VISCOELASTIC PROPERTIES; LARGE-DEFORMATION; ANIMAL-MODEL; SIMPLE SHEAR; STRAIN-RATE; BEHAVIOR	Mechanical properties of brain tissue are crucial to understand the mechanism of traumatic brain injury (TBI). Over the past several decades, most of the studies focused on healthy brain tissues, while few of them are about the injured tissues. Therefore, limited knowledge is known about the mechanical properties of the injured brain tissues. In this study, we used an in vivo mouse model with a weight drop device to study injured brain tissues. Around the injury site, mechanical properties of the injured, neighboring, and the corresponding contralateral regions of interest (ROIs) were measured over five temporal points by indentation. Longitudinal and regional comparisons of the mechanical properties revealed that the ROI of the injured tissue had a higher elastic modulus than the contralateral counterpart one-hour post-injury. However, the elastic modulus decreased one day post-injury and recovered to be close to the contralateral ROI in 7 days. The elastic modulus curves of the injured and the contralateral counterpart ROIs crossed at time points of 12 h and 1 day post-injury, where two significant increases of glial fibrillary acidic protein (GFAP) positive cells were observed. Biological staining results indicated that both the astrocytic responses and the morphological structure could affect the mechanical properties of the injured tissue. The observed longitudinal changes of the mechanical properties at the tissue level and the morphological and biological changes at the cellular level provide insights into understanding the mechanism of TBI. Results are also meaningful for applying emerging in vivo diagnostic tools such as magnetic resonance elastography (MRE) in TBI detection.	[Feng, Yuan; Qiu, Suhao; Zhao, Xuefeng] Soochow Univ, Collaborat Innovat Ctr Radiol Med, Ctr Mol Imaging & Nucl Med, Jiangsu Higher Educ Inst,Sch Radiol & Interdiscip, Suzhou 215123, Jiangsu, Peoples R China; [Feng, Yuan; Qiu, Suhao; Zhao, Xuefeng] Soochow Univ, Sch Mech & Elect Engn, Suzhou 215021, Jiangsu, Peoples R China; [Gao, Yuan; Wang, Tao; Tao, Luyang] Soochow Univ, Dept Forens Sci, Suzhou 215021, Jiangsu, Peoples R China	Feng, Y (corresponding author), Soochow Univ, Ctr Mol Imaging & Nucl Med, Sch Radiol & Interdisciplinary Sci RAD X, 199 RenAiLu,401-1121, Suzhou 215021, Jiangsu, Peoples R China.	fengyuan@suda.edu.cn			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [61503267]; Jiangsu Province [BK20140356, 16KJB460018]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education MinistryScientific Research Foundation for the Returned Overseas Chinese Scholars [K511701515]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NSFCNational Natural Science Foundation of China (NSFC) [81530062]	Funding is provided by grant 61503267 (YF) from National Natural Science Foundation of China (NSFC), grant BK20140356 (YF) and 16KJB460018 (YF) from Jiangsu Province, and by grant K511701515 (YF) from Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. Support from Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and grant 81530062 (LT) from NSFC are also acknowledged. We thank Prof. Philip V. Bayly for helpful discussions and suggestions.	Alfasi AM, 2013, J NEUROSURG, V119, P1255, DOI 10.3171/2013.7.JNS121973; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Bayly PV, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/1/016005; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bayly PV, 2004, J NEUROTRAUM, V21, P1276; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Boulet T, 2011, J NEUROSCI METH, V201, P296, DOI 10.1016/j.jneumeth.2011.08.019; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Destrade M, 2015, INT J NONLIN MECH, V75, P54, DOI 10.1016/j.ijnonlinmec.2015.02.014; Elkin B.S., 2013, J BIOMECH ENG-T ASME, P135; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Kulkarni SG, 2016, MATH MECH SOLIDS, V21, P747, DOI 10.1177/1081286514536921; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Namani R, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006848; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2013, J BIOMECH, V46, P1276, DOI 10.1016/j.jbiomech.2013.02.014; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Schiavone P, 2009, MED IMAGE ANAL, V13, P673, DOI 10.1016/j.media.2009.04.001; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Suarez MW, 2015, ULTRASONICS, V61, P151, DOI 10.1016/j.ultras.2015.04.014; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Xu ZNS, 2014, J ULTRAS MED, V33, P1763, DOI 10.7863/ultra.33.10.1763; Zeng X, 2012, CURR GERIATR REP, V1, P167, DOI 10.1007/s13670-012-0018-1; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	62	15	17	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUL	2017	71						407	415		10.1016/j.jmbbm.2017.04.008			9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	EV6LM	WOS:000401880900045	28412646				2021-06-18	
J	Klein, P; Tyrlikova, I				Klein, Pavel; Tyrlikova, Ivana			Prevention of epilepsy: Should we be avoiding clinical trials?	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Seizures; Traumatic brain injury; Post-traumatic epilepsy; Epileptogenesis	TRAUMATIC BRAIN-INJURY; HIGH-FREQUENCY OSCILLATIONS; POSTTRAUMATIC EPILEPSY; STATUS EPILEPTICUS; GENETIC-VARIATION; KINDLING MODEL; EPILEPTOGENESIS; SEIZURES; LEVETIRACETAM; INFLAMMATION	Epilepsy prevention is one of the great unmet needs in epilepsy. Approximately 15% of all epilepsy is caused by an acute acquired CNS insult such as traumatic brain injury (TBI), stroke or encephalitis. There is a latent period between the insult and epilepsy onset that presents an opportunity to intervene with preventive treatment that is unique in neurology. Yet no phase 3 epilepsy prevention studies, and only 2 phase 2 studies have been initiated in the last 16 years. Current prevailing opinion is that the research community is not ready for clinical preventive epilepsy studies, and that animal models should first be refined and biomarkers of epileptogenesis and of epilepsy discovered before clinical studies are embarked upon. We review data to suggest that there is basis to do epilepsy prevention studies now with the current knowledge and available drugs, and that those studies are feasible with currently available tools. We suggest that a different approach is needed from the past in order to maximize chances of success, minimize the cost, and set up platform for future preventive treatment development. That approach should include close coordination of preclinical and clinical development programs in a combined PTE prevention strategy, consideration of polytherapy, and simultaneous, combined clinical development of preventive treatment and of biomarker discovery. We argue that the currently favored approach of eschewing clinical studies until biomarkers are available will delay the discovery of epilepsy prevention treatment by at least 10 years and significantly increase the cost of such discovery. (C) 2017 Elsevier Inc. All rights reserved.	[Klein, Pavel; Tyrlikova, Ivana] Midatlantic Epilepsy & Sleep Ctr, 6410 Rockledge Dr,Suite 410, Bethesda, MD 20817 USA	Klein, P (corresponding author), Midatlantic Epilepsy & Sleep Ctr, 6410 Rockledge Dr,Suite 410, Bethesda, MD 20817 USA.	kleinp@epilepsydc.com; tyrlikovai@epilepsydc.com			Esai; LundbeckLundbeck Corporation; Acorda, Inc.; Marinus; SK Life Sciences; UCB PharmaUCB Pharma SA; Upsher Smith	Dr. Klein has served on advisory boards of Lundbeck, Sunovion and UCB Pharma, has acted as a consultant to Eisai, Lundbeck, Sunovion and UCB Pharma, is on Speaker's Bureau of Eisai, Sunovion and UCB Pharma, has received research support from Esai and Lundbeck, and has participated in clinical trials sponsored by Acorda, Inc., Marinus, SK Life Sciences, UCB Pharma, and Upsher Smith.	Alves OL, 2003, ANN NY ACAD SCI, V993, P34; Amhaoul H, 2015, NEUROBIOL DIS, V82, P526, DOI 10.1016/j.nbd.2015.09.004; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2015, NAT NEUROSCI, V18, P317, DOI 10.1038/nn.3964; Bar-Klein G, 2014, ANN NEUROL, V75, P864, DOI 10.1002/ana.24147; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Brooks-Kayal AR, 2013, EPILEPSIA, V54, P44, DOI 10.1111/epi.12298; Chu K, 2008, EPILEPSIA, V49, P1723, DOI 10.1111/j.1528-1167.2008.01644.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Dedeurwaerdere S, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-60; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Dudek FE, 2012, TIME COURSE CIRCUIT; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; EPITARGET, TARG BIOM ANT; Finnema SJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6667; Galanopoulou AS, 2012, EPILEPSIA, V53, P571, DOI 10.1111/j.1528-1167.2011.03391.x; Gao F, 2012, PHARMACOL BIOCHEM BE, V103, P187, DOI 10.1016/j.pbb.2012.08.025; Gershen LD, 2015, JAMA NEUROL, V72, P882, DOI 10.1001/jamaneurol.2015.0941; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Guo J, 2015, NEUROLOGY, V85, P701, DOI 10.1212/WNL.0000000000001814; Gusakov I V, PATOL FIZIOL EKSP TE, P4; Hauser WA, 2003, EPILEPSIA, V44, P1, DOI 10.1046/j.1528-1157.44.s10.7.x; Hauser WA, PREVALENCE EPILEPSY, V32, P429; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Irlbacher K, 2002, ANN NEUROL, V52, P119, DOI 10.1002/ana.10229; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jones RT, 2015, EPILEPSIA, V56, P1879, DOI 10.1111/epi.13218; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Jung KH, 2011, EPILEPSIA, V52, P541, DOI 10.1111/j.1528-1167.2010.02916.x; Kaminski RM, 2014, NEUROTHERAPEUTICS, V11, P385, DOI 10.1007/s13311-014-0266-1; Klein P, 2012, ARCH NEUROL-CHICAGO, V69, P1290, DOI 10.1001/archneurol.2012.445; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Komatsu M, 2000, EPILEPSIA, V41, P1091, DOI 10.1111/j.1528-1157.2000.tb00312.x; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Ling D, 2009, LEVETIRACETAM PREVEN; Liu GM, 2013, NEURON, V79, P31, DOI 10.1016/j.neuron.2013.04.027; Loane D.J., 2015, NEUROPROTECTION TRAU, V127; Loscher W, 2015, EPILEPSY BEHAV, V49, P20, DOI 10.1016/j.yebeh.2015.02.027; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Loscher W, 2010, JASPERS BASIC MECH E, V51; Mani R, 2011, NEUROSCI LETT, V497, P251, DOI 10.1016/j.neulet.2011.03.010; Mazarati AM, 2004, EPILEPSY RES, V58, P167, DOI 10.1016/j.eplepsyres.2004.02.002; McDaniel SS, 2011, NEUROSCI LETT, V497, P231, DOI 10.1016/j.neulet.2011.02.037; Mishra M, 2013, EPILEPSY RES, V106, P83, DOI 10.1016/j.eplepsyres.2013.06.008; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Parent JM., 2012, NEUROGENESIS EPILEPS, V4; Pitkanen A., 2012, HEAD TRAUMA EPILEPSY; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pitkanen A, 2013, EPILEPSIA, V54, P35, DOI 10.1111/epi.12297; Prince D. A., 2012, TRAUMATIC BRAIN INJU; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Sandsmark DK, 2007, HISTOL HISTOPATHOL, V22, P895, DOI 10.14670/HH-22.895; Shafi MM, 2015, ANN NEUROL, V77, P487, DOI 10.1002/ana.24343; Shetty AK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00172; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; Simonato M, 2014, LANCET NEUROL, V13, P949, DOI 10.1016/S1474-4422(14)70076-6; Simonato M, 2012, EPILEPSIA, V53, P1860, DOI 10.1111/j.1528-1167.2012.03541.x; SUTULA T, 1992, J NEUROSCI, V12, P4173; Suzer T, 2000, RES EXP MED, V199, P223; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vezzani A, 2016, ACTA NEUROPATHOL, V131, P211, DOI 10.1007/s00401-015-1481-5; Weiss SA, 2016, EPILEPSIA, V57, P111, DOI 10.1111/epi.13251; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; White HS, 2014, NEUROTHERAPEUTICS, V11, P373, DOI 10.1007/s13311-013-0250-1; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Willmore LJ, 2012, EPILEPSY CURR, V12, P87, DOI 10.5698/1535-7511-12.3.87; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zeng YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140624; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	88	15	16	0	103	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JUL	2017	72						188	194		10.1016/j.yebeh.2017.05.024			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	FB7LE	WOS:000406321300032	28647441				2021-06-18	
J	Rokad, D; Ghaisas, S; Harischandra, DS; Jin, HJ; Anantharam, V; Kanthasamy, A; Kanthasamy, AG				Rokad, Dharmin; Ghaisas, Shivani; Harischandra, Dilshan S.; Jin, Huajun; Anantharam, Vellareddy; Kanthasamy, Arthi; Kanthasamy, Anumantha G.			Role of neurotoxicants and traumatic brain injury in alpha-synuclein protein misfolding and aggregation	BRAIN RESEARCH BULLETIN			English	Article						Alpha-synuclein; Pesticides; Metals; Protein aggregation; Traumatic brain injury; Oxidative stress; Parkinson disease; Neurodegenerative disease	ENVIRONMENTAL RISK-FACTORS; KINASE-C-DELTA; PARKINSONS-DISEASE; OXIDATIVE STRESS; LEWY BODIES; CELL-DEATH; IN-VITRO; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; DOPAMINERGIC DEGENERATION	Protein misfolding and aggregation are key pathological features of many neurodegenerative diseases including Parkinson's disease (PD) and other forms of human Parkinsonism. PD is a complex and multifaceted disorder whose etiology is not fully understood. However, several lines of evidence support the multiple hit hypothesis that genetic vulnerability and environmental toxicants converge to trigger PD pathology. Alpha-synuclein (alpha-Syn) aggregation in the brain is an important pathophysiological characteristic of synucleinopathies including PD. Epidemiological and experimental studies have shown that metals and pesticides play a crucial role in alpha-Syn aggregation leading to the onset of various neurodegenerative diseases including PD. In this review, we will emphasize key findings of several epidemiological as well as experimental studies of metal- and pesticide-induced alpha-Syn aggregation and neurodegeneration. We will also discuss other factors such as traumatic brain injury and oxidative insult in the context of alpha-Syn-related neurodegenerative processes. (C) 2016 Elsevier Inc. All rights reserved.	[Rokad, Dharmin; Ghaisas, Shivani; Harischandra, Dilshan S.; Jin, Huajun; Anantharam, Vellareddy; Kanthasamy, Arthi; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neuroroxicol, Parkinson Disorders Res Program, Ames, IA 50011 USA; [Harischandra, Dilshan S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, Parkinson Disorders Res Lab, 1222 Vet Med Bldg, Ames, IA 50011 USA.	akanthas@iastate.edu	Ghaisas, Shivani/AAO-7105-2020	Ghaisas, Shivani/0000-0001-7827-8190; Kanthasamy, Anumantha/0000-0002-6454-4264; Harischandra, Dilshan/0000-0003-3220-8765	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ES19267, ES26892, NS074443, ES10586, N5088206]; Linda Lloyd Endowed Chair; Syngenta Fellowship Award in Human Health Applications of New Technologies; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES010586, R01ES026892, R01ES019267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088206, R01NS074443] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health RO1 grants ES19267, ES26892, NS074443 and ES10586 awarded to A.G.K, and N5088206 to A.K. The W. Eugene and Linda Lloyd Endowed Chair to A.G.K, the Dean Endowed Professorship to AK and the Syngenta Fellowship Award in Human Health Applications of New Technologies to D.S.H. are also acknowledged. We also thank Mr. Gary Zenitsky for assistance in preparing this manuscript.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Askanas V, 2000, J NEUROPATH EXP NEUR, V59, P592, DOI 10.1093/jnen/59.7.592; Babadi VY, 2014, J TOXICOL-US, V2014, DOI 10.1155/2014/946372; Bates CA, 2015, ADMET DMPK, V3, P15, DOI 10.5599/admet.3.1.159; Bayer TA, 1999, NEUROSCI LETT, V266, P213, DOI 10.1016/S0304-3940(99)00311-0; Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Biasiotto G, 2016, MOL NEUROBIOL, V53, P5542, DOI 10.1007/s12035-015-9473-y; Bihaqi SW, 2013, NEUROTOXICOLOGY, V39, P95, DOI 10.1016/j.neuro.2013.07.010; Binolfi A, 2008, J AM CHEM SOC, V130, P11801, DOI 10.1021/ja803494v; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Binolfi Q. L., 2014, J BACTERIOL, V196, P3980; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; Cai TJ, 2010, BRAIN RES, V1359, P201, DOI 10.1016/j.brainres.2010.08.055; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Carboni E, 2015, METALLOMICS, V7, P395, DOI 10.1039/c4mt00339j; Chatterjee S, 2014, CHEM RES TOXICOL, V27, P1887, DOI 10.1021/tx500264s; Chen P., 2016, METALS NEURODEGENERA; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chun HS, 2001, J NEUROCHEM, V76, P1010, DOI 10.1046/j.1471-4159.2001.00096.x; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Cook C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009423; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Corrigan FM, 1996, HUM EXP TOXICOL, V15, P262, DOI 10.1177/096032719601500314; Corrigan FM, 1998, EXP NEUROL, V150, P339, DOI 10.1006/exnr.1998.6776; Corrigan FM, 2000, J TOXICOL ENV HEAL A, V59, P229, DOI 10.1080/009841000156907; Couraud PO, 1998, PATHOL BIOL, V46, P176; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Culvenor JG, 1999, AM J PATHOL, V155, P1173, DOI 10.1016/S0002-9440(10)65220-0; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Desai V, 2008, AM J CLIN NUTR, V88, p855S; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Di Monte DA, 2002, NEUROTOXICOLOGY, V23, P487, DOI 10.1016/S0161-813X(02)00099-2; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; Drew SC, 2008, J AM CHEM SOC, V130, P7766, DOI 10.1021/ja800708x; Du HN, 2006, FEBS LETT, V580, P3657, DOI 10.1016/j.febslet.2006.05.050; Dunning CJR, 2013, PRION, V7, P92, DOI 10.4161/pri.23806; Eid Aseel, 2016, Alzheimers Dement (Amst), V2, P123, DOI 10.1016/j.dadm.2016.02.002; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; ENZENAUER RW, 1989, JAMA-J AM MED ASSOC, V261, P1463, DOI 10.1001/jama.261.10.1463; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Febbraro F, 2012, NEUROREPORT, V23, P576, DOI 10.1097/WNR.0b013e328354a1f0; Feng LR, 2011, NEUROTOX RES, V20, P387, DOI 10.1007/s12640-011-9255-x; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Fukushima T, 2011, NEUROEPIDEMIOLOGY, V36, P240, DOI 10.1159/000328253; George W., 2002, GENOME BIOL, V3; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gorell JM, 1997, NEUROLOGY, V48, P650, DOI 10.1212/WNL.48.3.650; Gorojod RM, 2015, FREE RADICAL BIO MED, V87, P237, DOI 10.1016/j.freeradbiomed.2015.06.034; Ha Y, 2014, J NEUROSCI RES, V92, P359, DOI 10.1002/jnr.23323; Harischandra DS, 2015, TOXICOL SCI, V143, P454, DOI 10.1093/toxsci/kfu247; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hashimoto M, 1997, BIOCHEM BIOPH RES CO, V237, P611, DOI 10.1006/bbrc.1997.6978; Hatcher JM, 2007, EXP NEUROL, V204, P619, DOI 10.1016/j.expneurol.2006.12.020; He Q, 2013, INT J BIOCHEM CELL B, V45, P1019, DOI 10.1016/j.biocel.2013.02.012; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Ibanez P, 2009, ARCH NEUROL-CHICAGO, V66, P102, DOI 10.1001/archneurol.2008.555; Jackson MS, 2009, INORG CHEM, V48, P9303, DOI 10.1021/ic901157w; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Ji HJ, 1997, CANCER RES, V57, P759; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Jorgenson JL, 2001, ENVIRON HEALTH PERSP, V109, P113, DOI 10.2307/3434852; Kanthasamy AG, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-12; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Kitazawa M, 2003, NEUROSCIENCE, V119, P945, DOI 10.1016/S0306-4522(03)00226-4; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kwakye GF, 2015, INT J ENV RES PUB HE, V12, P7519, DOI 10.3390/ijerph120707519; Kwik-Uribe C, 2006, J NEUROSCI RES, V83, P1601, DOI 10.1002/jnr.20836; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Li Y, 2010, BRAIN RES BULL, V81, P428, DOI 10.1016/j.brainresbull.2009.11.007; Liang GQ, 2015, FOOD CHEM TOXICOL, V83, P261, DOI 10.1016/j.fct.2015.07.005; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez-Finley EJ, 2013, FREE RADICAL BIO MED, V62, P65, DOI 10.1016/j.freeradbiomed.2013.01.032; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Michalke B, 2014, J TRACE ELEM MED BIO, V28, P106, DOI 10.1016/j.jtemb.2013.08.005; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Navarro-Otano J, 2013, PARKINSONISM RELAT D, V19, P27, DOI 10.1016/j.parkreldis.2012.07.005; Negro A, 2001, FASEB J, V15, P210, DOI 10.1096/fj.01-0517fje; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Povlishock JT, 2008, J NEUROTRAUM, V25, P717, DOI 10.1089/neu.2008.9964; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Pyatigorskaya N, 2015, MOVEMENT DISORD, V30, P1077, DOI 10.1002/mds.26218; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Roth JA, 2014, NEUROTOXICOLOGY, V44, P314, DOI 10.1016/j.neuro.2014.08.006; RYBICKI BA, 1993, MOVEMENT DISORD, V8, P87, DOI 10.1002/mds.870080116; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saberzadeh J, 2016, BRAIN RES, V1635, P153, DOI 10.1016/j.brainres.2016.01.037; Sanchez-Ramos J, 1998, EXP NEUROL, V150, P263, DOI 10.1006/exnr.1997.6770; Schildknecht S, 2005, FASEB J, V19, P1169, DOI 10.1096/fj.04-3465fje; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Sheftel AD, 2012, BBA-GEN SUBJECTS, V1820, P161, DOI 10.1016/j.bbagen.2011.08.002; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Shin EC, 2000, MOL CELLS, V10, P65, DOI 10.1007/s10059-000-0065-x; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; SPILLANTINI MG, 1995, GENOMICS, V27, P379, DOI 10.1006/geno.1995.1063; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sun F, 2005, J PHARMACOL EXP THER, V315, P69, DOI 10.1124/jpet.105.084632; Surguchov A, 1999, MOL CELL NEUROSCI, V13, P95, DOI 10.1006/mcne.1999.0735; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tavassoly O, 2014, FEBS J, V281, P2738, DOI 10.1111/febs.12817; TOBE T, 1992, J NEUROCHEM, V59, P1624, DOI 10.1111/j.1471-4159.1992.tb10991.x; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Uversky VN, 2001, FEBS LETT, V500, P105, DOI 10.1016/S0014-5793(01)02597-2; Valensin D, 2016, J INORG BIOCHEM, V163, P292, DOI 10.1016/j.jinorgbio.2016.04.012; Verina T, 2013, TOXICOL LETT, V217, P177, DOI 10.1016/j.toxlet.2012.12.006; Villaran RF, 2010, J NEUROCHEM, V114, P1687, DOI 10.1111/j.1471-4159.2010.06879.x; Visanji Naomi P, 2013, Acta Neuropathol Commun, V1, P2, DOI 10.1186/2051-5960-1-2; Wang XY, 2010, J NEUROCHEM, V113, P704, DOI 10.1111/j.1471-4159.2010.06638.x; White AR, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00127; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Xiang W, 2013, MOL CELL NEUROSCI, V54, P71, DOI 10.1016/j.mcn.2013.01.004; Xu B, 2013, TOXICOLOGY, V305, P71, DOI 10.1016/j.tox.2013.01.006; Yuan YH, 2015, TOXICOL LETT, V233, P163, DOI 10.1016/j.toxlet.2014.11.029; Zarbiv Y, 2014, NEUROBIOL DIS, V70, P90, DOI 10.1016/j.nbd.2014.05.031; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang HY, 2013, BIOPHYS J, V104, P2706, DOI 10.1016/j.bpj.2013.04.050; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	151	15	15	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUL	2017	133				SI		60	70		10.1016/j.brainresbull.2016.12.003			11	Neurosciences	Neurosciences & Neurology	FH0ZR	WOS:000410869700007	27993598	Green Accepted			2021-06-18	
J	Werff, KRV; Rieger, B				Werff, Kathy R. Vander; Rieger, Brian			Brainstem Evoked Potential Indices of Subcortical Auditory Processing After Mild Traumatic Brain Injury	EAR AND HEARING			English	Article						Audiology; Auditory brainstem response; Auditory dysfunction; Central auditory processing; Concussion; Mild traumatic brain injury	CLOSED-HEAD INJURY; DIFFUSE AXONAL INJURY; POST-CONCUSSION SYNDROME; HEARING-LOSS; LEARNING-PROBLEMS; NERVOUS-SYSTEM; SPEECH; RESPONSES; DYSFUNCTION; CHILDREN	Objectives: The primary aim of this study was to assess subcortical auditory processing in individuals with chronic symptoms after mild traumatic brain injury (mTBI) by measuring auditory brainstem responses (ABRs) to standard click and complex speech stimuli. Consistent with reports in the literature of auditory problems after mTBI (despite normal-hearing thresholds), it was hypothesized that individuals with mTBI would have evidence of impaired neural encoding in the auditory brainstem compared to noninjured controls, as evidenced by delayed latencies and reduced amplitudes of ABR components. We further hypothesized that the speech-evoked ABR would be more sensitive than the click-evoked ABR to group differences because of its complex nature, particularly when recorded in a background noise condition. Design: Click- and speech-ABRs were collected in 32 individuals diagnosed with mTBI in the past 3 to 18 months. All mTBI participants were experiencing ongoing injury symptoms for which they were seeking rehabilitation through a brain injury rehabilitation management program. The same data were collected in a group of 32 age-and gender-matched controls with no history of head injury. ABRs were recorded in both left and right ears for all participants in all conditions. Speech-ABRs were collected in both quiet and in a background of continuous 20-talker babble ipsilateral noise. Peak latencies and amplitudes were compared between groups and across subgroups of mTBI participants categorized by their behavioral auditory test performance. Results: Click-ABR results were not significantly different between the mTBI and control groups. However, when comparing the control group to only those mTBI subjects with measurably decreased performance on auditory behavioral tests, small differences emerged, including delayed latencies for waves I, III, and V. Similarly, few significant group differences were observed for peak amplitudes and latencies of the speech-ABR when comparing at the whole group level but were again observed between controls and those mTBI subjects with abnormal behavioral auditory test performance. These differences were seen for the onset portions of the speech-ABR waveforms in quiet and were close to significant for the onset wave. Across groups, quiet versus noise comparisons were significant for most speech-ABR measures but the noise condition did not reveal more group differences than speech-ABR in quiet, likely because of variability and overall small amplitudes in this condition for both groups. Conclusions: The outcomes of this study indicate that subcortical neural encoding of auditory information is affected in a significant portion of individuals with long-term problems after mTBI. These subcortical differences appear to relate to performance on tests of auditory processing and perception, even in the absence of significant hearing loss on the audiogram. While confounds of age and slight differences in audiometric thresholds cannot be ruled out, these preliminary results are consistent with the idea that mTBI can result in neuronal changes within the subcortical auditory pathway that appear to relate to functional auditory outcomes. Although further research is needed, clinical audiological evaluation of individuals with ongoing post-mTBI symptoms is warranted for identification of individuals who may benefit from auditory rehabilitation as part of their overall treatment plan.	[Werff, Kathy R. Vander] Syracuse Univ, Dept Commun Sci & Disorders, Syracuse, NY USA; [Rieger, Brian] SUNY Upstate Med Univ, Dept Phys Med & Rehabil, Syracuse, NY 13210 USA	Werff, KRV (corresponding author), Dept Commun Sci & Disorders, 621 Skytop Rd,Suite 1200, Syracuse, NY 13244 USA.	kvander@syr.edu		Vander Werff, Kathy/0000-0003-0526-9490	National Institutes of Health/National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03 DC010246]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC010246] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health/National Institute on Deafness and Other Communication Disorders, R03 DC010246.	Ahadi M, 2014, INT J AUDIOL, V53, P243, DOI 10.3109/14992027.2013.866281; Aiken SJ, 2008, EAR HEARING, V29, P139, DOI 10.1097/AUD.0b013e31816453dc; American Academy of Audiology, 2010, CLIN PRACT GUID; American Congress of Rehabilitation Medicine (ACRM), 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American National Standards Institute, 2010, S361996 ANSI; American National Standards Institute, 2008, S311999 ANSI; Anderson S, 2012, J NEUROSCI, V32, P14156, DOI 10.1523/JNEUROSCI.2176-12.2012; Anderson S, 2011, EAR HEARING, V32, P750, DOI 10.1097/AUD.0b013e31822229d3; Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bergemalm PO, 2003, ACTA OTO-LARYNGOL, V123, P836, DOI 10.1080/00016480310002474; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Biasca N, 2007, PROG BRAIN RES, V161, P263, DOI 10.1016/S0079-6123(06)61019-4; BOHNEN N, 1993, ACTA NEUROL BELG, V93, P23; Murphy CFB, 2011, CLINICS, V66, P713, DOI 10.1590/S1807-59322011000400030; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; COCKRELL J L, 1992, Brain Injury, V6, P261, DOI 10.3109/02699059209029667; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fligor BJ, 2002, ARCH PHYS MED REHAB, V83, P141, DOI 10.1053/apmr.2002.26813; Flood GM, 2005, BRAIN INJURY, V19, P1019, DOI 10.1080/02699050500110223; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Green, 2004, GREENS MED SYMPTOM V; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; Gutierrez-Cadavid JE., 2005, IMAGING NERVOUS SYST, P869; HALL JW, 1983, OTOLARYNG HEAD NECK, V91, P50, DOI 10.1177/019459988309100110; Hayes EA, 2003, CLIN NEUROPHYSIOL, V114, P673, DOI 10.1016/S1388-2457(02)00414-5; Hornickel J, 2009, AUDIOL NEURO-OTOL, V14, P198, DOI 10.1159/000188533; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Johnson KL, 2008, J NEUROSCI, V28, P4000, DOI 10.1523/JNEUROSCI.0012-08.2008; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Katz J, 1991, Ann N Y Acad Sci, V620, P233; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Munjal SK, 2010, J TRAUMA, V68, P13, DOI 10.1097/TA.0b013e3181c9f274; Munjal SK, 2010, J NEUROTRAUM, V27, P309, DOI 10.1089/neu.2009.0957; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, V38, P275, DOI 10.1001/archneur.1981.00510050041004; OTTAVIANI F, 1986, ELECTROEN CLIN NEURO, V65, P196, DOI 10.1016/0168-5597(86)90054-7; Parbery-Clark A, 2011, EUR J NEUROSCI, V33, P549, DOI 10.1111/j.1460-9568.2010.07546.x; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; Russo N, 2004, CLIN NEUROPHYSIOL, V115, P2021, DOI 10.1016/j.clinph.2004.04.003; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; SCHOENHUBER R, 1988, J NEUROSURG, V68, P742, DOI 10.3171/jns.1988.68.5.0742; Song JH, 2006, AUDIOL NEURO-OTOL, V11, P233, DOI 10.1159/000093058; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; Tillman T. W., 1966, SAMTR6655 USAF SCH A; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tremblay KL, 2002, J SPEECH LANG HEAR R, V45, P564, DOI 10.1044/1092-4388(2002/045); Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Werff KRV, 2011, EAR HEARING, V32, P168, DOI 10.1097/AUD.0b013e3181f534b5; Wible B, 2004, BIOL PSYCHOL, V67, P299, DOI 10.1016/j.biopsycho.2004.02.002; Wible B, 2005, BRAIN, V128, P417, DOI 10.1093/brain/awh367; Wilson RH, 2007, J AM ACAD AUDIOL, V18, P813, DOI 10.3766/jaaa.18.10.2; Wilson RH, 2005, J REHABIL RES DEV, V42, P839, DOI 10.1682/JRRD.2005.01.0009; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	70	15	15	2	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-0202	1538-4667		EAR HEARING	Ear Hear.	JUL-AUG	2017	38	4					E200	E214		10.1097/AUD.0000000000000411			15	Audiology & Speech-Language Pathology; Otorhinolaryngology	Audiology & Speech-Language Pathology; Otorhinolaryngology	EY6VS	WOS:000404122300001	28319479	Green Accepted			2021-06-18	
J	Yee, MK; Janulewicz, PA; Seichepine, DR; Sullivan, KA; Proctor, SP; Krengel, MH				Yee, Megan K.; Janulewicz, Patricia A.; Seichepine, Daniel R.; Sullivan, Kimberly A.; Proctor, Susan P.; Krengel, Maxine H.			Multiple Mild Traumatic Brain Injuries Are Associated with Increased Rates of Health Symptoms and Gulf War Illness in a Cohort of 1990-1991 Gulf War Veterans	BRAIN SCIENCES			English	Article						mild traumatic brain injury; Gulf War Illness (GWI); chronic multisymptom illness; Gulf War	RECURRENT CONCUSSION; MULTISYMPTOM ILLNESS; COGNITIVE IMPAIRMENT; RISK-FACTORS; DEPRESSION; IMPACT; LIFE; EPIDEMIOLOGY; EXPOSURES	Recent research demonstrated a relation between traumatic brain injury (TBI), health symptoms and diagnosis of Gulf War Illness (GWI) in Gulf War Veterans, but no study has examined the impact of multiple mild TBIs (mTBIs). A total of 229 male Gulf War Veterans from the Ft Devens Cohort were categorized by a number of mTBIs reported. One-way ANOVA and chi-square test of independence were used to test for differences in total reported health symptoms and diagnosis of chronic multisymptom illness (CMI) or Kansas GWI criteria, two of the most common case definitions of GWI. A total of 72 veterans reported no mTBIs (31.4%), 26 reported one mTBI (11.4%), 25 reported two mTBIs (10.9%), and 106 veterans reported sustaining three or more mTBIs (46.3%). Veterans reporting two or more mTBIs (p < 0.01) or three or more mTBIs (p < 0.001) endorsed significantly higher rates of health symptoms than Veterans reporting no mTBIs. Significantly higher rates of CMI (p = 0.035) and Kansas GWI criteria (p < 0.001) were seen in the three or more mTBI group. Results suggest two mTBIs increase risk of health symptoms, but three mTBIs may be the threshold needed to sustain chronic symptom reporting needed for a formal diagnosis. These findings highlight the importance of implementing policies and procedures monitoring head injuries in military personnel.	[Yee, Megan K.] Boston VA Res Inst Inc, Boston, MA 02130 USA; [Janulewicz, Patricia A.; Sullivan, Kimberly A.; Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA; [Seichepine, Daniel R.] Univ New Hampshire, Neuropsychol Lab, Manchester, NH 03101 USA; [Proctor, Susan P.] US Army Res Inst Environm Med, Mil Performance Div, Natick, MA 01760 USA; [Proctor, Susan P.; Krengel, Maxine H.] VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA; [Krengel, Maxine H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Krengel, MH (corresponding author), VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA.; Krengel, MH (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	meganyee@bu.edu; paj@bu.edu; daniel.seichepine@unh.edu; tty@bu.edu; susan.p.proctor.civ@mail.mil; mhk@bu.edu		Sullivan, Kimberly/0000-0001-7940-6123	Department of Defense GWIRP grantUnited States Department of Defense [GW100046]	Department of Defense GWIRP grant to Krengel GW100046.	Abou-Donia MB, 2017, NEUROTOXICOL TERATOL, V61, P36, DOI 10.1016/j.ntt.2017.03.002; Center for Disease Control, 2003, REP CONGR MILD TRAUM; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Dursa EK, 2016, J OCCUP ENVIRON MED, V58, P41, DOI 10.1097/JOM.0000000000000627; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Institute of Medicine, 2014, CHRON MULT ILLN GULF; Institute of Medicine Gulf War and Health, 2010, UPD HLTH EFF SERV GU; Ismail K, 2011, OCCUP MED-OXFORD, V61, P483, DOI 10.1093/occmed/kqr086; Kelsall HL, 2009, AM J EPIDEMIOL, V170, P1048, DOI 10.1093/aje/kwp238; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Ozakinci G, 2006, ENVIRON HEALTH PERSP, V114, P1553, DOI 10.1289/ehp.9251; Proctor SP, 2001, MIL MED, V166, P510; Proctor SP, 2001, J OCCUP ENVIRON MED, V43, P259, DOI 10.1097/00043764-200103000-00014; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Research Advisory Committee on Gulf War Veterans' Illnesses (RAC-GWVI), 2013, GULF WAR ILLN HLTH G; Salamon R, 2006, INT J EPIDEMIOL, V35, P479, DOI 10.1093/ije/dyi318; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Smith BN, 2013, J OCCUP ENVIRON MED, V55, P116, DOI 10.1097/JOM.0b013e318270d709; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; VA/DoD, 2014, CLIN PRACT GUID MAN; White RF, 2001, AM J IND MED, V40, P42, DOI 10.1002/ajim.1070; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wolfe J, 1998, AM J IND MED, V33, P104, DOI 10.1002/(SICI)1097-0274(199802)33:2<104::AID-AJIM2>3.0.CO;2-Y; Wolfe J, 2002, J OCCUP ENVIRON MED, V44, P271, DOI 10.1097/00043764-200203000-00015; Yee MK, 2016, J HEAD TRAUMA REHAB, V31, P320, DOI 10.1097/HTR.0000000000000173; 1997, JAMA-J AM MED ASSOC, V277, P238, DOI DOI 10.1001/JAMA.1997.03540270064028	39	15	15	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JUL	2017	7	7							79	10.3390/brainsci7070079			10	Neurosciences	Neurosciences & Neurology	FD3PH	WOS:000407444400010	28698487	DOAJ Gold, Green Published			2021-06-18	
J	Taylor, JA; Rodgers, KM; Bercum, FM; Booth, CJ; Dudek, FE; Barth, DS				Taylor, Jeremy A.; Rodgers, Krista M.; Bercum, Florencia M.; Booth, Carmen J.; Dudek, F. Edward; Barth, Daniel S.			Voluntary Control of Epileptiform Spike-Wave Discharges in Awake Rats	JOURNAL OF NEUROSCIENCE			English	Article						absence; epilepsy; SWD	SPRAGUE-DAWLEY RATS; PHOTOTHROMBOTIC BRAIN INFARCTION; FLUID PERCUSSION INJURY; TEMPORAL-LOBE EPILEPSY; LONG-EVANS RATS; POSTTRAUMATIC EPILEPSY; ABSENCE SEIZURES; ANIMAL-MODELS; COMMON; EPILEPTOGENESIS	Genetically inherited absence epilepsy in humans is typically characterized by brief (seconds) spontaneous seizures, which involve spike-wave discharges (SWDs) in the EEG and interruption of consciousness and ongoing behavior. Genetic (inbred) models of this disorder in rats have been used to examine mechanisms, comorbidities, and antiabsence drugs. SWDs have also been proposed as models of complex partial seizures (CPSs) following traumatic brain injury (post-traumatic epilepsy). However, the ictal characteristics of these rat models, including SWDs and associated immobility, are also prevalent in healthy outbred laboratory rats. We therefore hypothesized that SWDs are not always associated with classically defined absence seizures or CPSs. To test this hypothesis, we used operant conditioning in male rats to determine whether outbred strains, Sprague Dawley and Long-Evans, and/or the inbred WAG/Rij strain (a rat model of heritable human absence epilepsy) could exercise voluntary control over these epileptiform events. We discovered that both inbred and outbred rats could shorten the duration of SWDs to obtain a reward. These results indicate that SWD and associated immobility in rats may not reflect the obvious cognitive/behavioral interruption classically associated with absence seizures or CPSs in humans. One interpretation of these results is that human absence seizures and perhaps CPSs could permit a far greater degree of cognitive capacity than often assumed and might be brought under voluntary control in some cases. However, these results also suggest that SWDs and associated immobility may be nonepileptic in healthy outbred rats and reflect instead voluntary rodent behavior unrelated to genetic manipulation or to brain trauma.	[Taylor, Jeremy A.; Rodgers, Krista M.; Bercum, Florencia M.; Barth, Daniel S.] Univ Colorado, Dept Psychol & Neurosci, Campus Box 345, Boulder, CO 80309 USA; [Booth, Carmen J.] Yale Univ, Dept Comparat Med, Sch Med, New Haven, CT 06520 USA; [Dudek, F. Edward] Univ Utah, Dept Neurosurg, Sch Med, Salt Lake City, UT 84108 USA	Barth, DS (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Campus Box 345, Boulder, CO 80309 USA.	daniel.barth@colorado.edu	Rodgers, Krista/AAC-5063-2020	BARTH, DANIEL/0000-0001-5474-1320; RODGERS, KRISTA/0000-0003-4393-6389; Booth, Carmen Jane/0000-0002-2153-738X	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [PR100040, EP150033]; Citizens United for Research in Epilepsy [7153]; Rugen Biomedical and Neurona Therapeutics; Epitel	This work was supported by the U.S. Army Medical Research and Material Command (Grants PR100040 and EP150033) and by Citizens United for Research in Epilepsy (Grant #7153).; F.E. Dudek has received consulting fees from Rugen Biomedical and Neurona Therapeutics. He has equity interest in and receives consultant fees from Epitel, a company that makes telemetric recording devices; however, this work did not use these devices. The other authors declare no competing financial interests.	ALDINIO C, 1985, METHOD FIND EXP CLIN, V7, P563; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blumenfeld H, 2005, PROG BRAIN RES, V150, P271, DOI 10.1016/S0079-6123(05)50020-7; Blumenfeld H, 2012, LANCET NEUROL, V11, P814, DOI 10.1016/S1474-4422(12)70188-6; BUZSAKI G, 1990, NEUROSCIENCE, V36, P1, DOI 10.1016/0306-4522(90)90345-5; BUZSAKI G, 1990, NEUROSCIENCE, V38, P323, DOI 10.1016/0306-4522(90)90031-X; Chipaux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058180; Coenen AML, 2003, BEHAV GENET, V33, P635, DOI 10.1023/A:1026179013847; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Hughes JR, 2009, EPILEPSY BEHAV, V15, P404, DOI 10.1016/j.yebeh.2009.06.007; KAPLAN BJ, 1985, EXP NEUROL, V88, P425, DOI 10.1016/0014-4886(85)90204-3; Kelly KM, 2006, EXP NEUROL, V201, P495, DOI 10.1016/j.expneurol.2006.05.006; Kelly Kevin M, 2004, Epilepsy Curr, V4, P176, DOI 10.1111/j.1535-7597.2004.04503.x; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; KLEINLOGEL H, 1985, NEUROPSYCHOBIOLOGY, V13, P206, DOI 10.1159/000118189; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Nandan M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036001; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Osterhagen L, 2010, EPILEPSY RES, V90, P75, DOI 10.1016/j.eplepsyres.2010.03.010; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; ROBINSON PF, 1980, BRAIN RES, V201, P452, DOI 10.1016/0006-8993(80)91052-5; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Sarkisova K, 2011, PROG NEURO-PSYCHOPH, V35, P854, DOI 10.1016/j.pnpbp.2010.11.010; SEMBA K, 1980, BRAIN RES, V195, P281, DOI 10.1016/0006-8993(80)90065-7; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Stefan H, 2008, EPILEPSY COMPREHANSI, P537; VANDERWOLF CH, 1975, J COMP PHYSIOL PSYCH, V88, P300, DOI 10.1037/h0076211; VANLUIJTELAAR ELJM, 1991, ELECTROEN CLIN NEURO, V79, P430, DOI 10.1016/0013-4694(91)90208-L; VERGNES M, 1982, NEUROSCI LETT, V33, P97, DOI 10.1016/0304-3940(82)90136-7; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107	37	15	15	0	4	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUN 14	2017	37	24					5861	5869		10.1523/JNEUROSCI.3235-16.2017			9	Neurosciences	Neurosciences & Neurology	EX4VC	WOS:000403232000008	28522734	Green Published, Bronze			2021-06-18	
J	Hall, AA; Mendoza, MI; Zhou, HB; Shaughness, M; Maudlin-Jeronimo, E; McCarron, RM; Ahlers, ST				Hall, Aaron A.; Mendoza, Mirian I.; Zhou, Hanbing; Shaughness, Michael; Maudlin-Jeronimo, Eric; McCarron, Richard M.; Ahlers, Stephen T.			Repeated Low Intensity Blast Exposure Is Associated with Damaged Endothelial Glycocalyx and Downstream Behavioral Deficits	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						blast; glycocalyx; behavioral deficits; traumatic brain injury; repeated low intensity	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; CEREBRAL-BLOOD-FLOW; RAT-BRAIN; IN-VIVO; MODEL; MICE; HYALURONIDASE; PRESSURE; SIZE	Current clinical research into mild traumatic brain injury (mTBI) has focused on white matter changes as identified by advanced MRI based imaging techniques. However, perivascular tau accumulation in the brains of individuals diagnosed with mTBI suggests that the vasculature plays a key role in the pathology. This study used a rat model to examine whether the endothelial glycocalyx, a layer of the vasculature responsible for sensing luminal shear forces, is damaged by exposure to repeated low intensity blast, and whether this layer is associated with observed behavioral deficits. The blast exposure used consisted of 12, 40 kPa blast exposures conducted with a minimum of 24 h between blasts. We found that repeated blast exposure reduced glycocalyx length and density in various brain regions indicating damage. This blast exposure paradigm was associated with a mild performance decrement in the Morris water maze (MWM) which assesses learning and memory. Administration of hyaluronidase, an enzyme that binds to and degrades hyaluronan (a major structural component of the glycocalyx) prior to blast exposure reduced the observed behavioral deficits and induced a thickening of the glycocalyx layer. Taken together these findings demonstrate that the endothelial glycocalyx degradation following repeated blast is associated with behavioral decrements which can be prevented by treatment with hyaluronidase.	[Hall, Aaron A.; Mendoza, Mirian I.; Zhou, Hanbing; Shaughness, Michael; Maudlin-Jeronimo, Eric; McCarron, Richard M.; Ahlers, Stephen T.] Naval Med Res Ctr, Neurotrauma Dept, Operat & Undersea Med, Silver Spring, MD 20910 USA	Hall, AA (corresponding author), Naval Med Res Ctr, Neurotrauma Dept, Operat & Undersea Med, Silver Spring, MD 20910 USA.	aaron.a.hall6.civ@mail.mil			DMRDP [D61_I_10_J6_243]	The views expressed here are those of the authors and do not necessarily reflect the official policy of position of the Department of the Navy, Department of Defense, nor the U.S. Government. This work was funded by the DMRDP award number D61_I_10_J6_243. This work was prepared as a part of official duties; Title 17 USC (sic) 105 provides that 'Copyright protection under this title is not available for any work of the U.S. Government.' Title 17 (sic) USC 101 defines a US Government work as a work prepared by a military service member of employee of the US Government as part of that person's official duties.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Eskens BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055399; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Landsverk SA, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/842545; Lennon FE, 2011, AM J CARDIOVASC DIS, V1, P200; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; McConnell ED, 2016, J CEREBR BLOOD F MET, V36, P1537, DOI 10.1177/0271678X15608389; Muckenschnabel I, 1998, CANCER LETT, V131, P71, DOI 10.1016/S0304-3835(98)00203-1; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sverrisson K, 2014, AM J PHYSIOL-RENAL, V307, pF1136, DOI 10.1152/ajprenal.00181.2014; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Vogel J, 2000, J CEREBR BLOOD F MET, V20, P1571, DOI 10.1097/00004647-200011000-00007; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043168	29	15	15	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JUN 9	2017	11								104	10.3389/fnbeh.2017.00104			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	EX2LK	WOS:000403057600001	28649193	DOAJ Gold, Green Published			2021-06-18	
J	Wang, ZJ; Wang, Q; Wang, CJ; Xu, XZ; Yu, HM				Wang, Zhijing; Wang, Qi; Wang, Cuijie; Xu, Xiuzhen; Yu, Hongmei			Tetramethylpyrazine attenuates periorbital allodynia and neuroinflammation in a model of traumatic brain injury	JOURNAL OF INFLAMMATION-LONDON			English	Article						Traumatic brain injury; Tetramethylpyrazine; Pain; Neuroinflammation	NEUROPATHIC PAIN; RAT; RECEPTORS; STRESS	Background: Traumatic brain injury (TBI) is a public health issue. As the major complaint in 51% of TBI patients, chronic pain is an important aspect in TBI treatment. Tetramethylpyrazine (TMP) is an important compound in Ligustrazine, an analgesic drug in traditional Chinese medicine, but its potential in relieving pain symptom in TBI has not been tested. We established a TBI mouse model with controlled cortical impact (CCI), and measured periorbital hypersensitivity with von Frey monofilaments. We examined activated microglia and astrocytes and the levels of substance P (SP) and inducible isoform of nitric oxide synthase (iNOS) with immunohistochemistry, measured mRNA and protein levels of proinflammatory cytokines with qPCR and enzyme-linked immunosorbent assay, respectively. Western blot was employed to detect molecules in NF-kappa B signaling pathway. Results: TMP significantly attenuated periorbital hypersensitivity in TBI mice. Within 3 days after CCI, TMP attenuated activation of microglia and astrocytes, levels of SP, iNOS, and CGRP in trigeminal pathway, and levels of proinflammatory cytokines (including IL-6, TNF-alpha, IL-12). In isolated microglia, TMP attenuated the effects of lipopolysaccharide on the phosphorylation of cytoplasmic IKKa/beta and IKB-a, and levels of nucleic p65. Conclusion: TMP reversed periorbital hypersensitivity by limiting neuroinflammation at the primary stage of TBI, and could be a promising drug for pain treatment in TBI.	[Wang, Zhijing; Wang, Cuijie] Cangzhou Cent Hosp, Operating Theatre, Brain Branch, Cangzhou City 061000, Hebei Province, Peoples R China; [Wang, Qi; Yu, Hongmei] Cangzhou Cent Hosp, Dept Anesthesiol, Brain Branch, Cangzhou City 061000, Hebei Province, Peoples R China; [Xu, Xiuzhen] Cangzhou Cent Hosp, Dept Neurosurg 4, Brain Branch, Cangzhou City 061000, Hebei Province, Peoples R China	Wang, ZJ (corresponding author), Cangzhou Cent Hosp, Operating Theatre, Brain Branch, Cangzhou City 061000, Hebei Province, Peoples R China.	zxyywzj@126.com			The Cangzhou Central Hospital Foundation	This study was supported by The Cangzhou Central Hospital Foundation.	Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Gao Y, 2008, BRAIN RES BULL, V77, P27, DOI 10.1016/j.brainresbull.2008.02.026; Gao Y, 2010, BURNS, V36, P127, DOI 10.1016/j.burns.2009.04.032; Hsieh T. H., 2016, CEREB CORTEX; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Leng YF, 2012, AM J CHINESE MED, V40, P1229, DOI 10.1142/S0192415X12500917; Liang SD, 2005, BRAIN RES, V1040, P92, DOI 10.1016/j.brainres.2005.01.076; Liang SD, 2004, BRAIN RES, V995, P247, DOI 10.1016/j.brainres.2003.09.070; Liang SD, 2010, NEUROCHEM INT, V57, P705, DOI 10.1016/j.neuint.2010.09.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nemzek JA, 2001, J IMMUNOL METHODS, V255, P149, DOI 10.1016/S0022-1759(01)00419-7; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Shao HK, 2015, MED SCI MONITOR, V21, P3704, DOI 10.12659/MSM.895362; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858	24	15	16	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1476-9255			J INFLAMM-LOND	J. Inflamm.-Lond.	JUN 8	2017	14								13	10.1186/s12950-017-0161-8			9	Immunology	Immunology	EX3YZ	WOS:000403171900001	28603455	DOAJ Gold, Green Published			2021-06-18	
J	Cardim, D; Schmidt, B; Robba, C; Donnelly, J; Puppo, C; Czosnyka, M; Smielewski, P				Cardim, Danilo; Schmidt, Bernhard; Robba, Chiara; Donnelly, Joseph; Puppo, Corina; Czosnyka, Marek; Smielewski, Peter			Transcranial Doppler Monitoring of Intracranial Pressure Plateau Waves	NEUROCRITICAL CARE			English	Article						Transcranial Doppler; Noninvasive ICP; Traumatic brain injury; ICP plateau waves	HEAD-INJURED PATIENTS; CEREBRAL PERFUSION-PRESSURE; BLOOD-FLOW; NONINVASIVE ASSESSMENT; ULTRASONOGRAPHY; HYDROCEPHALUS; HYPERTENSION; INFUSION; VOLUME; BRAIN	Background Transcranial Doppler (TCD) has been used to estimate ICP noninvasively (nICP); however, its accuracy varies depending on different types of intracranial hypertension. Given the high specificity of TCD to detect cerebrovascular events, this study aimed to compare four TCD-based nICP methods during plateau waves of ICP. Methods A total of 36 plateau waves were identified in 27 patients (traumatic brain injury) with TCD, ICP, and ABP simultaneous recordings. The nICP methods were based on: (1) interaction between flow velocity (FV) and ABP using a "black-box" mathematical model (nICP_BB); (2) diastolic FV (nICP_FV (d) ); (3) critical closing pressure (nICP_CrCP), and (4) pulsatility index (nICP_PI). Analyses focused on relative changes in time domain between ICP and noninvasive estimators during plateau waves and the magnitude of changes (a dagger between baseline and plateau) in real ICP and its estimators. A ROC analysis for an ICP threshold of 35 mmHg was performed. Results In time domain, nICP_PI, nICP_BB, and nICP_CrCP presented similar correlations: 0.80 +/- 0.24, 0.78 +/- 0.15, and 0.78 +/- 0.30, respectively. nICP_FV (d) presented a weaker correlation (R = 0.62 +/- 0.46). Correlations between a dagger ICP and a dagger nICP were better represented by nICP_CrCP and BB, R = 0.48, 0.44 (p < 0.05), respectively. nICP_FV (d) and PI presented nonsignificant a dagger correlations. ROC analysis showed moderate to good areas under the curve for all methods: nICP_BB, 0.82; nICP_FV (d) , 0.77; nICP_CrCP, 0.79; and nICP_PI, 0.81. Conclusion Changes of ICP in time domain during plateau waves were replicated by nICP methods with strong correlations. In addition, the methods presented high performance for detection of intracranial hypertension. However, absolute accuracy for noninvasive ICP assessment using TCD is still low and requires further improvement.	[Cardim, Danilo; Robba, Chiara; Donnelly, Joseph; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Schmidt, Bernhard] Univ Hosp Chemnitz, Dept Neurol, Chemnitz, Germany; [Robba, Chiara] Cambridge Univ NHS Fdn Trust, Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Puppo, Corina] Univ Republica, Sch Med Hosp, Montevideo, Uruguay; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland	Cardim, D (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge, England.	dac69@cam.ac.uk	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018; Robba, Chiara/AAS-7421-2020; Cardim, Danilo Augusto/B-8447-2012	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Cardim, Danilo Augusto/0000-0002-9261-1321; Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: Medline		AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Budohoski Karol P, 2012, Acta Neurochir Suppl, V114, P121, DOI 10.1007/978-3-7091-0956-4_22; Cardim D, 2016, ACTA NEUROCHIR, V158, P279, DOI 10.1007/s00701-015-2661-8; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka Marek, 2007, Neurosurg Focus, V22, pE10; DAHL A, 1992, STROKE, V23, P15, DOI 10.1161/01.STR.23.1.15; Eide PK, 2010, ACTA NEUROL SCAND, V122, P262, DOI 10.1111/j.1600-0404.2009.01304.x; HAYASHI M, 1987, J NEUROSURG, V67, P97, DOI 10.3171/jns.1987.67.1.0097; HAYASHI M, 1991, BRAIN, V114, P2681, DOI 10.1093/brain/114.6.2681; HAYASHI M, 1984, J NEUROSURG, V61, P30, DOI 10.3171/jns.1984.61.1.0030; Hosmer D, 1989, APPL LOGISTIC REGRES; Ibaraki M, 2007, J CEREBR BLOOD F MET, V27, P404, DOI 10.1038/sj.jcbfm.9600337; JANNY P, 1950, PRESSION INTRACRANIE; Kasprowicz Magdalena, 2012, Acta Neurochir Suppl, V114, P17, DOI 10.1007/978-3-7091-0956-4_4; KASUGA Y, 1987, J NEUROSURG, V66, P907, DOI 10.3171/jns.1987.66.6.0907; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Marmarelis P, 1978, ANAL PHYSL SYSTEMS; RENIER D, 1982, J NEUROSURG, V57, P370, DOI 10.3171/jns.1982.57.3.0370; Robin AX, 2013, PACKAGE PROC; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt B, 1999, J CEREBR BLOOD F MET, V19, P990, DOI 10.1097/00004647-199909000-00006; Schmidt B, 2000, J NEUROSURG, V92, P793, DOI 10.3171/jns.2000.92.5.0793; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; Varsos GV, 2015, J NEUROSURG, V123, P638, DOI 10.3171/2014.10.JNS14613; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9	35	15	15	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2017	26	3					330	338		10.1007/s12028-016-0356-5			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	EV9JA	WOS:000402101100003	28000131	Green Published, Other Gold			2021-06-18	
J	Chien, WC; Chung, CH; Lin, FH; Yeh, CB; Huang, SY; Lu, RB; Chang, HA; Kao, YC; Chiang, WS; Chou, YC; Tsao, CH; Wu, YF; Tzeng, NS				Chien, Wu-Chien; Chung, Chi-Hsiang; Lin, Fu-Huang; Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band; Chang, Hsin-An; Kao, Yu-Chen; Chiang, Wei-Shan; Chou, Yu-Ching; Tsao, Chang-Huei; Wu, Yung-Fu; Tzeng, Nian-Sheng			The risk of injury in adults with attention-deficit hyperactivity disorder: A nationwide, matched-cohort, population-based study in Taiwan	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Adults; Attention-deficit hyperactivity disorder; Injury; National Health Insurance Database	TRAUMATIC BRAIN-INJURY; DEFICIT/HYPERACTIVITY DISORDER; UNINTENTIONAL INJURY; LIFE-SPAN; FOLLOW-UP; ADHD; CHILDREN; COMORBIDITY; EFFICACY; METHYLPHENIDATE	Background: Few studies have investigated the risk of injuries associated with adults with attention-deficit hyperactivity disorder (ADHD), even though several studies have suggested a higher risk of injury in children and adolescents with ADHD. Aims: To investigate the risk of injury in adults with ADHD. Methods and procedures: We included 665 adults with ADHD from January 1, to December 31, 2000, and 1995 sex-, age- and index day-matched controls without ADHD from the Longitudinal Health Insurance Database (LHID) subset of the National Health Insurance Research Database in Taiwan. The Cox proportional hazard models were used to analyze the associations between the relevant demographics, and the psychiatric comorbidities and the risk of injury. Outcomes and results: The patients with ADHD had a 143% increased risk of overall injuries than the controls after considering all the confounding factors. In addition, the use of methylphenidate was associated with a 22.6% decrease in the risk of injuries in the patients with ADHD. Conclusions and implications: Our findings strongly support that adults with ADHD are at an increased risk of injury, and imply that methylphenidate therapy may attenuate this risk.	[Chien, Wu-Chien; Chung, Chi-Hsiang; Tsao, Chang-Huei; Wu, Yung-Fu] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang; Lin, Fu-Huang; Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band; Chang, Hsin-An; Kao, Yu-Chen; Chiang, Wei-Shan; Tzeng, Nian-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Taipei, Taiwan; [Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Div Clin Psychol, Tainan, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Coll Med, Dept Psychiat, Tainan, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan, Taiwan; [Lu, Ru-Band] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Miaoli County, Taiwan; [Chang, Hsin-An; Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan; [Kao, Yu-Chen] Triserv Gen Hosp, Natl Def Med Ctr, Song Shan Branch, Dept Psychiat, Taipei, Taiwan; [Chiang, Wei-Shan] Tamkang Univ, Dept & Inst Math, New Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan	Tzeng, NS (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Psychiat, 325,Sect 2,Cheng Kung Rd, Taipei 11490, Taiwan.	pierrens@mail.ndmctsgh.edu.tw		Chang, Hsin-An/0000-0001-5572-7109	Tri-Service General Hospital Research Foundation [TSGH-C105-003, TSGH-C105-130, TSGH-C106-002]	This study is funded by Tri-Service General Hospital Research Foundation (TSGH-C105-003, TSGH-C105-130, and TSGH-C106-002).	Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Cadman T, 2012, J AM ACAD CHILD PSY, V51, P879, DOI 10.1016/j.jaac.2012.06.017; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089867; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chinese hospital association, 2000, ICD 9 CM ENGL CHIN D; Chou IC, 2014, DEV MED CHILD NEUROL, V56, P1111, DOI 10.1111/dmcn.12501; Chou IC, 2013, J DEV BEHAV PEDIATR, V34, P181, DOI 10.1097/DBP.0b013e3182829f2b; Cumyn L, 2009, CAN J PSYCHIAT, V54, P673, DOI 10.1177/070674370905401004; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Dalsgaard S, 2014, J CHILD ADOL PSYCHOP, V24, P253, DOI 10.1089/cap.2013.0101; Ertan C, 2012, EMERG MED J, V29, P911, DOI 10.1136/emermed-2011-200298; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Groom MJ, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0566-y; Guo NW, 2016, J PEDIATR ORTHOP B, V25, P369, DOI 10.1097/BPB.0000000000000243; Hartman CA, 2016, NEUROSCI BIOBEHAV R, V71, P529, DOI 10.1016/j.neubiorev.2016.09.003; Hinshaw SP, 2012, J CONSULT CLIN PSYCH, V80, P1041, DOI 10.1037/a0029451; Hutchison SL, 2016, THER ADV PSYCHOPHARM, V6, P317, DOI 10.1177/2045125316647686; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Jensen PS, 2001, J AM ACAD CHILD PSY, V40, P147, DOI 10.1097/00004583-200102000-00009; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Lam L T, 2002, J Atten Disord, V6, P77, DOI 10.1177/108705470200600204; Lam LT, 2006, ACCIDENT ANAL PREV, V38, P1176, DOI 10.1016/j.aap.2006.05.004; Lam LT, 2005, J ADOLESCENT HEALTH, V36, P19, DOI 10.1016/j.jadohealth.2003.12.010; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Liang JA, 2011, CANCER EPIDEM BIOMAR, V20, P473, DOI 10.1158/1055-9965.EPI-10-1280; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; London AS, 2016, PREV MED, V90, P8, DOI 10.1016/j.ypmed.2016.06.021; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Marcus SC, 2008, J ATTEN DISORD, V12, P64, DOI 10.1177/1087054707305168; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Mota-Veloso I, 2016, INT J PAEDIATR DENT, V26, P471, DOI 10.1111/ipd.12222; Nag S, 1999, NEUROL INDIA, V47, P32; National Health Insurance Administration, 2013, NAT HLTH INS ADM INS; National Health Insurance Administration, 2008, REV REG MED REIMB NA, V2016; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Olazagasti M. A. Ramos, 2013, J AM ACAD CHILD ADOL, V52; Perroud N, 2014, J AFFECT DISORDERS, V168, P161, DOI 10.1016/j.jad.2014.06.053; Peterson K, 2008, PSYCHOPHARMACOLOGY, V197, P1, DOI 10.1007/s00213-007-0996-4; Santosh PJ, 2011, CNS DRUGS, V25, P737, DOI 10.2165/11593070-000000000-00000; Schwebel DC, 2002, J PEDIATR PSYCHOL, V27, P727, DOI 10.1093/jpepsy/27.8.727; Shyu YC, 2015, SCHIZOPHR RES, V168, P161, DOI 10.1016/j.schres.2015.08.033; Silva D, 2014, EUR CHILD ADOLES PSY, V23, P1043, DOI 10.1007/s00787-014-0545-8; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Sobanski E, 2006, EUR ARCH PSY CLIN N, V256, P26, DOI 10.1007/s00406-006-1004-4; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Spencer TJ, 2001, AM J PSYCHIAT, V158, P611, DOI 10.1176/appi.ajp.158.4.611; STONER HB, 1980, J ROY SOC MED, V73, P19; Swanson EN, 2014, J CHILD PSYCHOL PSYC, V55, P505, DOI 10.1111/jcpp.12193; Swensen A., 2004, J ADOLESC HLTH OFF P, V35, pe341; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Van Patten R, 2016, J CLIN EXP NEUROPSYC, V38, P12, DOI 10.1080/13803395.2015.1091064; Walker DJ, 2015, POSTGRAD MED, V127, P686, DOI 10.1080/00325481.2015.1081046; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85	62	15	15	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	JUN	2017	65						57	73		10.1016/j.ridd.2017.04.011			17	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	EZ4PT	WOS:000404695700006	28458048				2021-06-18	
J	Faria, LC; Gu, F; Parada, I; Barres, B; Luo, ZD; Prince, DA				Faria, Leonardo C.; Gu, Feng; Parada, Isabel; Barres, Ben; Luo, Z. David; Prince, David A.			Epileptiform activity and behavioral arrests in mice overexpressing the calcium channel subunit alpha 2 delta-1	NEUROBIOLOGY OF DISEASE			English	Article						Excitation; EEG; Synaptogenesis; Pyramidal cells; Astrocytes; Epilepsy; Epileptogenesis; Nonconvulsive; Neocortex	TEMPORAL-LOBE EPILEPSY; INJURED EPILEPTOGENIC NEOCORTEX; VESICULAR GLUTAMATE TRANSPORTERS; CELL AXON REORGANIZATION; CENTRAL-NERVOUS-SYSTEM; V PYRAMIDAL NEURONS; UP-REGULATION; IN-VITRO; SYNAPTIC CONNECTIVITY; ALPHA(2)DELTA SUBUNIT	The alpha2delta-1 subunit (alpha 2 delta-1) of voltage-gated calcium channels is a receptor for astrocyte-secreted thrombospondins that promote developmental synaptogenesis. Alpha2delta-1 receptors are upregulated in models of injury-induced peripheral pain and epileptogenic neocortical trauma associated with an enhancement of excitatory synaptic connectivity. These results lead to the hypothesis that overexpression of alpha 2 delta-1 alone in neocortex of uninjured transgenic (TG) mice might result in increased excitatory connectivity and consequent cortical hyperexcitability and epileptiform activity. Whole cell recordings from layer V pyramidal neurons in somatosensory cortical slices of TG mice showed increased frequency and amplitude of miniature and spontaneous EPSCs and prolonged bursts of polysynaptic EPSCs. Epileptiform field potentials were evoked in layers and V of brain slices from TG mice, but not controls. Dual immunoreactivity for Vglut-2 and PSD95 showed increased density of close appositions in TG mice compared to controls, suggesting an increased number of excitatory synapses. Video-EEG monitoring showed that 13/13 implanted TG mice aged >P21, but not controls, had frequent abnormal spontaneous epileptiform events, consisting of variable duration, high amplitude bi-hemispheric irregular bursts of delta activity, spikes and sharp waves lasting many seconds, with a variable peak frequency of similar to 1-3 Hz, associated with behavioral arrest. The epileptiform EEG abnormalities and behavioral arrests were reversibly eliminated by treatment with i.p. ethosuximide. Behavioral seizures, consisting of similar to 15-30 s duration episodes of rigid arched tail and head and body extension, followed by loss of balance and falling, frequently occurred in adult TG mice during recovery from isoflurane-induced anesthesia, but were rare in WT mice. Results show that over-expression of alpha 2 delta-1 subunits increases cortical excitatory connectivity and leads to neocortical hyperexcitability and epileptiform activity associated with behavioral arrests in adult TG mice. Similar increases in expression of alpha 2 delta-1 in models of cortical injury may play an important role in epileptogenesis. Significance: Binding of astrocytic-secreted thrombospondins to their alpha 2 delta-1 receptor facilitates excitatory synapse formation and excitatory transmission during cortical development and after injury. Upregulation of alpha 2 delta-1 is present in models of injury-induced pain and epileptogenic cortical trauma, along with many other molecular alterations. Here we show that overexpression of alpha 2 delta-1 alone in TG mice can enhance excitatory connectivity in neocortex and lead to neural circuit hyperexcitability and episodes of electrographic epileptiform activity, associated with behavioral arrests in transgenic mice. alpha 2 delta-1 is the high-affinity receptor for gabapentinoids and a potential target for prophylactic treatment of posttraumatic epilepsy and other disorders in which excessive aberrant excitatory connectivity is a pathophysiological feature. Published by Elsevier Inc.	[Faria, Leonardo C.; Gu, Feng; Parada, Isabel; Prince, David A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Barres, Ben] Stanford Univ, Dept Neurobiol, Howard Hughes Med Inst, Stanford Sch Med, Stanford, CA 94305 USA; [Luo, Z. David] Univ Calif Irvine, Irvine Med Ctr, Dept Pharmacol, Dept Anesthesiol & Perioperat Care, Orange, CA 92868 USA	Prince, DA (corresponding author), Stanford Univ, 300 Pasteur Dr SUMC RM MO16, Stanford, CA 94305 USA.	daprince@stanford.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12151, NS39579, NS090076, NS40135, NS064341]; Epilepsy Foundation of America/American Epilepsy Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090076] Funding Source: NIH RePORTER	Supported by NINDS grants NS12151, NS39579 and NS090076 (DAP); NS40135, NS064341 (ZDL) and a postdoctoral fellowship to LCF from the Epilepsy Foundation of America/American Epilepsy Society.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Boroujerdi A, 2008, PAIN, V139, P358, DOI 10.1016/j.pain.2008.05.004; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Buckmaster PS, 1997, J NEUROPHYSIOL, V77, P2685; Caraiscos VB, 2004, J NEUROSCI, V24, P8454, DOI 10.1523/JNEUROSCI.2063-04.2004; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; COULTER DA, 1989, NEUROSCI LETT, V98, P74, DOI 10.1016/0304-3940(89)90376-5; D'Arco M, 2015, J NEUROSCI, V35, P5891, DOI 10.1523/JNEUROSCI.3997-14.2015; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Dolphin A. C., 2012, JASPERS BASIC MECH E, V4th; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; Erickson JD, 2006, NEUROCHEM INT, V48, P643, DOI 10.1016/j.neuint.2005.12.029; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Faria LC, 2010, J NEUROPHYSIOL, V104, P280, DOI 10.1152/jn.00351.2010; FRANCK JE, 1988, J NEUROSCI, V8, P1991; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li HF, 2005, J NEUROPHYSIOL, V93, P146, DOI 10.1152/jn.00665.2004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; Loscher W, 2007, EPILEPSIA, V48, P1245, DOI 10.1111/j.1528-1167.2007.01093.x; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Ma YY, 2012, NEUROBIOL DIS, V47, P102, DOI 10.1016/j.nbd.2012.03.027; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Mountney A, 2013, J NEUROTRAUM, V30, P1973, DOI 10.1089/neu.2013.3001; Nahmani M, 2005, J COMP NEUROL, V484, P458, DOI 10.1002/cne.20505; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; Nishikawa K, 2000, ANESTHESIOLOGY, V92, P228, DOI 10.1097/00000542-200001000-00035; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; POULTON TJ, 1984, ANESTHESIOLOGY, V61, P471, DOI 10.1097/00000542-198410000-00022; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Rossi AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078516; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Salin P, 1995, J NEUROSCI, V15, P8234; SAYER RJ, 1990, NEUROSCI LETT, V120, P175, DOI 10.1016/0304-3940(90)90031-4; Su H, 2002, J NEUROSCI, V22, P3645; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Taylor CP, 2008, NEUROSCIENCE, V155, P510, DOI 10.1016/j.neuroscience.2008.05.053; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Williamson A, 1999, ANN NEUROL, V45, P92, DOI 10.1002/1531-8249(199901)45:1<92::AID-ART15>3.0.CO;2-N; Zhu WJ, 2000, J NEUROSCI, V20, P8925	67	15	16	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUN	2017	102						70	80		10.1016/j.nbd.2017.01.009			11	Neurosciences	Neurosciences & Neurology	ES1BG	WOS:000399262300007	28193459				2021-06-18	
J	Gangolli, M; Holleran, L; Kim, JH; Stein, TD; Alvarez, V; Mckee, AC; Brody, DL				Gangolli, Mihika; Holleran, Laurena; Kim, Joong Hee; Stein, Thor D.; Alvarez, Victor; Mckee, Ann C.; Brody, David L.			Quantitative validation of a nonlinear histology-MRI coregistration method using generalized Q-sampling imaging in complex human cortical white matter	NEUROIMAGE			English	Article						Diffusion MRI; Generalized Q-sampling Imaging; Radiological-Pathological Correlations; White Matter Injury; Chronic Traumatic Encephalopathy	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; EX-VIVO MRI; HEAD-INJURY; IN-VIVO; NERVOUS-SYSTEM; MOUSE MODEL; REGISTRATION; ENCEPHALOPATHY; TRACTOGRAPHY	Advanced diffusion MRI methods have recently been proposed for detection of pathologies such as traumatic axonal injury and chronic traumatic encephalopathy which commonly affect complex cortical brain regions. However, radiological-pathological correlations in human brain tissue that detail the relationship between the multi-component diffusion signal and underlying pathology are lacking. We present a nonlinear voxel based two dimensional coregistration method that is useful for matching diffusion signals to quantitative metrics of high resolution histological images. When validated in ex vivo human cortical tissue at a 250 x 250x 500 mu m spatial resolution, the method proved robust in correlations between generalized q-sampling imaging and histologically based white matter fiber orientations, with r=0.94 for the primary fiber direction and r=0.88 for secondary fiber direction in each voxel. Importantly, however, the correlation was substantially worse with reduced spatial resolution or with fiber orientations derived using a diffusion tensor model. Furthermore, we have detailed a quantitative histological metric of white matter fiber integrity termed power coherence capable of distinguishing architecturally complex but intact white matter from disrupted white matter regions. These methods may allow for more sensitive and specific radiological-pathological correlations of neurodegenerative diseases affecting complex gray and white matter.	[Gangolli, Mihika; Brody, David L.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA; [Holleran, Laurena; Kim, Joong Hee; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Stein, Thor D.; Alvarez, Victor; Mckee, Ann C.] Boston Univ, Sch Med, Boston Univ Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Stein, Thor D.; Alvarez, Victor; Mckee, Ann C.] VA Boston Healthcare Syst, Boston, MA USA; [Brody, David L.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA.; Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.; Brody, DL (corresponding author), Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu		Stein, Thor/0000-0001-6954-4477	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH UO1 NS086659]; Hope Center Alafi Neuroimaging Laboratory at Washington University in St. Louis [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, P30NS057105] Funding Source: NIH RePORTER	This work is supported by the National Institutes of Health [NIH UO1 NS086659]; the Hope Center Alafi Neuroimaging Laboratory at Washington University in St. Louis [P30 NS057105].	Amato SP, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00031; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Behrens T.E.J., 2014, MR DIFFUSION TRACTOG, P429; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bogoslovsky T., 2016, J NEUROTRAUMA; Breen MS, 2005, ANN BIOMED ENG, V33, P1100, DOI 10.1007/s10439-005-5778-8; Breen MS, 2005, COMPUT MED IMAG GRAP, V29, P405, DOI 10.1016/j.compmedimag.2005.04.006; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budde MD, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00003; Budde MD, 2012, NEUROIMAGE, V63, P1, DOI 10.1016/j.neuroimage.2012.06.042; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Choe AS, 2011, MAGN RESON IMAGING, V29, P683, DOI 10.1016/j.mri.2011.02.022; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; D'Arceuil HE, 2007, NEUROIMAGE, V35, P553, DOI 10.1016/j.neuroimage.2006.12.028; Dauguet J, 2007, J NEUROSCI METH, V164, P191, DOI 10.1016/j.jneumeth.2007.04.017; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Donahue CJ, 2016, J NEUROSCI, V36, P6758, DOI 10.1523/JNEUROSCI.0493-16.2016; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Edgar J.M., 2014, DIFFUSION MRI, P127; Gangolli M., 2015, NAT NEUR S MAR ANN L, pA54; Gonzalez R.C, 2009, DIGITAL IMAGE PROCES; GOSHTASBY A, 1988, IMAGE VISION COMPUT, V6, P255, DOI 10.1016/0262-8856(88)90016-9; Goubran M, 2015, J NEUROSCI METH, V241, P53, DOI 10.1016/j.jneumeth.2014.12.005; Goubran M, 2013, NEUROIMAGE, V83, P770, DOI 10.1016/j.neuroimage.2013.07.053; Hagmann P, 2006, NEUROIMAGE, V32, P665, DOI 10.1016/j.neuroimage.2006.02.043; Herrera J.J., 2016, J NEUROTRAUMA; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hubbard PL, 2014, DIFFUSION MRI, P453, DOI [10.1016/B978-0-12-396460-1.00020-2, DOI 10.1016/B978-0-12-396460-1.00020-2]; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.3.CO;2-H; Kier EL, 2004, AM J NEURORADIOL, V25, P670; Kim JH, 2007, NMR BIOMED, V20, P352, DOI 10.1002/nbm.1138; Lazebnik RS, 2003, IEEE T MED IMAGING, V22, P653, DOI 10.1109/TMI.2003.812246; LeBihan D, 1995, NMR BIOMED, V8, P375; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Nazaran A, 2016, J NEUROSCI METH, V261, P75, DOI 10.1016/j.jneumeth.2015.11.023; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Prins N, 2003, J OPT SOC AM A, V20, P401, DOI 10.1364/JOSAA.20.000401; Reich D.S., 2014, J NEUROPATHOL EXP NE, V73, P780; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Savaskan NE, 2009, CELL TISSUE RES, V337, P213, DOI 10.1007/s00441-009-0815-9; Schilling K, 2016, NEUROIMAGE, V129, P185, DOI 10.1016/j.neuroimage.2016.01.022; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Suri S, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0475-3; Thelwall PE, 2006, MAGN RESON MED, V56, P282, DOI 10.1002/mrm.20962; Wang Y, 2015, BRAIN, V138, P1223, DOI 10.1093/brain/awv046; Weiss M, 2015, BRAIN STRUCT FUNCT, V220, P1695, DOI 10.1007/s00429-014-0754-4; White E, 2011, J NEUROSCI METH, V195, P78, DOI 10.1016/j.jneumeth.2010.10.023; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Zagorchev L, 2006, IEEE T IMAGE PROCESS, V15, P529, DOI 10.1109/TIP.2005.863114; Zarow C, 2004, J NEUROSCI METH, V139, P209, DOI 10.1016/j.jneumeth.2004.04.034; Zemmoura I, 2014, NEUROIMAGE, V103, P106, DOI 10.1016/j.neuroimage.2014.09.016	70	15	15	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JUN	2017	153						152	167		10.1016/j.neuroimage.2017.03.059			16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EX6XD	WOS:000403384500013	28365421	Green Accepted			2021-06-18	
J	Krishna, G; Agrawal, R; Zhuang, YM; Ying, Z; Paydar, A; Harris, NG; Royes, LFF; Gomez-Pinilla, F				Krishna, Gokul; Agrawal, Rahul; Zhuang, Yumei; Ying, Zhe; Paydar, Afshin; Harris, Neil G.; Royes, Luiz Fernando F.; Gomez-Pinilla, Fernando			7,8-Dihydroxyflavone facilitates the action exercise to restore plasticity and functionality: Implications for early brain trauma recovery	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						7,8-Dihydroxyflavone; Exercise; Memory; Traumatic brain injury; Functional connectivity; Rehabilitation	SPATIAL MEMORY DEFICITS; TRKB RECEPTOR; AGONIST 7,8-DIHYDROXYFLAVONE; MITOCHONDRIAL BIOGENESIS; COGNITIVE IMPAIRMENT; DOPAMINERGIC-NEURONS; CREB PHOSPHORYLATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; INJURY	Metabolic dysfunction accompanying traumatic brain injury (TBI) severely impairs the ability of injured neurons to comply with functional demands. This limits the success of rehabilitative strategies by compromising brain plasticity and function, and highlights the need for early interventions to promote energy homeostasis. We sought to examine whether the TrkB agonist, 7,8-dihydroxyflavone (7,8-DHF) normalizes brain energy deficits and reestablishes more normal patterns of functional connectivity, while enhancing the effects of exercise during post-TBI period. Moderate fluid percussion injury (FPI) was performed and 7,8-DHF (5 mg/kg, i.p.) was administered in animals subjected to FPI that either had access to voluntary wheel running for 7 days after injury or were sedentary. Compared to sham-injured controls, TBI resulted in reduced hippocampal activation of the BDNF receptor TrkB and associated CREB, reduced levels of plasticity markers GAP-43 and Syn I, as well as impaired memory as indicated by the Barnes maze task. While 7,8-DHF treatment and exercise individually mitigated TBI-induced effects, administration of 7,8-DHF concurrently with exercise facilitated memory performance and augmented levels of markers of cell energy metabolism viz., PGC-1 alpha, COII and AMPK. In parallel to these findings, resting-state functional MRI (fMRI) acquired at 2 weeks after injury showed that 7,8-DHF with exercise enhanced hippocampal functional connectivity, and suggests 7,8-DHF and exercise to promote increases in functional connectivity. Together, these findings indicate that post-injury 7,8-DHF treatment promotes enhanced levels of cell metabolism, synaptic plasticity in combination with exercise increases in brain circuit function that facilitates greater physical rehabilitation after TBI.	[Krishna, Gokul; Agrawal, Rahul; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Zhuang, Yumei; Paydar, Afshin; Harris, Neil G.; Gomez-Pinilla, Fernando] UCLA, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA; [Royes, Luiz Fernando F.] Univ Fed Santa Maria, Ctr Phys Educ & Sports CEFD, Exercise & Biochem Lab, Santa Maria, RS, Brazil	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Gokul, Krishna/H-3365-2019	Gokul, Krishna/0000-0001-5869-2204; Harris, Neil/0000-0002-1965-6750; Agrawal, Rahul/0000-0001-8128-3724	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050465, NS091222]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465, R01NS091222] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant NS050465 and NS091222.	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Arbat-Plana A., 2016, NEUROSCIENCE; Bernard-Gauthier V, 2013, BIOORGAN MED CHEM, V21, P7816, DOI 10.1016/j.bmc.2013.10.012; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Han M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36087; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; He JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34339; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; John JPP, 2009, HIPPOCAMPUS, V19, P731, DOI 10.1002/hipo.20553; Juan WS, 2014, J PINEAL RES, V56, P213, DOI 10.1111/jpi.12114; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Liu CY, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-015-0048-7; Liu X, 2014, J BIOL CHEM, V289, P27571, DOI 10.1074/jbc.M114.562561; Makela J, 2016, NEUROPHARMACOLOGY, V102, P266, DOI 10.1016/j.neuropharm.2015.11.020; Marte A., 2016, MOL NEUROBIOL; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Porte Y, 2008, NEUROBIOL AGING, V29, P1533, DOI 10.1016/j.neurobiolaging.2007.03.023; Ren Q, 2013, PHARMACOL BIOCHEM BE, V106, P124, DOI 10.1016/j.pbb.2013.03.016; Sanz-Garcia A, 2016, HIPPOCAMPUS, V26, P1179, DOI 10.1002/hipo.22599; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Shama S., 2010, EXP NEUROL, V226, P191; Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Thomason ME, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.055.2009; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	53	15	16	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	JUN	2017	1863	6					1204	1213		10.1016/j.bbadis.2017.03.007			10	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ4TE	WOS:000404704600005	28315455	Green Accepted, Bronze			2021-06-18	
J	Yang, WJ; Chen, W; Chen, L; Guo, YJ; Zeng, JS; Li, GY; Tong, WS				Yang, W-J.; Chen, W.; Chen, L.; Guo, Y-J.; Zeng, J-S.; Li, G-Y.; Tong, W-S.			Involvement of tau phosphorylation in traumatic brain injury patients	ACTA NEUROLOGICA SCANDINAVICA			English	Article						cognitive impairment; GSK-3; PP2A; tau phosphorylation; traumatic brain injury	CSF TOTAL TAU; ALZHEIMERS-DISEASE; COGNITIVE DYSFUNCTION; PROTEIN PHOSPHATASES; CEREBROSPINAL-FLUID; HEAD-INJURY; BIOMARKERS; DISORDERS; TAUOPATHY; PATHOLOGY	ObjectivesTraumatic brain injury (TBI) results in significant morbidity and mortality throughout the world. In TBI patients suffering cognitive, emotional, and behavioral deficits, the leading cause derives from the physical injury to the central nervous system (CNS) that impairs brain function. Materials and MethodsHere, we applied a targeted approach to understand the potential mechanisms of neuron damage after TBI. Tau protein phosphorylation was compared in the brain tissues collected from patients underwent brain surgery based on the assessment of brain injury extent by Glasgow Coma Scale (GCS). ResultsThe results indicated that the levels of phosphorylated tau were significantly higher in the severe and extremely severe TBI groups, compared to the moderate group of patients. Phosphorylated, but not the total tau protein was uniquely correlated with the GCS score (R-2=.7849, P<.01) in 142 TBI patients. Consistently, the activities of key players associated with tau hyperphosphorylation GSK-3 and PP2A showed parallel correlations with the severity of TBI as well. ConclusionThese data suggest that the enhanced tau protein phosphorylation occurs upon severe neuron injures and may contribute to the pathological structural changes of CNS leading to brain damage of TBI.	[Yang, W-J.; Chen, W.; Chen, L.; Guo, Y-J.; Zeng, J-S.; Li, G-Y.; Tong, W-S.] Peoples Hosp Pudong New Area, Dept Neurosurg, Shanghai, Peoples R China	Tong, WS (corresponding author), Peoples Hosp Pudong New Area, Dept Neurosurg, Shanghai, Peoples R China.	tongwusongws@sina.com			Health Planning Commission Project of Pudong New Area Shanghai [PKJ2015-Y45]; Additional Subject of Pudong New Area Key Construction Project [PWZz2013-13]	None of the authors have potential conflict of interests to be disclosed. This work was supported by the following funding: the Health Planning Commission Project of Pudong New Area Shanghai (PKJ2015-Y45) and the Additional Subject of Pudong New Area Key Construction Project (PWZz2013-13).	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Blennow K, 2001, MOL NEUROBIOL, V24, P87, DOI 10.1385/MN:24:1-3:087; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kins S, 2001, J BIOL CHEM, V276, P38193; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Metcalfe MJ, 2010, MT SINAI J MED, V77, P50, DOI 10.1002/msj.20163; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Wang JW, 2016, EXP THER MED, V11, P1147, DOI 10.3892/etm.2016.3017; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zheng P, 2015, ARCH MED SCI, V11, P696, DOI 10.5114/aoms.2015.52380	25	15	15	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	JUN	2017	135	6					622	627		10.1111/ane.12644			6	Clinical Neurology	Neurosciences & Neurology	ET3DJ	WOS:000400157100005	27439764				2021-06-18	
J	Sussman, D; da Costa, L; Chakrayarty, MM; Pang, EW; Taylor, MJ; Dunkley, BT				Sussman, Dafna; da Costa, Leodante; Chakrayarty, Mallar M.; Pang, Elizabeth W.; Taylor, Margot J.; Dunkley, Benjamin T.			Concussion induces focal and widespread neuromorphological changes	NEUROSCIENCE LETTERS			English	Article						Concussion; MRI; Cortical thickness; Cortical volume; Cerebellum	TRAUMATIC BRAIN-INJURY; MILD; MRI; SEGMENTATION; CONNECTIVITY; HIPPOCAMPUS; CORTEX	Concussion induces transient, and oftentimes chronic, lingering impairment to mental functioning, which must be driven by some underlying neurobiological perturbation - however, the physical changes related to sequelae are difficult to detect. Previous imaging studies on concussion have focused on alterations to cortical anatomy, but few have examined the cerebrum, subcortex, and cerebellum. Here, we present an analysis of these structures in a single cohort (all males, 21 patients, 22 controls) using MRI and diagnosed with a single-concussive episode in the acute and sub-acute stages of injury. Structural images were segmented into 78 cortical brain regions and 81,924 vertices using the CIVET algorithm. Sub cortical volumetric analyses of the cerebellum, thalamus, globus pallidus, caudate and putamen were conducted following segmentation. Participants with concussion were found to have reduced white and grey matter volume, total cortical volume, as well as cortical thinning, primarily in left frontal areas. No differences were observed in the cerebellum or subcortical structures. In conclusion, just a single concussive episode induces measurable changes in brain structure manifesting as diffuse and local patterns of altered neuromorphometry. Crown Copyright (C) 2017 Published by Elsevier Ireland Ltd.	[Sussman, Dafna] Hosp Sick Children, Physiol & Expt Med, Toronto, ON, Canada; [da Costa, Leodante] Sunnybrook Med Ctr, Div Neurosurg, Toronto, ON, Canada; [Chakrayarty, Mallar M.] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Montreal, PQ, Canada; [Chakrayarty, Mallar M.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Chakrayarty, Mallar M.] McGill Univ, Dept Biol & Biomed Engn, Montreal, PQ, Canada; [Pang, Elizabeth W.] Hosp Sick Children, Neurol, Toronto, ON, Canada; [Taylor, Margot J.; Dunkley, Benjamin T.] Hosp Sick Children, Diagnost Imaging, Toronto, ON, Canada; [Dunkley, Benjamin T.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada	Dunkley, BT (corresponding author), Hosp Sick Chidlren, Dept Diagnost Imaging, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ben.dunkley@sickkids.ca		Dunkley, Ben/0000-0001-6173-1171	Defence Research and Development Canada [W7719-135182/001/TOR]	This study was supported by a Defence Research and Development Canada contract (W7719-135182/001/TOR) to MJT and EWP.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benjamini Y, 2001, ANN STAT, V29, P1165; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chakravarty MM, 2006, LECT NOTES COMPUT SC, V4191, P389; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Collins DL, 2010, NEUROIMAGE, V52, P1355, DOI 10.1016/j.neuroimage.2010.04.193; Costa L. da, 2014, J NEUROL NEUROSUR PS, P1; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Evaluation S., 2009, BRIT J SPORT MED, V43, P1; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132093, 10.3171/2013.12.JNS132090]; Hovda D.A., 2016, CONCUSSION, V2012, P28; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Misic B, 2016, J NEUROSCI, V36, P419, DOI 10.1523/JNEUROSCI.1506-15.2016; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Pang E.W., 2015, ANN CLIN TRANSL NEUR; Park MTM, 2014, NEUROIMAGE, V95, P217, DOI 10.1016/j.neuroimage.2014.03.037; Pipitone J, 2014, NEUROIMAGE, V101, P494, DOI 10.1016/j.neuroimage.2014.04.054; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUTHERFORD WH, 1977, LANCET, V1, P1; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; TEASDALE G, 1974, LANCET, V2, P81; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wechsler D., 2011, WECHLSER ABBREVIATED; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	55	15	15	0	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 22	2017	650						52	59		10.1016/j.neulet.2017.04.026			8	Neurosciences	Neurosciences & Neurology	EW2XK	WOS:000402359100009	28428014	Other Gold			2021-06-18	
J	Yap, YC; King, AE; Guijt, RM; Jiang, TC; Blizzard, CA; Breadmore, MC; Dickson, TC				Yap, Yiing C.; King, Anna E.; Guijt, Rosanne M.; Jiang, Tongcui; Blizzard, Catherine A.; Breadmore, Michael C.; Dickson, Tracey C.			Mild and repetitive very mild axonal stretch injury triggers cystoskeletal mislocalization and growth cone collapse	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; TRANSGENIC MOUSE MODEL; COGNITIVE IMPAIRMENT; MICROTUBULES; DEGENERATION; TRANSPORT; NEUROFILAMENTS; VULNERABILITY; CYTOSKELETAL; REGENERATION	Diffuse axonal injury is a hallmark pathological consequence of non-penetrative traumatic brain injury (TBI) and yet the axonal responses to stretch injury are not fully understood at the cellular level. Here, we investigated the effects of mild (5%), very mild (0.5%) and repetitive very mild (2x0.5%) axonal stretch injury on primary cortical neurons using a recently developed compartmentalized in vitro model. We found that very mild and mild levels of stretch injury resulted in the formation of smaller growth cones at the tips of axons and a significantly higher number of collapsed structures compared to those present in uninjured cultures, when measured at both 24 h and 72 h post injury. Immunocytochemistry studies revealed that at 72 h following mild injury the axonal growth cones had a significantly higher colocalization of ss III tubulin and F-actin and higher percentage of collapsed morphology than those present following a very mild injury. Interestingly, cultures that received a second very mild stretch injury, 24 h after the first insult, had a further increased proportion of growth cone collapse and increased ss III tubulin and F-actin colocalization, compared with a single very mild injury at 72 h PI. In addition, our results demonstrated that microtubule stabilization of axons using brain penetrant Epothilone D (EpoD) (100 nM) resulted in a significant reduction in the number of fragmented axons following mild injury. Collectively, these results suggest that mild and very mild stretch injury to a very localized region of the cortical axon is able to trigger a degenerative response characterized by growth cone collapse and significant abnormal cytoskeletal rearrangement. Furthermore, repetitive very mild stretch injury significantly exacerbated this response. Results suggest that axonal degeneration following stretch injury involves destabilization of the microtubule cytoskeleton and hence treatment with EpoD reduced fragmentation. Together, these results contribute a better understanding of the pathogenesis of mild and repetitive TBI and highlight the therapeutic effect of microtubule targeted drugs on distal part of neurons using a compartmentalized culturing model.	[Yap, Yiing C.; Jiang, Tongcui; Blizzard, Catherine A.; Dickson, Tracey C.] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia; [Yap, Yiing C.; King, Anna E.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Australia; [Yap, Yiing C.; Guijt, Rosanne M.] Univ Tasmania, Pharm Sch Med, Australian Ctr Res Separat Sci ACROSS, Hobart, Australia; [Yap, Yiing C.; Breadmore, Michael C.] Univ Tasmania, Sch Phys Sci, ACROSS, Hobart, Australia	Dickson, TC (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Australia.	Tracey.Dickson@utas.edu.au	Guijt, Rosanne Marieke/R-2428-2017; King, Anna/J-7927-2014; Breadmore, Michael/J-7628-2014	Guijt, Rosanne Marieke/0000-0003-0011-5708; King, Anna/0000-0003-1792-0965; Breadmore, Michael/0000-0001-5591-4326; Blizzard, Catherine/0000-0002-8683-2937; Dickson, Tracey/0000-0002-9196-1661	Select Foundation; Wicking Dementia Research and Education Centre; Australian Research CouncilAustralian Research Council; ARC Discovery ProjectAustralian Research Council [DP150100998]; UTAS Pro Vice Chancellor for Research; UTAS Cross Theme Grant; NHMRC project grantNational Health and Medical Research Council of Australia [APP1042556]; NHMRC project grantNational Health and Medical Research Council of Australia	This research is supported by Select Foundation (Fellowship to TD), the Wicking Dementia Research and Education Centre (Fellowship to AK), Australian Research Council (Future Fellowship to MCB), ARC Discovery Project Grant (DP150100998), UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant and NHMRC project grant (APP1042556) to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Mr Graeme McCormark, Miss Clara Lee, Mr Justin Dittman and Mr John Davis for their technical assistance in completing this work. This research is supported by Select Foundation (Fellowship to TD), the Wicking Dementia Research and Education Centre (Fellowship to AK), Australian Research Council (Future Fellowship to MCB), ARC Discovery Project Grant (DP150100998), UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant and NHMRC project grant to TD.	Adlard PA, 2000, ACTA NEUROPATHOL, V100, P183, DOI 10.1007/s004019900160; Andrieux A, 2006, BIOL PSYCHIAT, V60, P1224, DOI 10.1016/j.biopsych.2006.03.048; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Brizuela M, 2015, MOL CELL NEUROSCI, V66, P129, DOI 10.1016/j.mcn.2015.02.006; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Childs WR, 2005, LANGMUIR, V21, P10096, DOI 10.1021/la050011b; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Farkas O, 2007, PROGR BRAIN RES, V161, P43; Finn JT, 2000, J NEUROSCI, V20, P1333; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Jang EH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5056418; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; King CE, 2000, CLIN EXP PHARMACOL P, V27, P548, DOI 10.1046/j.1440-1681.2000.03292.x; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller CCJ, 2002, CELL MOL LIFE SCI, V59, P323, DOI 10.1007/s00018-002-8425-7; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vickers JC, 2009, BRAIN RES BULL, V80, P217, DOI 10.1016/j.brainresbull.2009.08.004; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Yap YC, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4891098; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	54	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176997	10.1371/journal.pone.0176997			19	Multidisciplinary Sciences	Science & Technology - Other Topics	ET9SP	WOS:000400648500112	28472086	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Dams-O'Connor, K; Mellick, D; Dreer, LE; Hammond, FM; Hoffman, J; Landau, A; Zafonte, R; Pretz, C				Dams-O'Connor, Kristen; Mellick, Dave; Dreer, Laura E.; Hammond, Flora M.; Hoffman, Jeanne; Landau, Alexandra; Zafonte, Ross; Pretz, Christopher			Rehospitalization Over 10 Years Among Survivors of TBI: A National Institute on Disability, Independent Living, and Rehabilitation Research Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						chronic health; longitudinal outcomes; rehospitalization; traumatic brain injury	INPATIENT REHABILITATION; MULTICENTER ANALYSIS; AFTER-DISCHARGE; INDIVIDUALS; MORTALITY; DISEASE	Objective: To describe the rates and causes for rehospitalization over 10 years after moderate-severe traumatic brain injury (TBI), and to characterize longitudinal trajectories of the probability of rehospitalization using generalized linear mixed models and individual growth curve models conditioned on factors that help explain individual variability in rehospitalization risk over time. Design: Secondary analysis of data from a multicenter longitudinal cohort study. Setting: Acute inpatient rehabilitation facilities and community follow-up. Participants: Individuals 16 years and older with a primary diagnosis of TBI. Main Outcome Measures: Rehospitalization (and reason for rehospitalization) as reported by participants or proxy during follow-up telephone interviews at 1, 2, 5, and 10 years postinjury. Results: The greatest number of rehospitalizations occurred in the first year postinjury (27.8% of the sample), and the rates of rehospitalization remained largely stable (22.1%-23.4%) at 2, 5, and 10 years. Reasons for rehospitalization varied over time: Orthopedic and reconstructive surgery rehospitalizations were most common in year 1, whereas general health maintenance was most common by year 2 with rates increasing at each follow-up. Longitudinal models indicate that multiple demographic and injury-related factors are associated with the probability of rehospitalization over time. Conclusions: These findings can inform the content and timing of interventions to improve health and longevity after TBI.	[Dams-O'Connor, Kristen; Landau, Alexandra] Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave Levy Pl,Box 1163, New York, NY 10029 USA; [Mellick, Dave; Pretz, Christopher] Craig Hosp, Res Dept, Englewood, CO USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hoffman, Jeanne] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA USA	Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave Levy Pl,Box 1163, New York, NY 10029 USA.	mrlin@tmu.edu.tw			National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0010-01-00]; New York TBI Model System [90DP0038-02-00]; Indiana University/Rehabilitation Hospital of Indiana TBI Model System [90DP0036-01-00]; University of Washington Traumatic Brain Injury Model System [90DP0031-01-00]; Spaulding-Harvard TBI Model System [2012P002490]; University of Alabama at Birmingham Traumatic Brain Injury Care System [90DP0044-01-00]; National Institutes of Health, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K01HD074651-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000031, R43DP000010, U48DP000036] Funding Source: NIH RePORTER	This work was funded by grants from the National Institute on Disability, Independent Living, and Rehabilitation Research to the Traumatic Brain Injury Model Systems National Data and Statistical Center (Grant Number is 90DP0010-01-00), the New York TBI Model System (Grant Number 90DP0038-02-00), Indiana University/Rehabilitation Hospital of Indiana TBI Model System (Grant Number 90DP0036-01-00), University of Washington Traumatic Brain Injury Model System (Grant Number 90DP0031-01-00), Spaulding-Harvard TBI Model System (Grant Number 2012P002490), University of Alabama at Birmingham Traumatic Brain Injury Care System (Grant Number 90DP0044-01-00), and by a grant from the National Institutes of Health, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (Grant Number K01HD074651-01A1).	Ashley J, 2012, 2 ANN SANT CLAR VALL; Biester RC, 2016, PROF CASE MANAG, V21, P22, DOI 10.1097/NCM.0000000000000121; Boaz TL, 2015, AGING MENT HEALTH, P1; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Centers for Medicare & Medicaid Services, 2013, SPEC ALL CAUS UNPL R; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Davydow DS, 2014, J GEN INTERN MED, V29, P1362, DOI 10.1007/s11606-014-2916-8; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; Granger CV, 2010, AM J PHYS MED REHAB, V89, P781, DOI 10.1097/PHM.0b013e3181f1c83a; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; IBM SPSS Statistics for Windows, 2010, IBM SPSS STAT WIND C; Institute of Medicine, 2009, GULF WAR AND HLTH, V7; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Pretz CR, 2014, J HEAD TRAUMA REHAB, V29, pE65, DOI 10.1097/HTR.0000000000000025; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Pretz CR, 2015, JOINT STAT M SEATTL; SAS, 2013, SAS COMP PROGR VERS; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	29	15	15	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					147	157		10.1097/HTR.0000000000000263			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900001	28476056	Green Accepted			2021-06-18	
J	Gasenzer, ER; Kanat, A; Neugebauer, EAM				Gasenzer, Elena Romana; Kanat, Ayhan; Neugebauer, Edmund A. M.			First Report of Awake Craniotomy of a Famous Musician: Suprasellar Tumor Surgery of Pianist Clara Haskil in 1942	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						pianist; history of neurosurgery; awake craniotomy; suprasellar meningioma; traumatic brain injury	MONITORED CONSCIOUS SEDATION; LOCAL-ANESTHESIA; PITUITARY-TUMORS; ELOQUENT CORTEX; MOZART; RESECTION; ANXIETY; CRANIOPHARYNGIOMAS; INTERVENTION; AROUSAL	Clara Haskil (January 7, 1895-December 7, 1960) was one of the most famous female pianists of the 20th century. In her life and work she set new standards in piano playing. However, her career was beset by poor health and the adversities of two world wars. In her lifetime Haskil had three major disorders: juvenile scoliosis requiring treatment in her adolescence, a tumor of the sellar region requiring surgery at age 47 years, and a traumatic brain injury causing her death at the age of 65. Her medical history illustrates the development of surgical methods and rehabilitation in medicine before and after World War II. At an early age, she spent a year in a nursing home for orthopedic diseases due to scoliosis. In 1942, when she was 47 years old, she displayed the first symptoms of a suprasellar brain tumor: headache and hemianopsia. The famous surgeon Marcel David performed surgery on her without general anesthesia while Haskil mentally played a Mozart piano concerto as a neuronal representation to control her memory and mental abilities. Only 3 months after that operation she played a Mozart piano concerto at a concert that began her career as a great interpreter of Mozart. Her neurologic rehabilitation was remarkable and highlighted new methods in the field. In 1960, she traveled to Brussels for a concert. In the train station she stumbled on the stairs and hit her head on one of the steps. Skull fracture and intracranial hematoma were diagnosed. Doctors tried to operate on her but she lost consciousness and died. Haskil created new styles in piano playing, and her medical history offers indications of new concepts in neurosurgery.	[Gasenzer, Elena Romana] Univ Witten Herdecke, IFOM, Campus Koln Merheim, Cologne, Nordrhein Westf, Germany; [Kanat, Ayhan] Recep Tayyip Erdogan Univ, Fac Med, Dept Neurosurg, Riz, Turkey; [Neugebauer, Edmund A. M.] Med Sch Brandenburg Theodor Fontane, Campus Neuruppin, Neuruppin, Germany	Gasenzer, ER (corresponding author), Univ Witten Herdecke, IFOM, Campus Koln Merheim, Cologne, Nordrhein Westf, Germany.	elena-romana.gasenzer@gmx.de	Kanat, Ayhan/N-2296-2015	Kanat, Ayhan/0000-0002-8189-2877; Gasenzer, Elena Romana/0000-0002-1221-2735			Apuzzo MLJ, 2001, NEUROSURGERY, V48, P1, DOI 10.1097/00006123-200101000-00001; Attari Mohammadali, 2013, Adv Biomed Res, V2, P63, DOI 10.4103/2277-9175.115815; Baars BJ, 2010, COGNITION, BRAIN, AND CONSCIOUSNESS: INTRODUCTION TO COGNITIVE NEUROSCIENCE, 2ND EDITION, P127; Bailey P, 1951, HYPOPHYSENADENOM HIR, P77; Balik MS, 2016, J CRANIOVERTEBRAL JU, V7, P87, DOI 10.4103/0974-8237.181829; Bourgery JM, 1866, TRAITE COMPLET ANATO, Vsixieme; Buchet A, 2000, ILLUSTRIERTE GESCH M, V5, P2493; Buchet A, 2000, ILLUSTRIERTE GESCH M, P2519; Buchet A, 2000, ILLUSTRIERTE GESCH M, P2507; CARMEL PW, 1982, NEUROSURGERY, V11, P382, DOI 10.1227/00006123-198209000-00008; Clara Spycket J, 1977, C HASKIL BIOGRAPHIE; Clarke R. H., 2007, CLIN ORTHOP RELAT R, V463, P1799; Cushing H, 1905, B JOHNS HOPKINS HOSP, V16, P77; Cushing H, 2005, NEUROSURGERY, V57, p6 1075; Danks RA, 2000, J NEURO-ONCOL, V49, P131, DOI 10.1023/A:1026577518902; Davis T, 2012, DIMENS CRIT CARE NUR, V31, P159, DOI 10.1097/DCC.0b013e31824dffc6; De l'Etoile S.K., 2010, MUSIC MED, V2, P78, DOI DOI 10.1177/1943862110364232; De Pue A, 2016, J HEADACHE PAIN, p17 23; Dick Jutta, 1993, JUDISCHE FRAUEN 19 2; Evans D, 2002, J ADV NURS, V37, P8, DOI 10.1046/j.1365-2648.2002.02052.x; Faber T, 2010, CLIN NUCL CARDIOLOGY, P53; Fukui H, 2008, MED HYPOTHESES, V71, P765, DOI 10.1016/j.mehy.2008.06.019; Galarza M, 2014, WORLD NEUROSURG, V81, DOI 10.1016/j.wneu.2013.09.042; Gillen E, 2008, INT J EVID-BASED HEA, V6, P24, DOI [10.1111/j.1479-6988.2007.00097.x, 10.1111/j.1744-1609.2007.00097.x]; Girad P, 2000, ILLUSTRIERTE GESCH M, V3, P1143; Hadab A, 2013, J NEUROL NEUROSCI, V4, P3, DOI [10.3823/338, DOI 10.3823/338]; Hegde S, 2014, FRONT NEUROL, p5 34; Hegde S, 2016, NEUROCASE       0701; Horsley V, 1887, Br Med J, V1, P863; Horwitz NH, 1996, NEUROSURGERY, V38, P844, DOI 10.1227/00006123-199604000-00044; Houdart R, 1988, Bull Acad Natl Med, V172, P241; Hughes JR, 2000, CLIN ELECTROENCEPHAL, V31, P94, DOI 10.1177/155005940003100208; Hughes JR, 1998, CLIN ELECTROENCEPHAL, V29, P109, DOI 10.1177/155005949802900301; Husain G, 2002, MUSIC PERCEPT, V20, P151, DOI 10.1525/mp.2002.20.2.151; Jadavji-Mithani R, 2015, CAN J NEUROL SCI, V42, P7, DOI 10.1017/cjn.2014.127; Jenkins JS, 2001, J ROY SOC MED, V94, P170; Johnson H C, 1956, HIST NEUROLOGICAL SU, P157; Joswig H, 2016, WORLD NEUROSURG, V90, P588, DOI 10.1016/j.wneu.2016.02.051; Kaiser J, 2004, GRO PIANISTEN UNSERE; Kanat A, 2010, CLIN NEUROL NEUROSUR, V112, P839, DOI 10.1016/j.clineuro.2010.07.012; Kanat A, 2010, ACTA NEUROCHIR, V152, P737, DOI 10.1007/s00701-009-0507-y; Kane E, 1914, JAMA-J AM MED ASSOC, V62, P1829, DOI DOI 10.1001/JAMA.1914.02560480063031; Kase CS, 2004, STROKE PATHOPHYSIOLO, P327; Kobets Andrew Joshua, 2011, Yale Journal of Biology and Medicine, V84, P161; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Konzert Mozart W, 2001, AUSGABE 2 KLAVIERE W; Kruger J, 2005, NEUROCHIRURGIE, P808; KUHLENDAHL H, 1973, Z NEUROL, V204, P159, DOI 10.1007/BF00316358; Levy MJ, 2008, CURR PAIN HEADACHE R, V12, P74, DOI 10.1007/s11916-008-0014-5; Low D, 2007, ANN ACAD MED SINGAP, V36, P326; Meng LZ, 2016, J CLIN NEUROSCI, V24, P160, DOI 10.1016/j.jocn.2015.08.021; Moskopp D, 2005, NEUROCHIRURGIE; Mozart Kloiber R, 1983, HDB INSTRUMENTALKONZ, P193; Nilsson Ulrica, 2008, AORN J, V87, P780, DOI 10.1016/j.aorn.2007.09.013; Park S, 2016, WESTERN J NURS RES, V38, P394, DOI 10.1177/0193945915593180; Pintea B, 2013, NEUROSURGERY, V20, P80; Pittman S, 2011, INT NURS REV, V58, P157, DOI 10.1111/j.1466-7657.2011.00888.x; Pollock JR, 2003, NEUROSURGERY, V52, P914, DOI 10.1227/01.NEU.0000053148.34310.BB; Potters JW, 2015, CURR OPIN ANESTHESIO, V28, P511, DOI 10.1097/ACO.0000000000000231; Preti Costanza, 2004, BRIT J MUSIC EDUC, V21, P329; PUSEY E, 1987, AM J ROENTGENOL, V149, P383, DOI 10.2214/ajr.149.2.383; Puttgen KB, 2013, PEDIAT DERMATOLOGY, P14; Rauscher FH, 2006, EDUC PSYCHOL-US, V41, P233, DOI 10.1207/s15326985ep4104_3; Sacks O, 2013, UNWIDERSTEHLICH MUSI; Schinner K M, 1995, J Neurosci Nurs, V27, P348; Schirmer M, 1998, NEUROCHIRURGIE; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Sharma M, 2013, CLIN NEUROL NEUROSUR, V115, P1951, DOI 10.1016/j.clineuro.2013.05.020; Sihvonen Aleksi J, 2014, Duodecim, V130, P1852; Taylor MD, 1999, J NEUROSURG, V90, P35, DOI 10.3171/jns.1999.90.1.0035; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345; Thorek P, 1985, ANATOMY IN SURG, P1; Van Elst E, 2000, ILLUSTRIERTE GESCH M, P1637; Verrusio W, 2015, CONSCIOUS COGN, V35, P150, DOI 10.1016/j.concog.2015.05.005; von Hartnack J, 1983, GRO GEIGER UNSERER Z, P47; von Hartnack J, 1983, GRO GEIGER UNSERER Z, P226; Wang CW, 2011, WORLD NEUROSURG, V75, P294, DOI 10.1016/j.wneu.2010.08.021; Wernhard E, 1997, C HASKIL APROPOS C H; Wolfensberger R, 1961, BEITRAGEN PIERRE FOU; Zada G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.5.FOCUS1183	81	15	15	3	17	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAY	2017	78	3					260	268		10.1055/s-0036-1597895			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	ES3IF	WOS:000399422600008	28219086				2021-06-18	
J	Khor, D; Inaba, K; Aiolfi, A; Delapena, S; Benjamin, E; Matsushima, K; Strumwasser, AM; Demetriades, D				Khor, Desmond; Inaba, Kenji; Aiolfi, Alberto; Delapena, Samantha; Benjamin, Elizabeth; Matsushima, Kazuhide; Strumwasser, Aaron M.; Demetriades, Demetrios			The impact of helmet use on outcomes after a motorcycle crash	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Helmet; Cervical spine; Motorcyclist; Motorcycle collisions; Trauma	CERVICAL-SPINE INJURY; SOCIETY; BURDEN; NECK; HEAD; LAWS	Background: Helmet use in a motorcycle collision has been shown to reduce head injury and death. Its protective effect on the cervical spine (C-spine), however, remains unclear. The objective of this study was to explore the relationship between helmet use and C-spine injuries. Method: Retrospective National Trauma Data Bank (NTDB) study. All motorcycle collisions between 2007 and 2014 involving either a driver or passenger were included. Data collected included demographics, vital signs, Abbreviated Injury Scale (AIS), Injury Severity Score (ISS) and specific injuries. The primary outcome was the prevalence of C-spine injuries. Secondary outcomes included were overall mortality, ventilation days, intensive care unit length of stay (LOS), total hospital LOS, and in-hospital complications. Results: A total of 270,525 patients were included. Helmets were worn by 57.6% of motorcyclists. The non-helmeted group was found to have a higher incidence of head injury with head AIS > 2 (27.6% vs 14.8%, p < 0.001). Univariate analysis showed a higher prevalence of C-spine injuries in the non-helmeted group (10.4% vs 9.4%, p < 0.001), with a higher proportion of severe C-spine injuries with AIS > 2 (3.2% vs 2.6%, p < 0.001). Additionally, traumatic brain injury (TBI) was found to be two times higher in the nonhelmeted group (20.7% vs 10.9%, p < 0.001). Multiple logistic regression showed helmet use to be an independent protective factor against mortality (OR = 0.832, 95% CI 0.781-0.887, p < 0.001). Although statistically significant in univariate analysis, helmet use was not associated with C-spine injuries after adjusting for relevant covariates. However, helmet use reduced the risk of severe head injuries by almost 50% (OR = 0.488, 95% CI 0.475-0.500, p < 0.001). Conclusions: Helmet use reduces the risk of head injury and death among motorcyclists; however, no association with C-spine injuries could be detected. (C) 2017 Elsevier Ltd. All rights reserved.	[Khor, Desmond; Inaba, Kenji; Aiolfi, Alberto; Delapena, Samantha; Benjamin, Elizabeth; Matsushima, Kazuhide; Strumwasser, Aaron M.; Demetriades, Demetrios] LAC USC Med Ctr, Div Acute Care Surg & Surg Crit Care, Los Angeles, CA 90033 USA	Inaba, K (corresponding author), Univ Southern Calif, LAC USC Med Ctr, Div Trauma & Surg Crit Care, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	kenji.inaba@med.usc.edu	INABA, KENJI/AAC-8532-2020; Aiolfi, Alberto/ABA-7242-2020; Benjamin, Elizabeth/AAD-2457-2020	Aiolfi, Alberto/0000-0002-7764-6075			Croce MA, 2009, ANN SURG, V250, P390, DOI 10.1097/SLA.0b013e3181b365a2; Crompton JG, 2011, J AM COLL SURGEONS, V212, P295, DOI 10.1016/j.jamcollsurg.2010.09.032; Dao H, 2012, J TRAUMA ACUTE CARE, V72, P638, DOI 10.1097/TA.0b013e318243d9ca; Duane TM, 2012, J TRAUMA ACUTE CARE, V72, P641; GOLDSTEIN JP, 1986, EVALUATION REV, V10, P355, DOI 10.1177/0193841X8601000306; Hooten KG, 2014, J NEUROTRAUM, V31, P1329, DOI 10.1089/neu.2013.3253; Hundley JC, 2004, J TRAUMA, V57, P944, DOI 10.1097/01.TA.0000149497.20065.F4; Lam C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/487985; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Manan MMA, 2012, IATSS RES, V36, P30, DOI 10.1016/j.iatssr.2012.02.005; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; O'Connor Peter J, 2005, Traffic Inj Prev, V6, P60, DOI 10.1080/15389580590903195; Ooi SS, 2011, ASIA-PAC J PUBLIC HE, V23, P608, DOI 10.1177/1010539511413750; Rice TM, 2016, ACCIDENT ANAL PREV, V91, P200, DOI 10.1016/j.aap.2016.03.002; Vaca F, 2006, ANN EMERG MED, V47, P204, DOI 10.1016/j.annemergmed.2005.12.007; Van Camp L A, 1998, Eur J Emerg Med, V5, P207; WAGLE VG, 1993, J TRAUMA, V34, P120, DOI 10.1097/00005373-199301000-00022; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	18	15	16	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2017	48	5					1093	1097		10.1016/j.injury.2017.02.006			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EW4QG	WOS:000402485400023	28242065				2021-06-18	
J	Seo, JS; Lee, S; Shin, JY; Hwang, YJ; Cho, H; Yoo, SK; Kim, Y; Lim, S; Kim, YK; Hwang, EM; Kim, SH; Kim, CH; Hyeon, SJ; Yun, JY; Kim, J; Kim, Y; Alvarez, VE; Stein, TD; Lee, J; Kim, DJ; Kim, JI; Kowall, NW; Ryu, H; McKee, AC				Seo, Jeong-Sun; Lee, Seungbok; Shin, Jong-Yeon; Hwang, Yu Jin; Cho, Hyesun; Yoo, Seong-Keun; Kim, Yunha; Lim, Sungsu; Kim, Yun Kyung; Hwang, Eun Mi; Kim, Su Hyun; Kim, Chong-Hyun; Hyeon, Seung Jae; Yun, Ji-Young; Kim, Jihye; Kim, Yona; Alvarez, Victor E.; Stein, Thor D.; Lee, Junghee; Kim, Dong Jin; Kim, Jong-Il; Kowall, Neil W.; Ryu, Hoon; McKee, Ann C.			Transcriptome analyses of chronic traumatic encephalopathy show alterations in protein phosphatase expression associated with tauopathy	EXPERIMENTAL AND MOLECULAR MEDICINE			English	Article							DISEASE; EPIDEMIOLOGY; CALCINEURIN	Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disorder that is associated with repetitive head injury and has distinctive neuropathological features that differentiate this disease from other neurodegenerative diseases. Intraneuronal tau aggregates, although they occur in different patterns, are diagnostic neuropathological features of CTE, but the precise mechanism of tauopathy is not known in CTE. We performed whole RNA sequencing analysis of post-mortem brain tissue from patients with CTE and compared the results to normal controls to determine the transcriptome signature changes associated with CTE. The results showed that the genes related to the MAP kinase and calcium-signaling pathways were significantly downregulated in CTE. The altered expression of protein phosphatases (PPs) in these networks further suggested that the tauopathy observed in CTE involves common pathological mechanisms similar to Alzheimer's disease (AD). Using cell lines and animal models, we also showed that reduced PPP3CA/PP2B phosphatase activity is directly associated with increases in phosphorylated (p)-tau proteins. These findings provide important insights into PP-dependent neurodegeneration and may lead to novel therapeutic approaches to reduce the tauopathy associated with CTE.	[Seo, Jeong-Sun; Lee, Seungbok; Shin, Jong-Yeon; Cho, Hyesun; Yoo, Seong-Keun; Yun, Ji-Young; Kim, Jihye; Kim, Jong-Il] Seoul Natl Univ, Genom Med Inst, Med Res Ctr, Med Sci Bldg 405,28 Yongon Dong, Seoul 110799, South Korea; [Seo, Jeong-Sun; Cho, Hyesun; Kim, Jong-Il] Seoul Natl Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Seo, Jeong-Sun; Cho, Hyesun; Kim, Jong-Il] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea; [Seo, Jeong-Sun; Shin, Jong-Yeon; Yun, Ji-Young; Kim, Jihye] Macrogen Inc, Seoul, South Korea; [Hwang, Yu Jin; Kim, Yunha; Lim, Sungsu; Kim, Yun Kyung; Hyeon, Seung Jae; Kim, Dong Jin; Ryu, Hoon] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea; [Yoo, Seong-Keun] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Hwang, Eun Mi] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Funct Connect, Seoul, South Korea; [Kim, Su Hyun; Kim, Chong-Hyun] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neurosci, Seoul, South Korea; [Hwang, Eun Mi; Kim, Su Hyun] Univ Sci & Technol, Dept Neurosci, Daejeon, South Korea; [Kim, Yona] Seoul Natl Univ, Canc Res Inst, Coll Med, Dept Neurosurg, Seoul, South Korea; [Alvarez, Victor E.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; Ryu, Hoon; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA USA; [Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; Ryu, Hoon; McKee, Ann C.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Seo, JS (corresponding author), Seoul Natl Univ, Genom Med Inst, Med Res Ctr, Med Sci Bldg 405,28 Yongon Dong, Seoul 110799, South Korea.; Ryu, H; McKee, AC (corresponding author), Boston Univ, Sch Med, Dept Neurol, VA Boston Healthcare Syst, Res Bldg 1A,150 S Huntington Ave, Boston, MA 02130 USA.	jeongsun@snu.ac.kr; hoonryu@bu.edu; amckee@bu.edu	KIM, Yunha/J-4698-2019; KIM, JONG-IL/D-1019-2011; Kowall, Neil/M-5378-2019	KIM, JONG-IL/0000-0002-7240-3744; Kowall, Neil/0000-0002-6624-0213; Stein, Thor/0000-0001-6954-4477	Macrogen Inc. [MGR14-02]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS067283]; Brain Science Flagship Grant [2E26200, 2N41600]; Korea Institute of Science and TechnologyKorea Institute of Science & Technology (KIST) [2E26640 CHK]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086659-01]; Department of Veterans Affairs, Veterans Affairs BiorepositoryUS Department of Veterans Affairs [CSP 501]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; National Institute of Aging Boston University Framingham Heart Study [R01AG1649]; Concussion Legacy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, R01NS067283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	We thank Thomas Bleazard at Faculty of Medical and Human Sciences, University of Manchester for discussion and assistance with manuscript preparation. This work was financially supported by grants from Macrogen Inc. (grant no. MGR14-02), NIH R01 NS067283 (HR), Brain Science Flagship Grant (2E26200 and 2N41600 HR) and an intramural grant (2E26640 CHK) from the Korea Institute of Science and Technology. The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA, USA). This work was financially supported by grants from the National Institute of Neurological Disorders and Stroke (1U01NS086659-01, Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5), the National Institute of Aging Boston University Framingham Heart Study (R01AG1649), and the Concussion Legacy Foundation. This work was also financially supported by unrestricted gifts from the Andlinger Foundation, the World Wrestling Entertainment and the National Football League.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Braithwaite SP, 2012, PROG MOL BIOL TRANSL, V106, P343, DOI 10.1016/B978-0-12-396456-4.00012-2; Chiocco MJ, 2010, SUBST USE MISUSE, V45, P1809, DOI 10.3109/10826084.2010.482449; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gratuze M, 2015, HUM MOL GENET, V24, P86, DOI 10.1093/hmg/ddu456; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee J, 2013, ACTA NEUROPATHOL, V125, P727, DOI 10.1007/s00401-013-1103-z; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nowinski C, 2006, HEAD GAMES FOOTBALLS; Rahman A, 2006, J NEURAL TRANSM, V113, P219, DOI 10.1007/s00702-005-0313-5; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; RUDELLI R, 1982, ARCH NEUROL-CHICAGO, V39, P570, DOI 10.1001/archneur.1982.00510210040009; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; STILLER JW, 1985, PSYCHIAT CLIN N AM, V8, P339; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tak H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081682; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	31	15	15	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1226-3613	2092-6413		EXP MOL MED	Exp. Mol. Med.	MAY	2017	49								e333	10.1038/emm.2017.56			12	Biochemistry & Molecular Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Research & Experimental Medicine	EY7HD	WOS:000404159600007	28524178	DOAJ Gold, Green Published			2021-06-18	
J	Zheng, SL; Han, F; Shi, YX; Wen, LL; Han, D				Zheng, Shilei; Han, Fang; Shi, Yuxiu; Wen, Lili; Han, Dan			Single-Prolonged-Stress-Induced Changes in Autophagy-Related Proteins Beclin-1, LC3, and p62 in the Medial Prefrontal Cortex of Rats with Post-traumatic Stress Disorder	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Post-traumatic stress disorder; Autophagy; Medial prefrontal cortex; Single-prolonged stress; Beclin-1; Microtubule-associated protein 1 light chain 3; p62/SQSTM1	UP-REGULATION; ALZHEIMERS-DISEASE; BRAIN-INJURY; CELL-DEATH; MODEL; BCL-2; PTSD; ACTIVATION; APOPTOSIS; TRAUMA	Autophagy, or type II programmed cell death, plays a crucial role in many nervous system diseases. However, few studies have examined the role of autophagy in post-traumatic stress disorder (PTSD), and the mechanisms underlying PTSD are poorly understood. The objective of this research was to explore the expression of three important autophagy-related proteins, Beclin-1, microtubule-associated protein 1 light chain 3 (LC3), and p62/SQSTM1 (p62), in the medial prefrontal cortex (mPFC) of an animal model of PTSD to identify changes in autophagic activity during PTSD pathogenesis. PTSD was induced in rats by exposure to a single-prolonged stress (SPS). The Morris water maze was used to assess cognitive changes in rats from the SPS and control groups. Transmission electron microscopy (TEM) was employed to observe mPFC morphological changes. Immunohistochemistry, immunofluorescence, and Western blotting techniques were used to detect expression of Beclin-1, LC3, and p62 in the mPFC. The Morris water maze test results showed that the escape latency time was increased and that the percent time in the target quadrant was decreased in the SPS group compared with that in the control group. Numerous visible autolysosomes in mPFC neurons were observed using TEM after SPS stimulation. Compared with that in the control group, the expression of Beclin-1 and the LC3-II/I ratio significantly decreased at 1 day, then increased and peaked at 7 days, and slightly decreased at 14 days after SPS stimulation, whereas the converse was found for p62 expression. In conclusion, dysregulation of autophagic activity in the mPFC may play a crucial role in PTSD pathogenesis.	[Zheng, Shilei; Han, Fang; Shi, Yuxiu; Wen, Lili; Han, Dan] China Med Univ, Inst Pathol & Pathophysiol, Basic Med Sci Coll, PTSD Lab,Dept Histol & Embryol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Zheng, Shilei] Jinzhou Med Univ, Dept Radiol, Affiliated Hosp 1, 2 Fifth Duan,Renmin St, Jinzhou 121001, Liaoning, Peoples R China	Shi, YX (corresponding author), China Med Univ, Inst Pathol & Pathophysiol, Basic Med Sci Coll, PTSD Lab,Dept Histol & Embryol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	shiyuxiu@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571324]; Specialized Research Fund for the Doctoral Program of Higher EducationSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20132104110021]	This research was supported by grants from the National Natural Science Foundation of China (No. 81571324) and Specialized Research Fund for the Doctoral Program of Higher Education (No. 20132104110021). The authors would like to thank the reviewers for their valuable comments.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Bailey CR, 2013, CNS DRUGS, V27, P221, DOI 10.1007/s40263-013-0051-4; Boccia M, 2016, BRAIN IMAGING BEHAV, V10, P226, DOI 10.1007/s11682-015-9387-3; Caccamo A., 2016, MOL PSYCHIAT; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Ding JL, 2010, J PSYCHIATR RES, V44, P48, DOI 10.1016/j.jpsychires.2009.06.001; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI [10.1038/nchembio.500, 10.1038/NCHEMBIO.500]; Gibson BM, 2016, LEARN BEHAV, V44, P97, DOI 10.3758/s13420-016-0214-5; Giustino TF, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00298; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Khan S, 2004, PSYCHOPHARMACOLOGY, V172, P225, DOI 10.1007/s00213-003-1634-4; Kim JH, 2014, EXP CELL RES, V327, P340, DOI 10.1016/j.yexcr.2014.08.001; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lee JY, 2009, BRAIN RES, V1287, P126, DOI 10.1016/j.brainres.2009.06.028; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li YN, 2013, J MOL NEUROSCI, V51, P127, DOI 10.1007/s12031-013-9965-z; Longatti A, 2010, CELL RES, V20, P1181, DOI 10.1038/cr.2010.132; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mellman TA, 2009, DEPRESS ANXIETY, V26, P993, DOI 10.1002/da.20627; Meng LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33748; Moghaddam B, 2004, NEUROTOX RES, V6, P73, DOI 10.1007/BF03033299; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Oral O, 2016, HISTOL HISTOPATHOL, V31, P479, DOI 10.14670/HH-11-714; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pollice R, 2012, RIV PSICHIATR, V47, P59, DOI 10.1708/1034.11292; Pratchett LC, 2011, EXPERT OPIN PHARMACO, V12, P2339, DOI 10.1517/14656566.2011.604030; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rangaraju S, 2011, AUTOPHAGY, V7, P238, DOI 10.4161/auto.7.2.14278; Rangaraju S, 2010, J NEUROSCI, V30, P11388, DOI 10.1523/JNEUROSCI.1356-10.2010; Roozendaal B, 2009, J NEUROSCI, V29, P14299, DOI 10.1523/JNEUROSCI.3626-09.2009; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Wan JL, 2016, ACTA HISTOCHEM, V118, P10, DOI 10.1016/j.acthis.2015.11.003; Wang DK, 2015, J ETHNOPHARMACOL, V161, P99, DOI 10.1016/j.jep.2014.12.005; Wang QW, 2013, BIOCHEM BIOPH RES CO, V438, P186, DOI 10.1016/j.bbrc.2013.07.050; Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27131; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Wu C, 2014, OSTEOARTHR CARTILAGE, V22, P1936, DOI 10.1016/j.joca.2014.08.010; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 2014, ANNU REV NEUROSCI, V37, P55, DOI 10.1146/annurev-neuro-071013-014149; Yang Z, 2015, J MOL MED, V93, P707, DOI 10.1007/s00109-015-1297-8; Yehuda R, 2005, HANDB EXP PHARM, V169, P371; Yu B, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0115-5; Zhao DM, 2014, J MOL NEUROSCI, V54, P147, DOI 10.1007/s12031-014-0263-1; Zhou L, 2013, ACTA PHARMACOL SIN, V34, P651, DOI 10.1038/aps.2013.12	61	15	18	0	11	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2017	62	1					43	54		10.1007/s12031-017-0909-x			12	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	EV1PY	WOS:000401519700007	28341893				2021-06-18	
J	Robertsen, A; Forde, R; Skaga, NO; Helseth, E				Robertsen, Annette; Forde, Reidun; Skaga, Nils Oddvar; Helseth, Eirik			Treatment-limiting decisions in patients with severe traumatic brain injury in a Norwegian regional trauma center	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Withholding treatment; Futility; Potentially inappropriate treatment; Traumatic brain injury; Decision-making	INTENSIVE-CARE UNITS; OF-LIFE DECISIONS; POTENTIALLY INAPPROPRIATE TREATMENTS; NO ESCALATION; CANADIAN INTENSIVISTS; NEUROSURGICAL UNIT; POLICY STATEMENT; ROUTINE STRATEGY; WITHDRAWAL; END	Background: Treatment-limiting decisions (TLD) for severe traumatic brain injury (sTBI) have been sparsely studied. This study determine prevalence, main reason for, categories and timing of TLDs in a Norwegian regional trauma setting. Methods: A retrospective study of a 2-year cohort of 579 sTBI patients admitted to Oslo University Hospital (OUH). Prospectively collected data in the OUH Trauma Registry were combined with retrospective data from a chart review regarding TLDs. Results: TLDs were documented for 101/579 sTBI patients (17%). The situation was evaluated as futile in 59 cases and as potentially inappropriate in 42 cases. The three most frequent types of TLDs were withholding of neurosurgery, do not resuscitate orders and withdrawing of organ support. In 70% of cases, the first TLD was made within 2 days after injury, while in 14%, the first TLD was made later than day 7. Twenty percent (20/101) of the first TLDs were later adjusted, revoked in 4 patients and broadening of TLDs in 16 patients. The median time from the decision to death was 2 days (range 1-652). TLDs were documented in 93% of in-hospital death cases (n = 79). In-hospital deaths occurred in 73% of TLD group cases and 1% of non-TLD group cases. Family interaction and multi-team discussions were documented in > 88% of cases, but no advanced directives were found, and notifications of patients' preferences were found in only 7% of cases. Discussion: Clinicians should consider limiting treatment if continued treatment is not in the patients best interest. A range of different types of TLDs were applied for patients after sTBI in the trauma hospital setting. Conclusion: TLDs were found in 17% of sTBI patients. Value considerations behind TLDs in this care context need to be further explored.	[Robertsen, Annette; Skaga, Nils Oddvar] Oslo Univ Hosp, Dept Anesthesiol & Crit Care, POB 4950Nydalen, N-0424 Oslo, Norway; [Robertsen, Annette; Helseth, Eirik] Univ Oslo, Dept Clin Med, Oslo, Norway; [Forde, Reidun] Univ Oslo, Ctr Med Eth, POB 1130Blindern, N-0318 Oslo, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, POB 4950Nydalen, N-0424 Oslo, Norway; [Skaga, Nils Oddvar] Oslo Univ Hosp, Trauma Registry, Oslo, Norway	Robertsen, A (corresponding author), Oslo Univ Hosp, Dept Anesthesiol & Crit Care, POB 4950Nydalen, N-0424 Oslo, Norway.; Robertsen, A (corresponding author), Univ Oslo, Dept Clin Med, Oslo, Norway.	anerob@ous-hf.no	Helseth, Eirik/AAH-2466-2020		Division of Critical Care at OUH	Thanks to OUH-TR for providing some of the data, Division of Critical Care at OUH for supporting the study and Manuela Zucknick for statistical support.	ACCORD EU, 2015, ACH COMPR COORD ORG; Association of Official Analytical Chemists, 1998, AOAC PEER VER METH P, P1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARLOW P, 1991, SCOT MED J, V36, P109, DOI 10.1177/003693309103600404; Bell D, 2012, ANAESTHESIA, V67, P1405, DOI 10.1111/anae.12080; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Cai XM, 2015, NEUROCRIT CARE, V23, P131, DOI 10.1007/s12028-015-0149-2; Cape D, 2016, J MED ETHICS, V42, P180, DOI 10.1136/medethics-2015-102856; Cochrane TI, 2009, AM J BIOETHICS, V9, P47, DOI 10.1080/15265160902718857; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Curtis JR, 2014, INTENS CARE MED, V40, P1374, DOI 10.1007/s00134-014-3421-6; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; JENNETT B, 1992, BRIT J HOSP MED, V47, P354; Kitzinger C, 2014, TIMELINE ADM WITHHOL; Kon AA, 2016, CRIT CARE MED, V44, P1769, DOI 10.1097/CCM.0000000000001965; Long AC, 2016, INTENS CARE MED, V42, P1043, DOI 10.1007/s00134-016-4336-1; Manara Alex R, 2016, J Intensive Care Soc, V17, P295, DOI 10.1177/1751143716647980; Manara AR, 1998, ANAESTHESIA, V53, P523, DOI 10.1046/j.1365-2044.1998.t01-1-00407.x; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Morgan CK, 2014, CRIT CARE MED, V42, P357, DOI 10.1097/CCM.0b013e3182a276c9; Norwegian Directorate of Health, 2013, NAT GUID DEC MAK PRO; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Rubin MA, 2016, AM J RESP CRIT CARE, V193, P466, DOI 10.1164/rccm.201510-2086LE; Schaller C, 2006, J MED ETHICS, V32, P65, DOI 10.1136/jme.2005.011767; Schenker Y, 2013, J CRIT CARE, V28, P862, DOI 10.1016/j.jcrc.2013.04.015; Smith AK, 2013, NEW ENGL J MED, V368, P2448, DOI 10.1056/NEJMp1303295; Smith M, 2012, ANAESTHESIA, V67, P941, DOI 10.1111/j.1365-2044.2012.07304.x; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Sovik S, 2014, INJURY, V45, P1722, DOI 10.1016/j.injury.2014.05.038; Sprung CL, 2008, INTENS CARE MED, V34, P271, DOI 10.1007/s00134-007-0927-1; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Thompson DR, 2014, INTENS CARE MED, V40, P1372, DOI 10.1007/s00134-014-3422-5; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Turnbull AE, 2014, CRIT CARE MED, V42, P1455, DOI 10.1097/CCM.0000000000000227; Verkade MA, 2012, NEUROCRIT CARE, V16, P130, DOI 10.1007/s12028-011-9567-y; Wilson WT, 2017, BRIT J NEUROSURG, V31, P254, DOI 10.1080/02688697.2016.1226259; Wunsch H, 2005, INTENS CARE MED, V31, P823, DOI 10.1007/s00134-005-2644-y; Yee AH, 2010, NEUROLOGY, V74, P1380, DOI 10.1212/WNL.0b013e3181dad5f0	43	15	16	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 26	2017	25								44	10.1186/s13049-017-0385-x			9	Emergency Medicine	Emergency Medicine	ET6SQ	WOS:000400423100001	28441973	DOAJ Gold, Green Published			2021-06-18	
J	Reynolds, BB; Patrie, J; Henry, EJ; Goodkin, HP; Broshek, DK; Wintermark, M; Druzgal, TJ				Reynolds, Bryson B.; Patrie, James; Henry, Erich J.; Goodkin, Howard P.; Broshek, Donna K.; Wintermark, Max; Druzgal, T. Jason			Effects of Sex and Event Type on Head Impact in Collegiate Soccer	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						head injuries/concussion; football (soccer); biomechanics (general); subconcussion; accelerometer	WHITE-MATTER INTEGRITY; HIGH-SCHOOL; FOOTBALL PLAYERS; NECK STRENGTH; CONCUSSION; EXPOSURE; BIOMECHANICS; HISTORY; SPORTS	Background: The effects of head impact in sports are of growing interest for clinicians, scientists, and athletes. Soccer is the most popular sport worldwide, but the burden of head impact in collegiate soccer is still unknown. Purpose: To quantify head impact associated with practicing and playing collegiate soccer using wearable accelerometers. Study Design: Descriptive epidemiological study. Methods: Mastoid patch accelerometers were used to quantify head impact in soccer, examining differences in head impact as a function of sex and event type (practice vs game). Seven female and 14 male collegiate soccer players wore mastoid patch accelerometers that measured head impacts during team events. Data were summarized for each athletic exposure, and statistical analyses evaluated the mean number of impacts, mean peak linear acceleration, mean peak rotational acceleration, and cumulative linear and rotational acceleration, each grouped by sex and event type. Results: There were no differences in the frequency or severity of head impacts between men's and women's soccer practices. For men's soccer, games resulted in 285% more head impacts than practices, but there were no event-type differences in mean impact severity. Men's soccer games resulted in more head impacts than practices across nearly all measured impact severities, which also resulted in men's soccer games producing a greater cumulative impact burden. Conclusion: Similar to other sports, men's soccer games have a greater impact burden when compared with practices, and this effect is driven by the quantity rather than severity of head impacts. In contrast, there were no differences in the quantity or severity of head impacts in men's and women's soccer practices. These data could prompt discussions of practical concern to collegiate soccer, such as understanding sex differences in head impact and whether games disproportionately contribute to an athlete's head impact burden.	Univ Virginia, Charlottesville, VA USA; Univ Virginia Hlth Syst, Charlottesville, VA USA; [Reynolds, Bryson B.] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN USA; [Patrie, James] Univ Virginia, Publ Hlth Sci, Charlottesville, VA USA; [Henry, Erich J.] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Broshek, Donna K.] Univ Virginia, Dept Psychiat & Neurobehavioral Sci, Charlottesville, VA USA; [Wintermark, Max] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	Druzgal, TJ (corresponding author), Univ Virginia, Dept Radiol, Box 800170, Charlottesville, VA 22908 USA.; Druzgal, TJ (corresponding author), Univ Virginia, Div Neuroradiol, Med Imaging, Box 800170, Charlottesville, VA 22908 USA.			Reynolds, Bryson/0000-0001-9196-1461; Druzgal, Jason/0000-0001-7240-9487; Goodkin, Howard/0000-0003-0528-4949	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB001628] Funding Source: NIH RePORTER; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32 EB001628] Funding Source: Medline		Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Huber P.J., 1967, P 5 BERK S MATH STAT, V1; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	44	15	15	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	APR 24	2017	5	4							2325967117701708	10.1177/2325967117701708			10	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	EV4KK	WOS:000401728300001	28491885	DOAJ Gold, Green Published			2021-06-18	
J	Lagerstedt, L; Egea-Guerrero, JJ; Bustamante, A; Montaner, J; Rodriguez-Rodriguez, A; El Rahal, A; Turck, N; Quintana, M; Garcia-Armengol, R; Prica, CM; Andereggen, E; Rinaldi, L; Sarrafzadeh, A; Schaller, K; Sanchez, JC				Lagerstedt, Linnea; Jose Egea-Guerrero, Juan; Bustamante, Alejandro; Montaner, Joan; Rodriguez-Rodriguez, Ana; El Rahal, Amir; Turck, Natacha; Quintana, Manuel; Garcia-Armengol, Roser; Melinda Prica, Carmen; Andereggen, Elisabeth; Rinaldi, Lara; Sarrafzadeh, Asita; Schaller, Karl; Sanchez, Jean-Charles			H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury	PLOS ONE			English	Article							ACID-BINDING PROTEIN; INTRACRANIAL LESIONS; COMPUTED-TOMOGRAPHY; SERUM-LEVELS; AGE; MARKER; S100B; MANAGEMENT; S100-BETA	The majority of patients with mild traumatic brain injury (mTBI) will have normal Glasgow coma scale (GCS) of 15. Furthermore, only 5%-8% of them will be CT-positive for an mTBI. Having a useful biomarker would help clinicians evaluate a patient's risk of developing intracranial lesions. The S100B protein is currently the most studied and promising biomarker for this purpose. Heart fatty-acid binding protein (H-FABP) has been highlighted in brain injury models and investigated as a biomarker for stroke and severe TBI, for example. Here, we evaluate the performances of S100B and H-FABP for differentiating between CT-positive and CT-negative patients. A total of 261 patients with a GCS score of 15 and at least one clinical symptom of mTBI were recruited at three different European sites. Blood samples from 172 of them were collected <= 6 h after trauma. Patients underwent a CT scan and were dichotomised into CT-positive and CT-negative groups for statistical analyses. H-FABP and S100B levels were measured using commercial kits, and their capacities to detect all CT-positive scans were evaluated, with sensitivity set to 100%. For patients recruited <= 6 h after trauma, the CT-positive group demonstrated significantly higher levels of both H-FABP (p = 0.004) and S100B (p = 0.003) than the CT-negative group. At 100% sensitivity, specificity reached 6% (95% CI 2.8-10.7) for S100B and 29% (95% CI 21.4-37.1) for H-FABP. Similar results were obtained when including all the patients recruited, i.e. hospital arrival within 24 h of trauma onset. H-FABP out-performed S100B and thus seems to be an interesting protein for detecting all CT-positive mTBI patients with a GCS score of 15 and at least one clinical symptom.	[Lagerstedt, Linnea; Turck, Natacha; Sanchez, Jean-Charles] Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland; [Jose Egea-Guerrero, Juan; Rodriguez-Rodriguez, Ana] Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, Seville, Spain; [Bustamante, Alejandro; Montaner, Joan] Univ Autonoma Barcelona, VHIR, Neurovasc Res Lab, Barcelona, Spain; [El Rahal, Amir; Schaller, Karl] Geneva Univ Hosp, Div Neurosurg, Dept Clin Neurosci, Geneva Neurosci Ctr, Geneva, Switzerland; [Quintana, Manuel] Univ Autonoma Madrid, Intens Med Unit, Hosp Univ La Paz, IdiPAZ,Dept Med, Madrid, Spain; [Garcia-Armengol, Roser] Hosp Badalona Germans Trias & Pujol, Dept Neurosurg, Neurosci Unit, Badalona, Spain; [Melinda Prica, Carmen] Hosp Tortosa Verge Cinta, Emergency Dept, Tortosa, Spain; [Andereggen, Elisabeth; Rinaldi, Lara] Geneva Univ Hosp, Emergency Ctr, Geneva, Switzerland; [Andereggen, Elisabeth] Geneva Univ Hosp, Dept Surg, Geneva, Switzerland; [Sarrafzadeh, Asita] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany	Sanchez, JC (corresponding author), Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland.	Jean-Charles.Sanchez@unige.ch	Montaner, Joan/D-3063-2015; IBiS, Neurovascular/P-5842-2016; Egea-Guerrero, Juan Jose/P-5080-2014	Montaner, Joan/0000-0003-4845-2279; Lagerstedt, Linnea/0000-0002-3405-9938; Egea-Guerrero, Juan Jose/0000-0002-4166-313X			Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Erenler AK, 2013, J PAK MED ASSOC, V63, P1176; Hainard A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000459; Heidari K, 2015, BRAIN INJURY, V29, P33, DOI 10.3109/02699052.2014.948068; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Lescuyer Pierre, 2005, Mol Diagn, V9, P1, DOI 10.2165/00066982-200509010-00001; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2016, JAMA NEUROL; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pelsers MMAL, 2005, CLIN CHEM LAB MED, V43, P802, DOI 10.1515/CCLM.2005.135; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Pelsers MMAL, 1999, CLIN CHEM, V45, P441; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Welch RD, 2016, J NEUROTRAUMA; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wolf H, 2015, J NEUROTRAUM, V32, P23, DOI 10.1089/neu.2013.3202; Wunderlich MT, 2005, J NEUROL, V252, P718, DOI 10.1007/s00415-005-0725-z; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200	36	15	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175572	10.1371/journal.pone.0175572			11	Multidisciplinary Sciences	Science & Technology - Other Topics	ES9KH	WOS:000399875200027	28419114	DOAJ Gold, Green Published			2021-06-18	
J	Hellstrom, T; Kaufmann, T; Andelic, N; Soberg, HL; Sigurdardottir, S; Helseth, E; Andreassen, OA; Westlye, LT				Hellstrom, Torgeir; Kaufmann, Tobias; Andelic, Nada; Soberg, Helene L.; Sigurdardottir, Solrun; Helseth, Eirik; Andreassen, Ole A.; Westlye, Lars T.			Predicting Outcome 12 Months after Mild Traumatic Brain injury in Patients admitted to a neurosurgery service	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; cortical thickness; volumetric analysis; prediction; outcome	POST-CONCUSSION SYMPTOMS; HUMAN CEREBRAL-CORTEX; CENTER-TASK-FORCE; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; DIFFUSE AXONAL INJURY; SPINAL-CORD-INJURY; HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; RISK-FACTORS	Objective: Accurate outcome prediction models for patients with mild traumatic brain injury (MTBI) are key for prognostic assessment and clinical decision-making. Using multivariate machine learning, we tested the unique and added predictive value of (1) magnetic resonance imaging (MRI)-based brain morphometric and volumetric characterization at 4-week postinjury and (2) demographic, preinjury, injury-related, and postinjury variables on 12-month outcomes, including global functioning level, postconcussion symptoms, and mental health in patients with MTBI. Methods: A prospective, cohort study of patients (n = 147) aged 16-65 years with a 12-month follow-up. T1-weighted 3 T MRI data were processed in FreeSurfer, yielding accurate cortical reconstructions for surface-based analyses of cortical thickness, area, and volume, and brain segmentation for subcortical and global brain volumes. The 12-month outcome was defined as a composite score using a principal component analysis including the Glasgow Outcome Scale Extended, Rivermead Postconcussion Questionnaire, and Patient Health Questionnaire-9. Using leave-one-out cross-validation and permutation testing, we tested and compared three prediction models: (1) MRI model, (2) clinical model, and (3) MRI and clinical combined. Results: We found a strong correlation between observed and predicted outcomes for the clinical model (r = 0.55, p < 0.001). The MRI model performed at the chance level (r = 0.03, p = 0.80) and the combined model (r = 0.45, p < 0.002) were slightly weaker than the clinical model. Univariate correlation analyses revealed the strongest association with outcome for postinjury factors of posttraumatic stress (Posttraumatic Symptom Scale-10, r = 0.61), psychological distress (Hospital Anxiety and Depression Scale, r = 0.52), and widespread pain (r = 0.43) assessed at 8 weeks. Conclusion: We found no added predictive value of MRI-based measures of brain cortical morphometry and subcortical volumes over and above demographic and clinical features.	[Hellstrom, Torgeir; Andelic, Nada; Soberg, Helene L.] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Hellstrom, Torgeir; Helseth, Eirik] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Kaufmann, Tobias; Andreassen, Ole A.; Westlye, Lars T.] Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Norwegian Ctr Mental Disorder Res NORMENT, Div Mental Hlth & Addict, Oslo, Norway; [Andelic, Nada] Univ Oslo, Fac Med, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Inst Hlth & Soc, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway	Hellstrom, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.; Hellstrom, T (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	torgehel@uio.no	Andreassen, Ole A./AAY-7531-2020; Helseth, Eirik/AAH-2466-2020; Kaufmann, Tobias/M-8972-2017	Kaufmann, Tobias/0000-0002-4003-1018; Andelic, Nada/0000-0002-3719-4406; Westlye, Lars T./0000-0001-8644-956X	Department of Physical Medicine and Rehabilitation, Oslo University Hospital; South-Eastern Norway Regional Health Authority [2014097]	The authors thank all the patients who took time to participate in the study. We also thank radiograph Anne-Hilde Farstad for practical MRI assistance and the Department of Physical Medicine and Rehabilitation, Oslo University Hospital for institutional and financial support. The research was funded by the South-Eastern Norway Regional Health Authority (2014097).	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chang FH, 2012, ARCH PHYS MED REHAB, V93, P2264, DOI 10.1016/j.apmr.2012.06.008; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Constantino MJ, 2011, J CLIN PSYCHOL, V67, P184, DOI 10.1002/jclp.20754; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Eid J, 1999, SCAND J PSYCHOL, V40, P101, DOI 10.1111/1467-9450.00105; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Friborg O, 2005, INT J METH PSYCH RES, V14, P29, DOI 10.1002/mpr.15; Friborg O, 2003, INT J METH PSYCH RES, V12, P65, DOI 10.1002/mpr.143; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hart T, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000210; Hellstrom T, 2016, BRAIN INJURY, V30, P1683, DOI 10.1080/02699052.2016.1199905; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rimol LM, 2012, BIOL PSYCHIAT, V71, P552, DOI 10.1016/j.biopsych.2011.11.026; Roe C, 2012, J NEUROL RES, V2, P134, DOI DOI 10.4021/JNR133W; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Studerus-Germann AM, 2016, INT J NEUROSCI, V126, P289, DOI 10.3109/00207454.2015.1033620; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; TEASDALE G, 1974, LANCET, V2, P81; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zeller B, 2013, J CLIN ONCOL, V31, P2078, DOI 10.1200/JCO.2012.47.4031; Zhou GY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14329; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	77	15	16	0	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 10	2017	8								125	10.3389/fneur.2017.00125			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	ER5GF	WOS:000398829000001	28443058	DOAJ Gold, Green Published			2021-06-18	
J	Chen, C; Shi, JX; Stanley, RM; Sribnick, EA; Groner, JI; Xiang, H				Chen, Cheng; Shi, Junxin; Stanley, Rachel M.; Sribnick, Eric A.; Groner, Jonathan I.; Xiang, Henry			US Trends of ED Visits for Pediatric Traumatic Brain Injuries: Implications for Clinical Trials	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						pediatric; traumatic brain injury; emergency department	CHILDREN	Our goal in this paper was to use the 2006-2013 Nationwide Emergency Department Sample (NEDS) database to describe trends of annual patient number, patient demographics and hospital characteristics of pediatric traumatic brain injuries (TBI) treated in U.S. emergency departments (EDs); and to use the same database to estimate the available sample sizes for various clinical trials of pediatric TBI cases. National estimates of patient demographics and hospital characteristics were calculated for pediatric TBI. Simulation analyses assessed the potential number of pediatric TBI cases from randomly selected hospitals for inclusion in future clinical trials under different scenarios. Between 2006 and 2013, the NEDS database estimated that of the 215,204,932 children who visited the ED, 6,089,930 (2.83%) had a TBI diagnosis. During the study period in the US EDs, pediatric TBI patients increased by 34.1%. Simulation analyses suggest that hospital EDs with annual TBI ED visits >1000, Levels I and II Trauma Centers, pediatric hospitals, and teaching hospitals will likely provide ample cases for pediatric TBI studies. However, recruiting severe pediatric TBI cases for clinical trials from a limited number of hospital EDs will be challenging due to small sample sizes. Pediatric TBI-related ED visits in the U.S. increased by over 30% from 2006 to 2013. Including unspecified head injury cases with ICD-9-CM code 959.01 would significantly change the national estimates and demographic patterns of pediatric TBI cases. Future clinical trials of children with TBI should conduct a careful feasibility assessment to estimate their sample size and study power in selected study sites.	[Chen, Cheng; Shi, Junxin; Stanley, Rachel M.; Sribnick, Eric A.; Groner, Jonathan I.; Xiang, Henry] Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, 700 Childrens Dr, Columbus, OH 43205 USA; [Chen, Cheng; Shi, Junxin; Groner, Jonathan I.; Xiang, Henry] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA; [Stanley, Rachel M.; Xiang, Henry] Ohio State Univ, Dept Pediat, Coll Med, 370 West 9th Ave, Columbus, OH 43210 USA; [Stanley, Rachel M.] Ohio State Univ, Dept Neurosurg, Coll Med, 370 West 9th Ave, Columbus, OH 43210 USA; [Sribnick, Eric A.] Ohio State Univ, Dept Surg, Coll Med, 370 West 9th Ave, Columbus, OH 43210 USA; [Groner, Jonathan I.] Nationwide Childrens Hosp, Div Emergency Med, Columbus, OH 43205 USA	Xiang, H (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, 700 Childrens Dr, Columbus, OH 43205 USA.; Xiang, H (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.; Xiang, H (corresponding author), Ohio State Univ, Dept Pediat, Coll Med, 370 West 9th Ave, Columbus, OH 43210 USA.	Cheng.Chen@nationwidechildrens.org; Junxin.Shi@nationwidechildrens.org; Rachel.Stanley@nationwidechildrens.org; Eric.Sribnick@nationwidechildrens.org; Jonathan.Groner@nationwidechildrens.org; Henry.Xiang@nationwidechildrens.org	Sribnick, Eric/AAH-6693-2020		Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01/HS2426301]; Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) [R40/MC29448]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS024263] Funding Source: NIH RePORTER	An abstract of this study was presented at the International Conference on Pediatrics Acquired Brain Injury, 16-18 September 2015, Liverpool, UK. This research was funded by grants from the Agency for Healthcare Research and Quality (AHRQ) (R01/HS2426301) and the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) (R40/MC29448: Emergency Medical Care of Severely Injured U.S. Children). The conclusions are those of the author and should not be construed as the official position of the funding agencies. Melody L. Davis is acknowledged for her efforts in editing the text during the revision of the manuscript.	[Anonymous], 1974, ANN EST RES POP SEX; [Anonymous], SEARCH FOR STUD; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, C TRAUM BRAIN INJ US; Chan V, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0031-x; Cook Alan, 2014, J Trauma Acute Care Surg, V76, P47, DOI 10.1097/TA.0b013e3182ab0d5d; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Kohn MA, 2004, ACAD EMERG MED, V11, P1, DOI 10.1197/S1069-656(03)00578-5; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marr A., CENTRAL NERVOUS SYST; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; The Clinical Trials Subcommittee, DES COND CLIN TRIALS; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Verger K, 2000, BRAIN INJURY, V14, P495; World health Organization, INT CLASS DIS ICD	23	15	15	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-7827	1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2017	14	4							414	10.3390/ijerph14040414			13	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	EY6PG	WOS:000404105100078	28406438	DOAJ Gold, Green Published			2021-06-18	
J	Fu, F; Qin, Z; Xu, C; Chen, XY; Li, RX; Wang, LN; Peng, DW; Sun, HT; Tu, Y; Chen, C; Zhang, S; Zhao, ML; Li, XH				Fu, Feng; Qin, Zhe; Xu, Chao; Chen, Xu-yi; Li, Rui-xin; Wang, Li-na; Peng, Ding-wei; Sun, Hong-tao; Tu, Yue; Chen, Chong; Zhang, Sai; Zhao, Ming-liang; Li, Xiao-hong			Magnetic resonance imaging-three-dimensional printing technology fabricates customized scaffolds for brain tissue engineering	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; three-dimensional printing; traumatic brain injury; tissue engineering; scaffolds; magnetic resonance imaging; collagen; chitosan; mimics; neural regeneration	COLLAGEN SCAFFOLDS; INJURY; REGENERATION; DIFFERENTIATION; TRANSPLANTATION; NEUROGENESIS; CONSEQUENCES; MECHANISMS; GROWTH; CELLS	Conventional fabrication methods lack the ability to control both macro- and micro-structures of generated scaffolds. Three-dimensional printing is a solid free-form fabrication method that provides novel ways to create customized scaffolds with high precision and accuracy. In this study, an electrically controlled cortical impactor was used to induce randomized brain tissue defects. The overall shape of scaffolds was designed using rat-specific anatomical data obtained from magnetic resonance imaging, and the internal structure was created by computer-aided design. As the result of limitations arising from insufficient resolution of the manufacturing process, we magnified the size of the cavity model prototype five-fold to successfully fabricate customized collagen-chitosan scaffolds using three-dimensional printing. Results demonstrated that scaffolds have three-dimensional porous structures, high porosity, highly specific surface areas, pore connectivity and good internal characteristics. Neural stem cells co-cultured with scaffolds showed good viability, indicating good biocompatibility and biodegradability. This technique may be a promising new strategy for regenerating complex damaged brain tissues, and helps pave the way toward personalized medicine.	[Fu, Feng; Xu, Chao; Chen, Xu-yi; Wang, Li-na; Peng, Ding-wei; Sun, Hong-tao; Tu, Yue; Chen, Chong; Zhang, Sai; Zhao, Ming-liang; Li, Xiao-hong] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Inst Traumat Brain Injury & Neurol, Tianjin, Peoples R China; [Fu, Feng; Xu, Chao; Chen, Xu-yi; Wang, Li-na; Peng, Ding-wei; Sun, Hong-tao; Tu, Yue; Chen, Chong; Zhang, Sai; Zhao, Ming-liang; Li, Xiao-hong] Key Lab Neurotrauma Repair Tianjin, Tianjin, Peoples R China; [Qin, Zhe] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Tianjin, Peoples R China; [Li, Rui-xin] Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China	Zhao, ML; Li, XH (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Inst Traumat Brain Injury & Neurol, Tianjin, Peoples R China.; Zhao, ML; Li, XH (corresponding author), Key Lab Neurotrauma Repair Tianjin, Tianjin, Peoples R China.	physolar@sohu.com; lixiaohong12@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301050, 81401067, 81271392, 81471275, 81541034]; Natural Science Foundation of Tianjin City of ChinaNatural Science Foundation of Tianjin [14JCQNJC10200, 15JCQNJC11100, 16JCYBJC27600]	This work was supported by the National Natural Science Foundation of China, No. 81301050, 81401067, 81271392, 81471275, 81541034; the Natural Science Foundation of Tianjin City of China, No. 14JCQNJC10200, 15JCQNJC11100, 16JCYBJC27600.	Ahu A-Y, 2016, BIOFABRICATION, V8; Ajioka I, 2015, TISSUE ENG PT A, V21, P193, DOI [10.1089/ten.tea.2014.0080, 10.1089/ten.TEA.2014.0080]; Alvarez Z, 2014, BIOMATERIALS, V35, P4769, DOI 10.1016/j.biomaterials.2014.02.051; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Chimene D, 2016, ANN BIOMED ENG, V44, P2090, DOI 10.1007/s10439-016-1638-y; Crozier A, 2016, ANN BIOMED ENG, V44, P58, DOI 10.1007/s10439-015-1474-5; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Domingos M, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045004; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Eagle KS, 1995, J COMP NEUROL, V363, P377, DOI 10.1002/cne.903630304; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guan YX, 2015, INT J CLIN EXP MED, V8, P14308; Haghbayan H, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0184-x; Hsieh FY, 2015, BIOMATERIALS, V71, P48, DOI 10.1016/j.biomaterials.2015.08.028; Huang KF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/672409; Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040; Jardini AL, 2014, J CRANIO MAXILL SURG, V42, P1877, DOI 10.1016/j.jcms.2014.07.006; Jiao Qian, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1318; Johnson BN, 2015, ADV FUNCT MATER, V25, P6205, DOI 10.1002/adfm.201501760; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kikinis R, 2011, IEEE ENG MED BIO, P6982, DOI 10.1109/IEMBS.2011.6091765; Klein GT, 2013, WORLD NEUROSURG, V80, P233, DOI 10.1016/j.wneu.2013.07.009; Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057; Lee JY, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045003; Lee SJ, 2017, IEEE T BIO-MED ENG, V64, P408, DOI 10.1109/TBME.2016.2558493; Leung GKK, 2012, METHOD ENZYMOL, V508, P177, DOI 10.1016/B978-0-12-391860-4.00009-4; Mahmoud AA, 2016, EUR J PHARM SCI, V83, P155, DOI 10.1016/j.ejps.2015.12.026; Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011; Maravelakis E., 2008, Journal of Medical Engineering & Technology, V32, P115, DOI 10.1080/03091900600700749; Marro A, 2016, CURR PROBL DIAGN RAD, V45, P2, DOI 10.1067/j.cpradiol.2015.07.009; Mitsouras D, 2015, RADIOGRAPHICS, V35, P1966, DOI 10.1148/rg.2015140320; Monsell F, 2014, STRATEG TRAUMA LIMB, V9, P45, DOI 10.1007/s11751-014-0188-9; Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571; Otto IA, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/3/032001; Park JH, 2017, ANN BIOMED ENG, V45, P180, DOI 10.1007/s10439-016-1611-9; Patra S, 2016, CELL BIOCHEM BIOPHYS, V74, P93, DOI 10.1007/s12013-016-0730-0; Radenkovic D, 2016, MED HYPOTHESES, V87, P30, DOI 10.1016/j.mehy.2015.12.017; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Spater T, 2016, J BIOMED MATER RES B, DOI [10.1002/jbm.b.33813:n/a-n/a, DOI 10.1002/JBM.B.33813:N/A-N/A]; Suri S, 2011, BIOMED MICRODEVICES, V13, P983, DOI 10.1007/s10544-011-9568-9; Tian LL, 2015, REGEN BIOMATER, V2, P31, DOI 10.1093/rb/rbu017; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Ventola C Lee, 2014, P T, V39, P704; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Wust S, 2015, J BIOMED MATER RES A, V103, P2558, DOI 10.1002/jbm.a.35393; Xu XH, 2014, STROKE, V45, P3433, DOI 10.1161/STROKEAHA.114.007095; Yan F, 2015, NEURAL REGEN RES, V10, P1421, DOI 10.4103/1673-5374.163466; Yang P, 2016, ZHONGGUO ZUZHI GONGC, V20, P7773; Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495; Zeng W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101300; Zhang Wei-guo, 2006, Zhonghua Yi Xue Za Zhi, V86, P1065; Zhang XY, 2015, CELL BIOCHEM BIOPHYS, V72, P777, DOI 10.1007/s12013-015-0531-x	57	15	16	0	16	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2017	12	4					614	622		10.4103/1673-5374.205101			9	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	EU3HO	WOS:000400920000025	28553343	DOAJ Gold, Green Published			2021-06-18	
J	Hoffmann, M; Czorlich, P; Lehmann, W; Spiro, AS; Rueger, JM; Lefering, R				Hoffmann, Michael; Czorlich, Patrick; Lehmann, Wolfgang; Spiro, Alexander S.; Rueger, Johannes M.; Lefering, Rolf		TraumaRegister DGU German	The Impact of Prehospital Intubation With and Without Sedation on Outcome in Trauma Patients With a GCS of 8 or Less	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						Glasgow Coma Scale; intubation; ventilation; sedation; prehospital; traumatic brain injury	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; BRAIN-INJURY; ENDOTRACHEAL INTUBATION; LIFE-SUPPORT; VENTILATION; MANAGEMENT; AIRWAY; FIELD; RISK	Background: Although unconsciousness (Glasgow Coma Scale [GCS] 3 to 8) necessitates intubation according national guidelines, there is a notable lack of evidence to support this approach. This study evaluates the impact on outcome of prehospital intubation with and without sedation in trauma patients with a GCS of r8. Methods: A retrospective cohort analysis of severely injured trauma patients registered in the TraumaRegister DGU of the German Trauma Society (DGU) from 2002 to 2013 was conducted. Only directly admitted patients alive on admission and with a GCS of r8 at the scene were included. The observed outcome was matched with the expected outcome deriving from the Revised Injury Severity Classification, version II (RISC-II). Furthermore, a Standardized Mortality Ratio (SMR) was calculated for various subgroups. Early neurological outcome was classified using the Glasgow Outcome Scale. Results: A total of 21,242 patients fulfilled the study inclusion criteria. A total of 18,975 patients (89.3%) received prehospital intubation. Intubation rates were continuously increasing with decreasing GCS score values. Difference between observed and expected mortality was lower in intubated patients (42.2% [95% confidence interval (CI), 41.5%-42.9%]; RISC-II prognosis 41.4%; SMR 1.020 [95% CI, 1.003-1.037]) compared with nonintubated (30.0% [95% CI, 28.1-31.9%] RISC-II prognosis 26.6% and SMR 1.128 [95% CI, 1.057-1.199]). Patients being sedated before intubation presented significant (P<0.001) lower observed mortality (37.7% [95% CI, 36.7-38.7%], RISCII prognosis 39.0%, SMR 0.967 [95% CI, 0.951-0.983]) associated with a less poor early neurological outcome compared with those being intubated without sedation. Conclusions: Observed outcome of prehospital intubated patients with a GCS of <= 8 seems less poor than predicted compared with nonintubated patients. Sedation before intubation might potentially decrease mortality and improve early neurological outcome. Further studies are required to clarify this issue.	[Hoffmann, Michael; Lehmann, Wolfgang; Spiro, Alexander S.; Rueger, Johannes M.] Univ Med Ctr Hamburg Eppendorf, Trauma Hand & Reconstruct Surg, Hamburg, Germany; [Hoffmann, Michael; Czorlich, Patrick; Lehmann, Wolfgang; Spiro, Alexander S.; Rueger, Johannes M.] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-D20246 Hamburg, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany	Czorlich, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-D20246 Hamburg, Germany.		Czorlich, Patrick/H-8934-2019				Bigham BL, 2013, PREHOSP EMERG CARE, V17, P361, DOI 10.3109/10903127.2013.792890; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DP, 2008, CAN MED ASSOC J, V178, P1171, DOI 10.1503/cmaj.080234; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Hatley T, 1998, J Emerg Med, V16, P731, DOI 10.1016/S0736-4679(98)00087-0; Kim D, 2014, J TRAUMA ACUTE CARE, V76, P167, DOI 10.1097/TA.0b013e3182a92596; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Seder DB, 2015, NEUROCRIT CARE, V23, pS5, DOI 10.1007/s12028-015-0164-3; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; TEASDALE G, 1974, LANCET, V2, P81; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	22	15	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	2017	29	2					161	167		10.1097/ANA.0000000000000275			7	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	EN3ZH	WOS:000395946100006	26797107				2021-06-18	
J	Hu, JJ; Yang, XL; Luo, WD; Han, S; Yin, J; Liu, WH; He, XH; Peng, BW				Hu, Jiang-Jian; Yang, Xing-Liang; Luo, Wen-Di; Han, Song; Yin, Jun; Liu, Wan-Hong; He, Xiao-Hua; Peng, Bi-Wen			Bumetanide reduce the seizure susceptibility induced by pentylenetetrazol via inhibition of aberrant hippocampal neurogenesis in neonatal rats after hypoxia-ischemia	BRAIN RESEARCH BULLETIN			English	Article						Hypoxia-ischemia brain damage; NKCC1; Bumetanide; Neurogenesis; Cognitive decline	ECTOPIC GRANULE CELLS; TEMPORAL-LOBE EPILEPSY; CATION-CHLORIDE COTRANSPORTERS; INDUCED STATUS EPILEPTICUS; TRAUMATIC BRAIN INJURY; DENTATE GYRUS; NA+-K+-2CL(-) COTRANSPORTER; BASAL DENDRITES; INTERMITTENT HYPOXIA; CORTICAL-NEURONS	Hypoxia-ischemia brain damage (HIBD) is one of prevalent causes of neonatal mortality and morbidity. Our data demonstrated that hypoxia-ischemia (HI) induced Na+-K+-Cl--co-transporter 1 (NKCC1) increasing in hippocampus. Previous studies demonstrated that NKCC1 regulates various stages of neurogenesis. In this study, we studied the role of increased NKCC1 in regulating of HI-induced neurogenesis. HIBD model was established in 7 days old Sprague-Dawley rat pup, and the expression of NKCC1 was detected by western blot and qPCR. Brain electrical activity in freely rats was monitored by electroencephalography (EEG) recordings. HI-induced neurogenesis was detected by immunofluorescence staining. Neurobehavioral test was to investigate the neuro-protective role of bumetanide, an inhibitor of NKCC1, on neonatal rats after HI. The results showed that bumetanide treatment significantly reduced brain electrical activity and the seizure stage of epilepsy induced by pentylenetetrazol (PTZ) in vivo after HI. In addition, bumetanide restored aberrant hippocampal neurogenesis and associated cognitive function. Our data demonstrated that bumetanide reduces the susceptibility of epilepsy induced by PTZ in rats suffering from HI injury during neonatal period via restoring the ectopic newborn neurons in dentate gyrus (DG) and cognitive function. (C) 2017 Elsevier Inc. All rights reserved.	[Hu, Jiang-Jian; Yang, Xing-Liang; Luo, Wen-Di; Peng, Bi-Wen] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev OriginatedDisorder, Dept Physiol, Wuhan, Hubei, Peoples R China; [Han, Song; Yin, Jun; He, Xiao-Hua] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev OriginatedDisorder, Dept Pathophysiol, Wuhan, Hubei, Peoples R China; [Liu, Wan-Hong] Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan, Hubei, Peoples R China	Peng, BW (corresponding author), Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev OriginatedDisorder, Dept Physiol, Wuhan, Hubei, Peoples R China.	pengbiwen@whu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81370737, 81571481, 81371422]	This work was supported by the National Natural Science Foundation of China (No. 81370737, 81571481 and 81371422), the authors confirm that they have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.	Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Austin JE, 2004, J COMP NEUROL, V476, P205, DOI 10.1002/cne.20182; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Beck J, 2003, J NEUROSCI, V23, P5061; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Cameron MC, 2011, J COMP NEUROL, V519, P2175, DOI 10.1002/cne.22623; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Castro OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046044; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Dai Y, 2005, CAN J PHYSIOL PHARM, V83, P767, DOI 10.1139/Y05-076; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Ellender TJ, 2014, J NEUROSCI, V34, P15208, DOI 10.1523/JNEUROSCI.1747-14.2014; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Haering C, 2015, J BIOL CHEM, V290, P9767, DOI 10.1074/jbc.M115.640656; Hochman DW, 2012, EPILEPSIA, V53, P18, DOI 10.1111/j.1528-1167.2012.03471.x; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Jung KH, 2004, EUR J NEUROSCI, V19, P3219, DOI 10.1111/j.0953-816X.2004.03412.x; Kahle KT, 2009, J CHILD NEUROL, V24, P572, DOI 10.1177/0883073809333526; Kahle KT, 2012, JASPERS BASIC MECH E; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Lee V, 2013, J NEUROPHYSIOL, V110, P2520, DOI 10.1152/jn.00047.2013; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Loscher W, 2013, NEUROPHARMACOLOGY, V69, P62, DOI 10.1016/j.neuropharm.2012.05.045; Lu K. T., 2014, PFLUGERS ARCH; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Luo J, 2008, J CEREBR BLOOD F MET, V28, P737, DOI 10.1038/sj.jcbfm.9600561; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Mejia-Gervacio S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-4; Min JW, 2015, NEUROPHARMACOLOGY, V99, P38, DOI 10.1016/j.neuropharm.2015.07.007; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068208; Noebels JL, 2010, EPILEPSIA, V51, P1, DOI 10.1111/j.1528-1167.2010.02792.x; O'Toole KK, 2014, EPILEPSY RES, V108, P29, DOI 10.1016/j.eplepsyres.2013.10.013; Parent JM, 1997, J NEUROSCI, V17, P3727; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; Puskarjov M, 2014, EPILEPSIA, V55, P806, DOI 10.1111/epi.12620; RAKIC P, 1981, J COMP NEUROL, V196, P99, DOI 10.1002/cne.901960109; Ribak CE, 2000, J COMP NEUROL, V428, P240, DOI 10.1002/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q; Ribak CE, 2012, JASPERS BASIC MECH E; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Sanchez M., 2012, EPILEPSIA; Scharfman H. E., 2002, NEUROSCIENCE; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Sivakumaran S., 2015, EPILEPSIA; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939; Thind KK, 2008, J COMP NEUROL, V509, P190, DOI 10.1002/cne.21745; Tollner K, 2015, EUR J PHARMACOL, V746, P78, DOI 10.1016/j.ejphar.2014.10.056; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Wang GB, 2014, INT J CLIN EXP PATHO, V7, P1487; WENZEL J, 1981, J HIRNFORSCH, V22, P629; Williams PA, 2004, EPILEPSIA, V45, P1210, DOI 10.1111/j.0013-9580.2004.60403.x; Xu W., 2016, MOL NEUROBIOL; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Ye ZY, 2012, J NEUROSCI, V32, P8560, DOI 10.1523/JNEUROSCI.1346-12.2012; Young SZ, 2012, J NEUROSCI, V32, P13630, DOI 10.1523/JNEUROSCI.2864-12.2012; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhan RZ, 2010, J NEUROPHYSIOL, V104, P3293, DOI 10.1152/jn.00663.2010; Zhu LL, 2005, BRAIN RES, V1055, P1, DOI 10.1016/j.brainres.2005.04.075	67	15	16	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	APR	2017	130						188	199		10.1016/j.brainresbull.2017.01.022			12	Neurosciences	Neurosciences & Neurology	EU9XZ	WOS:000401394300026	28161194				2021-06-18	
J	Lim, SW; Sung, KC; Shiue, YL; Wang, CC; Chio, CC; Kuo, JR				Lim, Sher-Wei; Sung, Kuan-Chin; Shiue, Yow-Ling; Wang, Che-Chuan; Chio, Chung-Ching; Kuo, Jinn-Rung			Hyperbaric Oxygen Effects on Depression-Like Behavior and Neuroinflammation in Traumatic Brain Injury Rats	WORLD NEUROSURGERY			English	Article						Depression-like behavior; Fluid percussion injury; Forced swim; Hippocampus; Microglia; Tumor necrosis factor-alpha	LATERAL FLUID-PERCUSSION; NECROSIS-FACTOR-ALPHA; FORCED-SWIMMING TEST; MICROGLIAL ACTIVATION; MODEL; HIPPOCAMPUS; SEROTONIN; THERAPY; ANGIOGENESIS; STIMULATION	OBJECTIVE: The aim of this study was to determine whether hyperbaric oxygen (HBO) therapy causes attenuation of traumatic brain injury (TBI)-induced depressionlike behavior and its associated anti-neuroinflammatory effects after fluid percussion injury. METHODS: Anesthetized male Sprague-Dawley rats were divided into 3 groups: sham operation plus normobaric air (NBA) (21% oxygen at 1 absolute atmosphere [ATA]), TBI plus NBA, and TBI plus HBO (100% oxygen at 2.0 ATA). HBO was applied immediately for 60 min/d after TBI for 3 days. Depression-like behavior was tested by a forced swimming test, motor function was tested by an inclined plane test, and infarction volume was tested by triphenyltetrazolium chloride (TTC) staining on days 4, 8, and 15. Neuronal apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling assay), microglial (marker OX42) activation, and tumor necrosis factor (TNF)-alpha expression in microglia in the hippocampus CA3 were measured by immunofluorescence methods. RESULTS: Compared with the TBI controls, without significant changes in TTC staining or in the motor function test, TBI-induced depression-like behavior was significantly attenuated by HBO therapy by day 15 after TBI. Simultaneously, TBI-induced neuronal apoptosis, microglial (marker OX42) activation, and TNF-alpha expression in the microglia in the hippocampus CA3 were significantly reduced by HBO. CONCLUSIONS: Our results suggest that HBO treatment may ameliorate TBI-induced depression-like behavior in rats by attenuating neuroinflammation, representing one possible mechanism by which depression-like behavior recovery might occur. We also recommend HBO as a potential treatment for TBI-induced depression-like behavior if early intervention is possible.	[Lim, Sher-Wei; Shiue, Yow-Ling] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Lim, Sher-Wei] Chi Mei Med Ctr, Dept Neurosurg, Chiali, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Sung, Kuan-Chin; Wang, Che-Chuan; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan	Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com			Chi-Mei Medical Center [NSC-102-2314-B-384 -004-MY1, CHM10217]	The research was funded by CHM10217 and NSC-102-2314-B-384 -004-MY1 grants from Chi-Mei Medical Center.	Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Basso AM, 2005, NEUROPSYCHOPHARMACOL, V30, P1257, DOI 10.1038/sj.npp.1300677; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Cao H, 2013, EXP THER MED, V5, P1609, DOI 10.3892/etm.2013.1043; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Dong Y, 2015, J PHYS THER SCI, V27, P1295, DOI 10.1589/jpts.27.1295; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Jorge R, 2002, NEUROREHABILITATION, V17, P311; Kaster MP, 2012, NEUROPHARMACOLOGY, V62, P419, DOI 10.1016/j.neuropharm.2011.08.018; Kennedy RE, 2005, J HEAD TRAUMA REHAB, V20, P512, DOI 10.1097/00001199-200511000-00004; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu S, 2015, EXP BRAIN RES, V233, P3359, DOI 10.1007/s00221-015-4405-7; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; MARTIN P, 1990, PSYCHOPHARMACOLOGY, V101, P403, DOI 10.1007/BF02244061; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MELTZER HY, 1990, ANN NY ACAD SCI, V600, P486, DOI 10.1111/j.1749-6632.1990.tb16904.x; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nemoto EM, 2007, NEUROL RES, V29, P116, DOI 10.1179/016164107X174138; Nielsen CK, 2000, BEHAV BRAIN RES, V107, P21; PORSOLT RD, 1979, EUR J PHARMACOL, V57, P201, DOI 10.1016/0014-2999(79)90366-2; Sumen-Secgin G, 2005, METHOD FIND EXP CLIN, V27, P471, DOI 10.1358/mf.2005.27.7.896829; Tai PA, 2010, J NEUROTRAUM, V27, P1121, DOI 10.1089/neu.2009.1162; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; van Heesch F, 2013, BEHAV BRAIN RES, V253, P191, DOI 10.1016/j.bbr.2013.07.038; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang CC, 2016, FORMOS J SURG, V49, P101, DOI 10.1016/j.fjs.2015.12.003; Wang CC, 2013, J SURG RES, V185, P753, DOI 10.1016/j.jss.2013.07.002; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wang Y, 1997, J NEUROSCI, V17, P4341; [尤志珺 YOU Zhi-jun], 2009, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V31, P667; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	42	15	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2017	100						128	137		10.1016/j.wneu.2016.12.118			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EV7BT	WOS:000401930000016	28065873				2021-06-18	
J	Schmidt, JD; Hoffman, NL; Ranchet, M; Miller, LS; Tomporowski, PD; Akinwuntan, AE; Devos, H				Schmidt, Julianne D.; Hoffman, Nicole L.; Ranchet, Maud; Miller, L. Stephen; Tomporowski, Phillip D.; Akinwuntan, Abiodun E.; Devos, Hannes			Driving after Concussion: Is It Safe To Drive after Symptoms Resolve?	JOURNAL OF NEUROTRAUMA			English	Article						driving safety; mild traumatic brain injury; post-concussion	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL DEFICITS; ON-ROAD; PERFORMANCE; PARKINSONS; SPORT; ASSOCIATION; IMPAIRMENTS; CONCURRENT; STATEMENT	Post-concussion impairments may result in unsafe driving performance, but little research is available to guide consensus on when concussed individuals should return to driving. The purpose of this study was to compare driving performance between individuals with and without a concussion and to explore relationships between neuropsychological and driving performance. Fourteen participants with concussion (age 20.2 +/- 0.9 years old) and 14 non-concussed age-and driving experience-matched controls (age 20.4 +/- 1.1 years old) completed a graded symptom checklist, a brief neuropsychological exam, and a 20.5 km driving simulation task. Participants with a concussion completed driving simulation within 48 h of becoming asymptomatic (15.9 +/- 9.0 days post-concussion). One-way analyses of variance were used to compare total number of crashes, tickets, and lane excursions, as well as standard deviation of lateral position (SDLP) and standard deviation of speed. Pearson's correlations were conducted to explore the relationship between the neuropsychological and driving performance separately by group (a = 0.05). Participants with a concussion committed more frequent lane excursions (concussed 10.9 +/- 4.5; controls 7.4 +/- 2.4; p = 0.017) and exhibited greater SDLP, compared with controls, during the first curve (concussed 45.7 +/- 21.3 cm, controls 27.4 +/- 6.1 cm; p = 0.030) and final curve (concussed 39.6 +/- 24.4 cm; controls 33.5 +/- 21.3 cm; p = 0.036). Poorer performance on symbol digit modalities (r = -0.54), Rey Osterrieth Complex Figure (r = -0.53), verbal memory (r = -0.77), and motor speed (r = -0.54) were correlated with more frequent lane excursions in the concussed group, but not in the control group. Despite being asymptomatic, concussed participants exhibited poorer vehicle control, especially when navigating curves. Driving impairments may persist beyond when individuals with a concussion have returned to driving. Our study provides preliminary guidance regarding which neuropsychological functions may best indicate driving impairment following concussion.	[Schmidt, Julianne D.; Hoffman, Nicole L.; Tomporowski, Phillip D.] Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA; [Miller, L. Stephen] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Ranchet, Maud; Devos, Hannes] Augusta Univ, Coll Allied Hlth Sci, Dept Phys Therapy, Augusta, GA USA; [Ranchet, Maud] Lab Ergon & Cognit Sci Appl Transport, Lyon, France; [Akinwuntan, Abiodun E.; Devos, Hannes] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu	Akinwuntan, Abiodun/G-6029-2019; Maud, Ranchet/AAF-2672-2019; Devos, Hannes/I-6852-2019	Akinwuntan, Abiodun/0000-0002-0167-685X; Maud, Ranchet/0000-0002-5325-064X; Devos, Hannes/0000-0002-8853-6840	Office of the Vice President of Research at the University of Georgia	This study was funded by the Office of the Vice President of Research at the University of Georgia.	Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Barrash J, 2010, J INT NEUROPSYCH SOC, V16, P679, DOI 10.1017/S1355617710000470; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brouwer W, 2011, HDB DRIVING SIMULATI; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Devos H, 2013, MOVEMENT DISORD, V28, P1949, DOI 10.1002/mds.25701; Devos H, 2013, DISABIL REHABIL, V35, P1387, DOI 10.3109/09638288.2012.731468; Dovoedo YH, 2015, COMMUN STAT-SIMUL C, V44, P1492, DOI 10.1080/03610918.2013.813037; Fisk GD, 1998, BRAIN INJURY, V12, P683; Grace J, 2005, J INT NEUROPSYCH SOC, V11, P766, DOI 10.1017/S135561770505848; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Kennedy R. S., 1993, Int'l. J. Aviat. Psychol., V3, P203, DOI [DOI 10.1207/S15327108IJAP0303_3, 10.1207/s15327108ijap0303_3]; Krantz J. H., 2014, MENTAL ROTATION EXPT; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marcotte TA, 2008, ARCH PHYS MED REHAB, V89, P1753, DOI 10.1016/j.apmr.2007.12.049; Mayhew DR, 2011, J SAFETY RES, V42, P267, DOI 10.1016/j.jsr.2011.06.004; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Moore Catherine, 2004, N Z Med J, V117, pU1046; Neyens DM, 2015, HUM FACTORS, V57, P1472, DOI 10.1177/0018720815594057; Owens Katherine, 2009, P43, DOI 10.1007/978-3-7643-9923-8_3; Preece M.H.W., 2016, BRAIN INJURY, V3, P1; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Reed MP, 1999, ERGONOMICS, V42, P1015, DOI 10.1080/001401399185117; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Stolwyk RJ, 2005, MOVEMENT DISORD, V20, P846, DOI 10.1002/mds.20420; Uc EY, 2009, NEUROLOGY, V73, P2112, DOI 10.1212/WNL.0b013e3181c67b77; Uc EY, 2009, NEUROLOGY, V73, P1103, DOI 10.1212/WNL.0b013e3181bacf6e; Verster JC, 2014, HUM PSYCHOPHARM CLIN, V29, P322, DOI 10.1002/hup.2406	39	15	15	3	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1571	1578		10.1089/neu.2016.4668			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500009	27959745				2021-06-18	
J	Zhou, YX				Zhou, Yongxia			Abnormal structural and functional hypothalamic connectivity in mild traumatic brain injury	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						mild traumatic brain injury; hypothalamus; functional connectivity; diffusion kurtosis; functional activity; fatigue	DIFFUSE AXONAL INJURY; KURTOSIS; MRI; TENSOR; CORTEX	PurposeTo investigate whether there is imaging evidence of hypothalamic injury in patients with mild traumatic brain injury (MTBI), which is a major public health problem due to the high prevalence and difficulty in diagnosis and treatment. Materials and MethodsTwenty-four patients (mean age 34.2, range, 18-56 years) with symptomatic MTBI and 22 age-matched healthy controls (mean age 37.0, range 20-61 years) participated in the study. Diffusion kurtosis imaging was performed with diffusion-weighted images acquired along 30 gradient directions and three b-values (b=0, 1000, 2000 s/mm(2)) based on a twice-refocused spin-echo sequence with a 3T magnetic resonance imaging (MRI) scanner. Resting-state functional (f)MRI with standard echo planar imaging (EPI) were performed to localize the resting-state networks (RSN) and hypothalamic functional connectivity. ResultsThere were significantly reduced mean kurtosis (P=0.0092) and radial kurtosis (P=0.0078) in patients as compared to controls in the hypothalamus. Furthermore, there was a significant negative correlation (r=-0.675, P=0.0007) between radial kurtosis in the hypothalamus and fatigue severity scale in patients. The MTBI group also showed disrupted hypothalamic RSNs, with significantly decreased positive connectivity in medial prefrontal cortex, inferior posterior parietal, and cingulate regions but increased connectivity in the peri-hypothalamic regions and cerebellum, together with significantly decreased negative RSNs in visual and bilateral premotor areas (cluster corrected P < 0.05). ConclusionOur results show disruption of functional and structural hypothalamic connectivity in patients with MTBI, and might further the understanding of an array of clinical symptoms in MTBI such as sleep disturbance and fatigue.	[Zhou, Yongxia] NYU, Langone Med Ctr, Ctr Biomed Imaging, Dept Radiol, New York, NY 10016 USA	Zhou, YX (corresponding author), NYU, Langone Med Ctr, Ctr Biomed Imaging, Dept Radiol, New York, NY 10016 USA.	yongxiazhou@gmail.com		Zhou, Yongxia (Sharon)/0000-0002-4931-2318	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-RO1 NS039135-10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health (NIH); contract grant number: NIH-RO1 NS039135-10.	Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Haehnel S, 2015, NEUROLOGY, V84, P554, DOI 10.1212/WNL.0000000000001244; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Jensen JH, 2011, J MAGN RESON, V210, P233, DOI 10.1016/j.jmr.2011.03.012; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kolassa IT, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-56; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Nunez A, 2009, CURR NEUROPHARMACOL, V7, P50, DOI 10.2174/157015909787602797; Pang H, 2016, J MAGN RESON IMAGING, V44, P30, DOI 10.1002/jmri.25090; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Rosenkrantz AB, 2015, J MAGN RESON IMAGING, V42, P1190, DOI 10.1002/jmri.24985; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00048; Silver JM., 2011, TXB TRAUMATIC BRAIN, V2nd ed.; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Wong PK, 2015, NEUROLOGY, V85, P921; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou Y, 2013, P ISMRM, V21, P2688; Zhou Y, RADIOLOGY, V265, P882; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2013, NEUROLOGY, V80, P1822, DOI 10.1212/WNL.0b013e318292a37d	42	15	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	APR	2017	45	4					1105	1112		10.1002/jmri.25413			8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	EP6KT	WOS:000397489100016	27467114	Green Accepted			2021-06-18	
J	Hsu, LJ; Hong, QY; Chen, ST; Kuo, HL; Schultz, L; Heath, J; Lin, SR; Lee, MH; Li, DZ; Li, ZL; Cheng, HC; Armand, G; Chang, NS				Hsu, Li-Jin; Hong, Qunying; Chen, Shur-Tzu; Kuo, Hsiang-Lin; Schultz, Lori; Heath, John; Lin, Sing-Ru; Lee, Ming-Hui; Li, Dong-Zhang; Li, Zih-Ling; Cheng, Hui-Ching; Armand, Gerard; Chang, Nan-Shan			Hyaluronan activates Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed	ONCOTARGET			English	Article						hyaluronan; hyaluronidase; Hyal-2; Smad; WWOX	DOMAIN-CONTAINING OXIDOREDUCTASE; CANDIDATE TUMOR-SUPPRESSOR; HUMAN-PROSTATE-CANCER; NECROSIS-FACTOR CYTOTOXICITY; IN-VIVO; ANGIOGENIC OLIGOSACCHARIDES; L929 FIBROBLASTS; DOWN-REGULATION; POTENTIAL ROLE; WWOX	Malignant cancer cells frequently secrete significant amounts of transforming growth factor beta (TGF-beta), hyaluronan (HA) and hyaluronidases to facilitate metastasizing to target organs. In a non-canonical signaling, TGF-beta binds membrane hyaluronidase Hyal-2 for recruiting tumor suppressors WWOX and Smad4, and the resulting Hyal-2/WWOX/Smad4 complex is accumulated in the nucleus to enhance SMAD-promoter dependent transcriptional activity. Yeast two-hybrid analysis showed that WWOX acts as a bridge to bind both Hyal-2 and Smad4. When WWOX-expressing cells were stimulated with high molecular weight HA, an increased formation of endogenous Hyal-2/WWOX/Smad4 complex occurred rapidly, followed by relocating to the nuclei in 20-40 min. In WWOX-deficient cells, HA failed to induce Smad2/3/4 relocation to the nucleus. To prove the signaling event, we designed a real time trimolecular FRET analysis and revealed that HA induces the signaling pathway from ectopic Smad4 to WWOX and finally to p53, as well as from Smad4 to Hyal-2 and then to WWOX. An increased binding of the Smad4/Hyal-2/WWOX complex occurs with time in the nucleus that leads to bubbling cell death. In contrast, HA increases the binding of Smad4/WWOX/p53, which causes membrane blebbing but without cell death. In traumatic brain injury-induced neuronal death, the Hyal-2/WWOX complex was accumulated in the apoptotic nuclei of neurons in the rat brains in 24 hr post injury, as determined by immunoelectron microscopy. Together, HA activates the Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed.	[Hsu, Li-Jin; Hong, Qunying; Chen, Shur-Tzu; Schultz, Lori; Heath, John; Chang, Nan-Shan] Guthrie Res Inst, Lab Mol Immunol, Sayre, PA 18840 USA; [Kuo, Hsiang-Lin; Lin, Sing-Ru; Lee, Ming-Hui; Li, Dong-Zhang; Li, Zih-Ling; Chang, Nan-Shan] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan, Taiwan; [Hsu, Li-Jin; Cheng, Hui-Ching] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Chen, Shur-Tzu] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan, Taiwan; [Chang, Nan-Shan] Natl Cheng Kung Univ, Adv Optoelectron Technol Ctr, Tainan, Taiwan; [Chang, Nan-Shan] China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung, Taiwan; [Armand, Gerard] GlycoMed Res Inc, Hastings On Hudson, NY USA	Chang, NS (corresponding author), Guthrie Res Inst, Lab Mol Immunol, Sayre, PA 18840 USA.; Chang, NS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan, Taiwan.; Chang, NS (corresponding author), Natl Cheng Kung Univ, Adv Optoelectron Technol Ctr, Tainan, Taiwan.; Chang, NS (corresponding author), China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung, Taiwan.	nschang13827@gmail.com	Hsu, Li-Jin/G-7822-2011		Guthrie Foundation for Education and Research; American Heart AssociationAmerican Heart Association; Department of Defense USAUnited States Department of Defense [W81XWH-08-1-0682]; Ministry of Science and Technology, Taiwan, ROCMinistry of Science and Technology, Taiwan [105-2320-B-006-046, 105-2320-B-006-036]	This work was supported, in part, by the Guthrie Foundation for Education and Research, the American Heart Association, the Department of Defense USA (W81XWH-08-1-0682), and the Ministry of Science and Technology, Taiwan, ROC (105-2320-B-006-046 and 105-2320-B-006-036). This article is in our memory of Professor Shur-Tzu Chen with deepest respect and great love. Dr. Chen passed away on February 28, 2015 with lymphoma.	Abu-Remaileh M, 2015, J BIOL CHEM, V290, P30728, DOI 10.1074/jbc.R115.676346; Aldaz CM, 2014, BBA-REV CANCER, V1846, P188, DOI 10.1016/j.bbcan.2014.06.001; Alkhateeb AM, 2016, METAB BRAIN DIS, V31, P901, DOI 10.1007/s11011-016-9827-9; Bednarek AK, 2000, CANCER RES, V60, P2140; Beech DJ, 2002, J SURG RES, V103, P203, DOI 10.1006/jsre.2002.6351; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Chang HT, 2014, ONCOTARGET, V5, P11792, DOI 10.18632/oncotarget.2961; Chang JY, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.3; Chang JY, 2015, ONCOTARGET, V6, P3578, DOI 10.18632/oncotarget.2876; Chang JY, 2010, EXP BIOL MED, V235, P796, DOI 10.1258/ebm.2010.009351; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 2016, EXP BIOL MED, V241, P1306, DOI 10.1177/1535370216644531; Chang NS, 2015, EXP BIOL MED, V240, P281, DOI 10.1177/1535370215574226; Chang NS, 1997, AM J PHYSIOL-CELL PH, V273, pC1987; Chang NS, 1998, CANCER LETT, V131, P45, DOI 10.1016/S0304-3835(98)00200-6; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2005, ONCOGENE, V24, P714, DOI 10.1038/sj.onc.1208124; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; Chang NS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-8; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chen ST, 2005, NEUROSCIENCE, V130, P397, DOI 10.1016/j.neuroscience.2004.07.054; Chen ST, 2004, NEUROSCIENCE, V124, P831, DOI 10.1016/j.neuroscience.2003.12.036; Chen SJ, 2015, ONCOTARGET, V6, P8007, DOI 10.18632/oncotarget.3153; COEZY E, 1982, CANCER RES, V42, P317; Csoka TB, 1998, GENOMICS, V48, P63, DOI 10.1006/geno.1997.5158; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; Ferguson BW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-593; Franzmann EJ, 2003, INT J CANCER, V106, P438, DOI 10.1002/ijc.11252; Frost GI, 2000, ONCOGENE, V19, P870, DOI 10.1038/sj.onc.1203317; Hsu LJ, 2009, J BIOL CHEM, V284, P16049, DOI 10.1074/jbc.M806688200; Huang SS, 2016, J BIOL CHEM, V291, P17319, DOI 10.1074/jbc.M116.716167; Husanie H, 2016, CANC RES IN PRESS; ISAACS WB, 1991, CANCER RES, V51, P4716; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Kultti Anne, 2012, Cancers (Basel), V4, P873, DOI 10.3390/cancers4030873; Lai FJ, 2005, CLIN CANCER RES, V11, P5769, DOI 10.1158/1078-0432.CCR-04-2274; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lee MH, 2015, ONCOTARGET, V6, P3737, DOI 10.18632/oncotarget.2895; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Li MY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007820; Lin Hsin-Ping, 2011, Genes Cancer, V2, P550, DOI 10.1177/1947601911418498; Lo JY, 2015, EXP BIOL MED, V240, P383, DOI 10.1177/1535370214566747; McAtee CO, 2014, ADV CANCER RES, V123, P1, DOI 10.1016/B978-0-12-800092-2.00001-0; Nikitovic D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/929531; O'Keefe LV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136356; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Park BJ, 2000, CANCER RES, V60, P3031; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Richards RI, 2015, EXP BIOL MED, V240, P338, DOI 10.1177/1535370214565990; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Schmaus A, 2014, CANCER METAST REV, V33, P1059, DOI 10.1007/s10555-014-9532-2; Schrock MS, 2015, EXP BIOL MED, V240, P296, DOI 10.1177/1535370214561590; Sherman Larry S, 2015, Int J Cell Biol, V2015, P368584, DOI 10.1155/2015/368584; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 1998, LAB INVEST, V78, P987; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Sze CI, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.251; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Tsai CW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.308; Wang J, 2015, NEUROCHEM RES, V40, P98, DOI 10.1007/s11064-014-1470-4; WOLLIN M, 1989, RADIOTHER ONCOL, V15, P285, DOI 10.1016/0167-8140(89)90097-2	65	15	16	0	3	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	MAR 21	2017	8	12					19137	19155		10.18632/oncotarget.13268			19	Oncology; Cell Biology	Oncology; Cell Biology	EO7OE	WOS:000396879200044	27845895	Other Gold, Green Published			2021-06-18	
J	Miller, AP; Shah, AS; Aperi, BV; Kurpad, SN; Stemper, BD; Glavaski-Joksimovic, A				Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra			Acute death of astrocytes in blast-exposed rat organotypic hippocampal slice cultures	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; FIBRILLARY ACIDIC PROTEIN; IN-VITRO MODEL; AMYOTROPHIC-LATERAL-SCLEROSIS; AUTOPHAGIC ASTROGLIAL DEATH; GLUTAMATE TRANSPORTER GLT-1; EXCITATORY AMINO-ACIDS; CLOSED-HEAD INJURY; CELL-DEATH	Blast traumatic brain injury (bTBI) affects civilians, soldiers, and veterans worldwide and presents significant health concerns. The mechanisms of neurodegeneration following bTBI remain elusive and current therapies are largely ineffective. It is important to better characterize blast-evoked cellular changes and underlying mechanisms in order to develop more effective therapies. In the present study, our group utilized rat organotypic hippocampal slice cultures (OHCs) as an in vitro system to model bTBI. OHCs were exposed to either 138 +/- 22 kPa (low) or 273 +/- 23 kPa (high) overpressures using an open-ended helium-driven shock tube, or were assigned to sham control group. At 2 hours (h) following injury, we have characterized the astrocytic response to a blast overpressure. Immunostaining against the astrocytic marker glial fibrillary acidic protein (GFAP) revealed acute shearing and morphological changes in astrocytes, including clasmatodendrosis. Moreover, overlap of GFAP immunostaining and propidium iodide (PI) indicated astrocytic death. Quantification of the number of dead astrocytes per counting area in the hippocampal cornu Ammonis 1 region (CA1), demonstrated a significant increase in dead astrocytes in the low- and high-blast, compared to sham control OHCs. However only a small number of GFAP-expressing astrocytes were co-labeled with the apoptotic marker Annexin V, suggesting necrosis as the primary type of cell death in the acute phase following blast exposure. Moreover, western blot analyses revealed calpain mediated breakdown of GFAP. The dextran exclusion additionally indicated membrane disruption as a potential mechanism of acute astrocytic death. Furthermore, although blast exposure did not evoke significant changes in glutamate transporter 1 (GLT-1) expression, loss of GLT-1-expressing astrocytes suggests dysregulation of glutamate uptake following injury. Our data illustrate the profound effect of blast overpressure on astrocytes in OHCs at 2 h following injury and suggest increased calpain activity and membrane disruption as potential underlying mechanisms.	[Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Miller, Anna P.; Kurpad, Shekar N.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA; [Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA	Glavaski-Joksimovic, A (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.	aglavaski@mcw.edu	Kurpad, Shekar/V-2188-2019; Stemper, Brian/AAX-7611-2020	Miller, Anna/0000-0002-6823-0852	Department of Neurosurgery, Medical College of Wisconsin; VA Medical ResearchUS Department of Veterans Affairs	This work was supported by the Department of Neurosurgery, Medical College of Wisconsin and the VA Medical Research.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Benediktsson AM, 2012, GLIA, V60, P175, DOI 10.1002/glia.21249; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bi Dan, 2015, Yichuan, V37, P140, DOI 10.16288/j.yczz.14-207; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Burda JE, 2015, EXP NEUROL; Campbell SL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00425; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Chen JL, 2013, CELL BIOCHEM BIOPHYS, V67, P1015, DOI 10.1007/s12013-013-9597-5; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Collin C, 1997, J NEUROPHYSIOL, V77, P1614; Coltman BW, 1996, INT J DEV NEUROSCI, V14, P707, DOI 10.1016/S0736-5748(96)00071-8; Conti AC, 1998, J NEUROSCI, V18, P5663; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cummings Brian S, 2004, Curr Protoc Pharmacol, VChapter 12, DOI 10.1002/0471141755.ph1208s25; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.3.CO;2-0; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Effgen GB, 2016, JOURNAL OF NEUROTRAU; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Giffard RG, 2005, GLIA, V50, P299, DOI 10.1002/glia.20167; Glavaski-Joksimovic A, 2009, NEUROSCIENCE, V162, P472, DOI 10.1016/j.neuroscience.2009.04.070; Glavaski-Joksimovic A, 2008, CLONING STEM CELLS, V10, P75, DOI 10.1089/clo.2007.0065; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heales SJR, 2004, NEUROCHEM RES, V29, P513, DOI 10.1023/B:NERE.0000014822.69384.0f; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hlavac Nora, 2015, Biomed Sci Instrum, V51, P439; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Huang QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061345; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Ibolja Cernak FAA, 2010, MEDICAL DATA, V2, P297; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; Jeremic A, 2001, J NEUROCHEM, V77, P664, DOI 10.1046/j.1471-4159.2001.00272.x; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Castejon OJ, 2015, FOLIA NEUROPATHOL, V53, P173, DOI 10.5114/fn.2015.54419; Jurado-Arjona J, 2015, BRAIN RES, V1611, P84, DOI 10.1016/j.brainres.2015.03.016; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kodama T, 1998, ULTRASOUND MED BIOL, V24, P1459, DOI 10.1016/S0301-5629(98)00094-5; Krishnamurthy K, 2016, TRANSLATIONAL RESEAR; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lee JY, 2015, J KOREAN NEUROSURG S, V58, P93, DOI 10.3340/jkns.2015.58.2.93; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Levine J, 2015, GLIA; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Liu J, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.123tr3; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Macdonald CL, 2014, JOURNAL OF NEUROTRAU; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mari C, 2004, EUR J NUCL MED MOL I, V31, P733, DOI 10.1007/s00259-004-1473-5; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mennerick S, 1998, J NEUROSCI, V18, P4490; Mewes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045017; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Morin-Brureau M, 2011, J NEUROSCI, V31, P10677, DOI 10.1523/JNEUROSCI.5692-10.2011; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Ryu HJ, 2011, BRAIN RES BULL, V85, P368, DOI 10.1016/j.brainresbull.2011.05.007; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sakai K, 2013, BRAIN INJURY, V27, P1692, DOI 10.3109/02699052.2013.837198; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; Sawyer TW, 2016, JOURNAL OF NEUROTRAU; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; Shah AS, 2012, BIOMED SCI INSTRUM, V48, P1; Shah AS, 2011, THE AMERICAN SOCIETY, P17; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Suh EC, 2008, NEUROTOXICOLOGY, V29, P691, DOI 10.1016/j.neuro.2008.04.001; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tanielian T., 2008, INVISIBLE WOUNDS OF; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang Ke-Wan, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P687; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Yong-Ming Z, 2012, AFR HEALTH SCI, V12, P552, DOI 10.4314/ahs.v12i4.24; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhou SD, 2011, BIOTECHNOL J, V6, P513, DOI 10.1002/biot.201000254; Zhu F, 2015, CHIN J TRAUMATOL, V18, P10, DOI 10.1016/j.cjtee.2014.10.001; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077; Zuo HY, 2014, INT J MED SCI, V11, P426, DOI 10.7150/ijms.6540	193	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173167	10.1371/journal.pone.0173167			25	Multidisciplinary Sciences	Science & Technology - Other Topics	EN5OE	WOS:000396054300042	28264063	DOAJ Gold, Green Published			2021-06-18	
J	Chandra, N; Sundaramurthy, A; Gupta, RK				Chandra, Namas; Sundaramurthy, Aravind; Gupta, Raj K.			Validation of Laboratory Animal and Surrogate Human Models in Primary Blast Injury Studies	MILITARY MEDICINE			English	Article							SHOCK; TBI	Blast-induced neurotrauma has affected more than 300,000 service members. It is important to understand the effect of single and repeated shock-blast wave exposures on the neuropsychological behavior of soldiers, to offer them better protection, diagnostics, and treatment. Preclinical animal models and helmet design studies on human surrogate models have relied on the use of compression gas-driven shock tubes. Traditional shock tubes are so simple that if not carefully designed and operated, the test results can easily introduce detrimental artifacts clouding the conclusions. In this work, we present live-fire test results of an instrumented human surrogate head-neck model and compare with the data obtained in a carefully designed shock tube. We present various features incorporated in the shock tube design that led to better fidelity between live-fire and laboratory shock-blast conditions. The effect of specimen placement, choice of driver gas, pressure and volume of driver, end-plate conditions, and measurement techniques all determine the successful replication of live-fire loading conditions. These parameters become more important when conducting animal testing as the totality of loading will dictate the injury severity and type which ultimately will determine the mechanisms of blast-induced neurotrauma and hence their prevention and treatment strategies.	[Chandra, Namas; Sundaramurthy, Aravind] New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med, 111 Lock St, Newark, NJ 07102 USA; [Gupta, Raj K.] US Army Med Res & Mat Command, DOD Blast Injury Res Program Coordinating Off, HQ, 504 Scott St, Ft Detrick, MD 21792 USA	Chandra, N (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med, 111 Lock St, Newark, NJ 07102 USA.		Sundaramurthy, Aravind/O-2047-2019	Sundaramurthy, Aravind/0000-0002-0359-8680	U.S. Army Research office [W911NF-08-1-0483]	NC acknowledges the financial support provided by the U.S. Army Research office with contract number W911NF-08-1-0483 and laboratory members for some of the laboratory shock field data.	Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Fomin NA, 2010, J ENG PHYS THERMOPH+, V83, P1118, DOI 10.1007/s10891-010-0437-9; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Hyde DW., 1991, CONVENTIONAL WEAPONS; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Sundaramurthy A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00253; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, V1; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wortman JD, 1982, DTIC DOCUMENT	14	15	16	0	5	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			105	113		10.7205/MILMED-D-16-00144			9	Medicine, General & Internal	General & Internal Medicine	ER6VN	WOS:000398947100018	28291460	Bronze			2021-06-18	
J	Chapple, LAS; Deane, AM; Williams, LT; Strickland, R; Schultz, C; Lange, K; Heyland, DK; Chapman, MJ				Chapple, Lee-Anne S.; Deane, Adam M.; Williams, Lauren T.; Strickland, Richard; Schultz, Chris; Lange, Kylie; Heyland, Daren K.; Chapman, Marianne J.			Longitudinal changes in anthropometrics and impact on self-reported physical function after traumatic brain injury	CRITICAL CARE AND RESUSCITATION			English	Article							X-RAY ABSORPTIOMETRY; INTENSIVE-CARE-UNIT; QUADRICEPS MUSCLE; NUTRITIONAL ASSESSMENT; CLINICAL-TRIALS; ULTRASOUND; STRENGTH; MASS; RELIABILITY; RECOVERY	Background and aims: Patients admitted to the ICU with a traumatic brain injury (TBI) are at risk of muscle wasting but this has not been quantified. Our aims were to describe longitudinal changes in anthropometrical data, compare the accuracy of non-invasive methodologies to the validated dual-energy x-ray absorptiometry (DXA), and assess the relationships between anthropometrical data and self-reported physical function. Methods: In a prospective observational study, we recruited patients admitted to the ICU with a moderate-to-severe TBI over 12 months. Anthropometric measurements included the subjective global assessment (SGA), bodyweight and ultrasound derived quadriceps muscle layer thickness (QMLT), which we performed weekly in hospital and 3 months after admission. We assessed total body composition using DXA within 7 days of ICU discharge, and compared the total lean muscle mass with ultrasound-derived QMLT taken within 5 days of the DXA measurement. We assessed functional outcomes at 3 months using the physical component score of the Short Form-36 (SF-36) and the Extended Glasgow Outcome Scale (GOS-E). Results: Thirty-seven patients were included, with a mean age of 45 years (SD, 16 years), and 87% were men. Participants were admitted to the ICU for a mean of 13 days (IQR, 6-18 days) and to hospital for a mean of 38 days (IQR, 19-52 days). They had significant weight loss in hospital (mean, 4.9% [SD, 7.7%]; P= 0.001). Malnutrition, measured with the SGA, was twice as prevalent at hospital discharge than at admission (P = 0.005). A reduction in QMLT occurred in the ICU but stabilised after ICU discharge. DXA-derived total lean mass taken within 7 days of ICU discharge strongly correlated with ultrasound-derived QMLT taken within 5 days of DXA measurements (rho = 0.74, P = 0.037). Improvements in self-reported physical function, using the SF 36 and GOS-E at 3 months, were associated with a greater QMLT at hospital discharge (SF-36: rho = 0.536, P= 0.010; GOS-E: rho = 0.595, P = 0.003, n = 23) and at 3 months (SF-36: rho = 0.658, P = 0.020; GOS-E: rho = 0.642, P = 0.025, n = 12). Conclusions: Patients with a TBI lose muscle thickness while in the ICU but the trajectory of loss stabilises after ICU discharge. Ultrasound-derived QMLT is related to total lean mass and physical function after discharge. Further studies are needed to confirm that ultrasound measurement of QMLT is a useful surrogate measure of muscle mass and functional outcomes after trauma and critical illness.	[Chapple, Lee-Anne S.; Deane, Adam M.] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia; [Chapple, Lee-Anne S.; Deane, Adam M.; Lange, Kylie; Chapman, Marianne J.] Natl Hlth & Med Res Council, Ctr Clin Res Nutr Physiol & Outcomes, Ctr Excellence Nutr Physiol & Outcomes, Adelaide, SA, Australia; [Deane, Adam M.; Strickland, Richard; Chapman, Marianne J.] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA, Australia; [Williams, Lauren T.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Schultz, Chris] Royal Adelaide Hosp, Dept Nucl Med & Bone Densitometry, Adelaide, SA, Australia; [Heyland, Daren K.] Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON, Canada	Chapple, LAS (corresponding author), Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia.; Chapple, LAS (corresponding author), Natl Hlth & Med Res Council, Ctr Clin Res Nutr Physiol & Outcomes, Ctr Excellence Nutr Physiol & Outcomes, Adelaide, SA, Australia.	lee-anne.costello@adelaide.edu.au	Deane, Adam/AAF-7370-2020; Williams, Lauren T./G-6301-2013; Chapple, Lee-anne/AAN-7751-2021	Deane, Adam/0000-0002-7620-5577; Williams, Lauren T./0000-0002-7860-0319; Chapple, Lee-anne S/0000-0002-9818-2484	Australasian Society of Parenteral and Enteral Nutrition (AuSPEN); Neurosurgical Research Foundation; Australian Post-Graduate AwardAustralian Government; Royal Adelaide Hospital Dawes Top-Up Scholarship; School of Medicine Top-Up Scholarship	We thank Amelia Kranz, Research Assistant, Discipline of Acute Care Medicine, University of Adelaide, for her contribution to data entry. Our research was funded by an Australasian Society of Parenteral and Enteral Nutrition (AuSPEN) small project grant and a Neurosurgical Research Foundation grant. L C was supported by an Australian Post-Graduate Award, a Royal Adelaide Hospital Dawes Top-Up Scholarship and a School of Medicine Top-Up Scholarship	Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; BAKER JP, 1982, NEW ENGL J MED, V306, P969, DOI 10.1056/NEJM198204223061606; Chapple LS, 2016, CLIN NUTR, DOI [10.1016/j.clftu.2016.02.0Q9, DOI 10.1016/J.CLFTU.2016.02.0Q9]; Chrispin PS, 1997, ANAESTHESIA, V52, P15, DOI 10.1111/j.1365-2044.1997.015-az014.x; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Dhandapani SS, 2007, INDIAN J NEUROTRAUM, V4, P35, DOI 10.1016/S0973-0508(07)80009-8; Duz S, 2009, EUR J SPORT SCI, V9, P181, DOI 10.1080/17461390902763425; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Fuller NJ, 1999, INT J OBESITY, V23, P1295, DOI 10.1038/sj.ijo.0801070; Gruther W, 2008, J REHABIL MED, V40, P185, DOI 10.2340/16501977-0139; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Mador MJ, 2002, AM J RESP CRIT CARE, V166, P787, DOI 10.1164/rccm.2206003; MITCHELL CO, 1982, JPEN-PARENTER ENTER, V6, P226, DOI 10.1177/0148607182006003226; Mizner RL, 2005, J ORTHOP SPORT PHYS, V35, P424, DOI 10.2519/jospt.2005.35.7.424; Modlesky CM, 2004, J APPL PHYSIOL, V96, P561, DOI 10.1152/japplphysiol.00207.2003; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Paris MT, 2017, JPEN-PARENTER ENTER, V41, P171, DOI 10.1177/0148607116637852; Parry SM, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.05.024; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Reid DB, 2016, ANAESTH INTENS CARE, V44, P406, DOI 10.1177/0310057X1604400309; Rogers J, 1997, ANAESTHESIA, V52, P1137, DOI 10.1111/j.1365-2044.1997.240-az0374.x; Segers J, 2015, INTENS CARE MED, V41, P562, DOI 10.1007/s00134-015-3668-6; Seymour JM, 2009, THORAX, V64, P418, DOI 10.1136/thx.2008.103986; SIPILA S, 1991, MUSCLE NERVE, V14, P527, DOI 10.1002/mus.880140607; Strasser EM, 2013, AGE, V35, P2377, DOI 10.1007/s11357-013-9517-z; Tillquist M, 2014, JPEN-PARENTER ENTER, V38, P886, DOI 10.1177/0148607113501327; Toombs RJ, 2012, OBESITY, V20, P30, DOI 10.1038/oby.2011.211; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Worsley PR, 2014, MANUAL THER, V19, P259, DOI 10.1016/j.math.2014.02.002	34	15	15	0	2	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	MAR	2017	19	1					29	36					8	Critical Care Medicine	General & Internal Medicine	EL9DT	WOS:000394920300006	28215129				2021-06-18	
J	Gardner, RC; Langa, KM; Yaffe, K				Gardner, Raquel C.; Langa, Kenneth M.; Yaffe, Kristine			Subjective and objective cognitive function among older adults with a history of traumatic brain injury: A population-based cohort study	PLOS MEDICINE			English	Article							ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTOR; DEMENTIA; RELIABILITY; ASSOCIATION; VALIDITY; HEALTH; INDIVIDUALS; IMPAIRMENT	Background Traumatic brain injury (TBI) is extremely common across the lifespan and is an established risk factor for dementia. The cognitive profile of the large and growing population of older adults with prior TBI who do not have a diagnosis of dementia, however, has not been well described. Our aim was to describe the cognitive profile associated with prior TBI exposure among community-dwelling older adults without dementia-an understudied but potentially vulnerable population. Methods and findings In this population-based cohort study, we studied 984 community-dwelling older adults (age 51 y and older and their spouses) without dementia who had been randomly selected from respondents to the 2014 wave of the Health and Retirement Study to participate in a comprehensive TBI survey and who either reported no prior TBI (n = 737) or prior symptomatic TBI resulting in treatment in a hospital (n = 247). Mean time since first TBI was 38 +/- 19 y. Outcomes assessed included measures of global cognitive function, verbal episodic memory, semantic fluency, and calculation as well as a measure of subjective memory ("How would you rate your memory at the present time?"). We compared outcomes between the two TBI groups using regression models adjusting for demographics, medical comorbidities, and depression. Sensitivity analyses were performed stratified by TBI severity (no TBI, TBI without loss of consciousness [LOC], and TBI with LOC). Respondents with TBI were younger (mean age 64 +/- 10 y versus 68 +/- 11 y), were less likely to be female, and had higher prevalence of medical comorbidities and depression than respondents without TBI. Respondents with TBI did not perform significantly differently from respondents without TBI on any measure of objective cognitive function in either raw or adjusted models (fully adjusted: global cognitive function score 15.4 versus 15.2, p = 0.68; verbal episodic memory score 4.4 versus 4.3, p = 0.79; semantic fluency score 15.7 versus 14.0, p = 0.21; calculation impairment 22% versus 26%, risk ratio [RR] [95% CI] = 0.86 [0.67 +/- 1.11], p = 0.24). Sensitivity analyses stratified by TBI severity produced similar results. TBI was associated with significantly increased risk for subjective memory impairment in models adjusted for demographics and medical comorbidities (29% versus 24%; RR [95% CI]: 1.26 [1.02 +/- 1.57], p = 0.036). After further adjustment for active depression, however, risk for subjective memory impairment was no longer significant (RR [95% CI]: 1.18 [0.95 +/- 1.47], p = 0.13). Sensitivity analyses revealed that risk of subjective memory impairment was increased only among respondents with TBI with LOC and not among those with TBI without LOC. Furthermore, the risk of subjective memory impairment was significantly greater among those with TBI with LOC versus those without TBI even after adjustment for depression (RR [95% CI]: partially adjusted, 1.38 [1.09 +/- 1.74], p = 0.008; fully adjusted, 1.28 [1.01 +/- 1.61], p = 0.039). Conclusions In this population-based study of community-dwelling older adults without dementia, those with prior TBI with LOC were more likely to report subjective memory impairment compared to those without TBI even after adjustment for demographics, medical comorbidities, and active depression. Lack of greater objective cognitive impairment among those with versus without TBI may be due to poor sensitivity of the cognitive battery or survival bias, or may suggest that post-TBI cognitive impairment primarily affects executive function and processing speed, which were not rigorously assessed in this study. Our findings show that among community-dwelling non-demented older adults, history of TBI is common but may not preferentially impact cognitive domains of episodic memory, attention, working memory, verbal semantic fluency, or calculation.	[Gardner, Raquel C.; Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Gardner, Raquel C.; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Langa, Kenneth M.] Univ Michigan Hlth Syst, Div Gen Med, Ann Arbor, MI USA; [Langa, Kenneth M.] Vet Affairs Ctr Practice Management & Outcomes Re, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Gardner, RC (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA.; Gardner, RC (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	raquel.gardner@ucsf.edu		Langa, Kenneth/0000-0002-2798-1836; Gardner, Raquel C./0000-0003-4028-440X	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS095755]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24 AG031155, U01 AG009740]; American Federation for Aging Research [K23 NS095755]; Weill Institute for Neurosciences; Departments of Defense and Veterans Affairs [W81XWH-12-1-0581, W81XWH-12-PHTBI-CENC]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG053760, U01AG009740, P30AG044281, K24AG031155] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke (Beeson K23 NS095755 to RCG), National Institute on Aging (K24 AG031155 to KY); the American Federation for Aging Research (K23 NS095755 to RCG); the Weill Institute for Neurosciences (to RCG), and the Departments of Defense and Veterans Affairs (W81XWH-12-1-0581 and W81XWH-12-PHTBI-CENC to KY). The Health and Retirement Study is funded by the National Institute on Aging (U01 AG009740), and performed at the Institute for Social Research, University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Farfel JM, 2013, NEUROLOGY, V81, P650, DOI 10.1212/WNL.0b013e3182a08f1b; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frieden T., 2014, REPORT C TRAUMATIC B; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hedden T, 2013, NEUROLOGY, V80, P1341, DOI 10.1212/WNL.0b013e31828ab35d; Helmes E, 2011, BRAIN INJURY, V25, P338, DOI 10.3109/02699052.2011.556104; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kaup AR, 2015, NEUROLOGY, V85, P1852, DOI 10.1212/WNL.0000000000002153; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; McKinlay A, 2016, DISABIL REHABIL 0626; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; National Institute of Neurological Disorders and Stroke, 2017, COMM DAT EL TRAUM BR; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; StataCorp, 2013, STATA STAT SOFTW REL; Suhanov AV, 2006, EUR J NEUROL, V13, P990, DOI 10.1111/j.1468-1331.2006.01391.x; Turvey C L, 1999, Int Psychogeriatr, V11, P139, DOI 10.1017/S1041610299005694; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141	59	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1277	1549-1676		PLOS MED	PLos Med.	MAR	2017	14	3							e1002246	10.1371/journal.pmed.1002246			16	Medicine, General & Internal	General & Internal Medicine	EQ2NJ	WOS:000397906100004	28267747	DOAJ Gold, Green Published			2021-06-18	
J	Genet, GF; Bentzer, P; Ostrowski, SR; Johansson, PI				Genet, Gustav Folmer; Bentzer, Peter; Ostrowski, Sisse Rye; Johansson, Paer Ingemar			Resuscitation with Pooled and Pathogen-Reduced Plasma Attenuates the Increase in Brain Water Content following Traumatic Brain Injury and Hemorrhagic Shock in Rats	JOURNAL OF NEUROTRAUMA			English	Article						brain water content; fluid percussion brain injury; hemorrhagic shock; plasma resuscitation	LARGE ANIMAL-MODEL; COLLOID ONCOTIC THERAPY; INTRACRANIAL-PRESSURE; EDEMA; VOLUME; PERMEABILITY; ELECTROLYTE; NEUTROPHILS; GLYCOCALYX; OSMOLALITY	Traumatic brain injury and hemorrhagic shock is associated with blood-brain barrier (BBB) breakdown and edema formation. Recent animal studies have shown that fresh frozen plasma (FFP) resuscitation reduces brain swelling and improves endothelial function compared to isotonic NaCl (NS). The aim of this study was to investigate whether pooled and pathogen-reduced plasma (OctaplasLG((R)) [OCTA]; Octapharma, Stockholm, Sweden) was comparable to FFP with regard to effects on brain water content, BBB permeability, and plasma biomarkers of endothelial glycocalyx shedding and cell damage. After fluid percussion brain injury, hemorrhage (20mL/kg), and 90-min shock, 48 male Sprague-Dawley rats were randomized to resuscitation with OCTA, FFP, or NS (n=16/group). Brain water content (wet/dry weight) and BBB permeability (transfer constant for Cr-51-EDTA) were measured at 24h. Plasma osmolality, oncotic pressure, and biomarkers of systemic glycocalyx shedding (syndecan-1) and cell damage (histone-complexed DNA) were measured at 0 and 23h. At 24h, brain water content was 80.44 +/- 0.39%, 80.82 +/- 0.82%, and 81.15 +/- 0.86% in the OCTA, FFP, and NS groups (lower in OCTA vs. NS; p=0.026), with no difference in BBB permeability. Plasma osmolality and oncotic pressures were highest in FFP and OCTA resuscitated, and osmolality was further highest in OCTA versus FFP (p=0.027). In addition, syndecan-1 was highest in FFP and OCTA resuscitated (p=0.010). These results suggest that pooled solvent-detergent (SD)-treated plasma attenuates the post-traumatic increase in brain water content, and that this effect may, in part, be explained by a high crystalloid and colloid osmotic pressure in SD-treated plasma.	[Genet, Gustav Folmer; Ostrowski, Sisse Rye; Johansson, Paer Ingemar] Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, Transfus Med Sect, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Bentzer, Peter] Helsingborg Hosp, Dept Anesthesia & Intens Care, Helsingborg, Sweden; [Bentzer, Peter] Lund Univ, Lund, Sweden; [Johansson, Paer Ingemar] Univ Texas Med Sch Houston, CeTIR, Dept Surg, Houston, TX USA	Genet, GF (corresponding author), Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, Transfus Med Sect, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	gustavgenet@hotmail.com	Ostrowski, Sisse R/E-7423-2011	Ostrowski, Sisse R/0000-0001-5288-3851; Johansson, Par Ingemar/0000-0001-9778-5964			Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Bansch P, 2014, ANESTHESIOLOGY, V121, P817, DOI 10.1097/ALN.0000000000000363; BENSON RE, 1980, ANAESTH INTENS CARE, V8, P152, DOI 10.1177/0310057X8000800209; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2012, SCAND J CLIN LAB INV, V72, P490, DOI 10.3109/00365513.2012.699099; Bicakci Z, 2014, TRANSFUS APHER SCI, V50, P418, DOI 10.1016/j.transci.2014.03.002; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Brown LM, 2011, J TRAUMA, V71, pS358, DOI 10.1097/TA.0b013e318227f152; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; Drummond JC, 2010, ANESTHESIOLOGY, V112, P1079, DOI 10.1097/ALN.0b013e3181d94e53; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Fenstermacher J.D., 1984, EDEMA, P384; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Heger A, 2009, VOX SANG, V97, P219, DOI 10.1111/j.1423-0410.2009.01190.x; Imam A, 2015, J NEUROTRAUM, V32, P307, DOI 10.1089/neu.2014.3535; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Jankowski S, 1995, J Intensive Care Med, V10, P91; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johansson PI, 2014, BLOOD, V124, P3052, DOI 10.1182/blood-2014-05-575340; Johansson Par I, 2013, J Emerg Trauma Shock, V6, P171, DOI 10.4103/0974-2700.115327; Jungner M, 2013, MICROVASC RES, V88, P48, DOI 10.1016/j.mvr.2013.03.004; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, pS83, DOI 10.1097/TA.0000000000000631; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; LINKO K, 1986, ACTA ANAESTH SCAND, V30, P139, DOI 10.1111/j.1399-6576.1986.tb02384.x; Liu FC, 2014, SHOCK, V41, P491, DOI 10.1097/SHK.0000000000000146; Ma AC, 2008, J THROMB HAEMOST, V6, P415, DOI 10.1111/j.1538-7836.2007.02865.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Nelson Axel, 2016, Intensive Care Med Exp, V4, P6, DOI 10.1186/s40635-016-0080-7; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Sillesen M, 2014, DAN MED J, V61; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TOMITA H, 1994, ACTA NEUROCHIR, P547; TONE O, 1994, ACTA NEUROCHIR, P568; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; WILSON RF, 1992, AM SURGEON, V58, P535; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	48	15	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1054	1062		10.1089/neu.2016.4574			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200010	27626366				2021-06-18	
J	Lagraoui, M; Sukumar, G; Latoche, JR; Maynard, SK; Dalgard, CL; Schaefer, BC				Lagraoui, Mouna; Sukumar, Gauthaman; Latoche, Joseph R.; Maynard, Sean K.; Dalgard, Clifton L.; Schaefer, Brian C.			Salsalate treatment fallowing traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery	BRAIN BEHAVIOR AND IMMUNITY			English	Article						TBI; Myeloid cells; Microglia; NF-kappaB; Salicylate; Neuroprotection; Neuroregeneration; Oxytocin; Motor function; NSAID	NF-KAPPA-B; ACID RECEPTOR-BETA; NEURONAL DEGENERATION; REACTIVE ASTROCYTES; INSULIN-RESISTANCE; NEURODEGENERATION; SALICYLATE; EXPRESSION; OXYTOCIN; GENES	Neuroinflammation plays a critical role in the pathogenesis of traumatic brain injury (TBI). TBI induces rapid activation of astrocytes and microglia, infiltration of peripheral leukocytes, and secretion of inflammatory cytokines. In the context of modest or severe TBI, such inflammation contributes to tissue destruction and permanent brain damage. However, it is clear that the inflammatory response is also necessary to promote post-injury healing. To date, anti-inflammatory therapies, including the broad class of non-steroidal anti-inflammatory drugs (NSAIDs), have met with little success in treatment of TBI, perhaps because these drugs have inhibited both the tissue-damaging and repair-promoting aspects of the inflammatory response, or because inhibition of inflammation alone is insufficient to yield therapeutic benefit. Salsalate is an unacetylated salicylate with long history of use in limiting inflammation. This drug is known to block activation of NF-KB, and recent data suggest that salsalate has a number of additional biological activities, which may also contribute to its efficacy in treatment of human disease. Here, we show that salsalate potently blocks pro-inflammatory gene expression and nitrite secretion by microglia in vitro. Using the controlled cortical impact (CCI) model in mice, we find that salsalate has a broad antiinflammatory effect on in vivo TBI-induced gene expression, when administered post-injury. Interestingly, salsalate also elevates expression of genes associated with neuroprotection and neurogenesis, including the neuropeptides, oxytocin and thyrotropin releasing hormone. Histological analysis reveals salsalate-dependent decreases in numbers and activation-associated morphological changes in microglia/macrophages, proximal to the injury site. Flow cytometry data show that salsalate changes the kinetics of CCI-induced accumulation of various populations of CD11b-positive myeloid cells in the injured brain. Behavioral assays demonstrate that salsalate treatment promotes significant recovery of function following CCI. These pre-clinical data suggest that salsalate may show promise as a TBI therapy with a multifactorial mechanism of action to enhance functional recovery.	[Lagraoui, Mouna; Latoche, Joseph R.; Schaefer, Brian C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Lagraoui, Mouna; Sukumar, Gauthaman; Latoche, Joseph R.; Maynard, Sean K.; Dalgard, Clifton L.; Schaefer, Brian C.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Sukumar, Gauthaman; Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA; [Latoche, Joseph R.] Windber Res Inst, Integrat Cardiac & Metab Hlth Program, 620 7th St, Windber, PA 15963 USA; [Maynard, Sean K.] MedImmune, One MedImmune Way,2214F, Gaithersburg, MD 20878 USA	Schaefer, BC (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	brian.schaefer@usuhs.edu	Sukumar, Gauthaman/A-1697-2018	Maynard, Sean/0000-0002-0953-4362	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM109887]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U01GM109887] Funding Source: NIH RePORTER	The authors thank A. Fu and L. Tucker for help with design and execution of TBI surgeries and behavior assays; C. Olsen for statistical consultation; D. McDaniel for help with microscopy analyses; and A. Kashyap and C. Huaman for excellent technical assistance. This work was supported by grants from the Center for Neuroscience and Regenerative Medicine and the NIH (GM109887) to B.C.S. The opinions or assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Department of Defense, the Uniformed Services University or any other agency of the U.S. Government. The authors declare no competing financial interests.	Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295; Appolloni I, 2008, CEREB CORTEX, V18, P553, DOI 10.1093/cercor/bhm092; Betts-Henderson J, 2010, HUM MOL GENET, V19, P342, DOI 10.1093/hmg/ddp500; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Burbach JPH, 2001, PHYSIOL REV, V81, P1197; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Calabresi P, 2013, MOVEMENT DISORD, V28, P51, DOI 10.1002/mds.25096; Cao YG, 2012, BIOPHARM DRUG DISPOS, V33, P285, DOI 10.1002/bdd.1797; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; de Vries EM, 2016, ENDOCRINOLOGY, V157, P2947, DOI 10.1210/en.2016-1027; DeLegge MH, 2008, NUTR CLIN PRACT, V23, P35, DOI 10.1177/011542650802300135; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gainer H, 2012, J NEUROENDOCRINOL, V24, P528, DOI 10.1111/j.1365-2826.2011.02236.x; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Gumus B, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0301-x; HARRISON LI, 1981, J CLIN PHARMACOL, V21, P401, DOI 10.1002/j.1552-4604.1981.tb01740.x; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hedner T, 1998, CLIN RHEUMATOL, V17, P17, DOI 10.1007/BF01450953; Hellewell S, 2015, BRAIN RES; Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012; Jin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041892; Karelina K, 2011, STROKE, V42, P3606, DOI 10.1161/STROKEAHA.111.628008; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Knudsen SH, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0642-1; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lewis M. M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P345, DOI 10.2174/187152706777452245; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marin I. A., 2016, NEUROPSYCHOPHARMACOL; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Paintlia MK, 2013, J BIOL CHEM, V288, P3831, DOI 10.1074/jbc.M112.405654; Perera M, 2004, MOL CELL NEUROSCI, V25, P153, DOI 10.1016/j.mcn.2003.10.004; Pierce JW, 1996, J IMMUNOL, V156, P3961; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078898; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rataj-Baniowska M, 2015, J NEUROSCI, V35, P14467, DOI 10.1523/JNEUROSCI.1278-15.2015; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Serpente P, 2005, DEVELOPMENT, V132, P503, DOI 10.1242/dev.01593; Shirakawa K, 2016, ELIFE, V5, DOI 10.7554/eLife.11156; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Soares HD, 1995, J NEUROSCI, V15, P8223; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; SWEENEY JD, 1991, THROMB RES, V61, P23, DOI 10.1016/0049-3848(91)90165-S; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644; Tay T.L., 2016, J PHYSL; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Wynshaw-Boris A, 2010, SEMIN CELL DEV BIOL, V21, P823, DOI 10.1016/j.semcdb.2010.07.008; Yin MJ, 1998, NATURE, V396, P77; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	76	15	15	0	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAR	2017	61						96	109		10.1016/j.bbi.2016.12.005			14	Immunology; Neurosciences; Psychiatry	Immunology; Neurosciences & Neurology; Psychiatry	EM5PZ	WOS:000395365900012	27939247	Green Accepted, Bronze, Green Published			2021-06-18	
J	Meyers, MC				Meyers, Michael C.			Incidence, Mechanisms, and Severity of Match-Related Collegiate Men's Soccer Injuries on FieldTurf and Natural Grass Surfaces: A 6-Year Prospective Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						artificial surface; knee; head; trauma	SCHOOL FOOTBALL INJURIES; ARTIFICIAL TURF; PLAYING SURFACE; DATA-COLLECTION; RISK-FACTORS; PLAYERS; EPIDEMIOLOGY; SPORT; PREVENTION; CONCUSSION	Background: Numerous injuries have been attributed to playing on artificial turf. More recently, newer generations of artificial turf have been developed to duplicate the playing characteristics of natural grass. Although artificial turf has been deemed safer than natural grass in some studies, few long-term studies have been conducted comparing match-related collegiate soccer injuries between the 2 playing surfaces. Hypothesis: Collegiate male soccer athletes do not experience any difference in the incidence, mechanisms, or severity of match-related injuries between FieldTurf and natural grass. Study Design: Cohort study; Level of evidence, 2. Methods: Male soccer athletes from 11 universities were evaluated over 6 seasons. Demographic features and predictors included player position, cleat design, player weight, turf age, and environmental factors. Outcomes of interest included injury incidence, injury category, time loss, injury mechanism and situation, type of injury, injury grade and anatomic location, injury severity, head and lower extremity trauma, and elective medical procedures. All match-related injuries were evaluated by the attending head athletic trainer and team physicians on site and subsequently in the physician's office when further follow-up and treatment were deemed necessary. In sum, 765 collegiate games were evaluated for match-related soccer injuries sustained on FieldTurf or natural grass during 6 seasons. Results: Overall, 380 team games (49.7%) were played on FieldTurf versus 385 team games (50.3%) played on natural grass. A total of 722 injuries were documented, with 268 (37.1%) occurring on FieldTurf and 454 (62.9%) on natural grass. Multivariate analysis per 10 team games indicated a significant playing surface effect: F-2,F-720 = 7.260, P = .001. A significantly lower total injury incidence rate (IIR) of 7.1 (95% CI, 6.6-7.5) versus 11.8 (95% CI, 11.3-12.2; P < .0001) and lower rate of substantial injuries, 0.7 (95% CI, 0.5-1.0) versus 1.9 (95% CI, 1.5-2.3; P < .03), were documented on FieldTurf versus natural grass, respectively. Analyses also indicated significantly less trauma on FieldTurf when comparing injury category, time loss, player position, injury mechanism and situation, injuries under various environmental conditions, cleat design, turf age, anatomic location, and elective medical procedures. No significant difference (F-11,F-710 = 0.822, P = .618) between surfaces by knee injury was observed, with the majority of knee injuries involving patellar tendinopathies/syndromes followed by medial collateral ligament injuries on both surfaces. Conclusion: Although similarities existed between FieldTurf and natural grass during competitive match play, FieldTurf is, in many cases, safer than natural grass when comparing injuries in collegiate men's soccer. The findings of this study, however, may not be generalizable to other levels of competition or to other artificial surfaces.	[Meyers, Michael C.] Idaho State Univ, Pocatello, ID 83209 USA	Meyers, MC (corresponding author), Idaho State Univ, Dept Sport Sci & Phys Educ, Human Performance Lab, 921 South 8th Ave, Pocatello, ID 83209 USA.	meyersgroupinc@gmail.com	FACSM, Michael C Meyers PhD/AAH-9728-2019	FACSM, Michael C Meyers PhD/0000-0003-3108-7279	FieldTurf USA	This research was partially funded by FieldTurf USA. M.C.M. has received reimbursement for attending a symposium as well as fees for speaking or organizing an educational program, conducting research, and consulting from FieldTurf USA.	Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bergfeld JA, 2001, PRINCIPLES PRACTICE, P477; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P278; Dvorak J, 2000, AM J SPORT MED, V28, pS69; Ekstrand J, 2006, BRIT J SPORT MED, V40, P975, DOI 10.1136/bjsm.2006.027623; Ekstrand J, 2011, SCAND J MED SCI SPOR, V21, P824, DOI 10.1111/j.1600-0838.2010.01118.x; Faude O, 2005, AM J SPORT MED, V33, P1694, DOI 10.1177/0363546505275011; Ford KR, 2006, J SCI MED SPORT, V9, P433, DOI 10.1016/j.jsams.2006.03.019; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Giza E, 2005, BRIT J SPORT MED, V39, P212, DOI 10.1136/bjsm.2004.011973; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagglund M, 2011, AM J SPORT MED, V39, P1906, DOI 10.1177/0363546511408877; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Junge A, 2000, AM J SPORT MED, V28, pS40; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Krosshaug T, 2005, BRIT J SPORT MED, V39, P330, DOI 10.1136/bjsm.2005.018358; Lankhorst NE, 2012, J ORTHOP SPORT PHYS, V42, P81, DOI 10.2519/jospt.2012.3803; Lee AJ, 2001, BRIT J SPORT MED, V35, P412, DOI 10.1136/bjsm.35.6.412; LEVY IM, 1990, AM J SPORT MED, V18, P406, DOI 10.1177/036354659001800413; Lindenfeld T N, 1988, Am J Sports Med, V16 Suppl 1, pS69; Livesay GA, 2006, AM J SPORT MED, V34, P415, DOI 10.1177/0363546505284182; Luthje P, 1996, SCAND J MED SCI SPOR, V6, P180; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; Meeuwisse W.H., 1994, CLIN J SPORT MED, V4, P166, DOI [DOI 10.1097/00042752-199407000-00004, 10.1097/00042752-199407000-00004]; Meyers MC, 2004, AM J SPORT MED, V32, P1626, DOI 10.1177/0363546504266978; Meyers MC, 2001, INT J SPORT PSYCHOL, V32, P29; Meyers MC, 2013, AM J SPORT MED, V41, P2409, DOI 10.1177/0363546513498994; Meyers MC, 2010, AM J SPORT MED, V38, P687, DOI 10.1177/0363546509352464; Milne C, 2011, BRIT J SPORT MED, V45, P945, DOI 10.1136/bjsm.2010.076943; National Collegiate Athletic Association, 2010, 1981 1982 2009 2010; National Federation of State High School Associations, 2011, 2010 2011 HIGH SCH A; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Noyes F R, 1988, Am J Sports Med, V16 Suppl 1, pS65; Orchard J, 2002, SPORTS MED, V32, P419, DOI 10.2165/00007256-200232070-00002; Orchard JW, 2003, MED SCI SPORT EXER, V35, P1118, DOI 10.1249/01.MSS.0000074563.61975.9B; Peterson L, 2000, AM J SPORT MED, V28, pS51; PRAGER BI, 1989, AM J SPORT MED, V17, P681, DOI 10.1177/036354658901700516; Rudicel S, 1988, Am J Sports Med, V16 Suppl 1, pS48; Sassi A, 2011, J STRENGTH COND RES, V25, P606, DOI 10.1519/JSC.0b013e3181c7baf9; Sigward SM, 2012, MED SCI SPORT EXER, V44, P1497, DOI 10.1249/MSS.0b013e31824e8813; Small K, 2010, J SCI MED SPORT, V13, P120, DOI 10.1016/j.jsams.2008.08.005; Steffen K, 2007, BRIT J SPORT MED, V41, pI33, DOI 10.1136/bjsm.2007.036665; Stiles VH, 2009, SPORTS MED, V39, P65, DOI 10.2165/00007256-200939010-00005; Swenson DM, 2010, CLIN J SPORT MED, V20, P293, DOI 10.1097/JSM.0b013e3181e8fae8; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Tabachnick B.G., 1989, USING MULTIVARIATE S; Theobald P, 2010, SPORT BIOMECH, V9, P29, DOI 10.1080/14763141003690245; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Villwock MR, 2009, AM J SPORT MED, V37, P518, DOI 10.1177/0363546508328108; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Wallace R B, 1988, Am J Sports Med, V16 Suppl 1, pS22; Williams S, 2011, SPORTS MED, V41, P903, DOI 10.2165/11593190-000000000-00000; Wong P, 2005, BRIT J SPORT MED, V39, P473, DOI 10.1136/bjsm.2004.015511	55	15	15	0	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2017	45	3					708	718		10.1177/0363546516671715			11	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	EN7RI	WOS:000396199500030	27872124				2021-06-18	
J	Pattuwage, L; Olver, J; Martin, C; Lai, F; Piccenna, L; Gruen, R; Bragge, P				Pattuwage, Loyal; Olver, John; Martin, Caius; Lai, Francis; Piccenna, Loretta; Gruen, Russell; Bragge, Peter			Management of Spasticity in Moderate and Severe Traumatic Brain Injury: Evaluation of Clinical Practice Guidelines	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						AGREE instrument; craniocerebral trauma (MeSH); head injuries (MeSH); methodological quality; muscle spasticity (MeSH); practice guideline (MeSH); quality appraisal; spasticity management; TBI; traumatic brain injury	EASTERN ASSOCIATION; AGREE II; REHABILITATION; QUALITY; IMPLEMENTATION; SURGERY	Introduction: Moderate to severe traumatic brain injury (TBI) can result in development of spasticity, which adversely affects function and quality of life. Given the foundation of optimal clinical practice is use of the best available evidence, we aimed to identify, describe, and evaluate methodological quality of evidence-based spasticity clinical practice guidelines (CPGs). Methods: A comprehensive search for CPGs encompassed electronic databases and online sources. Eligible CPGs were evaluated using the validated Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument. Results: Five CPGs were eligible for review; 2 were specific to acquired brain injury and 1 to TBI. The 3 brain injury-specific CPGs contained 423 recommendations overall, but only 8 spasticity recommendations. On the basis of AGREE appraisals, all CPGs performed well in the areas of reporting scope and purpose; clearly presenting recommendations; including various stakeholders in the CPG development process; and reporting conflict of interest. However, only one CPG performed adequately on describing facilitators and barriers to implementation, advice, and tools on how to implement recommendations and provision of audit criteria. Intraclass correlation coefficient (ICC) for agreement between raters showed high agreement (ICC > 0.80) for most guidelines. Conclusion: Given the unique etiological features and treatment challenges associated with managing spasticity after TBI, more TBI-specific spasticity CPGs are required. These should incorporate information on the facilitators and barriers to implementation, advice on implementing recommendations, and audit criteria.	[Pattuwage, Loyal] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Olver, John] Monash Univ, Epworth Hosp, Richmond, Vic, Australia; [Lai, Francis] Monash Hlth, Melbourne, Vic, Australia; [Martin, Caius] Monash Univ, Melbourne, Vic, Australia; [Piccenna, Loretta] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Gruen, Russell] Nanyang Technol Univ, Singapore, Singapore; [Bragge, Peter] Monash Univ, Monash Sustainabil Inst, Melbourne, Vic, Australia	Pattuwage, L (corresponding author), Monash Univ, Natl Trauma Res Inst, Level 1,549 St Kilda Rd, Melbourne, Vic 3004, Australia.; Pattuwage, L (corresponding author), Alfred Hosp, Level 1,549 St Kilda Rd, Melbourne, Vic 3004, Australia.	loyal.pattuwage@gmail.com	piccenna, Loretta/I-2533-2014	piccenna, Loretta/0000-0003-3895-8145; Bragge, Peter/0000-0003-0745-5131; Olver, John/0000-0001-7069-1191	Victorian Transport Accident Commission	This project was funded by the Victorian Transport Accident Commission as part of a project entitled "Harnessing Victoria's Neurotrauma Expertise: Promoting Excellence and Realising Value."	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Bell MJ, 2013, CRIT CARE CLIN, V29, P223, DOI 10.1016/j.ccc.2012.11.004; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Bragge P, 2014, J HEAD TRAUMA REHAB, V29, P277, DOI 10.1097/HTR.0000000000000066; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cincinnati Children's Hospital Medical Center, 2009, EV BAS CAR GUID SER; Alarcon JD, 2013, J TRAUMA ACUTE CARE, V75, P311, DOI 10.1097/TA.0b013e3182924bf8; Dressler D, 2005, EUR NEUROL, V53, P3, DOI 10.1159/000083259; Elbasiouny SM, 2010, NEUROREHAB NEURAL RE, V24, P23, DOI 10.1177/1545968309343213; Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603; Field MJ, 1990, CLIN PRACTICE GUIDEL; Glasziou P, 2011, BMJ QUAL SAF, V20, pI13, DOI 10.1136/bmjqs.2010.046524; Harrison MB, 2010, CAN MED ASSOC J, V182, pE78, DOI 10.1503/cmaj.081232; Hurdowar A, 2007, J EVAL CLIN PRACT, V13, P657, DOI 10.1111/j.1365-2753.2007.00708.x; Katrak Persis, 2004, BMC Med Res Methodol, V4, P22, DOI 10.1186/1471-2288-4-22; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Lance J. W., 1980, SPASTICITY DISORDERE, P485; Lundstrom E, 2010, STROKE, V41, P319, DOI 10.1161/STROKEAHA.109.558619; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; MOZAFFARIAN D, 2015, CIRCULATION, V131, pE29, DOI [DOI 10.1161/CIR.0000000000000152, 10.1161/CIR.0000000000000152]; Puerto MAN, 2008, INT J TECHNOL ASSESS, V24, P333, DOI 10.1017/S0266462308080446; New Zealand Guidelines Group, 2006, 9780478279344 ACC CO; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Royal College of Physicians, 2009, SPAST AD MAN US BOT; Rusnak M, 2008, BRATISL MED J, V109, P374; Sagher O, 2013, J NEUROSURG, V119, P1246, DOI 10.3171/2013.4.JNS13634; Saulino Michael, 2006, J Neurosci Nurs, V38, P456; Scottish Intercollegiate Guidelines Network (SIGN), 2013, BRAIN INJ REH AD NAT; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; The AGREE next Steps Consortium, 2009, APPR GUID RES EV 2 A; Truchon C, 2014, BRAIN INJURY, V28, P773; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	46	15	18	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					E1	E12		10.1097/HTR.0000000000000234			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700003	27120291				2021-06-18	
J	Ulndreaj, A; Tzekou, A; Mothe, AJ; Siddiqui, AM; Dragas, R; Tator, CH; Torlakovic, EE; Fehlings, MG				Ulndreaj, Antigona; Tzekou, Apostolia; Mothe, Andrea J.; Siddiqui, Ahad M.; Dragas, Rachel; Tator, Charles H.; Torlakovic, Emina E.; Fehlings, Michael G.			Characterization of the Antibody Response after Cervical Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						antibody-secreting cells (ASCs); astrocytes; autoantibodies; cervical spinal cord injury (cSCI); IgG/IgM immunoglobulins	FIBRILLARY ACIDIC PROTEIN; AUTOIMMUNE-DISEASE; IMMUNE SUPPRESSION; NERVOUS-SYSTEM; NATURAL IGM; T-CELLS; SERUM; NEURONS; BRAIN; SCI	The immune system plays a critical and complex role in the pathobiology of spinal cord injury (SCI), exerting both beneficial and detrimental effects. Increasing evidence suggests that there are injury level-dependent differences in the immune response to SCI. Patients with traumatic SCI have elevated levels of circulating autoantibodies against components of the central nervous system, but the role of these antibodies in SCI outcomes remains unknown. In rodent models of mid-thoracic SCI, antibody-mediated autoimmunity appears to be detrimental to recovery. However, whether autoantibodies against the spinal cord are generated following cervical SCI (cSCI), the most common level of injury in humans, remains undetermined. To address this knowledge gap, we investigated the antibody responses following cSCI in a rat model of injury. We found increased immunoglobulin G (IgG) and IgM antibodies in the spinal cord in the subacute phase of injury (2 weeks), but not in more chronic phases (10 and 20 weeks). At 2 weeks post-cSCI, antibodies were detected at the injury epicenter and co-localized with the astroglial scar and neurons of the ventral horn. These increased levels of antibodies corresponded with enhanced activation of immune responses in the spleen. Higher counts of antibody secreting cells were observed in the spleen of injured rats. Further, increased levels of secreted IgG antibodies and enhanced proliferation of T-cells in splenocyte cultures from injured rats were found. These findings suggest the potential development of autoantibody responses following cSCI in the rat. The impact of the post-traumatic antibody responses on functional outcomes of cSCI is a critical topic that requires further investigation.	[Ulndreaj, Antigona; Tzekou, Apostolia; Mothe, Andrea J.; Siddiqui, Ahad M.; Dragas, Rachel; Tator, Charles H.; Fehlings, Michael G.] Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Ulndreaj, Antigona; Tzekou, Apostolia; Mothe, Andrea J.; Siddiqui, Ahad M.; Dragas, Rachel; Tator, Charles H.; Fehlings, Michael G.] Univ Hlth Network, Univ Toronto Spinal Program, Krembil Neurosci Ctr, Toronto, ON, Canada; [Ulndreaj, Antigona; Dragas, Rachel; Tator, Charles H.; Fehlings, Michael G.] Univ Toronto, Fac Med, Inst Med Sci, 100 Coll St, Toronto, ON, Canada; [Tator, Charles H.; Fehlings, Michael G.] Univ Toronto, Dept Surg, 100 Coll St, Toronto, ON, Canada; [Tator, Charles H.; Fehlings, Michael G.] Univ Toronto, Univ Toronto Spine Program, 100 Coll St, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Dept Lab Hematol, 100 Coll St, Toronto, ON, Canada	Fehlings, MG (corresponding author), Toronto Western Hosp, 399 Bathurst St,Suite 4W449, Toronto, ON M5T 2S8, Canada.	michael.fehlings@uhn.ca		Fehlings, Michael/0000-0002-5722-6364	Stem Cell Network; Halbert Chair in Neural Repair and Regeneration; DeZwirek Foundation	We are thankful to Stem Cell Network for supporitng AU with a bursary to learn flow cytometry at the University of British Columbia Flow Cytometry Facility. We also thank Drs. Joan Wither and Tania Watts for their constructive feedback throughout the course of this study, Drs. Pia Vidal and Nicole Forgione for their feedback during the preparation of this manuscript, and Dr. Madeleine O' Higgins for copyediting this manuscript. MGF is supported by the Halbert Chair in Neural Repair and Regeneration and the DeZwirek Foundation.	ADIB M, 1990, J IMMUNOL, V145, P3807; AIHARA N, 1994, J COMP NEUROL, V342, P481, DOI 10.1002/cne.903420402; Anderson DK, 2005, SPINAL CORD, V43, P453, DOI 10.1038/sj.sc.3101746; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Baumgarth N, 2015, ANN NY ACAD SCI, V1362, P188, DOI 10.1111/nyas.12804; BENNER R, 1981, IMMUNOBIOLOGY, V158, P225, DOI 10.1016/S0171-2985(81)80072-1; BERNSTEIN JJ, 1987, BRAIN RES, V426, P112, DOI 10.1016/0006-8993(87)90430-6; BERNSTEIN JJ, 1993, INT J DEV NEUROSCI, V11, P117, DOI 10.1016/0736-5748(93)90072-L; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; BRIGHTMA.MW, 1970, J NEUROL SCI, V10, P215, DOI 10.1016/0022-510X(70)90151-6; BRINDEL I, 1994, NEUROSCI LETT, V181, P103, DOI 10.1016/0304-3940(94)90570-3; Carnini Anna, 2010, Prion, V4, P80; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Nguyen DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-224; Dvorak MF, 2014, J NEUROTRAUM, V31, P1540, DOI 10.1089/neu.2013.3278; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Ehrenstein MR, 2000, J EXP MED, V191, P1253, DOI 10.1084/jem.191.7.1253; FABIAN RH, 1990, NEUROLOGY, V40, P419, DOI 10.1212/WNL.40.3_Part_1.419; FABIAN RH, 1986, J NEUROL SCI, V73, P257, DOI 10.1016/0022-510X(86)90150-4; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Forgione N, 2014, J NEUROTRAUM, V31, P1776, DOI 10.1089/neu.2014.3388; Grammatikos AP, 2012, TRENDS MOL MED, V18, P101, DOI 10.1016/j.molmed.2011.10.005; Hauben E, 2000, LANCET, V355, P286, DOI 10.1016/S0140-6736(99)05140-5; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Holodick NE, 2010, EUR J IMMUNOL, V40, P3007, DOI 10.1002/eji.201040545; Ibarra A, 2007, SPINAL CORD, V45, P380, DOI 10.1038/sj.sc.3101972; Iversen PO, 2000, BLOOD, V96, P2081; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Jones TB, 2002, J NEUROSCI, V22, P2690, DOI 10.1523/JNEUROSCI.22-07-02690.2002; Kopp MA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-168; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Lucin KM, 2009, J NEUROCHEM, V110, P1409, DOI 10.1111/j.1471-4159.2009.06232.x; Marques CP, 2011, J VIROL, V85, P6136, DOI 10.1128/JVI.00202-11; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mori A, 2014, J NEUROL SCI, V337, P215, DOI 10.1016/j.jns.2013.11.026; Mothe AJ, 2011, SPINAL CORD, V49, P967, DOI 10.1038/sc.2011.46; National Spinal Cord Injury Statistical Center, 2015, SPIN CORD INJ FACTS; Niebroj-Dobosz I, 2004, EUR J NEUROL, V11, P13, DOI 10.1046/j.1351-5101.2003.00697.x; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Oropallo MA, 2012, J IMMUNOL, V188, P5257, DOI 10.4049/jimmunol.1101934; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Popovich PG, 2001, J NEUROTRAUM, V18, P957, DOI 10.1089/089771501750451866; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Reynolds AE, 2015, J IMMUNOL, V194, P231, DOI 10.4049/jimmunol.1401203; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Saltzman JW, 2013, J NEUROTRAUM, V30, P434, DOI 10.1089/neu.2012.2501; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sengupta MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110885; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Tzekou A, 2014, J CLIN IMMUNOL, V34, pS132, DOI 10.1007/s10875-014-0021-8; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Watzlawik JO, 2013, EXPERT REV NEUROTHER, V13, P1017, DOI 10.1586/14737175.2013.835601; Wu B, 2012, EXP NEUROL, V237, P274, DOI 10.1016/j.expneurol.2012.07.016; YAMAMOTO T, 1987, NEUROLOGY, V37, P843, DOI 10.1212/WNL.37.5.843; Yoshimi K, 2002, BRAIN RES, V956, P53, DOI 10.1016/S0006-8993(02)03479-0; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8; Zhang Y, 2013, J NEUROSCI, V33, P12970, DOI 10.1523/JNEUROSCI.1974-13.2013	70	15	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2017	34	6					1209	1226		10.1089/neu.2016.4498			18	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EN7ZR	WOS:000396221200009	27775474	Green Published			2021-06-18	
J	White, ER; Pinar, C; Bostrom, CA; Meconi, A; Christie, BR				White, Emily R.; Pinar, Cristina; Bostrom, Crystal A.; Meconi, Alicia; Christie, Brian R.			Mild Traumatic Brain Injury Produces Long-Lasting Deficits in Synaptic Plasticity in the Female Juvenile Hippocampus	JOURNAL OF NEUROTRAUMA			English	Article						gender; hippocampus; long-term potentiation; mTBI; synaptic plasticity	GABA(A) RECEPTOR ACTIVATION; DENDRITIC SPINE DENSITY; FLUID PERCUSSION INJURY; CLOSED-HEAD INJURY; DENTATE GYRUS; TERM POTENTIATION; ADULT HIPPOCAMPUS; GONADAL-STEROIDS; SEX-DIFFERENCES; COGNITIVE DEFICITS	Mild traumatic brain injury (mTBI) is becoming recognized as a significant concern in modern society. In particular, youth is being increasingly seen as a vulnerable time period for mTBI, as this is the final developmental period for the brain and typically involves robust synaptic reorganization and axonal myelination. Another issue that is being hotly debated is whether mTBI differentially impacts the male and female brain. To examine the impact of mTBI in the juvenile brain, we measured hippocampal synaptic plasticity using a closed-head mTBI model in male and female Long-Evans rats (25-28 days of age) at either 1h, 1 day, 7 days, or 28 days post-injury. In female rats, the dentate gyrus (DG) region ipsilateral to the impact showed a significant reduction in long-term potentiation (LTP) at 1 day, which persisted to 28 days following injury. In male rats, the deficit in LTP was maximal in the CA1 and DG subfields ipsilateral to the impact site 7 days post-injury; however, these deficits did not persist to 28 days post-injury. These data indicate that mTBI can produce more immediate and persistent impairments in synaptic plasticity in the female brain.	[White, Emily R.; Pinar, Cristina; Bostrom, Crystal A.; Meconi, Alicia; Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [White, Emily R.; Pinar, Cristina; Bostrom, Crystal A.; Meconi, Alicia; Christie, Brian R.] Univ Victoria, Neurosci Grad Program, Victoria, BC, Canada; [Christie, Brian R.] Univ British Columbia, Ctr Brain Hlth, Vancouver, BC, Canada; [Christie, Brian R.] Univ British Columbia, Program Neurosci, Vancouver, BC, Canada; [Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada	Christie, BR (corresponding author), Univ Victoria, Med Sci Bldg,POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.	brain64@uvic.ca	Christie, Brian/AAF-3766-2019	Christie, Brian/0000-0002-6830-0160	Agusti Pedro i Pons Foundation scholarship (Spain); Natural Sciences and Engineering Research Council (NSERC) Discovery grantNatural Sciences and Engineering Research Council of Canada (NSERC) [FRN 103103]; Canadian Institutes of Health Research (CIHR) awardCanadian Institutes of Health Research (CIHR) [FRN 125888]; Canadian Foundation for Innovation (CFI)/British Development Knowledge Development Fund (BCKDF)	The authors acknowledge assistance from Jessica DeVries, Jennifer Graham, and Christine Fontaine in this work. C.P. is a recipient of an Agusti Pedro i Pons Foundation scholarship (Spain). Funding to B.R.C. was provided by a Natural Sciences and Engineering Research Council (NSERC) Discovery grant (FRN 103103); a Canadian Institutes of Health Research (CIHR) award (FRN 125888); and Canadian Foundation for Innovation (CFI)/British Development Knowledge Development Fund (BCKDF).	Adelson PD, 1998, ACT NEUR S, V71, P104; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; ALLEN LS, 1990, J COMP NEUROL, V302, P697, DOI 10.1002/cne.903020402; ALLEN LS, 1989, J NEUROSCI, V9, P497; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amaral D G, 1993, Curr Opin Neurobiol, V3, P225, DOI 10.1016/0959-4388(93)90214-J; ANDERSEN P, 1969, ACTA PHYSIOL SCAND, V76, pA4; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P295; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; BAYER SA, 1980, J COMP NEUROL, V190, P115, DOI 10.1002/cne.901900108; Brake WG, 2001, ENDOCRINOLOGY, V142, P1284, DOI 10.1210/en.142.3.1284; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Fester L, 2015, BRAIN RES, V1621, P162, DOI 10.1016/j.brainres.2014.10.033; Foy MR, 1999, J NEUROPHYSIOL, V81, P925; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gengenbach Marianne S, 2007, CONSERVATIVE MANAGEM; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Golarai G, 2001, J NEUROSCI, V21, P8523; GOULD E, 1990, J NEUROSCI, V10, P1286; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hilton GD, 2003, NEUROSCIENCE, V116, P383, DOI 10.1016/S0306-4522(02)00716-9; HINE RJ, 1974, Z ANAT ENTWICKLUNGS, V144, P173, DOI 10.1007/BF00519773; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Isgor C, 1998, HORM BEHAV, V34, P183, DOI 10.1006/hbeh.1998.1477; Isgor C, 2003, J NEUROBIOL, V55, P179, DOI 10.1002/neu.10200; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kohn D, 2002, LAB ANIMAL MED, V2, P121, DOI DOI 10.1016/B978-012263951-7/50007-7; Kramar Eniko A, 2009, Mol Cell Pharmacol, V1, P258; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Long JA, 1920, ANA REC, V18, P244; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MADEIRA MD, 1995, PROG NEUROBIOL, V45, P275, DOI 10.1016/0301-0082(94)00052-J; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Nunez JL, 2003, EXP NEUROL, V181, P258, DOI 10.1016/S0014-4886(03)00053-0; Nunez JL, 2003, EXP NEUROL, V181, P270, DOI 10.1016/S0014-4886(03)00051-7; Ooishi Y, 2012, J STEROID BIOCHEM, V131, P37, DOI 10.1016/j.jsbmb.2011.10.004; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rabinowicz T, 1999, J CHILD NEUROL, V14, P98, DOI 10.1177/088307389901400207; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.3.CO;2-2; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; ROOF RL, 1992, BRAIN RES, V572, P310, DOI 10.1016/0006-8993(92)90491-Q; ROOF RL, 1993, BRAIN RES, V610, P148, DOI 10.1016/0006-8993(93)91228-K; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Sickmann HM, 2014, HIPPOCAMPUS, V24, P54, DOI 10.1002/hipo.22203; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Spencer JL, 2008, FRONT NEUROENDOCRIN, V29, P219, DOI 10.1016/j.yfrne.2007.08.006; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Team R.C, 2012, R LANG ENV STAT COMP; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Titterness AK, 2012, HIPPOCAMPUS, V22, P69, DOI 10.1002/hipo.20849; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; WINSON J, 1977, SCIENCE, V196, P1223, DOI 10.1126/science.193192; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; WONG M, 1992, J NEUROSCI, V12, P3217; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035; Woolley CS, 1999, CURR OPIN NEUROBIOL, V9, P349, DOI 10.1016/S0959-4388(99)80051-8; Yamashita Shin, 2011, Kurume Medical Journal, V58, P47; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 1997, TRAUMATIC BRAIN INJU; Ylvisaker M., 2002, FORGET IT SOURCES TH, P147; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065	108	15	15	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1111	1123		10.1089/neu.2016.4638			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200015	27735217				2021-06-18	
J	Fino, PC; Peterka, RJ; Hullar, TE; Murchison, C; Horak, FB; Chesnutt, JC; King, LA				Fino, Peter C.; Peterka, Robert J.; Hullar, Timothy E.; Murchison, Chad; Horak, Fay B.; Chesnutt, James C.; King, Laurie A.			Assessment and rehabilitation of central sensory impairments for balance in mTBI using auditory biofeedback: a randomized clinical trial	BMC NEUROLOGY			English	Article						Sensorimotor integration; mTBI; Concussion; Balance; Gait; Biofeedback	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; POSTURAL-CONTROL; SENSORIMOTOR INTEGRATION; HEAD-INJURY; GAIT; DIZZINESS; CONCUSSION; STABILITY; DEFICITS	Background: Complaints of imbalance are common non-resolving signs in individuals with post-concussive syndrome. Yet, there is no consensus rehabilitation for non-resolving balance complaints following mild traumatic brain injury (mTBI). The heterogeneity of balance deficits and varied rates of recovery suggest varied etiologies and a need for interventions that address the underlying causes of poor balance function. Our central hypothesis is that most chronic balance deficits after mTBI result from impairments in central sensorimotor integration that may be helped by rehabilitation. Two studies are described to 1) characterize balance deficits in people with mTBI who have chronic, non-resolving balance deficits compared to healthy control subjects, and 2) determine the efficacy of an augmented vestibular rehabilitation program using auditory biofeedback to improve central sensorimotor integration, static and dynamic balance, and functional activity in patients with chronic mTBI. Methods: Two studies are described. Study 1 is a cross-sectional study to take place jointly at Oregon Health and Science University and the VA Portland Health Care System. The study participants will be individuals with non-resolving complaints of balance following mTBI and age-and gender-matched controls who meet all inclusion criteria. The primary outcome will be measures of central sensorimotor integration derived from a novel central sensorimotor integration test. Study 2 is a randomized controlled intervention to take place at Oregon Health & Science University. In this study, participants from Study 1 with mTBI and abnormal central sensorimotor integration will be randomized into two rehabilitation interventions. The interventions will be 6 weeks of vestibular rehabilitation 1) with or 2) without the use of an auditory biofeedback device. The primary outcome measure is the daily activity of the participants measured using an inertial sensor. Discussion: The results of these two studies will improve our understanding of the nature of balance deficits in people with mTBI by providing quantitative metrics of central sensorimotor integration, balance, and vestibular and ocular motor function. Study 2 will examine the potential for augmented rehabilitation interventions to improve central sensorimotor integration.	[Fino, Peter C.; Murchison, Chad; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,L226, Portland, OR 97239 USA; [Peterka, Robert J.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Hullar, Timothy E.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97201 USA; [Peterka, Robert J.; King, Laurie A.] Vet Affairs Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR USA; [Fino, Peter C.; Horak, Fay B.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA	King, LA (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,L226, Portland, OR 97239 USA.; King, LA (corresponding author), Vet Affairs Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR USA.	kingla@ohsu.edu		Fino, Peter/0000-0002-8621-3706	 [W81XWH-15-1-0620]	This work was supported by the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-15-1-0620. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Basta D, 2005, HUM MOVEMENT SCI, V24, P268, DOI 10.1016/j.humov.2005.04.002; Beck A. T., 1996, BECK DEPRESSION INVE, P78204; Bennett RM, 2014, ARTHRIT CARE RES, V66, P1364, DOI 10.1002/acr.22301; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Capo-Aponte J. E., 2012, MIL MED, V177, P804; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Dozza M, 2005, ARCH PHYS MED REHAB, V86, P1401, DOI 10.1016/j.apmr.2004.12.036; Dozza M, 2007, EXP BRAIN RES, V178, P37, DOI 10.1007/s00221-006-0709-y; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Ernst A, 2005, SOLID MECH APPL, V124, P213; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Friend R, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3311; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Herdman SJ, 1998, OTOLARYNG HEAD NECK, V119, P49, DOI 10.1016/S0194-5998(98)70195-0; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kansagara D, 2013, COMPLICATIONS MILD T; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mancini Martina, 2011, J Bioeng Biomed Sci, VSuppl 1, P007; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2012, BR J SPORTS MED; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2003, IEEE ENG MED BIOL, V22, P63, DOI 10.1109/MEMB.2003.1195698; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterka Robert J, 2011, Front Neurol, V2, P57, DOI 10.3389/fneur.2011.00057; Pintelon R, 2001, IEEE T INSTRUM MEAS, V50, P1753, DOI 10.1109/19.982976; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; TOGLIA JU, 1970, ARCHIV OTOLARYNGOL, V92, P485; Weathers FW., 1993, ANN CONVENTION INT S; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3	65	15	15	1	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	FEB 23	2017	17								41	10.1186/s12883-017-0812-7			14	Clinical Neurology	Neurosciences & Neurology	EL5XJ	WOS:000394694500003	28231824	DOAJ Gold, Green Published			2021-06-18	
J	Baugh, CM; Kroshus, E; Kiernan, PT; Mendel, D; Meehan, WP				Baugh, Christine M.; Kroshus, Emily; Kiernan, Patrick T.; Mendel, David; Meehan, William P., III			Football Players' Perceptions of Future Risk of Concussion and Concussion-Related Health Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						American football; brain injury; chronic traumatic encephalopathy; concussion; risk	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; STATES HIGH-SCHOOL; RECURRENT CONCUSSION; UNITED-STATES; HEAD-INJURY; ILLNESS PERCEPTIONS; NCAA CONCUSSION; FEAR APPEALS; ICE HOCKEY	Concussion is increasingly recognized as a risk of participation in contact and collision sports. There have been few examinations of athletes' perceptions of their susceptibility to concussion or concussion-related health consequences. We examine college football players' perceptions of their risk of sustaining a concussion and concussion-related health consequences in their future, whether these perceptions change over time, and how concussion history is related to perceived future risk of concussion and concussion-related health consequences. A survey was administered to National Collegiate Athletic Association Division I Football Championship Series athletes on 10 teams in 2013 and to nine of those teams in 2014. Athletes answered questions assessing their perceptions of concussion and potential concussion-related health consequences. Approximately 40% of athletes believed there was a strong possibility that they would sustain a concussion in the future, while approximately one-in-four thought a concussion would make them miss a few games. About one-in-10 athletes predicted dementia, Alzheimer's disease, or chronic traumatic encephalopathy would develop from concussions. These beliefs were stronger among athletes who had sustained previous concussions. Across the two years studied, athletes' perceptions of the risk of concussion and missing a few games because of concussion decreased significantly. Overall, a substantial proportion of college football players believe they will have long-term health consequences as a result of sustaining sport-related concussions. The true incidence and prevalence of many of these outcomes are unknown. Further research is needed to determine whether athletes have an accurate perception of the risks of these outcomes developing.	[Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, 14 Story St,Fourth Floor, Cambridge, MA 02138 USA; [Baugh, Christine M.; Mendel, David; Meehan, William P., III] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Boston, MA USA; [Baugh, Christine M.; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Kiernan, Patrick T.] Boston Univ, Chron Traumat Encephalopathy Ctr, Boston, MA 02215 USA; [Meehan, William P., III] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA	Baugh, CM (corresponding author), Harvard Univ, Interfac Initiat Hlth Policy, 14 Story St,Fourth Floor, Cambridge, MA 02138 USA.	cbaugh@g.harvard.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; Edmond J. Safra Center for Ethics at Harvard University; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER	C.M.B. is supported by the National Institute of Mental Health of Award Number T32MH019733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was funded, in part, by a grant from the Edmond J. Safra Center for Ethics at Harvard University. The authors would like to thank the athletes who contributed to this research and to the sports medicine providers and coaches who fostered the athletes' participation.	Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Houck Z, 2016, AM J SPORTS MED; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leventhal H, 1980, MED PSYCHOL, P7; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moreau M. S., 2014, INT J EXERC SCI, V7, P8; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Rothman Alexander J., 1999, Journal of the National Cancer Institute Monographs, P44; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	60	15	15	2	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					790	797		10.1089/neu.2016.4585			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200005	27526721	Green Published			2021-06-18	
J	Genc, S; Anderson, V; Ryan, NP; Malpas, CB; Catroppa, C; Beauchamp, MH; Silk, TJ				Genc, Sila; Anderson, Vicki; Ryan, Nicholas P.; Malpas, Charles B.; Catroppa, Cathy; Beauchamp, Miriam H.; Silk, Timothy J.			Recovery of White Matter following Pediatric Traumatic Brain Injury Depends on Injury Severity	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; pediatric; severity; traumatic brain injury; white matter	SPORTS-RELATED CONCUSSION; TENSOR IMAGING DETECTS; CORPUS-CALLOSUM; AXONAL INJURY; DIFFUSION; CHILDHOOD; CHILDREN; DTI; INTEGRITY; MICROSTRUCTURE	Previous studies in pediatric traumatic brain injury (TBI) have been variable in describing the effects of injury severity on white-matter development. The present study used diffusion tensor imaging to investigate prospective sub-acute and longitudinal relationships between early clinical indicators of injury severity, diffusion metrics, and neuropsychological outcomes. Pediatric patients with TBI underwent magnetic resonance imaging (MRI) (n = 78, mean [M] = 10.56, standard deviation [SD] = 2.21 years) at the sub-acute stage after injury (M = 5.55, SD = 3.05 weeks), and typically developing children were also included and imaged (n = 30, M = 10.60, SD = 2.88 years). A sub-set of the patients with TBI (n = 15) was followed up with MRI 2 years post-injury. Diffusion MRI images were acquired at sub-acute and 2-year follow-up time points and analyzed using Tract-Based Spatial Statistics. At the sub-acute stage, mean diffusivity and axial diffusivity were significantly higher in the TBI group compared with matched controls (p < 0.05). TBI severity significantly predicted diffusion profiles at the sub-acute and 2-year post-injury MRI. Patients with more severe TBI also exhibited poorer information processing speed at 6-months post-injury, which in turn correlated with their diffusion metrics. These findings highlight that the severity of the injury not only has an impact on white-matter microstructure, it also impacts its recovery over time. Moreover, findings suggest that sub-acute microstructural changes may represent a useful prognostic marker to identify children at elevated risk for longer term deficits.	[Genc, Sila; Anderson, Vicki; Ryan, Nicholas P.; Malpas, Charles B.; Catroppa, Cathy; Silk, Timothy J.] Murdoch Childrens Res Inst, Dev Imaging, Clin Sci, Melbourne, Vic, Australia; [Anderson, Vicki; Ryan, Nicholas P.; Catroppa, Cathy] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Silk, Timothy J.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia	Genc, S (corresponding author), Royal Childrens Hosp, Dev Imaging, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	sila.genc@mcri.edu.au	Malpas, Charles/L-4741-2019; Silk, Tim/K-4295-2019; Ryan, Nicholas/K-5445-2019	Ryan, Nicholas/0000-0002-0878-8889; Silk, Tim/0000-0002-7290-512X; Genc, Sila/0000-0002-4624-7071	Victoria Neurotrauma Initiative, Australia; Murdoch Childrens Research Institute; Royal Children's Hospital; Royal Children's Hospital Foundation; Department of Paediatrics, University of Melbourne; Victorian Government's Operational Infrastructure Support Program	This work was supported by a grant from the Victoria Neurotrauma Initiative, Australia. This research was conducted within the Australian Centre for Child Neuropsychological Studies and Developmental Imaging research groups, Murdoch Childrens Research Institute and the Children's MRI Centre, Royal Children's Hospital, Melbourne, Victoria. It was supported by the Murdoch Childrens Research Institute, The Royal Children's Hospital, The Royal Children's Hospital Foundation, The Department of Paediatrics, The University of Melbourne and the Victorian Government's Operational Infrastructure Support Program.	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beauchamp MH, 2011, BRAIN INJURY, V25, P950, DOI 10.3109/02699052.2011.589791; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Bobinski M, 2000, NEUROSCIENCE, V95, P721; Bonett DG, 2008, PSYCHOL METHODS, V13, P99, DOI 10.1037/1082-989X.13.2.99; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Chaddock-Heyman L, 2013, BIOL PSYCHOL, V94, P109, DOI 10.1016/j.biopsycho.2013.05.008; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kantarci K, 2010, NEUROLOGY, V74, P1814, DOI 10.1212/WNL.0b013e3181e0f7cf; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Sasson E, 2012, BRAIN STRUCT FUNCT, V217, P503, DOI 10.1007/s00429-011-0344-7; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; TEASDALE G, 1974, LANCET, V2, P81; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHLSER ABBREVIATED; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	47	15	15	2	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					798	806		10.1089/neu.2016.4584			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200006	27468807				2021-06-18	
J	Wang, WX; Sullivan, PG; Springer, JE				Wang, Wang-Xia; Sullivan, Patrick G.; Springer, Joe E.			Mitochondria and microRNA crosstalk in traumatic brain injury	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY			English	Article						Traumatic brain injury; Mitochondrial function; Glutamate excitotoxicity; Oxidative damage	CENTRAL-NERVOUS-SYSTEM; NEURONAL CELL-DEATH; CORTICAL IMPACT; DOWN-REGULATION; DYSFUNCTION; EXPRESSION; APOPTOSIS; RESPONSES; RAT; HIPPOCAMPUS	Traumatic brain injury (TBI) is a leading cause of long-term impairments in higher cognitive functioning, including deficits in attention and memory. It is well known that some of these persistent deficits are related, in part, to ongoing secondary injury events characterized by pervasive biochemical and pathophysiological stressors, including a rapid and sustained phase of mitochondrial dysfunction. A loss of mitochondrial function impacts a number of important cellular events and we have begun to investigate the novel hypothesis that mitochondria play a critical role in regulating the cellular activity of specific microRNAs in response to cellular demands and stressors. In this special issue report, we summarize briefly the rationale for investigating the crosstalk between mitochondria and microRNA, and provide recent preliminary data suggesting that mitochondria-microRNA interactions are modified in response to TBI-related cellular stressors. We postulate that this interaction is critical for regulating appropriate cellular microRNA responses, which opens up opportunities for therapeutic interventions targeting both mitochondrial function and microRNA activity. (C) 2016 Elsevier Inc. All rights reserved.	[Wang, Wang-Xia] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Springer, Joe E.] Univ Kentucky, Phys Med & Rehabil, Lexington, KY 40536 USA; [Sullivan, Patrick G.; Springer, Joe E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Sullivan, Patrick G.; Springer, Joe E.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA	Wang, WX (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Springer, JE (corresponding author), Univ Kentucky, Phys Med & Rehabil, Lexington, KY 40536 USA.	wwangc@email.uky.edu; jspring@uky.edu	Wang, Wang-Xia/AAD-6900-2019	Wang, Wang-Xia/0000-0002-8104-3779	Kentucky Spinal Cord and Head Injury Research Trust [15-12A]	Supported by grant #15-12A from the Kentucky Spinal Cord and Head Injury Research Trust.	Bandiera S, 2013, FREE RADICAL BIO MED, V64, P12, DOI 10.1016/j.freeradbiomed.2013.06.013; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Colamaio M, 2015, J CLIN ENDOCR METAB, V100, pE59, DOI 10.1210/jc.2014-2280; Danger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060702; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Fordham JB, 2015, J LEUKOCYTE BIOL, V98, P195, DOI 10.1189/jlb.1A1014-519RR; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Hollander JM, 2014, AM J PHYSIOL-HEART C, V307, pH1, DOI 10.1152/ajpheart.00747.2013; Hu Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/728342; Huang L, 2011, J BIOL CHEM, V286, P24219, DOI 10.1074/jbc.M111.240259; Jagannathan R, 2015, CIRC-CARDIOVASC GENE, V8, P785, DOI 10.1161/CIRCGENETICS.115.001067; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li PF, 2012, J CELL BIOCHEM, V113, P1104, DOI 10.1002/jcb.24004; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Liu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095514; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu NK, 2011, PHYSIOL GENOMICS, V43, P571, DOI 10.1152/physiolgenomics.00168.2010; Marciano PG, 2004, J NEUROSCI, V24, P2866, DOI 10.1523/JNEUROSCI.5051-03.2004; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Ouyang YB, 2015, ANTIOXID REDOX SIGN, V22, P187, DOI 10.1089/ars.2013.5757; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sripada L, 2012, MITOCHONDRION, V12, P593, DOI 10.1016/j.mito.2012.10.009; Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873; Su SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9523; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Wang WX, 2015, NEURAL REGEN RES, V10, P1026, DOI 10.4103/1673-5374.160061; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang Wang-Xia, 2014, Genomics Proteomics & Bioinformatics, V12, P19, DOI 10.1016/j.gpb.2013.10.003; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Watson William D, 2013, Front Neuroenergetics, V5, P12, DOI 10.3389/fnene.2013.00012; Wong JJ., 2016, NUCL ACIDS RES; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218	54	15	16	1	27	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-5846	1878-4216		PROG NEURO-PSYCHOPH	Prog. Neuro-Psychopharmacol. Biol. Psychiatry	FEB 6	2017	73						104	108		10.1016/j.pnpbp.2016.02.011			5	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	ED8ZR	WOS:000389160100013	26925707				2021-06-18	
J	DiCesare, CA; Kiefer, AW; Nalepka, P; Myer, GD				DiCesare, Christopher A.; Kiefer, Adam W.; Nalepka, Patrick; Myer, Gregory D.			Quantification and analysis of saccadic and smooth pursuit eye movements and fixations to detect oculomotor deficits	BEHAVIOR RESEARCH METHODS			English	Article						Concussion; Oculomotor; Eye tracking; Saccade; Fixation; Smooth pursuit	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; MILD; CONCUSSION; TARGET; RECOVERY; SYSTEM	Assessment of deficits in oculomotor functionmay be useful to detect visuomotor impairments due to a closed head injury. Systematic analysis schemes are needed to reliably quantify oculomotor deficits associated with oculomotor impairment via brain trauma. We propose a systematic, automated analysis scheme using various eye-tracking tasks to assess oculomotor function in a cohort of adolescents with acute concussion symptoms and aged-matched healthy controls. From these data we have evidence that thesemethods reliably detect oculomotor deficits in the concussed group, including reduced spatial accuracy and diminished tracking performance during visually guided prosaccade and self-paced saccade tasks. The accuracy and tracking deficits are consistent with prior studies on oculomotor function, while introducing novel discriminatory measures relative to fixation assessments -methodologically, a less complicated measure of performance - and thus represent a reliable and simple scheme of detection and analysis of oculomotor deficits associated with brain injury.	[DiCesare, Christopher A.; Kiefer, Adam W.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA; [Kiefer, Adam W.; Nalepka, Patrick] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Kiefer, Adam W.; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Ohio State Univ, Sports Hlth & Performance Inst, Columbus, OH 43210 USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Boston, MA USA	DiCesare, CA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Sports Med, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	christopher.dicesare@cchmc.org	Kiefer, Adam/F-1756-2018; DiCesare, Christopher/AAA-3327-2021; DiCesare, Christopher/ABH-9573-2020; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422; Nalepka, Patrick/0000-0003-1719-8044	state of Ohio Emergency Medical Services grant; Q30 Sports Sciences, LLC	This work was funded in part by a state of Ohio Emergency Medical Services grant and also by Q30 Sports Sciences, LLC.	Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; BECKER W, 1985, EXP BRAIN RES, V57, P562; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Ettinger U, 2003, PSYCHOPHYSIOLOGY, V40, P620, DOI 10.1111/1469-8986.00063; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; KAPOULA Z, 1985, VISION RES, V25, P1155, DOI 10.1016/0042-6989(85)90105-1; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Olsen A, 2012, TOBII I VT FIXATION; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2	22	15	15	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1554-351X	1554-3528		BEHAV RES METHODS	Behav. Res. Methods	FEB	2017	49	1					258	266		10.3758/s13428-015-0693-x			9	Psychology, Mathematical; Psychology, Experimental	Psychology	EP2FJ	WOS:000397198300018	26705117	Bronze			2021-06-18	
J	Karelina, K; Gaier, KR; Prabhu, M; Wenger, V; Corrigan, TED; Weil, ZM				Karelina, Kate; Gaier, Kristopher R.; Prabhu, Maya; Wenger, Vanessa; Corrigan, Timothy E. D.; Weil, Zachary M.			Binge ethanol in adulthood exacerbates negative outcomes following juvenile traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; Alcohol; Axon degeneration; Microglia; Neuroinflammation; Learning and memory; Neurogenesis	SEIZURE-INDUCED NEUROGENESIS; INDUCED NEUROINFLAMMATION; ALCOHOLIC BRAINS; SUBSTANCE-ABUSE; MICROGLIA; EXPRESSION; CELLS; EPIDEMIOLOGY; RECEPTORS; DRINKING	Traumatic brain injuries (TBI) are a major public health problem with enormous costs in terms of health care dollars, lost productivity, and reduced quality of life. Alcohol is bidirectionally linked to TBI as many TBI patients are intoxicated at the time of their injury and we recently reported that, in accordance with human epidemiological data, animals injured during juvenile development self-administered significantly more alcohol as adults than did sham injured mice. There are also clinical data that drinking after TBI significantly reduces the efficacy of rehabilitation and leads to poorer long-term outcomes. In order to determine whether juvenile traumatic brain injury also increased the vulnerability of the brain to the toxic effects of high dose alcohol, mice were injured at 21 days of age and then seven weeks later treated daily with binge-like levels of alcohol 5 g/kg (by oral gavage) for ten days. Binge-like alcohol produced a greater degree of neuronal damage and neuroinflammation in mice that sustained a TBI. Further, mice that sustained a juvenile TBI exhibited mild learning and memory impairments in adulthood following binge alcohol and express a significant increase in hippocampal ectopic localization of newborn neurons. Taken together, these data provide strong evidence that a mild brain injury occurring early in life renders the brain highly vulnerable to the consequences of binge-like alcohol consumption. (C) 2016 Elsevier Inc. All rights reserved.	Ohio State Univ, Dept Neurosci, Grp Behav Neuroendocrinol, Wexner Med Ctr, Columbus, OH 43210 USA; Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA	Karelina, K (corresponding author), Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA.	Ekaterina.karelina@osumc.edu	Weil, Zachary M/A-2439-2008; Weil, Zachary M/B-5003-2008	Weil, Zachary M/0000-0003-3758-1809; Weil, Zachary M/0000-0003-3758-1809; Karelina Weil, Kate/0000-0002-6628-0768	OSU Neurological Institute Pilot Award; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS045758]	This work was supported by an OSU Neurological Institute Pilot Award and the National Institutes of Health (NS045758). The authors gratefully acknowledge Joseph Abraham, Katie Centner, Samuel Nicholson, Benjamin Sarac, and Lauren Martin for their assistance and support on these experiments. We also thank Dr. Kristina Kigerl for guidance through the microglial extraction protocol and Dr. Jacqueline Barker for assistance with the BEC assay.	Abr`amoff M.D., 2005, BIOPHOTONICS INT, V11, P36, DOI [10.1117/1.3589100, DOI 10.1117/1.3589100]; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Berry C, 2011, AM SURGEON, V77, P1416; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bilbo SD, 2008, BRAIN BEHAV IMMUN, V22, P451, DOI 10.1016/j.bbi.2007.10.003; Bilbo SD, 2010, PSYCHONEUROENDOCRINO, V35, P369, DOI 10.1016/j.psyneuen.2009.07.014; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI 10.1089/neu.2008-0849; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bowers M. S., ALCOHOL CLI IN PRESS; Boyadjieva NI, 2010, ALCOHOL CLIN EXP RES, V34, P1835, DOI 10.1111/j.1530-0277.2010.01271.x; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chastain LG, 2014, INT REV NEUROBIOL, V118, P81, DOI [10.1016/B978-0-12-801284-0.00004-X, 10.1016/B978-0-12-801284-0.00001-X]; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dodd PR, 2000, NEUROCHEM INT, V37, P509, DOI 10.1016/S0197-0186(00)00061-9; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Ikegami Y, 2003, NEUROSCI LETT, V349, P201, DOI 10.1016/S0304-3940(03)00826-7; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; KREUTZER J S, 1990, Brain Injury, V4, P1, DOI 10.3109/02699059009026142; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McClain JA, 2011, BRAIN BEHAV IMMUN, V25, pS120, DOI 10.1016/j.bbi.2011.01.006; Montesinos J, 2016, BRAIN BEHAV IMMUN, V53, P159, DOI 10.1016/j.bbi.2015.12.006; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; PRENCIPE L, 1987, CLIN CHEM, V33, P486; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-130; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Vaaramo K, 2014, J NEUROL NEUROSUR PS, V85, P598, DOI 10.1136/jnnp-2012-304457; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Yang JY, 2014, PHARMACOL THERAPEUT, V144, P321, DOI 10.1016/j.pharmthera.2014.07.002	48	15	15	0	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	FEB	2017	60						304	311		10.1016/j.bbi.2016.11.009			8	Immunology; Neurosciences; Psychiatry	Immunology; Neurosciences & Neurology; Psychiatry	EH6UA	WOS:000391908200031	27845195				2021-06-18	
J	Khaing, ZZ; Cates, LN; Fischedick, AE; McClintic, AM; Mourad, PD; Hofstetter, CP				Khaing, Zin Z.; Cates, Lindsay N.; Fischedick, Amanda E.; McClintic, Abbi M.; Mourad, Pierre D.; Hofstetter, Christoph P.			Temporal and Spatial Evolution of Raised Intraspinal Pressure after Traumatic Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						intraspinal pressure; spinal cord injury	INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; ANIMAL-MODEL; DECOMPRESSION; COMPRESSION; MYELOPATHY	Traumatic spinal cord injury (SCI) often leads to permanent neurological impairment. Currently, the only clinically effective intervention for patients with acute SCI is surgical decompression by removal of impinging bone fragments within 24 h after injury. Recent clinical studies suggest that elevated intraparenchymal spinal pressure (ISP) limits functional recovery following SCI. Here, we report on the temporal and spatial patterns of elevated ISP following a moderate rodent contusion SCI. Compared with physiological ISP in the intact cord (2.7+/-0.5mm Hg), pressures increase threefold 30 min following injury (8.9+/-1.1mm Hg, p < 0.001) and remain elevated for up to 7 days (4.3+/-0.8mm Hg). Measurements of rostrocaudal ISP distribution reveal peak pressures in the injury center and in segments rostral to the injury during the acute phase(<= 24 h). During the subacute phase(>= 72 h), peak ISP decreases while a 7.5 mm long segment of moderately elevated ISP remains, centered on the initial contusion site. Interestingly, the contribution of the dural and pial compartments toward increased ISP changes with time after injury: Dural and pial linings contribute almost equally to increased ISP during the acute phase, whereas the dural lining is primarily responsible for elevated ISP during the subacute phase (78.9%). Our findings suggest that a rat contusion SCI model in combination with novel micro-catheters allows for direct measurement of ISP after SCI. Similarly to traumatic brain injury, raised tissue pressure is likely to have detrimental effects on spontaneous recovery following SCI.	[Khaing, Zin Z.; Cates, Lindsay N.; Fischedick, Amanda E.; McClintic, Abbi M.; Mourad, Pierre D.; Hofstetter, Christoph P.] Univ Washington, Dept Neurol Surg, Campus Box 356470,Room RR734 1959 NE Pacific St, Seattle, WA 98195 USA	Hofstetter, CP (corresponding author), Univ Washington, Dept Neurol Surg, Campus Box 356470,Room RR734 1959 NE Pacific St, Seattle, WA 98195 USA.	chh9045@uw.edu		Khaing, Zin/0000-0001-5652-5891	Department of Neurological Surgery; University of WashingtonUniversity of Washington [65-3210]	This work was supported by the start-up funds from the Department of Neurological Surgery and the Royalty Research Fund from the University of Washington (65-3210) to CPH. The authors would also like to thank Dr. Nikolai C. Dembrow for help with writing a custom code in Igor Pro.	BALENTINE JD, 1978, LAB INVEST, V39, P254; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cao Y., 2011, TOP SPINAL CORD INJ, V16, P10, DOI DOI 10.1310/SCI1604-10; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; GELLAD F, 1983, AM J NEURORADIOL, V4, P614; Hurlbert R John, 2015, Neurosurgery, V76 Suppl 1, pS71, DOI 10.1227/01.neu.0000462080.04196.f7; Jones CF, 2012, SPINE, V37, pE1422, DOI 10.1097/BRS.0b013e31826ba7cd; Jones CF, 2012, SPINE, V37, pE890, DOI 10.1097/BRS.0b013e3182553d1d; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Martirosyan NL, 2015, NEUROSURGERY, V76, P461, DOI 10.1227/NEU.0000000000000638; Meagher TM, 2012, SPINAL CORD, V50, P638, DOI 10.1038/sc.2011.133; MENDELOW AD, 1983, J NEUROSURG, V58, P45, DOI 10.3171/jns.1983.58.1.0045; MILLEN JW, 1961, BRAIN, V84, P514, DOI 10.1093/brain/84.3.514; Miller BA, 2016, WORLD NEUROSURG, V88, DOI 10.1016/j.wneu.2015.11.058; MILLER JD, 1986, NEUROSURGERY, V19, P253, DOI 10.1227/00006123-198608000-00012; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NICHOLAS DS, 1988, J NEUROSURG, V69, P276, DOI 10.3171/jns.1988.69.2.0276; Noussitou FL, 2015, VET SURG, V44, P944, DOI 10.1111/vsu.12399; Okada S, 2014, SPINE J, V14, pE9, DOI 10.1016/j.spinee.2014.08.449; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sakka L., 2015, NEUROSURGERY; SCIMS, 2015, SPIN CORD INJ SCI FA; SHAPIRO K, 1977, SURG NEUROL, V7, P275; SOMERSON SK, 1987, EXP NEUROL, V96, P82, DOI 10.1016/0014-4886(87)90170-1; Soubeyrand M, 2012, SPINE, V37, pE1376, DOI 10.1097/BRS.0b013e318269790f; Surkin J, 2000, SPINE, V25, P716, DOI 10.1097/00007632-200003150-00011; Ulbrich EJ, 2014, RADIOLOGY, V271, P172, DOI 10.1148/radiol.13120370; van Asbeck FWA, 2000, SPINAL CORD, V38, P420, DOI 10.1038/sj.sc.3101003; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; YU YL, 1983, AM J NEURORADIOL, V4, P839	36	15	15	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2017	34	3					645	651		10.1089/neu.2016.4490			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EI9GJ	WOS:000392815600012	27503121				2021-06-18	
J	Kunitake, RC; Howard, BM; Kornblith, LZ; Christie, SA; Conroy, AS; Cohen, MJ; Callcut, RA				Kunitake, Ryan C.; Howard, Benjamin M.; Kornblith, Lucy Z.; Christie, Sabrinah A.; Conroy, Amanda S.; Cohen, Mitchell J.; Callcut, Rachael A.			Individual clotting factor contributions to mortality following trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Clotting factors; hemorrhage; trauma-related mortality	PRINCIPAL COMPONENT ANALYSIS; ACTIVATED PROTEIN-C; TISSUE FACTOR; ORGAN FAILURE; COAGULOPATHY; COAGULATION; INJURY; HEMOSTASIS; HYPOPERFUSION; HEMORRHAGE	BACKGROUND: Acute traumatic coagulopathy affects 20% to 30% of trauma patients, but the extensive collinearity of the coagulation cascade complicates attempts to clarify global clotting factor dysfunction. This study aimed to characterize phenotypes of clotting factor dysfunction and their contributions to mortality after major trauma. METHODS: This prospective cohort study examines all adult trauma patients of the highest activation level presenting to San Francisco General Hospital between February 2005 and February 2015. Factors II, V, VII, VIII, IX, and X and protein C activity on admission and mortality status at 28 days were assessed. Predictors of 28-day mortality in univariate analysis were included in multiple logistic regression controlling for traumatic brain injury (TBI), acidosis, age, and mechanism of injury. Principal component analysis was utilized to identify phenotypic coagulation. RESULTS: Complete coagulation factor data were available for 876 (61%) of 1,429 patients. In multiple logistic regression, factors V (odds ratio [OR], 0.86; 95% confidence interval [CI], 0.76-0.97), VIII (OR, 0.97; 95% CI, 0.95-0.99), and X (OR, 0.79; 95% CI, 0.68-0.92) and protein C (OR, 1.17; 95% CI, 1.05-1.30) significantly predicted 28-day mortality after controlling for age, base deficit, mechanism of injury, and TBI. Principal component analysis identified two significant principal components (Phenotypes 1 and 2) that accounted for 66.3% of the total variance. Phenotype 1 (factors II, VII, IX, and X and protein C abnormalities) explained 49.3% and was associated with increased injury, coagulopathy, TBI, and mortality. Phenotype 2 (factors V and VIII abnormalities) explained 17.0% and was associated with increased coagulopathy, blunt injury, and mortality. Only Phenotype 2 remained significantly associated with 28-day mortality in multiple logistic regression. CONCLUSIONS: Principal component analysis identified two distinct phenotypes within the entirety of global clotting factor abnormalities, and these findings substantiate the crucial association of factors Vand VIII on mortality following trauma. This may be the first step toward identifying unique phenotypes after injury and personalizing hemostatic resuscitation. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Kunitake, Ryan C.; Howard, Benjamin M.; Kornblith, Lucy Z.; Christie, Sabrinah A.; Conroy, Amanda S.; Cohen, Mitchell J.; Callcut, Rachael A.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Kunitake, Ryan C.; Howard, Benjamin M.; Kornblith, Lucy Z.; Christie, Sabrinah A.; Conroy, Amanda S.; Cohen, Mitchell J.; Callcut, Rachael A.] Zuckerberg San Francisco Gen Hosp, Dept Surg, 1001 Potrero Ave,Ward 3A, San Francisco, CA 94110 USA	Callcut, RA (corresponding author), Zuckerberg San Francisco Gen Hosp, Dept Surg, 1001 Potrero Ave,Ward 3A, San Francisco, CA 94110 USA.	Rachael.Callcut@ucsf.edu			National Center for Advancing Translational Sciences, National Institutes of Health (NIH) via the University of California San Francisco Clinical and Translational Institute [TL1 TR000144]; career development award from the National Institute of Environmental Health Sciences, National Institute of Health Big Data to Knowledge Initiative [K01ES026834]; Department of DefenseUnited States Department of Defense [W81XWH-10-1-0509]; NIH Tactic Grant [1UM1HL120877]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000144] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER	R.C.K. is supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) via the University of California San Francisco Clinical and Translational Institute (TL1 TR000144). R.A.C. is supported with a career development award from the National Institute of Environmental Health Sciences, National Institute of Health Big Data to Knowledge Initiative (K01ES026834). Additional funding was provided by the Department of Defense (W81XWH-10-1-0509) and NIH Tactic Grant (1UM1HL120877).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Chin TL, 2014, SURGERY, V156, P570, DOI 10.1016/j.surg.2014.04.030; Christiaans SC, 2013, AM J PHYSIOL-LUNG C, V305, pL455, DOI 10.1152/ajplung.00093.2013; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Dobson GP, 2015, J TRAUMA ACUTE CARE, V79, P301, DOI 10.1097/TA.0000000000000729; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Dunteman GH., 1989, PRINCIPAL COMPONENTS; Esmon CT, 2012, SEMIN IMMUNOPATHOL, V34, P127, DOI 10.1007/s00281-011-0284-6; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Howard BM, 2015, J TRAUMA ACUTE CARE, V79, P1009, DOI 10.1097/TA.0000000000000707; Jansen JO, 2011, J TRAUMA, V71, pS435, DOI 10.1097/TA.0b013e318232e5cb; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kerlin BA, 2003, BLOOD, V102, P3085, DOI 10.1182/blood-2003-06-1789; Kutcher ME, 2015, J TRAUMA ACUTE CARE, V78, P516, DOI 10.1097/TA.0000000000000545; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Liang HPH, 2015, BLOOD, V126, P2415, DOI 10.1182/blood-2015-05-644401; Lu Rommel P, 2013, J Trauma Acute Care Surg, V74, P1474, DOI 10.1097/TA.0b013e3182923193; Mackman N, 2009, ANESTH ANALG, V108, P1447, DOI 10.1213/ane.0b013e31819bceb1; Oshiro A, 2014, CRIT CARE, V18, DOI 10.1186/cc13816; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rizoli S, 2013, J TRAUMA ACUTE CARE, V74, P1229; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Utter GH, 2002, J TRAUMA, V52, P1071, DOI 10.1097/00005373-200206000-00008; Zulian MC, 2015, LANGENBECK ARCH SURG, V400, P589, DOI 10.1007/s00423-015-1290-2	29	15	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2017	82	2					302	308		10.1097/TA.0000000000001313			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	EJ8GO	WOS:000393463600014	27906868	Green Accepted			2021-06-18	
J	Nam, SJ; Park, EY				Nam, Su-Jung; Park, Eun-Young			Relationship between caregiving burden and depression in caregivers of individuals with intellectual disabilities in Korea	JOURNAL OF MENTAL HEALTH			English	Article						Caregiving burden; caregiver depression; individuals with intellectual disabilities	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CES-D; PSYCHOLOGICAL DISTRESS; INFORMAL CAREGIVERS; DEMENTIA; CHILDREN; PARENTS; HEALTH; SCALE	Background: Individuals with intellectual disabilities (IWID) need intensive long-term care. Consequently, caregivers experience not only economic burdens but also tension, depression, insecurity, etc.Aim: This study aimed to provide basic data and materials for preparing policy alternatives to improve caregiver quality of life of by examining relationships between IWID caregiving burden and depression.Methods: This study involved secondary analysis of data from the 2011 Survey on the Actual Conditions of Individuals with Developmental Disabilities, conducted by the Ministry of Health and Welfare of Korea. Effects of caregivers' characteristics, caregiving time and cost, and perceptions of time and cost, on depression were analyzed.Results: All components of caregiving burden and depression were significantly higher in the 1st grade, designating the most severe disabilities. Overall, caregiving burden tended to be higher in female caregivers, the unemployed, parents, co-residents, and people with health problems. Caregivers' characteristics such as spouse relationship, having health problems, and perception of caregiving time and cost were associated with depression.Conclusion: Caregiving burden and depression vary depending on the characteristics of IWID and their caregivers. Services for decreasing caregiving burden may be optimized by focusing on these characteristics.	[Nam, Su-Jung] Jeonju Univ, Coll Educ, Dept Home Econ Educ, Jeonju, Jeollabuk Do, South Korea; [Park, Eun-Young] Jeonju Univ, Coll Educ, Dept Secondary Special Educ, 45 Baengma Gil, Jeonju, Jeollabuk Do, South Korea	Park, EY (corresponding author), Jeonju Univ, Coll Educ, Dept Secondary Special Educ, 45 Baengma Gil, Jeonju, Jeollabuk Do, South Korea.	eunyoung@jj.ac.kr					AGRELL B, 1989, STROKE, V20, P1190, DOI 10.1161/01.STR.20.9.1190; Blacher J, 1997, FAM RELAT, V46, P325, DOI 10.2307/585093; Buhse M, 2008, J NEUROSCI NURS, V40, P25, DOI 10.1097/01376517-200802000-00005; Bull M, 1990, WESTERN J NURS RES, V23, P756; Burgener S, 2002, ALZ DIS ASSOC DIS, V16, P88, DOI 10.1097/00002093-200204000-00006; Carretero S, 2009, ARCH GERONTOL GERIAT, V49, P74, DOI 10.1016/j.archger.2008.05.004; Cho NO, 1996, THESIS; Clyburn LD, 2000, J GERONTOL B-PSYCHOL, V55, pS2, DOI 10.1093/geronb/55.1.s2; Davis NO, 2008, J AUTISM DEV DISORD, V38, P1278, DOI 10.1007/s10803-007-0512-z; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; Gellis ZD, 2010, J GERONTOL SOC WORK, V53, P289, DOI 10.1080/01634371003741417; Grayson DA, 2000, J GERONTOL B-PSYCHOL, V55, pP273, DOI 10.1093/geronb/55.5.P273; Grzywacz JG, 2006, HISPANIC J BEHAV SCI, V28, P404, DOI 10.1177/0739986306290645; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; Ingersoll D, 1996, GERONTOLOGIST, V44, P318; Kim H, 1996, KOREA J RES GERONTOL, V5, P107; 이영휘, 2008, [The Journal of Fundamentals of Nursing, 기본간호학회지], V15, P274; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; KOSBERG JI, 1986, GERONTOLOGIST, V26, P273, DOI 10.1093/geront/26.3.273; Kwon JD, 1995, THESIS; Lai DWL, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012470467; Lee AS, 2003, HLTH SOC SCI, V13, P29; Lee HS, 2012, J KOREAN ACAD NURS, V42, P236, DOI 10.4040/jkan.2012.42.2.236; Lee S., 1994, THESIS; Lee Y-W, 2007, J NURS QUERY, V16, P135; Lehmann V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-109; Magana SM, 2007, PSYCHIAT SERV, V58, P378, DOI 10.1176/appi.ps.58.3.378; Mannse Hoe，, 2015, [Mental Health & Social Work, 정신건강과 사회복지], V43, P313; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Meyers J L, 2001, Oncol Nurs Forum, V28, P73; Molyneux GJ, 2008, INT PSYCHOGERIATR, V20, P1193, DOI 10.1017/S1041610208007515; MONTGOMERY RJV, 1985, FAM RELAT, V34, P19, DOI 10.2307/583753; MORRIS LW, 1988, BRIT J MED PSYCHOL, V61, P231, DOI 10.1111/j.2044-8341.1988.tb02784.x; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Papastavrou E, 2007, J ADV NURS, V58, P446, DOI 10.1111/j.1365-2648.2007.04250.x; Park C, 2003, J WELFARE AGED, V20, P179; Parks SM, 2000, AM FAM PHYSICIAN, V62, P2613; Phipps S, 2005, J PEDIATR PSYCHOL, V30, P139, DOI 10.1093/jpepsy/jsi002; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126, DOI 10.1093/geronb/62.2.P126; Raina Parminder, 2004, BMC Pediatr, V4, P1, DOI 10.1186/1471-2431-4-1; Sawyer MG, 2011, DEV MED CHILD NEUROL, V53, P338, DOI 10.1111/j.1469-8749.2010.03848.x; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Serrano-Aguilar PG, 2006, NEUROEPIDEMIOLOGY, V27, P136, DOI 10.1159/000095760; Silver EJ, 1998, J PEDIATR PSYCHOL, V23, P5, DOI 10.1093/jpepsy/23.1.5; SLOPER P, 1993, J CHILD PSYCHOL PSYC, V34, P167, DOI 10.1111/j.1469-7610.1993.tb00978.x; Thompson A, 2008, INT J GERIATR PSYCH, V23, P511, DOI 10.1002/gps.1929; Wada K, 2007, AM J IND MED, V50, P8, DOI 10.1002/ajim.20403; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Yoo SH, 2004, J WELFARE AGED I, V26, P191; Yoon Hyun-sook, 2007, [Journal of the Korea Gerontological Society, 한국노년학], V27, P195; Yun E., 2010, J WELFARE AGED, V47, P289; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; 백용운, 2010, [Korean Journal of Gerontological Social Welfare, 노인복지연구], V49, P215	54	15	16	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0963-8237	1360-0567		J MENT HEALTH	J. Ment. Heal.	FEB	2017	26	1					50	56		10.1080/09638237.2016.1276538			7	Psychology, Clinical	Psychology	EM3EY	WOS:000395198500009	28084102				2021-06-18	
J	Folweiler, KA; Bondi, CO; Ogunsanya, EA; LaPorte, MJ; Leary, JB; Radabaugh, HL; Monaco, CM; Kline, AE				Folweiler, Kaitlin A.; Bondi, Corina O.; Ogunsanya, Elizabeth A.; LaPorte, Megan J.; Leary, Jacob B.; Radabaugh, Hannah L.; Monaco, Christina M.; Kline, Anthony E.			Combining the Antipsychotic Drug Haloperidol and Environmental Enrichment after Traumatic Brain Injury Is a Double-Edged Sword	JOURNAL OF NEUROTRAUMA			English	Article						antipsychotic drugs; behavioral outcome; controlled cortical impact; environmental enrichment; functional recovery; learning and memory; Morris water maze; traumatic brain injury	CONTROLLED CORTICAL IMPACT; WATER MAZE PERFORMANCE; RAT CEREBRAL-CORTEX; COGNITIVE FUNCTION; ATYPICAL ANTIPSYCHOTICS; LIPID-PEROXIDATION; WORKING-MEMORY; UNITED-STATES; IN-VIVO; RECOVERY	Environmental enrichment (EE) confers significant benefits after experimental traumatic brain injury (TBI). In contrast, the antipsychotic drug (APD) haloperidol (HAL) exerts deleterious effects on neurobehavioral and cognitive recovery. Neurorehabilitation and management of agitation, however, are integral components of the treatment strategy for patients with TBI. Hence, the goal of this study was to determine how the two therapeutic approaches interact and influence motor and cognitive recovery. Anesthetized adult male rats received a controlled cortical impact (2.8mmtissue deformation at 4 m/sec) or sham injury and then were provided HAL (0.5 mg/kg; intraperitoneally [IP]) or vehicle (VEH; 1 mL/kg; IP) commencing 24 h after surgery and once daily for 19 days while housed in EE or standard (STD) conditions. Beam balance/walk and Morris water maze performance were assessed on post-injury days 1-5 and 14-19, respectively, followed immediately by quantification of cortical lesion volumes. The data revealed both expected and unexpected findings. It was not surprising that the TBI groups receiving EE performed significantly better than those in STD housing and that the TBI + STD + HAL group performed worse than the TBI + STD + VEH group (p < 0.05). What was surprising was that the therapeutic effects of EE were greatly reduced by concomitant administration of HAL. No differences in cortical lesion volumes were observed among the groups (p > 0.05). The potential clinical implications of these findings suggest that administering HAL to patients undergoing neurorehabilitation may be a double-edged sword because agitation must be controlled before rehabilitation can be safely initiated and executed, but its use may compromise therapeutic efficacy.	[Folweiler, Kaitlin A.; Bondi, Corina O.; Ogunsanya, Elizabeth A.; LaPorte, Megan J.; Leary, Jacob B.; Radabaugh, Hannah L.; Monaco, Christina M.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Folweiler, Kaitlin A.; Bondi, Corina O.; Ogunsanya, Elizabeth A.; LaPorte, Megan J.; Leary, Jacob B.; Radabaugh, Hannah L.; Monaco, Christina M.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Folweiler, Kaitlin A.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Folweiler, Kaitlin A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Leary, Jacob B.] NIH, Dept Rehabil Med, Ctr Clin, Bethesda, MD 20892 USA; [Monaco, Christina M.] Philadelphia Coll Osteopath Med, Philadelphia, PA USA	Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Psychol, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Bondi, Corina/0000-0002-5733-4912	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS060005, R01HD069620, HD069620-S1, R01NS084967]; University of Pittsburgh Physicians / UPMC Academic Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants R01NS060005, R01HD069620, HD069620-S1, R01NS084967 (AEK) and the University of Pittsburgh Physicians / UPMC Academic Foundation (COB).	Abadi AHA, 2016, BEHAV PHARMACOL, V27, P270, DOI 10.1097/FBP.0000000000000197; BENES FM, 1985, BRAIN RES, V329, P265, DOI 10.1016/0006-8993(85)90532-3; Besret L, 2000, EUR J PHARMACOL, V408, P35, DOI 10.1016/S0014-2999(00)00747-0; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Briones TL, 2011, J NEUROTRAUM, V28, P2485, DOI 10.1089/neu.2011.1842; CADET JL, 1994, NEUROSCI BIOBEHAV R, V18, P457, DOI 10.1016/0149-7634(94)90001-9; CAMPBELL A, 1985, PSYCHOPHARMACOLOGY, V87, P161, DOI 10.1007/BF00431801; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Crofton EJ, 2015, NEUROSCI BIOBEHAV R, V49, P19, DOI 10.1016/j.neubiorev.2014.11.017; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; DIAMOND MC, 1976, J NEUROBIOL, V7, P75, DOI 10.1002/neu.480070108; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Galili-Mosberg R, 2000, J NEURAL TRANSM, V107, P479, DOI 10.1007/s007020070089; Hajheidari S, 2015, NEUROSCI LETT, V605, P39, DOI 10.1016/j.neulet.2015.08.010; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; HOVDA DA, 1985, P W PHARMACOL SOC, V28, P209; Hutchings EJ, 2013, J PHARMACOL EXP THER, V347, P547, DOI 10.1124/jpet.113.209031; KAPETANOVIC IM, 1982, J PHARMACOL EXP THER, V221, P434; Karl T, 2006, BEHAV BRAIN RES, V171, P286, DOI 10.1016/j.bbr.2006.04.004; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Klitenick MA, 1996, NEUROPSYCHOPHARMACOL, V15, P424, DOI 10.1016/0893-133X(96)00017-6; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leary L. B., 2016, J NEUROTRAUMA; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Li XJ, 2015, NEUROSCI LETT, V599, P92, DOI 10.1016/j.neulet.2015.05.035; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Naidu PS, 2002, BRIT J PHARMACOL, V136, P193, DOI 10.1038/sj.bjp.0704717; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Park SW, 2013, SYNAPSE, V67, P224, DOI 10.1002/syn.21634; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PAYLOR R, 1992, BEHAV BRAIN RES, V52, P49, DOI 10.1016/S0166-4328(05)80324-9; Peck JA, 2015, PHARMACOL BIOCHEM BE, V138, P20, DOI 10.1016/j.pbb.2015.09.009; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pillai A, 2007, J PSYCHIATR RES, V41, P372, DOI 10.1016/j.jpsychires.2006.01.011; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Roemer RA, 1996, J PSYCHIATR NEUROSCI, V21, P325; Rosengarten H, 2002, PROG NEURO-PSYCHOPH, V26, P1047, DOI 10.1016/S0278-5846(02)00221-X; Saout V., 2011, Annals of Physical and Rehabilitation Medicine, V54, P259, DOI 10.1016/j.rehab.2011.04.003; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Seo MK, 2015, PSYCHIAT RES, V229, P968, DOI 10.1016/j.psychres.2015.05.098; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ukai W, 2004, J NEURAL TRANSM, V111, P667, DOI 10.1007/s00702-004-0109-z; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Weeks J. J., 2016, BEHAV BRAIN RES; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	83	15	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					451	+		10.1089/neu.2016.4417			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800021	26975872	Green Published			2021-06-18	
J	Ucal, M; Kraitsy, K; Weidinger, A; Paier-Pourani, J; Patz, S; Fink, B; Molcanyi, M; Schafer, U				Uecal, Muammer; Kraitsy, Klaus; Weidinger, Adelheid; Paier-Pourani, Jamile; Patz, Silke; Fink, Bruno; Molcanyi, Marek; Schaefer, Ute			Comprehensive Profiling of Modulation of Nitric Oxide Levels and Mitochondrial Activity in the Injured Brain: An Experimental Study Based on the Fluid Percussion Injury Model in Rats	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; fluid percussion; glutamate; mitochondria; NO	CEREBRAL-BLOOD-FLOW; CONTROLLED CORTICAL IMPACT; APOPTOTIC CELL-DEATH; OXIDATIVE DAMAGE; PROGRAMMED NECROSIS; SYNTHASE ACTIVATION; NADPH-OXIDASE; TIME-COURSE; L-ARGININE; COMPLEX-I	Nitric oxide (NO) has frequently been associated with secondary damage after brain injury. However, average NO levels in different brain regions before and after traumatic brain injury (TBI) and its role in post-TBI mitochondrial dysfunction remain unclear. In this comprehensive profiling study, we demonstrate for the first time that basal NO levels vary significantly in the healthy cortex (0.44 +/- 0.04 mu M), hippocampus (0.26 +/- 0.03 mu M), and cerebellum (1.24 +/- 0.08 mu M). Within 4 h of severe lateral fluid percussion injury, NO levels almost doubled in these regions, thereby preserving regional differences in NO levels. TBI-induced NO generation was associated with inducible NO synthase (iNOS) increase in ipsilateral but not in contralateral regions. The transient NO increase resulted in a persistent tyrosine nitration adjacent to the injury site. Nitrosative stress-associated cell loss via apoptosis and receptor-interacting serine/threonine-protein kinase 3 (RIPK3)-mediated necrosis were also observed in the ipsilateral cortex, despite high levels of NO in the contralateral cortex. NO-mediated impairment of mitochondrial state 3 respiration dependent on complex I substrates was transient and confined to the ipsilateral cortex. Our results demonstrate that NO dynamics and associated effects differ in various regions of the injured brain. A potential association between the observed mitochondrial electron flow through complex I, but not complex II, and the modulation of TBI induced NO levels in different brain regions has to be prospectively analyzed in more detail.	[Uecal, Muammer; Kraitsy, Klaus; Patz, Silke; Schaefer, Ute] Med Univ Graz, Dept Neurosurg, Res Unit Expt Neurotraumatol, Graz, Austria; [Weidinger, Adelheid; Paier-Pourani, Jamile] Ludwig Boltzmann Inst Clin & Expt Traumatol, Vienna, Austria; [Fink, Bruno] NOXYGEN Sci Transfer & Diagnost GmbH, Elzach, Germany; [Molcanyi, Marek] Univ Cologne, Fac Med, Inst Neurophysiol, Cologne, Germany	Schafer, U (corresponding author), Auenbruggerpl 2 2, A-8036 Graz, Austria.	ute.schaefer@medunigraz.at			BioPersMed (COMET K-project) [825329]; Austrian Federal Ministry of Transport, Innovation, and Technology (BMVIT); Austrian Federal Ministry of Economy, Family, and Youth (BMWFJ); Styrian Business Promotion Agency (SFG)	This work was supported by BioPersMed (COMET K-project 825329), which is funded by the Austrian Federal Ministry of Transport, Innovation, and Technology (BMVIT); the Austrian Federal Ministry of Economy, Family, and Youth (BMWFJ); and the Styrian Business Promotion Agency (SFG).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Almeida A, 2001, J NEUROCHEM, V77, P676, DOI 10.1046/j.1471-4159.2001.00276.x; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Borutaite V, 2003, FREE RADICAL BIO MED, V35, P1457, DOI 10.1016/j.freeradbiomed.2003.08.003; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Carreira BP, 2010, STEM CELLS, V28, P1219, DOI 10.1002/stem.444; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cheung THC, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-36; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Fujii H, 1999, MAGNET RESON MED, V42, P599, DOI 10.1002/(SICI)1522-2594(199909)42:3<599::AID-MRM24>3.3.CO;2-P; Gahm C, 2000, NEUROSURGERY, V46, P169; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Greenwood MT, 1997, BIOCHEM BIOPH RES CO, V238, P617, DOI 10.1006/bbrc.1997.7361; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hara S, 2004, NEUROSCI LETT, V366, P302, DOI 10.1016/j.neulet.2004.05.055; Higgins GC, 2012, FREE RADICAL BIO MED, V53, P1960, DOI 10.1016/j.freeradbiomed.2012.08.586; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jung CS, 2014, INT J MOL SCI, V15, P4088, DOI 10.3390/ijms15034088; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Kraitsy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097750; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MITROVIC B, 1995, NEUROSCIENCE, V65, P531, DOI 10.1016/0306-4522(94)00491-M; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; RINK A, 1995, AM J PATHOL, V147, P1575; ROSKAMS AJ, 1994, NEURON, V13, P289; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Santos RM, 2011, NEUROCHEM INT, V59, P90, DOI 10.1016/j.neuint.2011.05.016; SAXON DW, 1994, NEUROREPORT, V5, P809, DOI 10.1097/00001756-199403000-00018; Sharma AC, 1998, NEUROL RES, V20, P632; Shi QL, 2011, J BIOL CHEM, V286, P17640, DOI 10.1074/jbc.M110.203018; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Takuma K, 2002, JPN J PHARMACOL, V89, P64, DOI 10.1254/jjp.89.64; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Trabace L, 2004, BRAIN RES, V1008, P293, DOI 10.1016/j.brainres.2004.01.090; Uchiyama T, 2002, J MOL CELL CARDIOL, V34, P1049, DOI 10.1006/jmcc.2002.2045; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Watson William D, 2013, Front Neuroenergetics, V5, P12, DOI 10.3389/fnene.2013.00012; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yuksel H, 2013, NEUROL SCI, V34, P1941, DOI 10.1007/s10072-013-1411-z; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou P, 2005, J CEREBR BLOOD F MET, V25, P348, DOI 10.1038/sj.jcbfm.9600036; Ziaja M, 2007, J NEUROTRAUM, V24, P1845, DOI 10.1089/neu.2007.0303	74	15	15	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					475	486		10.1089/neu.2016.4411			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800023	27165518				2021-06-18	
J	Tanaka, M; Moran, S; Wen, J; Affram, K; Chen, TH; Symes, AJ; Zhang, YM				Tanaka, Mikiei; Moran, Sean; Wen, Jie; Affram, Kwame; Chen, Tinghua; Symes, Aviva J.; Zhang, Yumin			WWL70 attenuates PGE(2) production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism	JOURNAL OF NEUROINFLAMMATION			English	Article						Endocannabinoid; 2-AG; Arachidonic acid; ABHD6; COX-2; PGE(2); PGE(2)-glyceryl ester; PGE synthase; BV2 cells; Microglia	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; CONTAINING 6 ABHD6; CANNABINOID RECEPTORS; MULTIPLE-SCLEROSIS; THERAPEUTIC TARGET; MASS-SPECTROMETRY; PROSTAGLANDIN E-2; RAT-BRAIN; INHIBITION	Background: alpha/beta-Hydrolase domain 6 (ABHD6) is one of the major enzymes for endocannabinoid 2-arachidonoylglycerol (2-AG) hydrolysis in microglia cells. Our recent studies have shown that a selective ABHD6 inhibitor WWL70 has anti-inflammatory and neuroprotective effects in animal models of traumatic brain injury and multiple sclerosis. However, the role of ABHD6 in the neuroinflammatory response and the mechanisms by which WWL70 suppresses inflammation has not yet been elucidated in reactive microglia. Methods: The hydrolytic activity and the levels of 2-AG in BV2 cells were measured by radioactivity assay and liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). The expression of cyclooxygenase-2 (COX-2) and prostaglandin E-2 (PGE(2)) synthases in microglia treated with lipopolysaccharide (LPS) with/without WWL70 was determined by western blot and quantitative RT-PCR. The conversion of 2-AG to PGE(2) or PGE(2)-glyceryl ester (PGE(2)-G) was assessed by enzyme-linked immunoassay (EIA) or LC-MS/MS. The involvement of ABHD6 in PGE(2) production was assessed using pharmacological inhibitors and small interfering RNA (siRNA). The effect of WWL70 on PGE(2) biosynthesis activity in the microsome fraction from BV2 cells and experimental autoimmune encephalopathy (EAE) mouse brain was also examined. Results: We found that WWL70 suppressed PGE2 production in LPS-activated microglia via cannabinoid receptor-independent mechanisms, although intracellular levels of 2-AG were elevated by WWL70 treatment. This reduction was not attributable to WWL70 inhibition of ABHD6, given the fact that downregulation of ABHD6 by siRNA or use of KT182, an alternative ABHD6 inhibitor failed to suppress PGE2 production. WWL70 attenuated the expression of COX-2 and PGES-1/2 leading to the downregulation of the biosynthetic pathways of PGE(2) and PGE(2)-G. Moreover, PGE(2) production from arachidonic acid was reduced in the microsome fraction, indicating that WWL70 also targets PGE(2) biosynthetic enzymes, which are likely to contribute to the therapeutic mechanisms of WWL70 in the EAE mouse model. Conclusions: WWL70 is an anti-inflammatory therapeutic agent capable of inhibiting PGE(2) and PGE(2)-G production, primarily due to its reduction of COX-2 and microsomal PGES-1/2 expression and their PGE(2) biosynthesis activity in microglia cells, as well as in the EAE mouse brain.	[Tanaka, Mikiei; Wen, Jie; Chen, Tinghua; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Moran, Sean] Uniformed Serv Univ Hlth Sci, Biomed Instrumentat Ctr, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Affram, Kwame; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Affram, Kwame; Symes, Aviva J.; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	yumin.zhang@usuhs.edu	Symes, Aviva J/S-7471-2016	Symes, Aviva J/0000-0003-2557-9939	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG3741]; Defense Medical Research and Development Program [0130-10-00003-00002]; Military Center of Excellence Research Award [306514-1.00-63671]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [308049-14.01-60855]	This work was supported by grants from the National Multiple Sclerosis Society (RG3741), the Defense Medical Research and Development Program (0130-10-00003-00002), the Military Center of Excellence Research Award (306514-1.00-63671), and the Center for Neuroscience and Regenerative Medicine (308049-14.01-60855).	Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Cabral G. A., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P159, DOI 10.2174/187153008785700118; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hsu KL, 2013, J MED CHEM, V56, P8270, DOI 10.1021/jm400899c; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Kingsley PJ, 2005, ANAL BIOCHEM, V343, P203, DOI 10.1016/j.ab.2005.05.005; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Laine K, 2002, INVEST OPHTH VIS SCI, V43, P3216; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Pryce G, 2007, BRIT J PHARMACOL, V150, P519, DOI 10.1038/sj.bjp.0707003; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; van der Stelt M, 2001, J NEUROSCI, V21, P6475; Wen J, 2015, NEUROPHARMACOLOGY, V99, P196, DOI 10.1016/j.neuropharm.2015.07.010; Zhang MY, 2010, J MASS SPECTROM, V45, P167, DOI 10.1002/jms.1701	38	15	15	0	12	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JAN 10	2017	14								7	10.1186/s12974-016-0783-4			15	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	EH6PH	WOS:000391895200001	28086912	DOAJ Gold, Green Published			2021-06-18	
J	Bennett, KS; DeWitt, PE; Harlaar, N; Bennett, TD				Bennett, Kimberly Statler; DeWitt, Peter E.; Harlaar, Nicole; Bennett, Tellen D.			Seizures in Children With Severe Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						child abuse; seizures; subdural hematoma; traumatic brain injury	EARLY POSTTRAUMATIC SEIZURES; HEAD-INJURY; HYPOTHERMIA; EPILEPSY; CONSEQUENCES; PREDICTORS; MECHANISMS; OUTCOMES; INFANTS; TRIAL	Objective: Traumatic brain injury causes substantial morbidity and mortality in children. Posttraumatic seizures may worsen outcomes after traumatic brain injury. Posttraumatic seizures risk factors are not completely understood. Our objective was to clarify posttraumatic seizures risk factors in a large cohort of children with severe traumatic brain injury. Design: Retrospective cohort study of a probabilistically linked dataset from the National Trauma Data Bank and the Pediatric Health Information Systems database, 2007-2010. Setting: Twenty-nine U.S. children's hospitals. Patients: A total of 2,122 children (age, < 18 yr old at admission) with linked National Trauma Data Bank and Pediatric Health Information Systems records, severe (emergency department Glasgow Coma Scale, < 8) traumatic brain injury, hospital length of stay more than 24 hours, and nonmissing disposition. Interventions: None. Measurements and Main Results: The outcome was posttraumatic seizures, identified using validated International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes. Prespecified candidate predictors of posttraumatic seizures included age, injury mechanism, emergency department Glasgow Coma Scale, intracranial hemorrhage type, hypoxia, hypotension, and cardiac arrest. Posttraumatic seizures were diagnosed in 25.2% of children with severe traumatic brain injury. In those without abuse/assault or subdural hemorrhage, the posttraumatic seizures rate varied between 36.6% in those less than 2 years old and 16.4% in those 14-17 years old. Age, abusive mechanism, and subdural hemorrhage are each significant predictors of posttraumatic seizures. The risk of posttraumatic seizures has a complex relationship with these predictors. The estimated odds of posttraumatic seizures decrease with advancing age, odds ratio equal to 0.929 (0.905-0.954) per additional year of age with no abuse/assault and no subdural hemorrhage; odds ratio equal to 0.820 (0.730-0.922) per additional year of age when abuse and subdural hemorrhage are present. An infant with accidental traumatic brain injury and subdural hemorrhage has approximately the same estimated probability of posttraumatic seizures as an abused infant without subdural hemorrhage (47% [95% CI, 39-55%] vs 50% [95% CI, 41-58%]; p = 0.69). The triad of young age, injury by abuse/assault, and subdural hemorrhage confers the greatest estimated probability for posttraumatic seizures (60% [95% CI, 53-66%]). Conclusions: Posttraumatic seizures risk in children with severe traumatic brain injury is greatest with a triad of younger age, injury by abuse/assault, and subdural hemorrhage. However, posttraumatic seizures are common even in the absence of these factors.	[Bennett, Kimberly Statler; Bennett, Tellen D.] Univ Colorado, Childrens Hosp Colorado, Pediat Crit Care Sect, Dept Pediat,Sch Med, Aurora, CO 80045 USA; [DeWitt, Peter E.] Univ Colorado Denver, Dept Bioinformat & Biostat, Aurora, CO USA; [Harlaar, Nicole] Univ Colorado, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Childrens Hosp Colorado, Dept Pediat,Sch Med, Aurora, CO USA; [Bennett, Tellen D.] Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA	Bennett, TD (corresponding author), Univ Colorado, Childrens Hosp Colorado, Pediat Crit Care Sect, Dept Pediat,Sch Med, Aurora, CO 80045 USA.; Bennett, TD (corresponding author), Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA.	tell.bennett@ucdenver.edu		Bennett, Tellen/0000-0003-1483-4236; DeWitt, Peter/0000-0002-6391-0795	Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health [K23HD074620]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	Supported, in part, by the grant from Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health (grant K23HD074620 to Dr. Tellen D. Bennett).; Dr. Bennett received support for article research from the National Institutes of Health (NIH); his institution received funding from the NICHD. Dr. Harlaar received support for article research from the NIH and her institution received funding from the NIH NICHD. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; American College of Surgeons Committee on Trauma, 2010, NAT TRAUM DAT BANK R; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2016, J CHILD NEUROL, V31, P46, DOI 10.1177/0883073814562249; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Bennett TD, 2015, METHOD INFORM MED, V54, P328, DOI 10.3414/ME14-01-0093; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Centers for Disease Control and Prevention, 2013, CONV TABL NEW ICD 9; Centers for Disease Control and Prevention, 1995, MMWR-MORBID MORTAL W, V46, P1; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P740; Chiaretti A, 2002, CHILD NERV SYST, V18, P109, DOI 10.1007/s00381-002-0561-8; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Frieden T.R., 2014, C TRAUM BRAIN INJ US; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Hernandez TD, 1997, NEUROLOGY, V48, P803, DOI 10.1212/WNL.48.4.803; Hooft A, 2013, J PEDIATR-US, V162, P80, DOI 10.1016/j.jpeds.2012.06.037; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kee VR, 2012, PHARMACOEPIDEM DR S, V21, P183, DOI 10.1002/pds.2329; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Slonim AD, 2010, PEDIATRICS, V125, P1208, DOI 10.1542/peds.2009-1451; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	40	15	16	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2017	18	1					54	63		10.1097/PCC.0000000000000948			10	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	EI1PJ	WOS:000392249300007	27654815	Green Accepted			2021-06-18	
J	Brekke, E; Berger, HR; Wideroe, M; Sonnewald, U; Morken, TS				Brekke, Eva; Berger, Hester Rijkje; Wideroe, Marius; Sonnewald, Ursula; Morken, Tora Sund			Glucose and Intermediary Metabolism and Astrocyte-Neuron Interactions Following Neonatal Hypoxia-Ischemia in Rat	NEUROCHEMICAL RESEARCH			English	Article						Glucose metabolism; Astrocyte-neuron interactions; Neonatal hypoxia-ischemia; C-13 NMR; Pentose-phosphate-pathway; Glutamate-glutamine cycle; Pyruvate carboxylation	PENTOSE-PHOSPHATE PATHWAY; MAGNETIC-RESONANCE-SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; TRANSPORTER GENE-EXPRESSION; SECONDARY ENERGY FAILURE; EXCITATORY AMINO-ACIDS; CEREBRAL-BLOOD-FLOW; WHITE-MATTER INJURY; NMDA-BINDING-SITES; IMMATURE RAT	Neonatal hypoxia-ischemia (HI) and the delayed injury cascade that follows involve excitotoxicity, oxidative stress and mitochondrial failure. The susceptibility to excitotoxicity of the neonatal brain may be related to the capacity of astrocytes for glutamate uptake. Furthermore, the neonatal brain is vulnerable to oxidative stress, and the pentose phosphate pathway (PPP) may be of particular importance for limiting this kind of injury. Also, in the neonatal brain, neurons depend upon de novo synthesis of neurotransmitters via pyruvate carboxylase in astrocytes to increase neurotransmitter pools during normal brain development. Several recent publications describing intermediary brain metabolism following neonatal HI have yielded interesting results: (1) Following HI there is a prolonged depression of mitochondrial metabolism in agreement with emerging evidence of mitochondria as vulnerable targets in the delayed injury cascade. (2) Astrocytes, like neurons, are metabolically impaired following HI, and the degree of astrocytic malfunction may be an indicator of the outcome following hypoxic and hypoxic-ischemic brain injury. (3) Glutamate transfer from neurons to astrocytes is not increased following neonatal HI, which may imply that astrocytes fail to upregulate glutamate uptake in response to the massive glutamate release during HI, thus contributing to excitotoxicity. (4) In the neonatal brain, the activity of the PPP is reduced following HI, which may add to the susceptibility of the neonatal brain to oxidative stress. The present review aims to discuss the metabolic temporal alterations observed in the neonatal brain following HI.	[Brekke, Eva; Sonnewald, Ursula] Norwegian Univ Sci & Technol NTNU, Dept Neurosci, N-7489 Trondheim, Norway; [Brekke, Eva] Bodo Hosp, Dept Neurol, Bodo, Norway; [Berger, Hester Rijkje; Morken, Tora Sund] NTNU, Dept Lab Med, Childrens & Womens Hlth, N-7489 Trondheim, Norway; [Berger, Hester Rijkje] Univ Trondheim Hosp, Dept Pediat, St Olavs Hosp, N-7006 Trondheim, Norway; [Wideroe, Marius] NTNU, Dept Circulat & Med Imaging, N-7489 Trondheim, Norway; [Sonnewald, Ursula] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Morken, Tora Sund] Univ Trondheim Hosp, St Olavs Hosp, Dept Ophthalmol, N-7006 Trondheim, Norway	Morken, TS (corresponding author), NTNU, Dept Lab Med, Childrens & Womens Hlth, N-7489 Trondheim, Norway.; Morken, TS (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Ophthalmol, N-7006 Trondheim, Norway.	tora.sund.morken@stolav.no					Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Ben-Ari Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00035; BenYoseph O, 1996, NEUROCHEM RES, V21, P1005, DOI 10.1007/BF02532410; Berger HR, 2016, J NEUROCHEM, V136, P339, DOI 10.1111/jnc.13420; BONDY CA, 1992, MOL CELL NEUROSCI, V3, P305, DOI 10.1016/1044-7431(92)90027-Y; Borges K, 2012, EPILEPSY RES, V100, P239, DOI 10.1016/j.eplepsyres.2011.05.023; Brekke E, 2015, NEUROCHEM INT, V82, P33, DOI 10.1016/j.neuint.2015.02.002; Brekke EMF, 2014, J CEREBR BLOOD F MET, V34, P724, DOI 10.1038/jcbfm.2014.8; Brooks KJ, 2002, NEUROCHEM RES, V27, P1599, DOI 10.1023/A:1021622724485; Buckley EM, 2015, DEV NEUROSCI-BASEL, V37, P407, DOI 10.1159/000381704; Chowdhury GMI, 2007, J CEREBR BLOOD F MET, V27, P1895, DOI 10.1038/sj.jcbfm.9600490; Clarke DD, 1999, BASIC NEUROCHEMISTRY; Corbo ET, 2012, PEDIATR RES, V71, P85, DOI 10.1038/pr.2011.8; CREMER JE, 1982, J CEREBR BLOOD F MET, V2, P394, DOI 10.1038/jcbfm.1982.45; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dehaes M, 2014, J CEREBR BLOOD F MET, V34, P87, DOI 10.1038/jcbfm.2013.165; Demarest TG, 2016, J NEUROCHEM, V137, P714, DOI 10.1111/jnc.13590; DIETRICH WD, 1993, STROKE, V24, P111, DOI 10.1161/01.STR.24.1.111; DOMBROWSKI GJ, 1989, NEUROCHEM RES, V14, P667, DOI 10.1007/BF00964877; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; Fullerton HJ, 1998, ANN NEUROL, V44, P357, DOI 10.1002/ana.410440311; Furuta A, 1997, J NEUROSCI, V17, P8363; Haberg A, 2001, J CEREBR BLOOD F MET, V21, P1451, DOI 10.1097/00004647-200112000-00010; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jantzie LL, 2015, CEREB CORTEX, V25, P482, DOI 10.1093/cercor/bht246; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Koehler-Stec EM, 1998, AM J PHYSIOL-ENDOC M, V275, pE516; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; KUNNECKE B, 1993, NMR BIOMED, V6, P264, DOI 10.1002/nbm.1940060406; Kusaka T, 2004, PEDIATR RES, V55, P273, DOI 10.1203/01.PDR.0000102702.39608.82; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Liu J, 2013, ANESTHESIOLOGY, V119, P1120, DOI 10.1097/ALN.0b013e31829c2d90; Liu J, 2013, PEDIATR RES, V74, P170, DOI 10.1038/pr.2013.88; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; Maltepe E, 2009, PEDIATR RES, V65, P261, DOI 10.1203/PDR.0b013e31818fc83f; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; McKenna MC, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P200; McKenna MC, 1995, NEUROCHEM RES, V20, P1491, DOI 10.1007/BF00970599; McKenna MC, 1996, J NEUROCHEM, V66, P386; McKenna MC, 2000, NEUROCHEM INT, V36, P451, DOI 10.1016/S0197-0186(99)00148-5; McQuillen PS, 2004, PEDIATR NEUROL, V30, P227, DOI 10.1016/j.pediatrneurol.2003.10.001; MICHEVA KD, 1995, EUR J NEUROSCI, V7, P419, DOI 10.1111/j.1460-9568.1995.tb00338.x; Morken TS, 2014, STROKE, V45, P2777, DOI 10.1161/STROKEAHA.114.005341; Morken TS, 2014, NEUROCHEM RES, V39, P556, DOI 10.1007/s11064-013-1014-3; Morken TS, 2013, PEDIATR RES, V73, P171, DOI 10.1038/pr.2012.170; MUJSCE DJ, 1990, PEDIATR RES, V27, P450, DOI 10.1203/00006450-199005000-00007; Nehlig A, 2004, PROSTAG LEUKOTR ESS, V70, P265, DOI 10.1016/j.plefa.2003.07.006; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Nijboer CH, 2013, NEUROBIOL DIS, V54, P206, DOI 10.1016/j.nbd.2012.12.013; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; PALMER C, 1990, J CEREBR BLOOD F MET, V10, P227, DOI 10.1038/jcbfm.1990.39; PATEL MS, 1974, J NEUROCHEM, V22, P717, DOI 10.1111/j.1471-4159.1974.tb04285.x; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; PukaSundvall M, 1997, BRAIN RES, V750, P325, DOI 10.1016/S0006-8993(97)00024-3; PukaSundvall M, 1996, METAB BRAIN DIS, V11, P109, DOI 10.1007/BF02069499; REPRESA A, 1989, NEUROSCI LETT, V99, P61, DOI 10.1016/0304-3940(89)90265-6; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Schousboe A, 2000, NEUROCHEM RES, V25, P1241, DOI 10.1023/A:1007692012048; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sheldon RA, 2004, PEDIATR RES, V56, P656, DOI 10.1203/01.PDR.0000139413.27864.50; Sipila S, 2004, J NEUROSCI, V24, P5877, DOI 10.1523/JNEUROSCI.1287-04.2004; SONNEWALD U, 1994, NEUROCHEM INT, V24, P473, DOI 10.1016/0197-0186(94)90095-7; Sonnewald U, 2014, J NEUROCHEM, V131, P399, DOI 10.1111/jnc.12812; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; Taylor DL, 2002, PEDIATR RES, V51, P13, DOI 10.1203/00006450-200201000-00005; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; TREMBLAY E, 1988, BRAIN RES, V461, P393, DOI 10.1016/0006-8993(88)90275-2; Tyzio R, 1999, J NEUROSCI, V19, P10372; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P185, DOI 10.1159/000085991; Vannucci RC, 2004, J CEREBR BLOOD F MET, V24, P1090, DOI 10.1097/01.WCB.0000133250.03953.63; Vannucci RC, 1996, J CEREBR BLOOD F MET, V16, P1026, DOI 10.1097/00004647-199609000-00028; VANNUCCI RC, 1976, AM J PHYSIOL, V230, P1269; Vannucci RC, 1999, DEV BRAIN RES, V118, P147, DOI 10.1016/S0165-3806(99)00142-X; VANNUCCI RC, 1988, STROKE, V19, P245, DOI 10.1161/01.STR.19.2.245; VANNUCCI RC, 1994, J CEREBR BLOOD F MET, V14, P279, DOI 10.1038/jcbfm.1994.35; Vannucci SJ, 1998, DEV BRAIN RES, V107, P255, DOI 10.1016/S0165-3806(98)00021-2; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; VANNUCCI SJ, 1980, J NEUROCHEM, V34, P1100, DOI 10.1111/j.1471-4159.1980.tb09946.x; VANNUCCI SJ, 1994, MOL CELL BIOCHEM, V140, P177, DOI 10.1007/BF00926756; Vannucci SJ, 1996, J CEREBR BLOOD F MET, V16, P77, DOI 10.1097/00004647-199601000-00009; VANNUCCI SJ, 1994, J NEUROCHEM, V62, P240; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Vitellaro-Zuccarello L, 2003, CELL TISSUE RES, V313, P245, DOI 10.1007/s00441-003-0746-9; Wallin C, 2000, DEV BRAIN RES, V125, P51, DOI 10.1016/S0165-3806(00)00112-7; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; WELSH FA, 1982, J CEREBR BLOOD F MET, V2, P221, DOI 10.1038/jcbfm.1982.22; Wideroe M, 2012, EUR J NEUROSCI, V36, P2006, DOI 10.1111/j.1460-9568.2012.08114.x; Wideroe M, 2009, NEUROIMAGE, V45, P880, DOI 10.1016/j.neuroimage.2008.12.007; WILBUR DO, 1974, J NEUROCHEM, V22, P709, DOI 10.1111/j.1471-4159.1974.tb04284.x; Williams GD, 1997, PEDIATR RES, V42, P700, DOI 10.1203/00006450-199711000-00024; Wisnowski JL, 2016, J CEREBR BLOOD F MET, V36, P1075, DOI 10.1177/0271678X15607881; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Xu S, 2015, MAGN RESON MED, V74, P1530, DOI 10.1002/mrm.25537; YAGER JY, 1991, AM J PHYSIOL, V261, pH1102; YAN XX, 1992, DEV BRAIN RES, V65, P191, DOI 10.1016/0165-3806(92)90179-Z; YU ACH, 1983, J NEUROCHEM, V41, P1484, DOI 10.1111/j.1471-4159.1983.tb00849.x	111	15	15	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JAN	2017	42	1			SI		115	132		10.1007/s11064-016-2149-9			18	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	EK4TD	WOS:000393918800011	28019006				2021-06-18	
J	Chiu, LS; Anderton, RS; Cross, JL; Clark, VW; Edwards, AB; Knuckey, NW; Meloni, BP				Chiu, Li Shan; Anderton, Ryan S.; Cross, Jane L.; Clark, Vince W.; Edwards, Adam B.; Knuckey, Neville W.; Meloni, Bruno P.			ASSESSMENT OF R18, COG1410, AND APP96-110 IN EXCITOTOXICITY AND TRAUMATIC BRAIN INJURY	TRANSLATIONAL NEUROSCIENCE			English	Article						TBI; cationic arginine-rich peptides (CARPs); R18; APP96-110; COG1410; axonal injury; neuroprotection	ARGININE-RICH PEPTIDES; IMPROVES COGNITIVE PERFORMANCE; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E; NEUROPROTECTIVE EFFICACY; POLY-ARGININE; MIMETIC PEPTIDE; CELLULAR UPTAKE; GLUTAMIC-ACID; MODEL	Cationic arginine-rich and poly-arginine peptides (referred to as CARPs) have potent neuroprotective properties in in vitro excitotoxicity and in vivo models of stroke. Traumatic brain injury (TBI) shares many pathophysiological processes as stroke, including excitotoxicity. Therefore, we evaluated our lead peptide, poly-arginine R18, with the COG1410 and APP96-110 peptides, which have neuroprotective actions following TBI. In an in vitro cortical neuronal glutamic acid excitotoxicity injury model, R18 was highly neuroprotective and reduced neuronal calcium influx, while COG1410 and APP96-110 displayed modest neuroprotection and were less effective at reducing calcium influx. In an impact-acceleration closed-head injury model (Marmarou model), R18, COG1410, and APP96-110 were administered intravenously (300 nmol/kg) at 30 minutes after injury in male Sprague-Dawley rats. When compared to vehicle, no peptide significantly improved functional outcomes, however the R18 and COG1410 treatment groups displayed positive trends in the adhesive tape test and rotarod assessments. Similarly, no peptide had a significant effect on hippocampal neuronal loss, however a significant reduction in axonal injury was observed for R18 and COG1410. In conclusion, this study has demonstrated that R18 is significantly more effective than COG1410 and APP96-110 at reducing neuronal injury and calcium influx following excitotoxicity, and that both R18 and COG1410 reduce axonal injury following TBI. Additional dose response and treatment time course studies are required to further assess the efficacy of R18 in TBI.	[Chiu, Li Shan; Anderton, Ryan S.; Cross, Jane L.; Clark, Vince W.; Edwards, Adam B.; Knuckey, Neville W.; Meloni, Bruno P.] Perron Inst Neurol & Translat Sci, Nedlands, WA 6009, Australia; [Chiu, Li Shan; Anderton, Ryan S.; Cross, Jane L.; Clark, Vince W.; Knuckey, Neville W.; Meloni, Bruno P.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia; [Cross, Jane L.; Clark, Vince W.; Knuckey, Neville W.; Meloni, Bruno P.] Sir Charles Gairdner Hosp, QEII Med Ctr, Dept Neurosurg, Nedlands, WA 6009, Australia; [Anderton, Ryan S.; Edwards, Adam B.] Univ Notre Dame Australia, Sch Heath Sci, Fremantle, WA 6160, Australia; [Anderton, Ryan S.] Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA 6160, Australia	Meloni, BP (corresponding author), Perron Inst Neurol & Translat Sci, Nedlands, WA 6009, Australia.; Meloni, BP (corresponding author), Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia.; Meloni, BP (corresponding author), Sir Charles Gairdner Hosp, QEII Med Ctr, Dept Neurosurg, Nedlands, WA 6009, Australia.	bruno.meloni@perron.uwa.edu.au	Edwards, Adam/U-3386-2019; Chiu, Li Shan/AAQ-5330-2020	Edwards, Adam/0000-0002-7503-3232; Chiu, Li Shan/0000-0002-5601-7739	Neurotrauma Research Program of Western Australia; Brain Foundation (Australia); Perron Institute for Neurological and Translational Science; Department of Neurosurgery at Sir Charles Gairdner Hospital	This study was supported by grants from the Neurotrauma Research Program of Western Australia and Brain Foundation (Australia), and financial support was also provided by the Perron Institute for Neurological and Translational Science and the Department of Neurosurgery at Sir Charles Gairdner Hospital. We also thank Jim Litis for providing a student PhD scholarship for Li Shan Chiu, Argeo Siliquini for constructing the weight-drop device, and Professor Frank Mastaglia for his assistance in the preparation of this manuscript.	Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Buki A, 2000, J NEUROSCI, V20, P2825; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Chiu LS, 2016, EXPERT REV NEUROTHER, V16, P361, DOI 10.1586/14737175.2016.1150180; Chiu LS, 2016, MOL NEUROBIOL; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Davceva N, 2015, AM J FOREN MED PATH, P1; Edwards AB, 2017, MOL CELL BIOCHEM, V426, P75, DOI 10.1007/s11010-016-2882-z; Haberg AK, 2014, J NEUROSCI RES, P1126; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaufman NA, 2010, BEHAV BRAIN RES, V214, P395, DOI 10.1016/j.bbr.2010.06.017; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Lei BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34834; Leupold E, 2008, BBA-BIOMEMBRANES, V1778, P2781, DOI 10.1016/j.bbamem.2008.09.008; MacDougall G, 2016, J MOL NEUROSCI, V12, P1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meloni BP, 2017, NEUROMOL MED, P1; Meloni BP, 2015, PHARMACOL THERAPEUT, V153, P36, DOI 10.1016/j.pharmthera.2015.06.002; Meloni BP, 2015, J CEREBR BLOOD F MET, V35, P993, DOI 10.1038/jcbfm.2015.11; Meloni BP, 2014, CELL MOL NEUROBIOL, V34, P173, DOI 10.1007/s10571-013-9999-3; Milani D, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/2372710; Milani D, 2017, NEUROSCI RES, V114, P9, DOI 10.1016/j.neures.2016.09.002; Milani D, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0253-z; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Qin X, 2016, J NEUROTRAUM, V2016, P4485; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Tu TM, 2017, ANN CLIN TRANSL NEUR, V4, P246, DOI 10.1002/acn3.399; Tukhovskaya EA, 2009, J NEUROSCI RES, V87, P677, DOI 10.1002/jnr.21874; Wang XS, 1997, J CELL PHYSIOL, V173, P73, DOI 10.1002/(SICI)1097-4652(199710)173:1<73::AID-JCP9>3.0.CO;2-G; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	42	15	15	0	2	DE GRUYTER POLAND SP ZOO	WARSAW	BOGUMILA ZUGA 32A STR., 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2017	8	1					147	157		10.1515/tnsci-2017-0021			11	Neurosciences	Neurosciences & Neurology	FM9LP	WOS:000415591200001	29177102	DOAJ Gold, Green Published			2021-06-18	
J	Dennis, EL; Faskowitz, J; Rashid, F; Babikian, T; Mink, R; Babbitt, C; Johnson, J; Giza, CC; Jahanshad, N; Thompson, PM; Asarnow, RF				Dennis, Emily L.; Faskowitz, Joshua; Rashid, Faisal; Babikian, Talin; Mink, Richard; Babbitt, Christopher; Johnson, Jeffrey; Giza, Christopher C.; Jahanshad, Neda; Thompson, Paul M.; Asarnow, Robert F.			Diverging volumetric trajectories following pediatric traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Tensor-based morphometry; Pediatric; Traumatic brain injury; Longitudinal	TENSOR-BASED MORPHOMETRY; CORPUS-CALLOSUM; PITUITARY DYSFUNCTION; ALZHEIMERS-DISEASE; CHILDREN; MRI; MODERATE; OUTCOMES; GROWTH	Traumatic brain injury (TBI) is a significant public health concern, and can be especially disruptive in children, derailing on-going neuronal maturation in periods critical for cognitive development. There is considerable heterogeneity in post-injury outcomes, only partially explained by injury severity. Understanding the time course of recovery, and what factors may delay or promote recovery, will aid clinicians in decision-making and provide avenues for future mechanism-based therapeutics. We examined regional changes in brain volume in a pediatric/adolescent moderate-severe TBI (msTBI) cohort, assessed at two time points. Children were first assessed 2-5 months post-injury, and again 12 months later. We used tensor-based morphometry (TBM) to localize longitudinal volume expansion and reduction. We studied 21 msTBI patients (5 F, 8-18 years old) and 26 well-matched healthy control children, also assessed twice over the same interval. In a prior paper, we identified a subgroup of msTBI patients, based on interhemispheric transfer time (IHTT), with significant structural disruption of the white matter (WM) at 2-5 months post injury. We investigated how this subgroup (TBI-slow, N = 11) differed in longitudinal regional volume changes from msTBI patients (TBI-normal, N= 10) with normal WM structure and function. The TBI-slow group had longitudinal decreases in brain volume in several WM clusters, including the corpus callosum and hypothalamus, while the TBI-normal group showed increased volume in WM areas. Our results show prolonged atrophy of the WM over the first 18 months postinjury in the TBI-slow group. The TBI-normal group shows a different pattern that could indicate a return to a healthy trajectory.	[Dennis, Emily L.; Faskowitz, Joshua; Rashid, Faisal; Jahanshad, Neda; Thompson, Paul M.] Univ Southern Calif, Keck Sch Med, Mark & Mary Stevens Inst Neuroimaging & Informat, Imaging Genet Ctr, Marina Del Rey, CA 90292 USA; [Babikian, Talin; Asarnow, Robert F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Mink, Richard] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Mink, Richard] Los Angeles BioMed Res Inst, Dept Pediat, Torrance, CA 90509 USA; [Babbitt, Christopher] Miller Childrens Hosp, Long Beach, CA 90806 USA; [Johnson, Jeffrey] LAC USC Med Ctr, Dept Pediat, Los Angeles, CA 90033 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Steve Tisch BrainSPORT Program, Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA 90033 USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Giza, Christopher C.; Asarnow, Robert F.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	Dennis, EL (corresponding author), Univ Southern Calif, Keck Sch Med, 2001 N Soto St, Los Angeles, CA 90033 USA.	emily.dennis@ini.usc.edu	Faskowitz, Joshua/K-1330-2019; Dennis, Emily/AAD-5223-2021; Thompson, Paul M/C-4194-2018	Faskowitz, Joshua/0000-0003-1814-7206; Thompson, Paul M/0000-0002-4720-8867; Dennis, Emily/0000-0001-7112-4009	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061504]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99 NS096116]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54 EB020403, R01 EB008432, R01 AG040060, R01 NS080655]; NCAA; US Dept of DefenseUnited States Department of Defense; UCLA BIRC; UCLA Steve Tisch BrainSPORT Program; Easton Laboratories for Brain Injury; Staglin IMHRO Center for Cognitive Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB020403, P41EB015922, R01EB008432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99NS096116, R01NS027544, R01NS080655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040060] Funding Source: NIH RePORTER	This study was supported by the NICHD (R01 HD061504). ELD is supported by a grant from the NINDS (K99 NS096116). ELD, FR, JF, and PT are also supported by NIH grants to PT: U54 EB020403, R01 EB008432, R01 AG040060, and R01 NS080655. CCG is supported by grants from NINDS (R01 NS027544, SBIR), NCAA, US Dept of Defense, UCLA BIRC, UCLA Steve Tisch BrainSPORT Program, Easton Laboratories for Brain Injury. Scanning was supported by the Staglin IMHRO Center for Cognitive Neuroscience. We gratefully acknowledge the contributions of Alma Martinez and Alma Ramirez in assisting with participant recruitment and study coordination. Finally, the authors thank the participants and their families for contributing their time to this study.	Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; CROSSON B, 1985, BRAIN LANG, V25, P257, DOI 10.1016/0093-934X(85)90085-9; Delis D, 1994, CALIFORNIA VERBAL LE; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dennis E.L., 2017, NEUROLOGY; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dennis Emily L, 2013, Dialogues Clin Neurosci, V15, P359; Ellis M. U., 2015, J NEUROTRAU IN PRESS; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hua X, 2016, NEUROBIOL AGING, V37, P26, DOI 10.1016/j.neurobiolaging.2015.09.018; Hua X, 2013, NEUROIMAGE, V66, P648, DOI 10.1016/j.neuroimage.2012.10.086; Hua X, 2009, HUM BRAIN MAPP, V30, P209, DOI 10.1002/hbm.20498; Hua X, 2008, NEUROIMAGE, V43, P458, DOI 10.1016/j.neuroimage.2008.07.013; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Langers DRM, 2007, NEUROIMAGE, V38, P43, DOI 10.1016/j.neuroimage.2007.07.031; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Luders E, 2010, J NEUROSCI, V30, P10985, DOI 10.1523/JNEUROSCI.5122-09.2010; Maclaren J, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.37; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Wechsler D., 2003, WECHSLER INTELLIGENC; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	41	15	15	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	15						125	135		10.1016/j.nicl.2017.03.014			11	Neuroimaging	Neurosciences & Neurology	FG3MN	WOS:000410067200015	28507895	DOAJ Gold, Green Published			2021-06-18	
J	Forslund, MV; Roe, C; Perrin, PB; Sigurdardottir, S; Lu, J; Berntsen, S; Andelic, N				Forslund, Marit V.; Roe, Cecilie; Perrin, Paul B.; Sigurdardottir, Solrun; Lu, Juan; Berntsen, Svein; Andelic, Nada			The trajectories of overall disability in the first 5 years after moderate and severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; disability; outcome measures; GOSE	GLASGOW OUTCOME SCALE; LONG-TERM DISABILITY; HEAD-INJURY; NATIONAL INSTITUTE; GENDER-DIFFERENCES; PROSPECTIVE COHORT; PRACTICAL SCALE; MODEL SYSTEMS; UNITED-STATES; HEALTH	Primary objectives: To assess longitudinal trajectories of overall disability after moderate-to-severe traumatic brain injury (TBI) and to examine whether those trajectories could be predicted by sociodemographic and injury characteristics. Methods: Demographics and injury characteristics of 105 individuals with moderate-to-severe TBI were extracted from medical records. At the 1-, 2-, and 5-year follow-ups, TBI-related disability was assessed by the GOSE. A hierarchical linear model (HLM) was used to examine-functional outcomes up to 5 years following injury and whether those outcomes could be predicted by: time, gender, age, relationship, education, employment pre-injury, occupation, GCS, cause of injury, length of post-traumatic amnesia (PTA), CT findings and injury severity score, as well as the interactions between each of these predictors and time. Results: Higher GOSE trajectories (lower disability) were predicted by younger age at injury and shorter PTA, as well as by the interaction terms of time*PTA and time*employment. Those who had been employed at injury decreased in disability over time, while those who had been unemployed increased in disability. Conclusion: The study results support the view that individual factors generally outweigh injury-related factors as predictors of disability after TBI, except for PTA.	[Forslund, Marit V.; Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Sigurdardottir, Solrun; Andelic, Nada] Univ Oslo, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Fac Med, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Lu, Juan] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA USA; [Berntsen, Svein] Sorlandet Hosp, Dept Phys Med & Rehabil, Kristiansand, Norway	Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway.	nadand@ous-hf.no	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X; Andelic, Nada/0000-0002-3719-4406; Lu, Juan/0000-0002-5389-7603	Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo	The authors report no conflicts of interest. This study was funded by grant from The Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Forslund MV, 2014, NEUROREHABILITATION, V34, P781, DOI 10.3233/NRE-141084; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Roe C, 2012, J NEUROL RES, V2, P134, DOI DOI 10.4021/JNR133W; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Skandsen T, CLIN REHABILITATION, P653; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; TEASDALE G, 1974, LANCET, V2, P81; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	38	15	15	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					329	335		10.1080/02699052.2016.1255778			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900007	28095032				2021-06-18	
J	Gao, J; Lin, MQ; Zhao, JH; Bi, SW; Ni, ZY; Shang, XL				Gao, Jie; Lin, Meiqing; Zhao, Jiuhan; Bi, Siwei; Ni, Ziyan; Shang, Xiuli			Different interventions for post-ischaemic stroke depression in different time periods: a single-blind randomized controlled trial with stratification by time after stroke	CLINICAL REHABILITATION			English	Article						Depression; stroke; rehabilitation; antidepressive agents; psychotherapy	COGNITIVE-BEHAVIORAL THERAPY; TRAUMATIC BRAIN-INJURY; POSTSTROKE DEPRESSION; ANTIDEPRESSANT TREATMENT; FUNCTIONAL DISABILITY; DOSE-RESPONSE; CITALOPRAM; REHABILITATION; PSYCHOTHERAPY; FLUOXETINE	Objective: To determine the appropriate treatments for post-ischaemic stroke depression at different times after stroke. Design: A single-blind, randomized, controlled trial that compared three intervention groups, with subgroups stratified by time after stroke. Setting: Outpatient clinic. Subjects: Eligible patients were recruited at discharge (n = 73) and three (n = 67), six (n = 65), and nine months (n = 69) after discharge, and patients completed mood questionnaires. Interventions: Patients were randomly distributed into three groups: Group A received placebos and participated in general discussions; Group B, received citalopram and participated in general discussions; and Group C, received placebos and underwent cognitive behavioural therapy. All three groups participated in rehabilitation during three months of follow-up. Main measures: Outcome was assessed three months after baseline using the 17-item Hamilton Depression Scale (HAMD(17)) and the Bech-Rafaelsen Melancholia Scale (MES). During treatment, the Udvalg for Kliniske Undersogelser side-effect scale was also administered. Results: When stratification was not considered, the scores of Group B on the Melancholia Scale were lower than those of Group A (P = 0.02); when the four time-based subgroups were analysed, significant differences were observed between Groups A and B (P-MES = 0.02, P-HAMD17 = 0.02) in the group recruited six months after discharge and between Groups A and C (P-MES = 0.01) in the last time period nine months after discharge. Conclusions: The effects of citalopram or cognitive behavioural therapy is similar to the effect of rehabilitation alone for early-onset post-ischaemic depression; rehabilitation and citalopram for delayed-onset post-ischaemic depression; and rehabilitation and cognitive behavioural therapy for late-onset postischaemic depression are more effective than rehabilitation alone.	[Gao, Jie; Lin, Meiqing; Zhao, Jiuhan; Bi, Siwei; Ni, Ziyan; Shang, Xiuli] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Peoples R China	Shang, XL (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Peoples R China.	shang_zhao@sohu.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100243, 81171131, 81272564, 81272795, 81100893, 81172197, 81372484]; Natural Science Foundation of Liaoning Province in ChinaNatural Science Foundation of Liaoning Province [L2013296]; Liaoning Science and Technology Plan Projects [2011225020]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the Natural Science Foundation of China [81100243, 81171131, 81272564, 81272795, 81100893, 81172197, and 81372484], the Natural Science Foundation of Liaoning Province in China [No. L2013296], and Liaoning Science and Technology Plan Projects [No. 2011225020].	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; ANDERSON CS, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003689.PUB2; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Arseniou S, 2011, Psychiatriki, V22, P240; BECH P, 1986, ACTA PSYCHIAT SCAND, V73, P1; Bech P, 2002, PSYCHOPHARMACOLOGY, V163, P20, DOI 10.1007/s00213-002-1147-6; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Burvill P, 1997, INT J GERIATR PSYCH, V12, P219; Chen Y, 2006, ANN PHARMACOTHER, V40, P2115, DOI 10.1345/aph.1H389; Coppell AL, 2003, NEUROPHARMACOLOGY, V44, P903, DOI 10.1016/S0028-3908(03)00077-7; ERIKSSON S, 1987, J CHRON DIS, V40, P1025, DOI 10.1016/0021-9681(87)90116-0; FEDOROFF JP, 1989, J CLIN PSYCHIAT, V50, P18; Gainotti G, 2001, J NEUROL NEUROSUR PS, V71, P258, DOI 10.1136/jnnp.71.2.258; GUSTAFSON Y, 1995, DRUG AGING, V7, P298, DOI 10.2165/00002512-199507040-00005; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Hackett ML, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003437.PUB2; Hou WH, 2013, J CLIN PSYCHIAT, V74, pE859, DOI 10.4088/JCP.12m08259; Kauhanen ML, 1999, STROKE, V30, P1875, DOI 10.1161/01.STR.30.9.1875; Klausner EJ, 1998, INT J GERIATR PSYCH, V13, P707, DOI 10.1002/(SICI)1099-1166(1998100)13:10<707::AID-GPS856>3.3.CO;2-H; Kneebone II, 2000, BRIT J CLIN PSYCHOL, V39, P53, DOI 10.1348/014466500163103; Kootker JA, 2015, CLIN REHABIL, V29, P833, DOI 10.1177/0269215514559987; LAURITZEN L, 1994, PSYCHOPHARMACOLOGY, V114, P119, DOI 10.1007/BF02245452; Lim CM, 2009, J NEUROSCI RES, V87, P1037, DOI 10.1002/jnr.21899; Lincoln NB, 2003, STROKE, V34, P111, DOI 10.1161/01.STR.0000044167.44670.55; Lincoln NB, 1997, CLIN REHABIL, V11, P114, DOI 10.1177/026921559701100204; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; MAHONEY F I, 1965, Md State Med J, V14, P61; Mohr DC, 2012, JAMA-J AM MED ASSOC, V307, P2278, DOI 10.1001/jama.2012.5588; Neau JP, 1998, CEREBROVASC DIS, V8, P296, DOI 10.1159/000015869; Paolucci S, 2001, CEREBROVASC DIS, V12, P264, DOI 10.1159/000047714; Parker G, 2013, ACTA PSYCHIAT SCAND, V128, P271, DOI 10.1111/acps.12049; Rampello L, 2004, PSYCHOPHARMACOLOGY, V173, P73, DOI 10.1007/s00213-003-1698-1; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Shin TK, 2009, KOREAN J PHYSIOL PHA, V13, P257, DOI 10.4196/kjpp.2009.13.3.257; Sondergaard MP, 2006, PSYCHOTHER PSYCHOSOM, V75, P244, DOI 10.1159/000092895; STRAND T, 1985, STROKE, V16, P29, DOI 10.1161/01.STR.16.1.29; Taylor-Piliae RE, 2013, J CARDIOVASC NURS, V28, P460, DOI 10.1097/JCN.0b013e318258ad57; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Zedlitz AMEE, 2012, STROKE, V43, P1046, DOI 10.1161/STROKEAHA.111.632117	42	15	16	0	25	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JAN	2017	31	1					71	81		10.1177/0269215515626232			11	Rehabilitation	Rehabilitation	EF5XJ	WOS:000390402800008	26817808				2021-06-18	
J	Gross, BW; Gillio, M; Rinehart, CD; Lynch, CA; Rogers, FB				Gross, Brian W.; Gillio, Maria; Rinehart, Cole D.; Lynch, Caitlin A.; Rogers, Frederick B.			Omega-3 Fatty Acid Supplementation and Warfarin: A Lethal Combination in Traumatic Brain Injury	JOURNAL OF TRAUMA NURSING			English	Article						Bleeding risk; Fish oil; Omega-3 fatty acid; Warfarin		Polyunsaturated fatty acids such as omega-3 eicosapentaenoic acid and omega-6 docosahexaenoic acid, found in over-the-counter fish oil supplements, are often consumed for their beneficial, prophylactic, anti-inflammatory effects. Although the mechanisms of action are not fully known, a diet rich in polyunsaturated fats may reduce the risk of hyperlipidemia, atherosclerosis, high low-density lipoprotein cholesterol levels, hypertension, and inflammatory diseases. Masked by its many benefits, the risks of omega-3 fatty acid supplementation are often underappreciated, particularly its ability to inhibit platelet aggregation and promote bleeding in patients taking anticoagulant medications. The following details the clinical case of an elderly patient taking warfarin and fish oil supplementation whose warfarin-induced coagulopathy could not be reversed after suffering blunt head trauma.	[Gross, Brian W.; Gillio, Maria; Rinehart, Cole D.; Lynch, Caitlin A.; Rogers, Frederick B.] Penn Med Lancaster Gen Hlth, 555 N Duke St, Lancaster, PA 17602 USA	Gross, BW (corresponding author), Penn Med Lancaster Gen Hlth, 555 N Duke St, Lancaster, PA 17602 USA.	bgross2@lghealth.org					Adams RLC, 2009, NEPHROLOGY, V14, P462, DOI 10.1111/j.1440-1797.2009.01128.x; Buckley MS, 2004, ANN PHARMACOTHER, V38, P50, DOI 10.1345/aph.1D007; DYERBERG J, 1981, PHILOS T ROY SOC B, V294, P373, DOI 10.1098/rstb.1981.0113; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Jalili M, 2007, ARCH MED RES, V38, P901, DOI 10.1016/j.arcmed.2007.05.004; King M. W., 2016, INTRO BLOOD COAGULAT; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Mayo Clinic, 2013, OM 3 FATT AC FISH OI; McClaskey EM, 2007, PHARMACOTHERAPY, V27, P152, DOI 10.1592/phco.27.1.152; Stranger M. J., 2012, NUTR REV, V70, P107; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x	11	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	JAN-FEB	2017	24	1					15	18		10.1097/JTN.0000000000000256			4	Critical Care Medicine; Nursing	General & Internal Medicine; Nursing	EI2AK	WOS:000392288100004	28033135				2021-06-18	
J	Hansen, C; Cushman, D; Chen, W; Bounsanga, J; Hung, M				Hansen, Colby; Cushman, Dan; Chen, Wei; Bounsanga, Jerry; Hung, Man			Reliability Testing of the Balance Error Scoring System in Children Between the Ages of 5 and 14	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						brain concussion; sports; pediatrics; child; reproducibility of results	HIGH-SCHOOL; POSTURAL STABILITY; CONCUSSION; RECOVERY; PLAYERS; SPORTS	Objective: Pediatric concussion is an extensive public health concern with a complex clinical presentation. Balance assessment has been well-studied in the adult population, but has been limited in children. We aimed to assess the reliability and minimum detectable change (MDC) of the Balance Error Scoring System (BESS) in healthy children. Design: This prospective observational study included 373 healthy children aged 5 to 14. Interrater reliability was assessed by having 4 assessors review videos of 50 random subjects distributed evenly by age and sex across the entire cohort. Intrarater reliability was performed by having assessors review videos of other assessors' live evaluations. Test-retest reliability was obtained by comparing BESS scores as recorded live at the 2 separate time points by the same rater. Setting: Local elementary and junior high schools. Participants: Three hundred and seventy three healthy children between the ages of 5 and 14. Interventions: The BESS was performed on all children. Main Outcome Measures: Intraclass Correlation Coefficients (ICCs) and MDC Scores. Results: The overall interrater ICC was determined to be 0.93 [95% confidence interval (CI), 0.79-0.97] and intrarater ICC was 0.96 (95% CI, 0.95-0.97) with individual intrarater ICCs ranging between 0.69 and 0.99. The test-retest reliability was 0.90 (95% CI, 0.88-0.92). The MDCs were 9.6, 4.6, and 7.3 points at the 95% CIs for interrater, intrarater, and test-retest comparisons, respectively. No learning effect was seen. Conclusions: The BESS demonstrates excellent reliability in the pediatric population without evidence of a learning effect.	[Hansen, Colby; Cushman, Dan] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT USA; [Chen, Wei] Univ Utah, Div Epidemiol, Salt Lake City, UT USA; [Bounsanga, Jerry; Hung, Man] Univ Utah, Dept Orthoped, Salt Lake City, UT USA	Hansen, C (corresponding author), 590 Wakara Way, Salt Lake City, UT 84108 USA.	colby.hansen@hsc.utah.edu	Hansen, Colby/AAP-7680-2021	Hansen, Colby/0000-0002-8012-2483; Cushman, Daniel/0000-0002-4580-1173	University of Utah, Division of PM&R pilot research grant fund; University of Utah Department of Orthopedics; Center for Outcomes Research and Assessment; Study Design and Biostatistics Center; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [Grant 8UL1TR000105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000105, UL1TR001067] Funding Source: NIH RePORTER	This investigation was supported by the University of Utah, Division of PM&R pilot research grant fund, the University of Utah Department of Orthopedics, the Center for Outcomes Research and Assessment and the Study Design and Biostatistics Center, with funding in part from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 8UL1TR000105.	[Anonymous], 2013, Br J Sports Med, V47, P259; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Erkmen N, 2009, ISOKINET EXERC SCI, V17, P121, DOI 10.3233/IES-2009-0343; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Graham R., 2014, SPORTS RELATED CONCU; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; MANCUSO JJ, 2002, J ATHL TRAINING, V37, pS10; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valovich TC, 2003, J ATHL TRAINING, V38, P51	25	15	15	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2017	27	1					64	68		10.1097/JSM.0000000000000293			5	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	EH9OP	WOS:000392101000012	26829611	Green Accepted			2021-06-18	
J	Johansson, B; Wentzel, AP; Andrell, P; Ronnback, L; Mannheimer, C				Johansson, B.; Wentzel, A. -P.; Andrell, P.; Ronnback, L.; Mannheimer, C.			Long-term treatment with methylphenidate for fatigue after traumatic brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						cognition; mental fatigue; methylphenidate; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; MENTAL FATIGUE; DOUBLE-BLIND; ATTENTION DEFICITS; HEAD-INJURY; VITAL SIGNS; SAFETY; ADULTS; MILD; REHABILITATION	Objectives - Traumatic brain injury (TBI) may cause long-lasting post-concussive symptoms, such as mental fatigue and concentration difficulties, and this may become the main hindrance for returning to work and studies. There is currently no effective treatment for longlasting mental fatigue. In this hypothesis generating study, the long-term effects of methylphenidate on mental fatigue, cognitive function, and safety were assessed. Materials & methods - Thirty participants who suffered from long-term post-concussion symptoms after a mild TBI or moderate TBI and who had reported positive effects with methylphenidate during an initial phase of this follow-up study were treated with methylphenidate for a further six months. Results - After six-month follow-up, effects on Mental Fatigue Scale (MFS), depression, anxiety, and cognitive function (processing speed, attention, working memory) were significantly improved compared to baseline data (P < 0.001, respectively). Heart rate was significantly increased (P = 0.01), while blood pressure was not changed. Conclusions - Individuals suffering from prolonged symptoms after TBI reported reduced mental fatigue and improved cognitive functions with long-term methylphenidate treatment. It is suggested that methylphenidate can be a treatment option for long-term mental fatigue and cognitive impairment after a TBI, but further randomized control research is warranted.	[Johansson, B.; Ronnback, L.] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden; [Wentzel, A. -P.; Andrell, P.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Multidisciplinary Pain Ctr, Gothenburg, Sweden; [Wentzel, A. -P.; Mannheimer, C.] Kungalv Hosp, Multidisciplinary Pain Ctr, Gothenburg, Sweden	Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Dubbsgatan 14,1tr, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		, Birgitta/0000-0003-0240-1142; Johansson, Birgitta/0000-0002-8942-5771	Health & Medical Care Committee of the Region, Vastra Gotaland	The study was funded by grants from The Health & Medical Care Committee of the Region, Vastra Gotaland. Silva Litrop, Mona Roos, Lena Stiller, and Christina Wikman-Lundbom (Head of Department) are acknowledged for clinical support at the Kungalv Hospital.	Adler LA, 2009, J CLIN PSYCHOPHARM, V29, P239, DOI 10.1097/JCP.0b013e3181a390ce; Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; ASBERG M, 1978, ACTA PSYCHIAT SCAND, V271, P527; Godfrey J, 2009, J PSYCHOPHARMACOL, V23, P194, DOI 10.1177/0269881108089809; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Johansson B., 2012, BRAIN INJURY FUNCTIO, V1, P3, DOI [10.5772/27042, DOI 10.5772/27042]; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Reitan RM., 1985, HALSTEAD REITAN NEUR; Ripley DL, 2014, BRAIN INJURY, V28, P1514, DOI 10.3109/02699052.2014.919530; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; Ronnback L., 2012, LONG LASTING MENTAL; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wechsler D., 2003, WECHSLER ADULT INTEL; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369	32	15	15	0	24	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	JAN	2017	135	1					100	107		10.1111/ane.12587			8	Clinical Neurology	Neurosciences & Neurology	EE2NM	WOS:000389421400010	26991608				2021-06-18	
J	Malec, JF; Van Houtven, CH; Tanielian, T; Atizado, A; Dorn, MC				Malec, James F.; Van Houtven, Courtney Harold; Tanielian, Terri; Atizado, Adrian; Dorn, Michael C.			Impact of TBI on caregivers of veterans with TBI: Burden and interventions	BRAIN INJURY			English	Article						Caregivers; Brain Injury; Veterans	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; COPING SKILLS GROUP; MULTIFAMILY GROUP TREATMENT; US SERVICE MEMBERS; FAMILY-MEMBERS; CARE; DEMENTIA; IMPLEMENTATION; PREVALENCE	Objectives: Describe State-of-the-Art in practice and research in caregiving with individuals, specifically, Veterans with traumatic brain injury (TBI) and the implications for current practice and future research. Sources: Professional literature and personal experience of review panel. Main Outcomes: Unpaid caregiving for individuals with TBI is most often provided by a spouse, parent or other blood relative; the majority of caregivers are women. Although caregiving can be rewarding, it also may create financial burden and psychological stress. Depression among family caregivers occurs four times more frequently than in the general population. Positive coping can help reduce the impact of stress, and Department of Veterans Affairs (VA) programmes are available to ease financial burden. Group interventions show promise in reinforcing and improving positive coping for both family caregivers and Veterans with TBI. Conclusions: Identifying the specific needs of caregivers and families of Veterans with TBI and other traumatic injuries, including post-traumatic stress syndrome (PTSD), will require further longitudinal research. Currently available group interventions and programmes appear to benefit injured Veterans and their family caregivers financially and psychologically. Increased understanding of characteristics of quality family caregiving and its long term costs and benefits is likely to lead to additional improvements in these interventions and programmes.	[Malec, James F.] Indiana Univ, Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46077 USA; [Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Malec, James F.] Mayo Clin, Psychol, Rochester, MN USA; [Van Houtven, Courtney Harold] Durham VA Med Ctr, HSR&D, Durham, NC USA; [Van Houtven, Courtney Harold] Duke Univ, Dept Med, Durham, NC USA; [Tanielian, Terri] RAND Corp, Arlington, VA USA; [Atizado, Adrian] DAV Natl Serv & Legislat Headquarters, Washington, DC USA	Malec, JF (corresponding author), Indiana Univ, Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46077 USA.	jmalec@rhin.com		Van Houtven, Courtney/0000-0002-0783-1611	Department of Veterans AffairsUS Department of Veterans Affairs; Caregiver Support Program; Quality Enhancement Research Initiative [PEC 14-272]; Durham VA Center for Health Services Research in Primary Care	Dr. Van Houtven's work on this project was partially funded by the Department of Veterans Affairs, Caregiver Support Program and Quality Enhancement Research Initiative (PEC 14-272). She also received support from the Durham VA Center for Health Services Research in Primary Care.	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Backhaus S, 2016, BRAIN INJURY, V30, P975, DOI 10.3109/02699052.2016.1147601; Backhaus S, 2016, ARCH PHYS MED REHAB, V97, P281, DOI 10.1016/j.apmr.2015.10.097; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Backhaus SL, 2012, BRAIN INJURY COPING; Coe NB, 2009, HEALTH ECON, V18, P991, DOI 10.1002/hec.1512; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Epstein NB, 2006, J MARITAL FAM THER, V20, P575; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Feinberg L., 2013, HOM COMM BAS SERV C; Feinberg L., 2011, VALUING INVALUABLE 2; Ford JH, 2014, J REHABIL RES DEV, V51, P1311, DOI 10.1682/JRRD.2014.03.0066; Godwin EE, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1329; Griffin JM, AM J ORTHOP IN PRESS; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Implementation of Caregiver Assistance, 2011, IMPL CAR ASS MOV FOR; Johnson R.W., 2000, TRADE OFF HOURS PAID; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; MADRIAN BC, 1994, Q J ECON, V109, P27, DOI 10.2307/2118427; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Nichols LO, 2011, ARCH INTERN MED, V171, P353, DOI 10.1001/archinternmed.2010.548; Ory MG, 1999, GERONTOLOGIST, V39, P177, DOI 10.1093/geront/39.2.177; Perlick DA, 2013, PSYCHIAT SERV, V64, P534, DOI 10.1176/appi.ps.001622012; Ramchand R, 2014, RR499TEDF RAND CORP; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Schulz R, 2014, CLIN GERONTOLOGIST, V37, P347, DOI 10.1080/07317115.2014.907594; Skira MM, 2015, INT ECON REV, V56, P63, DOI 10.1111/iere.12095; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Straits-Troster K, 2013, PSYCHIAT SERV, V64, P541, DOI 10.1176/appi.ps.001632012; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; Thompson L., 2004, ISSUE BRIEF LONG TER; Van Houtven CH, 2004, J HEALTH ECON, V23, P1159, DOI 10.1016/j.jhealeco.2004.04.008; Van Houtven CH, 2016, VA CARES EVALUATION, P1; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080	42	15	15	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	9			SI		1235	1245		10.1080/02699052.2016.1274778			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FK0NN	WOS:000413176600009	28981343	Green Published, Other Gold			2021-06-18	
J	Merkel, SF; Andrews, AM; Lutton, EM; Razmpour, R; Cannella, LA; Ramirez, SH				Merkel, Steven F.; Andrews, Allison M.; Lutton, Evan M.; Razmpour, Roshanak; Cannella, Lee Anne; Ramirez, Servio H.			Dexamethasone Attenuates the Enhanced Rewarding Effects of Cocaine Following Experimental Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						traumatic brain injury; nucleus accumbens; conditioned place preference; cocaine; dexamethasone	GLUCOCORTICOIDS INDUCE; LY6C(-) MONOCYTES; BLOOD MONOCYTES; DENDRITIC CELLS; IN-VITRO; EXPRESSION; ADDICTION; MICRODIALYSIS; MACROPHAGES; SUBSETS	Clinical studies have identified traumatic brain injury (TBI) as a risk factor for the development of cocaine dependence. This claim is supported by our recent preclinical studies showing enhancement of the rewarding effects of cocaine in mice sustaining moderate controlled cortical impact (CCI) injury during adolescence. Here we test the efficacy of dexamethasone, an anti-inflammatory corticosteroid, to attenuate augmentation of the behavioral response to cocaine observed in CCI-TBI animals using the conditioned place preference (CPP) assay. These studies were performed in order to determine whether proinflammatory activity in the nucleus accumbens (NAc), a key brain nucleus in the reward pathway, mediates enhanced cocaine-induced CPP in adolescent animals sustaining moderate CCI-TBI. Our data reveal robust glial activation in the NAc following CCI-TBI and a significant increase in the cocaine-induced CPP of untreated CCI-TBI mice. Furthermore, our results show that dexamethasone treatment following CCI-TBI can attenuate the cocaine place preference of injured animals without producing aversion in the CPP assay. Our studies also found that dexamethasone treatment significantly reduced the expression of select immune response genes including Monocyte chemoattractant protein-1 (MCP-1/CCL2) and intercellular adhesion molecule-1 (ICAM-1), returning their expression to control levels, which prompted an investigation of peripheral blood monocytes in dexamethasone-treated animals. Experimental findings showed that no craniectomy/dexamethasone mice had a significant increase, while CCI-TBI/dexamethasone animals had a significant decrease in the percentage of circulating nonclassical patrolling monocytes. These results suggest that a portion of these monocytes may migrate to the brain in response to CCI-TBI, potentially sparing the development of chronic neuroinflammation in regions associated with the reward circuitry such as the NAc. Overall, our findings indicate that anti-inflammatory agents, such as dexamethasone, may be effective in normalizing the rewarding effects of cocaine following CCI-TBI.	[Merkel, Steven F.; Andrews, Allison M.; Lutton, Evan M.; Razmpour, Roshanak; Cannella, Lee Anne; Ramirez, Servio H.] Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, 3500 N Broad St,MERB 844, Philadelphia, PA 19140 USA; [Merkel, Steven F.; Andrews, Allison M.; Cannella, Lee Anne; Ramirez, Servio H.] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19122 USA; [Ramirez, Servio H.] Temple Univ, Shriners Hosp Pediat Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Ramirez, SH (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, 3500 N Broad St,MERB 844, Philadelphia, PA 19140 USA.	servio@temple.edu		ramirez, servio/0000-0002-4609-5653	National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [F32 DA041282, T32 DA007237, P30 DA013429-16]; NIH/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS086570-01]; Shriners Hospitals for Children [85110-PHI-14]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS086570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA007237, F32DA041282, P30DA013429] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA) F32 DA041282 (AMA), T32 DA007237 (LAC), and P30 DA013429-16 (SHR); NIH/National Institute of Neurological Disorders and Stroke (NINDS) R01 NS086570-01 (SHR); and The Shriners Hospitals for Children 85110-PHI-14 (SHR).	Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222; Administration SAMHS, 2014, 144863 SMA ADM SAMHS; Administration SAMHS, 2014, NSDUH SER H, V48; Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bellavance MA, 2015, BRAIN STRUCT FUNCT, V220, P1759, DOI 10.1007/s00429-014-0759-z; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Hutchinson MR, 2014, NEUROPHARMACOLOGY, V76, P218, DOI 10.1016/j.neuropharm.2013.05.039; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kozai TDY, 2016, BIOMATERIALS, V87, P157, DOI 10.1016/j.biomaterials.2016.02.013; Lee J, 2014, J TRAUMA ACUTE CARE, V77, P709, DOI 10.1097/TA.0000000000000445; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Michaud JP, 2014, J CEREBR BLOOD F MET, V34, P1253, DOI 10.1038/jcbfm.2014.80; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nesbitt KM, 2015, ACS CHEM NEUROSCI, V6, P163, DOI 10.1021/cn500257x; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Osterndorff-Kahanek EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121522; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Ramesh D, 2015, AM J ADDICTION, V24, P341, DOI 10.1111/ajad.12192; Roberts ES, 2004, J NEUROPATH EXP NEUR, V63, P1255, DOI 10.1093/jnen/63.12.1255; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Vachharajani V, 2006, MICROCIRCULATION, V13, P477, DOI 10.1080/10739680600777599; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wen ZH, 2005, NEUROSCIENCE, V133, P807, DOI 10.1016/j.neuroscience.2005.03.015; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Xiao GD, 2013, J NEUROL SCI, V330, P78, DOI 10.1016/j.jns.2013.04.010; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zhang ZR, 2008, ACTA NEUROPATHOL, V115, P335, DOI 10.1007/s00401-007-0301-y; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x	63	15	15	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1178	1192		10.1177/0963689717714341			15	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800007	28933216	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Peeters, W; Majdan, M; Brazinova, A; Nieboer, D; Maas, AIR				Peeters, Wouter; Majdan, Marek; Brazinova, Alexandra; Nieboer, Daan; Maas, Andrew I. R.			Changing Epidemiological Patterns in Traumatic Brain Injury: A Longitudinal Hospital-Based Study in Belgium	NEUROEPIDEMIOLOGY			English	Article						Traumatic brain injury; Head injury; Epidemiology; Incidence; Mortality; Belgium; Longitudinal study	TRENDS; MORTALITY; ADULTS; FALLS	Background: Various reports have suggested that epidemiological patterns of Traumatic Brain Injury (TBI) are changing in high-income countries, but the evidence to support this is often indirect and only a few longitudinal studies exist. We aimed to explore epidemiological patterns of TBI in Belgium over a 10-year period. Methods: A retrospective analysis of Minimum Hospital Data provided by Statistics Belgium was performed for the period 2003-2012. ICD-9 classification was used to identify TBI and to differentiate subtypes. The annual incidence of hospital admissions and in-hospital mortality rates were calculated and further differentiated for age, gender and cause of injury. Results: The age-adjusted incidence of hospital admissions decreased by 3.6% per year. An increase in the number of elderly patients with TBI and a decrease in the younger age groups were found. Falls now represent the main cause of TBI. A mortality rate of 6.5 per 100,000 population per year was found and did not change significantly over time. Conclusions: This longitudinal study confirms that epidemiological patterns in TBI are changing: overall incidence is steadily decreasing, but in el-derly patients, the incidence is increasing. Falls are the leading cause, occurring most frequently in elderly patients. These changes are relevant for prevention. (C) 2017 S. Karger AG, Basel	[Peeters, Wouter; Maas, Andrew I. R.] Univ Antwerp, Antwerp, Belgium; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Wilrijkstraat 10, BE-2650 Edegem, Belgium; [Majdan, Marek; Brazinova, Alexandra] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Nieboer, Daan] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Peeters, W (corresponding author), Antwerp Univ Hosp, Dept Neurosurg, Wilrijkstraat 10, BE-2650 Edegem, Belgium.	dr.peeters.w@gmail.com	Majdan, Marek/K-5017-2012; Brazinova, Alexandra/C-4265-2016	Majdan, Marek/0000-0001-8037-742X; Brazinova, Alexandra/0000-0003-0625-256X; Peeters, Wouter/0000-0001-7783-1425	European Union Seventh Framework Programme (FP7) [602150]	This study was conducted within the project: Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury supported by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 602150.	Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dias C, 2014, ACTA MEDICA PORT, V27, P349, DOI 10.20344/amp.4892; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Milos V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-40; Nishtala PS, 2014, PHARMACOEPIDEM DR S, V23, P753, DOI 10.1002/pds.3624; Peck KA, 2014, J TRAUMA ACUTE CARE, V77, P978, DOI 10.1097/TA.0000000000000356; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Sung KC, 2015, J NEUROTRAUM, V32, P1078, DOI 10.1089/neu.2014.3509; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1995, GUIDELINES FRO SURVE; U.S. Department of Health and Human Services, 1997, INT CLASS DIS 9 REV	25	15	15	0	6	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2017	48	1-2					63	70		10.1159/000471877			8	Public, Environmental & Occupational Health; Clinical Neurology	Public, Environmental & Occupational Health; Neurosciences & Neurology	EX6OP	WOS:000403361900009	28448968				2021-06-18	
S	Snow, P; Douglas, J		Cummings, L		Snow, Pamela; Douglas, Jacinta			Psychosocial Aspects of Pragmatic Disorders	RESEARCH IN CLINICAL PRAGMATICS	Perspectives in Pragmatics Philosophy and Psychology		English	Article; Book Chapter						Community integration; Employment; Friendship; Pragmatics; Psychosocial functioning; Restorative justice; School exclusion; Social relationship; Youth justice	TRAUMATIC BRAIN-INJURY; ORAL LANGUAGE COMPETENCE; SOCIAL COMMUNICATION; POSTSTROKE DEPRESSION; JUVENILE-OFFENDERS; COCHLEAR IMPLANTS; DEMENTIA PATIENTS; MARITAL QUALITY; MENTAL-HEALTH; CHILDREN	This chapter considers the everyday psychological and social costs attached to having pragmatic language difficulties. We briefly review key terminology concerning pragmatic language functions, before summarizing features of pragmatic language difficulties that occur in both the developmental period (e.g. associated with language impairment, autism spectrum disorder, hearing impairment, traumatic brain injury, intellectual disability) and in adulthood (e.g. in fronto-temporal dementia, aphasia, and Alzheimer's disease). We present a schematic model as a means of conceptualizing the elements of pragmatic language competence and its inverse, pragmatic language difficulties, within the broader psycho-social context. We argue that psychological factors such as coping style and self-efficacy for communication need to be considered alongside social factors (such as cultural mores and everyday communication contexts) if the true impact of pragmatic language difficulties is to be both documented and adequately addressed when interventions for affected individuals are designed, implemented, and evaluated.	[Snow, Pamela] La Trobe Univ, La Trobe Rural Hlth Sch, Bendigo, Vic, Australia; [Douglas, Jacinta] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia	Snow, P (corresponding author), La Trobe Univ, La Trobe Rural Hlth Sch, Bendigo, Vic, Australia.	p.snow@latrobe.edu.au; j.douglas@latrobe.edu.au		Snow, Pamela/0000-0002-2426-8349			American Pshychiatric Association, 2013, DIAGN STAT MAN MENT; Anti-Bullying Network, 2016, INF CIRCL TIM; Australian Institute of Health and Welfare, 2008, DISABILITY AUSTR INT, V67; Ayerbe L, 2011, STROKE, V42, P1907, DOI 10.1161/STROKEAHA.110.605808; Bakas T, 2006, REHABIL NURS, V31, P33, DOI 10.1002/j.2048-7940.2006.tb00008.x; Barry S. S., 2000, ADV SPEECH LANGUAGE, V2, P77, DOI DOI 10.3109/14417040008996793; Baseman S, 2010, J NEUROSCI NURS, V42, P237, DOI 10.1097/JNN.0b013e3181ecafea; Beitchman J., 2014, 0ANGUAGE DISORDERS C; Bishop DVM, 2014, INT J LANG COMM DIS, V49, P381, DOI 10.1111/1460-6984.12101; Bittner R., 2006, BRAIN INJURY, V21, P971; Blieszner R, 2010, GERONTOLOGIST, V50, P11, DOI 10.1093/geront/gnp068; Blonder LX, 2012, J CLIN EXP NEUROPSYC, V34, P634, DOI 10.1080/13803395.2012.667069; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Boylstein C, 2012, J FAM ISSUES, V33, P584, DOI 10.1177/0192513X11416449; Bracy C. A., 2005, BRAIN IMPAIR, V6, P1, DOI [10.1375/brim.6.1.1.65476., DOI 10.1375/BRIM.6.1.1.65476, DOI 10.1375/brim.6.1.1.65476]; Braun M, 2009, AGING MENT HEALTH, V13, P426, DOI 10.1080/13607860902879441; Brinton B, 2015, LANG SPEECH HEAR SER, V46, P325, DOI 10.1044/2015_LSHSS-14-0096; Broderick A, 2005, THEOR PRACT, V44, P194, DOI 10.1207/s15430421tip4403_3; Bryan K, 2004, INT J LANG COMM DIS, V39, P391, DOI 10.1080/13682820410001666376; Bryan K, 2007, INT J LANG COMM DIS, V42, P505, DOI 10.1080/13682820601053977; Burleson B. R., 1992, SO COMMUNICATION J, V57, P260, DOI DOI 10.1080/10417949209372873; Burnett N., 2015, RESTORATIVE PRACTICE; Camarata SM, 1999, MENT RETARD DEV D R, V5, P207, DOI 10.1002/(SICI)1098-2779(1999)5:3<207::AID-MRDD7>3.3.CO;2-F; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Christle CA, 2005, EXCEPTIONALITY, V13, P69, DOI [10.1207/s15327035ex1302_2, DOI 10.1207/S15327035EX1302_2]; Clare L, 2012, ALZ DIS ASSOC DIS, V26, P148, DOI 10.1097/WAD.0b013e318221ba23; Cohen N. J., 2001, LANGUAGE IMPAIRMENT; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x; Cornelius-White J. H., 2010, LEARNER CENTERED INS; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Davidson JRT, 2008, J ALTERN COMPLEM MED, V14, P795, DOI 10.1089/acm.2008.0213; de Vugt ME, 2013, PROG NEUROBIOL, V110, P54, DOI 10.1016/j.pneurobio.2013.04.005; de Vugt ME, 2003, INT J GERIATR PSYCH, V18, P149, DOI 10.1002/gps.807; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482; Douglas J., 2016, J SPEECH LA IN PRESS; Douglas J, 2015, INT J SPEECH-LANG PA, V17, P199, DOI 10.3109/17549507.2015.1016113; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Duck S, 1988, RELATING TO OTHERS; Dunn M., 1995, J SPEECH LANG HEAR R, V39, P643; Ebbels S, 2014, INT J LANG COMM DIS, V49, P377, DOI 10.1111/1460-6984.12119; Eloniemi-Sulkava U, 2002, INT PSYCHOGERIATR, V14, P47, DOI 10.1017/S104161020200827X; Finestack LH, 2012, AM J SPEECH-LANG PAT, V21, P29, DOI 10.1044/1058-0360(2011/10-0095); Frank L, 2006, INT PSYCHOGERIATR, V18, P151, DOI 10.1017/S1041610205002450; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Garand L, 2007, WESTERN J NURS RES, V29, P976, DOI 10.1177/0193945907303086; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gillies B, 2012, DEMENTIA-LONDON, V11, P657, DOI 10.1177/1471301211421262; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Goodwin RD, 2008, J GERIATR PSYCH NEUR, V21, P41, DOI 10.1177/0891988707311041; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grawburg M, 2013, DISABIL REHABIL, V35, P1324, DOI 10.3109/09638288.2012.735341; Green BC, 2014, INT J LANG COMM DIS, V49, P15, DOI 10.1111/1460-6984.12056; Grice H., 1975, SYNTAX SEMANTICS, P41, DOI DOI 10.1111/J.1365-2664.2006.01229.X; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hale CM, 2005, AUTISM, V9, P157, DOI 10.1177/1362361305051395; Harciarek M, 2014, APHASIOLOGY, V28, P964, DOI 10.1080/02687038.2014.904498; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); Hemphill SA, 2014, CHILD YOUTH SERV REV, V36, P187, DOI 10.1016/j.childyouth.2013.11.022; Hilari K, 2010, CLIN REHABIL, V24, P181, DOI 10.1177/0269215509346090; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889; Hughes N., 2012, NOBODY MADE CONNECTI; Hurley AD, 2006, CURR OPIN PSYCHIATR, V19, P465, DOI 10.1097/01.yco.0000238471.84206.0a; Huttenen K., 2010, CLIN LINGUIST PHONET, V26, P833; Jetten J., 2012, SOCIAL CURE IDENTITY; Karlovits T, 1999, BRAIN INJURY, V13, P845; KINSELLA GJ, 1979, SCAND J REHABIL MED, V11, P129; Klusek J, 2014, J SPEECH LANG HEAR R, V57, P1692, DOI 10.1044/2014_JSLHR-L-13-0064; Knopman DS, 2011, J MOL NEUROSCI, V45, P330, DOI 10.1007/s12031-011-9538-y; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lemieux L, 2001, SEX DISABIL, V19, P253, DOI 10.1023/A:1017953308761; Lindsay G, 2012, LANG SPEECH HEAR SER, V43, P445, DOI 10.1044/0161-1461(2012/11-0069); Lum JAG, 2015, J SPEECH LANG HEAR R, V58, P961, DOI 10.1044/2015_JSLHR-L-14-0056; Mackay J, 2004, ATLAS HEART DIS STRO; Martin GE, 2009, TOP LANG DISORD, V29, P112, DOI 10.1097/TLD.0b013e3181a71fe1; Massimo L, 2013, GERIATR NURS, V34, P302, DOI 10.1016/j.gerinurse.2013.05.001; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; Most T, 2010, J DEAF STUD DEAF EDU, V15, P422, DOI 10.1093/deafed/enq032; National Institute of Neurological Disorders and Stroke, 2011, TRAUM BRAIN INJ; Nickels L, 2014, APHASIOLOGY, V28, P885, DOI 10.1080/02687038.2014.933521; Nussbaum J., 1994, INTERPERSONAL COMMUN, P209; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouimet MA, 2001, CAN J PSYCHIAT, V46, P819; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Paterson J., 2002, REHABILITATION NURSI, V27, P13, DOI [10.1002/j.2048-7940.2002.tb01973.x, DOI 10.1002/J.2048-7940.2002.TB01973.X]; Paul R., 2011, LANGUAGE DISORDERS I; Perlman D., 2008, INTIMATE RELATIONSHI; Peterson CC, 2004, J CHILD PSYCHOL PSYC, V45, P1096, DOI 10.1111/j.1469-7610.2004.t01-1-00302.x; Ponsford J., 2013, TRAUMATIC BRAIN INJU, P291; Pound P, 1998, CLIN REHABIL, V12, P338, DOI 10.1191/026921598677661555; Pozzebon M, 2016, INT PSYCHOGERIATR, V28, P537, DOI 10.1017/S1041610215002239; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Reilly S, 2014, INT J LANG COMM DIS, V49, P416, DOI 10.1111/1460-6984.12102; Rice ML, 2008, J SPEECH LANG HEAR R, V51, P394, DOI 10.1044/1092-4388(2008/029); Rogge RD, 1999, J CONSULT CLIN PSYCH, V67, P340, DOI 10.1037/0022-006X.67.3.340; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutledge T, 2008, PSYCHOSOM MED, V70, P282, DOI 10.1097/PSY.0b013e3181656e09; Sale P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, 10.1097/00001199-199109000-00004.]; Sanger D., 2001, COMMUN DISORD Q, V23, P17, DOI [10.1177/152574010102300104, DOI 10.1177/152574010102300104, 10.1177/152574010102300104.]; Schorr E. A., 2008, COMMUN DISORD Q, V29, P195, DOI DOI 10.1177/1525740108321217; Schrauf R. W., 2014, DIALOGUE DEMENTIA CO, P27; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snow PC, 2008, CHILD SOC, V22, P16, DOI 10.1111/j.1099-0860.2006.00076.x; Snow PC, 2016, INT J SPEECH-LANG PA, V18, P20, DOI 10.3109/17549507.2015.1081291; Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Snow PC, 2011, INT J LANG COMM DIS, V46, P324, DOI 10.3109/13682822.2010.496763; Snow PC, 2009, INT J SPEECH-LANG PA, V11, P95, DOI 10.1080/17549500802415712; St Clair MC, 2011, J COMMUN DISORD, V44, P186, DOI 10.1016/j.jcomdis.2010.09.004; Stewart A., 2002, PATHWAYS CHILD MALTR; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Tarolla SM, 2002, AGGRESS VIOLENT BEH, V7, P125, DOI 10.1016/S1359-1789(00)00041-0; Turkstra L., 1995, BRAIN INJURY, V10, P319; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Wang YT, 2005, FOLIA PHONIATR LOGO, V57, P59, DOI 10.1159/000083569; Weissman M.M., 2000, COMPREHENSIVE GUIDE; WHELDALL K, 1988, EDUC REV, V40, P13, DOI 10.1080/0013191880400102; White CL, 2003, RES NURS HEALTH, V26, P177, DOI 10.1002/nur.10084; White P, 2005, AUST NZ J PSYCHIAT, V39, P395, DOI 10.1111/j.1440-1614.2005.01587.x; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willmott P, 1987, FRIENDSHIP NETWORKS	138	15	15	0	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2214-3807		978-3-319-47489-2; 978-3-319-47487-8	PERSP PRAGMAT PHILO			2017	11						617	649		10.1007/978-3-319-47489-2_23	10.1007/978-3-319-47489-2		33	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	BI8BR	WOS:000414965000024					2021-06-18	
J	Stein, DM; Feather, CB; Napolitano, LM				Stein, Deborah M.; Feather, Cristina B.; Napolitano, Lena M.			Traumatic Brain Injury Advances	CRITICAL CARE CLINICS			English	Article						Traumatic brain injury; Antiseizure prophylaxis; Hyperosmolar therapy; Targeted temperature modulation; Intracranial pressure monitoring; Decompressive craniectomy	INTRACRANIAL-PRESSURE; THERAPEUTIC HYPOTHERMIA; DECOMPRESSIVE CRANIECTOMY; PROPHYLACTIC HYPOTHERMIA; HYPERTONIC SALINE; CONTROLLED-TRIAL; CLINICAL-TRIAL; PROGESTERONE; MANAGEMENT; PHENYTOIN	There have been many recent advances in the management of traumatic brain injury (TBI). Research regarding established and novel therapies is ongoing. Future research must not only focus on development of new strategies but determine the long-term benefits or disadvantages of current strategies. In addition, the impact of these adyances on varying severities of brain injury must not be ignored. It is hoped that future research strategies in TBI will prioritize large-scale trials using common data elements to develop large registries and databases, and leverage international collaborations.	[Stein, Deborah M.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Neurotrauma Crit Care,Sect Trauma Crit Care, 22 South Greene St, Baltimore, MD 21201 USA; [Feather, Cristina B.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Surg Crit Care, 22 South Greene St, Baltimore, MD 21201 USA; [Napolitano, Lena M.] Univ Michigan Hlth Syst, Dept Surg Trauma & Surg Crit Care, Div Acute Care Surg Trauma Burns Surg Crit Care E, Room 1C340-UH,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA	Stein, DM (corresponding author), Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Neurotrauma Crit Care,Sect Trauma Crit Care, 22 South Greene St, Baltimore, MD 21201 USA.	dstein@umm.edu		Stein, Deborah/0000-0003-3683-3963			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-277; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Cardim D, 2016, NEUROCRIT CARE; Carney N, 2016, NEUROSURGERY; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Ditillo M, 2011, J TRAUMA, V71, P373; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Forsyth RJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub3; Fox JL, 2010, CAN J EMERG MED, V12, P355; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Honeybul S, 2016, J CLIN NEUROSCI, V28, P12, DOI 10.1016/j.jocn.2016.01.002; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Liu WC, 2017, J NEUROSURG, V127, P8, DOI 10.3171/2016.4.JNS152909; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, CRIT CARE RESUSC, V17, P92; O'Phelan Kristine H, 2015, World J Crit Care Med, V4, P296, DOI 10.5492/wjccm.v4.i4.296; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; Wang JQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5692852; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30	52	15	19	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	JAN	2017	33	1					1	13		10.1016/j.ccc.2016.08.008			13	Critical Care Medicine	General & Internal Medicine	EG3ZW	WOS:000390984200002	27894490				2021-06-18	
J	Surmacki, JM; Ansel-Bollepalli, L; Pischiutta, F; Zanier, ER; Ercole, A; Bohndiek, SE				Surmacki, Jakub Maciej; Ansel-Bollepalli, Laura; Pischiutta, Francesca; Zanier, Elisa R.; Ercole, Ari; Bohndiek, Sarah Elizabeth			Label-free monitoring of tissue biochemistry following traumatic brain injury using Raman spectroscopy	ANALYST			English	Article							AMYLOID-BETA; MICE BRAIN; IN-VIVO; CELLS; HEMORRHAGE; PATHOLOGY	Traumatic brain injury (TBI) constitutes a major cause of death and long-term disability. At present, we lack methods to non-invasively track tissue biochemistry and hence select appropriate interventions for patients. We hypothesized that detailed label-free vibrational chemical analysis of focal TBI could provide such information. We assessed the early spatial and temporal changes in tissue biochemistry that are associated with brain injury in mice. Numerous differences were observed in the spectra of the contusion core and pericontusional tissue between 2 and 7 days. For example, a strong signal from haem was seen in the contusion core at 2 days due to haemorrhage, which subsequently resolved. More importantly, elevated cholesterol levels were demonstrated by 7 days, which may be a marker of important cell repair processes. Principal component analysis revealed an early 'acute' component dominated by haemorrhage and a delayed component reflecting changes in protein and lipid composition. Notably we demonstrated changes in Raman signature with time even in the contralateral hemisphere when compared to sham control mice. Raman spectroscopy therefore shows promise as a probe that is sensitive to important pathobiological processes in TBI and could be applied in future both in the experimental setting, as well as in the clinic.	[Surmacki, Jakub Maciej; Ansel-Bollepalli, Laura; Bohndiek, Sarah Elizabeth] Univ Cambridge, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England; [Surmacki, Jakub Maciej; Ansel-Bollepalli, Laura; Bohndiek, Sarah Elizabeth] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England; [Pischiutta, Francesca; Zanier, Elisa R.] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy; [Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Hills Rd, Cambridge CB2 0QQ, England	Bohndiek, SE (corresponding author), Univ Cambridge, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.; Bohndiek, SE (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.; Zanier, ER (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy.; Ercole, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Hills Rd, Cambridge CB2 0QQ, England.	js2238@cam.ac.uk; laura.bollepalli@cruk.cam.ac.uk; francesca.pischiutta@marionegri.it; elisa.zanier@marionegri.it; ae105@cam.ac.uk; seb53@cam.ac.uk	Surmacki, Jakub M./N-1140-2016; Pischiutta, Francesca/AAA-7927-2020; Ercole, Ari/B-6288-2009; Zanier, Elisa/AAA-8095-2020; Bohndiek, Sarah/S-9416-2019	Surmacki, Jakub M./0000-0001-6654-0286; Pischiutta, Francesca/0000-0002-7151-0812; Ercole, Ari/0000-0001-8350-8093; Bollepalli, Laura/0000-0001-5902-059X; Bohndiek, Sarah/0000-0003-0371-8635; Zanier, Elisa/0000-0002-3011-8718	European Union Seventh Framework ProgrammeEuropean Commission [FP7-PEOPLE-CIG-630729]; CRUKCancer Research UK [C14303/A17197]; CRUK (Career Establishment Award) [C47594/A16267]; University of Cambridge Departments of Physics and Oncology; "Fondazione Umberto Veronesi" (FUV)Fondazione Umberto Veronesi; Cancer Research UKCancer Research UK [16267, 21142] Funding Source: researchfish	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. FP7-PEOPLE-2013-CIG-630729, CRUK (C14303/A17197 and Career Establishment Award grant no. C47594/A16267) and the University of Cambridge Departments of Physics and Oncology. FP was supported by "Fondazione Umberto Veronesi" (FUV). The authors would like to thank Prof. David K. Menon for numerous useful discussions.	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Krafft C, 2005, SPECTROCHIM ACTA A, V61, P1529, DOI 10.1016/j.saa.2004.11.017; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lakshmi RJ, 2002, RADIAT RES, V157, P175, DOI 10.1667/0033-7587(2002)157[0175:TRSFTS]2.0.CO;2; Michael R, 2014, EXP EYE RES, V119, P44, DOI 10.1016/j.exer.2013.11.016; Mohs AM, 2010, ANAL CHEM, V82, P9058, DOI 10.1021/ac102058k; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Stone N, 2004, FARADAY DISCUSS, V126, P141, DOI 10.1039/b304992b; Surmacki J, 2015, ANALYST, V140, P2121, DOI 10.1039/c4an01876a; Tay LL, 2011, ANALYST, V136, P1620, DOI 10.1039/c0an00897d; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Wachsmann-Hogiu S, 2009, CURR OPIN BIOTECH, V20, P63, DOI 10.1016/j.copbio.2009.02.006; Wood BR, 2007, ANAL BIOANAL CHEM, V387, P1691, DOI 10.1007/s00216-006-0881-8; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3	28	15	15	0	16	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0003-2654	1364-5528		ANALYST	Analyst	JAN 1	2017	142	1					132	139		10.1039/c6an02238c			8	Chemistry, Analytical	Chemistry	EH0IV	WOS:000391448300014	27905576	Green Published, Other Gold			2021-06-18	
J	Vien, L; DalPorto, C; Yang, D				Vien, Lee; DalPorto, Christina; Yang, David			Retrograde Degeneration of Retinal Ganglion Cells Secondary to Head Trauma	OPTOMETRY AND VISION SCIENCE			English	Article						transsynaptic retrograde degeneration; traumatic brain injury; retinal nerve fiber layer; optical coherence tomography; post-geniculate lesion	OPTICAL COHERENCE TOMOGRAPHY; TRANSSYNAPTIC DEGENERATION; HOMONYMOUS HEMIANOPIA; MULTIPLE-SCLEROSIS; VISUAL PATHWAY; LAYER; INFARCTION; TRACT; HUMANS; SYSTEM	Purpose. To discuss the clinical case of a patient with transsynaptic retrograde degeneration (TRD) demonstrated by progressive retinal nerve fiber layer loss documented by serial spectral domain optical coherence tomography secondary to traumatic brain injury after 2 months post-trauma. Case Report. A 25-year-old Caucasian male patient presented to a polytrauma rehabilitation center (PRC) for evaluation and treatment secondary to a severe traumatic brain injury (TBI) from a motorcycle accident 2 months before. Spectral-domain optical coherence tomography (SD-OCT) was completed at intervals that ranged between 8 and 42 days for a duration of 119 days. A comparison to the pre-trauma SD-OCT 10 months before revealed progressive thinning of the retinal nerve fiber layer (RNFL) in both eyes over multiple follow-ups post-trauma. Humphrey visual field (HVF) testing revealed an incomplete congruous right homonymous hemianopsia that gradually improved over the follow-ups. Analysis of the macular ganglion cell-inner plexiform layer (GCIPL) thickness displayed loss that corresponded to the pattern of visual field defect. Conclusions. TRD can occur as soon as 2 months after severe TBI with damage posterior to the lateral geniculate nucleus. Progressive RNFL loss can be tracked with SD-OCT, and the rate of thinning may slowly stabilize over time. Visual field defects can improve months after the trauma but may not correspond to the progressive RNFL loss detected by SD-OCT.	[Vien, Lee; DalPorto, Christina; Yang, David] Vet Affairs Palo Alto Healthcare Syst, 3801 Miranda Ave,112 OPTOM, Palo Alto, CA 94304 USA; [Vien, Lee; Yang, David] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	Vien, L (corresponding author), Vet Affairs Palo Alto Healthcare Syst, 3801 Miranda Ave,112 OPTOM, Palo Alto, CA 94304 USA.	Lee.vien@va.gov					Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Bai HQ, 2009, EUR J OPHTHALMOL, V19, P201; BEATTY RM, 1982, J NEUROL NEUROSUR PS, V45, P143, DOI 10.1136/jnnp.45.2.143; Bermel RA, 2014, NEUROLOGY, V82, P2152, DOI 10.1212/WNL.0000000000000532; Bridge H, 2011, INVEST OPHTH VIS SCI, V52, P382, DOI 10.1167/iovs.10-5708; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; Cowey A, 2011, BRAIN, V134, P2149, DOI 10.1093/brain/awr125; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Huang-Link YM, 2014, J NEUROL, V261, P2453, DOI 10.1007/s00415-014-7538-x; Jindahra P, 2012, BRAIN, V135, P534, DOI 10.1093/brain/awr324; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Johnson H, 2000, EXP BRAIN RES, V132, P269, DOI 10.1007/s002210000384; Keller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097444; Lawlor M, 2014, OPHTHALMOLOGY, V121, pE15, DOI 10.1016/j.ophtha.2013.11.016; Meier PG, 2015, J NEURO-OPHTHALMOL, V35, P112, DOI 10.1097/WNO.0000000000000182; Miliaras G, 2013, J NEUROL SURG PART A, V74, P168, DOI 10.1055/s-0032-1330115; Park HYL, 2013, OPHTHALMOLOGY, V120, P1292, DOI 10.1016/j.ophtha.2012.11.021; Romero RS, 2012, J NEURO-OPHTHALMOL, V32, P150, DOI 10.1097/WNO.0b013e3182504688; Shin HY, 2014, GRAEF ARCH CLIN EXP, V252, P1501, DOI 10.1007/s00417-014-2706-3; Sriram P, 2012, INVEST OPHTH VIS SCI, V53, P1271, DOI 10.1167/iovs.11-8732; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; TIEL K, 1991, NEURO-OPHTHALMOLOGY, V11, P33, DOI 10.3109/01658109109009640; VANBUREN JM, 1963, J NEUROL NEUROSUR PS, V26, P402; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22	24	15	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					125	134		10.1097/OPX.0000000000000899			10	Ophthalmology	Ophthalmology	EM5ZZ	WOS:000395393900018	27273271				2021-06-18	
J	Yue, JK; Winkler, EA; Rick, JW; Burke, JF; McAllister, TW; Oh, SS; Burchard, EG; Hu, DL; Rosand, J; Temkin, NR; Korley, FK; Sorani, MD; Ferguson, AR; Lingsma, HF; Sharma, S; Robinson, CK; Yuh, EL; Tarapore, PE; Wang, KKW; Puccio, AM; Mukherjee, P; Diaz-Arrastia, R; Gordon, WA; Valadka, AB; Okonkwo, DO; Manley, GT				Yue, John K.; Winkler, Ethan A.; Rick, Jonathan W.; Burke, John F.; McAllister, Thomas W.; Oh, Sam S.; Burchard, Esteban G.; Hu, Donglei; Rosand, Jonathan; Temkin, Nancy R.; Korley, Frederick K.; Sorani, Marco D.; Ferguson, Adam R.; Lingsma, Hester F.; Sharma, Sourabh; Robinson, Caitlin K.; Yuh, Esther L.; Tarapore, Phiroz E.; Wang, Kevin K. W.; Puccio, Ava M.; Mukherjee, Pratik; Diaz-Arrastia, Ramon; Gordon, Wayne A.; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.		TRACK-TBI Investigators	DRD2 C957T polymorphism is associated with improved 6-month verbal learning following traumatic brain injury	NEUROGENETICS			English	Article						Traumatic brain injury; Genetic factors; Cognition; Outcome measures; Human studies	COMMON DATA ELEMENTS; RECEPTOR GENE; TRANSFORMING RESEARCH; CLINICAL KNOWLEDGE; DOPAMINE-RECEPTORS; WORKING-MEMORY; BASAL GANGLIA; DRD2; D2; RECOMMENDATIONS	Traumatic brain injury (TBI) often leads to heterogeneous clinical outcomes, which may be influenced by genetic variation. A single-nucleotide polymorphism (SNP) in the dopamine D2 receptor (DRD2) may influence cognitive deficits following TBI. However, part of the association with DRD2 has been attributed to genetic variability within the adjacent ankyrin repeat and kinase domain containing 1 protein (ANKK1). Here, we utilize the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study to investigate whether a novel DRD2 C957T polymorphism (rs6277) influences outcome on a cognitive battery at 6 months following TBI-California Verbal Learning Test (CVLT-II), Wechsler Adult Intelligence Test Processing Speed Index Composite Score (WAIS-PSI), and Trail Making Test (TMT). Results in 128 Caucasian subjects show that the rs6277 T-allele associates with better verbal learning and recall on CVLT-II Trials 1-5 (T-allele carrier 52.8 +/- 1.3 points, C/C 47.9 +/- 1.7 points; mean increase 4.9 points, 95% confidence interval [0.9 to 8.8]; p = 0.018), Short-Delay Free Recall (T-carrier 10.9 +/- 0.4 points, C/C 9.7 +/- 0.5 points; mean increase 1.2 points [0.1 to 2.5]; p = 0.046), and Long-Delay Free Recall (T-carrier 11.5 +/- 0.4 points, C/C 10.2 +/- 0.5 points; mean increase 1.3 points [0.1 to 2.5]; p = 0.041) after adjusting for age, education years, Glasgow Coma Scale, presence of acute intracranial pathology on head computed tomography scan, and genotype of the ANKK1 SNP rs1800497 using multivariable regression. No association was found between DRD2 C947T and non-verbal processing speed (WAIS-PSI) or mental flexibility (TMT) at 6 months. Hence, DRD2 C947T (rs6277) may be associated with better performance on select cognitive domains independent of ANKK1 following TBI.	[Yue, John K.; Winkler, Ethan A.; Rick, Jonathan W.; Burke, John F.; Sorani, Marco D.; Ferguson, Adam R.; Sharma, Sourabh; Robinson, Caitlin K.; Yuh, Esther L.; Tarapore, Phiroz E.; Mukherjee, Pratik; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Yue, John K.; Winkler, Ethan A.; Rick, Jonathan W.; Burke, John F.; Sorani, Marco D.; Ferguson, Adam R.; Sharma, Sourabh; Robinson, Caitlin K.; Tarapore, Phiroz E.; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Oh, Sam S.; Burchard, Esteban G.; Hu, Donglei] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Rosand, Jonathan] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Rosand, Jonathan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Temkin, Nancy R.] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Korley, Frederick K.] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD USA; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat & Neurosci, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Diaz-Arrastia, Ramon] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA	Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.; Manley, GT (corresponding author), San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu	; Yue, John/P-1348-2015	Wang, Kevin/0000-0002-9343-6473; Yue, John/0000-0001-9694-7722; Burke, John/0000-0002-6190-5116; Diaz-Arrastia, Ramon/0000-0001-6051-3594; Ferguson, Adam/0000-0001-7102-1608	 [NIH RC2 NS069409];  [NIH RC2 NS069409-02S1];  [NIH U01 NS086090-01];  [DOD W81XWH-13-1-0441];  [DOD W81XWH-14-2-0176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090, RC2NS069409] Funding Source: NIH RePORTER	This work was supported by the following grants: NIH RC2 NS069409, NIH RC2 NS069409-02S1, NIH U01 NS086090-01, DOD W81XWH-13-1-0441, and DOD W81XWH-14-2-0176 (to G.T.M.)	Bolton JL, 2010, BEHAV GENET, V40, P630, DOI 10.1007/s10519-010-9372-y; Chien YL, 2013, J HUM GENET, V58, P229, DOI 10.1038/jhg.2012.157; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davidson J., 2014, NEUROSCIENTIST; Delis DC, 2000, CALIFORNIA VERBAL LE; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kane JM, 2012, SCHIZOPHRENIA BULL, V38, P1, DOI 10.1093/schbul/sbr131; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Libon DJ, 2011, J INT NEUROPSYCH SOC, V17, P905, DOI 10.1017/S1355617711000944; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ramsay H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127602; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Swagell CD, 2012, ALCOHOL ALCOHOLISM, V47, P397, DOI 10.1093/alcalc/ags047; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Voisey J, 2012, PSYCHIAT RES, V196, P285, DOI 10.1016/j.psychres.2011.09.024; Voisey J, 2009, DEPRESS ANXIETY, V26, P28, DOI 10.1002/da.20517; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; WHITE NM, 1991, BEHAV NEURAL BIOL, V55, P255, DOI 10.1016/0163-1047(91)90609-T; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E	47	15	15	1	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1364-6745	1364-6753		NEUROGENETICS	Neurogenetics	JAN	2017	18	1					29	38		10.1007/s10048-016-0500-6			10	Genetics & Heredity; Clinical Neurology	Genetics & Heredity; Neurosciences & Neurology	EJ1CE	WOS:000392947100004	27826691	Green Accepted			2021-06-18	
J	Annis, RP; Swahari, V; Nakamura, A; Xie, AX; Hammond, SM; Deshmukh, M				Annis, Ryan P.; Swahari, Vijay; Nakamura, Ayumi; Xie, Alison X.; Hammond, Scott M.; Deshmukh, Mohanish			Mature neurons dynamically restrict apoptosis via redundant premitochondrial brakes	FEBS Journal			English	Article						apoptosis; maturation; miR-24; miR-29; neurons	TROPHIC FACTOR DEPENDENCE; TRAUMATIC BRAIN-INJURY; ACTIVATING FACTOR-I; CELL-DEATH; SYMPATHETIC NEURONS; ENDOGENOUS XIAP; CYTOCHROME-C; DIFFERENTIAL EXPRESSION; BAX DELETION; CANCER-CELLS	Apoptotic cell death is critical for the early development of the nervous system, but once the nervous system is established, the apoptotic pathway becomes highly restricted in mature neurons. However, the mechanisms underlying this increased resistance to apoptosis in these mature neurons are not completely understood. We have previously found that members of the miR-29 family of microRNAs (miRNAs) are induced with neuronal maturation and that overexpression of miR-29 was sufficient to restrict apoptosis in neurons. To determine whether endogenous miR-29 alone was responsible for the inhibition of cytochrome c release in mature neurons, we examined the status of the apoptotic pathway in sympathetic neurons deficient for all three miR-29 family members. Unexpectedly, we found that the apoptotic pathway remained largely restricted in miR-29-deficient mature neurons. We therefore probed for additional mechanisms by which mature neurons resist apoptosis. We identify miR-24 as another miRNA that is upregulated in the maturing cerebellum and sympathetic neurons that can act redundantly with miR-29 by targeting a similar repertoire of prodeath BH3-only genes. Overall, our results reveal that mature neurons engage multiple redundant brakes to restrict the apoptotic pathway and ensure their long-term survival.	[Annis, Ryan P.; Swahari, Vijay; Nakamura, Ayumi; Deshmukh, Mohanish] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27514 USA; [Annis, Ryan P.; Nakamura, Ayumi; Deshmukh, Mohanish] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Xie, Alison X.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Hammond, Scott M.; Deshmukh, Mohanish] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA	Deshmukh, M (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27514 USA.	mohanish@med.unc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS042197, NS083384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS083384, R01NS042197] Funding Source: NIH RePORTER	We thank members of the Deshmukh laboratory for their critical review of the manuscript. We also thank Dr JrGang Cheng for help with generating the luciferase construct, and Dr Ken McCarthy for the use of his electrophysiology equipment. This work was supported by NIH grants NS042197 and NS083384 to MD.	Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Donovan M, 2002, CELL DEATH DIFFER, V9, P1220, DOI 10.1038/sj.cdd.4401105; Easton RM, 1997, J NEUROSCI, V17, P9656; Gama V, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005309; Ham J, 2005, CELL DEATH DIFFER, V12, P1015, DOI 10.1038/sj.cdd.4401689; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Kole AJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.220; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kristiansen M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-551; Liu XJ, 2015, INT J CLIN EXP PATHO, V8, P3811; Madden SD, 2007, INT J DEV BIOL, V51, P415, DOI 10.1387/ijdb.062263sm; Mayorga M, 2004, J BIOL CHEM, V279, P34882, DOI 10.1074/jbc.M404616200; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Olah G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134227; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Ouyang YB, 2013, GLIA, V61, P1784, DOI 10.1002/glia.22556; Pandi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058039; Papadopoulou AS, 2015, NEUROBIOL DIS, V73, P275, DOI 10.1016/j.nbd.2014.10.006; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Potts PR, 2003, J CELL BIOL, V163, P789, DOI 10.1083/jcb.200307130; Putcha GV, 2000, J CELL BIOL, V149, P1011, DOI 10.1083/jcb.149.5.1011; Qi YL, 2014, J BIOL CHEM, V289, P10201, DOI 10.1074/jbc.M113.535195; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sanchis D, 2003, CELL DEATH DIFFER, V10, P977, DOI 10.1038/sj.cdd.4401267; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Smith MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005097; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; Unsain N, 2015, NEURON, V88, P461, DOI 10.1016/j.neuron.2015.08.029; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang XD, 2001, GENE DEV, V15, P2922; Werth JL, 2000, EXP NEUROL, V161, P203, DOI 10.1006/exnr.1999.7241; Wright KM, 2007, J CELL BIOL, V179, P825, DOI 10.1083/jcb.200708086; Wright KM, 2006, CELL CYCLE, V5, P1616, DOI 10.4161/cc.5.15.3129; Wright KM, 2004, J CELL BIOL, V167, P303, DOI 10.1083/jcb.200406073; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; Xiao RJ, 2011, APOPTOSIS, V16, P221, DOI 10.1007/s10495-010-0566-9; Yakovlev AG, 2001, J NEUROSCI, V21, P7439	42	15	15	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	DEC	2016	283	24					4569	4582		10.1111/febs.13944			14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EI8GT	WOS:000392744800013	27797453	Green Accepted			2021-06-18	
J	LaRovere, KL; O'Brien, NF; Tasker, RC				LaRovere, Kerri L.; O'Brien, Nicole F.; Tasker, Robert C.			Current Opinion and Use of Transcranial Doppler Ultrasonography in Traumatic Brain Injury in the Pediatric Intensive Care Unit	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; Doppler ultrasonography; transcranial; intracranial hypertension; severe TBI; vasospasm	CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; CHILDREN; AUTOREGULATION; VELOCITY; VASOSPASM; MODERATE; VALUES	The purpose of this study was to identify and review clinical studies using transcranial Doppler (TCD) ultrasonography in children with severe traumatic brain injury (TBI) in the pediatric intensive care unit (PICU). We identified 16 articles from January 2005 to July 2015 that met inclusion (TBI, five or more cases in case series, subjects < 18 years old, TCD performed in PICU) and exclusion criteria (age not stated, data from subjects < 18 years not separated from adult data, < 85% study population < 18 years in mixed population with adults). TCD parameters were used to assess autoregulation, intracranial pressure, and vasospasm, and to predict neurological outcome. Incidence of impaired autoregulation varied in severe TBI from 25% to 80%. Altered TCD flows and pulsatility index variably predicted intracranial hypertension across studies. Sonographic vasospasm in the middle cerebral artery occurred in 34% of 69 children with severe TBI. Outcomes seem to be related to altered TCD-derived flow velocities while in the ICU. TCD may be a useful tool to assess autoregulation, intracranial pressure, and vasospasm following TBI in the PICU. Further research is needed to establish gold standards and validate the findings in children. TCD may then impact day-to-day management in the PICU, and potentially improve outcomes in children with severe TBI.	[LaRovere, Kerri L.; Tasker, Robert C.] Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave,BCH 3224, Boston, MA 02115 USA; [Tasker, Robert C.] Boston Childrens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA USA; Harvard Med Sch, Boston, MA USA; [O'Brien, Nicole F.] Nationwide Childrens Hosp, Dept Pediat, Div Pediat Crit Care Med, Columbus, OH USA; [O'Brien, Nicole F.] Ohio State Univ, Columbus, OH 43210 USA	LaRovere, KL (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave,BCH 3224, Boston, MA 02115 USA.	kerri.larovere@childrens.harvard.edu	Tasker, Robert C/R-5837-2019	Tasker, Robert/0000-0003-3647-8113			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chin RFM, 2004, EUR J NEUROL, V11, P800, DOI 10.1111/j.1468-1331.2004.00943.x; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; JENNETT B, 1975, LANCET, V1, P480; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; MAEDA H, 1990, ULTRASOUND MED BIOL, V16, P9, DOI 10.1016/0301-5629(90)90080-V; Matta B., 2010, COTTRELL YOUNGS NEUR, P131; Moftakhar P, 2015, J NEUROSURG-PEDIATR, V15, P282, DOI 10.3171/2014.9.PEDS14313; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; O'Brien NF, 2015, J NEUROSURG-PEDIATR, V16, P420, DOI 10.3171/2015.3.PEDS14521; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; O'Brien NF, 2015, CHILD NERV SYST, V31, P2269, DOI 10.1007/s00381-015-2873-5; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; Philip S, 2009, CRIT CARE MED, V37, P2973, DOI 10.1097/CCM.0b013e3181a963f6; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Visocchi M, 2007, ACTA NEUROCHIR, V149, P347, DOI 10.1007/s00701-006-1102-0	28	15	15	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2105	2114		10.1089/neu.2015.4344			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800006	26983462				2021-06-18	
J	Latifi, R; Gunn, JKL; Bakiu, E; Boci, A; Dasho, E; Olldashi, F; Pipero, P; Stroster, JA; Qesteri, O; Kucani, J; Sulo, A; Oshafi, M; Osmani, KL; Dogjani, A; Doarn, CR; Shatri, Z; Kociraj, A; Merrell, RC				Latifi, Rifat; Gunn, Jayleen K. L.; Bakiu, Evis; Boci, Arian; Dasho, Erion; Olldashi, Fatos; Pipero, Pellumb; Stroster, John A.; Qesteri, Orland; Kucani, Julian; Sulo, Ardi; Oshafi, Manjola; Osmani, Kalterina L.; Dogjani, Agron; Doarn, Charles R.; Shatri, Zhaneta; Kociraj, Agim; Merrell, Ronald C.			Access to Specialized Care Through Telemedicine in Limited-Resource Country: Initial 1,065 Teleconsultations in Albania	TELEMEDICINE AND E-HEALTH			English	Article						telemedicine; initiate-build-operate-transfer (IBOT); low- and middle-income countries; teleconsultations; teleneurotrauma; telestroke; teleradiology	BUILD-OPERATE-TRANSFER; MEDICAL SYSTEMS; PROGRAM; STRATEGY	Objective: To analyze the initial experience of the nationwide clinical telemedicine program of Albania, as a model of implementation of telemedicine using Initiate-Build-Operate-Transfer strategy. Methods: This was a retrospective study of prospectively collected data from teleconsultations in Albania between January 1, 2014 and August 26, 2015, delivered synchronously, asynchronously, or a combination of both methods. Patient's demographics, mode of consultation, clinical specialty, hospitals providing referral and consultation, time from initial call to completion of consultation, and patient disposition following teleconsultation were analyzed. Challenges of the newly created program have been identified and analyzed as well. Results: There were 1,065 teleconsultations performed altogether during the study period. Ninety-one patients with autism managed via telemedicine were not included in this analysis and will be reported separately. Of 974 teleconsults, the majority were for radiology, neurotrauma, and stroke (55%, 16%, and 10% respectively). Asynchronous technology accounted for nearly two-thirds of all teleconsultations (63.7%), followed by combined (24.3%), and then synchronous (12.0%). Of 974 cases, only 20.0% of patients in 2014 and 22.72% of patients in 2015 were transferred to a tertiary hospital. A majority (98.5%) of all teleconsultations were conducted within the country itself. Conclusions: The Integrated Telemedicine and e-Health program of Albania has become a useful tool to improve access to high-quality healthcare, particularly in high demanding specialty disciplines. A number of challenges were identified and these should serve as lessons for other countries in their quest to establish nationwide telemedicine programs.	[Latifi, Rifat] Westchester Med Ctr, Dept Surg, Valhalla, NY 10595 USA; [Latifi, Rifat] New York Med Coll, Valhalla, NY 10595 USA; [Latifi, Rifat] Univ Arizona, Dept Surg, Tucson, AZ USA; [Latifi, Rifat; Gunn, Jayleen K. L.; Bakiu, Evis; Boci, Arian; Dasho, Erion; Olldashi, Fatos; Pipero, Pellumb; Stroster, John A.; Qesteri, Orland; Kucani, Julian; Sulo, Ardi; Oshafi, Manjola; Osmani, Kalterina L.; Dogjani, Agron; Merrell, Ronald C.] Int Virtual E Hosp Fdn, Tirana, Albania; [Latifi, Rifat; Gunn, Jayleen K. L.; Bakiu, Evis; Boci, Arian; Dasho, Erion; Olldashi, Fatos; Pipero, Pellumb; Stroster, John A.; Qesteri, Orland; Kucani, Julian; Sulo, Ardi; Oshafi, Manjola; Osmani, Kalterina L.; Dogjani, Agron; Merrell, Ronald C.] Integrated Telemed & E Hlth Program Albania, Tirana, Albania; [Gunn, Jayleen K. L.] Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ USA; [Olldashi, Fatos] Univ Trauma Hosp, Dept Neurosurg, Tirana, Albania; [Dogjani, Agron] Univ Trauma Hosp, Trauma Sect, Tirana, Albania; [Doarn, Charles R.] Univ Cincinnati, Dept Family & Community Med, Cincinnati, OH USA; [Shatri, Zhaneta; Kociraj, Agim] USAID Albania, Tirana, Albania	Latifi, R (corresponding author), Westchester Med Ctr, Dept Surg, Valhalla, NY 10595 USA.; Latifi, R (corresponding author), New York Med Coll, Valhalla, NY 10595 USA.	rifat.latifi@wmchealth.org	Doarn, Charles/L-3934-2019	Latifi, Rifat/0000-0003-1091-3682; Doarn, Charles/0000-0002-7092-8774	USAID in AlbaniaUnited States Agency for International Development (USAID) [182-A-00-09-00101-00]	The Integrated Telemedicine and e-Health Program was funded by the USAID in Albania (Contract No. 182-A-00-09-00101-00). Special thanks to Dr. Petro Mercini for continuous support of the telemedicine program.	Acosta L, 2015, STUD HEALTH TECHNOL, V216, P923, DOI 10.3233/978-1-61499-564-7-923; Bagayoko CO, 2014, BMC HLTH SERV RES S1, V14, P9; Charles B L, 2000, Healthc Financ Manage, V54, P66; Currell R., 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002098; Doarn Charles R, 2009, Telemed J E Health, V15, P379, DOI 10.1089/tmj.2009.0023; INSTAT, 2015, POP 2001 2015 REG; Kammerer FJ, 2015, J TELEMED TELECARE, V21, P355, DOI 10.1177/1357633X15575237; Latifi K, 2011, TELEMED E-HEALTH, V17, P757, DOI 10.1089/tmj.2011.0102; Latifi R, 2006, TELEMED J E-HEALTH, V12, P332, DOI 10.1089/tmj.2006.12.332; Latifi R, 2015, TELEMED E-HEALTH, V21, P503, DOI 10.1089/tmj.2014.0138; Latifi R, 2014, TELEMED E-HEALTH, V20, P1027, DOI 10.1089/tmj.2014.0026; Latifi Rifat, 2012, Bull Am Coll Surg, V97, P15; Latifi R, 2012, TELEMED E-HEALTH, V18, P388, DOI [10.1089/tmj.2011.1263, 10.1089/tmj.2011.0263]; Latifi R, 2011, STUD HEALTH TECHNOL, V165, P3, DOI 10.3233/978-1-60750-735-2-3; Latifi Rifat, 2009, Am J Surg, V198, P905, DOI 10.1016/j.amjsurg.2009.08.011; Latifi R, 2009, TELEMED J E-HEALTH, V15, P956, DOI 10.1089/tmj.2009.0084; Sangare M, 2015, J TELEMED TELECARE, V21, P131, DOI 10.1177/1357633X15569966; Wilson LS, 2015, HEALTHC INFORM RES, V21, P213, DOI 10.4258/hir.2015.21.4.213; World Health Organization, 2011, WHO GLOB SER, V2; World Health Organization (WHO), 2015, INT CLASS DIS ICD; Yilmaz AO, 2016, COMPUT METH PROG BIO, V123, P159, DOI 10.1016/j.cmpb.2015.10.005	21	15	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	DEC	2016	22	12					1024	1031		10.1089/tmj.2016.0050			8	Health Care Sciences & Services	Health Care Sciences & Services	EF5ZB	WOS:000390407500009	27219617				2021-06-18	
J	Middleton, A; Graham, JE; Lin, YL; Goodwin, JS; Bettger, JP; Deutsch, A; Ottenbacher, KJ				Middleton, Addie; Graham, James E.; Lin, Yu-Li; Goodwin, James S.; Bettger, Janet Prvu; Deutsch, Anne; Ottenbacher, Kenneth J.			Motor and Cognitive Functional Status Are Associated with 30-day Unplanned Rehospitalization Following Post-Acute Care in Medicare Fee-for-Service Beneficiaries	JOURNAL OF GENERAL INTERNAL MEDICINE			English	Article						rehabilitation; functional status; health care reform; health services research; medicare	TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; HOSPITAL READMISSION; INDEPENDENCE MEASURE; IMPAIRMENT; RELIABILITY; DISCHARGE	The Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014 stipulates that standardized functional status (self-care and mobility) and cognitive function data will be used for quality reporting in post-acute care settings. Thirty-day post-discharge unplanned rehospitalization is an established quality metric that has recently been extended to post-acute settings. The relationships between the functional domains in the IMPACT Act and 30-day unplanned rehospitalization are poorly understood. To determine the degree to which discharge mobility, self-care, and cognitive function are associated with 30-day unplanned rehospitalization following discharge from post-acute care. This was a retrospective cohort study. Inpatient rehabilitation facilities submitting claims and assessment data to the Centers for Medicare and Medicaid Services in 2012-2013. Medicare fee-for-service enrollees discharged from post-acute rehabilitation in 2012-2013. The sample included community-dwelling adults admitted for rehabilitation following an acute care stay who survived for 32 days following discharge (N = 252,406). Not applicable. Thirty-day unplanned rehospitalization following post-acute rehabilitation. The unadjusted 30-day unplanned rehospitalization rate was 12.0 % (n = 30,179). Overall, patients dependent at discharge for mobility had a 50 % increased odds of rehospitalization (OR = 1.50, 95 % CI: 1.42-1.59), patients dependent for self-care a 36 % increased odds (OR = 1.36, 95 % CI: 1.27-1.47), and patients dependent for cognition a 19 % increased odds (OR = 1.19, 95 % CI: 1.09-1.29). Patients dependent for both self-care and mobility at discharge (n = 8312, 3.3 %) had a 16.1 % (95 % CI: 15.3-17.0 %) adjusted rehospitalization rate versus 8.5 % (95 % CI: 8.3-8.8 %) for those independent for both (n = 74,641; 29.6 %). The functional domains identified in the IMPACT Act were associated with 30-day unplanned rehospitalization following post-acute care in this large national sample. Further research is needed to better understand and improve the functional measures, and to determine if their association with rehospitalizations varies across post-acute settings, patient populations, or episodes of care.	[Middleton, Addie; Graham, James E.; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, 301 Univ Blvd, Galveston, TX 77555 USA; [Lin, Yu-Li] Univ Texas Med Branch, Off Biostat, Galveston, TX 77555 USA; [Goodwin, James S.] Univ Texas Med Branch, Div Geriatr Med, Dept Internal Med, Galveston, TX 77555 USA; [Bettger, Janet Prvu] Duke Univ Med Ctr, Duke Clin Res Inst, Dept Orthopaed Surg, Durham, NC USA; [Deutsch, Anne] RTI Int & Rehabil Inst Chicago, Chicago, IL USA	Middleton, A (corresponding author), Univ Texas Med Branch, Div Rehabil Sci, 301 Univ Blvd, Galveston, TX 77555 USA.	jamiddle@utmb.edu		Ottenbacher, Kenneth/0000-0001-5990-3982; Middleton, Addie/0000-0001-8970-3703; Deutsch, Anne/0000-0003-2290-7757	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24-HD065702, R01-HD069443, 5K12HD055929-09]; National Institute for Disability, Independent Living, and Rehabilitation Research [H133G140127]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069443, P2CHD065702, K12HD055929] Funding Source: NIH RePORTER	The study was supported by the National Institutes of Health (R24-HD065702, R01-HD069443 and 5K12HD055929-09, PI, K. Ottenbacher) and the National Institute for Disability, Independent Living, and Rehabilitation Research (H133G140127, PI, K. Ottenbacher).	[Anonymous], 2014, FED REG, V79; Barnett ML, 2015, JAMA INT MED; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Centers for Medicare and Medicaid Services, 2014, BUNDL PAYM CAR IMPR; Chen C, 2014, JAMA-J AM MED ASSOC, V311, P673, DOI 10.1001/jama.2014.11; Cutler DM, 2015, JAMA-J AM MED ASSOC, V313, P1606, DOI 10.1001/jama.2015.1926; Deutsch A, 2012, ANAL CROSSCUTTING ME; Faulk CE, 2013, PM&R, V5, P757, DOI 10.1016/j.pmrj.2013.06.002; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; Greysen SR, 2015, JAMA INTERN MED, V175, P559, DOI 10.1001/jamainternmed.2014.7756; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS293, DOI 10.1016/j.apmr.2014.08.026; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Hoyer EH, 2014, J HOSP MED, V9, P277, DOI 10.1002/jhm.2152; Hoyer EH, 2013, ARCH PHYS MED REHAB, V94, P1951, DOI 10.1016/j.apmr.2013.05.028; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; Lum HD, 2012, J GEN INTERN MED, V27, P1467, DOI 10.1007/s11606-012-2116-3; Medicare Payment Advisory Commission (MedPAC), 2015, C MED PAYM POL MAR; Morandi A, 2013, J AM MED DIR ASSOC, V14, P761, DOI 10.1016/j.jamda.2013.03.013; Neuman MD, 2014, JAMA-J AM MED ASSOC, V312, P1542, DOI 10.1001/jama.2014.13513; Ottenbacher KJ, 2012, J GERONTOL A-BIOL, V67, P875, DOI 10.1093/gerona/glr247; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Ottenbacher KJ, 2001, ARCH PHYS MED REHAB, V82, P1367, DOI 10.1053/apmr.2001.26088; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Shih SL, 2015, J GEN INTERN MED; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P29, DOI 10.1053/apmr.2003.50061; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; UB Foundation Activities, 2012, INP REH FAC PAT ASS; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation, 2014, 2014 MEAS UPD SPEC R	29	15	15	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0884-8734	1525-1497		J GEN INTERN MED	J. Gen. Intern. Med.	DEC	2016	31	12					1427	1434		10.1007/s11606-016-3704-4			8	Health Care Sciences & Services; Medicine, General & Internal	Health Care Sciences & Services; General & Internal Medicine	EE5DX	WOS:000389626600007	27439979	Green Published, Bronze			2021-06-18	
J	Moretti, R; Chhor, V; Bettati, D; Banino, E; De Lucia, S; Le Charpentier, T; Lebon, S; Schwendimann, L; Pansiot, J; Rasika, S; Degos, V; Titomanlio, L; Gressens, P; Fleiss, B				Moretti, Raffaella; Chhor, Vibol; Bettati, Donatella; Banino, Elena; De Lucia, Silvana; Le Charpentier, Tifenn; Lebon, Sophie; Schwendimann, Leslie; Pansiot, Julien; Rasika, Sowmyalakshmi; Degos, Vincent; Titomanlio, Luigi; Gressens, Pierre; Fleiss, Bobbi			Contribution of Mast Cells to Injury Mechanisms in a Mouse Model of Pediatric Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neuroinflammation; histamine; apoptosis; myelin; neuron; microglia	WHITE-MATTER; SYSTEMIC INFLAMMATION; IMMATURE RAT; HISTAMINE; MICROGLIA; NEUROPROTECTION; RECEPTORS; ACCUMULATION; ACTIVATION; PLASTICITY	The cognitive and behavioral deficits caused by traumatic brain injury (TBI) to the immature brain are more severe and persistent than injuries to the adult brain. Understanding this developmental sensitivity is critical because children under 4 years of age of sustain TBI more frequently than any other age group. One of the first events after TBI is the infiltration and degranulation of mast cells (MCs) in the brain, releasing a range of immunomodulatory substances; inhibition of these cells is neuroprotective in other types of neonatal brain injury. This study investigates for the first time the role of MCs in mediating injury in a P7 mouse model of pediatric contusion-induced TBI. We show that various neural cell types express histamine receptors and that histamine exacerbates excitotoxic cell death in primary cultured neurons. Cromoglycate, an inhibitor of MC degranulation, altered the inflammatory phenotype of microglia activated by TBI, reversing several changes but accentuating others, when administered before TBI. However, without regard to the time of cromoglycate administration, inhibiting MC degranulation did not affect cell loss, as evaluated by ventricular dilatation or cleaved caspase-3 labeling, or the density of activated microglia, neurons, or myelin. In double-heterozygous cKit mutant mice lacking MCs, this overall lack of effect was confirmed. These results suggest that the role of MCs in this model of pediatric TBI is restricted to subtle effects and that they are unlikely to be viable neurotherapeutic targets. (C) 2016 Wiley Periodicals, Inc.	[Moretti, Raffaella; Chhor, Vibol; Bettati, Donatella; Banino, Elena; De Lucia, Silvana; Le Charpentier, Tifenn; Lebon, Sophie; Schwendimann, Leslie; Pansiot, Julien; Rasika, Sowmyalakshmi; Degos, Vincent; Titomanlio, Luigi; Gressens, Pierre; Fleiss, Bobbi] Unversit Paris Diderot, INSERM, PROTECT, Sorbonne Paris Cite, Paris, France; [Moretti, Raffaella; Chhor, Vibol; Bettati, Donatella; Banino, Elena; De Lucia, Silvana; Le Charpentier, Tifenn; Lebon, Sophie; Schwendimann, Leslie; Pansiot, Julien; Rasika, Sowmyalakshmi; Degos, Vincent; Titomanlio, Luigi; Gressens, Pierre; Fleiss, Bobbi] PremUP, Paris, France; [Moretti, Raffaella; Bettati, Donatella; Banino, Elena; De Lucia, Silvana] Univ Udine, Udine, Italy; [Chhor, Vibol] Georges Pompidou European Hosp, Dept Anesthesia & Intens Care, Paris, France; [Degos, Vincent] Hop La Pitie Salpetriere, Dept Anesthesia & Intens Care, Paris, France; [Gressens, Pierre; Fleiss, Bobbi] St Thomas Hosp, Kings Hlth Partners, Kings Coll London, Dept Perinatal Imaging & Hlth,Div Imaging Sci & B, London, England	Fleiss, B (corresponding author), Hop Robert Debre, INSERM, U1141, 48 Blvd Serurier, F-75019 Paris, France.	bobbi.fleiss@inserm.fr	Fleiss, Bobbi/F-9899-2011; gressens, pierre/M-7557-2017	Fleiss, Bobbi/0000-0001-7828-673X; gressens, pierre/0000-0002-0909-4221	INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; Universite Paris Diderot; Universite Sorbonne-Paris-Cite, Investissement d'AvenirFrench National Research Agency (ANR) [ANR-11-INBS-0011 NeurATRIS]; ERA-NET Neuron (Micromet); DHU PROTECT; PremUP; Fondation de FranceFondation de France; Fondation pour la Recherche sur le Cerveau; Fondation des Gueules Cassees; Roger de Spoelberch Foundation; Grace de Monaco Foundation; Leducq FoundationLeducq Foundation; Cerebral Palsy Alliance Research Foundation Australia; Wellcome TrustWellcome TrustEuropean Commission [WSCR P32674]; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR)	Contract grant sponsor: INSERM, Universite Paris Diderot, Universite Sorbonne-Paris-Cite, Investissement d'Avenir; Contract grant number: ANR-11-INBS-0011 NeurATRIS; Contract grant sponsor: ERA-NET Neuron (Micromet); Contract grant sponsor: DHU PROTECT; Contract grant sponsor: PremUP; Contract grant sponsor: Fondation de France; Contract grant sponsor: Fondation pour la Recherche sur le Cerveau; Contract grant sponsor: Fondation des Gueules Cassees; Contract grant sponsor: Roger de Spoelberch Foundation; Contract grant sponsor: Grace de Monaco Foundation; Contract grant sponsor: Leducq Foundation; Contract grant sponsor: Cerebral Palsy Alliance Research Foundation Australia; Contract grant sponsor: Wellcome Trust; Contract grant number: WSCR P32674; Contract grant sponsor: National Institute for Health Research (NIHR) (to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Bennet L, 2013, CLIN EXP PHARMACOL P, V40, P774, DOI 10.1111/1440-1681.12135; Biran V, 2008, BRAIN PATHOL, V18, P1, DOI 10.1111/j.1750-3639.2007.00092.x; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Dean JM, 2010, BRAIN BEHAV IMMUN, V24, P776, DOI 10.1016/j.bbi.2009.10.018; Dimitriadou V, 1996, DEV BRAIN RES, V97, P29, DOI 10.1016/S0165-3806(96)00127-7; Dong H, 2016, MOL NEUROBIOL; DROPP JJ, 1979, ACTA ANAT, V105, P505; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Ferreira R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-90; Fleiss B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-70; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Hendrix S, 2013, FASEB J, V27, P920, DOI 10.1096/fj.12-204800; Husson I, 2005, CEREB CORTEX, V15, P250, DOI 10.1093/cercor/bhh127; Jin YX, 2007, DEV NEUROSCI-BASEL, V29, P373, DOI 10.1159/000105478; Jin YX, 2009, STROKE, V40, P3107, DOI 10.1161/STROKEAHA.109.549691; Kaindl AM, 2007, PROTEOM CLIN APPL, V1, P640, DOI 10.1002/prca.200600696; Kaindl AM, 2012, ANN NEUROL, V72, P536, DOI 10.1002/ana.23626; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Khalil M, 2007, BRAIN RES, V1171, P18, DOI 10.1016/j.brainres.2007.07.034; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lozada A, 2005, NEUROPATH APPL NEURO, V31, P150, DOI 10.1111/j.1365-2990.2004.00622.x; MEININGER CJ, 1992, BLOOD, V79, P958; Mesples B, 2005, NEUROBIOL DIS, V18, P193, DOI 10.1016/j.nbd.2004.09.018; Monk KR, 2007, NEURON GLIA BIOL, V3, P233, DOI 10.1017/S1740925X08000021; Panula P, 2014, TRENDS NEUROSCI, V37, P159, DOI 10.1016/j.tins.2014.01.001; Patkai J, 2001, PEDIATR RES, V50, P222, DOI 10.1203/00006450-200108000-00010; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ribatti D, 2015, EXP CELL RES, V338, P119, DOI 10.1016/j.yexcr.2015.05.013; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Schang AL, 2014, BRAIN BEHAV IMMUN, V37, P95, DOI 10.1016/j.bbi.2013.11.005; Shimada R, 2012, J CLIN NEUROSCI, V19, P447, DOI 10.1016/j.jocn.2011.06.033; Silver R, 1996, TRENDS NEUROSCI, V19, P25, DOI 10.1016/0166-2236(96)81863-7; Smith PLP, 2014, DEV NEUROSCI-BASEL, V36, P119, DOI 10.1159/000359950; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Stolp HB, 2005, CELL TISSUE RES, V320, P369, DOI 10.1007/s00441-005-1088-6; Strbian D, 2007, J CEREBR BLOOD F MET, V27, P795, DOI 10.1038/sj.jcbfm.9600387; Strbian D, 2006, J CEREBR BLOOD F MET, V26, P605, DOI 10.1038/sj.jcbfm.9600228; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	47	15	15	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC	2016	94	12			SI		1546	1560		10.1002/jnr.23911			15	Neurosciences	Neurosciences & Neurology	EC9DG	WOS:000388443700020	27614029				2021-06-18	
J	Radabaugh, HL; Carlson, LJ; O'Neil, DA; LaPorte, MJ; Monaco, CM; Cheng, JP; de la Tremblaye, PB; Lajud, N; Bondi, CO; Kline, AE				Radabaugh, Hannah L.; Carlson, Lauren J.; O'Neil, Darik A.; LaPorte, Megan J.; Monaco, Christina M.; Cheng, Jeffrey P.; de la Tremblaye, Patricia B.; Lajud, Naima; Bondi, Corina O.; Kline, Anthony E.			Abbreviated environmental enrichment confers neurobehavioral, cognitive, and histological benefits in brain-injured female rats	EXPERIMENTAL NEUROLOGY			English	Article						Behavioral outcome; Controlled cortical impact; Environmental enrichment; Functional recovery; Learning and memory; Morris water maze; Traumatic brain injury	MEDIATED FUNCTIONAL IMPROVEMENT; RANDOMIZED CONTROLLED-TRIAL; RECEPTOR AGONIST 8-OH-DPAT; CONTROLLED CORTICAL IMPACT; TREATMENT REGIMEN; CLINICAL-TRIALS; RECOVERY; 5-HT1A; REHABILITATION; MODERATE	Environmental enrichment (EE) promotes behavioral recovery after experimental traumatic brain injury (TBI). However, the chronic rehabilitation provided in the laboratory is not analogous to the clinic where physiotherapy is typically limited. Moreover, females make up approximately 40% of the clinical TBI population, yet they are seldom studied in brain trauma. Hence, the goal of this study was to test the hypothesis that abbreviated EE would confer neurobehavioral, cognitive, and histological benefits in brain injured female rats. Anesthetized rats received a cortical impact of moderate-to-severe injury (2.8 mm tissue deformation at 4 m/s) or sham surgery and then were randomly assigned to groups receiving standard (STD) housing or 4 h, 6 h, or 24 h of EE daily. Motor function (beam-balance/walk and rotarod) was assessed on post-operative days 1-5 and every other day from 1 to 19, respectively. Spatial learning/memory (Morris water maze) was evaluated on days 14-19, and cortical lesion volume was quantified on day 21. No statistical differences were appreciated among the sham controls in any assessment and thus the data were pooled. All EE conditions improved motor function and memory retention, but only 6 h and 24 h enhanced spatial learning relative to STD (p < 0.05). Moreover, EE, regardless of duration reduced cortical lesion volume (p < 0.05). These data confirm that abbreviated EE confers robust neurobehavioral, cognitive, and histological benefits in TBI female rats, which supports the hypothesis and strengthens the utility of EE as a pre-clinical model of neurorehabilitation. (C) 2016 Elsevier Inc. All rights reserved.	[Radabaugh, Hannah L.; Carlson, Lauren J.; O'Neil, Darik A.; LaPorte, Megan J.; Monaco, Christina M.; Cheng, Jeffrey P.; de la Tremblaye, Patricia B.; Lajud, Naima; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Radabaugh, Hannah L.; Carlson, Lauren J.; O'Neil, Darik A.; LaPorte, Megan J.; Monaco, Christina M.; Cheng, Jeffrey P.; de la Tremblaye, Patricia B.; Lajud, Naima; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA; [Lajud, Naima] Inst Mexicana Segura Social Morelia, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15213 USA; [Monaco, Christina M.] Philadelphia Coll Osteopath Med, Philadelphia, PA 19131 USA	Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, Crit Care Med, Psychol, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X; Bondi, Corina/0000-0002-5733-4912	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060005, HD069620, HD069620-S1, NS084967, NS094950]; University of Pittsburgh Physicians/UPMC Academic Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005, R03NS094950, R01NS084967] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants NS060005, HD069620, HD069620-S1, NS084967 (AEK), NS094950 (COB), and the University of Pittsburgh Physicians/UPMC Academic Foundation (COB).	Barry NC, 2015, J CLIN EXP NEUROPSYC, V37, P994, DOI 10.1080/13803395.2015.1038981; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI 10.1139/y10-103; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Richter KM, 2015, J CLIN EXP NEUROPSYC, V37, P571, DOI 10.1080/13803395.2015.1030358; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Yelleswarapu NK, 2012, NEUROSCI LETT, V515, P153, DOI 10.1016/j.neulet.2012.03.033; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	53	15	15	1	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2016	286						61	68		10.1016/j.expneurol.2016.09.015			8	Neurosciences	Neurosciences & Neurology	EC3ZB	WOS:000388064500007	27693618	Green Accepted			2021-06-18	
J	Mohammed, HS				Mohammed, Haitham S.			Transcranial low-level infrared laser irradiation ameliorates depression induced by reserpine in rats	LASERS IN MEDICAL SCIENCE			English	Article						Low-level infrared laser; Depression; FST; ECoG; Rat	LIGHT; MODEL; MICE; PHOTOBIOMODULATION; SYMPTOMS	Transcranial low-level infrared laser is a modality of therapy based on the principle of photons delivered in a non-invasive manner through the skull for the treatment of some neurological conditions such as psychological disorders, traumatic brain injuries, and neurodegenerative diseases among others. In the present study, effects of low-level infrared laser irradiation with different radiation powers (80, 200, and 400 mW, continuous wave) were investigated on normal animals subjected to forced swimming test (FST). Results indicated that there are changes in FST parameters in animals irradiated with laser; the lowest dose provoked a significant increase in animal activity (swimming and climbing) and a significant decrease in animal's immobility, while the highest laser dose resulted in a complete inverse action by significantly increasing animal immobility and significantly decreasing animal activity with respect to control animals. The lowest dose (80 mW) of transcranial laser irradiation has then utilized on animals injected with a chronic dose of reserpine (0.2 mg/kg i.p. for 14 days) served as an animal model of depression. Laser irradiation has successfully ameliorated depression induced by reserpine as indicated by FST parameters and electrocorticography (ECoG) spectral analysis in irradiated animals. The findings of the present study emphasized the beneficial effects of low-level infrared laser irradiation on normal and healthy animals. Additionally, it indicated the potential antidepressant activity of the low dose of infrared laser irradiation.	[Mohammed, Haitham S.] Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt	Mohammed, HS (corresponding author), Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt.	Haitham@sci.cu.edu.eg		Mohammed, Haitham S./0000-0002-6055-9514			Antkiewicz-Michaluk L, 2014, NEUROTOX RES, V26, P85, DOI 10.1007/s12640-013-9454-8; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Blasco-Serra A, 2015, PHYSIOL BEHAV, V151, P456, DOI 10.1016/j.physbeh.2015.07.033; Cassano Paolo, 2015, Psychiatry J, V2015, P352979, DOI 10.1155/2015/352979; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; El-Ghazaly MA, 2015, TOXICOL IND HEALTH, V31, P1128, DOI 10.1177/0748233713487251; Huang QJ, 2004, ACTA PHARMACOL SIN, V25, P293; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Hunter AM, 2010, ACTA PSYCHIAT SCAND, V122, P461, DOI 10.1111/j.1600-0447.2010.01560.x; Leuchter AF, 2009, PSYCHIAT RES, V169, P132, DOI 10.1016/j.psychres.2009.04.004; Li JY, 2014, J NEUROPHYSIOL, V111, P2061, DOI 10.1152/jn.00475.2013; MAINA G, 1974, BIOCHIM BIOPHYS ACTA, V333, P481, DOI 10.1016/0005-2728(74)90132-7; Michalikova S, 2008, NEUROBIOL LEARN MEM, V89, P480, DOI 10.1016/j.nlm.2007.07.014; Mohammed HS, 2011, BEHAV BRAIN RES, V225, P39, DOI 10.1016/j.bbr.2011.06.018; Mrazek DA, 2014, PSYCHIAT SERV, V65, P977, DOI 10.1176/appi.ps.201300059; Nagakura Y, 2009, PAIN, V146, P26, DOI 10.1016/j.pain.2009.05.024; Olvera-Cortes E, 2002, BRAIN RES BULL, V58, P261, DOI 10.1016/S0361-9230(02)00769-4; OSUBOR CC, 1994, RES EXP MED, V194, P109, DOI 10.1007/BF02576371; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Robbins TW, 1998, ANN NY ACAD SCI, V846, P222, DOI 10.1111/j.1749-6632.1998.tb09740.x; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Rojas-Corrales MO, 2004, J PSYCHOPHARMACOL, V18, P404, DOI 10.1177/026988110401800305; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Tian FH, 2016, LASER SURG MED, V48, P343, DOI 10.1002/lsm.22471; Vakalopoulos C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00063; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Zwierzynska E, 2015, AM J DRUG ALCOHOL AB, V41, P153, DOI 10.3109/00952990.2014.987349	31	15	16	0	11	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	NOV	2016	31	8					1651	1656		10.1007/s10103-016-2033-5			6	Engineering, Biomedical; Surgery	Engineering; Surgery	EA1QW	WOS:000386367900017	27437987				2021-06-18	
J	Ostergard, T; Sweet, J; Kusyk, D; Herring, E; Miller, J				Ostergard, Thomas; Sweet, Jennifer; Kusyk, Dorian; Herring, Eric; Miller, Jonathan			Animal models of post-traumatic epilepsy	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Epilepsy; Traumatic brain injury; Animal models	LATERAL FLUID-PERCUSSION; TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; RAT; SEIZURES; MOUSE; RISK	Post-traumatic epilepsy (PTE) is defined as the development of unprovoked seizures in a delayed fashion after traumatic brain injury (TBI). PTE lies at the intersection of two distinct fields of study, epilepsy and neurotrauma. TBI is associated with a myriad of both focal and diffuse anatomic injuries, and an ideal animal model of epilepsy after TBI must mimic the characteristics of human PTE. The three most commonly used models of TBI are lateral fluid percussion, controlled cortical injury, and weight drop. Much of what is known about PTE has resulted from use of these models. In this review, we describe the most commonly used animal models of TBI with special attention to their advantages and disadvantages with respect to their use as a model of PTE. (C) 2016 Elsevier B.V. All rights reserved.	[Ostergard, Thomas; Sweet, Jennifer; Kusyk, Dorian; Herring, Eric; Miller, Jonathan] Case Western Reserve Univ, Sch Med, Neurol Inst, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA	Miller, J (corresponding author), Univ Hosp Case Med Ctr, Dept Neurol Surg, 11100 Euclid Ave, Cleveland, OH 44106 USA.	Jonathan.Miller@UHHospitals.org					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hameed MQ, 2014, NEUROREPORT, V25, P532, DOI 10.1097/WNR.0000000000000132; Heise T, 2010, J HEALTH CARE POOR U, V21, P401; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1108, DOI 10.1038/sj.jcbfm.9600410; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Messori A, 2005, EPILEPSIA, V46, P1472, DOI 10.1111/j.1528-1167.2005.34004.x; Nemes A., 2016, J NEUROTRAUMA; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	30	15	16	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 15	2016	272				SI		50	55		10.1016/j.jneumeth.2016.03.023			6	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA6LF	WOS:000386740000006	27044802				2021-06-18	
J	Shibahashi, K; Doi, T; Tanaka, S; Hoda, H; Chikuda, H; Sawada, Y; Takasu, Y; Chiba, K; Nozaki, T; Hamabe, Y; Ogata, T				Shibahashi, Keita; Doi, Toru; Tanaka, Sakae; Hoda, Hidenori; Chikuda, Hirotaka; Sawada, Yasuhiro; Takasu, Yuichi; Chiba, Kentaro; Nozaki, Toshiki; Hamabe, Yuichi; Ogata, Toru			The Serum Phosphorylated Neurofilament Heavy Subunit as a Predictive Marker for Outcome in Adult Patients after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; assessment tool; traumatic brain injury	NF-H; PNF-H; BIOMARKER; SEVERITY; DAMAGE	The serum phosphorylated neurofilament heavy subunit (pNF-H) is a nervous system-specific protein that is released from damaged neural tissue after traumatic brain injury (TBI). The aim of this study was to elucidate the usefulness of serum pNF-H as a predictive marker for the outcome of patients after TBI. Patients with TBI (Glasgow Coma Scale score of 13 or less on admission) were included. Patients who were younger than age 18, dependent on others for daily activities before injury, pregnant, or who were not likely to survive for more than 24h after injury were excluded. The outcome was assessed using the Glasgow Outcome Scale at 6 months after injury. Blood was collected from subjects (n=32), and the serum pNF-H value was assessed at 24 and 72h after TBI. The optimal cutoff value and usefulness of the serum pNF-H value for predicting the long-term outcome were investigated. We found that the serum pNF-H value at 24h after injury was a good predictive marker of death at 6 months (p<0.001) after injury. The optimal cutoff value was 240pg/mL, and the area under the curve in the receiver operating characteristic analysis was 0.930. The serum pNF-H value at 72h after injury was correlated with an unfavorable outcome (vegetative state or death) at 6 months (p<0.01) with a cutoff value of 80pg/mL. Collectively, the results of this study indicate that the serum pNF-H value is a useful predictive marker for patient outcome after TBI.	[Shibahashi, Keita; Hoda, Hidenori; Chikuda, Hirotaka; Takasu, Yuichi; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Tokyo, Japan; [Shibahashi, Keita; Hoda, Hidenori; Chikuda, Hirotaka; Takasu, Yuichi; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Intens Care Ctr, Tokyo, Japan; [Doi, Toru; Sawada, Yasuhiro; Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan; [Doi, Toru; Tanaka, Sakae] Univ Tokyo, Dept Orthoped Surg, Fac Med, Tokyo, Japan; [Chiba, Kentaro] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan; [Nozaki, Toshiki] Nippon Med Sch, Dept Neurol Surg, Tokyo, Japan	Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan.; Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Intens Care Ctr, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan.	kshibahashi@yahoo.co.jp	Tanaka, Sakae/Y-3061-2019; Sawada, Yasuhiro/H-8044-2012; Doi, Toru/AAC-3441-2020	Tanaka, Sakae/0000-0001-9210-9414; Sawada, Yasuhiro/0000-0003-0625-3335; Nozaki, Toshiki/0000-0002-6941-4645	Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15H04966] Funding Source: KAKEN		Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; [Anonymous], 2008, BMJ-BRIT MED J, V336, P336; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Kato S, 2015, J CLIN NEUROSCI, V22, P1638, DOI 10.1016/j.jocn.2015.03.047; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Natori A, 2015, CLIN CANCER RES, V21, P1348, DOI 10.1158/1078-0432.CCR-14-2775; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	15	15	16	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1826	1833		10.1089/neu.2015.4237			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300003	27098610				2021-06-18	
J	Song, HL; Lu, Y; Qu, Z; Mossine, VV; Martin, MB; Hou, J; Cui, JK; Peculis, BA; Mawhinney, TP; Cheng, JL; Greenlief, CM; Fritsche, K; Schmidt, FJ; Walter, RB; Lubahn, DB; Sun, GY; Gu, ZZ				Song, Hailong; Lu, Yuan; Qu, Zhe; Mossine, Valeri V.; Martin, Matthew B.; Hou, Jie; Cui, Jiankun; Peculis, Brenda A.; Mawhinney, Thomas P.; Cheng, Jianlin; Greenlief, C. Michael; Fritsche, Kevin; Schmidt, Francis J.; Walter, Ronald B.; Lubahn, Dennis B.; Sun, Grace Y.; Gu, Zezong			Effects of aged garlic extract and FruArg on gene expression and signaling pathways in lipopolysaccharide-activated microglial cells	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; NITRIC-OXIDE; TRANSCRIPTION FACTOR; MAILLARD REACTION; ANTIOXIDANT; INFLAMMATION; MECHANISM; ARGININE; IMMUNE	Aged garlic extract (AGE) is widely used as a dietary supplement on account of its protective effects against oxidative stress and inflammation. But less is known about specific molecular targets of AGE and its bioactive components, including N-alpha-(1-deoxy-D-fructos-1-yl)-L-arginine (FruArg). Our recent study showed that both AGE and FruArg significantly attenuate lipopolysaccharide (LPS)-induced neuroinflammatory responses in BV-2 microglial cells. This study aims to unveil effects of AGE and FruArg on gene expression regulation in LPS stimulated BV-2 cells. Results showed that LPS treatment significantly altered mRNA levels from 2563 genes. AGE reversed 67% of the transcriptome alteration induced by LPS, whereas FruArg accounted for the protective effect by reversing expression levels of 55% of genes altered by LPS. Key pro-inflammatory canonical pathways induced by the LPS stimulation included toll-like receptor signaling, IL-6 signaling, and Nrf2-mediated oxidative stress pathway, along with elevated expression levels of genes, such as Il6, Cd14, Casp3, Nfkb1, Hmox1, and Tnf. These effects could be modulated by treatment with both AGE and FruArg. These findings suggests that AGE and FruArg are capable of alleviating oxidative stress and neuroinflammatory responses stimulated by LPS in BV-2 cells.	[Song, Hailong; Qu, Zhe; Cui, Jiankun; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Song, Hailong; Qu, Zhe; Cui, Jiankun; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65212 USA; [Song, Hailong; Qu, Zhe; Hou, Jie; Cui, Jiankun; Cheng, Jianlin; Greenlief, C. Michael; Fritsche, Kevin; Lubahn, Dennis B.; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Ctr Bot Interact Studies, Columbia, MO 65211 USA; [Lu, Yuan; Mossine, Valeri V.; Martin, Matthew B.; Peculis, Brenda A.; Mawhinney, Thomas P.; Schmidt, Francis J.; Lubahn, Dennis B.; Sun, Grace Y.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Lu, Yuan; Walter, Ronald B.] Texas State Univ, Xiphophorus Genet Stock Ctr, San Marcos, TX 78666 USA; [Hou, Jie; Cheng, Jianlin] Univ Missouri, Inst Informat, Dept Comp Sci, Columbia, MO 65211 USA; [Greenlief, C. Michael] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Fritsche, Kevin] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA	Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA.; Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65212 USA.; Gu, ZZ (corresponding author), Univ Missouri, Ctr Bot Interact Studies, Columbia, MO 65211 USA.	guze@health.missouri.edu	Cheng, Jianlin/N-8209-2013; Song, Hailong/I-9418-2018; Walter, Ronald/AAI-5522-2020	Song, Hailong/0000-0002-4204-6459; Hou, Jie/0000-0002-8584-5154; Mawhinney, Thomas/0000-0002-1807-2550; Cheng, Jianlin/0000-0003-0305-2853	Department of Pathology and Anatomical Sciences research fund at the University of Missouri School of Medicine; National Center for Complementary and Integrative Health (NCCIH) [P50AT006273]; Office of Dietary Supplements (ODS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [P50AT006273] Funding Source: NIH RePORTER	This publication was made possible by funding of the Department of Pathology and Anatomical Sciences research fund at the University of Missouri School of Medicine (to Z.G.), as well as by Grant Number P50AT006273 from the National Center for Complementary and Integrative Health (NCCIH), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS, NCCIH, ODS, NCI, or the National Institutes of Health.	Amagase H, 2006, J NUTR, V136, p716S, DOI 10.1093/jn/136.3.716S; Amagase H, 1996, J NUTR, V126, P817; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Baune BT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-125; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Borek C, 2001, J NUTR, V131, p1010S, DOI 10.1093/jn/131.3.1010S; Bryce PJ, 2006, INT IMMUNOL, V18, P101, DOI 10.1093/intimm/dxh354; Buchwalow I, 2013, SCI REP-UK, V3, DOI 10.1038/srep01899; Calabrese V, 2006, ANTIOXID REDOX SIGN, V8, P1975, DOI 10.1089/ars.2006.8.1975; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Chino A, 2005, INT IMMUNOPHARMACOL, V5, P871, DOI 10.1016/j.intimp.2005.01.004; Colton CA, 2008, J ALZHEIMERS DIS, V15, P571; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; Das A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121117; Dawson VL, 1998, PROG BRAIN RES, V118, P215; Di Filippo M., 2016, SCI REPORTS, V6; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gu Z, 2005, CELL DEATH DIFFER, V12, P1202, DOI 10.1038/sj.cdd.4401705; Ide N, 1999, J NUTR BIOCHEM, V10, P372, DOI 10.1016/S0955-2863(99)00021-2; IMAI J, 1994, PLANTA MED, V60, P417, DOI 10.1055/s-2006-959522; Jiang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089748; Jung JS, 2013, BBA-MOL CELL BIOL L, V1831, P1016, DOI 10.1016/j.bbalip.2013.01.020; Kyo E, 2001, J NUTR, V131, p1075S, DOI 10.1093/jn/131.3.1075S; LEDL F, 1990, ADV LIF SCI, P19; Li JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125000; Lu Y, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0047-3; Martins SIFS, 2000, TRENDS FOOD SCI TECH, V11, P364, DOI 10.1016/S0924-2244(01)00022-X; Moriguchi T, 1997, CLIN EXP PHARMACOL P, V24, P235, DOI 10.1111/j.1440-1681.1997.tb01813.x; Morihara N, 2011, PLANT FOOD HUM NUTR, V66, P17, DOI 10.1007/s11130-011-0216-6; Mossine VV, 2010, MAILLARD REACTION: INTERFACE BETWEEN AGING, NUTRITION AND METABOLISM, P170; Mossine VV, 2008, CANCER RES, V68, P4384, DOI 10.1158/0008-5472.CAN-08-0108; Mossine VV, 2010, ADV CARBOHYD CHEM BI, V64, P291, DOI 10.1016/S0065-2318(10)64006-1; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Patwardhan B, 2005, DRUG DISCOV TODAY, V10, P495, DOI 10.1016/S1359-6446(04)03357-4; Pugh ND, 2005, INT IMMUNOPHARMACOL, V5, P637, DOI 10.1016/j.intimp.2004.12.011; Qian L, 2008, IMMUNOL RES, V41, P155, DOI 10.1007/s12026-008-8018-0; Rahman K, 2000, J NUTR, V130, P2662; Rahman K, 2007, MOL NUTR FOOD RES, V51, P1335, DOI 10.1002/mnfr.200700058; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Ryu K, 2001, J NUTR, V131, p972S, DOI 10.1093/jn/131.3.972S; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sethy NK, 2011, FUNCT INTEGR GENOMIC, V11, P119, DOI 10.1007/s10142-010-0195-y; Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007; Stabler SN, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007653.pub2; Steiner M, 1996, AM J CLIN NUTR, V64, P866; Steiner M, 2001, J NUTR, V131, p980S, DOI 10.1093/jn/131.3.980S; Streit WJ, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00022; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wood P., 2002, NEUROINFLAMMATION ME; Yoon YD, 2003, INT IMMUNOPHARMACOL, V3, P1873, DOI 10.1016/j.intimp.2003.09.005; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhao L, 2011, NUTR REV, V69, P310, DOI 10.1111/j.1753-4887.2011.00394.x; Zhou H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113531	60	15	15	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 13	2016	6								35323	10.1038/srep35323			10	Multidisciplinary Sciences	Science & Technology - Other Topics	DZ2RC	WOS:000385687900001	27734935	DOAJ Gold, Green Published			2021-06-18	
J	Lopez-Rodriguez, AB; Acaz-Fonseca, E; Spezzano, R; Giatti, S; Caruso, D; Viveros, MP; Melcangi, RC; Garcia-Segura, LM				Belen Lopez-Rodriguez, Ana; Acaz-Fonseca, Estefania; Spezzano, Roberto; Giatti, Silvia; Caruso, Donatella; Viveros, Maria-Paz; Melcangi, Roberto C.; Garcia-Segura, Luis M.			Profiling Neuroactive Steroid Levels After Traumatic Brain Injury in Male Mice	ENDOCRINOLOGY			English	Article							ACUTE REGULATORY PROTEIN; MALE-RATS; PITUITARY DYSFUNCTION; CEREBROSPINAL-FLUID; CEREBRAL EDEMA; D-AMPHETAMINE; HEAD-INJURY; FEMALE RATS; IN-VIVO; MODEL	The incidence of traumatic brain injuries (TBIs) in humans has rapidly increased in the last ten years. The most common causes are falls and car accidents. Approximately 80 000-90 000 persons per year will suffer some permanent disability as a result of the lesion, and one of the most common symptoms is the decline of hormone levels, also known as post-TBI hormonal deficiency syndrome. This issue has become more and more important, and many studies have focused on shedding some light on it. The hormonal decline affects not only gonadal steroid hormones but also neuroactive steroids, which play an important role in TBI recovery by neuroprotective and neurotrophic actions. The present work used an adolescent close-head murine model to analyze brain and plasma neurosteroid level changes after TBI and to establish correlations with edema and neurological impairments, 2 of the hallmarks of TBI. Our results showed changes in brain pregnenolone, testosterone, dihydrotestosterone (DHT), and 3 alpha-diol levels whereas in plasma, the changes were present in progesterone, DHT, 3 alpha-diol, and 3 beta-diol. Within them, pregnenolone, progesterone, DHT, and 3 alpha-diol levels positively correlated with edema formation and neurological score, whereas testosterone inversely correlated with these 2 variables. These findings suggest that changes in the brain levels of some neuroactive steroids may contribute to the alterations in brain function caused by the lesion and that plasma levels of some neuroactive steroids could be good candidates of blood markers to predict TBI outcome.	[Belen Lopez-Rodriguez, Ana; Acaz-Fonseca, Estefania; Garcia-Segura, Luis M.] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Belen Lopez-Rodriguez, Ana; Viveros, Maria-Paz] Univ Complutense Madrid, Fac Biol, Dept Anim Physiol Anim Physiol 2, E-28040 Madrid, Spain; [Spezzano, Roberto; Giatti, Silvia; Caruso, Donatella; Melcangi, Roberto C.] Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy	Lopez-Rodriguez, AB (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Inst Neurosci, Dublin 2, Ireland.	lopezroa@tcd.ie	Acaz-Fonseca, Estefania/S-5884-2016; Garcia-Segura, Luis M/U-3711-2017; Lopez-Rodriguez, Ana Belen/H-3631-2017; Giatti, Silvia/G-9334-2016; Viveros, Maria-Paz/S-6855-2016	Acaz-Fonseca, Estefania/0000-0003-2549-6420; Garcia-Segura, Luis M/0000-0002-2450-2916; Lopez-Rodriguez, Ana Belen/0000-0002-0747-7966; Giatti, Silvia/0000-0001-7741-826X; Viveros, Maria-Paz/0000-0002-4119-4636; MELCANGI, COSIMO ROBERTO/0000-0003-0861-8967	Ministerio de Economia y Competividad, Spain [BFU2014-51836-C2-1-R]; Fondazione CariploFondazione Cariplo [2012-0547]	This work was supported by the Ministerio de Economia y Competividad, Spain Grant BFU2014-51836-C2-1-R and by the Fondazione Cariplo Grant 2012-0547.	Aadal L, 2015, J NEUROSCI NURS, V47, P85, DOI 10.1097/JNN.0000000000000121; Adriani W, 2003, BEHAV NEUROSCI, V117, P695, DOI 10.1037/0735-7044.117.4.695; Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Belanger M, 2005, J HEPATOL, V42, P694, DOI 10.1016/j.jhep.2004.12.029; Lopez-Rodriguez AB, 2016, EXP NEUROL, V279, P274, DOI 10.1016/j.expneurol.2016.03.018; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; CLARK JDA, 1988, CLIN ENDOCRINOL, V29, P153, DOI 10.1111/j.1365-2265.1988.tb00257.x; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Franklin KB, 2008, MOUSE BRAIN STEREOTA; FRYE CA, 1995, BRAIN RES, V696, P113, DOI 10.1016/0006-8993(95)00793-P; Frye CA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00015; Frye CA, 2009, EPILEPSY BEHAV, V16, P418, DOI 10.1016/j.yebeh.2009.09.008; Giatti S, 2010, NEUROCHEM INT, V56, P118, DOI 10.1016/j.neuint.2009.09.009; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Lavaque E, 2006, J NEUROBIOL, V66, P308, DOI 10.1002/neu.20221; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Lorenzo Monica, 2005, Pituitary, V8, P233, DOI 10.1007/s11102-006-6046-0; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Melcangi RC, 2016, NEUROSCI BIOBEHAV R, V67, P25, DOI 10.1016/j.neubiorev.2015.09.023; Mirzatoni A, 2010, J NEUROTRAUM, V27, P1875, DOI 10.1089/neu.2010.1330; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Reddy DS, 2004, NEUROSCIENCE, V129, P195, DOI 10.1016/j.neuroscience.2004.08.002; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Sierra A, 2003, EUR J NEUROSCI, V18, P1458, DOI 10.1046/j.1460-9568.2003.02872.x; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; WU X, 2004, J TRAUMA ACUTE CARE, V64, P1313; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhao YZ, 2015, NEURAL REGEN RES, V10, P1076, DOI 10.4103/1673-5374.160097	61	15	15	0	13	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	OCT	2016	157	10					3983	3993		10.1210/en.2016-1316			11	Endocrinology & Metabolism	Endocrinology & Metabolism	DZ7QT	WOS:000386061800029	27547849				2021-06-18	
J	Kamal, VK; Agrawal, D; Pandey, RM				Kamal, Vineet Kumar; Agrawal, Deepak; Pandey, Ravindra Mohan			Epidemiology, clinical characteristics and outcomes of traumatic brain injury: Evidences from integrated level 1 trauma center in India	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Epidemiology; Glasgow Outcome Scale; mortality; outcome; traumatic brain injury	HEAD-INJURIES; MODERATE	Introduction: Traumatic brain injury (TBI) is a leading cause of mortality, morbidity, disability, and socioeconomic losses in the Indian subcontinent. However, for policymaking and research, there is a lack of reliable and larger data in our settings. Aims and Objectives: To evaluate and describe the epidemiological, clinical characteristics, and outcomes of patients with TBI in a Level 1 Trauma Center in India. Materials and Methods: In this retrospective study, all patients with moderate or severe TBI, based on emergency department Glasgow Coma Scale, admitted to neurosurgery Intensive Care Unit (ICU) during May 2010-July 2012 were evaluated to provide detailed information on TBI-related variables and outcomes using descriptive statistics. Results: Among the 1527 patients with moderate or severe TBI patients with mean age 32.15 +/- 16.76 years (range: 1-90) and male: female ratio 6.5: 1, 1281 (83.89%) had severe TBI. The majority of cases took place in the age group of 21-40 years (50.24%) with the most common mode of injury as road traffic accidents (RTAs) (64.96%). Surgical intervention (craniotomy) was done in 49.12% of patients. About 34.58% (n = 528) patients died in hospital, and 67.21% (n = 701) had unfavorable outcome at 6 months. Conclusions: This is the first study of its kind from the Indian subcontinent that gives data on the admission characteristics, mortality, and 6 months outcome of such patients. Most of the injuries occurred due to RTAs, more common among the economic productive age groups and mostly in males with a high rate of mortality and unfavorable outcome.	[Kamal, Vineet Kumar; Pandey, Ravindra Mohan] All India Inst Med Sci, Dept Biostat, JPN Apex Trauma Ctr, New Delhi, India; [Agrawal, Deepak] All India Inst Med Sci, Dept Neurosurg, JPN Apex Trauma Ctr, New Delhi, India	Pandey, RM (corresponding author), All India Inst Med Sci, Dept Biostat, New Delhi 110029, India.	rmpandey@yahoo.com	GARG, RAKESH/H-4591-2011; /AAG-3032-2021	GARG, RAKESH/0000-0001-5842-8024; /0000-0002-5499-0746; Kamal, Vineet Kumar/0000-0002-7295-1644	ICMR, New DelhiIndian Council of Medical Research (ICMR)	ICMR, New Delhi.	Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bajracharya A, 2010, J NEUROSCI RURAL PRA, V1, P2, DOI 10.4103/0976-3147.63092; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Gururaj G., 2005, BACKGROUND PAPERS BU, P325; Gururaj G, 2005, USITC PUBL, V61; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lopez A.D., 1996, GLOBAL BURDEN DIS CO; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Murray CJL., 1996, GLOBAL HLTH STAT COM; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P7; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; WHO, 2003, WORLD HLTH REP 2003	23	15	15	0	6	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT-DEC	2016	7	4					515	525		10.4103/0976-3147.188637			11	Clinical Neurology	Neurosciences & Neurology	DW7BS	WOS:000383806800009	27695230	DOAJ Gold, Green Published			2021-06-18	
J	Kroll, MW; Adamec, J; Wetli, CV; Williams, HE				Kroll, Mark W.; Adamec, Jiri; Wetli, Charles V.; Williams, Howard E.			Fatal traumatic brain injury with electrical weapon falls	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						TASER; Arrest-related-death; Traumatic brain injury; Falls; Electrical weapons; CEW; ECD	SUDDEN CARDIAC-ARREST; POLICE USE; VENTRICULAR-FIBRILLATION; DEATH; TASER; RESTRAINT; DEVICES; BIOMECHANICS; CUSTODY; SAFETY	Introduction: While generally reducing morbidity and mortality, electrical weapons have risks associated with their usage, including eye injuries and falls. With sufficient probe spread, an uncontrolled fall to the ground typically occurs along with the possibility of a fatal brain injury. Methods: We analyzed possible risk factors including running and elevated surfaces with established head-injury criteria to estimate the risk of brain injury. We searched for cases of arrest-related or incustody death, with TASER (R) electrical weapon usage where fall-induced injuries might have contributed to the death. We found 24 cases meeting our initial inclusion criteria of a fatal fall involving electronic control. We then excluded 5 cases as intentional jumps, leaving 19 cases of forced falls. Autopsy reports and other records were analyzed to determine which of these deaths were from brain injury caused by the fall. Results: We found 16 probable cases of fatal brain injuries induced by electronic control from electrical weapons. Out of 3 million field uses, this gives a risk of 5.3 +/- 2.6 PPM which is higher than the theoretical risk of electrocution. The mean age was 46 +/- 14 years which is significantly greater that the age of the typical ARD (36 +/- 10). Probe shots to the subject's back may present a higher risk of a fatal fall. Conclusions: The use of electronic control presents a small but real risk of death from fatal traumatic brain injury. Increased age represents an independent risk factor for such fatalities. (C) 2016 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Kroll, Mark W.] Univ Minnesota, Calif Polytech Inst, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Adamec, Jiri] LMU, Inst Legal Med, Munich, Germany; [Williams, Howard E.] Texas State Univ, Sch Criminal Justice, San Marcos, TX USA	Kroll, MW (corresponding author), Box 23, Crystal Bay, MN 55323 USA.	mark@kroll.name; Jiri.Adamec@med.uni-muenchen.de; charlesvwetli@gmail.com; howardewilliams@msn.com			TASER corporate and scientific advisory board	MWK & CVW have been expert witnesses in law-enforcement litigation. MWK is a member of the TASER corporate and scientific advisory board who partially funded this work. HEW is a retired Police Chief.	Adler A., 2013, MODERN INSTRUMENTATI, V2, P7; Advani S, 1975, P INT C BIOM SER TRA, P153; Allsop DL, 1991, 01487191 SAE; [Anonymous], 2006, 60335276 IEC; Bozeman WP, 2009, ANN EMERG MED, V53, P480, DOI 10.1016/j.annemergmed.2008.11.021; Brewer J, 2009, TASER CONDUCTED ELEC; Cormier Joseph, 2010, Ann Adv Automot Med, V54, P3; Criscione JC, 2014, FORENSIC SCI MED PAT, V10, P203, DOI 10.1007/s12024-014-9551-x; Eastman AL, 2008, J TRAUMA, V64, P1567, DOI 10.1097/TA.0b013e31817113b9; Ferdik FV, 2014, POLICE Q, V17, P328, DOI 10.1177/1098611114548098; Fox AW, 2012, FORENSIC SCI INT, V223, P261, DOI 10.1016/j.forsciint.2012.09.016; Freeman MD, 2014, J FORENSIC LEG MED, V21, P64, DOI 10.1016/j.jflm.2013.08.005; Hajiaghamemar M, 2015, ANN BIOMED ENG, P1; Hall C, 2015, J FORENSIC LEG MED, V31, P29, DOI 10.1016/j.jflm.2014.12.007; Hamel A, 2013, INT J LEGAL MED, V127, P111, DOI 10.1007/s00414-011-0627-9; Hickman M.J., 2008, CRIMINOLOGY PUBLIC P, V7, P563, DOI [DOI 10.1111/J.1745-9133.2008.00528.X, https://doi.org/10.1111/j.1745-9133.2008.00528.x]; Ho J, 2012, FORENSIC SCI MED PAT, V8, P358, DOI 10.1007/s12024-012-9346-x; Ho JD, 2009, WEST J EMERG MED, V10, P68; Ideker RE, 2007, AM J FOREN MED PATH, V28, P195, DOI 10.1097/PAF.0b013e31803179a9; IEEE, 2011, IEEE ENG MED BIO, P255, DOI 10.1109/IEMBS.2011.6090049; Kim PJ, 2005, NEW ENGL J MED, V353, P958, DOI 10.1056/NEJMc051625; Kroll MW, 2014, CIRCULATION, V129, P93, DOI 10.1161/CIRCULATIONAHA.113.004401; Kroll MW, 2011, IEEE ENG MED BIO, P271, DOI 10.1109/IEMBS.2011.6090053; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; MacDonald JM, 2009, AM J PUBLIC HEALTH, V99, P2268, DOI 10.2105/AJPH.2009.159616; Mallory Ann, 2010, Ann Adv Automot Med, V54, P51; Mangus BE, 2008, AM SURGEON, V74, P862; Meyer G., 2009, POLICEONE        NOV, P9; Mumola C, 2011, BUREAU JUSTICE STAT; Nahum A. M., 1968, SAE TECHNICAL PAPER; Naunheim RS, 2010, EMERG MED J, V27, P645, DOI 10.1136/emj.2009.088468; Nimunkar AJ, 2009, PHYSIOL MEAS, V30, P101, DOI 10.1088/0967-3334/30/1/007; Nyquist G., 1986, SAE TECHNICAL PAPER; Panescu D, 2013, IEEE ENG MED BIO, P5342, DOI 10.1109/EMBC.2013.6610756; Pollanen MS, 1998, CAN MED ASSOC J, V158, P1603; Schneider D. C., 1972, SAE TECHNICAL PAPER; Schwarz ES, 2009, AM J EMERG MED, V27; Southall Pamela, 2008, J Forensic Leg Med, V15, P227, DOI 10.1016/j.jflm.2007.10.005; STRATTON SJ, 1995, ANN EMERG MED, V25, P710, DOI 10.1016/S0196-0644(95)70187-7; Strote J, 2006, PREHOSP EMERG CARE, V10, P447, DOI 10.1080/10903120600884863; Swerdlow CD, 2009, ACAD EMERG MED, V16, P726, DOI 10.1111/j.1553-2712.2009.00432.x; Taylor B, 2010, POLICE Q, V13, P260, DOI 10.1177/1098611110373994; Thierauf A, 2010, FORENSIC SCI INT, V198, P92, DOI 10.1016/j.forsciint.2010.01.010; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Zipes DP, 2012, CIRCULATION, V125, P2417, DOI 10.1161/CIRCULATIONAHA.112.097584	46	15	15	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	OCT	2016	43						12	19		10.1016/j.jflm.2016.07.001			8	Medicine, Legal	Legal Medicine	EE3SB	WOS:000389516900003	27423132				2021-06-18	
J	Lazaridis, C; Robertson, CS				Lazaridis, Christos; Robertson, Claudia S.			The Role of Multimodal Invasive Monitoring in Acute Traumatic Brain Injury	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Intracranial pressure; Cerebral perfusion pressure; Brain tissue oxygen; Lactate/pyruvate ratio; Pressure reactivity index; Neuromonitoring	POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; PERIINFARCT DEPOLARIZATIONS; SPREADING DEPOLARIZATIONS; COMBINED MICRODIALYSIS; TISSUE OXYGENATION; CLINICAL ARTICLE	This article reviews the role of modalities that directly monitor brain parenchyma in patients with severe traumatic brain injury. The physiology monitored involves compartmental and perfusion pressures, tissue oxygenation and metabolism, quantitative blood flow, pressure autoregulation, and electrophysiology. There are several proposed roles for this multimodality monitoring, such as to track, prevent, and treat the cascade of secondary brain injury; monitor the neurologically injured patient; integrate various data into a composite, patient-specific, and dynamic picture; apply protocolized, pathophysiology-driven intensive care; use as a prognostic marker; and understand pathophysiologic mechanisms involved in secondary brain injury to develop preventive and abortive therapies, and to inform future clinical trials.	[Lazaridis, Christos] Baylor Coll Med, Med Ctr, Dept Neurol, Div Neurocrit Care, McNair Campus,7200 Cambridge St,9th Floor, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, One Baylor Plaza, Houston, TX 77030 USA	Lazaridis, C (corresponding author), Baylor Coll Med, Med Ctr, Dept Neurol, Div Neurocrit Care, McNair Campus,7200 Cambridge St,9th Floor, Houston, TX 77030 USA.	lazaridi@bcm.edu					Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Diringer MN, 2011, TRANSL STROKE RES, V2, P517, DOI 10.1007/s12975-011-0119-8; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Frontera J, 2015, NEUROCRIT CARE, V22, P348, DOI 10.1007/s12028-015-0133-x; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Gupta AK, 2002, J NEUROSURG, V96, P263, DOI 10.3171/jns.2002.96.2.0263; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Lazaridis C, 2014, NEUROCRIT CARE, V21, P345, DOI 10.1007/s12028-014-0007-7; Lazaridis C, 2014, J NEUROSURG, V120, P892; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Li CY, 2016, BIOSENS BIOELECTRON, V77, P62, DOI 10.1016/j.bios.2015.09.021; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Myers RB, 2016, CRIT CARE MED; Nielsen TH, 2014, NEUROCRIT CARE, V21, P35, DOI 10.1007/s12028-013-9875-5; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Shutter L., 2014, ANN M NEUR CAR SOC S; SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P137; Smielewski P, 2008, ACTA NEUROCHIR SUPPL, V102, P145, DOI 10.1007/978-3-211-85578-2_30; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wolf Stefan, 2012, Acta Neurochir Suppl, V114, P187, DOI 10.1007/978-3-7091-0956-4_36	54	15	17	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					509	+		10.1016/j.nec.2016.05.010			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800012	27637400				2021-06-18	
J	Skop, NB; Calderon, F; Cho, CH; Gandhi, CD; Levison, SW				Skop, Nolan B.; Calderon, Frances; Cho, Cheul H.; Gandhi, Chirag D.; Levison, Steven W.			Optimizing a multifunctional microsphere scaffold to improve neural precursor cell transplantation for traumatic brain injury repair	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						chitosan; fibroblast growth factors; fibronectin; immobilized growth factors; multifunctional scaffold; neurotrauma; radial glia; regenerative medicine	FIBROBLAST-GROWTH-FACTOR; SPINAL-CORD-INJURY; TISSUE ENGINEERING APPLICATIONS; STEM-CELLS; FUNCTIONAL RECOVERY; COGNITIVE FUNCTION; EXTRACELLULAR-MATRIX; ADULT BRAIN; RAT-BRAIN; CHITOSAN	Tissue engineering using stem cells is widely used to repair damaged tissues in diverse biological systems; however, this approach has met with less success in regenerating the central nervous system (CNS). In this study we optimized and characterized the surface chemistry of chitosan-based scaffolds for CNS repair. To maintain radial glial cell (RGC) character of primitive neural precursors, fibronectin was adsorbed to chitosan. The chitosan was further modified by covalently linking heparin using genipin, which then served as a linker to immobilize fibroblast growth factor-2 (FGF-2), creating a multifunctional film. Fetal rat neural precursors plated onto this multifunctional film proliferated and remained multipotent for at least 3 days without providing soluble FGF-2. Moreover, they remained less mature and more highly proliferative than cells maintained on fibronectin-coated substrates in culture medium supplemented with soluble FGF-2. To create a vehicle for cell transplantation, a 3% chitosan solution was electrosprayed into a coagulation bath to generate microspheres (range 30-100 mu m, mean 64 mu m) that were subsequently modified. Radial glial cells seeded onto these multifunctional microspheres proliferated for at least 7 days in culture and the microspheres containing cells were small enough to be injected, using 23 Gauge Hamilton syringes, into the brains of adult rats that had previously sustained cortical contusion injuries. When analysed 3 days later, the transplanted RGCs were positive for the stem cell/progenitor marker Nestin. These results demonstrate that this multifunctional scaffold can be used as a cellular and growth factor delivery vehicle for the use in developing cell transplantation therapies for traumatic brain injuries. Copyright (C) 2013 John Wiley & Sons, Ltd.	[Skop, Nolan B.; Calderon, Frances; Levison, Steven W.] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA; [Skop, Nolan B.; Gandhi, Chirag D.] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ USA; [Cho, Cheul H.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	Levison, SW (corresponding author), NJMS UH Canc Ctr, Dept Neurol & Neurosci, Off H-1226,205 South Orange Ave, Newark, NJ 07103 USA.	steve.levison@umdnj.edu	Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309	New Jersey Commission on Brain Injury Research grant [08.001.BIR2, CBIR12FEL025]	This study was partly supported by the New Jersey Commission on Brain Injury Research grant number 08.001.BIR2 awarded to CDG and SWL and grant number CBIR12FEL025 awarded to NBS.	Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Aplin AE, 1999, J CELL SCI, V112, P695; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35; Caldwell MA, 2004, EXP NEUROL, V188, P408, DOI 10.1016/j.expneurol.2004.05.007; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018; Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044; Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7; Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010; Dunnett S B, 2000, Prog Brain Res, V127, P345; Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gong HP, 2000, J BIOMED MATER RES, V52, P285; Gupta KC, 2000, BIOMATERIALS, V21, P1115, DOI 10.1016/S0142-9612(99)00263-X; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hasegawa K, 2005, EXP NEUROL, V193, P394, DOI 10.1016/j.expneurol.2004.12.024; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Ingber D E, 1992, Semin Cancer Biol, V3, P57; Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049; Kang JM, 2012, ACTA BIOMATER, V8, P1759, DOI 10.1016/j.actbio.2012.01.005; Kendall A L, 2000, Prog Brain Res, V127, P381; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; Kimura H, 2003, KIDNEY INT, V64, P1829, DOI 10.1046/j.1523-1755.2003.00285.x; Kou JH, 1997, J CONTROL RELEASE, V43, P123, DOI 10.1016/S0168-3659(96)01477-0; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063; Lindvall Olle, 2004, NeuroRx, V1, P382; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Martinez-Ramos C, 2012, J BIOMED MATER RES A, V100A, P3276, DOI 10.1002/jbm.a.34273; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Maysinger D, 1996, EXP NEUROL, V138, P177, DOI 10.1006/exnr.1996.0056; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078; MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muzzarelli R.A.A., 1977, CHITIN; Nicholas AP, 2002, NEUROSCI LETT, V323, P85, DOI 10.1016/S0304-3940(01)02534-4; Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Reid CB, 2002, J NEUROSCI, V22, P4002, DOI 10.1523/JNEUROSCI.22-10-04002.2002; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sanberg PR, 2012, BRIT MED BULL, V101, P163, DOI 10.1093/bmb/lds001; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043; Snyder Evan Y., 1994, Current Opinion in Neurobiology, V4, P742, DOI 10.1016/0959-4388(94)90018-3; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Yoshida N, 2003, EXP CELL RES, V287, P262, DOI 10.1016/S0014-4827(03)00158-7; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049	77	15	15	1	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	OCT	2016	10	10					E419	E432		10.1002/term.1832			14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	EC0JI	WOS:000387786200019	27730762				2021-06-18	
J	Angeleri, R; Gabbatore, I; Bosco, FM; Sacco, K; Colle, L				Angeleri, Romina; Gabbatore, Ilaria; Bosco, Francesca M.; Sacco, Katiuscia; Colle, Livia			Pragmatic abilities in children and adolescents with autism spectrum disorder: a study with the ABaCo battery	MINERVA PSICHIATRICA			English	Article						Autism spectrum disorder; Linguistics; Communication	TRAUMATIC BRAIN-INJURY; EMOTION-RECOGNITION; IMPAIRMENT; GESTURES; DEFICITS; ADULTS; FACE; MIND	BACKGROUND: Pragmatic disorders are a core problem in individuals with autism spectrum disorder (ASD). Despite the clinical importance of detecting specific impairments, there are relatively few tools available to assess pragmatic abilities in these individuals. The present study aims to gain greater insight into the pragmatic skills of individuals with high -functioning ASD by using the Assessment Battery for Communication (ABaCo), a new clinical tool that assesses a wide range of communicative behaviors. METHODS: The pragmatic performance of 16 individuals with ASD and 16 control participants were compared. RESULTS: Participants with ASD had significantly poorer scores compared with healthy matched controls on all ABaCo scales, with the sole exception of paralinguistic production. CONCLUSIONS: ABaCo is an effective tool in identifying and assessing pragmatic impairments in individuals with Autism Spectrum Disorders.	[Angeleri, Romina] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Gabbatore, Ilaria] Univ Oulu, Fac Humanities, Child Language Res Ctr, Res Unit Logoped, POB 1000, Oulu 90014, Finland; [Bosco, Francesca M.; Sacco, Katiuscia; Colle, Livia] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Bosco, Francesca M.; Sacco, Katiuscia; Colle, Livia] Neurosci Inst, Turin, Italy; [Sacco, Katiuscia] Univ Turin, Dept Psychol, Imaging & Plast Res Grp, Turin, Italy	Gabbatore, I (corresponding author), Univ Oulu, Fac Humanities, Child Language Res Ctr, Res Unit Logoped, POB 1000, Oulu 90014, Finland.	ilaria.gabbatore@oulu.fi	bosco, francesca marina/B-6746-2013; Gabbatore, Ilaria/AAC-1925-2019	bosco, francesca marina/0000-0001-6101-8587; Gabbatore, Ilaria/0000-0002-9724-8066			American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; ATTWOOD A, 1988, J AUTISM DEV DISORD, V18, P241, DOI 10.1007/BF02211950; Bara B. G., 2010, LINGUISTIC PHILOS IN, V9, P182; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; BATES E, 1975, MERRILL PALMER QUART, V21, P205; Bishop DV., 2003, CHILDRENS COMMUNICAT; Bono MA, 2004, J AUTISM DEV DISORD, V34, P495, DOI 10.1007/s10803-004-2545-x; Bosco FM, 2016, PSYCHOL CLIN SETTING, V7, P1, DOI DOI 10.3389/FPSYG.2016.00566; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Buitelaar JK, 1999, DEV PSYCHOPATHOL, V11, P39, DOI 10.1017/S0954579499001947; Cohen, 2005, HDB AUTISM PERVASIVE, P335, DOI DOI 10.1002/9780470939345.CH12; Colgan SE, 2006, CHILD NEUROPSYCHOL, V12, P307, DOI 10.1080/09297040600701360; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; DAVIES S, 1994, J CHILD PSYCHOL PSYC, V35, P1033, DOI 10.1111/j.1469-7610.1994.tb01808.x; de Marchena A, 2010, AUTISM RES, V3, P311, DOI 10.1002/aur.159; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Gabbatore L, 2014, MINERVA PSICHIATR, V55, P45; Gilliam J., 2006, PRAGMATIC LANGUAGE S; Golan O, 2015, MOL AUTISM, V6; Hendricks D. R., 2009, FOCUS AUTISM OTHER D; HOBSON RP, 1988, BRIT J PSYCHOL, V79, P441, DOI 10.1111/j.2044-8295.1988.tb02745.x; Jolliffe T, 2000, PSYCHOL MED, V30, P1169, DOI 10.1017/S003329179900241X; Lam YG, 2012, RES AUTISM SPECT DIS, V6, P792, DOI 10.1016/j.rasd.2011.08.004; Landa R., 2000, ASPERGER SYNDROME, P125, DOI [10.1016/S1056-4993(02)00055-X., DOI 10.1016/S1056-4993(02)00055-X]; Lindner JL, 2006, J AUTISM DEV DISORD, V36, P769, DOI 10.1007/s10803-006-0105-2; Lord C., 2002, AUTISM DIAGNOSTIC OB; Losh M, 2003, J AUTISM DEV DISORD, V33, P239, DOI 10.1023/A:1024446215446; Loukusa S, 2014, INT J LANG COMM DIS, V49, P498, DOI 10.1111/1460-6984.12091; Loukusa S, 2009, RES AUTISM SPECT DIS, V3, P890, DOI 10.1016/j.rasd.2009.05.002; Loveland KA, 1997, DEV PSYCHOPATHOL, V9, P579, DOI 10.1017/S0954579497001351; LOVELAND KA, 1988, J SPEECH HEAR RES, V31, P593, DOI 10.1044/jshr.3104.593; Luyster R, 2007, J CHILD LANG, V34, P623, DOI 10.1017/S0305000907008094; Mawhood L, 2000, J CHILD PSYCHOL PSYC, V41, P547, DOI 10.1111/1469-7610.00642; Morett LM, 2015, J AUTISM DEV DISORD, P1; Morgan J. L., 1978, SYNTAX SEMANTICS, P261; O'Hearn K, 2011, AUTISM RES, V4, P132, DOI 10.1002/aur.179; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; Phelps-Terasaki D., 2007, TEST PRAGMATIC LANGU, V2nd; Rutter M., 2005, ADI R AUTISM DIAGNOS; Sacco K, 2008, J COGN SCI, V9, P111; Sacco K, 2013, B PSICOL APPL, P55; SIGMAN MD, 1992, CHILD DEV, V63, P796, DOI 10.2307/1131234; Silverman LB, 2010, COGNITION, V115, P380, DOI 10.1016/j.cognition.2010.01.002; Sperry LA, 2005, AUTISM, V9, P362, DOI 10.1177/1362361305056077; VOLDEN J, 2002, J SPEECH LANGUAGE LA, V26, P138	51	15	15	0	10	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0374-9320	1827-1731		MINERVA PSICH	Minerva Psich.	SEP	2016	57	3					93	103					11	Psychiatry	Psychiatry	EQ7FY	WOS:000398251100002					2021-06-18	
J	Delle Rose, D; Pezzotti, P; Fortunato, E; Sordillo, P; Gini, S; Boros, S; Meledandri, M; Gallo, MT; Prignano, G; Caccese, R; D'Ambrosio, M; Citterio, G; Rocco, M; Leonardis, F; Natoli, S; Fontana, C; Favaro, M; Celeste, MG; Franci, T; Testore, GP; Andreoni, M; Sarmati, L				Delle Rose, D.; Pezzotti, P.; Fortunato, E.; Sordillo, P.; Gini, S.; Boros, S.; Meledandri, M.; Gallo, M. T.; Prignano, G.; Caccese, R.; D'Ambrosio, M.; Citterio, G.; Rocco, M.; Leonardis, F.; Natoli, S.; Fontana, C.; Favaro, M.; Celeste, M. G.; Franci, T.; Testore, G. P.; Andreoni, M.; Sarmati, L.			Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES			English	Article							TRAUMATIC BRAIN-INJURY; MULTIDRUG-RESISTANT ORGANISMS; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; OUTCOMES; CARBAPENEMASES; INFECTIONS; PREVALENCE; PREVENTION; PATTERNS	The purpose of this study was to assess the main clinical predictors and microbiological features of ventilator-associated pneumonia (VAP) in the Intensive Care Unit (ICU) environment. This work is a retrospective analysis over one year from September 2010 to September 2011. Patients' risk factors, causes of admission, comorbidities and respiratory specimens collected in six Italian ICUs were reviewed. Incidence and case fatality rate of VAP were evaluated. After stratification for VAP development, univariate and multivariate analyses were performed to assess the impact of patients' conditions on the onset of this infection. A total of 1, 647 ICU patients (pts) were considered. Overall, 115 patients (6.9 %) experienced at least one episode of VAP. The incidence rate for VAP was 5.82/1,000 pts-days, with a case fatality rate of 44.3 %. Multivariate analysis showed that admission for neurological disorders (aIRR 4.12, CI 1.24-13.68, p = 0.02) and emergency referral to ICU from other hospitals (aIRR 2.11, CI 1.03-4.31, p = 0.04) were associated with higher risk of VAP, whereas a tendency to a higher risk of infection was detected for admission due to respiratory disease, cardiac disease, trauma and for having obesity or renal failure. A total of 372 microbiological isolates from respiratory specimens were collected in VAP patients. The most common species were Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa, showing high resistance rates to carbapenems. Neurological disorders and emergency referral at the admission into the ICU are significantly associated with the onset of VAP. A high incidence of multi-drug resistant Gram-species was detected in the respiratory specimens.	[Delle Rose, D.; Fortunato, E.; Sordillo, P.; Gini, S.; Testore, G. P.; Andreoni, M.; Sarmati, L.] Tor Vergata Univ Hosp, Clin Infect Dis, Vle Oxford 81, I-00133 Rome, Italy; [Pezzotti, P.; Boros, S.] Ist Super Sanita, Rome, Italy; [Meledandri, M.] S Filippo Neri Hosp, Rome, Italy; [Gallo, M. T.; Prignano, G.] IRCCS, IFO, San Gallicano Dermatol Inst, Rome, Italy; [Caccese, R.; D'Ambrosio, M.] S Giovanni Hosp, Intens Care Unit, Rome, Italy; [Citterio, G.; Rocco, M.] Univ Roma La Sapienza, Intens Care Unit, Rome, Italy; [Leonardis, F.; Natoli, S.] Tor Vergata Univ Hosp, Intens Care Unit, Rome, Italy; [Fontana, C.; Favaro, M.] Tor Vergata Univ Hosp, Clin Microbiol Labs, Rome, Italy; [Celeste, M. G.] Tor Vergata Univ Hosp, Clin Pharm, Rome, Italy; [Franci, T.] S Andrea Hosp, Rome, Italy	Delle Rose, D (corresponding author), Tor Vergata Univ Hosp, Clin Infect Dis, Vle Oxford 81, I-00133 Rome, Italy.	diego.dellerose82@gmail.com	Rocco, Monica/B-8407-2013; Prignano, Grazia/J-9509-2018; Fontana, Carla/AAE-3757-2020; Fontana, Carla/AAH-6112-2019	Rocco, Monica/0000-0001-8380-3607; Prignano, Grazia/0000-0003-2474-3354; Fontana, Carla/0000-0003-2198-1947; Natoli, Silvia/0000-0003-3758-5375; Boros, Stefano/0000-0003-2521-0883	Italian Drug Agency (AIFA), Pharmacovigilance Projects in the Lazio Region, Analysis of Nosocomial Infections in Roman Intensive Care Units [D 3012]	This work was financially supported by a grant from the Italian Drug Agency (AIFA), Pharmacovigilance Projects in the Lazio Region, Analysis of Nosocomial Infections in Roman Intensive Care Units, 2009. Grant No D 3012 28/09/2009.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bouadma L, 2010, CLIN INFECT DIS, V51, P1115, DOI 10.1086/656737; Boyer AF, 2015, CHEST, V147, P68, DOI 10.1378/chest.14-0544; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chittawatanarat K, 2014, INFECT DRUG RESIST, V7, P203, DOI 10.2147/IDR.S67267; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Corbellini S, 2014, NEW MICROBIOL, V37, P177; Corcione S, 2015, CLIN MICROBIOL INFEC, V21, pE11, DOI 10.1016/j.cmi.2014.09.012; Decelle L, 2013, EUR J EMERG MED, V20, P61, DOI 10.1097/MEJ.0b013e3283501677; Denys GA, 2014, CLIN LAB MED, V34, P257, DOI 10.1016/j.cll.2014.02.004; Djahmi N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/305784; ECDC, 2012, ANT RES SURV EUR 201; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Efrati S, 2010, J CLIN MONIT COMPUT, V24, P161, DOI 10.1007/s10877-010-9228-2; European Centre for Disease Prevention and Control, 2012, SURV HLTH CAR ASS IN; Gadani H, 2010, INDIAN J ANAESTH, V54, P535, DOI 10.4103/0019-5049.72643; Gastmeier P, 2006, J HOSP INFECT, V64, P16, DOI 10.1016/j.jhin.2006.04.017; Gianakis A, 2015, J TRAUMA NURS, V22, P125, DOI 10.1097/JTN.0000000000000121; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Hussein K, 2009, INFECT CONT HOSP EP, V30, P666, DOI 10.1086/598244; INVS, 2007, RES AL INV SURV INF; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI, Vsecond; Khorvash F, 2014, J RES MED SCI, V19, pS46; Klompas M, 2008, CLIN INFECT DIS, V46, P1443, DOI 10.1086/587103; Kollef MH, 1997, CHEST, V112, P765, DOI 10.1378/chest.112.3.765; Martin-Loeches I, 2015, J INFECTION, V70, P213, DOI 10.1016/j.jinf.2014.10.004; Gago MM, 2013, MEDICC REV, V15, P26; Parisi SG, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0996-7; Parker CM, 2008, J CRIT CARE, V23, P18, DOI 10.1016/j.jcrc.2008.02.001; Piskin N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-268; Plurad DS, 2013, J SURG RES, V183, P371, DOI 10.1016/j.jss.2013.01.036; Quartin AA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-561; Ranjan N, 2014, INDIAN J CRIT CARE M, V18, P200, DOI 10.4103/0972-5229.130570; Rea-Neto A, 2008, CRIT CARE, V12, DOI 10.1186/cc6877; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sandiumenge A, 2012, CURR OPIN PULM MED, V18, P187, DOI 10.1097/MCP.0b013e328351f974; Tan X, 2016, MED MYCOL; Terraneo S, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.09.002; Uckay I, 2008, CLIN INFECT DIS, V46, P557, DOI 10.1086/526534; Wilke M, 2014, INFECT DRUG RESIST, V7, P1, DOI 10.2147/IDR.S25985; Wroblewska MM, 2006, INT J ANTIMICROB AG, V27, P285, DOI 10.1016/j.ijantimicag.2005.11.015; Zhu S, 2015, INFECT CONT HOSP EP, V27, P1, DOI DOI 10.1088/0953-8984/27/36/362201	44	15	16	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0934-9723	1435-4373		EUR J CLIN MICROBIOL	Eur. J. Clin. Microbiol. Infect. Dis.	SEP	2016	35	9					1531	1539		10.1007/s10096-016-2694-9			9	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	DZ4VC	WOS:000385857700022	27272120				2021-06-18	
J	Lopez, MC; Efron, PA; Ozrazgat-Baslanti, T; Zhang, JY; Cuschieri, J; Maier, RV; Minei, JP; Baker, HV; Moore, FA; Moldawer, LL; Brakenridge, SC				Lopez, Maria-Cecilia; Efron, Philip A.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Cuschieri, Joseph; Maier, Ronald V.; Minei, Joseph P.; Baker, Henry V.; Moore, Frederick A.; Moldawer, Lyle L.; Brakenridge, Scott C.			Sex-based differences in the genomic response, innate immunity, organ dysfunction, and clinical outcomes after severe blunt traumatic injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Sex; trauma; hemorrhagic shock; leukocyte; genomics	INSTITUTE PROSPECTIVE EVALUATION; MATCHED-PAIR-ANALYSIS; PERSISTENT INFLAMMATION; HORMONE ENVIRONMENT; CATABOLISM SYNDROME; VENTILATOR BUNDLE; GENDER DIMORPHISM; BRAIN-INJURY; EXPRESSION; IMMUNOSUPPRESSION	INTRODUCTION The effect of sex on posttraumatic pathophysiology and outcomes after severe traumatic injury remains debated. We sought to determine the relationship of sex to the genomic and inflammatory responses, and clinical outcomes after hemorrhagic shock. METHODS We analyzed blunt trauma patients in hemorrhagic shock from a prospective multi-institutional cohort study to assess for sex-based differences in the genomic response and clinical outcomes. Serially drawn blood samples were analyzed to evaluate peripheral leukocyte genomewide expression and circulating inflammatory mediators at intervals between 0.5 and 28 days after injury. Multivariate logistic regression models were developed to assess the effect of sex on outcomes after controlling for age, injury and shock severity, blood transfusion, and comorbidities. RESULTS The cohort consisted of 1,285 (67%) male and 643 (33%) female blunt trauma patients. Injury and shock severity were similar between the two groups. There were small but statistically significant differences between males and females regarding their age, body mass index, and 12-hour blood and crystalloid administration. Organ failure was more severe in males, with slower recovery (9.0 vs. 6.5 days) in males compared to females (p < 0.01). However, there were no differences between males and females in plasma levels of IL-6, IL-8, IL-10, IL-1, tumor necrosis factor alpha, and monocyte chemoattractant protein 1. Multivariate analysis revealed that sex was not a significant independent risk factor for complicated recovery or 28-day mortality. Transcriptomic analysis revealed 333 genes with significant differential expression patterns between males and females (FDR, <0.001), including genes associated with general inflammation, innate immunity, cell adhesion, and cell signaling. None of the former genes were directly associated with sex hormones or X/Y chromosomes. CONCLUSION There are sex-specific differences in the leukocyte genomic response to severe injury that are associated with more robust and longer-duration organ dysfunction. However, these expression patterns do not seem to be associated with sex-linked genes or circulating cytokine level differences, and do not translate to worsened sex-specific organ failure outcomes or inpatient mortality. LEVEL OF EVIDENCE Prognostic/epidemiologic study, level III.	[Lopez, Maria-Cecilia; Efron, Philip A.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Baker, Henry V.; Moore, Frederick A.; Moldawer, Lyle L.; Brakenridge, Scott C.] Univ Florida, Dept Surg, Gainesville, FL USA; [Lopez, Maria-Cecilia; Efron, Philip A.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Baker, Henry V.; Moore, Frederick A.; Moldawer, Lyle L.; Brakenridge, Scott C.] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Lopez, Maria-Cecilia; Efron, Philip A.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Baker, Henry V.; Moore, Frederick A.; Moldawer, Lyle L.; Brakenridge, Scott C.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Cuschieri, Joseph; Maier, Ronald V.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Minei, Joseph P.] Univ Texas Southwestern, Dept Surg, Dallas, TX USA	Brakenridge, SC (corresponding author), Univ Florida, Dept Surg, Div Acute Care Surg, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	Scott.Brakenridge@surgery.ufl.edu	Brakenridge, Scott C/AAD-6691-2019	Brakenridge, Scott C/0000-0002-7327-3718; Zhang, Jianyi/0000-0002-1501-4822	National Institutes of Health, National Institute for General Medical Sciences, including the Inflammation and Host Response to Injury Large-Scale Collaborative Research Program (NIH/NIGMS) [U54 GM062119]; University of Florida Sepsis and Critical Illness Research Center (NIH/NIGMS) [P50 GM111152-01]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM-08431, R01 GM-40586-24, R01 GM-081923-06]; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [NIH GM-113945]; University of Florida Claude D. Pepper Older Americans Independence Center [2P30AG028740]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM111152, R01GM040586, R01GM104481, U54GM062119, R01GM113945, R01GM081923, T32GM008721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028740] Funding Source: NIH RePORTER	This project was supported by funding from the National Institutes of Health, National Institute for General Medical Sciences, including the Inflammation and Host Response to Injury Large-Scale Collaborative Research Program (NIH/NIGMS, U54 GM062119), awarded to Dr Ronald G Tompkins. SCB, TB, JZ, HVB, FA, LLM, and PAE were additionally supported by funding awarded to the University of Florida Sepsis and Critical Illness Research Center (NIH/NIGMS, P50 GM111152-01), awarded to Dr Frederick A Moore. This work was also supported by NIH grants T32 GM-08431, R01 GM-40586-24, R01 GM-081923-06, and NIH GM-113945 awarded by the NIGMS. Additionally, SCB was funded with support from the University of Florida Claude D. Pepper Older Americans Independence Center (2P30AG028740).	Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P1395, DOI 10.1097/TA.0b013e31825b9f05; Croce MA, 2013, J TRAUMA ACUTE CARE, V74, P354, DOI 10.1097/TA.0b013e31827a0c65; Cuenca AG, 2013, CRIT CARE MED, V41, P1175, DOI 10.1097/CCM.0b013e318277131c; Cuschieri J, 2012, ANN SURG, V255, P993, DOI 10.1097/SLA.0b013e31824f1ebc; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Doucet D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009421; Efron PA, 2015, J LEUKOCYTE BIOL, V98, P945, DOI 10.1189/jlb.5MR0315-127R; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Gentile LF, 2014, CRIT CARE MED, V42, P1406, DOI 10.1097/CCM.0000000000000222; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Laudanski K, 2006, P NATL ACAD SCI USA, V103, P15564, DOI 10.1073/pnas.0607028103; Moore F, 2013, J TRAUMA ACUTE CARE, V74, P360; Nacionales DC, 2015, J IMMUNOL, V195, P2396, DOI 10.4049/jimmunol.1500984; Schoeneberg C, 2013, CRIT CARE, V17, DOI 10.1186/cc13132; Sharpe JP, 2014, J TRAUMA ACUTE CARE, V77, P161, DOI 10.1097/TA.0000000000000251; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sperry JL, 2008, J LEUKOCYTE BIOL, V83, P499, DOI 10.1189/jlb.0607360; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Sperry JL, 2014, ANN SURG, V260, P698, DOI 10.1097/SLA.0000000000000918; Sperry JL, 2012, J AM COLL SURGEONS, V214, P973, DOI 10.1016/j.jamcollsurg.2012.02.020; Summers JI, 2014, J BURN CARE RES, V35, P484, DOI 10.1097/BCR.0000000000000018; Tominaga GT, 2008, J TRAUMA, V64, P578; Trentzsch H, 2015, ANN SURG, V261, P774, DOI 10.1097/SLA.0000000000000789; Vanzant EL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0788-x; Vanzant EL, 2014, J TRAUMA ACUTE CARE, V76, P21, DOI 10.1097/TA.0b013e3182ab1ab5; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yang KC, 2014, SHOCK, V42, P11, DOI 10.1097/SHK.0000000000000168; Zolin SJ, 2015, J TRAUMA ACUTE CARE, V78, P451, DOI 10.1097/TA.0000000000000550	32	15	15	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2016	81	3					478	485		10.1097/TA.0000000000001113			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	DW8MX	WOS:000383911200011	27306446	Green Accepted			2021-06-18	
J	Marcoux, J; Bracco, D; Saluja, RS				Marcoux, Judith; Bracco, David; Saluja, Rajeet S.			Temporal delays in trauma craniotomies	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; trauma craniotomy; acute epidural hematoma; acute subdural hematoma; quality of care; delay in treatment; surgery	ACUTE SUBDURAL-HEMATOMA; ACUTE STROKE; COMATOSE PATIENTS; EPIDURAL HEMATOMA; EMERGENCY; THROMBOLYSIS; PROGNOSIS; MORTALITY; SCALE; CARE	OBJECTIVE The Brain Trauma Foundation recommendation regarding the timing of surgical evacuation of epidural hematomas and subdural hematomas is to perform the procedure as soon as possible. Indeed, faster evacuation is associated with better outcome. However, to the authors' knowledge, no study has looked at where delays in intrahospital care occurred for patients suffering from traumatic intracranial mass lesions. The goals of this study were as follows: 1) to characterize the performance of a Level 1 trauma center in terms of delays for emergency trauma craniotomies, 2) to review step by step where delays occurred in patient care, and 3) to propose ways to improve performance. METHODS A retrospective review was conducted covering a 5-year period of all emergency trauma craniotomies. Demographic data, injury severity, neurological status, and functional outcome data were collected. The time elapsed between emergency department (ED) arrival and CT imaging, between CT imaging and arrival at the operating room (OR), between ED arrival and OR arrival, between OR arrival and skin incision, and between ED arrival and skin incision were calculated. Patients were also subcategorized as either having immediate life-threatening emergencies (EO) or life threatening emergencies (El). The operative technique was also reviewed (standard craniotomy opening vs immediate bur hole decompression followed by craniotomy). RESULTS The study included 166 patients. Of these, 58 (35%) were classified into the EO group and 108 (64.2%) into the El group. The median ED-to-CT delay was 54 minutes with no significant difference between the E0 and the E1 groups. The median CT-to-OR time delay was 57 minutes. The median delay for the EO group was 39 minutes and that for the El group was 70 minutes (p = 0.002). The median delay from ED to OR arrival for patients with a CT scanning done at an outside hospital was 75 minutes. The median delay from ED to OR arrival was 85 minutes for the EO group and 127 minutes for the El group (p < 0.0001). The median delay from OR arrival to skin incision was 35 minutes (EO: median 27 minutes; El: median 39 minutes; p < 0.0001). The median total time elapsed between ED arrival and skin incision was 150 minutes (EO: median 131 minutes; El: median 180 minutes). Overall, only 17% of patients underwent immediate bur hole decompression, but the proportion climbed to 41% in the EO group. A lower Glasgow Coma Scale score was associated with a shorter delay (p = 0.0004). CONCLUSIONS A long delay until surgery still exists for patients requiring urgent mass lesion evacuation. Many factors contribute to this delay, including performing imaging and transfer to and preparation in the OR. Strategies can be implemented to reduce delays and improve the delivery of care.	[Marcoux, Judith; Saluja, Rajeet S.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Marcoux, Judith; Saluja, Rajeet S.] McGill Univ, Ctr Hlth, Dept Neurosurg, Montreal, PQ, Canada; [Bracco, David] McGill Univ, Ctr Hlth, Dept Anesthesia, Montreal, PQ, Canada	Marcoux, J (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Neurosurg, 1650 Cedar Ave,Rm L7-516, Montreal, PQ H3G 1A4, Canada.	judith.marcoux@mcgill.ca					Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Bullock MR, 2006, NEUROSURGERY S, V58, pS16; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Gomez C R, 1993, J Stroke Cerebrovasc Dis, V3, P1, DOI 10.1016/S1052-3057(10)80125-9; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kwan J, 2004, QJM-INT J MED, V97, P273, DOI 10.1093/qjmed/hch054; Lacy CR, 2001, STROKE, V32, P63, DOI 10.1161/01.STR.32.1.63; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lindsberg PJ, 2006, NEUROLOGY, V67, P334, DOI 10.1212/01.wnl.0000224759.44743.7d; Morris DL, 2000, STROKE, V31, P2585, DOI 10.1161/01.STR.31.11.2585; PICKARD JD, 1990, BRIT MED J, V301, P629, DOI 10.1136/bmj.301.6753.629; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SEELIG JM, 1984, NEUROSURGERY, V15, P617, DOI 10.1227/00006123-198411000-00001; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sekoranja L, 2009, SWISS MED WKLY, V139, P393, DOI smw-12506; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Tveiten A, 2009, EMERG MED J, V26, P324, DOI 10.1136/emj.2008.063610; Wright KD, 1996, INJURY, V27, P719, DOI 10.1016/S0020-1383(96)00119-2	26	15	15	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2016	125	3					642	647		10.3171/2015.6.JNS15175			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DT8YS	WOS:000381782300015	26722857	Bronze			2021-06-18	
J	Millet, A; Bouzat, P; Trouve-Buisson, T; Batandier, C; Pernet-Gallay, K; Gaide-Chevronnay, L; Barbier, EL; Debillon, T; Fontaine, E; Payen, JF				Millet, Anne; Bouzat, Pierre; Trouve-Buisson, Thibaut; Batandier, Cecile; Pernet-Gallay, Karin; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Debillon, Thierry; Fontaine, Eric; Payen, Jean-Francois			Erythropoietin and Its Derivates Modulate Mitochondrial Dysfunction after Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; erythropoietin; mitochondrial permeability; transition pore; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; POSITRON-EMISSION-TOMOGRAPHY; PERMEABILITY TRANSITION PORE; CYCLOSPORINE-A; CARBAMYLATED ERYTHROPOIETIN; AXONAL INJURY; ATP SYNTHASE; CELL-DEATH; RATS; MODEL	Inhibiting the opening of mitochondrial permeability transition pore (mPTP), thereby maintaining the mitochondrial membrane potential and calcium homeostasis, could reduce the induction of cell death. Although recombinant human erythropoietin (rhEpo) and carbamylated erythropoietin (Cepo) were shown to prevent apoptosis after traumatic brain injury (TBI), their impact on mPTP is yet unknown. Thirty minutes after diffuse TBI (impact-acceleration model), rats were intravenously administered a saline solution (TBI-saline), 5000 UI/kg rhEpo (TBI-rhEpo) or 50 lg/kg Cepo (TBI-Cepo). A fourth group received no TBI insult (sham-operated) (n = 11 rats per group). Post-traumatic brain edema was measured using magnetic resonance imaging. A first series of experiments was conducted 2 h after TBI (or equivalent) to investigate the mitochondrial function with the determination of thresholds for mPTP opening and ultrastructural mitochondrial changes. In addition, the intramitochondrial calcium content [Ca-im] was measured. In a second series of experiments, brain cell apoptosis was assessed at 24 h post-injury. TBI-rhEpo and TBI-Cepo groups had a reduced brain edema compared with TBI-saline. They had higher threshold for mPTP opening with succinate as substrate: 120 (120-150) (median, interquartiles) and 100 (100-120) versus 80 (60-90) nmol calcium/mg protein in TBI-saline, respectively (p < 0.05). Similar findings were shown with glutamate-malate as substrate. TBI-rhEpo and Cepo groups had less morphological mitochondrial disruption in astrocytes. The elevation in [Ca-im] after TBI was not changed by rhEpo and Cepo treatment. Finally, rhEpo and Cepo reduced caspase-3 expression at 24 h post-injury. These results indicate that rhEpo and Cepo could modulate mitochondrial dysfunction after TBI. The mechanisms involved are discussed.	[Millet, Anne; Bouzat, Pierre; Trouve-Buisson, Thibaut; Pernet-Gallay, Karin; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Payen, Jean-Francois] INSERM, U1216, Grenoble, France; [Millet, Anne; Bouzat, Pierre; Trouve-Buisson, Thibaut; Pernet-Gallay, Karin; Gaide-Chevronnay, Lucie; Payen, Jean-Francois] Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France; [Millet, Anne; Debillon, Thierry] Hop Couple Enfant, Dept Reanimat Pediat & Neonatale, Grenoble, France; [Bouzat, Pierre; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Payen, Jean-Francois] CHU Grenoble Alpes, Pole Anesthesie Reanimat, Grenoble, France; [Batandier, Cecile; Fontaine, Eric] Univ Grenoble 1, INSERM, U1055, Lab Biol Fondamentale & Appl, Grenoble, France; [Fontaine, Eric] CHU Grenoble Alpes, Unite Nutr Parenterale, Pole Med Aigue Specialisee, Grenoble, France	Payen, JF (corresponding author), Univ Grenoble 1, INSERM, U836, Grenoble Inst Neurosci,Equipe 5, Site Sante Tronche,BP 170, F-38042 Grenoble 9, France.	jfpayen@ujf-grenoble.fr	Barbier, Emmanuel/E-6302-2011; Bouzat, Pierre/L-6881-2014; Payen, Jean-Francois/L-6667-2014; Fontaine, Eric/ABA-8853-2020; Bouzat, Pierre/AAC-4105-2019	Barbier, Emmanuel/0000-0002-4952-1240; Bouzat, Pierre/0000-0003-4667-6738; Fontaine, Eric/0000-0002-5204-9477			Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Buki A, 2000, J NEUROSCI, V20, P2825; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Hammond J B, 1988, Methods Mol Biol, V3, P25, DOI 10.1385/0-89603-126-8:25; Hansson MJ, 2011, J NEUROTRAUM, V28, P143, DOI 10.1089/neu.2010.1613; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kobayashi H, 2008, CLIN EXP PHARMACOL P, V35, P812, DOI 10.1111/j.1440-1681.2008.04925.x; Lablanche S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.15; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wenker SD, 2013, FEBS J, V280, P1630, DOI 10.1111/febs.12172; Xie ZY, 2012, BRAIN RES, V1472, P113, DOI 10.1016/j.brainres.2012.06.053; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2009, NEUROL RES, V31, P496, DOI 10.1179/174313208X353703; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	44	15	17	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1625	1633		10.1089/neu.2015.4160			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300008	26530102				2021-06-18	
J	Banks, SD; Coronado, RA; Clemons, LR; Abraham, CM; Pruthi, S; Conrad, BN; Morgan, VL; Guillamondegui, OD; Archer, KR				Banks, Sarah D.; Coronado, Rogelio A.; Clemons, Lori R.; Abraham, Christine M.; Pruthi, Sumit; Conrad, Benjamin N.; Morgan, Victoria L.; Guillamondegui, Oscar D.; Archer, Kristin R.			Thalamic Functional Connectivity in Mild Traumatic Brain Injury: Longitudinal Associations With Patient-Reported Outcomes and Neuropsychological Tests	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Annual Conference of the American-Congress-of-Rehabilitation-Medicine	OCT 25-30, 2015	Dallas, TX	Amer Congress Rehabil Med		Brain injuries; Functional neuroimaging; Magnetic resonance imaging; Neuropsychological tests; Rehabilitation; Thalamus	POSTTRAUMATIC-STRESS-DISORDER; FRONTOPARIETAL CONTROL-SYSTEM; RESTING-STATE FMRI; NETWORK CONNECTIVITY; COGNITIVE DECLINE; HEAD-INJURY; PAIN; CORTEX; SCHIZOPHRENIA; ACTIVATIONS	Objectives: (1) To examine differences in patient-reported outcomes, neuropsychological tests, and thalamic functional connectivity (FC) between patients with mild traumatic brain injury (mTBI) and individuals without mTBI and (2) to determine longitudinal associations between changes in these measures. Design: Prospective observational case-control study. Setting: Academic medical center. Participants: A sample (N=24) of 13 patients with mTBI (mean age, 39.3 +/- 14.0y; 4 women [31%]) and 11 age- and sex-matched controls without mTBI (mean age, 37.6 +/- 13.3y; 4 women [36%]). Interventions: Not applicable. Main Outcome Measures: Resting state FC (3T magnetic resonance imaging scanner) was examined between the thalamus and the default mode network, dorsal attention network, and frontoparietal control network. Patient-reported outcomes included pain (Brief Pain Inventory), depressive symptoms (Patient Health Questionnaire-9), posttraumatic stress disorder ([PTSD] Checklist - Civilian Version), and postconcussive symptoms (Rivermead Post-Concussion Symptoms Questionnaire). Neuropsychological tests included the Delis-Kaplan Executive Function System Tower test, Trails B, and Hotel Task. Assessments occurred at 6 weeks and 4 months after hospitalization in patients with mTBI and at a single visit for controls. Results: Student t tests found increased pain, depressive symptoms, PTSD symptoms, and postconcussive symptoms; decreased performance on Trails B; increased FC between the thalamus and the default mode network; and decreased FC between the thalamus and the dorsal attention network and between the thalamus and the frontoparietal control network in patients with mTBI as compared with controls. The Spearman correlation coefficient indicated that increased FC between the thalamus and the dorsal attention network from baseline to 4 months was associated with decreased pain and postconcussive symptoms (corrected P<.05). Conclusions: Findings suggest that alterations in thalamic FC occur after mTBI, and improvements in pain and postconcussive symptoms are correlated with normalization of thalamic FC over time. (C) 2016 by the American Congress of Rehabilitation Medicine	[Banks, Sarah D.; Coronado, Rogelio A.; Clemons, Lori R.; Abraham, Christine M.; Archer, Kristin R.] Vanderbilt Univ, Med Ctr, Dept Orthopaed Surg, Nashville, TN USA; [Abraham, Christine M.] Lehigh Univ, Dept Educ & Human Serv, Bethlehem, PA 18015 USA; [Pruthi, Sumit; Conrad, Benjamin N.; Morgan, Victoria L.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Conrad, Benjamin N.; Morgan, Victoria L.] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN USA; [Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA; [Archer, Kristin R.] Vanderbilt Univ, Med Ctr, Dept Phys Med & Rehabil, Nashville, TN USA	Archer, KR (corresponding author), Vanderbilt Orthopaed Inst, Med Ctr East, South Tower,Suite 4200,1215 21st Ave S, Nashville, TN 37232 USA.	kristin.archer@vanderbilt.edu		Conrad, Benjamin/0000-0003-3755-6988; Coronado, Rogelio/0000-0002-7112-4903	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54 HD083211] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS075270] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD083211] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075270] Funding Source: NIH RePORTER		Ab Aziz CB, 2006, MALAYS J MED SCI, V13, P11; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cai SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115573; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cauda F, 2010, J NEUROL NEUROSUR PS, V81, P806, DOI 10.1136/jnnp.2009.188631; Cetin MS, 2014, NEUROIMAGE, V97, P117, DOI 10.1016/j.neuroimage.2014.04.009; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cohen J., 1988, STAT POWER ANAL BEHA, P567; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cummiford CM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0934-0; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gerberding JL, 2003, REP C MILD TRAUM BRA, P9; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.3.CO;2-5; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Ichesco E, 2016, EUR J PAIN      0115; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kandel E.R., 2013, PRINCIPLES NEURAL SC; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keane T., 1994, PTSD CHECKLIST CIVIL; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Li R, 2013, AM J NEURORADIOL, V34, P340, DOI 10.3174/ajnr.A3197; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Melzack Ronald, 2005, Pain Pract, V5, P85, DOI 10.1111/j.1533-2500.2005.05203.x; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Militana AR, 2015, BRAIN IMAGING BEHAV; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Niesters M, 2014, BRAIN CONNECT, V4, P404, DOI 10.1089/brain.2014.0247; Onoda K, 2012, J COGNITIVE NEUROSCI, V24, P2186, DOI 10.1162/jocn_a_00269; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Shulman GL, 1997, HUM BRAIN MAPP, V5, P317, DOI 10.1002/(SICI)1097-0193(1997)5:4<317::AID-HBM19>3.0.CO;2-A; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tu PC, 2013, SCHIZOPHR RES, V147, P339, DOI 10.1016/j.schres.2013.04.011; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wilcox CE, 2015, PAIN MED, V16, P2121, DOI 10.1111/pme.12785; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Yin Y, 2011, BRAIN RES, V1411, P98, DOI 10.1016/j.brainres.2011.07.016; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	72	15	15	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2016	97	8					1254	1261		10.1016/j.apmr.2016.03.013			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DT1LM	WOS:000381244200006	27085849	Green Accepted			2021-06-18	
J	Chatelle, C; Bodien, YG; Carlowicz, C; Wannez, S; Charland-Verville, V; Gosseries, O; Laureys, S; Seel, RT; Giacino, JT				Chatelle, Camille; Bodien, Yelena G.; Carlowicz, Cecilia; Wannez, Sarah; Charland-Verville, Vanessa; Gosseries, Olivia; Laureys, Steven; Seel, Ron T.; Giacino, Joseph T.			Detection and Interpretation of Impossible and Improbable Coma Recovery Scale-Revised Scores	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Consciousness disorders; Outcome assessment (health care); Rehabilitation	MINIMALLY CONSCIOUS STATE; VEGETATIVE STATE; LEVEL	Objective: To determine the frequency with which specific Coma Recovery Scale-Revised (CRS-R) subscale scores co-occur as a means of providing clinicians and researchers with an empirical method of assessing CRS-R data quality. Design: We retrospectively analyzed CRS-R subscale scores in hospital inpatients diagnosed with disorders of consciousness (DOCs) to identify impossible and improbable subscore combinations as a means of detecting inaccurate and unusual scores. Impossible subscore combinations were based on violations of CRS-R scoring guidelines. To determine improbable subscore combinations, we relied on the Mahalanobis distance, which detects outliers within a distribution of scores. Subscore pairs that were not observed at all in the database (ie, frequency of occurrence = 0%) were also considered improbable. Setting: Specialized DOC program and university hospital. Participants: Patients diagnosed with DOCs (N=1190; coma: n=76, vegetative state: n=464, minimally conscious state: n=586, emerged from minimally conscious state: n=64; 794 men; mean age, 43 +/- 20y; traumatic etiology: n=747; time postinjury, 162 +/- 568d). Interventions: Not applicable. Main Outcome Measure: Impossible and improbable CRS-R subscore combinations. Results: Of the 1190 CRS-R profiles analyzed, 4.7% were excluded because they met scoring criteria for impossible co-occurrence. Among the 1137 remaining profiles, 12.2% (41/336) of possible subscore combinations were classified as improbable. Conclusions: Clinicians and researchers should take steps to ensure the accuracy of CRS-R scores. To minimize the risk of diagnostic error and erroneous research findings, we have identified 9 impossible and 36 improbable CRS-R subscore combinations. The presence of any one of these subscore combinations should trigger additional data quality review. (C) 2016 by the American Congress of Rehabilitation Medicine	[Chatelle, Camille; Bodien, Yelena G.; Carlowicz, Cecilia; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Chatelle, Camille; Bodien, Yelena G.; Carlowicz, Cecilia; Giacino, Joseph T.] Harvard Med Sch, Boston, MA USA; [Chatelle, Camille] Massachusetts Gen Hosp, Lab NeuroImaging Coma & Consciousness, 175 Cambridge St,Ste 300, Boston, MA 02114 USA; [Chatelle, Camille; Wannez, Sarah; Charland-Verville, Vanessa; Gosseries, Olivia; Laureys, Steven] Univ Hosp Liege, GIGA Res Ctr, Coma Sci Grp, Liege, Belgium; [Gosseries, Olivia] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Gosseries, Olivia] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Seel, Ron T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA	Chatelle, C (corresponding author), Massachusetts Gen Hosp, Lab NeuroImaging Coma & Consciousness, 175 Cambridge St,Ste 300, Boston, MA 02114 USA.	cchatelle@partners.org	Laureys, Steven/AAN-2097-2021; Giacino, Joseph/AAF-1952-2021; Gosseries, Olivia/AAB-6469-2020; Laureys, Steven/A-3349-2011	Laureys, Steven/0000-0002-3096-3807; Giacino, Joseph/0000-0002-7916-9698; Gosseries, Olivia/0000-0001-9011-7496; Chatelle, Camille/0000-0002-7526-2107; Bodien, Yelena/0000-0003-4858-2903	National Institute on Disability, Independent Living, and Rehabilitation Research, Department of Health and Human Services, Administration for Community Living [90DP0039-01-00]; James S. McDonnell Foundation; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University and its affiliated academic health care centers; Belgian American Educational Foundation; Wallonie Bruxelles International Concerted Research Action; Belgian Funds for Scientific Research, European CommissionFonds de la Recherche Scientifique - FNRS; European Foundation for Biomedical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000039] Funding Source: NIH RePORTER	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, Department of Health and Human Services, Administration for Community Living (grant no. 90DP0039-01-00); The James S. McDonnell Foundation; Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health award no. UL1 TR001102); financial contributions from Harvard University and its affiliated academic health care centers; The Belgian American Educational Foundation; Wallonie Bruxelles International Concerted Research Action; Belgian Funds for Scientific Research, European Commission; and the European Foundation for Biomedical Research.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; La Porta F, 2013, ARCH PHYS MED REHAB, V94, P527, DOI 10.1016/j.apmr.2012.09.035; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Mahalanobis P, 1936, P NATL I SCI INDIA, V3, P49, DOI DOI 10.1145/1390156.1390302; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Stender J, 2015, J CEREBR BLOOD F MET, V35, P58, DOI 10.1038/jcbfm.2014.169	13	15	17	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2016	97	8					1295	1300		10.1016/j.apmr.2016.02.009			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DT1LM	WOS:000381244200011	26944708	Green Accepted			2021-06-18	
J	Chiang, CC; Guo, SE; Huang, KC; Lee, BO; Fan, JY				Chiang, Chia-Chen; Guo, Su-Er; Huang, Kuo-Chang; Lee, Bih-O; Fan, Jun-Yu			Trajectories and associated factors of quality of life, global outcome, and post-concussion symptoms in the first year following mild traumatic brain injury	QUALITY OF LIFE RESEARCH			English	Article						Quality of life; Global outcome; Post-concussion symptoms; Mild traumatic brain injury; Trajectory	ANALYZING DEVELOPMENTAL TRAJECTORIES; POSTCONCUSSIVE SYMPTOMS; STRUCTURED INTERVIEWS; SCALE; QOLIBRI; WORK; RELIABILITY; PREDICTORS; RETURN	To investigate the associated factors and change trajectories of quality of life (QoL), global outcome, and post-concussion symptoms (PCS) over the first year following mild traumatic brain injury (mTBI). This was a prospective longitudinal study of 100 participants with mTBI from neurosurgical outpatient departments in Chiayi County District Hospitals in Taiwan. The checklist of post-concussion syndromes (CPCS) was used to assess PCS at enrollment and at 1, 3, and 12 months after mTBI; the glasgow outcome scale extended (GOSE), the quality of life after brain injured (QOLIBRI), Chinese version, and the Short Form 36 Health Survey (SF-36), Taiwan version, were used to assess mTBI global outcome and QoL at 1, 3, and 12 months after mTBI. Latent class growth models (LCGMs) indicated the change trajectories of QOLIBRI, PCS SF-36, MCS SF-36, GOSE, and PCS. Classes of trajectory were associated with age a parts per thousand yen40 years, unemployment at 1 month after injury, and educational level a parts per thousand currency sign12 years. Univariate analysis revealed that employment status at 1 month post-injury was correlated with the trajectories of QOLIBRI, PCS SF-36, MCS SF-36, and GOSE, but not PCS. Employment status was the most crucial associated factor for QoL in individuals with mTBI at the 1-year follow-up. Future studies should explore the benefits of employment on QoL of individuals with mTBI.	[Chiang, Chia-Chen] Sinying Hosp, Dept Nursing, Minist Hlth & Welf, Tainan, Taiwan; [Guo, Su-Er; Lee, Bih-O] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Dept Nursing, Chiayi, Taiwan; [Guo, Su-Er; Lee, Bih-O] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Grad Inst Nursing, Chiayi, Taiwan; [Lee, Bih-O] Ditmanson Med Fdn Chiayi Christian Hosp, Sect Neurosurg, Dept Surg, Chiayi, Taiwan; [Fan, Jun-Yu] Chang Gung Univ Sci & Technol, Dept Nursing, 261,Wen Hua 1st Rd, Taoyuan 33303, Taiwan; [Fan, Jun-Yu] Chang Gung Univ Sci & Technol, Grad Inst Nursing, 261,Wen Hua 1st Rd, Taoyuan 33303, Taiwan	Fan, JY (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, 261,Wen Hua 1st Rd, Taoyuan 33303, Taiwan.; Fan, JY (corresponding author), Chang Gung Univ Sci & Technol, Grad Inst Nursing, 261,Wen Hua 1st Rd, Taoyuan 33303, Taiwan.	joyful5230@gmail.com; seguo@gw.cgust.edu.tw; 05780@cych.org.tw; bih-olee@gw.cgust.edu.tw; jyfan@gw.cgust.edu.tw		Lee, Bih-O/0000-0003-1903-8378	Administration Center of the Medical Research Department, Chang Gung Memorial Hospital, Taiwan [BMRPB80]	The authors wish to acknowledge all 100 participants for their time and effort contributed to this study. This research was supported by a Grant from the Administration Center of the Medical Research Department, Chang Gung Memorial Hospital, Taiwan (BMRPB80), to the corresponding author.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beseoglu K, 2013, BRIT J NEUROSURG, V27, P202, DOI 10.3109/02688697.2012.717984; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI [10.1097/00001199-199309000-00003, DOI 10.1097/00001199-199309000-00003]; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Injury Prevention and Control, INJ PREV CONTR TRAUM; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; Lu J.-F.R., 2003, TAIWAN J PUB HLTH, V22, P501, DOI DOI 10.6288/TJPH2003-22-06-09; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	44	15	15	0	17	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	AUG	2016	25	8					2009	2019		10.1007/s11136-015-1215-0			11	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	DR6IP	WOS:000380005900015	26706751				2021-06-18	
J	Kesinger, MR; Juengst, SB; Bertisch, H; Niemeier, JP; Krellman, JW; Pugh, M; Kumar, RG; Sperry, JL; Arenth, PM; Fann, JR; Wagner, AK				Kesinger, Matthew R.; Juengst, Shannon B.; Bertisch, Hillary; Niemeier, Janet P.; Krellman, Jason W.; Pugh, MaryJo; Kumar, Raj G.; Sperry, Jason L.; Arenth, Patricia M.; Fann, Jesse R.; Wagner, Amy K.			Acute Trauma Factor Associations With Suicidality Across the First 5 Years After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Injury Severity Score; Multiple trauma; Rehabilitation; Suicidal ideation; Suicide; attempted	DEPLOYED MILITARY PERSONNEL; SUBSTANCE-ABUSE; RISK-FACTORS; CHRONIC PAIN; FOLLOW-UP; DEPRESSION; IDEATION; REHABILITATION; POPULATION; PREVALENCE	Objective: To determine whether severity of head and extracranial injuries (ECI) is associated with suicidal ideation (SI) or suicide attempt (SA) after traumatic brain injury (TBI). Design: Factors associated with SI and SA were assessed in this inception cohort study using data collected 1, 2, and 5 years post-TBI from the National Trauma Data Bank and Traumatic Brain Injury Model Systems (TRIMS) databases. Setting: Level I trauma centers, inpatient rehabilitation centers, and the community. Participants: Participants with TBI from 15 TBIMS Centers with linked National Trauma Data Bank trauma data (N=3575). Interventions: Not applicable. Main Outcome Measures: SI was measured via the Patient Health Questionnaire 9 (question 9). SA in the last year was assessed via interview. ECI was measured by the Injury Severity Scale (nonhead) and categorized as none, mild, moderate, or severe. Results: There were 293 (8.2%) participants who had SI without SA and 109 (3.0%) who had SA at least once in the first 5 years postinjury. Random effects logit modeling showed a higher likelihood of SI when ECI was severe (odds ratio = 2.73; 95% confidence interval, 1.55-4.82; P=.001). Drug use at time of injury was also associated with SI (odds ratio =1.69; 95% confidence interval, 1.11-2.86; P=.015). Severity of ECI was not associated with SA. Conclusions: Severe ECI carried a nearly 3-fold increase in the odds of SI after TBI, but it was not related to SA. Head injury severity and less severe ECI were not associated with SI or SA. These findings warrant additional work to identify factors associated with severe ECI that make individuals more susceptible to SI after TBI. (C) 2016 by the American Congress of Rehabilitation Medicine	[Kesinger, Matthew R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Juengst, Shannon B.; Kumar, Raj G.; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave, Pittsburgh, PA 15213 USA; [Bertisch, Hillary] NYU, Dept Rehabil Med, Sch Med, New York, NY USA; [Niemeier, Janet P.] Carolinas Med Ctr, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA; [Niemeier, Janet P.] Univ N Carolina, Chapel Hill, NC USA; [Krellman, Jason W.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Pugh, MaryJo] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Pugh, MaryJo] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Sperry, Jason L.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA	Juengst, SB (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave, Pittsburgh, PA 15213 USA.	sbj7@pitt.edu	Juengst, Shannon B/AAC-5891-2019; Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763; Juengst, Shannon/0000-0003-4709-545X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0041]; NIDILRRUnited States Department of Health & Human Services [90DP0038, 90DP0047]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH K23GM093032]; National Institute of Mental Health Medical Student Research Fellowship [TL1TR000005, R25 MH054318]; Rusk Advanced Rehabilitation Research Training Postdoctoral Fellowship [NIDILRR 90AR5014-01-00]; Polytrauma Rehabilitation Center Traumatic Brain Injury Model System; Department of Veterans Affairs (VA)US Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25MH054318] Funding Source: NIH RePORTER	Support for the collection of the original data was by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (grant no. 90DP0041); and the National Trauma Data Bank. Support for the content of this article was by the NIDILRR (grant nos. 90DP0038 and 90DP0047); the National Institutes of Health (grant no. NIH K23GM093032); the National Institute of Mental Health Medical Student Research Fellowship (fellowship no. TL1TR000005) administered by the University of Pittsburgh (grant no. R25 MH054318); a Rusk Advanced Rehabilitation Research Training Postdoctoral Fellowship (grant no. NIDILRR 90AR5014-01-00); and the Polytrauma Rehabilitation Center Traumatic Brain Injury Model System.; The Polytrauma Rehabilitation Center Traumatic Brain Injury Model System is a funded collaboration between the Department of Veterans Affairs (VA) and the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). The NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of the VA, NIDILRR, ACL, NIH, or HHS, and endorsement of this content by the Federal Government should not be assumed.	Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; Artenie AA, 2015, ADDICTION, V110, P1636, DOI 10.1111/add.13030; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Campbell G, 2016, CLIN J PAIN, V32, P292, DOI 10.1097/AJP.0000000000000283; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Cook AJ, 2015, BEHAV RES THER, V73, P25, DOI 10.1016/j.brat.2015.07.003; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Darke S, 2015, PSYCHIAT RES, V227, P166, DOI 10.1016/j.psychres.2015.04.010; Desseilles M, 2012, J AFFECT DISORDERS, V136, P398, DOI 10.1016/j.jad.2011.11.013; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Fountoulakis KN, 2004, NEUROPSYCHOBIOLOGY, V49, P42, DOI 10.1159/000075338; Giegling I, 2009, J PSYCHIATR RES, V43, P1262, DOI 10.1016/j.jpsychires.2009.04.013; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Homaifar BY, 2012, REHABIL PSYCHOL, V57, P337, DOI 10.1037/a0030480; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kesinger MR, 2016, AM J PHYS MED REHABI; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; March J, 2014, J TRAUMA ACUTE CARE, V76, P180, DOI 10.1097/TA.0b013e3182a900bc; McConnell D, 2015, COMMUNITY MENT HLTH; McCullumsmith CB, 2015, ARCH PHYS MED REHAB, V96, P799, DOI 10.1016/j.apmr.2014.12.017; Nowrangi MA, 2014, PSYCHOSOMATICS, V55, P430, DOI 10.1016/j.psym.2013.11.006; Ortiz-Gomez LD, 2014, J AFFECT DISORDERS, V169, P10, DOI 10.1016/j.jad.2014.07.033; Randall JR, 2014, CAN J PSYCHIAT, V59, P531; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Rockett IRH, 2015, JAMA PSYCHIAT, V72, P1069, DOI 10.1001/jamapsychiatry.2015.1418; Ryb GE, 2006, J TRAUMA, V61, P799, DOI 10.1097/01.ta.0000196763.14289.4e; Serafini G, 2013, EUR NEUROPSYCHOPHARM, V23, P1672, DOI 10.1016/j.euroneuro.2013.06.002; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Tupler LA, 2015, J NERV MENT DIS, V203, P269, DOI 10.1097/NMD.0000000000000277; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wagner AK, 2000, ARCH PHYS MED REHAB, V81, P1267; Zhang XY, 2014, DRUG ALCOHOL DEPEN, V142, P63, DOI 10.1016/j.drugalcdep.2014.05.025	52	15	15	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2016	97	8					1301	1308		10.1016/j.apmr.2016.02.017			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DT1LM	WOS:000381244200012	26987622	Green Published, Bronze			2021-06-18	
J	Kroshus, E; Garnett, BR; Baugh, CM; Calzo, JP				Kroshus, Emily; Garnett, Bernice R.; Baugh, Christine M.; Calzo, Jerel P.			Engaging Teammates in the Promotion of Concussion Help Seeking	HEALTH EDUCATION & BEHAVIOR			English	Article						bystander; concussion; education; norms; sport	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; ICE HOCKEY; FOOTBALL PLAYERS; PLANNED BEHAVIOR; EDUCATION; RISK; KNOWLEDGE; OUTCOMES; INJURY	Concussion underreporting contributes to the substantial public health burden of concussions from sport. Teammates may be able to play an important role in encouraging injury identification and help seeking. This study assessed whether there was an association between beliefs about the consequences of continued play with a concussion and intentions to engage as a proactive bystander in facilitating or encouraging teammate help seeking for a possible concussion. Participants were 328 (male and female) members of 19 U.S. collegiate contact or collision sports teams. Athletes who believed that there were negative health or performance consequences of continued play with a concussion were significantly more likely than their peers to intend to encourage teammate help seeking, but not more likely to alert a coach or medical personnel. Additionally, athletes who believed that their teammates were more supportive of concussion safety were more likely to intend to engage as proactive bystanders in encouraging teammate help seeking. Exploring how to encourage bystander promotion of concussion safety is an important direction for future programming and evaluation research and may provide an opportunity to improve the effectiveness of concussion education.	[Kroshus, Emily] Univ Washington, Dept Pediat, 2001 Eighth Ave,Suite 400, Seattle, WA 98121 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Garnett, Bernice R.] Univ Vermont, Coll Educ & Social Serv, Burlington, VT USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Baugh, Christine M.; Calzo, Jerel P.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Calzo, Jerel P.] Harvard Med Sch, Dept Pediat, Cambridge, MA USA; [Calzo, Jerel P.] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA	Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 Eighth Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Calzo, Jerel/0000-0002-4656-1052			AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Banyard VL, 2011, PSYCHOL VIOLENCE, V1, P287, DOI 10.1037/a0023544; Benabou R., 2005, 11535 NAT BUR EC RES; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Chekroun P, 2002, EUR J SOC PSYCHOL, V32, P853, DOI 10.1002/ejsp.126; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Dovidio J. F., 2006, SOCIAL PSYCHOL PROSO; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Fredricks JA, 2006, DEV PSYCHOL, V42, P698, DOI 10.1037/0012-1649.42.4.698; Frings D, 2010, GROUP DYN-THEOR RES, V14, P80, DOI 10.1037/a0016092; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hootman JM, 2007, J ATHL TRAINING, V42, P311; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Latane B., 1970, UNRESPONSIVE BYSTAND; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Long J. B. V., 2012, U VIRGINIAS STEP UP; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; National Collegiate Athletic Association, 2013, 198182201213 NCAA; National Collegiate Athletic Association, 2014, DIV STEER COMM GOV R; National Federation of High School Sports, 2014, HIGH SCH SPORT PART; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; The National Collegiate Athletic Association, 2014, 2014 2015 NCAA SPORT; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Vast RL, 2010, AUST PSYCHOL, V45, P132, DOI 10.1080/00050060903261538; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	53	15	15	1	25	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.	AUG	2016	43	4					442	451		10.1177/1090198115602676			10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	DS7KG	WOS:000380961800008	27405801				2021-06-18	
J	McKinlay, A; Horwood, LJ; Fergusson, DM				McKinlay, Audrey; Horwood, L. John; Fergusson, David M.			Accuracy of Self-report as a Method of Screening for Lifetime Occurrence of Traumatic Brain Injury Events that Resulted in Hospitalization	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injury; Head injury; Concussion; Self-report; Recall; Accuracy; Cohort; Prospective	NEUROPSYCHOLOGICAL FUNCTION; POSTCONCUSSION SYNDROME; PSYCHOSOCIAL OUTCOMES; SUBSTANCE-ABUSE; HEAD-INJURY; CHILDHOOD; CHILDREN; HEALTH; EPIDEMIOLOGY; ADOLESCENTS	Background Traumatic brain injury (TBI) occurs frequently during child and early adulthood, and is associated with negative outcomes including increased risk of drug abuse, mental health disorders and criminal offending. Identification of previous TBI for at-risk populations in clinical settings often relies on self-report, despite little information regarding self-report accuracy. This study examines the accuracy of adult self-report of hospitalized TBI events and the factors that enhance recall. Methods The Christchurch Health and Development Study is a birth cohort of 1265 children born in Christchurch, New Zealand, in 1977. A history of TBI events was prospectively gathered at each follow-up (yearly intervals 0-16, 18, 21, 25 years) using parental/self-report, verified using hospital records. Results At 25 years, 1003 cohort members were available, with 59/101 of all hospitalized TBI events being recalled. Recall varied depending on the age at injury and injury severity, with 10/11 of moderate/severe TBI being recalled. Logistic regression analysis indicated that a model using recorded loss of consciousness, age at injury, and injury severity, could accurately classify whether or not TBI would be reported in over 74% of cases. Conclusions This research demonstrates that, even when individuals are carefully cued, many instances of TBI will not recalled in adulthood despite the injury having required a period of hospitalization. Therefore, screening for TBI may require a combination of self-report and review of hospital files to ensure that all cases are identified.	[McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Horwood, L. John; Fergusson, David M.] Univ Otago, Christchurch Hlth & Dev Study, Christchurch, New Zealand	McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Psychol Clin, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		Horwood, L./0000-0003-4881-1956; McKinlay, Audrey/0000-0001-9846-8514			Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Bruce D, 2000, PSYCHOL SCI, V11, P360, DOI 10.1111/1467-9280.00271; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Fergusson DM, 1998, J EMOT BEHAV DISORD, V6, P2, DOI 10.1177/106342669800600101; FERGUSSON DM, 1991, J CHILD PSYCHOL PSYC, V32, P257, DOI 10.1111/j.1469-7610.1991.tb00305.x; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A., 2013, INT NEUROTRAUMA LETT, V33; McKinlay A, 2017, DISABIL REHABIL, V39, P1296, DOI 10.1080/09638288.2016.1193905; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2014, J FAM VIOLENCE, V29, P391, DOI 10.1007/s10896-014-9591-8; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Youngblut JM, 2006, J PEDIATR PSYCHOL, V31, P608, DOI 10.1093/jpepsy/jsj066; Youngblut JM, 2008, J HEAD TRAUMA REHAB, V23, P92, DOI 10.1097/01.HTR.0000314528.85758.30	40	15	15	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2016	22	7					717	723		10.1017/S1355617716000497			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	DU8SQ	WOS:000382485100003	27265159				2021-06-18	
J	Schmidt, JD; Guskiewicz, KM; Mihalik, JP; Blackburn, JT; Siegmund, GP; Marshall, SW				Schmidt, Julianne D.; Guskiewicz, Kevin M.; Mihalik, Jason P.; Blackburn, J. Troy; Siegmund, Gunter P.; Marshall, Stephen W.			Head Impact Magnitude in American High School Football	PEDIATRICS			English	Article							STATES HIGH-SCHOOL; PROFESSIONAL FOOTBALL; CONCUSSION; BIOMECHANICS; PLAYERS; INJURY; EXPOSURE; EPIDEMIOLOGY; POSITION; SPORTS	OBJECTIVES: To describe determinants of head impact magnitudes between various play aspects in high school football. METHODS: Thirty-two high school American football players wore Head Impact Telemetry System instrumented helmets to capture head impact magnitude (linear acceleration, rotational acceleration, and Head Impact Technology severity profile [HITsp]). We captured and analyzed video from 13 games (n = 3888 viewable head impacts) to determine the following play aspects: quarter, impact cause, play type, closing distance, double head impact, player's stance, player's action, direction of gaze, athletic readiness, level of anticipation, player stationary, ball possession, receiving ball, and snapping ball. We conducted random intercepts general linear mixed models to assess the differences in head impact magnitude between play aspects (alpha = 0.05). RESULTS: The following aspects resulted in greater head impact magnitude: impacts during the second quarter (HITsp: P =.03); contact with another player (linear, rotational, HITsp: P < .001); initial head impact when the head is struck twice (linear, rotational, HITsp: P < .001); longer closing distances, especially when combined with a 3-point stance or when being struck in the head (linear: P = .03); the 2-point stance (linear, rotational, HITsp: P < .001); and offensive linemen not snapping the ball compared with those snapping the ball (rotational: P = .02, HITsp: P = .02). CONCLUSIONS: Preventing head impacts caused by contact with another player may reduce head impact magnitude in high school football. Rule or coaching changes that reduce collisions after long closing distances, especially when combined with the 3-point stance or when a player is being struck in the head, should be considered.	[Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Schmidt, Julianne D.] Univ Georgia, Concuss Res Lab, Athens, GA 30602 USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.; Blackburn, J. Troy] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Blackburn, J. Troy] Univ N Carolina, Neuromuscular Res Lab, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Siegmund, Gunter P.] MEA Forens Engineers & Scientists, Richmond, BC, Canada; [Siegmund, Gunter P.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada	Schmidt, JD (corresponding author), 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu	Siegmund, Gunter P/B-7003-2013				Allison MA, MED SCI SPORTS EXERC; [Anonymous], 2013, HEADACHE, V53, P817; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Bonnechere B, 2014, J SPORT SCI MED, V13, P423; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; DeLamielleure J, 2014, J LAW MED ETHICS, V42, P133, DOI 10.1111/jlme.12127; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Eckner JT, J NEUROTRAUMA; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2012, RES SPORTS MED, V20, P86, DOI 10.1080/15438627.2012.660824; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125; Mihalik JP, 2012, 2012 ASTM SPECIAL TE; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; van der Kamp J, 2011, MOTOR CONTROL, V15, P342, DOI 10.1123/mcj.15.3.342; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Viera AJ, 2005, FAM MED, V37, P360; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19	32	15	15	0	17	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2016	138	2							e20154231	10.1542/peds.2015-4231			9	Pediatrics	Pediatrics	DS7ZP	WOS:000381002500015	27432843	Green Published, Bronze			2021-06-18	
J	Thakkar, K; Maricich, SM; Alper, G				Thakkar, Kavita; Maricich, Stephen M.; Alper, Gulay			Acute Ataxia in Childhood: 11-Year Experience at a Major Pediatric Neurology Referral Center	JOURNAL OF CHILD NEUROLOGY			English	Article						cerebellar ataxia; case studies; case series; acute cerebellitis; postinfectious cerebellar ataxia; acute ataxia	ACUTE CEREBELLAR-ATAXIA; BARR-VIRUS-INFECTION; HEAD-INJURY; AUTOANTIBODIES; VARICELLA; CHILDREN	We categorized the causes of acute ataxia in the pediatric populationreferred to the Division of Neurologyat a large, urban pediatric medical center. Of the 120 cases identified over the past 11 years, post-infectious cerebellar ataxia was the most commonly diagnosed (59%), followed by drug intoxication, opsoclonus-myoclonus ataxia syndrome, episodic ataxia, acute cerebellitis, cerebellar stroke, ADEM, meningitis, cerebral vein thrombosis, Leigh's disease, Miller-Fisher syndrome, and concussion. Among the patients with post-infectious cerebellar ataxia, 85% were 1-6 years old and all had a history of antecedent viral illness. CSF pleocytosis was present in 40% of patients; all had normal brain MRIs. The majority (91%) recovered within 30 days. We conclude that post-infectious cerebellar ataxia remains the most common cause of acute ataxia in childhood and that it carries a good prognosis. We also differentiate acute post-infectious cerebellar ataxia from other causes with similar presentations.	[Thakkar, Kavita; Maricich, Stephen M.; Alper, Gulay] UPMC, Div Child Neurol, Dept Pediat, Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Maricich, Stephen M.] Univ Pittsburgh, Dept Pediat, Richard King Mellon Fdn Inst Pediat Res, Pittsburgh, PA 15260 USA	Thakkar, K (corresponding author), UPMC, Div Child Neurol, Dept Pediat, Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	thakkarkp@upmc.edu	Thakkar, Kavita/AAN-8599-2021				Adams C, 2000, CAN J NEUROL SCI, V27, P316, DOI 10.1017/S0317167100001074; Bakshi R, 1998, CLIN IMAG, V22, P79, DOI 10.1016/S0899-7071(97)00093-4; Chan A K, 2000, Semin Pediatr Neurol, V7, P301, DOI 10.1053/spen.2000.20075; CLEARY TG, 1980, JAMA-J AM MED ASSOC, V243, P148, DOI 10.1001/jama.243.2.148; COHEN HA, 1992, AM J DIS CHILD, V146, P930, DOI 10.1001/archpedi.1992.02160200052025; CONNOLLY AM, 1994, ANN NEUROL, V35, P673, DOI 10.1002/ana.410350607; CURNEN EC, 1961, YALE J BIOL MED, V34, P219; Daaboul Y, 1998, NEUROL RES, V20, P85; Davis DP, 2003, J EMERG MED, V24, P281, DOI 10.1016/S0736-4679(02)00746-1; De Bruecker Y, 2004, EUR RADIOL, V14, P1478, DOI 10.1007/s00330-004-2247-y; DREYFUS PM, 1974, WESTERN J MED, V120, P161; Fritzler Marvin J, 2003, BMC Pediatr, V3, P11, DOI 10.1186/1471-2431-3-11; GIERONKORTHALS MA, 1994, J CHILD NEUROL, V9, P381, DOI 10.1177/088307389400900408; Go T, 2003, ACTA PAEDIATR, V92, P504; Gohil JR, 2006, INDIAN PEDIATR, V43, P829; Hata A, 2008, J PAEDIATR CHILD H, V44, P607, DOI 10.1111/j.1440-1754.2008.01395.x; ITO H, 1994, NEUROLOGY, V44, P1506, DOI 10.1212/WNL.44.8.1506; Keller C, 1998, J CHILD NEUROL, V13, P93, DOI 10.1177/088307389801300211; KING G, 1958, PEDIATRICS, V21, P731; Martinez-Gonzalez MJ, 2006, REV NEUROLOGIA, V42, P321, DOI 10.33588/rn.4206.2006075; NAKAO T, 1970, TOHOKU J EXP MED, V101, P47, DOI 10.1620/tjem.101.47; Nussinovitch M, 2003, CLIN PEDIATR, V42, P581, DOI 10.1177/000992280304200702; Rafay MF, 2006, J CHILD NEUROL, V21, P8, DOI 10.1177/08830738060210010101; SENANAYAKE N, 1994, J NEUROL, V241, P456, DOI 10.1007/BF00900965; Shiihara T, 2007, BRAIN DEV-JPN, V29, P254, DOI 10.1016/j.braindev.2006.09.004; Shimizu Y, 1999, ARCH DIS CHILD, V80, P72, DOI 10.1136/adc.80.1.72; Spacey S., GENEREVIEWS R; Uchibori A, 2005, NEUROLOGY, V65, P1114, DOI 10.1212/01.wnl.0000178802.38268.1e; van der Maas NAT, 2009, VACCINE, V27, P1970, DOI 10.1016/j.vaccine.2009.01.019; Visudtibhan Anannit, 1998, Journal of the Medical Association of Thailand, V81, P1015; YABEK SM, 1973, PEDIATRICS, V52, P718; Yeoh HK, 2006, CHILD NERV SYST, V22, P310, DOI 10.1007/s00381-005-1154-0; Yeung W. L., 2003, Hong Kong Medical Journal, V9, P142	33	15	15	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	AUG	2016	31	9					1156	1160		10.1177/0883073816643407			5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	DS7DN	WOS:000380943100009	27071467				2021-06-18	
J	Young, JY; Duhaime, AC; Caruso, PA; Rincon, SP				Young, Joseph Yeen; Duhaime, Ann-Christine; Caruso, Paul Albert; Rincon, Sandra Patricia			Comparison of non-sedated brain MRI and CT for the detection of acute traumatic injury in children 6 years of age or less	EMERGENCY RADIOLOGY			English	Article						Rapid MRI; CT; Brain; Pediatric; Trauma	HEAD-INJURY; EVENTS	CT is considered the first-line study for acute intracranial injury in children because of its availability, detection of acute hemorrhage, and lack of sedation. An MRI study with rapidly acquired sequences can obviate the need for sedation and radiation. We compared the detection rate of rapid non-sedated brain MRI to CT for traumatic head injury in young children. We reviewed a series of children 6 years of age or less who presented to our ED during a 5-year period with head trauma and received a non-sedated brain MRI and CT within 24 h of injury. Most MRI studies were limited to triplane T2 and susceptibility sequences. Two neuroradiologists reviewed the MRIs and CTs and assessed the following findings: fracture, epidural hematoma (EDH)/subdural hematoma (SDH), subarachnoid hemorrhage (SAH), intraventricular hemorrhage (IVH), and parenchymal injury. Thirty of 33 patients had radiologically identified traumatic injuries. There was an overall agreement of 82 % between the two modalities. Skull fracture was the only injury subtype which had a statistically significant difference in detection between CT and MRI (p = 0.0001), with MRI missing 14 of 21 fractures detected on CT. While not statistically significant, MRI had a higher detection rate of EDH/SDH (p = 0.34), SAH (p = 0.07), and parenchymal injuries (p = 0.50). Non-sedated MRI has similar detection rates to CT for intracranial injury in young children presenting with acute head trauma and may be an alternative to CT in select patients.	[Young, Joseph Yeen; Caruso, Paul Albert; Rincon, Sandra Patricia] Massachusetts Gen Hosp, Neuroradiol Sect, Dept Radiol, 55 Fruit St,Gray 273A, Boston, MA 02114 USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St,Gray 273A, Boston, MA 02114 USA	Young, JY (corresponding author), Massachusetts Gen Hosp, Neuroradiol Sect, Dept Radiol, 55 Fruit St,Gray 273A, Boston, MA 02114 USA.	joseph.y.young@gmail.com					Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; Ashley WW, 2005, J NEUROSURG, V103, P124, DOI 10.3171/ped.2005.103.2.0124; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Cote CJ, 2000, PEDIATRICS, V106, P633, DOI 10.1542/peds.106.4.633; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Malviya S, 2000, BRIT J ANAESTH, V84, P743; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Missios S, 2008, J NEUROS-PEDIATR, V2, P438, DOI 10.3171/PED.2008.2.12.438; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; O'Neill BR, 2013, WORLD NEUROSURG, V80, pE307, DOI 10.1016/j.wneu.2012.10.066; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Wang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085760; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	22	15	15	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	AUG	2016	23	4					325	331		10.1007/s10140-016-1392-3			7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	DR1BQ	WOS:000379641400002	27166965				2021-06-18	
J	Fiorin, FD; Ferreira, APD; Ribeiro, LR; Silva, LFA; de Castro, MRT; da Silva, LRH; da Silveira, MEP; Zemolin, APP; Dobrachinski, F; de Oliveira, SM; Franco, JL; Soares, FA; Furian, AF; Oliveira, MS; Fighera, MR; Royes, LFF				Fiorin, Fernando da Silva; de Oliveira Ferreira, Ana P.; Ribeiro, Leandro R.; Silva, Luiz F. A.; de Castro, Mauro R. T.; da Silva, Luis R. H.; da Silveira, Mauro E. P.; Zemolin, Ana P. P.; Dobrachinski, Fernando; de Oliveira, Sara Marchesan; Franco, Jeferson L.; Soares, Felix A.; Furian, Ana F.; Oliveira, Mauro S.; Fighera, Michele R.; Freire Royes, Luiz F.			The Impact of Previous Physical Training on Redox Signaling after Traumatic Brain Injury in Rats: A Behavioral and Neurochemical Approach	JOURNAL OF NEUROTRAUMA			English	Article						cognition; fluid percussion injury; oxidative stress; physical exercise; spontaneous epileptiform events	CONTROLLED CORTICAL IMPACT; HEAT-SHOCK-PROTEIN; GLUTAMATE TRANSPORTERS; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; POSTTRAUMATIC EPILEPSY; VOLUNTARY EXERCISE; TIME-COURSE; MECHANISMS; ANTIOXIDANT	Throughout the world, traumatic brain injury (TBI) is one of the major causes of disability, which can include deficits in motor function and memory, as well as acquired epilepsy. Although some studies have shown the beneficial effects of physical exercise after TBI, the prophylactic effects are poorly understood. In the current study, we demonstrated that TBI induced by fluid percussion injury (FPI) in adult male Wistar rats caused early motor impairment (24 h), learning deficit (15 days), spontaneous epileptiform events (SEE), and hilar cell loss in the hippocampus (35 days) after TBI. The hippocampal alterations in the redox status, which were characterized by dichlorofluorescein diacetate oxidation and superoxide dismutase (SOD) activity inhibition, led to the impairment of protein function (Na+, K+-adenosine triphosphatase [ATPase] activity inhibition) and glutamate uptake inhibition 24 h after neuronal injury. The molecular adaptations elicited by previous swim training protected against the glutamate uptake inhibition, oxidative stress, and inhibition of selected targets for free radicals (e.g., Na+, K+-ATPase) 24 h after neuronal injury. Our data indicate that this protocol of exercise protected against FPI-induced motor impairment, learning deficits, and SEE. In addition, the enhancement of the hippocampal phosphorylated nuclear factor erythroid 2-related factor (P-Nrf2)/Nrf2, heat shock protein 70, and brain-derived neurotrophic factor immune content in the trained injured rats suggests that protein expression modulation associated with an antioxidant defense elicited by previous physical exercise can prevent toxicity induced by TBI, which is characterized by cell loss in the dentate gyrus hilus at 35 days after TBI. Therefore, this report suggests that previous physical exercise can decrease lesion progression in this model of brain damage.	[Fiorin, Fernando da Silva; de Oliveira Ferreira, Ana P.; Ribeiro, Leandro R.; Silva, Luiz F. A.; de Castro, Mauro R. T.; da Silva, Luis R. H.; da Silveira, Mauro E. P.; Fighera, Michele R.; Freire Royes, Luiz F.] Univ Fed Santa Maria, Lab Bioquim Exercicio, BR-97105900 Santa Maria, RS, Brazil; [Zemolin, Ana P. P.; Dobrachinski, Fernando; de Oliveira, Sara Marchesan; Franco, Jeferson L.; Soares, Felix A.; Fighera, Michele R.; Freire Royes, Luiz F.] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol, Bioquim Toxicol, BR-97105900 Santa Maria, RS, Brazil; [Furian, Ana F.; Oliveira, Mauro S.; Fighera, Michele R.; Freire Royes, Luiz F.] Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97105900 Santa Maria, RS, Brazil	Royes, LFF (corresponding author), Univ Fed Santa Maria, Dept Metodos & Tecn Desportivas, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Dobrachinski, Fernando/C-4316-2014; Franco, Jeferson Luis/F-7797-2012; Soares, Felix/AAE-6251-2020; Fighera, Michele R/J-9576-2014; da Silva Fiorin, Fernando/AAQ-9472-2021; Soares, Felix AA/K-7611-2012; Oliveira, Mauro Schneider/G-3437-2012	Dobrachinski, Fernando/0000-0002-3948-1273; Franco, Jeferson Luis/0000-0002-3874-8618; Soares, Felix/0000-0002-6453-7902; Soares, Felix AA/0000-0002-6453-7902; Oliveira, Mauro Schneider/0000-0002-5381-1208; Almeida Silva, Luiz Fernando/0000-0002-7621-4836; Ribeiro, Leandro/0000-0002-8442-4075; da Silva Fiorin, Fernando/0000-0002-6517-7160; oliveira, sara/0000-0003-2960-5284			Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; ALI SF, 1992, NEUROTOXICOLOGY, V13, P637; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ansari MN, 2008, INDIAN J EXP BIOL, V46, P521; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Asghar M, 2007, AM J PHYSIOL-RENAL, V293, pF914, DOI 10.1152/ajprenal.00272.2007; Ashman TA, 2006, MT SINAI J MED, V73, P999; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Chuang De-Maw, 2004, Critical Reviews in Neurobiology, V16, P83, DOI 10.1615/CritRevNeurobiol.v16.i12.90; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; de Oliveira CV, 2015, PHYSIOL BEHAV, V143, P142, DOI 10.1016/j.physbeh.2015.03.004; DeKosky ST, 2004, J NEUROTRAUM, V21, P491, DOI 10.1089/089771504774129838; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Fiske CH, 1925, J BIOL CHEM, V66, P375; Franco JL, 2010, TOXICOL SCI, V113, P150, DOI 10.1093/toxsci/kfp245; Frizzo MED, 2002, CELL MOL NEUROBIOL, V22, P353; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Gonzalez-Lima F, 2004, LEARN MEMORY, V11, P633, DOI 10.1101/lm.82404; Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; HALL ED, 1994, ANN NY ACAD SCI, V738, P15; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hong Y, 2010, J INT MED RES, V38, P1893, DOI 10.1177/147323001003800602; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; INIGUEZ C, 1985, J NEUROSCI METH, V13, P77, DOI 10.1016/0165-0270(85)90045-7; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Kelly S, 2002, ANN NEUROL, V52, P160, DOI 10.1002/ana.10264; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Liu X, 2010, NEUROSCI LETT, V476, P99, DOI 10.1016/j.neulet.2010.04.011; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marquezi ML, 2003, INT J SPORT NUTR EXE, V13, P65, DOI 10.1123/ijsnem.13.1.65; McColl E, 2003, QUAL LIFE RES, V12, P217; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meeusen R, 2014, SPORTS MED, V44, P47, DOI 10.1007/s40279-014-0150-5; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Packer L, 2007, FREE RADICAL RES, V41, P951, DOI 10.1080/10715760701490975; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Roach JT, 2004, BRAIN RES, V1015, P161, DOI 10.1016/j.brainres.2004.05.004; Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Scharfman HE, 2014, ADV EXP MED BIOL, V813, P133, DOI 10.1007/978-94-017-8914-1_11; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Szabo Z, 2010, BRAIN RES, V1341, P25, DOI 10.1016/j.brainres.2009.01.035; Toth Z, 1997, J NEUROSCI, V17, P8106; Trotti D, 1997, EUR J NEUROSCI, V9, P1236, DOI 10.1111/j.1460-9568.1997.tb01478.x; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	99	15	15	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1317	1330		10.1089/neu.2015.4068			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100004	26651029				2021-06-18	
J	Moen, KG; Vik, A; Olsen, A; Skandsen, T; Haberg, AK; Evensen, KAI; Eikenes, L				Moen, Kent Goran; Vik, Anne; Olsen, Alexander; Skandsen, Toril; Haberg, Asta Kristine; Evensen, Kari Anne I.; Eikenes, Live			Traumatic Axonal Injury: Relationships Between Lesions in the Early Phase and Diffusion Tensor Imaging Parameters in the Chronic Phase of Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain injuries; magnetic resonance imaging; diffusion magnetic resonance imaging; fractional anisotropy; longitudinal studies	CLOSED-HEAD INJURY; MR-IMAGES; INTRACEREBRAL HEMORRHAGE; CORPUS-CALLOSUM; MODERATE; MILD; MICROBLEEDS; DIAGNOSIS; SEVERITY; CLASSIFICATION	This prospective study of traumatic brain injury (TBI) patients investigates fractional anisotropy (FA) from chronic diffusion tensor imaging (DTI) in areas corresponding to persistent and transient traumatic axonal injury (TAI) lesions detected in clinical MRI from the early phase. Thirty-eight patients (mean 24.7 [range 13-63] years of age) with moderate-to-severe TBI and 42 age- and sex-matched healthy controls were included. Patients underwent 1.5-T clinical MRI in the early phase (median 7 days), including fluid-attenuated inversion recovery (FLAIR) and T2*gradient echo (T2*GRE) sequences. TAI lesions from the early phase were characterized as nonhemorrhagic or microhemorrhagic. In the chronic phase (median 3 years), patients and controls were imaged at 3 T with FLAIR, T2*GRE, T1, and DTI sequences. TAI lesions were classified as transient or persistent. The FLAIR/T2*GRE images from the early phase were linearly registered to the FA images from the chronic phase and lesions manually segmented on the FA-registered FLAIR/T2*GRE images. For regions of interest (ROIs) from both nonhemorrhagic and microhemorrhagic lesion, we found a significant linear trend of lower mean FA from ROIs in healthy controls to ROIs in patients without either nonhemorrhagic or microhemorrhagic lesions and further to transient and finally persistent lesion ROIs (P < 0.001). Histogram analyses showed lower FA in persistent compared with transient nonhemorrhagic lesion ROIs (P < 0.001), but this was not found in microhemorrhagic lesion ROIs (P = 0.08-0.55). The demonstrated linear trend of lower FA values from healthy controls to persistent lesion ROIs was found in both nonhemorrhagic and microhemorrhagic lesions and indicates a gradual increasing disruption of the microstructure. Lower FA values in persistent compared with transient lesions were found only in nonhemorrhagic lesions. Thus, clinical MRI techniques are able to depict important aspects of white matter pathology across the stages of TBI. (C) 2016 Wiley Periodicals, Inc.	[Moen, Kent Goran; Vik, Anne; Skandsen, Toril; Haberg, Asta Kristine] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Moen, Kent Goran] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Imaging, Trondheim, Norway; [Vik, Anne] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Olsen, Alexander; Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Olsen, Alexander; Haberg, Asta Kristine; Eikenes, Live] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway; [Evensen, Kari Anne I.] Trondheim Municipal, Dept Physiotherapy, Trondheim, Norway; [Moen, Kent Goran] Norwegian Univ Sci & Technol, Fac Med, Post Box 8905, N-7491 Trondheim, Norway	Moen, KG (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Post Box 8905, N-7491 Trondheim, Norway.	kent.g.moen@ntnu.no	Olsen, Alexander/P-5235-2019	Olsen, Alexander/0000-0001-8691-3860; Evensen, Kari Anne I./0000-0002-0129-0164	Central Norway Regional Health Authority; Norwegian University of Science and Technology Liaison Committee; Norwegian Research Council (MI Lab); National Center of Competence Services for Functional MRI, Department of Medical Imaging, Trondheim University Hospital	Contract grant sponsor: Central Norway Regional Health Authority and Norwegian University of Science and Technology Liaison Committee (to K.G.M., T.S.); Contract grant sponsor: Norwegian Research Council (MI Lab) (to A.O.); Contract grant sponsor: National Center of Competence Services for Functional MRI, Department of Medical Imaging, Trondheim University Hospital	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Asano Y, 2012, NEUROL MED-CHIR, V52, P31, DOI 10.2176/nmc.52.31; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Chung SW, 2012, J KOREAN NEUROSURG S, V52, P377, DOI 10.3340/jkns.2012.52.4.377; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Gasperini C, 2001, MULT SCLER, V7, P27, DOI 10.1177/135245850100700106; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Holland DJ, 2010, J MAGN RESON, V203, P236, DOI 10.1016/j.jmr.2010.01.001; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Scheid R, 2011, CEREBRAL MICROBLEEDS, P125; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Siegel S., 1988, NONPARAMETRIC STAT B; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Tatsumi S, 2008, CEREBROVASC DIS, V26, P142, DOI 10.1159/000139661; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Young VG, 2008, NEUROLOGY, V71, P804, DOI 10.1212/01.wnl.0000319691.50117.54	42	15	15	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL	2016	94	7					623	635		10.1002/jnr.23728			13	Neurosciences	Neurosciences & Neurology	DV9SC	WOS:000383280800002	26948154	Green Accepted			2021-06-18	
J	Eriksson, K; Forsgren, E; Hartelius, L; Saldert, C				Eriksson, Karin; Forsgren, Emma; Hartelius, Lena; Saldert, Charlotta			Communication partner training of enrolled nurses working in nursing homes with people with communication disorders caused by stroke or Parkinson's disease	DISABILITY AND REHABILITATION			English	Article						training; nurses; Parkinson's disease; functional communication; communication; Aphasia; partner	TRAUMATIC BRAIN-INJURY; CONVERSATION PARTNERS; SUPPORTED CONVERSATION; OLDER-PEOPLE; APHASIA; ADULTS; CARE; INDIVIDUALS; VOLUNTEERS; SPOUSES	Purpose: To evaluate the effect of a communication partner training programme directed to enrolled nurses working with people with communication disorders in nursing homes, using an individualised approach. Method: Five dyads consisting of a person with stroke-induced aphasia (n = 4) or Parkinson's disease (PD) (n = 1) living in different nursing homes and his/her enrolled nurse participated in the study, which had a replicated single-subject design with multiple baselines across individuals. The main element of the intervention was supervised analysis of video-recorded natural interaction in everyday nursing situations and the formulation of individual goals to change particular communicative strategies. Results: Outcome was measured via blinded assessments of filmed natural interaction obtained at baseline, intervention and follow-up and showed an increased use of the target communicative strategies. Subjective measures of goal attainment by the enrolled nurses were consistent with these results. Measures of perceived functional communication on behalf of the persons with communication disorders were mostly positive; four of five participants with communication disorders and two of five enrolled nurses reported improved functional communication after intervention. Conclusions: The use of an individualised communication partner training programme led to significant changes in natural interaction, which contributes importantly to a growing body of knowledge regarding communication partner training. Implications for rehabilitation Communication partner training can improve the communicative environment of people with communication disorders. For people with communication disorders who live in institutions, the main conversation partner is likely to be a professional caretaker. An individualised approach for communication partner training that focussed on specific communication patterns was successful in increasing the use of supportive strategies that enrolled nurses used in natural interaction with persons with communication disorders. The training also positively affected the perceived functional communication of the persons with communication disorders.	[Eriksson, Karin; Forsgren, Emma; Hartelius, Lena; Saldert, Charlotta] Univ Gothenburg, Div Speech & Language Pathol, Inst Neurosci & Physiol, Bldg 3,POB 452, SE-40530 Gothenburg, Sweden; [Eriksson, Karin; Forsgren, Emma; Hartelius, Lena; Saldert, Charlotta] Univ Gothenburg, Ctr Person Ctr Care GPCC, SE-40530 Gothenburg, Sweden	Eriksson, K (corresponding author), Univ Gothenburg, Div Speech & Language Pathol, Inst Neurosci & Physiol, Bldg 3,POB 452, SE-40530 Gothenburg, Sweden.	karin.eriksson@neuro.gu.se	Saldert, Charlotta/ABH-1746-2020	Saldert, Charlotta/0000-0001-8808-3610; Forsgren, Emma/0000-0002-2402-0909			Apt P., 2008, TOKEN TEST; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barker J, 2011, SINGLE-CASE RESEARCH METHODS IN SPORT AND EXERCISE PSYCHOLOGY, P1; Beeson PM, 2006, NEUROPSYCHOL REV, V16, P161, DOI 10.1007/s11065-006-9013-7; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bloch S, 2008, CLIN LINGUIST PHONET, V22, P974, DOI 10.1080/02699200802394831; Bryan K, 2002, AGING MENT HEALTH, V6, P248, DOI 10.1080/13607860220142495; Carlsson E, 2014, INT J LANG COMM DIS, V49, P722, DOI 10.1111/1460-6984.12106; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Davidson B, 2003, APHASIOLOGY, V17, P243, DOI 10.1080/729255457; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Eriksson K, 2014, J INTERACT RES COM D, V5, P245, DOI 10.1558/jircd.v5i2.245; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsgren E, 2016, INT J NURS STUD, V54, P112, DOI 10.1016/j.ijnurstu.2015.05.006; Forsgren E, 2013, LOGOP PHONIATR VOCO, V38, P82, DOI 10.3109/14015439.2012.731081; Fukkink R, 2011, EDUC PSYCHOL REV, V23, P45, DOI 10.1007/s10648-010-9144-5; Genereux S, 2004, APHASIOLOGY, V18, P1161, DOI 10.1080/02687030444000507; Gordon C, 2009, J ADV NURS, V65, P544, DOI 10.1111/j.1365-2648.2008.04917.x; Gottfries C G, 1997, Lakartidningen, V94, P1099; Hersh D, 2016, APHASIOLOGY, V30, P609, DOI 10.1080/02687038.2014.933520; Hickey EM, 2004, APHASIOLOGY, V18, P625, DOI 10.1080/02687030444000093; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hutchby I, 2008, CONVERSATION ANAL; Jensen LR, 2015, APHASIOLOGY, V29, P57, DOI 10.1080/02687038.2014.955708; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); KAGAN A, 1999, THESIS U TORONTO; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kiresuk T., 1994, GOAL ATTAINMENT SCAL; Kolb D., 2014, EXPERIENCE SOURCE LE; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; LOCK S, 2001, SUPPORTING PARTNERS; Long AF, 2008, CLIN REHABIL, V22, P1083, DOI 10.1177/0269215508090091; Long A, 2009, CLIN REHABIL, V23, P846, DOI 10.1177/0269215509336055; Lyon JG, 1997, APHASIOLOGY, V11, P693, DOI 10.1080/02687039708249416; McConachie H, 1997, EUR J DISORDER COMM, V32, P277; McGilton K, 2011, INT J OLDER PEOPLE N, V6, P13, DOI 10.1111/j.1748-3743.2010.00210.x; Nehring WM, 2009, SIMULAT GAMING, V40, P528, DOI 10.1177/1046878109332282; Purdy M, 2005, APHASIOLOGY, V19, P377, DOI 10.1080/02687030444000822; Rautakoski P, 2008, APHASIOLOGY, V22, P1269, DOI 10.1080/02687030802374788; Rayner H, 2003, INT J LANG COMM DIS, V38, P149, DOI 10.1080/1368282021000060308; RIPICH DN, 1995, GERIATR NURS, V16, P15, DOI 10.1016/S0197-4572(05)80073-4; Saldert C, 2013, APHASIOLOGY, V27, P271, DOI 10.1080/02687038.2012.710317; Schiavetti N, 1992, INTELLIGIBILITY SPEE, P11; Scruggs T. E., 2001, EXCEPTIONALITY, V9, P227, DOI [DOI 10.1207/S15327035EX0904_5, 10.1207/S15327035EX0904_5]; SHEWAN CM, 1984, J COMMUN DISORD, V17, P175, DOI 10.1016/0021-9924(84)90010-8; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Simmons-Mackie NN, 2007, APHASIOLOGY, V21, P39, DOI 10.1080/02687030600798287; Sorin-Peters R, 2014, APHASIOLOGY, V28, P731, DOI 10.1080/02687038.2014.891094; SORINPETERS R, 1995, APHASIOLOGY, V9, P565, DOI 10.1080/02687039508248715; Sundin K, 2003, J CLIN NURS, V12, P107, DOI 10.1046/j.1365-2702.2003.00676.x; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; Wadensten B, 2009, INT J OLDER PEOPLE N, V4, P203, DOI 10.1111/j.1748-3743.2009.00170.x; Wilkinson R, 2014, RES LANG SOC INTERAC, V47, P219, DOI 10.1080/08351813.2014.925659; Wilkinson R, 2010, J INTERACT RES COM D, V1, P45, DOI 10.1558/jircd.v1i1.45; Wood M, 2012, RANDOMIZATION TEST S; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	59	15	15	0	68	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUN 4	2016	38	12					1187	1203		10.3109/09638288.2015.1089952			17	Rehabilitation	Rehabilitation	DH5OT	WOS:000372840800008	26457882				2021-06-18	
J	Abdelmalik, PA; Boorman, DW; Tracy, J; Jallo, J; Rincon, F				Abdelmalik, Peter A.; Boorman, David W.; Tracy, Joseph; Jallo, Jack; Rincon, Fred			Acute Traumatic Coagulopathy Accompanying Isolated Traumatic Brain Injury is Associated with Worse Long-Term Functional and Cognitive Outcomes	NEUROCRITICAL CARE			English	Article						Coagulation; Trauma; Neuropsychology; Head injury	VERBAL-LEARNING TEST; DISSEMINATED INTRAVASCULAR COAGULATION; DISABILITY RATING-SCALE; FRESH-FROZEN PLASMA; EDITION CVLT-II; EXTRACRANIAL COMPLICATIONS; 2ND EDITION; HEAD-INJURY; DYSFUNCTION; DISORDERS	Approximately one-third of patients with isolated traumatic brain injury (iTBI) present with acute traumatic coagulopathy (ATC). ATC is associated with increased morbidity and mortality. Its effects on long-term functional and cognitive outcomes are not as well characterized. Data from the Citicoline Brain Injury Treatment Trial (COBRIT) were analyzed retrospectively. Exclusion criteria were renal failure or malignancy, and any extracranial injury severity score > 3. ATC was defined as INR > 1.3, PTT > 38 s, or platelets < 100 K, determined at baseline, and during the first 7 days of hospitalization. Six hundred forty-seven patients were included; 21 % were found to have ATC. Highest incidence occurred at baseline, and Day Two. Forty-two percent of ATC patients had a GCS < 8, compared with 11.3 % of non-ATC patients (p < 0.001). A significantly higher proportion of ATC patients was transfused blood products, required greater than 4L of fluids, demonstrated hyperthermia and hypothermia, were hypotensive and demonstrated elevated lactate when compared to non-ATC patients. In-hospital mortality, mean hospital length of stay, incidence of DVT and seizures were also significantly higher in ATC patients. A significantly lower portion of ATC patients had good outcomes on the GOS-E (i.e., score > 6), and the DRS (i.e., score < 2) at 180 days, for which ATC was found to be an independent predictor with binary logistic regression. ATC patients also performed significantly worse on several components of the CVLT-II at 180 days. ATC accompanying iTBI is associated with worse functional and cognitive outcomes at 180 days.	[Abdelmalik, Peter A.; Tracy, Joseph; Rincon, Fred] Thomas Jefferson Univ Hosp, Dept Neurol, 909 Walnut St,4th Floor COB Bldg, Philadelphia, PA 19107 USA; [Boorman, David W.; Jallo, Jack; Rincon, Fred] Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA 19107 USA	Abdelmalik, PA; Rincon, F (corresponding author), Thomas Jefferson Univ Hosp, Dept Neurol, 909 Walnut St,4th Floor COB Bldg, Philadelphia, PA 19107 USA.; Rincon, F (corresponding author), Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA 19107 USA.	peterabdelmalik@yahoo.com; fred.rincon@jefferson.edu		Boorman, David/0000-0002-5974-8692; Jallo, Jack/0000-0002-5512-1729; Rincon, Fred/0000-0002-8510-118X	American Heart Association (AHA)American Heart Association [12CRP12050342]; GenentechRoche HoldingGenentech [G-29902]; National Institute of Child Health and Human Development of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute Award [NICHD U01HD042823, U01HD042738, U01HD 042687, U01HD042736, U01HD042678, U01HD042686, U01H D042653, U01HD042689, U01HD042652]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042678, U01HD042736, U01HD042653, U01HD042738, U01HD042689, U01HD042823, U01HD042686, U01HD042687] Funding Source: NIH RePORTER	Drs. Abdelmalik, Tracy and Jallo, as well as Mr. Boorman, have no sources of funding to disclose. Dr. Rincon has received salary and research grant support from the American Heart Association (AHA 12CRP12050342) and Genentech (G-29902). Data used in this study was generated by the investigators in the Clinical Sites and Data Coordinating Center composing the NIH Collaborative Multicenter TBI Clinical Trials Network. This project was funded by the National Institute of Child Health and Human Development of the National Institutes of Health. COBRIT was supported in part by National Institute Award numbers NICHD U01HD042823, U01HD042738, U01HD 042687, U01HD042736, U01HD042678, U01HD042686, U01H D042653, U01HD042689, and U01HD042652, to eight clinical sites and a data coordinating center.	AUER L, 1978, ACTA NEUROCHIR, V43, P51, DOI 10.1007/BF01809225; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Elwood RW, 1995, NEUROPSYCHOL REV, V5, P173, DOI 10.1007/BF02214761; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Gardner RC, 2014, JAMA NEUROL, V94121, P1; Geerts W, 1994, MED NEW ENGL J; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jacobs ML, 2008, ARCH CLIN NEUROPSYCH, V23, P113, DOI 10.1016/j.acn.2007.09.003; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kemp CD, 2008, AM SURGEON, V74, P866; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; MCNAMARA JJ, 1972, ANN SURG, V176, P243, DOI 10.1097/00000658-197208000-00021; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pringsheim T, 2014, NEUROLOGY, V83, P1661, DOI 10.1212/WNL.0000000000000929; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schrieber M, 2007, J TRAUMA, V63, P1261; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Talving P, 2013, J TRAUMA ACUTE CARE, V75, P699, DOI 10.1097/TA.0b013e31829a2c19; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; WINTER JP, 1989, ANN EMERG MED, V18, P553, DOI 10.1016/S0196-0644(89)80842-X; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	51	15	17	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2016	24	3					361	370		10.1007/s12028-015-0191-0			10	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	DN2ZP	WOS:000376932100006	26293923				2021-06-18	
J	Abou-Abbass, H; Bahmad, H; Abou-El-Hassan, H; Zhu, R; Zhou, SY; Dong, X; Hamade, E; Mallah, K; Zebian, A; Ramadan, N; Mondello, S; Fares, J; Comair, Y; Atweh, S; Darwish, H; Zibara, K; Mechref, Y; Kobeissy, F				Abou-Abbass, Hussein; Bahmad, Hisham; Abou-El-Hassan, Hadi; Zhu, Rui; Zhou, Shiyue; Dong, Xue; Hamade, Eva; Mallah, Khalil; Zebian, Abir; Ramadan, Naify; Mondello, Stefania; Fares, Jawad; Comair, Youssef; Atweh, Samir; Darwish, Hala; Zibara, Kazem; Mechref, Yehia; Kobeissy, Firas			Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment	ELECTROPHORESIS			English	Article						Aspirin; Clopidogrel; Neuroproteomics; PTMs; TBI	MANNOSE-BINDING LECTIN; MASS-SPECTROMETRIC ANALYSIS; SOLID-PHASE PERMETHYLATION; SPINAL-CORD-INJURY; INTRACRANIAL HEMORRHAGE; CEREBRAL-ISCHEMIA; PROTEOMIC IDENTIFICATION; PLATELET DYSFUNCTION; ACETYLSALICYLIC-ACID; AUTOMATED ANNOTATION	As populations age, the number of patients sustaining traumatic brain injury (TBI) and concomitantly receiving preinjury antiplatelet therapy such as aspirin (ASA) and clopidogrel (CLOP) is rising. These drugs have been linked with unfavorable clinical outcomes following TBI, where the exact mechanism(s) involved are still unknown. In this novel work, we aimed to identify and compare the altered proteome profile imposed by ASA and CLOP when administered alone or in combination, prior to experimental TBI. Furthermore, we assessed differential glycosylation PTM patterns following experimental controlled cortical impact model of TBI, ASA, CLOP, and ASA + CLOP. Ipsilateral cortical brain tissues were harvested 48 h postinjury and were analyzed using an advanced neuroproteomics LC-MS/MS platform to assess proteomic and glycoproteins alterations. Of interest, differential proteins pertaining to each group (22 in TBI, 41 in TBI + ASA, 44 in TBI + CLOP, and 34 in TBI + ASA + CLOP) were revealed. Advanced bioinformatics/systems biology and clustering analyses were performed to evaluate biological networks and protein interaction maps illustrating molecular pathways involved in the experimental conditions. Results have indicated that proteins involved in neuroprotective cellular pathways were upregulated in the ASA and CLOP groups when given separately. However, ASA + CLOP administration revealed enrichment in biological pathways relevant to inflammation and proinjury mechanisms. Moreover, results showed differential upregulation of glycoproteins levels in the sialylated N-glycans PTMs that can be implicated in pathological changes. Omics data obtained have provided molecular insights of the underlying mechanisms that can be translated into clinical bedside settings.	[Abou-Abbass, Hussein; Zebian, Abir; Ramadan, Naify; Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon; [Abou-Abbass, Hussein; Bahmad, Hisham] Beirut Arab Univ, Fac Med, Beirut, Lebanon; [Bahmad, Hisham] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Beirut, Lebanon; [Abou-El-Hassan, Hadi; Fares, Jawad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Zhu, Rui; Zhou, Shiyue; Dong, Xue; Mechref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Hamade, Eva; Mallah, Khalil; Zibara, Kazem] Lebanese Univ, DSST, Lab Stem Cells ER045, Beirut, Lebanon; [Hamade, Eva; Mallah, Khalil; Zibara, Kazem] Lebanese Univ, Dept Biol, Fac Sci 1, Beirut, Lebanon; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Comair, Youssef] Lebanese Amer Univ, Div Neurosurg, Dept Surg, Beirut, Lebanon; [Atweh, Samir] Amer Univ Beirut, Dept Neurol, Fac Med, Beirut, Lebanon; [Darwish, Hala] Amer Univ Beirut, Fac Med, Sch Nursing, New York, NY USA	Kobeissy, F (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon.	firasko@gmail.com	Kobeissy, Firas/E-7042-2017; Mondello, Stefania/A-1813-2012; Bahmad, Hisham/A-5369-2019; Fares, Jawad/X-4341-2018; Mechref, Yehia/I-5126-2013	Kobeissy, Firas/0000-0002-5008-6944; Mondello, Stefania/0000-0002-8587-3614; Bahmad, Hisham/0000-0003-3799-2595; Fares, Jawad/0000-0002-5368-8764; Darwish, Hala/0000-0001-5744-6466; Mallah, Khalil/0000-0001-7622-8106; Zibara, Kazem/0000-0002-9887-072X; Ramadan, Naify/0000-0001-7339-0263; Hamade, Eva/0000-0001-5152-913X; Mechref, Yehia/0000-0002-6661-6073	National Council for Scientific Research (CNRS), LebanonCentre National de la Recherche Scientifique (CNRS); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01GM112490-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM112490] Funding Source: NIH RePORTER	This work was supported by the National Council for Scientific Research (CNRS), Lebanon, for the grant entitled "The Effect of Aspirin and Clopidogrel on Bleeding, platelet aggregation and Neuronal Damage after Moderate Brain Injury"; PI: Professor Samir Atweh, MD. This work was also partially supported by a grant from the NIH (5R01GM112490-02) for Professor Dr. Yehia Mechref. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2015, EXPERT REV MOL DIAGN, V15, P41, DOI 10.1586/14737159.2015.976557; Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Azcona L, 2012, J PHARM SCI-US, V101, P2821, DOI 10.1002/jps.23201; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Bonnet Agnes, 2009, BMC Proc, V3 Suppl 4, pS11, DOI 10.1186/1753-6561-3-S4-S11; Bruning RS, 2013, MED SCI SPORT EXER, V45, P674, DOI 10.1249/MSS.0b013e31827981dc; Chambers AG, 2015, MOL CELL PROTEOMICS, V14, P3094, DOI 10.1074/mcp.O115.049957; Chen LF, 2011, J NEUROSURG, V114, P1159, DOI 10.3171/2010.10.JNS10861; Daily D, 2001, J BIOL CHEM, V276, P21618, DOI 10.1074/jbc.M101400200; Daraselia N, 2012, AM J CANCER RES, V2, P93; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; De Cristobal J, 2001, J NEUROCHEM, V79, P456, DOI 10.1046/j.1471-4159.2001.00600.x; De la Cruz JP, 2003, N-S ARCH PHARMACOL, V367, P204, DOI 10.1007/s002100-002-0657-4; de la Rosa X, 2014, STROKE, V45, P1453, DOI 10.1161/STROKEAHA.113.004111; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fiebich BL, 2003, J NEUROCHEM, V86, P173, DOI 10.1046/j.1471-4159.2003.01822.x; Finamore F, 2015, J PROTEOMICS, V114, P125, DOI 10.1016/j.jprot.2014.11.005; Floyd CN, 2014, BRIT J CLIN PHARMACO, V78, P320, DOI 10.1111/bcp.12335; Fournier AE, 2003, J NEUROSCI, V23, P1416; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gavella M, 2013, ASIAN J ANDROL, V15, P375, DOI 10.1038/aja.2012.144; Gavella M, 2010, INT J ANDROL, V33, P536, DOI 10.1111/j.1365-2605.2009.00962.x; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; Hahl P, 2013, J NEUROCHEM, V125, P89, DOI 10.1111/jnc.12165; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/j.molcel.2004.10.026; Hashimoto Y, 2011, J PATHOL, V224, P289, DOI 10.1002/path.2894; HERBERT JM, 1993, ARTERIOSCLER THROMB, V13, P1171, DOI 10.1161/01.ATV.13.8.1171; Hopp S, 2015, NEURAL REGEN RES, V10, P885, DOI 10.4103/1673-5374.158339; Hu YL, 2015, RAPID COMMUN MASS SP, V29, P135, DOI 10.1002/rcm.7093; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; Iijima R, 2004, FEBS LETT, V561, P163, DOI 10.1016/S0014-5793(04)00164-4; Iijima R, 2009, CARBOHYD RES, V344, P933, DOI 10.1016/j.carres.2009.02.025; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Kang P, 2005, RAPID COMMUN MASS SP, V19, P3421, DOI 10.1002/rcm.2210; Kang P, 2008, RAPID COMMUN MASS SP, V22, P721, DOI 10.1002/rcm.3395; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khayyam N, 1999, NEUROREPORT, V10, P371, DOI 10.1097/00001756-199902050-00029; King MD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09223; Kizuka Yasuhiko, 2014, Adv Neurobiol, V9, P117, DOI 10.1007/978-1-4939-1154-7_6; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Lai C, 2015, MOL MED REP, V12, P1473, DOI 10.3892/mmr.2015.3545; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; Li CX, 2007, BRAIN RES, V1139, P201, DOI 10.1016/j.brainres.2006.12.039; Londono C, 2012, BIOMOLECULES, V2, P143, DOI 10.3390/biom2010143; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Martinez-Marquez A, 2013, J PROTEOME RES, V12, P5709, DOI 10.1021/pr4006712; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Modi KK, 2013, J BIOL CHEM, V288, P18533, DOI 10.1074/jbc.M112.447268; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Mori T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/jbc.M700770200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Papastefanaki F, 2015, GLIA, V63, P1101, DOI 10.1002/glia.22809; Patel BN, 2002, J NEUROSCI, V22, P6578; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Percy Andrew J, 2013, Methods Mol Biol, V1000, P167, DOI 10.1007/978-1-62703-405-0_13; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Pyatnitskiy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084955; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Sangkuhl K, 2010, PHARMACOGENET GENOM, V20, P463, DOI 10.1097/FPC.0b013e3283385420; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Schwarzer C, 2002, INT J BIOCHEM CELL B, V34, P1059, DOI 10.1016/S1357-2725(02)00026-2; Scornavacca G, 2012, J NEUROCHEM, V122, P1219, DOI 10.1111/j.1471-4159.2012.07874.x; Scott DW, 2013, AM J PHYSIOL-CELL PH, V305, pC228, DOI 10.1152/ajpcell.00116.2013; Shi Geng-Xian, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P114; Silajdzic E, 2013, J HUNTINGTONS DIS, V2, P125, DOI 10.3233/JHD-130049; SKAPER SD, 1989, EXP NEUROL, V106, P297, DOI 10.1016/0014-4886(89)90163-5; Sura P, 2008, FOLIA BIOL-KRAKOW, V56, P73, DOI 10.3409/fb56_1-2.73-75; Thaler HW, 2015, J NEUROSURG, V123, P1202, DOI 10.3171/2014.12.JNS142276; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Tsai TH, 2015, PROTEOMICS, V15, P2369, DOI 10.1002/pmic.201400364; Uslu E., 2002, TURKISH J TRAUMA EME, V8, P74; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Whitehead SN, 2007, STROKE, V38, P381, DOI 10.1161/01.STR.0000254464.05561.72; XU J, 1991, J NEUROCHEM, V57, P975, DOI 10.1111/j.1471-4159.1991.tb08246.x; Yang H, 2011, BIOCHEM BIOPH RES CO, V410, P114, DOI 10.1016/j.bbrc.2011.05.116; Yang WS, 2011, FREE RADICAL BIO MED, V50, P1242, DOI 10.1016/j.freeradbiomed.2011.02.005; Yin XH, 2006, J CELL BIOL, V172, P469, DOI 10.1083/jcb.200509174; Yu CY, 2013, BIOINFORMATICS, V29, P1706, DOI 10.1093/bioinformatics/btt190; Yu W, 2015, CLIN CHIM ACTA, V451, P111, DOI 10.1016/j.cca.2015.10.017; Yuryev A, 2009, EXPERT OPIN DRUG DIS, V4, P1307, DOI 10.1517/17460440903413488; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zhao X., 2011, CRTOPROTECTIVE ROLE	99	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	JUN	2016	37	11			SI		1562	1576		10.1002/elps.201500583			15	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	DQ3WT	WOS:000379135200018	27249377	Green Accepted			2021-06-18	
J	Bang, SA; Song, YS; Moon, BS; Lee, BC; Lee, HY; Kim, JM; Kim, SE				Bang, Seong Ae; Song, Yoo Sung; Moon, Byung Seok; Lee, Byung Chul; Lee, Ho-young; Kim, Jong-Min; Kim, Sang Eun			Neuropsychological, Metabolic, and GABA(A) Receptor Studies in Subjects with Repetitive Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain metabolism; GABA(A) receptor; neuropsychological evaluation; repetitive traumatic brain injury	POSITRON-EMISSION-TOMOGRAPHY; MOTOR COORDINATION; CORTICAL DAMAGE; BASAL GANGLIA; ENCEPHALOPATHY; SPORT; RISK; HYPOMETABOLISM; NEUROGENESIS; RELIABILITY	Repetitive traumatic brain injury (rTBI) occurs as a result of mild and accumulative brain damage. A prototype of rTBI is chronic traumatic encephalopathy (CTE), which is a degenerative disease that occurs in patients with histories of multiple concussions or head injuries. Boxers have been the most commonly studied patient group because they may experience thousands of subconcussive hits over the course of a career. This study examined the consequences of rTBI with structural brain imaging and biomolecular imaging and investigated whether the neuropsychological features of rTBI were related to the findings of the imaging studies. Five retired professional boxers (mean age, 46.8 +/- 3.19 years) and four age-matched controls (mean age, 48.5 +/- 3.32 years) were studied. Cognitive-motor related functional impairment was assessed, and all subjects underwent neuropsychological evaluation and behavioral tasks, as well as structural brain imaging and functional-molecular imaging. In neuropsychological tests, boxers showed deficits in delayed retrieval of visuospatial memory and motor coordination, which had a meaningful relationship with biomolecular imaging results indicative of neuronal injury. Morphometric abnormalities were not found in professional boxers by structural magnetic resonance imaging (MRI). Glucose metabolism was impaired in frontal areas associated with cognitive dysfunction, similar to findings in Alzheimer's disease. Low binding potential (BP) of F-18-flumazenil (FMZ) was found in the angular gyrus and temporal cortical regions, revealing neuronal deficits. These results suggested that cognitive impairment and motor dysfunction reflect chronic damage to neurons in professional boxers with rTBI.	[Bang, Seong Ae; Kim, Sang Eun] Seoul Natl Univ, Coll Med, Dept Neurosci, Seoul, South Korea; [Bang, Seong Ae; Song, Yoo Sung; Moon, Byung Seok; Lee, Byung Chul; Lee, Ho-young; Kim, Sang Eun] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Nucl Med, 300 Gumi Dong, Songnam 463707, South Korea; [Kim, Jong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Neurol, Songnam, South Korea; [Kim, Sang Eun] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Seoul, South Korea; [Lee, Byung Chul; Kim, Sang Eun] Adv Inst Convergence Technol, Ctr Nanomol Imaging & Innovat Drug Dev, Suwon, South Korea	Kim, SE (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Nucl Med, 300 Gumi Dong, Songnam 463707, South Korea.	kse@snu.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [HI14C1072]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2014M3C7A1046042]	This research was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1072) and the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning, Republic of Korea (NRF-2014M3C7A1046042).	Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BEAUVOIS MF, 1978, BRAIN, V101, P381, DOI 10.1093/brain/101.3.381; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brett M., 2002, NEUROIMAGE, V16, pS497, DOI 10.1016/S1053-8119(02)90010-8.; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; Claassen DO, 2013, NEUROPSYCHOLOGIA, V51, P267, DOI 10.1016/j.neuropsychologia.2012.09.018; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; DELFORGE J, 1995, J CEREBR BLOOD F MET, V15, P284, DOI 10.1038/jcbfm.1995.34; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Gardner A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00141; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 1998, STROKE, V29, P454, DOI 10.1161/01.STR.29.2.454; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Karchemskiy A, 2011, PSYCHIAT RES-NEUROIM, V194, P319, DOI 10.1016/j.pscychresns.2011.03.006; Kuroda S, 2004, J NUCL MED, V45, P943; Lalonde R, 2003, BEHAV GENET, V33, P59, DOI 10.1023/A:1021003600900; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moon BS, 2014, MOL IMAGING BIOL, V16, P619, DOI 10.1007/s11307-014-0738-z; Moon BS, 2011, ORG BIOMOL CHEM, V9, P8346, DOI 10.1039/c1ob06277h; Odano I, 2009, NEUROIMAGE, V45, P891, DOI 10.1016/j.neuroimage.2008.12.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Quadrato G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00017; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; ROSS RJ, 1987, CLIN SPORT MED, V6, P41; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Schiffmann SN, 1999, P NATL ACAD SCI USA, V96, P5257, DOI 10.1073/pnas.96.9.5257; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Siderowf A, 2002, MOVEMENT DISORD, V17, P758, DOI 10.1002/mds.10011; Sosa I, 2011, MED HYPOTHESES, V77, P633, DOI 10.1016/j.mehy.2011.07.002; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	56	15	15	1	24	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1005	1014		10.1089/neu.2015.4051			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600004	26414498				2021-06-18	
J	Couch, JR; Stewart, KE				Couch, James R.; Stewart, Kenneth E.			Headache Prevalence at 4-11 Years After Deployment-Related Traumatic Brain Injury in Veterans of Iraq and Afghanistan Wars and Comparison to Controls: A Matched Case-Controlled Study	HEADACHE			English	Article						traumatic brain injury; headache; chronic daily headache; migraine; veterans; tension-type headache	CHRONIC POSTTRAUMATIC HEADACHES; US SOLDIERS; MIGRAINE; CONCUSSION; PERSONNEL; SEVERITY; SYMPTOMS; BURDEN; RISK	ObjectiveEvaluate the extent and severity of headache following deployment-related TBI (D-TBI) in veterans of the Iraq (OIF) and Afghanistan (OEF) wars over a follow-up period of 4-11 years with comparison to age, sex, race, and time of deployment matched controls. BackgroundTBI has been recognized as the signature Injury of the OEF/OIF campaigns occurring in 14-20% of deployed soldiers. Currently, there are very few data on the longer term follow-up of soldiers with D-TBI. This study deals with prevalence and severity of headache and headache burden at 4-11 years following D-TBI for OEF/OIF veterans with comparison to controls without D-TBI. MethodsThis is a matched case controlled-study. All subjects were recruited from Operation New Dawn (OND), a voluntary program for OEF/OIF Veterans at the Oklahoma VAMC designed to assist with re-integrating into civilian life. On entry into OND a medical questionnaire was administered that included a brief screen for D-TBI, and those with a possible D-TBI were referred to a TBI clinic, For this study, the first 500 TBI clinic patients who were found to have had a D-TBI (TBIS) were matched by age, sex, race, and time of deployment to control subjects (CS), drawn from the 4411 OND program members with no D-TBI, creating a pool of 500 TBIS/CS pairs. From this pool, 55 pairs (11%) were randomly selected for this study. Data were collected from both TBIS and CS by telephone interview with questionnaires regarding the DTBI, headache, depression, and PTSD. TBI severity was measured by duration of loss of consciousness (LOC) as: [a] Very Mild (VMTBI, dazed only, no LOC), [b] Mild (MTBI, LOC 1-30 minutes), and [c] Moderate-Severe (MSTBI, LOC>30 minutes). Intensity for individual headaches was measured by disability produced by the headache as: [a] Disabling (must be in bed), [b] Severe (50-90% decrease in activity), or [c] Mild-Moderate (>50% of usual activity possible). Statistical analysis employed Fisher's exact test and odds ratio. ResultsThe 55 TBIS/CS pairs were segregated by severity of TBI for the TBIS. For the TBIS there were no significant differences among these three subgroups as to mechanism producing the TBI (blast injury or direct head trauma). Comparing TBIS vs CS for phenotypic classification of headaches, for TBIS - 89% had migraine, 2% probable migraine, 9% had tension, and 0% had no headaches, while for CS - 36% had migraine, 15% probable migraine, 27% tension, and 22% no headache (P<.0001). Migraine with aura occurred in 38% of TBIS and 6% of CS (P<.0001). As to headache frequency, for TBIS - chronic daily headache (CDH) occurred in 44%, frequent headache in 33%, and infrequent or no headache in 23%, while for CS - CDH occurred in 7%, frequent headache in 13%, and infrequent or no headache in 80% (P<.0001). For TBIS, 54% had severe or disabling headache 2 days/week as opposed to only 16% of CS (OR 6.13 [2.5-14.9]). As to onset of most severe and frequent headaches, this occurred shortly after TBI in 89% of TBIS while only 27% of CS reported most severe headaches starting during deployment. There was no correlation of severity of headache problem with severity of TBI. Comparing TBIS at 4-7 vs 8-11 years after injury, there was no difference in frequency or severity of headache between these groups. ConclusionsAt 4-11 years after D-TBI for TBIS, or after deployment for CS, the TBIS as compared to CS suffered much more frequent and severe headaches. For TBIS, there was no relation of headache intensity or phenotype to severity or cause of the TBI, and the Headache Burden has not improved over time up to 11 years after D-TBI. The process initiated by the D-TBI that relates to the headache has a prolonged effect up to and beyond 11 years.	[Couch, James R.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, 920 Stanton L Young Blvd,Suite 2040, Oklahoma City, OK 73104 USA; [Stewart, Kenneth E.] Univ Oklahoma, Hlth Sci Ctr, Sch Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK USA	Couch, JR (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, 920 Stanton L Young Blvd,Suite 2040, Oklahoma City, OK 73104 USA.	james-couch@ouhsc.edu			Education and Research Fund of the Oklahoma City Veterans Affairs Medical Center	This study was funded, in part, by the Education and Research Fund of the Oklahoma City Veterans Affairs Medical Center.	Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; Cartlidge NEF, 1981, HEAD INJURY, P95; Couch James R., 2003, Curr Treat Options Neurol, V5, P467, DOI 10.1007/s11940-996-0015-9; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Couch JR, 2011, HEADACHE, V51, P33, DOI 10.1111/j.1526-4610.2010.01800.x; COUCH JR, 1979, ARCH NEUROL-CHICAGO, V36, P695, DOI 10.1001/archneur.1979.00500470065013; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Couch JR, 2007, DRUG DEVELOP RES, V68, P1; Couch JR, 2004, HEADACHE, V44, P512; COUCH JR, 2012, HEADACHE, V52, P907; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Guttmann E, 1943, LANCET, V1, P10; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KAY DWK, 1971, LANCET, V2, P1052; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olesen J, 2013, CEPHALALGIA, V33, P627, DOI 10.1177/0333102413487610; RASKIN NH, 1987, HEADACHE, V27, P416, DOI 10.1111/j.1526-4610.1987.hed2708416.x; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTHERFORD WH, 1977, LANCET, V1, P1; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; SPEED WG, 1989, HEADACHE, V29, P643, DOI 10.1111/j.1526-4610.1989.hed2910643.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Streel S, 2015, REV NEUROL-FRANCE, V171, P707, DOI 10.1016/j.neurol.2015.04.009; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Welch KMA, 2001, HEADACHE, V41, P629, DOI 10.1046/j.1526-4610.2001.041007629.x; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x	52	15	15	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2016	56	6					1004	1021		10.1111/head.12837			18	Clinical Neurology	Neurosciences & Neurology	DQ4DO	WOS:000379154300009	27237921				2021-06-18	
J	Dhaliwal, SS; Sowerby, LJ; Rotenberg, BW				Dhaliwal, Sandeep S.; Sowerby, Leigh J.; Rotenberg, Brian W.			Timing of endoscopic surgical decompression in traumatic optic neuropathy: a systematic review of the literature	INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY			English	Article; Proceedings Paper	61st Annual Meeting of the American-Rhinologic-Society (ARS) during the Annual Meeting of the American-Academy-of-Otolaryngology-Head-and-Neck-Surgery-Foundation (AAO-HNS) / Annual Meeting of the American-Academy-of-Otolaryngic-Allergy	SEP 25-30, 2015	Dallas, TX	Amer Rhinol Soc, Amer Acad Otolaryngol Head & Neck Surg Fdn, Amer Acad Otolaryng Allergy		optic neuropathy; optic nerve injury; optic nerve decompression; surgical decompression; endoscopic sinus surgery	NERVE DECOMPRESSION; SURGERY	BackgroundTraumatic optic neuropathy (TON) represents a rare but devastating complication of closed head injuries. No accepted guidelines are available for medical and surgical management algorithms. A systematic review of the literature was performed to determine the optimal timing and candidacy for endoscopic surgical intervention. MethodsA systematic review of multiple databases was performed including Medline-Ovid, EMBASE, and PubMed. Data was extracted and patients stratified based on surgical delay from trauma (3 days, >3 days, 7 days, or >7 days) as well as preoperative and postoperative vision testing (no light perception [NLP]; light perception [LP]; hand motion [HM]; or finger counting [FC] or better). ResultsThe literature review identified 24 studies meeting inclusion criteria. In the group of patients receiving surgery 3 days after the antecedent event, 57% (105/183) had visual improvement, whereas in the >7-days group 51% (145/283) of patients improved. In those with NLP preoperatively, 41% (172/411) saw improvement, whereas those with LP (89%), HM (93%), or FC (85%) fared better. ConclusionThe literature suggests that surgical intervention for TON is indicated despite delayed presentation, and is a better choice than no intervention at all. Patients with complete blindness on presentation (NLP) tend to have a poorer surgical outcome.	[Dhaliwal, Sandeep S.; Sowerby, Leigh J.; Rotenberg, Brian W.] Western Univ, Dept Otolaryngol Head & Neck Surg, London, ON, Canada	Rotenberg, BW (corresponding author), St Josephs Hosp, Room B2-501,268 Grosvenor St, London, ON N6A 4V2, Canada.	brian.rotenberg@sjhc.london.on.ca					Chen C, 2006, OTOLARYNG HEAD NECK, V135, P155, DOI 10.1016/j.otohns.2005.03.056; Chen FH, 2014, N AM J MED SCI, V6, P270, DOI 10.4103/1947-2714.134372; Cook MW, 1996, ARCH OTOLARYNGOL, V122, P389; De Ganseman A, 2000, Acta Otorhinolaryngol Belg, V54, P175; Emanuelli E, 2015, EUR ARCH OTO-RHINO-L, V272, P3301, DOI 10.1007/s00405-014-3408-5; FUJITANI T, 1986, JPN J OPHTHALMOL, V30, P125; HAMEED AS, 2014, J EVIDENCE BASED MED, V1, P696; Horiguchi K, 2010, NEUROL MED-CHIR, V50, P518, DOI 10.2176/nmc.50.518; Jiang RS, 2001, RHINOLOGY, V39, P71; Kong DS, 2011, J CLIN NEUROSCI, V18, P1541, DOI 10.1016/j.jocn.2011.02.042; Kountakis SE, 2000, OTOLARYNG HEAD NECK, V123, P34, DOI 10.1067/mhn.2000.106007; Kountakis SE, 1997, OTOLARYNG HEAD NECK, V116, P652, DOI 10.1016/S0194-5998(97)70243-2; Krings JG, 2014, LARYNGOSCOPE, V124, P838, DOI 10.1002/lary.24401; Kuppersmith RB, 1997, LARYNGOSCOPE, V107, P311, DOI 10.1097/00005537-199703000-00006; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Li H, 2008, J LARYNGOL OTOL, V122, P1325, DOI 10.1017/S0022215108002296; Li HB, 2007, CLIN OTOLARYNGOL, V32, P447, DOI 10.1111/j.1749-4486.2007.01560.x; Luxenberger W, 1998, LARYNGOSCOPE, V108, P873, DOI 10.1097/00005537-199806000-00016; Mabuchi F, 2003, INVEST OPHTH VIS SCI, V44, P4321, DOI 10.1167/iovs.03-0138; Maurer J, 1999, EUR ARCH OTO-RHINO-L, V256, P341, DOI 10.1007/s004050050160; Mine S, 1999, ACTA NEUROCHIR, V141, P27, DOI 10.1007/s007010050262; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI [10.1186/2046-4053-4-1, 10.14306/renhyd.20.2.223]; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; NAYAK SR, 1991, J LARYNGOL OTOL, V105, P205, DOI 10.1017/S0022215100115361; Nazir SA, 2010, AM J OTOLARYNG, V31, P193, DOI 10.1016/j.amjoto.2008.11.015; Peng AQ, 2011, INT J PEDIATR OTORHI, V75, P992, DOI 10.1016/j.ijporl.2011.05.004; Rajiniganth MG, 2003, ARCH OTOLARYNGOL, V129, P1203, DOI 10.1001/archotol.129.11.1203; Ropposch T, 2013, LARYNGOSCOPE, V123, P1082, DOI 10.1002/lary.23845; SOFFERMAN RA, 1981, LARYNGOSCOPE, V91, P184; Song YX, 2013, ACTA OTO-LARYNGOL, V133, P1196, DOI 10.3109/00016489.2013.822556; Thakar A, 2003, LARYNGOSCOPE, V113, P112, DOI 10.1097/00005537-200301000-00021; Wang DH, 2008, ORL-J OTO-RHIN-LARYN, V70, P130, DOI 10.1159/000114537; Wu WC, 2011, OPHTHAL PLAST RECONS, V27, pE13, DOI 10.1097/IOP.0b013e3181dc8323; Xu R, 2014, ORL J OTO-RHINO-LARY, V76, P44, DOI 10.1159/000358305; Yang QT, 2012, J TRAUMA ACUTE CARE, V72, P1350, DOI 10.1097/TA.0b013e3182493c70; Yu-Wai-Man P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006032.pub2	36	15	17	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2042-6976	2042-6984		INT FORUM ALLERGY RH	Int. Forum Allergy Rhinol.	JUN	2016	6	6					661	667		10.1002/alr.21706			7	Otorhinolaryngology	Otorhinolaryngology	DR1YL	WOS:000379700700016	26782715				2021-06-18	
J	Kallet, RH; Branson, RD				Kallet, Richard H.; Branson, Richard D.			Should Oxygen Therapy Be Tightly Regulated to Minimize Hyperoxia in Critically Ill Patients?	RESPIRATORY CARE			English	Article; Proceedings Paper	54th Respiratory Care Journal Conference on Respiratory Care Controversies III	JUN 05-06, 2015	St Petersburg, FL			hyperoxia; hyperoxic acute lung injury; lung protective ventilation; oxygen toxicity; reactive oxygen species; ventilator-induced lung injury	ACUTE RESPIRATORY-DISTRESS; MECHANICALLY VENTILATED PATIENTS; INDUCED LUNG INJURY; OBSTRUCTIVE PULMONARY-DISEASE; TRAUMATIC BRAIN-INJURY; HIGH TIDAL VOLUME; ARTERIAL HYPEROXIA; OXIDATIVE STRESS; CARDIAC-ARREST; NORMOBARIC HYPEROXIA	Oxygen is both lifesaving and toxic. Appropriate use of oxygen aims to provide a balance between the two effects. Although local oxygen toxicity to the lung is well accepted, recent evidence has called into question the negative consequences of hyperoxemia in other organ beds. Hyperoxia following cardiac arrest, traumatic brain injury, and stroke has been shown to worsen outcomes. The role of hyperoxemia in mechanically ventilated patients, in the face of non-toxic inspired oxygen concentrations, is less clear. This paper will review the data for and against the use of conservative oxygen targets and the avoidance of hyperoxemia in mechanically ventilated patients. (C) 2016 Daedalus Enterprises	[Kallet, Richard H.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia, NH GA-2,1001 Potrero Ave, San Francisco, CA 94110 USA; [Branson, Richard D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA	Kallet, RH (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia, NH GA-2,1001 Potrero Ave, San Francisco, CA 94110 USA.		Branson, Richard/ABD-7229-2020; Branson, Richard/K-4567-2019	Branson, Richard/0000-0002-0912-3360; 			Abdelsalam M, 2010, RESP CARE, V55, P1483; Aboab J, 2006, INTENS CARE MED, V32, P1979, DOI 10.1007/s00134-006-0382-4; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Andrade PV, 2014, INFLAMMATION, V37, P486, DOI 10.1007/s10753-013-9762-4; ASHBAUGH DG, 1967, LANCET, V2, P319; Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; Bailey TC, 2003, J APPL PHYSIOL, V94, P975, DOI 10.1152/japplphysiol.00619.2002; Barbaro MPF, 2005, FREE RADICAL RES, V39, P1111, DOI 10.1080/10715760500250257; Bellani G, 2009, CRIT CARE MED, V37, P2216, DOI 10.1097/CCM.0b013e3181aab31f; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; BLAISDELL FW, 1970, SURG GYNECOL OBSTETR, V130, P15; Boissier F, 2013, INTENS CARE MED, V39, P1725, DOI 10.1007/s00134-013-2941-9; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Buczynski BW, 2013, SEMIN PERINATOL, V37, P69, DOI 10.1053/j.semperi.2013.01.002; Bull TM, 2010, AM J RESP CRIT CARE, V182, P1123, DOI 10.1164/rccm.201002-0250OC; Cameron L, 2012, POSTGRAD MED J, V88, P684, DOI 10.1136/postgradmedj-2012-130809; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Chiang CH, 2008, RESUSCITATION, V79, P147, DOI 10.1016/j.resuscitation.2008.02.028; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; CLARK JM, 1971, PHARMACOL REV, V23, P37; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; DAVIS JM, 1989, J APPL PHYSIOL, V67, P1007; de Graaff AE, 2011, INTENS CARE MED, V37, P46, DOI 10.1007/s00134-010-2025-z; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; DREYFUSS D, 1985, AM REV RESPIR DIS, V132, P880; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Eastwood G, 2012, INTENS CARE MED, V38, P91, DOI 10.1007/s00134-011-2419-6; Eastwood GM, 2016, RESUSCITATION, V101, P108, DOI 10.1016/j.resuscitation.2015.11.026; Eastwood GM, 2014, AUST CRIT CARE, V27, P120, DOI 10.1016/j.aucc.2013.11.004; Eastwood GM, 2014, CURR OPIN CRIT CARE, V20, P266, DOI 10.1097/MCC.0000000000000084; Ehlert CA, 2006, BIOL NEONATE, V90, P89, DOI 10.1159/000092005; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; FAIRLEY HB, 1964, CAN MED ASSOC J, V90, P1394; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FINCH CA, 1972, NEW ENGL J MED, V286, P407, DOI 10.1056/NEJM197202242860806; Fisher AO, 2012, PEDIATR PULM, V47, P979, DOI 10.1002/ppul.22517; Fisher AB, 2008, AM J PHYSIOL-LUNG C, V295, pL1066, DOI 10.1152/ajplung.90486.2008; Fluck M, 2007, INTEGR COMP BIOL, V47, P524, DOI 10.1093/icb/icm080; GANZ W, 1972, CIRCULATION, V45, P763, DOI 10.1161/01.CIR.45.4.763; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; Gattinoni L, 2010, CRIT CARE MED, V38, pS539, DOI 10.1097/CCM.0b013e3181f1fcf7; GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623; Hafner S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0084-6; Helmerhorst HJF, 2016, CRIT CARE MED, V44, P554, DOI 10.1097/CCM.0000000000001461; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1067-6; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0996-4; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; HESS ML, 1984, J MOL CELL CARDIOL, V16, P969, DOI 10.1016/S0022-2828(84)80011-5; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Hubmayr RD, 2012, AM J PHYSIOL-LUNG C, V302, pL1233, DOI 10.1152/ajplung.00121.2012; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kielan-Jaworowska Z, 2004, MAMMALS AGE DINOSAUR; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Kuipers MT, 2011, CRIT CARE, V15, DOI 10.1186/cc10437; LENFANT C, 1965, ANN NY ACAD SCI, V121, P797, DOI 10.1111/j.1749-6632.1965.tb14249.x; Leverve XM, 2008, CRIT CARE MED, V36, P637, DOI 10.1097/CCM.0B013E31816296AD; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; Linton R C, 1965, Can Anaesth Soc J, V12, P451; Liu YY, 2009, TRANSL RES, V154, P228, DOI 10.1016/j.trsl.2009.06.006; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; LUND T, 1984, CRIT CARE MED, V12, P75, DOI 10.1097/00003246-198401000-00020; Mak S, 2001, CHEST, V120, P467, DOI 10.1378/chest.120.2.467; Makena PS, 2011, J APPL PHYSIOL, V111, P1467, DOI 10.1152/japplphysiol.00539.2011; Makena PS, 2010, AM J PHYSIOL-LUNG C, V299, pL711, DOI 10.1152/ajplung.00072.2010; Malley WJ, 2005, CLIN BLOOD GASES ASS, P170; Martin DS, 2013, CRIT CARE MED, V41, P423, DOI 10.1097/CCM.0b013e31826a44f6; McNulty PH, 2005, AM J PHYSIOL-HEART C, V288, pH1057, DOI 10.1152/ajpheart.00625.2004; Meyhoff CS, 2012, CURR OPIN ANESTHESIO, V25, P363, DOI 10.1097/ACO.0b013e328352b402; Morita K, 2012, GEN THORAC CARDIOVAS, V60, P549, DOI 10.1007/s11748-012-0115-2; Nastos C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/906965; Nieuwenhuizen L, 2009, EUR J HAEMATOL, V82, P413, DOI 10.1111/j.1600-0609.2009.01238.x; Nitzan M, 2014, MED DEVICES-EVID RES, V7, P231, DOI 10.2147/MDER.S47319; Panwar R, 2016, AM J RESP CRIT CARE, V193, P43, DOI 10.1164/rccm.201505-1019OC; PETTY TL, 1971, ANN INTERN MED, V75, P361, DOI 10.7326/0003-4819-75-3-361; Pilcher J, 2012, RESUSCITATION, V83, P417, DOI 10.1016/j.resuscitation.2011.12.021; Pontoppidan H, 1967, JAMA, V201, P89, DOI 10.1001/jama.201.1.89; PONTOPPIDAN H, 1972, NEW ENGL J MED, V287, P690, DOI 10.1056/NEJM197210052871404; POWERS SR, 1972, J TRAUM, V12, P1, DOI 10.1097/00005373-197201000-00001; PRATT PC, 1958, AM J PATHOL, V34, P1033; Quinn DA, 2002, J APPL PHYSIOL, V93, P517, DOI 10.1152/japplphysiol.00570.2001; Rachmale S, 2012, RESP CARE, V57, P1887, DOI 10.4187/respcare.01696; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Roan E, 2012, AM J PHYSIOL-LUNG C, V302, pL1235, DOI 10.1152/ajplung.00223.2011; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rousseau A, 2005, ACTA PHYSIOL SCAND, V183, P231, DOI 10.1111/j.1365-201X.2005.01405.x; Sandroni C, 2014, MINERVA ANESTESIOL, V80, P1105; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; Severinghaus J W, 1986, J Clin Monit, V2, P125, DOI 10.1007/BF01637680; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Suzuki S, 2015, J CRIT CARE, V30, P1232, DOI 10.1016/j.jcrc.2015.07.033; Suzuki S, 2014, CRIT CARE MED, V42, P1414, DOI 10.1097/CCM.0000000000000219; Tao F, 2003, FREE RADICAL BIO MED, V35, P327, DOI 10.1016/S0891-5849(03)00280-6; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Tiwari YV, 2016, BRAIN RES, V1635, P121, DOI 10.1016/j.brainres.2016.01.030; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720; Wang CH, 2014, RESUSCITATION, V85, P1142, DOI 10.1016/j.resuscitation.2014.05.021; Wang Y, 2015, NEUROREPORT, V26, P131, DOI 10.1097/WNR.0000000000000314; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; West JB, 2012, RESP PHYSL ESSENTIAL, P80; Wu O, 2012, J CEREBR BLOOD F MET, V32, P1800, DOI 10.1038/jcbfm.2012.87; Zangl Q, 2014, ANESTHESIOLOGY, V121, P1217, DOI 10.1097/ALN.0000000000000447; Zhao S, 2015, CRIT CARE MED, V43, pE560, DOI 10.1097/CCM.0000000000001297	113	15	16	0	7	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	JUN	2016	61	6			SI		801	815		10.4187/respcare.04933			15	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	DN7CU	WOS:000377233700014	27235315	Bronze			2021-06-18	
J	Tobinick, EL				Tobinick, Edward Lewis			Perispinal Delivery of CNS Drugs	CNS DRUGS			English	Article							NECROSIS-FACTOR-ALPHA; TRANSFORAMINAL EPIDURAL ETANERCEPT; DYSFUNCTION SCIENTIFIC RATIONALE; VERTEBRAL VENOUS PLEXUS; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; TNF-ALPHA; SUBARACHNOID HEMORRHAGE; NEUROLOGICAL RECOVERY; TARGETED ETANERCEPT	Perispinal injection is a novel emerging method of drug delivery to the central nervous system (CNS). Physiological barriers prevent macromolecules from efficiently penetrating into the CNS after systemic administration. Perispinal injection is designed to use the cerebrospinal venous system (CSVS) to enhance delivery of drugs to the CNS. It delivers a substance into the anatomic area posterior to the ligamentum flavum, an anatomic region drained by the external vertebral venous plexus (EVVP), a division of the CSVS. Blood within the EVVP communicates with the deeper venous plexuses of the CSVS. The anatomical basis for this method originates in the detailed studies of the CSVS published in 1819 by the French anatomist Gilbert Breschet. By the turn of the century, Breschet's findings were nearly forgotten, until rediscovered by American anatomist Oscar Batson in 1940. Batson confirmed the unique, linear, bidirectional and retrograde flow of blood between the spinal and cerebral divisions of the CSVS, made possible by the absence of venous valves. Recently, additional supporting evidence was discovered in the publications of American neurologist Corning. Analysis suggests that Corning's famous first use of cocaine for spinal anesthesia in 1885 was in fact based on Breschet's anatomical findings, and accomplished by perispinal injection. The therapeutic potential of perispinal injection for CNS disorders is highlighted by the rapid neurological improvement in patients with otherwise intractable neuroinflammatory disorders that may ensue following perispinal etanercept administration. Perispinal delivery merits intense investigation as a new method of enhanced delivery of macromolecules to the CNS and related structures.	[Tobinick, Edward Lewis] Inst Neurol Recovery, 2300 Glades Rd,Suite 305E, Boca Raton, FL 33431 USA	Tobinick, EL (corresponding author), Inst Neurol Recovery, 2300 Glades Rd,Suite 305E, Boca Raton, FL 33431 USA.	nrimed@gmail.com		Tobinick, Edward/0000-0001-7614-499X			ANDERSON R, 1951, J NEUROSURG, V8, P411, DOI 10.3171/jns.1951.8.4.0411; Andral M, 1845, DISCOURS PRONONCES O; [Anonymous], 1886, VA MED MONTH, V12, P713; [Anonymous], 2008, NAT CLIN PRACT NEURO, V4, P181; Arango-Davila CA, 2015, INT J NEUROSCI, V125, P936, DOI 10.3109/00207454.2014.980906; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; Barami K, 2016, CHILD NERV SYST, V32, P599, DOI 10.1007/s00381-015-3010-1; Bassi E, 2010, AM J CLIN DERMATOL, V11, P44, DOI 10.2165/1153423-S0-000000000-00000; Batson OV, 1940, ANN SURG, V112, P138, DOI 10.1097/00000658-194007000-00016; BATSON OV, 1957, AMER J ROENTGENOL RA, V78, P195; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Biceroglu H, 2012, J NEUROSURG-SPINE, V16, P394, DOI 10.3171/2011.12.SPINE11108; Bier A., 1899, DTSCH Z CHIRURGIE, V51, P361; Boivin N, 2013, ANTIVIR RES, V100, P649, DOI 10.1016/j.antiviral.2013.10.007; Breschet G, 1819, THESIS; Breschet G., 1829, RECHERCHES ANATOMIQU; Breschet M, 1845, LANCET, V2, P188; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; Brown DL, 1998, NEURAL BLOCKADE CLIN, P3; Byrod G, 2000, J PERIPHER NERV SYST, V5, P218, DOI 10.1046/j.1529-8027.2000.00023.x; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Clark I, 2012, CNS DRUGS, V26, P1071, DOI 10.1007/s40263-012-0014-1; Clark IA, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/358263; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Clausen BH, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0203-6; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Corning JL, 1894, PAIN ITS NEUROPATHOL; Corning JL, 1886, BOSTON MED SURG J, V115, P541; Corning JL, 1885, NY MED J, V42, P483; Corning JL, 1886, LOCAL ANAESTHESIA GE; Corning JL, 1897, REFERENCE BOOK PRACT; Corning JL, 1885, NY MED J, V42, P317; Corning JL, 1888, T MED SOC STATE N Y, P260; Corning JL, 1888, MED REC, V33, P291; Corning Sr JL, 1898, RECOLLECTIONS LIFE; COUSINS MJ, 1984, ANESTHESIOLOGY, V61, P276; Cruveilhier J, 1844, ANATOMY HUMAN BODY 1; EPSTEIN HM, 1970, ANESTHESIOLOGY, V32, P332, DOI 10.1097/00000542-197004000-00007; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Feng P, 2015, BRAIN BEHAV IMMUN, V49, P32, DOI 10.1016/j.bbi.2015.04.001; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Freeman BJC, 2013, SPINE, V38, P1986, DOI 10.1097/01.brs.0000435140.61593.4c; Freud S, 1884, CENTRALBLATT GESMATE, V2, P289; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Gray H, 1878, ANATOMY DESCRIPTIVE; Gray H, 1858, ANATOMY DESCRIPTIVE; Greig NH, 1995, NEW CONCEPTS OF A BLOOD-BRAIN BARRIER, P251; Griessenauer CJ, 2015, CLIN ANAT, V28, P75, DOI 10.1002/ca.22354; Griffin WST, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-3; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; HERLIHY W F, 1947, Med J Aust, V1, P661; Huard P, 2008, COMPLETE DICT SCI BI; Ignatowski TA, 2014, CNS DRUGS, V28, P1207, DOI 10.1007/s40263-014-0212-0; Ignatowski TA, 2014, CNS DRUGS, V28, P679, DOI 10.1007/s40263-014-0174-2; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Iwata N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/189292; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johanson CE, 2005, PHARM RES-DORDR, V22, P1011, DOI 10.1007/s11095-005-6039-0; Koller C, 1884, LANCET, V124, P990, DOI 10.1016/S0140-6736(02)28859-5; KOTANI J, 1993, J NEUROSURG ANESTH, V5, P121; Lei BL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-103; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Luo C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.63; Marchand F, 2009, EUR J PAIN, V13, P673, DOI 10.1016/j.ejpain.2008.08.001; Marcus L, 1900, MED REC, V58, P561; MAX MB, 1985, CLIN PHARMACOL THER, V38, P631, DOI 10.1038/clpt.1985.237; Moes P, 1981, Arch Anat Histol Embryol, V64, P5; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Nathoo N, 2011, NEUROSURGERY, V69, P1007, DOI 10.1227/NEU.0b013e3182274865; Netter FH, 2013, NETTER COLLECTION ME, V7, P54; Ohtori S, 2012, SPINE, V37, P439, DOI 10.1097/BRS.0b013e318238af83; Parkinson D, 2000, SURG NEUROL, V54, P422, DOI 10.1016/S0090-3019(00)00342-6; Parkinson D, 2000, NEUROSURG FOCUS, V8; Perez-Polo JR, 2016, J NEUROSCI RES, V94, P27, DOI 10.1002/jnr.23617; Puri AS, 2013, J NEUROINTERV SURG; Quain J, 1878, QUAINS ELEMENTS ANAT, VII; Quain J, 1867, ELEMENTS ANATOMY; RIESELBACH RE, 1962, NEW ENGL J MED, V267, P1273, DOI 10.1056/NEJM196212202672502; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; Rubenstein JL, 2003, BLOOD, V101, P466, DOI 10.1182/blood-2002-06-1636; Sainoh T, 2016, PAIN MED, V17, P40, DOI 10.1111/pme.12892; Shen CH, 2011, ANESTH ANALG, V112, P454, DOI 10.1213/ANE.0b013e3182025b15; Shi XL, 2013, CRIT CARE, V17, DOI 10.1186/cc13171; Siniscalchi A, 2016, CURR VASC PHARMACOL, V14, P98, DOI 10.2174/1570161113666150923111329; Siniscalchi Antonio, 2014, Journal of Basic and Clinical Physiology and Pharmacology, V25, P131, DOI 10.1515/jbcpp-2013-0121; Standring S., 2016, GRAYS ANATOMY ANATOM; Stringer MD, 2012, CLIN ANAT, V25, P609, DOI 10.1002/ca.21281; Strong C, 2013, J CLIN NEUROSCI, V20, P1546, DOI 10.1016/j.jocn.2013.02.014; Tobinick E, 2004, CURR MED RES OPIN, V20, P1075, DOI 10.1185/030079903125004286; Tobinick E, 2002, US patent, Patent No. [6,419,944, 6419944]; Tobinick E, 2007, CURR ALZHEIMER RES, V4, P550, DOI 10.2174/156720507783018217; Tobinick Edward, 2006, MedGenMed, V8, P25; Tobinick Edward, 2006, MedGenMed, V8, P53; Tobinick E, 2014, CLIN DRUG INVEST, V34, P361, DOI 10.1007/s40261-014-0186-1; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tobinick E, 2012, CURR ALZHEIMER RES, V9, P99, DOI 10.2174/156720512799015073; Tobinick E, 2011, CNS DRUGS, V25, P145, DOI 10.2165/11588400-000000000-00000; Tobinick E, 2010, EXPERT REV NEUROTHER, V10, P985, DOI 10.1586/ERN.10.52; Tobinick E, 2009, CNS DRUGS, V23, P713, DOI 10.2165/11310810-000000000-00000; Tobinick Edward, 2008, Medscape J Med, V10, P135; Tobinick E, 2009, DRUG DISCOV TODAY, V14, P168, DOI 10.1016/j.drudis.2008.10.005; Tobinick EL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-27; Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2; Tobinick Edward L, 2009, BMC Res Notes, V2, P28; Tobinick EL, 2003, CLIN THER, V25, P2279, DOI 10.1016/S0149-2918(03)80219-9; Tobinick EL, 2003, SWISS MED WKLY, V133, P170; Tobinick EL, 2003, CLIN THER, V25, P1211, DOI 10.1016/S0149-2918(03)80077-2; Todd RB, 1852, CYCLOPEDIA ANATOMY P; Todd RB, 1847, CYCLOPAEDIA ANATOMY; Tsutsumi S, 2015, J ANAT, V227, P297, DOI 10.1111/joa.12349; Tubbs RS, 2007, CLIN ANAT, V20, P755, DOI 10.1002/ca.20494; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Vallejo MC, 2006, ANESTH ANALG, V102, P973, DOI 10.1213/01.ANE.0000199174.30944.B4; Wallace M, 2000, REGION ANESTH PAIN M, V25, P117; Watanabe K, 2011, EUR SPINE J, V20, P1877, DOI 10.1007/s00586-011-1854-y; WEN TS, 1994, J APPL PHYSIOL, V77, P1081; Winkelstein BA, 2014, INTERVERTEBRAL DISC; Wu MH, 2015, MOL NEUROBIOL, DOI [10.1007/s12035-105-9418-5, DOI 10.1007/S12035-105-9418-5]; Wulf HFW, 1998, ANESTHESIOLOGY, V89, P500, DOI 10.1097/00000542-199808000-00028; Wyeth JA, 1902, N Y STATE J MED, V2, P17; Yagi K, 2015, STROKE, V46, P2260, DOI 10.1161/STROKEAHA.114.006365; Ye J, 2014, J INFECT DIS, V210, P875, DOI 10.1093/infdis/jiu179; Zhang BF, 2015, NEUROCHEM RES, V40, P591, DOI 10.1007/s11064-014-1506-9	127	15	15	0	6	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1172-7047	1179-1934		CNS DRUGS	CNS Drugs	JUN	2016	30	6					469	480		10.1007/s40263-016-0339-2			12	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	DQ8TW	WOS:000379485000001	27120182	Green Published			2021-06-18	
J	Weimer, JM; Nowacki, AS; Frontera, JA				Weimer, Jonathan M.; Nowacki, Amy S.; Frontera, Jennifer A.			Withdrawal of Life-Sustaining Therapy in Patients With Intracranial Hemorrhage: Self-Fulfilling Prophecy or Accurate Prediction of Outcome?	CRITICAL CARE MEDICINE			English	Article						intracranial hemorrhage; palliative care; withdrawal of life-sustaining therapy	SPONTANEOUS INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; SUBARACHNOID HEMORRHAGE; ISCHEMIC-STROKE; RECOVERY; SCALE; MORTALITY; SUPPORT; IMPACT	Objectives: Withdrawal of life-sustaining therapy may lead to premature limitations of life-saving treatments among patients with intracranial hemorrhage, representing a self-fulfilling prophecy. We aimed to determine whether our algorithm for the withdrawal of life-sustaining therapy decision would accurately identify patients with a high probability of poor outcome, despite aggressive treatment. Design: Retrospective analysis of prospectively collected data. Setting: Tertiary-care Neuro-ICU. Patients: Intraparenchymal, subdural, and subarachnoid hemorrhage patients. Interventions: Baseline demographics, clinical status, and hospital course were assessed to determine the predictors of in-hospital mortality and 12-month death/severe disability among patients receiving maximal therapy. Multivariable logistic regression models developed on maximal therapy patients were applied to patients who underwent withdrawal of life-sustaining therapy to predict their probable outcome had they continued maximal treatment. A validation cohort of propensity score-matched patients was identified from the maximal therapy cohort, and their predicted and actual outcomes compared. Measurements and Main Results: Of 383 patients enrolled, there were 128 subarachnoid hemorrhage (33.4%), 134 subdural hematoma (35.0%), and 121 intraparenchymal hemorrhage (31.6%). Twenty-six patients (6.8%) underwent withdrawal of life-sustaining therapy and died, 41 (10.7%) continued maximal therapy and died in hospital, and 316 (82.5%) continued maximal therapy and survived to discharge. The median predicted probability of in-hospital death among withdrawal of life-sustaining therapy patients was 35% had they continued maximal therapy, whereas the median predicted probability of 12-month death/severe disability was 98%. In the propensity-matched validation cohort, 16 of 20 patients had greater than or equal to 80% predicted probability of death/severe disability at 12 months, matching the observed outcomes and supporting the strength and validity of our prediction models. Conclusions: The withdrawal of life-sustaining therapy decision may contribute to premature in-hospital death in some patients who may otherwise have been expected to survive to discharge. However, based on probability models, nearly all of the patients who underwent withdrawal of life-sustaining therapy would have died or remained severely disabled at 12 months had maximal therapy been continued. Withdrawal of life-sustaining therapy may not represent a self-fulfilling prophecy.	[Weimer, Jonathan M.; Frontera, Jennifer A.] Cleveland Clin, Neurol Inst, Ctr Cardiovasc, Lerner Coll Med, Cleveland, OH 44106 USA; [Nowacki, Amy S.] Cleveland Clin, Quantitat Hlth Sci Dept, Cleveland, OH 44106 USA	Frontera, JA (corresponding author), Cleveland Clin, Neurol Inst, Ctr Cardiovasc, Lerner Coll Med, Cleveland, OH 44106 USA.	frontej@ccf.org	Viani, Rafael/V-1196-2018				Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Brizzi M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-36; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Christakis Nicholas A., 1999, DEATH FORETOLD; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Frontera JA, 2011, NEUROCRIT CARE, V14, P260, DOI 10.1007/s12028-010-9418-2; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Hankey GJ, 2007, NEUROLOGY, V68, P1583, DOI 10.1212/01.wnl.0000260967.77422.97; HARTLEY C, 1995, BRIT J NEUROSURG, V9, P179, DOI 10.1080/02688699550041520; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Jain A, 2013, NEUROCRIT CARE, V19, P342, DOI 10.1007/s12028-013-9878-2; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kong KH, 2014, NEUROREHABILITATION, V35, P221, DOI 10.3233/NRE-141110; Kowalski RG, 2013, NEUROCRIT CARE, V19, P269, DOI 10.1007/s12028-013-9929-8; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Naidech AM, 2009, NEUROCRIT CARE, V11, P45, DOI 10.1007/s12028-009-9186-z; Qureshi AI, 2014, WORLD NEUROSURG, V82, pE579, DOI 10.1016/j.wneu.2014.07.008; Rost NS, 2008, STROKE, V39, P2304, DOI 10.1161/STROKEAHA.107.512202; Scheunemann LP, 2012, AM J RESP CRIT CARE, V186, P480, DOI 10.1164/rccm.201204-0710CP; TEASDALE G, 1974, LANCET, V2, P81; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Varelas PN, 2009, J NEUROSURG, V111, P396, DOI 10.3171/2009.3.JNS08493; Varelas PN, 2008, SEMIN NEUROL, V28, P726, DOI 10.1055/s-0028-1105969; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Wijdicks EFM, 2004, CRIT CARE MED, V32, P2332, DOI 10.1097/01.CCM.0000145949.34618.E1; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72	35	15	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2016	44	6					1161	1172		10.1097/CCM.0000000000001570			12	Critical Care Medicine	General & Internal Medicine	DL9EK	WOS:000375944200045	26807687				2021-06-18	
J	Huang, H; Li, RH; Yuan, JX; Zhou, X; Liu, X; Ott, S; Xu, T; Chen, YM				Huang, Hao; Li, Ruohan; Yuan, Jinxian; Zhou, Xin; Liu, Xi; Ott, Shu; Xu, Tao; Chen, Yangmei			Up-regulated ephrinB3/EphB3 expression in intractable temporal lobe epilepsy patients and pilocarpine induced experimental epilepsy rat model	BRAIN RESEARCH			English	Article						EphrinB3; EphB3; Temporal lobe epilepsy; Pilocarpine; Synaptogenesis; Synaptic plasticity	TRAUMATIC BRAIN-INJURY; SYNAPTIC FUNCTIONS; EPH RECEPTORS; CNS INJURY; FAMILY; EPHRIN-B3; SYNAPSES; SEIZURE; DEATH; CELLS	EphB family receptor tyrosine kinases, in cooperation with cell surface-bound ephrinB ligands, play a critical role in maintenance of dendritic spine morphogenesis, axons guidance, synaptogenesis, synaptic reorganization and plasticity in the central nervous system (CNS). However, the expression pattern of ephrinB/EphB in intractable temporal lobe epilepsy (TLE) and the underlying molecular mechanisms during epileptogenesis remain poorly understood. Here we investigated the expression pattern and cellular distribution of ephrinB/EphB in intractable TLE patients and lithium chloride-pilocarpine induced TLE rats using real-time quantitative polymerase chain reaction (RT-qPCR), immunohistochemistry, double-labeled immunofluorescence and Western blot analysis. Compared to control groups, ephrinB3 and EphB3 mRNA expression were significantly up regulated in intractable TLE patients and TLE rats, while the mRNA expression trend of ephrinB1/2 and EphB1/2/4/6 in intractable TLE patients and TLE rats were inconsistent. Western blot analysis and semi-quantitative immunohistochemistry confirmed that ephrinB3 and EphB3 protein level were up-regulated in intractable TLE patients and TLE rats. At the same time, double-labeled immunofluorescence indicate that ephrinB3 was expressed mainly in the cytoplasm and protrusions of glia and neurons, while EphB3 was expressed mainly in the cytoplasm of neurons. Taken together, up-regulated expression of ephrinB3/EphB3 in intractable TLE patients and experimental TLE rats suggested that ephrinB3/EphB3 might be involved in the pathogenesis of TLE. (C) 2016 Elsevier B.V. All rights reserved.	[Huang, Hao; Li, Ruohan; Yuan, Jinxian; Zhou, Xin; Liu, Xi; Ott, Shu; Xu, Tao; Chen, Yangmei] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China	Chen, YM (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China.	chenym1997@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171225, 81571259]	This work was supported by a grant from the National Natural Science Foundation of China (Nos. 81171225 and 81571259). The authors sincerely thank the Xinqiao Hospital of The Third Military Medical University for supplying the brain tissues used in this study, the patients and their families for their participation in this study, and the National Board of the Medical Affairs and the local ethics committee.	Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Arisi GM, 2007, BRAIN RES, V1165, P126, DOI 10.1016/j.brainres.2007.06.037; Bellot A, 2014, BRAIN RES, V1573, P1, DOI 10.1016/j.brainres.2014.05.024; Bharucha NE, 1997, EPILEPSIA, V38, P614; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; ENGEL J, 1995, EPILEPSIA, V36, pS23; Flanagan JG, 1997, CELL, V90, P403; Gardiner J, 2010, NEUROSCIENTIST, V16, P28, DOI 10.1177/1073858409334422; Gauthier LR, 2003, LIFE SCI, V74, P207, DOI 10.1016/j.lfs.2003.09.029; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Hruska M, 2015, NAT NEUROSCI, V18, P1594, DOI 10.1038/nn.4140; Huang H, 2015, INT J CLIN EXP PATHO, V8, P12708; Huang H, 2015, INT J CLIN EXP MED, V8, P625; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Liu X, 2006, J NEUROSCI, V26, P3087, DOI 10.1523/JNEUROSCI.4797-05.2006; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sloniowski S, 2012, SEMIN CELL DEV BIOL, V23, P75, DOI 10.1016/j.semcdb.2011.10.020; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Wang L, 2008, BRAIN RES, V1241, P157, DOI 10.1016/j.brainres.2008.07.097; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003	36	15	15	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2016	1639						1	12		10.1016/j.brainres.2016.02.035			12	Neurosciences	Neurosciences & Neurology	DP4DW	WOS:000378447400001	26930615				2021-06-18	
J	Bouvier, D; Duret, T; Rouzaire, P; Jabaudon, M; Rouzaire, M; Nourrisson, C; Bourgne, C; Pereira, B; Evrard, B; Sapin, V				Bouvier, Damien; Duret, Thomas; Rouzaire, Paul; Jabaudon, Matthieu; Rouzaire, Marion; Nourrisson, Celine; Bourgne, Celine; Pereira, Bruno; Evrard, Bertrand; Sapin, Vincent			Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						children; lymphocyte; pregnancy; reference ranges; S100B	MINOR HEAD-INJURY; REFERENCE RANGES; PROTEIN; SERUM; S-100B; BLOOD; DELIVERY	Background: Traumatic brain injury management is a tricky issue in children and pregnant women (due to adverse effects of computer tomography). To facilitate management, we report the main analytical performances and reference ranges for blood tests for the well-established S100B biomarker in under-16 children on a DiaSorin (R) Liaison XL analyzer and in pregnant women on DiaSorin (R) Liaison XL and Roche Diagnostics (R) Cobas e411 analyzers. Methods: Serum S100B concentrations were determined by chemiluminescent immunoassay on a DiaSorin (R) analyzer in a population of 409 healthy children aged 0-16 years and on DiaSorin (R)/Roche Diagnostics (R) instruments in a population of 50 pregnant women (one blood sample for each trimester). The analytical performances of both instruments and the influence of blood cells and skin pigmentation on the assay were also studied. Results: For children, four age-groups emerged, i.e. 0-3 months (mean: 0.97 mu g/L; standard deviation (SD): 0.36; 95th percentile: 1.55), 4-9 months (mean: 0.58 mu g/L; SD: 0.30; 95th: 1.18), 10-24 months (mean: 0.31 mu g/L; SD: 0.12; 95th: 0.54) and 2-16 years (mean: 0.20 mu g/L; SD: 0.07; 95th: 0.32). For pregnant women, serum S100B concentrations were similar to defined ranges for adults and not significantly different between trimesters on DiaSorin (R) (p = 0.652)/Roche Diagnostics (R) (p = 0.877) analyzers. We also found S100B expression (protein, total mRNA) in lymphocytes, an influence of skin pigmentation, and good analytical performances for both instruments. Conclusions: Data provided here is useful for interpreting serum S100B test results, in terms of preanalytical conditions, analytical performances, pediatric and pregnancy' environment.	[Sapin, Vincent] Fac Med, Lab Biochim Med, 4R3,28 Pl Henri Dunant,BP38, F-63001 Clermont Ferrand, France; [Bouvier, Damien; Duret, Thomas; Sapin, Vincent] CHU Clermont Ferrand, Biochem & Mol Biol Dept, Clermont Ferrand, France; [Bouvier, Damien; Jabaudon, Matthieu; Rouzaire, Marion; Sapin, Vincent] Univ Auvergne, Clermont Univ, EA7281, Retinoids,Reprod,Dev Dis,Fac Med, Clermont Ferrand, France; [Rouzaire, Paul; Evrard, Bertrand] CHU Clermont Ferrand, Dept Immunol, Clermont Ferrand, France; [Nourrisson, Celine] CHU Clermont Ferrand, Parasitol & Mycol Dept, Clermont Ferrand, France; [Bourgne, Celine] CHU Clermont Ferrand, Hematol Biol Dept, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Biostat Dept DRCI, Clermont Ferrand, France	Sapin, V (corresponding author), Fac Med, Lab Biochim Med, 4R3,28 Pl Henri Dunant,BP38, F-63001 Clermont Ferrand, France.; Sapin, V (corresponding author), CHU Clermont Ferrand, Biochem & Mol Biol Dept, Clermont Ferrand, France.; Sapin, V (corresponding author), Univ Auvergne, Clermont Univ, EA7281, Retinoids,Reprod,Dev Dis,Fac Med, Clermont Ferrand, France.	vincent.sapin@udamail.fr	Nourrisson, Celine/AAC-1527-2019	Nourrisson, Celine/0000-0002-4003-805X; Bouvier, Damien/0000-0002-2707-4320; Pereira, Bruno/0000-0003-3778-7161			Amer-Wahlin I, 2001, CLIN CHIM ACTA, V304, P57, DOI 10.1016/S0009-8981(00)00408-3; Beaudeux JL, 2000, CLIN CHEM, V46, P989; Beaudeux JL, 1999, ANN BIOL CLIN-PARIS, V57, P261; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; De Santis Marco, 2007, Birth Defects Research, V81, P177, DOI 10.1002/bdrc.20099; Feriel J, 2015, CLIN CHEM LAB MED, V53, pE169, DOI 10.1515/cclm-2014-1090; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Jennen-Steinmetz C, 2014, STAT MED, V33, P1336, DOI 10.1002/sim.6024; Klajnbard A, 2010, CLIN CHEM LAB MED, V48, P237, DOI 10.1515/CCLM.2010.033; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Michetti F, 2003, CLIN CHIM ACTA, V335, P1, DOI 10.1016/S0009-8981(03)00243-2; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; Ogungbenro K, 2008, EUR J CLIN PHARMACOL, V64, P705, DOI 10.1007/s00228-008-0493-7; Portela LVC, 2002, CLIN CHEM, V48, P950; Remontet L, 1999, ARCH PEDIATRIE, V6, P520, DOI 10.1016/S0929-693X(99)80558-2; Sannia A, 2011, CLIN CHIM ACTA, V412, P1337, DOI 10.1016/j.cca.2011.03.034; Schulpis KH, 2006, SCAND J CLIN LAB INV, V66, P733, DOI 10.1080/00365510600977737; Steiner J, 2011, BRAIN BEHAV IMMUN, V25, P1233, DOI 10.1016/j.bbi.2011.03.015; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vendittelli F, 2001, J Gynecol Obstet Biol Reprod (Paris), V30, P51; Zimmer DB, 2013, CELL CALCIUM, V53, P170, DOI 10.1016/j.ceca.2012.11.006	25	15	15	0	3	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	MAY	2016	54	5					833	842		10.1515/cclm-2015-0771			10	Medical Laboratory Technology	Medical Laboratory Technology	DK5WE	WOS:000374991000024	26479347				2021-06-18	
J	Burns, TC; Awad, AJ; Li, MD; Grant, GA				Burns, Terry C.; Awad, Ahmed J.; Li, Matthew D.; Grant, Gerald A.			Radiation-induced brain injury: low-hanging fruit for neuroregeneration	NEUROSURGICAL FOCUS			English	Article						radiation; brain injury; neuroregeneration; oligodendrocyte progenitor cell; transplantation; myelination; neurogenesis	OLIGODENDROCYTE PROGENITOR CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT HIPPOCAMPAL NEUROGENESIS; MESENCHYMAL STEM-CELLS; SYNAPTIC PLASTICITY; IN-VIVO; GENE-EXPRESSION; MOUSE MODELS; IRRADIATION; TRANSPLANTATION	Brain radiation is a fundamental tool in neurooncology to improve local tumor control, but it leads to profound and progressive impairments in cognitive function. Increased attention to quality of life in neurooncology has accelerated efforts to understand and ameliorate radiation-induced cognitive sequelae. Such progress has coincided with a new understanding of the role of CNS progenitor cell populations in normal cognition and in their potential utility for the treatment of neurological diseases. The irradiated brain exhibits a host of biochemical and cellular derangements, including loss of endogenous neurogenesis, demyelination, and ablation of endogenous oligodendrocyte progenitor cells. These changes, in combination with a state of chronic neuroinflammation, underlie impairments in memory, attention, executive function, and acquisition of motor and language skills. Animal models of radiation-induced brain injury have demonstrated a robust capacity of both neural stem cells and oligodendrocyte progenitor cells to restore cognitive function after brain irradiation, likely through a combination of cell replacement and trophic effects. Oligodendrocyte progenitor cells exhibit a remarkable capacity to migrate, integrate, and functionally remyelinate damaged white matter tracts in a variety of preclinical models. The authors here critically address the opportunities and challenges in translating regenerative cell therapies from rodents to humans. Although valiant attempts to translate neuroprotective therapies in recent decades have almost uniformly failed, the authors make the case that harnessing human radiation-induced brain injury as a scientific tool represents a unique opportunity to both successfully translate a neuroregenerative therapy and to acquire tools to facilitate future restorative therapies for human traumatic and degenerative diseases of the central nervous system.	[Burns, Terry C.; Grant, Gerald A.] Stanford Univ, Dept Neurosurg, 300 Pasteur Dr, Stanford, CA 94305 USA; [Burns, Terry C.; Grant, Gerald A.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Awad, Ahmed J.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Awad, Ahmed J.] An Najah Natl Univ, Fac Med & Hlth Sci, Nablus, Palestine; [Li, Matthew D.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Burns, TC (corresponding author), Stanford Univ, Dept Neurosurg, 300 Pasteur Dr, Stanford, CA 94305 USA.	tcburns@stanford.edu		Terry, Burns/0000-0001-7633-3045	California Institute of Regenerative MedicineCalifornia Institute for Regenerative Medicine	Dr. Burns has received research funding from the California Institute of Regenerative Medicine, which had no direct role in the research design or preparation of this manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Acharya MM, 2011, CANCER RES, V71, P4834, DOI 10.1158/0008-5472.CAN-11-0027; Acharya MM, 2009, P NATL ACAD SCI USA, V106, P19150, DOI 10.1073/pnas.0909293106; Bellinzona M, 1996, NEUROSCI LETT, V208, P163, DOI 10.1016/0304-3940(96)12572-6; Bergles DE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020453; Blakemore WF, 2008, J NEUROL SCI, V265, P43, DOI 10.1016/j.jns.2007.08.004; Brown PD, 2013, NEURO-ONCOLOGY, V15, P1429, DOI 10.1093/neuonc/not114; Brown PD, 2015, J CLIN ONCOL S, V33, pLBA4; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; Burns TC, 2015, EUR J PHARMACOL, V759, P90, DOI 10.1016/j.ejphar.2015.03.041; Burns TC, 2015, EUR J PHARMACOL, V759, P101, DOI 10.1016/j.ejphar.2015.03.021; Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Coderre JA, 2006, RADIAT RES, V166, P495, DOI 10.1667/RR3597.1; Combs SE, 2013, ACTA ONCOL, V52, P147, DOI 10.3109/0284186X.2012.692882; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Doucette T, 2011, NEOPLASIA, V13, P716, DOI 10.1593/neo.101680; Eaton ML, 2015, CURR TOP BEHAV NEURO, V19, P297, DOI 10.1007/7854_2014_337; Franklin RJM, 1996, EXP NEUROL, V137, P263, DOI 10.1006/exnr.1996.0025; FRANKLIN RJM, 1995, GLIA, V13, P39, DOI 10.1002/glia.440130105; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gondi V, 2014, J CLIN ONCOL, V32, P3810, DOI 10.1200/JCO.2014.57.2909; Greene-Schloesser D, 2012, NEURO-ONCOLOGY, V14, P37, DOI 10.1093/neuonc/nos196; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Han Ruolan, 2008, J Biol, V7, P12, DOI 10.1186/jbiol69; Higgins SC, 2015, ANTICANCER RES, V35, P77; Hinks GL, 2001, NEUROPATH APPL NEURO, V27, P59, DOI 10.1046/j.0305-1846.2001.00303.x; HONG JH, 1995, INT J RADIAT ONCOL, V33, P619, DOI 10.1016/0360-3016(95)00279-8; Hyrien O, 2010, CANCER RES, V70, P10051, DOI 10.1158/0008-5472.CAN-10-1400; Irvine KA, 2007, EUR J NEUROSCI, V25, P417, DOI 10.1111/j.1460-9568.2007.05313.x; Ishii A, 2009, P NATL ACAD SCI USA, V106, P14605, DOI 10.1073/pnas.0905936106; Ji JF, 2014, STEM CELL TRANSL MED, V3, P356, DOI 10.5966/sctm.2013-0135; Kempf SJ, 2015, J PROTEOME RES, V14, P4674, DOI 10.1021/acs.jproteome.5b00564; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Kohutek ZA, 2015, J NEURO-ONCOL, V125, P149, DOI 10.1007/s11060-015-1881-3; Leach JK, 2001, CANCER RES, V61, P3894; Lee WH, 2010, INT J RADIAT BIOL, V86, P132, DOI 10.3109/09553000903419346; Leoni G, 2014, J ANAT, V224, P216, DOI 10.1111/joa.12141; Leten C, 2014, STEM CELLS, V32, P2833, DOI 10.1002/stem.1819; Li MD, 2015, GLIA, V63, P754, DOI 10.1002/glia.22782; Li Q, 2014, CLIN CANCER RES, V20, P2375, DOI 10.1158/1078-0432.CCR-13-1415; Nigro A, 2012, J MOL CELL BIOL, V4, P423, DOI 10.1093/jmcb/mjs046; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; Machida M, 2010, RADIAT RES, V174, P618, DOI 10.1667/RR1988.1; Madany M, 2015, ADV EXP MED BIOL, V853, P139, DOI 10.1007/978-3-319-16537-0_8; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Merchant TE, 2014, INT J RADIAT ONCOL, V90, P554, DOI 10.1016/j.ijrobp.2014.06.058; Merchant TE, 2009, J CLIN ONCOL, V27, P3691, DOI 10.1200/JCO.2008.21.2738; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Meyers CA, 2000, INT J RADIAT ONCOL, V46, P51, DOI 10.1016/S0360-3016(99)00376-4; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Niranjan A, 2007, J NEUROSURG, V107, P383, DOI 10.3171/JNS-07/08/0383; Okada S, 2001, NEUROPATHOLOGY, V21, P247, DOI 10.1046/j.1440-1789.2001.00408.x; Oluich LJ, 2012, J NEUROSCI, V32, P8317, DOI 10.1523/JNEUROSCI.1053-12.2012; Pan WY, 2015, CLIN CHEM, V61, P514, DOI 10.1373/clinchem.2014.235457; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Penderis J, 2003, BRAIN, V126, P1382, DOI 10.1093/brain/awg126; Piao JH, 2015, CELL STEM CELL, V16, P198, DOI 10.1016/j.stem.2015.01.004; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Purger D., 2015, NEUROPHARMACOLOGY; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rapp SR, 2015, J CLIN ONCOL, V33, P1653, DOI 10.1200/JCO.2014.58.4508; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Scott CT, 2014, STEM CELL TRANSL MED, V3, P1398, DOI 10.5966/sctm.2014-0147; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Silver DJ, 2016, NEURO-ONCOLOGY, V18, P153, DOI 10.1093/neuonc/nov157; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423; Stock K, 2012, NAT MED, V18, P1232, DOI 10.1038/nm.2827; Sypecka J, 2014, MOL NEUROBIOL, V49, P685, DOI 10.1007/s12035-013-8549-9; Szerlip N, 2011, J NEURO-ONCOL, V103, P111, DOI 10.1007/s11060-010-0358-7; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; Vlkolinsky R, 2008, RADIAT RES, V169, P523, DOI 10.1667/RR1228.1; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wang YX, 2015, P NATL ACAD SCI USA, V112, P9704, DOI 10.1073/pnas.1511694112; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Wong-Goodrich SJE, 2010, CANCER RES, V70, P9329, DOI 10.1158/0008-5472.CAN-10-1854; Xu LY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0087-0; YAMAGUCHI N, 1991, J NEUROSURG, V74, P625, DOI 10.3171/jns.1991.74.4.0625; Yazlovitskaya EM, 2006, CANCER RES, V66, P11179, DOI 10.1158/0008-5472.CAN-06-2740; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Zachrisson O, 2011, J PARKINSON DIS, V1, P49, DOI 10.3233/JPD-2011-0003; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	99	15	16	0	12	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2016	40	5							E3	10.3171/2016.2.FOCUS161			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DK7PX	WOS:000375119300002	27132524	Bronze			2021-06-18	
J	Calhoun, PS; Schry, AR; Wagner, HR; Kimbrel, NA; Dennis, P; McDonald, SD; Beckham, JC; Dedert, EA; Kudler, H; Straits-Troster, K				Calhoun, Patrick S.; Schry, Amie R.; Wagner, H. Ryan; Kimbrel, Nathan A.; Dennis, Paul; McDonald, Scott D.; Beckham, Jean C.; Dedert, Eric A.; Kudler, Harold; Straits-Troster, Kristy			The prevalence of binge drinking and receipt of provider drinking advice among US veterans with military service in Iraq or Afghanistan	AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE			English	Article						Afghanistan; binge drinking; Iraq; provider advice; PTSD; veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PRIMARY-CARE; ALCOHOL-USE; COMBAT DEPLOYMENT; OEF/OIF VETERANS; PHYSICAL HEALTH; COLLEGE ALCOHOL; NATIONAL-SURVEY	Background: Binge drinking is a significant public health concern linked to a number of health and psychosocial problems. Military service in Afghanistan (OEF) and Iraq (OIF) has been associated with posttraumatic stress disorder (PTSD) and increased hazardous drinking. Brief alcohol interventions may reduce hazardous drinking but are infrequently provided to at-risk drinkers. Objectives: This study examined the association of combat exposure, PTSD symptoms, binge drinking, use of VA and non-VA healthcare services, and the incidence of provider drinking advice. Methods: OEF/OIF veterans (n=1087) completed measures of demographics, military history, combat exposure, PTSD symptoms, and binge drinking as part of a confidential mail survey study conducted in 2009 and 2010 (response rate=29%). Patient report of receiving advice in the past year from a provider about their drinking was queried for frequent binge drinkers. The association of demographic variables, combat exposure, PTSD, and use of healthcare services with binge drinking and receipt of provider drinking advice was estimated using logistic regression. Results: Overall, 51% of the sample reported at least one episode of binge drinking in the past year and 19% were identified as frequent binge drinkers. PTSD was related to frequent binge drinking. At-risk veterans using VA healthcare services were significantly more likely to receive provider drinking advice (50%) than veterans not using VA (13.4%). Conclusions: There is a need for increased vigilance and action to identify and counsel at-risk veterans about alcohol misuse in this population.	[Calhoun, Patrick S.; Schry, Amie R.; Wagner, H. Ryan; Kimbrel, Nathan A.; McDonald, Scott D.; Beckham, Jean C.; Dedert, Eric A.; Kudler, Harold; Straits-Troster, Kristy] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Calhoun, Patrick S.; Schry, Amie R.; Wagner, H. Ryan; Kimbrel, Nathan A.; Dennis, Paul; Beckham, Jean C.; Dedert, Eric A.; Kudler, Harold] Durham VA Med Ctr, Durham, NC USA; [Calhoun, Patrick S.; Schry, Amie R.; Wagner, H. Ryan; Kimbrel, Nathan A.; Dennis, Paul; Beckham, Jean C.; Dedert, Eric A.; Kudler, Harold; Straits-Troster, Kristy] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Calhoun, Patrick S.; Dennis, Paul] Ctr Hlth Serv Res Primary Care, Durham, NC USA; [McDonald, Scott D.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [McDonald, Scott D.] Virginia Commonwealth Univ, Dept Psychol & Phys Med & Rehabil, Richmond, VA USA; [Straits-Troster, Kristy] Phoenix VA Healthcare Syst, Phoenix, AZ USA	Calhoun, PS (corresponding author), Mental Illness Res Educ & Clin Ctr, Bldg 16 DVAMC,508 Fulton St, Durham, NC 27705 USA.	Patrick.Calhoun2@med.va.gov	Kimbrel, Nathan/P-3109-2016	Kimbrel, Nathan/0000-0001-7218-1005	VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center; Clinical Science Research and Development Service of the VA Office of Research and Development [IK2 CX000525, 1IK2CX000718]; VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; Durham VA Medical CenterUS Department of Veterans Affairs; Department of Veterans Affairs, Rehabilitation Research and Development Career Development Award-2 [1IK2RX000703-01]; Veterans AffairsUS Department of Veterans Affairs [IK6BX003777, IK2CX000525, IK2CX000718] Funding Source: NIH RePORTER	This work was supported by the VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center. This work was also supported by a Career Development Award-2 to Dr. Kimbrel (IK2 CX000525) and Dr. Dedert (1IK2CX000718) and a Research Career Scientist Award to Dr. Beckham from the Clinical Science Research and Development Service of the VA Office of Research and Development. Dr. Schry's contributions were also supported by the VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment and the Durham VA Medical Center. Work on this article was also supported by a Department of Veterans Affairs, Rehabilitation Research and Development Career Development Award-2 to Dr. McDonald (1IK2RX000703-01).	Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Bradley KA, 2002, J GEN INTERN MED, V17, P315; Bradley KA, 2006, AM J MANAG CARE, V12, P597; Bradley KA, 2011, J GEN INTERN MED, V26, P299, DOI 10.1007/s11606-010-1509-4; Bradley Katharine A, 2007, Subst Abus, V28, P133, DOI 10.1300/J465v28n04_05; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; Burnett-Zeigler I, 2011, ADDICT BEHAV, V36, P801, DOI 10.1016/j.addbeh.2010.12.032; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Calhoun PS, 2008, J CLIN PSYCHIAT, V69, P1686, DOI 10.4088/JCP.v69n1103; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Crawford EF, 2013, DRUG ALCOHOL DEPEN, V132, P101, DOI 10.1016/j.drugalcdep.2013.01.012; D'Amico EJ, 2005, MED CARE, V43, P229, DOI 10.1097/00005650-200503000-00005; Dillman D.A., 2000, MAIL INTERNET SURVEY; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Fleming MF, 1997, ALCOHOL HEALTH RES W, V21, P340; Garnick DW, 2002, AM J MANAG CARE, V8, P879; Grossbard JR, 2013, J SUBST ABUSE TREAT, V45, P409, DOI 10.1016/j.jsat.2013.04.007; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Heltemes KJ, 2011, MIL MED, V176, P132, DOI 10.7205/MILMED-D-09-00238; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hooper R, 2008, ADDICT BEHAV, V33, P1067, DOI 10.1016/j.addbeh.2008.03.010; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Keller S, 2007, ADDICT BEHAV, V32, P505, DOI 10.1016/j.addbeh.2006.05.017; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lapham GT, 2012, MED CARE, V50, P179, DOI 10.1097/MLR.0b013e3181e35743; LIN IF, 1995, PUBLIC OPIN QUART, V59, P236, DOI 10.1086/269471; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Maddock JE, 2001, ADDICT BEHAV, V26, P385, DOI 10.1016/S0306-4603(00)00116-7; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mukamal KJ, 2005, CIRCULATION, V112, P3839, DOI 10.1161/CIRCULATIONAHA.105.574749; Murray RP, 2002, AM J EPIDEMIOL, V155, P242, DOI 10.1093/aje/155.3.242; National Institute on Alcohol Abuse and Alcoholism, DRINK LEV DEF; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Rose HL, 2008, ADDICTION, V103, P1271, DOI 10.1111/j.1360-0443.2008.02199.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Voogt R.J.J., 1998, ACTA POLIT, V33, P250; Weathers F. W., 1993, INT SOC TRAUM STRESS; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Wood MD, 2000, J STUD ALCOHOL, V61, P278, DOI 10.15288/jsa.2000.61.278	55	15	15	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0095-2990	1097-9891		AM J DRUG ALCOHOL AB	Am. J. Drug Alcohol Abuse	MAY	2016	42	3					269	278		10.3109/00952990.2015.1051185			10	Psychology, Clinical; Substance Abuse	Psychology; Substance Abuse	DN5FB	WOS:000377090800004	26154366	Green Accepted			2021-06-18	
J	Chan, V; Mollayeva, T; Ottenbacher, KJ; Colantonio, A				Chan, Vincy; Mollayeva, Tatyana; Ottenbacher, Kenneth J.; Colantonio, Angela			Sex-Specific Predictors of Inpatient Rehabilitation Outcomes After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							GENDER-DIFFERENCES; OLDER-ADULTS; MODERATE; NEUROTRAUMA; DISCHARGE; SYMPTOMS; ONTARIO; WORK; MEN; AGE	Objective: To identify sex-specific predictors of inpatient rehabilitation outcomes among patients with a traumatic brain injury (TBI) from a population-based perspective. Design: Retrospective cohort study. Setting: Inpatient rehabilitation. Participants: Patients in inpatient rehabilitation for a TBI within 1 year of acute care discharge between 2008/2009 and 2011/2012 (N=1730, 70% men, 30% women). Interventions: None. Main Outcome Measures: Inpatient rehabilitation length of stay, total FIM score, and motor and cognitive FIM ratings at discharge. Results: Sex, as a covariate in multivariable linear regression models, was not a significant predictor of rehabilitation outcomes. Although many of the predictors examined were similar across men and women, sex-specific multivariable models identified some predictors of rehabilitation outcome that are specific for men and women; mechanism of injury (P<.0001) was a significant predictor of functional outcome only among women, whereas comorbidities (P<.0001) was a significant predictor for men only. Conclusions: Predictors of outcomes after inpatient rehabilitation differed by sex, providing evidence for a sex-specific approach in planning and resource allocation for inpatient rehabilitation services for patients with TBI. (C) 2016 by the American Congress of Rehabilitation Medicine	[Chan, Vincy; Mollayeva, Tatyana; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Chan, Vincy; Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Ottenbacher, Kenneth J.] Univ Texas Med Branch, Rehabil Sci, Galveston, TX 77555 USA	Chan, V (corresponding author), 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	vincy.chan@uhn.ca	Chan, Vincy/AAA-7813-2020; , Mollayeva/A-4522-2018	Colantonio, Angela/0000-0003-2094-4765; Ottenbacher, Kenneth/0000-0001-5990-3982; Chan, Vincy/0000-0002-6884-044X	Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; Ontario Institute for Cancer Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065702]; Canadian Institutes of Health Research (CIHR) Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Frederick Banting and Charles Best Canada Gradate Scholarships Doctoral AwardCanadian Institutes of Health Research (CIHR); Pediatric Oncology Group of Ontario for a Doctoral Research Award, Brain Canada; Canadian Imperial Bank of Commerce for a Brain Cancer Training Award; Jane Gillett Pediatric Acquired Brain Injury Studentship from the Ontario Neurotrauma Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065702, P2CHD065702] Funding Source: NIH RePORTER	Supported by the provision of data by the Institute for Clinical Evaluative Sciences (ICES) and Cancer Care Ontario; funding support to the ICES from an annual grant by the Ministry of Health and Long-Term Care and the Ontario Institute for Cancer Research; the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (award no. R24HD065702); the Canadian Institutes of Health Research (CIHR) Chair in Gender, Work and Health (grant no. CGW-126580) and Frederick Banting and Charles Best Canada Gradate Scholarships Doctoral Award; the Pediatric Oncology Group of Ontario for a Doctoral Research Award, Brain Canada; the Canadian Imperial Bank of Commerce for a Brain Cancer Training Award; and the Jane Gillett Pediatric Acquired Brain Injury Studentship from the Ontario Neurotrauma Foundation.	[Anonymous], 2014, MAPP CONN UND NEUR C; Babitsch B, 2012, PSYCHOSOC MED, V9, P1, DOI DOI 10.3205/PSM000089; Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Canadian Institute for Health Information, 2015, REHABILITATION; Canadian Institute for Health Information, 2009, NRS MIN DAT SET MAN; Canadian Institute for Health Information, 2015, AC CAR; Canadian Institutes of Health Research, 2015, SEX GEND HLTH RES GU; Centers for Disease Control and Prevention, 2015, ICD INJ MATR; Centers for Disease Control and Prevention, 2015, SEV TBI; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Chen A, 2014, J REHABIL MED, V46, P144, DOI 10.2340/16501977-1243; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2010, J REHABIL MED, V42, P773, DOI 10.2340/16501977-0582; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Commission on Accreditation of Rehabilitation Facilities (CARF), 2015, CARF CCAC STAND MAN; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Cullen N, 2014, EFFICACY MODELS CARE; Farace E, 2000, Neurosurg Focus, V8, pe6; Faul M, 2010, TRAUAMTIC BRAIN INJU; Flaskerud Jacquelyn H, 2012, Issues Ment Health Nurs, V33, P494, DOI 10.3109/01612840.2012.662581; Freeman JD, 2008, MED CARE, V46, P1023, DOI 10.1097/MLR.0b013e318185c913; Gendered Innovations in Science Health & Medicine Enginerring and Environment, 2011, WHAT IS GEND INN; Glazier RH, 2012, COMP PRIMARY CARE MO; Government of Canada, 2015, FACTS FIG 2014 IMM O; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Health Canada, 2010, HEALTH PORTFOLIO SEX; Health Services Research & Development Center, 2009, J HOPK ACG SYST; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; John-Baptiste A, 2004, J GEN INTERN MED, V19, P221, DOI 10.1111/j.1525-1497.2004.21205.x; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Malmusi D, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23189; Markovits EK, 2014, PERSPECT POLIT, V12, P81, DOI 10.1017/S1537592713003721; Mikkonen J., 2010, SOCIAL DETERMINANTS; Ministry of Finance, 2014, ONT POP PROJ; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Neysmith SM, 2010, CAN REV SOCIOL, V47, P149, DOI 10.1111/j.1755-618X.2010.01228.x; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Ontario Ministry of Health and Long-Term Care, 2015, ALT LEV CAR ALC PAT; Parsons Daria, 2012, BMC Res Notes, V5, P584, DOI 10.1186/1756-0500-5-584; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Sarver J, 2000, J GEN INTERN MED, V15, P256, DOI 10.1111/j.1525-1497.2000.06469.x; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Statistics Canada, 2015, LING CHAR CAN; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; World Health Organization, 2009, EX SUMM WOM HLTH TOD; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532	59	15	15	1	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2016	97	5					772	780		10.1016/j.apmr.2016.01.011			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DL4UM	WOS:000375633300016	26836952	Green Accepted			2021-06-18	
J	Concannon, LG				Concannon, Leah G.			Effects of Legislation on Sports-Related Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; Legislation; Athletics; Sports	HIGH-SCHOOL; YOUTH SPORTS; LYSTEDT LAW; KNOWLEDGE; EDUCATION; COACHES; GUIDELINES; MANAGEMENT; INJURIES; HEADS	Following the lead of Washington state and passage of the Lystedt Law in 2009, all states now have sports concussion laws designed to help protect youth athletes. This article examines the 3 basic tenets of youth sports concussion laws, challenges in implementation of state laws, and the first measures of success. Some of the major differences among state laws are also discussed.	[Concannon, Leah G.] Univ Washington, Dept Rehabil Med, Div Sports & Spine, 325 9th Ave,Box 359721, Seattle, WA 98104 USA	Concannon, LG (corresponding author), Univ Washington, Dept Rehabil Med, Div Sports & Spine, 325 9th Ave,Box 359721, Seattle, WA 98104 USA.	lgconcan@uw.edu					Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Adler RH, 2011, PHYS MED REH CLIN N, V22, P721, DOI 10.1016/j.pmr.2011.08.010; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Centers for disease control and prevention, HEADS UP ONL TRAIN C; Centers for Disease Control and Prevention, HEADS UP; Centers for disease control and prevention, HEADS UP CONC YOUTH; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Institute of Medicine (IOM) & National Research Council (NRC), 2013, SPORTS REL CONC YOUT; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Lowrey KM, 2014, J BUSINESS TECH L, V10, P61; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Morrissey D, 2014, J TRAUMA ACUTE CARE, V77, pS8, DOI 10.1097/TA.0000000000000331; O'Kane JW, 2014, PHYSICIAN SPORTSMED, V42, P39, DOI 10.3810/psm.2014.09.2074; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sarris CE, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12224; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	29	15	15	0	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2016	27	2					513	+		10.1016/j.pmr.2015.12.006			16	Rehabilitation	Rehabilitation	DN4RU	WOS:000377055700012	27154860				2021-06-18	
J	Cope, EC; Morris, DR; Gower-Winter, SD; Brownstein, NC; Levenson, CW				Cope, Elise C.; Morris, Deborah R.; Gower-Winter, Shannon D.; Brownstein, Naomi C.; Levenson, Cathy W.			Effect of zinc supplementation on neuronal precursor proliferation in the rat hippocampus after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Brain trauma; Neurogenesis; Hippocampus; Zinc; Depression; Proliferation; Neuronal precursor	ANTIDEPRESSANT-LIKE ACTIVITY; INDUCED NEUROGENESIS; ADULT NEUROGENESIS; CELL-PROLIFERATION; SUBGRANULAR ZONE; DENTATE GYRUS; X-IRRADIATION; ANIMAL-MODEL; DEPRESSION; REDUCTION	There is great deal of debate about the possible role of adult-born hippocampal cells in the prevention of depression and related mood disorders. We first showed that zinc supplementation prevents the development of the depression-like behavior anhedonia associated with an animal model of traumatic brain injury (TBI). This work then examined the effect of zinc supplementation on the proliferation of new cells in the hippocampus that have the potential to participate in neurogenesis. Rats were fed a zinc adequate (ZA, 30 ppm) or zinc supplemented (ZS, 180 ppm) diet for 4 wk followed by TBI using controlled cortical impact. Stereological counts of EdU-positive cells showed that TBI doubled the density of proliferating cells 24 h post-injury (p < 0.05), and supplemental zinc significantly increased this by an additional 2-fold (p < 0.0001). While the survival of these proliferating cells decreased at the same rate in ZA and in ZS rats after injury, the total density of newly born cells was approximately 60% higher in supplemented rats 1 wk after TBI. Furthermore, chronic zinc supplementation resulted in significant increases in the density of new doublecortin-positive neurons one week post-TBI that were maintained for 4 wk after injury (p < 0.01). While the effect of zinc supplementation on neuronal precursor cells in the hippocampus was robust, use of targeted irradiation to eliminate these cells after zinc supplementation and TBI revealed that these cells are not the sole mechanism through which zinc acts to prevent depression associated with brain injury, and suggest that other zinc dependent mechanisms are needed for the antidepressant effect of zinc in this model of TBI. (C) 2016 Elsevier Inc. All rights reserved.	[Cope, Elise C.; Morris, Deborah R.; Gower-Winter, Shannon D.; Levenson, Cathy W.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Levenson, Cathy W.] Florida State Univ, Coll Med, Program Neurosci, Tallahassee, FL 32306 USA; [Brownstein, Naomi C.] Florida State Univ, Coll Med, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA; [Brownstein, Naomi C.] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Morris, Deborah R.] Princeton Neurosci Inst, Dept Psychol, Peretsman Scully Hall, Princeton, NJ 08544 USA	Levenson, CW (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.; Levenson, CW (corresponding author), Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.	cathy.levenson@med.fsu.edu		Brownstein, Naomi/0000-0002-9991-427X; Cope, Elise/0000-0001-6239-690X; Levenson, Cathy W/0000-0003-4463-3136	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Army Research Institute of Environmental Medicine [W81XWH-11-2-0121]	The authors would like to thank Charles Badland for his excellent assistance in producing the figures presented in this manuscript, Megan Muroski for her assistance with the fluorescent microscopy for the images, Dr. Tim Megraw for his advice and support of the confocal microscopy, and Dr. Frank Johnson and the members of his lab for their advice and support with the use of stereology, and Daniel Pierce for the technical help with the collection of behavioral data. The authors would also like to acknowledge the U.S. Army Medical Research and Material Command and the U.S. Army Research Institute of Environmental Medicine (W81XWH-11-2-0121) for funding this work.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gao HL, 2009, NEUROTOX RES, V16, P416, DOI 10.1007/s12640-009-9072-7; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gower-Winter SD, 2013, NUTR NEUROSCI, V16, P174, DOI 10.1179/1476830512Y.0000000043; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Jayatissa MN, 2009, BRAIN RES, V1290, P133, DOI 10.1016/j.brainres.2009.07.001; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P231, DOI 10.1016/0149-7634(81)90004-X; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Lazic SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113855; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McGinn MJ, 2008, J NEUROSCI METH, V170, P9, DOI 10.1016/j.jneumeth.2007.12.012; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris DR, 2013, J NUTR BIOCHEM, V24, P1940, DOI 10.1016/j.jnutbio.2013.06.002; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Nowak G, 2003, POL J PHARMACOL, V55, P1143; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Seth R, 2015, J TRACE ELEM MED BIO, V30, P59, DOI 10.1016/j.jtemb.2014.10.010; Siwek M, 2009, J AFFECT DISORDERS, V118, P187, DOI 10.1016/j.jad.2009.02.014; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Szewczyk B, 2015, NEUROPHARMACOLOGY, V99, P517, DOI 10.1016/j.neuropharm.2015.08.026; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Xu H, 2011, HIPPOCAMPUS, V21, P495, DOI 10.1002/hipo.20767; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616	53	15	16	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2016	279						96	103		10.1016/j.expneurol.2016.02.017			8	Neurosciences	Neurosciences & Neurology	DK0OU	WOS:000374612900008	26902472				2021-06-18	
J	Murphy, RKJ; Sun, P; Xu, JQ; Wang, Y; Sullivan, S; Gamble, P; Wagner, J; Wright, NN; Dorward, IG; Riew, D; Santiago, P; Kelly, MP; Trinkaus, K; Ray, WZ; Song, SK				Murphy, Rory K. J.; Sun, Peng; Xu, Junqian; Wang, Yong; Sullivan, Samir; Gamble, Paul; Wagner, Joanne; Wright, Neill N.; Dorward, Ian G.; Riew, Daniel; Santiago, Paul; Kelly, Michael P.; Trinkaus, Kathryn; Ray, Wilson Z.; Song, Sheng-Kwei			Magnetic Resonance Imaging Biomarker of Axon Loss Reflects Cervical Spondylotic Myelopathy Severity	SPINE			English	Article						cervical; DBSI; DTI; myelopathy	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; DIFFUSION; DISEASE; SURGERY	Study Design. A prospective cohort study. Objective. In this study, we employed diffusion basis spectrum imaging (DBSI) to quantitatively assess axon/myelin injury, cellular inflammation, and axonal loss of cervical spondylotic myelopathy (CSM) spinal cords. Summary of Background Data. A major shortcoming in the management of CSM is the lack of an effective diagnostic approach to stratify treatments and to predict outcomes. No current clinical diagnostic imaging approach is capable of accurately reflecting underlying spinal cord pathologies. Methods. Seven patients with mild (mJOA >= 15), five patients with moderate (14 >= mJOA >= 11), and two patients with severe (mJOA <11) CSM were prospectively enrolled. Given the low number of severe patients, moderate and severe patients were combined for comparison with seven age-matched controls and statistical analysis. We employed the newly developed DBSI to quantitatively measure axon and myelin injury, cellular inflammation, and axonal loss. Results. Median DBSI-inflammation volume is similar in control (266 mu L) and mild CSM (171 mu L) subjects, with a significant overlap of the middle 50% of observations (quartile 3-quartile 1). This was in contrast to moderate CSM subjects that had higher DBSI-inflammation volumes (382 mu L, P=0.033). DBSI-axon volume shows a strong correlation with clinical measures (r=0.79 and 0.87, P=1.9 x10-5 and 2 x10-4 for mJOA and MDI, respectively). In addition to axon and myelin injury, our findings suggest that both inflammation and axon loss contribute to neurological impairment. Most strikingly, DBSI-derived axon volume declines as severity of impairment increases. Conclusion. DBSI-quantified axonal loss may be an imaging biomarker to predict functional recovery following decompression in CSM. Our results demonstrate an increase of about 60% in the odds of impairment relative to the control for each decrease of 100 L in axon volume.	[Murphy, Rory K. J.; Gamble, Paul; Wright, Neill N.; Dorward, Ian G.; Riew, Daniel; Santiago, Paul; Ray, Wilson Z.] Washington Univ, Dept Neurosurg, St Louis, MO USA; [Sun, Peng; Wang, Yong; Sullivan, Samir; Song, Sheng-Kwei] Washington Univ, Dept Radiol, St Louis, MO USA; [Xu, Junqian] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, Dept Radiol, New York, NY 10029 USA; [Wagner, Joanne] St Louis Univ, Dept Phys Therapy & Athlet Training, St Louis, MO 63103 USA; [Riew, Daniel; Santiago, Paul; Kelly, Michael P.] Washington Univ, Dept Orthoped Surg, St Louis, MO USA; [Trinkaus, Kathryn] Washington Univ, Div Biostat, St Louis, MO USA	Ray, WZ (corresponding author), Dept Neurosurg, 660 South Euclid Ave,Box 8057, St Louis, MO 63110 USA.	rayz@wudosis.wustl.edu	Xu, Junqian/D-2247-2009	Xu, Junqian/0000-0001-8438-2066	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS047592, K23NS084932]; Missouri SCIRP; National Multiple Sclerosis Society (NMSS)National Multiple Sclerosis Society [RG 4549A4/1, RG 5265A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047592, K23NS084932] Funding Source: NIH RePORTER	National Institute of Health R01NS047592, K23NS084932, and Missouri SCIRP, National Multiple Sclerosis Society (NMSS) RG 4549A4/1 and RG 5265A1 funds were received in support of this work.	Beattie MS, 2011, BRAIN, V134, P1259, DOI 10.1093/brain/awr088; BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005; Boogaarts HD, 2015, EUR SPINE J, V24, pS139, DOI 10.1007/s00586-013-2781-x; Casey ATH, 1996, ANN RHEUM DIS, V55, P901, DOI 10.1136/ard.55.12.901; Chiang CW, 2014, NEUROIMAGE, V101, P310, DOI 10.1016/j.neuroimage.2014.06.064; Ellingson BM, 2014, SPINE J, V14, P2589, DOI 10.1016/j.spinee.2014.02.027; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Fehlings MG, 2012, J NEUROSURG-SPINE, V16, P425, DOI 10.3171/2012.1.SPINE11467; Fehlings MG, 2009, J NEUROSURG-SPINE, V11, P97, DOI 10.3171/2009.5.SPINE09210; Furlan JC, 2008, J NEUROTRAUM, V25, P1273, DOI 10.1089/neu.2008.0617; Jones JGA, 2013, AM J NEURORADIOL, V34, P471, DOI 10.3174/ajnr.A3199; Kadanka Z, 2000, EUR SPINE J, V9, P538, DOI 10.1007/s005860000132; Karadimas SK, 2015, EUR SPINE J, V24, pS132, DOI 10.1007/s00586-014-3264-4; Klineberg E, 2010, ORTHOP CLIN N AM, V41, P193, DOI 10.1016/j.ocl.2009.12.010; Krishna V, 2014, J NEUROTRAUM, V31, P215, DOI 10.1089/neu.2013.2982; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; Naismith RT, 2013, NEUROLOGY, V80, P2201, DOI 10.1212/WNL.0b013e318296e8f1; Nakamura M, 2012, J NEUROSURG-SPINE, V17, P147, DOI 10.3171/2012.5.SPINE1196; NURICK S, 1972, BRAIN, V95, P101, DOI 10.1093/brain/95.1.101; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Uda T, 2013, SPINE, V38, P407; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Xiangshui M, 2010, CLIN RADIOL, V65, P465, DOI 10.1016/j.crad.2010.01.019; Xu JQ, 2013, NEUROIMAGE, V67, P64, DOI 10.1016/j.neuroimage.2012.11.014; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	28	15	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY	2016	41	9					751	756		10.1097/BRS.0000000000001337			6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	DL4QV	WOS:000375623200014	26650876	Green Accepted			2021-06-18	
J	Sun, F; Nguyen, T; Jin, X; Huang, RQ; Chen, ZL; Cunningham, RL; Singh, M; Su, C				Sun, Fen; Trinh Nguyen; Jin, Xin; Huang, Renqi; Chen, Zhenglan; Cunningham, Rebecca L.; Singh, Meharvan; Su, Chang			Pgrmc1/BDNF Signaling Plays a Critical Role in Mediating Glia-Neuron Cross Talk	ENDOCRINOLOGY			English	Article							MEMBRANE COMPONENT 1; TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; PROGESTERONE; PROTEIN; BDNF; HIPPOCAMPUS; EXPRESSION; LTP; ESTROGEN	Progesterone (P4) exerts robust cytoprotection in brain slice cultures (containing both neurons and glia), yet such protection is not as evident in neuron-enriched cultures, suggesting that glia may play an indispensable role in P4's neuroprotection. We previously reported that a membrane-associated P4 receptor, P4 receptor membrane component 1, mediates P4-induced brain-derived neurotrophic factor (BDNF) release from glia. Here, we sought to determine whether glia are required for P4's neuroprotection and whether glia's roles are mediated, at least partially, via releasing soluble factors to act on neighboring neurons. Our data demonstrate that P4 increased the level of mature BDNF (neuroprotective) while decreasing pro-BDNF (potentially neurotoxic) in the conditioned media (CMs) of cultured C6 astrocytes. We examined the effects of CMs derived from P4-treated astrocytes (P4-CMs) on 2 neuronal models: 1) all-trans retinoid acid-differentiated SH-SY5Y cells and 2) mouse primary hippocampal neurons. P4-CM increased synaptic marker expression and promoted neuronal survival against H2O2. These effects were attenuated by Y1036 (an inhibitor of neurotrophin receptor [tropomysin-related kinase] signaling), as well as tropomysin-related kinase B-IgG (a more specific inhibitor to block BDNF signaling), which pointed to BDNF as the key protective component within P4-CM. These findings suggest that P4 may exert its maximal protection by triggering a glia-neuron cross talk, in which P4 promotes mature BDNF release from glia to enhance synaptogenesis as well as survival of neurons. This recognition of the importance of glia in mediating P4's neuroprotection may also inform the design of effective therapeutic methods for treating diseases wherein neuronal death and/or synaptic deficits are noted.	[Sun, Fen; Trinh Nguyen; Jin, Xin; Huang, Renqi; Chen, Zhenglan; Cunningham, Rebecca L.; Singh, Meharvan; Su, Chang] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	Su, C (corresponding author), Univ N Texas, Hlth Sci Ctr, Inst Hlth Aging, Ctr Neurosci Discovery, Ft Worth, TX 76107 USA.	chang.su@unthsc.edu	Sun, Fen/I-8516-2016	Cunningham, Rebecca/0000-0001-5984-5516; Singh, Meharvan/0000-0002-8072-1769	American Federation of Aging Research; American Heart AssociationAmerican Heart Association; National Institutes of Health National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG022550, AG027956]; Alzheimer's AssociationAlzheimer's Association; Texas Garvey Foundation; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG027956, T32AG020494, P01AG022550] Funding Source: NIH RePORTER	This work was supported by funds from the American Federation of Aging Research and the American Heart Association (C.S.), National Institutes of Health National Institute of Aging Grants AG022550 and AG027956, the Alzheimer's Association, and the Texas Garvey Foundation (M.S.).	Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Bali N, 2012, ENDOCRINOLOGY, V153, P759, DOI 10.1210/en.2011-1699; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Bashour NM, 2012, ENDOCRINOLOGY, V153, P4457, DOI 10.1210/en.2012-1122; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Chamniansawat S, 2009, NEUROSCI LETT, V452, P130, DOI 10.1016/j.neulet.2009.01.010; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Frye CA, 2008, NEUROSCI LETT, V437, P116, DOI 10.1016/j.neulet.2008.04.004; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Guennoun R, 2008, BRAIN RES REV, V57, P493, DOI 10.1016/j.brainresrev.2007.05.009; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hock C, 1998, NEUROSCI LETT, V241, P151, DOI 10.1016/S0304-3940(98)00019-6; Intlekofer KA, 2011, NEUROSCIENCE, V172, P55, DOI 10.1016/j.neuroscience.2010.10.051; Lewis MC, 2008, HORM BEHAV, V54, P455, DOI 10.1016/j.yhbeh.2008.05.010; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Ma JP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub2; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Morita S, 2013, CELL BIOCHEM FUNCT, V31, P400, DOI 10.1002/cbf.2914; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peluso JJ, 2010, MOL CELL ENDOCRINOL, V320, P153, DOI 10.1016/j.mce.2010.02.005; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; PrugininBluger M, 1997, MECH DEVELOP, V61, P99, DOI 10.1016/S0925-4773(96)00623-5; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Singh M, 1999, J NEUROSCI, V19, P1179; STROEMER RP, 1992, NEUROSCI LETT, V147, P21, DOI 10.1016/0304-3940(92)90765-Y; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; Vandromme M, 2008, CRIT CARE, V12, DOI 10.1186/cc6899; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhao YZ, 2011, SYNAPSE, V65, P880, DOI 10.1002/syn.20915	45	15	16	0	5	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	MAY	2016	157	5					2067	2079		10.1210/en.2015-1610			13	Endocrinology & Metabolism	Endocrinology & Metabolism	DL3XT	WOS:000375567600034	26990062	Bronze, Green Published			2021-06-18	
J	Teel, E; Gay, M; Johnson, B; Slobounov, S				Teel, Elizabeth; Gay, Michael; Johnson, Brian; Slobounov, Semyon			Determining Sensitivity/Specificity of Virtual Reality-Based Neuropsychological Tool for Detecting Residual Abnormalities Following Sport-Related Concussion	NEUROPSYCHOLOGY			English	Article						concussion; virtual reality; neuropsychological testing	TRAUMATIC BRAIN-INJURY; PROSPECTIVE MEMORY; COGNITIVE IMPAIRMENT; POSTURAL STABILITY; SPATIAL NAVIGATION; INITIAL VALIDATION; EXECUTIVE FUNCTION; CORTICAL ACTIVITY; HIGH-SCHOOL; SENSITIVITY	Objective: Computer-based neuropsychological (NP) evaluation is an effective clinical tool used to assess cognitive function which complements the clinical diagnosis of a concussion. However, some researchers and clinicians argue its lack of ecological validity places limitations on externalizing results to a sensory rich athletic environment. Virtual reality-based NP assessment offers clinical advantages using an immersive environment and evaluating domains not typically assessed by traditional NP assessments. The sensitivity and specificity of detecting lingering cognitive abnormalities was examined on components of a virtual reality-based NP assessment battery to cohort affiliation (concussed vs. controls). Method: Data were retrospectively gathered on 128 controls (no concussion) and 24 concussed college-age athletes on measures of spatial navigation, whole body reaction, attention, and balance in a virtual environment. Concussed athletes were tested within 10 days (M = 8.33, SD = 1.06) of concussion and were clinically asymptomatic at the time of testing. Results: A priori alpha level was set at 0.05 for all tests. Spatial navigation (sensitivity 95.8%/specificity 91.4%, d = 1.89), whole body reaction time (sensitivity 95.2%/specificity 89.1%, d = 1.50) and combined virtual reality modules (sensitivity 95.8%,/specificity 96.1%, d = 3.59) produced high sensitivity/specificity values when determining performance-based variability between groups. Conclusions: Use of a virtual reality-based NP platform can detect lingering cognitive abnormalities resulting from concussion in clinically asymptomatic participants. Virtual reality NP platforms may compliment the traditional concussion assessment battery by providing novel information.	[Teel, Elizabeth; Johnson, Brian; Slobounov, Semyon] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Gay, Michael; Johnson, Brian; Slobounov, Semyon] Penn State Univ, Penn State Ctr Sport Concuss Res & Serv, University Pk, PA 16802 USA; [Gay, Michael] Penn State Univ, Dept Intercollegiate Athlet, University Pk, PA 16802 USA; [Teel, Elizabeth] Univ N Carolina, Chapel Hill, NC USA	Slobounov, S (corresponding author), Penn State Univ, Dept Kinesiol, Coll Hlth & Human Dev, University Pk, PA 16802 USA.	sms18@psu.edu		Teel, Elizabeth/0000-0002-2846-5884			Banville F, 2010, BEHAV NEUROL, V23, P209, DOI [10.3233/BEN-2010-0297, 10.1155/2010/320707]; Barkhoudarian G., 2010, CLIN SPORTS MED, V30, pvii; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barth JT., 1989, MILD HEAD INJURY, P257; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Canovas R, 2011, EPILEPSY BEHAV, V22, P364, DOI 10.1016/j.yebeh.2011.07.021; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Curaudeau GA, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11186; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gorrindo T, 2009, ACAD PSYCHIATR, V33, P413, DOI 10.1176/appi.ap.33.5.413; Grewe P, 2014, EPILEPSY BEHAV, V31, P57, DOI 10.1016/j.yebeh.2013.11.014; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry M, 2012, J NEUROSCI METH, V210, P125, DOI 10.1016/j.jneumeth.2012.07.025; Iverson GL, 2006, CLIN NEUROPSYCHOL, V20, P695, DOI 10.1080/138540491005857; Jaiswal N, 2010, BRAIN RES, V1347, P80, DOI 10.1016/j.brainres.2010.05.086; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P207, DOI 10.1080/09084282.2011.643956; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mihalik JP, 2008, J SPORT REHABIL, V17, P38, DOI 10.1123/jsr.17.1.38; Nolin P, 2012, BRAIN INJURY, V26, P1564, DOI 10.3109/02699052.2012.698359; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Parsons TD, 2008, CYBERPSYCHOL BEHAV, V11, P17, DOI 10.1089/cpb.2007.9934; Parsons TD, 2014, J NEUROSCI METH, V222, P15, DOI 10.1016/j.jneumeth.2013.10.006; Pollak Y, 2009, J DEV BEHAV PEDIATR, V30, P2, DOI 10.1097/DBP.0b013e3181969b22; Quatman-Yates CC, 2013, INT J SPORTS PHYS TH, V8, P741; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Slobounov S, 2006, BIOL PSYCHOL, V72, P188, DOI 10.1016/j.biopsycho.2005.10.005; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Slobounov S, 2011, IEEE ENG MED BIO, P1383, DOI 10.1109/IEMBS.2011.6090325; Slobounov SM, 2015, INT J PSYCHOPHYSIOL, V95, P254, DOI 10.1016/j.ijpsycho.2014.11.003; Slobounov SM, 2013, NEUROSCI LETT, V547, P6, DOI 10.1016/j.neulet.2013.05.001; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sweeney S, 2010, NEUROPSYCHOL REHABIL, V20, P239, DOI 10.1080/09602010903080531; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	62	15	16	3	25	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2016	30	4					474	483		10.1037/neu0000261			10	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	DK2XM	WOS:000374777700008	27045961				2021-06-18	
J	Hernandez, RV; Puro, AC; Manos, JC; Huitron-Resendiz, S; Reyes, KC; Liu, K; Vo, K; Roberts, AJ; Gruol, DL				Hernandez, Ruben V.; Puro, Alana C.; Manos, Jessica C.; Huitron-Resendiz, Salvador; Reyes, Kenneth C.; Liu, Kevin; Vo, Khanh; Roberts, Amanda J.; Gruol, Donna L.			Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function	NEUROPHARMACOLOGY			English	Article						Synaptic plasticity; EEG; Gamma frequency; Glia; Ethanol withdrawal hyperexcitability; Neuroimmune; STAT3; Long-term potentiation	LONG-TERM POTENTIATION; CHRONIC INTERMITTENT ETHANOL; RAT HIPPOCAMPAL SLICES; CONTAINING GABA(A) RECEPTORS; HANDLING-INDUCED CONVULSIONS; REGION-SPECIFIC CHANGES; TRAUMATIC BRAIN-INJURY; GLIAL TNF-ALPHA; NMDA-RECEPTOR; WITHDRAWAL SEVERITY	A growing body of evidence has revealed that resident cells of the central nervous system (CNS), and particularly the glial cells, comprise a neuroimmune system that serves a number of functions in the normal CNS and during adverse conditions. Cells of the neuroimmune system regulate CNS functions through the production of signaling factors, referred to as neuroimmune factors. Recent studies show that ethanol can activate cells of the neuroimmune system, resulting in the elevated production of neuroimmune factors, including the cytokine interleukin-6 (IL-6). Here we analyzed the consequences of this CNS action of ethanol using transgenic mice that express elevated levels of IL-6 through increased astrocyte expression (IL-6-tg) to model the increased IL-6 expression that occurs with ethanol use. Results show that increased IL-6 expression induces neuroadaptive changes that alter the effects of ethanol. In hippocampal slices from non-transgenic (non-tg) littermate control mice, synaptically evoked dendritic field excitatory postsynaptic potential (fEPSP) and somatic population spike (PS) at the Schaffer collateral to CM pyramidal neuron synapse were reduced by acute ethanol (20 or 60 mM). In contrast, acute ethanol enhanced the fEPSP and PS in hippocampal slices from IL-6 tg mice. Long-term synaptic plasticity of the fEPSP (i.e., LTP) showed the expected dose-dependent reduction by acute ethanol in non-tg hippocampal slices, whereas LW in the IL-6 tg hippocampal slices was resistant to this depressive effect of acute ethanol. Consistent with altered effects of acute ethanol on synaptic function in the IL-6 tg mice, EEG recordings showed a higher level of CNS activity in the IL-6 tg mice than in the non-tg mice during the period of withdrawal from an acute high dose of ethanol. These results suggest a potential role for neuroadaptive effects of ethanol-induced astrocyte production of IL-6 as a mediator or modulator of the actions of ethanol on the CNS, including persistent changes in CNS function that contribute to cognitive dysfunction and the development of alcohol dependence. (C) 2015 Elsevier Ltd. All rights reserved.	[Hernandez, Ruben V.; Puro, Alana C.; Manos, Jessica C.; Huitron-Resendiz, Salvador; Reyes, Kenneth C.; Liu, Kevin; Vo, Khanh; Roberts, Amanda J.; Gruol, Donna L.] Scripps Res Inst, Mol & Cellular Neurosci Dept, SP30-1522,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	Gruol, DL (corresponding author), Scripps Res Inst, Mol & Cellular Neurosci Dept, SP30-1522,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	gruol@scripps.edu			NIAAA GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA019261]; Integrated Neuroscience Initiative on Alcoholism (INAI)-West grant [AA020893]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [U01AA020893, RC1AA019261] Funding Source: NIH RePORTER	Supported by NIAAA Grant AA019261 and the Integrated Neuroscience Initiative on Alcoholism (INAI)-West grant AA020893.	Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Bachtell RK, 2002, J PHARMACOL EXP THER, V302, P516, DOI 10.1124/jpet.102.036046; Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Becker HC, 2000, ALCOHOL RES HEALTH, V24, P105; Becker Howard C, 2014, Handb Clin Neurol, V125, P133, DOI 10.1016/B978-0-444-62619-6.00009-4; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blednov YA, 2005, BEHAV BRAIN RES, V165, P110, DOI 10.1016/j.bbr.2005.06.026; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; BLITZER RD, 1990, BRAIN RES, V537, P203, DOI 10.1016/0006-8993(90)90359-J; Boyadjieva NI, 2010, ALCOHOL CLIN EXP RES, V34, P1835, DOI 10.1111/j.1530-0277.2010.01271.x; Bray JG, 2013, NEUROPHARMACOLOGY, V67, P115, DOI 10.1016/j.neuropharm.2012.11.007; Briere FN, 2014, COMPR PSYCHIAT, V55, P526, DOI 10.1016/j.comppsych.2013.10.007; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; Chandler LJ, 2005, ALCOHOL CLIN EXP RES, V29, P672, DOI 10.1097/01.ALC.0000158935.53360.5F; Cheaha D, 2014, NEUROPHARMACOLOGY, V77, P49, DOI 10.1016/j.neuropharm.2013.09.020; Chen JP, 1999, FEBS LETT, V457, P162, DOI 10.1016/S0014-5793(99)01031-5; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; Coogan A, 1997, NEUROREPORT, V8, P2107, DOI 10.1097/00001756-199707070-00004; Crabbe J C, 1980, Subst Alcohol Actions Misuse, V1, P159; Crabbe JC, 1998, J PHARMACOL EXP THER, V286, P263; CRABBE JC, 1991, J PHARMACOL EXP THER, V257, P663; CRABBE JC, 1983, PHARMACOL BIOCHEM BE, V18, P541, DOI 10.1016/0091-3057(83)90233-2; Doremus-Fitzwater TL, 2015, PHYSIOL BEHAV, V148, P131, DOI 10.1016/j.physbeh.2015.02.032; Doremus-Fitzwater TL, 2014, ALCOHOL CLIN EXP RES, V38, P2186, DOI 10.1111/acer.12481; Erickson MA, 2010, J COGNITIVE NEUROSCI, V22, P2530, DOI 10.1162/jocn.2009.21375; Farook JM, 2008, PHYSIOL BEHAV, V95, P267, DOI 10.1016/j.physbeh.2008.05.020; Ferando I, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00144; Finn DA, 2007, ALCOHOL CLIN EXP RES, V31, P939, DOI 10.1111/j.1530-0277.2007.00379.x; Foltran F, 2011, NUTR REV, V69, P642, DOI 10.1111/j.1753-4887.2011.00417.x; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Fujii S, 2008, BRAIN RES, V1211, P13, DOI 10.1016/j.brainres.2008.02.052; Fujita N, 2003, INT J OBESITY, V27, P55, DOI 10.1038/sj.ijo.0802194; GADIENT RA, 1994, BRAIN RES, V637, P10, DOI 10.1016/0006-8993(94)91211-4; Ghozland S, 2005, NEUROPHARMACOLOGY, V49, P493, DOI 10.1016/j.neuropharm.2005.04.006; Gilpin NW, 2009, ALCOHOL CLIN EXP RES, V33, P2113, DOI 10.1111/j.1530-0277.2009.01051.x; Giralt M, 2013, GLIA, V61, P587, DOI 10.1002/glia.22457; GOLDSTEI.DB, 1971, SCIENCE, V172, P288, DOI 10.1126/science.172.3980.288; Gruol DL, 2011, J NEUROIMMUNOL, V239, P28, DOI 10.1016/j.jneuroim.2011.08.009; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Gruol DL, 2015, NEUROPHARMACOLOGY, V96, P42, DOI 10.1016/j.neuropharm.2014.10.023; Gruol DL, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ricel.2014.00234, 10.3389/fncel.2014.00234]; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Heilig M, 2010, ADDICT BIOL, V15, P169, DOI 10.1111/j.1369-1600.2009.00194.x; Hendricson AW, 2007, J PHARMACOL EXP THER, V321, P60, DOI 10.1124/jpet.106.111419; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hingson RW, 2006, PEDIATRICS, V118, pE755, DOI 10.1542/peds.2006-0223; Huang DR, 2002, J NEUROSCI, V22, P10633; Huitron-Resendiz S, 2004, SLEEP, V27, P857, DOI 10.1093/sleep/27.5.857; Huitron-Resendiz S, 2005, J NEUROSCI, V25, P5465, DOI 10.1523/JNEUROSCI.4501-04.2005; Ikegaya Y, 2003, SYNAPSE, V47, P54, DOI 10.1002/syn.10154; Izumi Y, 2005, NEUROSCIENCE, V136, P509, DOI 10.1016/j.neuroscience.2005.08.002; Jankowsky JL, 2000, LEARN MEMORY, V7, P400, DOI 10.1101/lm.32600; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kachadourian LK, 2014, J PSYCHIATR RES, V55, P35, DOI 10.1016/j.jpsychires.2014.04.018; Kalluri HSG, 2003, NEUROCHEM RES, V28, P765, DOI 10.1023/A:1022822119560; Kalluri HSG, 2002, EUR J PHARMACOL, V439, P53, DOI 10.1016/S0014-2999(01)01599-0; Kane CJM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-66; Kane CJM, 2014, ALCOHOL CLIN EXP RES, V38, P384, DOI 10.1111/acer.12244; KATSUKI H, 1990, EUR J PHARMACOL, V181, P323, DOI 10.1016/0014-2999(90)90099-R; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Li AJ, 1997, BRAIN RES, V748, P30, DOI 10.1016/S0006-8993(96)01283-8; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Lippai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070945; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Long JM, 1998, NEUROBIOL AGING, V19, P497, DOI 10.1016/S0197-4580(98)00088-8; LOVINGER DM, 1990, J NEUROSCI, V10, P1372; Luterman JD, 2000, ARCH NEUROL-CHICAGO, V57, P1153, DOI 10.1001/archneur.57.8.1153; Mann EO, 2010, NAT NEUROSCI, V13, P205, DOI 10.1038/nn.2464; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; McCool BA, 2011, NEUROPHARMACOLOGY, V61, P1097, DOI 10.1016/j.neuropharm.2010.12.028; MCQUARRIE DG, 1958, J PHARMACOL EXP THER, V124, P264; Medvedev A, 2000, BRAIN RES BULL, V52, P89, DOI 10.1016/S0361-9230(00)00239-2; Metten P, 2010, ALCOHOL CLIN EXP RES, V34, P1552, DOI 10.1111/j.1530-0277.2010.01240.x; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mulholland PJ, 2015, PSYCHOPHARMACOLOGY, V232, P1995, DOI 10.1007/s00213-014-3835-4; Mulholland PJ, 2009, ALCOHOL CLIN EXP RES, V33, P1125, DOI 10.1111/j.1530-0277.2009.00936.x; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Nelson TE, 2012, BRAIN BEHAV IMMUN, V26, P959, DOI 10.1016/j.bbi.2012.05.005; Nelson TE, 2005, BRAIN RES, V1048, P69, DOI 10.1016/j.brainres.2005.04.041; Neupane SP, 2014, CNS NEUROSCI THER, V20, P898, DOI 10.1111/cns.12303; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; O'Connor JJ, 1999, EXP PHYSIOL, V84, P601, DOI 10.1017/S0958067099018928; Olive MF, 2008, ALCOHOL, V42, P191, DOI 10.1016/j.alcohol.2008.01.007; Papatheodoropoulos C, 2002, BRAIN RES, V948, P117, DOI 10.1016/S0006-8993(02)02958-X; Peng S, 2011, MOL BIOL REP, V38, P453, DOI 10.1007/s11033-010-0128-9; Peris Joanna, 1997, Frontiers in Bioscience (online), V2, pD309; PERPER JA, 1986, J FORENSIC SCI, V31, P212; Petrides T, 2007, EXP BRAIN RES, V177, P370, DOI 10.1007/s00221-006-0681-6; Piana JP, 2008, BRAIN RES, V1194, P28, DOI 10.1016/j.brainres.2007.11.057; Pribiag H, 2013, J NEUROSCI, V33, P15879, DOI 10.1523/JNEUROSCI.0530-13.2013; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-130; Qiu ZH, 1998, J NEUROSCI, V18, P10445; Ramachandran B, 2015, HIPPOCAMPUS, V25, P106, DOI 10.1002/hipo.22356; Rizzo SJS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.120; Roberto M, 2003, EUR J NEUROSCI, V17, P1646, DOI 10.1046/j.1460-9568.2003.02614.x; ROBERTS AJ, 1992, BRAIN RES, V579, P296, DOI 10.1016/0006-8993(92)90064-G; Sallmann S, 2000, J NEUROSCI, V20, P8637; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; Sanz E, 2008, GLIA, V56, P190, DOI 10.1002/glia.20602; Sarc L, 2011, HUM EXP TOXICOL, V30, P1256, DOI 10.1177/0960327110388533; Savchenko VL, 2000, NEUROSCIENCE, V96, P195, DOI 10.1016/S0306-4522(99)00538-2; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; Schumann G, 1999, J NEUROCHEM, V73, P2009; Schummers J, 1997, ALCOHOL CLIN EXP RES, V21, P404; Schwieler L, 2015, J PSYCHIATR NEUROSCI, V40, P126, DOI 10.1503/jpn.140126; Shield KD, 2013, ALCOHOL RES-CURR REV, V35, P155; Shu MF, 2011, MOL ONCOL, V5, P265, DOI 10.1016/j.molonc.2011.03.003; Silverstein PS, 2014, CURR HIV RES, V12, P282, DOI 10.2174/1570162X12666140721122956; SINCLAIR JG, 1986, GEN PHARMACOL, V17, P231, DOI 10.1016/0306-3623(86)90144-8; Smiley JF, 2015, ALCOHOL, V49, P571, DOI 10.1016/j.alcohol.2015.04.008; SMOLEN TN, 1989, ALCOHOL, V6, P33, DOI 10.1016/0741-8329(89)90070-0; Spanos M, 2012, BEHAV BRAIN RES, V230, P158, DOI 10.1016/j.bbr.2012.02.010; STEFFENSEN SC, 1994, BRAIN RES, V652, P149, DOI 10.1016/0006-8993(94)90329-8; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tipps ME, 2014, NEUROBIOL LEARN MEM, V112, P87, DOI 10.1016/j.nlm.2013.12.002; Tiwari V, 2009, BEHAV BRAIN RES, V203, P296, DOI 10.1016/j.bbr.2009.05.016; Trapero I, 2014, METAB BRAIN DIS, V29, P593, DOI 10.1007/s11011-014-9551-2; Udomuksorn W, 2011, ACTA HISTOCHEM, V113, P283, DOI 10.1016/j.acthis.2009.11.001; Valles SL, 2004, BRAIN PATHOL, V14, P365; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Vollenweider F, 2003, NEUROSCI LETT, V341, P49, DOI 10.1016/S0304-3940(03)00136-8; Vongvatcharanon U, 2010, ACTA HISTOCHEM, V112, P392, DOI 10.1016/j.acthis.2009.04.001; Ward RJ, 2014, ALCOHOL ALCOHOLISM, V49, P193, DOI 10.1093/alcalc/agu002; Ward RJ, 2009, J NEUROCHEM, V111, P1119, DOI 10.1111/j.1471-4159.2009.06389.x; Wei H, 2013, NEUROSCIENCE, V252, P320, DOI 10.1016/j.neuroscience.2013.08.025; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Weiner JL, 2006, PHARMACOL THERAPEUT, V111, P533, DOI 10.1016/j.pharmthera.2005.11.002; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; White AM, 2004, ANN NY ACAD SCI, V1021, P206, DOI 10.1196/annals.1308.026; White AM, 2003, ALCOHOL RES HEALTH, V27, P186; Wirkner K, 1999, NEUROCHEM INT, V35, P153, DOI 10.1016/S0197-0186(99)00057-1; Yang S, 2005, BRAIN RES, V1034, P172, DOI 10.1016/j.brainres.2004.11.018; Young JJ, 2014, J AFFECT DISORDERS, V169, P15, DOI 10.1016/j.jad.2014.07.032; Zhang RY, 2010, NEUROBIOL DIS, V38, P68, DOI 10.1016/j.nbd.2009.12.028; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V452, P450, DOI 10.1016/j.bbrc.2014.08.092; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052; Zhu B, 2012, NEUROBIOL DIS, V48, P348, DOI 10.1016/j.nbd.2012.06.022; Zorumski CF, 2014, ALCOHOL, V48, P1, DOI 10.1016/j.alcohol.2013.09.045; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	152	15	16	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	APR	2016	103						27	43		10.1016/j.neuropharm.2015.12.015			17	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	DF1KO	WOS:000371098800003	26707655	Green Accepted			2021-06-18	
J	Hughes, J; Maguire, S; Jones, M; Theobald, P; Kemp, A				Hughes, Jonathon; Maguire, Sabine; Jones, Michael; Theobald, Peter; Kemp, Alison			Biomechanical characteristics of head injuries from falls in children younger than 48 months	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							TRAUMATIC BRAIN-INJURY; LOW-HEIGHT FALLS; SKULL FRACTURES; INFANTS; CHILDHOOD; IMPACTS; BED; AGE	Background A fall-height threshold is important when evaluating the likelihood of structural head injury or abusive head trauma. This study investigates witnessed falls to correlate the fall characteristics with the extent of injury. Method Case-control study of children aged <= 48 months who attended one hospital following a fall from < 3 m (10 ft), comparing cases who sustained a skull fracture or intracranial injury (ICI) with controls, who had minor head injuries. Characteristics included: the mechanism of injury, surface of impact, site of impact to the head and fall height. Results Forty-seven children had a skull fracture or ICI, while 416 children had minor head injuries. The mean fall height for minor head injuries was significantly lower than that causing skull fracture/ICI (p< 0.001). No skull fracture/ICI was recorded in children who fell < 0.6 m (2 ft), based on the height of the head centre of gravity. Skull fractures/ICI were more likely in children aged <= 12 months (p< 0.001) from impacts to the temporal/ parietal or occipital region (p< 0.001), impacts onto wood (p= 0.004) and falls from a carer's arms, particularly when on stairs (p< 0.001). No significant difference was reported between the mean fall heights of children who had a simple skull fracture (n= 17) versus those who had a complex fracture or ICI (n= 30). Conclusions An infant is more likely to sustain a skull fracture/ICI from a fall above a 0.6 m (2 ft) threshold, based on the height of the head centre of gravity, or with a parietal/temporal or occipital impact. These variables should be recorded when evaluating the likelihood of skull fracture/ICI.	[Hughes, Jonathon; Jones, Michael; Theobald, Peter] Cardiff Univ, Cardiff Sch Engn, Inst Med Engn & Med Phys, Cardiff CF10 3AX, S Glam, Wales; [Maguire, Sabine; Kemp, Alison] Cardiff Sch Med, Inst Primary Care & Publ Hlth, Heath Pk, Cardiff CF14 4YS, S Glam, Wales	Kemp, A (corresponding author), Cardiff Sch Med, Inst Primary Care & Publ Hlth, Heath Pk, Cardiff CF14 4YS, S Glam, Wales.	KempAM@cf.ac.uk	Theobald, Peter S/C-2490-2013	Theobald, Peter S/0000-0002-3227-7130	Schools of Engineering and Medicine (Cardiff University)	JH received a doctoral scholarship to support this study, funded equally by the Schools of Engineering and Medicine (Cardiff University).	[Anonymous], 2004, INT CLASS EXT CAUS I; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Cory CZ, 2006, FORENSIC SCI INT, V163, P102, DOI 10.1016/j.forsciint.2005.11.014; Crowe LM, 2012, INJURY, V43, P2141, DOI 10.1016/j.injury.2012.07.195; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; HELFER RE, 1977, PEDIATRICS, V60, P533; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Ibrahim NG, 2012, INT J DEV NEUROSCI, V30, P201, DOI 10.1016/j.ijdevneu.2011.10.007; Ibrahim NG, 2010, J NEUROSURG-PEDIATR, V6, P57, DOI 10.3171/2010.3.PEDS09357; IDB, 2005, INJ DAT IDB VERS 1 1; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; Loyd Andre M, 2010, Stapp Car Crash J, V54, P167; LYONS TJ, 1993, PEDIATRICS, V92, P125; Nakahira Y, 2000, COMBINED EVALUATION, P147; NICE, HEAD INJ TRIAG ASS I; Park SH, 2004, YONSEI MED J, V45, P229, DOI 10.3349/ymj.2004.45.2.229; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Schneider Lawrence, 1986, SIZE SHAPE HEAD NECK; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; Snyder R.G., 1975, PHYS CHARACTERISTICS; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Thomas AG, 2013, ARCH DIS CHILD, V98, P787, DOI 10.1136/archdischild-2013-304267; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Van Ee C, 2009, EVALUATION REFINEMEN; WEBER W, 1985, Z RECHTSMED, V94, P93; WEBER W, 1984, Z RECHTSMED, V92, P87, DOI 10.1007/BF02116216; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005	37	15	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	APR	2016	101	4					310	315		10.1136/archdischild-2014-306803			6	Pediatrics	Pediatrics	DH0VS	WOS:000372502800005	26384509				2021-06-18	
J	Kolev, OI; Sergeeva, M				Kolev, Ognyan I.; Sergeeva, Michaela			Vestibular disorders following different types of head and neck trauma	FUNCTIONAL NEUROLOGY			English	Article						concussion; dizziness; imbalance; traumatic brain injury; vertigo; vestibular	SALT WASTING SYNDROME; BRAIN-INJURY; WHIPLASH INJURY; PERILYMPHATIC FISTULA; POSTURAL VERTIGO; CONCUSSION; HYPONATREMIA; CLASSIFICATION; CONSEQUENCES; DYSFUNCTION	This review focuses on the published literature on vestibular disorders following different types of head and neck trauma. Current knowledge of the different causes and underlying mechanisms of vestibular disorders, as well as the sites of organic damage, is presented. Non-organic mechanisms are also surveyed. The frequency of occurrence of vestibular symptoms, and of other accompanying subjective complaints, associated with different types of trauma is presented and related to the specific causes. Hypotheses about the pathogenesis of traumatic vestibular disorders are presented, and the knowledge derived from animal experiments is also discussed. We believe this to be a very important topic, since vestibular complaints in traumatic patients often remain undiagnosed or underestimated in clinical practice. This review article aims to suggest directions for additional research and to provide guidance to both the scientific and clinical practice communities.	[Kolev, Ognyan I.; Sergeeva, Michaela] Med Univ Sofia, Univ Hosp Neurol & Psychiat, Sofia, Bulgaria; [Kolev, Ognyan I.] Bulgarian Acad Sci, Inst Neurobiol, Sofia, Bulgaria	Kolev, OI (corresponding author), Med Univ Sofia, Univ Hosp Neurol & Psychiat, Sofia, Bulgaria.; Kolev, OI (corresponding author), Bulgarian Acad Sci, Inst Neurobiol, Sofia, Bulgaria.	kolev_ogi@yahoo.com					Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Allison L, 2000, NEUROLOGICAL REHABIL, V116, P616; Armstrong LE, 2004, J SPORT SCI, V22, P144; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Brandt T, 1996, NEUROLOGY, V46, P1515, DOI 10.1212/WNL.46.6.1515; Brandt T, 2001, J NEUROL NEUROSUR PS, V71, P8, DOI 10.1136/jnnp.71.1.8; CARTLIDGE NEF, 1978, SCOT MED J, V23, P103, DOI 10.1177/003693307802300146; Daroff RB, 2005, HARRISONS PRINCIPLES, P100; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; de Jong P T, 1977, Ann Neurol, V1, P240, DOI 10.1002/ana.410010307; DIETERICH M, 1993, CEPHALALGIA, V13, P285, DOI 10.1046/j.1468-2982.1993.1304285.x; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; FISCHER AJEM, 1995, J NEUROL SCI, V132, P35, DOI 10.1016/0022-510X(95)00118-L; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; Fitzgerald DC, 1997, ANN OTO RHINOL LARYN, V106, P830, DOI 10.1177/000348949710601005; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Friedland D, 2015, ACNR, V15, P24; GANNON RP, 1978, ARCH OTOLARYNGOL, V104, P404; Gdowski GT, 2000, EXP BRAIN RES, V135, P511, DOI 10.1007/s002210000542; GRAY L P, 1956, J Laryngol Otol, V70, P352, DOI 10.1017/S0022215100053032; GRIMM RJ, 1989, ACTA OTO-LARYNGOL, P1, DOI 10.3109/00016488909138632; HALMAGYI GM, 1994, OTOLARYNG HEAD NECK, V111, P571, DOI 10.1016/S0194-5998(94)70523-2; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; HEALY GB, 1982, NEW ENGL J MED, V306, P1029, DOI 10.1056/NEJM198204293061705; Hinoki M., 1984, ACTA OTO-LARYNGOL, V419, P9; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Huppert D, 1994, J AUDIOLOGICAL MED, V4, P97; ILDIZ F, 1994, AVIAT SPACE ENVIR MD, V65, P67; JAFFE BF, 1979, NEW ENGL J MED, V301, P1385, DOI 10.1056/NEJM197912203012507; Jellinger K, 1967, Wien Z Nervenheilkd Grenzgeb, V25, P223; KARNATH HO, 1994, EXP BRAIN RES, V101, P140; Kelders WPA, 2005, J NEUROTRAUM, V22, P133, DOI 10.1089/neu.2005.22.133; Kim SH, 2001, INT J PEDIATR OTORHI, V60, P147, DOI 10.1016/S0165-5876(01)00485-2; KORTSCHOT HW, 1994, ORTHOPADE, V23, P275; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Luxon LM, 1996, DISORDERS VESTIBULAR, P381; MELAMED Y, 1992, NEW ENGL J MED, V326, P30; Nacci A, 2011, ACTA OTORHINOLARYNGO, V31, P378; OOSTERVELD WJ, 1991, ACTA OTO-LARYNGOL, V111, P201, DOI 10.3109/00016489109137375; PULLEN FW, 1992, AM J OTOL, V13, P270; Rajan GP, 2003, ANN OTO RHINOL LARYN, V112, P221, DOI 10.1177/000348940311200305; RUBIN W, 1990, NEUROL CLIN, V8, P225, DOI 10.1016/S0733-8619(18)30352-9; RUTHERFORD WH, 1977, LANCET, V1, P1; SANDSTROM J, 1962, Acta Otolaryngol, V54, P207, DOI 10.3109/00016486209126940; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schessel D. A., 2005, OTOLARYNGOLOGY HEAD; Schumway-Cook A, 2000, VESTIBULAR REHABILIT, P476; Shepard NT, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P779; SHEPARD NT, 1990, NEUROL CLIN, V8, P459, DOI 10.1016/S0733-8619(18)30367-0; TAYLOR SL, 1995, NEUROSURGERY, V37, P649, DOI 10.1227/00006123-199510000-00007; Tranter RMD, 2009, J FORENSIC LEG MED, V16, P53, DOI 10.1016/j.jflm.2008.09.001; Tuohimaa P, 1978, Acta Otolaryngol Suppl, V359, P3; WEEKS VD, 1955, J PEDIATR-US, V47, P315, DOI 10.1016/S0022-3476(55)80006-6; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P540, DOI 10.1016/S0003-9993(97)90173-8; Zee D. S., 2006, NEUROLOGY EYE MOVEME; Zhou D, 1994, Zhonghua Er Bi Yan Hou Ke Za Zhi, V29, P350	61	15	16	0	8	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	APR-JUN	2016	31	2					75	80					6	Clinical Neurology	Neurosciences & Neurology	DR5RH	WOS:000379959600003	27358219	Green Published			2021-06-18	
J	Jesus, TS; Silva, IL				Silva Jesus, Tiago; Lopes Silva, Isabel			Toward an evidence-based patient-provider communication in rehabilitation: linking communication elements to better rehabilitation outcomes	CLINICAL REHABILITATION			English	Article						Patient-physician communication; patient-physician relations; engagement; psychological adaptation; rehabilitation outcomes	SPINAL-CORD-INJURY; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; HEALTH-RELATED QUALITY; LOW-BACK-PAIN; THERAPEUTIC WORKING ALLIANCE; LOWER-LIMB AMPUTATION; INPATIENT REHABILITATION; PSYCHOSOCIAL ADAPTATION; PHYSICAL-ACTIVITY	Background: There is a growing interest in linking aspects of patient-provider communication to rehabilitation outcomes. However, the field lacks a conceptual understanding on: (a) how' rehabilitation outcomes can be improved by communication; and (b) through which' elements in particular. This article elaborates on the conceptual developments toward informing further practice and research. Methods: Existing models of communication in healthcare were adapted to rehabilitation, and its outcomes through a comprehensive literature review. Results: After depicting mediating mechanisms and variables (e.g. therapeutic engagement, adjustment toward disability), this article presents the 4 Rehab Communication Elements' deemed likely to underpin rehabilitation outcomes. The four elements are: (a) knowing the person and building a supportive relationship; (b) effective information exchange and education; (c) shared goal-setting and action planning; and (d) fostering a more positive, yet realistic, cognitive and self-reframing. Discussion: This article describes an unprecedented, outcomes-oriented approach toward the design of rehabilitation communication, which has resulted in the development of a new intervention model: the 4 Rehab Communication Elements'. Further trials are needed to evaluate the impact of this whole intervention model on rehabilitation outcomes.	[Silva Jesus, Tiago] Univ Miguel Hernandez, Hlth Psychol Dept, Sch Med, Elche, Spain; [Silva Jesus, Tiago; Lopes Silva, Isabel] Univ Fernando Pessoa, Oporto, Portugal	Jesus, TS (corresponding author), Univ Miguel Hernandez, Hlth Psychol Dept, Sch Med, Elche, Spain.; Jesus, TS (corresponding author), Univ Fernando Pessoa, Oporto, Portugal.; Jesus, TS (corresponding author), Rua Fogaceiras, P-4520322 Fornos, Santa Maria Da, Portugal.	jesus-ts@outlook.com		Silva Jesus, Tiago/0000-0003-1300-6308; Silva, Isabel/0000-0002-6259-2182			Ahalt C, 2012, J GEN INTERN MED, V27, P568, DOI 10.1007/s11606-011-1933-0; Ahlund K, 2013, J REHABIL MED, V45, P1028, DOI 10.2340/16501977-1219; Alexanders J, 2015, PHYSIOTHERAPY, V101, P95, DOI 10.1016/j.physio.2014.03.008; Amtmann D, 2012, ARCH PHYS MED REHAB, V93, P1757, DOI 10.1016/j.apmr.2012.05.001; Anderson DR, 2014, HEALTH PSYCHOL, V33, P1614, DOI 10.1037/hea0000017; Anderson LM, 2013, J CLIN EPIDEMIOL, V66, P1223, DOI 10.1016/j.jclinepi.2013.06.014; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arbour-Nicitopoulos KP, 2009, ARCH PHYS MED REHAB, V90, P2003, DOI 10.1016/j.apmr.2009.06.019; Balcazar FE, 2009, DISABIL REHABIL, V31, P1153, DOI 10.1080/09638280902773752; Barclay-Goddard R, 2011, ARCH PHYS MED REHAB, V92, P1762, DOI 10.1016/j.apmr.2011.06.013; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Brands I, 2015, CLIN REHABIL, V29, P611, DOI 10.1177/0269215514549484; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; Bravata DM, 2005, ANN INTERN MED, V142, P1056, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00005; Bryant C, 2014, PHYS THER, V94, P1443, DOI 10.2522/ptj.20130444; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Chan DK, 2009, ARCH PHYS MED REHAB, V90, P1977, DOI 10.1016/j.apmr.2009.05.024; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Chow EOW, 2015, CLIN REHABIL, V29, P315, DOI 10.1177/0269215514544039; Clark AM, 2013, SOC SCI MED, V93, P185, DOI 10.1016/j.socscimed.2012.03.035; Coffey L, 2014, ARCH PHYS MED REHAB, V95, P1895, DOI 10.1016/j.apmr.2014.05.012; Coffey L, 2014, ARCH PHYS MED REHAB, V95, P244, DOI 10.1016/j.apmr.2013.08.011; Craig P, 2013, INT J NURS STUD, V50, P587, DOI 10.1016/j.ijnurstu.2012.09.010; Darlington ASE, 2009, J REHABIL MED, V41, P237, DOI 10.2340/16501977-0313; de Haes H, 2009, PATIENT EDUC COUNS, V74, P287, DOI 10.1016/j.pec.2008.12.006; Dibbelt S, 2009, PATIENT EDUC COUNS, V76, P328, DOI 10.1016/j.pec.2009.07.031; Dijkers MP, 2013, ARCH PHYS MED REHAB, V94, pS115, DOI 10.1016/j.apmr.2012.11.047; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P515, DOI 10.1080/09602011.2011.583500; Ehde DM, 2013, ARCH PHYS MED REHAB, V94, pS30, DOI 10.1016/j.apmr.2012.10.025; Del Bano-Aledo ME, 2014, PHYSIOTHERAPY, V100, P73, DOI 10.1016/j.physio.2013.05.001; Epstein R.M., 2007, PATIENT CTR COMMUNIC; Epstein RM, 2011, ANN FAM MED, V9, P454, DOI 10.1370/afm.1301; Escolar-Reina P, 2009, ARCH PHYS MED REHAB, V90, P1734, DOI 10.1016/j.apmr.2009.05.012; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Eyssen ICJM, 2014, J REHABIL MED, V46, P527, DOI 10.2340/16501977-1797; Fadyl JK, 2011, BMJ QUAL SAF, V20, P87, DOI 10.1136/bmjqs.2010.042812; Farin E, 2013, J BEHAV MED, V36, P246, DOI 10.1007/s10865-012-9419-z; Ferreira PH, 2013, PHYS THER, V93, P470, DOI 10.2522/ptj.20120137; Forster A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001919.pub3; Fuentes J, 2014, PHYS THER, V94, P477, DOI 10.2522/ptj.20130118; Glattacker M, 2013, J REHABIL MED, V45, P268, DOI 10.2340/16501977-1104; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Gregorio GW, 2011, J REHABIL MED, V43, P190, DOI 10.2340/16501977-0633; Hafsteinsdottir TB, 2011, PATIENT EDUC COUNS, V85, P14, DOI 10.1016/j.pec.2010.07.046; Haggman S, 2004, PHYS THER, V84, P1157, DOI 10.1093/ptj/84.12.1157; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS106, DOI 10.1016/j.apmr.2012.12.023; Hanks RA, 2014, ARCH PHYS MED REHAB, V95, P2096, DOI 10.1016/j.apmr.2014.06.017; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Hart T, 2014, ARCH PHYS MED REHAB, V95, pS33, DOI 10.1016/j.apmr.2013.05.032; Hart T, 2013, DISABIL REHABIL, V35, P1668, DOI 10.3109/09638288.2012.751131; Hart T, 2012, ARCH PHYS MED REHAB, V93, pS117, DOI 10.1016/j.apmr.2011.11.039; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Hemsley B, 2014, AUGMENT ALTERN COMM, V30, P329, DOI 10.3109/07434618.2014.955614; Henry SG, 2012, PATIENT EDUC COUNS, V86, P297, DOI 10.1016/j.pec.2011.07.006; Hill AM, 2011, ARCH PHYS MED REHAB, V92, P1395, DOI 10.1016/j.apmr.2011.04.009; Hunt MR, 2013, AM J PHYS MED REHAB, V92, P818, DOI 10.1097/PHM.0b013e318292309b; Jensen MP, 2011, ARCH PHYS MED REHAB, V92, P146, DOI 10.1016/j.apmr.2010.09.021; Kortte KB, 2007, ARCH PHYS MED REHAB, V88, P877, DOI 10.1016/j.apmr.2007.03.030; Kortte KB, 2012, REHABIL PSYCHOL, V57, P248, DOI 10.1037/a0029004; Kortte KB, 2010, REHABIL PSYCHOL, V55, P40, DOI 10.1037/a0018624; Kruithof WJ, 2013, PATIENT EDUC COUNS, V93, P169, DOI 10.1016/j.pec.2013.06.003; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P1599, DOI 10.1016/j.apmr.2004.03.027; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levasseur M, 2010, CLIN REHABIL, V24, P756, DOI 10.1177/0269215509360752; Livneh H, 2014, REHABIL PSYCHOL, V59, P329, DOI 10.1037/a0036733; Makoul G, 2007, PATIENT EDUC COUNS, V67, P333, DOI 10.1016/j.pec.2007.05.005; Martz E, 2005, ARCH PHYS MED REHAB, V86, P1182, DOI 10.1016/j.apmr.2004.11.036; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Morris JH, 2014, ARCH PHYS MED REHAB, V95, P956, DOI 10.1016/j.apmr.2013.12.016; Morris MA, 2015, DISABIL HEALTH J, V8, P208, DOI 10.1016/j.dhjo.2014.09.007; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Muller R, 2015, ARCH PHYS MED REHAB, V96, P447, DOI 10.1016/j.apmr.2014.09.006; Murray A, 2015, ARCH PHYS MED REHAB, V96, P809, DOI 10.1016/j.apmr.2014.11.007; Neumann M, 2010, PATIENT EDUC COUNS, V80, P307, DOI 10.1016/j.pec.2010.07.020; Nielsen M, 2014, PHYS THER, V94, P197, DOI 10.2522/ptj.20130047; O'Halloran PD, 2014, CLIN REHABIL, V28, P1159, DOI 10.1177/0269215514536210; Oliveira VC, 2012, J PHYSIOTHER, V58, P215, DOI 10.1016/S1836-9553(12)70123-6; Parry RH, 2009, PHYSIOTHERAPY, V95, P294, DOI 10.1016/j.physio.2009.05.003; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Peiris CL, 2012, J PHYSIOTHER, V58, P261, DOI 10.1016/S1836-9553(12)70128-5; Peter C, 2012, SPINAL CORD, V50, P188, DOI 10.1038/sc.2011.125; Peter C, 2014, QUAL LIFE RES, V23, P2693, DOI 10.1007/s11136-014-0721-9; Peter C, 2014, ARCH PHYS MED REHAB, V95, P1662, DOI 10.1016/j.apmr.2014.04.012; Pinto RZ, 2012, J PHYSIOTHER, V58, P77, DOI 10.1016/S1836-9553(12)70087-5; Playford ED, 2009, CLIN REHABIL, V23, P334, DOI 10.1177/0269215509103506; Portegijs E, 2012, ARCH PHYS MED REHAB, V93, P2340, DOI 10.1016/j.apmr.2012.05.022; Rosewilliam S, 2011, CLIN REHABIL, V25, P501, DOI 10.1177/0269215510394467; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Schmid AA, 2012, ARCH PHYS MED REHAB, V93, P1101, DOI 10.1016/j.apmr.2012.01.020; Schmid AA, 2012, ARCH PHYS MED REHAB, V93, P978, DOI 10.1016/j.apmr.2011.12.012; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Schmitz MA, 2010, TOP STROKE REHABIL, V17, P204, DOI 10.1310/tsr1703-204; Schonberger M, 2007, BRAIN INJURY, V21, P825, DOI 10.1080/02699050701499433; Schoenthaler A, 2014, PATIENT EDUC COUNS, V96, P3, DOI 10.1016/j.pec.2014.04.006; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schrijnemaekers AC, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/01.HTR.0000438117.63852.b4; Schwartz CE, 2010, ARCH PHYS MED REHAB, V91, pS38, DOI 10.1016/j.apmr.2009.11.029; Schwarzer R, 2008, HEALTH PSYCHOL, V27, pS54, DOI 10.1037/0278-6133.27.1(Suppl.).S54; Schwarzer R, 2011, REHABIL PSYCHOL, V56, P161, DOI 10.1037/a0024509; Scobbie L, 2011, CLIN REHABIL, V25, P468, DOI 10.1177/0269215510389198; Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010; Jesus TS, 2015, ARCH PHYS MED REHAB, V96, P960, DOI 10.1016/j.apmr.2014.12.007; Silverman J, 2009, PATIENT EDUC COUNS, V76, P361, DOI 10.1016/j.pec.2009.06.011; Skidmore ER, 2010, ARCH PHYS MED REHAB, V91, P203, DOI 10.1016/j.apmr.2009.10.026; Smedema SM, 2010, DISABIL REHABIL, V32, P1311, DOI 10.3109/09638280903514721; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Tate DG, 2015, ARCH PHYS MED REHAB, V96, P340, DOI 10.1016/j.apmr.2014.09.036; Tielemans NS, 2014, CLIN REHABIL, V28, P530, DOI 10.1177/0269215513514460; Tielemans NS, 2014, ARCH PHYS MED REHAB, V95, P670, DOI 10.1016/j.apmr.2013.11.010; van Leeuwen CMC, 2012, SPINAL CORD, V50, P174, DOI 10.1038/sc.2011.120; van Leeuwen CMC, 2012, QUAL LIFE RES, V21, P1499, DOI 10.1007/s11136-011-0073-7; van Mierlo ML, 2014, INT J STROKE, V9, P341, DOI 10.1111/ijs.12149; van Til JA, 2010, J REHABIL MED, V42, P598, DOI 10.2340/16501977-0549; Venetis MK, 2009, PATIENT EDUC COUNS, V77, P379, DOI 10.1016/j.pec.2009.09.015; Wanyonyi KL, 2011, PATIENT EDUC COUNS, V85, P348, DOI 10.1016/j.pec.2011.02.006; Watkins CL, 2011, STROKE, V42, P1956, DOI 10.1161/STROKEAHA.110.602227; Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x; Wiles R, 2004, SOC SCI MED, V59, P1263, DOI 10.1016/j.socscimed.2003.12.022; Wiles R, 2008, J ADV NURS, V64, P564, DOI 10.1111/j.1365-2648.2008.04815.x; Wright BJ, 2014, J REHABIL MED, V46, P153, DOI 10.2340/16501977-1241; Zimmermann L, 2014, PATIENT EDUC COUNS, V96, P98, DOI 10.1016/j.pec.2014.04.015	128	15	15	0	29	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	APR	2016	30	4					315	328		10.1177/0269215515585133			14	Rehabilitation	Rehabilitation	DH0LD	WOS:000372474800002	25952588				2021-06-18	
J	Sacco, K; Galetto, V; Dimitri, D; Geda, E; Perotti, F; Zettin, M; Geminiani, GC				Sacco, Katiuscia; Galetto, Valentina; Dimitri, Danilo; Geda, Elisabetta; Perotti, Francesca; Zettin, Marina; Geminiani, Giuliano C.			Concomitant Use of Transcranial Direct Current Stimulation and Computer-Assisted Training for the Rehabilitation of Attention in Traumatic Brain Injured Patients: Behavioral and Neuroimaging Results	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						transcranial direct current stimulation (tDCS); cognitive rehabilitation; attention; traumatic brain injury (TB!); functional magnetic resonance imaging (fMRI); cerebral plasticity	DORSOLATERAL PREFRONTAL CORTEX; DIVIDED ATTENTION; COGNITIVE REHABILITATION; TDCS; DRIVERS; MEMORY; QUESTION; EVENTS; HEALTH	Divided attention (DA), the ability to distribute cognitive resources among two or more simultaneous tasks, may be severely compromised after traumatic brain injury (TBI), resulting in problems with numerous activities involved with daily living. So far, no research has investigated whether the use of non-invasive brain stimulation associated with neuropsychological rehabilitation might contribute to the recovery of such cognitive function. The main purpose of this study was to assess the effectiveness of 10 transcranial direct current stimulation (tDCS) sessions combined with computer-assisted training; it also intended to explore the neural modifications induced by the treatment. Thirty-two patients with severe TBI participated in the study: 16 were part of the experimental group, and 16 part of the control group. The treatment included 20' of tDCS, administered twice a day for 5 days. The electrodes were placed on the dorsolateral prefrontal cortex. Their location varied across patients and it depended on each participant's specific area of damage. The control group received sham tDCS. After each tDCS session, the patient received computer-assisted cognitive training on DA for 40'. The results showed that the experimental group significantly improved in DA performance between pre- and post-treatment, showing faster reaction times (RTs), and fewer omissions. No improvement was detected between the baseline assessment (i.e., 1 month before treatment) and the pre-training assessment, or within the control group. Functional magnetic resonance imaging (fMRI) data, obtained on the experimental group during a DA task, showed post-treatment lower cerebral activations in the right superior temporal gyrus (BA 42), right and left middle frontal gyrus (BA 6), right postcentral gyrus (BA 3) and left inferior frontal gyrus (BA 9). We interpreted such neural changes as normalization of previously abnormal hyperactivations.	[Sacco, Katiuscia; Galetto, Valentina; Dimitri, Danilo; Geda, Elisabetta; Perotti, Francesca; Zettin, Marina; Geminiani, Giuliano C.] Univ Turin, Imaging & Cerebral Plast Res Grp, Dept Psychol, Turin, Italy; [Sacco, Katiuscia; Geminiani, Giuliano C.] Univ Turin, Neurosci Inst Turin, Turin, Italy; [Galetto, Valentina; Dimitri, Danilo; Zettin, Marina] Ctr Puzzle, Turin, Italy	Galetto, V (corresponding author), Univ Turin, Imaging & Cerebral Plast Res Grp, Dept Psychol, Turin, Italy.; Galetto, V (corresponding author), Ctr Puzzle, Turin, Italy.	valentinagaletto@virgilio.it			ex WO	This research has been supported by local research funds (ex WO managed by University of Turin, Department of Psychology, year 2014, and by the Brain Imaging Group Association. The authors are grateful to the patients who participated in the research, and to the reviewers. A special thanks goes to our radiology technician, Dumitru Scafesi, for his courtesy and kindness.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; Bikson M, 2012, NEUROMODULATION, V15, P306, DOI 10.1111/j.1525-1403.2012.00481.x; Brouwer W, 2001, BRAIN COGNITION, V46, P54, DOI 10.1016/S0278-2626(01)80033-6; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clark VP, 2014, NEUROIMAGE, V85, P889, DOI 10.1016/j.neuroimage.2013.08.071; Collette F, 2005, COGNITIVE BRAIN RES, V24, P237, DOI 10.1016/j.cogbrainres.2005.01.023; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; De Luca R, 2014, DISABIL HEALTH J, V7, P356, DOI 10.1016/j.dhjo.2014.04.003; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Jackson ML, 2011, BRAIN IMAGING BEHAV, V5, P97, DOI 10.1007/s11682-011-9115-6; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Johnson JA, 2007, J COGNITIVE NEUROSCI, V19, P907, DOI 10.1162/jocn.2007.19.6.907; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Klingberg T, 2000, PROG BRAIN RES, V126, P95; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P257; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Loose R, 2003, HUM BRAIN MAPP, V18, P249, DOI 10.1002/hbm.10082; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Masson M, 2013, BRAIN INJURY, V27, P538, DOI 10.3109/02699052.2013.766926; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Montani V, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00409; Nebel K, 2005, COGNITIVE BRAIN RES, V25, P760, DOI 10.1016/j.cogbrainres.2005.09.011; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Park SH, 2013, J KOREAN NEUROSURG S, V54, P484, DOI 10.3340/jkns.2013.54.6.484; PONSFORD A, 1991, Radiography Today, V57, P10; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Scelzo E, 2011, EUR PSYCHIAT, V26; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shin YI, 2015, NEUROPSYCHOLOGIA, V69, P154, DOI 10.1016/j.neuropsychologia.2015.02.002; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Tachibana A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-26; Toyokura Minoru, 2012, Tokai J Exp Clin Med, V37, P19; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wagner M, 2006, J PSYCHIATR RES, V40, P315, DOI 10.1016/j.jpsychires.2005.06.001; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	53	15	16	0	23	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	MAR 31	2016	10								57	10.3389/fnbeh.2016.00057			11	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	DH8IF	WOS:000373036000001	27065823	DOAJ Gold, Green Published			2021-06-18	
J	Morawska, MM; Buchele, F; Moreira, CG; Imbach, LL; Noain, D; Baumann, CR				Morawska, Marta M.; Buechele, Fabian; Moreira, Carlos Goncalves; Imbach, Lukas L.; Noain, Daniela; Baumann, Christian R.			Sleep Modulation Alleviates Axonal Damage and Cognitive Decline after Rodent Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article						diffuse axonal damage; memory; sleep; traumatic brain injury	GAMMA-HYDROXYBUTYRIC ACID; AMYLOID PRECURSOR PROTEIN; EEG POWER SPECTRA; VIGILANCE STATES; MEMORY; DEPRIVATION; RATS; BETA; ACCUMULATION; IMPAIRMENT	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. It produces diffuse axonal injury (DAI), which contributes to cognitive impairment, but effective disease-modifying treatment strategies are missing. We have recently developed a rat model of closed skull TBI that reproduces human TBI consequences, including DAI and clinical sequelae such as memory impairment. Here, we investigated whether sleep modulation after trauma has an impact on DAI and memory outcome. We assessed cognition with the novel object recognition test and stained for amyloid precursor protein, a DAI marker. We found that both sleep induction and restriction acutely after TBI enhanced encephalographic slow-wave activity, markedly reduced diffuse axonal damage in the cortex and hippocampus, and improved memory impairment 2 weeks after trauma. These results suggest that enhancing slow-wave sleep acutely after trauma may have a beneficial disease-modifying effect in subjects with acute TBI.	[Morawska, Marta M.; Buechele, Fabian; Moreira, Carlos Goncalves; Imbach, Lukas L.; Noain, Daniela; Baumann, Christian R.] Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland	Morawska, MM (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	marta.morawska@usz.ch		Imbach, Lukas/0000-0002-6135-8642; Morawska, Marta/0000-0003-1612-6786; Baumann, Christian/0000-0003-3417-1978; Buechele, Fabian/0000-0001-7091-1676			Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Bellesi M, 2013, J NEUROSCI, V33, P14288, DOI 10.1523/JNEUROSCI.5102-12.2013; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buchele F, 2015, J NEUROTRAU IN PRESS; Cam E, 2013, EXP NEUROL, V247, P673, DOI 10.1016/j.expneurol.2013.03.003; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; ENTHOLZNER E, 1995, ANAESTHESIST, V44, P345, DOI 10.1007/s001010050163; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198; Gao B, 2008, CEREBROVASC DIS, V26, P413, DOI 10.1159/000151683; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hodor A, 2015, NEUROSCIENCE, V284, P18, DOI 10.1016/j.neuroscience.2014.08.061; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klein C, 2015, NEUROBIOL AGING, V36, P832, DOI 10.1016/j.neurobiolaging.2014.10.003; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LETTIERI JT, 1979, J PHARMACOL EXP THER, V208, P7; Li SH, 2006, NEUROSCI LETT, V409, P182, DOI 10.1016/j.neulet.2006.09.054; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mander BA, 2015, NAT NEUROSCI, V18, P1051, DOI 10.1038/nn.4035; Martinez-Vargas M, 2012, NEUROSCI LETT, V529, P118, DOI 10.1016/j.neulet.2012.09.037; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Meerlo P, 2004, SLEEP, V27, P899, DOI 10.1093/sleep/27.5.899; Nava F, 2001, EUR J PHARMACOL, V430, P261, DOI 10.1016/S0014-2999(01)01163-3; Plante DT, 2015, CLIN NEUROPHYSIOL; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TOBLER I, 1987, J COMP PHYSIOL A, V161, P449, DOI 10.1007/BF00603970; Tobler I, 1997, J NEUROSCI, V17, P1869; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	42	15	15	0	8	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 23	2016	36	12					3422	3429		10.1523/JNEUROSCI.3274-15.2016			8	Neurosciences	Neurosciences & Neurology	DH4HU	WOS:000372747100005	27013672	Green Accepted, Green Published, Bronze			2021-06-18	
J	Chou, A; Morganti, JM; Rosi, S				Chou, Austin; Morganti, Josh M.; Rosi, Susanna			Frontal Lobe Contusion in Mice Chronically Impairs Prefrontal-Dependent Behavior	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CARD SORTING TEST; SOCIAL COGNITION; ORBITOFRONTAL CORTEX; HEAD-INJURY; LESIONS; ANXIETY; DYSFUNCTION; PERFORMANCE; REVERSAL	Traumatic brain injury (TBI) is a major cause of chronic disability in the world. Moderate to severe TBI often results in damage to the frontal lobe region and leads to cognitive, emotional, and social behavioral sequelae that negatively affect quality of life. More specifically, TBI patients often develop persistent deficits in social behavior, anxiety, and executive functions such as attention, mental flexibility, and task switching. These deficits are intrinsically associated with prefrontal cortex (PFC) functionality. Currently, there is a lack of analogous, behaviorally characterized TBI models for investigating frontal lobe injuries despite the prevalence of focal contusions to the frontal lobe in TBI patients. We used the controlled cortical impact (CCI) model in mice to generate a frontal lobe contusion and studied behavioral changes associated with PFC function. We found that unilateral frontal lobe contusion in mice produced long-term impairments to social recognition and reversal learning while having only a minor effect on anxiety and completely sparing rule shifting and hippocampal-dependent behavior.	[Chou, Austin; Morganti, Josh M.; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Chou, Austin; Rosi, Susanna] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Chou, Austin; Morganti, Josh M.; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA.	rosis@ptrehab.ucsf.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049; Chou, Austin/0000-0003-4328-5811	National Institute Of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21NS087458, R21AG042016]; Alzheimer's AssociationAlzheimer's Association [IIRG-11-202064]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS087458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG042016] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute Of Neurological Disorders And Stroke and National Institute on Aging of the National Institutes of Health under award numbers R21NS087458 (S.R.); R21AG042016 (S.R.); Alzheimer's Association IIRG-11-202064 (S.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsop SA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00241; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Brooks JM, 2012, NEUROPSYCHOPHARMACOL, V37, P2476, DOI 10.1038/npp.2012.106; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Cho KKA, 2015, NEURON, V85, P1332, DOI 10.1016/j.neuron.2015.02.019; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fox MT, 2003, J NEUROSCI, V23, P676; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Placek K, 2013, BEHAV BRAIN RES, V256, P405, DOI 10.1016/j.bbr.2013.08.034; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Rudebeck PH, 2014, NEURON, V84, P1143, DOI 10.1016/j.neuron.2014.10.049; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Sobota R, 2015, BEHAV NEUROSCI, V129, P389, DOI 10.1037/bne0000074; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; Wood Jacqueline N, 2003, Behav Cogn Neurosci Rev, V2, P97; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Young JW, 2010, COGN AFFECT BEHAV NE, V10, P243, DOI 10.3758/CABN.10.2.243	51	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151418	10.1371/journal.pone.0151418			14	Multidisciplinary Sciences	Science & Technology - Other Topics	DG3TL	WOS:000371993000150	26964036	DOAJ Gold, Green Published			2021-06-18	
J	Konstantinou, N; Pettemeridou, E; Seimenis, I; Eracleous, E; Papacostas, SS; Papanicolaou, AC; Constantinidou, F				Konstantinou, Nikos; Pettemeridou, Eva; Seimenis, Ioannis; Eracleous, Eleni; Papacostas, Savvas S.; Papanicolaou, Andrew C.; Constantinidou, Fofi			Assessing the Relationship between Neurocognitive Performance and Brain Volume in Chronic Moderate-Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						TBI; VBM; grey matter; white matter; neurocognitive/neuropsychological assessment; brain atrophy	VOXEL-BASED MORPHOMETRY; SHORT-TERM-MEMORY; WHITE-MATTER; HEAD-INJURY; ALZHEIMERS-DISEASE; DIFFUSION-TENSOR; LONGITUDINAL CHANGES; COGNITIVE CONTROL; AXONAL INJURY; CELL-DEATH	Objectives: Characterize the scale and pattern of long-term atrophy in gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF) in chronic moderate-severe traumatic brain injury (TBI) and its relationship to neurocognitive outcomes. Participants: The TBI group consisted of 17 males with primary diagnosis of moderate-severe closed head injury. Participants had not received any systematic, postacute rehabilitation and were recruited on average 8.36 years post- injury. The control group consisted of 15 males matched on age and education. Main measures: Neurocognitive battery included widely used tests of verbal memory, visual memory, executive functioning, and attention/organization. GM, WM, and CSF volumes were calculated from segmented T1-weighted anatomical MR images. Voxelbased morphometry was employed to identify brain regions with differences in GM and WM between TBI and control groups. Results: Chronic TBI results in significant neurocognitive impairments, and significant loss of GM and WM volume, and significant increase in CSF volume. Brain atrophy is not widespread, but it is rather distributed in a fronto-thalamic network. The extent of volume loss is predictive of performance on the neurocognitive tests. Conclusion: Significant brain atrophy and associated neurocognitive impairments during the chronic stages of TBI support the notion that TBI results in a chronic condition with lifelong implications.	[Konstantinou, Nikos; Pettemeridou, Eva; Constantinidou, Fofi] Univ Cyprus, Ctr Appl Neurosci, CY-1678 Nicosia, Cyprus; [Konstantinou, Nikos; Pettemeridou, Eva; Constantinidou, Fofi] Univ Cyprus, Dept Psychol, CY-1678 Nicosia, Cyprus; [Seimenis, Ioannis] Democritus Univ Thrace, Sch Med, Dept Med Phys, Alexandroupolis, Greece; [Eracleous, Eleni] Med Diagnost Ctr Ayios Therissos, Nicosia, Cyprus; [Papacostas, Savvas S.] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Neurol Clin B, Nicosia, Cyprus; [Papanicolaou, Andrew C.] Univ Tennessee, Hlth Sci Ctr, Div Clin Neurosci, Dept Pediat,Le Bonheur Neurosci Inst, Memphis, TN USA; [Papanicolaou, Andrew C.] Univ Tennessee, Hlth Sci Ctr, Div Clin Neurosci, Dept Neurobiol & Anat,Le Bonheur Neurosci Inst, Memphis, TN USA	Konstantinou, N (corresponding author), Univ Cyprus, Ctr Appl Neurosci, CY-1678 Nicosia, Cyprus.; Konstantinou, N (corresponding author), Univ Cyprus, Dept Psychol, CY-1678 Nicosia, Cyprus.	nkonstantinou@gmail.com	Seimenis, Ioannis/AAF-4406-2021	Seimenis, Ioannis/0000-0003-3665-5271; Constantinidou, Fofi/0000-0002-7928-8363; Konstantinou, Nikos/0000-0003-4531-3636; Papacostas, Savvas/0000-0003-3845-7439	Cyprus Research Promotion Foundation; Cyprus Government; European Regional Development FundEuropean Commission [NEW INFRASTRUCTURE/STRATEGIC/0309/37]	This work was supported by the Cyprus Research Promotion Foundation through a grant co-funded by the Cyprus Government and the European Regional Development Fund (FC, PI; NEW INFRASTRUCTURE/STRATEGIC/0309/37).	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Aleman-Gomez Y., 2006, 12 ANN M ORG HUM BRA; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Areza-Fegyveres R, 2007, ARQ NEURO-PSIQUIAT, V65, P830, DOI 10.1590/S0004-282X2007000500019; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 1997, AM J NEURORADIOL, V18, P24; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Braitenberg V, 1977, TEXTURE BRAINS INTRO; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Constantinidou F, 2011, CHILD NEUROPSYCHOL, V2011, P37; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Frisoni GB, 2010, ALZHEIMERS DEMENT, V6, P280, DOI 10.1016/j.jalz.2010.03.005; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Klauer KC, 2004, J EXP PSYCHOL GEN, V133, P355, DOI 10.1037/0096-3445.133.3.355; Konstantinou N, 2013, J VIS, V13, P6, DOI [10.1167/13.9.6, DOI 10.1167/13.9.6]; Konstantinou N, 2014, ATTEN PERCEPT PSYCHO, V76, P1985, DOI 10.3758/s13414-014-0742-z; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MAWDSLEY C, 1963, LANCET, V2, P795; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Rey A., 1993, CLIN NEUROPSYCHOL, V7, P4; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; XU Y, 2009, J CEREB BLOOD FLOW M, V30, P883, DOI DOI 10.1038/JCBFM.2009.263; Zalonis I, 2008, CLIN NEUROPSYCHOL, V22, P842, DOI 10.1080/13854040701629301; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	81	15	15	0	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 10	2016	7								29	10.3389/fneur.2016.00029			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DF9DI	WOS:000371660100001	27014183	DOAJ Gold, Green Published			2021-06-18	
J	Goble, DJ; Manyak, KA; Abdenour, TE; Rauh, MJ; Baweja, HS				Goble, Daniel J.; Manyak, Kristin A.; Abdenour, Thomas E.; Rauh, Mitchell J.; Baweja, Harsimran S.			AN INITIAL EVALUATION OF THE BTRACKS BALANCE PLATE AND SPORTS BALANCE SOFTWARE FOR CONCUSSION DIAGNOSIS	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						balance; BTrackS; concussion; diagnostic accuracy; sensitivity	MILD HEAD-INJURY; POSTURAL STABILITY; FOOTBALL PLAYERS; RECOVERY; RELIABILITY; COLLEGIATE; STATEMENT; VALIDITY	Background: As recently dictated by the American Medical Society, balance testing is an important component in the clinical evaluation of concussion. Despite this, previous research on the efficacy of balance testing for concussion diagnosis suggests low sensitivity (similar to 30%), based primarily on the popular Balance Error Scoring System (BESS). The Balance Tracking System (BTrackS, Balance Tracking Systems Inc., San Diego, CA, USA) consists of a force plate (BTrackS Balance Plate) and software (BTrackS Sport Balance) which can quickly (<2 min) perform concussion balance testing with gold standard accuracy. Purpose: The present study aimed to determine the sensitivity of the BTrackS Balance Plate and Sports Balance Software for concussion diagnosis. Study Design: Cross-Sectional Study Methods: Preseason baseline balance testing of 519 healthy Division I college athletes playing sports with a relatively high risk for concussions was performed with the BTrackS Balance Test. Testing was administered by certified athletic training staff using the BTrackS Balance Plate and Sport Balance software. Of the baselined athletes, 25 later experienced a concussion during the ensuing sport season. Post-injury balance testing was performed on these concussed athletes within 48 of injury and the sensitivity of the BTrackS Balance Plate and Sport Balance software was estimated based on the number of athletes showing a balance decline according to the criteria specified in the Sport Balance software. This criteria is based on the minimal detectable change statistic with a 90% confidence level (i.e. 90% specificity). Results: Of 25 athletes who experienced concussions, 16 had balance declines relative to baseline testing results according to the BTrackS Sport Balance software criteria. This corresponds to an estimated concussion sensitivity of 64%, which is twice as great as that reported previously for the BESS. Conclusions: The BTrackS Balance Plate and Sport Balance software has the greatest concussion sensitivity of any balance testing instrument reported to date.	[Goble, Daniel J.; Rauh, Mitchell J.; Baweja, Harsimran S.] San Diego State Univ, Sch Exercise & Nutr Sci, Coll Hlth & Human Sci, San Diego, CA 92182 USA; [Manyak, Kristin A.; Abdenour, Thomas E.] San Diego State Univ, Dept Athlet, San Diego, CA 92182 USA	Goble, DJ (corresponding author), San Diego State Univ, Dept Exercise & Nutr Sci, 5500 Campanile Dr, San Diego, CA 92182 USA.	dgoble@mail.sdsu.edu	Goble, Daniel/A-1317-2007	Goble, Daniel/0000-0002-8027-6722			Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Goble D. J., 2015, BALANCE TRACKING SYS; Golriz S, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-15; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kerr ZY, J ATHL TRAI IN PRESS; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Wasserman EB, AM J SPORTS IN PRESS	23	15	15	1	6	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	MAR	2016	11	2					149	155					7	Sport Sciences	Sport Sciences	FG1PP	WOS:000409600700001	27104048				2021-06-18	
J	Mullah, SH; Saha, BK; Abutarboush, R; Walker, PB; Haque, A; Arnaud, FG; Hazzard, B; Auker, CR; McCarron, RM; Scultetus, AH; Moon-Massat, P				Mullah, Saad H.; Saha, Biswajit K.; Abutarboush, Rania; Walker, Peter B.; Haque, Ashraful; Arnaud, Francoise G.; Hazzard, Brittany; Auker, Charles R.; McCarron, Richard M.; Scultetus, Anke H.; Moon-Massat, Paula			Perfluorocarbon NVX-108 increased cerebral oxygen tension after traumatic brain injury in rats	BRAIN RESEARCH			English	Article						Brain interstitial oxygen pressure; Oxygen therapeutics; Perfluorocarbon; Early resuscitation; Traumatic brain injury; Phosphorescence quenching method	SEVERE HEAD-INJURY; DODECAFLUOROPENTANE EMULSION; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; TISSUE OXYGENATION; INTERSTITIAL SPACE; SKELETAL-MUSCLE; CORTICAL IMPACT; STROKE MODEL; IN-VIVO	Background: Hypoxia is a critical secondary injury mechanism in traumatic brain injury (TBI), and early intervention to alleviate post-TBI hypoxia may be beneficial. NVX-108, a dodecafluoropentane perfluorocarbon, was screened for its ability to increase brain tissue oxygen tension (PbtO(2)) when administered soon after TBI. Methods: Ketamine-acepromazine anesthetized rats ventilated with 40% oxygen underwent moderate controlled cortical impact (CCI)-TBI at time O (TO). Rats received either no treatment (NON, n=8) or 0.5 ml/kg intravenous (IV) NVX-108 (NVX, n=9) at T15 (15 min after TBI) and T75. Results: Baseline cortical PbtO(2) was 28+3 mm Hg and CCI-TBI resulted in a 46+6% reduction in PbtO(2) at T15 (P <0.001). Significant differences in time-group interactions (P=0.013) were found when comparing either absolute or percentage change of PbtO(2) to post-injury (mixed-model ANOVA) suggesting that administration of NVX-108 increased PbtO(2) above injury levels while it remained depressed in the NON group. Specifically in the NVX group, PbtO(2) increased to a peak 143% of T15 (P=0.02) 60 min after completion of NVX-108 injection (T135). Systemic blood pressure was not different between the groups. Conclusion: NVX-108 caused an increase in PbtO(2) following CCI-TBI in rats and should be evaluated further as a possible immediate treatment for TBI. Published by Elsevier B.V.	[Mullah, Saad H.; Saha, Biswajit K.; Abutarboush, Rania; Walker, Peter B.; Haque, Ashraful; Arnaud, Francoise G.; Hazzard, Brittany; Auker, Charles R.; McCarron, Richard M.; Scultetus, Anke H.; Moon-Massat, Paula] Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Arnaud, Francoise G.; Auker, Charles R.; McCarron, Richard M.; Scultetus, Anke H.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA	Mullah, SH (corresponding author), Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.				Defense Health Program (DHP) work unit [603115HP.3730.001.A1247]	The work was supported by Defense Health Program (DHP) work unit number 603115HP.3730.001.A1247.	Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Briceno JC, 1999, ASAIO J, V45, P322, DOI 10.1097/00002480-199907000-00013; Cabrales P, 2011, ANESTHESIOLOGY, V114, P901, DOI 10.1097/ALN.0b013e31820efb36; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Chowdhury T, 2014, SAUDI J ANAESTH, V8, P114, DOI 10.4103/1658-354X.125971; Correas JM, 1996, CLIN RADIOL, V51, P11; Culp WC, 2012, J VASC INTERV RADIOL, V23, P116, DOI 10.1016/j.jvir.2011.10.001; Daugherty WP, 2004, NEUROSURGERY, V54, P1223, DOI 10.1227/01.NEU.0000119238.68938.5D; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Fraker CA, 2013, CELL TRANSPLANT, V22, P1723, DOI 10.3727/096368912X657873; GEYER RP, 1988, BIOMATER ARTIF CELL, V16, P31; Johnson JLH, 2015, J BIOMED NANOTECHNOL, V11, P274, DOI 10.1166/jbn.2015.1903; Johnson JLH, 2009, ARTIF CELL BLOOD SUB, V37, P156, DOI 10.1080/10731190903043192; Kim HW, 2004, ARTIF ORGANS, V28, P813, DOI 10.1111/j.1525-1594.2004.07345.x; Lundgren CEG, 2006, ARTIF CELL BLOOD SUB, V34, P473, DOI 10.1080/10731190600769271; Melani A, 2003, BRAIN RES, V959, P243, DOI 10.1016/S0006-8993(02)03753-8; Mendez DR, 2004, J TRAUMA, V57, P244, DOI 10.1097/01.TA.0000103983.22362.67; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Moon-Massat P., 2015, J NEUROTRAUMA; Moon-Massat P.F., 2014, CURR DRUG DISCOV TEC; Mullah S.H., 2013, ACTA NEUROCHIR SUP S, V118, pS89; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ohata H, 2001, ANESTH ANALG, V93, P697, DOI 10.1097/00000539-200109000-00032; Paxian M, 2003, SHOCK, V20, P449, DOI 10.1097/01.shk.0000090601.26659.87; Riess JG, 2005, ARTIF CELL BLOOD SUB, V33, P47, DOI 10.1081/BIO-200046659; Schroeder JL, 2008, J NEUROSURG-SPINE, V9, P213, DOI 10.3171/SPI/2008/9/8/213; Swyer T, 2014, PERFUSION; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Torres IP, 1996, MICROVASC RES, V51, P202; Tsai AG, 2007, ANTIOXID REDOX SIGN, V9, P979, DOI 10.1089/ars.2007.1633; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; WEINER M, 1994, ARTIF CELL BLOOD SUB, V22, P763, DOI 10.3109/10731199409117909; Wilson DF, 2008, ADV EXP MED BIOL, V614, P53, DOI 10.1007/978-0-387-74911-2_7; Wilson DF, 2006, J APPL PHYSIOL, V101, P1648, DOI 10.1152/japplphysiol.00394.2006; Woods SD, 2013, MOL NEUROBIOL, V48, P363, DOI 10.1007/s12035-013-8495-6; Yu J, 2013, ANAESTHESIA, V68, P723, DOI 10.1111/anae.12227	38	15	15	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 1	2016	1634						132	139		10.1016/j.brainres.2016.01.012			8	Neurosciences	Neurosciences & Neurology	DH3LK	WOS:000372688300013	26794250	Bronze			2021-06-18	
J	Schaufelberger, SA; Rosselli, M; Barchiesi, F; Gillespie, DG; Jackson, EK; Dubey, RK				Schaufelberger, Sara A.; Rosselli, Marinella; Barchiesi, Federica; Gillespie, Delbert G.; Jackson, Edwin K.; Dubey, Raghvendra K.			2-Methoxyestradiol, an endogenous 17 beta-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism	AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM			English	Article						stroke; microglia; 17 beta-estradiol; 2-hydroxyestradiol; 2-methoxyestradiol	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; CATECHOLAMINES BLOCK; ESTRADIOL; RISK; BETA; THERAPY; ALPHA	17 beta-Estradiol (estradiol) inhibits microglia proliferation. 2-Methoxyestradiol (2-ME) is an endogenous metabolite of estradiol with little affinity for estrogen receptors (ERs). We hypothesize that 2-ME inhibits microglial proliferation and activation and contributes to estradiol's inhibitory effects on microglia. We compared the effects of estradiol, 2-hydroxyestradiol [2-OE; estradiol metabolite produced by cytochrome P450 (CYP450)], and 2-ME [formed by catechol-O-methyltransferase (COMT) acting upon 2-OE] on microglial (BV2 cells) DNA synthesis, cell proliferation, activation, and phagocytosis. 2-ME and 2-OE were approximately three-and 10-fold, respectively, more potent than estradiol in inhibiting microglia DNA synthesis. The antimitogenic effects of estradiol were reduced by pharmacological inhibitors of CYP450 and COMT. Inhibition of COMT blocked the conversion of 2-OE to 2-ME and the antimitogenic effects of 2-OE but not 2-ME. Microglia expressed ER beta and GPR30 but not ER alpha. 2,3-Bis(4-hydroxyphenyl)-propionitrile (ER beta agonist), but not 4,4', 4 ''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (ER alpha agonist) or G1 (GPR30 agonist), inhibited microglial proliferation. The antiproliferative effects of estradiol, but not 2-OE or 2-ME, were partially reversed by ICI-182,780 (ER alpha/beta antagonist) but not by 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole (ER alpha antagonist) or G15 (GPR30 antagonist). Lipopolysaccharide increased microglia iNOS and COX-2 expression and phagocytosing activity of microglia; these effects were inhibited by 2-ME. We conclude that in microglia, 2-ME inhibits proliferation, proinflammatory responses, and phagocytosis. 2-ME partially mediates the effects of estradiol via ER-independent mechanisms involving sequential metabolism of estradiol to 2-OE and 2-ME. 2-ME could be of potential therapeutic use in postischemic stroke injuries. Interindividual differences in estradiol metabolism might affect the individual's ability to recover from stroke.	[Schaufelberger, Sara A.; Rosselli, Marinella; Barchiesi, Federica; Dubey, Raghvendra K.] Univ Zurich Hosp, Dept Reprod Endocrinol, CH-8091 Zurich, Switzerland; [Dubey, Raghvendra K.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Gillespie, Delbert G.; Jackson, Edwin K.; Dubey, Raghvendra K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Dubey, RK (corresponding author), Areal Wagi Schlieren, Univ Zurich Hosp, Dept Reprod Endocrinol, Wagistr 14, CH-8952 Schlieren, Switzerland.	raghvendra.dubey@usz.ch		Jackson, Edwin/0000-0002-8101-6009	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [IZERO-142213/1, 31003A-138067]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-087978, HL-109002, DK-091190, HL-069846, DK-068575, DK-079307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL069846, R01HL109002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK091190, R01DK068575, P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087978] Funding Source: NIH RePORTER	This work was supported by Swiss National Science Foundation Grants IZERO-142213/1 and 31003A-138067 (to R. K. Dubey) and by National Institutes of Health Grants NS-087978, HL-109002, DK-091190, HL-069846, DK-068575, and DK-079307 (to E. K. Jackson).	Azcoitia I, 2011, NEUROSCIENCE, V191, P139, DOI 10.1016/j.neuroscience.2011.02.012; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; BERG D, 1983, ACTA ENDOCRINOL-COP, V103, P282, DOI 10.1530/acta.0.1030282; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; BRUEGGEMEIER RW, 1981, J BIOL CHEM, V256, P239; Carswell HVO, 2004, AM J PHYSIOL-HEART C, V287, pH1501, DOI 10.1152/ajpheart.00227.2004; Chen CH, 2007, J NEUROCHEM, V102, P1831, DOI 10.1111/j.1471-4159.2007.04652.x; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Dawling S, 2003, CANCER RES, V63, P3127; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.041483198; Dubey RK, 2007, ENDOCRINOLOGY, V148, P4125, DOI 10.1210/en.2007-0514; Dubey RK, 2001, J APPL PHYSIOL, V91, P1868; Dubey RK, 2005, J CLIN ENDOCR METAB, V90, P247, DOI 10.1210/jc.2003-032154; Dubey RK, 2004, J CLIN ENDOCR METAB, V89, P3922, DOI 10.1210/jc.2004-0115; Duncan GS, 2012, P NATL ACAD SCI USA, V109, P21034, DOI 10.1073/pnas.1215558110; Dutheil F, 2009, DRUG METAB DISPOS, V37, P1528, DOI 10.1124/dmd.109.027011; Gaikwad NW, 2011, BIOMARKERS, V16, P434, DOI 10.3109/1354750X.2011.588725; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Koellhoffer EC, 2013, TRANSL STROKE RES, V4, P390, DOI 10.1007/s12975-012-0230-5; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kognati S, 2014, EUR J PHARMACOL, V723, P131; Lemaitre RN, 2002, ARCH INTERN MED, V162, P1954, DOI 10.1001/archinte.162.17.1954; Li R, 2005, FRONT BIOSCI-LANDMRK, V10, P257, DOI 10.2741/1525; Mikkola TS, 2015, MENOPAUSE, V22, P976, DOI 10.1097/GME.0000000000000450; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Offner H, 2006, ANN NY ACAD SCI, V1089, P343, DOI 10.1196/annals.1386.021; Ostensen M, 2007, SEMIN IMMUNOPATHOL, V29, P185, DOI 10.1007/s00281-007-0072-5; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Rocca WA, 2012, MENOPAUSE, V19, P272, DOI 10.1097/gme.0b013e31822a9937; Sampei K, 2000, STROKE, V31, P738, DOI 10.1161/01.STR.31.3.738; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schulze J, 2014, AGING DIS, V5, P327, DOI 10.14336/AD.2014.0500327; Thiel A, 2011, STROKE, V42, P507, DOI 10.1161/STROKEAHA.110.598821; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Wise PM, 2005, ENDOCR REV, V26, P308, DOI 10.1210/er.2004-0014; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zacharia LC, 2002, HYPERTENSION, V39, P854, DOI 10.1161/01.HYP.0000014502.44988.39; Zhang ZG, 1997, BRAIN RES, V744, P189, DOI 10.1016/S0006-8993(96)01085-2	40	15	15	0	13	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1849	1522-1555		AM J PHYSIOL-ENDOC M	Am. J. Physiol.-Endocrinol. Metab.	MAR 1	2016	310	5					E313	E322		10.1152/ajpendo.00418.2015			10	Endocrinology & Metabolism; Physiology	Endocrinology & Metabolism; Physiology	DF4EN	WOS:000371300700002	26732685	Green Published			2021-06-18	
J	Seedat, J; Penn, C				Seedat, Jaishika; Penn, Claire			Implementing oral care to reduce aspiration pneumonia amongst patients with dysphagia in a South African setting	SOUTH AFRICAN JOURNAL OF COMMUNICATION DISORDERS			English	Article							HEALTH; INTERVENTIONS; NURSES; WATER	Oral care is a crucial routine for patients with dysphagia that, when completed routinely, can prevent the development of aspiration pneumonia. There is no standardised protocol for oral care within government hospitals in South Africa. This study aimed to investigate the outcome of an oral care protocol. Participants were patients with oropharyngeal dysphagia, with either stroke or traumatic brain injury as the underlying medical pathology, and nurses. All participants were recruited from one tertiary level government hospital in Gauteng, South Africa. 139 nurses participated in the study and received training on the oral care protocol. There were two groups of participants with oropharyngeal dysphagia. Group one (study group, n = 23) was recruited by consecutive sampling, received regular oral care and were not restricted from drinking water; however, all other liquids were restricted. Group two (comparison group, n = 23) was recruited via a retrospective record review, received inconsistent oral care and were placed on thickened liquids or liquid restricted diets. Results showed that a regimen of regular oral care and free water provision when combined with dysphagia intervention did prevent aspiration pneumonia in patients with oropharyngeal dysphagia. The article highlights two key findings: that regular and routine oral care is manageable within an acute government hospital context and a strict routine of oral care can reduce aspiration pneumonia in patients with oropharyngeal dysphagia. An implication from these findings is confirmation that teamwork in acute care settings in developing contexts must be prioritised to improve dysphagia management and patient prognosis.	[Seedat, Jaishika; Penn, Claire] Univ Witwatersrand, Dept Speech Pathol & Audiol, Johannesburg, South Africa	Seedat, J (corresponding author), Univ Witwatersrand, Dept Speech Pathol & Audiol, Johannesburg, South Africa.	jaishika.seedat@wits.ac.za					Adams R, 1996, J ADV NURS, V24, P552, DOI 10.1046/j.1365-2648.1996.22416.x; Becker D. L., 2008, AM SPEECH LANG HEAR; Begley CM, 2009, NURS EDUC TODAY, V29, P276, DOI 10.1016/j.nedt.2008.09.006; Berry Angela M, 2006, Intensive Crit Care Nurs, V22, P318, DOI 10.1016/j.iccn.2006.04.003; Bronson-Lowe C, 2008, DYSPHAGIA, V23, P430; Byers J F, 2000, Am J Crit Care, V9, P344; Carlaw C, 2012, DYSPHAGIA, V27, P297, DOI 10.1007/s00455-011-9366-9; Cichero JAY., 2006, DYSPHAGIA FDN THEORY; Colodny N, 2005, AM J SPEECH-LANG PAT, V14, P61, DOI 10.1044/1058-0360(2005/008); Cook IJ, 1999, GASTROENTEROLOGY, V116, P455, DOI 10.1016/S0016-5085(99)70144-7; DONOGHUE H, 1987, NEW SCI, V113, P61; Effros R. M., 2000, AM J MED, V108, P15; El-Solh AA, 2003, AM J RESP CRIT CARE, V167, P1650, DOI 10.1164/rccm.200212-1543OC; Evans G, 2001, Nurs Stand, V15, P33; Fields LB, 2008, J NEUROSCI NURS, V40, P291, DOI 10.1097/01376517-200810000-00007; Frey KL, 2011, J NEUROSCI NURS, V43, P165, DOI 10.1097/JNN.0b013e3182135adf; Garon BR, 1997, J NEUROL REHABIL, V11, P139; Grap MJ, 2003, AM J CRIT CARE, V12, P113, DOI 10.4037/ajcc2003.12.2.113; Jones C V, 1998, Br J Nurs, V7, P74; Karagiannis MJP, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-9; Kite K, 1995, Intensive Crit Care Nurs, V11, P71, DOI 10.1016/S0964-3397(95)82017-5; LANGMORE S E, 1991, Seminars in Speech and Language, V12, P199, DOI 10.1055/s-2008-1064221; Langmore SE, 2002, DYSPHAGIA, V17, P298, DOI 10.1007/s00455-002-0072-5; LANGMORE SE, 1994, ARCH PHYS MED REHAB, V75, P1154, DOI 10.1016/0003-9993(94)90094-9; Logemanin JA, 2008, J SPEECH LANG HEAR R, V51, P173, DOI 10.1044/1092-4388(2008/013); Logemann J. A., 1994, Acta Oto-Rhino-Laryngologica Belgica, V48, P235; Logemann J. A., 1983, EVALUATION TREATMENT; LOGEMANN JA, 1997, DEGLUTITION ITS DISO, P449; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; MARSH PD, 1992, ORAL MICROBIOL IMMUN, P98; Martin Bonnie J. W., 1994, Dysphagia, V9, P1; Mathivha LR, 2002, CRIT CARE, V6, P22; McCullough GH., 2013, CLIN EVALUATION PATI, P11, DOI DOI 10.1007/978-1-4614-3779-6_2; Milins B, 2003, GERONTOLOGY, V49, P173, DOI 10.1159/000069171; Miller R, 1987, J Nurs Educ, V26, P362; Mojoyinolla JK, 2008, STUD ETHNO-MED, V2, P143; Nevitt J., 2010, FRAZIER FREE WATER P; Panther K, 2005, PERSP SWALL SWALL DI, V14, P4, DOI DOI 10.1161/STR.0000000000000098; Rello J, 2007, INTENS CARE MED, V33, P1066, DOI 10.1007/s00134-007-0605-3; Robbins J, 2002, J REHABIL RES DEV, V39, P543; Robbins J, 2008, ANN INTERN MED, V148, P509, DOI 10.7326/0003-4819-148-7-200804010-00007; Rofes L, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/818979; Rosenvinge SK, 2005, AGE AGEING, V34, P587, DOI 10.1093/ageing/afi187; Sarin J, 2008, J AM MED DIR ASSOC, V9, P128, DOI 10.1016/j.jamda.2007.10.003; Scott A., 2010, EMBEDDING EVIDENCE B, P184; Scribante J., 2008, S AFR MED J, V97, P1315; Seedat J., 2013, THESIS; Singh S, 2006, POSTGRAD MED J, V82, P383, DOI 10.1136/pgmj.2005.043281; South African Nursing Council (SANC), 2004, CHART NURS PRACT 200; Steele C., 2006, AM SPEECH LANG HEAR; THEILADE E, 1986, J CLIN PERIODONTOL, V13, P905, DOI 10.1111/j.1600-051X.1986.tb01425.x; Wardh I, 1997, Gerodontology, V14, P28, DOI 10.1111/j.1741-2358.1997.00028.x; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Yoon MN, 2007, TOP GERIATR REHABIL, V23, P280	54	15	15	0	8	AOSIS	CAPE TOWN	POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH AFRICA	0379-8046	2225-4765		S AFR J COMMUN DISOR	S. Afr. J. Commun. Disord.	FEB 16	2016	63	1							102	10.4102/sajcd.v63i1.102			11	Audiology & Speech-Language Pathology	Audiology & Speech-Language Pathology	EA6QD	WOS:000386752900001	26974243	DOAJ Gold			2021-06-18	
J	Bombardier, CH; Adams, LM; Fann, JR; Hoffman, JM				Bombardier, Charles H.; Adams, Leah M.; Fann, Jesse R.; Hoffman, Jeanne M.			Depression Trajectories During the First Year After Spinal Cord Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Depression; Longitudinal studies; Prognosis; Rehabilitation; Resilience; psychological; Spinal cord injuries	RANDOMIZED CLINICAL-TRIAL; TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL OUTCOMES; MAJOR DEPRESSION; SUBSTANCE USE; RISK-FACTORS; RESILIENCE; REHABILITATION; ALCOHOL; ANXIETY	Objective: To determine the number and type of longitudinal depression trajectories during the first year after spinal cord injury (SCI) and to identify baseline predictors of these trajectories. Design: Cohort study. Setting: Rehabilitation and postacute community settings. Participants: Of 168 consecutive admissions to inpatient rehabilitation for acute SCI, 141 (115 men, 26 women) patients were enrolled in a randomized controlled trial telephone follow-up intervention, which showed no outcome differences, and completed assessments on at least 2 of the 4 follow-up occasions (3, 6, 9, and 12 months after SCI). Participants were on average 41 years old, most were non-Hispanic (96%) and white (86%), and 61.7% had tetraplegia. Interventions: Data were drawn from the ineffective randomized controlled trial. Main Outcome Measure: Patient Health Questionnaire-9 (PHQ-9). Results: Unconditional linear latent class growth analysis models of PHQ-9 total scores revealed an optimal 3-class solution: stable low depression (63.8%), mild to moderate depression (29.1%), and persistent moderate to severe depression (7.1%). Preinjury mental health history and baseline pain, quality of life, and grief predicted class membership. Conclusions: The modal response to SCI was stable low depression, whereas persistent moderate to severe depression primarily represented a continuation or relapse of preinjury depression. This line of research has the potential to improve identification of subgroups destined for poor outcomes and to inform early intervention studies. (C) 2016 by the American Congress of Rehabilitation Medicine	[Bombardier, Charles H.; Fann, Jesse R.; Hoffman, Jeanne M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Adams, Leah M.] Grp Hlth Res Inst, Seattle, WA USA; [Fann, Jesse R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Bombardier, CH (corresponding author), Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Box 359612,325 9th Ave, Seattle, WA 98104 USA.	chb@uw.edu			Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems [H133N060033, H133N110009]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5T32AG027677]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG027677] Funding Source: NIH RePORTER	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems (grant nos. H133N060033 and H133N110009) and the National Institute on Aging (grant no. 5T32AG027677).	Adamson BC, 2015, ARCH PHYS MED REHAB, V96, P1329, DOI 10.1016/j.apmr.2015.01.005; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews F. M., 1976, SOCIAL INDICATORS WE; Banerjea R, 2009, SPINAL CORD, V47, P789, DOI 10.1038/sc.2009.42; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1488, DOI 10.1016/j.apmr.2003.10.010; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P1838, DOI 10.1016/j.apmr.2012.04.019; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P775, DOI 10.1016/j.apmr.2011.12.020; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Cairns DM, 1996, ARCH PHYS MED REHAB, V77, P329, DOI 10.1016/S0003-9993(96)90079-9; Cardenas DD, 2013, NEUROLOGY, V80, P533, DOI 10.1212/WNL.0b013e318281546b; Catalano D, 2011, REHABIL PSYCHOL, V56, P200, DOI 10.1037/a0024571; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; CRAIG AR, 1994, PARAPLEGIA, V32, P675, DOI 10.1038/sc.1994.109; Craig AR, 1997, ARCH PHYS MED REHAB, V78, P33, DOI 10.1016/S0003-9993(97)90006-X; Dorstyn D, 2012, ARCH PHYS MED REHAB, V93, P2100, DOI 10.1016/j.apmr.2012.06.002; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; Duchnick JJ, 2009, REHABIL PSYCHOL, V54, P123, DOI 10.1037/a0015571; ELLIOTT TR, 1992, REHABIL PSYCHOL, V37, P37, DOI 10.1037/h0079091; Fann JR, 2015, JAMA PSYCHIAT, V72, P247, DOI 10.1001/jamapsychiatry.2014.2482; Fann JR, 2011, ARCH PHYS MED REHAB, V92, P352, DOI 10.1016/j.apmr.2010.05.016; Ginis KAM, 2010, SPINAL CORD, V48, P65, DOI 10.1038/sc.2009.87; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; Hoffman JM, 2013, AM SPIN INJ ASS ANN; JUDD FK, 1989, BRIT J PSYCHIAT, V154, P668, DOI 10.1192/bjp.154.5.668; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kalpakjian CZ, 2014, J SPINAL CORD MED, V37, P218, DOI 10.1179/2045772313Y.0000000169; Kemp BJ, 2004, J SPINAL CORD MED, V27, P22, DOI 10.1080/10790268.2004.11753726; Kennedy P, 2003, BRIT J CLIN PSYCHOL, V42, P41, DOI 10.1348/014466503762842002; King C, 1999, BRIT J CLIN PSYCHOL, V38, P5, DOI 10.1348/014466599162629; KISHI Y, 1994, J NEUROPSYCH CLIN N, V6, P237; Klyce DW, 2015, ARCH PHYS MED REHAB, V96, P1419, DOI 10.1016/j.apmr.2015.02.018; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; MCCRAE RR, 1986, J GERONTOL, V41, P390, DOI 10.1093/geronj/41.3.390; Monden KR, 2014, SPINAL CORD, V52, P197, DOI 10.1038/sc.2013.159; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Shear MK, 2014, JAMA PSYCHIAT, V71, P1287, DOI 10.1001/jamapsychiatry.2014.1242; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; The EuroQol Group, 1990, HLTH POLICY ED, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9	47	15	15	2	21	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2016	97	2					196	203		10.1016/j.apmr.2015.10.083			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DC4RH	WOS:000369207500003	26525525	Green Accepted			2021-06-18	
J	Zhan, J; Gao, L; Zhou, FQ; Bai, LJ; Kuang, HM; He, LC; Zeng, XJ; Gong, HH				Zhan, Jie; Gao, Lei; Zhou, Fuqing; Bai, Lijun; Kuang, Hongmei; He, Laichang; Zeng, Xianjun; Gong, Honghan			Amplitude of Low-Frequency Fluctuations in Multiple-Frequency Bands in Acute Mild Traumatic Brain Injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						resting-state fMRI; mild traumatic brain injury; acute; amplitude of low-frequency fluctuations; frequency band	POSTTRAUMATIC-STRESS-DISORDER; STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; VOXEL-BASED ANALYSIS; VISUAL-CORTEX; MOTION; MRI; REGISTRATION; OSCILLATIONS; DYSFUNCTION	Functional disconnectivity during the resting state has been observed in mild traumatic brain injury (mTBI) patients during the acute stage. However, it remains largely unknown whether the abnormalities are related to specific frequency bands of the low-frequency oscillations (LFO). Here, we used the amplitude of low-frequency fluctuations (ALFF) to examine the amplitudes of LFO in different frequency bands (slow-5: 0.01-0.027 Hz; slow-4: 0.027-0.073 Hz; and typical: 0.01-0.08 Hz) in patients with acute mTBI. A total of 24 acute mTBI patients and 24 age-, sex-, and education-matched healthy controls participated in this study. In the typical band, acute mTBI patients showed lower standardized ALFF in the right middle frontal gyrus and higher standardized ALFF in the right lingual/fusiform gyrus and left middle occipital gyrus. Further analyses showed that the difference between groups was concentrated in a narrower (slow-4) frequency band. In the slow-5 band, mTBI patients only exhibited higher standardized ALFF in the occipital areas. No significant correlation between the mini-mental state examination score and the standardized ALFF value was found in any brain region in the three frequency bands. Finally, no significant interaction between frequency bands and groups was found in any brain region. We concluded that the abnormality of spontaneous brain activity in acute mTBI patients existed in the frontal lobe as well as in distributed brain regions associated with integrative, sensory, and emotional roles, and the abnormal spontaneous neuronal activity in different brain regions could be better detected by the slow-4 band. These findings might contribute to a better understanding of local neural psychopathology of acute mTBI. Future studies should take the frequency bands into account when measuring intrinsic brain activity of mTBI patients.	[Zhan, Jie; Gao, Lei; Zhou, Fuqing; Kuang, Hongmei; He, Laichang; Zeng, Xianjun; Gong, Honghan] Nanchang Univ, Dept Radiol, Affiliated Hosp 1, Nanchang, Peoples R China; [Bai, Lijun] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn,Dept Biomed Engn, Xian 710049, Peoples R China	Gong, HH (corresponding author), Nanchang Univ, Dept Radiol, Affiliated Hosp 1, Nanchang, Peoples R China.	honghan_gong@sina.com		Gao, Lei/0000-0002-0081-0172	National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81260217, 81460263, 81371630]; Shaanxi Nova Program; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities	This work was supported by the National Natural Science Foundations of China (grants 81260217,81460263,and 81371630), the Shaanxi Nova Program, and the Fundamental Research Funds for the Central Universities.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bai F, 2011, J ALZHEIMERS DIS, V23, P87, DOI 10.3233/JAD-2010-101533; Baillieux H, 2010, CORTEX, V46, P869, DOI 10.1016/j.cortex.2009.09.002; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120323; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; Mazard A, 2005, COGNITIVE BRAIN RES, V24, P423, DOI 10.1016/j.cogbrainres.2005.02.018; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Sui SG, 2010, ASIA-PAC PSYCHIAT, V2, P129, DOI 10.1111/j.1758-5872.2010.00076.x; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang K, 2008, CEREB CORTEX, V18, P697, DOI 10.1093/cercor/bhm105; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039845; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037828; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yin Y, 2011, BRAIN RES, V1411, P98, DOI 10.1016/j.brainres.2011.07.016; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	59	15	18	2	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 1	2016	10								27	10.3389/fnhum.2016.00027			9	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	DC1NX	WOS:000368984100001	26869907	DOAJ Gold, Green Published			2021-06-18	
J	Nikolaeva, I; Crowell, B; Valenziano, J; Meaney, D; D'Arcangelo, G				Nikolaeva, Ina; Crowell, Beth; Valenziano, Julia; Meaney, David; D'Arcangelo, Gabriella			Beneficial Effects of Early mTORC1 Inhibition after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; mTOR; rapamycin	TUBEROUS SCLEROSIS COMPLEX; CONTROLLED CORTICAL IMPACT; MAMMALIAN TARGET; MOUSE MODEL; RAPAMYCIN TOXICITY; AKT; NEURONS; RECEPTORS; RECOVERY; SURVIVAL	The mammalian target of rapamycin complex 1 (mTORC1) signaling pathway mediates many aspects of cell growth and regeneration and is upregulated after moderate to severe traumatic brain injury (TBI). The significance of this increased signaling event for recovery of brain function is presently unclear. We analyzed the time course and cell specificity of mTORC1 signal activation in the mouse hippocampus after moderate controlled cortical impact (CCI) and identified an early neuronal peak of activity that occurs within a few hours after injury. We suppressed this peak activity by a single injection of the mTORC1 inhibitor rapamycin 1h after CCI and showed that this acute treatment significantly diminishes the extent of neuronal death, astrogliosis, and cognitive impairment 1-3 days after injury. Our findings suggest that the early neuronal peak of mTORC1 activity after TBI is deleterious to brain function, and that acute, early intervention with mTORC1 inhibitors after injury may represent an effective form of treatment to improve recovery in human patients.	[Nikolaeva, Ina; Crowell, Beth; D'Arcangelo, Gabriella] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Nikolaeva, Ina; D'Arcangelo, Gabriella] Rutgers State Univ, Grad Program Mol Biosci, Piscataway, NJ 08854 USA; [Valenziano, Julia; Meaney, David] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	D'Arcangelo, G (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd,B323, Piscataway, NJ 08854 USA.	darcangelo@dls.rutgers.edu		Meaney, David/0000-0002-0954-4122; D'Arcangelo, Gabriella/0000-0003-1575-1010	New Jersey Commission on Brain Injury Research [CBIR12-MIG011]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS093293] Funding Source: NIH RePORTER	This work is supported by multiprogrammatic grant CBIR12-MIG011 from the New Jersey Commission on Brain Injury Research (GD and DM).	Barlow AD, 2012, DIABETOLOGIA, V55, P1355, DOI 10.1007/s00125-012-2475-7; Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Kazdoba TM, 2012, DEV NEUROSCI-BASEL, V34, P198, DOI 10.1159/000337229; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Krueger DA, 2013, ANN NEUROL, V74, P679, DOI 10.1002/ana.23960; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shein NA, 2008, J NEUROTRAUM, V25, P112, DOI 10.1089/neu.2007.0358; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Way SW, 2012, HUM MOL GENET, V21, P3226, DOI 10.1093/hmg/dds156; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	31	15	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					183	193		10.1089/neu.2015.3899			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800004	26122481	Green Published			2021-06-18	
J	Alavi, SA; Tan, CL; Menon, DK; Simpson, HL; Hutchinson, PJ				Alavi, Seyed Alireza; Tan, Chin Lik; Menon, David K.; Simpson, Helen L.; Hutchinson, Peter J.			Incidence of pituitary dysfunction following traumatic brain injury: A prospective study from a regional neurosurgical centre	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Hypopituitarism; pituitary; trauma; traumatic brain injury	POSTTRAUMATIC HYPOPITUITARISM; SUBARACHNOID HEMORRHAGE; PREVALENCE; DEFICIENCY	Patients with traumatic brain injury (TBI) may develop pituitary dysfunction. Although, there is now increasing awareness of and investigations into such post-traumatic hypopituitarism (PTHP), the exact prevalence and incidence remain uncertain. Here, we aim to identify the incidence of PTHP in a selected population of TBI patients deemed at risk of PTHP at a regional neurosurgical centre in the UK. A total of 105 patients have been assessed in two cohorts: (i) 58 patients in serial cohort and (ii) 47 patients in cross-sectional late cohort. We found that in serial cohort, 10.3% (6/58) of TBI patients had abnormalities of the pituitary-adrenal axis in the acute phase (Day 0-7 post injury). In comparison, in cross-sectional late cohort, 21.3% (10/47) of the patients developed dysfunction in at least one of their pituitary axes at 6 months or more post-TBI, with hypogonadotrophic hypogonadism being the most common. Twenty-two patients from these two cohorts had their growth hormone assessment at 12 months or more post-TBI and 9.1% (2/22) were found to have growth hormone deficiency. Our results suggest that PTHP is a common condition amongst sufferers of TBI, and appropriate measures should be taken to detect and manage it.	[Alavi, Seyed Alireza; Tan, Chin Lik; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge CB2 0QQ, England; [Simpson, Helen L.] Univ Cambridge, Addenbrookes Hosp, Dept Endocrinol, Cambridge CB2 0QQ, England	Hutchinson, PJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England.	pjah2@cam.ac.uk		Alavi, Seyed Alireza/0000-0001-7250-3860; Hutchinson, Peter/0000-0002-2796-1835	NIHR Research Professorship; NIHR Cambridge BRC; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, NF-SI-0512-10090] Funding Source: researchfish	P. J. Hutchinson is supported by a NIHR Research Professorship and the NIHR Cambridge BRC.	Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Cyran E, 1918, DEUT MED WOCHENSCHR, V44, P1261; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Pickel J, 2009, F1000 MED REP, V1, P63; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x	17	15	15	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2016	30	3					302	306		10.3109/02688697.2015.1109060			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DL7SF	WOS:000375839700005	26610235				2021-06-18	
J	Carlson, SW; Yan, H; Ma, M; Li, YM; Henchir, J; Dixon, CE				Carlson, Shaun W.; Yan, Hong; Ma, Michelle; Li, Youming; Henchir, Jeremy; Dixon, C. Edward			Traumatic Brain Injury Impairs Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptor Complex Formation and Alters Synaptic Vesicle Distribution in the Hippocampus	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; SNARE; synapse; traumatic brain injury; vesicle docking	CONTROLLED CORTICAL IMPACT; REDUCED EVOKED RELEASE; SNARE-COMPLEX; KNOCKOUT MICE; NEUROTRANSMITTER RELEASE; CSP-ALPHA; IN-VITRO; EXPRESSION; RATS; NEURODEGENERATION	Traumatic brain injury (TBI) impairs neuronal function and can culminate in lasting cognitive impairment. While impaired neurotransmitter release has been well established after experimental TBI, little is understood about the mechanisms underlying this consequence. In the synapse, vesicular docking and neurotransmitter release requires the formation of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex. Impairments in vesicle docking, and alterations in SNARE complex formation are associated with impaired neurotransmitter release. We hypothesized that TBI reduces SNARE complex formation and disrupts synaptic vesicle distribution in the hippocampus. To examine the effect of TBI on the SNARE complex, rats were subjected to controlled cortical impact (CCI) or sham injury, and the brains were assessed at 6h, 1 d, one week, two weeks, or four weeks post-injury. Immunoblotting of hippocampal homogenates revealed significantly reduced SNARE complex formation at one week and two weeks post-injury. To assess synaptic vesicles distribution, rats received CCI or sham injury and the brains were processed for transmission electron microscopy at one week post-injury. Synapses in the hippocampus were imaged at 100k magnification, and vesicle distribution was assessed in pre-synaptic terminals at the active zone. CCI resulted in a significant reduction in vesicle number within 150nm of the active zone. These findings provide the first evidence of TBI-induced impairments in synaptic vesicle docking, and suggest that reductions in the pool of readily releasable vesicles and impaired SNARE complex formation are two novel mechanisms contributing to impaired neurotransmission after TBI.	[Carlson, Shaun W.; Yan, Hong; Ma, Michelle; Li, Youming; Henchir, Jeremy; Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Safar Ctr Resuscitat Res, Pittsburgh, PA USA	Dixon, CE (corresponding author), Pittsburgh VA Healthcare Syst, Safar Ctr Resuscitat Res, Dept Neurosurg, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu		Carlson, Shaun/0000-0002-1413-5075	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1NS079061, 5T32HD040686-14]; Veteran's Affairs grantUS Department of Veterans Affairs [RX001127]; Pittsburgh Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091062, F32NS090748, R01NS079061] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001127] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants 1RO1NS079061 and 5T32HD040686-14, Veteran's Affairs grant RX001127, and The Pittsburgh Foundation. We would like to thank Larry Jenkins, PhD, for his assistance during the development of the ultrastructural study. We would like to thank Jonathan Franks, M.S., and Donna Stolz, PhD, in the Center for Biologic Imaging at the University of Pittsburgh, for their assistance with tissue processing and consultation on quantification of electron micrographs.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; DICKINSONNELSON A, 1983, J NEUROSCI, V3, P42; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Janezic S, 2013, P NATL ACAD SCI USA, V110, pE4016, DOI 10.1073/pnas.1309143110; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Paxinos G., 2009, RAT BRAIN STEREOTAXI; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Reist NE, 1998, J NEUROSCI, V18, P7662; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sharma M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004028; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Shin SS, 2012, J NEUROTRAUM, V29, P843, DOI 10.1089/neu.2011.1966; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86	48	15	15	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					113	121		10.1089/neu.2014.3839			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200014	25923735	Green Published			2021-06-18	
J	Dagher, JH; Costa, C; Lamoureux, J; de Guise, E; Feyz, M				Dagher, Jehane H.; Costa, Camille; Lamoureux, Julie; de Guise, Elaine; Feyz, Mitra			Comparative Outcomes of Traumatic Brain Injury from Biking Accidents With or Without Helmet Use	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Acute Care; Bicycle; Helmets; Outcome; Traumatic Brain Injury	PREVENTING HEAD-INJURY; BICYCLE SAFETY HELMETS; SEVERITY SCORE; EMERGENCY; CHILDREN; IMPACT; SCALE	Objective: To determine if health outcomes and demographics differ according to helmet status between persons with cycling-related traumatic brain injuries (TBI). Methods: This is a retrospective study of 128 patients admitted to the Montreal General Hospital following a TBI that occurred while cycling from 2007-2011. Information was collected from the Quebec trauma registry and the coroner's office in cases of death from cycling accidents. The independent variables collected were socio-demographic, helmet status, clinical and neurological patient information. The dependent variables evaluated were length of stay (LOS), extended Glasgow outcome scale (GOS-E), injury severity scale (ISS), discharge destination and death. Results: 25% of cyclists wore a helmet. The helmet group was older, more likely to be university educated, married and retired. Unemployment, longer intensive care unit (ICU) stay, severe intracranial bleeding and neurosurgical interventions were more common in the no helmet group. There was no significant association between the severity of the TBI, ISS scores, GOS-E or death and helmet wearing. The median age of the subjects who died was higher than those who survived. Conclusion: Cyclists without helmets were younger, less educated, single and unemployed. They had more severe TBIs on imaging, longer LOS in ICU and more neurosurgical interventions. Elderly cyclists admitted to the hospital appear to be at higher risk of dying in the event of a TBI.	[Dagher, Jehane H.] McGill Univ, Hlth Centre, Montreal Gen Hosp, Phys Med & Rehabil Dept, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine; Feyz, Mitra] McGill Univ, Hlth Centre, Montreal Gen Hosp, Traumat Brain Injury Programme, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] McGill Univ, Hlth Centre, Montreal Gen Hosp, Neurol & Neurosurg Dept, Montreal, PQ H3G 1A4, Canada; [Dagher, Jehane H.; Costa, Camille] Univ Montreal, Phys Med & Rehabil Dept, Montreal, PQ, Canada; Univ Montreal, Inst Readaptat Lindsay Gingras Montreal, Montreal, PQ, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Dagher, Jehane H.] McGill Univ, Ctr Hlth, Montreal Gen Hosp Site, Phys Med & Rehabil, Room D13-124,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada	Dagher, JH (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp Site, Phys Med & Rehabil, Room D13-124,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	DrDagher@hotmail.com					Adams J, 2001, Inj Prev, V7, P343, DOI 10.1136/ip.7.4.343; American Association of Neurological Surgeons Web site, 2011, SPORTS REL HEAD INJ; [Anonymous], 1971, JAMA, V215, P277; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Burigusa G, 2011, SECURITE ELEVES PRIM; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; DORSCH MM, 1987, ACCIDENT ANAL PREV, V19, P183, DOI 10.1016/0001-4575(87)90002-9; Ekman R, 2001, PUBLIC HEALTH, V115, P38, DOI 10.1038/sj.ph.1900713; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fyhri A, 2012, TRANSPORT RES F-TRAF, V15, P612, DOI 10.1016/j.trf.2012.06.003; Goldacre B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3817; Gouvernement du Quebec, 2005, OR MIN TRAUM CRAN LE; Grenier T, 2013, CAN J PUBLIC HEALTH, V104, pE400, DOI 10.17269/cjph.104.3936; Irvine A, 2002, CAN J PUBLIC HEALTH, V93, P368, DOI 10.1007/BF03404572; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B, 2005, NEPAL J NEUROSCI, V2, P24; Jolicoeur MC, 2010, ETAT VELO QUEBEC 201; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Linn S, 1998, Inj Prev, V4, P122; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Salottolo K, 2009, INJURY, V40, P999, DOI 10.1016/j.injury.2009.05.013; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thompson DC, 2000, COCHRANE DB SYST REV, V2; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; WASSERMAN RC, 1988, AM J PUBLIC HEALTH, V78, P1220, DOI 10.2105/AJPH.78.9.1220; WASSERMAN RC, 1990, AM J SPORT MED, V18, P96, DOI 10.1177/036354659001800116; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	40	15	18	0	25	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JAN	2016	43	1					56	64		10.1017/cjn.2015.281			9	Clinical Neurology	Neurosciences & Neurology	DB5FW	WOS:000368541000008	26786638	Bronze			2021-06-18	
J	Daniele, G; Weinstein, RN; Wallace, PW; Palmieri, V; Bianco, M				Daniele, Gianlorenzo; Weinstein, Richard N.; Wallace, Paul Wesley; Palmieri, Vincenzo; Bianco, Massimiliano			Rapid weight gain in professional boxing and correlation with fight decisions: analysis from 71 title fights	PHYSICIAN AND SPORTSMEDICINE			English	Article						Combat sport; martial art; hydration; traumatic brain injury; concussion	MIXED MARTIAL ARTS; COMBAT SPORTS; PERFORMANCE; SUCCESS; INJURY; BOXERS; IMPACT; MASS	Objectives: Boxing is a sport where athletes compete in several weight categories. Professional boxers typically dehydrate to cut their weight for the weigh-in (24 h before the contest) and then rehydrate before the fight. The International Boxing Federation (IBF) mandates a second weigh-in 12 h before the fight. Our objectives were: 1) To quantify the weight gain (WG) from the 1st to the 2nd weigh-in; 2) to investigate whether rapid WG affects boxing performance (win/loss rate) and 3) whether weight discrepancy (WD) 15 between boxers exposes them to increased health risks (rate of fights ended before time limit). Methods: From official weigh-in reports of 71 IBF fights (142 fighters) the following data were gathered/calculated for each boxer: age, weight division, 1st weight, 2nd weight, WG between weigh-ins (kg and %), WD between opponents, and fight decision. Results: Between the weigh-ins, the average WG was 2.52 +/- 1.37kg (range -0.3/6.4kg) and 3.8 +/- 2.2% of the initial body weight (range -0.4/9.3%) and the average WD 1.94 +/- 1.50kg (maximum 7.10kg). Both WG and WD did not affect match outcomes. We observed tendencies for higher loss rate among boxers gaining more weight, and for higher victory rate in boxers with larger WD, however without reaching significance. A significant negative correlation was found between the 1st weight and the WG, both in absolute (r=-0.278, p=0.001) and relative value (r=-0.497, p<0.0001). Conclusions: Although correlations between WG, WD and boxing performance were not found, single cases with an alarming high WG and WD were noted.	[Daniele, Gianlorenzo; Palmieri, Vincenzo; Bianco, Massimiliano] Univ Cattolica Sacro Cuore, Internal Med & Geriatr Inst, Sports Med Unit, Largo Agostino Gemelli 8, I-00168 Rome, Italy; [Weinstein, Richard N.] Westchester Hlth Associates, White Plains, NY USA; [Wallace, Paul Wesley] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	Bianco, M (corresponding author), Univ Cattolica Sacro Cuore, Internal Med & Geriatr Inst, Sports Med Unit, Largo Agostino Gemelli 8, I-00168 Rome, Italy.	massimiliano.bianco@fastwebnet.it	Bianco, Massimiliano/M-9907-2019	Bianco, Massimiliano/0000-0002-0587-5899			41st World Medical Assembly, 1990, B PAN AM HLTH ORG, V24, P606; Artioli GG, 2016, SPORTS MED; Artioli GG, 2010, J SPORT SCI, V28, P21, DOI 10.1080/02640410903428574; Artioli GG, 2010, MED SCI SPORT EXER, V42, P436, DOI 10.1249/MSS.0b013e3181ba8055; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Baird LC, 2010, NEUROSURGERY, V67, P1444, DOI 10.1227/NEU.0b013e3181e5e2cd; Berkovich BE, 2016, INT J SPORT NUTR EXE, V26, P276, DOI 10.1123/ijsnem.2015-0196; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; Brito CJ, 2012, INT J SPORT NUTR EXE, V22, P89, DOI 10.1123/ijsnem.22.2.89; Chaabene H, 2015, SPORTS MED, V45, P337, DOI 10.1007/s40279-014-0274-7; Crighton B, 2016, BRIT J SPORT MED, V50, P446, DOI 10.1136/bjsports-2015-094732; Davis P, 2015, INT J SPORT PHYSIOL, V10, P53, DOI 10.1123/ijspp.2013-0474; Peron APDN, 2009, MUNDO SAUDE, V33, P352; Degoutte F, 2006, INT J SPORTS MED, V27, P9, DOI 10.1055/s-2005-837505; Franchini E, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-52; FREISCHLAG J, 1984, PHYSICIAN SPORTSMED, V12, P121; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Hall CJ, 2001, BRIT J SPORT MED, V35, P390, DOI 10.1136/bjsm.35.6.390; HORSWILL CA, 1992, SPORTS MED, V14, P114, DOI 10.2165/00007256-199214020-00004; HORSWILL CA, 1994, MED SCI SPORT EXER, V26, P1290; Jetton AM, 2013, J STRENGTH COND RES, V27, P1322, DOI 10.1519/JSC.0b013e31828a1e91; Kazemi M, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-26; Khodaee M, 2015, CURR SPORT MED REP, V14, P435, DOI 10.1249/JSR.0000000000000206; Langan-Evans C, 2011, STRENGTH COND J, V33, P25, DOI 10.1519/SSC.0b013e318231bb64; Mendes SH, 2013, BRIT J SPORT MED, V47, P1155, DOI 10.1136/bjsports-2013-092689; Nybo L, 2014, COMPR PHYSIOL, V4, P657, DOI 10.1002/cphy.c130012; Periard JD, 2011, EXP PHYSIOL, V96, P134, DOI 10.1113/expphysiol.2010.054213; Pettersson S, 2013, J ATHL TRAINING, V48, P99, DOI 10.4085/1062-6050-48.1.04; Racinais S, 2015, SPORTS MED, V45, P925, DOI 10.1007/s40279-015-0343-6; Reljic D, 2015, J SPORT SCI, V33, P437, DOI 10.1080/02640414.2014.949825; Reljic D, 2013, J ATHL TRAINING, V48, P109, DOI 10.4085/1062-6050-48.1.05; STEEN SN, 1990, MED SCI SPORT EXER, V22, P762, DOI 10.1249/00005768-199012000-00005; Wroble RR, 1998, MED SCI SPORT EXER, V30, P949, DOI 10.1097/00005768-199806000-00026	33	15	17	0	30	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2016	44	4					349	354		10.1080/00913847.2016.1228421			6	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	EC0HN	WOS:000387780200006	27564844				2021-06-18	
J	Furness, Z				Furness, Zack			Reframing concussions, masculinity, and NFL mythology in League of Denial	POPULAR COMMUNICATION			English	Article							MALE BODY; FOOTBALL; MEDIA; IMAGES; WAR	This article explores how the PBS Frontline documentary League of Denial reframes the "concussion crisis" in three ways that contest the rationalization of injury and the normalization of violence in the hegemonic masculine discourses (visual, written, oral) produced about professional football. First, the film problematizes the notion of head injury as merely "part of the game" and a risk that players ostensibly understand when they enter the National Football League. Second, the film's depiction of Mike Webster's "unruly" body further de-naturalizes concussions and contests the masculine ideal of bodily sacrifice in pro football. Third, the film explicitly critiques the role of sports media in constructing a mythology and spectacle of pro football that contributed to the cultural context in which the concussion crisis has emerged.	[Furness, Zack] Penn State Univ, Mckeesport, PA 15132 USA	Furness, Z (corresponding author), Penn State Univ, Dept Commun, 4000 Univ Dr, Mckeesport, PA 15132 USA.	zackfurness@psu.edu					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Baker A., 2014, NFL CRITICAL CULTURA, P160; Butterworth ML, 2014, SPORT SOC, V17, P867, DOI 10.1080/17430437.2013.806033; Butterworth ML, 2008, COMMUN STUD, V59, P259, DOI 10.1080/10510970802257705; Butterworth Michael L., 2014, NFL CRITICAL CULTURA, P205; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Couturie B., 1985, DISPOSABLE HEROES OT; DeLuca M. K., 1999, ARGUMENTATION ADVOCA, V36, P9, DOI [10.1080/00028533.1999.11951634, DOI 10.1080/00028533.1999.11951634]; Donner R., 1999, ANY GIVEN SUNDAY; Fainaru-Wada M, 2013, LEAGUE OF DENIAL; Fischer M, 2014, J SPORT SOC ISSUES, V38, P199, DOI 10.1177/0193723513515889; Gilmore J., 2013, FRONTLINE INTERVIEWS; Grano D. A., 2014, NFL CRITICAL CULTURA, P13; JANSEN SC, 1994, SOCIOL SPORT J, V11, P1, DOI 10.1123/ssj.11.1.1; Jhally S., 1984, CRITICAL SOCIOLOGIST, V12, P41; King P., 2011, SPORTS ILLUSTRATED, V115, P74; King S, 2014, J SPORT SOC ISSUES, V38, P184, DOI 10.1177/0193723513515890; Kirk M., 2013, LEAGUE DENIAL NFLS C; Kirk M., 2013, FRONTLINE INTERVIEWS; Kusz Kyle W, 2014, NFL CRITICAL CULTURA, P226; Levy D., 2012, BLEACHER REPORT 0120; Lipsyte R, 2013, ESPN OMBUDSMAN  1015; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McLeod C, 2014, J SPORT SOC ISSUES, V38, P222, DOI 10.1177/0193723514520997; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Oates T.P., 2007, COMMUNICATION CRITIC, V4, P74, DOI [https://doi.org/10.1080/14791420601138351, DOI 10.1080/14791420601138351]; Oates TP, 2009, SOCIOL SPORT J, V26, P31, DOI 10.1123/ssj.26.1.31; Oates TP, 2004, PATTERNS PREJUDICE, V38, P301, DOI 10.1080/0031322042000250475; ORIARD M, 1981, J AM CULTURE, V4, P27, DOI 10.1111/j.1542-734X.1981.0403_27.x; Oriard M., 2007, BRAND NFL MAKING SEL; (Producer) Yablans F., 1979, N DALLAS 40; Real M. R., 1975, MASS MEDIATED CULTUR, P170; Rodgers K., 2014, NFL CRITICAL CULTURA, P142; Sabo D., 2004, SPORTING BODIES DAMA, P59; Sabo D., 1990, SPORT MEN GENDER ORD, P115; Sanderson J., 2014, COMMUNICATION S 0528; Sharp A., 2013, GRANTLAND      1009; Silcock BW, 2008, J MASS MEDIA ETHICS, V23, P36, DOI 10.1080/08900520701753205; TRUJILLO N, 1995, SOCIOL SPORT J, V12, P403, DOI 10.1123/ssj.12.4.403; Veri MJ, 2013, J SPORT SOC ISSUES, V37, P227, DOI 10.1177/0193723512472897; VOGAN T, 2014, KEEP FLAM NFL FILMS, P1; Zirin D., 2013, GAME POLITICS HAS TU	42	15	15	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1540-5702	1540-5710		POP COMMUN	Pop. Commun.		2016	14	1			SI		49	57		10.1080/15405702.2015.1084628			9	Communication	Communication	DN5MB	WOS:000377111200007					2021-06-18	
J	Humble, SS; Wilson, LD; Leath, TC; Marshall, MD; Sun, DZ; Pandharipande, PP; Patel, MB				Humble, Stephen S.; Wilson, Laura D.; Leath, Taylor C.; Marshall, Matthew D.; Sun, Daniel Z.; Pandharipande, Pratik P.; Patel, Mayur B.			ICU sedation with dexmedetomidine after severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; dexmedetomidine; sedation	CRITICALLY-ILL PATIENTS; CONTROLLED-TRIAL; INTENSIVE-CARE; MIDAZOLAM; PROPOFOL; PATIENT	Objective: To comprehensively describe the use of dexmedetomidine in a single institutional series of adult ICU patients with severe TBI. This study describes the dexmedetomidine dosage and infusion times, as well as the physiological parameters, neurological status and daily narcotic requirements before, during and after dexmedetomidine infusion.Methods: This study identified 85 adult patients with severe TBI who received dexmedetomidine infusions in the Trauma ICU at Vanderbilt University Medical Center between 2006-2010. Demographic, haemodynamic, narcotic use and sedative use data were systematically obtained from the medical record and analysed for changes associated with dexmedetomidine infusion.Results: During infusion with dexmedetomidine, narcotic and sedative use decreased significantly (p < 0.001 and p < 0.05). Median MAP, SBP, DBP and HR also decreased significantly during infusion when compared to pre-infusion values (p < 0.001). Despite the use of dexmedetomidine, RASS and GCS scores improved from pre-infusion to infusion time periods.Conclusions: The findings demonstrate that initiation of dexmedetomidine infusion is not associated with a decline in neurological functioning in adults with severe TBI. Although there was an observed decrease in haemodynamic parameters during infusion with dexmedetomidine, the change was not clinically significant and the requirements for narcotics and additional sedatives were minimized.	[Humble, Stephen S.; Leath, Taylor C.; Patel, Mayur B.] Vanderbilt Univ, Dept Surg, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN 37240 USA; [Humble, Stephen S.; Leath, Taylor C.; Patel, Mayur B.] Vanderbilt Univ, Dept Neurosurg, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA; [Wilson, Laura D.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN USA; [Wilson, Laura D.] Univ Tulsa, Dept Commun Sci & Disorders, Tulsa, OK 74104 USA; [Marshall, Matthew D.] Vanderbilt Univ, Med Ctr, Dept Pharmaceut Serv, Nashville, TN USA; [Sun, Daniel Z.] Cleveland Clin, Dept Urol, Glickman Urol Kidney Inst, Cleveland, OH 44106 USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Dept Biomed Informat, Med Ctr, Nashville, TN USA; [Pandharipande, Pratik P.; Patel, Mayur B.] Nashville VA Med Ctr, Vet Affairs VA Tennessee Valley Healthcare Syst, Nashville, TN USA	Patel, MB (corresponding author), 1211 21st Ave South,404 Med Arts Bldg, Nashville, TN 37212 USA.	mayur.b.patel@Vanderbilt.edu		Pandharipande, Pratik/0000-0002-1389-8580	REDCap; NCATS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG027472, R01HL111111, R01AG035117]; AHRQ Health Services [5T32HS013833-08]; AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality; Vanderbilt Faculty Research Scholars Program; Eastern Association for the Surgery of Trauma Foundation Research Scholarship; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [T32HS013833] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000448, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL111111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG027472, R01AG035117] Funding Source: NIH RePORTER	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper. Financial support was provided by: REDCap, UL1 TR000445 from NCATS/NIH (all authors); NIH grants R01AG027472 (PPP), R01HL111111(MBP/PPP), R01AG035117 (PPP); AHRQ Health Services 5T32HS013833-08, AHRQ (MBP); Vanderbilt Faculty Research Scholars Program (MBP); and the Eastern Association for the Surgery of Trauma Foundation Research Scholarship (MBP).	[Anonymous], FULL PRESCR INF PREC; Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; Flower O., 2012, EMERG MED INT, V2012, DOI DOI 10.1155/2012/637171; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; James ML, 2012, ANAESTH INTENS CARE, V40, P949, DOI 10.1177/0310057X1204000605; Kuhmonen J, 2001, J NEURAL TRANSM, V108, P261, DOI 10.1007/s007020170071; MAIER C, 1993, ANESTHESIOLOGY, V79, P306, DOI 10.1097/00000542-199308000-00016; Martin Eike, 2003, J Intensive Care Med, V18, P29, DOI 10.1177/0885066602239122; Mirski MA, 2008, SEMIN NEUROL, V28, P611, DOI 10.1055/s-0028-1105970; Nakano T, 2009, J ANESTH, V23, P378, DOI 10.1007/s00540-009-0777-9; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Tarabrin O, 2014, CRITICAL CARE S1, V18, pP416; Triltsch AE, 2002, CRIT CARE MED, V30, P1007, DOI 10.1097/00003246-200205000-00009; Venn RM, 2000, CRIT CARE, V4, P302, DOI 10.1186/cc712; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130	19	15	17	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1266	1270		10.1080/02699052.2016.1187289			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300016	27458990	Green Accepted			2021-06-18	
J	McCarthy, CG; Webb, RC				McCarthy, Cameron G.; Webb, R. Clinton			The toll of the gridiron: damage-associated molecular patterns and hypertension in American football	FASEB JOURNAL			English	Article						musculoskeletal trauma; inflammation; blood; pressure	DISEASE RISK-FACTORS; BODY-MASS INDEX; LEAGUE PLAYERS; BLOOD-PRESSURE; RECURRENT CONCUSSION; CREATINE-KINASE; CARDIAC MARKERS; NFL PLAYERS; MARATHON; EXERCISE	American football has unequivocally been linked to elevations in blood pressure and hypertension, especially in linemen. However, the mechanisms of this increase cannot be attributed solely to increased body weight and associated cardiometabolic risk factors (e.g., dyslipidemia or hyperglycemia). Therefore, understanding the etiology of football-associated hypertension is essential for improving the quality of life in this mostly young population, as well as for lowering the potential for chronic disease in the future. We propose that inflammatogenic damage-associated molecular patterns (DAMPs) released into the circulation from football-induced musculoskeletal trauma activate pattern-recognition receptors of the innate immune system-specifically, high mobility group box 1 protein (HMGB1) and mitochondrial (mt) DNA which activate Toll-like receptor (TLR)4 and -9, respectively. Previously, we observed that circulating levels of these 2 DAMPs are increased in hypertension, and activation of TLR4 and -9 causes endothelial dysfunction and hypertension. Therefore, our novel hypothesis is that musculoskeletal injury from repeated hits in football players, particularly in linemen, leads to elevated circulating HMGB1 and mtDNA to activate TLRs on endothelial cells leading to impaired endothelium-dependent vasodilation, increased vascular tone, and hypertension.-McCarthy, C. G., Webb, R. C. The toll of the gridiron: damage-associated molecular patterns and hypertension in American football. FASEB J. 30, 34-40 (2016). www.fasebj.org	[McCarthy, Cameron G.; Webb, R. Clinton] Georgia Regents Univ, Dept Physiol, Augusta, GA 30912 USA	McCarthy, CG (corresponding author), Georgia Regents Univ, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA.	cmccarthy@gru.edu			American Heart AssociationAmerican Heart Association; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071138]; NIH National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK083685]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK083685] Funding Source: NIH RePORTER	The authors thank Drs. T. Szasz and C. F. Wenceslau (Department of Physiology, Georgia Regents University, Augusta, GA, USA) and Drs. N. Jenkins and K. McCully (Department of Kinesiology, University of Georgia, Athens, GA, USA), for their critical evaluation of the manuscript and editorial expertise. The preparation of this report was supported in part by a predoctoral fellowship (to C.G.M.) and a grant-in-aid (to R.C.W.) from the American Heart Association; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01HL071138 (to R.C.W.); and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK083685 (to R.C.W.). The authors declare no conflicts of interest.	Allen TW, 2010, PHYSICIAN SPORTSMED, V38, P21, DOI 10.3810/psm.2010.04.1758; Basra SS, 2014, AM J CARDIOL, V114, P1836, DOI 10.1016/j.amjcard.2014.09.021; Biderman D, 2010, WALL STREET J; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Croft LB, 2008, AM J CARDIOL, V102, P343, DOI 10.1016/j.amjcard.2008.03.065; D'Andrea A, 2007, INT J CARDIOL, V115, P342, DOI 10.1016/j.ijcard.2006.03.041; Doucleff M., 2013, NPR             0201; Ehlers GG, 2002, J ATHL TRAINING, V37, P151; Fisman EZ, 1997, AM J CARDIOL, V79, P355, DOI 10.1016/S0002-9149(96)00761-8; Fisman EZ, 2002, AM J CARDIOL, V89, P887, DOI 10.1016/S0002-9149(02)02210-5; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Garrido-Chamorro RP, 2009, J SPORT MED PHYS FIT, V49, P278; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Harp JB, 2005, JAMA-J AM MED ASSOC, V293, P1061, DOI 10.1001/jama.293.9.1061-b; Hoffman JR, 2008, INTJ SPORT PHYSIOL, V3, P387, DOI 10.1123/ijspp.3.3.387; Jee H, 2013, AM J PHYS MED REHAB, V92, P513, DOI 10.1097/PHM.0b013e31829232db; Kahanov L., 2012, ONLINE J MED MED SCI, V1, P96; KANNEL WB, 1967, ANN INTERN MED, V67, P48, DOI 10.7326/0003-4819-67-1-48; Kaplan NM, 2005, J AM COLL CARDIOL, V45, P1346, DOI 10.1016/j.jacc.2005.02.012; Karpinos AR, 2013, CIRC-CARDIOVASC QUAL, V6, P716, DOI 10.1161/CIRCOUTCOMES.113.000463; Kilbaugh TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130927; Kim JH, 2015, AM J CARDIOL, V115, P262, DOI 10.1016/j.amjcard.2014.10.033; Kim YJ, 2012, INT J SPORTS MED, V33, P171, DOI 10.1055/s-0031-1285930; Kim YJ, 2015, J CLIN HYPERTENS, V17, P868, DOI 10.1111/jch.12591; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kraemer WJ, 2013, J STRENGTH COND RES, V27, P434, DOI 10.1519/JSC.0b013e318281d1b0; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; Land Walter G, 2015, Sultan Qaboos Univ Med J, V15, pe9; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McCarthy CG, 2015, CARDIOVASC RES, V107, P119, DOI 10.1093/cvr/cvv137; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Meredith PA, 2006, J RENIN-ANGIO-ALDO S, V7, P64, DOI 10.3317/jraas.2006.012; NISHIZAWA T, 1976, AM J CLIN NUTR, V29, P1167; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Owoeye OB, 2013, AM J HYPERTENSION RE, V3, P26; Pincivero DM, 1997, SPORTS MED, V23, P247, DOI 10.2165/00007256-199723040-00004; Pokharel Y, 2014, SOUTH MED J, V107, P633, DOI 10.14423/SMJ.0000000000000173; Rehm K, 2015, INT J SPORTS MED, V36, P832, DOI 10.1055/s-0035-1547218; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Selden MA, 2009, AM J MED, V122, P811, DOI 10.1016/j.amjmed.2009.03.027; Selden MA, 2009, AM J CARDIOL, V103, P969, DOI 10.1016/j.amjcard.2008.12.046; Seys SF, 2015, ALLERGY, V70, P187, DOI 10.1111/all.12540; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Siegel AJ, 2012, AM J MED, V125, P630, DOI 10.1016/j.amjmed.2011.11.008; Smith LL, 2000, MED SCI SPORT EXER, V32, P317, DOI 10.1097/00005768-200002000-00011; Smith LL, 2004, J STRENGTH COND RES, V18, P185, DOI 10.1519/00124278-200402000-00028; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; Vaneckova I, 2014, J ENDOCRINOL, V223, pR63, DOI 10.1530/JOE-14-0368; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Vinereanu D, 2002, CLIN SCI, V103, P249, DOI 10.1042/cs1030249; Virani SS, 2012, ATHEROSCLEROSIS, V222, P551, DOI 10.1016/j.atherosclerosis.2012.03.031; Weiner RB, 2013, CIRCULATION, V128, P524, DOI 10.1161/CIRCULATIONAHA.113.003522	58	15	16	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					34	40		10.1096/fj.15-279588			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	WOS:000367621000005	26316270	Green Published			2021-06-18	
J	Tamano, H; Koike, Y; Nakada, H; Shakushi, Y; Takeda, A				Tamano, Hanuna; Koike, Yuta; Nakada, Hiroyuki; Shakushi, Yukina; Takeda, Atsushi			Significance of synaptic Zn2+ signaling in zincergic and non-zincergic synapses in the hippocampus in cognition	JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY			English	Article						Zinc; Hippocampus; Memory; Schaffer collateral; Mossy fiber; Perforant pathway	LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; MAMMALIAN ZINC TRANSPORTERS; TRAUMATIC BRAIN-INJURY; MOSSY FIBER TERMINALS; DENTATE GYRUS; MICROMOLAR CONCENTRATIONS; RECOGNITION MEMORY; RAT HIPPOCAMPUS; CA2+ CHANNELS	A portion of zinc concentrates in the synaptic vesicles in the brain and is released from glutamatergic (zincergic) neuron terminals. It serves as a signaling factor (in a form of free Zn2+). Both extracellular Zn2+ signaling, which predominantly originates in Zn2+ release from zincergic neuron terminals, and intracellular Zn2+ signaling, which is often linked to extracellular Zn2+ signaling, are involved in hippocampus-dependent memory. At mossy fiber-CA3 pyramidal cell synapses and Schaffer collateral-CA1 pyramidal cell synapses, which are zincergic, extracellular Zn2+ signaling leads to intracellular Zn2+ signaling and is involved in learning and memory. At medial perforant pathway-dentate granule cell synapses, which are non-zincergic, intracellular Zn2+ signaling, which originates in the internal stores containing Zn2+, is involved in learning and memory. The blockade of Zn2+ signaling with Zn2+ chelators induces memory deficit, while the optimal amount range of Zn2+ signaling is unknown. It is possible that the degree and frequency of Zn2+ signaling, which determine the increased Zn2+ levels, modulates learning and memory as well as intracellular Ca2+ signaling. To understand the precise role of synaptic Zn2+ signaling in the hippocampus, the present paper summarizes the current knowledge on Zn2+ signaling at zincergic and non-zincergic synapses in the hippocampus in cognition and involvement of zinc transporters and zinc-binding proteins in synaptic Zn2+ signaling. (C) 2016 Elsevier GmbH. All rights reserved.	[Tamano, Hanuna; Koike, Yuta; Nakada, Hiroyuki; Shakushi, Yukina; Takeda, Atsushi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan	Takeda, A (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp			Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25293032] Funding Source: KAKEN		Adlard PA, 2015, NEUROBIOL DIS, V81, P196, DOI 10.1016/j.nbd.2014.12.012; Adlard PA, 2014, AGING CELL, V13, P351, DOI 10.1111/acel.12178; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Ando M, 2010, NEUROCHEM INT, V57, P608, DOI 10.1016/j.neuint.2010.07.010; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Breustedt J, 2003, P NATL ACAD SCI USA, V100, P12450, DOI 10.1073/pnas.2035117100; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Ceccom J, 2014, LEARN MEMORY, V21, P287, DOI 10.1101/lm.033472.113; Ceccom J, 2013, LEARN MEMORY, V20, P348, DOI 10.1101/lm.029017.112; Chen NS, 1997, MOL PHARMACOL, V51, P1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Colvin RA, 2006, BRAIN RES, V1085, P1, DOI 10.1016/j.brainres.2006.02.043; Cope EC, 2016, EXP NEUROL, V279, P96, DOI 10.1016/j.expneurol.2016.02.017; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; DiGirolamo AM, 2009, AM J CLIN NUTR, V89, p940S, DOI 10.3945/ajcn.2008.26692C; Erickson JC, 1997, J NEUROSCI, V17, P1271; Frazzini V, 2006, BIOGERONTOLOGY, V7, P307, DOI 10.1007/s10522-006-9045-7; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gonzalez J, 2014, J NEUROPHYSIOL, V111, P1259, DOI 10.1152/jn.00941.2012; Heiliger E, 2015, METALLOMICS, V7, P355, DOI 10.1039/c4mt00300d; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Kawahara M, 2014, METALLOMICS, V6, P209, DOI 10.1039/c3mt00257h; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Koumura A, 2009, NEUROSCI LETT, V467, P11, DOI 10.1016/j.neulet.2009.09.051; Lavoie N, 2011, J NEUROSCI, V31, P18251, DOI 10.1523/JNEUROSCI.4164-11.2011; Lee JY, 2011, BRAIN RES, V1418, P12, DOI 10.1016/j.brainres.2011.08.055; Li Y, 2001, J NEUROSCI, V21, P8015; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Lorca RA, 2011, EUR J NEUROSCI, V33, P1175, DOI 10.1111/j.1460-9568.2010.07589.x; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARKESBERY WR, 1984, NEUROBIOL AGING, V5, P19, DOI 10.1016/0197-4580(84)90081-2; Martel G, 2010, LEARN MEMORY, V17, P582, DOI 10.1101/lm.1962010; Minami A, 2006, J NEUROSCI RES, V83, P167, DOI 10.1002/jnr.20714; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Nakashima AS, 2008, J NEUROSCI, V28, P13995, DOI 10.1523/JNEUROSCI.4645-08.2008; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pan EH, 2011, NEURON, V71, P1116, DOI 10.1016/j.neuron.2011.07.019; Paoletti P, 1997, J NEUROSCI, V17, P5711; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Qian J, 2011, J NEUROSCI, V31, P97, DOI 10.1523/JNEUROSCI.5162-10.2011; Sandstead HH, 2014, J TRACE ELEM MED BIO, V28, P414, DOI 10.1016/j.jtemb.2014.08.011; Sandstead HH, 2012, J TRACE ELEM MED BIO, V26, P70, DOI 10.1016/j.jtemb.2012.04.018; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Seth R, 2015, J TRACE ELEM MED BIO, V30, P59, DOI 10.1016/j.jtemb.2014.10.010; Sindreu C, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-16; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Stork Christian J, 2010, J Mol Signal, V5, P5, DOI 10.1186/1750-2187-5-5; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Takeda A, 2015, NEUROSCIENCE, V304, P209, DOI 10.1016/j.neuroscience.2015.07.042; TAKEDA A, 1994, BRAIN RES, V658, P252, DOI 10.1016/S0006-8993(09)90032-4; TAKEDA A, 1995, BRAIN RES, V695, P53, DOI 10.1016/0006-8993(95)00916-E; Takeda A, 2003, J NEUROSCI RES, V72, P537, DOI 10.1002/jnr.10600; Takeda A, 2009, NEUROSCIENCE, V158, P585, DOI 10.1016/j.neuroscience.2008.10.009; Takeda A, 2001, J NEUROSCI RES, V63, P447, DOI 10.1002/1097-4547(20010301)63:5&lt;447::AID-JNR1040&gt;3.0.CO;2-C; Takeda A, 2008, J NEUROSCI RES, V86, P2906, DOI 10.1002/jnr.21732; Takeda A, 2016, BIOMETALS, V29, P177, DOI 10.1007/s10534-015-9907-z; Takeda A, 2014, HIPPOCAMPUS, V24, P1404, DOI 10.1002/hipo.22322; Takeda A, 2014, J NEUROSCI RES, V92, P819, DOI 10.1002/jnr.23385; Takeda A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00026; Takeda A, 2013, METALLOMICS, V5, P417, DOI 10.1039/c3mt20269k; Takeda A, 2012, BEHAV BRAIN RES, V226, P259, DOI 10.1016/j.bbr.2011.09.026; Takeda A, 2011, MOL NEUROBIOL, V44, P166, DOI 10.1007/s12035-010-8158-9; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Takeda A, 2009, NEUROTOXICOLOGY, V30, P712, DOI 10.1016/j.neuro.2009.05.009; Tamano H, 2015, HIPPOCAMPUS, V25, P952, DOI 10.1002/hipo.22418; Tyszka-Czochara M, 2014, ACTA POL PHARM, V71, P369; Valente T, 2002, EXP NEUROL, V174, P215, DOI 10.1006/exnr.2002.7876; Valente T, 2002, MOL CELL NEUROSCI, V21, P189, DOI 10.1006/mcne.2002.1159; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yu XD, 2013, BRIT J NUTR, V110, P2194, DOI 10.1017/S0007114513001657	91	15	15	1	11	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0946-672X			J TRACE ELEM MED BIO	J. Trace Elem. Med. Biol.		2016	38				SI		93	98		10.1016/j.jtemb.2016.03.003			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	DY9RU	WOS:000385473600011	26995290				2021-06-18	
J	Tepe, V; Yarnell, A; Nindl, BC; Van Arsdale, S; Deuster, PA				Tepe, Victoria; Yarnell, Angela; Nindl, Bradley C.; Van Arsdale, Stephanie; Deuster, Patricia A.			Women in Combat: Summary of Findings and a Way Ahead	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; GENDER-DIFFERENCES; UNINTENDED PREGNANCY; MILITARY PERSONNEL; IRON-DEFICIENCY; MENTAL-HEALTH; RISK-FACTORS; US MILITARY; DEPLOYMENT	The Women in Combat Symposium was held at the Defense Health Headquarters April 29 to May 1, 2014, cohosted by the Office of the Assistant Secretary of Defense for Health Affairs and the Consortium for Health and Military Performance. The conference was a call to renew and extend research investment and policy commitment to recognize operational scenarios, requirements, health priorities, and combat-related injury exposures uniquely relevant to the performance and well-being of female Service members. Symposium participants worked in groups to identify knowledge and capability gaps critical to the successful integration, health, and performance of female Service members in combat roles and to develop recommendations for researchers and policy makers to address gaps in three specific areas of concern: Leadership and Peer Behavior, Operational Performance, and Health and Well-Being. Consensus findings are summarized as 20 research gaps and accompanying recommendations. Each represents an opportunity to advance health and performance outcomes and to leverage female Service members' strengths and capacities to the general benefit of all Service members and their families.	[Tepe, Victoria] Dept Def Hearing Ctr Excellence HCE, 2200 Bergquist Dr, Jbsa Lackland, TX 78236 USA; [Yarnell, Angela] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci Res, Silver Spring, MD 20910 USA; [Nindl, Bradley C.] US Army, Inst Publ Hlth, Publ Hlth Command, Aberdeen Proving Ground, MD 21010 USA; [Van Arsdale, Stephanie; Deuster, Patricia A.] Uniformed Serv Univ Hlth Sci, Consortium Hlth & Mil Performance, Dept Mil & Emergency Med, Bethesda, MD 20814 USA	Tepe, V (corresponding author), Dept Def Hearing Ctr Excellence HCE, 2200 Bergquist Dr, Jbsa Lackland, TX 78236 USA.		Deuster, Patricia A/G-3838-2015	Deuster, Patricia A/0000-0002-7895-0888	CHAMP; APHC; DCoE; Office of the Assistant Secretary of Defense for Research and Engineering	We would like to thank Health Affairs for their support in hosting the Women in Combat Symposium. We are grateful to CHAMP, and APHC, DCoE, and the Office of the Assistant Secretary of Defense for Research and Engineering for their support. A special thanks to our keynote speakers, Dr. David J. Smith, DASD/HA, and Ms. Juliet Beyler, Director of Officer and Enlisted Personnel Management. Additional thanks to the anonymous reviewers for their contributions to this manuscript.	Albright TS, 2005, MIL MED, V170, P735, DOI 10.7205/MILMED.170.9.735; Bell NS, 2000, AM J PREV MED, V18, P141, DOI 10.1016/S0749-3797(99)00173-7; Bliese P. D., 2006, MILITARY LIFE PSYCHO, P213; Booth-Kewley S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-130; BORSAYTRINDLE LA, 1991, MIL MED, V156, P82; Bowles SV, 2010, MIL MED, V175, P382, DOI 10.7205/MILMED-D-10-00099; Chen GL, 2002, J APPL PSYCHOL, V87, P549, DOI 10.1037//0021-9010.87.3.549; Christopher MLA, 2007, MIL MED, V172, P9; Deuster PA, 1997, MIL MED, V162, P649; Dutra L, 2011, J TRAUMA DISSOCIATIO, V12, P25, DOI 10.1080/15299732.2010.496141; Erdman J., 2011, NUTR TRAUMATIC BRAIN; Friedl KE, 2008, MED SCI SPORT EXER, V40, pS609, DOI 10.1249/MSS.0b013e3181892d53; Friedl KE, 2005, J WOMENS HEALTH, V14, P764, DOI 10.1089/jwh.2005.14.764; Greenberg N., 2011, DEPLOYMENT PSYCHOL E, P69, DOI DOI 10.1037/12300-003; Grindlay K, 2013, OBSTET GYNECOL, V121, P241, DOI 10.1097/AOG.0b013e31827c616e; HawleyBowland C, 1996, WOMEN HEALTH ISS, V6, P353; Hill D W, 1993, Br J Sports Med, V27, P45; Holt K, 2011, MIL MED, V176, P1056, DOI 10.7205/MILMED-D-11-00012; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Jonas WB, 2010, MILITARY MED, V175, P6, DOI DOI 10.7205/MILMED-D-10-00280; Kelley ML, 2002, MIL PSYCHOL, V14, P199, DOI 10.1207/S15327876MP1403_2; KELLEY ML, 1994, MIL PSYCHOL, V6, P125, DOI DOI 10.1207/S15327876MP0602_4; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; KING N, 1993, J AM COLL NUTR, V12, P344, DOI 10.1080/07315724.1993.10718320; Knapik J, 2005, J STRENGTH COND RES, V19, P246; Kraemer WJ, 2001, MED SCI SPORT EXER, V33, P1011, DOI 10.1097/00005768-200106000-00022; LeardMann CA, 2013, WOMEN HEALTH ISS, V23, pE215, DOI 10.1016/j.whi.2013.05.002; Lindberg LD, 2011, CONTRACEPTION, V84, P249, DOI 10.1016/j.contraception.2011.01.017; Lipari RN, 2006, 2007002 DEF MANP DAT; Lowe NK, 2003, MIL MED, V168, P569; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; Maguen S, 2008, MIL MED, V173, P1; McClung JP, 2014, J TRACE ELEM MED BIO, V28, P388, DOI 10.1016/j.jtemb.2014.06.022; McClung JP, 2013, ANNU REV NUTR, V33, P271, DOI 10.1146/annurev-nutr-071812-161205; Millegan J, 2015, J TRAUMA STRESS, V28, P298, DOI 10.1002/jts.22028; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Moore J, 1996, WOMEN HEALTH ISS, V6, P374; Morgan BJ, 2011, MIL MED, V176, P976, DOI 10.7205/MILMED-D-10-00433; Murdoch M, 2007, MIL MED, V172, P718, DOI 10.7205/MILMED.172.7.718; Naclerio AL, 2011, CONCERNS WOMEN CURRE; Nindl BC, 2000, J APPL PHYSIOL, V88, P2251; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005; Reynolds KL, 2001, J STRENGTH COND RES, V15, P136; Ritchie EC, 2001, MIL MED, V166, P1033; Rona RJ, 2007, INT J EPIDEMIOL, V36, P319, DOI 10.1093/ije/dyl273; Rundell JR, 2006, GEN HOSP PSYCHIAT, V28, P352, DOI 10.1016/j.genhosppsych.2006.04.006; Schumm WR, 2001, PSYCHOL REP, V89, P153, DOI 10.2466/PR0.89.5.153-165; Segal MW, 2015, MIL BEHAV HLTH, P1; Shaffer RA, 1999, MIL MED, V164, P17; Steele N, 2013, UROL NURS, V33, P78; Steele Nancy, 2013, Urol Nurs, V33, P61; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Swan SC, 2008, VIOLENCE VICTIMS, V23, P301, DOI 10.1891/0886-6708.23.3.301; Taft CT, 2007, J FAM PSYCHOL, V21, P270, DOI 10.1037/0893-3200.21.2.270; Tepe V, 2015, WOMEN AT WAR; Turner JB, 2007, J TRAUMA STRESS, V20, P643, DOI 10.1002/jts.20245; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Vogt DS, 2005, J TRAUMA STRESS, V18, P271; Wardell D W, 2001, J Am Acad Nurse Pract, V13, P187; Wilson C, 2010, NURS CLIN N AM, V45, P95, DOI 10.1016/j.cnur.2010.02.005; Yanovich R, 2011, J STRENGTH COND RES, V25, P3412, DOI 10.1519/JSC.0b013e318215f779	65	15	15	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2016	181			1			109	118		10.7205/MILMED-D-15-00409			10	Medicine, General & Internal	General & Internal Medicine	DI3NW	WOS:000373406400016	26741909	Bronze			2021-06-18	
J	Wei, ZZ; Lee, JH; Zhang, YB; Zhu, YB; Deveau, TC; Gu, XH; Winter, MM; Li, JM; Wei, L; Yu, SP				Wei, Zheng Zachory; Lee, Jin Hwan; Zhang, Yongbo; Zhu, Yan Bing; Deveau, Todd C.; Gu, Xiaohuan; Winter, Megan M.; Li, Jimei; Wei, Ling; Yu, Shan Ping			Intracranial Transplantation of Hypoxia-Preconditioned iPSC-Derived Neural Progenitor Cells Alleviates Neuropsychiatric Defects After Traumatic Brain Injury in Juvenile Rats	CELL TRANSPLANTATION			English	Article						Induced pluripotent stem cell-derived neural progenitor cells (iPSC-NPCs); Hypoxic preconditioning; Regeneration; Juveniles; Traumatic brain injury (TBI); Posttraumatic disorders	PHARMACOLOGICALLY INDUCED HYPOTHERMIA; COMBINING ENRICHED ENVIRONMENT; EMBRYONIC STEM-CELLS; CLOSED-HEAD-INJURY; NEURONAL DIFFERENTIATION; INTRANASAL DELIVERY; CEREBRAL-ISCHEMIA; OXYTOCIN RELEASE; STROKE; VASOPRESSIN	Traumatic brain injury (TBI) is a common cause of mortality and long-term morbidity in children and adolescents. Posttraumatic stress disorder (PTSD) frequently develops in these patients, leading to a variety of neuropsychiatric syndromes. Currently, few therapeutic strategies are available to treat juveniles with PTSD and other developmental neuropsychiatric disorders. In the present investigation, postnatal day 14 (P14) Wistar rats were subjected to TBI induced by a controlled cortical impact (CCI) (velocity = 3 m/s, depth = 2.0 mm, contact time = 150 ms). This TBI injury resulted in not only cortical damages, but also posttrauma social behavior deficits. Three days after TBI, rats were treated with intracranial transplantation of either mouse iPSC-derived neural progenitor cells under normal culture conditions (N-iPSC-NPCs) or mouse iPSC-derived neural progenitor cells pretreated with hypoxic preconditioning (HP-iPSC-NPCs). Compared to TBI animals that received N-iPSC-NPCs or vehicle treatment, HP-iPSC-NPC-transplanted animals showed a unique benefit of improved performance in social interaction, social novelty, and social transmission of food preference tests. Western blotting showed that HP-iPSC-NPCs expressed significantly higher levels of the social behavior -related genes oxytocin and the oxytocin receptor. Overall, HP-iPSC-NPC transplantation exhibits a great potential as a regenerative therapy to improve neuropsychiatric outcomes after juvenile TBI.	[Wei, Zheng Zachory; Zhang, Yongbo; Zhu, Yan Bing; Li, Jimei; Wei, Ling] Capital Med Univ, Beijing Friendship Hosp, Expt Res Ctr, Dept Neurol,Labs Stem Cell Biol & Regenerat Med, Beijing, Peoples R China; [Wei, Zheng Zachory; Zhang, Yongbo; Zhu, Yan Bing; Li, Jimei; Wei, Ling] Capital Med Univ, Beijing Friendship Hosp, Ctr Neurol Dis, Beijing, Peoples R China; [Wei, Zheng Zachory; Lee, Jin Hwan; Deveau, Todd C.; Gu, Xiaohuan; Winter, Megan M.; Wei, Ling; Yu, Shan Ping] Emory Univ, Sch Med, Dept Anesthesiol, 101 Woodruff Circle WMRB Suite 620, Atlanta, GA 30322 USA; [Yu, Shan Ping] Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA USA	Yu, SP (corresponding author), Emory Univ, Sch Med, Dept Anesthesiol, 101 Woodruff Circle WMRB Suite 620, Atlanta, GA 30322 USA.	spyu@emory.edu	Wei, Zheng Zachory/I-2109-2019	Wei, Zheng Zachory/0000-0001-7682-9286	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS091585, NS062097, NS085568]; AHAAmerican Heart Association [12GRNT12060222]; VA National Merit grant [RX000666]; AHA Predoctoral/Postdoctoral Fellowships [15POST25710112, 15POST 25680013, 14PRE18830026]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371355/81500989]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7142045]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091585, R01NS085568, R01NS062097] Funding Source: NIH RePORTER	This work was supported by NIH grants NS091585 (L.W), NS062097 (LW), and NS085568 (LW.); AHA Grant-in-Aid 12GRNT12060222 (S.P.Y.); VA National Merit grant RX000666 (S.P.Y.); AHA Predoctoral/Postdoctoral Fellowships 15POST25710112 (Z.Z.W.), 15POST 25680013 (J.H.L.), and 14PRE18830026 (T.C.D.); National Natural Science Foundation of China 81371355/81500989 (Y.Z.); and Beijing Natural Science Foundation 7142045 (Y.Z.). The authors declare no conflicts of interest.	Adriani W, 2006, PSYCHOPHARMACOLOGY, V184, P155, DOI 10.1007/s00213-005-0223-0; All AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116933; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Baharnoori M, 2012, SCHIZOPHRENIA BULL, V38, P444, DOI 10.1093/schbul/sbq098; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Chau MJ, 2014, STEM CELLS, V32, P3075, DOI 10.1002/stem.1802; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dunkerson J, 2014, RESTOR NEUROL NEUROS, V32, P675, DOI 10.3233/RNN-140408; Eckert A, 2015, STEM CELL TRANSL MED, V4, P841, DOI 10.5966/sctm.2014-0184; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; GALEF BG, 1987, DEV PSYCHOBIOL, V20, P209, DOI 10.1002/dev.420200209; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Harbert MJ, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/914546; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Lam J, 2014, ADV FUNCT MATER, V24, P7053, DOI 10.1002/adfm.201401483; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee JH, 2015, AM J PHYSIOL-CELL PH, V308, pC570, DOI 10.1152/ajpcell.00353.2014; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Lepperhof V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107363; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Mason Christine Narad, 2013, Pediatr Nurs, V39, P267; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; McDonald S, 2014, SOCIAL COMMUNICATION; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mohamad O, 2013, DIFFERENTIATION, V86, P149, DOI 10.1016/j.diff.2013.12.002; Mohamad O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064160; Mu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101185; Nudi ET, 2015, J NEUROTRAUM, V32, P1117, DOI 10.1089/neu.2014.3618; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Qin I., 2015, PLOS ONE, V10; Romanyuk N, 2015, CELL TRANSPLANT, V24, P1781, DOI 10.3727/096368914X684042; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Sun JM, 2015, EXP NEUROL, V272, P78, DOI 10.1016/j.expneurol.2015.03.011; Szeto A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1495, DOI 10.1152/ajpendo.90718.2008; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; van Handel M, 2010, J PEDIATR PSYCHOL, V35, P286, DOI 10.1093/jpepsy/jsp049; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wang Z, 2015, ACS NANO, V9, P6683, DOI 10.1021/acsnano.5b00690; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Wei ZZ, 2015, CELL TRANSPLANT, V24, P391, DOI 10.3727/096368915X686887; Wei ZZ, 2014, CELL MOL NEUROBIOL, V34, P881, DOI 10.1007/s10571-014-0067-4; Weitzdoerfer R, 2004, SEMIN PERINATOL, V28, P249, DOI 10.1053/j.semperi.2004.08.001; Wrenn C. C., 2004, CURR PROTOC NEUROSCI, V28; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0	55	15	15	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2016	25	5					797	809		10.3727/096368916X690403			13	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Cell Biology; Research & Experimental Medicine; Transplantation	DL0UY	WOS:000375349300003	26766038	Bronze			2021-06-18	
J	Wilson, CL; Hayward, SL; Kidambi, S				Wilson, Christina L.; Hayward, Stephen L.; Kidambi, Srivatsan			Astrogliosis in a dish: substrate stiffness induces astrogliosis in primary rat astrocytes	RSC ADVANCES			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; TRAUMATIC BRAIN-INJURY; REACTIVE ASTROCYTES; AUTOIMMUNE ENCEPHALOMYELITIS; OXIDATIVE STRESS; IN-VIVO; TISSUE; MATRIX; ELASTICITY; DISEASE	Astrogliosis due to brain injury or disease can lead to varying molecular and morphological changes in astrocytes. Magnetic resonance elastography and ultrasound have demonstrated that brain stiffness varies with age and disease state. However, there is a lack in understanding the role of varied stiffness on the progression of astrogliosis highlighting a critical need to engineer in vitro models that mimic disease stages. Such models need to incorporate the dynamic changes in the brain microenvironment including the stiffness changes. In this study we developed a polydimethyl siloxane (PDMS) based platform that modeled the physiologically relevant stiffness of brain in both a healthy (200 Pa) and diseased (8000 Pa) state to investigate the effect of stiffness on astrocyte function. We observed that astrocytes grown on soft substrates displayed a consistently more quiescent phenotype while those on stiff substrates displayed an astrogliosis-like morphology. In addition to morphological changes, astrocytes cultured on stiff substrates demonstrated significant increase in other astrogliosis hallmarks - cellular proliferation and glial fibrillary acidic protein (GFAP) protein expression. Furthermore, culturing astrocytes on a stiff surface resulted in increased reactive oxygen species (ROS) production, increased super oxide dismutase activity and decreased glutamate uptake. Our platform lends itself for study of potential therapeutic strategies for brain injury focusing on the intricate brain microenvironment-astrocytes signaling pathways.	[Wilson, Christina L.; Hayward, Stephen L.; Kidambi, Srivatsan] Univ Nebraska, Dept Chem & Biomol Engn, 820 N 16th St,207 Othmer Hall, Lincoln, NE 68588 USA; [Kidambi, Srivatsan] Univ Nebraska, Nebraska Ctr Mat & Nanosci, 855 N 16th St, Lincoln, NE 68588 USA; [Kidambi, Srivatsan] Univ Nebraska, Nebraska Ctr Prevent Obes Dis, 316C Leverton Hall,1700 35th St, Lincoln, NE 68588 USA; [Kidambi, Srivatsan] Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, 42nd & Emile St, Omaha, NE USA; [Kidambi, Srivatsan] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	Kidambi, S (corresponding author), Univ Nebraska, Dept Chem & Biomol Engn, 820 N 16th St,207 Othmer Hall, Lincoln, NE 68588 USA.; Kidambi, S (corresponding author), Univ Nebraska, Nebraska Ctr Mat & Nanosci, 855 N 16th St, Lincoln, NE 68588 USA.; Kidambi, S (corresponding author), Univ Nebraska, Nebraska Ctr Prevent Obes Dis, 316C Leverton Hall,1700 35th St, Lincoln, NE 68588 USA.; Kidambi, S (corresponding author), Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, 42nd & Emile St, Omaha, NE USA.; Kidambi, S (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	skidambi2@unl.edu	Kidambi, Srivatsan/A-5689-2015	Kidambi, Srivatsan/0000-0002-0282-0411	start up funds from UNL's Layman Award; MRSEC Seed Grant; Nebraska Center for the Prevention of Obesity Diseases Pilot grant; UNL Interdisciplinary Award; UNL's MolecularMechanisms of Diseases T32 Graduate Fellowship	We thank Dr You Zhou of the UNL Center for Biotechnology Microscopy Core Facilities for his stimulating conversations about the brain microenvironment. We thank Dr Oleh Khalimonchuk and Dr Iryna Bohovych for assistance with flow cytometer experimental set up. This work was funded by the start up funds from UNL's Layman Award, MRSEC Seed Grant, Nebraska Center for the Prevention of Obesity Diseases Pilot grant, UNL Interdisciplinary Award (to S. K.) and UNL'sMolecularMechanisms of Diseases T32 Graduate Fellowship (to C. L. W.).	Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Araque A, 2010, PHILOS T R SOC B, V365, P2375, DOI 10.1098/rstb.2009.0313; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Buxboim A, 2014, CURR BIOL, V24, P1909, DOI 10.1016/j.cub.2014.07.001; Cole R, 2001, PROTOCOLS NEURAL CEL, P117; Correa-Cerro LS, 2007, J NEUROPATH EXP NEUR, V66, P169, DOI 10.1097/01.jnen.0000248555.53079.d5; Dambach H, 2014, EPILEPSIA, V55, P184, DOI 10.1111/epi.12473; Dasbiswas K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7085; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; ENG LF, 1992, PROG BRAIN RES, V94, P353; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOU YJ, 1995, J NEUROSCI RES, V40, P359, DOI 10.1002/jnr.490400310; JIANG X, 2007, OPEN NEUROSCI J, V1, P7; Kidambi S, 2008, ADV FUNCT MATER, V18, P294, DOI 10.1002/adfm.200601237; Kolokoltsova OA, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-126; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Medeiros R, 2013, EXP NEUROL, V239, P133, DOI 10.1016/j.expneurol.2012.10.007; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Natarajan V, 2015, RSC ADV, V5, P80956, DOI [10.1039/c5ra15208a, 10.1039/C5RA15208A]; Natarajan V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134541; Nimmerjahn A, 2009, J PHYSIOL-LONDON, V587, P1639, DOI 10.1113/jphysiol.2008.167171; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2001, Prog Brain Res, V132, P23; Perez-Alvarez A, 2013, CURR DRUG TARGETS, V14, P1220; Pirooznia SK, 2014, NEURON, V81, P961, DOI 10.1016/j.neuron.2014.02.024; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Prauzner-Bechcicki S, 2015, J MECH BEHAV BIOMED, V41, P13, DOI 10.1016/j.jmbbm.2014.09.020; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Qu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067094; Raab M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt38; Ribbers G. M., 2010, INT ENCY REHABILITAT; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Shanker G, 2003, MOL BRAIN RES, V110, P85, DOI 10.1016/S0169-328X(02)00642-3; Sidoryk-Wegrzynowicz M, 2011, TOXICOL PATHOL, V39, P115, DOI 10.1177/0192623310385254; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Swift J, 2014, J CELL SCI, V127, P3005, DOI 10.1242/jcs.149203; Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilson CL, 2015, NANOSCALE, V7, P18477, DOI 10.1039/c5nr03646a; Wu XF, 2010, BIOCHEM BIOPH RES CO, V393, P514, DOI 10.1016/j.bbrc.2010.02.038; Xu ZNS, 2013, J ULTRAS MED, V32, P485, DOI 10.7863/jum.2013.32.3.485; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yu ACH, 2004, NEUROCHEM RES, V29, P2171, DOI 10.1007/s11064-004-6891-z; Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21	73	15	15	0	11	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2016	6	41					34447	34457		10.1039/c5ra25916a			11	Chemistry, Multidisciplinary	Chemistry	DJ2QI	WOS:000374049700043	32742641	Green Published, Green Accepted			2021-06-18	
J	Zacks, JM; Kurby, CA; Landazabal, CS; Krueger, F; Grafman, J				Zacks, Jeffrey M.; Kurby, Christopher A.; Landazabal, Claudia S.; Krueger, Frank; Grafman, Jordan			Effects of penetrating traumatic brain injury on event segmentation and memory	CORTEX			English	Article						Traumatic brain injury; Event perception; Memory	MEDIAL PREFRONTAL CORTEX; PARSE CONTINUOUS ACTIONS; INFANTS ABILITY; WORKING-MEMORY; DYNAMIC ACTION; PERCEPTION; KNOWLEDGE; LOBE; REPRESENTATION; ORGANIZATION	Penetrating traumatic brain injury (pTBI) is associated with deficits in cognitive tasks including comprehension and memory, and also with impairments in tasks of daily living. In naturalistic settings, one important component of cognitive task performance is event segmentation, the ability to parse the ongoing stream of behavior into meaningful units. Event segmentation ability is associated with memory performance and with action control, but is not well assessed by standard neuropsychological assessments or laboratory tasks. Here, we measured event segmentation and memory in a sample of 123 male military veterans aged 59-81 who had suffered a traumatic brain injury as young men, and 34 demographically similar controls. Participants watched movies of everyday activities and segmented them to identify fine-grained or coarse-grained events, and then completed tests of recognition memory for pictures from the movies and of memory for the temporal order of actions in the movies. Lesion location and volume were assessed with computed tomography (CT) imaging. Patients with traumatic brain injury were impaired on event segmentation. Those with larger lesions had larger impairments for fine segmentation and also impairments for both memory measures. Further, the degree of memory impairment was statistically mediated by the degree of event segmentation impairment. There was some evidence that lesions to the ventromedial prefrontal cortex (vmPFC) selectively impaired coarse segmentation; however, lesions outside of a priori regions of interest also were associated with impaired segmentation. One possibility is that the effect of vmPFC damage reflects the role of prefrontal event knowledge representations in ongoing comprehension. These results suggest that assessment of naturalistic event comprehension can be a valuable component of cognitive assessment in cases of traumatic brain injury, and that interventions aimed at event segmentation could be clinically helpful. (C) 2015 Elsevier Ltd. All rights reserved.	[Zacks, Jeffrey M.; Kurby, Christopher A.; Landazabal, Claudia S.] Washington Univ, St Louis, MO 63130 USA; [Kurby, Christopher A.] Grand Valley State Univ, Allendale, MI 49401 USA; [Krueger, Frank] George Mason Univ, Fairfax, VA 22030 USA; [Grafman, Jordan] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Chicago, IL 60611 USA	Zacks, JM (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	jzacks@wustl.edu	Zacks, Jeffrey M/E-9099-2011	Zacks, Jeffrey M/0000-0003-1171-3690	 [T32AG000030];  [R01MH070674];  [R01AG031150]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH070674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000030, R01AG031150] Funding Source: NIH RePORTER	This study was conducted by the U.S. National Institute of Neurological Disorders and Stroke Intramural Research Program and took place at the National Institutes of Health Clinical Research Center. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the U.S. Government. For further information about the Vietnam Head Injury Study, contact J.G. at jgrafman@northwestern.edu. We thank the National Institutes of Health Clinical Center for the provision of their facilities and for their supportive services. We thank Sandra Bonifant, Michael Tierney, Leila Glass, Lyanne Yozawitz, Carolee Noury, Vivien YJ Tsen, and Anne Leopold who worked tirelessly to test subjects and organize the study. We thank Yinyuan Zheng for assistance with data coding. As always, the authors are grateful to all of the Vietnam veterans and care-givers who participated in this study. Their unending commitment to improving the health care of veterans is the reason this study could be completed. CAK's contribution was supported in part by training grant T32AG000030. JMZ's contribution was supported in part by grants R01MH070674 and R01AG031150.	Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Bailey HR, 2013, NEUROPSYCHOLOGIA, V51, P2294, DOI 10.1016/j.neuropsychologia.2013.06.022; Bailey HR, 2013, PSYCHOL SCI, V24, P1113, DOI 10.1177/0956797612466676; Baldwin DA, 2001, CHILD DEV, V72, P708, DOI 10.1111/1467-8624.00310; Beck AT, 1996, BDI 2 BECK DEPRESSIO; BOLTZ M, 1992, J EXP PSYCHOL HUMAN, V18, P90, DOI 10.1037/0096-1523.18.1.90; Cohen NJ, 1995, MEMORY AMNESIA HIPPO; Cooper RP, 2006, PSYCHOL REV, V113, P887, DOI 10.1037/0033-295X.113.4.887; Cowan N., 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, 10.1017/ CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Crozier S, 1999, NEUROPSYCHOLOGIA, V37, P1469, DOI 10.1016/S0028-3932(99)00054-8; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DESPOSITO M, 2002, PRINCIPLES FRONTAL L, P168, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0011; Dickman H.R, 1963, STREAM BEHAV, P23, DOI DOI 10.1037/11177-002; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Flores S., 2014, EFFECTIVE EVENT SEGM, V17, P204; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Glass L, 2013, CEREB CORTEX, V23, P1663, DOI 10.1093/cercor/bhs153; Gold D. A., 2014, P 26 ANN CONV ASS PS; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 1993, J HEAD TRAUMA REHAB, V8, P73, DOI DOI 10.1097/00001199-199303000-00008; HANSON C, 1989, J EXP PSYCHOL GEN, V118, P136, DOI 10.1037/0096-3445.118.2.136; HANSON C, 1991, J EXP PSYCHOL GEN, V120, P211, DOI 10.1037/0096-3445.120.2.211; Hard BM, 2006, MEM COGNITION, V34, P1221, DOI 10.3758/BF03193267; Hard BM, 2011, J EXP PSYCHOL GEN, V140, P586, DOI 10.1037/a0024310; Hespos SJ, 2010, NEURAL NETWORKS, V23, P1026, DOI 10.1016/j.neunet.2010.07.010; Hespos SJ, 2009, DEV PSYCHOL, V45, P575, DOI 10.1037/a0014145; Humphreys GW, 1998, COGN NEUROPSYCHOL, V15, P771; Kaplan E., 1983, BOSTON NAMING TEST; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Krueger F, 2007, CEREB CORTEX, V17, P2346, DOI 10.1093/cercor/bhl143; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Kurby CA, 2011, MEM COGNITION, V39, P75, DOI 10.3758/s13421-010-0027-2; LASSITER GD, 1991, J EXP PSYCHOL GEN, V120, P80, DOI 10.1037/0096-3445.120.1.80; NEWTSON D, 1973, J PERS SOC PSYCHOL, V28, P28, DOI 10.1037/h0035584; Newtson D., 1976, NEW DIRECTIONS ATTRI, P223; Partiot A, 1996, NEUROREPORT, V7, P761, DOI 10.1097/00001756-199602290-00020; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Radvansky G.A., 2014, EVENT COGNITION; Radvansky GA, 2010, PSYCHON B REV, V17, P900, DOI 10.3758/PBR.17.6.900; Raymont V., 2011, FRONTIERS NEUROLOGY, V2; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Rosen VM, 2003, BEHAV RES METH INS C, V35, P32, DOI 10.3758/BF03195495; Rubin DC, 2015, PSYCHOL REV, V122, P1, DOI 10.1037/a0037907; Sargent JQ, 2013, COGNITION, V129, P241, DOI 10.1016/j.cognition.2013.07.002; Schacter D. L., 1994, MEMORY SYSTEMS 1994; Schwan S, 2000, MEM COGNITION, V28, P214, DOI 10.3758/BF03213801; Schwartz MF, 1995, ANN NY ACAD SCI, V769, P321, DOI 10.1111/j.1749-6632.1995.tb38148.x; Sharon T, 1998, PSYCHOL SCI, V9, P357, DOI 10.1111/1467-9280.00068; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Sirigu A., 1995, ANN NY ACAD SCI, V769, P411; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Speer NK, 2007, PSYCHOL SCI, V18, P449, DOI 10.1111/j.1467-9280.2007.01920.x; Speer NK, 2003, COGN AFFECT BEHAV NE, V3, P335, DOI 10.3758/CABN.3.4.335; Tingley D, 2014, MEDIATION R PACKAGE; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Warrington E., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Whitney C, 2009, NEUROIMAGE, V47, P360, DOI 10.1016/j.neuroimage.2009.04.037; Zacks JM, 2007, PSYCHOL BULL, V133, P273, DOI 10.1037/0033-2909.133.2.273; Zacks JM, 2006, PSYCHOL AGING, V21, P466, DOI 10.1037/0882-7974.21.3.466; Zacks JM, 2011, J COGNITIVE NEUROSCI, V23, P4057, DOI 10.1162/jocn_a_00078; Zacks JM, 2009, J EXP PSYCHOL GEN, V138, P307, DOI 10.1037/a0015305; Zacks JM, 2004, COGNITIVE SCI, V28, P979, DOI 10.1016/j.cogsci.2004.06.003; Zacks JM, 2003, J EXP PSYCHOL-APPL, V9, P88, DOI 10.1037/1076-898X.9.2.88; Zacks JM, 2001, J EXP PSYCHOL GEN, V130, P29, DOI 10.1037//0096-3445.130.1.29; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486; Zalla T, 2004, PSYCHIAT RES, V128, P39, DOI 10.1016/j.psychres.2003.12.026; Zalla T, 2000, J COGNITIVE NEUROSCI, P115; Zalla T, 2013, J AUTISM DEV DISORD, V43, P2353, DOI 10.1007/s10803-013-1784-0	69	15	15	0	13	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	JAN	2016	74						233	246		10.1016/j.cortex.2015.11.002			14	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	DC8GS	WOS:000369458500018	26704077	Green Accepted			2021-06-18	
J	Saxena, MK; Taylor, C; Billot, L; Bompoint, S; Gowardman, J; Roberts, JA; Lipman, J; Myburgh, J				Saxena, Manoj K.; Taylor, Colman; Billot, Laurent; Bompoint, Severine; Gowardman, John; Roberts, Jason A.; Lipman, Jeffery; Myburgh, John			The Effect of Paracetamol on Core Body Temperature in Acute Traumatic Brain Injury: A Randomised, Controlled Clinical Trial	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE ISCHEMIC-STROKE; DOUBLE-BLIND; INTENSIVE-CARE; ACETAMINOPHEN; HYPERTHERMIA; HYPOTHERMIA; MANAGEMENT; MORTALITY; MULTICENTER	Background Strategies to prevent pyrexia in patients with acute neurological injury may reduce secondary neuronal damage. The aim of this study was to determine the safety and efficacy of the routine administration of 6 grams/day of intravenous paracetamol in reducing body temperature following severe traumatic brain injury, compared to placebo. Methods A multicentre, randomised, blind, placebo-controlled clinical trial in adult patients with traumatic brain injury (TBI). Patients were randomised to receive an intravenous infusion of either 1g of paracetamol or 0.9% sodium chloride (saline) every 4 hours for 72 hours. The primary outcome was the mean difference in core temperature during the study intervention period. Results Forty-one patients were included in this study: 21 were allocated to paracetamol and 20 to saline. The median (interquartile range) number of doses of study drug was 18 (17-18) in the paracetamol group and 18 (16-18) in the saline group (P = 0.85). From randomisation until 4 hours after the last dose of study treatment, there were 2798 temperature measurements (median 73 [67-76] per patient). The mean +/- standard deviation temperature was 37.4 +/- 0.5 degrees C in the paracetamol group and 37.7 +/- 0.4 degrees C in the saline group (absolute difference -0.3 degrees C; 95% confidence interval -0.6 to 0.0; P = 0.09). There were no significant differences in the use of physical cooling, or episodes of hypotension or hepatic abnormalities, between the two groups. Conclusion The routine administration of 6g/day of intravenous paracetamol did not significantly reduce core body temperature in patients with TBI.	[Saxena, Manoj K.; Taylor, Colman; Myburgh, John] George Inst Global Hlth, Div Crit Care, Sydney, NSW, Australia; [Saxena, Manoj K.; Taylor, Colman; Myburgh, John] George Inst Global Hlth, Trauma Div, Sydney, NSW, Australia; [Saxena, Manoj K.; Myburgh, John] Univ New S Wales, St George Hosp, Sch Clin, Dept Intens Care Med, Sydney, NSW 2052, Australia; [Taylor, Colman; Billot, Laurent] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Billot, Laurent; Bompoint, Severine] George Inst Global Hlth, Div Stat, Sydney, NSW, Australia; [Gowardman, John; Roberts, Jason A.; Lipman, Jeffery] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia; [Gowardman, John; Roberts, Jason A.; Lipman, Jeffery] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia; [Lipman, Jeffery] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4001, Australia	Saxena, MK (corresponding author), George Inst Global Hlth, Div Crit Care, Sydney, NSW, Australia.	m.saxena@georgeinstitute.org.au	Lipman, Jeffrey/G-2211-2010; Billot, Laurent/Y-1241-2019; Roberts, Jason A/F-6272-2010	Lipman, Jeffrey/0000-0002-5965-9876; Billot, Laurent/0000-0002-4975-9793; Roberts, Jason A/0000-0001-6218-435X; Saxena, Manoj/0000-0002-0385-6731	Australia and New Zealand College of Anaesthetists; St. George Medical research Foundation	This work was supported by: Project grant from the Australia and New Zealand College of Anaesthetists (MS JM JG JL); Unrestricted grant from the St. George Medical research Foundation (The Honda-St. George Critical Care and Trauma Fellowship) (MS JM). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, and approval of the manuscript.	Adelson PD, 2013, THE LANCET NEUROLOGY; Andrews P. J., 2015, N ENGL J MED; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Brain Trauma F, 2008, J NEUROTRAUM, V25, P276; Brain Trauma F, 2007, J NEUROTRAUM, V24, pS21; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Brown JM, 2008, CHILD NERV SYST, V24, P477, DOI 10.1007/s00381-007-0517-0; Daly FFS, 2004, ANN EMERG MED, V44, P393, DOI 10.1016/j.annemergmed.2004.05.005; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dippel DWJ, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-2; Dippel DWJ, 2001, STROKE, V32, P1607, DOI 10.1161/01.STR.32.7.1607; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Heyland DK, 1996, INTENS CARE MED, V22, P1339, DOI 10.1007/BF01709548; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jefferies S, 2012, CRIT CARE RESUSC, V14, P74; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Maekawa T, 2014, J NEUROTRAUMA; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; Mullins ME, 2011, NEUROCRIT CARE, V15, P375, DOI 10.1007/s12028-011-9533-8; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; PERUCCA E, 1979, BRIT J CLIN PHARMACO, V7, P201, DOI 10.1111/j.1365-2125.1979.tb00922.x; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Ridder IR, 2013, INT J; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; Saxena M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub3; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; Saxena MK, 2015, CRIT CARE RESUSC, V17, P129; Saxena MK, 2013, CRIT CARE RESUSC, V15, P110; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; van der Jagt M, 2015, INTENS CARE MED, V41, P1129, DOI 10.1007/s00134-015-3844-8; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; World Health Organization, 2006, NEUROLOGICAL DISORDE; Young P, 2015, N ENGL J MED	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144740	10.1371/journal.pone.0144740			13	Multidisciplinary Sciences	Science & Technology - Other Topics	CY9JO	WOS:000366723400023	26678710	DOAJ Gold, Green Published			2021-06-18	
J	Alsalaheen, B; Haines, J; Yorke, A; Broglio, SP				Alsalaheen, Bara; Haines, Jamie; Yorke, Amy; Broglio, Steven P.			Reliability and Construct Validity of Limits of Stability Test in Adolescents Using a Portable Forceplate System	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Ankle; Rehabilitation; Sports	EVALUATING POSTURAL CONTROL; ERROR SCORING SYSTEM; MILD HEAD-INJURY; DYNAMIC BALANCE; ANKLE INSTABILITY; GENERALIZABILITY; CONCUSSION; ADULTS; SPORT; PERTURBATION	Objective: To examine the reliability, convergent, and discriminant validity of the limits of stability (LOS) test to assess dynamic postural stability in adolescents using a portable forceplate system. Design: Cross-sectional reliability observational study. Setting: School setting. Participants: Adolescents (N=36) completed all measures during the first session. To examine the reliability of the LOS test, a subset of 15 participants repeated the LOS test after 1 week. Interventions: Not applicable. Main Outcome Measures: Outcome measurements included the LOS test, Balance Error Scoring System, Instrumented Balance Error Scoring System, and Modified Clinical Test for Sensory Interaction on Balance. Results: A significant relation was observed among LOS composite scores (r=.36.87, P<.05). However, no relation was observed between LOS and static balance outcome measurements. The reliability of the LOS composite scores ranged from moderate to good (intraclass correlation coefficient model 2,1=.73-.96). Conclusions: The results suggest that the LOS composite scores provide unique information about dynamic postural stability, and the LOS test completed at 100% of the theoretical limit appeared to be a reliable test of dynamic postural stability in adolescents. Clinicians should use dynamic balance measurement as part of their balance assessment and should not use static balance testing (eg, Balance Error Scoring System) to make inferences about dynamic balance, especially when balance assessment is used to determine rehabilitation outcomes, or when making return to play decisions after injury. (C) 2015 by the American Congress of Rehabilitation Medicine	[Alsalaheen, Bara; Haines, Jamie; Yorke, Amy] Univ Michigan, Dept Phys Therapy, Flint, MI 48502 USA; [Broglio, Steven P.] Univ Michigan, NeuroSport Res Lab, Ann Arbor, MI 48109 USA	Alsalaheen, B (corresponding author), Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 E Kearsley St, Flint, MI 48502 USA.	Alsalahe@umich.edu	Yorke, Amy/Q-4091-2019	Yorke, Amy/0000-0003-4998-0313	Dr. Ben F. Bryer Foundation Medical Research Fund; University of Michigan-Flint's Research and Creative Activity Award	Supported by the Dr. Ben F. Bryer Foundation Medical Research Fund and the University of Michigan-Flint's Research and Creative Activity Award.	Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; Arnold BL, 2009, MED SCI SPORT EXER, V41, P1048, DOI 10.1249/MSS.0b013e318192d044; Balter SGT, 2004, NEUROSCI LETT, V366, P71, DOI 10.1016/j.neulet.2004.05.015; Baumgartner T.A., 1999, MEASUREMENT EVALUATI; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Brouwer B, 1998, SCAND J REHABIL MED, V30, P131; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Clark S, 1997, ARCH PHYS MED REHAB, V78, P1078, DOI 10.1016/S0003-9993(97)90131-3; Clark S, 2001, ARCH PHYS MED REHAB, V82, P468, DOI 10.1053/apmr.2001.21859; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Davlin CD, 2004, PERCEPT MOTOR SKILL, V98, P1171, DOI 10.2466/PMS.98.4.1171-1176; FURMAN JM, 1994, BAILLIERE CLIN NEUR, V3, P501; Geldhof E, 2006, EUR J PEDIATR, V165, P779, DOI 10.1007/s00431-006-0173-5; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Hatzitaki V, 2002, J MOTOR BEHAV, V34, P161, DOI 10.1080/00222890209601938; Hertel J, 2006, J APPL BIOMECH, V22, P67, DOI 10.1123/jab.22.1.67; Hertel J, 2001, J ATHL TRAINING, V36, P363; Hoffman MA, 1997, ARCH PHYS MED REHAB, V78, P290, DOI 10.1016/S0003-9993(97)90036-8; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369; Hrysomallis C, 2006, J SCI MED SPORT, V9, P288, DOI 10.1016/j.jsams.2006.05.021; Hubbard TJ, 2007, FOOT ANKLE INT, V28, P343, DOI 10.3113/FAI.2007.0343; Karlsson A, 2000, CLIN BIOMECH, V15, P365, DOI 10.1016/S0268-0033(99)00096-0; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; National Federation of State High School Associations, 2013, ANN HIGH SCH ATHL PA; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Olsen BL, 2013, J ATHL TRAINING, V48, pS; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Pickerill ML, 2011, J ATHL TRAINING, V46, P600; Portney LG, 2009, FDN CLIN RES APPL PR; Quatman-Yates CC, 2013, INT J SPORTS PHYS TH, V8, P741; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sell TC, 2012, PHYS THER SPORT, V13, P80, DOI 10.1016/j.ptsp.2011.06.006; Shultz SJ, 2000, J ELECTROMYOGR KINES, V10, P159, DOI 10.1016/S1050-6411(00)00002-X; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.0.CO;2-E; Wikstrom EA, 2005, J ATHL TRAINING, V40, P305; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	46	15	15	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2015	96	12					2194	2200		10.1016/j.apmr.2015.08.418			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CY6SZ	WOS:000366540400015	26325240				2021-06-18	
J	Harada, C; Azuchi, Y; Noro, T; Guo, XL; Kimura, A; Namekata, K; Harada, T				Harada, Chikako; Azuchi, Yuriko; Noro, Takahiko; Guo, Xiaoli; Kimura, Atsuko; Namekata, Kazuhiko; Harada, Takayuki			TrkB Signaling in Retinal Glia Stimulates Neuroprotection after Optic Nerve Injury	AMERICAN JOURNAL OF PATHOLOGY			English	Article							NORMAL-TENSION GLAUCOMA; NEURAL CELL-DEATH; GANGLION-CELLS; NEUROTROPHIC FACTOR; MOUSE MODEL; GLUTAMATE TRANSPORTERS; AXONAL OUTGROWTH; MULLER CELLS; ADULT RATS; IN-VIVO	Brain-derived neurotrophic factor (BDNF) regulates neural cell survival mainly by activating TrkB receptors. Several tines of evidence support a key role for BDNF-TrkB signaling in survival of adult retinal ganglion cells in animal models of optic nerve injury (ONI), but the neuroprotective effect of exogenous BDNF is transient. Glial cells have recently attracted considerable attention as mediators of neural cell survival, and TrkB expression in retinal glia suggests its role in neuroprotection. To elucidate this point directly, we examined the effect of ONI on TrkB(flox/flox):glial fibrillary acidic protein (GFAP)-Cre+ (TrkB(GFAP)) knockout (KO) mice, in which TrkB is deleted in retinal glial cells. ONI markedly increased mRNA expression Levels of basic fibroblast growth factor (bFGF) in wild-type (WT) mice but not in TrkB(GFAP) KO mice. Immunohistochemical analysis at 7 days after ONI (d7) revealed bFGF up-regulation mainly occurred in Muller glia. ONI-induced retinal ganglion cell Loss in WT mice was consistently mild compared with TrkB(GFAP) KO mice at d7. On the other hand, ONI severely decreased TrkB expression in both WT and TrkB(GFAP) KO mice after d7, and the severity of retinal degeneration was comparable with TrkB(GFAP) KO mice at d14. Our data provide direct evidence that glial TrkB signaling plays an important role in the early stage of neural protection after traumatic injury.	[Harada, Chikako; Azuchi, Yuriko; Noro, Takahiko; Guo, Xiaoli; Kimura, Atsuko; Namekata, Kazuhiko; Harada, Takayuki] Tokyo Metropolitan Inst Med Sci, Visual Res Project, Tokyo 1568506, Japan; [Noro, Takahiko] Jikei Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Namekata, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Visual Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	namekata-kz@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [25462766, 25430082, 26861479, 256400043, 26640048, 15H04999]; Funding Program for Next Generation World-Leading Researchers (NEXT Program)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [LS133]; Uehara Memorial FoundationUehara Memorial Foundation; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15H04999, 25462766, 26640048, 25430082] Funding Source: KAKEN	Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (25462766 to C.H., 25430082 to X.G., 26861479 to A.K., 256400043 to K.N., 26640048 and 15H04999 to T.H.), the Funding Program for Next Generation World-Leading Researchers (NEXT Program; LS133 to T.H.), and the Uehara Memorial Foundation (T.H.).	Berk BA, 2015, NEUROSCIENCE, V295, P175, DOI 10.1016/j.neuroscience.2015.03.037; Blanco RE, 2000, J COMP NEUROL, V423, P646; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Chen H, 2004, BRAIN RES, V1011, P99, DOI 10.1016/j.brainres.2004.03.024; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Clarke DB, 1998, VISION RES, V38, P1517, DOI 10.1016/S0042-6989(97)00341-6; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Fujita Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.298; Harada C, 2006, AM J PATHOL, V168, P261, DOI 10.2353/ajpath.2006.050765; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 1998, P NATL ACAD SCI USA, V95, P4663, DOI 10.1073/pnas.95.8.4663; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Katome T, 2013, CELL DEATH DIFFER, V20, P270, DOI 10.1038/cdd.2012.122; Kimura A, 2015, AM J PATHOL, V185, P756, DOI 10.1016/j.ajpath.2014.11.005; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; KOSTYK SK, 1994, J NEUROSCI, V14, P1441; Lindqvist N, 2004, EXP NEUROL, V187, P487, DOI 10.1016/j.expneurol.2004.02.002; Luikart BW, 2005, J NEUROSCI, P25; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Miller G, 2005, SCIENCE, V308, P778, DOI 10.1126/science.308.5723.778; Namekata K, 2013, CELL DEATH DIFFER, V20, P1250, DOI 10.1038/cdd.2013.91; Namekata K, 2014, PROG RETIN EYE RES, V43, P1, DOI 10.1016/j.preteyeres.2014.06.005; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Noro T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.93; Noro T, 2015, INVEST OPHTH VIS SCI, V56, P5012, DOI 10.1167/iovs.15-17142; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Schuettauf F, 2004, CURR EYE RES, V29, P379, DOI 10.1080/02713680490517872; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.306; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.296; Semba K, 2014, NEUROSCI LETT, V581, P89, DOI 10.1016/j.neulet.2014.08.034; Soto I, 2003, J NEUROSCI RES, V73, P507, DOI 10.1002/jnr.10673; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Xie JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119119; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	45	15	15	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	DEC	2015	185	12					3238	3247		10.1016/j.ajpath.2015.08.005			10	Pathology	Pathology	CX8CB	WOS:000365929000010	26476348	Bronze			2021-06-18	
J	Lehre, MA; Eriksen, LM; Tirsit, A; Bekele, S; Petros, S; Park, KB; Bothun, ML; Wester, K				Lehre, Martin Andreas; Eriksen, Lars Magnus; Tirsit, Abenezer; Bekele, Segni; Petros, Saba; Park, Kee B.; Bothun, Marianne Lundervik; Wester, Knut			Outcome in patients undergoing surgery for spinal injury in an Ethiopian hospital	JOURNAL OF NEUROSURGERY-SPINE			English	Article						developing countries; Eastern Africa; neurotrauma; traumatic spinal cord injury; spinal instrumentation; surgery	CORD-INJURY; DEVELOPING-COUNTRIES; EPIDEMIOLOGY	OBJECT The objective of this study was to investigate epidemiology and outcome after surgical treatment for spinal injuries in Ethiopia. METHODS Medical records of patients who underwent surgery for spine injuries at Myungsung Christian Medical Center in Addis Ababa, Ethiopia, between January 2008 and September 2012 were reviewed retrospectively. Assessment of outcome and complications was determined froth patient consultations and phone interviews. RESULTS A total of 146 patients were included (129 males, 17 females). Their mean age was 31.7 years (range 15-81 years). The leading cause of injury was motor vehicle accidents (54.1%), and this was followed by falls (26.7%). The most common injury sites were lumbar (41.1%) and cervical (34.2%) regions of the spine. In 21.2% of patients, no.neurological deficit was present before surgery, 46.6% had incomplete spinal cord injury (American Spinal Injury Association [ASIA] Impairment Scale [AIS] Grade B D), and 32.2% had complete spinal cord injury (AIS Grade A). Follow-up was hampered by suboptimal infrastructure, but information regarding outcome was successfully obtained for 110 patients (75.3%). At follow-up (mean 22.9 months; range 2-57 months), 25 patients (17.1%) were confirmed dead and 85 patients (58.2%) were alive; 49 patients (33.6%) und'erwent physical examination. At least 8 of the 47 patients (17.0%) with a complete injury and 29 of the 68 patients (42.6%) with an incomplete injury showed neurological improvement. The reported incidences of pressure wounds, recurrent urinary tract infections, pneumonia, and thromboembolic events were 22.5%, 13.5%, 5.6%, and 1.1%, respectively. CONCLUSIONS Patients showed surprisingly good recovery considering the limited resources. Surgical treatment for spine injuries in Ethiopia is considered beneficial.	[Lehre, Martin Andreas; Eriksen, Lars Magnus; Bothun, Marianne Lundervik; Wester, Knut] Univ Bergen, Dept Clin Med K1, Bergen, Norway; [Bothun, Marianne Lundervik; Wester, Knut] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; [Tirsit, Abenezer] Univ Addis Ababa, Dept Surg, Neurosurg Unit, Addis Ababa, Ethiopia; [Bekele, Segni] Myungsung Christian Med Ctr, Addis Ababa, Ethiopia; [Petros, Saba] Yekatit 12 Hosp, Addis Ababa, Ethiopia; [Park, Kee B.] Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia	Wester, K (corresponding author), Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway.	kgwe@helse-bergen.no					Abebe M, 2011, E CENTRAL AFR J SURG, V16, P2073; Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Aung TS, 1997, SPINAL CORD, V35, P147, DOI 10.1038/sj.sc.3100375; Brasil AVB, 1998, SPINAL CORD, V36, P353, DOI 10.1038/sj.sc.3100630; Burns AS, 2012, J SPINAL CORD MED, V35, P3, DOI 10.1179/2045772311Y.0000000043; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Feng HY, 2011, J SPINAL CORD MED, V34, P388, DOI 10.1179/2045772311Y.0000000017; Gosselin RA, 2005, INT ORTHOP, V29, P330, DOI 10.1007/s00264-005-0665-3; Guserova J, 2013, COLLECTION SCI PAPER; Hagen EM, 2013, NEUROEPIDEMIOLOGY, V41, P86, DOI 10.1159/000351497; Haran MJ, 2005, ARCH PHYS MED REHAB, V86, P2290, DOI 10.1016/j.apmr.2005.07.293; Leduc BE, 2002, DISABIL REHABIL, V24, P196, DOI 10.1080/09638280110067603; Levy LF, 1998, SPINAL CORD, V36, P213, DOI 10.1038/sj.sc.3100574; Pagliacci MC, 2003, ARCH PHYS MED REHAB, V84, P1266, DOI 10.1016/S0003-9993(03)00234-X; Rahimi-Movaghar V, 2013, NEUROEPIDEMIOLOGY, V41, P65, DOI 10.1159/000350710; Roberts B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-108; Ware J. E., 2001, SCORE INTERPRET SING	18	15	15	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2015	23	6					772	779		10.3171/2015.3.SPINE141282			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CX0FI	WOS:000365371900013	26340379	Bronze			2021-06-18	
J	Lorente, L				Lorente, Leonardo			New Prognostic Biomarkers in Patients With Traumatic Brain Injury	ARCHIVES OF TRAUMA RESEARCH			English	Article						Biomarkers; Substance P; sCD40L; TIMP-1; Malondialdehyde; Cytokeratin-8; Brain Trauma	SOLUBLE CD40 LIGAND; SUBSTANCE-P; MATRIX METALLOPROTEINASES; ENDOTHELIAL-CELLS; TISSUE FACTOR; LIPID-PEROXIDATION; HEAD-INJURY; IN-VIVO; CYTOKERATIN-18 FRAGMENTS; TACHYKININ RECEPTORS	Context: Traumatic brain injury (TBI) is a leading cause of death, disability, and resource consumption per year. There are two kinds of brain injury in TBI, primary and secondary injuries. Primary injury refers to the initial physical forces applied to the brain at the moment of impact. Secondary injury occurs over a period of hours or days following the initial trauma and results from the activation of different pathways such as inflammation, coagulation, oxidation, and apoptosis. Evidence Acquisition: This review focuses on new prognostic biomarkers of mortality in TBI patients related to inflammation, coagulation, oxidation, and apoptosis. Results: Recently circulating levels of substance P (SP), soluble CD40 ligand (sCD40L), tissue inhibitor of matrix metalloproteinases (TIMP)1, malondialdehyde (MDA), and cytokeratin (CK)-18 fragmented have been found to be associated with mortality in TBI patients. Substance P is a neuropeptide of the tachykinin family, mainly synthesized in the central and peripheral nervous system, with proinflammatory effects when binding to their neurokinin-1 receptor (NK1R). Soluble CD40 ligand, a member of the tumor necrosis factor (TNF) family that is released into circulation from activated platelets, exhibit proinflamatory, and procoagulant properties on binding to their cell surface receptor CD40. Matrix metalloproteinases (MMPs) are a family of zinc-containing endoproteinases involved neuroinflammation and TIMP-1 is the inhibitor of some of them. Malondialdehyde is an end-product formed during lipid peroxidation due to degradation of cellular membrane phospholipids, that is released into extracellular space and finally into the blood. Cytokeratin -18 is cleaved by the action of caspases during apoptosis, and CK-18 fragmented is released into the blood. Conclusions: Circulating levels of some biomarkers, such as SP, sCD40L, TIMP-1, MDA, and CK-18 fragmented, related to inflammation, coagulation, oxidation, and apoptosis have been recently associated with mortality in patients with TBI. These biomarkers could help in the prognostic classification of the patients and open new research lines in the treatment of patients with TBI.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz de T, Spain	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz de T, Spain.	lorentemartin@msn.com					Almeida TA, 2004, CURR MED CHEM, V11, P2045, DOI 10.2174/0929867043364748; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Aukrust P, 2004, J AM COLL CARDIOL, V43, P2326, DOI 10.1016/j.jacc.2004.03.023; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Chen R, 2013, EXP THER MED, V6, P1463, DOI 10.3892/etm.2013.1342; Chen YL, 2006, BIOCHEM BIOPH RES CO, V345, P106, DOI 10.1016/j.bbrc.2006.04.034; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Davi G, 2009, J ATHEROSCLER THROMB, V16, P707; De Swert KO, 2006, EUR J PHARMACOL, V533, P171, DOI 10.1016/j.ejphar.2005.12.066; Dominguez-Rodriguez A, 2007, THROMB RES, V121, P293, DOI 10.1016/j.thromres.2007.04.007; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Ferro D, 2007, ARTERIOSCL THROM VAS, V27, P2763, DOI 10.1161/ATVBAHA.107.152777; Ferroni P, 2007, CURR MED CHEM, V14, P2170; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gabrielian Levon, 2013, Acta Neurochir Suppl, V118, P201, DOI 10.1007/978-3-7091-1434-6_37; Garlichs CD, 2003, STROKE, V34, P1412, DOI 10.1161/01.STR.0000074032.64049.47; Gong DS, 2012, BRAIN INJURY, V26, P291, DOI 10.3109/02699052.2011.648710; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Han SH, 2007, ATHEROSCLEROSIS, V190, P205, DOI 10.1016/j.atherosclerosis.2006.01.021; Hezi-Yamit A, 2005, P NATL ACAD SCI USA, V102, P12077, DOI 10.1073/pnas.0504526102; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Horakova L, 2000, GEN PHYSIOL BIOPHYS, V19, P195; Hu Shouxing, 1999, Hunan Yike Daxue Xuebao, V24, P56; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; Kolar M, 2008, ACTA NEUROCHIR SUPPL, V102, P373, DOI 10.1007/978-3-211-85578-2_71; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Lorente L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121739; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Lorente L, 2015, J CRIT CARE, V30, DOI [10.1016/j.jcrc.2015.03.023, 10.1016/j.jcrc.2014.09.012]; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109618; Lorente L, 2014, THROMB RES, V134, P832, DOI 10.1016/j.thromres.2014.07.034; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094318; Lorente L, 2013, CRIT CARE, V17, DOI 10.1186/cc12739; Lorente L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053741; Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104; Lorente L, 2009, CRIT CARE, V13, DOI 10.1186/cc8115; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luft T, 2007, BLOOD, V110, P4535, DOI 10.1182/blood-2006-10-049817; Lukasik M, 2012, PLATELETS, V23, P132, DOI 10.3109/09537104.2011.597528; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MANTYH PW, 1989, P NATL ACAD SCI USA, V86, P5193, DOI 10.1073/pnas.86.13.5193; Mao De-Jun, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P177; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; de Lizarrondo SM, 2012, ARTERIOSCL THROM VAS, V32, P1477, DOI 10.1161/ATVBAHA.112.248773; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Moore DJ, 2012, CLIN DRUG INVEST, V32, P179, DOI 10.2165/11598610-000000000-00000; Munoz M, 2014, AMINO ACIDS, V46, P1727, DOI 10.1007/s00726-014-1736-9; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Parfieniuk-Kowerda A, 2014, LIVER INT, V34, P544, DOI 10.1111/liv.12297; Pinto FM, 2004, EUR J PHARMACOL, V494, P233, DOI 10.1016/j.ejphar.2004.05.016; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Rasley A, 2002, GLIA, V37, P258, DOI 10.1002/glia.10034; Rodriguez JA, 2013, J THROMB HAEMOST, V11, P1464, DOI 10.1111/jth.12312; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Roth GA, 2004, SHOCK, V22, P218, DOI 10.1097/01.shk.0000136098.49672.0e; Saniova B, 2006, CELL MOL NEUROBIOL, V26, P1475, DOI 10.1007/s10571-006-9033-0; Satake H, 2006, CURR DRUG TARGETS, V7, P963, DOI 10.2174/138945006778019273; Schaller B, 2002, Swiss Surg, V8, P145, DOI 10.1024/1023-9332.8.4.145; Sgier C, 2010, J VIRAL HEPATITIS, V17, P845, DOI 10.1111/j.1365-2893.2009.01251.x; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008; Smrcka M, 2007, BRATISL MED J, V108, P144; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Sumer S, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10106; Ueno T, 2003, EUR J CANCER, V39, P769, DOI 10.1016/S0959-8049(02)00865-1; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Yamaguchi M, 2007, NEUROSURGERY, V61, P1067, DOI 10.1227/01.neu.0000303203.07866.18; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhou L, 1998, THROMB HAEMOSTASIS, V79, P1025	110	15	16	0	14	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	DEC	2015	4	4							e30165	10.5812/atr.30165			7	Orthopedics	Orthopedics	CV9VO	WOS:000364635800006	26848476	Green Published			2021-06-18	
J	Powell, DW; Williams, DSB				Powell, Douglas W.; Williams, D. S. Blaise, III			Athletes trained using stable compared to unstable surfaces exhibit distinct postural control profiles when assessed by traditional and nonlinear measures	HUMAN MOVEMENT SCIENCE			English	Article						Posture; Balance; Center of pressure; Training; Athletes; Sway	CEREBRAL CONCUSSION; APPROXIMATE ENTROPY; MULTIPLE-SCLEROSIS; GAIT VARIABILITY; HEALTHY CONTROLS; PARKINSONS-DISEASE; DOWNHILL WALKING; SWAY; YOUNG; DYNAMICS	Athletes are assumed to exhibit better balance than non-athletes; however, few studies have examined the role of different types of sports on balance measures. Two athlete groups that experience divergent sport-specific balance training are stable- (i.e. basketball) and unstable-surface athletes (i.e. surfers). The purpose of this study was to quantify the effect of stable- compared to unstable-surface sports on postural stability. Methods: Eight non-athletes (NON), eight stable-surface athletes (SSA) and eight unstable-surface athletes (USA) performed five 20-s quiet standing trials while ground reaction forces were recorded. Approximate entropy (ApEn), total excursion and root mean square distances (RMS) of the center of pressure position were calculated. Univariate ANOVAs with post hoc tests were conducted for each variable. Results: ApEn values were lower in SSA compared to NON in the ML direction (p = 0.012) and USA had lower ApEn values compared to SSA in the AP direction (p = 0.036). The USA had smaller AP RMS compared to SSA (p = 0.002) while the USA had greater ML RMS (p = 0.008) and resultant RMS values compared to SSA (p = 0.025). Discussion: These data suggest that USA and SSA may exhibit direction-specific differences in balance strategy due to feedback paradigm. (C) 2015 Elsevier B.V. All rights reserved.	[Powell, Douglas W.] Campbell Univ, Dept Phys Therapy, Buies Creek, NC 27506 USA; [Powell, Douglas W.] Campbell Univ, Sch Osteopath Med, Dept Physiol, Buies Creek, NC 27506 USA; [Williams, D. S. Blaise, III] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA USA; [Williams, D. S. Blaise, III] Virginia Commonwealth Univ, Dept Kinesiol & Hlth Sci, Richmond, VA USA	Powell, DW (corresponding author), Dept Phys Therapy, Buies Creek, NC 27506 USA.	dpowell@campbell.edu					Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen Wei-ting, 2006, J Zhejiang Univ Sci B, V7, P844, DOI 10.1631/jzus.2006.B0844; Fournier KA, 2014, GAIT POSTURE, V39, P420, DOI 10.1016/j.gaitpost.2013.08.016; Franz JR, 2013, GAIT POSTURE, V37, P378, DOI 10.1016/j.gaitpost.2012.08.004; Franz JR, 2013, J BIOMECH, V46, P535, DOI 10.1016/j.jbiomech.2012.09.032; Fujita T, 2005, J BONE MINER METAB, V23, P152, DOI 10.1007/s00774-004-0554-7; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Harringe ML, 2008, GAIT POSTURE, V28, P38, DOI 10.1016/j.gaitpost.2007.09.011; HOLM S, 1979, SCAND J STAT, V6, P65; Huisinga JM, 2013, ANN BIOMED ENG, V41, P1670, DOI 10.1007/s10439-012-0697-y; Jongman V, 2012, STUD HEALTH TECHNOL, V181, P93, DOI 10.3233/978-1-61499-121-2-93; Kaipust JP, 2012, MOTOR CONTROL, V16, P229, DOI 10.1123/mcj.16.2.229; Lamoth CJC, 2012, GAIT POSTURE, V35, P489, DOI 10.1016/j.gaitpost.2011.11.014; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; McKeon PO, 2008, J ATHL TRAINING, V43, P293, DOI 10.4085/1062-6050-43.3.293; Myers SA, 2010, J SURG RES, V164, P6, DOI 10.1016/j.jss.2010.04.030; Myers SA, 2009, J VASC SURG, V49, P924, DOI 10.1016/j.jvs.2008.11.020; Negahban H, 2013, NEUROSCI LETT, V553, P126, DOI 10.1016/j.neulet.2013.08.024; O'Connell M, 1998, GAIT POSTURE, V8, P136, DOI 10.1016/S0966-6362(98)00023-X; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Powell DW, 2014, MOTOR CONTROL, V18, P263, DOI 10.1123/mc.2013-0025; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Smart LJ, 2001, J MANIP PHYSIOL THER, V24, P340, DOI 10.1067/mmt.2001.115262; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Strang AJ, 2011, EUR J APPL PHYSIOL, V111, P1485, DOI 10.1007/s00421-010-1770-6; Thompson WR., 2010, ACSMS GUIDELINES EXE; Yamamoto R, 2001, DIABETES RES CLIN PR, V52, P213, DOI 10.1016/S0168-8227(01)00236-4	32	15	15	1	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	DEC	2015	44						73	80		10.1016/j.humov.2015.08.013			8	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	CX0BK	WOS:000365361700007	26319359				2021-06-18	
J	Buchsbaum, MS; Simmons, AN; DeCastro, A; Farid, N; Matthews, SC				Buchsbaum, Monte S.; Simmons, Alan N.; DeCastro, Alex; Farid, Nikdokht; Matthews, Scott C.			Clusters of Low F-18-Fluorodeoxyglucose Uptake Voxels in Combat Veterans with Traumatic Brain Injury and Post-Traumatic Stress Disorder	JOURNAL OF NEUROTRAUMA			English	Article						amygdala; cerebellum; cluster shape; mild traumatic brain injury; positron emission tomography	WHITE-MATTER; FDG-PET; GLUCOSE-METABOLISM; PREFRONTAL CORTEX; IMAGE-ANALYSIS; FOCAL LESIONS; DIFFUSE; ACTIVATION; MEMORY; ROBUST	Individuals with mild traumatic brain injury (TBI) show diminished metabolic activity when studied with positron emission tomography (PET) with F-18-fluorodeoxyglucose (FDG). Since blast injury may not be localized in the same specific anatomical areas in every patient or may be diffuse, significance probability mapping may be vulnerable to false-negative detection of abnormalities. To address this problem, we used an anatomically independent measure to assess PET scans: increased numbers of contiguous voxels that are 2 standard deviations below values found in an uninjured control group. We examined this in three age-matched groups of male patients: 16 veterans with a history of mild TBI, 17 veterans with both mild TBI and post-traumatic stress disorder (PTSD), and 15 veterans without either condition. After FDG administration, subjects performed a modified version of the California Verbal Learning Task. Clusters of low uptake voxels were identified by computing the mean and standard deviation for each voxel in the healthy combat veteran group and then determining the voxel-based z-score for the patient groups. Abnormal clusters were defined as those that contained contiguous voxels with a z-score <-2. Patients with mild TBI alone and patients with TBI+PTSD had larger clusters of low uptake voxels, and cluster size significantly differentiated the mild TBI groups from combat controls. Clusters were more irregular in shape in patients, and patients also had a larger number of low-activity voxels throughout the brain. In mild TBI and TBI+PTSD patients, but not healthy subjects, cluster volume was significantly correlated with verbal learning during FDG uptake.	[Buchsbaum, Monte S.; Simmons, Alan N.; DeCastro, Alex; Matthews, Scott C.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Buchsbaum, Monte S.; Farid, Nikdokht] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Simmons, Alan N.; Matthews, Scott C.] Vet Affairs San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Matthews, Scott C.] Vet Affairs San Diego Healthcare Syst, ASPIRE Ctr, San Diego, CA USA	Buchsbaum, MS (corresponding author), 11388 Sorrento Valley Rd, San Diego, CA 92121 USA.	monte.buchsbaum@gmail.com	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112	Veterans Administration via Merit Grant [1I01CX000292, I01-CX000715]; CDA-2 from the VA CSRD; Veterans AffairsUS Department of Veterans Affairs [I01CX000292, I01CX000715] Funding Source: NIH RePORTER	This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research. This work supported by a Veterans Administration via Merit Grant ((1I01CX000292 & I01-CX000715 ANS). Salary support was by a CDA-2 from the VA CSR&D (SCM).	Asha'ari ZA, 2011, J LARYNGOL OTOL, V125, P781, DOI 10.1017/S0022215111000545; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Bakshi R, 1998, J NEUROIMAGING, V8, P8, DOI 10.1111/jon1998818; Bartels P, 1976, DIGITAL PROCESSING B, P101; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bourne C, 2013, PSYCHOL MED, V43, P1521, DOI 10.1017/S0033291712002358; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Molina ME, 2010, WORLD J BIOL PSYCHIA, V11, P493, DOI 10.3109/15622970701472094; Esik O, 2004, PATHOL ONCOL RES, V10, P42, DOI 10.1007/BF02893408; Esik O, 1999, J NEUROL SCI, V163, P39, DOI 10.1016/S0022-510X(98)00324-4; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Hazlett EA, 2010, NEUROBIOL AGING, V31, P826, DOI 10.1016/j.neurobiolaging.2008.10.005; Heller W, 1997, J ABNORM PSYCHOL, V106, P376, DOI 10.1037/0021-843X.106.3.376; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; Honda Mitsuru, 2013, Acta Neurochir Suppl, V118, P259, DOI 10.1007/978-3-7091-1434-6_49; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Killgore WDS, 2014, DEPRESS ANXIETY, V31, P150, DOI 10.1002/da.22156; Kim JJ, 2003, AM J PSYCHIAT, V160, P919, DOI 10.1176/appi.ajp.160.5.919; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Morris A, 1995, ACCIDENT ANAL PREV, V27, P749, DOI 10.1016/0001-4575(95)00020-8; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nelson C, 2011, MIL MED, V176, P156, DOI 10.7205/MILMED-D-10-00252; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; Schiepers C, 1997, MULT SCLER, V3, P8, DOI 10.1177/135245859700300102; Schwab KA, 2006, NEUROLOGY, V66, pA235; Shin SE, 2005, PSYCHIAT RES-NEUROIM, V138, P33, DOI 10.1016/j.pscychresns.2004.11.005; Simmons AN, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-6; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Wang EW, 2013, NEUROL RES, V35, P285, DOI 10.1179/1743132812Y.0000000138; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Whalley MG, 2012, PSYCHIAT RES-NEUROIM, V201, P98, DOI 10.1016/j.pscychresns.2011.08.008; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Yehuda R, 2009, J NEUROPSYCH CLIN N, V21, P132, DOI 10.1176/appi.neuropsych.21.2.132; ZEKI S, 1991, J NEUROSCI, V11, P641; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049	61	15	15	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2015	32	22					1736	1750		10.1089/neu.2014.3660			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV6ST	WOS:000364401500004	25915799				2021-06-18	
J	Geva, S; Correia, MM; Warburton, EA				Geva, Sharon; Correia, Marta M.; Warburton, Elizabeth A.			Contributions of bilateral white matter to chronic aphasia symptoms as assessed by diffusion tensor MRI	BRAIN AND LANGUAGE			English	Article						Arcuate fasciculus; Diffusion Tensor Imaging; Language; Stroke	POSITRON-EMISSION-TOMOGRAPHY; PERISYLVIAN LANGUAGE NETWORKS; TRAUMATIC BRAIN-INJURY; ARCUATE FASCICULUS; POSTSTROKE APHASIA; STROKE PATIENTS; FUNCTIONAL MRI; NEUROLOGICAL RECOVERY; CONDUCTION APHASIA; HEALTHY-SUBJECTS	Language reorganisation following stroke has been studied widely. However, while studies of brain activation and grey matter examined both hemispheres, studies of white matter changes have mostly focused on the left hemisphere. Here we examined the relationship between bilateral hemispheric white matter and aphasia symptoms. 15 chronic stroke patients with aphasia and 18 healthy adults were studied using Diffusion Weighted Imaging data. By applying histogram analysis, Tract-Based Spatial Statistics, tractography and lesion-tract overlap methods, it was found that damage to the left hemisphere in general, and to the arcuate fasciculus in particular, correlated with impairments on word repetition, object naming, sentence comprehension and homophone and rhyme judgement. However, no such relationship was found in the right hemisphere. It is suggested that while some language function in aphasia can be explained by damage to the left arcuate fasciculus, it cannot be explained by looking at the contra-lesional tract. (C) 2015 The Authors. Published by Elsevier Inc.	[Geva, Sharon; Warburton, Elizabeth A.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 1TN, England; [Geva, Sharon] UCL Inst Child Hlth, Cognit Neurosci & Neuropsychiat Sect, London WC1N 1EH, England; [Correia, Marta M.] MRC Cognit & Brain Sci Unit, Cambridge, England	Geva, S (corresponding author), UCL Inst Child Hlth, Cognit Neurosci & Neuropsychiat Sect, 30 Guilford St, London WC1N 1EH, England.	sharon.geva@cantab.net		Morgado Correia, Marta/0000-0002-3231-7040	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0500874]; Pinsent-Darwin Fellowship; Wingate scholarship; Cambridge Overseas Trust; B'nai Brith Scholarship; Biomedical Centre Grant (BMC) from the UK National Institute of Health Research (NIHR)	This work was supported by the Medical Research Council (grant number G0500874). SG was supported by the Pinsent-Darwin Fellowship, Wingate scholarship, The Cambridge Overseas Trust and B'nai Brith Scholarship. EAW received support from the Biomedical Centre Grant (BMC) to Cambridge from the UK National Institute of Health Research (NIHR).	Abel S, 2015, BRAIN, V138, P1097, DOI 10.1093/brain/awv022; Allendorfer JB, 2012, RESTOR NEUROL NEUROS, V30, P103, DOI 10.3233/RNN-2011-0627; Anglade C, 2014, BRAIN INJURY, V28, P138, DOI 10.3109/02699052.2013.859734; Benson DF., 1996, APHASIA CLIN PERSPEC; Berthier ML, 2012, CORTEX, V48, P133, DOI 10.1016/j.cortex.2011.06.014; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Breier JI, 2008, AM J NEURORADIOL, V29, P483, DOI 10.3174/ajnr.A0846; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Calvert GA, 2000, BRAIN LANG, V71, P391, DOI 10.1006/brln.1999.2272; Campbell J. S. W., 2013, BRAIN LANGUAGE; Cappa SF, 1997, BRAIN LANG, V56, P55, DOI 10.1006/brln.1997.1737; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Coltheart, 1992, PSYCHOLINGUISTIC ASS; Crosson B, 2007, NEUROPSYCHOL REV, V17, P157, DOI 10.1007/s11065-007-9024-z; Dabul B.L., 1979, APRAXIA BATTERY ADUL; De Vega M., 2014, J COGNITIVE NEUROSCI; Diaz MT, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00167; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; Fernandez B, 2004, STROKE, V35, P2171, DOI 10.1161/01.STR.0000139323.76769.b0; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Forkel SJ, 2014, BRAIN, V137, P2027, DOI 10.1093/brain/awu113; Fridriksson J, 2010, J NEUROSCI, V30, P11057, DOI 10.1523/JNEUROSCI.1120-10.2010; Friederici A. D., 2009, TRENDS COGNITIVE SCI; Friederici A. D., 2011, PHYSL REV; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; Geva S, 2012, NEUROIMAGE-CLIN, V1, P37, DOI 10.1016/j.nicl.2012.08.003; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Geva S, 2011, APHASIOLOGY, V25, P323, DOI 10.1080/02687038.2010.511236; Hamilton RH, 2011, BRAIN LANG, V118, P40, DOI 10.1016/j.bandl.2011.02.005; Heller SL, 2005, CLIN IMAG, V29, P283, DOI 10.1016/j.clinimag.2004.09.003; Henriques RN, 2015, NEUROIMAGE, V111, P85, DOI 10.1016/j.neuroimage.2015.02.004; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hosomi A, 2009, NEURORADIOLOGY, V51, P549, DOI 10.1007/s00234-009-0534-7; Iglesias S, 1996, STROKE, V27, P1192, DOI 10.1161/01.STR.27.7.1192; Jang SH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00749; Jones OP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00024; Kim SH, 2011, NEUROREHABILITATION, V29, P305, DOI 10.3233/NRE-2011-0706; Kummerer D, 2013, BRAIN, V136, P619, DOI 10.1093/brain/aws354; Kunimatsu A, 2003, NEURORADIOLOGY, V45, P532, DOI 10.1007/s00234-003-0974-4; Kurland J, 2004, BEHAV NEUROL, V15, P87, DOI 10.1155/2004/974094; Kwon HG, 2011, NEUROREHABILITATION, V29, P401, DOI 10.3233/NRE-2011-0718; Lazar RM, 2008, CURR NEUROL NEUROSCI, V8, P497, DOI 10.1007/s11910-008-0079-x; Lebel C, 2009, HUM BRAIN MAPP, V30, P3563, DOI 10.1002/hbm.20779; Liegeois FJ, 2013, BRAIN LANG, V127, P388, DOI 10.1016/j.bandl.2013.05.003; Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; Marchina S, 2011, STROKE, V42, P2251, DOI 10.1161/STROKEAHA.110.606103; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Meinzer M, 2010, NEUROIMAGE, V53, P283, DOI 10.1016/j.neuroimage.2010.06.004; Meyers J., 1995, REY COMPLEX FIGURE T; Mori N, 2008, MAGN RESON IMAGING, V26, P835, DOI 10.1016/j.mri.2008.01.036; Naeser MA, 2004, NEUROIMAGE, V22, P29, DOI 10.1016/j.neuroimage.2003.11.016; Nelles M, 2008, AM J NEURORADIOL, V29, P488, DOI 10.3174/ajnr.A0855; Newman SD, 2012, PSYCHOL RES-PSYCH FO, V76, P280, DOI 10.1007/s00426-011-0347-2; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Poeppel D, 2004, COGNITION, V92, P1, DOI 10.1016/j.cognition.2003.11.001; Powell HWR, 2007, NEUROIMAGE, V36, P209, DOI 10.1016/j.neuroimage.2007.02.028; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 1999, J COGNITIVE NEUROSCI, V11, P371, DOI 10.1162/089892999563481; Price CJ, 2005, CURR OPIN NEUROL, V18, P429, DOI 10.1097/01.wco.0000168081.76859.c1; Raven J. C., 1938, RAVENS PROGR MATRICE; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rosso C, 2014, BRAIN STIMUL, V7, P627, DOI 10.1016/j.brs.2014.06.004; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schlaug G., 2009, NEUROSCIENCES MUSIC, V1; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schoot L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00208; Selnes OA, 2002, APHASIOLOGY, V16, P897, DOI 10.1080/02687030244000374; Shallice, 1997, HAYLING BRIXTON TEST; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song XJ, 2011, NEUROL RES, V33, P529, DOI 10.1179/016164111X13007856084322; Swinburn K., 2004, COMPREHENSIVE APHASI; Szaflarski JP, 2013, RESTOR NEUROL NEUROS, V31, P347, DOI 10.3233/RNN-120267; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Wan CY, 2014, BRAIN LANG, V136, P1, DOI 10.1016/j.bandl.2014.03.011; Warburton E, 1999, J NEUROL NEUROSUR PS, V66, P155, DOI 10.1136/jnnp.66.2.155; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; Winhuisen L, 2005, STROKE, V36, P1759, DOI 10.1161/01.STR.0000174487.81126.ef; Xu XJ, 2004, CHINESE MED J-PEKING, V117, P1011; Yamada K, 2007, NEUROLOGY, V69, P321; Yamada K, 2004, J MAGN RESON IMAGING, V20, P923, DOI 10.1002/jmri.20215; Zhang YM, 2010, NEUROL RES, V32, P775, DOI 10.1179/016164109X12478302362653; Zipse L, 2012, ANN NY ACAD SCI, V1252, P237, DOI 10.1111/j.1749-6632.2012.06454.x	93	15	15	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	NOV	2015	150						117	128		10.1016/j.bandl.2015.09.001			12	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	CY1EG	WOS:000366148900012	26401977	Green Published, Other Gold			2021-06-18	
J	Jawa, RS; Shapiro, MJ; McCormack, JE; Huang, EC; Rutigliano, DN; Vosswinkel, JA				Jawa, Randeep S.; Shapiro, Marc J.; McCormack, Jane E.; Huang, Emily C.; Rutigliano, Daniel N.; Vosswinkel, James A.			Preadmission Do Not Resuscitate advanced directive is associated with adverse outcomes following acute traumatic injury	AMERICAN JOURNAL OF SURGERY			English	Article						Do Not Resuscitate; DNR; Trauma; Injury; Outcome	INTENSIVE-CARE-UNIT; SURGICAL-PATIENTS; BRAIN-INJURY; ORDERS; MORTALITY; AGE; WITHDRAWAL; FRAILTY; IMPACT	BACKGROUND: Do Not Resuscitate (DNR) orders have been associated with poor outcomes in surgical patients. There is limited literature on admitted trauma patients with advanced directives indicating DNR status before admission (preadmission DNR [PADNR]). METHODS: A retrospective review of the trauma registry of a suburban county was carried out for admitted trauma patients with age >= 41 years, who were admitted between 2008 and 2013. RESULTS: Of 7,937 admitted patients, 327 had a preadmission advanced directive indicating DNR. PADNR patients were significantly older (87 vs 69 years), with more frequent comorbidities, and were more often admitted after a fall (94.2% vs 65.8%). PADNR patients had a higher Injury Severity Score (14 vs 11). They also had significantly increased rates of pneumonia, sepsis, myocardial infarction, and death (33.6% vs 5.9%). On multivariate logistic regression, the presence of a preadmission advanced directive indicating DNR status was independently associated with a 5.2-fold increased odds of mortality. CONCLUSION: An advanced directive indicating DNR is associated with adverse outcomes following trauma. Published by Elsevier Inc.	[Jawa, Randeep S.; Shapiro, Marc J.; McCormack, Jane E.; Huang, Emily C.; Rutigliano, Daniel N.; Vosswinkel, James A.] SUNY Stony Brook, Dept Surg, Div Trauma, Stony Brook, NY 11794 USA	Jawa, RS (corresponding author), SUNY Stony Brook, Dept Surg, Div Trauma, Stony Brook, NY 11794 USA.	Randeep.jawa@stonybrookmedicine.edu					Adams SD, 2013, J TRAUMA ACUTE CARE, V74, P1327, DOI 10.1097/TA.0b013e31828c4698; Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; American College of Surgeons, ANN REPORT; Centers for Disease Control and Prevention, FALLOLD AD OV; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; [Federal Highway Administration U. S. Department of Transportation], LIC DRIV; Franklin GA, 2011, SURGERY, V150, P854, DOI 10.1016/j.surg.2011.07.065; Gordy Stephanie, 2011, Int J Crit Illn Inj Sci, V1, P132, DOI 10.4103/2229-5151.84800; Hemphill JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5687; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Joseph B, 2014, J AM COLL SURGEONS, V219, P10, DOI 10.1016/j.jamcollsurg.2014.03.020; Kazaure H, 2011, ARCH SURG-CHICAGO, V146, P922, DOI 10.1001/archsurg.2011.69; Mahon MM, 2011, J PAIN SYMPTOM MANAG, V41, P801, DOI 10.1016/j.jpainsymman.2011.01.002; Mirarchi FL, 2012, J EMERG MED, V42, P511, DOI 10.1016/j.jemermed.2011.07.015; Morrell ED, 2008, J MED ETHICS, V34, P642, DOI 10.1136/jme.2007.022517; Mosenthal AC, 2008, J TRAUMA, V64, P1587, DOI 10.1097/TA.0b013e318174f112; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; *PRES COMM STUD, 1983, DEC FOR LIF SUST TRE; Puchalski C M, 2001, Proc (Bayl Univ Med Cent), V14, P352; Rothenberg D., 2011, CLIN ETHICS ANESTHES; Saager L, 2011, CRIT CARE MED, V39, P1036, DOI 10.1097/CCM.0b013e31820eb4fc; Salottolo K, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0094-2; Scarborough JE, 2012, ANN SURG, V256, P453, DOI 10.1097/SLA.0b013e31826578fb; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Shepardson LB, 1999, MED CARE, V37, P727, DOI 10.1097/00005650-199908000-00003; SLATER A L, 1991, Focus on Critical Care, V18, P476; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Tornetta P, 1999, J TRAUMA, V46, P702, DOI 10.1097/00005373-199904000-00024; U. S. Department of Transportation, HIGHW STAT 2001; Volandes A, PALLIATIVE MED, P98; Wade CE, 2013, J TRAUMA ACUTE CARE, V75, pS89, DOI 10.1097/TA.0b013e31828fa422; WENGER NS, 1995, ARCH INTERN MED, V155, P2063, DOI 10.1001/archinte.155.19.2063; Zehtabchi S, 2011, ACAD EMERG MED, V18, P637, DOI 10.1111/j.1553-2712.2011.01083.x; ZIMMERMAN JE, 1986, JAMA-J AM MED ASSOC, V255, P351, DOI 10.1001/jama.255.3.351	36	15	15	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	NOV	2015	210	5					814	821		10.1016/j.amjsurg.2015.04.007			8	Surgery	Surgery	CW6DC	WOS:000365086700004	26116324				2021-06-18	
J	Kawasaki, T; Ota, C; Yoneda, T; Maki, N; Urayama, S; Nagao, M; Nagayama, M; Kaketa, T; Takazawa, Y; Kaneko, K				Kawasaki, Takayuki; Ota, Chihiro; Yoneda, Takeshi; Maki, Nobukazu; Urayama, Shingo; Nagao, Masashi; Nagayama, Masataka; Kaketa, Takefumi; Takazawa, Yuji; Kaneko, Kazuo			Incidence of Stingers in Young Rugby Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						rugby; stinger; burner; epidemiology; young athlete	FOOTBALL PLAYERS; BURNER SYNDROME; UNION INJURIES; PART 2; EPIDEMIOLOGY; CONCUSSION; SCHOOL; NEURAPRAXIA; STENOSIS; NERVE	Background: A stinger is a type of neurapraxia of the cervical roots or brachial plexus and represents a reversible peripheral nerve injury. The incidence of and major risk factors for stingers among young rugby players remain uninvestigated. Purpose: To investigate the incidence, symptoms, and intrinsic risk factors for stingers in elite rugby union teams of young players. Study Design: Descriptive epidemiology study. Methods: A total of 569 male rugby players, including 358 players from 7 high school teams and 211 players from 2 university teams, were investigated using self-administered preseason and postseason questionnaires. Results: The prevalence of a history of stingers was 33.9% (95% CI, 30.3-37.9), and 20.9% (119/569) of players experienced at least 1 episode of a stinger during the season (34.2 [95% CI, 26.2-42.1] events per 1000 player-hours of match exposure). The reinjury rate for stingers per season was 37.3% (95% CI, 30.4-44.2). Using the multivariate Poisson regression method, a history of stingers in the previous season and the grade and position of the player were found to be risk factors for stingers during the current season. The mean severity of injury was 2.9 days, with 79.3% (191/241) of the players not losing any time from playing after sustaining a stinger injury and 5.8% (14/241) of the players recovering within more than 14 days. The most frequent symptom was numbness in the unilateral upper extremity, and the most severe symptom was weakness of grasping (mean severity, 6 days). A logistic regression analysis indicated that a history of stingers in the previous season and an injury with more than 3 symptoms, especially motor weakness, were correlated with the severity of injury. Conclusion: Young rugby players with a history of stingers have a significantly high rate of repeat injuries. Although nearly 80% of the players experienced only minimal (0-1 day) time loss injuries, neurological deficits sometimes last beyond 1 month. A history of stingers was identified to be the strongest risk factor for injuries and for lasting symptoms. This information may be useful for planning the proper treatment for stingers in young rugby players.	[Kawasaki, Takayuki] Juntendo Univ, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138421, Japan; [Kawasaki, Takayuki; Nagao, Masashi; Nagayama, Masataka; Kaketa, Takefumi; Takazawa, Yuji; Kaneko, Kazuo] Juntendo Univ, Fac Med, Dept Orthopaed Surg, Tokyo 1138421, Japan; [Ota, Chihiro; Yoneda, Takeshi] Keio Univ, Rugby Football Club, Yokohama, Kanagawa 223, Japan; [Maki, Nobukazu] Mejiro Orthopaed & Internal Med Clin, Tokyo, Japan; [Urayama, Shingo] Int Budo Univ, Dept Sports Med, Katsuura, Japan	Kawasaki, T (corresponding author), Juntendo Univ, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	k-saki@luck.ocn.ne.jp	t, Kawasaki/AAE-4548-2020				Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Bottini E, 2000, BRIT J SPORT MED, V34, P94, DOI 10.1136/bjsm.34.2.94; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7; Charbonneau RME, 2012, CLIN J SPORT MED, V22, P472, DOI 10.1097/JSM.0b013e3182699ed5; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; DAVIDSON RM, 1987, MED J AUSTRALIA, V147, P119, DOI 10.5694/j.1326-5377.1987.tb133299.x; Devereaux M D, 1983, Br J Sports Med, V17, P137; Feinberg Joseph H, 2008, HSS J, V4, P87, DOI 10.1007/s11420-007-9064-1; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2011, CLIN J SPORT MED, V21, P356, DOI 10.1097/JSM.0b013e31821f5085; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kawasaki T, 2014, J SHOULDER ELB SURG, V23, pE293, DOI 10.1016/j.jse.2014.04.009; Lee AJ, 1996, BRIT J SPORT MED, V30, P213, DOI 10.1136/bjsm.30.3.213; Levitz CL, 1997, AM J SPORT MED, V25, P73, DOI 10.1177/036354659702500114; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; McIntosh Andrew S, 2005, Med Sport Sci, V49, P120, DOI 10.1159/000085394; McManus A, 2004, J SCI MED SPORT, V7, P438, DOI 10.1016/S1440-2440(04)80261-5; MEYER SA, 1994, AM J SPORT MED, V22, P158, DOI 10.1177/036354659402200202; NATHAN M, 1983, S AFR MED J, V64, P132; Nicol A, 2011, J PUBLIC HEALTH-UK, V33, P256, DOI 10.1093/pubmed/fdq047; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; ROBERTSON WC, 1979, JAMA-J AM MED ASSOC, V241, P1480, DOI 10.1001/jama.241.14.1480; ROUX CE, 1987, S AFR MED J, V71, P307; Safran MR, 2004, AM J SPORT MED, V32, P1063, DOI 10.1177/0363546504265193; SALLIS RE, 1992, PHYSICIAN SPORTSMED, V20, P47, DOI 10.1080/00913847.1992.11947521; Shannon B, 2002, CLIN SPORT MED, V21, P29, DOI 10.1016/S0278-5919(03)00055-3; SPEER KP, 1990, AM J SPORT MED, V18, P591, DOI 10.1177/036354659001800606	33	15	15	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2015	43	11					2809	2815		10.1177/0363546515597678			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CV3XF	WOS:000364199100023	26337244				2021-06-18	
J	Long, JA; Watts, LT; Li, W; Shen, Q; Muir, ER; Huang, SL; Boggs, RC; Suri, A; Duong, TQ				Long, Justin A.; Watts, Lora T.; Li, Wei; Shen, Qiang; Muir, Eric R.; Huang, Shiliang; Boggs, Robert C.; Suri, Abhinav; Duong, Timothy Q.			The effects of perturbed cerebral blood flow and cerebrovascular reactivity on structural MRI and behavioral readouts in mild traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						functional outcomes; hypercapnia; MRI: diffusion tensor imaging; TBI	CONTROLLED CORTICAL IMPACT; PERFUSION; DIFFUSION; HYPERPERFUSION; RAT; HYPOXIA; STEAL; MICROCIRCULATION; HYPERCAPNIA; MECHANISMS	This study investigated the effects of perturbed cerebral blood flow (CBF) and cerebrovascular reactivity (CR) on relaxation time constant (T-2), apparent diffusion coefficient (ADC), fractional anisotropy (FA), and behavioral scores at 1 and 3 hours, 2, 7, and 14 days after traumatic brain injury (TBI) in rats. Open-skull TBI was induced over the left primary forelimb somatosensory cortex (N=8 and 3 sham). We found the abnormal areas of CBF and CR on days 0 and 2 were larger than those of the T-2, ADC, and FA abnormalities. In the impact core, CBF was reduced on day 0, increased to 2.5 times of.normal on day 2, and returned toward normal by day 14, whereas in the tissue surrounding the impact, hypoperfusion was observed on days 0 and 2. CR in the impact core was negative, most severe on day 2 but gradually returned toward normal. T-2, ADC, and FA abnormalities in the impact core were detected on day 0, peaked on day 2, and pseudonormalized by day 14. Lesion volumes peaked on day 2 and were temporally correlated with forelimb asymmetry and foot-fault scores. This study quantified the effects of perturbed CBF and CR on structural magnetic resonance imaging and behavioral readouts.	[Long, Justin A.; Watts, Lora T.; Li, Wei; Shen, Qiang; Muir, Eric R.; Huang, Shiliang; Boggs, Robert C.; Suri, Abhinav; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Watts, Lora T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora T.; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Opthalmol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, San Antonio, TX USA	Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	duongt@uthscsa.edu	Duong, Tim/AAL-8357-2021; Watts, Lora Talley/A-2724-2012	Duong, Tim/0000-0001-6403-2827; Watts, Lora Talley/0000-0002-2337-1504; SURI, ABHINAV/0000-0002-7900-8763	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45879]; Mike Hogg Fund via the Clinical Translational Science Awards (CTSA) [UL1TR000149, TL1TR001119, KL2TR001118];  [KL2 TR001118]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001119, UL1TR000149, UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER	This work was supported in part by NIH/NINDS R01 NS45879 (TQD), a TL1 (JAL) and KL2 TR001118 and Mike Hogg Fund (LTW) via the Clinical Translational Science Awards (CTSA, parent grants UL1TR000149, TL1TR001119, and KL2TR001118).	Arteaga DF, 2014, J CEREBR BLOOD F MET, V34, P1453, DOI 10.1038/jcbfm.2014.106; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Berne R M, 1974, Adv Cardiol, V12, P303; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Feuerstein D, 2014, J CEREBR BLOOD F MET, V34, P1117, DOI 10.1038/jcbfm.2014.53; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; JOO F, 1986, NATURE, V321, P197, DOI 10.1038/321197a0; KONTOS HA, 1985, ANN BIOMED ENG, V13, P329, DOI 10.1007/BF02584251; LEE JG, 1994, ANESTH ANALG, V79, P58; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; MACFARLANE R, 1991, J NEUROSURG, V75, P845, DOI 10.3171/jns.1991.75.6.0845; Marchal G, 1996, BRAIN, V119, P409, DOI 10.1093/brain/119.2.409; MCCASLAND JS, 1988, J COMP NEUROL, V278, P555, DOI 10.1002/cne.902780407; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Paksoy Y, 2003, AM J NEURORADIOL, V24, P1364; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Poublanc J, 2013, CEREBROVASC DIS EXTR, V3, P55, DOI 10.1159/000348841; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1265, DOI 10.1038/sj.jcbfm.9600132; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Shen Q, 2003, J CEREBR BLOOD F MET, V23, P1479, DOI 10.1097/01.WCB.0000100064.36077.03; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Thomale UW, 2002, ACTA NEUROCHIR SUPPL, V81, P229; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739	39	15	15	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2015	35	11					1852	1861		10.1038/jcbfm.2015.143			10	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CV4TR	WOS:000364259900018	26104285	Green Published, Bronze			2021-06-18	
J	Papa, L; Zonfrillo, MR; Ramirez, J; Silvestri, S; Giordano, P; Braga, CF; Tan, CN; Ameli, NJ; Lopez, M; Mittal, MK				Papa, Linda; Zonfrillo, Mark R.; Ramirez, Jose; Silvestri, Salvatore; Giordano, Philip; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco; Mittal, Manoj K.			Performance of Glial Fibrillary Acidic Protein in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth With Mild Head Trauma	ACADEMIC EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; CANCER-RISKS; BIOMARKERS; RADIATION; RECOMMENDATIONS; GFAP; CT	Objectives: This study examined the performance of serum glial fibrillary acidic protein (GFAP) in detecting traumatic intracranial lesions on computed tomography (CT) scan in children and youth with mild and moderate traumatic brain injury (TBI) and assessed its performance in trauma control patients without head trauma. Methods: This prospective cohort study enrolled children and youth presenting to three Level I trauma centers following blunt head trauma with Glasgow Coma Scale (GCS) scores of 9 to 15, as well as trauma control patients with GCS scores of 15 who did not have blunt head trauma. The primary outcome measure was the presence of intracranial lesions on initial CT scan. Blood samples were obtained in all patients within 6 hours of injury and measured by enzyme-linked immunosorbent assay for GFAP (ng/mL). Results: A total of 257 children and youth were enrolled in the study and had serum samples drawn within 6 hours of injury for analysis: 197 had blunt head trauma and 60 were trauma controls. CT scan of the head was performed in 52 patients and traumatic intracranial lesions on CT scan were evident in 18 (11%), all of whom had GCS scores of 13 to 15. When serum levels of GFAP were compared in children and youth with traumatic intracranial lesions on CT scan to those without CT lesions, median GFAP levels were significantly higher in those with intracranial lesions (1.01, interquartile range [IQR] = 0.59 to 1.48) than those without lesions (0.18, IQR = 0.06 to 0.47). The area under the receiver operating characteristic curve (AUC) for GFAP in detecting children and youth with traumatic intracranial lesions on CT was 0.82 (95% confidence interval [CI] = 0.71 to 0.93). In those presenting with GCS scores of 15, the AUC for detecting lesions was 0.80 (95% CI = 0.68 to 0.92). Similarly, in children under 5 years old the AUC was 0.83 (95% CI = 0.56 to 1.00). Performance for detecting intracranial lesions at a GFAP cutoff level of 0.15 ng/mL yielded a sensitivity of 94%, a specificity of 47%, and a negative predictive value of 98%. Conclusions: In children and youth of all ages, GFAP measured within 6 hours of injury was associated with traumatic intracranial lesions on CT and with severity of TBI. Further study is required to validate these findings before clinical application. (C) 2015 by the Society for Academic Emergency Medicine	[Papa, Linda; Silvestri, Salvatore; Giordano, Philip; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL 32806 USA; [Papa, Linda; Ramirez, Jose; Silvestri, Salvatore; Giordano, Philip] Arnold Palmer Hosp Children, Dept Pediat Emergency Med, Orlando, FL USA; [Zonfrillo, Mark R.; Mittal, Manoj K.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.; Mittal, Manoj K.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	Papa, L (corresponding author), Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL 32806 USA.	lpstat@aol.com	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676] Funding Source: NIH RePORTER	This study was supported in part by award R01NS057676 from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health.	Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Brenner DJ, 2010, RADIAT RES, V174, P809, DOI 10.1667/RR1859.1; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Faul M, TRAUMATIC BRAIN INJU; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI 10.1016/j.jen.2008.12.010; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Linet MS, 2012, CA-CANCER J CLIN, V62, P75, DOI 10.3322/caac.21132; Long A E, 1985, Emerg Med Clin North Am, V3, P437; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Papa L., 2014, CONCUSSIONS ATHLETIC, P235; Papa L, 2012, PROTEOMICS HUMAN DID, P89; Papa L, 2014, ACAD EMERG MED, V21, pS315; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002	30	15	17	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	NOV	2015	22	11					1274	1282		10.1111/acem.12795			9	Emergency Medicine	Emergency Medicine	CW1VG	WOS:000364779300005	26469937	Green Accepted, Bronze			2021-06-18	
J	Rael, LT; Bar-Or, R; Kelly, MT; Carrick, MM; Bar-Or, D				Rael, Leonard T.; Bar-Or, Raphael; Kelly, Michael T.; Carrick, Matthew M.; Bar-Or, David			Assessment of Oxidative Stress in Patients with an Isolated Traumatic Brain Injury Using Disposable Electrochemical Test Strips	ELECTROANALYSIS			English	Article						Isolated traumatic brain injury; Oxidative stress; Human plasma; Redox chemistry; Sensors	CEREBROSPINAL-FLUID; ASCORBIC-ACID; ANTIOXIDANT STATUS; FREE-RADICALS; PLASMA; BLOOD; SEPSIS; SERUM; DYSFUNCTION; CHILDREN	The barriers to using plasma redox potential as a measure of oxidative stress in patients are the use of specialized equipment, necessity of sterilization between tests, and inconsistent electrode surfaces and cell geometry. These problems are resolved using disposable test strips with built in electrochemical cells. Measuring the electrode potential at a small current yields a stable value that is similar to 50 mV higher for isolated traumatic brain injury (ITBI) patients than for healthy individuals. Even with natural variations within blood chemistry, this simple method may be clinically useful for assessing the degree of oxidative stress and injury severity in ITBI patients.	[Rael, Leonard T.; Bar-Or, Raphael; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80113 USA; [Rael, Leonard T.; Bar-Or, Raphael; Bar-Or, David] St Anthony Hosp, Lakewood, CO USA; [Rael, Leonard T.; Bar-Or, Raphael; Carrick, Matthew M.; Bar-Or, David] Med Ctr Plano, Plano, TX USA; [Rael, Leonard T.; Bar-Or, Raphael; Bar-Or, David] Aytu BioSci Inc, Englewood, CO USA; [Kelly, Michael T.] Princeton Univ, Princeton, NJ 08544 USA	Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Dept, 501 E Hampden Ave,Room 4-454, Englewood, CO 80113 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020	Rael, Leonard/0000-0003-3282-7072			Apak R, 2007, MOLECULES, V12, P1496, DOI 10.3390/12071496; Batra S, 2000, ANN TROP PAEDIATR, V20, P27, DOI 10.1080/02724930092039; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Cowley HC, 1996, CRIT CARE MED, V24, P1179, DOI 10.1097/00003246-199607000-00019; CROSS CE, 1990, J LAB CLIN MED, V115, P396; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; Ernst H, 2001, ANAL CHIM ACTA, V449, P129, DOI 10.1016/S0003-2670(01)01350-2; Evseev AK, 2014, PROT MET PHYS CHEM+, V50, P553, DOI 10.1134/S2070205114040029; Gaetani P, 1998, J NEUROSURG, V89, P748, DOI 10.3171/jns.1998.89.5.0748; Galley HF, 1996, CRIT CARE MED, V24, P1649, DOI 10.1097/00003246-199610000-00008; GOODE HF, 1995, CRIT CARE MED, V23, P646, DOI 10.1097/00003246-199504000-00011; GROSZ HJ, 1967, NATURE, V213, P717, DOI 10.1038/213717a0; Ido Y, 1997, DIABETOLOGIA, V40, pS115, DOI 10.1007/s001250051422; Khubutiya MS, 2010, RUSS J ELECTROCHEM+, V46, P537, DOI 10.1134/S1023193510050071; Lemasters JJ, 1997, BIOSCIENCE REP, V17, P281, DOI 10.1023/A:1027332611839; Manevich Y, 2014, FREE RADICAL BIO MED, V72, P210, DOI 10.1016/j.freeradbiomed.2014.04.002; MARMASSE C, 1964, NATURE, V202, P94, DOI 10.1038/202094a0; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; PEPPER JR, 1994, FREE RADICAL RES, V21, P377, DOI 10.3109/10715769409056590; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI [10.1089/neu.2008.0816, 10.1089/neu.2008-0816]; Rael LT, 2009, J TRAUMA, V66, P76, DOI 10.1097/TA.0b013e318191bfe0; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Rock Cheryl L., 1997, Journal of Burn Care and Rehabilitation, V18, P269; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; Schlesier K, 2002, FREE RADICAL RES, V36, P177, DOI 10.1080/10715760290006411; Sharma P., 2013, J FOOD TECH, V8, P83; Szczepanska-Szerej A, 2011, CLIN NEUROPHARMACOL, V34, P191, DOI 10.1097/WNF.0b013e3182309418; TURYAN YI, 1995, J ELECTROANAL CHEM, V380, P273, DOI 10.1016/0022-0728(94)03524-7; VANDERJAGT DJ, 1987, AM J CLIN NUTR, V46, P290; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; WARNER A, 1995, CLIN CHEM, V41, P867; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869	34	15	16	0	8	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1040-0397	1521-4109		ELECTROANAL	Electroanalysis	NOV	2015	27	11					2567	2573		10.1002/elan.201500178			7	Chemistry, Analytical; Electrochemistry	Chemistry; Electrochemistry	DB2LI	WOS:000368339700009					2021-06-18	
J	Seidl, JNT; Pastorek, NJ; Lillie, R; Rosenblatt, A; Troyanskaya, M; Miller, BI; Romesser, J; Lippa, S; Sim, AH; Linck, J				Seidl, Jennifer N. Travis; Pastorek, Nicholas J.; Lillie, Rema; Rosenblatt, Andrew; Troyanskaya, Maya; Miller, Brian I.; Romesser, Jennifer; Lippa, Sara; Sim, Anita H.; Linck, John			Factors Related to Satisfaction With Life in Veterans With Mild Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						satisfaction with life; veterans; mild traumatic brain injury; concussion; social support	QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; POLYTRAUMA CLINICAL TRIAD; CHRONIC PAIN; SOCIAL SUPPORT; ENDURING FREEDOM; SELF-EFFICACY; FOLLOW-UP; HEALTH; DISABILITY	Purpose/Objective: Satisfaction with life (SWL) is an important measure of outcome in rehabilitation. Previous research suggests that those with a history of traumatic brain injury (TBI), even mild TBI, report lower levels of life satisfaction when compared with the noninjured population. Although is it possible that TBI has a direct effect on SWL, various medical and psychosocial factors commonly affecting those recovering from TBI likely contribute to SWL. Research Method/Design: The present study aimed to identify factors related to SWL in 95 veterans of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) with a history of mild TBI. Results: Regression analyses indicated that headache impact, pain interference, sleep quality, posttraumatic stress symptom severity, and social support were all significantly related to SWL. However, when secondary analyses were conducted including posttraumatic stress symptom severity as a covariate before the entry of other predictors, only sleep quality and social support remained significantly associated with SWL. Conclusions/Implications: These results indicate the importance of properly identifying and treating symptoms of posttraumatic stress in veterans with a history of mTBI, as posttraumatic stress symptoms appear to be strongly related to SWL in those with a history of mild TBI. Optimizing sleep quality and social support may also be important in improving SWL.	[Seidl, Jennifer N. Travis; Rosenblatt, Andrew] Univ Houston, Dept Psychol, Houston, TX 77004 USA; [Seidl, Jennifer N. Travis; Troyanskaya, Maya] Michael E DeBakey VA Med Ctr, TBI Ctr Excellence, Houston, TX USA; [Pastorek, Nicholas J.] Michael E DeBakey VA Med Ctr, Rehabil Care Line, Houston, TX USA; [Pastorek, Nicholas J.; Troyanskaya, Maya] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Lillie, Rema] Mentis Neuro Rehabil, Houston, TX USA; [Miller, Brian I.] Michael E DeBakey VA Med Ctr, Mental Hlth Care Line, Houston, TX USA; [Miller, Brian I.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Romesser, Jennifer] VA Salt Lake City Healthcare Syst, Mental Hlth, Salt Lake City, UT USA; [Lippa, Sara] Walter Reed Natl Mil Med Ctr, Vet Brain Injury Ctr, Bethesda, MD USA; [Sim, Anita H.] Minneapolis VA Med Ctr, Dept Phys Med & Rehabil, Minneapolis, MN USA; [Linck, John] Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Norman, OK 73019 USA	Pastorek, NJ (corresponding author), 2002 Holcombe Blvd,RECL 117, Houston, TX 77007 USA.	nicholas.pastorek@va.gov					Asnaani A, 2014, J ANXIETY DISORD, V28, P310, DOI 10.1016/j.janxdis.2014.01.005; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boals A, 2013, STRESS HEALTH, V29, P156, DOI 10.1002/smi.2443; Boonstra AM, 2013, QUAL LIFE RES, V22, P93, DOI 10.1007/s11136-012-0132-8; Boosman H, 2011, CLIN REHABIL, V25, P460, DOI 10.1177/0269215510388314; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cloninger CR, 2011, J AFFECT DISORDERS, V128, P24, DOI 10.1016/j.jad.2010.06.012; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; d'Ardenne P, 2005, J NERV MENT DIS, V193, P62, DOI 10.1097/01.nmd.0000149221.09294.92; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; De Diego EV, 2005, CEPHALALGIA, V25, P184, DOI 10.1111/j.1468-2982.2004.00820.x; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Groeger JA, 2004, J SLEEP RES, V13, P359, DOI 10.1111/j.1365-2869.2004.00418.x; Henderson JV, 2013, PAIN MED, V14, P1346, DOI 10.1111/pme.12195; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huxhold O, 2013, PSYCHOL AGING, V28, P3, DOI 10.1037/a0030170; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Jean-Louis G, 2000, SLEEP, V23, P1115; Karatzias T, 2013, J MENT HEALTH, V22, P501, DOI 10.3109/09638237.2013.819418; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerr S, 2004, INTERN MED J, V34, P403, DOI 10.1111/j.1444-0903.2004.00627.x; Ketchum JM, 2012, NEUROREHABILITATION, V30, P23, DOI 10.3233/NRE-2012-0724; King DW, 2003, MANUAL DEPLOYMENT RI; Lanteri-Minet M, 2005, PAIN, V118, P319, DOI 10.1016/j.pain.2005.09.010; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lemola S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071292; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Martelli MF, 2012, NEUROREHABILITATION, V31, P3, DOI 10.3233/NRE-2012-0770; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Money N., 2011, BEST PRACTICES IDENT; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Paunio T, 2009, AM J EPIDEMIOL, V169, P206, DOI 10.1093/aje/kwn305; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Rissanen T, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-202; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Seligowski AV, 2012, APPL PSYCHOL-HLTH WE, V4, P261, DOI 10.1111/j.1758-0854.2012.01073.x; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stalnacke BM, 2011, NEUROPSYCH DIS TREAT, V7, P683, DOI 10.2147/NDT.S25321; Stovner LJ, 2008, J HEADACHE PAIN, V9, P139, DOI 10.1007/s10194-008-0038-6; Strine TW, 2008, SOC PSYCH PSYCH EPID, V43, P151, DOI 10.1007/s00127-007-0277-x; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tolin DF, 2010, PSYCHOL ASSESSMENT, V22, P729, DOI 10.1037/a0020973; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tsai J, 2012, PSYCHIATRY, V75, P135, DOI 10.1521/psyc.2012.75.2.135; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Wilder A, 2011, THER RECREAT J, V45, P268; Williams RM, 2012, J HEAD TRAUMA REHAB, V27, P261, DOI 10.1097/HTR.0b013e3182585cb6; World Health Organization, 2001, THE INTERNATIONAL CL; Yeung P, 2014, DISABIL REHABIL, V36, P63, DOI 10.3109/09638288.2013.777808	65	15	15	0	9	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2015	60	4					335	343		10.1037/rep0000064			9	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	CX4YL	WOS:000365706800004	26618214				2021-06-18	
J	Song, Q; Xie, DJ; Pan, SY; Xu, WJ				Song, Qi; Xie, Dujiang; Pan, Shiyong; Xu, Weijun			Rapamycin protects neurons from brain contusion-induced inflammatory reaction via modulation of microglial activation	MOLECULAR MEDICINE REPORTS			English	Article						rapamycin; brain contusion; inflammatory reaction; microglial activation; proinflammatory cytokines	TUMOR-NECROSIS-FACTOR; NERVE GROWTH-FACTOR; MAMMALIAN TARGET; OXIDATIVE STRESS; INJURY; MTOR; MICE; NEUROTOXICITY; IL-1-BETA; APOPTOSIS	The inflammatory reaction is important in secondary injury following traumatic brain injury (TBI). Rapamycin has been demonstrated as a neuroprotective agent in a mouse model of TBI, however, there is a lack of data regarding the effects of rapamycin on the inflammatory reaction following TBI. Therefore, the present study was designed to assess the effects of treatment with rapamycin on inflammatory reactions and examine the possible involvement of microglial activation following TBI. Male imprinting control region mice were randomly divided into four groups: Sham group (n=23), TBI group (n=23), TBI + dimethyl sulfoxide (DMSO) group (n=31) and TBI + rapamycin group (n=31). Rapamycin was dissolved in DMSO (50 mg/ml) and injected 30 min after TBI (2 mg/Kg; intraperitoneally). A weight-drop model of TBI was induced, and the brain tissues were harvested 24 h after TBI. The findings indicated that the administration of rapamycin following TBI was associated with decreased levels of activated microglia and neuron degeneration at the pen-injury site, reduced levels of proinflammatory cytokines and increased neurobehavioral function, possibly mediated by inactivation of the mammalian target of rapamycin pathway. The results of the present study offer novel insight into the mechanisms responsible for the anti-neuroinflammatory effects of rapamycin, possibly involving the modulation of microglial activation.	[Song, Qi; Pan, Shiyong; Xu, Weijun] Nanjing Gen Hosp Nanjing Command, Dept Healthcare, Nanjing 210002, Jiangsu, Peoples R China; [Xie, Dujiang] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing 210006, Jiangsu, Peoples R China	Song, Q (corresponding author), Nanjing Gen Hosp Nanjing Command, Dept Healthcare, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	pipisq@126.com			Project Planning of Nanjing General Hospital [2013067]	The present study was supported by the Project Planning of Nanjing General Hospital (grant no. 2013067).	Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P374, DOI 10.4161/oxim.3.6.14787; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dean JM, 2010, BRAIN BEHAV IMMUN, V24, P776, DOI 10.1016/j.bbi.2009.10.018; Dello Russo C, 2013, GLIA, V61, P301, DOI 10.1002/glia.22433; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fan WW, 2013, STEM CELLS, V31, P203, DOI 10.1002/stem.1265; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Hosoi H, 1999, CANCER RES, V59, P886; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; KIM KS, 1992, LYMPHOKINE CYTOK RES, V11, P293; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Min KJ, 2003, BIOCHEM BIOPH RES CO, V312, P969, DOI 10.1016/j.bbrc.2003.11.010; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Pinteaux-Jones F, 2008, J NEUROCHEM, V106, P442, DOI 10.1111/j.1471-4159.2008.05426.x; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Smith RM, 1998, J ROY SOC MED, V91, P417, DOI 10.1177/014107689809100805; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Wong Michael, 2013, Biomed J, V36, P40, DOI 10.4103/2319-4170.110365; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	43	15	18	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	NOV	2015	12	5	B				7203	7210		10.3892/mmr.2015.4407			8	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CW3JR	WOS:000364889100002	26458361	Other Gold, Green Published			2021-06-18	
J	Munoz-Bendix, C; Beseoglu, K; Kram, R				Munoz-Bendix, Christopher; Beseoglu, Kerim; Kram, Rainer			Extracorporeal decarboxylation in patients with severe traumatic brain injury and ARDS enables effective control of intracranial pressure	CRITICAL CARE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; CEREBRAL AUTOREGULATION; VENTILATION; ASSIST; PERFUSION; REMOVAL	Introduction: Acute respiratory distress syndrome (ARDS) with concomitant impairment of oxygenation and decarboxylation represents a complex problem in patients with increased intracranial pressure (ICP). Permissive hypercapnia is not an option to obtain and maintain lung-protective ventilation in the presence of elevated ICP. Pumpless extracorporeal lung assist (pECLA) devices (iLA Membrane Ventilator; Novalung, Heilbronn, Germany) can improve decarboxylation without aggravation associated with invasive ventilation. In this pilot series, we analyzed the safety and efficacy of pECLA in patients with ARDS and elevated ICP after severe traumatic brain injury (TBI). Methods: The medical records of ten patients (eight male, two female) with severe ARDS and severe TBI concurrently managed with external ventricular drainage in the neurointensive care unit (NICU) were retrospectively analyzed. The effect of pECLA on enabling lung-protective ventilation was evaluated using the difference between plateau pressure and positive end-expiratory pressure, defined as driving pressure (Delta P), during the 3 days preceding the implant of pECLA devices until 3 days afterward. The ICP threshold was set at 20 mmHg. To evaluate effects on ICP, the volume of daily cerebrospinal fluid (CSF) drainage needed to maintain the set ICP threshold was compared pre- and postimplant. Results: The Delta P values after pECLA implantation decreased from a mean 17.1 +/- 0.7 cm/H2O to 11.9 +/- 0.5 cm/H2O (p = 0.011). In spite of this improved lung-protective ventilation, carbon dioxide pressure decreased from 46.6 +/- 3.9 mmHg to 39.7 +/- 3.5 mmHg (p = 0.005). The volume of daily CSF drainage needed to maintain ICP at 20 mmHg decreased significantly from 141.5 +/- 103.5 ml to 62.2 +/- 68.1 ml (p = 0.037). Conclusions: For selected patients with concomitant severe TBI and ARDS, the application of pECLA is safe and effective. pECLA devices improve decarboxylation, thus enabling lung-protective ventilation. At the same time, potentially detrimental hypercapnia that may increase ICP is avoided. Larger prospective trials are warranted to further elucidate application of pECLA devices in NICU patients.	[Munoz-Bendix, Christopher; Beseoglu, Kerim] Univ Dusseldorf, Fac Med, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Kram, Rainer] Univ Dusseldorf, Fac Med, Dept Anesthesiol, D-40225 Dusseldorf, Germany	Kram, R (corresponding author), Univ Dusseldorf, Fac Med, Dept Anesthesiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	kram@med.uni-duesseldorf.de	Munoz-Bendix, Christopher/A-1943-2014	Munoz-Bendix, Christopher/0000-0002-2414-2463			Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; [Anonymous], 1971, JAMA, V215, P277; Bein T, 2006, CRIT CARE MED, V34, P1372, DOI 10.1097/01.CCM.0000215111.85483.BD; Bein T, 2002, INTENS CARE MED, V28, P554, DOI 10.1007/s00134-002-1273-y; Bein T, 2005, J TRAUMA, V58, P1294, DOI 10.1097/01.TA.0000173275.06947.5C; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Fanelli V, 2013, J THORAC DIS, V5, P326, DOI 10.3978/j.issn.2072-1439.2013.04.05; Haitsma JJ, 2006, MINERVA ANESTESIOL, V72, P117; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; HICKLING KG, 1990, INTENS CARE MED, V16, P372, DOI 10.1007/BF01735174; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Kreyer S, 2013, J NEUROSURG ANESTH, V25, P324, DOI 10.1097/ANA.0b013e3182905e6a; Liebold A, 2000, EUR J CARDIO-THORAC, V17, P608, DOI 10.1016/S1010-7940(00)00389-4; Mallick A, 2007, ANAESTHESIA, V62, P72, DOI 10.1111/j.1365-2044.2006.04863.X; Meng LZ, 2015, ANESTHESIOLOGY, V122, P196, DOI 10.1097/ALN.0000000000000506; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Petrucci N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003844.pub4; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Severdija EE, 2015, MED BIOL ENG COMPUT, V53, P195, DOI 10.1007/s11517-014-1225-z; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Vincent JL, 2002, CHEST, V121, P1602, DOI 10.1378/chest.121.5.1602; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7	28	15	17	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	OCT 30	2015	19								381	10.1186/s13054-015-1088-1			6	Critical Care Medicine	General & Internal Medicine	CU7WT	WOS:000363753200001	26518584	DOAJ Gold, Green Published			2021-06-18	
J	Lax, ID; Paniccia, M; Agnihotri, S; Reed, N; Garmaise, E; Azadbakhsh, M; Ng, J; Monette, G; Wiseman-Hakes, C; Taha, T; Keightley, M				Lax, Ilyse D.; Paniccia, Melissa; Agnihotri, Sabrina; Reed, Nick; Garmaise, Evan; Azadbakhsh, Mahdis; Ng, Justin; Monette, Georges; Wiseman-Hakes, Catherine; Taha, Tim; Keightley, Michelle			Developmental and gender influences on executive function following concussion in youth hockey players	BRAIN INJURY			English	Article						Athletes; concussion; executive functioning; gender; youth	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; PHYSICAL-ACTIVITY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; ICE HOCKEY; INTERNATIONAL-CONFERENCE; ATTENTIONAL DEFICITS; CONSENSUS STATEMENT	Background: Concussion is the most common athletic injury in youth who are simultaneously undergoing rapid developmental changes in the brain, specifically the development of executive functions (EF). The developing brain is more vulnerable to concussive injury with a protracted and different trajectory of recovery than that of adults. Thus, there is a critical need to enhance understanding of how concussion affects EF in youth.Objective: To investigate the effects of age, gender and concussion history (i.e. concussion incidence, recency, severity) on EF in youth hockey players.Methods: This 3-year cross-sectional and longitudinal multiple cohort study examined data from 211 hockey players of 8-15 years of age. Mixed-effects modelling was used to examine the influence of age, gender and concussion on EF in youth athletes.Findings: Baseline analyses revealed significant age and gender effects on measures of EF. Multiple effects of concussion history on measures of cognitive flexibility (F=2.48, p=0.03) and psychomotor speed (F=2.59, p=0.04) were found.Implications: This study highlights the impact of age, gender and concussion on EF in youth. These findings provide foundational knowledge to better manage cognitive sequelae following sports-related concussion.	[Lax, Ilyse D.; Paniccia, Melissa; Reed, Nick; Keightley, Michelle] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Lax, Ilyse D.; Paniccia, Melissa; Agnihotri, Sabrina; Reed, Nick; Wiseman-Hakes, Catherine; Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Lax, Ilyse D.] Univ Hlth Network, Princess Margaret Canc Ctr, Pencer Brain Tumor Ctr, Toronto, ON, Canada; [Paniccia, Melissa; Agnihotri, Sabrina; Reed, Nick; Wiseman-Hakes, Catherine; Keightley, Michelle] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Garmaise, Evan; Azadbakhsh, Mahdis; Ng, Justin; Monette, Georges; Keightley, Michelle] York Univ, Grad Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Keightley, Michelle] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Garmaise, Evan] Deloitte Inc, Toronto, ON, Canada; [Taha, Tim] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada	Keightley, M (corresponding author), Univ Toronto, Holland Bloorview Kids Rehabil Hosp, Acquired Brain Injury, Bloorview Res Inst, 150 Kilgour Rd,Room 2W355, Toronto, ON M4G 1R8, Canada.	mkeightley@hollandbloorview.ca	Wiseman-Hakes, Catherine/AAC-8303-2021; Meijer, Anna/K-5118-2016	Wiseman-Hakes, Catherine/0000-0001-8441-884X; 	Ontario Neurotrauma Foundation	The authors offer their sincere gratitude to all of the participating youth hockey players and their families for their involvement as well as the Ontario Neurotrauma Foundation who provided funding for this research. All of the members of the BrainFit lab are thanked for their support throughout all stages of this project.	Adirim TA, 2007, CLIN PEDIATR EMERG M, V8, P2, DOI 10.1016/j.cpem.2007.02.002; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bernstein DM, 2002, J INT NEUROPSYCHOLOG, V8; Best JR, 2010, DEV REV, V30, P331, DOI 10.1016/j.dr.2010.08.001; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050118215; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; DYCHE GM, 1991, PERCEPT MOTOR SKILL, V72, P563, DOI 10.2466/PMS.72.2.563-572; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Golden CJ, 2002, STROOP COLOR WORD TE; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hicks B, 2009, HARD TIMES AHEAD NAT; Hillman CH, 2011, PREV MED, V52, pS21, DOI 10.1016/j.ypmed.2011.01.024; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Johnston K. M, 2005, THINKFIRST CONCUSSIO; Landry BW, 2012, PM&R, V4, P826, DOI 10.1016/j.pmrj.2012.09.585; Llorente AM., 2003, CHILDRENS COLOR TRAI; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MacDonald S, 2013, FUNCTIONAL ASSESSMEN; MAJERES RL, 1988, INTELLIGENCE, V12, P149, DOI 10.1016/0160-2896(88)90013-X; MAJERES RL, 1990, INTELLIGENCE, V14, P357, DOI 10.1016/0160-2896(90)90023-M; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN SPORT MED, V30, P201, DOI 10.1016/j.csm.2010.08.002; Memmert D, 2011, J SPORT SCI, V29, P93, DOI 10.1080/02640414.2010.528014; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Ontario Minor Hockey Association, 2014, CHECK GUID PROGR APP; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pratt H, 2003, CHILD ADOLESCENT NEU, P624; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; RYAN SM, 1994, J AM COLL CARDIOL, V24, P1700, DOI 10.1016/0735-1097(94)90177-5; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Smith A., 2002, SYMBOL DIGIT MODALIT; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stein DG, 2007, PROG BRAIN RES, V161, P339, DOI 10.1016/S0079-6123(06)61024-8; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Trost S., 2009, ACTIVE ED PHYS ED PH; Trudeau F, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-10; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X	84	15	15	0	34	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1409	1419		10.3109/02699052.2015.1043344			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200003	26362811				2021-06-18	
J	Neville, IS; Hayashi, CY; El Hajj, SA; Zaninotto, ALC; Sabino, JP; Sousa, LM; Nagumo, MM; Brunoni, AR; Shieh, BDS; Amorim, RLO; Teixeira, MJ; Paiva, WS				Neville, Iuri Santana; Hayashi, Cintya Yukie; El Hajj, Simone Alves; Costa Zaninotto, Ana Luiza; Sabino, Juliana Perez; Sousa, Leonardo Moura, Jr.; Nagumo, Marcia Mitie; Brunoni, Andre Russowsky; Silva Shieh, Barbara Dal Forno; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Repetitive Transcranial Magnetic Stimulation (rTMS) for the cognitive rehabilitation of traumatic brain injury (TBI) victims: study protocol for a randomized controlled trial	TRIALS			English	Article						Brain Injury; Cognition; Cognitive; Diffuse Axonal Injury; Non-invasive brain stimulation; Psychology; Repetitive transcranial magnetic stimulation (TMS, rTMS)	DIFFUSE AXONAL INJURY; QUALITY-OF-LIFE; ANXIETY INVENTORY; HEAD-INJURY; IMPAIRMENT; DEPRESSION; INTEGRITY; MODERATE; DAMAGE	Background: Repetitive Transcranial Magnetic Stimulation (rTMS) has been proposed as a new tool in neurological rehabilitation of victims of traumatic brain injury (TBI). However, its usefulness to treat this condition has never been tested rigorously. The primary goal is to conduct a study protocol to determine whether rTMS used to cognitive rehabilitation of victims of TBI with diffuse axonal injury (DAI) is a safe instrument and if it enhances cognitive function recovery. Methods: Double-blind randomized controlled trial of patients with diffuse axonal injury. Thirty-six patients will be randomized to either an active coil group or sham group in a 1: 1 ratio. rTMS protocol: 10 sessions of high-frequency rTMS (10 Hz) over the left dorsolateral prefrontal cortex (DLPFC). Cortical Excitability measures will be obtained. Neuropsychological evaluations will be performed 1 week before, 1 week and 3 months after rTMS. There are 2 study hypotheses: (1) rTMS over the left DLPFC in patients with DAI will improve cognitive function and (2) whether rTMS is safe in TBI patients. Discussion: This study evaluates the immediate and delayed effects of rTMS over the DLPFC on the cognitive domain of patients with DAI following TBI. rTMS has shown good results in treating major depression and may be promising for patients with TBI. As such, the results of this study can greatly modify the cognitive rehabilitation strategies.	[Neville, Iuri Santana; Sousa, Leonardo Moura, Jr.; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Hosp Clin, Div Neurosurg, BR-05403010 Sao Paulo, SP, Brazil; [Neville, Iuri Santana; Hayashi, Cintya Yukie; Costa Zaninotto, Ana Luiza; Sousa, Leonardo Moura, Jr.; Nagumo, Marcia Mitie; Brunoni, Andre Russowsky; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Serv Interdisciplinary Neuromodulat, BR-05403010 Sao Paulo, SP, Brazil; [Hayashi, Cintya Yukie] Univ Sao Paulo, Sch Nursing, BR-05403010 Sao Paulo, SP, Brazil; [El Hajj, Simone Alves; Costa Zaninotto, Ana Luiza; Sabino, Juliana Perez; Silva Shieh, Barbara Dal Forno] Univ Sao Paulo, Hosp Clin, Div Neuropsychol, BR-05403010 Sao Paulo, SP, Brazil; [Neville, Iuri Santana; Sousa, Leonardo Moura, Jr.; Brunoni, Andre Russowsky; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Hosp Clin, Inst Psychiat, BR-05403010 Sao Paulo, SP, Brazil	Neville, IS (corresponding author), Univ Sao Paulo, Hosp Clin, Div Neurosurg, Rua Dr Eneas Aguiar 255-4079, BR-05403010 Sao Paulo, SP, Brazil.	iurineville@yahoo.com.br	Amorim, Robson/AAK-1368-2021; Brunoni, Andre R./H-8394-2012; Neville, Iuri S/P-5360-2014; Zaninotto, Ana Luiza C./I-4095-2016; Neville, Iuri/AAI-2852-2021; Paiva, Wellingson S/G-5517-2013	Amorim, Robson/0000-0003-2391-7519; Brunoni, Andre R./0000-0002-6310-3571; Neville, Iuri S/0000-0002-8561-9069; Zaninotto, Ana Luiza C./0000-0003-0639-0612; Neville, Iuri/0000-0002-8561-9069; Paiva, Wellingson S/0000-0002-5165-7040	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazilian National Council for Scientific and Technological Development)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [459077/2014-7]; NARSAD Young Investigator from the Brain & Behavior Research FoundationNARSAD [13/20493]; FAPESP Young Researcher from the Sao Paulo State FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [12/20911-5]; National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [13/470904]	The authors would like to acknowledge Ricardo Galhardoni (PhD) for the training provided and helpful discussions during the protocol design. We also acknowledge Vinicius Guirado (MD) for all his contribution during the recruitment. We acknowledge the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazilian National Council for Scientific and Technological Development) which awarded a grant (#459077/2014-7) to fund this study protocol. The principal investigator applied for the Chamada Universal (Universal Call, #14/2014), whose main goal is to select projects that could significantly contribute to the scientific and technologic development and innovation of the country (Brazil). ARB is supported by the following grants: 2013 NARSAD Young Investigator from the Brain & Behavior Research Foundation (Grant Number 13/20493), 2012 FAPESP Young Researcher from the Sao Paulo State Foundation (Grant Number 12/20911-5) and National Council for Scientific and Technological Development (CNPq, Grant Number 13/470904).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderkova L, 2014, J NEUROL SCI, V339, P15, DOI 10.1016/j.jns.2014.01.037; Barr MS, 2013, BIOL PSYCHIAT, V73, P510, DOI 10.1016/j.biopsych.2012.08.020; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; BECK AT, 1991, J ANXIETY DISORD, V5, P213, DOI 10.1016/0887-6185(91)90002-B; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bonni S, 2013, NEUROL SCI, V34, P2053, DOI 10.1007/s10072-013-1412-y; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; Demirtas-Tatlidede A, 2013, NEUROPHARMACOLOGY, V64, P566, DOI 10.1016/j.neuropharm.2012.06.020; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Jeurissen D, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00018; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Fernandez AL, 2009, CLIN NEUROPSYCHOL, V23, P501, DOI 10.1080/13854040802279675; Maset A, 1993, ARQ BRAS NEUROCIRURG, V12, P293; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MAXWELL WL, 1994, ACTA NEUROCHIR, P465; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nadeau SE, 2014, COGN BEHAV NEUROL, V27, P77, DOI 10.1097/WNN.0000000000000031; Nielson DM, ARCH PHYS MED REHABI; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Rabey JM, 2013, J NEURAL TRANSM, V120, P813, DOI 10.1007/s00702-012-0902-z; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Spielberger C.D., 1970, STATE TRAIT ANXIETY; Spreen O., 1998, COMPENDIUM NEUROPSYC; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Thurman, 2001, HEAD TRAUMA BASIC PR, P1193; Tiffin J., 1968, PURDUE PEGBOARD EXAM; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wechsler D., 1998, MANUAL WECHSLER ADUL	41	15	17	0	31	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	OCT 5	2015	16								440	10.1186/s13063-015-0944-2			7	Medicine, Research & Experimental	Research & Experimental Medicine	CS6DI	WOS:000362167200002	26438108	DOAJ Gold, Green Published			2021-06-18	
J	Taylor, JM; Montgomery, MH; Gregory, EJ; Berman, NEJ				Taylor, Jordan M.; Montgomery, Mitchell H.; Gregory, Eugene J.; Berman, Nancy E. J.			Exercise preconditioning improves traumatic brain injury outcomes	BRAIN RESEARCH			English	Article						Exercise; Traumatic brain injury; Sensorimotor function; Cognitive function; Vascular endothelial growth factor; Erythropoietin	REAL-TIME PCR; HEME OXYGENASE-1; MOUSE MODEL; HIPPOCAMPAL NEUROGENESIS; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; TRANSGENIC MICE; OLDER-ADULTS	Purpose: To determine whether 6 weeks of exercise performed prior to traumatic brain injury (TBI) could improve post-TBI behavioral outcomes in mice, and if exercise increases neuroprotective molecules (vascular endothelial growth factor-A [VEGF-A], erythropoietin [EPO], and heme oxygenase-1 [HO-1]) in brain regions responsible for movement (sensorimotor cortex) and memory (hippocampus). Methods: 120 mice were randomly assigned to one of four groups: (1) no exercise+no TBI (NOEX-NOTBI [n=301]), (2) no exercise+TBI (NOEX-TBI [n=30]), (3) exercise+no TBI (EX-NOTBI [n=30]), and (4) exercise+TBI (EX-TBI [n=301). The gridwalk task and radial arm water maze were used to evaluate sensorimotor and cognitive function, respectively. Quantitative real time polymerase chain reaction and immunostaining were performed to investigate VEGF-A, EPO, and HO-1 mRNA and protein expression in the right cerebral cortex and ipsilateral hippocampus. Results: EX-TBI mice displayed reduced post-TBI.sensorimotor and cognitive deficits when compared to NOEX-TBI mice. EX-NOTBI and EX-TBI mice showed elevated VEGF-A and EPO mRNA in the cortex and hippocampus, and increased VEGF-A and EPO staining of sensorimotor cortex neurons 1 day post-TBI and/or post-exercise. EX-TBI mice also exhibited increased VEGF-A staining of hippocampal neurons 1 day post-TBI/post-exercise. NOEX-TBI mice demonstrated increased HO-1 mRNA in the cortex (3 days post-TBI) and hippocampus (3 and 7 days post-TBI), but HO-1 was not increased in mice that exercised. Conclusions: Improved TBI outcomes following exercise preconditioning are associated with increased expression of specific neuroprotective genes and proteins (VEGF-A and EPO, but not HO-1) in the brain. (C) 2015 Elsevier B.V. All rights reserved.	[Taylor, Jordan M.; Montgomery, Mitchell H.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA; [Gregory, Eugene J.; Berman, Nancy E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Berman, NEJ (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Mailstop 3038,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	NBERMAN@kumc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 AG31140, P20 GM103418]; University of Kansas Alzheimer's Disease Center [P30 AG035982]; Landon Center on Aging; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG035982, R01AG031140] Funding Source: NIH RePORTER	This project was supported by the National Institutes of Health under grant numbers (RO1 AG31140) and (P20 GM103418). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by an award from the University of Kansas Alzheimer's Disease Center (P30 AG035982) and the Landon Center on Aging. The authors acknowledge the assistance of Lisa Stehno-Bittel (manuscript editing), Stanton Fernald (graphical design), and Jo Wick (statistical support).	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI [10.1089/neu.2008.0765, 10.1089/neu.2008-0765]; Aztatzi-Santillan Emmanuel, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P310; Bae JW, 2010, NEUROL SCI, V31, P307, DOI 10.1007/s10072-010-0216-6; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Burns JM, 2008, ALZ DIS ASSOC DIS, V22, P39, DOI 10.1097/WAD.0b013e31815a9ddc; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Hildebrandt AL, 2003, AM J PHYSIOL-ENDOC M, V285, pE1021, DOI 10.1152/ajpendo.00234.2003; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lin TK, 2014, INT J MOL SCI, V15, P1625, DOI 10.3390/ijms15011625; Lista I, 2010, CELL MOL NEUROBIOL, V30, P493, DOI 10.1007/s10571-009-9488-x; Ma YW, 2013, INT J MOL SCI, V14, P8570, DOI 10.3390/ijms14048570; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Neubauer JA, 2012, RESP PHYSIOL NEUROBI, V184, P178, DOI 10.1016/j.resp.2012.06.027; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Nichol KE, 2007, BEHAV BRAIN RES, V184, P124, DOI 10.1016/j.bbr.2007.06.027; Olenich SA, 2013, J PHYSIOL-LONDON, V591, P5157, DOI 10.1113/jphysiol.2013.254979; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Parachikova A, 2008, NEUROBIOL DIS, V30, P121, DOI 10.1016/j.nbd.2007.12.008; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Querido JS, 2007, SPORTS MED, V37, P765, DOI 10.2165/00007256-200737090-00002; Saaksjarvi K, 2014, EUR J EPIDEMIOL, V29, P285, DOI 10.1007/s10654-014-9887-2; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Thompson D, 2005, FREE RADICAL RES, V39, P63, DOI 10.1080/10715760400022327; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; van Dellen A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-34; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266; Viboolvorakul S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/230791; Wahl P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096024; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	60	15	16	1	27	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 5	2015	1622						414	429		10.1016/j.brainres.2015.07.009			16	Neurosciences	Neurosciences & Neurology	CS4OC	WOS:000362054100040	26165153	Green Accepted			2021-06-18	
J	Moore, M; Robinson, G; Mink, R; Hudson, K; Dotolo, D; Gooding, T; Ramirez, A; Zatzick, D; Giordano, J; Crawley, D; Vavilala, MS				Moore, Megan; Robinson, Gabrielle; Mink, Richard; Hudson, Kimberly; Dotolo, Danae; Gooding, Tracy; Ramirez, Alma; Zatzick, Douglas; Giordano, Jessica; Crawley, Deborah; Vavilala, Monica S.			Developing a Family-Centered Care Model for Critical Care After Pediatric Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						family-centered care; pediatrics; qualitative research; traumatic brain injury	HEALTH-CARE; SATISFACTION; CHILDREN; PARENTS; OUTCOMES; SUPPORT; NEEDS; UNIT	Objectives: This study examined the family experience of critical care after pediatric traumatic brain injury in order to develop a model of specific factors associated with family-centered care. Design: Qualitative methods with semi-structured interviews were used. Setting: Two level 1 trauma centers. Participants: Fifteen mothers of children who had an acute hospital stay after traumatic brain injury within the last 5 years were interviewed about their experience of critical care and discharge planning. Participants who were primarily English, Spanish, or Cantonese speaking were included. Interventions: None. Measurements and Main Results: Content analysis was used to code the transcribed interviews and develop the family-centered care model. Three major themes emerged: 1) thorough, timely, compassionate communication, 2) capacity building for families, providers, and facilities, and 3) coordination of care transitions. Participants reported valuing detailed, frequent communication that set realistic expectations and prepared them for decision making and outcomes. Areas for capacity building included strategies to increase provider cultural humility, parent participation in care, and institutional flexibility. Coordinated care transitions, including continuity of information and maintenance of partnerships with families and care teams, were highlighted. Participants who were not primarily English speaking reported particular difficulty with communication, cultural understanding, and coordinated transitions. Conclusions: This study presents a family-centered traumatic brain injury care model based on family perspectives. In addition to communication and coordination strategies, the model offers methods to address cultural and structural barriers to meeting the needs of non-English-speaking families. Given the stress experienced by families of children with traumatic brain injury, careful consideration of the model themes identified here may assist in improving overall quality of care to families of hospitalized children with traumatic brain injury.	[Moore, Megan; Robinson, Gabrielle; Gooding, Tracy; Zatzick, Douglas; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Moore, Megan; Hudson, Kimberly; Dotolo, Danae] Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA; [Robinson, Gabrielle; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Mink, Richard] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Mink, Richard; Ramirez, Alma] Los Angeles BioMed Res Inst, Torrance, CA USA; [Zatzick, Douglas] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Giordano, Jessica; Crawley, Deborah] Brain Injury Alliance Washington, Seattle, WA USA	Moore, M (corresponding author), Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA.	mm99@uw.edu	Hudson, Kimberly/AAO-4353-2021		National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS072308]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); University of WashingtonUniversity of Washington; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Center for Advancing Translational Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH through the University of WashingtonUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; PCORIPatient-Centered Outcomes Research Institute - PCORI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	Dr. Moore is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2TR000421). Dr. Vavilala (PI) is supported by the National Institute for Neurological Disorders and Stroke (1R01NS072308). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Moore received support for travel from the National Center for Advancing Translational Sciences of the National Institutes of Health (travel to conference provided by grant), received support for the development of educational presentations from the University of Washington (Received payment for 1 lecture provided to ALTSA group), and received support for article research from the National Institutes of Health (NIH) Dr. Moore and her institution received grant support from the National Center for Advancing Translational Sciences of the NIH. Dr. Mink consulted for the American Board of Pediatrics (Honorarium to serve on Education and Training Committee) and received support for article research from the NIH. His institution received grant support from a NIH Subcontract through the University of Washington. Dr. Dotolo received support for article research from the NIH. Her institution received grant support from the NIH. Dr. Gooding's institution received grant support from PCORI. Dr. Ramirez's institution received grant support from a NIH Subcontract through the University of Washington. Dr. Giordano's institution received support for participation in review activities from the Brain Injury Alliance of Washington. Dr. Crawley's institution received support for participation in review activities from the Brain Injury Alliance of Washington. Dr. Vavilala received support for article research from the NIH. Her institution received grant support from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Ammentorp J, 2005, ARCH PEDIAT ADOL MED, V159, P127, DOI 10.1001/archpedi.159.2.127; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Cavanagh S, 1997, Nurse Res, V4, P5, DOI 10.7748/nr.4.3.5.s2; Coker TR, 2010, PEDIATRICS, V125, P1159, DOI 10.1542/peds.2009-1994; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Dunn MS, 2006, PEDIATRICS, V118, pS95, DOI 10.1542/peds.2006-0913F; Eichner JM, 2012, PEDIATRICS, V129, P394, DOI 10.1542/peds.2011-3084; Fassier T, 2010, CURR OPIN CRIT CARE, V16, P654, DOI 10.1097/MCC.0b013e32834044f0; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gubrium JaberF., 2002, HDB INTERVIEW RES CO; Hemmelgarn AL, 2001, CHILD HEALTH CARE, V30, P93, DOI 10.1207/S15326888CHC3002_2; Heyland DK, 2002, CRIT CARE MED, V30, P1413, DOI 10.1097/00003246-200207000-00002; Lewin SA, 2001, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003267; Long AC, 2014, CRIT CARE MED, V42, P461, DOI 10.1097/CCM.0b013e3182a525b8; Mayring P., QUALITATIVE CONTENT; Neff JM, 2003, PEDIATRICS, V112, P691; Ngui EM, 2006, PEDIATRICS, V117, P1184, DOI 10.1542/peds.2005-1088; Patton M.Q., 2002, QUALITATIVE RES EVAL; Peigne V, 2011, CRIT CARE MED, V39, P1365, DOI 10.1097/CCM.0b013e3182120b68; Pollack MM, 2003, CRIT CARE MED, V31, P1620, DOI 10.1097/01.CCM.0000063302.76602.86; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; Rusinova K, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-21; Stewart M, 2000, J FAM PRACTICE, V49, P796; Tervalon M, 1998, J HEALTH CARE POOR U, V9, P117	27	15	15	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	OCT	2015	16	8					758	765		10.1097/PCC.0000000000000494			8	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	DD1UP	WOS:000369708000017	26135064	Green Accepted			2021-06-18	
J	Swan, AR; Nichols, S; Drake, A; Angeles, A; Diwakar, M; Song, T; Lee, RR; Huang, MX				Swan, Ashley Robb; Nichols, Sharon; Drake, Angela; Angeles, AnneMarie; Diwakar, Mithun; Song, Tao; Lee, Roland R.; Huang, Ming-Xiong			Magnetoencephalography Slow-Wave Detection in Patients with Mild Traumatic Brain Injury and Ongoing Symptoms Correlated with Long-Term Neuropsychological Outcome	JOURNAL OF NEUROTRAUMA			English	Article						executive functioning; magnetoencephalography (MEG); mild traumatic brain injury (mTBI); neuropsychological testing; postconcussive syndrome (PCS)	SIGNAL SPACE SEPARATION; MINOR HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; NEUROCOGNITIVE PERFORMANCE; CLINICAL NEUROPSYCHOLOGY; IMAGING APPROACH; MEG; CONCUSSION; ATTENTION; SYSTEM	Mild traumatic brain injury (mTBI) is common in the United States, accounting for as many as 75-80% of all TBIs. It is recognized as a significant public health concern, but there are ongoing controversies regarding the etiology of persistent symptoms post-mTBI. This constellation of nonspecific symptoms is referred to as postconcussive syndrome (PCS). The present study combined results from magnetoencephalography (MEG) and cognitive assessment to examine group differences and relationships between brain activity and cognitive performance in 31 military and civilian individuals with a history of mTBI+PCS and 33 matched healthy control subjects. An operator-free analysis was used for MEG data to increase reliability of the technique. Subjects completed a comprehensive neuropsychological assessment, and measures of abnormal slow-wave activity from MEG were collected. Results demonstrated significant group differences on measures of executive functioning and processing speed. In addition, significant correlations between slow-wave activity on MEG and patterns of cognitive functioning were found in cortical areas, consistent with cognitive impairments on exams. Results provide more objective evidence that there may be subtle changes to the neurobiological integrity of the brain that can be detected by MEG. Further, these findings suggest that these abnormalities are associated with cognitive outcomes and may account, at least in part, for long-term PCS in those who have sustained an mTBI.	[Swan, Ashley Robb; Angeles, AnneMarie; Lee, Roland R.; Huang, Ming-Xiong] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Lee, Roland R.; Huang, Ming-Xiong] VA San Diego Healthcare Syst, Serv Radiol, San Diego, CA USA; [Swan, Ashley Robb; Angeles, AnneMarie; Diwakar, Mithun; Song, Tao; Lee, Roland R.; Huang, Ming-Xiong] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Nichols, Sharon] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Drake, Angela] Natl Univ, Dept Community Hlth, San Diego, CA USA	Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu			Merit Review Grants from the Department of Veterans Affairs [I01-CX000499, NURC-022-10F, NEUC-044-06S]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007198] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX000499] Funding Source: NIH RePORTER	This work was supported by Merit Review Grants from the Department of Veterans Affairs (to M.X.H.; I01-CX000499, NURC-022-10F, and NEUC-044-06S). The authors thank Dr. Rebecca Theilmann for her efforts in preparing the MRI protocol and Terry Curry (RN) for his effort in recruiting TBI participants. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. government.	Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benedict R., 1997, BRIEF VISUOSPATIAL M; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cohen D., 2002, P BIOMAG; Conners K. C., 2004, CONNERS CONTINUOUS P; CRAMER EM, 1966, REV EDUC RES, V36, P604, DOI 10.3102/00346543036005604; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P850, DOI 10.1080/13854046.2012.686631; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Guarino A.J., 2006, APPL MULTIVARIATE RE; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Heaton RK, 2004, REVISED COMPREHENSIV; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huang MX, 2006, NEUROIMAGE, V31, P1025, DOI 10.1016/j.neuroimage.2006.01.029; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lees-Haley PR, 2003, ARCH CLIN NEUROPSYCH, V18, P585; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lishman WA, 1998, ORGANIC PSYCHIAT; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Morey L. C., 2005, PERSONALITY ASSESSME; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Niedermeyer E, 2005, ELECTROENCEPHALOGRAP; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; Risse GL, 2006, EPILEPSIA, V47, P87, DOI 10.1111/j.1528-1167.2006.00699.x; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Song T, 2009, J CLIN NEUROPHYSIOL, V26, P392, DOI 10.1097/WNP.0b013e3181c29896; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S, 2004, Neurol Clin Neurophysiol, V2004, P35; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 1996, TEST MEMORY MALINGER; Trites R, 1977, NEUROPSYCHOLOGICAL T; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Ward B. D., 2000, SIMULTANEOUS INTERFE; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D, 1997, WAIS 3 ADM SCORING M; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590	78	15	15	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2015	32	19					1510	1521		10.1089/neu.2014.3654			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CR8NC	WOS:000361609500009	25808909	Green Published			2021-06-18	
J	Maia, PD; Hemphill, MA; Zehnder, B; Zhang, CF; Parker, KK; Kutz, JN				Maia, Pedro D.; Hemphill, Matthew A.; Zehnder, Brendan; Zhang, Chenfei; Parker, Kevin K.; Kutz, J. Nathan			Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Focal Axonal Swelling; Traumatic brain injury; Concussions; Parkinson; Alzheimer; Multiple Sclerosis; Spike train propagation	ACTION-POTENTIALS; SPIKE PROPAGATION; ABNORMALITIES; TRANSMISSION; TRANSPORT; PATHOLOGY; BREAKAGE; DEMENTIA; MODELS	Background: Focal Axonal Swellings arise in several leading neurodegenerative diseases of the central nervous system and are hallmark features of concussions and traumatic brain injuries. Recent theories mapped how the shape of each swelling affects the propagation of spike trains and consequently the information encoded in them. Spikes can be selectively deleted, have their speed affected, or blocked depending upon the severity of the swelling. New method: Our computational toolbox extracts meaningful geometrical parameters from sequential images of injured axon segments. The algorithm provides a principled approach for dealing with imaging distortions caused by experimental artifacts in order to extract the cross-section of an axon by detecting local symmetries, turning points and turning regions. Results: Our characterization of the Focal Axonal Swelling allows for an assessment of its impact on spike propagation, leading to a color coding of the axon that highlights problematic regions for information propagation. Comparison with existing methods: Many theoretical works reported distortions in spike propagation related to axonal enlargements. Such estimates, however, were not incorporated to a toolbox that could classify axonal swellings directly from experimental images. Conclusions: Our MATLAB toolbox thus highlights potential trouble spots of axonal morphology, and similar to car traffic maps, identify blocked or impaired routes for information flow. This computational framework is a promising starting point for diagnosing and assessing the impact of axonal swellings implicated in concussions, Alzheimer's and Parkinson's disease, Multiple Sclerosis and other neurological pathologies. (C) 2015 Elsevier B.V. All rights reserved.	[Maia, Pedro D.; Zehnder, Brendan; Zhang, Chenfei; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Hemphill, Matthew A.; Parker, Kevin K.] Harvard Univ, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA	Maia, PD (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	pedro.doria.maia@gmail.com; matt.hemphill@gmail.com; brendan.zehnder@gmail.com; kkparker@seas.harvard.edu; kutz@uw.edu		D. Maia, Pedro/0000-0002-3335-4257			Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Altenberger R, 2001, J NEUROSCI METH, V112, P101, DOI 10.1016/S0165-0270(01)00456-3; Baccus SA, 1998, P NATL ACAD SCI USA, V95, P8345, DOI 10.1073/pnas.95.14.8345; Baccus SA, 2000, J NEUROPHYSIOL, V83, P1693; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Ermentrout G. B., 2010, MATH FDN NEUROSCIENC; Fainaru-Wada M., 2013, CROWN ARCHETYPE; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kolaric KV, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.59; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Liberski PP, 1999, ACTA NEUROPATHOL, V97, P329, DOI 10.1007/s004010050995; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maia PD, 2014, J COMPUT NEUROSCI, V37, P317, DOI 10.1007/s10827-014-0504-x; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Marcuse D, 1974, THEORY DIELECTRIC OP; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Parnas I, 1979, PROPAGATION NONUNIFO, P499; RAMON F, 1975, FED PROC, V34, P1357; Rinzel J, 1990, ANN N Y ACAD SCI, V591; Segev I, 1999, J PHYSIOLOGY-PARIS, V93, P263, DOI 10.1016/S0928-4257(00)80055-8; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Smith D, 1999, J NEUROSCI, V19, P4263; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; ZHOU Y, 1994, MATH BIOSCI, V119, P169, DOI 10.1016/0025-5564(94)90075-2	39	15	15	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2015	253						233	243		10.1016/j.jneumeth.2015.06.022			11	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CQ8OJ	WOS:000360867400023	26188255				2021-06-18	
J	Montalcini, T; Moraca, M; Ferro, Y; Romeo, S; Serra, S; Raso, MG; Rossi, F; Sannita, WG; Dolce, G; Pujia, A				Montalcini, Tiziana; Moraca, Marta; Ferro, Yvelise; Romeo, Stefano; Serra, Sebastiano; Raso, Maria Girolama; Rossi, Francesco; Sannita, Walter G.; Dolce, Giuliano; Pujia, Arturo			Nutritional parameters predicting pressure ulcers and short-term mortality in patients with minimal conscious state as a result of traumatic and non-traumatic acquired brain injury	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article						Malnutrition; Minimal conscious state; Pressure ulcer; Mid-arm circumference; Albumin	SERUM-ALBUMIN LEVEL; RISK-FACTORS; ADMISSION; MALNUTRITION; PREVALENCE; PREVENTION; SURVIVAL; DISEASE; PEOPLE; IMPACT	Background: The association between malnutrition and worse outcomes as pressure ulcers and mortality is well established in a variety of setting. Currently none investigation was conducted in patients with long-term consequences of the acquired brain injury in which recovery from brain injury could be influenced by secondary complications. The aim of this study was to investigate the association between various nutritional status parameters (in particular albumin) and pressure ulcers formation and short-term mortality in minimal conscious state patients. Methods: In this prospective, observational study of 5-months duration, a 30 patients sample admitted to a Neurological Institute was considered. All patients underwent a complete medical examination. Anthropometric parameters like mid-arm circumference and mid-arm muscle circumference and nutritional parameters as serum albumin and blood hemoglobin concentration were assessed. Results: At univariate and logistic regression analysis, mid-arm circumference (p = 0.04; beta = -0.89), mid-arm muscle circumference (p = 0.050; beta = -1.29), hemoglobin (p = 0.04, beta -1.1) and albumin (p = 0.04, beta -7.91) were inversely associated with pressure ulcers. The area under the ROC curve for albumin to predict sores was 0.76 (p = 0.02) and mortality was 0.83 (p = 0.03). Patient with lower albumin had significantly higher short-term mortality than those with higher serum albumin (p = 0.03; chi(2) test = 6.47). Conclusion: Albumin, haemoglobin and mid-arm circumference are inversely associated with pressure ulcers. Albumin is a prognostic index in MCS patients. Since albumin and haemoglobin could be affected by a variety of factors, this association suggests to optimize nutrition and investigate on other mechanism leading to mortality and pressure ulcers.	[Montalcini, Tiziana; Moraca, Marta; Ferro, Yvelise; Romeo, Stefano; Pujia, Arturo] Univ Magna Grecia, Dept Med & Surg Sci, Clin Nutr Unit, I-88100 Catanzaro, Italy; [Romeo, Stefano] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Gothenburg, Sweden; [Serra, Sebastiano; Raso, Maria Girolama; Rossi, Francesco; Sannita, Walter G.; Dolce, Giuliano] S Anna Neurol Inst, Crotone, Italy	Montalcini, T (corresponding author), Univ Magna Grecia, Dept Med & Surg Sci, Clin Nutr Unit, Viale S Venuta, I-88100 Catanzaro, Italy.	tmontalcini@unicz.it	Serra, Sebastiano/AAP-8391-2021; Romeo, Stefano/L-6861-2015; Ferro, Yvelise/AAC-1121-2020; Ferro, Yvelise/T-2539-2017	Romeo, Stefano/0000-0001-9168-4898; Ferro, Yvelise/0000-0001-7503-6188; MONTALCINI, Tiziana/0000-0001-7048-5830	Novo Nordisk FondenNovo Nordisk Foundation [NNF14OC0009321] Funding Source: researchfish		Allman RM, 1997, CLIN GERIATR MED, V13, P421; Anthony D, 2000, J ADV NURS, V32, P359, DOI 10.1046/j.1365-2648.2000.01484.x; Baltazar GA, 2015, AM SURGEON, V81, pE61; Baltazar GA, 2015, BRAIN INJURY, V29, P607, DOI 10.3109/02699052.2015.1004558; Banks M, 2010, NUTRITION, V26, P896, DOI 10.1016/j.nut.2009.09.024; Barron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127550; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Bredesen IM, 2015, INT J NURS STUD, V52, P149, DOI 10.1016/j.ijnurstu.2014.07.005; Cabrerizo S, 2015, MATURITAS, V81, P17, DOI 10.1016/j.maturitas.2015.02.009; Casiraghi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073651; CHUMLEA WMC, 1994, J AM DIET ASSOC, V94, P1385, DOI 10.1016/0002-8223(94)92540-2; Dhandapani M, 2014, J CLIN NURS, V23, P1114, DOI 10.1111/jocn.12396; Di Lorenzo G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-161; DIRREN H, 1991, EUR J CLIN NUTR, V45, P43; European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel, 2009, TREAT PRESS ULC QUIC; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grasso S, 2013, CLINICS, V68, P1413, DOI 10.6061/clinics/2013(11)05; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Guenter P, 2000, Adv Skin Wound Care, V13, P164; HARVEY KB, 1981, AM J CLIN NUTR, V34, P2013; Huo YR, 2015, J NUTR HEALTH AGING, V19, P474, DOI 10.1007/s12603-014-0543-z; Idicula TT, 2009, CEREBROVASC DIS, V28, P13, DOI 10.1159/000215938; Jaafar AF, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-124; Japur CC, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.12.007; Kurtul A, 2015, ANGIOLOGY; Kwak L, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-26; Langer G, 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003216; Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001; Montalcini T, 2013, ENDOCRINE, V43, P59, DOI 10.1007/s12020-012-9813-x; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Oh IH, 2015, ARTIF ORGANS, V39, P965, DOI 10.1111/aor.12473; Shahin Eman S M, 2008, Nurs Crit Care, V13, P71, DOI 10.1111/j.1478-5153.2007.00249.x; Shindo Y, 2015, LANCET INFECT DIS, V15, P1055, DOI 10.1016/S1473-3099(15)00151-6; Sugino H, 2014, J MED INVESTIG, V61, P15, DOI 10.2152/jmi.61.15; Sultana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121456; Talluri T, 1999, ANN NY ACAD SCI, V873, P94, DOI 10.1111/j.1749-6632.1999.tb09454.x; Thomas DR, 2014, NUTR CLIN PRACT, V29, P466, DOI 10.1177/0884533614539016; US Department of Health and Human Services National Institutes of Health Technology Assessment Conference Statement, 1994, BIOEL IMP AN BOD COM, P12; van Dijk PC, 2008, KIDNEY INT, V74, P705, DOI 10.1038/ki.2008.294; Waltman N L, 1991, Oncol Nurs Forum, V18, P867; WHO, WHO CHILD GROWTH STA; Wissing U, 1999, SCAND J CARING SCI, V13, P123, DOI 10.1080/02839319950162679	45	15	16	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1479-5876			J TRANSL MED	J. Transl. Med.	SEP 17	2015	13								305	10.1186/s12967-015-0660-4			8	Medicine, Research & Experimental	Research & Experimental Medicine	CR5CD	WOS:000361356100002	26376778	DOAJ Gold, Green Published			2021-06-18	
J	Bailey, ZS; Grinter, MB; Campos, DD; VandeVord, PJ				Bailey, Zachary S.; Grinter, Michael B.; Campos, Diego De La Torre; VandeVord, Pamela J.			Blast induced neurotrauma causes overpressure dependent changes to the DNA methylation equilibrium	NEUROSCIENCE LETTERS			English	Article						Blast neurotrauma; Brain injury; Epigenetics; DNA methylation	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; CONSEQUENCES; SINGLE; MEMORY	Traumatic brain injury (TBI) has a high prevalence in our society and often leads to morbidity and mortality. TBI also occurs frequently in a military setting where exposure to blast waves is common. Abnormal gene expression involved with oxidative stress, inflammation and neuronal apoptosis has been well documented following blast induced neurotrauma (BINT). Altered epigenetic transcriptional regulation through DNA methylation has been implicated in the pathology of the injury. Imbalance between DNA methylation and DNA demethylation may lead to altered methylation patterns and subsequent changes in gene transcription. DNA methyltransferase enzymes (DNMT1, DNMT3a, and DNMT3b) are responsible for the addition of methyl groups to DNA, DNA methylation. Whereas the combined function of ten-eleven translocation enzymes (TET1, TET2, and TET3) and thymine-DNA glycosylase (TDG) result in the removal of methyl groups from DNA, DNA demethylation. We used an established rodent model of BINT to assess changes in DNA methylation and demethylation enzymes following injury. Three different blast overpressures were investigated (10, 17 and 23 psi). Gene expression was investigated in the prefrontal cortex and hippocampus two weeks following injury. We observed DNMT, TET and TDG expression changes between pressure groups and brain regions. The hippocampus was more vulnerable to enzyme expression changes than the prefrontal cortex, which correlated with aberrant DNA methylation. A significant negative correlation was found between global DNA methylation and the magnitude of blast overpressure exposure. Through transcriptional regulation, altered DNA methylation patterns may offer insight into the characteristic outcomes associated with the injury pathology including inflammation, oxidative stress and apoptosis. As such, these enzymes may be important targets to future therapeutic intervention strategies. Published by Elsevier Ireland Ltd.	[Bailey, Zachary S.; Grinter, Michael B.; Campos, Diego De La Torre; VandeVord, Pamela J.] Virginia Tech, Biomed Engn & Mech, Blacksburg, VA 24060 USA; [VandeVord, Pamela J.] Salem Vet Affairs Med Ctr, Salem, VA 24153 USA	VandeVord, PJ (corresponding author), 447 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	pvord@vt.edu			Department of Veterans Affairs RED [RX001104-01]; Veterans AffairsUS Department of Veterans Affairs [I21RX001104] Funding Source: NIH RePORTER	This project was support by the Department of Veterans Affairs RED contract #RX001104-01. We would also like to thank Brad Hubbard, Dr. Michael Urban, C. Shaylen Hall, and Dr. Sujith Sajja for their technical assistance.	Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Berdasco M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt83; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seifert J., 2007, J EPIDEMIOL COMMUNIT, V61, P926, DOI DOI 10.1136/JECH.2007.059717; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wachsman JT, 1997, MUTAT RES-FUND MOL M, V375, P1, DOI 10.1016/S0027-5107(97)00003-1; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Watanabe D, 2006, NEUROSCIENCE, V142, P727, DOI 10.1016/j.neuroscience.2006.07.053; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2013.03.005]; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	33	15	16	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 14	2015	604						119	123		10.1016/j.neulet.2015.07.035			5	Neurosciences	Neurosciences & Neurology	CS1TG	WOS:000361850000022	26232681				2021-06-18	
J	Beauchamp, MH; Brooks, BL; Barrowman, N; Aglipay, M; Keightley, M; Anderson, P; Yeates, KO; Osmond, MH; Zemek, R				Beauchamp, Miriam H.; Brooks, Brian L.; Barrowman, Nick; Aglipay, Mary; Keightley, Michelle; Anderson, Peter; Yeates, Keith O.; Osmond, Martin H.; Zemek, Roger			Empirical Derivation and Validation of a Clinical Case Definition for Neuropsychological Impairment in Children and Adolescents	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Neuropsychology; Assessment; Pediatric; Cognition; Performance; Brain injury	TRAUMATIC BRAIN-INJURY; WECHSLER INTELLIGENCE SCALE; LOW SCORES; NEUROCOGNITIVE OUTCOMES; HEALTHY-CHILDREN; PREFRONTAL CORTEX; EARLY-CHILDHOOD; WORKING-MEMORY; FRONTAL-CORTEX; 4TH EDITION	Neuropsychological assessment aims to identify individual performance profiles in multiple domains of cognitive functioning; however, substantial variation exists in how deficits are defined and what cutoffs are used, and there is no universally accepted definition of neuropsychological impairment. The aim of this study was to derive and validate a clinical case definition rule to identify neuropsychological impairment in children and adolescents. An existing normative pediatric sample was used to calculate base rates of abnormal functioning on eight measures covering six domains of neuropsychological functioning. The dataset was analyzed by varying the range of cutoff levels [1, 1.5, and 2 standard deviations (SDs) below the mean] and number of indicators of impairment. The derived rule was evaluated by bootstrap, internal and external clinical validation (orthopedic and traumatic brain injury). Our neuropsychological impairment (NPI) rule was defined as two or more test scores that fall 1.5 SDs below the mean. The rule identifies 5.1% of the total sample as impaired in the assessment battery and consistently targets between 3 and 7% of the population as impaired even when age, domains, and number of tests are varied. The NPI rate increases in groups known to exhibit cognitive deficits. The NPI rule provides a psychometrically derived method for interpreting performance across multiple tests and may be used in children 6-18 years. The rule may be useful to clinicians and scientists who wish to establish whether specific individuals or clinical populations present within expected norms versus impaired function across a battery of neuropsychological tests.	[Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program Brain Injury & Rehabil, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Brooks, Brian L.; Barrowman, Nick; Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Aglipay, Mary] Childrens Hosp Eastern Ontario, Res Inst, Clin Res Unit, Ottawa, ON K1H 8L1, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Sci, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Therapy, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Keightley, Michelle] Toronto Rehabil Inst, Toronto, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Behav Neurosci & Consultat Liaison Program, Ottawa, ON K1H 8L1, Canada; [Anderson, Peter; Osmond, Martin H.; Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Yeates, Keith O.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Osmond, Martin H.; Zemek, Roger] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Osmond, Martin H.; Zemek, Roger] Univ Ottawa, Dept Emergency Med, Ottawa, ON K1N 6N5, Canada	Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca	Zemek, Roger/H-1039-2018; Yeates, Keith/AAJ-4223-2020; Barrowman, Nick/AAL-3166-2020	Barrowman, Nick/0000-0002-4704-9595; Yeates, Keith/0000-0001-7680-2892; Osmond, Martin/0000-0001-8275-8381	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293380, 231125]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01-HD02-3343, N01-MH9-0002, N01-NS-9-2314, -2315, -2316, -2317, -2319, -2320]; CNS Vital Signs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [N01HD023343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [N01MH090002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01NS092315, N01NS092314, N01NS092316, N01NS092319, N01NS092317] Funding Source: NIH RePORTER	This work was supported by the Canadian Institutes of Health Research (R.Z. 293380), (M.B. 231125). We would like to thank Dr. Gerry Taylor for his willingness to provide the external validation data and for facilitating access to it. B.L.B. reports that he receives royalties for a pediatric memory test (Sherman and Brooks, 2015, Child and Adolescent Memory Profile [ChAMP (TM)], PAR Inc.), past research support from a computerized test publisher (CNS Vital Signs) through in-kind test credits, and book royalties from Oxford University Press. None of the other authors report any conflicts of interest. Data used in the preparation of this article were obtained from the Pediatric MRI Data Repository created by the NIH MRI Study of Normal Brain Development. This is a multi-site, longitudinal study of typically developing children, from ages newborn through young adulthood, conducted by the Brain Development Cooperative Group and supported by the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke (Contract #s N01-HD02-3343, N01-MH9-0002, and N01-NS-9-2314, -2315, -2316, -2317, -2319, and -2320). A listing of the participating sites and a complete listing of the study investigators can be found at http://www.bic.mni.mcgill.ca/nihpd/info/participating_centers.html.	Achenbach TM., 1991, INTEGRATIVE GUIDE 19; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks B. L., 2012, PEDIAT FORENSIC NEUR, P66; Brooks BL, 2013, APPL NEUROPSYCH-CHIL, V2, P70, DOI 10.1080/21622965.2012.742792; Brooks BL, 2010, PSYCHOL ASSESSMENT, V22, P650, DOI 10.1037/a0019781; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P182, DOI 10.1093/arclin/acq005; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Brooks BL, 2009, J INT NEUROPSYCH SOC, V15, P613, DOI 10.1017/S1355617709090651; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Delis D.C., 1994, CVLT C CALIFORNIA VE; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gathercole SE, 1998, J CHILD PSYCHOL PSYC, V39, P3, DOI 10.1017/S0021963097001753; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Hurks PPM, 2013, CLIN NEUROPSYCHOL, V27, P988, DOI 10.1080/13854046.2013.797502; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; HUTTENLOCHER PR, 1997, DEV PREFRONTAL CORTE, P69; Isquith PK, 2005, MENT RETARD DEV D R, V11, P209, DOI 10.1002/mrdd.20075; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Korkman M, 1998, NEPSY DEV NEUROPSYCH; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Mather N., 2001, WOODCOCK JOHNSON 3 T; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; Schoenberg MR, 2007, J CHILD NEUROL, V22, P379, DOI 10.1177/0883073807301925; Tiffin J., 1968, PURDUE PEGBOARD EXAM; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; van der Sluis S, 2008, BEHAV GENET, V38, P348, DOI 10.1007/s10519-008-9212-5; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wechsler D., 2011, WECHLSER ABBREVIATED; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zimmerman I. L., 2002, PRESCHOOL LANGUAGE S	52	15	15	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2015	21	8					596	609		10.1017/S1355617715000636			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	CT6HB	WOS:000362913000003	26307381				2021-06-18	
J	Caeyenberghs, K; Siugzdaite, R; Drijkoningen, D; Marinazzo, D; Swinnen, SP				Caeyenberghs, Karen; Siugzdaite, Roma; Drijkoningen, David; Marinazzo, Daniele; Swinnen, Stephan P.			Functional Connectivity Density and Balance in Young Patients with Traumatic Axonal Injury	BRAIN CONNECTIVITY			English	Article						brain injury; functional connectivity density; fMRI; hubs; network; postural control; resting-state		Our previous study provided some evidence for the relationship between abnormal structural connectivity and poor balance performance in young traumatic axonal injury (TAI) patients. An enhanced understanding of the functional connectivity following TAI may allow targeted treatments geared toward improving brain function and postural control. Twelve patients with TAI and 28 normally developing children (aged 9-19 years) performed the sensory organization test (SOT) protocol of the EquiTest (Neurocom). All participants were scanned using resting-state functional magnetic resonance imaging series along with anatomical scans. We applied "functional connectivity density mapping'' (FCDM), a voxel-wise data-driven method that calculates individual functional connectivity maps to obtain both short-range and long-range FCD. Findings revealed that the TAI group scored generally lower than the control group on the SOT, especially when proprioceptive feedback was compromised. Between-group maps noted significantly decreased long-range FCD in the TAI group in frontal and subcortical regions and significantly increased short-range FCD in frontal regions, left inferior parietal, and cerebellar lobules. Moreover, lower balance levels in TAI patients were associated with a lower long-range FCD in left putamen and cerebellar vermis. These findings suggest that long-range connections may be more vulnerable to TAI than short-range connections. Moreover, higher values of short-range FCD may suggest adaptive mechanisms in the TAI group. Finally, this study supports the view that FCDM is a valuable tool for selectively predicting functional motor deficits in TAI patients.	[Caeyenberghs, Karen] Univ Ghent, Fac Med & Hlth Sci, Dept Phys Therapy & Motor Rehabil, Ghent, Belgium; [Caeyenberghs, Karen] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Ghent, Belgium; [Siugzdaite, Roma; Marinazzo, Daniele] Univ Ghent, Fac Psychol & Pedag Sci, Dept Data Anal, Ghent, Belgium; [Drijkoningen, David; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Movement Control & Neuroplast Res Grp, Leuven, Belgium	Caeyenberghs, K (corresponding author), Dept Phys Therapy & Motor Rehabil, Campus Heymans UZ 2B3,Pintelaan 185, B-9000 Ghent, Belgium.	karen.caeyenberghs@ugent.be	Marinazzo, Daniele/H-4793-2019	Marinazzo, Daniele/0000-0002-9803-0122; Caeyenberghs, Karen/0000-0001-7009-6843	Research Programme of the Research Foundation-Flanders (FWO)FWO [G.0482.10, G.A114.11]	Support for this study was provided through a grant from the Research Programme of the Research Foundation-Flanders (FWO; Levenslijn G.0482.10 and G.A114.11).	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Chan LL, 2014, PARKINSONISM RELAT D, V20, P53, DOI 10.1016/j.parkreldis.2013.09.017; Coffman KA, 2011, P NATL ACAD SCI USA, V108, P16068, DOI 10.1073/pnas.1107904108; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Duarte M, 2002, EXP BRAIN RES, V146, P60, DOI 10.1007/s00221-002-1154-1; Foerster BU, 2005, MAGNET RESON MED, V54, P1261, DOI 10.1002/mrm.20695; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Gagnon I, 2001, J HEAD TRAUMA REHAB, V16, P595, DOI 10.1097/00001199-200112000-00007; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Goble DJ, 2012, HUM BRAIN MAPP, V33, P895, DOI 10.1002/hbm.21257; GRAYBIEL AM, 1990, REV NEUROL, V146, P570; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; NEISTADT ME, 1994, AM J OCCUP THER, V48, P225, DOI 10.5014/ajot.48.3.225; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prosperini L, 2013, RADIOLOGY, V268, P181, DOI 10.1148/radiol.13121695; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ramnani N, 2012, CEREBELLUM, V11, P366, DOI 10.1007/s12311-011-0272-3; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; RUBIN AM, 1995, AM J OTOL, V16, P216; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tomasi D, 2012, HUM BRAIN MAPP, V33, P849, DOI 10.1002/hbm.21252; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; Wang TY, 2014, BRAIN RES, V1563, P41, DOI 10.1016/j.brainres.2014.03.015; Ward B., 2000, SIMULTANEOUS INFEREN; WARREN M, 1993, AM J OCCUP THER, V47, P55, DOI 10.5014/ajot.47.1.55; Weiner KS, 2011, NEUROIMAGE, V56, P2183, DOI 10.1016/j.neuroimage.2011.03.041	59	15	15	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	SEP	2015	5	7			SI		423	432		10.1089/brain.2014.0293			10	Neurosciences	Neurosciences & Neurology	VG7GK	WOS:000448203700003	25327385	Green Published			2021-06-18	
J	Grubenhoff', JA; Deakyne, SJ; Comstock, RD; Kirkwood, MW; Bajaj, L				Grubenhoff', Joseph A.; Deakyne, Sara J.; Comstock, R. Dawn; Kirkwood, Michael W.; Bajaj, Lalit			Outpatient follow-up and return to school after emergency department evaluation among children with persistent post-concussion symptoms	BRAIN INJURY			English	Article						Acute brain injury; brain concussion; emergency medicine; post-concussion symptoms; post-concussion syndrome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; NEUROCOGNITIVE OUTCOMES; ADOLESCENTS; PARENTS; IMPACT; NEEDS	Objective: To describe differences in outpatient follow-up and academic accommodations received by children with and without persistent post-concussion symptoms (PPCS) after emergency department (ED) evaluation. It was hypothesized that children with PPCS would have more outpatient visits and receive academic accommodations more often than children without PPCS and that follow-up would be positively associated with receiving accommodations. Methods: Children aged 8-18 years with acute (<= 6hours) concussion at time of presentation to a paediatric ED were enrolled in an observational study. Outcomes were assessed through a telephone survey 30 days after injury. Results: Of 234 enrolled participants, 179 (76%) completed follow-up. PPCS occurred in 21%. Only 45% of subjects had follow-up visits after ED discharge. Follow-up visit rates were similar for those with and without PPCS (58% vs. 41%, respectively; p=0.07). Children with PPCS missed twice as many school days as those without (3 vs. 1.5; p<0.001), but did not differ in receiving academic accommodations (36% vs. 53%; p=0.082). Outpatient follow-up was associated with receiving academic accommodations (RR=2.2; 95% Cl=1.4-3.5). Conclusions: Outpatient follow-up is not routine for concussed children. Despite missing more school days, children with PPCS do not receive academic accommodations more often. Outpatient follow-up may facilitate academic accommodations.	[Grubenhoff', Joseph A.; Comstock, R. Dawn; Bajaj, Lalit] Univ Colorado, Dept Pediat, Boulder, CO 80309 USA; [Grubenhoff', Joseph A.; Bajaj, Lalit] Childrens Hosp Colorado, Emergency Dept, Aurora, CO 80045 USA; [Deakyne, Sara J.] Childrens Hosp Colorado, Dept Res Informat, Aurora, CO 80045 USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Dept Phys Med & Rehabil, Boulder, CO 80309 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Rehabil Med, Aurora, CO 80045 USA	Grubenhoff', JA (corresponding author), Childrens Hosp Colorado, 13123 E 16th Ave,B-251, Aurora, CO 80045 USA.	joe.grubenhoff@childrenscolorado.org		Grubenhoff, Joseph/0000-0001-5072-4064	Thrasher Research Fund Early Career Award [9202]; NTH/NCATS Colorado CTSI [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER	Support for this study was provided by a Thrasher Research Fund Early Career Award (9202) to Dr Grubenhoff. Use of the REDCap research database was supported by NTH/NCATS Colorado CTSI Grant Number UL1 TR000154.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Berman S, 2005, PEDIATRICS, V116, P1474, DOI 10.1542/peds.2005-0923; BIJUR PE, 1990, PEDIATRICS, V86, P337; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Centers for Disease Control and Prevention, CONC FACT SHEET SCH; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Haboush-Deloye A, 2014, MATERN CHILD HLTH J, V18, P1753, DOI 10.1007/s10995-013-1420-9; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Lipkin PH, 2007, PEDIATRICS, V119, P1218, DOI 10.1542/peds.2007-0885; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; World Health Organization, 1992, ICD 10 CLASS MENT BE; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	38	15	15	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1186	1191		10.3109/02699052.2015.1035325			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400007	26004755	Green Accepted			2021-06-18	
J	Kreif, N; Grieve, R; Diaz, I; Harrison, D				Kreif, Noemi; Grieve, Richard; Diaz, Ivan; Harrison, David			Evaluation of the Effect of a Continuous Treatment: A Machine Learning Approach with an Application to Treatment for Traumatic Brain Injury	HEALTH ECONOMICS			English	Article; Proceedings Paper	23rd European Workshop on Econometrics and Health Economics	SEP 04-06, 2014	Starnberg, GERMANY	Univ Munich, Dept Econ, Munich Centre Econ Aging		programme evaluation; generalised propensity score; machine learning	PROPENSITY SCORE; CAUSAL INFERENCE; REGRESSION; PREDICTION; ROBUSTNESS; ADJUSTMENT	For a continuous treatment, the generalised propensity score (GPS) is defined as the conditional density of the treatment, given covariates. GPS adjustment may be implemented by including it as a covariate in an outcome regression. Here, the unbiased estimation of the dose-response function assumes correct specification of both the GPS and the outcome-treatment relationship. This paper introduces a machine learning method, the Super Learner', to address model selection in this context. In the two-stage estimation approach proposed, the Super Learner selects a GPS and then a dose-response function conditional on the GPS, as the convex combination of candidate prediction algorithms. We compare this approach with parametric implementations of the GPS and to regression methods. We contrast the methods in the Risk Adjustment in Neurocritical care cohort study, in which we estimate the marginal effects of increasing transfer time from emergency departments to specialised neuroscience centres, for patients with acute traumatic brain injury. With parametric models for the outcome, we find that dose-response curves differ according to choice of specification. With the Super Learner approach to both regression and the GPS, we find that transfer time does not have a statistically significant marginal effect on the outcomes. (c) 2015 The Authors. Health Economics Published by John Wiley & Sons Ltd.	[Kreif, Noemi; Grieve, Richard] London Sch Hyg & Trop Med, Dept Hlth, Serv Res & Policy, London WC1, England; [Diaz, Ivan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Harrison, David] Intens Care Natl Audit & Res Ctr, London, England	Kreif, N (corresponding author), London Sch Hyg & Trop Med, Dept Hlth, Serv Res & Policy, London WC1, England.	noemi.kreif@lshtm.ac.uk	Harrison, David A/O-4355-2018	Harrison, David A/0000-0002-9002-9098; Grieve, Richard/0000-0001-8899-1301	Policy Research Programme in the Department of Health [SRF-2013-06-016]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [SRF-2013-06-016]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/L012332/1]; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G00188X/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G106/1173] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [07/37/29] Funding Source: researchfish	This is an independent report jointly funded by the Policy Research Programme in the Department of Health to the Policy Innovation Research Unit (PIRU) at LSHTM, the National Institute for Health Research (Senior Research Fellowship, Dr Richard Grieve, SRF-2013-06-016), and the Medical Research Council (Eearly Career Fellowship in the Economics of Health, Dr Noemi Kreif MR/L012332/1). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health or the Medical Research Council. The authors are grateful to Prof. Kathy Rowan (ICNARC) for data access, Zia Sadique (LSHTM) and Manuel Gomes (LSHTM) for advice on data analysis and to Prof. David Menon (University of Cambridge) and Prof. Martin Smith (UCLH) for clinical advice on the empirical study. We are grateful to Eric Polley for help in using the Super Learner and to Mark van der Laan for helpful comments. We thank seminar participants from the Health, Econometrics and Data Group (University of York) and attendants of the 23rd European Workshop on Econometrics and Health Economics for helpful suggestions.	Austin PC, 2012, MULTIVAR BEHAV RES, V47, P115, DOI 10.1080/00273171.2012.640600; Bia M, 2011, CEPS INSTEAD WORKING; Bia M, 2008, STATA J, V8, P354, DOI 10.1177/1536867X0800800303; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Buuren S., 2011, J STAT SOFTWARE, V45; Diaz I, 2013, J CAUSAL INFERENCE, V1, P171, DOI 10.1515/jci-2012-0005; Dudoit S., 2003, UC BERKELEY DIVISION; Eliseeva E, 2013, APPL MACHINE LEARNIN; Flores CA, 2012, REV ECON STAT, V94, P153, DOI 10.1162/REST_a_00177; Gelman A.E., 2013, ARM DATA ANAL USING; Ghalanos A, 2012, RSOLNP GEN NONLINEAR; Harrison D, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17030; Hastie T., 2013, GAM GEN ADDITIVE MOD; Hirano K., 2004, APPL BAYESIAN MODEL, P73; Imai K, 2004, J AM STAT ASSOC, V99, P854, DOI 10.1198/016214504000001187; Imai K, 2014, J R STAT SOC B, V76, P243, DOI 10.1111/rssb.12027; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Kang JDY, 2007, STAT SCI, V22, P523, DOI 10.1214/07-STS227; Kluve J, 2012, J R STAT SOC A STAT, V175, P587, DOI 10.1111/j.1467-985X.2011.01000.x; Kreif N, 2016, STAT METHODS MED RES, V25, P2315, DOI 10.1177/0962280214521341; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; Neugebauer R, 2014, STAT MED, V33, P2480, DOI 10.1002/sim.6099; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Pirracchio R, 2015, AM J EPIDEMIOL, V181, P108, DOI 10.1093/aje/kwu253; Pirracchio R, 2015, LANCET RESP MED, V3, P42, DOI 10.1016/S2213-2600(14)70239-5; Polley E, 2013, SUPERLEARNER SUPER L; Polley E.C, 2010, UC BERKELEY DIVISION; Porter KE, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1308; R Core Team, 2013, R LANG ENV STAT COMP; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rose S, 2013, AM J EPIDEMIOL, V177, P443, DOI 10.1093/aje/kws241; ROSENBAUM PR, 1987, BIOMETRIKA, V74, P13, DOI 10.2307/2336017; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Rubin DB, 2005, J AM STAT ASSOC, V100, P322, DOI 10.1198/016214504000001880; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; van der Laan MJ, 2010, INT J BIOSTAT, V6, DOI [10.2202/1557-4679.1181, 10.2202/1557-4679.1260]; van dersLaan MJ, 2004, STAT APPL GENETICS M, V3; van dersLaan MJ, 2014, UC BERKELEY DIVISION; van dersLaan MJ, 2011, SPRINGER SER STAT; van dersLaan MJ, 2007, UC BERKELEY DIVISION; Vansteelandt S, 2014, STAT MED, V33, P4053, DOI 10.1002/sim.6207; Wyss R, 2014, AM J EPIDEMIOL, V180, P645, DOI 10.1093/aje/kwu181; Yang S, 2014, 2014 ATL CAUS INF C; Zhu YY, 2015, J CAUSAL INFERENCE, V3, P25, DOI 10.1515/jci-2014-0022	48	15	15	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1057-9230	1099-1050		HEALTH ECON	Health Econ.	SEP	2015	24	9					1213	1228		10.1002/hec.3189			16	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CO3PH	WOS:000359070000012	26059721	Green Published, Other Gold, Green Accepted			2021-06-18	
J	Tang, HL; Hua, F; Wang, J; Yousuf, S; Atif, F; Sayeed, I; Stein, DG				Tang, Huiling; Hua, Fang; Wang, Jun; Yousuf, Seema; Atif, Fahim; Sayeed, Iqbal; Stein, Donald G.			Progesterone and vitamin D combination therapy modulates inflammatory response after traumatic brain injury	BRAIN INJURY			English	Article						Cytokines; frontal cortex; neurosteroids; neuroprotection; toll-like receptors	NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTORS; B SIGNALING PATHWAY; CEREBRAL ISCHEMIA/REPERFUSION; EXPERIMENTAL STROKE; CORTICAL CONTUSION; IMMUNE-RESPONSE; MICE; RAT; ACTIVATION	Objective: Inflammation is an important component of the response to traumatic brain injury (TBI). Progesterone has been shown to inhibit neuroinflammation following (TBI) and may do so through Toll-like receptor (TLR)-mediated pathways. In vitro studies indicate that 1,25-dihydroxyvitamin D(3) (VDH) may also modulate the inflammatory response through the TLR4 pathway. This study tested the hypothesis that PROG and VDH would exert additive and synergistic neuroprotective effects compared with individual treatment by modulating TLR4/NF-kappa B-mediated inflammation pathways after TBI in rats. Research design and methods: Bilateral medial frontal cortical impact injury was induced in young adult Sprague-Dawley rats. Progesterone (i.p., 16 mg kg(-1) body weight) and VDH (1 mu g kg(-1) body weight) were injected separately or combined at 1 and 6 hours after surgery. Rats were killed 24 hours post-surgery and peri-contusional brain tissue harvested for immunostaining and protein measurement. Results: TLR4, phosphorylation of NF-kappa B, neuronal loss and astrocyte activation were significantly reduced with combination treatment after TBI compared to each agent given individually. Conclusions: At 24 hours after TBI, combination therapy shows greater efficacy in reducing neuroinflammation compared to progesterone and VDH given separately, and does so by modulating the TLR4/NF-kappa B signalling pathway.	[Tang, Huiling; Hua, Fang; Wang, Jun; Yousuf, Seema; Atif, Fahim; Sayeed, Iqbal; Stein, Donald G.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA	Stein, DG (corresponding author), Emory Univ, Sch Med, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5 R01 HD61971]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061971] Funding Source: NIH RePORTER	The research reported in the paper was supported by NIH 5 R01 HD61971 and by gifts from BHR Pharma, The Marcus Foundation, and Allen and Company. The authors report no conflicts of interest.	Alfonso-Loeches S, 2013, TOXICOLOGY, V311, P27, DOI 10.1016/j.tox.2013.03.001; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; De Nicola AF, 2013, CNS NEUROL DISORD-DR, V12, P1205; ELLIS E F, 1989, Journal of Neurotrauma, V6, P31, DOI 10.1089/neu.1989.6.31; Espinoza TR, 2011, J HEAD TRAUMA REHAB, V26, P497, DOI 10.1097/HTR.0b013e31823088fa; Foley LM, 2008, J NEUROTRAUM, V25, P299, DOI 10.1089/neu.2007.0471; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kong Y, 2011, INT IMMUNOPHARMACOL, V11, P1407, DOI 10.1016/j.intimp.2011.04.025; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; McIntosh TK, 1996, LAB INVEST, V74, P315; Michaud JP, 2013, P NATL ACAD SCI USA, V110, P1941, DOI 10.1073/pnas.1215165110; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ryu JK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-39; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; SHARMA N, 1994, CELL MOTIL CYTOSKEL, V27, P234, DOI 10.1002/cm.970270305; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Su L, 2009, IMMUNOL LETT, V125, P151, DOI 10.1016/j.imlet.2009.07.003; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Thota C, 2013, REPROD SCI, V20, P463, DOI 10.1177/1933719112459225; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003	55	15	17	1	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1165	1174		10.3109/02699052.2015.1035330			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400004	26083048	Green Accepted			2021-06-18	
J	Khaksari, M; Hajializadeh, Z; Shahrokhi, N; Esmaeili-Mahani, S				Khaksari, Mohammad; Hajializadeh, Zahra; Shahrokhi, Nader; Esmaeili-Mahani, Saeed			Changes in the gene expression of estrogen receptors involved in the protective effect of estrogen in rat's trumatic brain injury	BRAIN RESEARCH			English	Article						Estrogen; Traumatic brain injury; ER alpha; ER beta; Gene expression; Female rats	SEX STEROID-HORMONES; CEREBRAL-CORTEX; ANIMAL-MODELS; ER-BETA; ALPHA; NEUROPROTECTION; ISCHEMIA; LIGAND; 17-BETA-ESTRADIOL; PROGESTERONE	It has been demonstrated that estradiol has neuroprotective effects after traumatic brain injury (TBI) in female rats. Since estrogen receptors have an important role in estradiol effects at the cellular level and the exact mechanism(s) of estradiol-induced neuroprotection has not yet been fully clarified, the present study was designed to determine the changes in the levels of estrogen receptors mRNAs and proteins involved in this phenomenon. All experiments were carried out on female Wistar rats. The brain edema and blood-brain-barrier (BBB) disruption were assessed. The TBI method was diffuse type and induced by the Marmarou method. Semiquantitative RT-PCR and immunoblotting were used to assess ER a and ER beta gene expression. The data showed that the level of brain water content was significantly increased in TBI group. The increased water content was significantly attenuated in estradiol-treated (1 mg/kg) TBI rats. Disruption of BBB after TBI was significantly inhibited just by estradiol treatment. Estrogen-treated animals showed a significant increase in ER alpha mRNA (18%) and protein (35%) levels in the brain tissue. Furthermore, in the brain-injured rats the levels of ER beta mRNA were lower than those in control rats. Following estrogen treatment, the protein levels of ER beta were closed to those in control group. In conclusion, the data demonstrate that estrogen treatment can protect brain against traumatic brain injury. Estrogen treatment increases ER mRNA and protein levels which were coincident with its protective effects. It seems that such phenomenon participates in the induction of neuroprotective effects of estrogen. This article is part of a Special Issue entitled 1618. (C) 2015 Published by Elsevier B.V.	[Khaksari, Mohammad] Kerman Univ Med Sci, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran; [Hajializadeh, Zahra] Kerman Univ Med Sci, Inst Neuropharrnacol, Neurosci Res Ctr, Lab Mol Neurosci, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Esmaeili-Mahani, Saeed] Shahid Bahonar Univ Kerman, Dept Biol, Fac Sci, Kerman, Iran	Khaksari, M (corresponding author), Kerman Univ Med Sci, Inst Neuropharmacol, Physiol Res Ctr, POB 76135-133, Kerman, Iran.	khaksar38@yahoo.co.uk	Shahrokhi, Nader/AAV-3747-2020; Haddad, Mohammad Khaksari/AAB-9025-2019	Shahrokhi, Nader/0000-0002-0149-7819; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Esmaeili Mahani, Saeed/0000-0001-5550-9806	Kerman Neuroscience Research Center [KNRC/88/127]	This work was supported by funds (KNRC/88/127) from Kerman Neuroscience Research Center.	Afrazi S, 2014, J STEROID BIOCHEM, V139, P98, DOI 10.1016/j.jsbmb.2013.10.010; Almey A, 2012, ENDOCRINOLOGY, V153, P5373, DOI 10.1210/en.2012-1458; Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Ausubel FM, 1999, SHORT PROTOCOLS MOL; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Chakraborti A, 2007, REV NEUROSCIENCE, V18, P395; Chang YJ, 2009, HIPPOCAMPUS, V19, P1142, DOI 10.1002/hipo.20581; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Clipperton AE, 2008, NEUROPSYCHOPHARMACOL, V33, P2362, DOI 10.1038/sj.npp.1301625; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.041483198; Esmaeili-Mahani S, 2008, NEUROPEPTIDES, V42, P169, DOI 10.1016/j.npep.2007.12.002; Ezquer ME, 2008, BRAIN RES, V1214, P73, DOI 10.1016/j.brainres.2008.03.029; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Giatti S, 2012, J MOL ENDOCRINOL, V49, pR125, DOI 10.1530/JME-12-0127; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Gottfried-Blackmore A, 2007, BRAIN RES, V1186, P41, DOI 10.1016/j.brainres.2007.10.033; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hamilton KJ, 2014, REPROD BIOL, V14, P3, DOI 10.1016/j.repbio.2013.12.002; Ikeda Y, 2003, ENDOCRINOLOGY, V144, P5098, DOI 10.1210/en.2003-0267; Inagaki T, 2013, STEROIDS, V78, P597, DOI 10.1016/j.steroids.2012.12.015; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI 10.1139/y10-103; Mazzucco CA, 2006, NEUROSCIENCE, V141, P1793, DOI 10.1016/j.neuroscience.2006.05.032; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Raval AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060716; Sampei K, 2000, STROKE, V31, P738, DOI 10.1161/01.STR.31.3.738; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sawada M, 2000, J CEREBR BLOOD F MET, V20, P112, DOI 10.1097/00004647-200001000-00015; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SIMERLY RB, 1991, MOL ENDOCRINOL, V5, P424, DOI 10.1210/mend-5-3-424; Sinkevicius KW, 2008, ENDOCRINOLOGY, V149, P2970, DOI 10.1210/en.2007-1526; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Suzuki S, 2006, ENDOCRINE, V29, P209, DOI 10.1385/ENDO:29:2:209; Thakur MK, 2007, NEUROCHEM INT, V50, P314, DOI 10.1016/j.neuint.2006.08.019; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Wang CF, 2014, REV NEUROSCIENCE, V25, P255, DOI 10.1515/revneuro-2013-0055; Westberry JM, 2008, NEUROSCIENCE, V152, P982, DOI 10.1016/j.neuroscience.2008.01.048	42	15	15	1	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 27	2015	1618						1	8		10.1016/j.brainres.2015.05.017			8	Neurosciences	Neurosciences & Neurology	CP5XB	WOS:000359957600001	26003937	Green Accepted			2021-06-18	
J	Spitz, G; Downing, MG; McKenzie, D; Ponsford, JL				Spitz, Gershon; Downing, Marina G.; McKenzie, Dean; Ponsford, Jennie L.			Mortality following Traumatic Brain Injury Inpatient Rehabilitation	JOURNAL OF NEUROTRAUMA			English	Article						head injury; mortality; traumatic brain injury	LONG-TERM SURVIVAL; HEAD-INJURY; ADULTS; PREVALENCE; DISABILITY; PEOPLE; TRENDS; RATES; RISK; AGE	The aim of this study was to examine the rate and causes of mortality following mild to severe traumatic brain injury (TBI) rehabilitation and to develop a multivariate prognostic model of mortality. We conducted a cohort study of 3341 individuals with mild to severe TBI followed-up from a post-acute inpatient rehabilitation center. Rate of death and survival between one and 26 years following injury were examined using standardized mortality ratios (SMRs) and prognostic models developed using Cox regression. A mortality rate of 9.3% was observed and an overall SMR of 1.04 (95% confidence interval [CI]=1.04-1.05). A statistically significant elevated SMR of 1.20 (95% CI=1.06-1.37) was observed for males, and both males and females had an elevated risk of death from external causes. Females also were found to have a significantly elevated SMR of 5.02 (95% CI=1.36-12.80) for intentional self-harm. Individuals ages 15-44 had a two-fold increase in mortality, compared with the general population. The multivariate Cox model indicated that increased risk of mortality was associated with older age, being male, being unemployed prior to injury, having a history of stroke, alcohol use, mental health issues, and back injury sustained in the accident. Premorbid lifestyle factors exerted a greater influence on mortality following TBI, compared with injury-related factors. This risk was especially prominent for younger individuals, who died primarily due to external causes. These findings highlight the need for interventions that address premorbid issues, such as substance abuse and mental health issues.	[Spitz, Gershon; Downing, Marina G.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [McKenzie, Dean] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Spitz, Gershon; Downing, Marina G.; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKenzie, Dean] Epworth Healthcare, Clin Trials & Res Ctr, Melbourne, Vic, Australia	Spitz, G (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	gershon.spitz@monash.edu	Downing, Marina/AAX-2380-2020; Spitz, Gershon/H-7755-2014	Downing, Marina/0000-0002-3126-6632; Spitz, Gershon/0000-0002-7810-1480	Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research (ISCRR)	This project is funded by the Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research (ISCRR).	Armitage P., 2008, STAT METHODS MED RES; Australian Bureau of Statistics, 1996, DEATHS AUSTR CAT 220; Australian Bureau of Statistics, 2009, DEATHS AUSTR CAT 330; Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns Jr J, EPILEPSIA S10, V44, P2; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Corp. I, 2011, IBM SPSS STAT WIND V; DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kraus J. F., 1999, REHABILITATION ADULT, P3; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McMillan T, BRAIN, V130, P2520; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507	34	15	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1272	1280		10.1089/neu.2014.3814			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400011	25706104				2021-06-18	
J	Barbey, AK; Belli, A; Logan, A; Rubin, R; Zamroziewicz, M; Operskalski, JT				Barbey, Aron K.; Belli, Antonio; Logan, Ann; Rubin, Rachael; Zamroziewicz, Marta; Operskalski, Joachim T.			Network topology and dynamics in traumatic brain injury	CURRENT OPINION IN BEHAVIORAL SCIENCES			English	Article								We propose a network approach to clinical translation that defines core behavioral phenotypes of traumatic brain injury (TBI) with respect to damage to specific intrinsic connectivity networks (ICNs). We survey recent approaches to clinical translation from cognitive neuroscience that enhance network function and recovery from brain injury through interventions that deliver targeted (network specific) and global (systemic) effects. A network approach provides insight into the mechanisms of brain injury, linking ICN characteristics to specific profiles of cognitive impairment, providing key neurobiological targets for therapeutic intervention, and motivating new perspectives about the nature of cognitive recovery and rehabilitation in TBI.	[Barbey, Aron K.; Rubin, Rachael; Zamroziewicz, Marta; Operskalski, Joachim T.] Univ Illinois, Decis Neurosci Lab, Urbana, IL 61801 USA; [Barbey, Aron K.; Rubin, Rachael; Zamroziewicz, Marta; Operskalski, Joachim T.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Barbey, Aron K.] Univ Illinois, Dept Internal Med, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Inst Genom Biol, Champaign, IL 61820 USA; [Belli, Antonio; Logan, Ann] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Rubin, Rachael] Carle Fdn Hosp, Carle Neurosci Inst, Urbana, IL USA	Barbey, AK (corresponding author), Univ Illinois, Decis Neurosci Lab, Urbana, IL 61801 USA.	barbey@illinois.edu	Belli, Antonio/I-3799-2015; Barbey, Aron/L-7312-2015	Belli, Antonio/0000-0002-3211-9933; Logan, Ann/0000-0003-3215-5042; Barbey, Aron/0000-0002-6092-0912	Birmingham-Illinois Partnership Discovery, Engagement and Education (BRIDGE) Program	This work was supported by funding from the Birmingham-Illinois Partnership Discovery, Engagement and Education (BRIDGE) Program.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Antal A, 2004, EUR J NEUROSCI, V19, P2888, DOI 10.1111/j.1460-9568.2004.03367.x; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Barbey AK, 2014, BRAIN; Barbey AK, 2014, BRAIN, V137, P2823, DOI 10.1093/brain/awu207; Barbey AK, 2014, BRAIN STRUCT FUNCT, V219, P485, DOI 10.1007/s00429-013-0512-z; Barbey AK, 2014, BRAIN, V137, P277, DOI 10.1093/brain/awt312; Barbey AK, 2014, SOC COGN AFFECT NEUR, V9, P265, DOI 10.1093/scan/nss124; Barbey AK, 2013, NEUROIMAGE, V82, P547, DOI 10.1016/j.neuroimage.2013.05.087; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barbey AK, 2013, NEUROPSYCHOLOGIA, V51, P1361, DOI 10.1016/j.neuropsychologia.2012.05.017; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Barbey AK, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00162; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Barbey AK, 2009, PHILOS T R SOC B, V364, P1291, DOI 10.1098/rstb.2008.0315; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004959; Braver T S, 1999, Prog Brain Res, V121, P327; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burzynska AZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107413; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Chaddock L., 2012, KINESIOL REV, V1, P37, DOI DOI 10.1123/krj.1.1.37; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chaddock-Heyman L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00584; Chaddock-Heyman L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00072; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Coffman BA, 2012, NEUROPSYCHOLOGIA, V50, P1594, DOI 10.1016/j.neuropsychologia.2012.03.012; Coffman BA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-108; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Datta A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036018; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Ditye T, 2012, EXP BRAIN RES, V219, P363, DOI 10.1007/s00221-012-3098-4; Dmochowski JP, 2013, NEUROIMAGE, V75, P12, DOI 10.1016/j.neuroimage.2013.02.049; Dmochowski JP, 2012, IEEE ENG MED BIO, P6426, DOI 10.1109/EMBC.2012.6347465; Dmochowski JP, 2012, PHYS MED BIOL, V57, P6459, DOI 10.1088/0031-9155/57/20/6459; Dmochowski JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046011; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hellyer PJ, 2014, J NEUROSCI, V34, P451, DOI 10.1523/JNEUROSCI.1853-13.2014; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Hillman CH, 2006, INT J PSYCHOPHYSIOL, V59, P30, DOI 10.1016/j.ijpsycho.2005.04.009; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Kamijo K, 2010, PSYCHOPHYSIOLOGY, V47, P814, DOI 10.1111/j.1469-8986.2010.00992.x; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Leocani L, 2006, NEUROL SCI, V27, pS27, DOI 10.1007/s10072-006-0542-x; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2015, J NEUROTRAUMA; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monti JM, 2012, HIPPOCAMPUS, V22, P1876, DOI 10.1002/hipo.22023; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Pontifex MB, 2009, PSYCHOPHYSIOLOGY, V46, P379, DOI 10.1111/j.1469-8986.2008.00782.x; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Simmons WK, 2013, HUM BRAIN MAPP, V34, P2944, DOI 10.1002/hbm.22113; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Themanson JR, 2008, NEUROSCIENCE, V157, P319, DOI 10.1016/j.neuroscience.2008.09.014; Themanson JR, 2006, NEUROBIOL AGING, V27, P1335, DOI 10.1016/j.neurobiolaging.2005.07.002; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Voss MW, 2011, NEUROSCIENCE, V199, P166, DOI 10.1016/j.neuroscience.2011.10.009; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Warren DE, 2014, P NATL ACAD SCI USA, V111, P14247, DOI 10.1073/pnas.1322173111; Weinstein AM, 2012, BRAIN BEHAV IMMUN, V26, P811, DOI 10.1016/j.bbi.2011.11.008; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	118	15	15	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2352-1546	2352-1554		CURR OPIN BEHAV SCI	Curr. Opin. Behav. Sci.	AUG	2015	4						92	102		10.1016/j.cobeha.2015.04.002			11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	V3O5R	WOS:000218444200013					2021-06-18	
J	Beaulieu, CL; Dijkers, MP; Barrett, RS; Horn, SD; Giuffrida, CG; Timpson, ML; Carroll, DM; Smout, RJ; Hammond, FM				Beaulieu, Cynthia L.; Dijkers, Marcel. P.; Barrett, Ryan S.; Horn, Susan D.; Giuffrida, Clare G.; Timpson, Misti L.; Carroll, Deborah M.; Smout, Randy J.; Hammond, Flora M.			Occupational, Physical, and Speech Therapy Treatment Activities During Inpatient Rehabilitation for Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Occupational therapy; Physical therapy specialty; Rehabilitation; Speech therapy; Therapeutics	TREATMENT TIME; GALVESTON ORIENTATION; STROKE REHABILITATION; SCIREHAB; OUTCOMES; INTENSITY; DESIGN; KNEE	Objective: To describe the use of occupational therapy (OT), physical therapy (PT), and speech therapy (ST) treatment activities throughout the acute rehabilitation stay of patients with traumatic brain injury. Design: Multisite prospective observational cohort study. Setting: Inpatient rehabilitation settings. Participants: Patients (N=2130) admitted for initial acute rehabilitation after traumatic brain injury. Patients were categorized on the basis of admission FIM cognitive scores, resulting in 5 fairly homogeneous cognitive groups. Interventions: Not applicable. Main Outcome Measures: Percentage of patients engaged in specific activities and mean time patients engaged in these activities for each 10-hour block of time for OT, PT, and ST combined. Results: Therapy activities in OT, PT, and ST across all 5 cognitive groups had a primary focus on basic activities. Although advanced activities occurred in each discipline and within each cognitive group, these advanced activities occurred with fewer patients and usually only toward the end of the rehabilitation stay. Conclusions: The pattern of activities engaged in was both similar to and different from patterns seen in previous practice-based evidence studies with different rehabilitation diagnostic groups. (C) 2015 by the American Congress of Rehabilitation Medicine	[Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL 32216 USA; [Dijkers, Marcel. P.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Barrett, Ryan S.; Horn, Susan D.; Smout, Randy J.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Giuffrida, Clare G.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Timpson, Misti L.; Carroll, Deborah M.] Intermt Med Ctr, Salt Lake City, UT USA; [Timpson, Misti L.] Rocky Mt Univ Hlth Profess, Provo, UT USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Beaulieu, CL (corresponding author), Brooks Rehabil Hosp, 3599 Univ Blvd South, Jacksonville, FL 32216 USA.	cynthia.beaulieu@brooksrehab.org			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine	Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; Brougham R, 2011, J SPINAL CORD MED, V34, P186, DOI 10.1179/107902611X12971826988174; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; Dijkers MP, 2013, ARCH PHYS MED REHAB, V94, pS61, DOI 10.1016/j.apmr.2012.11.048; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Eng Janice J, 2007, Expert Rev Neurother, V7, P1417, DOI 10.1586/14737175.7.10.1417; Foy T, 2011, J SPINAL CORD MED, V34, P162, DOI 10.1179/107902611X12971826988093; Hatfield B, 2005, ARCH PHYS MED REHAB, V86, pS61, DOI 10.1016/j.apmr.2005.08.111; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2007, MED CARE, V45, pS50, DOI 10.1097/MLR.0b013e318070c07b; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2012, ARCH PHYS MED REHAB, V93, pS127, DOI 10.1016/j.apmr.2011.10.031; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Karges J, 2009, J ALLIED HLTH, V38, P1; Latham NK, 2005, ARCH PHYS MED REHAB, V86, pS41, DOI 10.1016/j.apmr.2005.08.128; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mallinson T, 2011, RASCH MEAS T, V251, P1317; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Richards LG, 2005, ARCH PHYS MED REHAB, V86, pS51, DOI 10.1016/j.apmr.2005.08.127; Taylor-Schroeder S, 2011, J SPINAL CORD MED, V34, P149, DOI 10.1179/107902611X12971826988057; The Moran Company, 2011, UT TRENDS INP REH UP; Whiteneck GG, 2013, ARCH PHYS MED REHAB, V94, pS67, DOI 10.1016/j.apmr.2012.12.022	26	15	15	0	34	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S222	S234		10.1016/j.apmr.2014.10.028			13	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100005	26212399	Green Accepted			2021-06-18	
J	Brenner, LA; Bahraini, N; Homaifar, BY; Monteith, LL; Nagamoto, H; Dorsey-Holliman, B; Forster, JE				Brenner, Lisa A.; Bahraini, Nazanin; Homaifar, Beeta Y.; Monteith, Lindsey L.; Nagamoto, Herbert; Dorsey-Holliman, Brooke; Forster, Jeri E.			Executive Functioning and Suicidal Behavior Among Veterans With and Without a History of Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation; Suicide; Veterans	GAMBLING TASK-PERFORMANCE; PREFRONTAL CORTEX; ATTEMPTERS; IDEATION; SCALE; RELIABILITY; IMPULSIVITY; DYSFUNCTION; POPULATION; PREVALENCE	Objective: To examine the relationship between executive dysfunction, as a multidimensional construct (ie, decision-making, impulsivity, aggression, concept formation), and suicide attempt (SA) history in a high-risk sample of veterans with moderate to severe traumatic brain injury (TBI). Design: Observational, 2 x 2 factorial design. To estimate group differences, linear regression was used to model the primary and secondary outcomes of interest as a function of history of SA, TBI, and the interaction between the 2 variables. Additionally, to determine the pattern of performance over the course of the Iowa Gambling Test (IGT), scores were modeled across the 5 IGT blocks by using a varying-coefficient model. Setting: Veterans Health Administration. Participants: Veterans (N=133; no SA/no TBI, n=48; no SA/yes TBI, n=51; yes SA/no TBI, n=12; yes SA/yes TBI, n=22) completed the study measures. Interventions: Not applicable. Main Outcome Measures: IGT, Immediate and Delayed Memory Test, State-Trait Anger Expression Inventory-2, Wisconsin Card Sorting Test. Results: All groups demonstrated learning over the course of the IGT, except for veterans with a history of both SA and TBI. No group differences were identified on other measures of executive functioning. Conclusions: These findings highlight the potential, unique decision-making challenges faced by veterans with a history of TBI and SA. Specialized interventions focused on overall distress reduction and means restriction may be required to prevent future self-directed violence. (C) 2015 by the American Congress of Rehabilitation Medicine	[Brenner, Lisa A.; Bahraini, Nazanin; Homaifar, Beeta Y.; Monteith, Lindsey L.; Dorsey-Holliman, Brooke; Forster, Jeri E.] Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, Denver, CO USA; [Brenner, Lisa A.; Bahraini, Nazanin; Homaifar, Beeta Y.; Monteith, Lindsey L.; Nagamoto, Herbert] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.; Bahraini, Nazanin; Homaifar, Beeta Y.; Forster, Jeri E.] Univ Colorado Denver, Dept Phys Med & Rehabil, Aurora, CO USA; [Nagamoto, Herbert] Eastern Colorado Hlth Care Syst, Vet Hlth Adm, Denver, CO 80220 USA	Brenner, LA (corresponding author), Eastern Colorado Hlth Care Syst, Rocky Mt MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019; Monteith, Lindsey L./X-3658-2019	Monteith, Lindsey L./0000-0002-8104-5280	Veterans Health Administration Rehabilitation Research and Development Merit Review [D7210R]; Rocky Mountain Mental Illness Research, Education, and Clinical Center	Supported by the Veterans Health Administration Rehabilitation Research and Development Merit Review (grant no. D7210R) and the Rocky Mountain Mental Illness Research, Education, and Clinical Center. The views, opinions and/or findings contained in this article are those of the author(s) and should not be construed as an official Department of Defense or Veterans Affairs position, policy, or decision unless so designated by other documentation.	Allen LM, 2004, CARB COMPUTERIZED AS; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Barnes SM, 2015, J HEALTH CARE POOR U, V26, P92, DOI 10.1353/hpu.2015.0010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; Blair RJR, 2008, PHILOS T R SOC B, V363, P2557, DOI 10.1098/rstb.2008.0027; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Brenner LA, 2011, J CLIN PSYCHOL MED S, V18, P116, DOI 10.1007/s10880-011-9240-9; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dougherty DM, 2004, SUICIDE LIFE-THREAT, V34, P374, DOI 10.1521/suli.34.4.374.53738; Dougherty DM, 2002, BEHAV RES METH INS C, V34, P391, DOI 10.3758/BF03195467; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Gorlyn M, 2013, PSYCHIAT RES, V207, P150, DOI 10.1016/j.psychres.2013.01.030; Heaton R., 1993, WISCONSIN CARD SORTI; Homaifar BY, 2012, REHABIL PSYCHOL, V57, P337, DOI 10.1037/a0030480; Jollant F, 2005, AM J PSYCHIAT, V162, P304, DOI 10.1176/appi.ajp.162.2.304; Jollant F, 2011, WORLD J BIOL PSYCHIA, V12, P319, DOI 10.3109/15622975.2011.556200; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; Keilp JG, 2001, AM J PSYCHIAT, V158, P735, DOI 10.1176/appi.ajp.158.5.735; Keilp JG, 2014, PSYCHIAT RES, V219, P129, DOI 10.1016/j.psychres.2014.04.050; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lambert MJ., 1996, ADM SCORING MANUAL O; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Linehan MM, 2006, PSYCHOL ASSESSMENT, V18, P303, DOI 10.1037/1040-3590.18.3.303; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Spielberger C.D., 1999, STATE TRAIT ANGER EX; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; U. S. Department of Veterans Affairs, 2009, CLIN PRACT GUID MAN; Wortzel HS, 2014, J PSYCHIATR PRACT, V20, P63, DOI 10.1097/01.pra.0000442940.46328.63; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	37	15	15	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8					1411	1418		10.1016/j.apmr.2015.04.010			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO3CU	WOS:000359035000006	25933916				2021-06-18	
J	Dismuke, CE; Gebregziabher, M; Yeager, D; Egede, LE				Dismuke, Clara E.; Gebregziabher, Mulugeta; Yeager, Derik; Egede, Leonard E.			Racial/Ethnic Differences in Combat- and Non-Combat-Associated Traumatic Brain Injury Severity in the Veterans Health Administration: 2004-2010	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							FUNCTIONAL OUTCOMES; ETHNIC DISPARITIES; MILITARY SERVICE; REHABILITATION; IRAQ; DISORDERS; RISK	Objectives. We examined the association between traumatic brain injury (TBI) severity and combat exposure by race/ethnicity. Methods. We estimated logit models of the fully adjusted association of combat exposure with TBI severity in separate race/ethnicity models for a national cohort of 132 995 veterans with TBI between 2004 and 2010. Results. Of veterans with TBI, 25.8% had served in a combat zone. Mild TBI increased from 11.5% to 40.3%, whereas moderate or severe TBI decreased from 88.5% to 59.7%. Moderate or severe TBI was higher in non-Hispanic Blacks (80.0%) and Hispanics (89.4%) than in non-Hispanic Whites (71.9%). In the fully adjusted all-race/ethnicity model, non-Hispanic Blacks (1.44; 95% confidence interval [CI] = 1.37, 1.52) and Hispanics (1.47; 95% CI = 1.26, 1.72) had higher odds of moderate or severe TBI than did non-Hispanic Whites. However, combat exposure was associated with higher odds of mild TBI in non-Hispanic Blacks (2.48; 95% CI = 2.22, 2.76) and Hispanics (3.42; 95% CI = 1.84, 6.35) than in non-Hispanic Whites (2.17; 95% CI = 2.09, 2.26). Conclusions. Research is needed to understand racial differences in the effect of combat exposure on mild TBI and on interventions to prevent TBI across severity levels.	[Dismuke, Clara E.; Gebregziabher, Mulugeta; Yeager, Derik; Egede, Leonard E.] Ralph H Johnson Vet Affairs Med Ctr, Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC USA; [Dismuke, Clara E.; Egede, Leonard E.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA; [Dismuke, Clara E.; Egede, Leonard E.] Med Univ S Carolina, Div Gen Internal Med & Geriatr, Charleston, SC 29425 USA; [Gebregziabher, Mulugeta] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA	Egede, LE (corresponding author), Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280H,POB 250593, Charleston, SC 29425 USA.	egedel@musc.edu		Gebregziabher, Mulugeta/0000-0002-4826-481X			Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Catalano D, 2007, NEUROREHABILITATION, V22, P157; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Defense and Veterans Brain Injury Center, DEP DEF ICD 9 COD GU; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gebregziabher M, 2012, J BIOMET BIOSTAT, V3, P1; Gebregziabher M, 2010, J STAT PLAN INFER, V140, P3252, DOI 10.1016/j.jspi.2010.04.020; Gifford B, 2005, ARMED FORCES SOC, V31, P201, DOI 10.1177/0095327X0503100203; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacLean A, 2011, SOC SCI RES, V40, P336, DOI 10.1016/j.ssresearch.2010.04.006; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Schafer JL., 1997, ANAL INCOMPLETE MULT; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; VA Information Resource Center, 2006, VIREC RES US GUID FY; World Health Organization, 1980, INT CLASS DIS	27	15	15	0	2	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	AUG	2015	105	8					1696	1702		10.2105/AJPH.2014.302545			7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CT6VL	WOS:000362950400059	26066928	Green Published			2021-06-18	
J	Ilie, G; Mann, RE; Ialomiteanu, A; Adlaf, EM; Hamilton, H; Wickens, CM; Asbridge, M; Rehm, J; Cusimano, MD				Ilie, Gabriela; Mann, Robert E.; Ialomiteanu, Anca; Adlaf, Edward M.; Hamilton, Hayley; Wickens, Christine M.; Asbridge, Mark; Rehm, Juergen; Cusimano, Michael D.			Traumatic brain injury, driver aggression and motor vehicle collisions in Canadian adults	ACCIDENT ANALYSIS AND PREVENTION			English	Article; Proceedings Paper	2nd International Conference on Transportation Information and Safety (ICTIS)	JUN 29-JUL 02, 2013	Wuhan, PEOPLES R CHINA			Traumatic brain injury; Concussions; Driver aggression; Adults; Motor vehicle collision	ILLICIT DRUG-USE; SELF-REPORTED COLLISIONS; ROAD RAGE; REPRESENTATIVE SAMPLE; CANNABIS USE; ALCOHOL-USE; POPULATION; PREVALENCE; IMPACT; PERFORMANCE	Objective: This study examines the associations between lifetime traumatic brain injury (TBI), driver aggression, and motor vehicle collisions among a population sample of adults who reside in the province of Ontario, Canada. Method: A cross-sectional sample of 3993 Ontario adults, aged 18-97 were surveyed by telephone in 2011 and 2012 as part of Center for Addiction and Mental Health's ongoing representative survey of adult mental health and substance use in Canada. TBI was defined as trauma to the head that resulted in loss of consciousness for at least five minutes or overnight hospitalization. Results: An estimated 91% (95% CI: 90.0, 91.9) of individuals in this sample held a valid Ontario driver's license at the time of testing. Among those, 16.7% reported a history of lifetime TB! and 83.3% reported no 'FBI. The prevalence of TBI was higher among men than women. Relative to licensed adults without 'FBI, adults with a history of TBI had significantly higher odds of engaging in serious driver aggression in the past 12 months, such as making threats to hurt another driver, passenger or their vehicle (AOR=4.39). These individuals also reported significantly higher odds (AOR=1.74) of being involved in a motor vehicle collision that resulted in hurting themselves, their passenger(s) or their vehicle. Conclusion: This is the first population-based study to demonstrate a relationship between a history of TBI and higher rates of serious driver aggression and collision involvement. Given the large proportion of adult drivers with a history of 'FBI, these individuals may account for a disproportion burden of all traffic safety problems. Whether the increased road safety risk of adults with a history of TBI is reflective of neurocognitive deficits or is merely evidence of a cluster of unsafe activities produced by a higher risk lifestyles requires further research attention. (C) 2015 Elsevier Ltd. All rights reserved.	[Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Mann, Robert E.; Ialomiteanu, Anca; Adlaf, Edward M.; Hamilton, Hayley; Wickens, Christine M.; Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res, Toronto, ON M5S 2S1, Canada; [Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Wickens, Christine M.; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS B3H 4R2, Canada	Ilie, G (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Wickens, Christine M./Q-2014-2017; Cusimano, Michael/X-4059-2019; Ilie, Gabriela/AAM-9122-2021	Wickens, Christine M./0000-0002-9865-850X; Cusimano, Michael/0000-0002-9989-0650	STAIR Team Grant from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR103946]; Ontario Neurotrauma Foundation; AUTO21; Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada; Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario	This work was financially supported by a STAIR Team Grant (TIR103946) from the Canadian Institutes of Health Research, by the Ontario Neurotrauma Foundation, and by AUTO21, a member of the Networks of Centres of Excellence program that is administered and funded by the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council, in partnership with Industry Canada. RM, AI, HH, CW and JR also acknowledge funding support from the Ontario Ministry of Health and Long Term Care. The funding agencies had no role in design and conduct of the study, the collection, management, analysis and interpretation of the data, or the preparation, review or approval of the manuscript.	Aday L.A., 1995, DESIGNING CONDUCTING; Adlaf E. M., 2013, CAMH MONITOR 2012 ME; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Asbridge Mark, 2003, Violence Vict, V18, P517, DOI 10.1891/vivi.2003.18.5.517; Asbridge M, 2014, INT J PUBLIC HEALTH, V59, P395, DOI 10.1007/s00038-013-0512-z; Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Borkenstein R.F., 1964, ROLE DRINKING DRIVER; Boufous S, 2010, INJURY PREV, V16, P275, DOI 10.1136/ip.2009.024877; Butters JE, 2006, CAN J PUBLIC HEALTH, V97, P96, DOI 10.1007/BF03405323; Butters JE, 2005, DRUG ALCOHOL DEPEN, V80, P169, DOI 10.1016/j.drugalcdep.2005.03.018; Callaghan RC, 2013, ACCIDENT ANAL PREV, V53, P149, DOI 10.1016/j.aap.2013.01.008; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centre for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US 2; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Deffenbacher JL, 2003, BEHAV RES THER, V41, P701, DOI 10.1016/S0005-7967(02)00046-3; Deffenbacher JL, 2001, PERS INDIV DIFFER, V31, P1321, DOI 10.1016/S0191-8869(00)00226-9; Eby DW, 2010, JAMA-J AM MED ASSOC, V303, P1642, DOI 10.1001/jama.2010.495; Ellis L., 2009, HDB CRIME CORRELATES; Fierro I, 2011, J STUD ALCOHOL DRUGS, V72, P185, DOI 10.15288/jsad.2011.72.185; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fong G, 2001, SOC PSYCH PSYCH EPID, V36, P277, DOI 10.1007/s001270170045; Galovski T, 2002, BEHAV RES THER, V40, P1157, DOI 10.1016/S0005-7967(01)00083-3; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Hemenway D, 2006, ACCIDENT ANAL PREV, V38, P687, DOI 10.1016/j.aap.2005.12.014; Hennessy Dwight A, 2004, Violence Vict, V19, P469, DOI 10.1891/088667004780927909; Ialomiteanu A. R., 2011, CAMH RES DOCUMENT SE, V35; Ilie G., 2015, J HEAD TRAU IN PRESS; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Joint M., 1995, AGGRESSIVE DRIVING 3; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Li MC, 2012, EPIDEMIOL REV, V34, P65, DOI 10.1093/epirev/mxr017; Mann RE, 2004, J STUD ALCOHOL, V65, P161, DOI 10.15288/jsa.2004.65.161; Mann RE, 2007, J SAFETY RES, V38, P669, DOI 10.1016/j.jsr.2007.09.004; Mann RE, 2007, AM J HEALTH BEHAV, V31, P384, DOI 10.5993/AJHB.31.4.5; Mann RE, 2010, TRAFFIC INJ PREV, V11, P115, DOI 10.1080/15389580903536704; Mann RE, 2010, STRESS HEALTH, V26, P127, DOI 10.1002/smi.1274; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Peden M., 2004, WORLD REPORT ROAD TR; PIDIKITI RD, 1991, ARCH PHYS MED REHAB, V72, P109; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sagar R, 2013, INT J SOC PSYCHIATR, V59, P407, DOI 10.1177/0020764011431547; Sansone RA, 2010, INT J PSYCHIAT MED, V40, P21, DOI 10.2190/PM.40.1.b; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; Smart Reginald, 2004, Traffic Inj Prev, V5, P343, DOI 10.1080/15389580490509482; Smart RG, 2003, CAN J PUBLIC HEALTH, V94, P247, DOI 10.1007/BF03403543; SMART RG, 2002, TRAFFIC INJ PREV, V3, P183; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; TURNER CF, 1992, SURVEY MEASUREMENT D; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wells-Parker E, 2002, ACCIDENT ANAL PREV, V34, P271, DOI 10.1016/S0001-4575(01)00021-5; Wickens CM, 2013, J AFFECT DISORDERS, V145, P253, DOI 10.1016/j.jad.2012.04.046; Wickens CM, 2012, ACCIDENT ANAL PREV, V45, P10, DOI 10.1016/j.aap.2011.11.013; Wickens CM, 2011, TRANSPORT RES F-TRAF, V14, P400, DOI 10.1016/j.trf.2011.04.007; Yu J, 2004, J CRIM JUST, V32, P421, DOI 10.1016/j.jcrimjus.2004.06.004	65	15	15	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	AUG	2015	81						1	7		10.1016/j.aap.2015.04.021			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CM2YR	WOS:000357548800001	25935425				2021-06-18	
J	Ioachimescu, AG; Hampstead, BM; Moore, A; Burgess, E; Phillips, LS				Ioachimescu, Adriana G.; Hampstead, Benjamin M.; Moore, Anna; Burgess, Elizabeth; Phillips, Lawrence S.			Growth hormone deficiency after mild combat-related traumatic brain injury	PITUITARY			English	Article						Growth hormone deficiency; Traumatic brain injury; Hypopituitarism	QUALITY-OF-LIFE; PITUITARY DYSFUNCTION; CONSENSUS GUIDELINES; REPLACEMENT THERAPY; GH DEFICIENCY; HYPOPITUITARISM; PREVALENCE; ADULTS; GLUCAGON; SECRETION	Traumatic brain injury (TBI) has been recognized as a cause of growth hormone deficiency (GHD) in civilians. However, comparable data are sparse in veterans who incurred TBI during combat. Our objective was to determine the prevalence of GHD in veterans with a history of combat-related TBI, and its association with cognitive and psychosocial dysfunction. Single center prospective study. Twenty male veterans with mild TBI incurred during combat 8-72 months prior to enrollment. GHD was defined by a GH peak < 3 mu g/L during glucagon stimulation test. Differences in neuropsychological, emotional, and quality of life of the GHD Veterans were described using Cohen's d. Large effect sizes were considered meaningful. Mean age was 33.7 years (SD 7.8) and all subjects had normal thyroid hormone and cortisol levels. Five (25 %) exhibited a subnormal response to glucagon. Sixteen participants (80 %) provided sufficient effort for valid neuropsychological assessment (12 GH-sufficient, 4 GHD). There were large effect size differences in self-monitoring during memory testing (d = 1.46) and inhibitory control (d = 0.92), with worse performances in the GHD group. While fatigue and post-traumatic stress disorder were comparable, the GHD group reported more depression (d = 0.80) and lower quality of life (d = 0.64). Our study found a 25 % prevalence of GHD in veterans with mild TBI as shown by glucagon stimulation. The neuropsychological findings raise the possibility that GHD has adverse effects on executive abilities and mood. Further studies are needed to determine whether GH replacement is an effective treatment in these patients.	[Ioachimescu, Adriana G.; Hampstead, Benjamin M.; Moore, Anna; Burgess, Elizabeth; Phillips, Lawrence S.] Emory Univ, Emory Clin, Atlanta Veteran Affairs Med Ctr, Atlanta, GA 30322 USA; [Ioachimescu, Adriana G.; Burgess, Elizabeth; Phillips, Lawrence S.] Emory Univ, Dept Med, Div Endocrinol, Atlanta, GA 30322 USA; [Ioachimescu, Adriana G.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Hampstead, Benjamin M.; Moore, Anna] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA	Ioachimescu, AG (corresponding author), Emory Univ, Emory Clin, Atlanta Veteran Affairs Med Ctr, 1365 B Clifton Rd, Atlanta, GA 30322 USA.	aioachi@emory.edu	Ioachimescu, Adriana/V-8070-2019		Novo Nordisk Inc.Novo Nordisk; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK066204, UL1 RR025008]; VA award [HSRD IIR 07-138]; Cystic Fibrosis Foundation [PHILLI12A0]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R21DK099716, R18DK066204] Funding Source: NIH RePORTER	The study was funded by an Investigator Initiated Study grant from Novo Nordisk Inc. During this study, LSP was also supported by NIH awards DK066204 and UL1 RR025008, VA award HSR&D IIR 07-138, and a Cystic Fibrosis Foundation award PHILLI12A0. The funding sources played no role in the design and conduct of the study, analysis and interpretation of the data, and preparation of the manuscript. We thank Mari Hart, RN, MSN and Gordana Pajkovic, CRC (research staff). The contents of this manuscript do not represent the views of the Department of Veterans Affairs or the United States Government. Portions of this work were presented at the annual meeting of the Endocrine Society that took place in Houston, TX in June 2012.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conceicao FL, 2003, GROWTH HORM IGF RES, V13, P347, DOI 10.1016/S1096-6374(03)00124-2; de Kloet CS, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.16206; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Hoge CW, 2008, AM J EPIDEMIOL, V168, P1095, DOI 10.1093/aje/kwn261; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Koltowska-Haggstrom M, 2005, HORM RES, V64, P46, DOI 10.1159/000087444; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Munoz A, 2013, CURR OPIN ENDOCRINOL, V20, P354, DOI 10.1097/MED.0b013e32836318ba; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P169, DOI 10.1080/00981380802533322; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Toogood A, 2012, ENDOCR PRACT, V18, P325, DOI 10.4158/EP11146.OR; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; VA/DoD, 2009, J REHABIL RES DEV, V46, pCP1; van Liempt S, 2011, PSYCHONEUROENDOCRINO, V36, P1361, DOI 10.1016/j.psyneuen.2011.03.009; Wilkinson Charles W, 2012, Front Neurol, V3, P11, DOI 10.3389/fneur.2012.00011; Yuen KCJ, 2013, PITUITARY, V16, P220, DOI 10.1007/s11102-012-0407-7	35	15	15	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	AUG	2015	18	4					535	541		10.1007/s11102-014-0606-5			7	Endocrinology & Metabolism	Endocrinology & Metabolism	CL3BQ	WOS:000356824300014	25266761				2021-06-18	
J	Kostering, L; Schmidt, CSM; Egger, K; Amtage, F; Peter, J; Kloppel, S; Beume, LA; Hoeren, M; Weiller, C; Kaller, CP				Koestering, Lena; Schmidt, Charlotte S. M.; Egger, Karl; Amtage, Florian; Peter, Jessica; Kloeppel, Stefan; Beume, Lena-A.; Hoeren, Markus; Weiller, Cornelius; Kaller, Christoph P.			Assessment of planning performance in clinical samples: Reliability,and validity of the Tower of London task (TOL-F)	NEUROPSYCHOLOGIA			English	Article						Executive function; Neuropsychological tests; Psychometrics; Stroke; Parkinson disease; Mild cognitive impairment	MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; EXECUTIVE FUNCTION DEFICITS; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; FUNCTIONAL STATUS; OLDER-ADULTS; DYSEXECUTIVE SYNDROME; ALZHEIMERS-DISEASE; LOWER BOUNDS	Objective: Executive deficits are frequent sequelae of neurological and psychiatric disorders, but their adequate neuropsychological assessment is still a matter of contention, given that executive tasks draw on a multitude of cognitive processes that are often not sufficiently specified. In line with this, results on psychometric properties of the Tower of London, a task measuring planning ability as a prototypical executive function, are equivocal and furthermore lacking completely for adult clinical populations. Methods: We used a structurally balanced item set implemented in the Tower of London (Freiburg version, TOL-F) that accounts for major determinants of problem difficulty beyond the commonly used minimum number of moves to solution. Split-half reliability, internal consistency, and criterion-related concurrent validity of TOL-F accuracy were assessed in patients with stroke (N=60), Parkinson syndrome (N=51), and mild cognitive impairment (N=29), and healthy adults (N=155). Results: Across samples, mean split-half and lower-bound indices of reliability of accuracy scores were adequate (r >=.7) or higher. Compared to a subset of healthy controls matched for age, sex, and education levels, deficits in planning accuracy emerged for all three clinical samples. Conclusions: Based on consistently adequate reliability and a good criterion-related validity of accuracy scores, the TOL-F demonstrates its utility for testing planning ability in clinical samples and healthy adults. Using item sets systematically accounting for several determinants of task difficulty can thus significantly enhance the contended reliability of executive tasks and provide an opportunity to resolve the underspecification of cognitive processes contributing to executive functioning in health and disease. (C) 2015 Elsevier Ltd. All rights reserved.	[Koestering, Lena; Schmidt, Charlotte S. M.; Amtage, Florian; Kloeppel, Stefan; Beume, Lena-A.; Hoeren, Markus; Weiller, Cornelius; Kaller, Christoph P.] Univ Freiburg, Dept Neurol, Univ Med Ctr, D-79106 Freiburg, Germany; [Koestering, Lena; Schmidt, Charlotte S. M.; Egger, Karl; Amtage, Florian; Peter, Jessica; Kloeppel, Stefan; Beume, Lena-A.; Hoeren, Markus; Weiller, Cornelius; Kaller, Christoph P.] Univ Freiburg, Freiburg Brain Imaging, D-79106 Freiburg, Germany; [Koestering, Lena; Schmidt, Charlotte S. M.] Univ Freiburg, Dept Psychol, Biol & Personal Psychol, D-79106 Freiburg, Germany; [Koestering, Lena; Schmidt, Charlotte S. M.; Beume, Lena-A.; Hoeren, Markus; Weiller, Cornelius; Kaller, Christoph P.] Univ Freiburg, BrainLinks BrainTools Cluster Excellence, D-79106 Freiburg, Germany; [Egger, Karl] Univ Freiburg, Univ Med Ctr, Dept Neuroradiol, D-79106 Freiburg, Germany; [Peter, Jessica; Kloeppel, Stefan] Univ Freiburg, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-79106 Freiburg, Germany	Kostering, L (corresponding author), Univ Freiburg, Dept Neurol, Univ Med Ctr, Breisacher Str 64, D-79106 Freiburg, Germany.	lena.koestering@uniklinik-freiburg.de		Schumacher, Lena/0000-0003-3785-9866; Kaller, Christoph/0000-0003-1206-889X; Peter, Jessica/0000-0002-0817-8431; Kloppel, Stefan/0000-0001-6452-9964	Brain-Links Brain-Tools Cluster of Excellence - German Research Foundation (DFG)German Research Foundation (DFG) [EXC 1086]; Wissenschaftliche Gesellschaft Freiburg im Breisgau; State Graduate Funding Program of Baden-Wurttemberg, Germany	This work was supported by the Brain-Links Brain-Tools Cluster of Excellence funded by the German Research Foundation (DFG; Grant no. EXC 1086) and the Wissenschaftliche Gesellschaft Freiburg im Breisgau. L.K. is supported by a PhD scholarship from the State Graduate Funding Program of Baden-Wurttemberg, Germany.	Andrews G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01032; Beck AT., 1996, BECK DEPRESSION INVE, V2; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; BENTLER PM, 1980, PSYCHOMETRIKA, V45, P249, DOI 10.1007/BF02294079; Berg WK, 2010, BRAIN COGNITION, V72, P472, DOI 10.1016/j.bandc.2010.01.002; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; Biederman J, 2006, AM J PSYCHIAT, V163, P1730, DOI 10.1176/appi.ajp.163.10.1730; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Brookes RL, 2014, NEUROPSYCHOLOGY, V28, P247, DOI 10.1037/neu0000015; Burgess P. W., 1997, METHODOLOGY FRONTAL, P81, DOI DOI 10.1024//1016-264X.10.2.123; Carder HP, 2004, Q J EXP PSYCHOL-A, V57, P1459, DOI 10.1080/02724980343000864; Carlin D, 2000, NEUROPSYCHOLOGIA, V38, P655, DOI 10.1016/S0028-3932(99)00102-5; Cattie JE, 2012, J CLIN EXP NEUROPSYC, V34, P906, DOI 10.1080/13803395.2012.692772; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297; Culbertson WC, 2004, ASSESSMENT, V11, P27, DOI 10.1177/1073191103258590; Culbertson WC, 1998, ARCH CLIN NEUROPSYCH, V13, P285, DOI 10.1016/S0887-6177(97)00033-4; Culbertson WC, 1998, ASSESSMENT, V5, P215, DOI 10.1177/107319119800500302; Davis JC, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-16; de Paula JJ, 2012, PSYCHOL REP, V110, P477, DOI 10.2466/03.10.13.PR0.110.2.477-488; Debelak R., ASSESSMENT OF PLANNI; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; EFPA, 2013, EFPA REV MOD DESCR E; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Fay MP, 2010, R J, V2, P53; Franceschi M, 2007, DEMENT GERIATR COGN, V24, P424, DOI 10.1159/000109827; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Guttman L.A., 1945, PSYCHOMETRIKA, V10, P255, DOI [10.1007/BF02288892, DOI 10.1007/BF02288892]; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Humes GE, 1997, ASSESSMENT, V4, P249, DOI 10.1177/107319119700400305; JACKSON PH, 1977, PSYCHOMETRIKA, V42, P567, DOI 10.1007/BF02295979; Kafer K L, 1997, J Int Neuropsychol Soc, V3, P108; Kaller CP, 2014, BIOL PSYCHIAT, V76, P486, DOI 10.1016/j.biopsych.2014.03.012; Kaller CP, 2012, PSYCHOL ASSESSMENT, V24, P46, DOI 10.1037/a0025174; Kaller CP, 2011, BEHAV BRAIN RES, V216, P1, DOI 10.1016/j.bbr.2010.07.029; Kaller CP, 2004, COGNITIVE BRAIN RES, V20, P462, DOI 10.1016/j.cogbrainres.2004.04.002; Kostering L, 2014, DEV PSYCHOL, V50, P293, DOI 10.1037/a0032467; Kostering L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038855; Kostering L., 2014, J GERONTOL B; Marchegiani A, 2010, AGING MENT HEALTH, V14, P155, DOI 10.1080/13607860903228804; Masson JD, 2010, J INTELL DISABIL RES, V54, P457, DOI 10.1111/j.1365-2788.2010.01280.x; Mastering L., 2015, PSYCHOL ASSESS; McDonald M. P., 1999, TEST THEORY UNIFIED; McKinlay A, 2008, NEUROPSYCHOLOGIA, V46, P384, DOI 10.1016/j.neuropsychologia.2007.08.018; McKinlay A, 2009, APPL NEUROPSYCHOL, V16, P177, DOI 10.1080/09084280903098661; Miller M, 2012, J ABNORM CHILD PSYCH, V40, P657, DOI 10.1007/s10802-011-9599-y; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Norman D.A., 1986, CONSCIOUSNESS SELF R, V4, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Perfetti B, 2010, PARKINSONISM RELAT D, V16, P46, DOI 10.1016/j.parkreldis.2009.07.011; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Pfeiffer HCV, 2014, ACTA NEUROL SCAND, V129, P307, DOI 10.1111/ane.12189; R Core Team, 2014, LANG ENV STAT COMP; Rabbitt P., 1997, METHODOLOGY FRONTAL, P1; Rainville C, 2012, J CLIN EXP NEUROPSYC, V34, P306, DOI 10.1080/13803395.2011.639298; Revelle W., 2015, PSYCH PROCEDURES PSY, V1; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Rog LA, 2014, CLIN NEUROPSYCHOL, V28, P215, DOI 10.1080/13854046.2013.876101; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Sanchez-Benavides G, 2010, J INT NEUROPSYCH SOC, V16, P836, DOI 10.1017/S135561771000069X; Schnirman GM, 1998, ASSESSMENT, V5, P355, DOI 10.1177/107319119800500404; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Sireci S.G., 2013, APA HDB TESTING ASSE, P61, DOI DOI 10.1037/14047-; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sullivan JR, 2009, APPL NEUROPSYCHOL, V16, P62, DOI 10.1080/09084280802644243; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tunstall J. R., 2014, J NEUROPSYCHOL; Unterrainer J. M., 2012, TOWER OF LONDON FREI; Ward G, 1997, Q J EXP PSYCHOL-A, V50, P49, DOI 10.1080/027249897392224; Weisberg S, 2011, AN R COMPANION TO AP; Zartman AL, 2013, ARCH CLIN NEUROPSYCH, V28, P307, DOI 10.1093/arclin/act014	78	15	16	1	29	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	AUG	2015	75						646	655		10.1016/j.neuropsychologia.2015.07.017			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	CQ4TE	WOS:000360596700061	26197091				2021-06-18	
J	Mohseni, S; Talving, P; Thelin, EP; Wallin, G; Ljungqvist, O; Riddez, L				Mohseni, Shahin; Talving, Peep; Thelin, Eric P.; Wallin, Goeran; Ljungqvist, Olle; Riddez, Louis			The Effect of beta-blockade on Survival After Isolated Severe Traumatic Brain Injury	WORLD JOURNAL OF SURGERY			English	Article							ORGAN DYSFUNCTION; HEAD-INJURY; OUTCOMES; CATECHOLAMINES; EPIDEMIOLOGY; PRINCIPLES; BLOCKERS; THERAPY; DEATH	Several North American studies have observed survival benefit in patients exposed to beta-blockers following traumatic brain injury (TBI). The purpose of this study was to evaluate the effect of beta-blockade on mortality in a Swedish cohort of isolated severe TBI patients. The trauma registry of an urban academic trauma center was queried to identify patients with an isolated severe TBI between 1/2007 and 12/2011. Isolated severe TBI was defined as an intracranial injury with an Abbreviated Injury Scale (AIS) a parts per thousand yen3 excluding extra-cranial injuries AIS a parts per thousand yen3. Multivariable logistic regression analysis was used to determine the effect of beta-blocker exposure on mortality. Also, a subgroup analysis was performed to investigate the risk of mortality in patients on pre-admission beta-blocker versus not and the effect of specific type of beta-blocker on the overall outcome. Overall, 874 patients met the study criteria. Of these, 33 % (n = 287) were exposed to beta-blockers during their hospital admission. The exposed patients were older (62 +/- A 16 years vs. 49 +/- A 21 years, p < 0.001), and more severely injured based on their admission GCS, ISS, and head AIS scores (GCS a parts per thousand currency sign8: 32 % vs. 28 %, p = 0.007; ISS a parts per thousand yen16: 71 % vs. 59 %, p = 0.001; head AIS a parts per thousand yen4: 60 % vs. 45 %, p < 0.001). The crude mortality was higher in patients who did not receive beta-blockers (17 % vs. 11 %, p = 0.007) during their admission. After adjustment for significant confounders, the patients not exposed to beta-blockers had a 5-fold increased risk of in-hospital mortality (AOR 5.0, CI 95 % 2.7-8.5, p = 0.001). No difference in survival was noted in regards to the type of beta-blocker used. Subgroup analysis revealed a higher risk of mortality in patients naive to beta-blockers compared to those on pre-admission beta-blocker therapy (AOR 3.0 CI 95 % 1.2-7.1, p = 0.015). beta-blocker exposure after isolated severe traumatic brain injury is associated with significantly improved survival. We also noted decreased mortality in patients on pre-admission beta-blocker therapy compared to patients naive to such treatment. Further prospective studies are warranted.	[Mohseni, Shahin; Wallin, Goeran; Ljungqvist, Olle] Orebro Univ Hosp, Div Acute Care Surg, Dept Surg, S-70185 Orebro, Sweden; [Mohseni, Shahin; Wallin, Goeran; Ljungqvist, Olle] Univ Orebro, S-70185 Orebro, Sweden; [Mohseni, Shahin; Riddez, Louis] Karolinska Univ Hosp Solna, Div Acute Care Surg & Trauma, Dept Surg, S-17176 Stockholm, Sweden; [Thelin, Eric P.] Karolinska Inst, Karolinska Univ Hosp Solna, Sect Neurosurg, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [Talving, Peep] Tartu Univ Hosp, Dept Surg, EE-50406 Tartu, Estonia; [Talving, Peep] North Estonia Med Ctr, Dept Surg, Tallinn, Estonia	Talving, P (corresponding author), Tartu Univ Hosp, Dept Surg, Puusepa 8, EE-50406 Tartu, Estonia.	mohsenishahin@yahoo.com; peep.talving@ut.ee; eric.thelin@ki.se; goran.wallin@orebroll.se; olle.ljugqvist@ki.se; Louis.riddez@karolinska.se	Talving, Peep/G-8621-2015; Talving, Peep/E-6015-2013; Thelin, Eric Peter/K-2144-2012	Talving, Peep/0000-0002-9741-2073; Thelin, Eric Peter/0000-0002-2338-4364			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ALEXANDER RW, 1975, NATURE, V258, P437, DOI 10.1038/258437a0; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Bukur M, 2012, J TRAUMA ACUTE CARE, V72, P1013, DOI 10.1097/TA.0b013e318241bc5b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; CLIFTON G L, 1989, Neurosurgical Review, V12, P465, DOI 10.1007/BF01790692; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Enderson BL, 2007, J TRAUMA, V62, P33; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kemp CD, 2008, AM SURGEON, V74, P866; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489; Mayer SA, 2011, CRIT CARE MED, V39, P2330, DOI 10.1097/CCM.0b013e3182227238; MEYER JS, 1976, STROKE, V7, P158, DOI 10.1161/01.STR.7.2.158; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pryor JP, 2007, J TRAUMA, V62, P61; Rose JC, 2004, NEUROCRIT CARE, V1, P287, DOI 10.1385/NCC:1:3:287; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	40	15	15	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	AUG	2015	39	8					2076	2083		10.1007/s00268-015-3039-z			8	Surgery	Surgery	CM4XW	WOS:000357690700032	25809062				2021-06-18	
J	Fitch, T; Villanueva, G; Quadir, MM; Sagiraju, HKR; Alamgir, H				Fitch, Taylor; Villanueva, Gabriela; Quadir, Mohammad M.; Sagiraju, Hari K. R.; Alamgir, Hasanat			The prevalence and risk factors of Post-Traumatic Stress Disorder among workers injured in Rana Plaza building collapse in Bangladesh	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article							PTSD; HEALTH; CHECKLIST; EPIDEMIOLOGY; BURDEN; TRAUMA	ObjectivesPrevalence and risk factors of PTSD among injured garment workers who survived a major factory collapse. MethodsSurvivors receiving treatment or rehabilitation care at one year post event were surveyed, which included Post Traumatic Stress Disorder Checklist Specific version. ResultsThe respondents consisted of 181 people with a mean age of 27.8 years and a majority had less than high school education (91.2%). Multivariable logistic regression found that the odds of having PTSD was higher among married (OR: 3.2 [95% CI: 1.3-8.0]), those who used to work more than 70hr/week (OR: 2.4 [1.1-5.3]), workers who used to hold higher job positions (OR: 2.6 [1.2-5.6]) or who had a concussion injury (OR: 3.7 [1.4-9.8]). Among the respondents, 83.4% remained unemployed, and only 57.3% (63 people) reported receiving a quarter or less of what they were promised as compensation. ConclusionsProbable PTSD was prevalent among surviving workers of the Rana Plaza building collapse in Bangladesh. Am. J. Ind. Med. 58:756-763, 2015. (c) 2015 Wiley Periodicals, Inc.	[Fitch, Taylor; Villanueva, Gabriela; Sagiraju, Hari K. R.; Alamgir, Hasanat] Univ Texas San Antonio, Sch Publ Hlth, San Antonio, TX 78229 USA; [Fitch, Taylor; Villanueva, Gabriela] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, San Antonio, TX 78229 USA; [Quadir, Mohammad M.] CRP, Dhaka, Bangladesh	Alamgir, H (corresponding author), Univ Texas San Antonio, Sch Publ Hlth, San Antonio Campus,7411 John Smith Dr,Suite 1100, San Antonio, TX 78229 USA.	Abul.h.alamgir@uth.tmc.cedu	Alamgir, Hasanat/U-9354-2019	Quadir, Mohammad Morshedul/0000-0002-2627-4726; Sagiraju, Hari Krishna Raju/0000-0002-9719-9380; Fitch, Taylor/0000-0002-8396-8919	Deutsche Gesellschaft fuer Internationale Zusammenarbeit (GIZ)	Deutsche Gesellschaft fuer Internationale Zusammenarbeit (GIZ) for partially funding the research and also to Dr. Anisuzzaman from GIZ for reviewing the study survey questionnaires.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; [Anonymous], 2013, SAF HLTH WORK HOP CH; [Anonymous], 2012, NY TIMES; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Cerda M, 2013, DEPRESS ANXIETY, V30, P413, DOI 10.1002/da.22007; Cloitre M, 2001, WOMEN HEALTH, V34, P1, DOI 10.1300/J013v34n03_01; DeAngelis T, 2008, APA MONITOR PSYCHOL, V39, P40; Devnath A, 2013, BLOOMBERG       1114; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Hidalgo RB, 2000, J CLIN PSYCHIAT, V61, P5; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Jason M., 2014, WASHINGTON POST; Jim Yardley, 2013, NY TIMES; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Litz B, 2009, PTSD RES Q, V20; Maes M, 2001, J AFFECT DISORDERS, V63, P113, DOI 10.1016/S0165-0327(00)00173-7; Manguno-Mire G, 2007, J NERV MENT DIS, V195, P144, DOI 10.1097/01.nmd.0000254755.53549.69; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pietrzak Robert H, 2009, J Spec Oper Med, V9, P67; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Walker WC, 2014, J REHABIL RES DEV, V51, P1203, DOI 10.1682/JRRD.2013.12.0271; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	25	15	15	0	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	JUL	2015	58	7					756	763		10.1002/ajim.22471			8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CK1PM	WOS:000355979300006	25964138				2021-06-18	
J	Kang, WH; Cao, WZ; Graudejus, O; Patel, TP; Wagner, S; Meaney, DF; Morrison, B				Kang, Woo Hyeun; Cao, Wenzhe; Graudejus, Oliver; Patel, Tapan P.; Wagner, Sigurd; Meaney, David F.; Morrison, Barclay, III			Alterations in Hippocampal Network Activity after In Vitro Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; hippocampus; network synchronization; traumatic brain injury	WORKING-MEMORY; MICROELECTRODE ARRAY; SLICE CULTURES; MODEL; RECORDINGS; HEAD; DYSFUNCTION; DEFORMATION; CONCUSSION; TOPOLOGY	Traumatic brain injury (TBI) alters function and behavior, which can be characterized by changes in electrophysiological function in vitro. A common cognitive deficit after mild-to-moderate TBI is disruption of persistent working memory, of which the in vitro correlate is long-lasting, neuronal network synchronization that can be induced pharmacologically by the gamma-aminobutyric acid A antagonist, bicuculline. We utilized a novel in vitro platform for TBI research, the stretchable microelectrode array (SMEA), to investigate the effects of TBI on bicuculline-induced, long-lasting network synchronization in the hippocampus. Mechanical stimulation significantly disrupted bicuculline-induced, long-lasting network synchronization 24h after injury, despite the continued ability of the injured neurons to fire, as revealed by a significant increase in the normalized spontaneous event rate in the dentate gyrus (DG) and CA1. A second challenge with bicuculline 24h after the first challenge significantly decreased the normalized spontaneous event rate in the DG. In addition, we illustrate the utility of the SMEA for TBI research by combining multiple experimental paradigms in one platform, which has the potential to enable novel investigations into the mechanisms responsible for functional consequences of TBI and speed the rate of drug discovery.	[Kang, Woo Hyeun; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Cao, Wenzhe; Graudejus, Oliver; Wagner, Sigurd] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Graudejus, Oliver] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Patel, Tapan P.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Meaney, David/0000-0002-0954-4122; Patel, Tapan/0000-0001-8959-6645	National Highway Traffic Safety Administration [DTNH22-08-C-00088]; New Jersey Commission on Brain Injury Research [08-3209-BIR-E-1]; Multidisciplinary University Research Initiative from the Army Research Office [W911MF-10-1-0526]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088176] Funding Source: NIH RePORTER	This work was supported, in part, by the National Highway Traffic Safety Administration (DTNH22-08-C-00088), the New Jersey Commission on Brain Injury Research (08-3209-BIR-E-1), and by a Multidisciplinary University Research Initiative from the Army Research Office (W911MF-10-1-0526). The authors grate-fully acknowledge the pioneering efforts of Stephanie P. Lacour (EPFL) in the early development of the SMEA.	Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Choi JH, 2006, IEEE T BIO-MED ENG, V53, P738, DOI 10.1109/TBME.2006.870239; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; DECURTIS M, 1994, J NEUROPHYSIOL, V71, P2463; Doetsch GS, 2000, PHYSIOL BEHAV, V69, P187, DOI 10.1016/S0031-9384(00)00201-8; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Egert U, 2005, PRACTICAL METHODS IN CARDIOVASCULAR RESEARCH, P432, DOI 10.1007/3-540-26574-0_22; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Graudejus O, 2009, J ELECTROCHEM SOC, V156, pP85, DOI 10.1149/1.3115465; Graudejus O, 2012, ADV FUNCT MATER, V22, P640, DOI 10.1002/adfm.201102290; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kralik JD, 2001, METHODS, V25, P121, DOI 10.1006/meth.2001.1231; Lacour SP, 2003, APPL PHYS LETT, V82, P2404, DOI 10.1063/1.1565683; Leinekugel X, 1999, Adv Neurol, V79, P189; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Li XN, 2007, BIOSENS BIOELECTRON, V22, P1538, DOI 10.1016/j.bios.2006.05.030; Li XL, 2007, J NEUROPHYSIOL, V98, P3341, DOI 10.1152/jn.00977.2007; Li XL, 2010, BIOPHYS J, V98, P1733, DOI 10.1016/j.bpj.2010.01.013; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Matsuyama S, 2008, NEUROREPORT, V19, P1809, DOI 10.1097/WNR.0b013e328319ab94; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; NOVAK JL, 1988, J NEUROSCI METH, V23, P149, DOI 10.1016/0165-0270(88)90187-2; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Patel TP, 2012, ANN BIOMED ENG, V40, P23, DOI 10.1007/s10439-011-0390-6; Pimashkin A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00046; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; SLOVITER RS, 1994, HIPPOCAMPUS, V4, P250, DOI 10.1002/hipo.450040304; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Tsay C, 2005, IEEE SENSOR, P1169; Tsirka V, 2011, INT J PSYCHOPHYSIOL, V79, P89, DOI 10.1016/j.ijpsycho.2010.09.006; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang W, 2006, NEUROSCI LETT, V406, P11, DOI 10.1016/j.neulet.2006.06.064; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Yu Z, 2009, J NEUROTRAUM, V26, P1135, DOI 10.1089/neu.2008.0810	58	15	15	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					1011	1019		10.1089/neu.2014.3667			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200010	25517970	Green Published			2021-06-18	
J	Li, YM; Gu, JW; Zhou, JH; Xia, X; Wang, KY; Zheng, XS; Kuang, YQ; Zhang, XY; Ou, S; He, C; Zhu, H; Qiu, J				Li, Yunming; Gu, Jianwen; Zhou, Jihong; Xia, Xun; Wang, Kuiying; Zheng, Xiushan; Kuang, Yongqin; Zhang, Xinyan; Ou, Shan; He, Ci; Zhu, Hui; Qiu, Jun			The epidemiology of traumatic brain injury in civilian inpatients of Chinese Military Hospitals, 2001-2007	BRAIN INJURY			English	Article						China; epidemiology; inpatient; military hospital; traumatic brain injury	UNITED-STATES; CARE	Primary objective: To investigate the epidemiology of TBI in Chinese inpatients. Research design: Civilian inpatients of Chinese military hospitals diagnosed with TBI between 2001-2007 were identified using ICD-9-CM codes. Methods and procedures: Demographic characteristics, admission time, injury cause, injury severity, length of stay and outcomes were compared between ICD-9-CM diagnosis groups. Main outcomes and results: In total, 203 553 civilian patients with TBI (74.86% male, 25.14% female) were identified from >200 Chinese military hospitals. TBI diagnoses increased by a mean of 4.67% each year. Admission peaked during the third quarter of the year and October annually. The leading causes of TBI were motor vehicle-traffic (51.41%), falls (21.49%) and assaults (15.77%). TBI was categorized by abbreviated injury scale score as mild in 36.64%, serious in 20.13%, severe in 26.81% and critical in 15.68% of inpatients. The mean length of stay was 17.8 +/- 24.1 days. Recovery rate was 93.06% and mortality was 4.14%. Conclusions: The epidemiological data may contribute to the development of effective, targeted strategies to prevent TBI.	[Li, Yunming; Gu, Jianwen; Xia, Xun; Wang, Kuiying; Zheng, Xiushan; Kuang, Yongqin; Zhang, Xinyan; Ou, Shan; He, Ci; Zhu, Hui] Chengdu Mil Gen Hosp Peoples Liberat Army, Dept Neurosurg, Chengdu 610000, Sichuan, Peoples R China; [Zhou, Jihong; Qiu, Jun] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Surg Res, Chongqing, Peoples R China	Gu, JW (corresponding author), Chengdu Mil Gen Hosp Peoples Liberat Army, Dept Neurosurg, Chengdu 610000, Sichuan, Peoples R China.	gu031702556@126.com		Li, Yunming/0000-0001-6363-4869	53 China postdoctoral science foundation projects [2013M532123]; Chengdu Military Command General Hospital [2013YG-B021]	The authors report no conflicts of interest. This work was supported by the 53 China postdoctoral science foundation projects (No. 2013M532123) and the Chengdu Military Command General Hospital first funded research talents (No. 2013YG-B021).	Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Faul M.D., 2010, TRAUMATIC BRAIN INJU; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Orlando Alessandro, 2013, J Clin Med Res, V5, P168, DOI 10.4021/jocmr1333w; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Sun ZG, 1997, HOSP ADM J CHINESE P, V4, P373; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang YC, 1987, CHINESE J NEUROSURGE, V3, P23; Yao Y, 2011, BURNS, V37, P1023, DOI 10.1016/j.burns.2011.03.021; Zhang YH, 2007, INT J MED INFORM, V76, P614, DOI 10.1016/j.ijmedinf.2006.05.003; Zhao YD, 2001, WORLD J SURG, V25, P1202	23	15	20	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					981	988		10.3109/02699052.2014.989405			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800026	25915805				2021-06-18	
J	Bannard-Smith, J; Alexander, P; Glassford, N; Chan, MJ; Lee, M; Wong, BT; Crawford, G; Bailey, M; Bellomo, R				Bannard-Smith, Jonathan; Alexander, Paschal; Glassford, Neil; Chan, Matthew J.; Lee, Matthew; Wong, Ben T.; Crawford, Grant; Bailey, Michael; Bellomo, Rinaldo			Haemodynamic and biochemical responses to fluid bolus therapy with human albumin solution, 4% versus 20%, in critically ill adults	CRITICAL CARE AND RESUSCITATION			English	Article							ACUTE LUNG INJURY; SEVERE SEPSIS; HYDROXYETHYL STARCH; 0.9-PERCENT SALINE; PATIENT OUTCOMES; INTENSIVE-CARE; SEPTIC SHOCK; RESUSCITATION; MORTALITY; BALANCE	Background: Fluid bolus therapy (FBT) is common in critically ill patients. With the exception of use in patients with traumatic brain injury, FBT with human albumin solution (HAS) appears safe and perhaps superior in severe sepsis. Objective: To determine the physiological effects of FBT with 4% v 20% HAS. Design, setting and participants: A retrospective observational study of 202 critically ill patients receiving FBT with HAS in a tertiary intensive care unit between April 2012 and March 2013. Methods: FBT was instituted with 4% or 20% HAS, according to clinician preference. Main outcome measures: We compared biochemical and haemodynamic data between groups at baseline and at 1, 2 and 4 hours after FBT. Results: Patients who had received 20% HAS had more liver disease, a greater need for renal replacement therapy and higher Acute Physiology and Chronic Health Evaluation III scores on admission. Patients who had received 4% HAS received a median volume of 500 mL (interquartile range [IQR], 350-500 mL), compared with 100 mL (IQR, 100 200 mL) in the 20% HAS group (P < 0.0001); a median of 70 mmol v 10 mmol of sodium (P < 0.0001); and a median of 64 mmol v 2 mmol of chloride (P < 0.0001). There was a trend toward higher mean arterial pressures in the 20% group after FBT (78.2 mmHg v 76.4 mmHg, P = 0.03). There were no significant differences in the absolute or percentage change for any haemodynamic parameters. Serum biochemical test results were comparable with a non-significant signal of higher serum chloride and more negative base excess in patients receiving 4% HAS. Conclusions: Haemodynamically, FBT with 100 mL of 20% HAS performs in an equivalent way to 500 mL of 4% HAS but delivers much less fluid, sodium and chloride.	[Bannard-Smith, Jonathan; Alexander, Paschal; Glassford, Neil; Chan, Matthew J.; Lee, Matthew; Wong, Ben T.; Crawford, Grant] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Res, Melbourne, Vic, Australia; [Glassford, Neil; Bailey, Michael; Bellomo, Rinaldo] Monash Univ, Alfred Hosp, Sch Publ Hlth & Preventat Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3181, Australia	Bellomo, R (corresponding author), Austin Hlth, Dept Intens Care, Res, Melbourne, Vic, Australia.	rinaldo.bellomo@austin.org.au	Bailey, Michael J/A-4499-2012	Bailey, Michael J/0000-0002-5551-1401; Glassford, Neil/0000-0003-1647-3745; Bannard-Smith, Jonathan/0000-0001-7120-480X; Bellomo, Rinaldo/0000-0002-1650-8939			Bayer O, 2012, CRIT CARE MED, V40, P2543, DOI 10.1097/CCM.0b013e318258fee7; Bayer O, 2011, CRIT CARE MED, V39, P1335, DOI 10.1097/CCM.0b013e318212096a; Bellomo R, 2012, CRIT CARE MED, V40, P1753, DOI 10.1097/CCM.0b013e318246b9c6; Bihari S, 2013, CRIT CARE RESUSC, V15, P294; Bihari S, 2013, SHOCK, V40, P28, DOI 10.1097/SHK.0b013e31829727f1; Bihari S, 2013, CRIT CARE RESUSC, V15, P89; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Brant R., INFERENCE MEANS COMP; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Gattas DJ, 2013, CRIT CARE RESUSC, V15, P255; Handy JM, 2008, BRIT J ANAESTH, V101, P141, DOI 10.1093/bja/aen148; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; WAGNER BKJ, 1993, CLIN PHARMACY, V12, P335; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	26	15	16	0	0	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	JUN	2015	17	2					122	128					7	Critical Care Medicine	General & Internal Medicine	CJ0ID	WOS:000355158100012	26017130				2021-06-18	
J	Goverover, Y; DeLuca, J				Goverover, Yael; DeLuca, John			Actual reality: Using the Internet to assess everyday functioning after traumatic brain injury	BRAIN INJURY			English	Article						Activities of daily living; cognition; outcome; rehabilitation; traumatic brain injury	QUALITY-OF-LIFE; SELF-AWARENESS; INSTRUMENTAL ACTIVITIES; SUBJECTIVE REPORTS; PERFORMANCE; TECHNOLOGY; DEPRESSION; DEMENTIA; ASSOCIATION; VALIDITY	Objectives: The aim of this pilot study was to examine and compare the performance of everyday life activities in persons with traumatic brain injury (TBI) and healthy controls (HC) using a new assessment tool called 'actual reality' (AR). Method: A between-subjects design was utilized to compare 10 individuals with TBI and 10 healthy controls (HC) performing an AR task. Participants were asked to access the Internet to purchase a decorative arrangement of cookies and were administered a battery of neuropsychological tests and questionnaires to assess quality-of-life, functional status, affect symptomatology and prior Internet experience. Results: Participants with TBI had significantly more difficulties than HC participants in accurately and independently completing the AR task primarily due to cognitive impairment. In addition, self-reports of quality-of-life and everyday functional abilities were not correlated with AR performance. Conclusions: The results provide initial evidence supporting the use of the AR approach in assessing persons with TBI performing everyday life activities. The utilization and interpretation of the AR approach is a significant step forward in increasing the sensitivity, accessibility and relevancy of functional assessments in people with cognitive impairments. Actual reality will be discussed in terms of accessibility and directions for assessment and treatment.	[Goverover, Yael] NYU, Dept Occupat Therapy, New York, NY USA; [Goverover, Yael; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07102 USA	Goverover, Y (corresponding author), Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA.	yg243@nyu.edu					BAUM C, 1993, GERONTOLOGIST, V33, P403, DOI 10.1093/geront/33.3.403; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Blackstone K, 2012, J INT NEUROPSYCH SOC, V18, P79, DOI 10.1017/S135561771100141X; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bottari C, 2006, AUST OCCUP THER J, V53, P98, DOI DOI 10.1111/J.1440-1630.2006.00547.X; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Delis D, 2000, DELIS KAPLAN EXECUTI; Delis D. C., 2000, CVLT 2 CALIFORNIA VE; Desai AK, 2004, CNS DRUGS, V18, P853, DOI 10.2165/00023210-200418130-00003; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Engstrom ALL, 2010, SCAND J OCCUP THER, V17, P233, DOI [10.3109/11038120903191806, 10.1080/11038120903191806]; Goverover Y, 2005, ARCH PHYS MED REHAB, V86, P2303, DOI 10.1016/j.apmr.2005.05.016; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Goverover Y, 2010, ARCH PHYS MED REHAB, V91, P252, DOI 10.1016/j.apmr.2009.09.022; Goverover Y, 2009, REHABIL PSYCHOL, V54, P60, DOI 10.1037/a0014556; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Kassberg AC, 2013, BRAIN INJURY, V27, P1583, DOI 10.3109/02699052.2013.837196; Lange ML, 2002, AM J OCCUP THER, V56, P107, DOI 10.5014/ajot.56.1.107; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lund ML, 2012, SCAND J OCCUP THER, V19, P164, DOI 10.3109/11038128.2011.582651; Malinowsky C, 2014, DISABILITY REHABILIT, V1, P1; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Nygard L, 2007, AGING MENT HEALTH, V11, P144, DOI 10.1080/13607860600844168; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Sadek JR, 2011, J INT NEUROPSYCH SOC, V17, P832, DOI 10.1017/S1355617711000841; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Sikkes SAM, 2009, J NEUROL NEUROSUR PS, V80, P7, DOI 10.1136/jnnp.2008.155838; Smith A, 1982, SYMBOL DIGITS MODALI; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; Tsai IH, 2014, ARCH PHYS MED REHAB, V95, P236, DOI 10.1016/j.apmr.2013.08.004; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Youngstrom MJ, 2002, AM J OCCUP THER, V56, P609	41	15	15	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					715	721		10.3109/02699052.2015.1004744			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700006	25688468				2021-06-18	
J	Kim, MO; Adji, A; O'Rourke, MF; Avolio, AP; Smielewski, P; Pickard, JD; Czosnyka, M				Kim, Mi Ok; Adji, Audrey; O'Rourke, Michael F.; Avolio, Alberto P.; Smielewski, Peter; Pickard, John D.; Czosnyka, Marek			Principles of cerebral hemodynamics when intracranial pressure is raised: lessons from the peripheral circulation	JOURNAL OF HYPERTENSION			English	Article						aortic pressure; intracranial pressure; plateau waves	INTENSIVE-CARE MANAGEMENT; BLOOD-FLOW-VELOCITY; ARTERIAL; TONOMETRY; FAILURE; STROKE; BRAIN; TRIAL; INDEX	Background: The brain is highly vascular and richly perfused, and dependent on continuous flow for normal function. Although confined within the skull, pressure within the brain is usually less than 15 mmHg, and shows small pulsations related to arterial pulse under normal circumstances. Pulsatile arterial hemodynamics in the brain have been studied before, but are still inadequately understood, especially during changes of intracranial pressure (ICP) after head injury. Method: In seeking cohesive explanations, we measured ICP and radial artery pressure (RAP) invasively with high-fidelity manometer systems, together with middle cerebral artery flow velocity (MCAFV) (transcranial Doppler) and central aortic pressure (CAP) generated from RAP, using a generalized transfer function technique, in eight young unconscious, ventilated adults following closed head trauma. We focused on vascular effects of spontaneous rises of ICP ('plateau waves'). Results: A rise in mean ICP from 29 to 53 mmHg caused no consistent change in pressure outside the cranium, or in heart rate, but ICP pulsations increased in amplitude from 8 to 20 mmHg, and ICP waveform came to resemble that in the aorta. Cerebral perfusion pressure (=central aortic pressure - ICP), which equates with transmural pressure, fell from 61 to 36 mmHg. Mean MCAFV fell from 53 to 40 cm/s, whereas pulsatile MCAFV increased from 77 to 98 cm/s. These significant changes (all P < 0.01) may be explained using the Monro-Kellie doctrine, because of compression of the brain, as occurs in a limb when external pressure is applied. Conclusion: The findings emphasize importance of reducing ICP, when raised, and on the additional benefits of reducing wave reflection from the lower body.	[Kim, Mi Ok; Adji, Audrey; O'Rourke, Michael F.; Avolio, Alberto P.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Adji, Audrey; O'Rourke, Michael F.] St Vincents Clin, Sydney, NSW 2010, Australia; [O'Rourke, Michael F.] Univ New S Wales, Sydney, NSW, Australia; [O'Rourke, Michael F.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Smielewski, Peter; Pickard, John D.; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Acad Neurosurg Unit, Cambridge CB2 2QQ, England	O'Rourke, MF (corresponding author), St Vincents Clin, Suite 810,438 Victoria St, Sydney, NSW 2010, Australia.	m.orourke@unsw.edu.au	Adji, Audrey/AAN-5624-2020	Adji, Audrey/0000-0002-5567-6206; Avolio, Alberto/0000-0002-8311-2010; Smielewski, Peter/0000-0001-5096-3938; czosnyka, marek/0000-0003-2446-8006	National Institute of Health ResearchNational Institute for Health Research (NIHR); Biomedical Research Centre (Neuroscience Theme); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390]; NIHRNational Institute for Health Research (NIHR); Australian Research CouncilAustralian Research Council [LP0884094]; AtCor Medical Australia; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	This study was supported by the National Institute of Health Research, the Biomedical Research Centre (Neuroscience Theme), and the Medical Research Council (Grants G0600986 and G9439390). J.D.P. has received the NIHR Investigator Awards. M.O.K. is sponsored by an Australian Postgraduate Awards Industrial Linkage Grant from the Australian Research Council (LP0884094), with AtCor Medical Australia as the collaborating organization.	Adji A, 2012, J HYPERTENS, V30, P1540, DOI 10.1097/HJH.0b013e328354e859; Avezaat C, 1984, CEREBROSPINAL FLUID; Byrom FB, 1969, HYPERTENSIVE VASCULA; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; DRZEWIECKI GM, 1983, J BIOMECH, V16, P141, DOI 10.1016/0021-9290(83)90037-4; Eide PK, 2011, NEUROSURGERY, V69, P1105, DOI 10.1227/NEU.0b013e318227e0e1; FOLKOW B, 1970, ACTA PHYSIOL SCAND, V80, P61, DOI 10.1111/j.1748-1716.1970.tb04770.x; FOLKOW B, 1993, PHYSIOL REV, V73, P725; FRY DL, 1969, CIRC RES, V24, P93, DOI 10.1161/01.RES.24.1.93; Fry DL, 1973, SYMPOSIUM, P93; Gupta S, 2014, HEART LUNG CIRC, V23, P963, DOI 10.1016/j.hlc.2014.04.259; Hirata K, 2007, J CLIN HYPERTENS SA, V9, pA29; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kety S., 1964, CIRCULATION BLOOD ME, P703; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Kim MO, 2014, CIRCULATION, V130; Kim MO, 2013, ARTERY RES, V7, P119; Kirkman MA, 2014, INTENS CARE MED, V40, P640, DOI 10.1007/s00134-014-3266-z; Kwiatkowski JL, 2006, BRIT J HAEMATOL, V134, P333, DOI 10.1111/j.1365-2141.2006.06193.x; Marmarou A, 1973, THESIS DREXER U PHIL; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Monro Alexander, 1783, OBSERVATIONS STRUCTU; Moore W., 2005, KNIFE MAN; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; O'Rourke MF., 1993, ARTERIAL VASODILATIO; Oliver G, 1895, PULSE GAUGING CLIN S; OROURKE MF, 1982, PHYSIOL REV, V62, P570; Pauca AL, 2005, HEART, V91, P1428, DOI 10.1136/hrt.2004.057356; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; RUSSELL RWR, 1975, LANCET, V2, P1283; Schmidt M, 2014, AM J RESP CRIT CARE, V189, P1374, DOI 10.1164/rccm.201311-2023OC; Smielewski P, 2005, ACT NEUR S, V95, P43; Soiza RL, 2010, AM J HYPERTENS, V23, P737, DOI 10.1038/ajh.2010.66; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	37	15	15	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	JUN	2015	33	6					1233	1241		10.1097/HJH.0000000000000539			9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH1YN	WOS:000353819700018	25764046	Green Published			2021-06-18	
J	Pang, KCH; Sinha, S; Avcu, P; Roland, JJ; Nadpara, N; Pfister, B; Long, M; Santhakumar, V; Servatius, RJ				Pang, Kevin C. H.; Sinha, Swamini; Avcu, Pelin; Roland, Jessica J.; Nadpara, Neil; Pfister, Bryan; Long, Mathew; Santhakumar, Vijayalakshmi; Servatius, Richard J.			Long-Lasting Suppression of Acoustic Startle Response after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; lateral fluid percussion; memory; pons; spatial learning	WORKING-MEMORY DEFICITS; FLUORO-JADE; RETICULAR-FORMATION; NEURONS; RATS; SEVERITY; REFLEX; PATHOPHYSIOLOGY; HIPPOCAMPUS; INHIBITION	Acoustic startle response (ASR) is a defensive reflex that is largely ignored unless greatly exaggerated. ASR is suppressed after moderate and severe traumatic brain injury (TBI), but the effect of mild TBI (mTBI) on ASR has not been investigated. Because the neural circuitry for ASR resides in the pons in all mammals, ASR may be a good measure of brainstem function after mTBI. The present study assessed ASR in Sprague-Dawley rats after mTBI using lateral fluid percussion and compared these effects to those on spatial working memory. mTBI caused a profound, long-lasting suppression of ASR. Both probability of emitting a startle and startle amplitude were diminished. ASR suppression was observed as soon as 1 day after injury and remained suppressed for the duration of the study (21 days after injury). No indication of recovery was observed. mTBI also impaired spatial working memory. In contrast to the suppression of ASR, working memory impairment was transient; memory was impaired 1 and 7 days after injury, but recovered by 21 days. The long-lasting suppression of ASR suggests long-term dysfunction of brainstem neural circuits at a time when forebrain neural circuits responsible for spatial working memory have recovered. These results have important implications for return-to-activity decisions because recovery of cognitive impairments plays an important role in these decisions.	[Pang, Kevin C. H.; Servatius, Richard J.] New Jersey Hlth Care Syst, Dept Vet Affairs Med Ctr, Neurobehav Res Lab, E Orange, NJ 07018 USA; [Pang, Kevin C. H.; Sinha, Swamini; Avcu, Pelin; Roland, Jessica J.; Servatius, Richard J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Stress & Motivated Behav Inst, Newark, NJ 07103 USA; [Pang, Kevin C. H.; Roland, Jessica J.; Santhakumar, Vijayalakshmi; Servatius, Richard J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Pang, Kevin C. H.; Sinha, Swamini; Avcu, Pelin; Long, Mathew; Santhakumar, Vijayalakshmi; Servatius, Richard J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Grad Sch Biomed Sci, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Pfister, Bryan; Long, Mathew] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Nadpara, Neil] Coll New Jersey, Ewing, NJ USA	Pang, KCH (corresponding author), New Jersey Hlth Care Syst, VA Med Ctr, 385 Tremont Ave,Mailstop 15, E Orange, NJ 07018 USA.	kevin.pang@va.gov	Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187; Servatius, Richard/0000-0002-7023-4895	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS044373, R01-NS44373] Funding Source: Medline; BLRD VA [I01 BX000132] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044373] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000132] Funding Source: NIH RePORTER; VAUS Department of Veterans Affairs [5I01BX000132-04, 2I01BX000132-05A2] Funding Source: Federal RePORTER		Abdul-Wahab R., 2011, IEEE 37 ANN NE, V1, P22011; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; BROWN JS, 1951, J EXP PSYCHOL, V41, P317, DOI 10.1037/h0060166; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Carlson S, 1998, J NEUROPHYSIOL, V79, P2603; Chaparro RE, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-23; DAVIS M, 1982, J NEUROSCI, V2, P791; DAVIS M, 1972, J COMP PHYSIOL PSYCH, V78, P260, DOI 10.1037/h0032811; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; HOY R, 1989, J EXP BIOL, V146, P287; Kalia M, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2005.01.009; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Pissiota A, 2002, EUR J NEUROSCI, V15, P395, DOI 10.1046/j.0953-816x.2001.01870.x; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Servatius RJ, 2005, BIOL PSYCHIAT, V57, P865, DOI 10.1016/j.biopsych.2005.01.015; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Trillo L, 2013, NEUROSCI BIOBEHAV R, V37, P1363, DOI 10.1016/j.neubiorev.2013.05.008; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Williams C, 2012, J CLIN EXP NEUROPSYC, V34, P948, DOI 10.1080/13803395.2012.703641; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	42	15	15	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					801	810		10.1089/neu.2014.3451			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700005	25412226	Green Published			2021-06-18	
J	Visser-Keizer, AC; Hogenkamp, A; Westerhof-Evers, HJ; Egberink, IJL; Spikman, JM				Visser-Keizer, Annemarie C.; Hogenkamp, Antoinette; Westerhof-Evers, Herma J.; Egberink, Iris J. L.; Spikman, Jacoba M.			Dutch Multifactor Fatigue Scale: A New Scale to Measure the Different Aspects of Fatigue After Acquired Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Fatigue; Neuropsychology; Rehabilitation; Self-assessment	1ST 2 YEARS; POSTSTROKE FATIGUE; PSYCHOMETRIC PROPERTIES; STROKE; MILD; DEPRESSION; VALIDATION; HISTORY; ANXIETY; IMPACT	Objectives: To develop the Dutch Multifactor Fatigue Scale (DMFS), a new scale to assess the nature and impact of fatigue and coping with fatigue in the chronic phase after acquired brain injury (ABI) and to analyze the psychometric properties of this scale in a mixed group of patients with ABI. Design: Cross-sectional survey study. Setting: Academic rehabilitation center. Participants: A mixed sample of patients with ABI (N=134). For the development of the DMFS: community-dwelling adults with stroke (n=9) and traumatic brain injury (n=5). For analyses of the psychometric properties of the DMFS: community-dwelling adults with ischemic stroke (n=55), hemorrhagic stroke (n=22), traumatic brain injury (n=35), or other ABIs (n=22), all at least 6 months after brain injury. Interventions: Not applicable. Main Outcome Measures: DMFS, Hospital Anxiety and Depression Scale, Checklist Individual Strength, and Dutch Personality Questionnaire. Results: Exploratory and confirmatory factor analyses on data of 134 patients showed that the final DMFS consisted of 5 factors (explaining 55% of the variance): Impact of fatigue, Mental fatigue, Signs and Direct consequences of fatigue, Physical fatigue, and Coping with fatigue. All subscales of the DMFS showed sufficient to good reliability, good convergent validity with an existing fatigue scale, and good divergent validity with measures of mood and self-esteem. Conclusions: The DMFS is believed to improve the diagnostic process of fatigue in the chronic phase after ABI. As it measures several factors of fatigue after brain injury, therapeutic indications can be targeted to patients' needs. (C) 2015 by the American Congress of Rehabilitation Medicine	[Visser-Keizer, Annemarie C.; Hogenkamp, Antoinette; Westerhof-Evers, Herma J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, NL-9700 RB Groningen, Netherlands; [Visser-Keizer, Annemarie C.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 RB Groningen, Netherlands; [Hogenkamp, Antoinette] Ctr Child Psychiat & Learning Disabil, Groningen, Netherlands; [Westerhof-Evers, Herma J.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Egberink, Iris J. L.; Spikman, Jacoba M.] Univ Groningen, Dept Psychometr & Stat, Groningen, Netherlands	Visser-Keizer, AC (corresponding author), Univ Med Ctr Groningen, Dept Neuropsychol, AB50,POB 30-001, NL-9700 RB Groningen, Netherlands.	a.c.visser@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; Egberink, Iris/0000-0003-0191-2733	Foundation Beatrixoord North Netherlands, Center for Rehabilitation, University Medical Center Groningen, Groningen, The NetherlandsNetherlands Government [210.101]	Supported by the Foundation Beatrixoord North Netherlands, Center for Rehabilitation, University Medical Center Groningen, Groningen, The Netherlands (grant no. 210.101).	Amtmann D, 2012, REHABIL PSYCHOL, V57, P159, DOI 10.1037/a0027890; Andersen G, 2012, ACTA NEUROL SCAND, V125, P248, DOI 10.1111/j.1600-0404.2011.01557.x; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Barelds DPH, 2007, DPQ 2 DUTCH PERSONAL; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Bogousslavsky J, 2003, STROKE, V34, P1046, DOI 10.1161/01.STR.0000061887.33505.B9; Bouma A., 2012, HDB NEUROPSYCHOLOGIC; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Butt Z, 2013, J PSYCHOSOM RES, V74, P64, DOI 10.1016/j.jpsychores.2012.10.011; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Egberink I. J. L., 2014, COTAN BEOORDELING 19; Egberink IJL, 2014, COTAN REV 1999 CHECK; Egberink IJL, 2014, COTAN REV 2009 DUTCH; Eilertsen G, 2013, J ADV NURS, V69, P514, DOI 10.1111/jan.12002; Evers A, 2010, INT J TEST, V10, P295, DOI 10.1080/15305058.2010.518325; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Hubacher M, 2012, EUR NEUROL, V67, P377, DOI 10.1159/000336736; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kirkevold M, 2012, DISABIL REHABIL, V34, P665, DOI 10.3109/09638288.2011.615373; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kutlubaev MA, 2012, ACTA NEUROL SCAND, V125, P219, DOI 10.1111/j.1600-0404.2011.01618.x; Kutlubaev MA, 2013, CEREBROVASC DIS EXTR, V3, P26, DOI 10.1159/000347113; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mead GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016988; Naess H, 2012, CEREBROVASC DIS, V33, P461, DOI 10.1159/000336760; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Parks NE, 2012, CAN J NEUROL SCI, V39, P619, DOI 10.1017/S0317167100015353; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Radman N, 2012, NEUROLOGY, V79, P1422, DOI 10.1212/WNL.0b013e31826d5f3a; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tyson SF, 2014, CLIN REHABIL, V28, P804, DOI 10.1177/0269215514521043; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1994, Ned Tijdschr Geneeskd, V138, P2279; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Verhage F, 1964, THESIS VAN GORCUM AS; Winward C, 2009, STROKE, V40, P757, DOI 10.1161/STROKEAHA.108.527101; Zedlitz Aglaia M E E, 2011, ISRN Neurol, V2011, P627081, DOI 10.5402/2011/627081; Zetlitz AM, 2013, THESIS RADBOUD U NIJ; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	52	15	16	0	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2015	96	6					1056	1063		10.1016/j.apmr.2014.12.010			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CK7FM	WOS:000356398200012	25559057				2021-06-18	
J	Stevanovic, A; Schmitz, S; Rossaint, R; Schurholz, T; Coburn, M				Stevanovic, Ana; Schmitz, Sabine; Rossaint, Rolf; Schuerholz, Tobias; Coburn, Mark			CONSORT Item Reporting Quality in the Top Ten Ranked Journals of Critical Care Medicine in 2011: A Retrospective Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; INTERVENTION; STATEMENT; ADHERENCE; GUIDELINES; REVIEWS	Introduction Reporting randomised controlled trials is a key element in order to disseminate research findings. The CONSORT statement was introduced to improve the reporting quality. We assessed the adherence to the CONSORT statement of randomised controlled trials published 2011 in the top ten ranked journals of critical care medicine (ISI Web of Knowledge 2011, Thomson Reuters, London UK). Methods Design. We performed a retrospective cross sectional data analysis. Setting. This study was executed at the University Hospital of RWTH, Aachen. Participants. We selected the following top ten listed journals according to ISI Web of Knowledge (Thomson Reuters, London, UK) critical care medicine ranking in the year 2011: American Journal of Respiratory and Critical Care Medicine, Critical Care Medicine, Intensive Care Medicine, CHEST, Critical Care, Journal of Neurotrauma, Resuscitation, Pediatric Critical Care Medicine, Shock and Minerva Anestesiologica. Main outcome measures. We screened the online table of contents of each included journal, to identify the randomised controlled trials. The adherence to the items of the CONSORT Checklist in each trial was evaluated. Additionally we correlated the citation frequency of the articles and the impact factor of the respective journal with the amount of reported items per trial. Results We analysed 119 randomised controlled trials and found, 15 years after the implementation of the CONSORT statement, that a median of 61,1% of the checklist-items were reported. Only 55.5% of the articles were identified as randomised trials in their titles. The citation frequency of the trials correlated significantly (rs = 0,433; p<0,001 and r = 0,331; p<0,001) to the CONSORT statement adherence. The impact factor showed also a significant correlation to the CONSORT adherence (r = 0,386; p<0,001). Conclusion The reporting quality of randomised controlled trials in the field of critical care medicine remains poor and needs considerable improvement.	[Stevanovic, Ana; Schmitz, Sabine; Rossaint, Rolf; Coburn, Mark] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Schuerholz, Tobias] Univ Hosp Aachen, Dept Intens Care & Intermediate Care, Aachen, Germany	Coburn, M (corresponding author), Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany.	mcoburn@ukaachen.de	Schuerholz, Tobias/E-8071-2011	Schuerholz, Tobias/0000-0003-3830-3499; Coburn, Mark/0000-0002-7930-0270			Ahmadzadeh J., 2013, Shiraz E Medical Journal, V14, P130; Altman DG, 2005, BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Dechartres A, 2011, J CLIN EPIDEMIOL, V64, P136, DOI 10.1016/j.jclinepi.2010.04.015; Elia N, 2011, EUR J ANAESTH, V28, P478, DOI 10.1097/EJA.0b013e3283461868; Geha NN, 2013, RESP CARE, V58, P1899, DOI 10.4187/respcare.02379; Gray R, 2012, ANN ROY COLL SURG, V94, P388, DOI 10.1308/003588412X13171221592339; Hill CL, 2002, J CLIN EPIDEMIOL, V55, P783, DOI 10.1016/S0895-4356(02)00440-7; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hopewell S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c723; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Latronico N, 2013, INTENS CARE MED, V39, P1386, DOI 10.1007/s00134-013-2947-3; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Munter NH, 2015, EUR J ANAESTH, V32, P117, DOI 10.1097/EJA.0000000000000176; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sibbald B, 1998, BRIT MED J, V316, P201; Silverman B. W., 1998, DENSITY ESTIMATION S; To MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084779; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008; Wager E, 2014, EUR J ANAESTH, V31, P397, DOI 10.1097/EJA.0000000000000084	29	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128061	10.1371/journal.pone.0128061			16	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ0SC	WOS:000355187300076	26020246	DOAJ Gold, Green Published			2021-06-18	
J	Saluja, RS; Chen, JK; Gagnon, IJ; Keightley, M; Ptito, A				Saluja, Rajeet Singh; Chen, Jen-Kai; Gagnon, Isabelle J.; Keightley, Michelle; Ptito, Alain			Navigational Memory Functional Magnetic Resonance Imaging: A Test for Concussion in Children	JOURNAL OF NEUROTRAUMA			English	Article						fMRI; children; navigational memory; concussion	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; FMRI; MRI; SPORTS; PERFORMANCE; SYMPTOMS; RECOVERY	Concussions are high incidence injuries with potentially devastating consequences. Youths are at risk because of a higher threat of repeated injury, and cumulative effects of concussions exist, making accurate diagnosis and follow-up essential. This study examines a navigational memory functional magnetic resonance imaging (fMRI) task to determine whether activation differences exist between children with concussion and uninjured controls. Fifty adolescents were recruited-35 controls and 15 with concussion. All subjects underwent structural and fMRI testing using our navigational memory task, and a battery of neuropsychological testing. The activation patterns of the 15 subjects with concussion were compared with those of 15 age and sex-matched controls. Subtraction and regression analyses were performed using the matched controls along with scatter-plots using means and 95% quantiles of the 35 controls. While no differences were seen with neuropsychological testing or task performance, subjects with concussion had significantly diminished activation in the retrosplenial, thalamic, and parahippocampal areas bilaterally, along with the right dorsolateral prefrontal cortex and left precuneus. Interestingly, they had increased activation in the left hippocampus and right middle temporal gyrus. Regression analysis demonstrated negative correlations between activation and post-concussive symptoms in the left premotor cortex, superior and inferior parietal lobules, and parahippocampal gyrus. Subjects with concussion show both diminished and increased activation in specific cerebral regions, differentiating them from controls. This is one of the first studies to look at such a task using fMRI and its applicability in testing for concussion in children. These findings support navigational memory fMRI as a potential objective test for concussions.	[Saluja, Rajeet Singh; Chen, Jen-Kai; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Hlth Ctr Res Inst, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Gagnon, Isabelle J.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3A 2B4, Canada; [Gagnon, Isabelle J.] McGill Univ, Ctr Hlth, Trauma Programs, Montreal Childrens Hosp, Montreal, PQ H3A 2B4, Canada; [Gagnon, Isabelle J.] McGill Univ, Ctr Hlth, Div Gen Pediat, Montreal Childrens Hosp, Montreal, PQ H3A 2B4, Canada; [Keightley, Michelle] Univ Toronto, Bloorview Res Inst, Holland Bloorview Kids Rehabil Hosp, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada	Ptito, A (corresponding author), McGill Univ, Dept Neurol Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	alain.ptito@mcgill.ca	Meijer, Anna/K-5118-2016		Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Frank Litvack Fellowship for Clinician Scientists; Fonds de recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec; CIHRCanadian Institutes of Health Research (CIHR) [231257]	This study was supported by grants from the Canadian Institutes of Health Research. R.S.S. was a recipient of the Frank Litvack Fellowship for Clinician Scientists and an award from the Fonds de recherche du Quebec - Sante for resident physician scientists. J- K.C. was a recipient of a postdoctoral award from Fonds de recherche du Quebec-Sante. IG is supported by a career award from the Fonds de recherche du Quebec-Sante. A.P. and I.G. are supported by CIHR grant #231257. The neuropsychological testing was performed by Dr. Gabriel Leonard at the Montreal Neurological Institute.	Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iaria G, 2007, EUR J NEUROSCI, V25, P890, DOI 10.1111/j.1460-9568.2007.05371.x; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Mami Ahmed G, 2008, Adv Pediatr, V55, P385, DOI 10.1016/j.yapd.2008.07.011; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Spiers HJ, 2007, NEUROSCIENCE, V149, P7, DOI 10.1016/j.neuroscience.2007.06.056; Steer, 2005, BECK YOUTH INVENTORI; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.3.CO;2-I; Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395	33	15	15	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2015	32	10					712	722		10.1089/neu.2014.3470			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CH3ZP	WOS:000353970200006	25270364				2021-06-18	
J	Mrazik, M; Perra, A; Brooks, BL; Naidu, D				Mrazik, Martin; Perra, Andrea; Brooks, Brian L.; Naidu, Dhiren			Exploring Minor Hockey Players' Knowledge and Attitudes Toward Concussion: Implications for Prevention	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attitudes; concussion; knowledge; minor hockey; traumatic brain injury	SPORT-RELATED CONCUSSION; EDUCATIONAL INTERVENTION; HEAD-INJURY; POPULATION; SYMPTOMS; ATHLETE; COACHES	Objective: To evaluate minor hockey players' attitudes and knowledge about sport concussions. Participants: Male and female Pee Wee, Bantam, and Midget level players (n = 183) participating in minor hockey and a comparison group of non-hockey players (n = 57). Design: Survey. Main Measures: Player knowledge and attitudes were evaluated with a standardized questionnaire developed for the purpose of this study. Descriptive statistics including cross-tabulations and proportion comparisons were used to report the data. Results: Players had foundational knowledge about concussions; however, more than half underestimated the prevalence and more than 30% were unaware of return to play protocols. Although nearly all players knew what they "should" do when concussed, 33% did not follow recommendations. Players reported more concern and appreciation of the seriousness of concussion than non-players, but they tended to minimize their vulnerability. The most common and helpful information sources were parents, doctors, and coaches, and therefore knowledge translation efforts should target theses audiences. Conclusion: Young athletes continue to demonstrate gaps in their knowledge of concussions. In addition, attitudes toward concussion suggest a developmental trajectory with younger athletes being most likely to ignore current recommended guidelines.	[Mrazik, Martin; Perra, Andrea] Univ Alberta, Dept Educ Psychol, Edmonton, AB T6G 2G5, Canada; [Brooks, Brian L.] Univ Calgary, Fac Med, Neurosci Brain Injury & Rehabil Programs, Alberta Childrens Hosp,Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Fac Med, Neurosci Brain Injury & Rehabil Programs, Alberta Childrens Hosp,Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB, Canada; [Naidu, Dhiren] Univ Alberta, Dept Phys Med & Rehabil, Sport Med, Edmonton, AB T6G 2M7, Canada	Mrazik, M (corresponding author), Univ Alberta, Dept Educ Psychol, 6-135 Educ North, Edmonton, AB T6G 2G5, Canada.	mrazik@ualberta.ca					Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *CDCP, HEADS CONC YOUTH SPO; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Echlin P. S., 2010, NEUROSURG FOCUS, V29, P1, DOI DOI 10.3171/2010.9FOCUS10187; ELKIND D, 1985, DEV REV, V5, P218, DOI 10.1016/0273-2297(85)90010-3; Emery CA, 2006, CLIN J SPORT MED, V16, P514, DOI 10.1097/01.jsm.0000251179.90840.58; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Morrongiello BA, 2008, INJURY PREV, V14, P176, DOI 10.1136/ip.2007.016782; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175	25	15	15	0	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					219	227		10.1097/HTR.0000000000000018			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100134	24590152				2021-06-18	
J	Sabre, L; Remmer, S; Adams, A; Vali, M; Rekand, T; Asser, T; Korv, J				Sabre, L.; Remmer, S.; Adams, A.; Vaeli, M.; Rekand, T.; Asser, T.; Korv, J.			Impact of fatal cases on the epidemiology of traumatic spinal cord injury in Estonia	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						early mortality; incidence; traumatic spinal cord injury	BRAIN-INJURY	Background and purposeMost epidemiological studies on traumatic spinal cord injury (TSCI) have not included patients who die before hospitalization. The aim of the research was to study the incidence of TSCI by including the individuals who die at the scene of the accident in addition to data retrieved from all hospitals in Estonia. MethodsMedical records of patients with TSCI from all hospitals in Estonia from 2005 to 2007 were studied. With collaboration from the Estonian Forensic Science Institute the data of the victims of TSCI who died before hospitalization were included. ResultsFrom 2005 to 2007, 391 TSCI cases were identified: 183 patients were found retrospectively from medical records and 208 cases were detected from autopsy reports. Fifty-three per cent of patients died before hospitalization. The annual incidence rate was 97.0 per million population (95% confidence interval 87.4-106.6). The mean age at injury was 44.418.7years. Motor vehicle accidents were the leading cause of TSCI amongst the individuals who died before hospitalization (75%). Falls accounted for the highest number of TSCIs (43%) amongst the patients who reached hospital. ConclusionsOur study shows that, when the cases that die at the scene of the accident are included, the incidence of TSCI in Estonia rises from 39.7 to 97.0 per million population.	[Sabre, L.; Asser, T.; Korv, J.] Univ Tartu, Dept Neurol & Neurosurg, EE-51014 Tartu, Estonia; [Remmer, S.; Adams, A.; Vaeli, M.] Estonian Forens Sci Inst, Tallinn, Estonia; [Remmer, S.; Adams, A.; Vaeli, M.] Univ Tartu, Inst Pathol Anat & Forens Med, EE-51014 Tartu, Estonia; [Rekand, T.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway	Sabre, L (corresponding author), Univ Tartu, Dept Neurol & Neurosurg, 8 L Puusepa St, EE-51014 Tartu, Estonia.	liis.sabre@ut.ee	Korv, Janika/I-4395-2015; Rekand, Tiina/A-6201-2008; Asser, Toomas/G-8446-2015; Sabre, Liis/D-7931-2014; Rekand, Tiina/V-7189-2019	Korv, Janika/0000-0002-6074-0727; Rekand, Tiina/0000-0002-2506-9501; Sabre, Liis/0000-0002-5727-8404; 	Estonian Science Foundation [7868]; Estonian IUT2-4 grant	The study was supported by the Estonian Science Foundation research grant No. 7868 and by an Estonian IUT2-4 grant. The authors would like to thank Anne Selart for valuable statistical assistance.	Bernhard M, 2005, RESUSCITATION, V66, P127, DOI 10.1016/j.resuscitation.2005.03.005; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; GRIFFIN MR, 1985, AM J EPIDEMIOL, V121, P884, DOI 10.1093/oxfordjournals.aje.a114058; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hagen EM, 2005, ACTA NEUROL SCAND, V112, P42, DOI 10.1111/j.1600-0404.2005.00430.x; Martins F, 1998, SPINAL CORD, V36, P574, DOI 10.1038/sj.sc.3100657; National Spinal Cord Injury Statistical Centre (NSCISC), 2010, ANN STAT REP 2010 CO; Sabre L, 2013, EUR J NEUROL, V20, P293, DOI 10.1111/j.1468-1331.2012.03845.x; Sabre L, 2012, SPINAL CORD, V50, P755, DOI 10.1038/sc.2012.54; Sabre L, 2013, J SPINAL CORD MED, V36, P687, DOI 10.1179/2045772313Y.0000000120; Surkin J, 2000, SPINE, V25, P716, DOI 10.1097/00007632-200003150-00011; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; THURMAN DJ, 1994, PARAPLEGIA, V32, P665, DOI 10.1038/sc.1994.107; van Asbeck FWA, 2000, SPINAL CORD, V38, P420, DOI 10.1038/sj.sc.3101003; van den Berg MEL, 2010, J NEUROTRAUM, V27, P1517, DOI 10.1089/neu.2009.1138; Warren S, 1995, Alaska Med, V37, P11; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	17	15	15	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	MAY	2015	22	5					768	772		10.1111/ene.12478			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CF5BC	WOS:000352568600008	24948203				2021-06-18	
J	Upchurch, C; Morgan, CD; Umfress, A; Yang, G; Riederer, MF				Upchurch, Cameron; Morgan, Clinton D.; Umfress, Allison; Yang, George; Riederer, Mark F.			Discharge Instructions for Youth Sports-Related Concussions in the Emergency Department, 2004 to 2012	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						youth sports; concussion; discharge instructions	UNITED-STATES	Objective: To evaluate the effect of the Centers for Disease Control and Prevention (CDC) Heads-Up concussion campaign on appropriateness of discharge instructions for youth sports-related concussion (SRC) patients presenting to a pediatric emergency department (ED). Design: Retrospective cohort study. Setting: Pediatric ED. Patients: Children up to 18 years. Assessment of Risk Factors: A retrospective chart review was conducted on patients evaluated from 2004 to 2012. Patients were selected by ICD-9 code for having a concussion during a sporting activity. Main Outcome Measures: Discharge instructions were reviewed for recommendations for cognitive rest, physical rest, primary care physician follow-up, and referral to a concussion specialist or center. Results: There were 497 youth SRCs from 392 908 total ED visits. Overall, only 66% had appropriate discharge recommendations. This improved to 75% after 2010, which was not statistically significant (odds ratio = 1.02, P = 0.179). Only 4% of patients received a recommendation of cognitive rest, which only increased to 12% of the patients seen after 2010. Finally, referrals to a sports concussion specialist or center dramatically increased from an average of 8% to 43% after 2010. Conclusions: Even with the CDC Heads-Up campaign on concussion education, there is still need to improve appropriateness of discharge instructions for youth SRCs. There have been dramatic increases in referrals to sports concussion specialists and centers after 2010.	[Upchurch, Cameron; Morgan, Clinton D.; Umfress, Allison; Yang, George] Vanderbilt Univ Sch Med, Nashville, TN USA; [Riederer, Mark F.] Univ Michigan, CS Mott Childrens Hosp, Dept Pediat Orthopaed Surg, Ann Arbor, MI 48109 USA	Riederer, MF (corresponding author), Univ Michigan, CS Mott Childrens Hosp, Dept Pediat Orthopaed Surg, 1540 E Hosp Dr, Ann Arbor, MI 48109 USA.	mriedere@med.umich.edu		Morgan, Clinton/0000-0002-7511-0488			Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Centers for Disease Control and Prevention, 2010, HEADS SCH KNOW YOUR; Centers for Disease Control National Football League and CDC Foundation, 2011, HEADS CLIN ADDR CONC; Faul M.D., 2010, TRAUMATIC BRAIN INJU; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; U.S. Department of Health and Human Services and Centers for Disease Control and Prevention, 2007, HEADS FACTS PHYS MIL	10	15	15	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2015	25	3					297	299		10.1097/JSM.0000000000000123			4	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	CH3EX	WOS:000353911700016	24977953				2021-06-18	
J	Gu, Y; Zhao, Y; Qian, K; Sun, M				Gu, Y.; Zhao, Y.; Qian, K.; Sun, M.			TAURINE ATTENUATES HIPPOCAMPAL AND CORPUS CALLOSUM DAMAGE, AND ENHANCES NEUROLOGICAL RECOVERY AFTER CLOSED HEAD INJURY IN RATS	NEUROSCIENCE			English	Article						taurine; closed head injury; calpain; corpus callosum; hippocampus	TRAUMATIC BRAIN-INJURY; DOWN-REGULATING CALPAIN; MYELIN BASIC-PROTEIN; ALPHA-II-SPECTRIN; WHITE-MATTER; BEHAVIORAL DEFICITS; CALPASTATIN; PATHOPHYSIOLOGY; DEGRADATION; PROTEOLYSIS	The protective effects of taurine against closed head injury (CHI) have been reported. This study was designed to investigate whether taurine reduced white matter damage and hippocampal neuronal death through suppressing calpain activation after CHI in rats. Taurine (50 mg/kg) was administered intravenously 30 min and 4 h again after CHI. It was found that taurine lessened the corpus callosum damage, attenuated the neuronal cell death in hippocampal CA1 and CA3 subfields and improved the neurological functions 7 days after CHI. Moreover, it suppressed the over-activation of calpain, enhanced the levels of calpastatin, and reduced the degradation of neurofilament heavy protein, myelin basic protein and alpha II-spectrin in traumatic tissue 24 h after CHI. These data confirm the protective effects of taurine against gray and white matter damage due to CHI, and suggest that down-regulating calpain activation could be one of the protective mechanisms of taurine against CHI. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Gu, Y.; Zhao, Y.; Sun, M.] Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, China Natl Clin Res Ctr Neurol Dis, Beijing Neurosurg Inst,Dept Neuropharmacol, Beijing 100050, Peoples R China; [Qian, K.] Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, China Natl Clin Res Ctr Neurol Dis, Beijing Tiantan Hosp,Dept Neurosurg, Beijing 100050, Peoples R China	Sun, M (corresponding author), Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, China Natl Clin Res Ctr Neurol Dis, Beijing Neurosurg Inst,Dept Neuropharmacol, 6 Tiantan Xili, Beijing 100050, Peoples R China.	sunming999@yahoo.com			National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2013BAI091303]	We would like to express our gratitude to Ms Jingjing Yang for her help in biochemical assay. This study was supported by National Key Technology Research and Development Program of the Ministry of Science and Technology of China (No. 2013BAI091303).	Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Bartosik-Psujek H, 2001, Ann Univ Mariae Curie Sklodowska Med, V56, P389; Blomgren K, 1999, J BIOL CHEM, V274, P14046, DOI 10.1074/jbc.274.20.14046; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cernak I, 2004, NEURORX, V2, P410; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cheng CM, 1998, J NEUROSCI, V18, P5673; El Idrissi A, 2004, NEUROCHEM RES, V29, P189, DOI 10.1023/B:NERE.0000010448.17740.6e; El Idrissi A, 2003, ADV EXP MED BIOL, V526, P527; Foos TM, 2002, NEUROCHEM RES, V27, P21, DOI 10.1023/A:1014890219513; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOODMAN SR, 1986, AM J PHYSIOL, V250, pC347; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101; Kamisaki Y, 1996, ADV EXP MED BIOL, V403, P445; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; LEE MK, 1994, CURR OPIN CELL BIOL, V6, P34, DOI 10.1016/0955-0674(94)90113-9; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MASSARO AR, 1990, ITAL J NEUROL SCI, V11, P537, DOI 10.1007/BF02337436; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; MOSS DE, 1991, PHARMACOL BIOCHEM BE, V39, P495, DOI 10.1016/0091-3057(91)90214-M; Palmi M, 1999, BIOCHEM PHARMACOL, V58, P1123, DOI 10.1016/S0006-2952(99)00183-5; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Park SH, 2006, J MED FOOD, V9, P33, DOI 10.1089/jmf.2006.9.33; PERLMUTTER LS, 1990, J COMP NEUROL, V296, P269, DOI 10.1002/cne.902960207; Pinder JC, 2000, NATURE, V406, P253, DOI 10.1038/35018679; Posmantur RM, 2000, EXP NEUROL, V161, P15, DOI 10.1006/exnr.1999.7244; Rami A, 2003, NEUROSCI RES, V47, P373, DOI 10.1016/j.neures.2003.07.002; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Richter-Landsberg C, 2000, J NEUROSCI RES, V59, P11, DOI 10.1002/(SICI)1097-4547(20000101)59:1<11::AID-JNR2>3.0.CO;2-O; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Salinska E, 2005, FOLIA NEUROPATHOL, V43, P322; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Sun M, 2014, J NEUROTRAU IN PRESS; Sun M, 2008, CELL MOL NEUROBIOL, V28, P593, DOI 10.1007/s10571-007-9183-8; Sun M, 2011, AMINO ACIDS, V40, P1419, DOI 10.1007/s00726-010-0751-8; Sun M, 2009, NEUROCHEM INT, V54, P339, DOI 10.1016/j.neuint.2008.12.017; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; WU JY, 1994, ADV EXP MED BIOL, V359, P289; YOSHIDA K, 1993, BIOCHIM BIOPHYS ACTA, V1182, P215, DOI 10.1016/0925-4439(93)90143-O	59	15	16	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 16	2015	291						331	340		10.1016/j.neuroscience.2014.09.073			10	Neurosciences	Neurosciences & Neurology	CD7VN	WOS:000351303100029	25290011				2021-06-18	
J	Llorens, R; Noe, E; Ferri, J; Alcaniz, M				Llorens, Roberto; Noe, Enrique; Ferri, Joan; Alcaniz, Mariano			Videogame-based group therapy to improve self-awareness and social skills after traumatic brain injury	Journal of NeuroEngineering and Rehabilitation			English	Article						Self-awareness; Social skills; Traumatic brain injury; Rehabilitation; Neuropsychology; Virtual reality	RANDOMIZED CONTROLLED-TRIAL; IMPAIRED AWARENESS; INTERVENTIONS; MANAGEMENT; FEEDBACK; DEFICITS; COMPETENCE; KNOWLEDGE; PROGRAM; PEOPLE	Background: This study determines the feasibility of different approaches to integrative videogame-based group therapy for improving self-awareness, social skills, and behaviors among traumatic brain injury (TBI) victims and retrieves participant feedback. Methods: Forty-two adult TBI survivors were included in a longitudinal study with a pre- and post-assessments. The experimental intervention involved weekly one-hour sessions conducted over six months. Participants were assessed using the Self-Awareness Deficits Interview (SADI), Patient Competency Rating Scale (PCRS), the Social Skills Scale (SSS), the Frontal Systems Behavior Scale (FrSBe), the System Usability Scale (SUS). Pearson's chi-squared test (chi(2)) was applied to determine the percentage of participants who had changed their clinical classification in these tests. Feedback of the intervention was collected through the Intrinsic Motivation Inventory (IMI). Results: SADI results showed an improvement in participant perceptions of deficits (chi(2) = 5.25, p < 0.05), of their implications (chi(2) = 4.71, p < 0.05), and of long-term planning (chi(2) = 7.86, p < 0.01). PCRS results confirm these findings (chi(2) = 5.79, p < 0.05). SSS results were also positive with respect to social skills outcomes (chi(2) = 17.52, p < 0.01), and FrSBe results showed behavioral improvements (chi(2) = 34.12, p < 0.01). Participants deemed the system accessible (80.43 +/- 8.01 out of 100) and regarded the intervention as interesting and useful (5.74 +/- 0.69 out of 7). Conclusions: Integrative videogame-based group therapy can improve self-awareness, social skills, and behaviors among individuals with chronic TBI, and the approach is considered effective and motivating.	[Llorens, Roberto; Alcaniz, Mariano] Univ Politecn Valencia, Inst Interuniv Invest Bioingn & Tecnol Orientada, E-46022 Valencia, Spain; [Llorens, Roberto; Noe, Enrique; Ferri, Joan] Fdn Hosp NISA, Serv Neurorrehabil, Valencia 46011, Spain; [Llorens, Roberto; Noe, Enrique; Ferri, Joan] Fdn Hosp NISA, Dano Cerebral Hosp NISA, Valencia 46011, Spain; [Alcaniz, Mariano] Univ Jaume 1, Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr, Castellon de La Plana 12071, Spain	Llorens, R (corresponding author), Univ Politecn Valencia, Inst Interuniv Invest Bioingn & Tecnol Orientada, Camino Vera S-N, E-46022 Valencia, Spain.	rllorens@labhuman.com	Llorens, Roberto/AAL-2604-2021; Alcaniz, Mariano L./I-9659-2016	Llorens, Roberto/0000-0002-8677-8707; Alcaniz, Mariano L./0000-0001-9207-0636; Noe Sebastian, Enrique/0000-0002-2547-8727	Ministerio de Economia y Competitividad of Spain [IDI-20110844, TIN2013-44741-R]; Ministerio de Educacion y Ciencia of SpainSpanish GovernmentEuropean Commission [SEJ2006-14301/PSIC]; Excellence Research Program PROMETEO [2008-157]	This study was funded in part by Ministerio de Economia y Competitividad of Spain (Project TEREHA, IDI-20110844; and NeuroVR, TIN2013-44741-R), by Ministerio de Educacion y Ciencia of Spain (Projects Consolider-C, SEJ2006-14301/PSIC; and "CIBER of Physiopathology of Obesity and Nutrition, an initiative of ISCIII"), and by the Excellence Research Program PROMETEO (Generalitat Valenciana. Conselleria de Educacion, 2008-157).	Alexy WD, 1983, COGNITIVE REHABILITA, V1, P8; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bennett T L, 1997, Appl Neuropsychol, V4, P55, DOI 10.1207/s15324826an0401_7; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Brooke J., 1996, IND USABILITY EVALUA, V189, P4; CARBERRY H, 1983, COGNITIVE REHABILITA, V1, P5; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chittum WR, 1996, BRAIN INJURY, V10, P763; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [10.1097/00001199-198909000-00008, DOI 10.1097/00001199-198909000-00008]; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Fleming JM, 1996, BRAIN INJURY, V10, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GISMERO E, 2000, ESCALA HABILIDADES S; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Lucas SE, 2005, AUST OCCUP THER J, V52, P160, DOI DOI 10.1111/J.1440-1630.2005.00485.X; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McGraw-Hunter M, 2006, BRAIN INJURY, V20, P1061, DOI 10.1080/02699050600912163; Nakase-Thompson R, 2005, BRAIN INJURY, V19, P685, DOI 10.1080/02699050400025331; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; PLANT RW, 1985, J PERS, V53, P435, DOI 10.1111/j.1467-6494.1985.tb00375.x; Pollens RD, 1988, COGNITIVE REHABILITA, V6, P26; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Schefft BK, 1997, CLIN NEUROPSYCHOLOGY, P237; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Schrijnemaekers AC, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/01.HTR.0000438117.63852.b4; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Simmond M, 2003, BRIT J OCCUPATIONAL, V66, P447, DOI DOI 10.1177/030802260306601003; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Zhou J, 1996, J HEAD TRAUMA REHAB, V11, P51, DOI 10.1097/00001199-199602000-00007	50	15	15	1	27	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	APR 11	2015	12								37	10.1186/s12984-015-0029-1			8	Engineering, Biomedical; Neurosciences; Rehabilitation	Engineering; Neurosciences & Neurology; Rehabilitation	CG5IW	WOS:000353325700001	25889914	DOAJ Gold, Green Published			2021-06-18	
J	Dias, C; Gaio, AR; Monteiro, E; Barbosa, S; Cerejo, A; Donnelly, J; Felgueiras, O; Smielewski, P; Paiva, JA; Czosnyka, M				Dias, Celeste; Rita Gaio, A.; Monteiro, Elisabete; Barbosa, Silvina; Cerejo, Antonio; Donnelly, Joseph; Felgueiras, Oscar; Smielewski, Peter; Paiva, Jose-Artur; Czosnyka, Marek			Kidney-Brain Link in Traumatic Brain Injury Patients? A preliminary report	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Cerebrovascular pressure reactivity index; Creatinine; Renal clearance; Outcome	AUGMENTED RENAL CLEARANCE; CEREBRAL PERFUSION-PRESSURE; CRITICALLY-ILL PATIENTS; CREATININE CLEARANCE; GLOMERULAR-FILTRATION; SERUM CREATININE; BLOOD-FLOW; AUTOREGULATION; REACTIVITY; DISEASE	Kidney hyperfiltration with augmented renal clearance is frequently observed in patients with traumatic brain injury. The aim of this study is to report preliminary findings about the relationship between brain autoregulation impairment, estimated kidney glomerular filtration rate and outcome in critically ill patients after severe traumatic brain injury. Data collected from a cohort of 18 consecutive patients with severe traumatic brain injury managed with ICP monitoring in a Neurocritical Care Unit, were retrospectively analyzed. Early morning blood tests were performed for routine chemistry assessments and we analyzed creatinine and estimated creatinine clearance, osmolarity, and sodium. Daily norepinephrine dose, protein intake, and water balance were documented. Time average of brain monitoring data (intracranial pressure, cerebral perfusion pressure, and cerebrovascular reactivity pressure index-PRx) were calculated for 6 h before blood sample tests. Patient outcome was evaluated using Glasgow outcome scale at 6-month follow-up, considering nonfatal outcome if GOS a parts per thousand yen3 and fatal outcome if GOS < 3. Multiple linear regression models were used to study the crude and adjusted effects of the above variables on PRx throughout time. A total of 199 complete daily observations from 18 adult consecutive multiple trauma patients with severe traumatic brain injury were analyzed. At hospital admission, the median post-resuscitation Glasgow coma score was 6 (range 3-12), mean SAPSII score was 44.65 with predicted mortality of 36 %. Hospital mortality rate was 27 % and median GOS at 6 month after discharge was 3. Creatinine clearance (CrCl) was found to have a negative correlation with PRx (Pearson correlation-0.82), with statistically significant crude (p < 0.001) and adjusted (p = 0.001) effects. For each increase of 10 ml/min in CrCl (estimated either by the Cockcroft-Gault or by Modification of Diet in Renal Disease Study equations) a mean decrease in PRx of approximately 0.01 was expected. Amongst possible confounders only norepinephrine was shown to have a significant effect. Mean PRx value for outcome fatal status was greater than mean PRx for nonfatal status (p < 0.05), regardless of the model used for the CrCl estimation. Better cerebral autoregulation evaluated with cerebrovascular PRx is significantly correlated with augmented renal clearance in TBI patients and associates with better outcome.	[Dias, Celeste; Rita Gaio, A.; Monteiro, Elisabete; Barbosa, Silvina; Cerejo, Antonio; Donnelly, Joseph; Felgueiras, Oscar; Smielewski, Peter; Paiva, Jose-Artur; Czosnyka, Marek] Hosp Sao Joao, Dept Intens Care, Neurocrit Care Unit, Oporto, Portugal	Dias, C (corresponding author), Hosp Sao Joao, Dept Intens Care, Neurocrit Care Unit, Oporto, Portugal.	mceleste.dias@gmail.com	Donnelly, Joseph/N-6803-2019; Dias, Celeste/L-9901-2014; Donnelly, Joseph/E-9235-2018; Paiva, Jose-Artur/AAO-9730-2021; Dias, Celeste/AAD-8711-2019; Dias, Celeste/AAV-3820-2020	Donnelly, Joseph/0000-0002-6502-8069; Dias, Celeste/0000-0003-0340-9808; Donnelly, Joseph/0000-0002-6502-8069; Dias, Celeste/0000-0003-0340-9808; Smielewski, Peter/0000-0001-5096-3938; Paiva, Jose-Artur/0000-0003-4323-0220; czosnyka, marek/0000-0003-2446-8006; Gaio, Rita/0000-0003-3906-0775; Felgueiras, Oscar/0000-0001-9010-2075	European Regional Development Fund through the program COMPETE; Portuguese Government through the FCT-Fundacao para a Ciencia e a Tecnologia [PEst-C/MAT/UI0144/2013]; Woolf Fisher Scholarship; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390] Funding Source: researchfish	The software for brain monitoring ICM + (www.neurosurg.cam.ac.uk/imcplus) is licensed by the University of Cambridge (Cambridge Enterprise). Peter Smielewski and Marek Czosnyka have financial interests in a part of the licensing fee. Rita Gaio and Oscar Felgueiras were partially funded by the European Regional Development Fund through the program COMPETE and by the Portuguese Government through the FCT-Fundacao para a Ciencia e a Tecnologia under the project PEst-C/MAT/UI0144/2013. Joseph Donnelly is supported by a Woolf Fisher Scholarship.	Albanese J, 2004, CHEST, V126, P534, DOI 10.1378/chest.126.2.534; [Anonymous], 2012, R LANG ENV STAT COMP; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Baptista JP, 2012, INT J ANTIMICROB AG, V39, P420, DOI 10.1016/j.ijantimicag.2011.12.011; Baptista JP, 2011, CRIT CARE, V15, DOI 10.1186/cc10262; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Davenport A, 2008, BLOOD PURIFICAT, V26, P526, DOI 10.1159/000167800; Delanaye P, 2010, ANN BIOL CLIN-PARIS, V68, P531, DOI 10.1684/abc.2010.0479; Gao J, 2014, CLIN SCI, V127, P135, DOI 10.1042/CS20130396; Ito S, 2009, HYPERTENS RES, V32, P115, DOI 10.1038/hr.2008.27; JENNETT B, 1975, LANCET, V1, P480; Jones GR, 2003, CLIN BIOCHEM REV, V24, P95; Just A, 2007, AM J PHYSIOL-REG I, V292, pR1, DOI 10.1152/ajpregu.00332.2006; LASSEN NA, 1964, CIRC RES, V15, P201; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Loutzenhiser R, 2006, AM J PHYSIOL-REG I, V290, pR1153, DOI 10.1152/ajpregu.00402.2005; Minkute R, 2013, J CLIN PHARM THER, V38, P462, DOI 10.1111/jcpt.12088; Minville V, 2011, CRIT CARE, V15, DOI 10.1186/cc10013; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI [10.4061/2011/306189, DOI 10.4061/2011/306189]; Nishimura Y, 2000, BRAIN RES, V871, P29, DOI 10.1016/S0006-8993(00)02377-5; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Ohshima K, 2013, CURR HYPERTENS REV, V9, P99, DOI 10.2174/15734021113099990004; Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Pedersen TF, 2003, AM J PHYSIOL-HEART C, V285, pH1097, DOI 10.1152/ajpheart.00098.2003; Rao V, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-78; Rhee CJ, 2012, J APPL PHYSIOL, V113, P307, DOI 10.1152/japplphysiol.00024.2012; Schiller A, 2010, NEPHROL DIAL TRANSPL, V25, P1370, DOI 10.1093/ndt/gfq068; Shorr AF, 2014, CRIT CARE MED, V42, P728, DOI 10.1097/CCM.0000000000000081; Sigurdsson ST, 2014, J CEREBR BLOOD F MET, V34, P467, DOI 10.1038/jcbfm.2013.219; Smielewski P, 2005, ACT NEUR S, V95, P43; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Udy AA, 2011, NAT REV NEPHROL, V7, P539, DOI 10.1038/nrneph.2011.92; Udy AA, 2010, CLIN PHARMACOKINET, V49, P1, DOI 10.2165/11318140-000000000-00000	40	15	16	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2015	22	2					192	201		10.1007/s12028-014-0045-1			10	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CD9VK	WOS:000351447100004	25273515				2021-06-18	
J	Kronvall, E; Valdemarsson, S; Saveland, H; Nilsson, OG				Kronvall, Erik; Valdemarsson, Stig; Saveland, Hans; Nilsson, Ola G.			High Prevalence of Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Long-Term Prospective Study Using Dynamic Endocrine Testing	WORLD NEUROSURGERY			English	Article						Growth hormone deficiency; Hypopituitarism; Outcome; Pituitary deficiency; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; HYPOPITUITARISM; DEFICIENCY; NEUROENDOCRINE; DISORDERS; DIAGNOSIS	OBJECTIVE: Impaired systemic hormonal activity caused by hypothalamic and pituitary injury may contribute to neuropsychologic disturbances and poor quality of life after aneurysmal subarachnoid hemorrhage (SAH). This prospective study was designed to longitudinally evaluate long-term clinical outcome and pituitary function after SAH using dynamic tests for adrencorticotropic and somatotropic secretory capacity. METHODS: Endocrine function was assessed by basal hormonal concentrations at 6-12 months and 12-24 months after SAH. At the 12-24 months follow-up, dynamic provocative evaluation of adrenocorticotropic hormone (ACTH) and growth hormone (GH) was performed using the insulin tolerance test (ITT). In patients where ITT was contraindicated, an ACTH stimulation test was used to assess ACTH capacity, and a growth hormone releasing hormone (GHRH)-arginine stimulation test was used to assess GH capacity. RESULTS: Of 60 patients with SAH screened, 51 were included in the study, and 44 remained to be tested at the two follow-up visits. As assessed by basal hormone concentrations alone, the prevalence of pituitary dysfunction was 34% at 6-12 months and 41% at 12-24 months. When using dynamic tests (12-24 months), impaired pituitary function was detected in 43%. The ITT detected more cases of central hypoadrenalism and GH deficiency compared with the ACTH-and GHRH-arginine-stimulation tests, respectively. CONCLUSIONS: Application of dynamic endocrine tests revealed a high frequency of long-term hypothalamic-pituitary dysfunction after aneurysmal SAH. The role of pituitary dysfunction in the recovery after SAH merits further evaluation.	[Kronvall, Erik; Saveland, Hans; Nilsson, Ola G.] Lund Univ, Dept Clin Sci, Neurosurg, Lund, Sweden; [Valdemarsson, Stig] Lund Univ, Dept Clin Sci, Oncol, Lund, Sweden	Kronvall, E (corresponding author), Lund Univ, Dept Clin Sci, Neurosurg, Lund, Sweden.	erik.kronvall@med.lu.se					Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P431, DOI 10.1046/j.1365-2265.2000.01106.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Finucane FM, 2008, CLIN ENDOCRINOL, V69, P603, DOI 10.1111/j.1365-2265.2008.03240.x; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Grossman AB, 2010, J CLIN ENDOCR METAB, V95, P4855, DOI 10.1210/jc.2010-0982; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENNETT B, 1975, LANCET, V1, P480; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Nieuwkamp DJ, 2014, J NEUROL, V261, P309, DOI 10.1007/s00415-013-7192-8; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Scharbrodt W, 2009, J CLIN NEUROSCI, V16, P1409, DOI 10.1016/j.jocn.2009.01.011; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schuiling WJ, 2005, STROKE, V36, P578, DOI 10.1161/01.STR.0000154862.33213.73; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277	27	15	15	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2015	83	4					574	582		10.1016/j.wneu.2014.12.007			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG1NJ	WOS:000353039500036	25514615				2021-06-18	
J	Mysliwiec, V; Capaldi, VF; Gill, J; Baxter, T; O'Reilly, BM; Matsangas, P; Roth, BJ				Mysliwiec, Vincent; Capaldi, Vincent F., II; Gill, Jessica; Baxter, Tristin; O'Reilly, Brian M.; Matsangas, Panagiotis; Roth, Bernard J.			Adherence to Positive Airway Pressure Therapy in US Military Personnel With Sleep Apnea Improves Sleepiness, Sleep Quality, and Depressive Symptoms	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MOTOR-VEHICLE COLLISIONS; CPAP ADHERENCE; DAYTIME SLEEPINESS; NASAL CPAP; PREVALENCE; HYPOPNEA; VETERANS; OBESITY; IMPACT	Objectives: Obstructive sleep apnea (OSA) is frequently diagnosed in U.S. military personnel. OSA is associated with sleepiness, poor sleep quality, and service-related illnesses of insomnia, depression, post-traumatic stress disorder, and traumatic brain injury. Methods: Observational study of active duty military personnel with OSA and adherence to positive airway pressure (PAP) assessed with smart chip technology. Results: 58 men with mean age 36.2 +/- 7.7 years, mean body mass index 31.4 +/- 3.7 with mean apnea-hypopnea index (AHI) 19.1 +/- 19.0 are reported. 23 (39.7%) participants were adherent to PAP, and 35 (60.3%) were nonadherent. No significant differences in baseline demographics, apnea-hypopnea index, service-related illnesses, or clinical instrument scores. Military personnel adherent to PAP had significantly improved sleepiness (p = 0.007), sleep quality (p = 0.013), depressive symptoms (p = 0.01), energy/fatigue (p = 0.027), and emotional well-being (p = 0.024). Participants with moderate-severe OSA were more likely to be in the adherent group when compared with participants diagnosed with mild OSA. Conclusions: Military personnel with OSA have low adherence to PAP. Adherence is associated with improved depressive symptoms, sleepiness, sleep quality, energy/fatigue, emotional well-being, and social functioning. Future research should focus on interventions to improve the management of OSA in military personnel.	[Mysliwiec, Vincent; Baxter, Tristin; O'Reilly, Brian M.; Roth, Bernard J.] Madigan Army Med Ctr, Dept Pulm Sleep Med Crit Care, Tacoma, WA 98431 USA; [Capaldi, Vincent F., II] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Gill, Jessica] NIH, Bethesda, MD 20892 USA; [Matsangas, Panagiotis] US Navy, Postgrad Sch, Dept Operat Res, Monterey, CA 93943 USA	Mysliwiec, V (corresponding author), Madigan Army Med Ctr, Dept Pulm Sleep Med Crit Care, 9040A Fitzsimmons Ave, Tacoma, WA 98431 USA.		Gill, Gill M/Q-2020-2017		Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027] Funding Source: NIH RePORTER	The authors thank Angela Mysliwiec, MD, Madigan Army Medical Center, for editing assistance and review of the manuscript. Dr. Angela Mysliwiec did not receive compensation for her contributions. This study was supported, in part, by grant no. 60855 from the Center for Neuroscience and Regenerative Medicine.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; American Congress of Rehabilitation Medicine, DEF MILD TRAUM BRAIN; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Armed Forces Health Surveillance Center, 2010, MSMR, V17, P8; Avlonitou E, 2012, SLEEP BREATH, V16, P563, DOI 10.1007/s11325-011-0543-8; Bardwell WA, 2001, PSYCHOSOM MED, V63, P579, DOI 10.1097/00006842-200107000-00010; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Collen JF, 2012, J CLIN SLEEP MED, V8, P667, DOI 10.5664/jcsm.2260; El-Solh AA, 2010, SLEEP, V33, P1495, DOI 10.1093/sleep/33.11.1495; Findley L, 2000, AM J RESP CRIT CARE, V161, P857, DOI 10.1164/ajrccm.161.3.9812154; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gay P, 2006, SLEEP, V29, P381, DOI 10.1093/sleep/29.3.381; George CFP, 2001, THORAX, V56, P508, DOI 10.1136/thorax.56.7.508; GUILLEMINAULT C, 1977, ARCH INTERN MED, V137, P296, DOI 10.1001/archinte.137.3.296; Hartenbaum N, 2006, J OCCUP ENVIRON MED, V48, pS1, DOI 10.1097/00043764-200609001-00001; Haynes P, 2013, J CLIN SLEEP MED, V9, P424, DOI 10.5664/jcsm.2654; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; Henke KG, 2001, AM J RESP CRIT CARE, V163, P911, DOI 10.1164/ajrccm.163.4.9910025; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kjelsberg FN, 2005, SLEEP MED, V6, P341, DOI 10.1016/j.sleep.2005.02.004; Krakow B, 2000, J PSYCHOSOM RES, V49, P291, DOI 10.1016/S0022-3999(00)00147-1; Lettieri CJ, 2005, J CLIN SLEEP MED, V1, P381; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Means Melanie K, 2003, Sleep Breath, V7, P31, DOI 10.1007/s11325-003-0031-x; MILLMAN RP, 1989, J CLIN PSYCHIAT, V50, P348; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Park JG, 2011, MAYO CLIN PROC, V86, P549, DOI 10.4065/mcp.2010.0810; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Poulet C, 2009, SLEEP MED, V10, P993, DOI 10.1016/j.sleep.2009.01.007; Profant J, 2003, HEART LUNG, V32, P52, DOI 10.1067/mhl.2003.8; RAUSCHER H, 1993, CHEST, V103, P1675, DOI 10.1378/chest.103.6.1675; REYNOLDS CF, 1984, J CLIN PSYCHIAT, V45, P287; Salepci B, 2013, RESP CARE, V58, P1467, DOI 10.4187/respcare.02139; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Sawyer AM, 2011, SLEEP MED REV, V15, P343, DOI 10.1016/j.smrv.2011.01.003; Schroder Carmen M, 2005, Ann Gen Psychiatry, V4, P13, DOI 10.1186/1744-859X-4-13; Schwartz DJ, 2007, J CLIN SLEEP MED, V3, P631; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Serra MM, 2012, MIL MED, V177, P1387, DOI 10.7205/MILMED-D-12-00172; Sin DD, 2002, CHEST, V122, P1679, DOI 10.1378/chest.122.5.1679; Sinnott C, 2005, DIABETES CARE, V28, P1534, DOI 10.2337/diacare.28.6.1534; Smith TJ, 2012, OBESITY, V20, P1534, DOI 10.1038/oby.2012.25; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	54	15	15	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	APR	2015	180	4					475	482		10.7205/MILMED-D-14-00197			8	Medicine, General & Internal	General & Internal Medicine	CF6UJ	WOS:000352691600016	25826354	Bronze			2021-06-18	
J	Tang, A; Pandit, V; Fennell, V; Jones, T; Joseph, B; O'Keeffe, T; Friese, RS; Rhee, P				Tang, Andrew; Pandit, Viraj; Fennell, Vernard; Jones, Trevor; Joseph, Bellal; O'Keeffe, Terence; Friese, Randall S.; Rhee, Peter			Intracranial pressure monitor in patients with traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Intracranial pressure monitoring; Brain trauma foundation; Mortality after traumatic brain injury	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; OUTCOMES; GUIDELINES	Background: Brain Trauma Foundation (BTF) guidelines recommend intracranial pressure (ICP) monitoring for traumatic brain injury(TBI) patients with a Glasgow Coma Scale score of 8 or less with an abnormal head computed tomography, or a normal head computed tomography scan with systolic blood pressure <= 90 mm Hg, posturing, or in patients of age >= 40. The benefits of these guidelines on outcome remain unproven. We hypothesized that adherence to BTF guidelines for ICP monitoring does not improve outcomes in patients with TBI. Methods: All TBI patients with an admission Glasgow Coma Scale <= 8 admitted to our level I trauma center over a 3-y period were identified. Adherence to the individual components of our institutional TBI Bundle (ICP monitoring, SpO(2) >= 95%, PaCO2 30-39 mm Hg, systolic blood pressure >= 90 mm Hg, cerebral perfusion pressure >= 60 mm Hg, ICP <= 25mm Hg, and temperature 36 degrees C-37 degrees C) was assessed. Patients were stratified into two groups as follows: patients with ICP monitoring (ICP) and patients without ICP monitoring (no-ICP). Outcome measures were survival and discharge disposition. Multivariate regression analysis was performed. Results: We identified 2618 TBI patients, 261 of whom met the BTF criteria for ICP monitoring. After excluding those with nonsurvivable injuries (n = 67), 194 patients were available for analysis. The two groups were similar in demographics and severity of head injury. Survival rate was higher in the no-ICP group compared with that in the ICP group (98% versus 76%, P < 0.004). Non-monitored patients were discharged with higher levels of function per discharge location (28% home versus 4% home; P < 0.001). Patients without ICP monitoring were 1.21 times more likely to survive compared with that of patients with ICP monitoring (odds ratio: 1.21, 95% confidence interval [1.1-1.9], P = 0.01). In the ICP group, the overall compliance rate to the ICP and cerebral perfusion pressure goals as required by the BTF guidelines was poor. Conclusions: Our data suggest that there is a subset of patients meeting BTF criteria for ICP monitoring that do well without ICP monitoring. This finding should provoke reevaluation of the indication and utility of ICP monitoring in TBI patients. (C) 2015 Elsevier Inc. All rights reserved.	[Tang, Andrew; Pandit, Viraj; Fennell, Vernard; Jones, Trevor; Joseph, Bellal; O'Keeffe, Terence; Friese, Randall S.; Rhee, Peter] Univ Arizona, Div Trauma Emergency Surg Crit Care & Burns, Dept Surg, Tucson, AZ 85724 USA	Tang, A (corresponding author), Univ Arizona, Div Trauma Crit Care & Emergency Surg, Dept Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	atang@surgery.arizona.edu					Akopian G, 2007, AM SURGEON, V73, P447; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; CDC IPaC, 2014, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Lane PL, 2000, CAN J SURG, V43, P442; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255	15	15	16	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					565	570		10.1016/j.jss.2014.11.017			6	Surgery	Surgery	CD4OC	WOS:000351061900034	25553841				2021-06-18	
J	Solchenberger, B; Russell, C; Kremmer, E; Haass, C; Schmid, B				Solchenberger, Barbara; Russell, Claire; Kremmer, Elisabeth; Haass, Christian; Schmid, Bettina			Granulin Knock Out Zebrafish Lack Frontotemporal Lobar Degeneration and Neuronal Ceroid Lipofuscinosis Pathology	PLOS ONE			English	Article							PROGRANULIN-DEFICIENT MICE; TRAUMATIC BRAIN-INJURY; IN-VIVO; ACTIVATED MICROGLIA; EARLY MACROPHAGES; GENE-EXPRESSION; HOST-DEFENSE; MUTATIONS; MODEL; DEMENTIA	Loss of function mutations in granulin (GRN) are linked to two distinct neurological disorders, frontotemporal lobar degeneration (FTLD) and neuronal ceroid lipofuscinosis (NCL). It is so far unknown how a complete loss of GRN in NCL and partial loss of GRN in FTLD can result in such distinct diseases. In zebrafish, there are two GRN homologues, Granulin A (Grna) and Granulin B (Grnb). We have generated stable Grna and Grnb loss of function zebrafish mutants by zinc finger nuclease mediated genome editing. Surprisingly, the grna and grnb single and double mutants display neither spinal motor neuron axonopathies nor a reduced number of myogenic progenitor cells as previously reported for Grna and Grnb knock down embryos. Additionally, grna(-/-);grnb(-/-) double mutants have no obvious FTLD- and NCL-related biochemical and neuropathological phenotypes. Taken together, the Grna and Grnb single and double knock out zebrafish lack any obvious morphological, pathological and biochemical phenotypes. Loss of zebrafish Grna and Grnb might therefore either be fully compensated or only become symptomatic upon additional challenge.	[Solchenberger, Barbara; Haass, Christian; Schmid, Bettina] Univ Munich, Adolf Butenandt Inst Biochem, Munich, Germany; [Russell, Claire] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, Munich, Germany; [Haass, Christian; Schmid, Bettina] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Haass, Christian; Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany	Schmid, B (corresponding author), Univ Munich, Adolf Butenandt Inst Biochem, Munich, Germany.	Bettina.Schmid@dzne.de	Russell, Claire/A-4879-2012	Russell, Claire/0000-0002-6748-9301	International Max Planck Research School for Molecular and Cellular Life Sciences; Elite Network of Bavaria; Short Term Scientific Mission COST Action [BM0804]; Batten Disease Family Association; European Research Council under the European UnionEuropean Research Council (ERC) [321366-Amyloid];  [Sonderforschungsbereich 596]	This work was supported by the Sonderforschungsbereich 596, International Max Planck Research School for Molecular and Cellular Life Sciences (B. So.), the Elite Network of Bavaria (B. So.), a Short Term Scientific Mission COST Action BM0804 (B. So.), the Batten Disease Family Association (C.R.), the European Research Council under the European Union's Seventh Framework Program FP7/2007-2013)/ ERC Grant Agreement No. 321366-Amyloid (advanced grant to C.H.), the general legacy of Mrs. Ammer (to the Ludwig-Maximilians University/ C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Bonvicini C, 2014, NEUROBIOL AGING, V35, P1206, DOI 10.1016/j.neurobiolaging.2013.10.097; Borst LB, 2013, VET PATHOL, V50, P457, DOI 10.1177/0300985811424731; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Chen-Plotkin AS, 2010, ACTA NEUROPATHOL, V119, P111, DOI 10.1007/s00401-009-0576-2; Chitramuthu BP, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-41; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; da Rosa CE, 2010, EXP GERONTOL, V45, P449, DOI 10.1016/j.exger.2010.03.012; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; De Muynck L, 2013, NEUROBIOLOGY AGING; Del Bo R, 2011, NEUROBIOL AGING, V32, P1157, DOI 10.1016/j.neurobiolaging.2009.06.006; den Broeder MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007910; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Filiano AJ, 2013, J NEUROSCI, V33, P5352, DOI 10.1523/JNEUROSCI.6103-11.2013; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Follo C, 2013, INT J BIOCHEM CELL B, V45, P273, DOI 10.1016/j.biocel.2012.10.010; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Ghidoni R, 2012, BRAIN RES, V1476, P172, DOI 10.1016/j.brainres.2012.01.075; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Gijselinck I, 2008, HUM MUTAT, V29, P53, DOI 10.1002/humu.20651; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Huang T, 2012, BIOCHEM BIOPH RES CO, V421, P214, DOI 10.1016/j.bbrc.2012.03.139; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kleinberger G, 2013, MOL NEUROBIOL, V47, P337, DOI 10.1007/s12035-012-8380-8; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Li YH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01176; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Mackenzie IRA, 2007, ACTA NEUROPATHOL, V114, P49, DOI 10.1007/s00401-007-0223-8; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mahmood F, 2013, BRAIN, V136, P1488, DOI 10.1093/brain/awt043; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Matthews M, 2012, ILAR J, V53, P192, DOI 10.1093/ilar.53.2.192; Meijer AH, 2005, MOL IMMUNOL, V42, P1185, DOI 10.1016/j.molimm.2004.11.014; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Patterson SE, 2008, DEV DYNAM, V237, P307, DOI 10.1002/dvdy.21400; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Schmid B, 2013, J NEUROCHEM, V127, P461, DOI 10.1111/jnc.12460; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Svahn AJ, 2013, DEV NEUROBIOL, V73, P60, DOI 10.1002/dneu.22039; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tucker B, 2006, HUM MOL GENET, V15, P3446, DOI 10.1093/hmg/ddl422; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	70	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118956	10.1371/journal.pone.0118956			20	Multidisciplinary Sciences	Science & Technology - Other Topics	CE9BN	WOS:000352138500060	25785851	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Chen, LM; Liu, YH; Dong, LL; Chu, XX				Chen, Liming; Liu, Yinghui; Dong, Liangliang; Chu, Xiaoxia			Edaravone protects human peripheral blood lymphocytes from gamma-irradiation-induced apoptosis and DNA damage	CELL STRESS & CHAPERONES			English	Article						Immune depletion; Edaravone; gamma-irradiation; Apoptosis; Lymphocytes	FREE-RADICAL SCAVENGER; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; IONIZING-RADIATION; IN-VITRO; MELATONIN; PEROXIDATION; ANTIOXIDANT; PRODUCTS	Radiation-induced cellular injury is attributed primarily to the harmful effects of free radicals, which play a key role in irradiation-induced apoptosis. In this study, we investigated the radioprotective efficacy of edaravone, a licensed clinical drug and a powerful free radical scavenger that has been tested against gamma-irradiation-induced cellular damage in cultured human peripheral blood lymphocytes in studies of various diseases. Edaravone was pre-incubated with lymphocytes for 2 h prior to gamma-irradiation. It was found that pretreatment with edaravone increased cell viability and inhibited generation of gamma-radiation-induced reactive oxygen species (ROS) in lymphocytes exposed to 3 Gy gamma-radiation. In addition, gamma-radiation decreased antioxidant enzymatic activity, such as superoxide dismutase and glutathione peroxidase, as well as the level of reduced glutathione. Conversely, treatment with 100 mu M edaravone prior to irradiation improved antioxidant enzyme activity and increased reduced glutathione levels in irradiated lymphocytes. Importantly, we also report that edaravone reduced gamma-irradiation-induced apoptosis through downregulation of Bax, upregulation of Bcl-2, and consequent reduction of the Bax:Bcl-2 ratio. The current study shows edaravone to be an effective radioprotector against gamma-irradiation-induced cellular damage in lymphocytes in vitro. Finally, edaravone pretreatment significantly reduced DNA damage in gamma-irradiated lymphocytes, as measured by comet assay (% tail DNA, tail length, tail moment, and olive tail moment) (p < 0.05). Thus, the current study indicates that edaravone offers protection from radiation-induced cytogenetic alterations.	[Chen, Liming; Liu, Yinghui; Chu, Xiaoxia] Yantai Yuhuangding Hosp, Dept Hematol, Yantai 264000, Shandong, Peoples R China; [Dong, Liangliang] Yantai Yuhuangding Hosp, Dept Oncol, Yantai 264000, Shandong, Peoples R China	Chu, XX (corresponding author), Yantai Yuhuangding Hosp, Dept Hematol, 20 Yuhuangding East Rd, Yantai 264000, Shandong, Peoples R China.	xiaoxia055@yeah.net					Ando K, 2014, INT J RADIAT BIOL, V13, P1; Borek C, 2004, J NUTR, V134, p3207S; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GARRISON JC, 1988, RADIAT RES, V116, P356, DOI 10.2307/3577472; Ghosh D, 2012, J ENVIRON PATHOL TOX, V31, P155, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i2.70; Higashi Yukihito, 2006, Recent Pat Cardiovasc Drug Discov, V1, P85; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Karbownik M, 2000, P SOC EXP BIOL MED, V225, P9, DOI 10.1046/j.1525-1373.2000.22502.x; Khan A, 2013, INT J RADIAT BIOL, V89, P965, DOI 10.3109/09553002.2013.811310; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Li GY, 2013, RHEUMATOLOGY, V52, P438, DOI 10.1093/rheumatology/kes313; Lovell DP, 2008, MUTAGENESIS, V23, P171, DOI 10.1093/mutage/gen015; Lu GY, 2007, EUR POLYM J, V43, P3807, DOI 10.1016/j.eurpolymj.2007.06.016; Maurya Dharmendra K., 2006, Indian Journal of Experimental Biology, V44, P93; Nakamura T, 2008, STROKE, V39, P463, DOI 10.1161/STROKEAHA.107.486654; NATARAJAN AT, 1980, MUTAT RES, V69, P293, DOI 10.1016/0027-5107(80)90094-9; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Rezaee M, 2013, RADIAT RES, V179, P323, DOI 10.1667/RR3185.1; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Roh MI, 2011, INVEST OPHTH VIS SCI, V52, P3825, DOI 10.1167/iovs.10-6797; Satoh M, 2003, J PHARMACOL EXP THER, V305, P1183, DOI 10.1124/jpet.102.047522; Sharma S, 2006, INT J RADIAT BIOL, V82, P411, DOI 10.1080/09553000600774105; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Sheng BY, 2009, FREE RADICAL BIO MED, V46, P1362, DOI 10.1016/j.freeradbiomed.2009.02.018; Shimizu S, 2009, BJU INT, V104, P713, DOI 10.1111/j.1464-410X.2009.08471.x; Shirazi A, 2007, J RADIAT RES, V48, P263, DOI 10.1269/jrr.06070; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Spitz DR, 2011, OXIDATIVE STRESS CAN; Sueishi K, 2002, EUR J PHARMACOL, V451, P203, DOI 10.1016/S0014-2999(02)02251-3; Takizawa Y, 2009, PEDIATR RES, V65, P636, DOI 10.1203/PDR.0b013e3181a16a9f; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Yan YF, 2012, NEUROSCI LETT, V531, P160, DOI 10.1016/j.neulet.2012.10.043; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06	37	15	18	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1355-8145	1466-1268		CELL STRESS CHAPERON	Cell Stress Chaperones	MAR	2015	20	2					289	295		10.1007/s12192-014-0542-3			7	Cell Biology	Cell Biology	CB8US	WOS:000349907600010	25181965	Green Published			2021-06-18	
J	Shi, ZF; Zhao, WJ; Xu, LX; Dong, LP; Yang, SH; Yuan, F				Shi Zhong Fang; Zhao Wei Jiang; Xu Li Xin; Dong Li Ping; Yang Shao Hua; Yuan Fang			Downregulation of Aquaporin 4 Expression through Extracellular Signal-regulated Kinases1/2 Activation in Cultured Astrocytes Following Scratch-injury	BIOMEDICAL AND ENVIRONMENTAL SCIENCES			English	Article						Astrocytes; Aquaporin 4; Scratch-injury; Extracellular signal-regulated kinases1/2	RAT ASTROCYTES; BRAIN EDEMA; MODEL; ERK	Objective To investigate the role of extracellular signal-regulated kinase1/2 (ERK1/2) pathway in the regulation of aquaporin 4 (AQP4) expression in cultured astrocytes after scratch-injury. Methods The scratch-injury model was produced in cultured astrocytes of rat by a 10-mu L plastic pipette tip. The morphological changes of astrocytes and lactate dehydrogenase (LDH) leakages were observed to assess the degree of scratch-injury. AQP4 expression was detected by immunofluorescence staining and Western blot, and phosphorylated-ERK1/2 (p-ERK1/2) expression was determined by Western blot. To explore the effect of ERK1/2 pathway on AQP4 expression in scratch-injured astrocytes, 10 mu mol/L U0126 (ERK1/2 inhibitor) was incubated in the medium at 30 min before the scratch-injury in some groups. Results Increases in LDH leakage were observed at 1, 12, and 24 h after scratch-injury, and AQP4 expression was reduced simultaneously. Decrease in AQP4 expression was associated with a significant increase in ERK1/2 activation. Furthermore, pretreatment with U0126 blocked both ERK1/2 activation and decrease in AQP4 expression induced by scratch-injury. Conclusion These results indicate that ERK1/2 pathway down-regulates AQP4 expression in scratch-injured astrocytes, and ERK1/2 pathway might be a novel therapeutic target in reversing the effects of astrocytes that contribute to traumatic brain edema.	[Shi Zhong Fang; Xu Li Xin; Dong Li Ping; Yang Shao Hua; Yuan Fang] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Pathophysiol, Beijing 100050, Peoples R China; [Shi Zhong Fang; Xu Li Xin; Dong Li Ping; Yang Shao Hua; Yuan Fang] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing 100050, Peoples R China; [Zhao Wei Jiang] Shantou Univ, Coll Med, Ctr Neurosci, Shantou 515041, Guangdong, Peoples R China; [Yang Shao Hua] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	Yuan, F (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Pathophysiol, Beijing 100050, Peoples R China.	florayuan@vip.sina.com		Zhao, Wei-jiang/0000-0002-6556-2827	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271286, 81228009]	This work was supported by the National Natural Science Foundation of China, No. 81271286 to YUAN Fang and No. 81228009 to YANG Shao Hua.	Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Marmarou A, 2003, ACT NEUR S, V86, P7; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nielsen S, 1997, J NEUROSCI, V17, P171; Nito C, 2012, J NEUROTRAUM, V29, P2404, DOI 10.1089/neu.2012.2430; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Qi LL, 2011, LIFE SCI, V88, P50, DOI 10.1016/j.lfs.2010.10.025; Qi YC, 2014, BIOMED ENVIRON SCI, V27, P410, DOI 10.3967/bes2014.070; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Tan L, 2014, BIOMED ENVIRON SCI, V27, P186, DOI 10.3967/bes2014.007; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yang M, 2013, J CELL BIOCHEM, V114, P111, DOI 10.1002/jcb.24308; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Yuan F, 1996, SCI CHINA SER C, V39, P517; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zhang L, 2008, SHOUDU YIKE DAXUE XU, V29, P732; Zhao WJ, 2011, NEURAL REGEN RES, V6, P60, DOI 10.3969/j.issn.1673-5374.2011.01.010	26	15	18	0	6	CHINESE CENTER DISEASE CONTROL & PREVENTION	BEIJING	155 CHANGBAI RD, CHANGPING DISTRICT, BEIJING, 102206, PEOPLES R CHINA	0895-3988			BIOMED ENVIRON SCI	Biomed. Environ. Sci.	MAR	2015	28	3					199	205		10.3967/bes2015.026			7	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CH7KO	WOS:000354215300004	25800444				2021-06-18	
J	Nguyen, CT; Green, D; Barr, WB				Nguyen, Constance T.; Green, Debbie; Barr, William B.			Evaluation of the MMPI-2-RF for Detecting Over-reported Symptoms in a Civil Forensic and Disability Setting	CLINICAL NEUROPSYCHOLOGIST			English	Article						Feigning; Forensic; Civil; Validity scales.; MMPI-2-RF	ADULT INTELLIGENCE SCALE; CARD SORTING TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; RESTRUCTURED FORM MMPI-2-RF; TRAUMATIC BRAIN-INJURY; VALIDITY TEST FAILURE; HEAD-INJURY; DIGIT SPAN; RESPONSE BIAS; INCOMPLETE EFFORT	Objective: This study investigated the classification accuracy of the Minnesota Multiphasic Personality Inventory-2-Restructured Form validity scales in a sample of disability claimants and civil forensic litigants. Method: A criterion-groups design was used, classifying examinees as "Failed Slick Criteria" through low performance on at least two performance validity indices (stand-alone or embedded) and "Passed Slick Criteria." The stand-alone measures included the Test of Memory Malingering and the Dot Counting Test. The embedded indices were extracted from the Wechsler Adult Intelligence Scales Digit Span and Vocabulary subtests, the California Verbal Learning Test-II, and the Wisconsin Card Sorting Test. Results: Among groups classified by primary complaints at the time of evaluation, those alleging neurological conditions were more frequently classified as Failed Slick Criteria than those alleging psychiatric or medical conditions. Among those with neurological or psychiatric complaints, the F-r, FBS-r, and RBS scales differentiated between those who Passed Slick Criteria from those who Failed Slick Criteria. The Fs scale was also significantly higher in the Failed Slick Criteria compared to Passed Slick Criteria examinees within the psychiatric complaints group. Conclusions: Results indicated that interpretation of scale scores should take into account the examinees' presenting illness. While this study has limitations, it highlights the possibility of different cutoffs depending on the presenting complaints and the need for further studies to cross-validate the results.	[Nguyen, Constance T.; Green, Debbie] Fairleigh Dickinson Univ, Sch Psychol, Teaneck, NJ 07666 USA; [Barr, William B.] NYU, Dept Neurol, Comprehens Epilepsy Ctr, Sch Med, New York, NY 10016 USA	Nguyen, CT (corresponding author), Fairleigh Dickinson Univ, Sch Psychol, T-WH1-01,Metropolitan Campus,1000 River Rd, Teaneck, NJ 07666 USA.	cnguyen@student.fdu.edu		Nguyen, Constance/0000-0002-0973-0750; Barr, William/0000-0001-7711-7758			Allen L.M., 1997, CARB 97 MANUAL COMPU; Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Ben-Porath Y. S., 2008, MINNESOTA MULTIPHASI; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; BINDER LM, 1993, PORTLAND DIGIT RECOG; Bolinger E, 2014, ARCH CLIN NEUROPSYCH, V29, P7, DOI 10.1093/arclin/act082; Boone K., 2002, DOT COUNTING TEST; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Covic T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-6; Delis DC, 2000, CALIFORNIA VERBAL LE; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Goodwin BE, 2013, PSYCHOL ASSESSMENT, V25, P671, DOI 10.1037/a0032214; Green P., 2003, GREENS WORD MEMORY T; Green P., 2004, GREEND MED SYMPTOM V; Green P., 1995, MANUAL ORAL WORD MEM; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heaton SK, 1993, WISCONSIN CARD SORTI; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kaemmer B, 2001, MMPI-2: Manual for Administration and Scoring; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Larrabee G. J., 2014, CLIN NEUROPSYCHOL PO, V3rd; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Locke DEC, 2010, EPILEPSY BEHAV, V17, P252, DOI 10.1016/j.yebeh.2009.12.004; Mason LH, 2013, J PERS ASSESS, V95, P585, DOI 10.1080/00223891.2013.819512; McBride WF, 2013, BEHAV SCI LAW, V31, P779, DOI 10.1002/bsl.2083; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rogers R., 1992, SIRS STRUCTURED INTE; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P22, DOI 10.1037/a0018222; Shandera AL, 2010, PSYCHOL ASSESSMENT, V22, P50, DOI 10.1037/a0016585; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick D., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tellegen A., 2008, MMPI 2 RF MINNESOTA; Tombaugh TN, 1996, TEST MEMORY MALINGER; Tovilla-Zarate C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036887; Van Der Heijden PT, 2010, J PERS ASSESS, V92, P254, DOI 10.1080/00223891003670208; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]	62	15	15	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2015	29	2					255	271		10.1080/13854046.2015.1033020			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	CH4YZ	WOS:000354041900005	25905684				2021-06-18	
J	Boldsen, JL; Milner, GR; Weise, S				Boldsen, Jesper L.; Milner, George R.; Weise, Svenja			Cranial vault trauma and selective mortality in medieval to early modern Denmark	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						selective mortality; cranial trauma survival|; violence; premodern Denmark	LONG-TERM SURVIVAL; BRAIN-INJURY; OSTEOLOGICAL PARADOX; ENAMEL HYPOPLASIA; CHILDHOOD STRESS; SKELETAL SAMPLES; LIFE EXPECTANCY; POPULATION; DEATH; AGE	To date, no estimates of the long-term effect of cranial vault fractures on the risk of dying have been generated from historical or prehistoric skeletons. Excess mortality provides a perspective on the efficacy of modern treatment, as well as the human cost of cranial injuries largely related to interpersonal violence in past populations. Three medieval to early modern Danish skeletal samples are used to estimate the effect of selective mortality on males with cranial vault injuries who survived long enough for bones to heal. The risk of dying for these men was 6.2 times higher than it was for their uninjured counterparts, estimated through a simulation study based on skeletal observations. That is about twice the increased risk of dying experienced by modern people with traumatic brain injuries. The mortality data indicate the initial trauma was probably often accompanied by brain injury. Although the latter cannot be directly observed in skeletal remains, it can be inferred through the relative risks of dying. The ability to identify the effects of selective mortality in this skeletal sample indicates it must be taken into account in paleopathological research. The problem is analogous to extrapolating from death register data to modern communities, so epidemiological studies based on mortality data have the same inherent possibility of biases as analyses of ancient skeletons.	[Boldsen, Jesper L.] Univ Southern Denmark, Inst Forens Med, Dept Anthropol, DK-5260 Odense S, Denmark; [Milner, George R.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Weise, Svenja] Max Planck Inst Demog Res, D-18057 Rostock, Germany	Boldsen, JL (corresponding author), Univ Southern Denmark, Inst Forens Med, Dept Anthropol, DK-5260 Odense S, Denmark.	ost@psu.edu; jboldsen@health.sdu.dk			G.R.M.'s grant from American-Scandinavian Foundation	The late Ulla Freund's assistance with the skeletal materials is much appreciated. Her insights and familiarity with the collections are sorely missed. This work was partly supported by G.R.M.'s grant from the American-Scandinavian Foundation.	Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Boldsen J.L., 1997, INTEGRATING ARCHAEOL, P229; Boldsen JL, 2006, AM J PHYS ANTHROPOL, V130, P344, DOI 10.1002/ajpa.20363; Boldsen JL, 2007, AM J PHYS ANTHROPOL, V132, P59, DOI 10.1002/ajpa.20467; Boldsen JL, 2012, BLACKW COMPANION ANT, P114; BOLDSEN JL, 2000, HIKUIN, V27, P233; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown AW, 2004, NEUROREHABILITATION, V19, P37; BYERS SN, 1994, CURR ANTHROPOL, V35, P282, DOI 10.1086/204274; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Cohen M.N., 1997, INTEGRATING ARCHAEOL, P242; Cohen Mark N., 2007, ANCIENT HLTH SKELETA, P320; COHEN MN, 1994, CURR ANTHROPOL, V35, P629, DOI 10.1086/204323; Cohen MN, 1992, CURR ANTHROPOL, V33, P358; DeWitte SN, 2008, P NATL ACAD SCI USA, V105, P1436, DOI 10.1073/pnas.0705460105; Duray SM, 1996, AM J PHYS ANTHROPOL, V99, P275; Faergemann Christian, 2007, J Forensic Leg Med, V14, P20, DOI 10.1016/j.jcfm.2006.01.001; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; GOODMAN AH, 1988, AM ANTHROPOL, V90, P936, DOI 10.1525/aa.1988.90.4.02a00120; GOODMAN AH, 1993, CURR ANTHROPOL, V34, P281, DOI 10.1086/204170; Grauer AL, 1996, AM J PHYS ANTHROPOL, V100, P531, DOI 10.1002/(SICI)1096-8644(199608)100:4<531::AID-AJPA7>3.0.CO;2-T; Grell Ole Peter, 1997, HLTH CARE POOR RELIE, P1; Hanawalt BA, 1986, TIES BOUND; Hansen BD, 1996, STORE DANSKE ENCYKLO, P237; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrod RP, 2014, CAM S BIO EVOL ANTHR, V67, P103; JACKES M, 1993, CURR ANTHROPOL, V34, P434, DOI 10.1086/204188; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Metzler I, 2013, SOCIAL HIST DIABILIT; Metzler I, 2011, HISTORY COMPASS, V9, P45, DOI 10.1111/j.1478-0542.2010.00746.x; Milner G. R., 2013, DEAD TELL TALES ESSA, P172; Milner GR, 2012, AM J PHYS ANTHROPOL, V148, P98, DOI 10.1002/ajpa.22047; Milner GR, 2011, ANTHROPOL ANZ, V68, P415, DOI 10.1127/0003-5548/2011/0152; Palubeckaite Z, 2002, INT J OSTEOARCHAEOL, V12, P189, DOI 10.1002/oa.607; Petersen H.C., 2006, URBANISM PREINDUSTRI, P110; Pinker S., 2011, BETTER ANGELS OUR NA; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; SAUNDERS SR, 1993, YEARB PHYS ANTHROPOL, V36, P127; Shavelle R, 2000, J Insur Med, V32, P163; Strauss D, 1999, J INSUR MED, V31, P104; Usher BM, 2000, THESIS PENNSYLVANIA; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; Walker P.L., 1997, TROUBLED TIMES VIOLE, P145; Walker PL, 2001, ANNU REV ANTHROPOL, V30, P573, DOI 10.1146/annurev.anthro.30.1.573; Weber J, 2001, AM J PHYS ANTHROPOL, V114, P352, DOI 10.1002/ajpa.1047; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; WOOD JW, 1994, CURR ANTHROPOL, V35, P631; Wright L.E., 2003, J ARCHAEOL RES, V11, P43, DOI DOI 10.1023/A:1021200925063	50	15	15	0	7	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	FEB 10	2015	112	6					1721	1726		10.1073/pnas.1412511112			6	Multidisciplinary Sciences	Science & Technology - Other Topics	CA8XL	WOS:000349204200036	25624493	Green Published, Bronze			2021-06-18	
J	Angstman, NB; Kiessling, MC; Frank, HG; Schmitz, C				Angstman, Nicholas B.; Kiessling, Maren C.; Frank, Hans-Georg; Schmitz, Christoph			High interindividual variability in dose-dependent reduction in speed of movement after exposing C. elegans to shock waves	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						C. elegans; mild traumatic brain injury; blast trauma; shock wave; locomotion; paralysis; tracking	TRAUMATIC BRAIN-INJURY; MILD; CAVITATION; MECHANISM; DAMAGE	In blast-related mild traumatic brain injury (br-mTBI) little is known about the connections between initial trauma and expression of individual clinical symptoms. Partly due to limitations of current in vitro and in vivo models of br-mTBI, reliable prediction of individual short-and long-term symptoms based on known blast input has not yet been possible. Here we demonstrate a dose-dependent effect of shock wave exposure on C. elegans using shock waves that share physical characteristics with those hypothesized to induce br-mTBI in humans. Increased exposure to shock waves resulted in decreased mean speed of movement while increasing the proportion of worms rendered paralyzed. Recovery of these two behavioral symptoms was observed during increasing post-traumatic waiting periods. Although effects were observed on a population-wide basis, large interindividual variability was present between organisms exposed to the same highly controlled conditions. Reduction of cavitation by exposing worms to shock waves in polyvinyl alcohol resulted in reduced effect, implicating primary blast effects as damaging components in shock wave induced trauma. Growing worms on NGM agar plates led to the same general results in initial shock wave effect in a standard medium, namely dose-dependence and high interindividual variability, as raising worms in liquid cultures. Taken together, these data indicate that reliable prediction of individual clinical symptoms based on known blast input as well as drawing conclusions on blast input from individual clinical symptoms is not feasible in br-mTBI.	[Angstman, Nicholas B.; Kiessling, Maren C.; Frank, Hans-Georg; Schmitz, Christoph] Univ Munich, Dept Neuroanat, D-80336 Munich, Germany	Schmitz, C (corresponding author), Univ Munich, Dept Neuroanat, Pettenkoferstr 11, D-80336 Munich, Germany.	christoph_schmitz@med.uni-muenchen.de	Cote, Rick H/G-3363-2013; Frank, Hans-Georg/G-6038-2012	Cote, Rick H/0000-0002-1573-6526; Frank, Hans-Georg/0000-0002-3562-138X	Friedrich-Baur Foundation at the Ludwig-Maximilians University of Munich	This work was supported by a grant from the Friedrich-Baur Foundation at the Ludwig-Maximilians University of Munich (to Maren C. Kiessling and Christoph Schmitz).	Associated Press, 2007, CARS STUD 1 6 SHOWS; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Csaszar Nikolaus B M, 2013, J Orthop Surg Res, V8, P22, DOI 10.1186/1749-799X-8-22; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Delius M., 1992, LITHOTROPSY RELATED, P27; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Department of Defense and Department of Veterans Affairs, 2013, DOD VA COD FIN PROP; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Gerdesmeyer L, 2008, AM J SPORT MED, V36, P2100, DOI 10.1177/0363546508324176; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; GOLDING EM, 1994, BRAIN RES, V668, P46, DOI 10.1016/0006-8993(94)90509-6; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hayakawa K., 1991, N Y I ELECT ELECT EN, V1989, P969; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; PORTMAN DS, 2006, PROFILING C ELEGANS; R Development Core Team, 2008, R LANGUAGE ENV STAT; Rajini PS, 2008, J TOXICOL ENV HEAL A, V71, P1043, DOI 10.1080/15287390801989002; Rassweiler JJ, 2011, EUR UROL, V59, P784, DOI 10.1016/j.eururo.2011.02.033; Ritz C, 2005, J STAT SOFTW, V12, P1; Robinson D. E., 1978, ULTRASOUND ITS APPL, P593, DOI [10.1016/B978-0-444-41641-4.50008-X, DOI 10.1016/B978-0-444-41641-4.50008-X]; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; SCHELLING G, 1994, BIOPHYS J, V66, P133, DOI 10.1016/S0006-3495(94)80758-1; Schmitz C, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-31; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Speed C, 2014, BRIT J SPORT MED, V48, P1538, DOI 10.1136/bjsports-2012-091961; SULSTON JE, 1974, GENETICS, V77, P95; Tukey J.W., 1977, EXPLORATORY DATA ANA; Wang CJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-11; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	40	15	15	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	FEB 6	2015	9								12	10.3389/fnbeh.2015.00012			11	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CA5XS	WOS:000348982300003	25705183	DOAJ Gold, Green Published			2021-06-18	
J	Dzhala, V; Staley, KJ				Dzhala, Volodymyr; Staley, Kevin J.			Acute and Chronic Efficacy of Bumetanide in an in vitro Model of Posttraumatic Epileptogenesis	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Bumetanide; NKCC1; phenobarbital; posttraumatic seizures; Trauma	CATION-CHLORIDE COTRANSPORTERS; K-CL COTRANSPORTER; EXCITATORY ACTIONS; INTERICTAL SPIKES; CULTURE MODEL; SEIZURES; NKCC1; GABA; ROLES; ACCUMULATION	BackgroundSeizures triggered by acute injuries to the developing brain respond poorly to first-line medications that target the inhibitory chloride-permeable GABA(A) receptor. Neuronal injury is associated with profound increases in cytoplasmic chloride ([Cl-](i)) resulting in depolarizing GABA signaling, higher seizure propensity and limited efficacy of GABAergic anticonvulsants. The Na+-K+-2Cl(-) (NKCC1) cotransporter blocker bumetanide reduces [Cl-](i) and causes more negative GABA equilibrium potential in injured neurons. We therefore tested both the acute and chronic efficacy of bumetanide on early posttraumatic ictal-like epileptiform discharges and epileptogenesis. MethodsAcute hippocampal slices were used as a model of severe traumatic brain injury and posttraumatic epileptogenesis. Hippocampal slices were then incubated for 3weeks. After a 1-week latent period, slice cultures developed chronic spontaneous ictal-like discharges. The anticonvulsant and anti-epileptogenic efficacy of bumetanide, phenobarbital, and the combination of these drugs was studied. ResultsBumetanide reduced the frequency and power of early posttraumatic ictal-like discharges in vitro and enhanced the anticonvulsant efficacy of phenobarbital. Continuous 2-3weeks administration of bumetanide as well as phenobarbital in combination with bumetanide failed to prevent posttraumatic ictal-like discharges and epileptogenesis. ConclusionsOur data demonstrate a persistent contribution of NKCC1 cotransport in posttraumatic ictal-like activity, presumably as a consequence of chronic alterations in neuronal chloride homeostasis and GABA-mediated inhibition. New strategies for more effective reduction in posttraumatic and seizure-induced [Cl-](i) accumulation could provide the basis for effective treatments for posttraumatic epileptogenesis and the resultant seizures.	[Dzhala, Volodymyr; Staley, Kevin J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Staley, KJ (corresponding author), MGH Neurol, CNY 114,Room 2600,114 16th St, Charlestown, MA 02129 USA.	staley.kevin@mgh.harvard.edu			NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS 40109-13]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH106013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS074772, R01NS040109] Funding Source: NIH RePORTER	This study was supported by NIH grant RO1 NS 40109-13 (NINDS). We thank Michelle Mail for technical assistance.	[Anonymous], 2014, PIL STUD BUM NEWB SE; [Anonymous], 2014, TREATM NEON SEIZ MED; BAK IJ, 1980, BRAIN RES, V197, P341, DOI 10.1016/0006-8993(80)91120-8; Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Berdichevsky Y, 2012, NEUROBIOL DIS, V45, P774, DOI 10.1016/j.nbd.2011.11.001; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Carmo KB, 2005, J PAEDIATR CHILD H, V41, P313, DOI 10.1111/j.1440-1754.2005.00638.x; Cleary RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057148; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 2014, J PHYSIOL-LONDON, V592, P4099, DOI 10.1113/jphysiol.2014.275529; Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Hannaert P, 2002, N-S ARCH PHARMACOL, V365, P193, DOI 10.1007/s00210-001-0521-y; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hasbargen T, 2010, ANN NY ACAD SCI, V1198, P168, DOI 10.1111/j.1749-6632.2010.05462.x; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Isenring P, 2001, COMP BIOCHEM PHYS A, V130, P487, DOI 10.1016/S1095-6433(01)00420-2; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Khazipov R, 2004, EUR J NEUROSCI, V19, P590, DOI 10.1111/j.0953-816X.2003.03152.x; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; Nardou R, 2011, BRAIN, V134, P987, DOI 10.1093/brain/awr041; Nardou R, 2009, J NEUROPHYSIOL, V101, P2878, DOI 10.1152/jn.90761.2008; Painter MJ, 1999, NEW ENGL J MED, V341, P485, DOI 10.1056/NEJM199908123410704; Pallud J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008065; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Sipila ST, 2009, J NEUROSCI, V29, P6982, DOI 10.1523/JNEUROSCI.0443-09.2009; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tollner K, 2014, ANN NEUROL, V75, P550, DOI 10.1002/ana.24124; Topfer M, 2014, EUR J NEUROSCI, V39, P673, DOI 10.1111/ejn.12424; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Wirrell EC, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00666.x; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471	55	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	FEB	2015	21	2			SI		173	180		10.1111/cns.12369			8	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CA3YL	WOS:000348841000011	25495911	Green Published, Green Accepted			2021-06-18	
J	Rao, VR; Parko, KL				Rao, Vikram R.; Parko, Karen L.			Clinical Approach to Posttraumatic Epilepsy	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; epilepsy; posttraumatic epilepsy; seizure; neuromodulation	TRAUMATIC BRAIN-INJURY; PSYCHOGENIC NONEPILEPTIC SEIZURES; VAGUS NERVE-STIMULATION; HEAD-INJURY; CONCUSSIVE CONVULSIONS; AMERICAN-ACADEMY; RISK-FACTORS; 4 SCORE; MILD; ADULTS	Traumatic brain injury (TBI) is one of the most common causes of acquired epilepsy, and posttraumatic epilepsy (PTE) results in significant somatic and psychosocial morbidity. The risk of developing PTE relates directly to TBI severity, but the latency to first seizure can be decades after the inciting trauma. Given this "silent period," much work has focused on identification of molecular and radiographic biomarkers for risk stratification and on development of therapies to prevent epileptogenesis. Clinical management requires vigilant neurologic surveillance and recognition of the heterogeneous endophenotypes associated with PTE. Appropriate treatment of patients who have or are at risk for seizures varies as a function of time after TBI, and the clinician's armamentarium includes an ever-expanding diversity of pharmacological and surgical options. Most recently, neuromodulation with implantable devices has emerged as a promising therapeutic strategy for some patients with refractory PTE. Here, we review the epidemiology, diagnostic considerations, and treatment options for PTE and develop a roadmap for providers encountering this challenging clinical entity.	[Rao, Vikram R.; Parko, Karen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Parko, Karen L.] San Francisco VA Med Ctr, Dept Neurol, San Francisco, CA USA	Rao, VR (corresponding author), Univ Calif San Francisco, Epilepsy Ctr, 400 Parnassus Ave,8th Floor, San Francisco, CA 94143 USA.	vikram.rao@ucsf.edu					Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; Ben-Menachem E, 2014, NAT REV NEUROL, V10, P247, DOI 10.1038/nrneurol.2014.69; Benbadis SR, 2000, NEUROLOGY, V55, P1780, DOI 10.1212/WNL.55.12.1780; BERG AT, 1991, NEUROLOGY, V41, P965, DOI 10.1212/WNL.41.7.965; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Brigo F, 2011, CLIN NEUROPHYSIOL, V122, P2116, DOI 10.1016/j.clinph.2011.07.024; Brodie MJ, 2013, EPILEPSIA, V54, P5, DOI 10.1111/epi.12175; Burneo JG, 2013, EPILEPSY CURR, V13, P232, DOI 10.5698/1535-7597-13.5.232; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Camfield P, 2008, EPILEPSIA, V49, P25, DOI 10.1111/j.1528-1167.2008.01923.x; CAVENESS WF, 1963, J NEUROSURG, V20, P570, DOI 10.3171/jns.1963.20.7.0570; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chen LLK, 2014, MIL MED, V179, P492, DOI 10.7205/MILMED-D-13-00413; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cornes Susannah Brock, 2011, Continuum (Minneap Minn), V17, P984, DOI 10.1212/01.CON.0000407056.94789.2d; Davidson J., 2014, NEUROSCIENTIST; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Elliott RE, 2013, J NEUROSURG, V119, P261, DOI 10.3171/2013.4.JNS121829; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; England MJ, 2012, EPILEPSY BEHAV, V25, P266, DOI 10.1016/j.yebeh.2012.06.016; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Englot DJ, 2012, NEUROLOGY, V78, P1200, DOI 10.1212/WNL.0b013e318250d7ea; Englot DJ, 2012, J NEUROSURG, V117, P970, DOI 10.3171/2012.8.JNS122; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fisher RS, 2014, NAT REV NEUROL, V10, P261, DOI 10.1038/nrneurol.2014.59; Fountain Nathan B, 2010, Continuum (Minneap Minn), V16, P121, DOI 10.1212/01.CON.0000368235.64857.cf; Fox WC, 2013, NEUROL RES, V35, P223, DOI 10.1179/1743132813Y.0000000162; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hamelin S, 2014, NEUROBIOL DIS, V69, P156, DOI 10.1016/j.nbd.2014.05.025; Hartzfeld P, 2008, BRIT J NEUROSURG, V22, P224, DOI 10.1080/02688690701818901; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Heck CN, 2014, EPILEPSIA, V55, P432, DOI 10.1111/epi.12534; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hernandez TD, 1997, NEUROLOGY, V48, P803, DOI 10.1212/WNL.48.4.803; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; Jensen RL, 1997, NEUROSURGERY, V41, P263, DOI 10.1097/00006123-199707000-00045; Kollevold T, 1978, J Oslo City Hosp, V28, P77; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; LaFrance WC, 2014, JAMA PSYCHIAT, V71, P997, DOI 10.1001/jamapsychiatry.2014.817; Langendorf FG, 2008, EPILEPSY COMPREHENSI, P2537; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maganti Rama K, 2013, Continuum (Minneap Minn), V19, P598, DOI 10.1212/01.CON.0000431378.51935.d8; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Medvdovsky M, 2006, EPILEPSY BEHAV, V8, P429, DOI 10.1016/j.yebeh.2005.12.010; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Morris GL, 2013, NEUROLOGY, V81, P1453, DOI 10.1212/WNL.0b013e3182a393d1; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Penfield W., 1961, EPILEPSIA, V2, P109; Perron AD, 2001, ACAD EMERG MED, V8, P296, DOI 10.1111/j.1553-2712.2001.tb01312.x; Pitkanen A, 2014, EPILEPSY BEHAV; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Pugh MJ, 2014, J HEAD TRAUMA REHABI; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sahaya K, 2011, J CLIN NEUROSCI, V18, P1602, DOI 10.1016/j.jocn.2011.05.016; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salinsky M, 2014, J HEAD TRAUMA REHABI; Scheffer IE, 2014, NEUROPEDIATRICS, V45, P70, DOI 10.1055/s-0034-1371508; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shrivastava V, 2013, NEUROL INDIA, V61, P156, DOI 10.4103/0028-3886.111122; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Smith Bret N, 2014, Epilepsy Curr, V14, P38, DOI 10.5698/1535-7597-14.1.38; Snell FI, 2010, J PSYCHOSOC NURS MEN, P1; So NK, 2014, NEUROLOGY, V83, P847, DOI 10.1212/WNL.0000000000000740; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Steinbaugh LA, 2012, EPILEPSY BEHAV, V23, P280, DOI 10.1016/j.yebeh.2011.12.005; Storti SF, 2012, MAGN RESON MATER PHY, V25, P345, DOI 10.1007/s10334-012-0316-9; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Temkin O., 1945, FALLING SICKNESS HIS; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Vale FL, 2011, SEIZURE-EUR J EPILEP, V20, P244, DOI 10.1016/j.seizure.2010.12.003; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Walker WC, 2011, PM&R, V3, P6, DOI 10.1016/j.pmrj.2010.11.001; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Zarocostas J, 2007, BRIT MED J, V335, P470, DOI 10.1136/bmj.39328.617269.DB	120	15	15	0	9	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					57	63		10.1055/s-0035-1544239			7	Clinical Neurology	Neurosciences & Neurology	CC4AP	WOS:000350293300009	25714868	Bronze			2021-06-18	
J	Peterson, JR; Eboda, ON; Brownley, RC; Cilwa, KE; Pratt, LE; De La Rosa, S; Agarwal, S; Buchman, SR; Cederna, PS; Morris, MD; Wang, SC; Levi, B				Peterson, Jonathan R.; Eboda, Oluwatobi N.; Brownley, R. Cameron; Cilwa, Katherine E.; Pratt, Lauren E.; De La Rosa, Sara; Agarwal, Shailesh; Buchman, Steven R.; Cederna, Paul S.; Morris, Michael D.; Wang, Stewart C.; Levi, Benjamin			Effects of Aging on Osteogenic Response and Heterotopic Ossification Following Burn Injury in Mice	STEM CELLS AND DEVELOPMENT			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; DIFFERENTIATION; PROLIFERATION; PATHWAYS; GROWTH; MOUSE; TUMOR	Heterotopic ossification (HO) is a common and debilitating complication of burns, traumatic brain injuries, and musculoskeletal trauma and surgery. Although the exact mechanism of ectopic bone formation is unknown, mesenchymal stem cells (MSCs) capable of osteogenic differentiation are known to play an essential role. Interestingly, the prevalence of HO in the elderly population is low despite the high overall occurrence of musculoskeletal injury and orthopedic procedures. We hypothesized that a lower osteogenicity of MSCs would be associated with blunted HO formation in old compared with young mice. In vitro osteogenic differentiation of adipose-derived MSCs from old (18-20 months) and young (6-8 weeks) C57/BL6 mice was assessed, with or without preceding burn injury. In vivo studies were then performed using an Achilles tenotomy with concurrent burn injury HO model. HO formation was quantified using mu CT scans, Raman spectroscopy, and histology. MSCs from young mice had more in vitro bone formation, upregulation of bone formation pathways, and higher activation of Smad and nuclear factor kappa B (NF-kappa B) signaling following burn injury. This effect was absent or blunted in cells from old mice. In young mice, burn injury significantly increased HO formation, NF-kappa B activation, and osteoclast activity at the tenotomy site. This blunted, reactive osteogenic response in old mice follows trends seen clinically and may be related to differences in the ability to mount acute inflammatory responses. This unique characterization of HO and MSC osteogenic differentiation following inflammatory insult establishes differences between age populations and suggests potential pathways that could be targeted in the future with therapeutics.	[Peterson, Jonathan R.; Eboda, Oluwatobi N.; Brownley, R. Cameron; Pratt, Lauren E.; De La Rosa, Sara; Agarwal, Shailesh; Buchman, Steven R.; Cederna, Paul S.; Levi, Benjamin] Univ Michigan, Div Plast Surg, Dept Surg, Ann Arbor, MI 48109 USA; [Cilwa, Katherine E.; Morris, Michael D.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Wang, Stewart C.; Levi, Benjamin] Univ Michigan, Dept Surg, Div Burn Surg, Ann Arbor, MI 48109 USA	Levi, B (corresponding author), Univ Michigan, Div Plast Surg, Dept Surg, 1500 East Med Ctr Dr,Room A552 MSRB2, Ann Arbor, MI 48109 USA.	benlevimd@gmail.com	Cilwa, Katherine/N-3840-2016	Cilwa, Katherine/0000-0003-3828-884X	Plastic Surgery Foundation National Endowment Award;  [R01 AR055222];  [1K08GM109105-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR055222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM109105] Funding Source: NIH RePORTER	The authors thank Kevin Heist, Benjamin Hoff, Amanda Fair, and the staff of the Center for Molecular Imaging at UM for their assistance with animal care and mu CT scanning. Source of funding: R01 AR055222, 1K08GM109105-01, and Plastic Surgery Foundation National Endowment Award.	Alfieri KA, 2012, BONE JOINT RES, V1, P174, DOI 10.1302/2046-3758.18.2000102; Chakkalakal SA, 2012, J BONE MINER RES, V27, P1746, DOI 10.1002/jbmr.1637; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Chen SQ, 2001, J BIOL CHEM, V276, P39259, DOI 10.1074/jbc.M105335200; Culbert AL, 2014, STEM CELLS, V32, P1289, DOI 10.1002/stem.1633; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eguchi Y, 2010, J BONE MINER METAB, V28, P157, DOI 10.1007/s00774-009-0127-x; Finnerty CC, 2008, MOL MED, V14, P553, DOI 10.2119/2007-00132.Finnerty; Fleet JC, 1996, ENDOCRINOLOGY, V137, P4605, DOI 10.1210/en.137.11.4605; Flurkey K., 2007, MOUSE BIOMEDICAL RES, P637, DOI [DOI 10.1016/B978-012369454-6/50074-1, 10.1016/B978-012369454-6/50074-1.]; Gala K, 2011, CELL BIOL INT, V35, P1055, DOI 10.1042/CBI20100586; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; HCUP Nationwide Inpatient Sample (NIS), 2010, HCUP NAT INP SAMPL N; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Ipaktchi K, 2007, SURGERY, V142, P86, DOI 10.1016/j.surg.2007.02.007; James AW, 2008, PLAST RECONSTR SURG, V122, P53, DOI 10.1097/PRS.0b013e31817747b5; Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37; Kamiya N, 2008, J BONE MINER RES, V23, P2007, DOI [10.1359/jbmr.080809, 10.1359/JBMR.080809]; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Levi B, 2011, STEM CELLS, V29, P2018, DOI 10.1002/stem.757; Levi B, 2011, PLAST RECONSTR SURG, V128, P373, DOI 10.1097/PRS.0b013e31821e6e49; Levi B, 2011, STEM CELLS, V29, P1241, DOI 10.1002/stem.670; Levi B, 2011, STEM CELLS DEV, V20, P243, DOI 10.1089/scd.2010.0250; Levi B, 2010, PLAST RECONSTR SURG, V126, P41, DOI 10.1097/PRS.0b013e3181da8858; Mace JE, 2012, BURNS, V38, P599, DOI 10.1016/j.burns.2011.10.013; Medici D, 2012, J BONE MINER RES, V27, P1619, DOI 10.1002/jbmr.1691; Nelson ER, 2012, J BURN CARE RES, V33, P463, DOI 10.1097/BCR.0b013e31825af547; Niederbichler AD, 2011, J SURG RES, V165, P128, DOI 10.1016/j.jss.2009.06.012; Patel SA, 2009, J INFLAMM RES, V2, P13; Peterson JR, 2014, ANN SURG, V259, P993, DOI 10.1097/SLA.0b013e318291da85; Peterson JR, 2013, BONE, V54, P28, DOI 10.1016/j.bone.2013.01.002; Potter BK, 2010, J BONE JOINT SURG AM, V92A, P74, DOI 10.2106/JBJS.J.00776; Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517; Shore EM, 2011, J BONE MINER RES, V26, P1163, DOI 10.1002/jbmr.404; Song DS, 2011, J PERIODONTAL RES, V46, P193, DOI 10.1111/j.1600-0765.2010.01328.x; Sun XF, 2007, HISTOL HISTOPATHOL, V22, P1387, DOI 10.14670/HH-22.1387; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wosczyna MN, 2012, J BONE MINER RES, V27, P1004, DOI 10.1002/jbmr.1562; Xu Y, 2008, PLAST RECONSTR SURG, V122, P1649, DOI 10.1097/PRS.0b013e31818cbf44	41	15	18	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	JAN 15	2015	24	2					205	213		10.1089/scd.2014.0291			9	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	AY4IR	WOS:000347542000007	25122460	Green Published			2021-06-18	
J	Ahmed, M; Sriganesh, K; Vinay, B; Rao, GSU				Ahmed, Masud; Sriganesh, Kamath; Vinay, Byrappa; Rao, Ganne S. Umamaheswara			Acute kidney injury in survivors of surgery for severe traumatic brain injury: Incidence, risk factors, and outcome from a tertiary neuroscience center in India	BRITISH JOURNAL OF NEUROSURGERY			English	Article						acute kidney injury; incidence; outcome; predictive factors; traumatic brain injury	ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; HOSPITAL MORTALITY; FLUID BALANCE; HEAD-INJURY; COMPLICATIONS; NEPHROTOXICITY; THERAPY	Background. Non-neurological complications like acute kidney injury (AKI) can affect outcome of traumatic brain injury (TBI). This study aims to analyze the incidence, predictive factors, and impact of AKI in operated patients with severe TBI. Methods. We retrospectively reviewed the data of 395 patients who underwent surgery for severe TBI and survived to be discharged from the hospital over a 1-year period. Of these, 95 patients were finally included in the analysis. Their demographic data, laboratory parameters, and clinical courses were reviewed. Diagnosis and staging of AKI was made using Acute Kidney Injury Network (AKIN) criteria. Results. The incidence of AKI was 11.6% (11 patients). Out of the11 patients who had AKI, 7 were in stage I (63.6%), 3 were in stage II (27.3%), and 1 in stage III (9.1%). Nine Patients (81.8%) developed AKI within 5 days of admission. Aminoglycoside therapy had an association with occurrence of AKI. There was no mortality and none of the patients required renal replacement therapy (RRT). Renal function of all these patients returned to baseline before hospital discharge. Hospital stay and intensive care unit (ICU) stay were longer and Glasgow coma scale (GCS) was lower in patients with AKI when compared with patients without AKI group at discharge. Conclusion. Reversible AKI without need for RRT occurred in nearly12% of patients with severe TBI requiring surgical intervention. Aminoglycoside therapy was the only predictive factor for the occurrence of AKI. Patients with AKI have a longer period of mechanical ventilation, longer ICU and hospital stay, and poorer GCS at discharge.	[Ahmed, Masud] Univ Dhaka, Combined Mil Hosp, Dhaka 1000, Bangladesh; [Sriganesh, Kamath; Vinay, Byrappa; Rao, Ganne S. Umamaheswara] Natl Inst Mental Hlth & NeuroSci NIMHANS, Dept Neuroanaesthesia, Bangalore, Karnataka, India	Sriganesh, K (corresponding author), NIMHANS, Dept Neuroanaesthesia, Fac Block, Bangalore 560029, Karnataka, India.	drsri23@rediffmail.com					Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Bellomo R, 2008, CRIT CARE MED, V36, pS179, DOI 10.1097/CCM.0b013e318169167f; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chou CY, 2011, ARTIF ORGANS, V35, pE11, DOI 10.1111/j.1525-1594.2010.01115.x; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Ghallab M, 1995, Saudi J Kidney Dis Transpl, V6, P294; Godin M, 2013, NEPHRON CLIN PRACT, V123, P238, DOI 10.1159/000354713; Harbrecht BG, 2007, AM SURGEON, V73, P836; Ho KM, 2006, BMJ-BRIT MED J, V333, P420, DOI 10.1136/bmj.38902.605347.7C; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mehta RL, 2003, J AM SOC NEPHROL, V14, P2178, DOI 10.1097/01.ASN.0000079042.13465.1A; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Musu M, 2011, EUR REV MED PHARMACO, V15, P1461; Mutter TC, 2013, COCHRANE DATABASE SY, V7, DOI DOI 10.1002/14651858.CD007594.PUB3; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Prescott GJ, 2007, NEPHROL DIAL TRANSPL, V22, P2513, DOI 10.1093/ndt/gfm264; Rybak MJ, 1999, ANTIMICROB AGENTS CH, V43, P1549, DOI 10.1128/AAC.43.7.1549; Schetz M, 2008, J AM SOC NEPHROL, V19, P571, DOI 10.1681/ASN.2006101091; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Schmidt-Ott KM, 2011, NEPHROL DIAL TRANSPL, V26, P762, DOI 10.1093/ndt/gfr006; Schortgen F, 2001, LANCET, V357, P911, DOI 10.1016/S0140-6736(00)04211-2; Tamma PD, 2013, JAMA PEDIATR, V167, P903, DOI 10.1001/jamapediatrics.2013.196; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2004, CRIT CARE MED, V32, P1669, DOI 10.1097/01.CCM.0000132892.51063.2F; Venkataram R, 2001, CONTRIB NEPHROL, V132, P158; Vitaz TW, 2001, J TRAUMA, V51, P369, DOI 10.1097/00005373-200108000-00025; Vivino G, 1998, INTENS CARE MED, V24, P808, DOI 10.1007/s001340050670; Zeng JS, 2013, J NEUROSURG, V119, P1228, DOI 10.3171/2013.7.JNS122131; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	37	15	16	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2015	29	4					544	548		10.3109/02688697.2015.1016892			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR4MM	WOS:000361306900013	25796992				2021-06-18	
J	Bellon, K; Kolakowsky-Hayner, S; Wright, J; Huie, H; Toda, K; Bushnik, T; Englander, J				Bellon, Kimberly; Kolakowsky-Hayner, Stephanie; Wright, Jerry; Huie, Henry; Toda, Ketra; Bushnik, Tamara; Englander, Jeffrey			A home-based walking study to ameliorate perceived stress and depressive symptoms in people with a traumatic brain injury	BRAIN INJURY			English	Article						Coaching; depression; exercise; nutrition; physical activity; stress; traumatic brain injury; walking	MINOR DEPRESSION; MODERATE; TBI; COMPLAINTS; EXERCISE; OUTCOMES; RATES; MOOD	Objective: To determine whether a 12-week home-based walking programme can decrease perceived stress and depressive symptoms in persons with a traumatic brain injury (TBI). Setting: Community-and home-based. Participants: Sixty-nine participants with a TBI. Design: Comparative effectiveness cross-over design with random assignment to treatment sequence and blinded post-hoc assessment of outcome where participants completed a 12-week walking intervention and a nutrition education module. The walking intervention utilized pedometers to track the amount of steps each participant walked daily. With the assistance of an assigned coach, weekly goals were given with the intent of increasing the amount of walking that the participant was initially completing. The nutrition control group was created to offset the impact of the coaching calls. Main measures: Measurement of perceived stress and depressive symptoms was completed through the use of the Perceived Stress Scale (PSS) and Center for Epidemiological Studies-Depression (CES-D). These measures were collected at three time points: baseline and following each 12-week intervention. Results: Results indicated that both perceived stress and depression symptoms significantly improved following the walking intervention. Conclusions: While limitations existed with the study, it is evident that walking can be used as an efficient and cost-effective tool to manage perceived stress and depressive symptoms in persons who have sustained a TBI.	[Bellon, Kimberly; Kolakowsky-Hayner, Stephanie; Wright, Jerry; Toda, Ketra] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Huie, Henry; Englander, Jeffrey] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; [Bushnik, Tamara] Rusk Inst Rehabil, New York, NY USA	Bellon, K (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA.	kimberly.bellon@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909	National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of EducationUS Department of Education [H133A070038]	This research was supported by grants from the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of Education, TBI Model Systems grant to Santa Clara Valley Medical Center (H133A070038).	Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Balke B., 1963, SIMPLE FIELD TEST AS, P1; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bay E, 2012, ARCH PSYCHIAT NURS, V26, P477, DOI 10.1016/j.apnu.2012.06.002; Bay E, 2012, BRAIN INJURY, V26, P941, DOI 10.3109/02699052.2012.666365; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; BERG K, 1989, Physiotherapy Canada, V41, P304; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Williams G., HIGH LEVEL MOBILITY; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009	35	15	15	0	25	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					313	319		10.3109/02699052.2014.974670			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000005	25356799				2021-06-18	
J	Bigler, ED; Jantz, PB; Farrer, TJ; Abildskov, TJ; Dennis, M; Gerhardt, CA; Rubin, KH; Stancin, T; Taylor, HG; Vannatta, K; Yeates, KO				Bigler, Erin D.; Jantz, Paul B.; Farrer, Thomas J.; Abildskov, Tracy J.; Dennis, Maureen; Gerhardt, Cynthia A.; Rubin, Kenneth H.; Stancin, Terry; Taylor, H. Gerry; Vannatta, Kathryn; Yeates, Keith Owen			Day of injury CT and late MRI findings: Cognitive outcome in a paediatric sample with complicated mild traumatic brain injury	BRAIN INJURY			English	Article						Complicated mild traumatic brain injury; magnetic resonance imaging; neuropsychological outcome; paediatric	ACUTE EPIDURAL HEMATOMA; CHILDREN TEA-CH; EVERYDAY ATTENTION; ADOLESCENTS; PERFORMANCE; MANAGEMENT; ATROPHY; VOLUME; ADHD; COMA	Objectives: Complicated mild traumatic brain injury (mTBI) or cmTBI is based on the presence of visibly identifiable brain pathology on the day-of-injury computed tomography (CT) scan. In a paediatric sample the relation of DOI CT to late MRI findings and neuropsychological outcome was examined. Methods: MRI (>12 months) was obtained in paediatric cmTBI patients and a sample of orthopaedically injured (OI) children. Those children with positive imaging findings (MRI+) were quantitatively compared to those without (MRI-) or with the OI sample. Groups were also compared in neurocognitive outcome from WASI sub-tests and the WISC-IV Processing Speed Index (PSI), along with the Test of Everyday Attention for Children (TEA-Ch) and a parent-rated behavioural functioning measure (ABAS-II). Results: Despite the MRI+ group having significantly more DOI CT findings than the MRI- group, no quantitative differences were found. WASI Vocabulary and Matrix Reasoning scores were significantly lower, but not PSI, TEA-Ch or ABAS-II scores. MRI+ and MRI- groups did not differ on these measures. Conclusions: Heterogeneity in the occurrence of MRI-identified focal pathology was not associated with uniform changes in quantitative analyses of brain structure in cmTBI. Increased number of DOI CT abnormalities was associated with lowered neuropsychological performance.	[Bigler, Erin D.; Farrer, Thomas J.; Abildskov, Tracy J.] Brigham Young Univ, Ctr Neurosci, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.; Farrer, Thomas J.; Abildskov, Tracy J.] Brigham Young Univ, Magnet Resonance Imaging MRI Res Facil, Provo, UT 84602 USA; [Bigler, Erin D.; Farrer, Thomas J.; Abildskov, Tracy J.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Jantz, Paul B.] Texas State Univ, Sch Psychol Program, San Marcos, TX USA; [Dennis, Maureen] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Gerhardt, Cynthia A.; Vannatta, Kathryn; Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Gerhardt, Cynthia A.; Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Rubin, Kenneth H.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Stancin, Terry] Metro Hlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Univ Hosp Cleveland, Div Dev Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada	Bigler, ED (corresponding author), Brigham Young Univ, Ctr Neurosci, Dept Psychol, 1001 Kimball Tower, Provo, UT 84602 USA.	erin_bigler@byu.edu	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019; Rubin, Kenneth H/M-5276-2018; Vannatta, Kathryn/E-4237-2011	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892; Farrer, Thomas J./0000-0001-8092-6214	NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R01HD048946, 3R01HD048946-05S1]; Poelman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	Erin D. Bigler does provide expert neuropsychological testimony in paediatric brain injury cases. No other conflicts of interest are declared by the other authors. The research presented in this manuscript was supported by NIH/NICHD Grant Numbers 5R01HD048946 and 3R01HD048946-05S1 titled 'Social Outcomes of Pediatric Traumatic Brain Injury'. Funding was also provided in part by the Poelman Foundation which supports the Brain Imaging and Behavior Laboratory at Brigham Young University.	[Anonymous], 2009, IBM SPSS STAT; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bassin SL, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P174; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Bigler E. D., 2012, PTSD MILD TRAUMATIC, P15; Bigler ED, 2007, BRAIN INJURY MED PRI, P201; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Fayol P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P497, DOI 10.1016/j.annrmp.2008.06.003; Gean A, 1994, IMAGING HEAD TRAUMA; Gene AD, 1994, IMAGING HEAD TRAUMA; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Hanten G, 2013, J NEUROTRAUM, V30, P618, DOI 10.1089/neu.2012.2392; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Heaton SC, 2001, CHILD NEUROPSYCHOL, V7, P251, DOI 10.1076/chin.7.4.251.8736; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P199, DOI 10.1007/s00402-012-1652-y; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T., 1998, TEST EVERYDAY ATTENT; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Muhlau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029809; Ortega-Carnicer J, 2005, RESUSCITATION, V64, P119, DOI 10.1016/j.resuscitation.2004.08.010; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Psychological Corporation, 1999, WECHSLER ABBREVIATED; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; TEASDALE G, 1974, LANCET, V2, P81; Ulrich PT, 2008, J CHILD NEUROL, V23, P1066, DOI 10.1177/0883073808315411; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D., 2003, WECHSLER INTELLIGENC; Wilde EA, 2012, NEUROREHABILITATION, V31, P245, DOI 10.3233/NRE-2012-0794; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zollman FS, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P1	50	15	15	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	9					1062	1070		10.3109/02699052.2015.1011234			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CR1UG	WOS:000361110000007	26186038	Green Accepted			2021-06-18	
J	Brown, AW; Watanabe, TK; Hoffman, JM; Bell, KR; Lucas, S; Dikmen, S				Brown, Allen W.; Watanabe, Thomas K.; Hoffman, Jeanne M.; Bell, Kathleen R.; Lucas, Sylvia; Dikmen, Sureyya			Headache After Traumatic Brain Injury: A National Survey of Clinical Practices and Treatment Approaches	PM&R			English	Article							PREVALENCE	Background: Individuals with headache after traumatic brain injury (TBI) receive care in a wide variety of clinical locations by physicians trained in multiple specialties. Objective: To understand current practice patterns and perceptions of treatment issues among clinicians managing headache after TBI. Design: National survey of current clinical practice using a 20-item questionnaire developed by the authors. Participants: Survey respondents were members of the Central Nervous System Council list survey of the American Academy of Physical Medicine and Rehabilitation (N = 1782) and the American Headache Society membership (N = 1260). Methods: The survey was sent electronically to potential participants and was followed by 2 biweekly reminders. The survey queried the physicians' clinical setting; their use of headache classification systems, headache diaries, checklists, and diagnostic procedures; the pharmacologic and nonpharmacologic treatments prescribed; and headache chronicity and associated symptoms and disorders among their patients with TBI. Results: Completed surveys were received from 193 respondents. The use of standardized classification systems and checklists was commonly reported. Respondents used nonpharmacologic and pharmacologic treatment approaches with similar frequency and modest perceived success rates. A high frequency of headache-associated new sleep and mood disorders was reported. When response differences occurred between practice settings, they reflected a focus on headache diagnosis, classification, and pharmacologic treatment among neurology and specialty headache clinics, whereas a nonpharmacologic approach to management among TBI specialty and general rehabilitation clinicians was more commonly reported. Conclusion: Management strategies for treating headache after TBI vary widely among general and specialty clinical practices. This suggests that additional research is needed that would lead to an increase in the use of established headache classification and the development of standardized management approaches so that all practitioners who care for patients after TBI can provide consistent effective care.	[Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Watanabe, Thomas K.] Moss Rehab, Dept Phys Med & Rehabil, Philadelphia, PA USA; [Hoffman, Jeanne M.; Bell, Kathleen R.; Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Lucas, Sylvia] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Brown, AW (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Brown, Allen W./0000-0001-7228-3351; Bell, Kathleen/0000-0002-0928-2046	Mayo Clinic NIDRR TBI Model System Center grant [H133A070013]; Moss Rehab NIDRR TBI Model System Center grant [H133A120037]; University of Washington NIDRR TBI Model System Center grant [H133A070032]	This work was supported by Mayo Clinic NIDRR TBI Model System Center grant H133A070013, Moss Rehab NIDRR TBI Model System Center grant H133A120037, and University of Washington NIDRR TBI Model System Center grant H133A070032.	Beithon J, 2013, DIAGNOSIS TREATMENT; D'Amico D, 2011, NEUROL SCI, V32, pS71, DOI 10.1007/s10072-011-0552-1; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Lipton RB, 2001, HEADACHE, V41, P854; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003	13	15	15	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JAN	2015	7	1					3	8		10.1016/j.pmrj.2014.06.016			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AZ2CF	WOS:000348041500010	25019492				2021-06-18	
J	Hauger, SL; Schnakers, C; Andersson, S; Becker, F; Moberget, T; Giacino, JT; Schanke, AK; Lovstad, M				Hauger, Solveig L.; Schnakers, Caroline; Andersson, Stein; Becker, Frank; Moberget, Torgeir; Giacino, Joseph T.; Schanke, Anne-Kristine; Lovstad, Marianne			Neurophysiological Indicators of Residual Cognitive Capacity in the Minimally Conscious State	BEHAVIOURAL NEUROLOGY			English	Article							EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; LOCKED-IN SYNDROME; SUBJECTS OWN NAME; VEGETATIVE STATE; UNRESPONSIVE WAKEFULNESS; RESPONSIVE PATIENTS; COVERT COGNITION; NOVELTY P3; DISORDERS	Background. The diagnostic usefulness of electrophysiological methods in assessing disorders of consciousness (DoC) remains to be established on an individual patient level, and there is need to determine what constitutes robust experimental paradigm to elicit electrophysiological indices of covert cognitive capacity. Objectives. Two tasks encompassing active and passive conditions were explored in an event-related potentials (ERP) study. The task robustness was studied in healthy controls, and their utility to detect covert signs of command-following on an individual patient level was investigated in patients in a minimally conscious state (MCS). Methods. Twenty healthy controls and 20 MCS patients participated. The active tasks included (1) listening for a change of pitch in the subject's own name (SON) and (2) counting SON, both contrasted to passive conditions. Midline ERPs are reported. Results. A larger P3 response was detected in the counting task compared to active listening to pitch change in the healthy controls. On an individual level, the counting task revealed a higher rate of responders among both healthy subjects and MCS patients. Conclusion. ERP paradigms involving actively counting SON represent a robust paradigm in probing for volitional cognition in minimally conscious patients and add important diagnostic information in some patients.	[Hauger, Solveig L.; Becker, Frank; Schanke, Anne-Kristine; Lovstad, Marianne] Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway; [Schnakers, Caroline] Univ Calif Los Angeles, Dept Psychol & Neurosurg, Los Angeles, CA 90095 USA; [Andersson, Stein; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, N-0317 Oslo, Norway; [Becker, Frank] Univ Oslo, Inst Clin Med, N-0318 Oslo, Norway; [Moberget, Torgeir] Oslo Univ Hosp, Norwegian Ctr Mental Disorders Res NORMENT, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, N-0424 Oslo, Norway; [Moberget, Torgeir] Sunnaas Rehabil Hosp, Reg Ctr Knowledge Translat Rehabil, N-1450 Nesoddtangen, Norway; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Charlestown, MA 02129 USA	Hauger, SL (corresponding author), Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway.	solveig.hauger@gmail.com	Giacino, Joseph/AAF-1952-2021; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Giacino, Joseph/0000-0002-7916-9698; Laureys, Steven/0000-0002-3096-3807; Becker, Frank/0000-0002-0857-0628	Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds [2012/2/0084]; Sunnaasstiftelsen	The authors wish to thank all the patients and their relatives in contributing to this study and Dr. T. Skandsen for help with patients' recruitment. This research is supported by the Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds (Grant 2012/2/0084), and Sunnaasstiftelsen funded NeuroScan equipment.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cavinato M, 2011, CLIN NEUROPHYSIOL, V122, P719, DOI 10.1016/j.clinph.2010.08.024; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2014, BRAIN INJURY, V28, P1197, DOI 10.3109/02699052.2014.920517; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Faugeras F, 2012, NEUROPSYCHOLOGIA, V50, P403, DOI 10.1016/j.neuropsychologia.2011.12.015; Field A., 2013, DISCOVERING STAT USI, V4; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828; Fowler B, 1997, BIOL PSYCHOL, V46, P113, DOI 10.1016/S0301-0511(97)05253-8; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2013, SEMIN NEUROL, V33, P142, DOI 10.1055/s-0033-1348960; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gibson RM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00950; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Kotchoubey B, 2013, RESTOR NEUROL NEUROS, V31, P473, DOI 10.3233/RNN-120307; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leonardi M, 2013, BRAIN INJURY, V27, P473, DOI 10.3109/02699052.2012.750758; Lovstad M, 2014, J HEAD TRAUMA REHAB, V29, pE31, DOI 10.1097/HTR.0000000000000017; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Majerus S, 2009, PROG BRAIN RES, V177, P49, DOI 10.1016/S0079-6123(09)17705-1; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Peterson A, 2015, NEUROIMAGE-CLIN, V7, P588, DOI 10.1016/j.nicl.2015.02.008; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pratt H, 1999, CLIN NEUROPHYSIOL, V110, P53, DOI 10.1016/S0168-5597(98)00044-6; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2015, NEUROREHAB NEURAL RE, V29, P308, DOI 10.1177/1545968314547767; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tome D, 2015, J NEURAL TRANSM, V122, P375, DOI 10.1007/s00702-014-1258-3; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027	60	15	16	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								145913	10.1155/2015/145913			12	Clinical Neurology	Neurosciences & Neurology	CT9KL	WOS:000363135800001	26504351	DOAJ Gold, Green Published			2021-06-18	
J	Kertmen, H; Gurer, B; Yilmaz, ER; Kanat, MA; Arikok, AT; Erguder, BI; Hasturk, AE; Ergil, J; Sekerci, Z				Kertmen, Hayri; Gurer, Bora; Yilmaz, Erdal Resit; Kanat, Mehmet Ali; Arikok, Ata Turker; Erguder, Berrin Imge; Hasturk, Askin Esen; Ergil, Julide; Sekerci, Zeki			Antioxidant and antiapoptotic effects of darbepoetin-alpha against traumatic brain injury in rats	ARCHIVES OF MEDICAL SCIENCE			English	Article						antiapoptosis; antioxidation; darbepoetin-alpha; methylprednisolone; neuroprotection; rat; traumatic brain injury	ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; SPINAL-CORD ISCHEMIA; LIPID-PEROXIDATION; OXIDATIVE STRESS; CEREBRAL-ISCHEMIA; XANTHINE-OXIDASE; IMPACT INJURY; FREE-RADICALS; HEAD-INJURY	Introduction: In this study, we tried to determine whether darbepoetin-alpha would protect the brain from oxidative stress and apoptosis in a rat traumatic brain injury model. Material and methods: The animals were randomized into four groups; group 1 (sham), group 2 (trauma), group 3 (darbepoetin a), group 4 (methylprednisolone). In the sham group only the skin incision was performed. In all the other groups, a moderate traumatic brain injury modelwas applied. Results: Following trauma both glutathione peroxidase, superoxide dismutase levels decreased (p < 0.001 for both); darbepoetin-a increased the activity of both antioxidant enzymes (p = 0.001 and p < 0.001 respectively). Trauma caused significant elevation in the nitric oxide synthetase and xanthine oxidase levels (p < 0.001 for both). Administration of darbepoetin-a significantly decreased the levels of nitric oxide synthetase and xanthine oxidase (p < 0.001 for both). Also, trauma caused significant elevation in the nitric oxide levels (p < 0.001); darbepoetin-a administration caused statistically significant reduction in the nitric oxide levels (p < 0.001). On the other hand, malondialdehyde levels were increased following trauma (p < 0.001), and darbepoetin a significantly reduced the malondialdehyde levels (p < 0.001). Due to the elevated apoptotic activity following the injury, caspase-3 activity increased significantly. Darbepoetin-a treatment significantly inhibited apoptosis by lowering the caspase-3 activity (p < 0.001). In the darbepoetin group, histopathological score was lower than the trauma group (p = 0.016). Conclusions: In this study, darbepoetin-a was shown to be at least as effective as methylprednisolone in protecting brain from oxidative stress, lipid peroxidation and apoptosis.	[Kertmen, Hayri; Gurer, Bora; Yilmaz, Erdal Resit; Sekerci, Zeki] Minist Hlth, Diskapi Yildirim Beyazit Educ & Res Hosp, Neurosurg Clin, Ankara, Turkey; [Kanat, Mehmet Ali] Minist Hlth, Refik Saydam Natl Publ Hlth Agcy, Ankara, Turkey; [Arikok, Ata Turker] Minist Hlth, Diskapi Yildirim Beyazit Educ & Res Hosp, Dept Pathol, Ankara, Turkey; [Erguder, Berrin Imge] Ankara Univ, Dept Biochem, TR-06100 Ankara, Turkey; [Hasturk, Askin Esen] Minist Hlth, Oncol Training & Res Hosp, Dept Neurosurg, Ankara, Turkey; [Ergil, Julide] Minist Hlth, Dept Anesthesiol, Diskapi Yildirim Beyazit Educ & Res Hosp, Ankara, Turkey	Gurer, B (corresponding author), Diskapi Yildirim Beyazit Egitim & Arastirma, Minist Hlth, Diskapi Yildirim Beyazit Educ & Res Hosp, Irfan Bastug Cad SB, Hastanesi 1, TR-06110 Ankara, Turkey.	boragurer@gmail.com	Erguder, Imge/AAZ-5673-2020; HASTURK, ASKIN ESEN/AAE-5065-2019; Gurer, Bora/K-1177-2012	KANAT, Mehmet Ali/0000-0003-3494-4563; Gurer, Bora/0000-0003-1500-6184			Akcora B, 2007, INT J UROL, V14, P846, DOI 10.1111/j.1442-2042.2007.01844.x; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Ates E, 2005, ANZ J SURG, V75, P1100, DOI 10.1111/j.1445-2197.2005.03612.x; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; Belayev L, 2005, STROKE, V36, P1065, DOI 10.1161/01.STR.0000160753.36093.da; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Cassis P, 2011, TRANSPLANTATION, V92, P271, DOI 10.1097/TP.0b013e3182241106; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chang CM, 2009, NEUROREPORT, V20, P968, DOI 10.1097/WNR.0b013e32832d0a28; Chattopadhyay A, 2000, BIOCHEM PHARMACOL, V59, P419, DOI 10.1016/S0006-2952(99)00277-4; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; d'Uscio LV, 2010, HYPERTENSION, V55, P998, DOI 10.1161/HYPERTENSIONAHA.110.150623; Diaz-Ruiz A, 2000, NEUROREPORT, V11, P1765, DOI 10.1097/00001756-200006050-00033; Dolgun H, 2010, J CLIN NEUROSCI, V17, P486, DOI 10.1016/j.jocn.2009.07.108; Durak I, 2001, ACTA ANAESTH SCAND, V45, P119, DOI 10.1034/j.1399-6576.2001.450118.x; Egrie JC, 2002, ONCOLOGY-NY, V16, P13; Egrie JC, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_3.3; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2006, J NEUROSURG-SPINE, V4, P310, DOI 10.3171/spi.2006.4.4.310; Grasso G, 2001, J Neurosurg Sci, V45, P7; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HILLE R, 1995, FASEB J, V9, P995; Iijima R, 2004, FEBS LETT, V561, P163, DOI 10.1016/S0014-5793(04)00164-4; IKEDA Y, 1990, NEUROSURGERY, V27, P1; ITOH T, 1986, STROKE, V17, P1284, DOI 10.1161/01.STR.17.6.1284; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; KANEMITSU H, 1989, BRAIN RES, V499, P367, DOI 10.1016/0006-8993(89)90786-5; Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y; Katavetin P, 2007, BIOCHEM BIOPH RES CO, V359, P928, DOI 10.1016/j.bbrc.2007.05.207; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KRANTZ SB, 1991, BLOOD, V77, P419; Lappin T, 2003, ONCOLOGIST, V8, P15, DOI 10.1634/theoncologist.8-suppl_1-15; Liu DX, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-23; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; Lukacova N, 1996, NEUROCHEM RES, V21, P869, DOI 10.1007/BF02532334; MARKHAM A, 1995, DRUGS, V49, P232, DOI 10.2165/00003495-199549020-00008; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Marti HH, 2000, NEWS PHYSIOL SCI, V15, P225; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Nishio S, 1997, ACT NEUR S, V70, P84; Ozdemir D, 2005, PHYSIOL RES, V54, P631; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; PRAJDA N, 1975, FEBS LETT, V59, P245, DOI 10.1016/0014-5793(75)80385-1; Qian H, 1997, NEUROCHEM RES, V22, P1231, DOI 10.1023/A:1021980929422; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Sadamoto Y, 1998, BIOCHEM BIOPH RES CO, V253, P26, DOI 10.1006/bbrc.1998.9748; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sakurai M, 2003, J THORAC CARDIOV SUR, V125, P370, DOI 10.1067/mtc.2003.112; Schaller B.J, 2006, ARCH MED SCI, V2, P146; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; SUN Y, 1988, CLIN CHEM, V34, P497; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Ustun ME, 2001, J TRAUMA, V51, P22, DOI 10.1097/00005373-200107000-00004; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; Yang WS, 2011, FREE RADICAL BIO MED, V50, P1242, DOI 10.1016/j.freeradbiomed.2011.02.005; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3; Yilmaz ER, 2012, ACTA NEUROCHIR, V154, P1037, DOI 10.1007/s00701-012-1298-0; Yurdakoc A, 2008, ACTA ANAESTH SCAND, V52, P658, DOI 10.1111/j.1399-6576.2008.01635.x	78	15	15	0	7	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1734-1922	1896-9151		ARCH MED SCI	Arch. Med. Sci.		2015	11	5					1119	1128		10.5114/aoms.2015.54869			10	Medicine, General & Internal	General & Internal Medicine	CU0RE	WOS:000363225600028	26528358	DOAJ Gold			2021-06-18	
J	Lin, LF; Liou, TH; Hu, CJ; Ma, HP; Ou, JC; Chiang, YH; Chiu, WT; Tsai, SH; Chu, WC				Lin, Li-Fong; Liou, Tsan-Hon; Hu, Chaur-Jong; Ma, Hon-Ping; Ou, Ju-Chi; Chiang, Yung-Hsiao; Chiu, Wen-Ta; Tsai, Shin-Han; Chu, Woei-Chyn			Balance function and sensory integration after mild traumatic brain injury	BRAIN INJURY			English	Article						Balance function; mild traumatic brain injury; postural stability; sensory integration	POST-CONCUSSION SYMPTOMS; PHYSICAL-THERAPY; DEFICITS; REHABILITATION; ASSOCIATIONS; PERFORMANCE; INSTABILITY; DISORDERS; DIZZINESS; RECOVERY	Objective: This study examined the disparities in balance functions and sensory integration in patients with mild traumatic brain injuries (mTBIs) and healthy controls. Participants: One hundred and seven patients with mTBI and 107 age-and sex-matched controls were recruaited for this study. Primary measures: Symptoms of dizziness, balance functions and the ability to perform daily activities were assessed using the dizziness handicap inventory (DHI). This study also performed the postural-stability test and a modified clinical test of sensory integration by using the Biodex Stability System (BBS). Results: DHI scores (functional, emotional, physical and total self-reported scores) were substantially increased in patients following an mTBI compared with the scores of the controls (p<0.000). The postural-stability test indices (anterior-posterior) (p = 0.045) and the sensory-integration test index (eyes-open-firm-surface index) (p = 0.006) were substantially lower in patients with mTBI than in the controls. However, indices of two other postural-stability test indices (overall and medial-lateral) and three other sensory-integration tests indices (eyes-closed-firm-surface, eyes-open-foam-surface and eyes-closed-foam-surface) measured for the mTBI group did not differ from those of the control group. Conclusion: Activities of daily living, balance in postural stability and sensory integration were strongly impaired in patients with mTBI.	[Lin, Li-Fong; Chu, Woei-Chyn] Natl Yang Ming Univ, Grad Inst Biomed Engn, Taipei 112, Taiwan; [Lin, Li-Fong; Liou, Tsan-Hon] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lin, Li-Fong] Taipei Med Univ, Inst Gerontol & Hlth Management, Taipei, Taiwan; [Liou, Tsan-Hon; Chiu, Wen-Ta; Tsai, Shin-Han] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan; [Ma, Hon-Ping; Ou, Ju-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan	Chu, WC (corresponding author), Natl Yang Ming Univ, Inst Biomed Engn, 155 Li Long St,Sec 2, Taipei 112, Taiwan.	shtsai@tmu.edu.tw; wchu@ym.edu.tw	Liou, Tsan-Hon/I-8808-2019	Liou, Tsan-Hon/0000-0002-0959-4023	National Science Council, TaiwanMinistry of Science and Technology, Taiwan [98-2321-B-038-003-MY3, 98-2321-B-038-005-MY3]; Department of Health, Executive Yuan, Taiwan [101-TD-B-111-003]; Shuang Ho Hospital, Taipei Medical University [102 SHH-HCP-12]	The authors report no conflicts of interest. This study was supported by research grants from the National Science Council, Taiwan (98-2321-B-038-003-MY3 and 98-2321-B-038-005-MY3); Department of Health, Executive Yuan, Taiwan (101-TD-B-111-003); Shuang Ho Hospital, Taipei Medical University (102 SHH-HCP-12).	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Arnold BL, 1998, J ATHL TRAINING, V33, P323; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Dehail P, 2007, J REHABIL MED, V39, P531, DOI 10.2340/16501977-0096; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Findling O, 2011, GAIT POSTURE, V34, P473, DOI 10.1016/j.gaitpost.2011.06.021; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3	35	15	15	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					41	46		10.3109/02699052.2014.955881			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000006	25265292				2021-06-18	
S	McCarthy, MT; Kosofsky, BE		Fink, ME; Barchas, JD; Sheikh, JI		McCarthy, Matthew T.; Kosofsky, Barry E.			Clinical features and biomarkers of concussion and mild traumatic brain injury in pediatric patients	AFFECTIVE DISORDERS AND TRAUMATIC BRAIN INJURY	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	Qatar Clinical Neuroscience Conference	MAR 15-17, 2014	Doha, QATAR	Qatar Fdn Educ Sci & Community Dev			NEURON-SPECIFIC ENOLASE; HIGH-SCHOOL; INTRACRANIAL LESIONS; SERUM CONCENTRATIONS; BIOCHEMICAL MARKERS; COMPUTED-TOMOGRAPHY; OUTCOME PREDICTION; ELEVATED LEVELS; SOCCER PLAYERS; DAMAGE S-100B	There has been increasing awareness of the incidence and potential long-term consequences of mild traumatic brain injury (mTBI) in children and young adults. While parents, school systems, and athletic programs are clamoring for evidence-based guidelines, the field remains primitive in understanding the factors resulting in a spectrum of individual outcomes, most of which are complete, but some of which are not. In this article, we discuss the definition, epidemiology, clinical presentation, course, and outcomes of mTBI, with a focus on the pediatric population as the context for reviewing the mechanisms and pathophysiology mediating, and biomarkers reflective of, more significant concussion-induced brain injury. Our goal is to present a general overview of the features of mTBI in the pediatric population in order to provide a conceptual model for pediatricians and pediatric subspecialists. This model emphasizes the importance of establishing actionable, noninvasive biomarkers that are reflective of brain injury and that may identify those pediatric patients who can benefit from earlier and more aggressive interventions. We will focus on the specific features of mTBI in pediatric patients; although given the relative lack of research in the pediatric population, we will also extrapolate from research on adults.	[McCarthy, Matthew T.; Kosofsky, Barry E.] NewYork Presbyterian Weill Cornell Med Ctr, Dept Pediat, New York, NY 10021 USA	Kosofsky, BE (corresponding author), NewYork Presbyterian Weill Cornell Med Ctr, Dept Pediat, Div Child Neurol, 1300 York Ave,Box 91, New York, NY 10021 USA.	bar2009@med.cornell.edu		McCarthy, Matthew/0000-0001-8543-7225			Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Centers for Disease Control and Prevention, 2014, INJ PREV CONTR TRAUM; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Institute of Medicine, 2014, SPORTS REL CONC YOUT; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kosofsky B. E., 2014, PREP AUDIO, V9; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2015, PEDIATRICS, V135, P362, DOI 10.1542/peds.2014-3665; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mussack T, 2003, EUR J MED RES, V8, P457; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	68	15	15	0	13	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND	0077-8923			ANN NY ACAD SCI	Ann.NY Acad.Sci.		2015	1345						89	98		10.1111/nyas.12736			10	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	BC7XP	WOS:000355312300011	25809391				2021-06-18	
J	Moreno, A; Gan, C; Zasler, N; McKerral, M				Moreno, Alexander; Gan, Caron; Zasler, Nathan; McKerral, Michelle			Experiences, attitudes, and needs related to sexuality and service delivery in individuals with traumatic brain injury	NEUROREHABILITATION			English	Article						Experiences; attitudes; needs; traumatic brain injury; sexuality; service delivery	DYSFUNCTION; PREDICTORS; EDUCATION; PATIENT; HEALTH; ADULTS; SEX	OBJECTIVE: To explore the experiences, attitudes, and needs related to service delivery regarding sexuality issues in individuals with traumatic brain injury (TBI). METHODS: Community-dwelling individuals with TBI having completed a post-acute TBI rehabilitation program. The TBI sample consisted of 16 men (42.1%) and 22 women (57.9%), with an average age of 38.9 years (SD = 9.9) and 12.8 years of education (SD = 2.8). They were on average 2.6 years post-injury (SD = 1.4). Glasgow coma scale at admission was on average 12.6 (SD = 3.5). Participants completed a questionnaire adapted to individuals with TBI addressing experiences, attitudes, and needs regarding sexuality and service delivery. RESULTS: Individuals with TBI reported a low frequency of specific discussions with their treating clinician(s) about sexual and reproductive health issues, as well as many unmet needs regarding sexuality. None of the participants considered discussion about these issues to be inappropriate. They reported more favourable attitudes towards discussing sexual health topics compared to actual service delivery with family physicians, general practitioners, psychologists, and other health care professionals (p's < 0.05). CONCLUSIONS: Individuals with TBI desired more openness about discussing sexual concerns. Findings are discussed in terms of the clinical implications to meet the individuals' needs regarding sexual concerns after TBI.	[Moreno, Alexander; McKerral, Michelle] CRLB, CRIR, Montreal, PQ H2H 2N8, Canada; [Moreno, Alexander; McKerral, Michelle] Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ H3C 3J7, Canada; [Gan, Caron] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA	Moreno, A (corresponding author), CRLB, CRIR, 2275 Laurier Ave East, Montreal, PQ H2H 2N8, Canada.	jhon.alexander.moreno@umontreal.ca			CRIR; CERNEC; Faculte des etudes superieures et postdoctorales de l'Universite de Montreal; CRLB	The authors wish to thank the CRIR, CERNEC, and Faculte des etudes superieures et postdoctorales de l'Universite de Montreal (scholarships to J.A.M.), the CRLB for partial funding of this study (grant to M.M.), as well the individuals who took part in this study.	Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Aloni R., 2003, SEXUAL DIFFICULTIES; Aloni Ronit, 2009, Harefuah, V148, P615; Anand P, 2010, AIDS BEHAV, V14, P1213, DOI 10.1007/s10461-010-9684-1; Bertazone E do C, 2000, Rev Lat Am Enfermagem, V8, P115; BLACKBURN M, 1991, EUR J PEDIATR SURG, V1, P37; Blackerby WF, 1990, J HEAD TRAUMA REHAB, V5, P73; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Comfort A., 1978, SEXUAL CONSEQUENCES; D'Eath M, 2013, J CARDIOVASC NURS, V28, pE1, DOI 10.1097/JCN.0b013e318281d0b3; De Wispelaere J, 2014, DISABIL SOC, V29, P402, DOI 10.1080/09687599.2013.823076; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Dyer K, 2013, J SEX MED, V10, P2658, DOI 10.1111/j.1743-6109.2012.02856.x; Franits LE, 2005, AM J OCCUP THER, V59, P577, DOI 10.5014/ajot.59.5.577; Fronek P, 2005, SEX DISABIL, V23, P51, DOI 10.1007/s11195-005-4669-0; Fronek P, 2011, SEX DISABIL, V29, P87, DOI 10.1007/s11195-010-9177-1; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gouvernement du Quebec/Ministere de la Sante et des Services Sociaux, 2005, OR MIN TCCL; Griffith ER, 1993, SEXUALITY PERSON TRA; Gumus H, 2014, J SEX MED, V11, P481, DOI 10.1111/jsm.12397; Hall Joy, 2013, Br J Nurs, V22, P556; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; IBM, 2012, IBM SPSS ADV STAT 21; Iezzoni LI, 2012, DISABIL HEALTH J, V5, P136, DOI 10.1016/j.dhjo.2012.03.003; Jimenez-Garcia R, 2012, PRIM CARE DIABETES, V6, P269, DOI 10.1016/j.pcd.2012.02.005; Katz S, 1999, INT J REHABIL RES, V22, P45, DOI 10.1097/00004356-199903000-00006; Kelly G, 2011, SEX DISABIL, V29, P313, DOI 10.1007/s11195-011-9213-9; Kobelt G, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-170; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; Moreno A., 2012, SEXUALITY INT J PSYC, V47, P684; Moreno A., 2014, 91 AM C REH MED TRAN; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Murdoch BE., 2001, TRAUMATIC BRAIN INJU; Neese LE, 2003, PSYCHO-ONCOL, V12, P463, DOI 10.1002/pon.657; Niderost S, 2011, AIDS CARE, V23, P908, DOI 10.1080/09540121.2010.538661; OPSQ, 2014, ORDR PROF SEX QUEB; Pederson A, 2010, CAN J PUBLIC HEALTH, V101, P259, DOI 10.1007/BF03404386; Post MWM, 2008, SEX DISABIL, V26, P3, DOI 10.1007/s11195-007-9068-2; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sandel ME, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P915; SANDEL ME, 2007, BRAIN INJURY MED PRI, P673; Sander A.M., 2011, SEXUAL FUNCTIONING S; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Simpson G, 2004, J HEAD TRAUMA REHAB, V19, P413, DOI 10.1097/00001199-200409000-00006; Simpson G., 1999, YOU ME GUIDE SEX SEX; SIMPSON GK, 1999, YOU ME ED PROGRAM SE; Sipski M, 1997, SEXUAL FUNCTION PEOP; Taylor Bridget, 2006, Nurs Stand, V21, P35; Valvano A., 2014, SEXUALITY DISABILITY; Verschuren JEA, 2010, J SEX RES, V47, P153, DOI 10.1080/00224491003658227; WHO, 2014, SEX REP HLTH; WHO, 2010, DEV SEX HLTH PROGR F; Zasler N. D., 1990, HEAD INJURY FAMILY M, P253; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P397	58	15	15	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	1					99	116		10.3233/NRE-151243			18	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CQ2ET	WOS:000360412900009	26409696				2021-06-18	
J	Roe, C; Skandsen, T; Manskow, U; Ader, T; Anke, A				Roe, Cecilie; Skandsen, Toril; Manskow, Unn; Ader, Tiina; Anke, Audny			Mortality and One-Year Functional Outcome in Elderly and Very Old Patients with Severe Traumatic Brain Injuries: Observed and Predicted	BEHAVIOURAL NEUROLOGY			English	Article							EXTERNAL VALIDATION; HEAD-INJURY; MODELS; IMPACT; ADULTS; AGE; HEMATOMA; QUALITY; NORWAY; SCORES	The aim of the present study was to evaluate mortality and functional outcome in old and very old patients with severe traumatic brain injury (TBI) and compare to the predicted outcome according to the internet based CRASH (Corticosteroid Randomization After Significant Head injury) model based prediction, fromtheMedical Research Council (MRC). Methods. Prospective, national multicenter study including patients with severe TBI >65 years. Predicted mortality and outcome were calculated based on clinical information (CRASH basic) (age, GCS score, and pupil reactivity to light), as well as with additional CT findings (CRASH CT). Observed 14-day mortality and favorable/unfavorable outcome according to the Glasgow Outcome Scale at one year was compared to the predicted outcome according to the CRASHmodels. Results. 97 patients, mean age 75 (SD 7) years, 64% men, were included. Two patients were lost to follow-up; 48 died within 14 days. The predicted versus the observed odds ratio (OR) for mortality was 2.65. Unfavorable outcome (GOSE < 5) was observed at one year follow-up in 72% of patients. The CRASH models predicted unfavorable outcome in all patients. Conclusion. The CRASH model overestimated mortality and unfavorable outcome in old and very old Norwegian patients with severe TBI.	[Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Oslo, Norway; [Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neurosci, Trondheim, Norway; [Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Manskow, Unn; Anke, Audny] Univ Tromso, Inst Clin Med, Fac Hlth Sci, N-9001 Tromso, Norway; [Manskow, Unn] Univ Hosp North Norway, Dept Neurosurg, Tromso, Norway; [Ader, Tiina] Haukeland Hosp, Dept Phys Med & Rehabil, N-5021 Bergen, Norway; [Anke, Audny] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway	Roe, C (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	eller@medisin.uio.no		Anke, Audny/0000-0002-2491-2560	Norwegian Research CouncilResearch Council of NorwayEuropean Commission	The authors thank all patients and relatives participating and the Norwegian Research Council for financial support. Special thanks are due to Nada Andelic responsible for assessment of patients and preparation of databases and paper.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anke A., 2015, J HEAD TRAUMA REHABI, V30; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; CARDOSO ER, 1989, ACTA NEUROCHIR, V97, P40, DOI 10.1007/BF01577738; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; de Guise E, 2015, BRAIN INJURY, V29, P558, DOI 10.3109/02699052.2014.976593; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Edwards P, 2005, LANCET, V365, P1957; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; JENNETT B, 1975, LANCET, V1, P480; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kristiansen Thomas, 2011, J Trauma Manag Outcomes, V5, P9, DOI 10.1186/1752-2897-5-9; LEE KL, 1986, AM J MED, V80, P553, DOI 10.1016/0002-9343(86)90807-7; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Ronning PA, 2011, J TRAUMA, V70, pE56, DOI 10.1097/TA.0b013e3181e80f0a; Sovik S, 2014, INJURY, V45, P1722, DOI 10.1016/j.injury.2014.05.038; Sundstrom Terje, 2005, Tidsskr Nor Laegeforen, V125, P1310; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	37	15	15	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								845491	10.1155/2015/845491			7	Clinical Neurology	Neurosciences & Neurology	CX9AU	WOS:000365997900001	26688614	DOAJ Gold, Green Accepted, Green Published			2021-06-18	
J	Steffens, S; Pacher, P				Steffens, Sabine; Pacher, Pal			The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?	CURRENT DRUG TARGETS			English	Article						Cannabinoid receptor CB1; CB2; diacylglycerol lipase; eicosanoid; fatty acid amide hydrolase; monoacylglycerol lipase	ACID AMIDE HYDROLASE; CB1 CANNABINOID RECEPTOR; REVERSE CHOLESTEROL TRANSPORT; MUSCLE-CELL PROLIFERATION; CORONARY-ARTERY-DISEASE; TRAUMATIC BRAIN-INJURY; CARDIOVASCULAR FUNCTION; NEOINTIMA FORMATION; HYPERTENSIVE-RATS; DENDRITIC CELLS	Atherosclerosis and its major acute complications, myocardial infarction and stroke, are the leading causes of death and morbidity worldwide. Despite major advances in cardiovascular intervention and healthcare, improving preventive care and treatment remains a continuous mission for cardiovascular research. Within the last 10 to 15 years, the endocannabinoid system has emerged as an important lipid signaling system involved in many biological processes. Growing evidence suggests that an overactive endocannabinoid-CB1 receptor signaling promotes the development of cardiovascular risk factors such as obesity, insulin resistance and dyslipidemia. This prompted an increasing interest in studying the role of the endocannabinoid system in atherosclerosis. As opposed to the detrimental actions of CB1 signaling, the endocannabinoid-CB2 receptor axis exhibits an anti-inflammatory and atheroprotective role. We will review recent findings from experimental and clinical studies aimed at understanding the complex actions of endocannabinoid signaling in cardiovascular disease. This is followed by an outlook on emerging targets for possible therapeutic intervention.	[Steffens, Sabine] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Steffens, Sabine] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany; [Pacher, Pal] NIAAA, Sect Oxidat Stress Tissue Injury, Lab Physiol Studies, NIH, Bethesda, MD USA	Steffens, S (corresponding author), Inst Cardiovasc Prevent, Pettenkoferstr 9, D-80336 Munich, Germany.	sabine.steffens@med.uni-muenchen.de	Steffens, Sabine/AAV-4551-2020; Pacher, Pal/B-6378-2008	Steffens, Sabine/0000-0002-6892-9751; Pacher, Pal/0000-0001-7036-8108	Intramural Program of the NIAAA/NIH; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [STE1053/3-1, SFB1123 C01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000375] Funding Source: NIH RePORTER	The related research studies were supported by the Intramural Program of the NIAAA/NIH (to Pal Pacher) and the Deutsche Forschungsgemeinschaft (STE1053/3-1, SFB1123 C01 to Sabine Steffens).	Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Bisogno T, 2013, BRIT J PHARMACOL, V169, P784, DOI 10.1111/bph.12013; Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; Bonz A, 2003, J CARDIOVASC PHARM, V41, P657, DOI 10.1097/00005344-200304000-00020; Cao ZX, 2013, GASTROENTEROLOGY, V144, P808, DOI 10.1053/j.gastro.2012.12.028; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Costola-De-Souza C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077706; Cota D, 2003, J CLIN INVEST, V112, P423, DOI [10.1172/JCI200317725, 10.1172/JCI17725]; Daigle TL, 2008, J NEUROCHEM, V106, P70, DOI 10.1111/j.1471-4159.2008.05336.x; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Delsing DJM, 2011, OPEN CARDIOVASC MED, V5, P15, DOI 10.2174/1874192401105010015; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, NAT CLIN PRACT CARD, V5, P610, DOI 10.1038/ncpcardio1319; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Dol-Gleizes F, 2009, ARTERIOSCL THROM VAS, V29, P12, DOI 10.1161/ATVBAHA.108.168757; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gardiner SM, 2002, BRIT J PHARMACOL, V135, P1889, DOI 10.1038/sj.bjp.0704649; Ghosh S, 2013, LIFE SCI, V92, P498, DOI 10.1016/j.lfs.2012.06.020; Godlewski G, 2010, CHEM BIOL, V17, P1256, DOI 10.1016/j.chembiol.2010.08.013; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hoyer FF, 2014, J MOL CELL CARDIOL, V66, P126, DOI 10.1016/j.yjmcc.2013.11.013; Hoyer FF, 2011, J MOL CELL CARDIOL, V51, P1007, DOI 10.1016/j.yjmcc.2011.08.008; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Ishac EJN, 1996, BRIT J PHARMACOL, V118, P2023, DOI 10.1111/j.1476-5381.1996.tb15639.x; Jiang LS, 2009, CARDIOVASC RES, V81, P805, DOI 10.1093/cvr/cvn344; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Klumpers LE, 2013, BRIT J CLIN PHARMACO, V76, P846, DOI 10.1111/bcp.12141; Kruth HS, 2011, CURR OPIN LIPIDOL, V22, P386, DOI 10.1097/MOL.0b013e32834adadb; Krylatov AV, 2005, B EXP BIOL MED+, V139, P558, DOI 10.1007/s10517-005-0344-9; Lake KD, 1997, HYPERTENSION, V29, P1204, DOI 10.1161/01.HYP.29.5.1204; Lenglet S, 2013, ARTERIOSCL THROM VAS, V33, P215, DOI 10.1161/ATVBAHA.112.300275; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Lobato NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063449; Long JZ, 2011, J LIPID RES, V52, P337, DOI 10.1194/jlr.M012153; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Maestroni GJM, 2004, FASEB J, V18, P1914, DOI 10.1096/fj.04-2190fje; Mallat A, 2008, AM J PHYSIOL-GASTR L, V294, pG9, DOI 10.1152/ajpgi.00467.2007; Maslov LN, 2004, B EXP BIOL MED+, V138, P550, DOI 10.1007/s10517-005-0123-7; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mauler F, 2003, CNS DRUG REV, V9, P343; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mendizabal VE, 2007, BRIT J PHARMACOL, V151, P427, DOI 10.1038/sj.bjp.0707261; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Molica F, 2012, AM J PHYSL HEART CIR; Molica F, 2014, THROMB HAEMOST; Molica F, 2013, J LIPID RES, V54, P1360, DOI 10.1194/jlr.M035147; Molica F, 2012, AM J PHYSIOL-HEART C, V302, pH1064, DOI 10.1152/ajpheart.00444.2011; Montecucco F, 2012, EUR HEART J, V33, P846, DOI 10.1093/eurheartj/ehr449; Montecucco F, 2009, ATHEROSCLEROSIS, V205, P433, DOI 10.1016/j.atherosclerosis.2008.12.040; Montecucco F, 2009, J MOL CELL CARDIOL, V46, P612, DOI 10.1016/j.yjmcc.2008.12.014; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V50, P179, DOI 10.1016/j.freeradbiomed.2010.11.002; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Netherland CD, 2010, ATHEROSCLEROSIS, V213, P102, DOI 10.1016/j.atherosclerosis.2010.07.060; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Noe SN, 2001, ADV EXP MED BIOL, V493, P215; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Nong L, 2001, ADV EXP MED BIOL, V493, P229; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2005, NEUROPHARMACOLOGY, V48, P1130, DOI 10.1016/j.neuropharm.2004.12.005; Pacher P, 2005, AM J PHYSIOL-HEART C, V289, pH533, DOI 10.1152/ajpheart.00107.2005; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Pacher P, 2008, HYPERTENSION, V52, P601, DOI 10.1161/HYPERTENSIONAHA.105.063651; Pacher P, 2008, AM J PHYSIOL-GASTR L, V294, pG850, DOI 10.1152/ajpgi.00523.2007; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Quercioli A, 2013, EUR HEART J, V34, P2063, DOI 10.1093/eurheartj/eht085; Quercioli A, 2012, JACC-CARDIOVASC IMAG, V5, P805, DOI 10.1016/j.jcmg.2012.01.020; Quercioli A, 2011, EUR HEART J, V32, P1369, DOI 10.1093/eurheartj/ehr029; Rajesh M, 2008, BRIT J PHARMACOL, V153, P347, DOI 10.1038/sj.bjp.0707569; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Rajesh M, 2008, BIOCHEM BIOPH RES CO, V377, P1248, DOI 10.1016/j.bbrc.2008.10.159; Randall MD, 2002, PHARMACOL THERAPEUT, V95, P191, DOI 10.1016/S0163-7258(02)00258-9; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Samson MT, 2003, J IMMUNOL, V170, P4953, DOI 10.4049/jimmunol.170.10.4953; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schmidt W, 2012, NEUROSCIENCE, V227, P313, DOI 10.1016/j.neuroscience.2012.09.080; Silvestri C, 2012, EXPERT OPIN INV DRUG, V21, P1309, DOI 10.1517/13543784.2012.704019; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Steffens S, 2012, BRIT J PHARMACOL, V167, P313, DOI 10.1111/j.1476-5381.2012.02042.x; Sterin-Borda L, 2005, BIOCHEM PHARMACOL, V69, P1705, DOI 10.1016/j.bcp.2005.03.027; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Szekeres M, 2012, J BIOL CHEM, V287, P31540, DOI 10.1074/jbc.M112.346296; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Wagner JA, 2001, EUR J PHARMACOL, V423, P203, DOI 10.1016/S0014-2999(01)01112-8; Walter L, 2003, J NEUROSCI, V23, P1398; Wang PF, 2012, J CARDIOVASC PHARM, V59, P301, DOI 10.1097/FJC.0b013e3182418997; Weis F, 2010, J MOL CELL CARDIOL, V48, P1187, DOI 10.1016/j.yjmcc.2009.10.025; Wheal AJ, 2007, BRIT J PHARMACOL, V152, P717, DOI 10.1038/sj.bjp.0707410; Willecke F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019405	117	15	15	0	18	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-4501	1873-5592		CURR DRUG TARGETS	Curr. Drug Targets		2015	16	4					334	341		10.2174/1389450115666141202113225			8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CF4IW	WOS:000352513400005	25469884				2021-06-18	
S	Thompson, HJ; Vavilala, MS; Rivara, FP		Conley, YP		Thompson, Hilaire J.; Vavilala, Monica S.; Rivara, Frederick P.			Common Data Elements and Federal Interagency Traumatic Brain Injury Research Informatics System for TBI Research	ANNUAL REVIEW OF NURSING RESEARCH, VOL 33: TRAUMATIC BRAIN INJURY	Annual Review of Nursing Research-Series		English	Article; Book Chapter							WORKING GROUP; RECOMMENDATIONS; DEMOGRAPHICS; BIOSPECIMENS	Despite increased attention to traumatic brain injury (TBI), there remains no specific treatment and available interventions focus rather on the prevention of secondary injury. One of the reasons posited for the lack of a successful therapy is the amalgamation of various types of injuries under the same severity category in clinical trials. Informatics approaches have been suggested as a means to develop an improved classification system for TBI. As a result of federal interagency efforts, common data elements (CDEs) for TBI have now been developed. Further, the Federal Interagency Traumatic Brain Injury Research Informatics System (FITBIR) has been created and is now available for TBI researchers to both add and retrieve data. This chapter will discuss the goals, development, and evolution of the CDEs and FITBIR and discuss how these tools can be used to support TBI research. A specific exemplar using the CDEs and lessons learned from working with the CDEs and FITBIR are included to aid future researchers.	[Thompson, Hilaire J.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA USA	Thompson, HJ (corresponding author), Univ Washington, Sch Nursing, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077913] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS077913, R01NS077913] Funding Source: Medline		Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Centers for Disease Control, 2001, TRAUM BRAIN INJ US R; Federal Interagency Traumatic Brain Injury Research Informatics System (FITBIR), 2014, FAQS; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Miller AC, 2012, J NEUROTRAUM, V29, P634, DOI 10.1089/neu.2011.1932; National Institute of Neurologic Disorders and Stroke (NINDS), 2014, NINDS COMM DAT EL; Pope AM, 1991, DISABILITY AM NATL A; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Stead LG, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-5; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	16	15	15	0	0	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA	0739-6686	1944-4028	978-0-8261-2922-2; 978-0-8261-7162-7	ANNU REV NURS RES-SE			2015	33						1	11		10.1891/0739-6686.33.1			11	Nursing	Nursing	BI5YI	WOS:000412973800002	25946381	Green Accepted			2021-06-18	
J	Johnson, BN; Palmer, CP; Bourgeois, EB; Elkind, JA; Putnam, BJ; Cohen, AS				Johnson, Brian N.; Palmer, Chris P.; Bourgeois, Elliot B.; Elkind, Jaclynn A.; Putnam, Brendan J.; Cohen, Akiva S.			Augmented inhibition from cannabinoid-sensitive interneurons diminishes CA1 output after traurnatic brain injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						interneuron; traumatic brain injury; CA1; cholecystokinin; cannabinoid type 1 receptor; action potential; lateral fluid percussion; voltage-sensitive dye	GABAERGIC NEURONS; PYRAMIDAL NEURONS; AXON TERMINALS; GABA RELEASE; RECEPTOR; RAT; CB1; DEPOLARIZATION; HIPPOCAMPUS; SUPPRESSION	The neurological impairments associated with traumatic brain injury include learning and memory deficits and increased risk of seizures. The hippocampus is critically involved in both of these phenomena and highly susceptible to damage by traumatic brain injury. To examine network activity in the hippocampal CA1 region after lateral fluid percussion injury, we used a combination of voltage-sensitive dye, field potential, and patch clamp recording in mouse hippocampal brain slices. When the stratum radiatum (SR) was stimulated in slices from injured mice, we found decreased depolarization in SR and increased hyperpolarization in stratum oriens (SO), together with a decrease in the percentage of pyramidal neurons firing stimulus-evoked action potentials. Increased hyperpolarization in SO persisted when glutamatergic transmission was blocked. However, we found no changes in SO responses when the alveus was stimulated to directly activate SO. These results suggest that the increased SO hyperpolarization evoked by SR stimulation was mediated by interneurons that have cell bodies and/or axons in SR, and form synapses in stratum pyramidale and SO. A low concentration (100 nM) of the synthetic cannabinoid WIN55,212-2, restored CA1 output in slices from injured animals. These findings support the hypothesis that increased GABAergic signaling by cannabinoid-sensitive interneurons contributes to the reduced CA1 output following traumatic brain injury.	[Johnson, Brian N.; Elkind, Jaclynn A.; Putnam, Brendan J.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Palmer, Chris P.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Bourgeois, Elliot B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Cohen, Akiva S.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	Cohen, AS (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Res Inst, Room 814,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	cohena@email.chop.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37 HD59288, RO1 NS069629]; Foerderer Foundation grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629] Funding Source: NIH RePORTER	This work was supported in part by NIH grants R37 HD59288 and RO1 NS069629, and a Foerderer Foundation grant. The authors thank Colin Smith, Catherine Kopil, Eric Marsh, Michael Schell, Les Satin and Diego Contreras for critiquing an earlier draft of the manuscript.	Ameri A, 1999, BRIT J PHARMACOL, V126, P1831, DOI 10.1038/sj.bjp.0702478; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Basu J, 2013, NEURON, V79, P1208, DOI 10.1016/j.neuron.2013.07.001; Brown JT, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.025; Cave C B, 1991, Hippocampus, V1, P329, DOI 10.1002/hipo.450010323; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Fink AE, 2009, J NEUROSCI, V29, P11203, DOI 10.1523/JNEUROSCI.1450-09.2009; Foldy C, 2010, NAT NEUROSCI, V13, P1047, DOI 10.1038/nn.2609; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Glickfeld LL, 2008, J NEUROSCI, V28, P1824, DOI 10.1523/JNEUROSCI.4700-07.2008; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Haller J, 2007, EUR J NEUROSCI, V25, P2445, DOI 10.1111/j.1460-9568.2007.05476.x; Hoffman AF, 2005, EUR J NEUROSCI, V22, P2387, DOI 10.1111/j.1460-9568.2005.04401.x; Hoffman AF, 2007, LEARN MEMORY, V14, P63, DOI 10.1101/lm.439007; Hoffman AF, 2010, J NEUROSCI, V30, P545, DOI 10.1523/JNEUROSCI.4920-09.2010; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kojima S, 1999, J NEUROSCI, V19, P2580; KONNERTH A, 1987, J PHYSIOL-LONDON, V393, P681, DOI 10.1113/jphysiol.1987.sp016848; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Lee SH, 2010, J NEUROSCI, V30, P7993, DOI 10.1523/JNEUROSCI.6238-09.2010; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Minge D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026664; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Oz M, 2006, PHARMACOL THERAPEUT, V111, P114, DOI 10.1016/j.pharmthera.2005.09.009; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916; Routh BN, 2009, J NEUROPHYSIOL, V102, P2288, DOI 10.1152/jn.00082.2009; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shen MX, 1998, BRAIN RES, V783, P77, DOI 10.1016/S0006-8993(97)01195-5; Shepherd GM., 2004, SYNAPTIC ORG BRAIN; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Takacs VT, 2015, BRAIN STRUCT FUNCT, V220, P919, DOI 10.1007/s00429-013-0692-6; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tyzio R, 2008, EUR J NEUROSCI, V27, P2515, DOI 10.1111/j.1460-9568.2008.06234.x; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wykes R, 2012, NEUROBIOL AGING, V33, P1609, DOI 10.1016/j.neurobiolaging.2011.05.001; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610	61	15	15	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	DEC 19	2014	8								435	10.3389/fncel.2014.00435			19	Neurosciences	Neurosciences & Neurology	AX9RQ	WOS:000347240100001	25565968	DOAJ Gold, Green Published			2021-06-18	
J	Bell, JD; Thomas, TC; Lass, E; Ai, JL; Wan, H; Lifshitz, J; Baker, AJ; Macdonald, RL				Bell, Joshua D.; Thomas, Theresa Currier; Lass, Elliot; Ai, Jinglu; Wan, Hoyee; Lifshitz, Jonathan; Baker, Andrew J.; Macdonald, R. Loch			Platelet-mediated changes to neuronal glutamate receptor expression at sites of microthrombosis following experimental subarachnoid hemorrhage	JOURNAL OF NEUROSURGERY			English	Article						subarachnoid hemorrhage; platelet; microthrombi; glutamate receptor expression; traumatic brain injury; vascular disorders	EXTRACELLULAR GLUTAMATE; GLUR2 ENDOCYTOSIS; AMPA-RECEPTOR; STRIATUM; RATS; PERMEABILITY; PLASTICITY; TRAUMA; INJURY; PICK1	Object. Glutamate is important in the pathogenesis of brain damage after cerebral ischemia and traumatic brain injury. Notably, brain extracellular and cerebrospinal fluid as well as blood glutamate concentrations increase after experimental and clinical trauma. While neurons are one potential source of glutamate, platelets also release glutamate as part of their recruitment and might mediate neuronal damage. This study investigates the hypothesis that platelet microthrombi release glutamate that mediates excitotoxic brain injury and neuron dysfunction after subarachnoid hemorrhage (SAH). Methods. The authors used two models, primary neuronal cultures exposed to activated platelets, as well as a whole-animal SAH preparation. Propidium iodide was used to evaluate neuronal viability, and surface glutamate receptor staining was used to evaluate the phenotype of platelet-exposed neurons. Results. The authors demonstrate that thrombin-activated platelet-rich plasma releases glutamate, at concentrations that can exceed 300 mu M. When applied to neuronal cultures, this activated plasma is neurotoxic, and the toxicity is attenuated in part by glutamate receptor antagonists. The authors also demonstrate that exposure to thrombin-activated platelets induces marked downregulation of the surface glutamate receptor glutamate receptor 2, a marker of excitotoxicity exposure and a possible mechanism of neuronal dysfunction. Linear regression demonstrated that 7 days after SAH in rats there was a strong correlation between proximity to microthrombi and reduction of surface glutamate receptors. Conclusions. The authors conclude that platelet-mediated microthrombosis contributes to neuronal glutamate receptor dysfunction and might mediate brain injury after SAH.	[Bell, Joshua D.; Baker, Andrew J.; Macdonald, R. Loch] Univ Toronto, Fac Med, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] Univ Toronto, Dept Anesthesia, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.; Macdonald, R. Loch] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Bell, Joshua D.; Lass, Elliot; Ai, Jinglu; Wan, Hoyee; Baker, Andrew J.; Macdonald, R. Loch] St Michaels Hosp, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] St Michaels Hosp, Dept Anesthesia, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] St Michaels Hosp, Dept Crit Care, Toronto, ON M5B 1W8, Canada; [Macdonald, R. Loch] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Thomas, Theresa Currier; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Thomas, Theresa Currier; Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Thomas, Theresa Currier; Lifshitz, Jonathan] Phoenix VA Healthcare Syst, Phoenix, AZ USA; [Lifshitz, Jonathan] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA	Macdonald, RL (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	macdonaldlo@smh.ca	Thomas, Theresa Currier/K-1979-2019	Thomas, Theresa Currier/0000-0002-9619-7666; AI, JINGLU/0000-0001-7414-0207	Physicians Services Incorporated Foundation; Brain Aneurysm Foundation; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada	Dr. Macdonald receives grant support from the Physicians Services Incorporated Foundation, Brain Aneurysm Foundation, Canadian Institutes for Health Research, and the Heart and Stroke Foundation of Canada; and is a consultant for Actelion Pharmaceuticals and the Chief Scientific Officer of Edge Therapeutics, Inc.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Friedrich V, 2010, NEUROSCIENCE, V165, P968, DOI 10.1016/j.neuroscience.2009.10.038; Friedrich V, 2010, BRAIN RES, V1354, P179, DOI 10.1016/j.brainres.2010.07.040; GERMANO A, 1992, NEUROSURGERY, V30, P882, DOI 10.1227/00006123-199206000-00011; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Jeon H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-103; LeRoux P D, 1994, Clin Neurosurg, V41, P325; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MCKENNA P, 1989, NEUROSURGERY, V24, P361, DOI 10.1227/00006123-198903000-00009; Morrell CN, 2008, J EXP MED, V205, P575, DOI 10.1084/jem.20071474; Nickell J, 2005, J NEURAL TRANSM, V112, P87, DOI 10.1007/s00702-004-0151-x; Prunell GF, 2002, NEUROREPORT, V13, P2553, DOI 10.1097/00001756-200212200-00034; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Tariq A, 2010, NEUROSCIENCE, V165, P418, DOI 10.1016/j.neuroscience.2009.10.040; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Thomas TC, 2009, NEUROPSYCHOPHARMACOL, V34, P436, DOI 10.1038/npp.2008.74; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74	26	15	18	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1424	1431		10.3171/2014.3.JNS132130			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700020	24745710				2021-06-18	
J	Wolf, H; Krall, C; Pajenda, G; Leitgeb, J; Bukaty, AJ; Hajdu, S; Sarahrudi, K				Wolf, Harald; Krall, Christoph; Pajenda, Gholam; Leitgeb, Johannes; Bukaty, Adam J.; Hajdu, Stefan; Sarahrudi, Kambiz			Alterations of the biomarker S-100B and NSE in patients with acute vertebral spine fractures	SPINE JOURNAL			English	Article						S100B; NSE; Vertebral spine fractures; Spinal cord injury; Spinal trauma; Biomarker; Neurologic deficit	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; SERUM S100B LEVELS; MINOR HEAD-INJURY; CORD-INJURY; PROTEIN; S-100-BETA; ELEVATION; FAMILY	BACKGROUND CONTEXT: Although several publications concerning the use of the biomarkers S100B and neuron-specific enolase (NSE) in vertebral spine fractures in animal experimental studies have proven their usefulness as early indicators of injury severity, there are no clinical reports on their effectiveness as indicators in patients with spinal injuries. As these biomarkers have been examined, with promising results, in patients with traumatic brain injury, there is a potential for their implementation in patients with vertebral spine fractures. PURPOSE: To investigate the early serum measurement of S100B and NSE in patients with vertebral spine fractures compared with those in patients with acute fractures of the proximal femur. STUDY DESIGN: Prospective longitudinal cohort study. PATIENT SAMPLE: A cohort of 34 patients admitted over an 18-month period to a single medical center for suspected vertebral spine trauma. Twenty-nine patients were included in the control group. OUTCOME MEASURES: S100B and NSE serum levels were assessed in different types of vertebral spine fractures. METHODS: We included patients older than 16 years with vertebral spine fractures whose injuries were sustained within 24 hours before admission to the emergency room and who had undergone a brief neurologic examination. Spinal cord injuries (SCIs) were classified as being paresthesias, incomplete paraplegias, or complete paraplegias. Blood serum was obtained from all patients within 24 hours after the time of injury. Serum levels of S100B and NSE were statistically analyzed using Wilcoxon signed-rank test. RESULTS: S100B serum levels were significantly higher in patients with vertebral spine fractures (p=.01). In these patients, the mean S100B serum level was 0.75 mu g/L (standard deviation [SD] 1.44, 95% confidence interval [CI] 0.24, 1.25). The mean S100B serum level in control group patients was 0.14 mu g/L (SD 0.11, 95% CI 0.10, 0.19). The 10 patients with neurologic deficits had significantly higher S100B serum levels compared with the patients with vertebral fractures but without neurologic deficits (p=.02). The mean S100B serum level in these patients was 1.18 mu g/L (SD 1.96). In the 26 patients with vertebral spine fractures but without neurologic injury, the mean S100B serum level was 0.42 mu g/L (SD 0.91, 95% CI 0.08, 0.76). The analysis revealed no significant difference in NSE levels. CONCLUSIONS: We observed a significant correlation not only between S100B serum levels and vertebral spine fractures but also between S100B serum levels and SCIs with neurologic deficit. These results may be meaningful in clinical practice and to future studies. (C) 2014 Elsevier Inc. All rights reserved.	[Wolf, Harald; Pajenda, Gholam; Leitgeb, Johannes; Hajdu, Stefan; Sarahrudi, Kambiz] Med Univ Vienna, Vienna Gen Hosp, Dept Trauma Surg, A-1090 Vienna, Austria; [Krall, Christoph] Med Univ Vienna, Dept Med Stat, A-1090 Vienna, Austria; [Bukaty, Adam J.] Med Univ Vienna, Vienna Gen Hosp, Dept Anaesthesia & Intens Care Med, A-1090 Vienna, Austria	Wolf, H (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Trauma Surg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	harald.wolf@meduniwien.ac.at					Aarabi B, 2012, J NEUROSURG-SPINE, V17, P243, DOI 10.3171/2012.6.SPINE12122; Benneker LM, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-13; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI [10.1089/neu.2008.0738, 10.1089/neu.2008-0738]; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Einav S, 2012, J AM COLL CARDIOL, V60, P304, DOI 10.1016/j.jacc.2012.04.020; Korfias S, 2006, BRAIN INJURY, V20, P867, DOI 10.1080/02699050600832395; Lee SJ, 2010, EMERG MED J, V27, P209, DOI 10.1136/emj.2008.063743; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Marquardt G, 2011, NEUROL RES, V33, P421, DOI 10.1179/1743132810Y.0000000005; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	20	15	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC	2014	14	12					2918	2922		10.1016/j.spinee.2014.04.027			5	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AU2EQ	WOS:000345429500021	24780247				2021-06-18	
J	Zhao, B; Shang, GW; Chen, J; Geng, XK; Ye, X; Xu, GX; Wang, J; Zheng, JS; Li, HJ; Akbary, F; Li, SL; Lu, J; Ling, F; Ji, XM				Zhao, Bo; Shang, Guowei; Chen, Jian; Geng, Xiaokun; Ye, Xin; Xu, Guoxun; Wang, Ju; Zheng, Jiasheng; Li, Hongjun; Akbary, Fauzia; Li, Shengli; Lu, Jing; Ling, Feng; Ji, Xunming			A more consistent intraluminal rhesus monkey model of ischemic stroke	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain injury; rhesus monkeys; model middle cerebral artery; microcoil; infarction; stroke; interventional therapy; digital subtraction angiography; magnetic resonance image; neuroimaging; neuroregeneration	CEREBRAL-ARTERY OCCLUSION; DIFFUSION TENSOR MRI; NONHUMAN PRIMATE; SUBCORTICAL INFARCTS; MACACA-FASCICULARIS; CALORIC RESTRICTION; REPERFUSED STROKE; NXY-059; TERRITORY; MACAQUES	Endovascular surgery is advantageous in experimentally induced ischemic stroke because it causes fewer cranial traumatic lesions than invasive surgery and can closely mimic the pathophysiology in stroke patients. However, the outcomes are highly variable, which limits the accuracy of evaluations of ischemic stroke studies. In this study, eight healthy adult rhesus monkeys were randomized into two groups with four monkeys in each group: middle cerebral artery occlusion at origin segment (M1) and middle cerebral artery occlusion at M2 segment. The blood flow in the middle cerebral artery was blocked completely for 2 hours using the endovascular microcoil placement technique (1 mm x 10 cm) (undetachable), to establish a model of cerebral ischemia. The microcoil was withdrawn and the middle cerebral artery blood flow was restored. A reversible middle cerebral artery occlusion model was identified by hematoxylin-eosin staining, digital subtraction angiography, magnetic resonance angiography, magnetic resonance imaging, and neurological evaluation. The results showed that the middle cerebral artery occlusion model was successfully established in eight adult healthy rhesus monkeys, and ischemic lesions were apparent in the brain tissue of rhesus monkeys at 24 hours after occlusion. The rhesus monkeys had symptoms of neurological deficits. Compared with the MI occlusion group, the M2 occlusion group had lower infarction volume and higher neurological scores. These experimental findings indicate that reversible middle cerebral artery occlusion can be produced with the endovascular microcoil technique in rhesus monkeys. The M2 occluded model had less infarction and less neurological impairment, which offers the potential for application in the field of brain injury research.	[Zhao, Bo; Shang, Guowei; Chen, Jian; Geng, Xiaokun; Ling, Feng; Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100053, Peoples R China; [Ye, Xin; Xu, Guoxun] Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing 100053, Peoples R China; [Wang, Ju; Lu, Jing] Capital Med Univ, Dept Lab Anim Sci, Beijing 100053, Peoples R China; [Zheng, Jiasheng; Li, Hongjun] Capital Med Univ, Beijing Youan Hosp, Dept Radiol, Beijing 100053, Peoples R China; [Akbary, Fauzia] Wayne State Univ, Sch Med, Detroit, MI USA; [Ji, Xunming] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China	Ji, XM (corresponding author), Capital Med Univ, Xuanwu Hosp, Ctr Stroke, Beijing Inst Brain Disorders,Dept Neurol, Beijing 100053, Peoples R China.	jixm@ccmu.edu.cn	Ji, Xunming/AAN-3370-2021		National Key Basic Research Program (973 Program) of ChinaNational Basic Research Program of China [2011CB707804]; Beijing Municipal Science and Technology Project [2121100005312016]	This study was financially supported by grants from the National Key Basic Research Program (973 Program) of China, No. 2011CB707804; Beijing Municipal Science and Technology Project, No. 2121100005312016.	Barnes DC, 2012, CAN VET J, V53, P780; Bradley DV, 1999, INVEST OPHTH VIS SCI, V40, P214; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cook DJ, 2012, NEUROTHERAPEUTICS, V9, P371, DOI 10.1007/s13311-012-0115-z; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; D'Arceuil HE, 2006, J MED PRIMATOL, V35, P78, DOI 10.1111/j.1600-0684.2006.00147.x; Feigin V, 2006, LANCET NEUROL, V5, P130, DOI 10.1016/S1474-4422(05)70325-2; Frazee JG, 1998, STROKE, V29, P1912, DOI 10.1161/01.STR.29.9.1912; Freret T, 2008, J CEREBR BLOOD F MET, V28, P786, DOI 10.1038/sj.jcbfm.9600575; Fukuda S, 2003, ILAR J, V44, P96, DOI 10.1093/ilar.44.2.96; Gao Huanmin, 2006, J Stroke Cerebrovasc Dis, V15, P202, DOI 10.1016/j.jstrokecerebrovasdis.2006.05.010; GARCIA JH, 1984, STROKE, V15, P5, DOI 10.1161/01.STR.15.1.5; Gauberti M, 2012, CEREBROVASC DIS, V33, P329, DOI 10.1159/000335309; Gauvrit JY, 2006, J NEUROL, V253, P631, DOI 10.1007/s00415-005-0075-x; Gerraty RP, 2002, STROKE, V33, P2019, DOI 10.1161/01.STR.0000020841.74704.5B; Gerriets T, 2004, STROKE, V35, P2372, DOI 10.1161/01.STR.0000142134.37512.a7; Ginsberg MD, 2003, STROKE, V34, P214, DOI 10.1161/01.STR.0000048846.09677.62; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Green AR, 2002, CLIN EXP PHARMACOL P, V29, P1030, DOI 10.1046/j.1440-1681.2002.03767.x; Halkes PHA, 2006, STROKE, V37, P1828, DOI 10.1161/01.STR.0000226993.88307.ff; Heinsius T, 1998, NEUROLOGY, V50, P341, DOI 10.1212/WNL.50.2.341; Hofer S, 2008, CEREB CORTEX, V18, P1079, DOI 10.1093/cercor/bhm141; Huang J, 2000, STROKE, V31, P3054, DOI 10.1161/01.STR.31.12.3054; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; Kaku S, 1998, EUR J PHARMACOL, V345, P185, DOI 10.1016/S0014-2999(98)00005-3; Kumar N, 2009, ANAT REC, V292, P976, DOI 10.1002/ar.20891; Kwiecien TD, 2014, NEUROL RES, V36, P417, DOI 10.1179/1743132814Y.0000000358; Lee KY, 2009, NEUROLOGY, V72, P1134, DOI 10.1212/01.wnl.0000345360.80382.69; Liu S, 2012, J NEUROSCI METH, V209, P90, DOI 10.1016/j.jneumeth.2012.06.009; LIU XG, 1992, STROKE, V23, P40, DOI 10.1161/01.STR.23.1.40; Liu YR, 2007, STROKE, V38, P138, DOI 10.1161/01.STR.0000252127.07428.9c; Mack WJ, 2003, NEUROL RES, V25, P846, DOI 10.1179/016164103771953943; Marshall JWB, 2003, STROKE, V34, P2228, DOI 10.1161/01.STR.0000087790.79851.A8; Marshall JWB, 2003, BRAIN RES, V972, P119, DOI 10.1016/S0006-8993(03)02511-3; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Min WK, 2000, STROKE, V31, P2055, DOI 10.1161/01.STR.31.9.2055; Neumann AB, 2009, STROKE, V40, P3768, DOI 10.1161/STROKEAHA.108.545368; O'Brien MD, 1973, STROKE, V4, P201, DOI 10.1161/01.STR.4.2.201; Paxinos G., 2000, RHESUS MONKEY BRAIN; Peters A, 2012, NEUROBIOL AGING, V33, P2357, DOI 10.1016/j.neurobiolaging.2011.11.015; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; Rodriguez-Mercado R, 2012, COMPARATIVE MED, V62, P427; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07; Sasaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026577; Saver JL, 2009, STROKE, V40, P2594, DOI 10.1161/STROKEAHA.109.552554; Sawada K, 2012, CONGENIT ANOM, V52, P16, DOI 10.1111/j.1741-4520.2011.00352.x; Schwartz AE, 2011, ACTA NEUROCHIR, V153, P327, DOI 10.1007/s00701-010-0816-1; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Spetzler R, 1980, NEUROSURGERY, V7, P5; TIGGES J, 1988, AM J PRIMATOL, V15, P263, DOI 10.1002/ajp.1350150308; Valentine LE, 2008, TRENDS MICROBIOL, V16, P605, DOI 10.1016/j.tim.2008.08.010; West GA, 2009, J CEREBR BLOOD F MET, V29, P1175, DOI 10.1038/jcbfm.2009.43; Woods SE, 2013, J AM ASSOC LAB ANIM, V52, P295	57	15	16	0	6	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	DEC	2014	9	23					2087	2094		10.4103/1673-5374.147936			8	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	AZ1SJ	WOS:000348017800018	25657726	DOAJ Gold, Green Published			2021-06-18	
J	Long, QF; Fan, CR; Kai, W; Luo, Q; Xin, WC; Wang, P; Wang, AS; Wang, ZY; Han, R; Fei, Z; Qiu, BS; Liu, WP				Long, Qianfa; Fan, Cairui; Kai, Wang; Luo, Qiang; Xin, Weichuan; Wang, Ping; Wang, Ansheng; Wang, Zhanyao; Han, Rui; Fei, Zhou; Qiu, Bensheng; Liu, Weiping			Hypoxia inducible factor-1 alpha expression is associated with hippocampal apoptosis during epileptogenesis	BRAIN RESEARCH			English	Article						Hypoxia inducible factor-1 alpha; Hippocampus; Apoptosis; Epilepsy	INDUCED STATUS EPILEPTICUS; LITHIUM-PILOCARPINE MODEL; TEMPORAL-LOBE EPILEPSY; CELL-DEATH; RAT MODEL; HIF-1-ALPHA; SEIZURES; OXYGEN; SPECTROSCOPY; MECHANISM	Cell apoptosis can cause hippocampal neuronal loss after epileptic seizures. Hypoxia inducible factor (HIF)-1 alpha is an important factor mediating apoptosis after brain injuries, such as cerebral ischemia and traumatic brain injures, but little research has been done on its role in the lithium chloride-pilocarpine induced epileptic model. Here, we used a rat model of pilocarpine-induced status epilepticus (SE) to investigate HIF-1 alpha expression and apoptosis in the hippocampus, and to explore their relationship during epileptogenesis. 120 male Sprague Dawley (SD) rats were treated with lithium chloride-pilocarpine injections and divided into an experimental group (administered by MK-801) and a positive control group (administered by saline). Then the HIF-1 alpha expression and hippocampal apoptosis were investigated by histological confirmation and western blotting at 24 h, 3 d, 7 d and 14 d, respectively. The results showed that the administration of MK-801 significantly reduced (P<0.05) HIF-1 alpha expression and hippocampal apoptosis during epileptogenesis in comparison with the positive control. Moreover, the expression of HIP-1 alpha and hippocampal apoptosis presented significant time-dependent changes (P<0.01) within 2 weeks, and their positive correlation (P<0.05) analyzed by Pearson's correlation analysis. Meanwhile, the HIF-1 alpha immunostained cells were distributed in accord with TUNEL immunostained cells and Caspase-3 immunopositive cells in the hippocampus. These results indicate that the HIP-1 alpha expression is associated with hippocampal apoptosis, and suggest that HIF-1 alpha is an important factor during epileptogenesis. (C) 2014 Elsevier B.V. All rights reserved.	[Long, Qianfa; Xin, Weichuan; Wang, Ping; Wang, Ansheng; Wang, Zhanyao] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp, Cent Hosp Xian,Dept Neurosurg, Xian 710003, Peoples R China; [Fan, Cairui; Kai, Wang; Luo, Qiang; Fei, Zhou; Liu, Weiping] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Qiu, Bensheng] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA; [Han, Rui] Armed Police Hosp Shaanxi Prov, Dept Pathol, Xian 710054, Peoples R China	Qiu, BS (corresponding author), Univ Washington, Sch Med, Dept Radiol, Box 357115, Seattle, WA 98195 USA.	bqiu@u.washington.edu; liuwp@fmmu.edu.cn	Long, Qianfa/F-6461-2017	Long, Qianfa/0000-0001-8848-9688	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31301216]; Project of Science and Technology Research of Shaanxi Province [2014KJXX-29]	We would like to thank Miss Yue Qiu and Andrius Baskys (MD & PhD, Clinical Professor of Psychiatry UCR SOM, USA) for their editorial help and valuable comments on this article. This work was supported by the National Natural Science Foundation of China (No. 31301216) and the Project of Science and Technology Research of Shaanxi Province (No. 2014KJXX-29). We are also grateful to Juan Li and Xiaoyan Chen for advices and technical assistance in this study.	Ambrogini P., 2014, MOL NEUROBIOL; Barsoum IB, 2014, CANCER RES, V74, P665, DOI 10.1158/0008-5472.CAN-13-0992; Bateman LM, 2008, BRAIN, V131, P3239, DOI 10.1093/brain/awn277; Berger EA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003457; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cheng YL, 2014, NEUROBIOL DIS, V62, P286, DOI 10.1016/j.nbd.2013.10.009; Costa-Ferro ZS, 2011, SEIZURE, V19, P84; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Nguyen DK, 2013, EPILEPSIA, V54, P331, DOI 10.1111/epi.12011; Faure JB, 2013, EPILEPSIA, V54, P1203, DOI 10.1111/epi.12219; Feast A, 2012, EPILEPSIA, V53, P1349, DOI 10.1111/j.1528-1167.2012.03591.x; GORCZYCA W, 1993, CANCER RES, V53, P1945; Gualtieri F, 2013, NEUROMOL MED, V15, P133, DOI 10.1007/s12017-012-8203-0; Hao Y, 2012, NEUROL RES, V34, P430, DOI 10.1179/1743132811Y.0000000055; Henshall DC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00110; Hota KB, 2012, J CEREBR BLOOD F MET, V32, P1046, DOI 10.1038/jcbfm.2012.21; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Liu Y, 2009, BRAIN RES, V1304, P149, DOI 10.1016/j.brainres.2009.09.083; Long QF, 2013, BRAIN RES, V1532, P1, DOI 10.1016/j.brainres.2013.07.020; Mikati MA, 2008, BRAIN DEV-JPN, V30, P513, DOI 10.1016/j.braindev.2008.01.002; Muller L, 2014, EPILEPSY RES, V108, P90, DOI 10.1016/j.eplepsyres.2013.10.017; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Paquet M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peng BW, 2013, EPILEPSIA, V54, P1223, DOI 10.1111/epi.12150; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; SGONC R, 1994, TRENDS GENET, V10, P41, DOI 10.1016/0168-9525(94)90140-6; Shakarjian MP, 2012, TOXICOL APPL PHARM, V265, P113, DOI 10.1016/j.taap.2012.08.037; Song ZC, 2012, CELL PROLIFERAT, V45, P239, DOI 10.1111/j.1365-2184.2012.00810.x; Southwell DG, 2014, SCIENCE, V344, P167, DOI 10.1126/science.1240622; Trinka E, 2012, EPILEPSIA, V53, P127, DOI 10.1111/j.1528-1167.2012.03622.x; Tzeng TT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-90; van Eijsden P, 2004, BRAIN RES, V1030, P11, DOI 10.1016/j.brainres.2004.09.025; Zhang C.C., 2013, ANTIOXID REDOX SIGNA	37	15	17	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 24	2014	1590						20	30		10.1016/j.brainres.2014.09.028			11	Neurosciences	Neurosciences & Neurology	AU6ST	WOS:000345732800003	25242614				2021-06-18	
J	Binder, LM; Larrabee, GJ; Millis, SR				Binder, Laurence M.; Larrabee, Glenn J.; Millis, Scott R.			Intent to Fail: Significance Testing of Forced Choice Test Results	CLINICAL NEUROPSYCHOLOGIST			English	Article						Motivation; Response bias; Performance validity testing; Malingering; Effort	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; DIGIT RECOGNITION TEST; SYMPTOM VALIDITY TEST; RESPONSE BIAS; CLASSIFICATION ACCURACY; BASE RATES; PERFORMANCE; MEMORY	A score that is significantly below the level of chance on a forced choice (FC) performance validity test results from the deliberate production of wrong answers. In order to increase the power of significance testing of a below chance result on standardized FC tests with empirically derived cutoff scores, we recommend using one-tailed tests of significance and selecting probability levels greater than .05 (.20 for most standardized FC tests with empirically derived cutoff scores). Under certain circumstances, we also recommend combining scores from different sections of the same FC test and combining scores across different FC tests. These recommendations require modifications when applied to non-standardized FC tests that lack empirically derived cutoff scores or to FC tests with a non-random topographical distribution of correct and incorrect answers.	[Millis, Scott R.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA	Binder, LM (corresponding author), 4900 SW Griffith Dr,Suite 244, Beaverton, OR 97005 USA.	pdxlarry@aol.com					Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Binder L. M., 2007, PORTLAND DIGIT RECOG; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Boone K. B., 2007, ASSESSMENT FEIGNED C, P29; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Denney RL, 1996, ARCH CLIN NEUROPSYCH, V11, P589, DOI 10.1016/0887-6177(95)00042-9; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Green P., 2008, ADV INTERPRETATION S; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Pankratz L., 1990, CLIN NEUROPSYCHOL, V4, P379; Reynolds CR, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P351, DOI 10.1007/978-1-4614-0442-2_13; Reynolds CR, 1998, CRIT ISS NE, P261; Runyon RP, 2000, FUNDAMENTALS BEHAV S; SIEGEL S, 1956, NONPAREMETRIC STAT B; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Thompson G. B., 2005, VSVT VICTORIA SYMPTO; Tombaugh TN, 1996, TEST MEMORY MALINGER	28	15	15	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 17	2014	28	8					1366	1375		10.1080/13854046.2014.978383			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	AY0KY	WOS:000347286600011	25386898				2021-06-18	
J	Hart, T; Kozlowski, AJ; Whyte, J; Poulsen, I; Kristensen, K; Nordenbo, A; Heinemann, AW				Hart, Tessa; Kozlowski, Allan J.; Whyte, John; Poulsen, Ingrid; Kristensen, Karin; Nordenbo, Annette; Heinemann, Allen W.			Functional Recovery After Severe Traumatic Brain Injury: An Individual Growth Curve Approach	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation	LENGTH-OF-STAY; REHABILITATION OUTCOMES; INDEPENDENCE MEASURE; NATIONAL INSTITUTE; MODEL SYSTEMS; DISABILITY; THERAPY; IMPAIRMENT; AGE	Objective: To examine person, injury, and treatment characteristics associated with recovery trajectories of people with severe traumatic brain injury (TBI) during inpatient rehabilitation. Design: Observational prospective longitudinal study. Setting: TBI rehabilitation units. Participants: Adults (N= 206) with severe nonpenetrating TBI admitted directly to inpatient rehabilitation from acute care. Participants were excluded for prior disability and intentional etiology of injury. Interventions: Naturally occurring treatments delivered within comprehensive multidisciplinary teams were recorded daily in 15-minute units provided to patients and family members, separately. Main Outcome Measures: Motor and cognitive FIM were measured on admission, discharge, and every 2 weeks in between and were analyzed with individual growth curve methodology. Results: Inpatient recovery was best modeled with linear, cubic, and quadratic components: relatively steep recovery was followed by deceleration of improvement, which attenuated prior to discharge. Slower recovery was associated with older age, longer coma, and interruptions to rehabilitation. Patients admitted at lower functional levels received more treatment, and more treatment was associated with slower recovery, presumably because treatment was allocated according to need. Therefore, effects of treatment on outcome could not be disentangled from effects of case mix factors. Conclusions: FIM gain during inpatient recovery from severe TBI is not a linear process. In observational studies, the specific effects of treatment on rehabilitation outcomes are difficult to separate from case mix factors that are associated with both outcome and allocation of treatment. (C) 2014 by the American Congress of Rehabilitation Medicine	[Hart, Tessa; Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Kozlowski, Allan J.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Poulsen, Ingrid; Kristensen, Karin; Nordenbo, Annette] Univ Copenhagen, Glostrup Hosp, Dept Neurorehabil, Res Unit Brain Injury Rehabil,Traumat Brain Injur, Copenhagen, Denmark; [Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu	Heinemann, Allen W./AAI-2790-2021; Poulsen, ingrid/AAH-2052-2019	Heinemann, Allen W./0000-0003-2782-7326; Whyte, John/0000-0002-4381-1474			Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 1987, UNIFORM DATA SET MED; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; National Data and Statistical Center, TRAUM BRAIN INJ MOD; Peiris CL, 2011, ARCH PHYS MED REHAB, V92, P1490, DOI 10.1016/j.apmr.2011.04.005; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V2nd ed; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225	15	15	15	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2014	95	11					2103	2110		10.1016/j.apmr.2014.07.001			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AS3XC	WOS:000344207500015	25010537				2021-06-18	
J	Mckay, CD; Meeuwisse, WH; Emery, CA				McKay, Carly D.; Meeuwisse, Willem H.; Emery, Carolyn A.			Informing body checking policy in youth ice hockey in Canada: A discussion meeting with researchers and community stakeholders	CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE			English	Article						Policy; injury; ice hockey; knowledge translation	INJURY; RISK	OBJECTIVES: Body checking is a significant risk factor for injury, including concussion, in youth ice hockey. Recent evidence regarding injury rates in youth leagues prompted USA Hockey to institute a national policy change in 2011 that increased the age of body checking introduction from 11-12 years old (Pee Wee) to 13-14 years old (Bantam). Body checking policy was more controversial in Canada, and research evidence alone was insufficient to drive change. The purpose of this paper is to provide an example of one of the knowledge exchange processes that occurred between researchers and community stakeholders, leading up to a national policy change in 2013. PARTICIPANTS: There were 28 stakeholder attendees, representing the research community, youth hockey organizations, and child health advocacy groups. SETTING: A one-day meeting held in Whistler, British Columbia, in April 2013. INTERVENTION: Researchers and stakeholders presented current perspectives on evidence and policy change, and discussion focused on an a priori set of questions designed to elicit facilitators and barriers to policy change. OUTCOMES: Three major factors that can drive policy change in the sport safety context were identified: the need for decision-making leadership, the importance of knowledge translation, and the role of sport culture as a barrier to change. CONCLUSION: There is a critical need for researcher and stakeholder partnership in facilitating ongoing policy discussion and informing evidence-based policy change in sport and recreation injury prevention.	[McKay, Carly D.; Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, SIPRC, Calgary, AB T2N 1N4, Canada; [Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Pediat, Alberta Childrens Hosp Res Inst Child & Maternal, Calgary, AB T2N 1N4, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada	Mckay, CD (corresponding author), Univ Calgary, Fac Kinesiol, SIPRC, Calgary, AB T2N 1N4, Canada.	cdmckay@ucalgary.ca	Emery, Carolyn/AAI-2761-2020		Alberta Innovates [201201160] Funding Source: researchfish		Emery CA, 2011, CMAJ, V183, P1249; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Hockey Canada, TEACHING CHECKING A; Houghton KM, 2012, PAED CHILD HEALT-CAN, V17, P509, DOI 10.1093/pch/17.9.509; USA Hockey Coaching Education Program, CHECKING THE RIGHT W; USA Hockey Player Development Committee, SUBCOMMITTEE ON BODY	7	15	15	0	14	CANADIAN PUBLIC HEALTH ASSOC	OTTAWA	1565 CARLING AVE, SUITE 300, OTTAWA, ONTARIO K1Z 8R1, CANADA	0008-4263	1920-7476		CAN J PUBLIC HEALTH	Can. J. Public Health-Rev. Can. Sante Publ.	NOV-DEC	2014	105	6					E445	E449		10.17269/cjph.105.4653			5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AZ8QB	WOS:000348478800008	25560891	Green Published, Green Accepted			2021-06-18	
J	McKinlay, A; Grace, RC; McLellan, T; Roger, D; Clarbour, J; MacFarlane, MR				McKinlay, Audrey; Grace, Randolph C.; McLellan, Tracey; Roger, Derek; Clarbour, Jane; MacFarlane, Martin R.			Predicting Adult Offending Behavior for Individuals Who Experienced a Traumatic Brain Injury During Childhood	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head injury; offending; outcomes; predictors; traumatic brain injury	PSYCHOSOCIAL OUTCOMES; HEAD-INJURY; NEUROPSYCHOLOGICAL FUNCTION; MENTAL-DISORDERS; CHILDREN; ADOLESCENTS; MILD; PREVALENCE; CRIMINALITY; PERFORMANCE	Objectives: To examine whether individuals who experienced a childhood traumatic brain injury (TBI) are at increased risk for subsequent offending behavior, to identify the emotional characteristics of adults who experienced childhood TBI, and to examine whether these predict offending behavior. Participants: Individuals from the Canterbury region who had experienced a childhood (<18 years of age) injury event and were now 18 years or older and more than 5 years postinjury (between 18 and 30 years of age). Three groups were formed: (1) moderate/severe TBI (n = 62); (2) mild TBI (n = 58); and (3) fracture control group (n = 38). Setting: University of Canterbury. Main Measures: A semistructured interview assessed lifetime involvement in offending behavior; the Emotional Behavior Scale measured internalizing and externalizing behaviors, including malevolent aggression, social anxiety, and social self-esteem. Results: Compared with controls, there was an increased risk of offending behavior (mild TBI: odds ratio = 8.7; moderate/severe TBI odds ratio = 20.4). Binary logistic regression analysis revealed that the strongest predictors of offending behavior were TBI status, higher levels of malevolent aggression, and age at injury. Conclusions: Individuals who experienced childhood TBI are at increased risk of offending behavior. Emotional behavior measures were useful predictors of offending behavior, offering opportunity for intervention.	[McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [McKinlay, Audrey; Grace, Randolph C.; McLellan, Tracey; Roger, Derek] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [Clarbour, Jane] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [MacFarlane, Martin R.] Christchurch Hosp, Dept Neurosurg, Christchurch, New Zealand	McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514; Grace, Randolph/0000-0003-1115-6089	Health Research Council/Accident Compensation Corporation of New Zealand	Dr McKinlay was supported by a postdoctoral fellowship from the Health Research Council/Accident Compensation Corporation of New Zealand.	Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Clarbour J, 2004, J CHILD PSYCHOL PSYC, V45, P496, DOI 10.1111/j.1469-7610.2004.00240.x; Clarbour J, 2000, FORENSIC UPDATE, V62, P10; Clarbour J, 1999, P BRIT PSYCH SOC SOC; Clarbour J, 2001, BRIT PSYCH SOC DIV F; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Fergusson DM, 1998, J EMOT BEHAV DISORD, V6, P2, DOI 10.1177/106342669800600101; Fergusson DM, 1997, J CHILD PSYCHOL PSYC, V38, P633, DOI 10.1111/j.1469-7610.1997.tb01690.x; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, BRAIN INJURY, V12, P41; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Soomro NH, 2012, PAK J SOC CLIN PSYCH, V10, P10; Tiihonen J, 1997, AM J PSYCHIAT, V154, P840; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Wall Sarah E, 2011, Clin Child Psychol Psychiatry, V16, P301, DOI 10.1177/1359104511401187; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Williams H, 2010, TLS-TIMES LIT SUPPL, P20; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wilson, 1991, NATL ADULT READING T	42	15	15	0	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2014	29	6					507	513		10.1097/HTR.0000000000000000			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AT7LI	WOS:000345117800011	24263174				2021-06-18	
J	Rincon, F; Maltenfort, M; Dey, S; Ghosh, S; Vibbert, M; Urtecho, J; Jallo, J; Ratliff, JK; McBride, JW; Bell, R				Rincon, Fred; Maltenfort, Mitchell; Dey, Saugat; Ghosh, Sayantani; Vibbert, Matthew; Urtecho, Jaqueline; Jallo, Jack; Ratliff, John K.; McBride, John William; Bell, Rodney			The Prevalence and Impact of Mortality of the Acute Respiratory Distress Syndrome on Admissions of Patients With Ischemic Stroke in the United States	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						epidemiology; outcome; NIS; nationwide inpatient sample; hypoxia	ACUTE LUNG INJURY; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; WEDGE PRESSURE; EPIDEMIOLOGY; OUTCOMES; ARDS; ACCURACY; ICD-9-CM; TRIALS	Purpose: To determine the epidemiology of the acute respiratory distress syndrome (ARDS) and impact on in-hospital mortality in admissions of patients with acute ischemic stroke (AIS) in the United States. Methods: Retrospective cohort study of admissions with a diagnosis of AIS and ARDS from 1994 to 2008 identified through the Nationwide Inpatient Sample. Results: During the 15-year study period, we found 55 58 091 admissions of patients with AIS. The prevalence of ARDS in admissions of patients with AIS increased from 3% in 1994 to 4% in 2008 (P < .001). The ARDS was more common among younger men, nonwhites, and associated with history of congestive heart failure, hypertension, chronic obstructive pulmonary disease, renal failure, chronic liver disease, systemic tissue plasminogen activator, craniotomy, angioplasty or stent, sepsis, and multiorgan failures. Mortality due to AIS and ARDS decreased from 8% in 1994 to 6% in 2008 (P < .001) and 55% in 1994 to 45% in 2008 (P < .001), respectively. The ARDS in AIS increased in-hospital mortality (odds ratio, 14; 95% confidence interval, 13.5-14.3). A significantly higher length of stay was seen in admissions of patients with AIS having ARDS. Conclusion: Our analysis demonstrates that ARDS is rare after AIS. Despite an overall significant reduction in mortality after AIS, ARDS carries a higher risk of death in this patient population.	[Rincon, Fred; Vibbert, Matthew; Urtecho, Jaqueline; McBride, John William; Bell, Rodney] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Rincon, Fred; Dey, Saugat; Ghosh, Sayantani; Vibbert, Matthew; Urtecho, Jaqueline; Jallo, Jack; Bell, Rodney] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Maltenfort, Mitchell] Rothman Inst, Dept Biostat, Philadelphia, PA USA; [Ratliff, John K.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [McBride, John William; Bell, Rodney] Thomas Jefferson Univ, Div Crit Care & Neurotrauma, Philadelphia, PA 19107 USA; [McBride, John William; Bell, Rodney] Thomas Jefferson Univ, Div Cerebrovasc Dis, Philadelphia, PA 19107 USA	Rincon, F (corresponding author), Thomas Jefferson Univ, Div Crit Care & Neurotrauma, Dept Neurol Surg, 909 Walnut St,3rd Floor, Philadelphia, PA 19107 USA.	fred.rincon@jefferson.edu	Dey, Saugat/ABI-5969-2020	Dey, Saugat/0000-0003-4128-3337; Rincon, Fred/0000-0002-8510-118X; Jallo, Jack/0000-0002-5512-1729	American Heart AssociationAmerican Heart Association [AHA 12CRP12050342]	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: Dr Rincon has received salary support from the American Heart Association (AHA 12CRP12050342).	ASHBAUGH DG, 1967, LANCET, V2, P319; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Erickson SE, 2009, CRIT CARE MED, V37, P1, DOI 10.1097/CCM.0b013e31819292ea; Ferguson ND, 2002, INTENS CARE MED, V28, P1073, DOI 10.1007/s00134-002-1354-y; Forfia PR, 2005, J AM COLL CARDIOL, V45, P1667, DOI 10.1016/j.jacc.2005.01.046; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Halpern NA, 2006, CRIT CARE MED, V34, P2105, DOI 10.1097/01.CCM.0000227174.30337.3E; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hudson LD, 1999, CHEST, V116, p74S, DOI 10.1378/chest.116.suppl_1.74S-a; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; LEIBSON CL, 1994, STROKE, V25, P2348, DOI 10.1161/01.STR.25.12.2348; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Luhr OR, 2000, INTENS CARE MED, V26, P508, DOI 10.1007/s001340051197; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Qureshi AI, 2005, NEUROSURGERY, V57, P647, DOI 10.1227/01.NEU.0000175546.62088.D6; Rana R, 2006, CRIT CARE MED, V34, P1941, DOI 10.1097/01.CCM.0000220492.15645.47; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reynolds HN, 1998, CRIT CARE, V2, P29, DOI DOI 10.1186/CC121; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rincon F, 2011, J CRIT CARE, V26, P620, DOI 10.1016/j.jcrc.2011.02.009; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; Saver JL, 2010, STROKE, V41, P2381, DOI 10.1161/STROKEAHA.110.583807; Silverboard H, 2005, J TRAUMA, V59, P717, DOI 10.1097/01.ta.0000174919.35240.21; THOMSEN GE, 1995, AM J RESP CRIT CARE, V152, P965, DOI 10.1164/ajrccm.152.3.7663811; VILLAR J, 1989, AM REV RESPIR DIS, V140, P814, DOI 10.1164/ajrccm/140.3.814; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	39	15	16	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	NOV-DEC	2014	29	6					357	364		10.1177/0885066613491919			8	Critical Care Medicine	General & Internal Medicine	AS6LR	WOS:000344375600006	23753254				2021-06-18	
J	Alali, AS; Naimark, DMJ; Wilson, JR; Fowler, RA; Scales, DC; Golan, E; Mainprize, TG; Ray, JG; Nathens, AB				Alali, Aziz S.; Naimark, David M. J.; Wilson, Jefferson R.; Fowler, Robert A.; Scales, Damon C.; Golan, Eyal; Mainprize, Todd G.; Ray, Joel G.; Nathens, Avery B.			Economic Evaluation of Decompressive Craniectomy Versus Barbiturate Coma for Refractory Intracranial Hypertension Following Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						barbiturate; cost-effectiveness; decompressive craniectomy; intracranial pressure; quality-adjusted life years; traumatic brain injury	SEVERE HEAD-INJURY; COST-EFFECTIVENESS; UNITED-STATES; HEALTH; OUTCOMES; STRATEGIES; MORTALITY; PRESSURE; DECRA; MODEL	Objectives: Decompressive craniectomy and barbiturate coma are often used as second-tier strategies when intracranial hypertension following severe traumatic brain injury is refractory to first-line treatments. Uncertainty surrounds the decision to choose either treatment option. We investigated which strategy is more economically attractive in this context. Design: We performed a cost-utility analysis. A Markov Monte Carlo microsimulation model with a life-long time horizon was created to compare quality-adjusted survival and cost of the two treatment strategies, from the perspective of healthcare payer. Model parameters were estimated from the literature. Two-dimensional simulation was used to incorporate parameter uncertainty into the model. Value of information analysis was conducted to identify major drivers of decision uncertainty and focus future research. Setting: Trauma centers in the United States. Subjects: Base case was a population of patients (mean age = 25 yr) who developed refractory intracranial hypertension following traumatic brain injury. Interventions: We compared two treatment strategies: decompressive craniectomy and barbiturate coma. Measurements and Main Results: Decompressive craniectomy was associated with an average gain of 1.5 quality-adjusted life years relative to barbiturate coma, with an incremental cost-effectiveness ratio of $ 9,565/quality-adjusted life year gained. Decompressive craniectomy resulted in a greater quality-adjusted life expectancy 86% of the time and was more cost-effective than barbiturate coma in 78% of cases if our willingness-to-pay threshold is $ 50,000/quality-adjusted life year and 82% of cases at a threshold of $ 100,000/quality-adjusted life year. At older age, decompressive craniectomy continued to increase survival but at higher cost (incremental cost-effectiveness ratio = $ 197,906/ quality-adjusted life year at mean age = 85 yr). Conclusions: Based on available evidence, decompressive craniectomy for the treatment of refractory intracranial hypertension following traumatic brain injury provides better value in terms of costs and health gains than barbiturate coma. However, decompressive craniectomy might be less economically attractive for older patients. Further research, particularly on natural history of severe traumatic brain injury patients, is needed to make more informed treatment decisions.	[Alali, Aziz S.; Fowler, Robert A.; Scales, Damon C.; Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Alali, Aziz S.; Naimark, David M. J.; Fowler, Robert A.; Scales, Damon C.; Golan, Eyal; Ray, Joel G.; Nathens, Avery B.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Alali, Aziz S.] Univ Ottawa, Div Neurosurg, Ottawa, ON, Canada; [Naimark, David M. J.; Ray, Joel G.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wilson, Jefferson R.; Mainprize, Todd G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Fowler, Robert A.; Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.; Scales, Damon C.; Golan, Eyal] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Ray, Joel G.; Nathens, Avery B.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Nathens, Avery B.] Univ Toronto, Dept Surg, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	Alali, AS (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	aziz.alali@mail.utoronto.ca	Golan, Eyal/D-3086-2014	Golan, Eyal/0000-0002-2904-9321	Physicians' Services Inc. Foundation.; Heart and Stroke Foundation Clinician-Scientist Award; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Physicians' Services Incorporated Foundation; Canada Research Chair Program in Systems of Trauma Care	Dr. Alali was supported by grants from Physicians' Services Inc. Foundation. Dr. Fowler was supported by a Heart and Stroke Foundation Clinician-Scientist Award. Dr. Scales was supported by a New Investigator Award from the Canadian Institutes of Health Research and a Fellowship in Translational Health Research from Physicians' Services Incorporated Foundation. Dr. Ray holds a Canadian Institutes for Health Research Chair in Reproductive and Child Health Services and Policy Research. Dr. Nathens was supported by grants from Canada Research Chair Program in Systems of Trauma Care. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; American Health Care Association, 2012 REP SHORTF MED; Arias Elizabeth, 2012, Natl Vital Stat Rep, V61, P1; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Briggs A., 2006, DECISION MODELLING H; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Committee on Injury Scaling, 1998, ABBR INJ SCAL; Cooper DJ, 2011, MED J AUSTRALIA, V194, P437, DOI 10.5694/j.1326-5377.2011.tb03053.x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; *CTR MED MED SERV, CMS FIL DOWNL MED PA; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gold M., 1996, Cost-Effectiveness in Health and Medicine.; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Kitagawa RS, 2013, WORLD NEUROSURG, V79, P82, DOI 10.1016/j.wneu.2012.10.031; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; Marion DW, 2006, NEUROSURGERY, V58, P655; Naimark DMJ, 2013, MED DECIS MAKING, V33, P961, DOI 10.1177/0272989X13501558; Owens DK, 1998, J GEN INTERN MED, V13, P716, DOI 10.1046/j.1525-1497.1998.00211.x; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; Quinn RR, 2007, AM J KIDNEY DIS, V50, P421, DOI 10.1053/j.ajkd.2007.05.019; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; ROBERTS I, 2000, COCHRANE DB SYST REV, V2; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Schneider GH, 2002, ACT NEUR S, V81, P77; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shaw JW, 2010, VALUE HEALTH, V13, P278, DOI 10.1111/j.1524-4733.2009.00675.x; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2014, TRAUM BRAIN INJ MOD; US Department of Labor, CONS PRIC IND; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	50	15	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2014	42	10					2235	2243		10.1097/CCM.0000000000000500			9	Critical Care Medicine	General & Internal Medicine	AP7BC	WOS:000342231500011	25054675				2021-06-18	
J	Callahan, DS; Kim, D; Bricker, S; Neville, A; Putnam, B; Smith, J; Bongard, F; Plurad, D				Callahan, Devon S.; Kim, Dennis; Bricker, Scott; Neville, Angela; Putnam, Brant; Smith, Jennifer; Bongard, Frederic; Plurad, David			Trends in Organ Donor Management: 2002 to 2012	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article								BACKGROUND: Refinements in donor management have resulted in increased numbers and quality of grafts after neurologic death. We hypothesize that the increased use of hormone replacement therapy (HRT) has been accompanied by improved outcomes over time. STUDY DESIGN: Using the Organ Procurement and Transplant Network donor database, all brain-dead donors procured from July 1, 2001 to June 30, 2012 were studied. Hormone replacement therapy was identified by an infusion of thyroid hormone. An expanded criteria donor was defined as age 60 years or older. Incidence of HRT administration and number of donors and organs recovered were calculated. Using the Organ Procurement and Transplant Network thoracic recipient database transplant list, wait times were examined. RESULTS: There were 74,180 brain-dead donors studied. Hormone replacement therapy use increased substantially from 25.6% to 72.3% of donors. However, mean number of organs procured per donor remained static (3.51 to 3.50; p = 0.083), and the rate of high-yield donors decreased (46.4% to 43.1%; p < 0.001). Incidence of traumatic brain injury donors decreased (42.1% to 33.9%; p < 0.001) relative to an increased number of expanded criteria donors (22.1% to 26%). Despite this, there has been an increase in the raw number of donors (20,558 to 24,308; p < 0.001) and organs (5,857 to 6,945; p < 0.001). There has been an increase in organs per traumatic brain injury donor (4.02 to 4.12; p = 0.002) and a decrease in days on the waiting list (462.2 to 170.4 days; p < 0.001) for a thoracic transplant recipient. CONCLUSIONS: The marked increase in the use of HRT in the management of brain-dead donors has been accompanied by increased organ availability overall. Potential mechanisms might include successful conversion of previously unacceptable donors and improved recovery in certain subsets of donors. (C) 2014 by the American College of Surgeons	[Callahan, Devon S.; Kim, Dennis; Bricker, Scott; Neville, Angela; Putnam, Brant; Smith, Jennifer; Bongard, Frederic; Plurad, David] Harbor UCLA Med Ctr, Div Trauma Surg Crit Care & Acute Care Surg, Los Angeles, CA 90502 USA	Plurad, D (corresponding author), Harbor UCLA Med Ctr, Div Trauma Surg Crit Care & Acute Care Surg, 1000 W Carson St,Box 42, Los Angeles, CA 90502 USA.	dplurad@dhs.lacounty.gov			Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [234-2005-37011C]	This work was supported in part by Health Resources and Services Administration contract 234-2005-37011C. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Callahan DS, 2014, J SURG RES, V186, P452, DOI 10.1016/j.jss.2013.09.028; Cooper David K C, 2008, Int J Surg, V6, P3, DOI 10.1016/j.ijsu.2006.11.007; Kutsogiannis DJ, 2006, CAN J ANAESTH, V53, P820, DOI 10.1007/BF03022800; Macdonald PS, 2012, CRIT CARE MED, V40, P1635, DOI 10.1097/CCM.0b013e3182416ee7; Otth M, 2011, SWISS MED WEEKLY, V141, P13230; POWNER DJ, 1990, CRIT CARE MED, V18, P702; Rosendale JD, 2003, TRANSPLANTATION, V75, P1336, DOI 10.1097/01.TP.0000062839.58826.6D; Sampson BG, 2013, CRIT CARE RESUSC, V15, P21	8	15	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	OCT	2014	219	4					752	756		10.1016/j.jamcollsurg.2014.04.017			5	Surgery	Surgery	AP9TJ	WOS:000342422500020	25154673				2021-06-18	
J	Miller, BA; Bass, DI; Chern, JJ				Miller, Brandon A.; Bass, David I.; Chern, Joshua J.			Development of a de novo arteriovenous malformation after severe traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						AVM; arteriovenous malformation; traumatic brain injury; vascular disorders; trauma	CHILD; ANEURYSMS; RESECTION; DISEASE	Arteriovenous malformations (AVMs) are typically considered congenital lesions, although there is growing evidence for de novo formation of these lesions as well. The authors present the case of an AVM in the same cerebral cortex that had been affected by a severe traumatic brain injury (TBI) more than 6 years earlier. To the best of the authors' knowledge, this is the first report attributing the formation of an AVM directly to TBI.	[Miller, Brandon A.; Bass, David I.; Chern, Joshua J.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Chern, Joshua J.] Childrens Healthcare Atlanta, Pediat Neurosurg Associates, Atlanta, GA USA	Miller, BA (corresponding author), Emory Univ, Sch Med, Dept Neurosurg, 1365-B Clifton Rd,Ste 6200, Atlanta, GA 30322 USA.	brandon.miller@emory.edu					Akimoto H, 2003, NEUROSURGERY, V52, P228, DOI 10.1097/00006123-200301000-00030; Alvarez H, 2012, J NEUROSURG-PEDIATR, V9, P327, DOI 10.3171/2011.12.PEDS11312; AWAD IA, 1990, J NEUROSURG, V72, P839, DOI 10.3171/jns.1990.72.6.0839; Bulsara KR, 2002, NEUROSURGERY, V50, P1137, DOI 10.1097/00006123-200205000-00036; DATTA NN, 2000, NEUROSURG FOCUS, V8; Du R, 2007, J NEUROSURG, V106, P470, DOI 10.3171/jns.2007.106.3.470; Gonzalez LF, 2005, J NEUROSURG, V102, P726, DOI 10.3171/jns.2005.102.4.0726; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Gross BA, 2012, J CLIN NEUROSCI, V19, P1093, DOI 10.1016/j.jocn.2011.11.021; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Jeffree RL, 2009, PEDIATR NEUROSURG, V45, P296, DOI 10.1159/000235604; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Mahajan A, 2010, NEUROSURG REV, V33, P115, DOI 10.1007/s10143-009-0227-z; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; O'Shaughnessy BA, 2005, J NEUROSURG, V102, P238, DOI 10.3171/jns.2005.102.2.0238; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; POZZATI E, 1986, NEUROCHIRURGIA, V29, P61; Schmit BP, 1996, J NEUROSURG, V84, P677, DOI 10.3171/jns.1996.84.4.0677; Stevens J, 2009, AM J NEURORADIOL, V30, P111, DOI 10.3174/ajnr.A1255; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334	20	15	15	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2014	14	4					418	420		10.3171/2014.7.PEDS1431			3	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AQ7CN	WOS:000342970300014	25084086				2021-06-18	
J	Veenith, TV; Carter, EL; Grossac, J; Newcombe, VF; Outtrim, JG; Nallapareddy, S; Lupson, V; Correia, MM; Mada, MM; Willianns, GB; Menon, DK; Coles, JP				Veenith, Tonny V.; Carter, Eleanor L.; Grossac, Julia; Newcombe, Virginia F.; Outtrim, Joanne G.; Nallapareddy, Sridhar; Lupson, Victoria; Correia, Marta M.; Mada, Marius M.; Willianns, Guy B.; Menon, David K.; Coles, Jonathan P.			Use of diffusion tensor imaging to assess the impact of normobaric hyperoxia within at-risk pericontusional tissue after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						contusion; diffusion tensor imaging; normobaric hyperoxia; penumbra; traumatic brain injury	SEVERE HEAD-INJURY; HYPERBARIC-OXYGEN; MITOCHONDRIAL-FUNCTION; INTRACRANIAL-PRESSURE; CEREBRAL METABOLISM; ISCHEMIC BURDEN; CARDIAC-ARREST; THERAPY; RESUSCITATION; IMPROVEMENT	Ischemia and metabolic dysfunction remain important causes of neuronal loss after head injury, and we have shown that normobaric hyperoxia may rescue such metabolic compromise. This study examines the impact of hyperoxia within injured brain using diffusion tensor imaging (DTI). Fourteen patients underwent DTI at baseline and after 1 hour of 80% oxygen. Using the apparent diffusion coefficient (ADC) we assessed the impact of hyperoxia within contusions and a 1 cm border zone of normal appearing pericontusion, and within a rim of perilesional reduced ADC consistent with cytotoxic edema and metabolic compromise. Seven healthy volunteers underwent imaging at 21%, 60%, and 100% oxygen. In volunteers there was no ADC change with hyperoxia, and contusion and pericontusion ADC values were higher than volunteers (P<0.01). There was no ADC change after hyperoxia within,contusion, but an increase within pericontusion (P<0.05). We identified a rim of perilesional cytotoxic edema in 13 patients, and hyperoxia resulted in an ADC increase towards normal (P=0.02). We demonstrate that hyperoxia may result in benefit within the perilesional rim of cytotoxic edema. Future studies should address whether a longer period of hyperoxia has a favorable impact on the evolution of tissue injury.	[Veenith, Tonny V.; Carter, Eleanor L.; Grossac, Julia; Newcombe, Virginia F.; Outtrim, Joanne G.; Nallapareddy, Sridhar; Menon, David K.; Coles, Jonathan P.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 0QQ, Cambs, England; [Lupson, Victoria; Correia, Marta M.; Mada, Marius M.; Willianns, Guy B.] Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge CB2 0QQ, Cambs, England	Coles, JP (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Hills Rd, Cambridge CB2 0QQ, Cambs, England.	jpc44@wbic.cam.ac.uk	Veenith, Tonny/AAI-3067-2020	Veenith, Tonny/0000-0002-4125-8804; Newcombe, Virginia/0000-0001-6044-9035; Morgado Correia, Marta/0000-0002-3231-7040	National Institute of Academic Anaesthesia; Raymond Beverly Sackler studentship; NIHR academic clinical fellowship; Wellcome TrustWellcome TrustEuropean Commission; NIHRNational Institute for Health Research (NIHR); Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390 ID 65883]; UK National Institute of Health Research Biomedical Research Centre at CambridgeNational Institute for Health Research (NIHR); UK Department of Health; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986, G0701532, G9439390, MC_U105579212] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2009-14-007, NF-SI-0512-10090, NF-SI-0508-10327] Funding Source: researchfish	TVV was supported by clinical research training fellowship from National Institute of Academic Anaesthesia and Raymond Beverly Sackler studentship. VFN is supported by an NIHR academic clinical fellowship. JPC was supported by Wellcome Trust Project grant. DKM is supported by an NIHR Senior Investigator Award. This work was supported by a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects (G9439390 ID 65883)), the UK National Institute of Health Research Biomedical Research Centre at Cambridge, and the Technology Platform funding provided by the UK Department of Health.	Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Anzai Y, 2004, AM J NEURORADIOL, V25, P274; Bennett MH, 2004, COCHRANE DB SYST REV, V12; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2009, J CEREBR BLOOD F MET, V29, P965, DOI 10.1038/jcbfm.2009.22; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Pilcher J, 2012, RESUSCITATION, V83, P417, DOI 10.1016/j.resuscitation.2011.12.021; Puccio AM, 2009, J NEUROTRAUM, V26, P1241, DOI [10.1089/neu.2008.0624, 10.1089/neu.2008-0624]; Reinert M, 2004, J NEUROSURG, V101, P323, DOI 10.3171/jns.2004.101.2.0323; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Slessarev M, 2006, CRIT CARE MED, V34, P829, DOI 10.1097/01.CCM.0000201877.82049.C3; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Tachtsidis I, 2011, ADV EXP MED BIOL, V701, P9, DOI 10.1007/978-1-4419-7756-4_2; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	42	15	16	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2014	34	10					1622	1627		10.1038/jcbfm.2014.123			6	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AQ1IV	WOS:000342536000006	25005875	Green Published, Other Gold			2021-06-18	
J	Ilie, G; Adlaf, EM; Mann, RE; Boak, A; Hamilton, H; Asbridge, M; Colantonio, A; Turner, NE; Rehm, J; Cusimano, MD				Ilie, Gabriela; Adlaf, Edward M.; Mann, Robert E.; Boak, Angela; Hamilton, Hayley; Asbridge, Mark; Colantonio, Angela; Turner, Nigel E.; Rehm, Juergen; Cusimano, Michael D.			The Moderating Effects of Sex and Age on the Association between Traumatic Brain Injury and Harmful Psychological Correlates among Adolescents	PLOS ONE			English	Article							GENDER-DIFFERENCES; RISK BEHAVIOR; UNITED-STATES; HEAD-INJURY; VALIDITY; HEALTH; WOMEN; PREVALENCE; DISORDERS; CHILDREN	Background: Although it is well established that sex is a risk factor in acquiring a traumatic brain injury (TBI) among adolescents, it has not been established whether it also moderates the influence of other TBI psychological health correlates. Methods and Findings: Data were derived from a 2011 population-based cross-sectional school survey, which included 9,288 Ontario 7th-12th graders who completed anonymous self-administered questionnaires in classrooms. Response rate was 62%. Preliminary analyses found no evidence of nonresponse bias in the reporting of TBI. TBI was defined as a hit or blow to the head that resulted in a 5 minutes loss of consciousness or at least one overnight hospitalization due to symptoms associated with it. Reports of lifetime TBI were more common among males than females (23.1%, 95% CI: 20.5, 25.8 vs. 17.1%, 95% CI: 14.7, 19.8). Thirteen correlates were examined and included cigarette smoking, elevated psychological distress, suicide ideation, bully victimization (at school, as well as cyber bullying), bullying others, cannabis use, cannabis dependence and drug use problems, physical injuries, daily smoking, drinking alcohol, binge drinking, use of cannabis, and poor academic performance. Among the outcomes examined, sex moderated the relationship between lifetime TBI and cigarette smoking. In addition, sex and age jointly moderated the relationship between lifetime TBI and daily smoking, alcohol use and physical injuries. Late adolescent males who reported lifetime TBI, relative to females, displayed elevated daily smoking and injuries, whereas their females counterparts displayed elevated past year drinking. Possible bias related to self-report procedures and the preclusion of causal inferences due to the cross-sectional nature of the data are limitations of this study. Conclusions: TBI differences in outcomes need to be assessed for potential moderating effects of sex and age. Results have important implications for more tailored injury prevention efforts.	[Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Adlaf, Edward M.; Mann, Robert E.; Boak, Angela; Hamilton, Hayley; Turner, Nigel E.; Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Adlaf, Edward M.; Mann, Robert E.; Hamilton, Hayley; Colantonio, Angela; Turner, Nigel E.; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada; [Colantonio, Angela] Toronto Rehabil Inst, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada	Ilie, G (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Cusimano, Michael/X-4059-2019; Turner, Nigel E/ABC-8263-2020; Ilie, Gabriela/AAM-9122-2021	Turner, Nigel E/0000-0002-1035-2064; Chen, Xinguang/0000-0001-8263-643X; Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; AUTO21, Networks of Centers of Excellence program - Natural Sciences and Engineering Research Council; Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; CIHR Research Chair in Gender Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Toronto Rehabilitation InstituteUniversity of Toronto	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research # TIR-103946, and the Ontario Neurotrauma Foundation. Additional funding was obtained from a grant from AUTO21, a member of the Networks of Centers of Excellence program that is administered and funded by the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council, in partnership with Industry Canada; ongoing funding support from the Ontario Ministry of Health and Long-Term Care; a CIHR Research Chair in Gender Work and Health #?CGW-126580; and the Toronto Rehabilitation Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Arnold C, 2014, LANCET NEUROL, V13, P136, DOI 10.1016/S1474-4422(13)70287-4; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Billette JM, 2013, 82624XWE; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Caro D. H., 2011, GLOBAL J HLTH SCI, V3, P19, DOI DOI 10.5539/GJHS.V3N1P19; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centre for Disease Control and Prevention Traumatic Brain Injury in the United States, 2010, EM DEP VIS HOSP DEAT; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Frances A, 2000, DSM 4 CLASSIFICATION; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Ilie G, J HEAD TRAUMA REHABI; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Knight JR, 2002, ARCH PEDIAT ADOL MED, V156, P607, DOI 10.1001/archpedi.156.6.607; Korn EL, 1999, ANAL HLTH SURVEYS, V1st; Levy DT, 2004, MED SCI MONITOR, V10, pCR17; May A, 2011, ASSESSMENT, V18, P379, DOI 10.1177/1073191110374285; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mckinlay A, 2013, J HEAD TRAUMA REHABI; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Paglia-Boak A., 2011, CAMH RES DOCUMENT SE, V32; Paglia-Boak A, 2011, CAMH RES DOCUMENT SE, V34; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Tait RJ, 2003, AUST NZ J PSYCHIAT, V37, P374, DOI 10.1046/j.1440-1614.2003.01133.x; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404; Zernicke R. F., 2009, Journal of Intercollegiate Sport, V2, P42	51	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108167	10.1371/journal.pone.0108167			14	Multidisciplinary Sciences	Science & Technology - Other Topics	AR6CW	WOS:000343671700069	25268238	DOAJ Gold, Green Published			2021-06-18	
J	Gomez, PA; Castano-Leon, AM; de-la-Cruz, J; Lora, D; Lagares, A				Gomez, Pedro A.; Castano-Leon, Ana M.; de-la-Cruz, Javier; Lora, David; Lagares, Alfonso			Trends in epidemiological and clinical characteristics in severe traumatic brain injury: Analysis of the past 25 years of a single centre data base	NEUROCIRUGIA			English	Article						Severe traumatic brain injury; Epidemiology; Mechanism; GCS	GLASGOW COMA SCALE; PROGNOSTIC VALUE; HEAD-INJURY; MODERATE; IMPACT; CLASSIFICATION; ENROLLMENT; MODELS	Objective: To describe the demographic and clinical profiles of a cohort of environmentally representative severe traumatic brain injury (TBI) cases collected for the past 25 years and to analyse the changes that occurred by dividing the analysis period into 3 equal time periods. Material and methods: This was an observational cohort study of consecutive adult patients (>14 years of age) with severe closed TEI (Glasgow Coma Scale score [GCS] <= 8) who were admitted during the first 48 h after injury to the 12 de Octubre hospital from 1987 to 2012. The most relevant epidemiological and clinical variables reported in the literature were defined and compared in 3 equal time periods (1987-1995,1996-2004 and 2005-2014). Results: There was a 13% reduction in the frequency of severe TBI from the first to the last time period. An increase in the mean age from 35 to 43 years was observed, whereas the frequency of severe TBI according to sex remained approximately the same during the last decades of life. A distinct change was observed in the injury mechanism; traffic accidents decreased from 76% to 55%, particularly those involving 4-wheeled vehicles. However, falls increased significantly, especially in older women, and contusion and subdural haematoma were the most frequent structural injuries. Motor scores could not be reliably assessed for the last time period because of early intubation and sedative drug use. Conclusions: TBI epidemiology in Western countries has changed. This trend was also observed in our environment as an increase in mean age, which reflected the increase in falls among elderly patients. (C) 2014 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Gomez, Pedro A.; Castano-Leon, Ana M.; Lagares, Alfonso] Univ Complutense Madrid, Octubre Univ Hosp 12, Dept Neurosurg, Madrid, Spain; [de-la-Cruz, Javier; Lora, David] 12 Octubre Univ Hosp, CIBERESP IMAS12, Clin Res Unit, Madrid, Spain	Gomez, PA (corresponding author), Univ Complutense Madrid, Octubre Univ Hosp 12, Dept Neurosurg, Madrid, Spain.	pedroantonio.gomez@salud.madrid.org	Lagares, Alfonso/B-2969-2011; Gomez, Pedro/N-5051-2019; Castano-Leon, Ana M/ABF-6322-2020	Lagares, Alfonso/0000-0003-3996-0554; Gomez, Pedro/0000-0002-4185-5238; Castano-Leon, Ana M/0000-0002-7918-5049	Mutua Madrilena Foundation (Spain) [2010-007]	This study was funded by grant no. 2010-007 from the Mutua Madrilena Foundation (Spain).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Boto GR, 2009, NEUROSURG REV, V32, P343, DOI 10.1007/s10143-008-0178-9; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Chesnut RM., 2000, J NEUROTRAUM, V17, P557; Direccion Generalde Trafico (DGT), 2011, PRINC CIFR SIN VIAL; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gomez, 1999, NEUROCIRUGIA, V10, P297; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Gomez PA, 1999, CIR ESPAN, V65, P277; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marion DW, 1994, J TRAUMA, P36; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2009, J NEUROTRAUM, V26, P1069, DOI 10.1089/neu.2008.0569; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328; Vilalta J, 1992, Rev Esp Anestesiol Reanim, V39, P277; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	38	15	15	0	7	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	SEP-OCT	2014	25	5					199	210		10.1016/j.neucir.2014.05.001			12	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	AQ5UB	WOS:000342873000001	24998417				2021-06-18	
J	Fontes, RBV; Smith, AP; Munoz, LF; Byrne, RW; Traynelis, VC				Fontes, Ricardo B. V.; Smith, Adam P.; Munoz, Lorenzo F.; Byrne, Richard W.; Traynelis, Vincent C.			Relevance of early head CT scans following neurosurgical procedures: an analysis of 892 intracranial procedures at Rush University Medical Center Clinical article	JOURNAL OF NEUROSURGERY			English	Article						computed tomography; radiography; craniotomy; reoperation; traumatic brain injury	EXTERNAL VENTRICULAR DRAIN; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; SUBARACHNOID HEMORRHAGE; INJURY; PLACEMENT; ACCURACY; TRAUMA; CARE	Object. Early postoperative head CT scanning is routinely performed following intracranial procedures for detection of complications, but its real value remains uncertain: so-called abnormal results are frequently found, but active, emergency intervention based on these findings may be rare. The authors' objective was to analyze whether early postoperative CT scans led to emergency surgical interventions and if the results of neurological examination predicted this occurrence. Methods. The authors retrospectively analyzed 892 intracranial procedures followed by an early postoperative CT scan performed over a 1-year period at Rush University Medical Center and classified these cases according to postoperative neurological status: baseline, predicted neurological change, unexpected neurological change, and sedated or comatose. The interpretation of CT results was reviewed and unexpected CT findings were classified based on immediate action taken: Type I, additional observation and CT; Type II, active nonsurgical intervention; and Type III, surgical intervention. Results were compared between neurological examination groups with the Fisher exact test. Results. Patients with unexpected neurological changes or in the sedated or comatose group had significantly more unexpected findings on the postoperative CT (p < 0.001; OR 19.2 and 2.3, respectively) and Type 111111 interventions (p < 0.001) than patients at baseline. Patients at baseline or with expected neurological changes still had a rate of Type II/III changes in the 2.2%-2.4% range; however, no patient required an immediate return to the operating room. Conclusions. Over a 1-year period in an academic neurosurgery service, no patient who was neurologically intact or who had a predicted neurological change required an immediate return to the operating room based on early postoperative CT findings. Obtaining early CT scans should not be a priority in these patients and may even be cancelled in favor of MRI studies, if the latter have already been planned and can be performed safely and in a timely manner. Early postoperative CT scanning does not assure an uneventful course, nor should it replace accurate and frequent neurological checks, because operative interventions were always decided in conjunction with the neurological examination.	[Fontes, Ricardo B. V.; Smith, Adam P.; Munoz, Lorenzo F.; Byrne, Richard W.; Traynelis, Vincent C.] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA	Fontes, RBV (corresponding author), Rush Univ, Med Ctr, Dept Neurosurg, 1725 W Harrison,Ste 855, Chicago, IL 60612 USA.	ricardo_fontes@rush.edu	Byrne, Richard/Q-9644-2019				Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Byrne RW, 2008, NEUROSURGERY, V62, P709, DOI 10.1227/01.neu.0000317320.79106.7e; Byrne RW, 2011, NEUROSURGERY, V68, P1063, DOI 10.1227/NEU.0b013e318209cde0; DAUCH WA, 1994, NEUROSURG REV, V17, P141, DOI 10.1007/BF00698770; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; FUKAMACHI A, 1986, NEUROSURGERY, V19, P589, DOI 10.1227/00006123-198610000-00013; Garrett MC, 2013, NEUROSURGERY, V73, P209, DOI 10.1227/01.neu.0000430328.25516.dd; Horowitz SW, 1996, SKULL BASE SURG, V6, P199, DOI 10.1055/s-2008-1058626; Hsieh CT, 2011, ACTA NEUROL BELG, V111, P22; KALFAS IH, 1988, NEUROSURGERY, V23, P343, DOI 10.1227/00006123-198809000-00010; Khaldi A, 2010, J NEUROSURG, V113, P1021, DOI 10.3171/2009.11.JNS081048; LIN JP, 1977, NEURORADIOLOGY, V12, P185, DOI 10.1007/BF00332366; MEYDINGLAMADE U, 1993, NEURORADIOLOGY, V35, P178, DOI 10.1007/BF00588487; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patil V, 2013, ACTA NEUROCHIR, V155, P1773, DOI 10.1007/s00701-013-1769-y; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; STAMMLER U, 1989, Neurosurgical Review, V12, P159, DOI 10.1007/BF01790640; Stein EG, 2010, J AM COLL RADIOL, V7, P351, DOI 10.1016/j.jacr.2009.12.015; Warmuth-Metz M, 2003, ACT NEUR S, V88, P13; Wilson TJ, 2013, J NEUROSURG, V119, P66, DOI 10.3171/2012.11.JNS111384; Wong JM, 2013, J NEUROSURG, V119, P215, DOI 10.3171/2013.3.JNS12253; YOSHIMIZU N, 1989, Neurosurgical Review, V12, P175, DOI 10.1007/BF01790642; ZAR Jh, 2009, BIOSTATISTICAL ANAL	25	15	15	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2014	121	2					307	312		10.3171/2014.4.JNS132429			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AL9PK	WOS:000339473000011	24878289				2021-06-18	
J	Mazzone, GL; Nistri, A				Mazzone, Graciela L.; Nistri, Andrea			S100 beta as an early biomarker of excitotoxic damage in spinal cord organotypic cultures	JOURNAL OF NEUROCHEMISTRY			English	Article						colchicine; glutamate receptor; kainic acid; neuroprotection; spinal cord injury	TRAUMATIC BRAIN-INJURY; SKELETAL-MUSCLE COCULTURE; S-100-BETA PROTEIN; SLICE CULTURES; S100B PROTEIN; EMBRYONIC RAT; NEURONS; ASTROCYTES; KAINATE; CELLS	S100 beta is a cytoplasmic calcium-binding protein mainly expressed by glia and considered to be a useful biomarker for brain or spinal cord injury. Indeed, clinical studies suggest that the S100 beta concentration in serum or cerebrospinal fluid may predict lesion outcome and prognosis. The relation of S100 beta levels to damage severity and its timecourse remains, however, unclear. This study used a validated in vitro model of spinal cord injury induced by kainate-mediated excitotoxicity to investigate these issues. After 22 days in vitro, rat organotypic spinal cord slices were subjected to one transient application (1 h) of 1 or 100 mu M kainate followed by washout. While the lower kainate concentration did not evoke neuronal loss or S100 beta increase, the larger concentration elicited 40% neuronal death, no change in glial number and a delayed, significant rise in extracellular S100 beta that peaked at 24 h. This increase was associated with a stronger expression of the S100 beta protein as indicated by western blotting and immunohistochemistry. Application of the microtubule disrupting agent colchicine did not change the rise in S100 beta induced by kainate, an effect blocked by the glutamate receptor antagonists CNQX and APV. Our data suggest that excitotoxicity was followed by release of S100 beta perhaps from a readily releasable pool through a mechanism independent of microtubule assembly. The raised extracellular level of sloop appeared to reflect glial reactivity to the kainate-evoked lesion in accordance with the view that this protein may be involved in tissue protection and repair after acute injury.	[Mazzone, Graciela L.; Nistri, Andrea] Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy	Nistri, A (corresponding author), SISSA, Via Bonomea 265, I-34136 Trieste, Italy.	nistri@sissa.it		Mazzone, Graciela Lujan/0000-0003-3360-9931	European Fund for CrossBorder Cooperation (MINA project)	We thank Dr. Beatrice Pastore for her assistance with organotypic cultures. This study was supported by the European Fund for CrossBorder Cooperation (MINA project) between Italy and Slovenia. The authors declare no conflicts of interest.	Barateiro A, 2014, MOL NEUROBIOL, V49, P424, DOI 10.1007/s12035-013-8530-7; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Cifra A, 2012, DEV NEUROBIOL, V72, P1140, DOI 10.1002/dneu.20991; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Gentleman D, 1999, BRIT MED BULL, V55, P910, DOI 10.1258/0007142991902718; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Kuzhandaivel Anujaianthi, 2011, Front Cell Neurosci, V5, P9, DOI 10.3389/fncel.2011.00009; Kuzhandaivel A, 2010, CELL MOL NEUROBIOL, V30, P1001, DOI 10.1007/s10571-010-9531-y; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Margaryan G, 2010, NEUROSCIENCE, V165, P996, DOI 10.1016/j.neuroscience.2009.10.066; Marquardt G, 2011, NEUROL RES, V33, P421, DOI 10.1179/1743132810Y.0000000005; Mazzone GL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.431; Mazzone GL, 2011, NEUROSCIENCE, V190, P318, DOI 10.1016/j.neuroscience.2011.06.013; Mazzone GL, 2010, NEUROSCIENCE, V168, P451, DOI 10.1016/j.neuroscience.2010.03.055; Mazzone GL, 2011, CELL MOL NEUROBIOL, V31, P469, DOI 10.1007/s10571-010-9640-7; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Rammes A, 1997, J BIOL CHEM, V272, P9496; RICKMANN M, 1995, NEUROSCIENCE, V67, P977, DOI 10.1016/0306-4522(94)00615-C; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Sorci G, 1998, BBA-MOL CELL RES, V1448, P277, DOI 10.1016/S0167-4889(98)00134-7; Sorci Guglielmo, 2013, World J Biol Chem, V4, P1, DOI 10.4331/wjbc.v4.i1.1; SPENGER C, 1991, EUR J NEUROSCI, V3, P1037, DOI 10.1111/j.1460-9568.1991.tb00041.x; STREIT J, 1991, EUR J NEUROSCI, V3, P1054, DOI 10.1111/j.1460-9568.1991.tb00042.x; Wang YF, 2009, J NEUROSCI, V29, P1743, DOI 10.1523/JNEUROSCI.4669-08.2009; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127	31	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2014	130	4					598	604		10.1111/jnc.12748			7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AN3ZN	WOS:000340527500014	24766228	Bronze			2021-06-18	
J	Sharma, B; Gupta, R; Anand, R; Ingle, R				Sharma, Bhavana; Gupta, Rachna; Anand, Reena; Ingle, Rashmi			Ocular manifestations of head injury and incidence of post-traumatic ocular motor nerve involvement in cases of head injury: a clinical review	INTERNATIONAL OPHTHALMOLOGY			English	Article								As the eyes are in close proximity to the skull, they can get simultaneously affected in head injuries. This close association warrants careful ocular examination in all cases of head injury. This is a prospective non-randomized analytical study to evaluate various ocular manifestations in cases of head injury with special reference to ocular motor nerve involvement, correlation between pupillary changes, and survival. A total of 1,184 patients with head injury were screened for ocular manifestations. This study comprises 594 patients with ocular manifestations of head injury. All the relevant data was compiled and analyzed as per proforma. Ocular manifestations were evaluated in each patient and appropriate investigations were carried out. Patients with ocular morbidity were analyzed for age, sex, mode of injury, Glasgow Coma Score, and associated injuries in addition to ophthalmic and neurosurgical evaluations. Of the 594 patients, 81.6 % were male and 18.4 % were female, with a male-to-female ratio of 4: 1. The major cause of head injury was road traffic accidents (70.37 %). The most common age group involved was, 21-40-year-olds (67.40 %). Out of 594 patients, ecchymosis was found in 51.85 %, subconjunctival hemorrhage in 44.44 %, lid edema in 41.48 %, lacerated wound in 22.59 %, pupillary involvement in 21.04 %, ptosis in 6.73 %, cranial nerve palsy in 11.62 %, orbital fractures in 10.44 %, optic nerve trauma in 4.04 %, and exposure keratitis in 4.21 %. Patients with bilaterally dilated or pinpoint fixed pupils had a 10 times higher risk of mortality than patients without pupillary involvement. Third nerve involvement was seen 2.85 times more frequently in frontal and parietal region injuries compared to other sites of injury. The involvement of the sixth nerve occurred 4.6 times more frequently in parietal region injuries compared to other sites of injury.		Sharma, B (corresponding author), E-7-545 Arera Colony, Bhopal, Madhya Pradesh, India.	drbhavana_s@yahoo.co.in					ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Blakeslee GA, 1929, ARCH OPHTHALMOL-CHIC, V2, P566; Cowan CL, 1983, J NATL MED ASSOC, V31, P789; Cross AG, 1957, TRANS OPHTHAL SURG, V9, P265; Elder Duke, 1957, TEXT BOOK OF OPHTHAL, V4, P39; Falbe Hansen I, 1959, ACTA OPHTHALMOL, V37, P359; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Herbella FAM, 2001, INJURY, V32, P745, DOI 10.1016/S0020-1383(01)00144-9; KEANE JR, 1989, ARCH NEUROL-CHICAGO, V46, P761, DOI 10.1001/archneur.1989.00520430055017; King AB, 1949, AM J OPHTHALMOL, V1949, P32; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; Kulkarni AR, 2005, EYE, V19, P1257, DOI 10.1038/sj.eye.6701753; Kumar A, 2008, INDIAN J NEUROTRAUM, V5, P63, DOI 10.1016/S0973-0508(08)80002-0; Lepore FE, 1995, ARCH NEUROL-CHICAGO, V52, P26; Malik SRK, 1968, INDIAN J OPHTHALMOL, V16, P178; Mariak Z, 1997, Eur J Ophthalmol, V7, P68; Masila F, 2012, OCULAR FINDINGS IN P, P1523; Moster ML, 1999, NEUROLOGY, V52, pA23; Odebode TO, 2005, EYE, V19, P561, DOI 10.1038/sj.eye.6701566; Pathak A, 2003, INDIAN J NEUROTRAUMA, V4, P31; Peden M, 2004, INJURY PREV, V10, P67, DOI 10.1136/ip.2004.005405; Raju N S, 1983, Indian J Ophthalmol, V31, P789; ROWBOTHAM GF, 1954, BRIT MED J, V1, P726, DOI 10.1136/bmj.1.4864.726; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; Shukla B, 1983, Indian J Ophthalmol, V31, P439; Singh YP, 1980, MED J ARMED FORCES, V61, P187; Turner JWA, 1943, BRAIN, V66, P140; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; WHO Neurological Disorder Survey, 2002, NCMH BACK GROUND PAP	30	15	15	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-5701	1573-2630		INT OPHTHALMOL	Int. Ophthalmol.	AUG	2014	34	4					893	900		10.1007/s10792-014-9898-8			8	Ophthalmology	Ophthalmology	AP1NV	WOS:000341838400027	24469117				2021-06-18	
J	Williams, SG; Collen, J; Wickwire, E; Lettieri, CJ; Mysliwiec, V				Williams, Scott G.; Collen, Jacob; Wickwire, Emerson; Lettieri, Christopher J.; Mysliwiec, Vincent			The Impact of Sleep on Soldier Performance	CURRENT PSYCHIATRY REPORTS			English	Article						Sleep deprivation; Combat related sleep disorder; Insomnia; Obstructive sleep apnea; Sleep disordered breathing; Posttraumatic stress disorder; Nightmares	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; RESTLESS LEGS SYNDROME; COGNITIVE-BEHAVIORAL THERAPY; QUALITY-OF-LIFE; STATES-MILITARY-ACADEMY; SHIFT WORK DISORDER; GENERAL-POPULATION; UNITED-STATES	The military population is particularly vulnerable to a multitude of sleep-related disorders owing to the type of work performed by active duty servicemembers (ADSMs). Inadequate sleep, due to insufficient quantity or quality, is increasingly recognized as a public health concern. Traditionally, ADSMs have been encouraged that they can adapt to insufficient sleep just as the body adapts to physical training, but there is a substantial body of scientific literature which argues that this is not possible. Additionally, the military work environment creates unique challenges with respect to treatment options for common sleep disorders like obstructive sleep apnea, restless legs syndrome, and parasomnias. This review highlights sleep disorders which are prevalent in the modern military force and discusses the impact of poor sleep on overall performance. Medical treatments and recommendations for unit leaders are also discussed.	[Williams, Scott G.] Womack Army Med Ctr, Ft Bragg, NC USA; [Williams, Scott G.; Collen, Jacob; Lettieri, Christopher J.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Collen, Jacob] San Antonio Mil Med Ctr, Ft Sam Houston, TX USA; [Wickwire, Emerson] Howard Cty Ctr Lung & Sleep Med, Columbia, MD USA; [Wickwire, Emerson] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Lettieri, Christopher J.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Mysliwiec, Vincent] Madigan Army Med Ctr, Joint Base Lewis McChord, Tacoma, WA 98431 USA	Williams, SG (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA.	scott.g.williams@us.army.mil		Lettieri, Christopher/0000-0001-7950-2908			Alattar M, 2007, J AM BOARD FAM MED, V20, P365, DOI 10.3122/jabfm.2007.04.060153; Allen RP, 2010, SLEEP MED, V11, P31, DOI 10.1016/j.sleep.2009.03.007; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; American Academy of Sleep Medicine, 2014, INT CLAS SLEEP DID; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Ancoli-Israel S, 1999, SLEEP, V22, pS347; [Anonymous], 2005, NIH Consens State Sci Statements, V22, P1; [Anonymous], 2010, MED SURVEILLANCE MON, V17, P12; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Armed Forces Health Surveillance Center, 2010, MSMR, P17; Arnedt JT, 2011, BEHAV RES THER, V49, P227, DOI 10.1016/j.brat.2011.02.003; Babson KA, 2013, J NERV MENT DIS, V201, P48, DOI 10.1097/NMD.0b013e31827ab059; Belleville G, 2009, J NERV MENT DIS, V197, P126, DOI 10.1097/NMD.0b013e3181961d8e; Bjorvatn B, 2010, SLEEP MED, V11, P1031, DOI 10.1016/j.sleep.2010.07.011; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Caldwell JL, 2001, MIL MED, V166, P159; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Collen JF, 2012, J CLIN SLEEP MED, V8, P667, DOI 10.5664/jcsm.2260; Crowley SK, 2012, MIL MED, V177, P823, DOI 10.7205/MILMED-D-12-00022; Czeisler Charles A, 2006, Trans Am Clin Climatol Assoc, V117, P159; Di Milia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055306; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; El-Solh AA, 2010, SLEEP, V33, P1495, DOI 10.1093/sleep/33.11.1495; Epstein DR, 2012, J REHABIL RES DEV, V49, P867, DOI 10.1682/JRRD.2011.06.0114; Faestel PM, 2013, J CLIN SLEEP MED, V9, P577, DOI 10.5664/jcsm.2754; Farkas RH, 2013, NEW ENGL J MED, V369, P689, DOI 10.1056/NEJMp1307972; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Garcia-Borreguero D, 2013, SLEEP MED, V14, P675, DOI 10.1016/j.sleep.2013.05.016; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Giam G. C. K., 1997, Annals Academy of Medicine Singapore, V26, P88; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; Huang QR, 2008, J CLIN SLEEP MED, V4, P543; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Joya FL, 2009, J CLIN SLEEP MED, V5, P377; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kennedy K., 2010, ARMY TIMES; Kinoshita LM, 2012, SLEEP BREATH, V16, P1201, DOI 10.1007/s11325-011-0632-8; Kolla BP, 2013, J HOSP MED, V8, P1, DOI 10.1002/jhm.1985; Krakow B, 2000, J PSYCHOSOM RES, V49, P291, DOI 10.1016/S0022-3999(00)00147-1; Krakow B, 2001, BIOL PSYCHIAT, V49, P948, DOI 10.1016/S0006-3223(00)01087-8; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kushida Clete A., 2000, Sleep Breath, V4, P9, DOI 10.1055/s-2000-11530; LeBlanc M, 2007, J PSYCHOSOM RES, V63, P157, DOI 10.1016/j.jpsychores.2007.03.004; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Leger D, 2001, PSYCHOSOM MED, V63, P49, DOI 10.1097/00006842-200101000-00006; Lichstein KL, 2006, SLEEP MED REV, V10, P3, DOI 10.1016/j.smrv.2005.10.001; LICHSTEIN KL, 1980, J ABNORM PSYCHOL, V89, P105, DOI 10.1037/0021-843X.89.1.105; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; Mackowiak PA, 2012, AM J MED SCI, V343, P146, DOI 10.1097/MAJ.0b013e31823bbcdd; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; MAHOWALD MW, 1990, J FORENSIC SCI, V35, P413; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Marks Fredric A, 2006, Aviat Space Environ Med, V77, P1094; Martin SA, 2004, SLEEP MED REV, V8, P63, DOI 10.1016/j.smrv.2003.08.001; Matheson A, 2014, J CLIN NURS, V23, P3309, DOI 10.1111/jocn.12524; McCrae CS, 2014, J CLIN SLEEP MED, V10, P127, DOI 10.5664/jcsm.3436; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P110; Miller NL, 2012, SLEEP, V35, P1123, DOI 10.5665/sleep.2002; Miller NL, 2010, SLEEP, V33, P1623, DOI 10.1093/sleep/33.12.1623; Miller NL, 2005, SLEEP, V28, P837, DOI 10.1093/sleep/28.7.837; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Mustafa Masroor, 2005, Sleep Breath, V9, P57, DOI 10.1007/s11325-005-0016-z; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Newman RA, 2013, PERCEPT MOTOR SKILL, V116, P280, DOI 10.2466/29.22.25.PMS.116.1.280-293; Office of the Surgeon General, 2013, ARM MED 2020 CAMP PL, P12; Ohayon MM, 2000, J NERV MENT DIS, V188, P340, DOI 10.1097/00005053-200006000-00004; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P547, DOI 10.1016/S0022-3999(02)00443-9; Oudiette D, 2009, SLEEP, V32, P1621, DOI 10.1093/sleep/32.12.1621; Patrick L, 2007, ALTERN MED REV, V12, P101; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Pressman MR, 2007, SLEEP, V30, P1039, DOI 10.1093/sleep/30.8.1039; Provini F, 1999, BRAIN, V122, P1017, DOI 10.1093/brain/122.6.1017; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Roberts RE, 2014, SLEEP, V37, P239, DOI 10.5665/sleep.3388; ROSS RJ, 1989, AM J PSYCHIAT, V146, P697; Roth T, 2012, SLEEP MED, V13, P335, DOI 10.1016/j.sleep.2011.11.006; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Rupp TL, 2009, SLEEP, V32, P311, DOI 10.1093/sleep/32.3.311; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sharafkhaneh A, 2004, SLEEP MED, V5, P345, DOI 10.1016/j.sleep.2004.01.019; Siclari F, 2010, BRAIN, V133, P3494, DOI 10.1093/brain/awq296; Silber MH, 2013, MAYO CLIN PROC, V88, P977, DOI 10.1016/j.mayocp.2013.06.016; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Sjostrom N, 2007, SLEEP, V30, P91; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Staff RT, 2012, NEUROIMAG CLIN N AM, V22, P99, DOI 10.1016/j.nic.2011.11.006; STOLLER MK, 1994, CLIN THER, V16, P873; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Taylor DJ, 2007, SLEEP, V30, P213, DOI 10.1093/sleep/30.2.213; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tippin J, 2009, J PSYCHOSOM RES, V67, P143, DOI 10.1016/j.jpsychores.2009.03.015; U.S. Army, 2009, 6225 FM; Vakulin A, 2011, J CLIN SLEEP MED, V7, P243, DOI 10.5664/JCSM.1062; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2001, SLEEP, V24, P813, DOI 10.1093/sleep/24.7.813; van Liempt S, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.19142; van Liempt S, 2013, DEPRESS ANXIETY, V30, P469, DOI 10.1002/da.22054; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Vitiello MV, 2013, J AM GERIATR SOC, V61, P947, DOI 10.1111/jgs.12275; Waage S, 2009, SLEEP, V32, P558, DOI 10.1093/sleep/32.4.558; Wallace DM, 2011, 200 PUBL HLTH RES; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wesensten Nancy J, 2013, US Army Med Dep J, P109; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Williams SG, 2014, SLEEP BREATH; Youakim JM, 1998, PSYCHOSOMATICS, V39, P168, DOI 10.1016/S0033-3182(98)71365-9	117	15	15	1	18	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1523-3812	1535-1645		CURR PSYCHIAT REP	Curr. Psychiatry Rep.	AUG	2014	16	8							459	10.1007/s11920-014-0459-7			13	Psychiatry	Psychiatry	AM4CX	WOS:000339801200003	24942599				2021-06-18	
J	Dekker, SE; Sillesen, M; Bambakidis, T; Andjelkovic, AV; Jin, G; Liu, BL; Boer, C; Johansson, PI; Linzel, D; Halaweish, I; Alam, HB				Dekker, Simone E.; Sillesen, Martin; Bambakidis, Ted; Andjelkovic, Anuska V.; Jin, Guang; Liu, Baoling; Boer, Christa; Johansson, Par I.; Linzel, Durk; Halaweish, Ihab; Alam, Hasan B.			Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	9th Annual Academic Surgical Congress of the Association-for-Academic-Surgery and the Society-of-University-Surgeons	FEB 04-07, 2014	San Diego, CA	Assoc Acad Surg, Soc Univ Surg		Traumatic brain injury; Hemorrhagic shock; Histone deacetylase inhibitor; Fresh frozen plasma	CELL ADHESION MOLECULE-1; FRESH-FROZEN PLASMA; COAGULATION DISORDERS; DYSFUNCTION; RESUSCITATION; COAGULOPATHY; COLLAGEN	Background: We have previously shown that resuscitation with fresh frozen plasma (FFP) in a large animal model of traumatic brain injury (TBI) and hemorrhagic shock (HS) decreases the size of the brain lesion, and that addition of a histone deacetylase inhibitor, valproic acid (VPA), provides synergistic benefits. In this study, we hypothesized that VPA administration would be associated with a conservation of platelet function as measured by increased platelet activation after resuscitation. Materials and methods: Ten swine (42-50 kg) were subjected to TBI and HS (40% blood loss). Animals were left in shock for 2 h before resuscitation with either FFP or FFP + VPA (300 mg/kg). Serum levels of platelet activation markers transforming growth factor beta, CD40 L, P-selectin, and platelet endothelial cell adhesion molecule (PECAM) 1 were measured at baseline, postresuscitation, and after a 6-h observation period. Platelet activation markers were also measured in the brain whole cell lysates and immunohistochemistry. Results: Circulating P-selectin levels were significantly higher in the FFP + VPA group compared with the FFP alone group (70.85 +/- 4.70 versus 48.44 +/- 7.28 ng/mL; P < 0.01). Likewise, immunohistochemistry data showed elevated P-selectin in the VPA treatment group (22.30 +/- 10.39% versus 8.125 +/- 3.94%, P < 0.01). Serum sCD40L levels were also higher in the FFP + VPA group (3.21 +/- 0.124 versus 2.38 +/- 0.124 ng/mL; P < 0.01), as was brain sCD40L levels (1.41 +/- 0.15 versus 1.22 +/- 0.12 ng/mL; P = 0.05). Circulating transforming growth factor beta levels were elevated in the FFP + VPA group, but this did not reach statistical significance (11.20 +/- 1.46 versus 8.09 +/- 1.41 ng/mL; P = 0.17). Brain platelet endothelial cell adhesion molecule 1 levels were significantly lower in the FFP + VPA group compared with the FFP group (5.22 +/- 2.00 pg/mL versus 7.99 +/- 1.13 pg/mL; P = 0.03). Conclusions: In this clinically relevant large animal model of combined TBI + HS, the addition of VPA to FFP resuscitation results in an early upregulation of platelet activation in the circulation and the brain. The previously observed neuroprotective effects of VPA may be due to a conservation of platelet function as measured by a higher platelet activation response after resuscitation. (C) 2014 Elsevier Inc. All rights reserved.	[Dekker, Simone E.; Bambakidis, Ted; Jin, Guang; Liu, Baoling; Linzel, Durk; Halaweish, Ihab; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA; [Dekker, Simone E.; Boer, Christa] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, Amsterdam, Netherlands; [Sillesen, Martin] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp,Div Trauma Emergency Surg, Boston, MA 02115 USA; [Sillesen, Martin] Copenhagen Univ Hosp, Dept Surg, Hillerod, Denmark; [Andjelkovic, Anuska V.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Andjelkovic, Anuska V.] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI USA; [Johansson, Par I.] Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, DK-1168 Copenhagen, Denmark; [Johansson, Par I.] Univ Texas Med Sch, Ctr Translat Injury Res CeTIR, Dept Surg, Houston, TX USA; [Linzel, Durk] Vrije Univ Amsterdam Med Ctr, Dept Emergency Med, Amsterdam, Netherlands	Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 2920, Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Johansson, Par I/P-9283-2015	Johansson, Par I/0000-0001-9778-5964; Sillesen, Martin/0000-0001-9494-5475; Boer, Christa/0000-0002-7781-6951			Anderson GD, 2003, EPILEPSY RES, V57, P111, DOI 10.1016/j.eplepsyres.2003.11.001; Banerjea MC, PRO ANTICOAGULATORY; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, GLOB TRAUM CAR; Cicmil M, 2002, BLOOD, V99, P137, DOI 10.1182/blood.V99.1.137; Davidson DC, 2011, J IMMUNOL, V186, P584, DOI 10.4049/jimmunol.1001911; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Falati S, 2006, BLOOD, V107, P535, DOI 10.1182/blood-2005-04-1512; Gesundheit B, 2002, J PEDIAT HEMATOL ONC, V24, P589, DOI 10.1097/00043426-200210000-00022; GIDAL B, 1994, NEUROLOGY, V44, P1418, DOI 10.1212/WNL.44.8.1418; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Jones KL, 2001, BLOOD, V98, P1456, DOI 10.1182/blood.V98.5.1456; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kis B, 1999, EPILEPSIA, V40, P307, DOI 10.1111/j.1528-1157.1999.tb00709.x; Ko C. H., 2001, Hong Kong Medical Journal, V7, P15; Koenig S, 2008, BLOOD COAGUL FIBRIN, V19, P375, DOI 10.1097/MBC.0b013e3282f3f9ec; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; Patil S, 2001, BLOOD, V97, P1727, DOI 10.1182/blood.V97.6.1727; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Serdaroglu G, 2002, J CHILD NEUROL, V17, P41, DOI 10.1177/088307380201700110; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Verrotti A, 1999, PEDIATR NEUROL, V21, P611, DOI 10.1016/S0887-8994(99)00060-0; Ward MM, 1996, EPILEPSIA, V37, P98, DOI 10.1111/j.1528-1157.1996.tb00519.x	33	15	16	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2014	190	1					312	318		10.1016/j.jss.2014.02.049			7	Surgery	Surgery	AK5DN	WOS:000338444700047	24694719				2021-06-18	
J	Guo, J; Li, YQ; He, ZN; Zhang, B; Li, YH; Hu, JH; Han, MY; Xu, YL; Li, YF; Gu, J; Dai, B; Chen, Z				Guo, Jian; Li, Yiqiao; He, Zhennian; Zhang, Bin; Li, Yonghuan; Hu, Jianghua; Han, Mingyuan; Xu, Yuanlin; Li, Yongfu; Gu, Jie; Dai, Bo; Chen, Zhong			Targeting endothelin receptors A and B attenuates the inflammatory response and improves locomotor function following spinal cord injury in mice	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						endothelin receptors; inflammatory response; long-term neurological improvement; oxidative stress	HEME OXYGENASE-1; ETB-RECEPTOR; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; RAT-BRAIN; TNF-ALPHA; EXPRESSION; BARRIER; MATRIX-METALLOPROTEINASE-9; NEUTROPHIL	After spinal cord injury (SCI), the disruption of blood-spinal cord barrier by activation of the endothelin (ET) system is a critical event leading to leukocyte infiltration, inflammatory response and oxidative stress, contributing to neurological disability. In the present study, we showed that blockade of ET receptor A (ETAR) and/or ET receptor B (ETBR) prevented early inflammatory responses directly via the inhibition of neutrophil and monocyte diapedesis and inflammatory mediator production following traumatic SCI in mice. Long-term neurological improvement, based on a series of tests of locomotor performance, occurred only in the spinal cord-injured mice following blockade of ETAR and ETBR. We also examined the post-traumatic changes of the micro-environment within the injured spinal cord of mice following blockade of ET receptors. Oxidative stress reflects an imbalance between malondialdehyde and superoxide dismutase in spinal cord-injured mice treated with vehicle, whereas blockade of ETAR and ETBR reversed the oxidation state imbalance. In addition, hemeoxygenase-1, a protective protease involved in early SCI, was increased in spinal cord-injured mice following the blockade of ETAR and ETBR, or only ETBR. Matrix metalloproteinase-9, a tissue-destructive protease involved in early damage; was decreased in the injured spinal cord of mice following blockade of ETAR, ETBR or a combination thereof. The findings of the present study therefore suggested an association between ETAR and ETBR in regulating early pathogenesis of SCI and determining the outcomes of long-term neurological recovery.	[Guo, Jian; He, Zhennian; Zhang, Bin; Li, Yonghuan; Hu, Jianghua; Han, Mingyuan; Xu, Yuanlin; Li, Yongfu; Gu, Jie; Dai, Bo] Ningbo Beilun People Hosp, Dept Orthopaed Surg, Ningbo 315800, Zhejiang, Peoples R China; [Li, Yiqiao] Ningbo Beilun People Hosp, Cent Lab, Ningbo 315800, Zhejiang, Peoples R China; [Chen, Zhong] Zhejiang Univ, Dept Orthopaed Surg, Coll Med, Affiliated Hosp 1, Hangzhou 310000, Zhejiang, Peoples R China	Chen, Z (corresponding author), Zhejiang Univ, Dept Orthopaed Surg, Coll Med, Affiliated Hosp 1, 79 Qingchun Rd, Hangzhou 310000, Zhejiang, Peoples R China.	zhongchenmed@163.com			Science and Technology Bureau Foundation of Ningbo [2012A610230]	This study was supported by the Science and Technology Bureau Foundation of Ningbo (no. 2012A610230).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ahnstedt H, 2012, ACTA PHYSIOL, V205, P266, DOI 10.1111/j.1748-1716.2011.02392.x; Bao F, 2008, EXP NEUROL, V214, P160, DOI 10.1016/j.expneurol.2008.09.006; Barnes K, 1997, NEUROCHEM RES, V22, P1033, DOI 10.1023/A:1022435111928; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Chou AK, 2007, EXP BIOL MED, V232, P214; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; Dang ABC, 2008, SPINE, V33, pE576, DOI 10.1097/BRS.0b013e31817ecc87; Dehouck MP, 1997, J CEREBR BLOOD F MET, V17, P464, DOI 10.1097/00004647-199704000-00012; DOUGLAS SA, 1995, CARDIOVASC RES, V29, P641, DOI 10.1016/0008-6363(96)88634-2; Fu LW, 2010, J PHYSIOL-LONDON, V588, P2473, DOI 10.1113/jphysiol.2010.188730; Gallelli L, 2005, J CELL BIOCHEM, V96, P858, DOI 10.1002/jcb.20608; Goldbaum O, 2001, J NEUROCHEM, V78, P1233, DOI 10.1046/j.1471-4159.2001.00507.x; Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; HUGGINS JP, 1993, PHARMACOL THERAPEUT, V59, P55, DOI 10.1016/0163-7258(93)90041-B; ISHIKAWA K, 1992, J MED CHEM, V35, P2139, DOI 10.1021/jm00089a028; Kallakuri S, 2010, NEUROSCIENCE, V168, P820, DOI 10.1016/j.neuroscience.2010.01.018; Kanno H, 2009, J NEUROTRAUM, V26, P31, DOI 10.1089/neu.2008.0667; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Lee SM, 2011, J NEUROTRAUM, V28, P1893, DOI 10.1089/neu.2011.1860; Leonard MG, 2011, BRAIN RES, V1420, P48, DOI 10.1016/j.brainres.2011.08.075; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lindsey M, 2001, CIRCULATION, V103, P2181; Liu DX, 2001, J NEUROCHEM, V77, P1036, DOI 10.1046/j.1471-4159.2001.00306.x; Liu Y, 2002, J NEUROTRAUM, V19, P479, DOI 10.1089/08977150252932424; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; Nagasaka J, 1999, PHARMACOL BIOCHEM BE, V64, P171, DOI 10.1016/S0091-3057(99)00123-9; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Noble LJ, 2002, J NEUROSCI, V22, P7526; Okada M, 2002, CARDIOVASC DRUG REV, V20, P53; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Reijerkerk A, 2012, J NEUROCHEM, V121, P730, DOI 10.1111/j.1471-4159.2011.07393.x; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Sallum CO, 2012, CHEM BIOL DRUG DES, V80, P374, DOI 10.1111/j.1747-0285.2012.01405.x; Salzman SK, 1996, J NEUROTRAUM, V13, P93, DOI 10.1089/neu.1996.13.93; Siren AL, 2000, NEUROCHEM RES, V25, P957, DOI 10.1023/A:1007552408463; Solini A, 2007, GROWTH FACTORS, V25, P392, DOI 10.1080/08977190801892341; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Wang HH, 2011, J CELL PHYSIOL, V226, P2244, DOI 10.1002/jcp.22560; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Yin X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038381; Zarpelon AC, 2012, CAN J PHYSIOL PHARM, V90, P187, DOI [10.1139/Y11-116, 10.1139/y11-116]	52	15	15	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUL	2014	34	1					74	82		10.3892/ijmm.2014.1751			9	Medicine, Research & Experimental	Research & Experimental Medicine	AK1MA	WOS:000338178000008	24756152	Other Gold, Green Published			2021-06-18	
J	Huang, EYK; Tsai, TH; Kuo, TT; Tsai, JJ; Tsui, PF; Chou, YC; Ma, HI; Chiang, YH; Chen, YH				Huang, Eagle Yi-Kung; Tsai, Tung-Han; Kuo, Tung-Tai; Tsai, Jing-Jr; Tsui, Pi-Fen; Chou, Yu-Ching; Ma, Hsin-I.; Chiang, Yung-Hsiao; Chen, Yuan-Hao			Remote effects on the striatal dopamine system after fluid percussion injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Fluid percussion injury; Dopamine releasing and reuptake; Fast-Scan Cyclic Voltammetry (FSCV); High-pressure liquid chromatography (HPLC); Neuroinflammation	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; RAT FRONTAL-CORTEX; INTERFERON-ALPHA; COGNITIVE DYSFUNCTION; SURFACE EXPRESSION; BASAL GANGLIA; INFLAMMATION; TRANSPORTER; AMANTADINE	Purpose: To investigate the effects of traumatic brain injury (TBI) on the dopamine system in the brain at different distances from the impaction site, we compared the release, reuptake, metabolism, and release probability of dopamine on the sides of the brain ipsilateral and contralateral to the injury at different time points after varying severities of fluid percussion injuries. Materials and methods: Tonic (1-pulse evoked) and bursting (10-pulse evoked) dopamine release changes in the ipsilateral and contralateral sides of the striatum resulting from mild (2-Pa) and severe (6-Pa) levels of fluid percussion injury were analyzed at the acute (2 hand 24 h), subacute (1 and 2 weeks), and chronic stages (4, 6, and 8 weeks) after injury by using fast scan cyclic voltammetry to measure brain slices. The metabolic rate of striatal dopamine was surveyed using high-performance liquid chromatography. The microglia reaction was analyzed using immunohistochemistry at each stage. Results: In 6-Pa injured animals, for both tonic and bursting dopamine release, reuptake and release probability were suppressed on both the ipsilateral and contralateral sides of the striatum from the acute to the chronic stage. These neuronal activities were also affected at the subacute stage on both sides of the striatum in 2-Pa injured animals. The turnover rate of dopamine was not affected in the 2-Pa injured animals but increased gradually during the chronic stage in the 6-Pa injured group. Conclusion: TBI suppresses dopamine release and reuptake and affects the metabolic rate and release probability of dopamine on the sides of the nigrostriatal system both ipsilateral and contralateral to the injury during both the acute and subacute stages after the injury. (C) 2014 Elsevier B.V. All rights reserved.	[Huang, Eagle Yi-Kung; Tsui, Pi-Fen] Natl Def Med Ctr, Dept Pharmacol, Taipei 114, Taiwan; [Kuo, Tung-Tai] Natl Taipei Univ Technol, Grad Inst Comp & Commun Engn, Taipei 106, Taiwan; [Tsai, Tung-Han; Tsai, Jing-Jr; Ma, Hsin-I.; Chen, Yuan-Hao] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Neurol Surg, Taipei 114, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei 114, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, PhD Program Neural Regenerat Med, Dept Neurosurg,Taipei Med Univ Hosp, Taipei 110, Taiwan	Chen, YH (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Neurol Surg, 4F,325,2nd Sec,Cheng Kung Rd, Taipei 114, Taiwan.	chenyh178@gmail.com			National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 102-2314-B-016-030-MY3, NSC102-2314-B-038-023-MY3]; Medical Research Project grants from the Tr-Service General Hospital of Taiwan [TSGH-C102-080, TSGH-C101-084, TSGH-C100-033]	This work was supported by the National Science Council of Taiwan under grant NSC 102-2314-B-016-030-MY3, NSC102-2314-B-038-023-MY3 and by Medical Research Project grants TSGH-C102-080, TSGH-C101-084 and TSGH-C100-033 from the Tr-Service General Hospital of Taiwan.	Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Baskaran H, 2000, J SURG RES, V93, P88, DOI 10.1006/jsre.2000.5955; Bhatia RK, 2005, INJURY, V36, P956, DOI 10.1016/j.injury.2005.03.009; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Capuron L, 2012, ARCH GEN PSYCHIAT, V69, P1044, DOI 10.1001/archgenpsychiatry.2011.2094; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Cunnington C, 2012, CIRCULATION, V125, P1356, DOI 10.1161/CIRCULATIONAHA.111.038919; Felger JC, 2007, BIOL PSYCHIAT, V62, P1324, DOI 10.1016/j.biopsych.2007.05.026; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; GARIANO RF, 1989, BRAIN RES BULL, V22, P511, DOI 10.1016/0361-9230(89)90103-2; Good CH, 2013, J NEUROSCI, V 33, P16853, DOI 10.1523/JNEUROSCI.1844-13.2013; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205; Huang EYK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086354; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Janhunen S, 2007, NEUROSCI BIOBEHAV R, V31, P287, DOI 10.1016/j.neubiorev.2006.09.008; Kamata M, 2000, EUR NEUROPSYCHOPHARM, V10, P129, DOI 10.1016/S0924-977X(99)00067-X; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Kulagina NV, 2001, NEUROSCIENCE, V102, P121, DOI 10.1016/S0306-4522(00)00480-2; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Moron JA, 2003, J NEUROSCI, V23, P8480; Nisell M, 1997, J NEURAL TRANSM, V104, P1, DOI 10.1007/BF01271290; Piras F, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00217; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Riggio S, 2009, MT SINAI J MED, V76, P95, DOI 10.1002/msj.20107; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Sato T, 2006, PSYCHIAT CLIN NEUROS, V60, P499, DOI 10.1111/j.1440-1819.2006.01538.x; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shi WX, 2000, SYNAPSE, V35, P111, DOI 10.1002/(SICI)1098-2396(200002)35:2<111::AID-SYN3>3.3.CO;2-Z; STOCK G, 1973, N-S ARCH PHARMACOL, V278, P347, DOI 10.1007/BF00501479; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang T, 2013, J NEUROTRAUMA; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Wu Y, 2000, NEUROSCIENCE, V96, P65, DOI 10.1016/S0306-4522(99)00539-4; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zhang LF, 2009, MOL PHARMACOL, V76, P396, DOI 10.1124/mol.109.056317; Zhu J, 2005, J NEUROCHEM, V93, P1434, DOI 10.1111/j.1471-4159.2005.03130.x	68	15	15	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUL 1	2014	267						156	172		10.1016/j.bbr.2014.03.033			17	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AI2UK	WOS:000336713400020	24675161				2021-06-18	
J	Natarajan, R; Singal, V; Benes, R; Gao, JL; Chan, H; Chen, HJ; Yu, YJ; Zhou, J; Wu, P				Natarajan, Rajalaxmi; Singal, Vinamrata; Benes, Richard; Gao, Junling; Chan, Hoi; Chen, Haijun; Yu, Yongjia; Zhou, Jia; Wu, Ping			STAT3 Modulation to Enhance Motor Neuron Differentiation in Human Neural Stem Cells	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FIBROBLAST-GROWTH-FACTOR; SMALL-MOLECULE INHIBITOR; SPINAL-CORD-INJURY; ASTROCYTE DIFFERENTIATION; PROMOTES NEUROGENESIS; REACTIVE ASTROCYTES; SIGNALING PATHWAY; FETAL BRAIN; ACTIVATION	Spinal cord injury or amyotrophic lateral sclerosis damages spinal motor neurons and forms a glial scar, which prevents neural regeneration. Signal transducer and activator of transcription 3 (STAT3) plays a critical role in astrogliogenesis and scar formation, and thus a fine modulation of STAT3 signaling may help to control the excessive gliogenic environment and enhance neural repair. The objective of this study was to determine the effect of STAT3 inhibition on human neural stem cells (hNSCs). In vitro hNSCs primed with fibroblast growth factor 2 (FGF2) exhibited a lower level of phosphorylated STAT3 than cells primed by epidermal growth factor (EGF), which correlated with a higher number of motor neurons differentiated from FGF2-primed hNSCs. Treatment with STAT3 inhibitors, Stattic and Niclosamide, enhanced motor neuron differentiation only in FGF2-primed hNSCs, as shown by increased homeobox gene Hb9 mRNA levels as well as HB9(+) and microtubule-associated protein 2 (MAP2)(+) co-labeled cells. The increased motor neuron differentiation was accompanied by a decrease in the number of glial fibrillary acidic protein (GFAP)-positive astrocytes. Interestingly, Stattic and Niclosamide did not affect the level of STAT3 phosphorylation; rather, they perturbed the nuclear translocation of phosphorylated STAT3. In summary, we demonstrate that FGF2 is required for motor neuron differentiation from hNSCs and that inhibition of STAT3 further increases motor neuron differentiation at the expense of astrogliogenesis. Our study thus suggests a potential benefit of targeting the STAT3 pathway for neurotrauma or neurodegenerative diseases.	[Natarajan, Rajalaxmi; Singal, Vinamrata; Benes, Richard; Gao, Junling; Chan, Hoi; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Chen, Haijun; Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Yu, Yongjia] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA	Wu, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	piwu@utmb.edu			John S. Dunn Research Foundation; TIRR Foundation Mission Connect; Gillson Longenbaugh Foundation; Moody Foundation	This study is supported by John S. Dunn Research Foundation, TIRR Foundation Mission Connect, Gillson Longenbaugh Foundation, and Moody Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cao F, 2010, BIOCHEM BIOPH RES CO, V394, P843, DOI 10.1016/j.bbrc.2010.03.092; Chen HJ, 2013, EUR J MED CHEM, V62, P498, DOI 10.1016/j.ejmech.2013.01.023; Chen HJ, 2013, ACS MED CHEM LETT, V4, P180, DOI 10.1021/ml3003082; Cheng PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022018; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gritti A, 1996, J NEUROSCI, V16, P1091; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jordan PM, 2009, J NEUROSCI RES, V87, P318, DOI 10.1002/jnr.21856; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lee S, 2013, P NATL ACAD SCI USA, V110, P11445, DOI 10.1073/pnas.1302676110; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Rai KS, 2007, EUR J NEUROSCI, V26, P1765, DOI 10.1111/j.1460-9568.2007.05820.x; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rajan P, 1998, J NEUROSCI, V18, P3620; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Schubert KO, 2005, EXP BRAIN RES, V165, P520, DOI 10.1007/s00221-005-2330-x; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shibata N, 2010, NEUROPATHOLOGY, V30, P353, DOI 10.1111/j.1440-1789.2009.01078.x; Shibata N, 2009, NEURODEGENER DIS, V6, P118, DOI 10.1159/000213762; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Walker Sarah R, 2012, JAKSTAT, V1, P292, DOI 10.4161/jkst.22662; Werner S, 2011, J NEUROSCI RES, V89, P1605, DOI 10.1002/jnr.22680; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x	37	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100405	10.1371/journal.pone.0100405			12	Multidisciplinary Sciences	Science & Technology - Other Topics	AN6QP	WOS:000340721500070	24945434	DOAJ Gold, Green Published			2021-06-18	
J	Karason, S; Reynisson, K; Sigvaldason, K; Sigurdsson, GH				Karason, Sigurbergur; Reynisson, Kristbjorn; Sigvaldason, Kristinn; Sigurdsson, Gisli H.			Evaluation of clinical efficacy and safety of cervical trauma collars: differences in immobilization, effect on jugular venous pressure and patient comfort	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Cervical collar; Intracranial pressure; Cervical spine injury; Head trauma; Internal jugular venous pressure	INTRACRANIAL-PRESSURE; RIGID COLLAR; SPINE; HEAD; ORTHOSES; MOTION	Background: Concern has been raised that cervical collars may increase intracranial pressure in traumatic brain injury. The purpose of this study was to compare four types of cervical collars regarding efficacy of immobilizing the neck, effect on jugular venous pressure (JVP), as a surrogate for possible effect on intracranial pressure, and patient comfort in healthy volunteers. Methods: The characteristics of four widely used cervical collars (Laerdal Stifneck (R) (SN), Vista (R) (VI), Miami J Advanced (R) (MJ), Philadelphia (R) (PH)) were studied in ten volunteers. Neck movement was measured with goniometry, JVP was measured directly through an endovascular catheter and participants graded the collars according to comfort on a scale 1-5. Results: The mean age of participants was 27 +/- 5 yr and BMI 26 +/- 5. The mean neck movement (53 +/- 9 degrees) decreased significantly with all the collars (p < 0.001) from 18 +/- 7 degrees to 25 +/- 9 degrees (SN < MJ < PH < VI). There was a significant increase in mean JVP (9.4 +/- 1.4 mmHg) with three of the collars, but not with SN, from 10.5 +/- 2.1 mmHg to 16.3 +/- 3.3 mmHg (SN < MJ < VI < PH). The grade of comfort between collars varied from 4.2 +/- 0.8 to 2.2 +/- 0.8 (VI > MJ > SN > PH). Conclusion: Stifneck and Miami J collars offered the most efficient immobilization of the neck with the least effect on JVP. Vista and Miami J were the most comfortable ones. The methodology used in this study may offer a new approach to evaluate clinical efficacy and safety of neck collars and aid their continued development.	[Karason, Sigurbergur; Sigvaldason, Kristinn; Sigurdsson, Gisli H.] Landspitali Univ Hosp, Dept Anesthesia & Intens Care, Reykjavik, Iceland; [Karason, Sigurbergur; Sigurdsson, Gisli H.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Reynisson, Kristbjorn] Landspitali Univ Hosp, Dept Radiol, Reykjavik, Iceland	Karason, S (corresponding author), Landspitali Univ Hosp, Dept Anesthesia & Intens Care, Reykjavik, Iceland.	skarason@landspitali.is			Ossur Inc, Reykjavik, Iceland	The study was partly supported by unconditional grant from Ossur Inc, Reykjavik, Iceland and from institutional funds.	Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Brohi K, 2005, J TRAUMA, V58, P897, DOI 10.1097/01.ta.0000171984.25699.35; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; CRAIG GR, 1991, INTENS CARE MED, V17, P504, DOI 10.1007/BF01690778; Davies G, 1996, INJURY, V27, P647, DOI 10.1016/S0020-1383(96)00115-5; Exo J, 2009, Ped Health, V3, P533, DOI 10.2217/phe.09.54; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Ho AMH, 2002, J TRAUMA, V53, P1185, DOI 10.1097/00005373-200212000-00028; Horodyski M, 2011, J EMERG MED, V41, P513, DOI 10.1016/j.jemermed.2011.02.001; Hostler D, 2009, PREHOSP EMERG CARE, V13, P256, DOI 10.1080/10903120802706195; Hunt K, 2001, ANAESTHESIA, V56, P511, DOI 10.1046/j.1365-2044.2001.02053.x; James CY, 2004, J ATHL TRAINING, V39, P138; Kwan I., 2001, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002803; Kwan I, 2005, PREHOSP DISASTER MED, V20, P47, DOI 10.1017/S1049023X00002144; Malik SA, 2008, EUR SPINE J, V17, P585, DOI 10.1007/s00586-008-0603-3; Mobbs RJ, 2002, ANZ J SURG, V72, P389, DOI 10.1046/j.1445-2197.2002.02462.x; Molinari RW, 2012, EUR SPINE J, V21, P855, DOI 10.1007/s00586-011-2069-y; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; PLAISIER B, 1994, J TRAUMA, V37, P714, DOI 10.1097/00005373-199411000-00004; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Richter D, 2001, J TRAUMA, V50, P848, DOI 10.1097/00005373-200105000-00012; Schneider AM, 2007, SPINE, V32, pE1, DOI 10.1097/01.brs.0000251019.24917.44; Stone MB, 2010, ACAD EMERG MED, V17, P100, DOI 10.1111/j.1553-2712.2009.00624.x; The ATLS Subcommittee ACoSCoT and the International ATLS working group, 2012, ADV TRAUM LIF SUPP A; Zhang SN, 2005, CLIN BIOMECH, V20, P264, DOI 10.1016/j.clinbiomech.2004.09.015	25	15	15	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUN 6	2014	22								37	10.1186/1757-7241-22-37			7	Emergency Medicine	Emergency Medicine	AK3CL	WOS:000338300300001	24906207	DOAJ Gold, Green Published			2021-06-18	
J	Bata, SC; Yung, M				Bata, Sonny C.; Yung, Michael			Role of routine repeat head imaging in paediatric traumatic brain injury	ANZ JOURNAL OF SURGERY			English	Article						children; CT scan; head injuries; TBI; traumatic brain injury	SERIAL COMPUTED-TOMOGRAPHY; INFLUENCE MANAGEMENT; UTILITY; CT; PROGRESSION; MODERATE	Background Paediatric traumatic brain injuries (TBI) remain a leading cause of morbidity and mortality in Australia. There are clear guidelines on head imaging for children with TBI, but there is conflicting evidence on the role of routine repeat head computed tomography (CT) scan. This study aims to determine whether routine repeat head CT scans in paediatric TBI alter surgical or medical management. Methods A retrospective study was performed at a level 1 tertiary paediatric trauma centre between January 2002 and July 2012. Patients with TBI who were admitted with acute intracranial injury and at least one repeat head CT scan were included. Mechanism of injury, severity of TBI, Glasgow Coma Score, use of intracranial pressure monitoring and operative procedures were listed. The need for operative management was compared for routine and clinically indicated head scans. Results Routine head CT scan was done in 36 out of 71 patients (51%). None from this group required craniotomy, but two children (6%) needed delayed ICP monitoring. Three patients with moderate to severe TBI required intracranial pressure monitor or external ventricular drain insertion based on a clinically indicated repeat head CT. Conclusion Repeat head imaging is more likely to alter management of children with moderate to severe TBI. There is no role for routine repeat CT scan on mild TBI. Results of repeat cranial imaging should be correlated with the clinical status of the patient.	[Bata, Sonny C.; Yung, Michael] Womens & Childrens Hosp, Dept Crit Care Med, Adelaide, SA, Australia	Bata, SC (corresponding author), Womens & Childrens Hosp, Dept Crit Care Med, 72 King William Rd, Adelaide, SA 5006, Australia.	sonnycyrusbata@gmail.com					Australian Institute of Health and Welfare, 2012, PICT AUSTR CHILDR 20; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Martin C, 2008, CURR OPIN PEDIATR, V20, P294, DOI 10.1097/MOP.0b013e3282ff0dfa; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	17	15	16	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	JUN	2014	84	6					438	441		10.1111/ans.12582			4	Surgery	Surgery	AJ3JB	WOS:000337561300011	24697988				2021-06-18	
J	Byers, AL; Yaffe, K				Byers, Amy L.; Yaffe, Kristine			Depression and dementias among military veterans	ALZHEIMERS & DEMENTIA			English	Article						Dementia; Alzheimer's disease; Cognitive impairment; Depression; Posttraumatic stress disorder; Traumatic brain injury; Older veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MILD COGNITIVE IMPAIRMENT; LATE-LIFE DEPRESSION; WHITE-MATTER HYPERINTENSITIES; CARDIOVASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; HIPPOCAMPAL VOLUME; MAJOR DEPRESSION; GERIATRIC DEPRESSION	Depression is very common throughout the course of veterans' lives, and dementia is common in late life. Previous studies suggest an association between depression and dementia in military veterans. The most likely biologic mechanisms that may link depression and dementia among military veterans include vascular disease, changes in glucocorticoid steroids and hippocampal atrophy, deposition of beta-amyloid plaques, inflammatory changes, and alterations of nerve growth factors. In addition, military veterans often have depression comorbid with posttraumatic stress disorder or traumatic brain injury. Therefore, in military veterans, these hypothesized biologic pathways going from depression to dementia are more than likely influenced by trauma-related processes. Treatment strategies for depression, posttraumatic stress disorder, or traumatic brain injury could alter these pathways and as a result decrease the risk for dementia. Given the projected increase of dementia, as well as the projected increase in the older segment of the veteran population, in the future, it is critically important that we understand whether treatment for depression alone or combined with other regimens improves cognition. In this review, we summarize the principal mechanisms of this relationship and discuss treatment implications in military veterans. (C) 2014 The Alzheimer's Association. All rights reserved.	[Byers, Amy L.; Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; [Byers, Amy L.; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Byers, AL (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA.	Amy.Byers@ucsf.edu			United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	Publication of this article was supported by the United States Army Medical Research and Materiel Command.	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 2006, BIOL PSYCHIAT, V60, P1304, DOI 10.1016/j.biopsych.2006.09.006; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Alexopoulos GS, 2003, J AM GERIATR SOC, V51, P1178, DOI 10.1046/j.1532-5415.2003.51373.x; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Arean PA, 2010, AM J PSYCHIAT, V167, P1391, DOI 10.1176/appi.ajp.2010.09091327; Ballard C, 1996, J AFFECT DISORDERS, V36, P135, DOI 10.1016/0165-0327(95)00072-0; Ballard C, 2000, J AFFECT DISORDERS, V59, P97, DOI 10.1016/S0165-0327(99)00057-9; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Benjamin S, 2010, AM J GERIAT PSYCHIAT, V18, P323, DOI 10.1097/JGP.0b013e3181cabd2b; Bhalla RK, 2006, AM J GERIAT PSYCHIAT, V14, P419, DOI 10.1097/01.JGP.0000203130.45421.69; Bragin Valentin, 2005, Am J Alzheimers Dis Other Demen, V20, P21, DOI 10.1177/153331750502000103; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; Byers AL, 2012, AM J GERIAT PSYCHIAT, V20, P664, DOI 10.1097/JGP.0b013e31822001c1; Camus V, 2004, J AFFECT DISORDERS, V81, P1, DOI 10.1016/j.jad.2003.08.003; Caraci F, 2010, EUR J PHARMACOL, V626, P64, DOI 10.1016/j.ejphar.2009.10.022; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cereseto M, 2006, EUR J NEUROSCI, V24, P3354, DOI 10.1111/j.1460-9568.2006.05232.x; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Cho S, 2007, EXP NEUROL, V203, P274, DOI 10.1016/j.expneurol.2006.07.021; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Colla M, 2007, J PSYCHIATR RES, V41, P553, DOI 10.1016/j.jpsychires.2006.06.011; Corrada MM, 2008, NEUROLOGY, V71, P337, DOI 10.1212/01.wnl.0000310773.65918.cd; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2005, NEUROCHEM RES, V30, P877, DOI 10.1007/s11064-005-6960-y; de Groot JC, 2000, ARCH GEN PSYCHIAT, V57, P1071, DOI 10.1001/archpsyc.57.11.1071; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Devanand DP, 2003, INT J GERIATR PSYCH, V18, P123, DOI 10.1002/gps.802; Doraiswamy PM, 2003, J GERONTOL A-BIOL, V58, P1137, DOI 10.1093/gerona/58.12.M1137; Flicker L, 2008, CURR OPIN PSYCHIATR, V21, P551, DOI 10.1097/YCO.0b013e32830ef736; Flicker L, 2010, CLIN GERIATR MED, V26, P17, DOI 10.1016/j.cger.2009.12.005; Fumagalli F, 2008, CNS DRUGS, V22, P1005, DOI 10.2165/0023210-200822120-00004; Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hashioka Sadayuki, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P12; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Herrera-Guzman I, 2009, J PSYCHIATR RES, V43, P855, DOI 10.1016/j.jpsychires.2008.10.015; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jessen F, 2009, PSYCHIAT GENET, V19, P99, DOI 10.1097/YPG.0b013e32832080ce; Johnson ML, 2004, AM J MANAG CARE, V10, P926; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kim JJ, 2006, STRESS, V9, P1, DOI 10.1080/10253890600678004; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Korczyn AD, 2009, J NEUROL SCI, V283, P139, DOI 10.1016/j.jns.2009.02.346; Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Leinonen V, 2010, ANN NEUROL, V68, P446, DOI 10.1002/ana.22100; Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y; Lezoualc'h F, 2007, EXP NEUROL, V205, P325, DOI 10.1016/j.expneurol.2007.02.001; Liebetrau M, 2008, STROKE, V39, P1960, DOI 10.1161/STROKEAHA.107.490797; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Metti AL, 2013, J GERONTOL A-BIOL, V68, P74, DOI 10.1093/gerona/gls093; Morishima-Kawashima M, 2002, J NEUROSCI RES, V70, P392, DOI 10.1002/jnr.10355; Mowla A, 2007, J CLIN PSYCHOPHARM, V27, P67, DOI 10.1097/jcp.0b013e31802e0002; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nebes RD, 2003, J PSYCHIATR RES, V37, P99, DOI 10.1016/S0022-3956(02)00085-7; O'Brien JT, 2004, AM J PSYCHIAT, V161, P2081, DOI 10.1176/appi.ajp.161.11.2081; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Park CR, 2008, LEARN MEMORY, V15, P271, DOI 10.1101/lm.721108; Park JH, 2007, DEMENT GERIATR COGN, V23, P67, DOI 10.1159/000097039; Pelton GH, 2008, INT J GERIATR PSYCH, V23, P670, DOI 10.1002/gps.1958; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Plantinga L, 2013, BRAIN BEHAV IMMUN, V30, P125, DOI 10.1016/j.bbi.2013.01.081; Rao R, 2000, INT J GERIATR PSYCH, V15, P419, DOI 10.1002/(SICI)1099-1166(200005)15:5<419::AID-GPS140>3.0.CO;2-9; Rapp MA, 2006, ARCH GEN PSYCHIAT, V63, P161, DOI 10.1001/archpsyc.63.2.161; Rapp MA, 2008, AM J GERIAT PSYCHIAT, V16, P168, DOI 10.1097/JGP.0b013e31816029ec; RICHLIE DG, 1991, ARCH INTERN MED, V151, P1433, DOI 10.1001/archinte.151.7.1433; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 2008, AM J PSYCHIAT, V165, P524, DOI 10.1176/appi.ajp.2007.07010175; Sierksma ASR, 2010, EUR J PHARMACOL, V626, P72, DOI 10.1016/j.ejphar.2009.10.021; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Steffens DC, 2008, PSYCHOL MED, V38, P163, DOI 10.1017/S003329170700102X; Steffens DC, 2011, AM J GERIAT PSYCHIAT, V19, P4, DOI 10.1097/JGP.0b013e3181d6c245; Steffens DC, 2002, STROKE, V33, P1636, DOI 10.1161/01.STR.0000018405.59799.D5; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P62, DOI 10.1176/appi.ajgp.10.1.62; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Sun XY, 2008, ARCH GEN PSYCHIAT, V65, P542, DOI 10.1001/archpsyc.65.5.542; Svenningsson P, 2014, MOL PSYCHIAT; Svenningsson P, 2013, NAT REV NEUROSCI, V14, P673, DOI 10.1038/nrn3564; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Teodorczuk A, 2007, BRIT J PSYCHIAT, V191, P212, DOI 10.1192/bjp.bp.107.036756; Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x; Thomas AJ, 2002, ANN NY ACAD SCI, V977, P333, DOI 10.1111/j.1749-6632.2002.tb04835.x; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; van de Pol LA, 2006, NEUROLOGY, V66, P236, DOI 10.1212/01.wnl.0000194240.47892.4d; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Wolkowitz OM, 2009, ANN NY ACAD SCI, V1179, P19, DOI 10.1111/j.1749-6632.2009.04980.x; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yaffe K, 2011, ARCH NEUROL-CHICAGO, V68, P631, DOI 10.1001/archneurol.2011.82	114	15	16	1	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUN	2014	10	3		1			S166	S173		10.1016/j.jalz.2014.04.007			8	Clinical Neurology	Neurosciences & Neurology	CP8GM	WOS:000360130700011	24924668	Other Gold			2021-06-18	
J	Corrigan, JD; Kreider, S; Cuthbert, J; Whyte, J; Dams-O'Connor, K; Faul, M; Harrison-Felix, C; Whiteneck, G; Pretz, CR				Corrigan, John D.; Kreider, Scott; Cuthbert, Jeffrey; Whyte, John; Dams-O'Connor, Kristen; Faul, Mark; Harrison-Felix, Cynthia; Whiteneck, Gale; Pretz, Christopher R.			Components of Traumatic Brain Injury Severity Indices	JOURNAL OF NEUROTRAUMA			English	Article						AIS; Barell matrix; craniocerebral trauma; GCS; MCA; TBI	GLASGOW COMA SCALE; PROGNOSTIC VALUE; MOTOR SCORE; PREDICTION; DIAGNOSIS	The purpose of this study was to determine whether there are underlying dimensions common among traditional traumatic brain injury (TBI) severity indices and, if so, the extent to which they are interchangeable when predicting short-term outcomes. This study had an observational design, and took place in United States trauma centers reporting to the National Trauma Data Bank (NTDB). The sample consisted of 77,470 unweighted adult cases reported to the NTDB from 2007 to 2010, with International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) TBI codes. There were no interventions. Severity indices used were the Emergency Department Glasgow Coma Scale (GCS) Total score and each of the subscales for eye opening (four levels), verbal response (five levels), and motor response (six levels); the worst Abbreviated Injury Scale (AIS) severity score for the head (six levels); and the worst Barell index type (three categories). Prediction models were computed for acute care length of stay (days), intensive care unit length of stay (days), hospital discharge status (alive or dead), and, if alive, discharge disposition (home versus institutional). Multiple correspondence analysis (MCA) indicated a two dimensional relationship among items of severity indexes. The primary dimension reflected overall injury severity. The second dimension seemed to capture volitional behavior without the capability for cogent responding. Together, they defined two vectors around which most of the items clustered. A scale that took advantage of the order of items along these vectors proved to be the most consistent index for predicting short-term health outcomes. MCA provided useful insight into the relationships among components of traditional TBI severity indices. The two vector pattern may reflect the impact of injury on different cortical and subcortical networks. Results are discussed in terms of score substitution and the ability to impute missing values.	[Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Kreider, Scott; Cuthbert, Jeffrey; Harrison-Felix, Cynthia; Whiteneck, Gale; Pretz, Christopher R.] Craig Hosp, Res Dept, Englewood, CO USA; [Dams-O'Connor, Kristen] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Faul, Mark] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA	Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu		Faul, Mark/0000-0002-7683-0348; Whyte, John/0000-0002-4381-1474	Intramural CDC HHS [CC999999] Funding Source: Medline		American College of Surgeons, NAT TRAUM DAT BANK N; *ASS ADV AUT MED, 1990, ABBR INJ SCAL; Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Centers for Disease Control and Prevention, 2014, DOD VA COMM DEF TBI; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; *COMM MED ASP AUT, 1971, JAMA-J AM MED ASSOC, V215, P277; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Oliveira Thais M. E., 2012, J NEUROPSYCHOL, V8, P125; Faul M, 2012, PREHOSP EMERG CARE, V16, P222, DOI 10.3109/10903127.2011.615013; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Greenacre M., 2006, MULTIPLE CORRES ANAL, V2nd ed., P680; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Kung WM, 2011, INJURY, V42, P940, DOI 10.1016/j.injury.2010.09.019; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; MACKENZIE E, 1997, ICDMAP 90 SOFTWARE U; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marr AL., 2004, CENTRAL NERVOUS SYST; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; TEASDALE G, 1974, LANCET, V2, P81; United States Department of Health and Human Services Centers for Disease Control and Prevention and the Centers for Medicare and Medicaid Services, 2005, INT CLASS DIS; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	28	15	15	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2014	31	11					1000	1007		10.1089/neu.2013.3145			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AJ7RS	WOS:000337895300002	24521197	Green Accepted			2021-06-18	
J	Dalsgaard, S; Leckman, JF; Nielsen, HS; Simonsen, M				Dalsgaard, Soren; Leckman, James F.; Nielsen, Helena Skyt; Simonsen, Marianne			Gender and Injuries Predict Stimulant Medication Use	JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; CHILDHOOD BEHAVIOR DISORDERS; TRAUMATIC BRAIN-INJURY; UNINTENTIONAL INJURY; INCREASED RISK; DRUG-USE; CHILDREN; PREVALENCE; ADOLESCENTS	Objective: The purpose of this article was to examine whether injuries in early childhood and gender predict prescriptions of stimulant medication in three groups of children: With attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and other psychiatric disorders (OPD). Methods: This was a population-based study with prospective and complete follow-up of children with ADHD (n=11,553), ASD (n=9698), and OPD (n=48,468), of whom 61%, 16%, and 3%, respectively, were treated with stimulants. For all 69,719 individual children data on psychiatric diagnoses, injuries, and drug prescriptions were obtained from national registers and merged. Results: Having sustained an injury before 5 years of age increased the likelihood of later stimulant treatment, in children with ADHD (odds ratio [OR]=1.09; 95% confidence interval [CI]=1.01-1.21), ASD (OR=1.19; 95% CI=1.02-1.40), and OPD (OR=1.24; 95% CI=1.08-1.42), with each injury increasing the likelihood by 3%, 10%, and 7%, respectively. Head injury did not increase the likelihood of later stimulant treatment. Within each of the three groups, ADHD, ASD, and OPD boys were more likely than girls to receive stimulant medication, OR=1.17 (95% CI=1.07-1.28); OR=1.71 (95% CI=1.47-2.01), and OR=2.41 (95% CI=2.16-2.71), respectively. Conclusions: To our knowledge, this is the first prospective study assessing early life predictors of later ADHD medication in children with a psychiatric disorder, taken from a national cohort with complete follow-up of all cases. We found that the number of injuries prior to diagnosis was associated with initiation of stimulant treatment in all three groups of patients. In addition, male gender predicted treatment with ADHD medications. Our results suggest that the number of injuries early in life prior to diagnosis is associated with stimulant treatment, and may serve as a proxy for the level of later severity of ADHD symptoms, as it is universally associated with pharmacological treatment for ADHD.	[Dalsgaard, Soren] Aarhus Univ, Dept Econ & Business, Natl Ctr Register Based Res, DK-8210 Aarhus V, Denmark; [Dalsgaard, Soren] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Dalsgaard, Soren] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Copenhagen, Denmark; [Dalsgaard, Soren] Hosp Telemark, Dept Child & Adolescent Psychiat, Kragero, Norway; [Leckman, James F.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Nielsen, Helena Skyt; Simonsen, Marianne] Aarhus Univ, Sch Business & Social Sci, Deparment Econ & Business, DK-8210 Aarhus V, Denmark	Dalsgaard, S (corresponding author), Aarhus Univ, Natl Ctr Register Ased Res, Fuglesangs Alle 4,Bldg K, DK-8210 Aarhus V, Denmark.	sdalsgaard@ncrr.dk	Leckman, James/O-2426-2015; Dalsgaard, Soren/I-4595-2013; Dalsgaard, Soren/AAA-4475-2020	Dalsgaard, Soren/0000-0003-4659-0969; Dalsgaard, Soren/0000-0003-4659-0969; Leckman, James/0000-0002-3902-4478; Nielsen, Helena/0000-0003-2577-4734; Simonsen, Marianne/0000-0003-3376-865X	Lundbeck FoundationLundbeckfonden; Danish Council for Independent ResearchDet Frie Forskningsrad (DFF) [10-079597]; Slagtermester Max Worzner and Inger Worzners Foundation; Lundbeck FoundationLundbeckfonden [R155-2014-1724] Funding Source: researchfish	The study was funded by grants from the Lundbeck Foundation, the Danish Council for Independent Research (Sapere Aude Starting Grant, 10-079597) and Slagtermester Max Worzner and Inger Worzners Foundation.	Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266; Andersen TF, 1999, DAN MED BULL, V46, P263; Brault MC, 2012, CAN J PSYCHIAT, V57, P93, DOI 10.1177/070674371205700206; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Bruce B, 2007, PAED CHILD HEALT-CAN, V12, P749, DOI 10.1093/pch/12.9.749; Bruckner TA, 2012, PHARMACOEPIDEM DR S, V21, P442, DOI 10.1002/pds.2264; Byrne JM, 2003, CHILD NEUROPSYCHOL, V9, P142, DOI 10.1076/chin.9.2.142.14501; Castle Lon, 2007, J Atten Disord, V10, P335, DOI 10.1177/1087054707299597; Chen CY, 2011, J CHILD ADOL PSYCHOP, V21, P265, DOI 10.1089/cap.2010.0107; Cox ER, 2003, PEDIATRICS, V111, P237, DOI 10.1542/peds.111.2.237; Dalsgaard S, 2002, BRIT J PSYCHIAT, V181, P416, DOI 10.1192/bjp.181.5.416; Dalsgaard S, 2013, J CHILD ADOL PSYCHOP, V23, P432, DOI 10.1089/cap.2012.0111; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; FARMER JE, 1995, HEALTH PSYCHOL, V14, P325, DOI 10.1037/0278-6133.14.4.325; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Hodgkins P, 2011, CLIN THER, V33, P188, DOI 10.1016/j.clinthera.2011.03.001; Hurtig T, 2013, J ATTEN DISORD; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Lang HC, 2010, HEALTH POLICY, V97, P71, DOI 10.1016/j.healthpol.2010.03.005; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Linnet KM, 2009, ACTA PAEDIATR, V98, P173, DOI 10.1111/j.1651-2227.2008.00980.x; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Maxson RT, 2009, J PEDIATR SURG, V44, P743, DOI 10.1016/j.jpedsurg.2008.08.003; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Miller AR, 2004, AMBUL PEDIATR, V4, P174, DOI 10.1367/A03-031R1.1; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Novik TS, 2006, EUR CHILD ADOLES PSY, V15, P15, DOI 10.1007/s00787-006-1003-z; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pottegard A, 2012, EUR J CLIN PHARMACOL, V68, P1443, DOI 10.1007/s00228-012-1265-y; Romano E, 2009, J PEDIATR-US, V155, P721, DOI 10.1016/j.jpeds.2009.05.028; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Rucklidge JJ, 2001, J AM ACAD CHILD PSY, V40, P530, DOI 10.1097/00004583-200105000-00012; Rucklidge JJ, 2010, PSYCHIAT CLIN N AM, V33, P357, DOI 10.1016/j.psc.2010.01.006; SAS Institute Inc, 2000, SAS REL 9 2; Schwartz A, 2013, NEW YORK TIMES  0331; Sclar DA, 2012, CLIN PEDIATR, V51, P584, DOI 10.1177/0009922812439621; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Thapar A, 2012, ARCH DIS CHILD, V97, P260, DOI 10.1136/archdischild-2011-300482; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; van den Ban E, 2014, EUR CHILD ADOLES PSY, V23, P95, DOI 10.1007/s00787-013-0432-8; Witwer A, 2005, J CHILD ADOL PSYCHOP, V15, P671, DOI 10.1089/cap.2005.15.671; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Xiang HY, 2005, AM J PUBLIC HEALTH, V95, P1970, DOI 10.2105/AJPH.2004.057505; Zetterqvist J, 2013, ACTA PSYCHIAT SCAND, V128, P70, DOI 10.1111/acps.12004; Zito JM, 1999, ARCH PEDIAT ADOL MED, V153, P1257, DOI 10.1001/archpedi.153.12.1257; Zuvekas SH, 2006, AM J PSYCHIAT, V163, P579, DOI 10.1176/appi.ajp.163.4.579	50	15	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1044-5463	1557-8992		J CHILD ADOL PSYCHOP	J. Child Adolesc. Psychopharmacol.	JUN	2014	24	5					253	259		10.1089/cap.2013.0101			7	Pediatrics; Pharmacology & Pharmacy; Psychiatry	Pediatrics; Pharmacology & Pharmacy; Psychiatry	AJ9EP	WOS:000338010400004	24813570	Green Published			2021-06-18	
J	Mandaville, A; Ray, A; Robertson, H; Foster, C; Jesser, C				Mandaville, Amy; Ray, Anjea; Robertson, Henry; Foster, Careen; Jesser, Christine			A Retrospective Review of Swallow Dysfunction in Patients with Severe Traumatic Brain Injury	DYSPHAGIA			English	Article						Deglutition; Deglutition disorders; Clinical prediction model; Long-term dysphagia; Severe traumatic brain injury; Percutaneous gastrostomy tube	PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; HEAD TRAUMA; DYSPHAGIA; TRACHEOSTOMY; DISORDERS; COMPLICATIONS; MANAGEMENT; RECOVERY; STROKE	In the acute-care setting, it is difficult for clinicians to determine which patients with severe traumatic brain injury will have long-term oropharyngeal dysphagia (> 6 weeks) and which patients will begin oral nutrition quickly. Patients frequently remain in the acute-care setting while physicians determine whether to place a percutaneous endoscopic gastrostomy (PEG) tube. To improve the acute-care clinician's ability to predict long-term oropharyngeal dysphagia and subsequent need for PEG tube placement in patients with severe traumatic brain injury [Glascow Coma Scale (GCS) a parts per thousand currency sign8), a novel prediction model was created utilizing clinical information and acute-care swallowing evaluation findings. Five years of retrospective data were obtained from trauma patients at a Level 1 trauma hospital. Of the 375 patients who survived their hospitalization with a GCS a parts per thousand currency sign8, a total of 269 patients received Ranchos Los Amigos (RLA) scores. Of those patients who were scored for RLA, 219 patients underwent swallowing evaluation. Ninety-six of the 219 patients were discharged from the hospital with a feeding tube, and 123 patients were discharged without one. Logistic regression models examined the association between clinical and patient characteristics and whether a patient with severe traumatic brain injury exhibited long-term oropharyngeal dysphagia. Multivariable logistic regression analysis revealed that increased age, low RLA score, tracheostomy tube placement, and aphonia observed on the initial swallowing evaluation significantly increased the odds of being discharged from the acute-care hospital with a feeding tube. The resultant model could be used clinically to guide decision making and to counsel patients and families.	[Mandaville, Amy; Ray, Anjea] Univ Med Ctr Brackenridge, Austin, TX 78701 USA; [Robertson, Henry; Jesser, Christine] Seton Family Hosp Analyt & Hlth Econ, Austin, TX 78723 USA; [Foster, Careen] Trauma Trust, Tacoma, WA 98405 USA	Mandaville, A (corresponding author), Univ Med Ctr Brackenridge, 601 E 15th St, Austin, TX 78701 USA.	amandaville@seton.org; aeray@seton.org; htrobertson@seton.org; cajesser@seton.org					Brain Injury Association of America, 2006, ESS BRAIN INJ GUID; Ciaglia P, 1993, J Trauma, V34, P916; DAMELIO LF, 1994, AM SURGEON, V60, P180; Gomes CAR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008096.pub2; Gurkin MA, 2002, AM SURGEON, V68, P324; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; Hill K, 2008, INT J STROKE, V3, P120, DOI 10.1111/j.1747-4949.2008.00189.x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jorgensen HS, 1999, STROKE, V30, P2008, DOI 10.1161/01.STR.30.10.2008; Jung SJ, 2012, ANN REHABIL MED-ARM, V36, P356, DOI 10.5535/arm.2012.36.3.356; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Linden P., 1993, Dysphagia, V8, P170, DOI 10.1007/BF01354535; Lockett MA, 2002, AM SURGEON, V68, P117; LOGEMANN JA, 1995, J SPEECH HEAR RES, V38, P556, DOI 10.1044/jshr.3803.556; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; MOORE FA, 1992, J TRAUMA, V33, P435, DOI 10.1097/00005373-199209000-00017; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nicholson FB, 2000, J GASTROEN HEPATOL, V15, P21, DOI 10.1046/j.1440-1746.2000.02004.x; Robbins J, 1988, Dysphagia, V3, P11, DOI 10.1007/BF02406275; Schroeder MF, 2006, J REHABIL RES DEV, V43, P301, DOI 10.1682/JRRD.2004.12.0154; Shaker R, 2002, GASTROENTEROLOGY, V122, P1314, DOI 10.1053/gast.2002.32999; VAUGHAN JR, 1991, AM SURGEON, V57, P214; VEIS SL, 1985, ARCH PHYS MED REHAB, V66, P372; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	28	15	18	0	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	JUN	2014	29	3					310	318		10.1007/s00455-013-9509-2			9	Otorhinolaryngology	Otorhinolaryngology	AK2DY	WOS:000338230500003	24414375				2021-06-18	
J	Ulutabanca, H; Hatipoglu, N; Tanriverdi, F; Gokoglu, A; Keskin, M; Selcuklu, A; Kurtoglu, S; Kelestimur, F				Ulutabanca, Halil; Hatipoglu, Nihal; Tanriverdi, Fatih; Gokoglu, Abdulkerim; Keskin, Mehmet; Selcuklu, Ahmet; Kurtoglu, Selim; Kelestimur, Fahrettin			Prospective investigation of anterior pituitary function in the acute phase and 12 months after pediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Pituitary function; Traumatic brain injury; Children	GROWTH-HORMONE DEFICIENCY; HEAD TRAUMA; SUBARACHNOID HEMORRHAGE; ILL PATIENTS; LONG-TERM; HIGH-RISK; FACTOR-I; CHILDREN; HYPOPITUITARISM; DYSFUNCTION	Although head trauma is common in childhood, there is no enough prospective study investigating both acute phase and 12 months after injury. Therefore, a prospective clinical trial was planned to evaluate the pituitary function in childhood in the acute and chronic phase after traumatic brain injury (TBI). Forty-one children (27 boys and 14 girls, mean age 7 +/- 4.3), who were admitted to neurosurgery intensive care unit due to head trauma, were included. Twenty-one (51.2 %) patients had mild, 10 (24.4 %) had moderate, and 10 (24.4 %) had severe TBI. Twenty-two of them were reevaluated 12 months after TBI. Basal pituitary hormone levels were measured during acute (first 24 h) and chronic phase of TBI. Additionally, in the chronic phase, GHRH-arginine test was used for the diagnosis of growth hormone (GH) deficiency. In the acute phase, 10 patients (24.4 %) had ACTH deficiency, and the overall 44.3 % of patients had at least one pituitary hormone dysfunction. All the pituitary hormone deficiencies during the acute phase were recovered after 12 months. Two patients (9.1 %) had new-onset GH deficiency in the chronic phase, and in one of them, ACTH deficiency was also present. Present prospective data clearly demonstrated that most of the hormonal changes in the early acute phase were transient, suggesting an adaptive response, and these changes did not predict the hormone deficiencies after 1 year. In the chronic phase, although GH deficiency was present, the frequency of TBI-induced hypopituitarism was clearly lower than the adult patients.	[Ulutabanca, Halil; Gokoglu, Abdulkerim; Selcuklu, Ahmet] Erciyes Univ, Sch Med, Dept Neurosurg, TR-38039 Kayseri, Turkey; [Hatipoglu, Nihal; Kurtoglu, Selim] Erciyes Univ, Sch Med, Dept Pediat Endocrinol, TR-38039 Kayseri, Turkey; [Tanriverdi, Fatih; Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Keskin, Mehmet] Gaziantep Univ, Sch Med, Dept Pediat Endocrinol, Kayseri, Turkey	Hatipoglu, N (corresponding author), Erciyes Univ, Sch Med, Dept Pediat Endocrinol, TR-38039 Kayseri, Turkey.	nihalhatipoglu@yahoo.com	Hatipoglu, Nihal/AAW-1933-2020	Hatipoglu, Nihal/0000-0002-0991-6539			Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Altunay C, 2011, J CLIN RES PEDIATR E, V3, P184, DOI 10.4274/jcrpe.452; [Anonymous], 2000, EXP VAL 6 SI UN CONV; BANG P, 1994, J ENDOCRINOL, V143, pC1; Bardoni A, 2013, BRAIN INJURY, V27, P1395, DOI 10.3109/02699052.2013.823652; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Capalbo D, 2012, MINERVA ENDOCRINOL, V37, P379; Casano-Sancho P, 2013, CLIN ENDOCRINOL, V79, P853, DOI 10.1111/cen.12237; Casanueva FF, 2007, HORM RES, V67, P208, DOI 10.1159/000097584; CHIOLERO RL, 1988, ACTA ENDOCRINOL-COP, V117, P80, DOI 10.1530/acta.0.1170080; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; EIHOLZER U, 1986, EUR J PEDIATR, V145, P128, DOI 10.1007/BF00441873; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Einaudi S, 2007, CURR OPIN PEDIATR, V19, P465, DOI 10.1097/MOP.0b013e3281ab6eeb; Ekbote VH, 2012, J PEDIATR ENDOCR MET, V25, P969, DOI 10.1515/jpem-2012-0177; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Gonzalez H, 2006, CRIT CARE CLIN, V22, P105, DOI 10.1016/j.ccc.2005.09.001; Hadziselimovic F, 2005, J UROLOGY, V174, P1536, DOI 10.1097/01.ju.0000181506.97839.b0; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Hatipoglu Nihal, 2009, J Clin Res Pediatr Endocrinol, V1, P129, DOI 10.4008/jcrpe.v1i3.47; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Kaiserman KB, 1998, J PEDIATR-US, V133, P300, DOI 10.1016/S0022-3476(98)70242-2; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Lamberts SWJ, 1998, LANCET, V352, P127; LEE PDK, 1990, PEDIATR RES, V27, P45, DOI 10.1203/00006450-199001000-00015; Masson F, 1996, ARCH PEDIATRIE, V3, P651, DOI 10.1016/0929-693X(96)87085-0; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Radovic S, 2003, PEDIAT ENDOCRINOLOGY; Rahim A, 1996, CLIN ENDOCRINOL, V45, P557; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; ROSS R, 1991, CLIN ENDOCRINOL, V35, P47, DOI 10.1111/j.1365-2265.1991.tb03495.x; Schmidt H, 2000, EUR J ENDOCRINOL, V143, P213, DOI 10.1530/eje.0.1430213; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Seoane LM, 2006, J ENDOCRINOL INVEST, V29, DOI 10.1007/BF03344190; Sizonenko PC, 2001, GROWTH HORM IGF RES, V11, P137, DOI 10.1054/ghir.2001.0203; Sockalosky SH, 1987, J PEDIAT, V3, P373; Srinivas R, 2010, CHILD NERV SYST, V26, P647, DOI 10.1007/s00381-009-1038-9; Stockigt JR, 1996, CLIN CHEM, V42, P188; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; TEASDALE G, 1974, LANCET, V2, P81; Vahl N, 2000, J CLIN ENDOCR METAB, V85, P1874, DOI 10.1210/jc.85.5.1874; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x; YAMANAKA C, 1993, EUR J PEDIATR, V152, P99, DOI 10.1007/BF02072482; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	69	15	16	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	2014	30	6					1021	1028		10.1007/s00381-013-2334-y			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AH8NZ	WOS:000336396100006	24322605				2021-06-18	
J	Rosema, S; Muscara, F; Anderson, V; Godfrey, C; Eren, S; Catroppa, C				Rosema, Stefanie; Muscara, Frank; Anderson, Vicki; Godfrey, Celia; Eren, Senem; Catroppa, Cathy			Agreement on and Predictors of Long-Term Psychosocial Development 16 Years Post-Childhood Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						predictors; agreement; adulthood; childhood traumatic brain injury; psychosocial outcomes	PSYCHIATRIC-DISORDERS; FUNCTIONAL RECOVERY; BEHAVIOR PROBLEMS; CHILDREN; ADOLESCENTS; HEAD; OUTCOMES; RATINGS; INDIVIDUALS; PATIENT	Childhood traumatic brain injury (CTBI) is one of the most common causes of childhood mortality and morbidity, with psychosocial impairment being among the most debilitating persisting consequences. Child and adolescent survivors of CTBI have fewer friends and lower self-esteem with a higher risk of developing a psychiatric disorder. In most research to date, findings in the psychosocial domain have been based on parent reports, with the child or adolescent only consulted infrequently. If there is a discrepancy identified between parent and child reported symptoms and behaviors, this is generally interpreted as resulting from impaired self-awareness in the child. The aim of this study was to 1) examine the agreement between self- and proxy-reported long-term psychosocial outcomes and 2) investigate the predictors of outcome 16 years post-CTBI. Thirty-three young adults (mean, 21.36 years; standard deviation, 2.75), with a CTBI sustained between 1 and 7 years of age, and a significant other completed questionnaires assessing the young adults' social and psychological functioning. Young adults and their significant other had good-to-excellent agreement on communication as well as alcohol and drug use scales. There was poorer agreement for the overall internalizing symptoms, anxious/depressed, withdrawn, thought, and rule-breaking behaviors. On the scales with poor agreement, there was no consistent contribution identified for any injury or preinjury factors. Preinjury adaptive behavior partly predicted withdrawn and overall internalizing symptoms, with a trend to also partly predict anxious/depressed and rule-breaking behavior reported by the significant other. Because young adults and significant others had poor agreement on the less-overt symptoms, these young adults may be at a higher risk of developing more-severe symptoms or disorders if it is not identified in time.	[Rosema, Stefanie; Muscara, Frank; Anderson, Vicki; Godfrey, Celia; Eren, Senem; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Muscara, Frank; Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia; [Rosema, Stefanie; Muscara, Frank; Anderson, Vicki; Godfrey, Celia; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic, Australia	Rosema, S (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Child Neuropsychol, 4th Floor West,Flemington Rd, Parkville, Vic 3053, Australia.	stefanie.rosema@mcri.edu.au			Victorian Neurotrauma Institute; Murdoch Childrens Research Institute Critical Care and Neuroscience Theme; Victorian Government's Operational Infrastructure Scheme	This work was funded through research grants awarded by the Victorian Neurotrauma Institute and the Murdoch Childrens Research Institute Critical Care and Neuroscience Theme and supported by the Victorian Government's Operational Infrastructure Scheme.	Achenbach T. M., 2003, MANUAL ASEBA ADULT F; Anderson V., 2012, DEV SOCIAL NEUROSCIE, P3; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Crowe LM, 2011, CLIN PSYCHOL REV, V31, P767, DOI 10.1016/j.cpr.2011.03.008; Crowe LM, 2012, INJURY, V43, P2141, DOI 10.1016/j.injury.2012.07.195; Daniel A. E., 1983, POWER PRIVILEGE PRES; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hellawell DJ, 2000, DISABIL REHABIL, V22, P446, DOI 10.1080/09638280050045910; IBM Corp, 2011, IBM SPSS Statistics for Windows, Version 20.0; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kurtz JE, 2006, CLIN NEUROPSYCHOL, V20, P453, DOI 10.1080/13854040590967090; Lachar D, 1992, PERSONALITY INVENTOR; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Leadbeater BJ, 1999, DEV PSYCHOL, V35, P1268, DOI 10.1037/0012-1649.35.5.1268; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Sparrow S., 1984, VINELAND ADAPTIVE BE; TEASDALE G, 1974, LANCET, V2, P81; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	35	15	15	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2014	31	10					899	905		10.1089/neu.2013.3226			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AH1ES	WOS:000335863200002	24417184				2021-06-18	
J	Cartagena, CM; Phillips, KL; Tortella, FC; Dave, JR; Schmid, KE				Cartagena, Casandra M.; Phillips, Katie L.; Tortella, Frank C.; Dave, Jitendra R.; Schmid, Kara E.			Temporal alterations in aquaporin and transcription factor HIF1 alpha et expression following penetrating ballistic-like brain injury (PBBI)	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Penetrating brain injury; PBBI; Edema; Aquaporins	EDEMA FORMATION; WATER CHANNELS; RAT-BRAIN; BLOOD; MODEL; MECHANISMS; HEMORRHAGE; CELLS; HIF-1; FLUID	Objectives: Brain edema is a primary factor in the morbidity and mortality of traumatic brain injury (TBI). The various isoforms of aquaporin 4 (AQP4) and aquaporin 9 (AQP9) are important factors influencing edema following TBI. Others have reported that these AQPs are regulated by the transcription factor hypoxia inducible factor (HIF)1 alpha. Therefore, we examined the temporal alterations in the multiple isoforms of AQP4 and AQP9, and its possible upstream regulation by HIF1 alpha, and evaluated whether different severities of penetrating injury influence these mechanisms. Methods: In the penetrating ballistic-like brain injury (PBBI) model, a temporary cavity and resultant injury was formed by the rapid inflation/deflation (i.e. <40 ms) of an elastic balloon attached to the end of the custom probe, injuring 10% of total rat brain volume. Tissue from the ipsilateral core and perilesional injury zones was collected. Total RNA was isolated at 4, 12, and 24 h, 3 and 7 days post-injury (sham and PBBI, n = 6 per group). cDNA was synthesized using oligodT primers. Quantitative real time PCR was performed using Taqman expression assays for aqp4 (recognizing all isoforms), aqp9, and hif1 alpha. Using separate animals, tissue lysate was collected at 4 and 24 h, 3 and 7 days post-injury and analyzed by immunoblot for protein expression of multiple isoforms of AQP4, the single known isoform of AQP9 and for expression of transcription factor HIF1 alpha (sham, probe only control, and PBBI, n = 8-10 per group). Results: Global aqp4 mRNA was decreased at 24 h (p < 0.01) with PBBI. Three of the four known protein isoforms of AQP4 were detected, M1 (34 kDa), M23 (32 kDa) and isoform 3 (30 kDa). AQP4 M1 decreased at 3 and 7 days post-injury (p < 0.001; p < 0.01). AQP4 M23 levels were highly variable with no significant changes. AQP4 isoform 3 levels were decreased 3 days post-PBBI (p < 0.05). From 4, 12, and 24 h aqp9 mRNA levels were decreased with injury (p < 0.01, p < 0.05, p < 0.01) while AQP9 levels were decreased at 3 and 7 days after PBBI (p < 0.001, p < 0.01). At 12 and 24 h post-PBBI hif1 alpha mRNA levels increased (p < 0.05, p < 0.01) but at 3 and 7 days mRNA levels decreased (p < 0.05, p < 0.01). From 24 h and 3 and 7 days HIF1 alpha protein levels were decreased (p < 0.0001, p < 0.0001, p < 0.0001). In comparison to probe control, PBBI led to greater decreases in protein for AQP4 M1 (trend), AQP4 isoform 3 (trend), AQP9 (p < 0.05) and HIFI (p < 0.05). Conclusion: PBBI is characterized by a loss of AQP4 Ml, AQP4 isoform 3 and AQP9 at delayed time-points. The severity of the injury (PBBI versus probe control) increased these effects. Therefore, AQP9 and the AQP4 M1 isoform may be regulated by HIF1 alpha, but not AQP4 isoform 3. This delayed loss of aquaporins may markedly reduce the ability of the brain to efflux water, contributing to the protracted edema that is a characteristic following severe penetrating TBI. Factors contributing to edema differ with different types and severities of TBI. For example, cellular based edema is more prominent in diffuse non-penetrating TBI whereas vasogenic edema is more prevalent with TBI involving hemorrhage. Molecular regulation leading to edema will likely also differ, such that treatments which have been suggested for non-hemorrhagic moderate TBI, such as the suppression of aquaporins, may be detrimental in more severe forms of TBI. Published by Elsevier Inc.	[Cartagena, Casandra M.; Phillips, Katie L.; Tortella, Frank C.; Dave, Jitendra R.; Schmid, Kara E.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA	Cartagena, CM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA.	casandra.m.cartagena.civ@mail.mil; katie.phillips1@us.army.mil; frank.c.tortella.civ@mail.mil; jitendra.r.dave.civ@mail.mil; kara.e.schmid.mil@mail.mil					Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mosbasheri A, 2004, AM J PHYSIOL-CELL PH, V286, pC529, DOI 10.1152/ajpcell.00408.2003; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022	26	15	15	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	MAY	2014	60						81	87		10.1016/j.mcn.2014.04.005			7	Neurosciences	Neurosciences & Neurology	AI5DX	WOS:000336886700009	24769105				2021-06-18	
J	Khosravizadeh, Z; Razavi, S; Bahramian, H; Kazemi, M				Khosravizadeh, Zahra; Razavi, Shahnaz; Bahramian, Hamid; Kazemi, Mohammad			The beneficial effect of encapsulated human adipose-derived stem cells in alginate hydrogel on neural differentiation	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						tissue engineering; proliferation; neural differentiation; human adipose-derived stem cells; alginate hydrogel	SPINAL-CORD; TISSUE; TRANSPLANTATION; CHONDROCYTES; SCAFFOLD; CULTURE	Tissue engineering employs combination of biomaterials and cell therapy to develop new therapeutic strategies for neurodegenerative diseases, spinal cord, and traumatic brain injuries. Alginate is a biocompatible hydrogel, which has been used broadly to encapsulate many types of cells. Human adipose-derived stem cells (hADSCs) have appropriate property to differentiate into neuron-like cells. Therefore, the aim of this study was to evaluate the effect of alginate hydrogel on the viability and neural differentiation potential of induced hADSCs. After neural induction of isolated hADSCs and encapsulated in alginate hydrogel, the cell viability using MTT assay and their neural differentiation potential by immunocytochemical and real time RT-PCR analysis for neural markers (Nestin, GFAP, and MAP2) were evaluated. Expression of Nestin, GFAP, and MAP2 markers was significantly increased compare to monolayer induced cells (p < 0.001), but we did not found any significant effect on viability of induced cells relative to monolayer induced cells. Although neural differentiation of encapsulated cells was increased relative to monolayer induced cells, the viability of these cells was not significantly different in alginate hydrogel as compared with monolayer induced cells. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 749-755, 2014.	[Khosravizadeh, Zahra; Razavi, Shahnaz; Bahramian, Hamid; Kazemi, Mohammad] Isfahan Univ Med Sci, Sch Med, Dept Anat Sci & Mol Biol, Esfahan 81744176, Iran	Razavi, S (corresponding author), Isfahan Univ Med Sci, Sch Med, Dept Anat Sci & Mol Biol, Esfahan 81744176, Iran.	razavi@med.mui.ac.ir	kazemi, mohammad/E-6492-2012; Razavi, Shahnaz/I-7599-2019	kazemi, mohammad/0000-0002-6794-6891; Razavi, Shahnaz/0000-0003-1726-9324; bahramian, hamid/0000-0003-2282-840X	Isfahan University of Medical Sciences	This research was supported by Isfahan University of Medical Sciences.	Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111; Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501; Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334; Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007; Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca; Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003; Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217; Carlson KB, 2011, GLIA, V59, P267, DOI 10.1002/glia.21099; Chayosumrit M, 2010, BIOMATERIALS, V31, P505, DOI 10.1016/j.biomaterials.2009.09.071; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Chernousov MA, 2008, GLIA, V56, P1498, DOI 10.1002/glia.20740; Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt228; Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606; Huang TT, 2007, J SPINAL CORD MED, V30, pS35, DOI 10.1080/10790268.2007.11753967; Hunt NC, 2010, ACTA BIOMATER, V6, P3649, DOI 10.1016/j.actbio.2010.03.026; Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25; Jung DI, 2009, J NEUROL SCI, V285, P67, DOI 10.1016/j.jns.2009.05.027; Kalbermatten DF, 2011, CELL TISSUE RES, V344, P251, DOI 10.1007/s00441-011-1142-5; Kemp MR, 2007, INNOV FOOD SCI EMERG, V8, P143, DOI 10.1016/j.ifset.2006.09.001; Kim MH, 2010, BIOMATERIALS, V31, P1213, DOI 10.1016/j.biomaterials.2009.10.057; Kong HJ, 2003, CELL TRANSPLANT, V12, P779, DOI 10.3727/000000003108747253; Li T, 2007, J BIOMED MATER RES A, V83A, P383, DOI 10.1002/jbm.a.31322; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Matyash M, 2012, TISSUE ENG PT A, V18, P55, DOI [10.1089/ten.tea.2011.0097, 10.1089/ten.TEA.2011.0097]; Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Schipper BM, 2008, ANN PLAS SURG, V60, P538, DOI 10.1097/SAP.0b013e3181723bbe; Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0; Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003; Tsang VL, 2007, ADV BIOCHEM ENG BIOT, V103, P189, DOI 10.1007/10_010; Xie XW, 2011, J HUAZHONG U SCI-MED, V31, P174, DOI 10.1007/s11596-011-0246-1; Yasuda A, 2006, TISSUE ENG, V12, P1237, DOI 10.1089/ten.2006.12.1237; Ying CC, 2012, CELL MOL NEUROBIOL, V32, P1255, DOI 10.1007/s10571-012-9850-2; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	44	15	17	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	MAY	2014	102	4					749	755		10.1002/jbm.b.33055			7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AE8IT	WOS:000334244300012	24142904				2021-06-18	
J	Schriever, VA; Studt, F; Smitka, M; Grosser, K; Hummel, T				Schriever, Valentin A.; Studt, Friederike; Smitka, Martin; Grosser, Kay; Hummel, Thomas			Olfactory Function After Mild Head Injury in Children	CHEMICAL SENSES			English	Article						children; head injury; olfaction	POST-TRAUMATIC ANOSMIA; ODOR DISCRIMINATION; BRAIN-INJURY; DYSFUNCTION; IDENTIFICATION; EPITHELIUM; DISORDERS; SMELL	Olfactory impairment has been shown to be linked to head injury. In addition, it is believed that measurement of olfactory function after head trauma represents a sensitive tool for measuring frontal brain damage. Aim of the study was to evaluate the effect of mild head trauma in children on olfactory function over a time period of up to 1 year after head trauma. The olfactory function of 114 children who suffered mild head trauma according to the Glasgow Coma Scale was assessed 3 times with an interval of 4 months. In addition, healthy, age-matched controls were tested for comparison of olfactory function. Patients scored significantly lower on the odor threshold test compared to the control groupubut still within normal range. Between the 2 groups, no difference was found for suprathreshold testing. Neither olfactory threshold scores nor olfactory discrimination scores changed significantly over the study period of 1 year. This data prove an impact of mild head trauma on olfactory function of children. It seems unlikely that children who suffered mild head trauma will become hyposmic or anosmic.	[Schriever, Valentin A.; Studt, Friederike; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, D-01307 Dresden, Germany; [Smitka, Martin] Tech Univ Dresden, Dept Neuropediat, D-01307 Dresden, Germany; [Grosser, Kay] Helios Clin Erfurt, Dept Pediat Surg, D-99089 Erfurt, Germany	Hummel, T (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Fetscherstr 74, D-01307 Dresden, Germany.	thummel@mail.zih.tu-dresden.de					Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Collet S, 2009, B-ENT, P97; Correia S, 2001, ARCH CLIN NEUROPSYCH, V16, P477, DOI 10.1016/S0887-6177(00)00059-7; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Costanzo RM, 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Delank KW, 1996, LARYNGO RHINO OTOL, V75, P154, DOI 10.1055/s-2007-997554; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Haxel BR, 2005, HNO, V53, P682, DOI 10.1007/s00106-004-1217-7; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2007, BEHAV BRAIN RES, V180, P133, DOI 10.1016/j.bbr.2007.02.040; JACOBI G, 1986, Acta Paediatrica Hungarica, V27, P173; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Loo AT, 1996, INT J DEV NEUROSCI, V14, P881, DOI 10.1016/S0736-5748(96)00046-9; Ogle W, 1870, Med Chir Trans, V53, P263; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Roberts M A, 1996, Appl Neuropsychol, V3, P86, DOI 10.1207/s15324826an0302_7; Roberts Richard J, 2010, Indian J Psychol Med, V32, P93, DOI 10.4103/0253-7176.78504; Sandford AA, 2006, INT J PEDIATR OTORHI, V70, P1015, DOI 10.1016/j.ijporl.2005.10.013; SCHECHTER PJ, 1974, J NEUROL NEUROSUR PS, V37, P802, DOI 10.1136/jnnp.37.7.802; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Suzukawa K, 2011, J COMP NEUROL, V519, P2154, DOI 10.1002/cne.22611; Swann IJ, 2006, EMERG MED J, V23, P618, DOI 10.1136/emj.2005.029017; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Tomii M, 2012, NEUROSURG REV, V35, P555, DOI 10.1007/s10143-012-0378-1; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	33	15	15	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAY	2014	39	4					343	347		10.1093/chemse/bju005			5	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	AF8ZL	WOS:000335004400008	24554732	Green Published			2021-06-18	
J	Greenberg, JK; Stoev, IT; Park, TS; Smyth, MD; Leonard, JR; Leonard, JC; Pineda, JA; Limbrick, DD				Greenberg, Jacob K.; Stoev, Ivan T.; Park, Tae Sung; Smyth, Matthew D.; Leonard, Jeffrey R.; Leonard, Julie C.; Pineda, Jose A.; Limbrick, David D.			Management of children with mild traumatic brain injury and intracranial hemorrhage	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Mild traumatic brain injury; pediatrics; intracranial hemorrhage	HEAD COMPUTED-TOMOGRAPHY; PEDIATRIC-PATIENTS; PROGRESSION; MODERATE; ADMISSION; UTILITY; SCAN	BACKGROUND Traumatic brain injury (TBI) is a significant public health problem affecting tens of thousands of children each year, and an important subset of these patients sustains intracranial hemorrhage (ICH). The purpose of this study was to test the hypothesis that we could identify a subset of children with traumatic ICH who could be monitored on a general neurosurgery ward with a low risk of clinical deterioration. METHODS We performed a retrospective review of pediatric patients 18 years or younger with mild TBI (Glasgow Coma Scale [GCS] score 14-15) and traumatic ICH admitted to Saint Louis Children's Hospital between 2006 and 2011. We excluded patients with injuries unrelated to the TBI that would require intensive care unit (ICU) admission and those with penetrating intracranial injuries. RESULTS We identified 118 patients meeting inclusion criteria. Repeat neuroimaging was obtained in 69 (58%) of 118 patients. Radiologic progression was noted in 6 (8.7%) of 69 patients, with a trend toward more frequent progression in patients with epidural hematoma (EDH) versus other ICH (3 [20%] of 15 vs. 3 [5.6%] of 54; p = 0.11). Of 118 patients, 8 (6.8%) experienced clinically important neurologic decline (CIND) and 6 (5.1%) required neurosurgical intervention. Both CIND and the need for neurosurgical intervention were significantly higher in patients with EDH (21% each) compared with those with other types of ICH (4% and 2%, respectively) (p = 0.02, p < 0.01). Based on these results, we developed a preliminary management framework to assist in determining which patients can be safely observed on a neurosurgery ward without an ICU admission. Specifically, those patients without EDH, intraventricular hemorrhage, coagulopathy, or concern for a high-risk neurosurgical lesion (e.g., arteriovenous malformation) may be safely observed on the ward. CONCLUSIONS These results demonstrate that few children with mild TBI and ICH experience CIND and the preliminary framework we developed assists in identifying which patients can safely avoid ICU admission. This framework should be validated prospectively and externally. LEVEL OF EVIDENCE Therapeutic/care management, level IV.	[Greenberg, Jacob K.; Stoev, Ivan T.; Park, Tae Sung; Smyth, Matthew D.; Leonard, Jeffrey R.; Limbrick, David D.] Washington Univ, Dept Neurol Surg, St Louis, MO USA; [Park, Tae Sung; Smyth, Matthew D.; Leonard, Jeffrey R.; Leonard, Julie C.; Pineda, Jose A.; Limbrick, David D.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA	Greenberg, JK (corresponding author), St Louis Childrens Hosp, 1 ChildrensWay,4S20, St Louis, MO 63110 USA.	greenbergj@wusm.wustl.edu	Pineda, Jose/W-2806-2019	Leonard, Julie/0000-0003-3670-1944	Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000448, TL1 TR000449]; Intellectual and Developmental Disabilities Research Center at Washington University [NIH/NICHD P30 HD062171]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000448, TL1TR000449] Funding Source: NIH RePORTER	This work was supported by the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) under Award Numbers UL1 TR000448 and TL1 TR000449 and by the Intellectual and Developmental Disabilities Research Center at Washington University (NIH/NICHD P30 HD062171).	Agency for Healthcare Research and Quality (AHRQ), 2005, HCUP STAT INP DAT SI; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Dawson EC, 2012, PEDIATR NEUROSURG, V48, P221, DOI 10.1159/000346697; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Healthcare Cost and Utilization Project (HCUP), 2005, COST TO CHARG RAT FI; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Servadei F, 2000, NEUROSURGERY, V46, P70; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; U.S. Department of Labor Bureau of Labor Statistics, CONS PRIC IND INFL C; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167	29	15	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2014	76	4					1089	1095		10.1097/TA.0000000000000155			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AE7FF	WOS:000334161500035	24662876	Green Accepted			2021-06-18	
J	Lee, JJ; Segar, DJ; Asaad, WF				Lee, Jonathan J.; Segar, David J.; Asaad, Wael F.			Comprehensive Assessment of Isolated Traumatic Subarachnoid Hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; subarachnoid hemorrhage; head injury; hospital transfer	MILD HEAD-INJURY; MINIMAL BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; ARTERIAL SPASM; UNITED-STATES; AXONAL INJURY; CT FINDINGS; MANAGEMENT; NIMODIPINE	Recent studies have shown that isolated traumatic subarachnoid hemorrhage (tSAH) in the setting of a high Glasgow Coma Scale (GCS) score (13-15) is a relatively less severe finding not likely to require operative neurosurgical intervention. This study sought to provide a more comprehensive assessment of isolated tSAH among patients with any GCS score, and to expand the analysis to examine the potential need for aggressive medical, endovascular, or open surgical interventions in these patients. By undertaking a retrospective review of all patients admitted to our trauma center from 2003-2012, we identified 661 patients with isolated tSAH. Only four patients (0.61%) underwent any sort of aggressive neurosurgical, medical, or endovascular intervention, regardless of GCS score. Most tSAH patients without additional systemic injury were discharged home (68%), including 53% of patients with a GCS score of 3-8. However, older patients were more likely to be discharged to a rehabilitation facility (p<0.01). There were six (1.7%) in-hospital deaths, and five patients of these patients were older than 80 years old. We conclude that isolated tSAH, regardless of admission GCS score, is a less severe intracranial injury that is highly unlikely to require aggressive operative, medical, or endovascular intervention, and is unlikely to be associated with major neurologic morbidity or mortality, except perhaps in elderly patients. Based upon our findings, we argue that impaired consciousness in the setting of isolated tSAH should strongly compel a consideration of non-traumatic factors in the etiology of the altered neurological status.	[Lee, Jonathan J.; Segar, David J.; Asaad, Wael F.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Asaad, Wael F.] Brown Inst Brain Sci, Providence, RI USA; [Asaad, Wael F.] Rhode Isl Hosp, Dept Neurosurg, Providence, RI 02903 USA; [Asaad, Wael F.] Rhode Isl Hosp, Norman Prince Neurosci Inst, Providence, RI 02903 USA	Asaad, WF (corresponding author), Rhode Isl Hosp, Dept Neurosurg, APC 633,593 Eddy St, Providence, RI 02903 USA.	wael_asaad@brown.edu	Asaad, Wael/I-8485-2012	Asaad, Wael/0000-0003-4406-9096	Department of Neurosurgery; Alpert Medical School of Brown University; Rhode Island Hospital	The authors wish to thank the support of the Department of Neurosurgery, the Alpert Medical School of Brown University and Rhode Island Hospital. All authors participated in designing the study, performing the analyses and writing the manuscript.	Almenawer SA, 2012, NEUROSURGERY, V71, pE561, DOI 10.1227/01.neu.0000417742.32171.86; ARUTIUNOV AI, 1974, J NEUROSURG, V40, P459, DOI 10.3171/jns.1974.40.4.0459; Babu MA, 2011, NEUROSURGERY, V69, P659, DOI 10.1227/NEU.0b013e31821bc667; Beaulieu C, 2000, MAGN RESON MED, V44, P110; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Boesiger BM, 2005, J EMERG MED, V29, P23, DOI 10.1016/j.jemermed.2005.02.002; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Conti A, 2008, ACTA NEUROCHIR, V150, P1197, DOI 10.1007/s00701-008-0141-0; Coronado VG., 2012, BRAIN INJURY MED PRI, P93; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; HUBSCHMANN OR, 1985, J NEUROSURG, V62, P698, DOI 10.3171/jns.1985.62.5.0698; HUBSCHMANN OR, 1980, J NEUROSURG, V52, P456, DOI 10.3171/jns.1980.52.4.0456; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; KIWAK KJ, 1985, J NEUROSURG, V62, P865, DOI 10.3171/jns.1985.62.6.0865; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; Macmillan CSA, 2002, ACTA NEUROCHIR, V144, P853, DOI 10.1007/s00701-002-0966-x; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morais DF, 2008, ARQ NEURO-PSIQUIAT, V66, P53, DOI 10.1590/S0004-282X2008000100013; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Rosner J, 2013, NEUROSURGERY, V60, P98, DOI 10.1227/01.neu.0000430309.86573.2d; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; SHIGEMORI M, 1990, Neurologia Medico-Chirurgica, V30, P396, DOI 10.2176/nmc.30.396; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Tajeu G. S., 2013, J GERONTOL A; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Thomas S, 2000, ACTA NEUROCHIR SUPPL, V76, P203; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Vorst MV, 2007, J TRAUMA, V62, P199, DOI 10.1097/01.ta.0000238665.09611.4b; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; Walcott B. P., 2011, PLOS ONE, V6; Wang HP, 2011, J TRAUMA, V70, pE6, DOI 10.1097/TA.0b013e3181cda3b9; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	58	15	15	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2014	31	7					595	609		10.1089/neu.2013.3152			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AD7PB	WOS:000333455000001	24224706				2021-06-18	
J	Post, A; Hoshizaki, TB; Gilchrist, MD; Brien, S; Cusimano, MD; Marshall, S				Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan; Cusimano, Michael D.; Marshall, Shawn			The influence of acceleration loading curve characteristics on traumatic brain injury	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury; Principle components analysis; Kinematics	HUMAN HEAD; ELEMENT; IMPACT; BIOMECHANICS; DEFORMATION; PREDICTION; TISSUE	To prevent brain trauma, understanding the mechanism of injury is essential. Once the mechanism of brain injury has been identified, prevention technologies could then be developed to aid in their prevention. The incidence of brain injury is linked to how the kinematics of a brain injury event affects the internal structures of the brain. As a result it is essential that an attempt be made to describe how the characteristics of the linear and rotational acceleration influence specific traumatic brain injury lesions. As a result, the purpose of this study was to examine the influence of the characteristics of linear and rotational acceleration pulses and how they account for the variance in predicting the outcome of TBI lesions, namely contusion, subdural hematoma (SDH), subarachnoid hemorrhage (SAH), and epidural hematoma (EDH) using a principal components analysis (PCA). Monorail impacts were conducted which simulated falls which caused the TBI lesions. From these reconstructions, the characteristics of the linear and rotational acceleration were determined and used for a PCA analysis. The results indicated that peak resultant acceleration variables did not account for any of the variance in predicting TBI lesions. The majority of the variance was accounted for by duration of the resultant and component linear and rotational acceleration. In addition, the components of linear and rotational acceleration characteristics on the x, y, and z axes accounted for the majority of the remainder of the variance after duration. (C) 2014 Elsevier Ltd. All rights reserved.	[Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan] Univ Ottawa, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland; [Brien, Susan] Hull Hosp, Gatineau, PQ, Canada; [Cusimano, Michael D.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Marshall, Shawn] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada	Post, A (corresponding author), 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650; Post, Andrew/0000-0002-5960-5552	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	Funding for this research was provided by the Canadian Institutes of Health Research.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Gadd CW, 1966, P 10 STAPP CAR CRASH; GOLDSMITH W, 1981, J BIOMECH, V14, P883, DOI 10.1016/0021-9290(81)90016-6; GURDJIAN ES, 1947, JAMA-J AM MED ASSOC, V134, P1072, DOI 10.1001/jama.1947.02880300014005; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Hrapko M, 2006, BIORHEOLOGY, V43, P623; King A., 2003, P IRCOBI C LISB PORT; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rashid B., 2014, J MECH BEHA IN PRESS; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Versace J., 1971, REV SEVERITY INDEX; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	28	15	16	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAR 21	2014	47	5					1074	1081		10.1016/j.jbiomech.2013.12.026			8	Biophysics; Engineering, Biomedical	Biophysics; Engineering	AE6GG	WOS:000334088000020	24484643	Green Accepted			2021-06-18	
J	Kronvall, E; Valdemarsson, S; Saveland, H; Nilsson, OG				Kronvall, Erik; Valdemarsson, Stig; Saveland, Hans; Nilsson, Ola G.			Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage Is Associated with Impaired Early Outcome	WORLD NEUROSURGERY			English	Article						Growth hormone deficiency; Hypopituitarism; Outcome; Pituitary deficiency; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; CEREBRAL VASOSPASM; HYPOPITUITARISM; MANAGEMENT; DIAGNOSIS; DEFICIENCY; GUIDELINES; NEUROENDOCRINE; HYPONATREMIA; PREVALENCE	OBJECTIVE: Poor outcome and neuropsychological sequelae after aneurysmal subarachnoid hemorrhage (SAH) is a persistent problem. Pituitary dysfunction has been proposed as a contributing factor. Clinical studies have given variable and conflicting results on its importance and incidence after SAH. The aim of this study was to prospectively examine SAH patients with assessment of endocrine function in the acute stage and at early follow-up and to compare clinical SAH features to endocrine abnormalities indicating pituitary dysfunction. METHODS: Endocrine function was assessed by basal hormonal concentrations at 5 to 10 days and 3 to 6 months after SAH. Growth hormone deficiency also was evaluated by the growth hormone releasing hormoneearginine stimulation test at follow-up. Clinical outcome was assessed and scored according to the Glasgow Outcome Scale. RESULTS: Fifty-one SAH patients were included and assessed in the acute stage after the bleed. Six were lost to follow-up. The overall prevalence of pituitary dysfunction was 37% and 27% in the acute stage and at follow-up, respectively. Patients with evidence of pituitary dysfunction had significantly worse outcome according to Glasgow Outcome Scale at both occasions. The ruptured aneurysm was more commonly located in the circle of Willis among patients with pituitary dysfunction in the acute stage. CONCLUSIONS: The present results support earlier findings that hormonal abnormalities are not infrequent after SAH. Furthermore, our data suggest that pituitary dysfunction is associated with worse clinical outcome and is more common among patients with bleeding sites close to the hypothalamus.	[Kronvall, Erik; Saveland, Hans; Nilsson, Ola G.] Lund Univ, Skane Univ Hosp, Dept Neurosurg, Lund, Sweden; [Valdemarsson, Stig] Lund Univ, Skane Univ Hosp, Dept Oncol, Lund, Sweden	Kronvall, E (corresponding author), Lund Univ, Skane Univ Hosp, Dept Neurosurg, Lund, Sweden.	erik.kronvall@med.lu.se					AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; Cesarini KG, 1999, J NEUROSURG, V90, P664, DOI 10.3171/jns.1999.90.4.0664; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P431, DOI 10.1046/j.1365-2265.2000.01106.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Finucane FM, 2008, CLIN ENDOCRINOL, V69, P603, DOI 10.1111/j.1365-2265.2008.03240.x; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fraser JF, 2006, NEUROSURGERY, V59, P222, DOI 10.1227/01.NEU.0000223440.35642.6E; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Grossman AB, 2010, J CLIN ENDOCR METAB, V95, P4855, DOI 10.1210/jc.2010-0982; Hillman J, 2002, J NEUROSURG, V97, P771, DOI 10.3171/jns.2002.97.4.0771; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENNETT B, 1975, LANCET, V7905, P480; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7; Rahman M, 2009, NEUROSURGERY, V65, P925, DOI 10.1227/01.NEU.0000358954.62182.B3; Rosen Thord, 2012, Lakartidningen, V109, P629; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277; Vora YY, 1999, NEUROSURGERY, V44, P1237, DOI 10.1097/00006123-199906000-00039; Wong GKC, 2011, NEUROSURGERY, V68, P1556, DOI 10.1227/NEU.0b013e31820cd40d	36	15	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR-APR	2014	81	3-4					529	537		10.1016/j.wneu.2013.10.038			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AG7EP	WOS:000335581200032	24140998				2021-06-18	
J	Lumba-Brown, A; Harley, J; Lucio, S; Vaida, F; Hilfiker, M				Lumba-Brown, Angela; Harley, Jim; Lucio, Simon; Vaida, Florin; Hilfiker, Mary			Hypertonic Saline as a Therapy for Pediatric Concussive Pain	PEDIATRIC EMERGENCY CARE			English	Article						concussion; pediatric mild traumatic brain injury; hypertonic saline; pediatric head injury; mild traumatic brain injury; pediatric concussion; concussion therapy; concussion treatment; closed-head injury; mTBI; TBI; HTS	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; EMERGENCY-DEPARTMENT; HEAD-INJURY; MANAGEMENT; STATEMENT; PRESSURE; CHILDREN; VALIDATION; REACTIVITY	Objective Three-percent hypertonic saline (HTS) is a hyperosmotic therapy used in pediatric traumatic brain injury to treat increased intracranial pressure and cerebral edema. It also promotes plasma volume expansion and cerebral perfusion pressure, immunomodulation, and anti-inflammatory response. We hypothesized that HTS will improve concussive symptoms of mild traumatic brain injury. Methods The study was a prospective, double-blind, randomized controlled trial. Children, 4 to 7 years of age with a Glasgow Coma Scale score greater than 13, were enrolled from a pediatric emergency department following closed-head injury upon meeting Acute Concussion Evaluation criteria with head pain. Patients were randomized to receive 10 mL/kg of HTS or normal saline (NS) over 1 hour. Self-reported pain values were obtained using the Wong-Baker FACES Pain Rating Scale initially, immediately following fluids, and at 2 to 3 days of discharge. The primary outcome measure was change in self-reported pain following fluid administration. Secondary outcome measures were a change in pain and postconcussive symptoms within 2 to 3 days of fluid administration. We used an intention-to-treat analysis. Results Forty-four patients, ranging from 7 to 16 years of age with comparable characteristics, were enrolled in the study; 23 patients (52%) received HTS, and 21 (48%) received NS. There was a significant difference (P < 0.001) identified in the self-reported improvement of pain following fluid administration between the HTS group (mean improvement = 3.5) and the NS group (mean improvement = 1.1). There was a significant difference (P = 0.01) identified in the self-reported improvement of pain at 2 to 3 days after treatment between the HTS group (mean improvement = 4.6) and the NS group (mean improvement = 3.0). We were unable to determine a difference in other postconcussive symptoms following discharge. Conclusions Three-percent HTS is more effective than NS in acutely reducing concussion pain in children.	[Lumba-Brown, Angela] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Lumba-Brown, Angela; Harley, Jim; Lucio, Simon] Univ Calif San Diego, Dept Emergency Med, Div Pediat Emergency Med, San Diego, CA 92103 USA; [Vaida, Florin] Univ Calif San Diego, Dept Family & Prevent Med, Div Biostat & Bioinformat, San Diego, CA 92103 USA; [Vaida, Florin] HIV Neurobehav Res Program, Stat Unit, San Diego, CA USA; [Hilfiker, Mary] Univ Calif San Diego, Rady Childrens Hosp, San Diego, CA 92103 USA	Lumba-Brown, A (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave,Campus Box 8116, St Louis, MO 63110 USA.	alumba@aol.com		Lumba-Brown, Angela/0000-0002-9102-8791	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001442] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001442] Funding Source: Medline		[Anonymous], 1997, NEUROLOGY, V48, P581; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bosenberg A, 2003, PAEDIATR ANAESTH, V13, P708, DOI 10.1046/j.1460-9592.2003.01142.x; CDC, 2003, REP C MILD TRAUM BRA; Centers for Disease Control, HEADS FACTS PHYS MIL; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Isayama K, 2012, J SURG RES, V172, P137, DOI 10.1016/j.jss.2010.07.042; Khan R, 2011, SHOCK, V36, P440, DOI 10.1097/SHK.0b013e3182336bda; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, P252; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; MOSS GS, 1988, AM J SURG, V155, P425, DOI 10.1016/S0002-9610(88)80106-5; NAKAYAMA SI, 1985, J SURG RES, V38, P180, DOI 10.1016/0022-4804(85)90025-3; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Weed LH, 1919, AM J PHYSIOL, V48, P531	30	15	16	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2014	30	3					139	145		10.1097/PEC.0000000000000084			7	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	AC6OR	WOS:000332644000001	24583571	Green Accepted			2021-06-18	
J	Makdissi, M; Davis, G; McCrory, P				Makdissi, Michael; Davis, Gavin; McCrory, Paul			Updated guidelines for the management of sports-related concussion in general practice	AUSTRALIAN FAMILY PHYSICIAN			English	Article						brain injuries; central nervous system diseases; brain concussion; sports medicine	TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; EPIDEMIOLOGY; STATEMENT; SEQUELAE; DISEASE; IMPACT	Background Concussion is common in many sports and recreational activities. It is thought to reflect a functional rather than structural injury to the brain. The clinical features are typically short-lived and usually resolve spontaneously. Complications, however, can occur and may include prolonged symptoms and/or cognitive deficits in the short term, as well as depression and cumulative deterioration in brain function in the longer term. Objective This article will provide an updated clinical review of concussion in sport, with an emphasis on assessment and management in general practice. Discussion The critical issues in the clinical management of concussion in sport include making a diagnosis, differentiating between concussion and other pathologies (particularly structural head injury), recognising the presence of any modifying factors (which may increase the risk of complications) and determining when the patient can safely return to competition. The key components of safe return-to-play decisions include rest, neuropsychological testing and a graded program of exertion before return to sport.	[Makdissi, Michael; Davis, Gavin; McCrory, Paul] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Makdissi, Michael] Australasian Coll Sports Phys, Olymp Pk Sports Med Ctr, Melbourne, Vic, Australia	Makdissi, M (corresponding author), Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia.	makdissi@unimelb.edu.au	McCrory, Paul/Q-8688-2019	McCrory, Paul/0000-0003-4850-0568			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chadwick D, 1997, BRIT MED J, V314, P1283; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; RUTHERFORD WH, 1977, LANCET, V1, P1	33	15	15	0	15	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	0300-8495			AUST FAM PHYSICIAN	Aust. Fam. Physician	MAR	2014	43	3					94	99					6	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	AS0DD	WOS:000343947700007	24600668				2021-06-18	
J	Mysliwiec, V; Matsangas, P; Baxter, T; McGraw, L; Bothwell, NE; Roth, BJ				Mysliwiec, Vincent; Matsangas, Panagiotis; Baxter, Tristin; McGraw, Leigh; Bothwell, Nici E.; Roth, Bernard J.			Comorbid Insomnia and Obstructive Sleep Apnea in Military Personnel: Correlation With Polysomnographic Variables	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; QUANTITATIVE CRITERIA; BREATHING DISORDERS; SOLDIERS; IRAQ; ASSOCIATION; AFGHANISTAN; DEPLOYMENT; ESZOPICLONE; PREVALENCE	Objectives: Military personnel undergoing polysomnography are typically diagnosed only with obstructive sleep apnea (OSA). Comorbid insomnia with OSA is a well-established, underappreciated diagnosis. We sought to determine if military personnel with mild OSA met clinical criteria for insomnia and if there was a pattern of polysomnogram (PSG) variables that identified insomnia in these patients. Methods: Retrospective chart review of military personnel with mild OSA; cluster analysis to describe PSG variables. Results: 206 personnel assessed, predominately male (96.6%), mean age 36.5 +/- 8.14 years, body mass index 30.2 +/- 3.66 kg/m(2) and apnea hypopnea index of 8.44 +/- 2.92 per hour; 167 (81.1%) met criteria for insomnia. Cluster analysis identified a group of patients (N = 52) with PSG variables of increased wakefulness after sleep onset 77.3 minutes (27.7) (p < 0.001) and decreased sleep efficiency 82.6% (5.82) (p < 0.001) consistent with insomnia. Patients in this group were more likely to meet criteria for insomnia with an odds ratio 5.27 (1.20, 23.1), (p = 0.009). Conclusions: The majority of military personnel with mild OSA meet criteria for insomnia. Roughly one-third of these patients can be identified by a pattern of PSG variables. Recognizing and treating both comorbid insomnia and OSA could improve clinical outcomes.	[Mysliwiec, Vincent; Baxter, Tristin; McGraw, Leigh; Bothwell, Nici E.; Roth, Bernard J.] Madigan Army Med Ctr, Dept Pulm, Tacoma, WA 98431 USA; [Matsangas, Panagiotis] Naval Postgrad Sch, Dept Operat Res, Monterey, CA 93943 USA	Mysliwiec, V (corresponding author), Madigan Army Med Ctr, Dept Pulm, 9040A Fitzsimmons Ave, Tacoma, WA 98431 USA.				Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]	The authors would like to thank Angela Mysliwiec, MD, Madigan Army Medical Center, for editing assistance and review of the manuscript. Dr. Angela Mysliwiec did not receive compensation for her contributions. This study was supported, in part, by grant no. 60855 from the Center for Neuroscience and Regenerative Medicine.	Al-Jawder SE, 2012, SLEEP BREATH, V16, P295, DOI 10.1007/s11325-011-0513-1; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Bjornsdottir E, 2012, J SLEEP RES, V21, P131, DOI 10.1111/j.1365-2869.2011.00972.x; Chung KF, 2005, RESPIRATION, V72, P460, DOI 10.1159/000087668; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Gelis LA, 2010, MIL MED, V175, P567, DOI 10.7205/MILMED-D-09-00123; GUILLEMINAULT C, 1973, SCIENCE, V181, P856, DOI 10.1126/science.181.4102.856; HAURI PJ, 1983, SLEEP, V6, P326, DOI 10.1093/sleep/6.4.326; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iber C, 2007, AASM MANUAL SCORING; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Krakow B, 2001, BIOL PSYCHIAT, V49, P948, DOI 10.1016/S0006-3223(00)01087-8; Krakow Barry, 2004, Sleep Breath, V8, P15, DOI 10.1007/s11325-004-0015-5; Krakow Barry, 2002, Sleep Breath, V6, P189; Krakow B, 2010, J NERV MENT DIS, V198, P734, DOI 10.1097/NMD.0b013e3181f4aca1; Krell Suzanne B, 2005, Sleep Breath, V9, P104, DOI 10.1007/s11325-005-0026-x; Lavie P, 2010, J SLEEP RES, V19, P1, DOI 10.1111/j.1365-2869.2010.00836.x; Lettieri CJ, 2008, SLEEP, V31, P1310; Lettieri CJ, 2005, J CLIN SLEEP MED, V1, P381; Lettieri CJ, 2009, ANN INTERN MED, V151, P696, DOI 10.7326/0003-4819-151-10-200911170-00006; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; Lineberger MD, 2006, SLEEP, V29, P479, DOI 10.1093/sleep/29.4.479; Littner M, 2003, SLEEP, V26, P754; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Miller NL, 2011, BEHAV SLEEP MED, V9, P53, DOI 10.1080/15402002.2011.533994; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, CHEST, V143, P582, DOI 10.1378/chest.12-2269; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Okun ML, 2009, J CLIN SLEEP MED, V5, P41; Ong JC, 2013, J CLIN PSYCHOL, V69, P1066, DOI 10.1002/jclp.21958; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Smith S, 2004, SLEEP MED, V5, P449, DOI 10.1016/j.sleep.2004.03.005; Tan PN, 2005, INTRO DATA MINING, P487, DOI DOI 10.1016/0022-4405(81)90007-8; Toblin Robin L., 2012, Morbidity and Mortality Weekly Report, V61, P895; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Wickwire EM, 2010, CHEST, V137, P1449, DOI 10.1378/chest.09-1485; Yang CM, 2011, J PSYCHOSOM RES, V70, P355, DOI 10.1016/j.jpsychores.2010.12.005	41	15	16	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2014	179	3					294	300		10.7205/MILMED-D-13-00396			7	Medicine, General & Internal	General & Internal Medicine	AN7UJ	WOS:000340806200014	24594464	Bronze			2021-06-18	
J	Rodgers, KM; Deming, YK; Bercum, FM; Chumachenko, SY; Wieseler, JL; Johnson, KW; Watkins, LR; Barth, DS				Rodgers, Krista M.; Deming, Yuetiva K.; Bercum, Florencia M.; Chumachenko, Serhiy Y.; Wieseler, Julie L.; Johnson, Kirk W.; Watkins, Linda R.; Barth, Daniel S.			Reversal of Established Traumatic Brain Injury-Induced, Anxiety-Like Behavior in Rats after Delayed, Post-Injury Neuroimmune Suppression	JOURNAL OF NEUROTRAUMA			English	Article						glial cell response to injury; inflammation; traumatic brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; CORPUS-CALLOSUM; LIFE-SPAN; MILD; MRI; QUANTIFICATION; SEGMENTATION; VALIDATION; ANISOTROPY	Traumatic brain injury (TBI) increases the risk of neuropsychiatric disorders, particularly anxiety disorders. Yet, there are presently no therapeutic interventions to prevent the development of post-traumatic anxiety or effective treatments once it has developed. This is because, in large part, of a lack of understanding of the underlying pathophysiology. Recent research suggests that chronic neuroinflammatory responses to injury may play a role in the development of post-traumatic anxiety in rodent models. Acute peri-injury administration of immunosuppressive compounds, such as Ibudilast (MN166), have been shown to prevent reactive gliosis associated with immune responses to injury and also prevent lateral fluid percussion injury (LFPI)-induced anxiety-like behavior in rats. There is evidence in both human and rodent studies that post-traumatic anxiety, once developed, is a chronic, persistent, and drug-refractory condition. In the present study, we sought to determine whether neuroinflammation is associated with the long-term maintenance of post-traumatic anxiety. We examined the efficacy of an anti-inflammatory treatment in decreasing anxiety-like behavior and reactive gliosis when introduced at 1 month after injury. Delayed treatment substantially reduced established LFPI-induced freezing behavior and reactive gliosis in brain regions associated with anxiety and continued neuroprotective effects were evidenced 6 months post-treatment. These results support the conclusion that neuroinflammation may be involved in the development and maintenance of anxiety-like behaviors after TBI.	[Rodgers, Krista M.; Deming, Yuetiva K.; Bercum, Florencia M.; Chumachenko, Serhiy Y.; Wieseler, Julie L.; Watkins, Linda R.; Barth, Daniel S.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Johnson, Kirk W.] MediciNova Inc, La Jolla, CA USA	Barth, DS (corresponding author), Univ Colorado, Dept Psychol & Neurosci, UCB 345, Boulder, CO 80309 USA.	dbarth@psych.colorado.edu	Rodgers, Krista/AAC-5063-2020; Robles, Yuetiva/AAS-3610-2020	Robles, Yuetiva/0000-0001-7512-5703; RODGERS, KRISTA/0000-0003-4393-6389	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [PR100040]; Craig Hospital Gift Fund, a University of Colorado Innovative Seed Grant; Autism Speaks Pilot Study [7153]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS36981, DA024044, DA01767]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K05DA024044] Funding Source: NIH RePORTER	This work was supported by the U.S. Army Medical Research and Material Command (grant PR100040), the Craig Hospital Gift Fund, a University of Colorado Innovative Seed Grant, the Autism Speaks Pilot Study (grant 7153), and the National Institutes of Health (grant nos. NS36981 [to D. S. B.] and DA024044 and DA01767 [to L.R.W.].	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Assistant Secretary D. O. D, 2007, TRAUM BRAIN INJ DEF; Barzo P, 1997, ACT NEUR S, V70, P115; Bastin ME, 1998, MAGN RESON IMAGING, V16, P773, DOI 10.1016/S0730-725X(98)00098-8; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chenevert TL, 2011, J MAGN RESON IMAGING, V34, P983, DOI 10.1002/jmri.22363; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Hasan KM, 2008, MAGN RESON MED, V59, P7, DOI 10.1002/mrm.21434; Hasan KM, 2007, NEUROREPORT, V18, P1735, DOI 10.1097/WNR.0b013e3282f0d40c; Hasan KM, 2007, MAGN RESON IMAGING, V25, P1196, DOI 10.1016/j.mri.2007.02.011; Hasan KM, 2007, NEUROIMAGE, V34, P1497, DOI 10.1016/j.neuroimage.2006.10.029; Hasan KM, 2013, MAGN RESON IMAGING, V31, P1445, DOI 10.1016/j.mri.2013.04.010; Hasan KM, 2013, J CHILD NEUROL, V28, P874, DOI 10.1177/0883073812452917; Hasan KM, 2011, COMPUT BIOL MED, V41, P1062, DOI 10.1016/j.compbiomed.2010.10.008; Hasan KM, 2011, HUM BRAIN MAPP, V32, P107, DOI 10.1002/hbm.21004; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hunsche S, 2001, RADIOLOGY, V221, P550, DOI 10.1148/radiol.2212001823; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kempton MJ, 2011, NEUROIMAGE, V58, P1051, DOI 10.1016/j.neuroimage.2011.06.080; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kreipke C. W., 2013, CEREBRAL BLOOD FLOW, P1; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	60	15	15	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2014	31	5					487	497		10.1089/NEU.2013.3090			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AB4ZV	WOS:000331799600247	24041015	Green Published			2021-06-18	
J	Thais, MERD; Cavallazzi, G; Formolo, DA; de Castro, LD; Schmoeller, R; Guarnieri, R; Schwarzbold, ML; Diaz, AP; Hohl, A; Prediger, RDS; Mader, MJ; Linhares, MN; Staniloiu, A; Markowitsch, HJ; Walz, R				Rodrigues de Oliveira Thais, Maria Emilia; Cavallazzi, Gisele; Formolo, Douglas Afonso; de Castro, Lucas D'Avila; Schmoeller, Roseli; Guarnieri, Ricardo; Schwarzbold, Marcelo Liborio; Diaz, Alexandre Paim; Hohl, Alexandre; Prediger, Rui D. S.; Mader, Maria Joana; Linhares, Marcelo Neves; Staniloiu, Angelica; Markowitsch, Hans J.; Walz, Roger			Limited predictive power of hospitalization variables for long-term cognitive prognosis in adult patients with severe traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article							DIFFUSION-TENSOR; HEAD-INJURY; MODERATE; RECOVERY; OUTCOMES; TBI; CLASSIFICATION; METAANALYSIS; PERFORMANCE; DISORDERS	ObjectivesTraumatic brain injury (TBI) is a main cause of mortality and morbidity. Association studies between hospitalization variables and cognitive impairment after TBI are frequently retrospective, including non-consecutive patients showing variable degrees of TBI severity, and poor management of missing (drop out) cases. MethodsWe assessed prospectively the demographic and hospitalization variables of 234 consecutive patients with severe TBI (admission Glasgow Coma Scale [GCS] 8) and determined their independent association with cognitive performance in a representative sample (n=46) of surviving patients (n=172) evaluated 3 (1.8) years after hospitalization. ResultsIn all, 85% of patients were male and the mean age was 34 (SD +/- 13) years. The education level was 9 (+/- 4.7) years. As expected, education and age showed a moderately to strong linear relationship with the cognitive performance in 14 of 15 neuropsychological tests (R coefficient=0.6-0.8). The cognitive test scores were not independently associated with gender, admission GCS, associated trauma, and Marshal CT classification. Admission-elevated blood glucose levels and the presence of sub-arachnoid haemorrhage were independently associated with lower scores on Rey Auditory Verbal Learning retention and Logical Memory-I tests, respectively. ConclusionsAfter correction for education and age distribution, the variables that are commonly associated with mortality or Glasgow Outcome Scale including admission pupils' examination, Marshal CT Classification, GCS, and serum glucose showed a limited predictive power for long-term cognitive prognosis. Identification of clinical, radiological, and laboratory variables as well as new biomarkers independently associated with cognitive outcome remains an important challenge for further work involving severe TBI patients.	[Rodrigues de Oliveira Thais, Maria Emilia; Cavallazzi, Gisele; Formolo, Douglas Afonso; de Castro, Lucas D'Avila; Schmoeller, Roseli; Guarnieri, Ricardo; Schwarzbold, Marcelo Liborio; Diaz, Alexandre Paim; Hohl, Alexandre; Prediger, Rui D. S.; Linhares, Marcelo Neves; Walz, Roger] Univ Fed Santa Catarina, Univ Hosp, Ctr Neurociencias Aplicadas CeNAp, Florianopolis, SC, Brazil; [Guarnieri, Ricardo; Diaz, Alexandre Paim; Linhares, Marcelo Neves; Walz, Roger] Hosp Governador Celso Ramos, Ctr Epilepsia Estado Santa Catarina CEPESC, Florianopolis, SC, Brazil; [Prediger, Rui D. S.] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Farmacol, Florianopolis, SC, Brazil; [Mader, Maria Joana] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil; [Linhares, Marcelo Neves] Univ Fed Santa Catarina, HU, Serv Cirurgia, Unidade Neurocirurgia, Florianopolis, SC, Brazil; [Staniloiu, Angelica; Markowitsch, Hans J.] Univ Bielefeld, D-33615 Bielefeld, Germany; [Walz, Roger] Univ Fed Santa Catarina, HU, Dept Clin Med, Florianopolis, SC, Brazil	Walz, R (corresponding author), UFSC, Univ Hosp, Dept Clin Med, 3 Andar,Campus Univ, Trindade Florianopolis, SC, Brazil.	rogerwalz@hotmail.com	Prediger, Rui D/C-4036-2013; Diaz, Alexandre Paim/AAD-8323-2019; Walz, Roger/K-9096-2013; Hohl, Alexandre/R-9269-2019; Prediger, Rui Daniel/AAV-3419-2020; Schwarzbold, Marcelo Liborio/J-8960-2014; Diaz, Alexandre Paim/J-9042-2014	Prediger, Rui D/0000-0002-7547-6463; Diaz, Alexandre Paim/0000-0002-6591-6648; Walz, Roger/0000-0002-9875-6687; Hohl, Alexandre/0000-0002-8073-5837; Prediger, Rui Daniel/0000-0002-7547-6463; Formolo, Douglas/0000-0003-1908-8658	Programa de Apoio a Nucleos de Excelencia PRONEX - FAPESC/CNPq (NENASC Project); CNPq (Brazilian Council for Scientific and Technologic Development, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESC (Foundation for Scientific Research and Technology of the State of Santa Catarina)	This work was supported by Programa de Apoio a Nucleos de Excelencia PRONEX - FAPESC/CNPq (NENASC Project), CNPq (Brazilian Council for Scientific and Technologic Development, Brazil), and FAPESC (Foundation for Scientific Research and Technology of the State of Santa Catarina).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bayen E., 2012, J HEAD TRAUMA REHABI, DOI 10. 1097/HTR. 0b013e31825413cf; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; Davis OSP, 2009, PSYCHOL SCI, V20, P1301, DOI 10.1111/j.1467-9280.2009.02433.x; Thais MERD, 2012, CNS NEUROSCI THER, V18, P606, DOI 10.1111/j.1755-5949.2012.00346.x; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Fraser RT, 2000, TRAUMATIC BRAIN INJU; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; HOLM S, 1979, SCAND J STAT, V6, P65; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Novack TA, 2000, BRAIN INJURY, V14, P987; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Rey A., 1958, EXAMEN CLIN PSICHOLO; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; van Hooren SAH, 2007, AGING NEUROPSYCHOL C, V14, P40, DOI 10.1080/138255890969483; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wechsler D., 2004, WAIS 3 MANUAL ADM AV; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	55	15	15	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2014	8	1					125	139		10.1111/jnp.12000			15	Psychology; Psychology, Experimental	Psychology	AA9YD	WOS:000331448100008	23167479				2021-06-18	
J	Sakai, K; Fukuda, T; Iwadate, K				Sakai, Kentaro; Fukuda, Takahiro; Iwadate, Kimiharu			Immunohistochemical Analysis of the Ubiquitin Proteasome System and Autophagy Lysosome System Induced After Traumatic Intracranial Injury Association With Time Between the Injury and Death	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						traumatic brain injury; ubiquitin; interval; autophagy	SPINAL-CORD TRAUMA; AXONAL INJURY; UP-REGULATION; BRAIN-INJURY; PROTEIN; DEGRADATION; P62/SQSTM1; P62; ACCUMULATION; COMPONENT	This study aimed to analyze how the ubiquitin proteasome system (UPS) or autophagy lysosome system (autophagy) are induced in brain tissues at different intervals after traumatic intracranial injury in humans. Injured cerebral cortices of 36 forensic autopsy cases were analyzed by immunohistochemistry using antibodies as the UPS marker (ubiquitin and lysine 48-linked polyubiquitin chains [K48]) and autophagy marker (lysine 63-linked polyubiquitin chains [K63], p62/sequestome 1 and microtubule-associated protein 1 light chain 3 [LC3]). The number of neurons and glial cells with cytoplasmic inclusions that stained positive for ubiquitin, K48, and p62 began to increase within 1 hour after intracranial injury, particularly at contusion sites. From 3.5 hours onward, an increase in cytoplasmic inclusions that stained positive for K63 and LC3 began to be detected. LC3-positive cytoplasmic inclusions were not identified after 37 days; however, the increased immunoreactivity to ubiquitin and anti-K48 antibody was maintained for 7 months. These results suggest that the UPS is activated earlier and lasts longer than autophagy, that autophagy is activated for a relatively short term (between a few hours and approximately 1 month), and that the activation occurs especially in severely damaged brain tissues following head trauma in humans.	[Sakai, Kentaro; Iwadate, Kimiharu] Jikei Univ, Sch Med, Res Ctr Med Sci, Dept Forens Med, Tokyo 1058461, Japan; [Fukuda, Takahiro] Jikei Univ, Sch Med, Res Ctr Med Sci, Div Neuropathol,Dept Neurosci, Tokyo 1058461, Japan	Sakai, K (corresponding author), Jikei Univ, Sch Med, Dept Forens Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	kentaro.sakai@jikei.ac.jp					Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Al-Sarraj S, 2004, CLIN NEUROPATHOL, V23, P62; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Chu CT, 2000, MODERN PATHOL, V13, P420, DOI 10.1038/modpathol.3880072; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; DiMaio D., 2000, CRC SER PR CRIM, P230; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Fortun J, 2005, J NEUROCHEM, V92, P1531, DOI 10.1111/j.1471-4159.2004.02987.x; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Ju JS, 2009, J CELL BIOL, V187, P855; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; LAIY H, 2008, J CEREB BLOOD FLOW M, V28, P540; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; LIMKL L, 2011, NEUROBIOL DIS, V43, P9; LIUCL C, 2008, J CEREB BLOOD FLOW M, V28, P674; MARTIN JE, 1990, BRAIN, V113, P1553, DOI 10.1093/brain/113.5.1553; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Sartori S, 2008, J CHILD NEUROL, V23, P912, DOI 10.1177/0883073808316367; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; TANJM W, 2008, AUTOPHAGY, V4, P251; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; ZHUC W, 2005, CELL DEATH DIFFER, V12, P162	53	15	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	2014	35	1					38	44		10.1097/PAF.0000000000000067			7	Medicine, Legal; Pathology	Legal Medicine; Pathology	AB0YP	WOS:000331518600011	24317096				2021-06-18	
J	Shih, CC; Hsu, YT; Wang, HH; Chen, TL; Tsai, CC; Lane, HL; Yeh, CC; Sung, FC; Chiu, WT; Cherng, YG; Liao, CC				Shih, Chun-Chuan; Hsu, Yi-Ting; Wang, Hwang-Huei; Chen, Ta-Liang; Tsai, Chin-Chuan; Lane, Hsin-Long; Yeh, Chun-Chieh; Sung, Fung-Chang; Chiu, Wen-Ta; Cherng, Yih-Giun; Liao, Chien-Chang			Decreased Risk of Stroke in Patients with Traumatic Brain Injury Receiving Acupuncture Treatment: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; ADVERSE OUTCOMES; WEIGHT-LOSS; TAIWAN; COUNTRIES; EPILEPSY; STRATEGY; CHILDREN; RECOVERY	Background: Patients with traumatic brain injury (TBI) face increased risk of stroke. Whether acupuncture can help to protect TBI patients from stroke has not previously been studied. Methods: Taiwan's National Health Insurance Research Database was used to conduct a retrospective cohort study of 7409 TBI patients receiving acupuncture treatment and 29,636 propensity-score-matched TBI patients without acupuncture treatment in 2000-2008 as controls. Both TBI cohorts were followed until the end of 2010 and adjusted for immortal time to measure the incidence and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) of new-onset stroke in the multivariable Cox proportional hazard models. Results: TBI patients with acupuncture treatment (4.9 per 1000 person-years) had a lower incidence of stroke compared with those without acupuncture treatment (7.5 per 1000 person-years), with a HR of 0.59 (95% CI = 0.50-0.69) after adjustment for sociodemographics, coexisting medical conditions and medications. The association between acupuncture treatment and stroke risk was investigated by sex and age group (20-44, 45-64, and >= 65 years). The probability curve with log-rank test showed that TBI patients receiving acupuncture treatment had a lower probability of stroke than those without acupuncture treatment during the follow-up period (p < 0.0001). Conclusion: Patients with TBI receiving acupuncture treatment show decreased risk of stroke compared with those without acupuncture treatment. However, this study was limited by lack of information regarding lifestyles, biochemical profiles, TBI severity, and acupuncture points used in treatments.	[Shih, Chun-Chuan; Tsai, Chin-Chuan; Lane, Hsin-Long] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Hsu, Yi-Ting] China Med Univ Hosp, Neurosci Lab, Dept Neurol, Taichung, Taiwan; [Wang, Hwang-Huei] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Cherng, Yih-Giun] Taipei Med Univ, Dept Anesthesiol, Shuang Ho Hosp, New Taipei City, Taiwan; [Liao, Chien-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan	Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.	jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/I-4893-2019; Yeh, Chun Chieh/Y-3304-2019	Yeh, Chun Chieh/0000-0001-6753-7564; Cherng, Yih-Giun/0000-0002-0201-4380	Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP98-RD-038, CCMP99-RD-035]; National Science Council, TaiwanMinistry of Science and Technology, Taiwan [102-2314-B-038-021-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	This study is supported in part by a Grant from the Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan (CCMP98-RD-038 and CCMP99-RD-035), the National Science Council, Taiwan (102-2314-B-038-021-MY3), and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Cabioglu MT, 2005, AM J CHINESE MED, V33, P525, DOI 10.1142/S0192415X05003132; Chang CC, 2013, BRIT J SURG, V100, P684, DOI 10.1002/bjs.9065; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Feigin VL, 2007, LANCET NEUROL, V6, P94, DOI 10.1016/S1474-4422(07)70007-8; Flachskampf FA, 2007, CIRCULATION, V115, P3121, DOI 10.1161/CIRCULATIONAHA.106.661140; He Jing, 2005, J Tradit Chin Med, V25, P171; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hsieh CH, 2010, AM J CHINESE MED, V38, P675, DOI 10.1142/S0192415X10008147; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Kim DD, 2006, MICROCIRCULATION, V13, P577, DOI 10.1080/10739680600885210; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/387164; Liao CC, 2012, J TRAUMA ACUTE CARE, V73, P1327, DOI 10.1097/TA.0b013e31826fc87f; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Lin JA, 2013, ANN RHEUMATOL DIS; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Quah-Smith I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012619; Shih CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/262039; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Shih CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032540; Shih CC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-27; Shih CC, 2009, CHINESE MED J-PEKING, V122, P1544, DOI 10.3760/cma.j.issn.0366-6999.2009.13.013; Sze FKH, 2002, STROKE, V33, P2604, DOI 10.1161/01.STR.0000035908.74261.C9; Tseng YJ, 2013, J ALTERN COMPLEM MED, V19, P474, DOI 10.1089/acm.2012.0163; Wong V, 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007700.PUB3; Wu P, 2010, STROKE, V41, pE171, DOI 10.1161/STROKEAHA.109.573576; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397	40	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89208	10.1371/journal.pone.0089208			6	Multidisciplinary Sciences	Science & Technology - Other Topics	AB3TA	WOS:000331711900105	24586597	DOAJ Gold, Green Published			2021-06-18	
J	Baylor, C; McAuliffe, MJ; Hughes, LE; Yorkston, K; Anderson, T; Kim, J; Amtmann, D				Baylor, Carolyn; McAuliffe, Megan J.; Hughes, Louise E.; Yorkston, Kathryn; Anderson, Tim; Kim, Jiseon; Amtmann, Dagmar			A Differential Item Functioning (DIF) Analysis of the Communicative Participation Item Bank (CPIB): Comparing Individuals With Parkinson's Disease From the United States and New Zealand	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						communicative participation; Parkinson's disease; dysarthria; outcomes measurement; item response theory; cultural and linguistic diversity	ORDINAL LOGISTIC-REGRESSION; TRAUMATIC BRAIN-INJURY; RESPONSE THEORY; SPEECH; OUTCOMES; LIFE; CALIBRATION; SYMPTOMS; SCALE	Purpose: To examine the cross-cultural applicability of the Communicative Participation Item Bank (CPIB) through a comparison of respondents with Parkinson's disease (PD) from the United States and New Zealand. Method: A total of 428 respondents-218 from the United States and 210 from New Zealand-completed the self-report CPIB and a series of demographic questions. Differential item functioning (DIF) analyses were conducted to examine whether response bias was present across the 2 groups. Results: No items were identified as having statistically significant DIF across the U.S. and N.Z. cohorts. Conclusion: The current CPIB items and scoring parameters are also suitable for use with respondents from New Zealand.	[Baylor, Carolyn; Yorkston, Kathryn; Kim, Jiseon; Amtmann, Dagmar] Univ Washington, Seattle, WA 98195 USA; [McAuliffe, Megan J.; Hughes, Louise E.] Univ Canterbury, Christchurch 1, New Zealand; [Anderson, Tim] New Zealand Brain Res Inst, Christchurch, New Zealand	Baylor, C (corresponding author), Univ Washington, Seattle, WA 98195 USA.	cbaylor@u.washington.edu		McAuliffe, Megan/0000-0003-3827-2215	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1R03DC010044]; New Zealand Institute of Language, Brain and Behaviour; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC010044] Funding Source: NIH RePORTER	This study was made possible by funding from the National Institute on Deafness and Other Communication Disorders (Grant 1R03DC010044; principal investigator Carolyn Baylor) and the New Zealand Institute of Language, Brain and Behaviour. We thank subjects for their time and efforts participating in this study. We would also like to acknowledge student research assistants in the United States who assisted with data collection, Christina Gray and Brittney Skrupky, and the Washington Parkinson's Disease Registry at the University of Washington. Assistance with participant recruitment in New Zealand was provided by Parkinson's New Zealand, the New Zealand Brain Research Institute, and speech therapists from district health boards across New Zealand.	Battle D. E., 1993, COMMUNICATION DISORD; Baylor C, 2013, J SPEECH LANG HEAR R, V56, P1190, DOI 10.1044/1092-4388(2012/12-0140); Baylor C, 2011, AM J SPEECH-LANG PAT, V20, P243, DOI 10.1044/1058-0360(2011/10-0079); Baylor CR, 2009, J SPEECH LANG HEAR R, V52, P1302, DOI 10.1044/1092-4388(2009/07-0275); Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Choi SW, 2011, J STAT SOFTW, V39, P1; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Cook KF, 2005, HEALTH SERV RES, V40, P1694, DOI 10.1111/j.1475-6773.2005.00446.x; Crane PK, 2007, QUAL LIFE RES, V16, P69, DOI 10.1007/s11136-007-9185-5; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; Crane PK, 2004, STAT MED, V23, P241, DOI 10.1002/sim.1713; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Eadie TL, 2006, AM J SPEECH-LANG PAT, V15, P307, DOI 10.1044/1058-0360(2006/030); Embretson S.E., 2013, ITEM RESPONSE THEORY; Embretson SE, 1996, PSYCHOL ASSESSMENT, V8, P341, DOI 10.1037/1040-3590.8.4.341; HARTELIUS L, 1994, FOLIA PHONIATR LOGO, V46, P9, DOI 10.1159/000266286; JOHNSON JA, 1990, BRIT J DISORD COMMUN, V25, P183; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; McLellan K, 2011, NEW ZEAL MED J, V124, P48; Miller N, 2006, AGE AGEING, V35, P235, DOI 10.1093/ageing/afj053; Perenboom RJM, 2003, DISABIL REHABIL, V25, P577, DOI 10.1080/0963828031000137081; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Samejima F., 1969, PSYCHOMETRIC MONOGRA, V17; Statistics New Zealand, 2006, 2006 CENS POP DWELL; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; World Health Organization, 2001, INT CLASS FUNCT DIS; Yorkston KM, 2008, DISABIL REHABIL, V30, P425, DOI 10.1080/09638280701625328; Yorkston KM, 2007, FOLIA PHONIATR LOGO, V59, P107, DOI 10.1159/000101769	30	15	15	0	5	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	FEB	2014	57	1					90	95		10.1044/1092-4388(2013/12-0414)			6	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AZ0EM	WOS:000347919100008	24687470	Green Accepted			2021-06-18	
J	Rodriguez, RA; Bussiere, M; Froeschl, M; Nathan, HJ				Rodriguez, Rosendo A.; Bussiere, Miguel; Froeschl, Michael; Nathan, Howard J.			Auditory-evoked potentials during coma: Do they improve our prediction of awakening in comatose patients?	JOURNAL OF CRITICAL CARE			English	Article						Coma; Cardiac arrest; Auditory-evoked potentials; Awakening; Consciousness	EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; MISMATCH NEGATIVITY; FUNCTIONAL OUTCOMES; STEM RESPONSES; RESUSCITATION; CONSCIOUSNESS; GUIDELINES; PROGNOSIS	Objective: The mismatch negativity (MMN), an auditory event-related potential, has been identified as a good indicator of recovery of consciousness during coma. We explored the predictive value of the MMN and other auditory-evoked potentials including brainstem and middle-latency potentials for predicting awakening in comatose patients after cardiac arrest or cardiogenic shock. Materials and Methods: Auditory brainstem, middle-latency (Pa wave), and event-related potentials (N100 and MMN waves) were recorded in 17 comatose patients and 9 surgical patients matched by age and coronary artery disease. Comatose patients were followed up daily to determine recovery of consciousness and classified as awakened and nonawakened. Results: Among the auditory-evoked potentials, the presence or absence of MMN best discriminated between patients who awakened or those who did not. Mismatch negativity was present during coma in all patients who awakened (7/7) and in 2 of those (2/10) who did not awaken. In patients who awakened and in whom MMN was detected, 3 of those awakened between 2 and 3 days and 4 between 9 and 21 days after evoked potential examination. All awakened patients had intact N100 waves and identifiable brainstem and middle-latency waves. In nonawakened patients, N100 and Pa waves were detected in 5 cases (50%) and brainstem waves in 9 (90%). Conclusions: The MMN is a good predictor of awakening in comatose patients after cardiac arrest and cardiogenic shock and can be measured days before awakening encouraging ongoing life support. (C) 2014 Elsevier Inc. All rights reserved.	[Rodriguez, Rosendo A.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON, Canada; [Rodriguez, Rosendo A.] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Bussiere, Miguel] Ottawa Hosp, Dept Med, Div Neurol, Ottawa, ON K1H 8L6, Canada; [Froeschl, Michael] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Nathan, Howard J.] Univ Ottawa, Inst Heart, Div Cardiac Anesthesia, Ottawa, ON, Canada	Rodriguez, RA (corresponding author), Ottawa Hosp, Room L-2217,Box 180,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	rrodriguez@toh.on.ca					Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; Booth CM, 2004, JAMA-J AM MED ASSOC, V291, P870, DOI 10.1001/jama.291.7.870; CHIAPPA KH, 1983, EVOKED POTENTIALS CL, P105; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Fischer C, 2000, AUDIOL NEURO-OTOL, V5, P192, DOI 10.1159/000013880; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; FISCHER C, 1994, NEUROSURGERY, V35, P45, DOI 10.1227/00006123-199407000-00007; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; KAGA K, 1985, LARYNGOSCOPE, V95, P321; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; NAATANEN R, 1995, EAR HEARING, V16, P6; Parkkonen L, 2009, HUM BRAIN MAPP, V30, P1772, DOI 10.1002/hbm.20788; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; PICTON TW, 1985, HUMAN COMMUNICATION, V9, P127; Pratt H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P69; Puettgen HA, 2007, J NEUROL SCI, V261, P108, DOI 10.1016/j.jns.2007.04.041; Rodriguez RA, 2013, ANN THORAC SURG, V95, P884, DOI 10.1016/j.athoracsur.2012.09.032; Rodriguez Rosendo A, 2004, Semin Cardiothorac Vasc Anesth, V8, P85, DOI 10.1177/108925320400800203; Schielke E, 2005, J NEUROL, V252, P648, DOI 10.1007/s00415-005-0711-5; TEASDALE G, 1974, LANCET, V2, P81; UZIEL A, 1978, ELECTROEN CLIN NEURO, V45, P515, DOI 10.1016/0013-4694(78)90295-X; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wityk RJ, 2001, ARCH NEUROL-CHICAGO, V58, P571, DOI 10.1001/archneur.58.4.571; Young GB, 2009, NEW ENGL J MED, V361, P605, DOI 10.1056/NEJMcp0903466	30	15	18	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2014	29	1					93	100		10.1016/j.jcrc.2013.08.020			8	Critical Care Medicine	General & Internal Medicine	275QT	WOS:000328693000017	24125771				2021-06-18	
J	Brown, AW; Leibson, CL; Mandrekar, J; Ransom, JE; Malec, JF				Brown, Allen W.; Leibson, Cynthia L.; Mandrekar, Jay; Ransom, Jeanine E.; Malec, James F.			Long-Term Survival After Traumatic Brain Injury: A Population-Based Analysis Controlled for Nonhead Trauma	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						epidemiology; risk; mortality; rehabilitation	MORTALITY TRENDS; HEAD TRAUMA; SPECTRUM; DISEASE; CARE; REHABILITATION; RESIDUALS; SEVERITY; COHORT; MODEL	Objective: To examine the contribution of cooccurring nonhead injuries to hazard of death after traumatic brain injury (TBI). Participants: A random sample of Olmsted County, Minnesota, residents with confirmed TBI from 1987 through 1999 was identified. Design: Each case was assigned an age- and sex-matched, non-TBI "regular control" from the population. For "special cases" with accompanying nonhead injuries, 2 matched "special controls" with nonhead injuries of similar severity were assigned. Measures: Vital status was followed from baseline (ie, injury date for cases, comparable dates for controls) through 2008. Cases were compared first with regular controls and second with regular or special controls, depending on case type. Results: In total, 1257 cases were identified (including 221 special cases). For both cases versus regular controls and cases versus regular or special controls, the hazard ratio was increased from baseline to 6 months (10.82 [2.86-40.89] and 7.13 [3.10-16.39], respectively) and from baseline through study end (2.92 [1.74-4.91] and 1.48 [1.09-2.02], respectively). Among 6-month survivors, the hazard ratio was increased for cases versus regular controls (1.43 [1.06-2.15]) but not for cases versus regular or special controls (1.05 [0.80-1.38]). Conclusions: Among 6-month survivors, accounting for nonhead injuries resulted in a nonsignificant effect of TBI on long-term mortality.	[Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Leibson, Cynthia L.] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA; [Mandrekar, Jay; Ransom, Jeanine E.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Mandrekar, Jay] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Malec, James F.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA	Brown, AW (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Brown, Allen W./0000-0001-7228-3351	National Institute on Disability and Rehabilitation Research [H133A020507, H133A070013]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD-07447]; Rochester Epidemiology Project (from the National Institute on Aging) [R01 AG034676]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007447] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD007447, R56HD007447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034676] Funding Source: NIH RePORTER	This work was supported by TBI Model System grants to Mayo Clinic from the National Institute on Disability and Rehabilitation Research (H133A020507, H133A070013) and a National Research Service Award from the National Institute of Health (Training Grant HD-07447). The study was made possible by the Rochester Epidemiology Project (grant no. R01 AG034676 from the National Institute on Aging).	ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bergen G, 2008, INJURY US 2007 CHART, P27; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ., 1995, GUIDELINES SURVEILLA; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	32	15	15	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					E1	E8		10.1097/HTR.0b013e318280d3e6			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400002	23381021	Green Published, Green Accepted			2021-06-18	
J	Donat, CK; Fischer, F; Walter, B; Deuther-Conrad, W; Brodhun, M; Bauer, R; Brust, P				Donat, Cornelius K.; Fischer, Felix; Walter, Bernd; Deuther-Conrad, Winnie; Brodhun, Michael; Bauer, Reinhard; Brust, Peter			Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet	ACTA NEUROBIOLOGIAE EXPERIMENTALIS			English	Article						traumatic brain injury; autoradiography; cannabinoid receptors; neuroprotection	LATERAL FLUID PERCUSSION; 18 KDA TSPO; TRANSLOCATOR PROTEIN; BLOOD-FLOW; CORPUS-CALLOSUM; AXONAL INJURY; CB2 RECEPTOR; IN-VITRO; RAT; LOCALIZATION	Paediatric traumatic brain injury (TBI) is a leading cause of death and disability. Previous studies showed neuroprotection after TBI by (endo)cannabinoid mechanisms, suggesting involvement of cannabinoid receptors (CBR). We therefore determined CBR densities and expression of the translocator protein 18 kDA (TSPO) in newborn piglets after experimental TBI. Newborn female piglets were subjected to sham operation (n=6) or fluid-percussion (FP) injury (n=7) under controlled physiological conditions. After six hours, brains were frozen, sagittally cut and incubated with radioligands for CBR ([(HCP)-H-3-55,940, [H-3]SR141716A) and TSPO ([H-3]PK11195), an indicator of gliosis/brain injury. Early after injury, FP-TBI elicited a significant ICP increase at a temporary reduced cerebral perfusion pressure; however, CBF and CMRO2 remained within physiological range. At 6 hours post injury, we found a statistically significant increase in binding of the non-selective agonist [H-3]CP-55,940 in 15 of the 24 investigated brain regions of injured animals. By contrast, no significant changes in binding of the CB1R-selective antagonist [H-3]SR141716A were observed. A non-significant trend towards increased binding of [H-3]PK11195 was observed, suggesting an incipient microglial activation. We therefore conclude that in this model and time span after injury, the increase in [H-3]CP-55,940 binding reflects changes in CB2R density, while CB1R density is not affected. The results may provide explanation for the neuroprotective properties of cannabinoid ligands and future therapeutic strategies of TBI.	[Donat, Cornelius K.; Fischer, Felix; Deuther-Conrad, Winnie; Brust, Peter] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Leipzig, Germany; [Walter, Bernd] Heinrich Braun Hosp, Zwickau, Germany; [Brodhun, Michael] Helios Klinikum Erfurt, Dept Pathol, Erfurt, Germany; [Bauer, Reinhard] Jena Univ Hosp, Inst Mol Cell Biol, Jena, Germany; [Bauer, Reinhard] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany	Donat, CK (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Res Site Leipzig, Leipzig, Germany.	cdonat@nru.dk	Deuther-Conrad, Winnie/B-7558-2015	, Peter/0000-0001-5555-7058; Deuther-Conrad, Winnie/0000-0003-3168-3062			Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Bahr BA, 2006, EXPERT OPIN INV DRUG, V15, P351, DOI 10.1517/13543784.15.4.351; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Capettini LSA, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/824093; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; COYLE MG, 1993, AM J PHYSIOL, V264, pH141; Cumming P, 2006, SYNAPSE, V59, P418, DOI 10.1002/syn.20257; Donat CK, 2010, NEUROPATH APPL NEURO, V36, P225, DOI 10.1111/j.1365-2990.2009.01050.x; Donat CK, 2010, INT J DEV NEUROSCI, V28, P31, DOI 10.1016/j.ijdevneu.2009.10.001; EISENHAUER CL, 1994, LAB ANIM SCI, V44, P245; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; FELDER CC, 1992, MOL PHARMACOL, V42, P838; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Finnie JW, 2012, AUST VET J, V90, P301, DOI 10.1111/j.1751-0813.2012.00955.x; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; Gallyas F, 1979, Neurol Res, V1, P203; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Harkany T, 2005, NEUROSCIENCE, V135, P595, DOI 10.1016/j.neuroscience.2005.06.043; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Herkenham M, 1991, NIDA Res Monogr, V112, P129; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hoffmeister PG, 2011, NEUROMOL MED, V13, P44, DOI 10.1007/s12017-010-8136-4; Hohmann AG, 1999, NEUROSCIENCE, V92, P1171, DOI 10.1016/S0306-4522(99)00220-1; Horvath B, 2012, BRIT J PHARMACOL, V165, P2462, DOI 10.1111/j.1476-5381.2011.01381.x; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Lopez-Rodriguez A. B., 2013, CEREB CORTEX; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; MAKOWSKI EL, 1968, CIRC RES, V23, P623, DOI 10.1161/01.RES.23.5.623; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McPartland JM, 2007, BRIT J PHARMACOL, V152, P583, DOI 10.1038/sj.bjp.0707399; Miller LK, 2011, PHARMACOL REV, V63, P461, DOI 10.1124/pr.110.003491; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Pertwee RG, 2000, EXPERT OPIN INV DRUG, V9, P1553, DOI 10.1517/13543784.9.7.1553; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Pazos MR, 2013, NEUROPHARMACOLOGY, V71, P282, DOI 10.1016/j.neuropharm.2013.03.027; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sarne Y, 2011, BRIT J PHARMACOL, V163, P1391, DOI 10.1111/j.1476-5381.2011.01280.x; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1602/neurorx.1.1.71; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/s003950050037; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; WESTLAKE TM, 1994, NEUROSCIENCE, V63, P637, DOI 10.1016/0306-4522(94)90511-8; White R, 1998, BRIT J PHARMACOL, V125, P689, DOI 10.1038/sj.bjp.0702127	78	15	15	0	3	NENCKI INST EXPERIMENTAL BIOLOGY	WARSAW	UL PASTEURA 3, 02-093 WARSAW, POLAND	0065-1400	1689-0035		ACTA NEUROBIOL EXP	Acta Neurobiol. Exp.		2014	74	2					197	210					14	Neurosciences	Neurosciences & Neurology	AL4FG	WOS:000339087700006	24993629				2021-06-18	
J	Goverover, Y; Genova, H; Griswold, H; Chiaravalloti, N; DeLuca, J				Goverover, Yael; Genova, Helen; Griswold, Hali; Chiaravalloti, Nancy; DeLuca, John			Metacognitive knowledge and online awareness in persons with multiple sclerosis	NEUROREHABILITATION			English	Article						Impaired self-awareness; error-monitoring; activities of daily living; cognition; quality of life; multiple sclerosis	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SELF-AWARENESS; FUNCTIONAL ASSESSMENT; COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTION; NEUROPSYCHOLOGY; METAMEMORY; COMPETENCE; VALIDATION	BACKGROUND: Recent models of self-awareness draw a distinction between intellectual awareness (metacognitive knowledge of disabilities) and online awareness of errors (emergent and anticipatory awareness). OBJECTIVE: The present study compared these two types of self-awareness (metacognitive knowledge of disabilities and online awareness) in individuals with multiple sclerosis (MS) and healthy participants. The relationship between self-awareness and functional performance was also examined. METHODS: Participants included 18 individuals with MS and 16 healthy controls (HC) between the ages of 27 and 60. Intellectual awareness was assessed via discrepancy scores on the Functional Behavior Profile (FBP) between participants and their informants. Online Awareness was examined using self-prediction and self-assessment of performance on a functional task. RESULTS: Participants with MS had significantly lower levels of intellectual awareness relative to HCs. The MS group demonstrated worse prediction online awareness than HCs. However, assessment online awareness did not differ between groups, indicating that experience with a task can improve online awareness in persons with MS. CONCLUSION: This study highlights the necessity of adopting a multidimensional approach to assessing the multifaceted phenomenon of self-awareness in MS. In addition, it provides initial evidence to support a self-awareness treatment model for persons with MS.	[Goverover, Yael] NYU, New York, NY 10012 USA; [Goverover, Yael; Genova, Helen; Griswold, Hali; Chiaravalloti, Nancy; DeLuca, John] Kessler Fdn, West Orange, NJ USA; [Genova, Helen; Chiaravalloti, Nancy; DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07102 USA; [Griswold, Hali] Fairleigh Dickinson Univ, Teaneck, NJ USA	Goverover, Y (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, 35 West 4th St,11th Floor, New York, NY 10012 USA.	yg243@nyu.edu		Chiaravalloti, Nancy/0000-0003-2943-7567	national multiple sclerosis societyNational Multiple Sclerosis Society [RG 3935A2/2, PP1331]	This research was supported by the national multiple sclerosis society (Grant #: RG 3935A2/2 and # PP1331). This study was presented in part at the 40th Annual Meeting of the International Neuropsychological Society in Montreal, Canada, February 2012.	BARCO PP, 1991, COGNITIVE REHABILITA; BAUM C, 1993, GERONTOLOGIST, V33, P403, DOI 10.1093/geront/33.3.403; Benedict RHB, 2002, J NEUROPSYCH CLIN N, V14, P44, DOI 10.1176/appi.neuropsych.14.1.44; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Brassington JC, 1998, NEUROPSYCHOL REV, V8, P43, DOI 10.1023/A:1025621700003; Bruck W, 2003, NEUROL SCI, V24, pS265, DOI 10.1007/s10072-003-0170-7; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Cella DF, 1996, NEUROLOGY, V47, P129, DOI 10.1212/WNL.47.1.129; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [10.1097/00001199-198909000-00008, DOI 10.1097/00001199-198909000-00008]; Fleming J., 2013, INT ENCY REHABILITAT; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Geraci L, 2010, CONSCIOUS COGN, V19, P606, DOI 10.1016/j.concog.2010.03.015; GORDON PA, 1994, J REHABIL, V60, P34; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Goverover Y, 2010, ARCH PHYS MED REHAB, V91, P252, DOI 10.1016/j.apmr.2009.09.022; Goverover Y, 2009, REHABIL PSYCHOL, V54, P60, DOI 10.1037/a0014556; Hoerold D, 2008, EXP BRAIN RES, V186, P509, DOI 10.1007/s00221-008-1341-9; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Kaszniak AW, 1996, LEARN INDIVID DIFFER, V8, P355, DOI 10.1016/S1041-6080(96)90023-0; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nelson T. O., 1992, METACOGNITION CORE R; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Randolph JJ, 2001, CLIN NEUROPSYCHOL, V15, P357, DOI 10.1076/clin.15.3.357.10278; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherman TE, 2008, J CLIN EXP NEUROPSYC, V30, P301, DOI 10.1080/13803390701380617; Simioni S, 2009, J INT NEUROPSYCH SOC, V15, P291, DOI 10.1017/S1355617709090262; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Zakzanis KK, 2000, ARCH CLIN NEUROPSYCH, V15, P115, DOI 10.1016/S0887-6177(98)00157-7	36	15	15	0	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	2					315	323		10.3233/NRE-141113			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AQ7OE	WOS:000343007000017	24990022				2021-06-18	
J	Haslach, HW; Leahy, LN; Riley, P; Gullapalli, R; Xu, S; Hsieh, AH				Haslach, Henry W., Jr.; Leahy, Lauren N.; Riley, Peter; Gullapalli, Rao; Xu, Su; Hsieh, Adam H.			Solid-extracellular fluid interaction and damage in the mechanical response of rat brain tissue under confined compression	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Brain tissue damage; Confined compression; Solid-fluid interaction; Extracellular fluid; Models of injury; Permeability; Rat brain	CENTRAL-NERVOUS-SYSTEM; ARTICULAR-CARTILAGE; FINITE DEFORMATION; WHITE-MATTER; PERMEABILITY; NEURONS; TENSION; STRESS; INJURY; MODEL	The mechanical processes that underlie mild traumatic brain injury from physical insults are not well understood. One aspect in particular that has not been examined is the tissue fluid, which is known to be critical in the mechanical function of other organs. To investigate the contributions of solid-fluid interactions to brain tissue mechanics, we performed confined compression tests, that force the extracellular fluid (ECF) to flow in the direction of the deformation, on 6.35 mm diameter, 3 mm long cylindrical samples excised from various regions of rat brains. Two types of tests in deformation control, (1) quasi-static, slow and moderate constant strain rate tests at 0.64 x 10(-5)/s, 0.001/s and 1/s to large strains and (2) several applications of slow linear deformation to 5% strain each followed by stress relaxation are employed to explore the solid-fluid interaction. At slow and moderate compressive strain rates, we observed stress peaks in the applied strain range at about 11%, whose magnitudes exhibited statistically significant dependence on strain rate. These data suggest that the ECF carries load until the tissue is sufficiently damaged to permit pathological fluid flow. Under the slow ramp rate in the ramp-relaxation cycles protocol, commonly used to estimate permeability, the stress relaxes to zero after the first cycle, rather than to a non-zero equilibrium stress corresponding to the applied strain, which further implicates mechanical damage. Magnetic resonance imaging (MRI) of changes in tissue microstructure during confined compression, before and after compression, provides further evidence of tissue damage. The solid-fluid interactions, reflected in the morphology of the stress-stretch curves and supported by the MRI data, suggest that increases in hydrostatic pressure in the ECF may contribute to mechanical damage of brain tissue. (C) 2013 Elsevier Ltd. All rights reserved.	[Haslach, Henry W., Jr.; Leahy, Lauren N.; Riley, Peter] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Hsieh, Adam H.] Univ Maryland, Fischell Dept Biomech Engn, College Pk, MD 20742 USA; [Gullapalli, Rao; Xu, Su] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA	Haslach, HW (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	haslach@umd.edu		Hsieh, Adam/0000-0003-3162-1152	University of Maryland SEED grant; Center for Energetics Concepts Development of the University of Maryland-College Park	This work was supported in part by a University of Maryland SEED grant and by the Center for Energetics Concepts Development of the University of Maryland-College Park.	Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Burgin LV, 2008, J MATER SCI-MATER M, V19, P703, DOI 10.1007/s10856-007-3187-2; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Hilgetag CC, 2006, PLOS COMPUT BIOL, V2, P146, DOI 10.1371/journal.pcbi.0020022; HOLMES MH, 1986, J BIOMECH ENG-T ASME, V108, P372, DOI 10.1115/1.3138633; Kaczmarek M, 1997, B MATH BIOL, V59, P295; Liu QL, 2011, J MECH BEHAV BIOMED, V4, P974, DOI 10.1016/j.jmbbm.2011.02.009; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NOYES FR, 1984, J BONE JOINT SURG AM, V66A, P344, DOI 10.2106/00004623-198466030-00005; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Perie D, 2005, J BIOMECH, V38, P2164, DOI 10.1016/j.jbiomech.2004.10.002; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; Shulyakov AV, 2009, BIOMECH MODEL MECHAN, V8, P415, DOI 10.1007/s10237-008-0147-9; Simon BR, 1998, INT J SOLIDS STRUCT, V35, P5021, DOI 10.1016/S0020-7683(98)00107-3; Simon BR, 1992, APPL MECH REV, V45, P191, DOI [10.1115/1.3121397, DOI 10.1115/1.3121397]; Soltz MA, 2006, J BIOMECH, V39, P594, DOI 10.1016/j.jbiomech.2005.09.020; STRICH S, 1961, LANCET, V1961, P443; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Xu G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001683; Xu G, 2009, BIOMECH MODEL MECHAN, V8, P253, DOI 10.1007/s10237-008-0131-4	35	15	15	1	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2014	29				SI		138	150		10.1016/j.jmbbm.2013.08.027			13	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	294ZF	WOS:000330085700013	24084652				2021-06-18	
J	Heinzelmann, M; Reddy, SY; French, LM; Wang, D; Lee, H; Barr, T; Baxter, T; Mysliwiec, V; Gill, J				Heinzelmann, Morgan; Reddy, Swarnalatha Y.; French, Louis M.; Wang, Dan; Lee, Hyunhwa; Barr, Taura; Baxter, Tristin; Mysliwiec, Vincent; Gill, Jessica			Military personnel with chronic symptoms following blast traumatic brain injury have differential expression of neuronal recovery and epidermal growth factor receptor genes	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; military; post-concussive disorder; gene-expression		Objective: Approximately one-quarter of military personnel who deployed to combat stations sustained one or more blast-related, closed-head injuries. Blast injuries result from the detonation of an explosive device. The mechanisms associated with blast exposure that give rise to traumatic brain injury (TBI), and place military personnel at high risk for chronic symptoms of post-concussive disorder (PCD), post-traumatic stress disorder (PTSD), and depression are not elucidated. Methods:To investigate the mechanisms of persistent blast-related symptoms, we examined expression profiles of transcripts across the genome to determine the role of gene activity in chronic symptoms following blast-TBI. Active duty military personnel with (1) a medical record of a blast-TBI that occurred during deployment (n= 19) were compared to control participants without TBI (n = 17). Controls were matched to cases on demographic factors including age, gender, and race, and also in diagnoses of sleep disturbance, and symptoms of PTSD and depression. Due to the high number of PCD symptoms in the TBI+ group, we did not match on this variable. Using expression profiles of transcripts in microarray platform in peripheral samples of whole blood, significantly differentially expressed gene lists were generated. Statistical threshold is based on criteria of 1.5 magnitude fold-change (up or down) and p-values with multiple test correction (false discovery rate <0.05). Results:There were 34 transcripts in 29 genes that were differentially regulated in blast-TBI participants compared to controls. Up-regulated genes included epithelial cell transforming sequence and zinc finger proteins, which are necessary for astrocyte differentiation following injury. Tensin-1, which has been implicated in neuronal recovery in pre-clinical TBI models, was down-regulated in blast-TBI participants. Protein ubiquitination genes, such as epidermal growth factor receptor, were also down-regulated and identified as the central regulators in the gene network determined by interaction pathway analysis. Conclusion: In this study, we identified a gene-expression pathway of delayed neuronal recovery in military personnel a blast-TBI and chronic symptoms. Future work is needed to determine if therapeutic agents that regulate these pathways may provide novel treatments for chronic blast-TBI-related symptoms.	[Heinzelmann, Morgan; Reddy, Swarnalatha Y.; Wang, Dan; Lee, Hyunhwa; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Barr, Taura] W Virginia Univ, Hlth Sci Ctr, Morgantown, WV 26506 USA; [Baxter, Tristin; Mysliwiec, Vincent] Madigan Army Med Ctr, Sleep Med Clin, Tacoma, WA 98431 USA	Gill, J (corresponding author), NINR, 1 Cloister Court,Room 256, Bethesda, MD 20814 USA.	gillj@mail.nih.gov	Gill, Gill M/Q-2020-2017; Reddy, Swarna/G-5349-2013; french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Lee, Hyunhwa/0000-0002-5625-3141; Heinzelmann, Morgan/0000-0002-4399-6229	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027] Funding Source: NIH RePORTER	This study was funded, in part, by the Center for Neuroscience and Regenerative Medicine (Grant 60855).	Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Caldeira MV, 2014, PROG NEUROBIOL, V112, P50, DOI 10.1016/j.pneurobio.2013.10.003; Chen YH, 2012, J NEUROTRAUM, V29, P1328, DOI 10.1089/neu.2011.2235; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Gill J, 2014, PSYCHIAT RES, V216, P116, DOI 10.1016/j.psychres.2014.01.046; Hanissian SH, 2005, BRAIN RES, V1047, P56, DOI 10.1016/j.brainres.2005.04.017; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Jerg-Bretzke Lucia, 2013, Psychosoc Med, V10, pDoc03, DOI 10.3205/psm000093; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kotepui M, 2012, ASIAN PAC J CANCER P, V13, P5879, DOI 10.7314/APJCP.2012.13.11.5879; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu B, 2004, GLIA, V46, P153, DOI 10.1002/glia.10358; Liu B, 2007, J NEUROSCI RES, V85, P3523, DOI 10.1002/jnr.21364; MacKenzie EJ, 2002, QUAL LIFE RES, V11, P797, DOI 10.1023/A:1020820017658; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reynolds JJ, 2013, DNA REPAIR, V12, P588, DOI 10.1016/j.dnarep.2013.04.011; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Siddiq I, 2012, J NEUROTRAUM, V29, P2647, DOI 10.1089/neu.2012.2444; Sun KJ, 2013, BRAIN RES, V1506, P132, DOI 10.1016/j.brainres.2013.02.011; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tado M, 2014, J NEUROTRAUM, V31, P691, DOI 10.1089/neu.2013.2940; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Tsai JCG, 2010, NEUROREHABILITATION, V26, P85, DOI [10.3233/NRE-2010-0538, 10.3233/NRE-2011-0538]; Vigodner M, 2013, HUM REPROD, V28, P210, DOI 10.1093/humrep/des317; Wan CH, 2014, J NEUROSCI RES, V92, P1, DOI 10.1002/jnr.23305; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yao XL, 2006, NEUROSCI LETT, V409, P65, DOI 10.1016/j.neulet.2006.09.015; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725; Yuksel H, 2013, NEUROL SCI, V34, P1941, DOI 10.1007/s10072-013-1411-z; Zhou Yi-wu, 2002, Fa Yi Xue Za Zhi, V18, P146	54	15	15	1	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								198	10.3389/fneur.2014.00198			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V42QW	WOS:000209629300186	25346719	DOAJ Gold, Green Published			2021-06-18	
J	Ling, H; Kara, E; Revesz, T; Lees, AJ; Plant, GT; Martino, D; Houlden, H; Hardy, J; Holton, JL				Ling, Helen; Kara, Eleanna; Revesz, Tamas; Lees, Andrew J.; Plant, Gordon T.; Martino, Davide; Houlden, Henry; Hardy, John; Holton, Janice L.			Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Boxer; Dementia pugilistica; Chronic traumatic encephalopathy; Progressive supranuclear palsy; Tauopathy	NINDS NEUROPATHOLOGIC CRITERIA; CORTICOBASAL DEGENERATION; ALZHEIMERS-DISEASE; BRAIN-INJURY; NEUROFIBRILLARY TANGLES; TDP-43 IMMUNOREACTIVITY; DEMENTIA-PUGILISTICA; DYSTROPHIC NEURITES; PARKINSONS-DISEASE; RISK-FACTORS	We report the case of a 75-year-old ex-professional boxer who developed diplopia and eye movement abnormalities in his 60's followed by memory impairment, low mood and recurrent falls. Examination shortly before death revealed hypomimia, dysarthria, vertical supranuclear gaze palsy and impaired postural reflexes. Pathological examination demonstrated 4-repeat tau neuronal and glial lesions, including tufted astrocytes, consistent with a diagnosis of progressive supranuclear palsy. In addition, neurofibrillary tangles composed of mixed 3-repeat and 4-repeat tau and astrocytic tangles in a distribution highly suggestive of chronic traumatic encephalopathy were observed together with limbic TDP-43 pathology. Possible mechanisms for the co-occurrence of these two tau pathologies are discussed.	[Ling, Helen; Revesz, Tamas; Lees, Andrew J.; Hardy, John; Holton, Janice L.] UCL, UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, Queen Sq Brain Bank Neurol Disorders, London, England; [Ling, Helen; Kara, Eleanna; Revesz, Tamas; Lees, Andrew J.; Houlden, Henry; Hardy, John; Holton, Janice L.] UCL, UCL Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England; [Ling, Helen; Revesz, Tamas; Lees, Andrew J.; Hardy, John; Holton, Janice L.] UCL, Sara Koe PSP Res Ctr, Neurol Inst, London, England; [Plant, Gordon T.; Holton, Janice L.] UCL, UCL Inst Neurol, Natl Hosp Neurol & Neurosurg, London, England; [Martino, Davide] Queen Elizabeth Hosp Woolwich, South London NHS Trust, London, England; [Martino, Davide] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England; [Martino, Davide] Queen Mary Univ London, Ctr Neurosci & Trauma, Blizard Inst, London, England	Holton, JL (corresponding author), UCL, UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, Queen Sq Brain Bank Neurol Disorders, London, England.	Janice.holton@ucl.ac.uk	Hardy, John/C-2451-2009; Holton, Janice L/F-6831-2011; Ling, Helen/J-3751-2013; Lees, Andrew J/A-6605-2009; Houlden, Henry/C-1532-2008	Hardy, John/0000-0002-3122-0423; Holton, Janice L/0000-0002-3882-5249; Lees, Andrew J/0000-0002-2476-4385; Houlden, Henry/0000-0002-2866-7777; Kara, Eleanna/0000-0001-5428-6743	Wellcome Trust/MRC Joint Call in Neurodegeneration award [WT089698]; Department of Health's NIHR Biomedical Research CentresNational Institute for Health Research (NIHR); National Institute for Health Research (NIHR) Biomedical Research Unit in Dementia based at University College London Hospitals (UCLH), University College London (UCL); CBD solutions; PSP (Europe) Association Research Grants; UCL Impact studentship; Parkinson's disease foundation; Alzheimer's Research UKAlzheimer's Research UK (ARUK); Parkinson's UKParkinson's UK; Multiple System Atrophy Trust; PSP Association, Weston Trust-The Reta Lila Howard Foundation; Reta Lila Weston Institute for Neurological Studies; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G108/638, MC_G1000735, G0802760, MR/J004758/1, G1001253] Funding Source: researchfish	This work was supported by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC) whose members are from the UCL Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee. This work was undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The research was partly supported by the National Institute for Health Research (NIHR) Biomedical Research Unit in Dementia based at University College London Hospitals (UCLH), University College London (UCL). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Funds for open access were provided by the Wellcome Trust.; HL is supported by CBD solutions and PSP (Europe) Association Research Grants and is employed by Reta Lila Weston Institute, Institute of Neurology, University College London.; EK is supported by UCL Impact studentship and Parkinson's disease foundation grant.; TR is supported by research grants from Alzheimer's Research UK, Parkinson's UK and the Multiple System Atrophy Trust.; AJL is supported by research grants from the PSP Association, Weston Trust-The Reta Lila Howard Foundation.; JLH is supported by the Reta Lila Weston Institute for Neurological Studies and research grants from Alzheimer's Research UK, Parkinson's UK and the Multiple System Atrophy Trust.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dickson DW, 2011, NEURODEGENERATION MO, DOI [10.1002/9781444341256, DOI 10.1002/9781444341256.CH15]; FOSTER JB, 1976, LANCET, V1, P981; Fujioka S, 2013, NEUROLOGY, V80, P2076, DOI 10.1212/WNL.0b013e318294b2eb; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Ghebranious N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni155; Golbe LI, 1996, NEUROLOGY, V47, P148, DOI 10.1212/WNL.47.1.148; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; Hayesmoore JBG, 2009, NEUROBIOL AGING, V30, P1652, DOI 10.1016/j.neurobiolaging.2007.12.017; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Houlden H, 2001, NEUROLOGY, V56, P1702, DOI 10.1212/WNL.56.12.1702; Ince PG, 2008, GREENFIELDS NEUROPAT, P889; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; Jung HH, 2012, EUR NEUROL, V67, P142, DOI 10.1159/000334731; Kaat LD, 2009, NEUROLOGY, V73, P98, DOI 10.1212/WNL.0b013e3181a92bcc; Kara E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.006; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Ling H, 2014, NEUROPATH APPL NEURO, V40, P149, DOI 10.1111/nan.12037; Ling HL, 2010, BRAIN, V133, P2045, DOI 10.1093/brain/awq123; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Lolekha P, 2010, MOVEMENT DISORD, V25, P1895, DOI 10.1002/mds.23210; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Massey LA, 2012, MOVEMENT DISORD, V27, P1755, DOI 10.1002/mds.24968; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Millspaugh JA, 1937, US NAV MED B, V35, P297; Mok HY, 1851, NEUROBIOL AGING; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; MUNOZ DG, 1992, AM J PATHOL, V140, P1167; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schwab C, 1997, ACTA NEUROPATHOL, V94, P486, DOI 10.1007/s004010050737; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tuite PJ, 2005, ARCH NEUROL-CHICAGO, V62, P1453, DOI 10.1001/archneur.62.9.1453; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Williams DR, 2007, MOVEMENT DISORD, V22, P2235, DOI 10.1002/mds.21698; Williams DR, 2005, BRAIN, V128, P1247, DOI 10.1093/brain/awh488; Yokota O, 2010, ACTA NEUROPATHOL, V120, P55, DOI 10.1007/s00401-010-0702-1; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	59	15	16	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.		2014	2								24	10.1186/2051-5960-2-24			11	Neurosciences	Neurosciences & Neurology	V9K3A	WOS:000422389300024	24559032	DOAJ Gold, Green Published			2021-06-18	
J	Liu, Y; Yi, XC; Guo, G; Long, QF; Wang, XA; Zhong, J; Liu, WP; Fei, Z; Wang, DM; Liu, J				Liu, Yang; Yi, Xi-Cai; Guo, Geng; Long, Qian-Fa; Wang, Xiao-An; Zhong, Jun; Liu, Wei-Ping; Fei, Zhou; Wang, Dong-Mei; Liu, Jun			Basic fibroblast growth factor increases the transplantation-mediated therapeutic effect of bone mesenchymal stem cells following traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						basic fibroblast growth factor; bone mesenchymal stem cells; traumatic brain injury; transplantation	MARROW STROMAL CELLS; RANDOMIZED CONTROLLED-TRIAL; SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; TIRILAZAD MESYLATE; CORTICAL INJURY; RAT MODEL; NEUROGENESIS; METHYLPREDNISOLONE; PROLIFERATION	Basic fibroblast growth factor (bFGF) has proven useful for neural stem and progenitor cells during the transplantation-mediated therapeutic effect of bone mesenchymal stem cells (BMSCs). Endogenous bFGF expression levels increase during brain development and gradually diminish with aging. To date, few studies have been conducted on exogenous bFGF promoting BMSC transplantation-mediated functional recovery in adult rats following traumatic brain injury (TBI). The results of the present study showed that BMSCs in the TBI cortex and dentate gyrus showed differentiation along the glial and neuronal lines, which are possibly enhanced by bFGF. The neuronal differentiation rate was not consistent with neurological functional recovery rate over time. bFGF may promote the transplantation-mediated therapeutic effect of BMSCs more significantly and rapidly in rats following TBI, with a small proportion of differentiated neurons. In conclusion, exogenous bFGF functions as a booster of the transplantation-mediated therapeutic effect of BMSCs following TBI.	[Liu, Yang; Wang, Dong-Mei] Third Hosp Mianyang, Dept Neurosurg, Mianyang 621000, Sichuan, Peoples R China; [Liu, Yang; Yi, Xi-Cai; Long, Qian-Fa; Wang, Xiao-An; Zhong, Jun; Liu, Wei-Ping; Fei, Zhou] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Guo, Geng] Shanxi Med Univ, Dept Neurosurg, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China; [Liu, Jun] Third Mil Med Univ, Dept Neurosurg, Xinqiao Hosp, Chongqing 400037, Peoples R China	Liu, J (corresponding author), Third Mil Med Univ, Dept Neurosurg, Xinqiao Hosp, 83 Zheng St, Chongqing 400037, Peoples R China.	JUNLIUCN@126.com	Long, Qianfa/F-6461-2017; guo, geng/M-4108-2014	Long, Qianfa/0000-0001-8848-9688; guo, geng/0000-0003-4197-0399	Foundation of Health Department Scientific Research Project in Sichuan Province [2010-100301, 2011-110547]; Mianyang City Health Bureau [201102]; Third Hospital of Mianyang [2010-2012]	The authors would like to thank Ling Sun and Xiaoyan Chen for their assistance in this study. This study was funded by grants from the Foundation of Health Department Scientific Research Project in Sichuan Province (grant nos. 2010-100301 and 2011-110547), Mianyang City Health Bureau (grant no. 201102) and the Third Hospital of Mianyang (grant no. 2010-2012).	Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; CADAY CG, 1990, DEV BRAIN RES, V52, P241, DOI 10.1016/0165-3806(90)90240-Y; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; LIAU LM, 1996, NEUROLOGICAL SURG, P1549; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Monfils MH, 2008, EXP BRAIN RES, V185, P453, DOI 10.1007/s00221-007-1172-0; Ourednik J, 2004, CELL TRANSPLANT, V13, P307, DOI 10.3727/000000004783983963; Raballo R, 2000, J NEUROSCI, V20, P5012; Ramirez JJ, 1999, NEUROREPORT, V10, P1201, DOI 10.1097/00001756-199904260-00008; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200	27	15	17	0	11	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JAN	2014	9	1					333	339		10.3892/mmr.2013.1803			7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	AA0KJ	WOS:000330783700053	24248266	Bronze			2021-06-18	
J	Munivenkatappa, A; Rajeswaran, J; Devi, BI; Bennet, N; Upadhyay, N				Munivenkatappa, Ashok; Rajeswaran, Jamuna; Devi, Bhagavatula Indira; Bennet, Niranjana; Upadhyay, Neeraj			EEG Neurofeedback therapy: Can it attenuate brain changes in TBI?	NEUROREHABILITATION			English	Article						EEG-NFT; TBI; MRI scan; neuropsychological scores; in vivo changes	INJURY; SCALE	BACKGROUND: Electroencephalogram Neurofeedback therapy (EEG-NFT) has several potential beneficial effects in terms of improving cognition and electrophysiological regulation among patients with brain injury. However, in vivo structural and functional changes remain less explored. OBJECTIVE: The aim of the present study is to explore EEG-NFT induced in vivo changes in traumatic brain injury (TBI) patients. METHOD: Two patients with mean age of 15 years with moderate head injury who had more than seven post concussion symptoms and poor cognitive performances (<5 percentile) were subjected to 20 sessions of EEG-NFT. The neuropsychological test scores, post concussion symptoms and MRI scan of the brain were recorded pre-post to EEG-NFT. RESULTS: During EEG-NFT the cognitive scores and concussion symptoms improved significantly (p < 0.05). The EEG-NFT has shown significant increase in cortical grey matter (GM) volumes (p < 0.0001) and fractional anisotropy (FA) of cortical white matter (WM) tracts (p < 0.0001, voxel max 60 and above). There was a significant decrease in global, local efficiency, cost and clustering coefficient of functional connectivity (Wilcoxon Sign Rank Test p < 0.05). Interestingly there was a significant increase in thalamo-cortical connection (increase FA value) after EEG-NFT. CONCLUSION: The EEG-NFT therapy has shown significant changes in structural and functional connectivity among young moderately injured TBI patients.	[Munivenkatappa, Ashok] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Neurosci, Bangalore, Karnataka, India; [Rajeswaran, Jamuna; Bennet, Niranjana] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Psychol, Bangalore, Karnataka, India; [Devi, Bhagavatula Indira; Upadhyay, Neeraj] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore, Karnataka, India	Rajeswaran, J (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Psychol, Bangalore, Karnataka, India.	drjamunarajan@gmail.com		Upadhyay, Neeraj/0000-0001-5165-9727			Freesurfer, MART CTR BIOM IM; JENNETT B, 1975, LANCET, V1, P480; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lubar JF, 1997, APPL PSYCHOPHYS BIOF, V22, P111, DOI 10.1023/A:1026276228832; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Rima E. L., 2002, J NEUROTHERAPY, V5, P45; Timothy P. T., 2000, J NEUROTHERAPY, V4, P27; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073	9	15	15	1	26	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	3					481	484		10.3233/NRE-141140			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AS8UO	WOS:000344523600014	25238859				2021-06-18	
J	Nageli, M; Fasshauer, M; Sommerfeld, J; Fendel, A; Brandi, G; Stover, JF				Naegeli, Mirjam; Fasshauer, Mario; Sommerfeld, Jutta; Fendel, Angela; Brandi, Giovanna; Stover, John F.			Prolonged continuous intravenous infusion of the dipeptide L-alanine-L-glutamine significantly increases plasma glutamine and alanine without elevating brain glutamate in patients with severe traumatic brain injury	CRITICAL CARE			English	Article							SUPPLEMENTED PARENTERAL-NUTRITION; CRITICALLY-ILL PATIENTS; ALANYL-L-GLUTAMINE; AMINO-ACID LEVELS; DOUBLE-BLIND; INDUCED THERMOGENESIS; ENERGY-EXPENDITURE; ABDOMINAL-SURGERY; RANDOMIZED-TRIAL; INTENSIVE-CARE	Introduction: Low plasma glutamine levels are associated with worse clinical outcome. Intravenous glutamine infusion dose-dependently increases plasma glutamine levels, thereby correcting hypoglutaminemia. Glutamine may be transformed to glutamate which might limit its application at a higher dose in patients with severe traumatic brain injury (TB. To date, the optimal glutamine dose required to normalize plasma glutamine levels without increasing plasma and cerebral glutamate has not yet been defined. Methods: Changes in plasma and cerebral glutamine, alanine, and glutamate as well as indirect signs of metabolic impairment reflected by increased intracranial pressure (ICP), lactate, lactate-to-pyruvate ratio, electroencephalogram (EEG) activity were determined before, during, and after continuous intravenous infusion of 0.75 g L-alanine-L-glutamine which was given either for 24 hours (group 1, n = 6) or 5 days (group 2, n = 6) in addition to regular enteral nutrition. Lab values including nitrogen balance, urea and ammonia were determined daily. Results: Continuous L-alanine-L-glutamine infusion significantly increased plasma and cerebral glutamine as well as alanine levels, being mostly sustained during the 5 day infusion phase (plasma glutamine: from 295 +/- 62 to 500 145 mu mol/I; brain glutamine: from 183 +/- 188 to 549 +/- 120 mu mol/I; plasma alanine: from 327 +/- 91 to 622 182 mu mol/I; brain alanine: from 48 55 to 89 129 mu mol/I; p<0.05, ANOVA, post hoc Dunn's test). Plasma glutamate remained unchanged and cerebral glutamate was decreased without any signs of cerebral impairment. Urea and ammonia were significantly increased within normal limits without signs of organ dysfunction (urea: from 2.7 +/- 1.6 to 5.5 +/- 1.5 mmol/I; ammonia: from 12 +/- 6.3 to 26 +/- 8.3 mu mol/ I; p<0.05, ANOVA, post hoc Dunn's test). Conclusions: High dose L-alanine-L-glutamine infusion (0.75 g/kg/d up to 5 days) increased plasma and brain glutamine and alanine levels. This was not associated with elevated glutamate or signs of potential glutamate-mediated cerebral injury. The increased nitrogen load should be considered in patients with renal and hepatic dysfunction.	[Naegeli, Mirjam; Fasshauer, Mario; Sommerfeld, Jutta; Fendel, Angela; Brandi, Giovanna; Stover, John F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland	Stover, JF (corresponding author), Univ Zurich Hosp, Raemistr 100, CH-8091 Zurich, Switzerland.	john.stover@access.uzh.ch			Swiss National Science Foundation (SNE); Division of Surgical Research; SUVA Fonds; Fresenius Kabi Switzerland	The assistance of the ICU nurses in data collection and Ursula Steckholzer in blood sampling is gratefully acknowledged. This study was supported by the Swiss National Science Foundation (SNE) to IFS, the Division of Surgical Research to JFS, the SUVA Fonds to JFS, and a research grant by Fresenius Kabi Switzerland to JFS. The funding bodies had no role in the design, collection, analysis and interpretation of data, writing of the manuscript, and in the decision to submit the manuscript for publication.	Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; Berg A, 2006, INTENS CARE MED, V32, P1741, DOI 10.1007/s00134-006-0375-3; Berg A, 2005, AMINO ACIDS, V29, P221, DOI 10.1007/s00726-005-0230-9; Berg A, 2008, CLIN NUTR, V27, P816, DOI 10.1016/j.clnu.2008.06.006; Biolo G, 2000, CLIN SCI, V99, P189, DOI 10.1042/CS19990254; Brandi G, 2010, ACTA NEUROCHIR, V152, P965, DOI 10.1007/s00701-010-0643-4; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Bruins MJ, 2003, CLIN SCI, V104, P127, DOI 10.1042/CS20020275; Curi R, 2007, FRONT BIOSCI-LANDMRK, V12, P344, DOI 10.2741/2068; Dechelotte P, 2006, CRIT CARE MED, V34, P598, DOI 10.1097/01.CCM.0000201004.30750.D1; Druml W, 2001, AM J CLIN NUTR, V73, P908; El Hage M, 2011, NEUROCHEM INT, V58, P896, DOI 10.1016/j.neuint.2011.02.018; Estivariz CF, 2008, JPEN-PARENTER ENTER, V32, P389, DOI 10.1177/0148607108317880; Fuentes-Orozco C, 2004, CLIN NUTR, V23, P13, DOI 10.1016/S0261-5614(03)00055-4; Gleeson M, 2008, J NUTR, V138, p2045S; Goeters C, 2002, CRIT CARE MED, V30, P2032, DOI 10.1097/00003246-200209000-00013; Griffiths RD, 2002, NUTRITION, V18, P546, DOI 10.1016/S0899-9007(02)00817-1; Griffiths RD, 1997, NUTRITION, V13, P295; HAMMARQVIST F, 1989, ANN SURG, V209, P455, DOI 10.1097/00000658-198904000-00011; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Hertz L, 2011, MAGN RESON IMAGING, V29, P1319, DOI 10.1016/j.mri.2011.04.013; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Johnston CS, 2002, J AM COLL NUTR, V21, P55, DOI 10.1080/07315724.2002.10719194; Kempski O, 1990, Adv Neurol, V52, P219; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; LOCHS H, 1990, JPEN-PARENTER ENTER, V14, pS114, DOI 10.1177/014860719001400416; MACBURNEY M, 1994, J AM DIET ASSOC, V94, P1263, DOI 10.1016/0002-8223(94)92457-0; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Melis GC, 2005, BRIT J NUTR, V94, P19, DOI 10.1079/BJN20051463; Mertes N, 2000, CLIN NUTR, V19, P395, DOI 10.1054/clnu.2000.0142; Mirtendorfer B, 1999, JPEN J PARENTER ENTE, V23, P243; Petersen SR, 1996, J TRAUMA, V41, P687, DOI 10.1097/00005373-199610000-00015; Pouw EM, 1998, AM J RESP CRIT CARE, V158, P797, DOI 10.1164/ajrccm.158.3.9708097; Rodas PC, 2012, CLIN SCI, V122, P591, DOI 10.1042/CS20110520; Schousboe A, 2003, NEUROCHEM INT, V43, P311, DOI 10.1016/S0197-0186(03)00017-2; Sellden E, 1999, ANESTH ANALG, V89, P1551, DOI 10.1097/00000539-199912000-00045; Sellden E, 1998, ANESTH ANALG, V87, P641, DOI 10.1097/00000539-199809000-00029; STEGINK LD, 1982, J NUTR, V112, P1953; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Stover JF, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13245; Suliman ME, 2005, AM J CLIN NUTR, V82, P342; Suzuki M, 2002, J NEUROTRAUM, V19, P285, DOI 10.1089/08977150252807027; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Tjader I, 2004, INTENS CARE MED, V30, P266, DOI 10.1007/s00134-003-2048-9; van Acker BAC, 2000, J NUTR, V130, P1566; Vanek VW, 2011, NUTR CLIN PRACT, V26, P479, DOI 10.1177/0884533611410975; Wischmeyer PE, 2001, CRIT CARE MED, V29, P2075, DOI 10.1097/00003246-200111000-00006; ZIEGLER TR, 1992, ANN INTERN MED, V116, P821, DOI 10.7326/0003-4819-116-10-821	49	15	15	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2014	18	4							R139	10.1186/cc13962			12	Critical Care Medicine	General & Internal Medicine	CA4MJ	WOS:000348878200023	24992948	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
S	Pekic, S; Popovic, V		Fliers, E; Korbonits, M; Romijn, JA		Pekic, Sandra; Popovic, Vera			Alternative causes of hypopituitarism: traumatic brain injury, cranial irradiation, and infections	CLINICAL NEUROENDOCRINOLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							GROWTH-HORMONE DEFICIENCY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY FUNCTION; GAMMA-KNIFE SURGERY; CENTRAL-NERVOUS-SYSTEM; LONG-TERM; POSTTRAUMATIC HYPOPITUITARISM; HIGH-RISK; HYPOTHALAMOPITUITARY DYSFUNCTION; NEUROENDOCRINE DYSFUNCTION		[Pekic, Sandra; Popovic, Vera] Univ Belgrade, Fac Med, Belgrade, Serbia; [Pekic, Sandra; Popovic, Vera] Univ Clin Ctr Belgrade, Clin Endocrinol Diabet & Metab Dis, Belgrade, Serbia	Popovic, V (corresponding author), Clin Endocrinol, Dr Subotica 13, Belgrade 11000, Serbia.	popver@eunet.rs	Pekic, Sandra/S-7175-2016				ADEM A, 1989, BRAIN RES, V503, P299, DOI 10.1016/0006-8993(89)91678-8; Agha A, 2005, J CLIN ENDOCR METAB, V90, P6355, DOI 10.1210/jc.2005-1525; Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; AGHA A, 2005, AM J MED, V118, pE4167; AHMED SR, 1986, ACTA PAEDIATR SCAND, V75, P255, DOI 10.1111/j.1651-2227.1986.tb10195.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Appelman-Dijkstra NM, 2011, J CLIN ENDOCR METAB, V96, P2330, DOI 10.1210/jc.2011-0306; Arunkumar MJ, 2001, NEUROL INDIA, V49, P407; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Beca SG, 2012, PITUITARY, V15, P10, DOI 10.1007/s11102-008-0133-3; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bhandare N, 2008, HEAD NECK-J SCI SPEC, V30, P1182, DOI 10.1002/hed.20847; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; BURMAN P, 1993, LANCET, V342, P1492, DOI 10.1016/0140-6736(93)92975-Y; Burman P, 1996, CLIN ENDOCRINOL, V44, P319, DOI 10.1046/j.1365-2265.1996.617439.x; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; Casanueva FF, 2005, ARCH PHYS MED REHAB, V86, P463, DOI 10.1016/j.apmr.2004.05.018; CDC, 2010, TRAUM BRAIN INJ US; CHEN MS, 1989, JPN J CLIN ONCOL, V19, P265; CHIENG PU, 1991, AM J NEURORADIOL, V12, P661; Ciappetta P, 2008, NEUROSURG REV, V31, P237, DOI 10.1007/s10143-007-0096-2; CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203; CONSTINE LS, 1987, J CLIN ONCOL, V5, P1841, DOI 10.1200/JCO.1987.5.11.1841; Cyran E, 1918, DEUT MED WOCHENSCHR, V44, P1261; Dalan R, 2008, PITUITARY, V11, P299, DOI 10.1007/s11102-007-0057-3; DANIEL PM, 1959, LANCET, V2, P927; DANIEL PM, 1966, PITUITARY GLAND, V2, P519; Darzy Ken H, 2005, Pituitary, V8, P203, DOI 10.1007/s11102-006-6042-4; Darzy KH, 2007, J CLIN ENDOCR METAB, V92, P1666, DOI 10.1210/jc.2006-2599; Darzy KH, 2009, PITUITARY, V12, P40, DOI 10.1007/s11102-008-0088-4; Darzy KH, 2009, CLIN ENDOCRINOL, V70, P287, DOI 10.1111/j.1365-2265.2008.03359.x; Darzy KH, 2009, NAT CLIN PRACT ENDOC, V5, P88, DOI 10.1038/ncpendmet1051; Darzy Ken H., 2009, V15, P1, DOI 10.1159/000207607; Darzy KH, 2003, HORM RES, V59, P1, DOI 10.1159/000067834; De Bellis Annamaria, 2005, Pituitary, V8, P25; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; Dhanwal DK, 2010, PITUITARY, V13, P304, DOI 10.1007/s11102-010-0234-7; EDWARDS OM, 1986, MEDICINE, V65, P281; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; ESCAMILLA RF, 1971, CALIF MED, V115, P72; Fernandez A, 2009, ENDOCR-RELAT CANCER, V16, P733, DOI 10.1677/ERC-08-0231; FORSLUND T, 1992, J INTERN MED, V232, P87, DOI 10.1111/j.1365-2796.1992.tb00555.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; Hautala T, 2002, CLIN INFECT DIS, V35, P96, DOI 10.1086/340859; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Heyman P, 2007, Euro Surveill, V12, pE15; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Ho KKY, 2000, LANCET, V356, P1125, DOI 10.1016/S0140-6736(00)02748-3; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Husain N, 2008, PITUITARY, V11, P313, DOI 10.1007/s11102-007-0068-0; Inoue HK, 1999, STEREOT FUNCT NEUROS, V72, P125, DOI 10.1159/000056448; Iplikcioglu AC, 2004, ACTA NEUROCHIR, V146, P521, DOI 10.1007/s00701-004-0256-x; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Jagannathan J, 2008, NEUROSURGERY, V62, P1262, DOI 10.1227/01.neu.0000333297.41813.3d; JOHANSSON JO, 1995, NEUROENDOCRINOLOGY, V61, P57, DOI 10.1159/000126813; JORGENSEN EV, 1993, J PEDIATR ENDOCRINOL, V6, P131; Kahler O., 1886, Z HEILK, V7, P105; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kim NH, 2001, J KOREAN MED SCI, V16, P355, DOI 10.3346/jkms.2001.16.3.355; Klebanov Iu A, 1990, Klin Med (Mosk), V68, P64; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2009, EUR J ENDOCRINOL, V161, pS75, DOI 10.1530/EJE-09-0328; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kreitschmann-Andermahr I, 2011, EXP CLIN ENDOCR DIAB, V119, P15, DOI 10.1055/s-0030-1253414; LAM KSL, 1991, Q J MED, V78, P165; LAM KSL, 1993, ANN INTERN MED, V118, P701, DOI 10.7326/0003-4819-118-9-199305010-00007; Lamberts SWJ, 1998, LANCET, V352, P127; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; LEIPER AD, 1987, ARCH DIS CHILD, V62, P1107, DOI 10.1136/adc.62.11.1107; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Li H, 2008, NEUROL INDIA, V56, P186; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LIM TH, 1986, AM J NEURORADIOL, V7, P633; Lissett CA, 2001, J CLIN ENDOCR METAB, V86, P663, DOI 10.1210/jc.86.2.663; LITTLEY MD, 1989, Q J MED, V70, P145; Liu WK, 2010, J CLIN NEUROSCI, V17, P1587, DOI 10.1016/j.jocn.2010.03.040; Mahajan T, 2000, J CLIN ENDOCR METAB, V85, P1473, DOI 10.1210/jc.85.4.1473; Maranon G, 1917, NOUV ICONOGR SALPET, V28, P185; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.1007/BF03350340, 10.3275/7045]; Medic-Stojanoska M, 2009, PEDIAT HELATH, V3, P1; Military Health System, 2011, DOD WORLDW NUMB TRAU; MILLIGAN SA, 1984, AM J MED, V77, P760, DOI 10.1016/0002-9343(84)90381-4; Minniti G, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/482861; Moses AM, 2003, J CLIN ENDOCR METAB, V88, P51, DOI 10.1210/jc.2002-020879; Mukherjee A, 2009, EUR J ENDOCRINOL, V161, pS33, DOI 10.1530/EJE-09-0247; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nyberg F, 2000, FRONT NEUROENDOCRIN, V21, P330, DOI 10.1006/frne.2000.0200; Nyberg F, 1996, HORM RES, V45, P18, DOI 10.1159/000184753; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; OGILVYSTUART AL, 1994, J CLIN ENDOCR METAB, V78, P1282, DOI 10.1210/jc.78.6.1282; OGILVYSTUART AL, 1994, CLIN ENDOCRINOL, V41, P163, DOI 10.1111/j.1365-2265.1994.tb02525.x; Park JE, 1996, CLIN NEPHROL, V46, P141; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Pekic S, 2005, ENDOCRINE, V26, P79, DOI 10.1385/ENDO:26:2:079; Pekic S, 2010, LANCET, V375, P432, DOI 10.1016/S0140-6736(09)61835-3; Pepene CE, 2010, PITUITARY, V13, P385, DOI 10.1007/s11102-008-0150-2; Plocinski Przemyslaw, 2007, Wiad Parazytol, V53, P263; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Popovic V, 2002, J CLIN ENDOCR METAB, V87, P2095, DOI 10.1210/jc.87.5.2095; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Roth C, 2001, NEUROSCI LETT, V297, P45, DOI 10.1016/S0304-3940(00)01663-3; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; SAMAAN NA, 1987, J LAB CLIN MED, V109, P364; SAMAAN NA, 1982, INT J RADIAT ONCOL, V8, P1857, DOI 10.1016/0360-3016(82)90442-4; Schaefer S, 2008, EUR J ENDOCRINOL, V158, P3, DOI 10.1530/EJE-07-0484; Scheinpflug K, 2006, EXP CLIN ENDOCR DIAB, V114, P31, DOI 10.1055/s-2005-873014; Schmiegelow M, 2000, CLIN ENDOCRINOL, V53, P191; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; SETTERGREN B, 1992, NEPHRON, V61, P234, DOI 10.1159/000186883; SHALET SM, 1976, CANCER, V37, P1144, DOI 10.1002/1097-0142(197602)37:2+<1144::AID-CNCR2820370824>3.0.CO;2-U; Shalet SM, 1997, J ROY SOC MED, V90, P192, DOI 10.1177/014107689709000404; SHALET SM, 1976, ARCH DIS CHILD, V51, P489, DOI 10.1136/adc.51.7.489; SHALET SM, 1977, ACTA ENDOCRINOL-COP, V84, P673, DOI 10.1530/acta.0.0840673; Sharma MC, 2000, CLIN NEUROL NEUROSUR, V102, P72, DOI 10.1016/S0303-8467(00)00063-9; Sicignano G, 2012, RADIOTHER ONCOL, V104, P119, DOI 10.1016/j.radonc.2012.03.021; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9; Starke RM, 2012, J NEUROSURG, V117, P129, DOI 10.3171/2012.4.JNS112250; Stein TD, 2002, J NEUROPATH EXP NEUR, V61, P1100, DOI 10.1093/jnen/61.12.1100; Stojanovic M, 2008, J CLIN ENDOCR METAB, V93, P2722, DOI 10.1210/jc.2008-0311; SUH DC, 1995, AM J NEURORADIOL, V16, P175; Tanriverdi F, 2008, J ENDOCRINOL INVEST, V31, P489, DOI 10.1007/BF03346395; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Torres A M, 2000, Endocr Pract, V6, P26; Treip C S, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P178; Tsiakalos A, 2010, J CLIN ENDOCR METAB, V95, P3277, DOI 10.1210/jc.2010-0144; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; VALTONEN M, 1995, SCAND J INFECT DIS, V27, P515, DOI 10.3109/00365549509047057; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; van der Eerden AW, 2010, EUR J ENDOCRINOL, V162, P19, DOI 10.1530/EJE-09-0436; van Nieuwpoort IC, 2008, EUR J ENDOCRINOL, V159, pS53, DOI 10.1530/EJE-08-0279; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Vates GE, 2001, J NEUROSURG, V95, P233, DOI 10.3171/jns.2001.95.2.0233; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009; Wilkinson CW, 2012, FRONT NEUROL, V3, P1; Zhang X, 2002, J CLIN PATHOL, V55, P965, DOI 10.1136/jcp.55.12.965; Zhang XL, 2012, CLIN NEUROL NEUROSUR, V114, P957, DOI 10.1016/j.clineuro.2012.02.020	172	15	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-444-62612-7; 978-0-444-59602-4	HAND CLINIC			2014	124						271	290					20	Endocrinology & Metabolism; Clinical Neurology	Endocrinology & Metabolism; Neurosciences & Neurology	BC1FG	WOS:000350056900020	25248593				2021-06-18	
S	Shin, SS; Pathak, S; Presson, N; Bird, W; Wagener, L; Schneider, W; Okonkwo, DO; Fernandez-Miranda, JC		Niranjan, A; Lunsford, LD		Shin, Samuel S.; Pathak, Sudhir; Presson, Nora; Bird, William; Wagener, Lauren; Schneider, Walter; Okonkwo, David O.; Fernandez-Miranda, Juan C.			Detection of White Matter Injury in Concussion Using High-Definition Fiber Tractography	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; TENSOR; IMPAIRMENT; MRI	Over the last few decades, structural imaging techniques of the human brain have undergone significant strides. High resolution provided by recent developments in magnetic resonance imaging (MRI) allows improved detection of injured regions in patients with moderate-to-severe traumatic brain injury (TBI). In addition, diffusion imaging techniques such as diffusion tensor imaging (DTI) has gained much interest recently due to its possible utility in detecting structural integrity of white matter pathways in mild TBI (mTBI) cases. However, the results from recent DTI studies in mTBI patients remain equivocal. Also, there are important shortcomings for DTI such as limited resolution in areas of multiple crossings and false tract formation. The detection of white matter damage in concussion remains challenging, and development of imaging biomarkers for mTBI is still in great need. In this chapter, we discuss our experience with high-definition fiber tracking (HDFT), a diffusion spectrum imaging-based technique. We also discuss ongoing developments and specific advantages HDFT may offer concussion patients. (C) 2014 S. Karger AG, Basel	[Shin, Samuel S.; Okonkwo, David O.; Fernandez-Miranda, Juan C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Pathak, Sudhir; Presson, Nora; Bird, William; Wagener, Lauren; Schneider, Walter] Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA	Fernandez-Miranda, JC (corresponding author), UPMC Presbyterian, Dept Neurol Surg, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	fernandezmirandajc@upmc.edu					Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fernandez-Miranda JC, 2010, J NEUROSURG, V113, P990, DOI 10.3171/2009.10.JNS09933; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Kraus J, 1989, EPIDEMIOLOGY MILD HE; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Verstynen T, 2011, J NEUROPHYSIOL, V105, P336, DOI 10.1152/jn.00698.2010; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642	26	15	15	0	4	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						86	93		10.1159/000358767	10.1159/isbn.978-3-318-02649-8		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000009	24923395				2021-06-18	
J	Sundaramurthy, A; Chandra, N				Sundaramurthy, Aravind; Chandra, Namas			A parametric approach to shape field-relevant blast wave profiles in compressed-gas-driven shock tube	FRONTIERS IN NEUROLOGY			English	Article						primary blast injury; explosion modeling; shock tube; blast induced neurotrauma; shock tube adjustable parameters; shock wave parameters	BRAIN-INJURY; MECHANISMS; RAT; PATHOPHYSIOLOGY; OVERPRESSURE; EXPOSURES; IMPACT; MODEL	Detonation of a high-explosive produces shock-blast wave, shrapnel, and gaseous products. While direct exposure to blast is a concern near the epicenter, shock-blast can affect subjects, even at farther distances. When a pure shock-blast wave encounters the subject, in the absence of shrapnels, fall, or gaseous products the loading is termed as primary blast loading and is the subject of this paper. The wave profile is characterized by blast overpressure, positive time duration, and impulse and called herein as shock-blast wave parameters (SWPs). These parameters in turn are uniquely determined by the strength of high explosive and the distance of the human subjects from the epicenter. The shape and magnitude of the profile determine the severity of injury to the subjects. As shown in some of our recent works (1-3), the profile not only determines the survival of the subjects (e.g., animals) but also the acute and chronic biomechanical injuries along with the following biochemical sequelae. It is extremely important to carefully design and operate the shock tube to produce field-relevant SWPs. Furthermore, it is vital to identify and eliminate the artifacts that are inadvertently introduced in the shock-blast profile that may affect the results. In this work, we examine the relationship between shock tube adjustable parameters (SAPs) and SWPs that can be used to control the blast profile; the results can be easily applied to many of the laboratory shock tubes. Further, replication of shock profile (magnitude and shape) can be related to field explosions and can be a standard in comparing results across different laboratories. Forty experiments are carried out by judiciously varying SAPs such as membrane thickness, breech length (66.68-1209.68 mm), measurement location, and type of driver gas (nitrogen, helium). The effects SAPs have on the resulting shock-blast profiles are shown. Also, the shock-blast profiles of a TNT explosion from ConWep software is compared with the profiles obtained from the shock tube. To conclude, our experimental results demonstrate that a compressed-gas shock tube when designed and operated carefully can replicate the blast time profiles of field explosions accurately. Such a faithful replication is an essential first step when studying the effects of blast induced neurotrauma using animal models.	[Sundaramurthy, Aravind; Chandra, Namas] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Newark, NJ 07102 USA	Chandra, N (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Newark, NJ 07102 USA.	namas.chandra@njit.edu	Sundaramurthy, Aravind/O-2047-2019	Sundaramurthy, Aravind/0000-0002-0359-8680	US Army Research Office	We kindly acknowledge the financial support provided by the US Army Research Office. We are also grateful for Brandon Perry and Veera Selvan for their contribution to some of the experimental work.	[Anonymous], 2006, AEP55 NATO, V2; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N., 2011, U.S. provisional patent application, Patent No. 61542354; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fischer H, 2010, US MILITARY CASUALTY; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gould K., 1981, HIGH EXPLOSIVE FIELD; HSD, HOM SEC BOMB THREAT; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kleinschmit NN, 2011, THESIS U NEBRASKA LI; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kuppuswamy VS, 2013, THESIS U NEBRASKA LI; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mott D, 2008, APS DIV FLUID DYN M, V53; PAYMAN W, 1946, PROC R SOC LON SER-A, V186, P293, DOI 10.1098/rspa.1946.0045; Prima V, 2013, J NEUROTRAUM, V30, P1881, DOI 10.1089/neu.2012.2758; Rafaels K, 2010, THESIS U VIRGINIA CH; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ritzel D., 1997, P 21 INT S SHOCK WAV, P97; Ritzel D. V., 2011, P HFM 207 NATO S SUR; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	33	15	15	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								253	10.3389/fneur.2014.00253			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V42QW	WOS:000209629300239	25520701	DOAJ Gold, Green Published			2021-06-18	
J	Tai, YT; Lee, WY; Lee, FP; Lin, TJ; Shih, CL; Wang, JY; Chiu, WT; Hung, KS				Tai, Yu-Ting; Lee, Wen-Yuan; Lee, Fei-Peng; Lin, Tien-Jen; Shih, Chia-Lin; Wang, Jia-Yi; Chiu, Wen-Ta; Hung, Kuo-Sheng			Low Dose of Valproate Improves Motor Function after Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							MECHANISMS; DAMAGE; RATS	Background. Traumatic brain injuries (TBIs) are a major health care problem worldwide. Approximately 1.5 million new TBI cases occur annually in the United States, with mortality rates ranging between 35% and 40% in severe patients. Despite the incidence of these injuries and their substantial socioeconomic implications, no specific pharmacological intervention is available for clinical use. Several studies have indicated that 300 mg/kg or 400 mg/kg of valproate (VPA) exhibits neuroprotective effects in animal models. However, humans cannot tolerate high doses of VPA. This study aims to investigate whether 30 mg/kg of VPA administered to rats affects TBIs. Methods. We used a rat model to test the effects of 30 mg/kg of VPA on TBIs. Molecular identifications for histone acetylation and phosphorylation of cAMP response element-binding protein (CREB) and phosphorylated extracellular signal regulated kinase (ERK) were performed. Results. The results indicated that treating adult rats with VPA after This significantly decreased the contusion volume and recovery of contusion-related skilled forelimb reaching deficits. Applying VPA also increased histone acetylation, p-ERK, and p-CREB expression in the brain. Furthermore, applying VPA reduced inflammation, glial fibrillary acidic protein activation, and apoptosis. Conclusion. This study found that 30 mg/kg of VPA assists in treating TBIs in rat models.	[Tai, Yu-Ting] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei 116, Taiwan; [Lee, Wen-Yuan] China Med Univ, China Med Univ Hosp, Dept Neurosurg, Taipei Branch, Taipei, Taiwan; [Lee, Fei-Peng] Taipei Med Univ, Wan Fang Hosp, Sch Med, Clin Res Ctr,Dept Otolaryngol, Taipei, Taiwan; [Lin, Tien-Jen; Shih, Chia-Lin; Chiu, Wen-Ta; Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Hosp, Grad Inst Injury Prevent & Control, Clin Res Ctr,Dept Neurosurg, Taipei 116, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Biomed Sci, Taipei, Taiwan	Hung, KS (corresponding author), Taipei Med Univ, Wan Fang Hosp, Grad Inst Injury Prevent & Control, Clin Res Ctr,Dept Neurosurg, 111,Sect 3,Hsing Long Rd, Taipei 116, Taiwan.	kshung25@gmail.com		Fei-Peng, Lee/0000-0002-6788-4336; Wang, Jia-Yi/0000-0002-9106-3351; Hung, Kuo-Sheng/0000-0002-4147-0960	Center of Excellence for Clinical Trial and Research in Neuroscience from the Department of Health, Taiwan [DOH101-TD-B-111-003]; National Science Counsel, TaiwanMinistry of Science and Technology, Taiwan [NSC 99-2314-B-038-004-MY3, NSC 102-2321-B-038-003, NSC 99-2323-B-038-003]	The authors thank Dr. Shih-Yen Tsai from the Research Service, Edward Hines Jr. VA Hospital, USA, for technical support in the skilled forelimb reaching test. This study was partly supported by Grants of Center of Excellence for Clinical Trial and Research in Neuroscience from the Department of Health, Taiwan, DOH101-TD-B-111-003, and the National Science Counsel, Taiwan, NSC 99-2314-B-038-004-MY3, NSC 102-2321-B-038-003 and NSC 99-2323-B-038-003.	Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Chatpun S, 2011, J TRAUMA, V70, P787, DOI 10.1097/TA.0b013e3181e7954f; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Miller Laura C, 2008, Expert Rev Neurother, V8, P1817, DOI 10.1586/14737175.8.12.1817; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Sacrey LAR, 2009, BEHAV BRAIN RES, V204, P153, DOI 10.1016/j.bbr.2009.05.035; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Whishaw I. Q., 2005, BEHAV LAB RAT HDB TE; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	22	15	15	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								980657	10.1155/2014/980657			8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AA8SS	WOS:000331365800001	24689067	DOAJ Gold, Green Published			2021-06-18	
J	Vikane, E; Hellstrom, T; Roe, C; Bautz-Holter, E; Assmus, J; Skouen, JS				Vikane, Eirik; Hellstrom, Torgeir; Roe, Cecilie; Bautz-Holter, Erik; Assmus, Jorg; Skouen, Jan Sture			Missing a follow-up after mild traumatic brain injury-Does it matter?	BRAIN INJURY			English	Article						Attendance or not to follow up; mild traumatic brain injury; return-to-work	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; TASK-FORCE; RANDOMIZED-TRIAL; RETURN; SEVERITY; WORK	Objective: This study sought to identify potential differing clinical characteristics between patients with a mild traumatic brain injury (MTBI) who attended a planned follow-up session and not. This study investigated whether clinical characteristics and attendance for a planned follow-up service 2-months after injury could be related to return-to-work (RTW) 1-year later. Method: Prospective cohort study of 343 patients with MTBI admitted consecutively to the Department of Neurosurgery in 2009-2011. Demographic and clinical data were obtained from the hospital files and data about sick leave from The Norwegian Labour and Welfare Service. Patients were categorized into two groups according to their attendance. Results: One hundred and sixty-one (67%) patients attended (AG) and 80 (33%) did not (NAG) attend their follow-up appointments. The AG had significantly more frequently intracranial pathology on CT scan, had consumed less alcohol and were older. Logistic regression showed that follow-up attendance (OR=16.89) and sick leave before injury (OR=9.70) are unfavourably related to RTW at 12-months. Skull fracture and cause of injury had no influence of the outcome. Conclusion: Not attending the follow-up has a favourable outcome after MBTI, indicating that these patients have a reduced need for medical and rehabilitation support for their brain injury.	[Vikane, Eirik; Skouen, Jan Sture] Haukeland Hosp, Dept Phys Med & Rehabil, N-5021 Bergen, Norway; [Vikane, Eirik; Skouen, Jan Sture] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Hellstrom, Torgeir; Roe, Cecilie; Bautz-Holter, Erik] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, Cecilie; Bautz-Holter, Erik] Univ Oslo, Fac Med, Oslo, Norway; [Assmus, Jorg] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway	Vikane, E (corresponding author), Haukeland Hosp, Dept Phys Med & Rehabil, POB 1400, N-5021 Bergen, Norway.	eirik.vikane@gmail.com			Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds	The first author Vikane has been financially supported in this project by the Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds. The authors alone are responsible for the content and writing of the paper.	Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Heskestad B, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-10; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Matsukawa H, 2013, BRAIN INJURY, V27, P1409, DOI 10.3109/02699052.2013.823655; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	34	15	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1374	1380		10.3109/02699052.2014.919532			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200003	24946256				2021-06-18	
J	Wei, X; Li, Y; Sun, XD; Zhu, XT; Feng, YH; Liu, J; Jiang, YJ; Shang, H; Cui, LW; Cao, YM				Wei, Xu; Li, Ying; Sun, Xiaodan; Zhu, Xiaotong; Feng, Yonghui; Liu, Jun; Jiang, Yongjun; Shang, Hong; Cui, Liwang; Cao, Yaming			Erythropoietin Protects against Murine Cerebral Malaria through Actions on Host Cellular Immunity	INFECTION AND IMMUNITY			English	Article							REGULATORY T-CELLS; BLOOD-BRAIN-BARRIER; DENDRITIC CELLS; PLASMODIUM-FALCIPARUM; IN-VITRO; RESPONSES; INNATE; CD8(+); MODEL; INDUCTION	Cerebral malaria (CM) is associated with excessive host proinflammatory responses and endothelial activation. The hematopoietic hormone erythropoietin (EPO) possesses neuroprotective functions in animal models of ischemic-hypoxic, traumatic, and inflammatory injuries. In the Plasmodium berghei ANKA model of experimental CM (ECM), recombinant human EPO (rhEPO) has shown evident protection against ECM. To elucidate the mechanism of EPO in this ECM model, we investigated the effect of rhEPO on host cellular immune responses. We demonstrated that improved survival of mice with ECM after rhEPO treatment was associated with reduced endothelial activation and improved integrity of the blood-brain barrier. Our results revealed that rhEPO downregulated the inflammatory responses by directly inhibiting the levels and functions of splenic dendritic cells. Conversely, rhEPO treatment led to significant expansion of regulatory T cells and increased expression of the receptor cytotoxic T lymphocyte antigen 4 (CTLA-4). The data presented here provide evidence of the direct effect of rhEPO on host cellular immunity during ECM.	[Wei, Xu; Li, Ying; Sun, Xiaodan; Zhu, Xiaotong; Feng, Yonghui; Liu, Jun; Cao, Yaming] China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang, Liaoning, Peoples R China; [Jiang, Yongjun; Shang, Hong] China Med Univ, Hosp 1, Dept Lab Med, Shenyang, Liaoning, Peoples R China; [Jiang, Yongjun; Shang, Hong] China Med Univ, Hosp 1, Minist Hlth, Key Lab AIDS Immunol, Shenyang, Liaoning, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Cao, YM (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang, Liaoning, Peoples R China.	luc2@psu.edu; ymcao@mail.cmu.edu.cn			National Institute of Allergy and Infectious Diseases, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI099611, U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI099611, U19AI089672] Funding Source: NIH RePORTER	This study was funded by the National Institute of Allergy and Infectious Diseases, NIH (R01AI099611 to Y.C. and U19AI089672 to L.C.).	Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bauer PR, 2002, MICROCIRCULATION, V9, P463, DOI 10.1038/sj.mn.7800159; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cao Ya-Ming, 1998, Parasitology International, V47, P157, DOI 10.1016/S1383-5769(98)00014-2; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Chen G, 2009, PARASITOLOGY, V136, P1107, DOI 10.1017/S0031182009990370; Chen SJ, 2010, CLIN EXP IMMUNOL, V162, P210, DOI 10.1111/j.1365-2249.2010.04238.x; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Core A, 2011, EXP PARASITOL, V127, P500, DOI 10.1016/j.exppara.2010.09.010; D'Andrea RJ, 2000, EXP HEMATOL, V28, P231, DOI 10.1016/S0301-472X(99)00159-9; DEKOSSODO S, 1993, STEM CELLS, V11, P41, DOI 10.1002/stem.5530110108; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; do Rosario APF, 2012, INT J PARASITOL, V42, P549, DOI 10.1016/j.ijpara.2012.03.010; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Favre N, 1999, MICROBES INFECT, V1, P961, DOI 10.1016/S1286-4579(99)80513-9; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Hempel C, 2011, AM J PATHOL, V179, P1939, DOI 10.1016/j.ajpath.2011.06.027; Ing R, 2006, J IMMUNOL, V176, P441, DOI 10.4049/jimmunol.176.1.441; Jangpatarapongsa K, 2008, EUR J IMMUNOL, V38, P2697, DOI 10.1002/eji.200838186; Jelkmann W, 2005, CURR PHARM BIOTECHNO, V6, P65; Kaiser K, 2006, J INFECT DIS, V193, P987, DOI 10.1086/500844; Katz O, 2007, EUR J IMMUNOL, V37, P1584, DOI 10.1002/eji.200637025; KRANTZ SB, 1991, BLOOD, V77, P419; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Kurtzhals JAL, 1997, BRIT J HAEMATOL, V97, P169, DOI 10.1046/j.1365-2141.1997.82654.x; Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Lifshitz L, 2009, MOL IMMUNOL, V46, P713, DOI 10.1016/j.molimm.2008.10.004; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Mittelman M, 2001, P NATL ACAD SCI USA, V98, P5181, DOI 10.1073/pnas.081275298; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Pouniotis DS, 2005, J IMMUNOL, V175, P3525, DOI 10.4049/jimmunol.175.6.3525; Prutchi-Sagiv S, 2006, BRIT J HAEMATOL, V135, P660, DOI 10.1111/j.1365-2141.2006.06366.x; Renia L, 2012, VIRULENCE, V3, P193, DOI 10.4161/viru.19013; Sagiv SP, 2008, EXP HEMATOL, V36, P1682, DOI 10.1016/j.exphem.2008.07.010; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Wiese L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-3; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yamakuchi M, 2007, P NATL ACAD SCI USA, V104, P1301, DOI 10.1073/pnas.0602035104; Yanez DM, 1996, J IMMUNOL, V157, P1620; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; Zheng W, 2009, FOLIA PARASIT, V56, P242	63	15	18	0	9	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	JAN	2014	82	1					165	173		10.1128/IAI.00929-13			9	Immunology; Infectious Diseases	Immunology; Infectious Diseases	278OM	WOS:000328899600017	24126529	Green Published, Bronze			2021-06-18	
J	Yadav, NK; Thiagarajan, P; Ciuffreda, KJ				Yadav, Naveen K.; Thiagarajan, Preethi; Ciuffreda, Kenneth J.			Effect of oculomotor vision rehabilitation on the visual-evoked potential and visual attention in mild traumatic brain injury	BRAIN INJURY			English	Article						Alpha band power; attenuation ratio; mild traumatic brain injury; oculomotor vision rehabilitation; visual attention; visual-evoked potential amplitude; visual-evoked potential latency	EEG ALPHA; VEP; ACCOMMODATION; PERFORMANCE; PROTOCOL; TBI	Primary objective: The purpose of the experiment was to investigate the effect of oculomotor vision rehabilitation (OVR) on the visual-evoked potential (VEP) and visual attention in the mTBI population. Research design and methods: Subjects (n = 7) were adults with a history of mild traumatic brain injury (mTBI). Each received 9 hours of OVR over a 6-week period. The effects of OVR on VEP amplitude and latency, the attention-related alpha band (8-13 Hz) power (mu V-2) and the clinical Visual Search and Attention Test (VSAT) were assessed before and after the OVR. Results: After the OVR, the VEP amplitude increased and its variability decreased. There was no change in VEP latency, which was normal. Alpha band power increased, as did the VSAT score, following the OVR. Conclusions: The significant changes in most test parameters suggest that OVR affects the visual system at early visuo-cortical levels, as well as other pathways which are involved in visual attention.	[Yadav, Naveen K.; Thiagarajan, Preethi; Ciuffreda, Kenneth J.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA	Yadav, NK (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	nyadav@sunyopt.edu					Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Briggs F, 2013, NATURE, V499, P476, DOI 10.1038/nature12276; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda KJ, 2013, BRAIN INJURY, V27, P41, DOI 10.3109/02699052.2012.700088; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Ciuffreda KJ, 2001, VISUAL VESTIBULAR CO, P77; Cohen A H, 1992, J Am Optom Assoc, V63, P569; DUMERMUTH G, 1987, NEUROPSYCHOBIOLOGY, V17, P85, DOI 10.1159/000118345; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; FULLER PW, 1978, J LEARN DISABIL-US, V11, P303, DOI 10.1177/002221947801100507; Gomarus HK, 2009, CLIN NEUROPHYSIOL, V120, P73, DOI 10.1016/j.clinph.2008.10.017; Green W, 2010, OPTOMETRY, V81, P129, DOI 10.1016/j.optm.2009.07.015; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; LEGEWIE H, 1969, ELECTROEN CLIN NEURO, V27, P470, DOI 10.1016/0013-4694(69)90187-4; Ludlam WM, 1996, NEUROREHABILITATION, V6, P183, DOI 10.3233/NRE-1996-6304; LUDLAM WM, 1979, J AM OPTOM ASSOC, V50, P111; Luria AR, 1966, HIGHER CORTICAL FUNC; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; MILLODOT M, 1981, BRIT J OPHTHALMOL, V65, P294, DOI 10.1136/bjo.65.4.294; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M., 2008, CLIN MANAGEMENT BINO, V3rd; Scheiman M, 2001, VISUAL VESTIBULAR CO, P89; Schnabel R, 2012, CLIN NEUROPSYCHOL, V26, P769, DOI 10.1080/13854046.2012.693541; Shelley-Trembley J, 2012, J CORRECTIONAL ED, V63, P49; Solan HA, 2003, J LEARN DISABIL-US, V36, P556, DOI 10.1177/00222194030360060601; Solan HA, 2001, J LEARN DISABIL-US, V34, P107, DOI 10.1177/002221940103400202; Solan Harold A, 2004, Optometry, V75, P640, DOI 10.1016/S1529-1839(04)70211-0; Steinman S. B., 2000, FDN BINOCULAR VISION; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Thiabault LE, 1990, 34 ANN P ASS ADV AUT, V34, P337; Thiagarajan P, NEUROREHABI IN PRESS; Thiagarajan P., 2012, THESIS STATE U NEW Y; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Trenerry MR, 1989, PROFESSIONAL MANUAL; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Willeford KT, 2013, DOC OPHTHALMOL, V126, P105, DOI 10.1007/s10633-012-9363-9; Willeford KT, 2013, DOC OPHTHALMOL, V126, P29, DOI 10.1007/s10633-012-9357-7; Yadav NK, 2012, DOC OPHTHALMOL, V124, P177, DOI 10.1007/s10633-012-9319-0	59	15	15	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					922	929		10.3109/02699052.2014.887227			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600006	24564831				2021-06-18	
J	Zhu, LH; Bai, X; Wang, SY; Hu, Y; Wang, T; Qian, LJ; Jiang, L				Zhu, Lihua; Bai, Xiang; Wang, Shiyu; Hu, Yan; Wang, Ting; Qian, Lijuan; Jiang, Li			Recombinant Human Erythropoietin Augments Angiogenic Responses in a Neonatal Rat Model of Cerebral Unilateral Hypoxia-Ischemia	NEONATOLOGY			English	Article						Erythropoietin; Premature brain; Hypoxia-ischemia; Angiogenesis factor; Vascular endothelial growth factor; Angiopoietin-1	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL PROGENITOR-CELL; THERAPEUTIC ANGIOGENESIS; PREMATURE-INFANTS; PRETERM INFANTS; GROWTH-FACTOR; PROTECTS	Background: Recombinant human erythropoietin (rh-EPO) has been used as a drug to treat premature infant anemia for over a decade. In addition to its erythropoietic effect, rh-EPO has also been reported to have protective effects against brain injury. Objectives: Our aim was to evaluate the levels of angiogenesis-related cells (CD34+ cells) and angiogenic factors (vascular endothelial growth factor, VEGF, and angiopoietin-1, Ang-1) in a neonatal rat model of cerebral unilateral hypoxia-ischemia (HI) and to identify the effects of rh-EPO on angiogenic responses. Methods: Postnatal day 3 (PD3) rats underwent permanent ligation of the right common carotid artery followed by 6% O-2 for 4 h (HI) or sham operation and normoxic exposure (sham). Immediately after HI, the rats received a single intraperitoneal injection of rh-EPO (5 U/g) or saline. Angiogenesis-related cells (CD34+ cells) and angiogenic factors (VEGF and Ang-1) were examined on PD5, 7, 10 and 14. Results: Compared with the sham rats, the number of CD34+ cells in HI rats increased from PD5 to 7 but decreased from PD10 to 14. VEGF and Ang-1 mRNA levels both increased from PD5 to 14. CD34+ cells, VEGF and Ang-1 were all upregulated in rh-EPO-treated rats compared with HI rats. Conclusions: In the present study, we show the angiogenic effects of rh-EPO in a rat model of neonatal cerebral unilateral HI. Our results highlight the powerful therapeutic potential of rh-EPO treatment of HI premature brain for the enhancement of angiogenic responses. (C) 2014 S. Karger AG, Basel	[Zhu, Lihua] Southeast Univ, Res Ctr Learning Sci, Nanjing 210009, Jiangsu, Peoples R China; [Zhu, Lihua; Bai, Xiang; Wang, Shiyu] Southeast Univ, Clin Med Coll, Div Pediat, Nanjing 210009, Jiangsu, Peoples R China; [Hu, Yan] Southeast Univ, Zhongda Hosp, Dept Obstet & Gynaecol, Nanjing 210009, Jiangsu, Peoples R China; [Wang, Ting] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210009, Jiangsu, Peoples R China; [Qian, Lijuan; Jiang, Li] Southeast Univ, Zhongda Hosp, Dept Pediat, Nanjing 210009, Jiangsu, Peoples R China	Jiang, L (corresponding author), Southeast Univ, Zhongda Hosp, Dept Pediat, Nanjing 210009, Jiangsu, Peoples R China.	jiangli77777@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81370739]; Science and Innovation Funds of Jiangsu Province [CXLX12_0123]	This work was supported by grants from the National Natural Science Foundation of China (81370739) and the Science and Innovation Funds of Jiangsu Province (CXLX12_0123).	Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Fan YF, 2007, J NEUROIMMUNE PHARM, V2, P284, DOI 10.1007/s11481-007-9073-3; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Kato S, 2011, J NEUROSCI RES, V89, P1566, DOI 10.1002/jnr.22702; Lu JJ, 2014, J NANOSCI NANOTECHNO, V14, P5614, DOI 10.1166/jnn.2014.8728; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Mazur M, 2010, J NEUROSURG-PEDIATR, V6, P206, DOI 10.3171/2010.5.PEDS1032; McPherson RJ, 2007, NEONATOLOGY, V91, P36, DOI 10.1159/000096969; McPherson RJ, 2010, CURR OPIN PEDIATR, V22, P139, DOI 10.1097/MOP.0b013e328336eb57; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Okada S, 2008, DIABETES CARE, V31, P157, DOI 10.2337/dc07-1125; PHIBBS RH, 1995, J PERINAT MED, V23, P127, DOI 10.1515/jpme.1995.23.1-2.127; Rayjada N, 2012, NEONATOLOGY, V102, P287, DOI 10.1159/000341615; Rees S, 2010, J NEUROPATH EXP NEUR, V69, P306, DOI 10.1097/NEN.0b013e3181d27138; Shin SH, 2013, PHARM RES-DORDR, V30, P2157, DOI 10.1007/s11095-013-1076-6; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; Volpe J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2001, NEUROLOGY NEWBORN, P217; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wan T, 2012, INT J PHARMACEUT, V422, P462; Westenbrink BD, 2007, EUR HEART J, V28, P2018, DOI 10.1093/eurheartj/ehm177; Yang YJ, 2005, CHIN J CONT PEDIAT, V7, P25; Zhu LH, 2007, J CLIN PEDIAT, V25, P784	27	15	21	2	19	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1661-7800	1661-7819		NEONATOLOGY	Neonatology		2014	106	2					143	148		10.1159/000362262			6	Pediatrics	Pediatrics	AM9WO	WOS:000340231900011	24969821				2021-06-18	
J	Rossi, S; Bozzali, M; Bari, M; Mori, F; Studer, V; Motta, C; Buttari, F; Cercignani, M; Gravina, P; Mastrangelo, N; Castelli, M; Mancino, R; Nucci, C; Sottile, F; Bernardini, S; Maccarrone, M; Centonze, D				Rossi, Silvia; Bozzali, Marco; Bari, Monica; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Cercignani, Mara; Gravina, Paolo; Mastrangelo, Nicolina; Castelli, Maura; Mancino, Raffaele; Nucci, Carlo; Sottile, Fabrizio; Bernardini, Sergio; Maccarrone, Mauro; Centonze, Diego			Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OPTICAL COHERENCE TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; NERVE-FIBER LAYER; COGNITIVE IMPAIRMENT; ENDOCANNABINOID SYSTEM; CB2 RECEPTORS; DISEASE; ATROPHY; ABNORMALITIES	Genetic ablation of type-1 cannabinoid receptors (CB(1)Rs) exacerbates the neurodegenerative damage of experimental autoimmune encephalomyelitis, the rodent model of multiple sclerosis (MS). To address the role on CB(1)Rs in the pathophysiology of human MS, we first investigated the impact of AAT trinucleotide short tandem repeat polymorphism of CNR1 gene on CB1R cell expression, and secondly on the inflammatory neurodegeneration process responsible for irreversible disability in MS patients. We found that MS patients with long AAT repeats within the CNR1 gene (>= 12 in both alleles) had more pronounced neuronal degeneration in response to inflammatory white matter damage both in the optic nerve and in the cortex. Optical Coherence Tomography (OCT), in fact, showed more severe alterations of the retinal nerve fiber layer (RNFL) thickness and of the macular volume (MV) after an episode of optic neuritis in MS patients carrying the long AAT genotype of CNR1. MS patients with long AAT repeats also had magnetic resonance imaging (MRI) evidence of increased gray matter damage in response to inflammatory lesions of the white matter, especially in areas with a major role in cognition. In parallel, visual abilities evaluated at the low contrast acuity test, and cognitive performances were negatively influenced by the long AAT CNR1 genotype in our sample of MS patients. Our results demonstrate the biological relevance of the (AAT)(n) CNR1 repeats in the inflammatory neurodegenerative damage of MS.	[Rossi, Silvia; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Castelli, Maura; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy; [Rossi, Silvia; Bozzali, Marco; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Cercignani, Mara; Castelli, Maura; Maccarrone, Mauro; Centonze, Diego] Fdn Santa Lucia, CERC, Rome, Italy; [Bari, Monica; Mastrangelo, Nicolina] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Chirurg, Rome, Italy; [Cercignani, Mara] Univ Sussex, Clin Imaging Sci Ctr, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Gravina, Paolo; Bernardini, Sergio] Policlin Tor Vergata, Dipartimento Med Lab, Rome, Italy; [Mancino, Raffaele; Nucci, Carlo] Univ Roma Tor Vergata, Dipartimento Biopatol, Clin Oculist, Rome, Italy; [Sottile, Fabrizio] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Bernardini, Sergio] Univ Roma Tor Vergata, Dipartimento Med Interna, Rome, Italy; [Maccarrone, Mauro] Campus Biomed Univ Rome, Sch Med, Ctr Integrated Res, Rome, Italy	Centonze, D (corresponding author), Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy.	centonze@uniroma2.it	Motta, Caterina/L-1513-2018; Centonze, Diego/J-7767-2016; Maccarrone, Mauro/K-5398-2012	Centonze, Diego/0000-0002-8390-8545; Maccarrone, Mauro/0000-0002-3990-2963; Rossi, Silvia/0000-0003-3257-8248; Cercignani, Mara/0000-0002-4550-2456; Mori, Francesco/0000-0002-4761-6174; studer, valeria/0000-0003-2529-7640; Bozzali, Marco/0000-0002-0568-2026	Fondazione Italiana Sclerosi Multipla (FISM Special Project); Italian National Ministero dell'Universita	This investigation was supported by Fondazione Italiana Sclerosi Multipla (FISM Special Project to DC), and by the Italian National Ministero dell'Universita to DC and MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar N, 2010, CAN J NEUROL SCI, V37, P608, DOI 10.1017/S0317167100010775; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Amato MP, 2006, J NEUROL, V253, P1054, DOI 10.1007/s00415-006-0161-8; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Arevalo-Martin A, 2012, NEUROPHARMACOLOGY, V63, P385, DOI 10.1016/j.neuropharm.2012.04.012; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Baier ML, 2005, NEUROLOGY, V64, P992, DOI 10.1212/01.WNL.0000154521.40686.63; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Barbarotto R, 1998, ITAL J NEUROL SCI, V19, P161, DOI 10.1007/BF00831566; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Catani MV, 2010, CURR NEUROVASC RES, V7, P311; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Costello F, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/148394; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Fine EM, 2009, J CLIN EXP NEUROPSYC, V31, P624, DOI 10.1080/13803390802419017; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Forn C, 2007, HUM BRAIN MAPP, V28, P424, DOI 10.1002/hbm.20284; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Horakova D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-10; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Huey ED, 2009, NEUROLOGY, V72, P453, DOI 10.1212/01.wnl.0000341781.39164.26; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2009, CURR TOP BEHAV NEURO, V1, P65, DOI 10.1007/978-3-540-88955-7_3; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanz M, 2007, J NEUROL, V254, P43, DOI 10.1007/s00415-007-2011-8; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lidster K, 2012, CNS NEUROL DISORD-DR, V11, P518, DOI 10.2174/187152712801661185; Lou ZY, 2012, J NEUROSCI RES, V90, P84, DOI 10.1002/jnr.22721; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Moll NM, 2011, ANN NEUROL, V70, P764, DOI 10.1002/ana.22521; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Patti F, 2009, MULT SCLER, V15, P779, DOI 10.1177/1352458509105544; Patti F, 2009, MULT SCLER J, V15, P2, DOI 10.1177/1352458508096684; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Ramil E, 2010, MULT SCLER J, V16, P139, DOI 10.1177/1352458509355071; Rao S., 1990, MANUAL BRIEF REPEATA; Reguero L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026167; Rossi S, 2012, J NEUROSCI, V32, P13896, DOI 10.1523/JNEUROSCI.1515-12.2012; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P1242, DOI 10.1016/j.bbi.2011.03.017; Rossi S, 2011, MULT SCLER J, V17, P281, DOI 10.1177/1352458510388680; Rypma B, 2005, CORTEX, V41, P582, DOI 10.1016/S0010-9452(08)70198-9; Saito VM, 2012, CURR NEUROPHARMACOL, V10, P159, DOI 10.2174/157015912800604515; Scotter EL, 2010, BRIT J PHARMACOL, V160, P480, DOI 10.1111/j.1476-5381.2010.00735.x; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560	58	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82848	10.1371/journal.pone.0082848			12	Multidisciplinary Sciences	Science & Technology - Other Topics	284NF	WOS:000329325200020	24391723	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Honeybul, S; Gillett, GR; Ho, K				Honeybul, Stephen; Gillett, Grant R.; Ho, Kwok			Futility in Neurosurgery: A Patient-Centered Approach	NEUROSURGERY			English	Article						Ethics; Futility; Severe traumatic brain injury	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; SUBARACHNOID HEMORRHAGE; MALIGNANT INFARCTION; CONTROLLED-TRIAL; HEAD-INJURY; HEMICRANIECTOMY; MULTICENTER; MANAGEMENT	The concept of futility has been a source of discussion for many years. Even though it is tempting to propose that an action or clinical intervention should be deemed futile if it does not achieve the goals of that action, further clarification is needed in terms of the nature of the likely outcomes of an intervention and the probabilities of various outcomes being achieved. The outcome, in an age of balance between autonomy and necessity, should, at a minimum, be acceptable to the person on whom the intervention is to be performed. This is especially the case when considering outcome following decompressive craniectomy for severe traumatic brain injury, in which certain outcomes are likely to be severely impaired states that the patient would consider unacceptable. In this article, we use some key ethical concepts such as substantial benefit and the risk of unbearable badness to explore the concept of futility in severe traumatic brain injury and, by linking that to recent advances in neurosurgical science, propose a pragmatic patient-centered approach to deal with the concept of futility.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Honeybul, Stephen] Royal Perth Hosp, Perth, WA 6001, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand; [Ho, Kwok] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia	Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; Coutinho JM, 2009, STROKE, V40, P2233, DOI 10.1161/STROKEAHA.108.543421; Dombrowski KE, 2011, BRIT J NEUROSURG, V25, P249, DOI 10.3109/02688697.2010.544784; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Foerch C, 2004, J NEUROSURG, V101, P248, DOI 10.3171/jns.2004.101.2.0248; Gillett G, 2001, NEW ZEAL MED J, V114, P188; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Gillett G, 2011, J BIOETHIC INQ, V8, P145, DOI 10.1007/s11673-011-9292-4; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Helft PR, 2000, NEW ENGL J MED, V343, P293, DOI 10.1056/NEJM200007273430411; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul S, 2011, ANAESTH INTENS CARE, V39, P659, DOI 10.1177/0310057X1103900420; Honeybul S, 2012, PLOS ONE, P7; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kiphuth IC, 2010, NEUROCRIT CARE, V13, P380, DOI 10.1007/s12028-010-9449-8; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Leonhardt G, 2002, J NEUROL, V249, P1433, DOI 10.1007/s00415-002-0875-1; Munch E, 2000, NEUROSURGERY, V47, P315; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Nilsson P, 2009, EUR J NEUROL, V16, P639, DOI 10.1111/j.1468-1331.2009.02547.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Puetz V, 2007, LANCET NEUROL, V6, P580, DOI 10.1016/S1474-4422(07)70160-6; Rabelino GAG, 2008, PEDIATR NEUROL, V39, P201, DOI 10.1016/j.pediatrneurol.2008.06.006; Romero CM, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	39	15	15	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2013	73	6					917	922		10.1227/NEU.0000000000000014			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	300QM	WOS:000330478600017	23756747				2021-06-18	
J	Issar, NM; Hedera, P; Phibbs, FT; Konrad, PE; Neimat, JS				Issar, Neil M.; Hedera, Peter; Phibbs, Fenna T.; Konrad, Peter E.; Neimat, Joseph S.			Treating post-traumatic tremor with deep brain stimulation: Report of five cases	PARKINSONISM & RELATED DISORDERS			English	Article						Tremor; Post-traumatic; Deep brain stimulation; Ventral intermediate nucleus; Globus pallidus internus	HEAD-INJURY; THALAMIC-STIMULATION; STEREOTAXIC SURGERY; SEGMENTAL DYSTONIA; RUBRAL TREMOR	Background: Post-traumatic tremor is one of the most common movement disorders resulting from severe head trauma. However, literature regarding successful deep brain stimulation (DBS) treatment is scarce, resulting in ambiguity regarding the optimal lead location. Most cases support the ventral intermediate nucleus, but there is evidence to defend DBS of the zona incerta, ventral oralis anterior/posterior, and/or a combination of these targets. We report five patients with disabling post-traumatic tremor treated with DBS of the ventral intermediate nucleus and of the globus pallidus internus. Methods: Patients were referred to the Vanderbilt Movement Disorders Division, and surgical intervention was determined by a DBS Multidisciplinary Committee. Standard DBS procedure was followed. Results: Patients 1-4 sustained severe diffuse axonal injuries. Patients 1-3 underwent unilateral ventral intermediate nucleus DBS for contralateral tremor, while Patient 4 underwent bilateral ventral intermediate nucleus DBS. Patients 1-3 experienced good tremor reduction, while Patient 4 experienced moderate tremor reduction with some dystonic posturing of the hands. Patient 5 had dystonic posturing of the right upper extremity with tremor of the left upper extremity. He was treated with bilateral DBS of the globus pallidus internus and showed good tremor reduction at follow-up. Conclusion: Unilateral or bilateral DBS of the ventral intermediate nucleus and bilateral DBS of the globus pallidus internus may be effective and safe treatment modalities for intractable post-traumatic tremor. Further studies are needed to clarify the optimal target for surgical treatment of post-traumatic tremor. Published by Elsevier Ltd.	[Issar, Neil M.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Hedera, Peter; Phibbs, Fenna T.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Konrad, Peter E.; Neimat, Joseph S.] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN 37232 USA	Neimat, JS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN 37232 USA.	jneimat@gmail.com		Konrad, Peter/0000-0003-4223-0819			ANDREW J, 1982, J NEUROL NEUROSUR PS, V45, P815, DOI 10.1136/jnnp.45.9.815; ANDY OJ, 1983, APPL NEUROPHYSIOL, V46, P107; Broggi G, 2006, ACTA NEUROCHIR SUPPL, V99, P13, DOI 10.1007/978-3-211-35205-2_2; BROGGI G, 1993, MOVEMENT DISORD, V8, P206, DOI 10.1002/mds.870080217; Capelle HH, 2009, NEUROMODULATION, V12, P8, DOI 10.1111/j.1525-1403.2009.00183.x; ELLISON PH, 1978, NEUROLOGY, V28, P197, DOI 10.1212/WNL.28.2.197; Fahn S, 1988, PARKINSONS DIS MOVEM, P225; Foote KD, 2006, NEUROSURGERY, V58, P280, DOI 10.1227/01.NEU.0000192692.95455.FD; Foote KD, 2005, NEUROSURGERY, V56, P415, DOI 10.1227/01.NEU.0000147978.67424.42; Franzini A, 2011, J NEURAL TRANSM, V118, P1497, DOI 10.1007/s00702-011-0656-z; Green A, 2005, ACNR, V5, P38; HARMON R L, 1991, Brain Injury, V5, P213, DOI 10.3109/02699059109008092; HASSLER R, 1960, BRAIN, V83, P337, DOI 10.1093/brain/83.2.337; Hooper J, 2001, BRIT J NEUROSURG, V15, P435, DOI 10.1080/02688690120082468; Jacob PC, 1998, MOVEMENT DISORD, V13, P977, DOI 10.1002/mds.870130622; Koller W, 1997, ANN NEUROL, V42, P292, DOI 10.1002/ana.410420304; Koller WC, 2001, MOVEMENT DISORD, V16, P464, DOI 10.1002/mds.1089; Krauss JK, 2004, J CLIN NEUROPHYSIOL, V21, P18, DOI 10.1097/00004691-200401000-00004; KRAUSS JK, 1994, J NEUROSURG, V80, P810, DOI 10.3171/jns.1994.80.5.0810; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Louis ED, 2001, MOVEMENT DISORD, V16, P89, DOI 10.1002/1531-8257(200101)16:1<89::AID-MDS1001>3.0.CO;2-L; Lyons KE, 2008, NEUROTHERAPEUTICS, V5, P331, DOI 10.1016/j.nurt.2008.01.004; NGUYEN JP, 1993, ARCH NEUROL-CHICAGO, V50, P498, DOI 10.1001/archneur.1993.00540050050014; Oyama G, 2011, PARKINSONISM RELAT D, V17, P451, DOI 10.1016/j.parkreldis.2011.03.009; Raina GB, 2007, CLIN NEUROPHARMACOL, V30, P95, DOI 10.1097/01.WNF.0000240957.56939.E6; REMY P, 1995, NEUROLOGY, V45, P472, DOI 10.1212/WNL.45.3.472; Romito M, 2007, NEUROLOGY, V68, P875; SAMIE MR, 1990, NEUROLOGY, V40, P62, DOI 10.1212/WNL.40.1.62; Sun B, 2007, ACTA NEUROCHIR SUPPL, V97, P207; Umemura A, 2004, CLIN NEUROL NEUROSUR, V106, P280, DOI 10.1016/j.clineuro.2003.12.004; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Woehrle JC, 2009, STEREOT FUNCT NEUROS, V87, P379, DOI 10.1159/000249819	33	15	15	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	DEC	2013	19	12					1100	1105		10.1016/j.parkreldis.2013.07.022			6	Clinical Neurology	Neurosciences & Neurology	295AV	WOS:000330089900006	23953511				2021-06-18	
J	Martinez-Vargas, M; Morales-Gomez, J; Gonzalez-Rivera, R; Hernandez-Enriquez, C; Perez-Arredondo, A; Estrada-Rojo, F; Navarro, L				Martinez-Vargas, Marina; Morales-Gomez, Julio; Gonzalez-Rivera, Ruben; Hernandez-Enriquez, Carla; Perez-Arredondo, Adan; Estrada-Rojo, Francisco; Navarro, Luz			Does the Neuroprotective Role of Anandamide Display Diurnal Variations?	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						cannabinoid receptor; anandamide; circadian rhythms; cerebral cortex; neuroprotection	CANNABINOID BINDING-SITES; TRAUMATIC BRAIN-INJURY; RAT-BRAIN; CIRCADIAN-RHYTHMS; CEREBRAL-ISCHEMIA; RECEPTOR-BINDING; TEMPORAL-CHANGES; DOWN-REGULATION; MESSENGER-RNA; CB1	The endocannabinoid system is a component of the neuroprotective mechanisms that an organism displays after traumatic brain injury (TBI). A diurnal variation in several components of this system has been reported. This variation may influence the recovery and survival rate after TBI. We have previously reported that the recovery and survival rate of rats is higher if TBI occurs at 1:00 than at 13:00. This could be explained by a diurnal variation of the endocannabinoid system. Here, we describe the effects of anandamide administration in rats prior to the induction of TBI at two different times of the day: 1:00 and 13:00. We found that anandamide reduced the neurological damage at both times. Nevertheless, its effects on bleeding, survival, food intake, and body weight were dependent on the time of TBI. In addition, we analyzed the diurnal variation of the expression of the cannabinoid receptors CB1R and CB2R in the cerebral cortex of both control rats and rats subjected to TBI. We found that CB1R protein was expressed more during the day, whereas its mRNA level was higher during the night. We did not find a diurnal variation for the CB2R. In addition, we also found that TBI increased CB1R and CB2R in the contralateral hemisphere and disrupted the CB1R diurnal cycle.	[Martinez-Vargas, Marina; Morales-Gomez, Julio; Gonzalez-Rivera, Ruben; Hernandez-Enriquez, Carla; Perez-Arredondo, Adan; Estrada-Rojo, Francisco; Navarro, Luz] Univ Nacl Autonoma Mexico, Dept Physiol, Sch Med, Mexico City 04510, DF, Mexico	Navarro, L (corresponding author), Univ Nacl Autonoma Mexico, Dept Physiol, Sch Med, AP 70-250, Mexico City 04510, DF, Mexico.	marvar_69@yahoo.com.mx; julio_macaco181@hotmail.com; rubengonzalezrivera@yahoo.com.mx; medicosita.06@gmail.com; aparredondo23@yahoo.com.mx; fesro@hotmail.com; lnavarro@unam.mx	Navarro, Luz/Q-9086-2019	Perez-Arredondo, Adan/0000-0002-0479-6734; MARTINEZ-VARGAS, MARINA/0000-0002-3729-2161	PAPIITPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN222209, IN221212]; CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [152510]	Supported by grants PAPIIT IN222209, IN221212 and CONACyT 152510.	Acuna-Goycolea C, 2010, J NEUROSCI, V30, P10061, DOI 10.1523/JNEUROSCI.5838-09.2010; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Braud S, 2000, FEBS LETT, V471, P12, DOI 10.1016/S0014-5793(00)01359-4; BRUININK A, 1983, LIFE SCI, V33, P31, DOI 10.1016/0024-3205(83)90708-7; BURBACH JPH, 1988, MOL BRAIN RES, V4, P157, DOI 10.1016/0169-328X(88)90007-1; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Coutts AA, 2001, J NEUROSCI, V21, P2425; DEFONSECA FR, 1994, PHARMACOL BIOCHEM BE, V47, P33, DOI 10.1016/0091-3057(94)90108-2; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Glaser ST, 2009, NEUROSCIENCE, V163, P594, DOI 10.1016/j.neuroscience.2009.06.043; Heller Joshua E, 2009, Clin Neurosurg, V56, P84; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.3.CO;2-G; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Maccarrone M, 1999, FEBS LETT, V447, P277, DOI 10.1016/S0014-5793(99)00308-7; Marco EM, 2009, BRAIN RES, V1257, P25, DOI 10.1016/j.brainres.2008.12.037; MARSHALL J, 1977, STROKE, V8, P230, DOI 10.1161/01.STR.8.2.230; Martinez-Vargas M, 2003, NEUROSCIENCE, V117, P197, DOI 10.1016/S0306-4522(02)00820-5; Martinez-Vargas M, 2006, NEUROSCI LETT, V400, P21, DOI 10.1016/j.neulet.2006.02.010; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Montagnana M, 2009, SEMIN THROMB HEMOST, V35, P23, DOI 10.1055/s-0029-1214145; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Murillo-Rodniguez E, 2006, LIFE SCI, V79, P30, DOI 10.1016/j.lfs.2005.12.028; Murillo-Rodriguez E, 1998, BRAIN RES, V812, P270, DOI 10.1016/S0006-8993(98)00969-X; NABER D, 1981, BIOL PSYCHIAT, V16, P831; Nagayama T, 1999, J NEUROSCI, V19, P2987; OVIEDO A, 1993, BRAIN RES, V616, P293, DOI 10.1016/0006-8993(93)90220-H; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perron RR, 2001, NEUROREPORT, V12, P3791, DOI 10.1097/00001756-200112040-00038; Romero J, 1998, SYNAPSE, V30, P298, DOI 10.1002/(SICI)1098-2396(199811)30:3<298::AID-SYN7>3.0.CO;2-6; ROMERO J, 1995, PHARMACOL BIOCHEM BE, V51, P731, DOI 10.1016/0091-3057(95)00023-P; Rueda-Orozco PE, 2008, PSYCHOPHARMACOLOGY, V198, P565, DOI 10.1007/s00213-007-0911-z; Sanford AE, 2008, BRAIN RES, V1222, P141, DOI 10.1016/j.brainres.2008.05.048; SCHMID PC, 1995, FEBS LETT, V375, P117, DOI 10.1016/0014-5793(95)01194-J; Schomacher M, 2006, ACTA NEUROPATHOL, V111, P8, DOI 10.1007/s00401-005-1109-2; Schomacher M, 2008, BRAIN RES, V1240, P213, DOI 10.1016/j.brainres.2008.09.019; Shen MX, 1998, MOL PHARMACOL, V54, P459; SOLOMON GD, 1992, CLEV CLIN J MED, V59, P326, DOI 10.3949/ccjm.59.3.326; SOULBAN G, 1989, LIFE SCI, V45, P2485, DOI 10.1016/0024-3205(89)90015-5; Sritharan K, 2009, BRIT J HOSP MED, V70, pM156, DOI 10.12968/hmed.2009.70.Sup10.44641; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; TOMINAGA K, 1992, NEUROREPORT, V3, P809, DOI 10.1097/00001756-199209000-00022; TONI D, 1991, CHRONOBIOL INT, V8, P321, DOI 10.3109/07420529109059168; Torner C, 1998, BIOL RHYTHM RES, V29, P538, DOI 10.1076/brhm.29.5.538.4817; TURNERWARWICK M, 1988, AM J MED, V85, P6, DOI 10.1016/0002-9343(88)90231-8; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Vickers SP, 2005, CURR DRUG TARGETS, V6, P215, DOI 10.2174/1389450053174514; Vinall PE, 2000, J NEUROSURG, V93, P82, DOI 10.3171/jns.2000.93.1.0082; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wittmann G, 2007, J COMP NEUROL, V503, P270, DOI 10.1002/cne.21383; Zhang M, 2008, NEUROSCIENCE, V152, P753, DOI 10.1016/j.neuroscience.2008.01.022; Zhuang SY, 1998, MOL BRAIN RES, V62, P141, DOI 10.1016/S0169-328X(98)00232-0	61	15	15	0	20	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2013	14	12					23341	23355		10.3390/ijms141223341			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	296XX	WOS:000330219800011	24287910	DOAJ Gold, Green Published			2021-06-18	
J	Vrkljan, BH; Myers, AM; Crizzle, AM; Blanchard, RA; Marshall, SC				Vrkljan, Brenda H.; Myers, Anita M.; Crizzle, Alexander M.; Blanchard, Robin A.; Marshall, Shawn C.			Evaluating medically at-risk drivers: A survey of assessment practices in Canada	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Assessment; Automobile driving; Automobiles; Clinical protocols; Safety	DRIVING CESSATION; OLDER DRIVER; ADULTS	Background. Assessing medical fitness to drive (FTD) can include both off-and on-road testing, although consistency of practice is unclear. Purpose. To examine actual practices being used to assess FTD at driver assessment centres (DACs) across Canada. Method. Surveys e-mailed to 90 DACs were returned by 47 assessors. Findings. The majority of respondents (89%) were occupational therapists. Assessors reported doing an average of eight FTD assessments per month (range = 1 to 40) at an average cost of $366 (SD = $225; range = $40 to $985). Referrals came from physicians (96%), other health professionals (70%), and licensing authorities (66%). Clients with stroke, dementia, traumatic brain injury, mild cognitive impairment, and multiple sclerosis composed 62% of estimated caseloads. Assessments took 3 hr on average (range = 1.24 to 4.5 hr); 64% reported they always took clients on road regardless of clinic results. Implications. Evidence-based guidelines for training and assessment are clearly needed given the inconsistency in practice.	[Vrkljan, Brenda H.] McMaster Univ, Sch Rehabil Sci, Occupat Therapy Program, Hamilton, ON L8S 1C7, Canada; [Myers, Anita M.; Blanchard, Robin A.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Crizzle, Alexander M.] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON L8S 1C7, Canada; [Marshall, Shawn C.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Marshall, Shawn C.] Ottawa Hosp Res Inst, Ottawa, ON, Canada	Vrkljan, BH (corresponding author), McMaster Univ, Sch Rehabil Sci, Occupat Therapy Program, 1400 Main St West, Hamilton, ON L8S 1C7, Canada.	vrkljan@mcmaster.ca			Ontario Neurotrauma Foundation	This project was funded by Ontario Neurotrauma Foundation as part of a larger project.	Adler G, 2006, J AGING STUD, V20, P227, DOI 10.1016/j.jaging.2005.09.003; Bedard M, 2011, J PRIM CARE COMMUNIT, V2, P133, DOI 10.1177/2150131910397704; Canadian Association of Occupational Therapists, 2009, CAOT POS STAT OCC TH; Canadian Medical Association, 2012, DET MED FITN OP MOT; Hogan DB, 2011, CAN GERIATR J, V14, P51; Kay L, 2008, ACCIDENT ANAL PREV, V40, P751, DOI 10.1016/j.aap.2007.09.012; Korner-Bitensky NA, 1998, AM J OCCUP THER, V52, P916, DOI 10.5014/ajot.52.10.916; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Korner-Bitensky N, 2010, AM J OCCUP THER, V64, P316, DOI 10.5014/ajot.64.2.316; Marshall S., 2007, SENIOR DRIVER ASSESS; Marshall SC, 2013, ACCIDENT ANAL PREV, V61, P233, DOI 10.1016/j.aap.2013.07.007; Myers AM, 2011, EVALUATING POLICIES; Ontario Ministry of Transportation, 2013, MED REV SECT; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Rapoport MJ, 2007, CAN MED ASSOC J, V177, P599, DOI 10.1503/cmaj.070342; Unsworth CA, 2007, AM J OCCUP THER, V61, P493, DOI 10.5014/ajot.61.5.493; Vrkljan BH, 2011, CAN J OCCUP THER, V78, P80, DOI 10.2182/cjot.2011.78.2.3; Windsor TD, 2006, CLIN INTERV AGING, V1, P205, DOI 10.2147/ciia.2006.1.3.205	18	15	15	0	13	CANADIAN ASSOC OCCUPATIONAL THERAPISTS	OTTAWA	CTTC BLDG, 3400-1125 COLONEL BY DRIVE, OTTAWA, ONTARIO K1S 5R1, CANADA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	DEC	2013	80	5					295	303		10.1177/0008417413511788			9	Rehabilitation	Rehabilitation	302HO	WOS:000330594700009	24640644				2021-06-18	
J	Ding, J; Guo, JY; Yuan, Q; Yuan, F; Chen, H; Tian, H				Ding, Jun; Guo, Jianyi; Yuan, Qiang; Yuan, Fang; Chen, Hao; Tian, Hengli			Inhibition of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Decreases Rat Cortical Neuron Injury and Blood-Brain Barrier Permeability, and Improves Neurological Functional Recovery in Traumatic Brain Injury Model	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PTEN; PATHWAY; SURVIVAL; AKT; PHOSPHORYLATION; STROKE; MICE; ANGIOGENESIS; OUTGROWTH	Background and Purpose: Recent evidence has supported the neuroprotective effect of bpV (pic), an inhibitor of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), in models of ischemic stroke. However, whether PTEN inhibitors improve long-term functional recovery after traumatic brain injury (TBI) and whether PTEN affects blood brain barrier (BBB) permeability need further elucidation. The present study was performed to address these issues. Methods: Adult Sprague-Dawley rats were subjected to fluid percussion injury (FPI) after treatment with a well-established PTEN inhibitor bpV (pic) or saline starting 24 h before FPI. Western blotting, real-time quantitative PCR, or immunostaining was used to measure PTEN, p-Akt, or MMP-9 expression. We determined the presence of neuron apoptosis by TUNEL assay. Evans Blue dye extravasation was measured to evaluate the extent of BBB disruption. Functional recovery was assessed by the neurological severity score (NSS), and Kaplan-Meier analysis was used for survival analysis. Results: PTEN expression was up-regulated after TBI. After bpV (pic) treatment, p-Akt was also up-regulated. We found that bpV (pic) significantly decreased BBB permeability and reduced the number of TUNEL-positive cells. We further demonstrated that PTEN inhibition improved neurological function recovery in the early stage after TBI. Conclusion: These data suggest that treatment with the PTEN inhibitor bpV (pic) has a neuroprotective effect in TBI rats.	[Ding, Jun; Guo, Jianyi; Yuan, Qiang; Yuan, Fang; Chen, Hao; Tian, Hengli] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China	Tian, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China.	tianhlsh@126.com			National Nature and Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271383]; Shanghai Science and Technique Committee [13411951400, 13411951401, 10JC1412500]	Grant support was provided by National Nature and Science Foundation of China (grant No. 81271383) and the Shanghai Science and Technique Committee (grant No. 13411951400, 13411951401 and 10JC1412500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cai QY, 2009, ANAT REC, V292, P498, DOI 10.1002/ar.20834; Cao L, 2011, INVEST OPHTH VIS SCI, V52, P2272, DOI 10.1167/iovs.10-5972; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chopp M, 2008, ACTA NEUROCHIR SUPPL, V105, P79; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Guo JY, 2013, INT J MOL SCI; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Huang JH, 2002, ARTERIOSCL THROM VAS, V22, P745, DOI 10.1161/01.ATV.0000016358.05294.8D; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Keyes KT, 2010, AM J PHYSIOL-HEART C, V298, pH1198, DOI 10.1152/ajpheart.00915.2009; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li PP, 2012, MOL BIOL CELL, V23, P4109, DOI 10.1091/mbc.E12-05-0367; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Mao L, 2013, NEUROSCIENCE, V231, P272, DOI 10.1016/j.neuroscience.2012.11.050; Marin D, 2005, LEUKEMIA, V19, P507, DOI 10.1038/sj.leu.2403664; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sedding DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055445; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Walker CL, 2013, FRONT BIOL; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013; Zhang YJ, 2012, BRAIN, V135, P2736, DOI 10.1093/brain/aws196; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	44	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80429	10.1371/journal.pone.0080429			10	Multidisciplinary Sciences	Science & Technology - Other Topics	261IJ	WOS:000327657900007	24312220	DOAJ Gold, Green Published			2021-06-18	
J	Radomski, KL; Zhou, Q; Yi, KJ; Doughty, ML				Radomski, Kryslaine L.; Zhou, Qiong; Yi, Kevin J.; Doughty, Martin L.			Cortical contusion injury disrupts olfactory bulb neurogenesis in adult mice	BMC NEUROSCIENCE			English	Article						Traumatic brain injury (TBI); Controlled cortical impact (CCI); Subventricular zone (SVZ); Neural stem cell (NSC); Olfactory bulb	TRAUMATIC BRAIN-INJURY; SUBVENTRICULAR ZONE CELLS; CEREBRAL-CORTEX; STEM-CELLS; FOREBRAIN NEUROGENESIS; NEUROBLAST MIGRATION; IMPACT; PROLIFERATION; RECOVERY; BEHAVIOR	Background: Experimental brain trauma activates quiescent neural stem cells (NSCs) to increase neuronal progenitor cell proliferation in the adult rodent brain. Previous studies have shown focal brain contusion in the form of a unilateral controlled cortical impact (CCI) stimulates NSCs to bilaterally increase neurogenesis in the adult hippocampus. Results: In this study we clarified the bi-lateral effects of a unilateral CCI on proliferation in the subventricular zone (SVZ) NSC niche and on neurogenesis in the olfactory bulb of adult mice. By varying the depth of impact from 1 mm to 2 mm depth, we show CCI to the left somatosensory cortex resulted in graded changes in mouse behavior and cellular pathology in the forebrain. As expected, contusion to the sensorimotor cortex resulted in motor coordination deficits in adult mice. During the first 3 days after injury, CCI increased proliferation in the impacted cortex, deeper striatum and SVZ of the forebrain ipsilateral to the CCI. In each of these regions proliferation was increased with increasing injury severity. At 30 days post-procedure, CCI resulted in a significant reduction in neurogenesis in the olfactory bulb ipsilateral to the CCI. Olfactory avoidance testing indicated disruptions in olfactory bulb neurogenesis were associated with impaired olfactory discrimination in mice post-injury. Conclusion: The data demonstrate a focal cortical contusion injury to the left somatosensory cortex disrupts SVZ-olfactory bulb neurogenesis and impairs olfactory discrimination and motor coordination in adult mice.	[Radomski, Kryslaine L.; Zhou, Qiong; Yi, Kevin J.; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, CNRM, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA	Doughty, ML (corresponding author), Uniformed Serv Univ Hlth Sci, CNRM, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	martin.doughty@usuhs.edu		Radomski, Kryslaine/0000-0001-9624-623X	Center for Neuroscience and Regenerative Medicine (CNRM)United States Department of Defense	We are grateful for assistance with surgical and behavioral procedures from Laura Tucker, Oz Malkesman and Amanda Fu in the Animal Models Core at the Center for Neuroscience and Regenerative Medicine (CNRM) at USU. We also thank Dennis McDaniel in the Bio-instrumentation Center (BIC) at USU for assistance with microscopy and stereology. This work was supported by a grant from the Center for Neuroscience and Regenerative Medicine (CNRM).	Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Gotts JE, 2005, J COMP NEUROL, V488, P201, DOI 10.1002/cne.20609; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mogensen J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00007; Ohira K, 2011, CELL MOL LIFE SCI, V68, P1645, DOI 10.1007/s00018-010-0552-y; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Russo I, 2011, J NEUROCHEM, V116, P947, DOI 10.1111/j.1471-4159.2010.07168.x; Saha B, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00014; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	31	15	15	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	NOV 13	2013	14								142	10.1186/1471-2202-14-142			12	Neurosciences	Neurosciences & Neurology	285XF	WOS:000329427600003	24224996	DOAJ Gold, Green Published			2021-06-18	
J	Gfeller, JD; Roskos, PT				Gfeller, Jeffrey D.; Roskos, P. Tyler			A Comparison of Insufficient Effort Rates, Neuropsychological Functioning, and Neuropsychiatric Symptom Reporting in Military Veterans and Civilians with Chronic Traumatic Brain Injury	BEHAVIORAL SCIENCES & THE LAW			English	Article							MEMORY MALINGERING TOMM; DISABILITY RATING-SCALE; METAANALYTIC METHODS; MISERABLE MINORITY; COGNITIVELY INTACT; EVALUATION CONTEXT; OEF/OIF VETERANS; VALIDITY; PERFORMANCE; VALIDATION	Neuropsychological evaluation of persons with chronic traumatic brain injury (TBI) symptoms is complicated by multiple factors. The authors explored the impact of mechanism of injury, effort testing performance, and neuropsychiatric status in a sample of military veterans (V-TBI) and civilians (C-TBI) with chronic TBI. V-TBI (n=74), C-TBI (n=67), and healthy civilian control (C-HC) participants (n=66), completed a battery of neuropsychological, effort, and self-report neuropsychiatric measures. Results indicated that C-HC and C-TBI participants exhibited comparably low failure rates on effort tests (6% and 3%, respectively). V-TBI participants exhibited significantly higher rates of failure (18%). Subgroups (n=20) of effort-screened participants matched for demographics and disability level were compared regarding neuropsychological performance and neuropsychiatric self-report. Both TBI groups exhibited limited neuropsychological impairment, relative to the C-HC participants. The V-TBI group exhibited pronounced neuropsychiatric symptomology compared with the other participant groups. The implications of these findings are discussed for evaluation in the context of disability and litigation. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Gfeller, Jeffrey D.; Roskos, P. Tyler] St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; [Roskos, P. Tyler] St Louis Univ, Dept Neurosurg, St Louis, MO 63103 USA	Gfeller, JD (corresponding author), St Louis Univ, Dept Psychol, 221 North Grand Blvd, St Louis, MO 63103 USA.	gfellerj@slu.edu					Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Beck A. T., 1996, BECK DEPRESSION INVE, VII; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck JG, 2007, PROF PSYCHOL-RES PR, V38, P629, DOI 10.1037/0735-7028.38.6.629; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bush S. S., 2013, MILD TRAUMATIC BRAIN, P381; Chafetz M. D., 2013, MILD TRAUMATIC BRAIN, P347; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Conners C., 2000, CONNERS CONTINUOUS P; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Golden C., 1978, STROOP COLOR WORD TE; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, MANUAL WORD MEMORY T; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Heaton R., 1993, WISCONSIN CARD SORTI; Herman D., 1993, ANN CONV INT SOC TRA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson G. L., 2010, J HEAD TRAUMA REHAB, V25, P576; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kaplan E., 1983, BOSTON NAMING TEST; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Matthews C, 1964, INSTRUCTION MANUAL A; Meyers J. E., 1999, REY COMPLEX FIGURE T; Morey L. C., 1991, PERSONALITY ASSESSME; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reitan R. M., 1992, TRAIL MAKING TEST MA; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1997, ARCH CLIN NEUROPSYCH, V12, P418, DOI 10.1093/arclin/12.4.418; Tombaugh TN, 1996, TEST MEMORY MALINGER; Vanderploeg R. D., 2013, J HEAD TRAUMA REHABI, DOI 10.1097/HTR.0b013e318281966e.; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wechsler D., 2001, WECHSLER TEST ADULT; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	66	15	15	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		833	849		10.1002/bsl.2084			17	Psychology, Applied; Law	Psychology; Government & Law	262KI	WOS:000327733400011	24123226				2021-06-18	
J	Jackson, TC; Verrier, JD; Drabek, T; Janesko-Feldman, K; Gillespie, DG; Uray, T; Dezfulian, C; Clark, RS; Bayir, H; Jackson, EK; Kochanek, PM				Jackson, Travis C.; Verrier, Jonathan D.; Drabek, Tomas; Janesko-Feldman, Keri; Gillespie, Delbert G.; Uray, Thomas; Dezfulian, Cameron; Clark, Robert S.; Bayir, Huelya; Jackson, Edwin K.; Kochanek, Patrick M.			Pharmacological Inhibition of Pleckstrin Homology Domain Leucine-Rich Repeat Protein Phosphatase Is Neuroprotective: Differential Effects on Astrocytess	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							SIGNAL-REGULATED KINASE; TRAUMATIC BRAIN-INJURY; GLOBAL CEREBRAL-ISCHEMIA; CELL-DEATH; HIPPOCAMPAL-NEURONS; CARDIAC-ARREST; SUPRACHIASMATIC NUCLEUS; CIRCULATORY ARREST; RAT HIPPOCAMPUS; ACTIVATION	Pleckstrin homology domain and leucine-rich repeat protein phosphatase 1 (PHLPP1) inhibits protein kinase B (AKT) survival signaling in neurons. Small molecule pan-PHLPP inhibitors (selective for PHLPP1 and PHLPP2) may offer a translatable method to induce AKT neuroprotection. We tested several recently discovered PHLPP inhibitors (NSC117079 and NSC45586; benzoic acid, 5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-, sodium salt.) in rat cortical neurons and astrocytes and compared the biochemical response of these agents with short hairpin RNA (shRNA)-mediated PHLPP1 knockdown (KD). In neurons, both PHLPP1 KD and experimental PHLPP inhibitors activated AKT and ameliorated staurosporine (STS)-induced cell death. Unexpectedly, in astrocytes, both inhibitors blocked AKT activation, and NSC117079 reduced viability. Only PHLPP2 KD mimicked PHLPP inhibitors on astrocyte biochemistry. This suggests that these inhibitors could have possible detrimental effects on astrocytes by blocking novel PHLPP2-mediated prosurvival signaling mechanisms. Finally, because PHLPP1 levels are reportedly high in the hippocampus (a region prone to ischemic death), we characterized hippocampal changes in PHLPP and several AKT targeting prodeath phosphatases after cardiac arrest (CA)-induced brain injury. PHLPP1 levels increased in rat brains subjected to CA. None of the other AKT inhibitory phosphatases increased after global ischemia (i.e., PHLPP2, PTEN, PP2A, and PP1). Selective PHLPP1 inhibition (such as by shRNA KD) activates AKT survival signaling in neurons and astrocytes. Nonspecific PHLPP inhibition (by NSC117079 and NSC45586) only activates AKT in neurons. Taken together, these results suggest that selective PHLPP1 inhibitors should be developed and may yield optimal strategies to protect injured hippocampal neurons and astrocytes-namely from global brain ischemia.	[Jackson, Travis C.; Janesko-Feldman, Keri; Uray, Thomas; Dezfulian, Cameron; Clark, Robert S.; Bayir, Huelya; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Verrier, Jonathan D.; Gillespie, Delbert G.; Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Drabek, Tomas] Presbyterian Hosp, Dept Anesthesiol, Pittsburgh, PA USA	Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Drabek, Tomas/AAJ-1595-2021; Kochanek, Patrick M/D-2371-2015	Drabek, Tomas/0000-0002-5702-4498; Kochanek, Patrick M/0000-0002-2627-913X; Uray, Thomas/0000-0002-8869-1912; Dezfulian, Cameron/0000-0002-4486-0446; Jackson, Edwin/0000-0002-8101-6009	American Heart AssociationAmerican Heart Association [11POST7320018]; National Institutes of Health National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK079307]; Laerdal Foundation; National Institutes of Health National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08-NS069817]; Max Kade Foundation; US ArmyUnited States Department of Defense [W81XWH-10-1-0623]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS069817] Funding Source: NIH RePORTER	This work was supported by the American Heart Association [Research Grant 11POST7320018]; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grant DK079307]; Laerdal Foundation; National Institutes of Health National Institutes of Neurological Disorders and Stroke [Grant K08-NS069817]; the Max Kade Foundation; and the US Army [Grant W81XWH-10-1-0623].	Aharon AS, 2004, EUR J CARDIO-THORAC, V26, P912, DOI 10.1016/j.ejcts.2004.05.040; Beiser DG, 2010, AM J PHYSIOL-HEART C, V298, pH1761, DOI 10.1152/ajpheart.00187.2010; Mai BK, 2010, J CHEM INF MODEL, V50, P2236, DOI 10.1021/ci100346s; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen B, 2013, J CEREBR BLOOD F MET, V33, P196, DOI 10.1038/jcbfm.2012.150; Cho DG, 2004, J THORAC CARDIOV SUR, V127, P1033, DOI 10.1016/j.jtcvs.2003.09.038; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Gabryel B, 2004, EUR J PHARMACOL, V494, P111, DOI 10.1016/j.ejphar.2004.04.042; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Ho Y, 2007, NEUROSCIENCE, V145, P248, DOI 10.1016/j.neuroscience.2006.11.039; Horstmann A, 2010, NEUROLOGY, V74, P306, DOI 10.1212/WNL.0b013e3181cbcd6f; Isaeva E, 2010, EUR J NEUROSCI, V32, P1889, DOI 10.1111/j.1460-9568.2010.07468.x; Ito M, 2009, J NEUROTRAUM, V26, P41, DOI 10.1089/neu.2008.0646; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Jackson TC, 2009, CELL DEATH DIFFER, V16, P439, DOI 10.1038/cdd.2008.171; Jackson TC, 2010, J NEUROCHEM, V115, P941, DOI 10.1111/j.1471-4159.2010.06984.x; Janata A, 2013, CRIT CARE MED, V41, pE211, DOI 10.1097/CCM.0b013e318287f51e; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Lobert VH, 2013, EMBO REP, V14, P10, DOI 10.1038/embor.2012.188; Lu K, 2010, J NEUROCHEM, V114, P237, DOI 10.1111/j.1471-4159.2010.06747.x; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Mandell JW, 1999, NEUROREPORT, V10, P3567, DOI 10.1097/00001756-199911260-00019; Mateen FJ, 2011, NEUROLOGY, V77, P1438, DOI 10.1212/WNL.0b013e318232ab33; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Namura S, 2000, J CEREBR BLOOD F MET, V20, P1301, DOI 10.1097/00004647-200009000-00004; Nawashiro H, 2000, J CEREBR BLOOD F MET, V20, P1040, DOI 10.1097/00004647-200007000-00003; Ozawa H, 1999, NEUROSCI LETT, V262, P57, DOI 10.1016/S0304-3940(99)00034-8; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; Sierecki E, 2010, J MED CHEM, V53, P6899, DOI 10.1021/jm100331d; Takuma K, 2000, EUR J PHARMACOL, V399, P1, DOI 10.1016/S0014-2999(00)00334-4; Verrier JD, 2011, J NEUROCHEM, V118, P979, DOI 10.1111/j.1471-4159.2011.07392.x; Zhan LX, 2012, NEUROPHARMACOLOGY, V63, P873, DOI 10.1016/j.neuropharm.2012.06.035; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	47	15	16	0	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	NOV	2013	347	2					516	528		10.1124/jpet.113.206888			13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	238HE	WOS:000325934400026	24023368	Green Published			2021-06-18	
J	Laxe, S; Terre, R; Leon, D; Bernabeu, M				Laxe, Sara; Terre, Rosa; Leon, Daniel; Bernabeu, Montserrat			How does dysautonomia influence the outcome of traumatic brain injured patients admitted in a neurorehabilitation unit?	BRAIN INJURY			English	Article						Dysautonomia; outcome; PSH; rehabilitation; traumatic brain injury	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; AFFERENT STIMULI; OVERRESPONSIVENESS; SCALE	Background: Patients surviving severe traumatic brain injury (TBI) may suffer from symptoms presumed to be related to an excessive sympathetic production known as paroxysmal sympathetic hyperactivity (PSH). While this condition is more common in the acute phase, prognosis is less clear in rehabilitation settings. Aim: The goal of this study is to describe the functional status of patients with PSH admitted in a rehabilitation hospital and to determine its prognostic influence during rehabilitation. Methods: A cohort study was undertaken of all the patients admitted in a neurorehabilitation hospital suffering from PSH. Functional outcomes were reported according to the Glasgow outcome scale-extended (GOSE), the Disability Rating Scale (DRS) and the Functional Independence Measure (FIM). Results: Thirteen out of 39 patients suffered symptoms compatible with PSH. Neuroimaging of PSH patients showed more diffuse lesions. The FIM at admission was lower in the PSH group who was transferred for rehabilitation at an earlier stage. At discharge no differences were seen using the FIM, DRS and GOS-E. Conclusions: Functional status is similar and PSH does not appear to influence recovery during the rehabilitation, although PSH patients are more likely to undergo psychoactive medications and special care is needed to approach their caregivers that perceive PSH as a complication for rehabilitation.	[Laxe, Sara; Terre, Rosa; Leon, Daniel; Bernabeu, Montserrat] Univ Autonoma Barcelona, Inst Guttmann, Brain Injury Unit, Badalona 08916, Spain	Laxe, S (corresponding author), Univ Autonoma Barcelona, Inst Guttmann, Brain Injury Unit, Cami Can Ruti Sn, Badalona 08916, Spain.	slaxe@guttmann.com					Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P52, DOI 10.1016/S0003-9993(98)90208-8; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hoarau X, 2012, BRAIN INJURY, V26, P927, DOI 10.3109/02699052.2012.661913; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Penfield W., 1954, EPILEPSY FUNCTIONAL, P378; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358	23	15	16	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1383	1387		10.3109/02699052.2013.823648			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500007	24102213				2021-06-18	
J	Sieswerda-Hoogendoorn, T; Bilo, RAC; van Duurling, LLBM; Karst, WA; Maaskant, JM; van Aalderen, WMC; van Rijn, RR				Sieswerda-Hoogendoorn, Tessa; Bilo, Rob A. C.; van Duurling, Lonneke L. B. M.; Karst, Wouter A.; Maaskant, Jolanda M.; van Aalderen, Wim M. C.; van Rijn, Rick R.			Abusive head trauma in young children in the Netherlands: evidence for multiple incidents of abuse	ACTA PAEDIATRICA			English	Article						Child abuse; Child advocacy; Head injuries closed; Risk factors; Shaken baby syndrome	SHAKEN BABY SYNDROME; BRAIN-INJURY; CONSEQUENCE; PREVENTION; PROGRAM	AimWe investigated the prevalence of risk factors for and the prevalence of prior abuse in abusive head trauma victims in the Netherlands. MethodsWe performed a retrospective file review of all abusive head trauma cases in the Netherlands in which forensic medical expertise was requested by the courts, between 2005 and 2010. Outcome measures were risk factors and indicators for prior abuse. ResultsEighty-nine cases were included; 62% boys, median age 3.5months. Impact trauma was found in 48% of cases, with a male perpetrator in 79%. Prematurity, dysmaturity and twins/triplets were found in 27%, 23% and 10% of cases, respectively, maternal age under 20years in 17%. Of the parents, 60% had completed only primary or secondary education, 38% of the families were known to child welfare authorities. There was evidence for prior abuse in 81% of the cases. ConclusionThe high number of families with prior abuse indicates that both the healthcare system and child welfare authorities failed to protect some of the children that have been in their care. Our results highlight the importance of training healthcare and child welfare professionals in recognizing physical abuse, as well as the importance of optimizing abusive head trauma prevention strategies.	[Sieswerda-Hoogendoorn, Tessa; Bilo, Rob A. C.; Karst, Wouter A.; van Rijn, Rick R.] Netherlands Forens Inst, Sect Forens Pediat, Dept Forens Med, The Hague, Netherlands; [Sieswerda-Hoogendoorn, Tessa; van Rijn, Rick R.] Emma Childrens Hosp, Dept Radiol, Acad Med Ctr, Amsterdam, Netherlands; [van Duurling, Lonneke L. B. M.] Forens Med Child Abuse Ctr, Utrecht, Netherlands; [Maaskant, Jolanda M.; van Aalderen, Wim M. C.] Emma Childrens Hosp, Dept Pediat, Acad Med Ctr, Amsterdam, Netherlands	Sieswerda-Hoogendoorn, T (corresponding author), Netherlands Forens Inst, Dept Med Forens Invest, POB 24044, NL-2490 AA The Hague, Netherlands.	t.sieswerda@amc.nl	van Rijn, Rick/H-5526-2019	van Rijn, Rick/0000-0002-8876-6515			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Altman RL, 2011, PEDIATRICS, V128, pE1164, DOI 10.1542/peds.2010-3260; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bennett S, 2011, CHILD ABUSE NEGLECT, V35, P930, DOI 10.1016/j.chiabu.2011.05.018; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Child abuse physician association, 2012, VER VERTR KIND POS M; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Garssen J, 2010, MANY TEENAGE PREGNAN; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2010, ACAD PEDIATR, V10, P389, DOI 10.1016/j.acap.2010.08.005; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2009, CHILD ABUSE NEGLECT, V33, P393, DOI 10.1016/j.chiabu.2008.09.008; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Ministry of Education CaS, 2011, ED LEV NETH; Mok JYQ, 2010, J EPIDEMIOL COMMUN H, V64, P1049, DOI 10.1136/jech.2009.090217; Netherlands Statistics, 2012, POP POP DYN MONTH QU; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Royal Dutch Medical Association, 2012, KNMG REP GUID CHILD; Sanderse C, 2012, BIRTH WHAT WERE MOST; STARLING SP, 1995, PEDIATRICS, V95, P259; Statistics Netherlands, 2008, NUMB FAM NUMB CHILDR; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Waelput AJM, 2012, WHAT IS INCIDENCE PR; Wobma E, 2011, ONE 6 FATHERS IS 40; Wobma E, 2011, NUMBER MULTIPLE BIRT	30	15	16	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253			ACTA PAEDIATR	Acta Paediatr.	NOV	2013	102	11					E497	E501		10.1111/apa.12377			5	Pediatrics	Pediatrics	229LF	WOS:000325265500007	23909838				2021-06-18	
J	Trontel, HG; Hall, S; Ashendorf, L; O'Connor, MK				Trontel, Haley G.; Hall, Stuart; Ashendorf, Lee; O'Connor, Maureen K.			Impact of diagnosis threat on academic self-efficacy in mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychological tests; Head injury; Self efficacy; Memory; Attention; Mild concussion	MIDDLE SCHOOL STUDENTS; GOOD-OLD-DAYS; HEAD-INJURY; POSTCONCUSSION-SYNDROME; COGNITIVE PERFORMANCE; AGREEMENT STATEMENT; CLINICAL MANAGEMENT; STEREOTYPE THREAT; COLLEGE OUTCOMES; BELIEFS	The current study examined the effect of diagnosis threat on self-efficacy and neuropsychological performance in mild traumatic brain injury (TBI). Forty-nine participants with a history of mild TBI were randomized to a diagnosis threat or control group. The diagnosis threat group were told they were selected based on their history of TBI, while control group participants were told to perform their best. Individuals in the diagnosis threat group reported significantly lower academic self-efficacy than control participants. The groups performed differently on only one neuropsychological measure. These results suggest that diagnosis threat may have a greater impact on psychological factors than on cognitive performance.	[Trontel, Haley G.; Hall, Stuart] Univ Montana, Dept Psychol, Missoula, MT 59812 USA; [Trontel, Haley G.; Ashendorf, Lee; O'Connor, Maureen K.] Edith Nourse Rogers Mem Vet Adm Hosp, Dept Psychol, Bedford, MA 01730 USA	Trontel, HG (corresponding author), Univ Montana, 1210 E Harrison Ave, Salt Lake City, UT 84105 USA.	htrontel@gmail.com					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3; Bandura A, 2001, CHILD DEV, V72, P187, DOI 10.1111/1467-8624.00273; Bandura A, 1996, CHILD DEV, V67, P1206, DOI 10.1111/j.1467-8624.1996.tb01791.x; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Britner SL, 2006, J RES SCI TEACH, V43, P485, DOI 10.1002/tea.20131; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, NAT CTR INJ PREV CON; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Delis DC, 2000, CALIFORNIA VERBAL LE; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEINGOLD A, 1983, EDUC PSYCHOL MEAS, V43, P1127, DOI 10.1177/001316448304300422; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gore PA, 2006, J CAREER ASSESSMENT, V14, P92, DOI 10.1177/1069072705281367; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kathol Roger, 1996, P321; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Kit KA, 2007, REHABIL PSYCHOL, V52, P25, DOI 10.1037/0090-5550.52.1.25; Klassen RM, 2004, INT J PSYCHOL, V39, P205, DOI 10.1080/00207590344000330; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Levin HS, 1989, MILD HEAD INJURY; Linnenbrink EA., 2003, READING WRITING Q OV, V19, P119, DOI [10.1080/10573560308223, DOI 10.1080/10573560308223]; Lucio R, 2012, DEV PSYCHOL, V48, P422, DOI 10.1037/a0025939; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mattern KD, 2010, J COLL STUDENT DEV, V51, P665, DOI 10.1353/csd.2010.0017; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Owen S, 1988, ANN M NAT COUNC MEAS; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pajares F, 2000, CONTEMP EDUC PSYCHOL, V25, P406, DOI 10.1006/ceps.1999.1027; Pintrich P. R., 1996, MOTIVATION ED THEORY; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Robbins SB, 2004, PSYCHOL BULL, V130, P261, DOI 10.1037/0033-2909.130.2.261; Salazar R., 2011, COGNITIVE PERF UNPUB; Schunk, 2003, READ WRIT Q, V19, P159, DOI [DOI 10.1080/10573560308219, 10.1080/10573560308219]; SORENSON SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI DOI 10.1097/00001199-199106000-00003; Sosin DM, 1996, BRAIN INJURY, V10, P47; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wechsler D, 1997, WAIS 3 ADM SCORING M; Zuffiano A, 2013, LEARN INDIVID DIFFER, V23, P158, DOI 10.1016/j.lindif.2012.07.010	63	15	15	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV 1	2013	35	9					960	970		10.1080/13803395.2013.844770			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	238PF	WOS:000325959200007	24099494				2021-06-18	
J	Hu, JH; Ugiliweneza, B; Meyer, K; Lad, SP; Boakye, M				Hu, Jiahui; Ugiliweneza, Beatrice; Meyer, Kimberly; Lad, Shivanand P.; Boakye, Maxwell			Trend and Geographic Analysis for Traumatic Brain Injury Mortality and Cost Based on MarketScan Database	JOURNAL OF NEUROTRAUMA			English	Article						hospital cost; length of stay; mortality rate; traumatic brain injury	HOSPITAL LENGTH; GENDER; MODERATE; OUTCOMES; CHARGES; ICISS; STAY	The objective of the current research was to examine the current epidemiology of traumatic brain injury (TBI); to determine the effects of geographic region, co-morbidities, year of injury, injury severity, and demographics on hospital costs, length of stay (LOS), and mortality. All subjects were drawn from the Thomason Reuters MarketScan((R)) database. Statistical methods used included descriptive analysis, bivariate analysis, logistic regression, and the Geographic Information System (GIS) software, ArcMap. We studied 76,313 patients with TBI from 2004 to 2009 (52,721 with commercial insurance and 23,592 with Medicare) from the MarketScan database. As age increased, mortality rate and median LOS increased. The median hospital costs for adults were the highest ($13,000 for ages 18-64) compared with children ($8000 for age 0-14) and elderly persons ($9000 for age 65). The mortality rate for the elderly population has decreased slightly (11.1% in 2004 to 9.9% in 2009 for men, and 7.0% to 6.9% for women); however, their hospital costs have increased significantly ($6899 in 2004 to $11,567 in 2009 for men; $6784 to $9782 for women). Concerning the impact of geography, the western United States (e.g., Washington and California) had lower mortality rates and higher median costs while the southeast United States had the highest mortality and mixed median costs. Both overall mortality and median LOS have remained relatively stable over the years. Hospital cost, however, has increased for the elderly population even after accounting for the inflation. There is significant geographic variation for both mortality and hospital costs.	[Hu, Jiahui] DuPont Manual High Sch, Louisville, KY USA; [Ugiliweneza, Beatrice] Univ Louisville, Ctr Adv Neurosurg, Dept Neurosurg, Louisville, KY 40202 USA; [Meyer, Kimberly] Univ Louisville Hosp, Louisville, KY USA; [Lad, Shivanand P.] Duke Univ, Med Ctr, Div Neurosurg, Durham, NC 27710 USA; [Boakye, Maxwell] Robley Rex VA Med Ctr, Dept Neurosurg, Louisville, KY USA	Boakye, M (corresponding author), Univ Louisville, Ctr Adv Neurosurg, 220 Abraham Flexner Way,1105, Louisville, KY 40202 USA.	max.boakye@louisville.edu	Meyer, Kimberly/L-5430-2019				Allison P., 1999, LOGISTIC REGRESSION; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brasel KJ, 2007, ARCH SURG-CHICAGO, V142, P461, DOI 10.1001/archsurg.142.5.461; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colantonio A, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-7; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Kurland K. S., 2006, GIS TUTORIAL FOR HEA; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Rutledge R, 1998, J TRAUMA, V44, P41, DOI 10.1097/00005373-199801000-00003; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; United States Department of Labor, 2012, CPI INFLATION CALCUL	22	15	15	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2013	30	20					1755	1761		10.1089/neu.2013.2857			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	232JW	WOS:000325491000008	23642155				2021-06-18	
J	Sullivan, S; Friess, SH; Ralston, J; Smith, C; Propert, KJ; Rapp, PE; Margulies, SS				Sullivan, Sarah; Friess, Stuart H.; Ralston, Jill; Smith, Colin; Propert, Kathleen J.; Rapp, Paul E.; Margulies, Susan S.			Improved Behavior, Motor, and Cognition Assessments in Neonatal Piglets	JOURNAL OF NEUROTRAUMA			English	Article						cognition; neurobehavioral assessment; pediatric brain injury; porcine; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MATURATION-DEPENDENT RESPONSE; ROTATIONAL HEAD-INJURY; IMMATURE BRAIN; AXONAL INJURY; ANIMAL-MODELS; GROSS MOTOR; SUS-SCROFA; CHILDREN; PIG	The alterations of animal behavior after traumatic brain injury (TBI) can be subtle, and their quantitative characterization can present significant methodological challenges. Meeting these challenges is a critical need, because quantitative measures are required in studies that compare the efficacy of different clinical interventions. We developed a battery of assessments to quantify behavioral, motor, and cognitive changes in neonatal piglets with good sensitivity and specificity to the detection of persistent deficits that correlate with axonal injury severity after a rapid non-impact head rotation with a diffuse pattern of axonal injury. The battery of measures developed included open field behaviors of sniffing and moving a toy, locomotion measures of Lempel-Ziv complexity and the probability of remaining in the current location, and a novel metric for evaluating motor performance. Our composite porcine disability score was able to detect brain injury with a sensitivity of 100% and specificity of 85.7% at day +4 post-injury for n=8 injured and n=7 sham piglets and significantly correlated with the percent axonal injury in these animals (day +4: =0.76, p=0.0011). A significant improvement over our previous assessments, this new porcine disability score has potential use in a wide variety of porcine disease and injury models.	[Sullivan, Sarah; Ralston, Jill; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Friess, Stuart H.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Smith, Colin] Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland; [Propert, Kathleen J.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Rapp, Paul E.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA	Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Smith, Colin/0000-0002-4507-5132	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679, U01NS069545, K08NS064051]; Traumatic Injury Research Program of the Uniformed Services University of the Health Sciences; Defense Medical Research and Development Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679, K08NS064051, U01NS069545] Funding Source: NIH RePORTER	The authors would like to acknowledge Benjamin Bruins, Erica Hummel, James Butler, and Sohaib Hashmi for their contributions in conducting and rating the assessments. This study was made possible by the support of NIH/NINDS grants R01NS039679, U01NS069545, and K08NS064051. PER would like to acknowledge support of the Traumatic Injury Research Program of the Uniformed Services University of the Health Sciences and the Defense Medical Research and Development Program. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as official or reflecting the views of their respective commands, the U. S. Navy or the Department of Defense.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Bona E, 1997, PEDIATR RES, V42, P678, DOI 10.1203/00006450-199711000-00021; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Dilger RN, 2010, BRAIN BEHAV IMMUN, V24, P1156, DOI 10.1016/j.bbi.2010.05.008; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fang MR, 2005, NEUROSIGNALS, V14, P102, DOI 10.1159/000086292; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Kuluz J, 2010, J SPINAL CORD MED, V33, P43, DOI 10.1080/10790268.2010.11689673; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Linder-Lucht M, 2007, PEDIATRICS, V120, P880, DOI 10.1542/peds.2006-2258; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Tanaka Y, 2008, STROKE, V39, P205, DOI 10.1161/STROKEAHA.107.489906; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; Wang B, 2007, AM J CLIN NUTR, V85, P561	39	15	15	1	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2013	30	20					1770	1779		10.1089/neu.2013.2913			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	232JW	WOS:000325491000010	23758416	Green Published			2021-06-18	
J	Grill, E; Klein, AM; Howell, K; Arndt, M; Bodrozic, L; Herzog, J; Jox, R; Koenig, E; Mansmann, U; Muller, F; Muller, T; Nowak, D; Schaupp, M; Straube, A; Bender, A				Grill, Eva; Klein, Anke-Maria; Howell, Kaitlen; Arndt, Marion; Bodrozic, Lydia; Herzog, Juergen; Jox, Ralf; Koenig, Eberhardt; Mansmann, Ulrich; Mueller, Friedemann; Mueller, Thomas; Nowak, Dennis; Schaupp, Matthias; Straube, Andreas; Bender, Andreas			Rationale and Design of the Prospective German Registry of Outcome in Patients With Severe Disorders of Consciousness After Acute Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Anoxia; Brain injuries; Disability evaluation; Persistent vegetative state; Registries; Rehabilitation	ICF CORE SETS; VEGETATIVE STATE; ASSESSMENT SCALES; CARDIAC-ARREST; REHABILITATION; RELIABILITY; RECOVERY; LIFE; RESUSCITATION; PROGNOSIS	Objective: To describe the rationale and design of a new patient registry (Koma Outcome von Patienten der Fruhrehabilitation-Register [KOPF-R; Registry for Coma Outcome in Patients Undergoing Acute Rehabilitation]) that has the scope to examine determinants of long-term outcome and functioning of patients with severe disorders of consciousness (DOC). Design: Prospective multicenter neurologic rehabilitation registry. Setting: Five specialized neurologic rehabilitation facilities. Participants: Patients (N=42) with DOC in vegetative state or minimally conscious state (MCS) as defined by the Coma Recovery Scale Revised (CRS-R) after brain injury. Patients are being continuously enrolled. The data presented here cover the enrollment period from August 2011 to January 2012. Interventions: Not applicable. Main Outcome Measures: CRS-R, FIM, and emergence from MCS. Results: The registry was set up in 5 facilities across the state of Bavaria/Germany with a special expertise in the rehabilitation of acquired brain injury. Inclusion of patients started in August 2011. Measures include sociodemographic and clinical characteristics, course of acute therapy, electrophysiologic measures (evoked potentials, electroencephalogram), neuron-specific enolase, current medication, functioning, cognition, participation, quality of life, quantity and characteristics of rehabilitation therapy, caregiver burden, and attitudes toward end-of-life decisions. Main diagnoses were traumatic brain injury (24%), intracerebral or subarachnoid hemorrhage (31%), and anoxic-ischemic encephalopathy (45%). Mean CRS-R score +/- SD at admission to rehabilitation was 5.9 +/- 3.3, and mean FIM score +/- SD at admission was 18 +/- 0.4. Conclusions: The KOPF-R aspires to contribute prospective data on prognosis in severe DOC. (c) 2013 by the American Congress of Rehabilitation Medicine	[Grill, Eva; Mansmann, Ulrich; Mueller, Thomas] Univ Munich, Inst Med Informat Proc Biometry & Epidemiol, D-81377 Munich, Germany; [Grill, Eva] Univ Munich, Integrated Ctr Res & Treatment Vertigo Balance &, D-81377 Munich, Germany; [Klein, Anke-Maria; Howell, Kaitlen; Straube, Andreas; Bender, Andreas] Univ Munich, Dept Neurol, D-81377 Munich, Germany; [Howell, Kaitlen; Arndt, Marion; Bodrozic, Lydia; Bender, Andreas] Therapiezentrum Burgau, Burgau, Germany; [Herzog, Juergen] Schon Klin Munchen Schwabing, Munich, Germany; [Jox, Ralf] Univ Munich, Inst Eth Hist & Theory Med, D-81377 Munich, Germany; [Koenig, Eberhardt; Mueller, Friedemann] Schon Klin Bad Aibling, Bad Aibling, Germany; [Nowak, Dennis] Klin Kipfenberg, Kipfenberg, Germany; [Schaupp, Matthias] Neurol Clin, Bad Neustadt an der Saale, Germany	Bender, A (corresponding author), Univ Munich, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany.	anbender@med.uni-muenchen.de	Grill, Eva/AAF-8104-2020; Grill, Eva/D-1875-2010	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984; Bender, Andreas/0000-0002-6328-7104	Hannelore-Kohl-Stiftung, Germany [2011013]; Deutsche Stiftung Neurologie, Germany	Supported in part by the Hannelore-Kohl-Stiftung, Germany (grant no. 2011013 to AB) and the Deutsche Stiftung Neurologie, Germany.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bender A, 2012, J NEUROL, V259, P2481, DOI 10.1007/s00415-012-6573-8; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Geocadin RG, 2006, NEUROLOGY, V67, P105, DOI 10.1212/01.wnl.0000223335.86166.b4; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Grassel E., 1993, HAUSLICHE PFLEGE SKA; Grill E, 2011, J REHABIL MED, V43, P131, DOI 10.2340/16501977-0641; Grill E, 2011, J REHABIL MED, V43, P123, DOI 10.2340/16501977-0646; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lule D, 2009, PROG BRAIN RES, V177, P339, DOI 10.1016/S0079-6123(09)17723-3; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Schmidt, 2000, NEUROL REHABIL, V6, P125; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Thornton M, 2003, J GERONTOL B-PSYCHOL, V58, pS127, DOI 10.1093/geronb/58.2.S127; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Voss A, 1993, SPECTRUM NEUROREHABI, P112; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f	29	15	16	1	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2013	94	10					1870	1876		10.1016/j.apmr.2012.10.040			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	231TU	WOS:000325442100004	23732165				2021-06-18	
J	Hanson, HR; Pomerantz, WJ; Gittelman, M				Hanson, Holly R.; Pomerantz, Wendy J.; Gittelman, Mike			ED Utilization Trends in Sports-Related Traumatic Brain Injury	PEDIATRICS			English	Article						traumatic brain injury; sports; pediatrics; admission; severity	PROFESSIONAL FOOTBALL PLAYERS; RECURRENT CONCUSSION; UNITED-STATES; US CHILDREN; MILD; HOSPITALIZATIONS; ASSOCIATION; SYMPTOMS	BACKGROUND: Emergency department (ED) visits for sports-related traumatic brain injuries (TBIs) have risen. This study evaluated how the number and severity of admissions have changed as ED visits for sports-related TBIs have increased. METHODS: A retrospective study of children aged 0 to 19 years at a level 1 trauma center was performed. Patients from 2002 to 2011 with a primary or secondary diagnosis of TBI were identified from the hospital's inpatient and outpatient trauma registries. Frequencies were used to characterize the population, chi(2) analysis was performed to determine differences between groups, and regression analysis looked at relationship between year and injury severity score or length of stay. RESULTS: Sport was responsible for injury in 3878 (15.4%) cases during the study period; 3506 (90.4%) were discharged from the hospital, and 372 (9.6%) were admitted. Seventy-three percent were male patients and 78% Caucasian; mean age was 13 +/- 3.5 years. ED visits for sports-related TBIs increased 92% over the study period, yet there was no significant change (chi(2) = 9.8, df = 9, P = .37) in the percentage of children admitted. Mean injury severity score for those admitted decreased from 7.8 to 4.8 (beta = -0.46; P = .006); length of stay trended downward (beta = -0.05; P = .05). CONCLUSIONS: The percentage of children being admitted from the ED with sports-related TBI has not changed over the past 10 years. The severity of admitted sports-related TBI is decreasing. Additional research is needed to correlate these trends with other TBI mechanisms.	[Hanson, Holly R.; Pomerantz, Wendy J.; Gittelman, Mike] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA	Hanson, HR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave,MLC 2008, Cincinnati, OH 45229 USA.	holly.hanson@cchmc.org			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000077] Funding Source: Medline		Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1137; Centers for Disease Control and Prevention, 2010, HEADS CONC; Faigenbaum AD, 2009, J STRENGTH COND RES, V23, pS60, DOI 10.1519/JSC.0b013e31819df407; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Metzl JD, 2006, PEDIATRICS, V117, P1813, DOI 10.1542/peds.2006-0480; Monaghan S, 2012, HIGH SCH SPORTS PART; *NAT CTR INJ PREV, 1999, TRAUM BRAIN INJ US R; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Sosin DM, 1996, BRAIN INJURY, V10, P47; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923	21	15	15	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2013	132	4					E859	E864		10.1542/peds.2013-1704			6	Pediatrics	Pediatrics	227FI	WOS:000325095400007	24081999	Green Published			2021-06-18	
J	Kramer, AH; Zygun, DA				Kramer, Andreas H.; Zygun, David A.			Declining mortality in neurocritical care patients: a cohort study in Southern Alberta over eleven years	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; HOSPITAL CARDIAC-ARREST; COLLABORATIVE STUDY-GROUP; LIFE-SUSTAINING THERAPY; CASE-FATALITY RATES; INTRACEREBRAL HEMORRHAGE; MECHANICAL VENTILATION; PROGNOSTIC-FACTORS; STROKE	Few interventions have been proven to improve outcomes in neurocritical care patients. It is unknown whether outcomes in Canada have changed over time. We performed a cohort study in Southern Alberta to determine whether survival and discharge disposition have improved. Using prospectively collected data, we identified patients admitted to regional intensive care units (ICUs) over a more than 11-year period with traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), intracerebral hemorrhage, anoxic encephalopathy, central nervous system infection, or status epilepticus. Four sequential time periods of 2.8 years were compared, as were periods before and after various practice modifications were introduced. Logistic regression was used to adjust for patient age, Glasgow Coma Scale score, and case mix. A total of 4,097 patients were assessed. The odds of death were lowest in the most recent time quartile (odds ratio [OR] 0.70, 95% confidence interval [CI] 0.56 to 0.88, P < 0.01). The odds of being discharged home without the need for support services increased over time (OR 1.45, 95% CI 1.38 to 1.85, P = 0.003). Improvements were not the same for all diagnostic subgroups. They were statistically significant for patients with TBI and SAH. Neurocritical care consultative services, evidence-based protocols, and clustering of patients within a multidisciplinary ICU were associated with improved outcomes. Length of stay in an ICU increased among hospital survivors (4.6 vs 3.8 days, P < 0.01). Mortality and discharge disposition of neurocritical care patients in Southern Alberta have improved over time. Practice modifications in the region were associated with positive outcome trends. Longer ICU length of stay may imply that intensivists are increasingly delaying decisions about withdrawing life-sustaining interventions.	[Kramer, Andreas H.] Univ Calgary, Hotchkiss Brain Inst, Foothills Med Ctr, Dept Crit Care Med, Calgary, AB T2N 2T9, Canada; [Kramer, Andreas H.] Univ Calgary, Hotchkiss Brain Inst, Foothills Med Ctr, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada; [Zygun, David A.] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada	Kramer, AH (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Foothills Med Ctr, Dept Crit Care Med, 3134 Hosp Dr NW, Calgary, AB T2N 2T9, Canada.	Andreas.Kramer@AlbertaHealthServices.ca					Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Berthiaume LR, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.07.004; Braga LHP, 2012, CAN J SURG, V55, P132, DOI 10.1503/cjs.036311; Broessner G, 2007, CRIT CARE MED, V35, P2025, DOI 10.1097/01.ccm.0000281449.07719.2b; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caulfield AF, 2010, NEUROLOGY, V74, P1096, DOI 10.1212/WNL.0b013e3181d8197f; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Christensen MC, 2009, STROKE, V40, P1677, DOI 10.1161/STROKEAHA.108.538967; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; de Keizer NF, 2000, INTENS CARE MED, V26, P577, DOI 10.1007/s001340051207; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Groenwold RHH, 2013, CAN MED ASSOC J, V185, P401, DOI 10.1503/cmaj.120592; Gujjar AR, 1998, NEUROLOGY, V51, P447, DOI 10.1212/WNL.51.2.447; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Hemphill JC, 2009, NEUROLOGY, V73, P1088, DOI 10.1212/WNL.0b013e3181b8b332; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Kramer AH, 2012, CAN J NEUROL SCI, V39, P328, DOI 10.1017/S0317167100013469; Kramer AH, 2011, NEUROCRIT CARE, V14, P329, DOI 10.1007/s12028-011-9530-y; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Mateen FJ, 2011, NEUROLOGY, V77, P1438, DOI 10.1212/WNL.0b013e318232ab33; Mayo NE, 1996, STROKE, V27, P1215, DOI 10.1161/01.STR.27.7.1215; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Ostbye T, 1997, STROKE, V28, P793, DOI 10.1161/01.STR.28.4.793; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Racine E, 2009, NEUROCRIT CARE, V11, P345, DOI 10.1007/s12028-009-9225-9; Redpath C, 2010, AM HEART J, V159, P577, DOI 10.1016/j.ahj.2009.12.030; Rocker G, 2004, CRIT CARE MED, V32, P1149, DOI 10.1097/01.CCM.0000126402.51524.52; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sandvei MS, 2011, NEUROLOGY, V77, P1833, DOI 10.1212/WNL.0b013e3182377de3; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vaillancourt C, 2004, CAN J CARDIOL, V20, P1081; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Varelas PN, 2004, CRIT CARE MED, V32, P2191, DOI 10.1097/01.CCM.0000146131.03578.21; Wright WL, 2012, CURR NEUROL NEUROSCI, V12, P466, DOI 10.1007/s11910-012-0284-5; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	70	15	15	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	OCT	2013	60	10					966	975		10.1007/s12630-013-0001-0			10	Anesthesiology	Anesthesiology	221DC	WOS:000324636700003	23877315	Bronze			2021-06-18	
J	Thomas, AG; Hegde, SV; Dineen, RA; Jaspan, T				Thomas, A. G.; Hegde, S. V.; Dineen, R. A.; Jaspan, T.			Patterns of accidental craniocerebral injury occurring in early childhood	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							TRAUMATIC HEAD-INJURY; SHORT-DISTANCE FALLS; YOUNG-CHILDREN; INFANTS; DEATH; BED; CONTROVERSIES	Objective To describe the range of intracranial injuries encountered in 0-2-year-olds in cases of accidental head injury where the mechanism of trauma was well characterised and to assess the clinical consequences. Design A retrospective review of imaging and clinical data. Setting Two tertiary paediatric referral centres. Patients All children aged 0-2 undergoing cranial CT as indicated by National Institute for Health and Clinical Excellence guidance for head injury from 2006 to 2011. After exclusion criteria, 149 patients were included. Main outcome measures Rates of skull fracture, intracranial haemorrhage, parenchymal injuries and ischaemic change per type of mechanism of injury. Rates of neurological sequelae on follow-up. Results Skull fractures were demonstrated in 54 (36%) patients of whom 17 (11%) had thin underlying subdural haemorrhage (SDH). Extradural haemorrhage complicated one fracture and two cases of isolated subdural haematomas were seen without skull fracture. Radiologically evident brain parenchymal injuries were present in three patients, all with mechanisms of injury involving high levels of force; severe neurological sequelae were only seen in one patient, who had diffuse hypoxic-ischaemic damage at presentation and whose (accidental) mechanism of injury involved extensive acceleration/deceleration/translational forces. Conclusions Skull fractures and focal SDH are relatively common following minor trauma in this age group but in the vast majority of cases there are no long-term neurological sequelae. Conversely, diffuse brain injury with severe subsequent neurological impairment was only seen in patients with a correspondingly severe mechanism of injury.	[Thomas, A. G.] Leicester Royal Infirm, Univ Hosp Leicester NHS Trust, Dept Radiol, Leicester LE1 5WW, Leics, England; [Hegde, S. V.] Arkansas Childrens Hosp, Dept Radiol, Little Rock, AR 72202 USA; [Dineen, R. A.] Univ Nottingham, Dept Radiol & Imaging Sci, Nottingham NG7 2RD, England; [Dineen, R. A.; Jaspan, T.] Nottingham Univ Hosp NHS Trust, Dept Neuroradiol, Nottingham, England	Thomas, AG (corresponding author), Leicester Royal Infirm, Univ Hosp Leicester NHS Trust, Dept Radiol, Infirm Sq, Leicester LE1 5WW, Leics, England.	adam.thomas@doctors.org.uk	Dineen, Robert/S-7192-2019	Dineen, Robert/0000-0002-9523-2546			Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; CHADWICK DL, 1993, J TRAUMA, V35, P968, DOI 10.1097/00005373-199312000-00031; Ciurea AV, 2007, CHILD NERV SYST, V23, P335, DOI 10.1007/s00381-006-0230-4; Datta S, 2005, ARCH DIS CHILD, V90, P947, DOI 10.1136/adc.2002.021154; Demaerel P, 2002, EUR RADIOL, V12, P849, DOI 10.1007/s00330-001-1145-9; Denton S, 2003, AM J FOREN MED PATH, V24, P371, DOI 10.1097/01.paf.0000097851.18478.16; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ehsani JP, 2010, AM J FOREN MED PATH, V31, P287, DOI 10.1097/PAF.0b013e3181db7eb5; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Fernando S, 2008, PEDIATR RADIOL, V38, P827, DOI 10.1007/s00247-007-0729-1; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Hedlund GL, 2009, FORENSIC SCI MED PAT, V5, P280, DOI 10.1007/s12024-009-9132-6; HELFER RE, 1977, PEDIATRICS, V60, P533; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; Jaspan T, 2008, PEDIATR RADIOL, V38, pS378, DOI 10.1007/s00247-008-0896-8; Kim KA, 2000, NEUROSURG FOCUS, V8, P1; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; LYONS TJ, 1993, PEDIATRICS, V92, P125; National Institute for Clinical Excellence (NICE), 2003, CG4 NICE; National Institute for Clinical Excellence (NICE), 2007, CG56 NICE; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; RIVARA FP, 1993, PEDIATRICS, V92, P61; *ROYAL COLL RAD, 2008, STAND RAD INV SUSP N; Spivack B, 2001, AM J FOREN MED PATH, V22, P332, DOI 10.1097/00000433-200109000-00028; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Vezina G, 2009, PEDIATR RADIOL, V39, P586, DOI 10.1007/s00247-009-1212-y; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005	35	15	18	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	OCT	2013	98	10					787	792		10.1136/archdischild-2013-304267			6	Pediatrics	Pediatrics	218FX	WOS:000324419300015	23922057				2021-06-18	
J	Willmott, C; Ponsford, J; McAllister, TW; Burke, R				Willmott, Catherine; Ponsford, Jennie; McAllister, Thomas W.; Burke, Richard			Effect of COMT Val158Met genotype on attention and response to methylphenidate following traumatic brain injury	BRAIN INJURY			English	Article						Attention; catechol-O-methyltransferase (COMT); methylphenidate; traumatic brain injury	CLOSED-HEAD INJURY; DEFICITS; GENE	Primary objective: To investigate whether COMT Val158Met allele status was associated with (i) attentional performance and (ii) response to methylphenidate (MP) following traumatic brain injury (TBI). Methods: Forty healthy controls and 32 patients with moderate-severe TBI (Mean time post-injury = 68 days) completed a baseline cognitive assessment. The TBI cohort then participated in a randomized, cross-over, double blind, placebo controlled 2-week MP trial. MP was administered at 0.3 mg/kg twice daily. TBI genotype distribution: val/val n = 11; val/met n = 14; met/met n = 7. Results: There were no significant differences across genotypes on baseline attentional measures. When compared with controls, the val/val group performed significantly more poorly on most measures. The met/met group performed more poorly than controls on measures of speed, but not in strategic control of attention. MP resulted in faster speed of information processing. Repeated measures mixed ANOVAs found only one significant drug x genotype interaction: (F-(2,F-29) = 4.257, p = 0.024) the met/met group demonstrated a greater response to MP on the Symbol Digit Modalities Test. Conclusions: COMT allele status was not strongly associated with attentional performance or response to MP in the TBI sample. The met/met group, whilst performing slowly, had relatively preserved strategic control of attention.	[Willmott, Catherine; Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Notting Hill, Vic 3168, Australia; [McAllister, Thomas W.] Dartmouth Med Sch, Lebanon, NH USA; [Burke, Richard] Monash Univ, Sch Biol Sci, Notting Hill, Vic 3168, Australia	Willmott, C (corresponding author), Monash Univ, Sch Psychol & Psychiat, Neuropsychol Clin, Bldg 1-270 Ferntree Gully Rd, Notting Hill, Vic 3168, Australia.	catherine.willmott@monash.edu	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035; Burke, Richard/0000-0003-0086-0767	Victorian Neurotrauma Initiative Pty Ltd; Wenkart Foundation	The authors report that, over the past 3 years or anticipated in the near future, no financial support or compensation for research or professional services has been received from any individual or corporate entity that may gain or lose financially through this publication. The authors report they have no personal financial interests that could be perceived as constituting a potential conflict of interest. This study was supported by the Victorian Neurotrauma Initiative Pty Ltd and the Wenkart Foundation, neither of which had any involvement in study design; collection, analysis and interpretation of data; writing of the report; or the decision to submit the article for publication. Drugs were purchased for the trial on a commercial basis, and the company that manufactures Ritalin (R) made no contribution to the study.	Arnsten AFT, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-2; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Cornish KM, 2010, ATTENTION GENES DEV; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Flashman L.A., 2004, J NEUROPSYCHIATRY CL, V16, P238; Karakucuk EI, 1997, NEUROPEPTIDES, V31, P259, DOI 10.1016/S0143-4179(97)90057-3; Leonard BE, 2004, HUM PSYCHOPHARM CLIN, V19, P151, DOI 10.1002/hup.579; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Ruff RM, 1995, RUFF 2 7 SELECTIVE A; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Smith A., 1991, SYMBOL DIGIT MODALIT; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Vernon-Wilkinson R, 1993, ARCH CLIN NEUROPSYCH, V9, P2; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D, 1997, WAIS 3 ADM SCORING M; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2010, DELISAS PHYS MED REH, P575; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	27	15	15	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2013	27	11					1281	1286		10.3109/02699052.2013.809553			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	217YQ	WOS:000324399800007	23924290				2021-06-18	
J	Brophy, GM; Mazzeo, AT; Brar, S; Alves, OL; Bunnell, K; Gilman, C; Karnes, T; Hayes, RL; Bullock, R				Brophy, Gretchen M.; Mazzeo, Anna Teresa; Brar, Satjit; Alves, Oscar Luis; Bunnell, Kristen; Gilman, Charlotte; Karnes, Tom; Hayes, Ron L.; Bullock, Ross			Exposure of Cyclosporin A in Whole Blood, Cerebral Spinal Fluid, and Brain Extracellular Fluid Dialysate in Adults with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cyclosporin; neuroprotection; TBI	MITOCHONDRIAL PERMEABILITY TRANSITION; REPERFUSION INJURY; HEALTHY-SUBJECTS; DOSE-RESPONSE; PHARMACOKINETICS; MICRODIALYSIS; DAMAGE; RAT; QUANTIFICATION; CORRELATE	Cyclosporin A (CsA), an immunosuppressive medication traditionally used in the prevention of post-transplant rejection, is a promising neuroprotective agent for traumatic brain injury (TBI). Preliminary studies in animals and humans describe the efficacy and safety of CsA when administered following neurotrauma. The objective of this study is to describe CsA exposure in adults with severe TBI by assessing concentrations in whole blood, cerebrospinal fluid (CSF), and brain extracellular fluid (ECF) dialysate as measured by brain microdialysis. Severe TBI patients were enrolled in a randomized controlled trial following the written informed consent of their legal guardians. Patients received either CsA 5 mg/kg as a continuous infusion over 24 h, or matching placebo. Noncompartmental exposure analyses were performed using CsA concentrations in whole blood, CSF, and ECF dialysate. There were 37 patients randomized to the CsA arm of the trial and included in this exposure analysis. CsA was detected in the ECF dialysate and CSF at a fraction of the whole blood concentration. Mean CsA maximum concentrations were achieved at 24 and 30 h from the start of the 24 h infusion, in the CSF and ECF dialysate, respectively. A correlation was found between ECF dialysate and CSF concentrations. CsA was detected in the blood, CSF, and brain ECF dialysate. CsA exposure characteristic differences exist for whole blood, CSF, and ECF dialysate in severe TBI patients when administered as a continuous intravenous infusion. These exposure characteristics should be used for safer CsA dose optimization to achieve target CsA concentrations for neuroprotection in future TBI studies.	[Brophy, Gretchen M.; Karnes, Tom] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23298 USA; [Bunnell, Kristen] Virginia Commonwealth Univ, Dept Pharm, Richmond, VA 23298 USA; [Brophy, Gretchen M.; Gilman, Charlotte] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Mazzeo, Anna Teresa] Univ Turin, Osped San Gioranni Betista, Dept Anaesthesia & Intens Care, Turin, Italy; [Brar, Satjit] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol, Silver Spring, MD USA; [Alves, Oscar Luis] Univ Porto, Serv Neurocirugia, Ctr Hosp Vila Nova Gaia, Fac Med, P-4100 Oporto, Portugal; [Hayes, Ron L.] Banyan Biomarkers Inc, Alachua, FL USA; [Bullock, Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Miami, FL 33136 USA	Brophy, GM (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia Campus,410 N 12th St,POB 980533, Richmond, VA 23298 USA.	gbrophy@vcu.edu		Bunnell, Kristen/0000-0002-7646-0594; Mazzeo, Anna Teresa/0000-0002-8454-7243; Brophy, Gretchen/0000-0002-4749-2693	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS 12587-27]; Reynolds Foundation; Lind-Lawrence Foundation; Fundacao para a Ciencia e TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission [SFRH/BD/3421/2000]; Fulbright Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587] Funding Source: NIH RePORTER	Funding for this study was provided by NIH NINDS grant N. P50 NS 12587-27, and Ross Bullock was supported by the Reynolds and Lind-Lawrence Foundations. Oscar L Alves was supported by grant number SFRH/BD/3421/2000 from Fundacao para a Ciencia e Tecnologia, and by a Fulbright Fellowship.	Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dahlin AP, 2012, ANAL BIOANAL CHEM, V402, P2057, DOI 10.1007/s00216-011-5614-y; DELANGE ECM, 1995, BRAIN RES, V702, P261, DOI 10.1016/0006-8993(95)01184-X; DYKSTRA KH, 1992, J NEUROCHEM, V58, P931, DOI 10.1111/j.1471-4159.1992.tb09346.x; Empey PE, 2006, J NEUROTRAUM, V23, P109, DOI 10.1089/neu.2006.23.109; FLECHNER SM, 1989, TRANSPLANTATION, V47, P806, DOI 10.1097/00007890-198905000-00012; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755; GUPTA SK, 1990, J CLIN PHARMACOL, V30, P643, DOI 10.1002/j.1552-4604.1990.tb01868.x; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Iyer SS, 2007, J LIQ CHROMATOGR R T, V30, P1733, DOI 10.1080/10826070701360301; KAHAN BD, 1986, TRANSPLANTATION, V41, P459, DOI 10.1097/00007890-198604000-00009; Kalsotra A, 2003, J NEUROTRAUM, V20, P1339, DOI 10.1089/089771503322686139; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Miller RJ, 1998, TRENDS NEUROSCI, V21, P95, DOI 10.1016/S0166-2236(97)01206-X; Min DI, 2004, THER DRUG MONIT, V26, P524, DOI 10.1097/00007691-200410000-00010; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; PTACHCINSKI RJ, 1985, CLIN PHARMACOL THER, V38, P296, DOI 10.1038/clpt.1985.174; PTACHCINSKI RJ, 1987, J CLIN PHARMACOL, V27, P243, DOI 10.1002/j.1552-4604.1987.tb02193.x; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P141, DOI 10.2165/11317350-000000000-00000; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282	39	15	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2013	30	17					1484	1489		10.1089/neu.2012.2524			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	202HX	WOS:000323205800003	23540442	Green Published			2021-06-18	
J	Hui, X; Haider, AH; Hashmi, ZG; Rushing, AP; Dhiman, N; Scott, VK; Selvarajah, S; Haut, ER; Efron, DT; Schneider, EB				Hui, Xuan; Haider, Adil H.; Hashmi, Zain G.; Rushing, Amy P.; Dhiman, Nitasha; Scott, Valerie K.; Selvarajah, Shalini; Haut, Elliott R.; Efron, David T.; Schneider, Eric B.			Increased risk of pneumonia among ventilated patients with traumatic brain injury: every day counts!	JOURNAL OF SURGICAL RESEARCH			English	Article						Pneumonia; Mechanical ventilation; Trauma; Traumatic brain injury	ACUTE LUNG INJURY; ASPIRATION; HEAD; EPIDEMIOLOGY; CARE	Background: Patients with traumatic brain injury (TBI) frequently require mechanical ventilation (MV). The objective of this study was to examine the association between time spent on MV and the development of pneumonia among patients with TBI. Materials and methods: Patients older than 18 y with head abbreviated injury scale (AIS) scores coded 1-6 requiring MV in the National Trauma Data Bank 2007-2010 data set were included. The study was limited to hospitals reporting pneumonia cases. AIS scores were calculated using ICDMAP-90 software. Patients with injuries in any other region with AIS score >3, significant burns, or a hospital length of stay >30 d were excluded. A generalized linear model was used to determine the approximate relative risk of developing all-cause pneumonia (aspiration pneumonia, ventilator-associated pneumonia [VAP], and infectious pneumonia identified by the International Classification of Disease, Ninth Revision, diagnosis code) for each day of MV, controlling for age, gender, Glasgow coma scale motor score, comorbidity (Charlson comorbidity index) score, insurance status, and injury type and severity. Results: Among the 24,525 patients with TBI who required MV included in this study, 1593 (6.5%) developed all-cause pneumonia. After controlling for demographic and injury factors, each additional day on the ventilator was associated with a 7% increase in the risk of pneumonia (risk ratio 1.07, 95% confidence interval 1.07-1.08). Conclusions: Patients who have sustained TBIs and require MV are at higher risk for VAP than individuals extubated earlier; therefore, shortening MV exposure will likely reduce the risk of VAP. As patients with TBI frequently require MV because of neurologic impairment, it is key to develop aggressive strategies to expedite ventilator independence. (C) 2013 Elsevier Inc. All rights reserved.	[Hui, Xuan; Haider, Adil H.; Hashmi, Zain G.; Rushing, Amy P.; Dhiman, Nitasha; Scott, Valerie K.; Selvarajah, Shalini; Haut, Elliott R.; Efron, David T.; Schneider, Eric B.] Johns Hopkins Univ, Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, Baltimore, MD 21287 USA	Haider, AH (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, 1800 New Orleans St,Zayed 6107, Baltimore, MD 21287 USA.	ahaider1@jhmi.edu	Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X	National Institutes of Health/National Institute of General Medical Science (NIGMS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093112-01]; American College of Surgeons; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093112] Funding Source: NIH RePORTER	Financial support for this work was provided by the National Institutes of Health/National Institute of General Medical Science (NIGMS) K23GM093112-01 and American College of Surgeons C. James Carrico Fellowship for the Study of Trauma and Critical Care (Dr. Haider).	Adnet F, 1996, LANCET, V348, P123, DOI 10.1016/S0140-6736(05)64630-2; [Anonymous], 2010, MEDICARE FACT SHEET; Association for Professional in Infection Control and Epidemiology, 2009, GUID EL VENT ASS PNE; Besser RE, 2009, CDCS ROLE PREVENTING, P16; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 2012, NEW ENGL J MED; CIOCON JO, 1988, ARCH INTERN MED, V148, P429, DOI 10.1001/archinte.148.2.429; Clark DE., 2010, ICDPIC STATA MODULE; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; FINEGOLD SM, 1991, REV INFECT DIS, V13, pS737; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; GEORGE DL, 1995, CLIN CHEST MED, V16, P29; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kikawada M, 2005, DRUG AGING, V22, P115, DOI 10.2165/00002512-200522020-00003; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; MacKenzie E, 1997, ICDMAP 90 SOFTWARE U, P1; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Palmer BL, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000308961.99857.33; Semenov YR, 2012, LARYNGOSCOPE, V122, P1994, DOI 10.1002/lary.23446; Spicer Rebecca S, 2011, Ann Adv Automot Med, V55, P365; Straube B, 2009, HEALTH AFFAIR, V28, P1494, DOI 10.1377/hlthaff.28.5.1494; Vadeboncoeur TF, 2006, J EMERG MED, V30, P131, DOI 10.1016/j.jemermed.2005.04.019; VERGHESE A, 1983, MEDICINE, V62, P271, DOI 10.1097/00005792-198309000-00002	30	15	16	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2013	184	1					438	443		10.1016/j.jss.2013.05.072			6	Surgery	Surgery	207NX	WOS:000323609400072	23816243				2021-06-18	
J	Jung, R; Aull-Watschinger, S; Moser, D; Czech, T; Baumgartner, C; Bonelli-Nauer, S; Pataraia, E				Jung, Rebekka; Aull-Watschinger, Susanne; Moser, Doris; Czech, Thomas; Baumgartner, Christoph; Bonelli-Nauer, Sivlia; Pataraia, Ekaterina			Is reoperation an option for patients with temporal lobe epilepsy after failure of surgery?	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Temporal lobe epilepsy; Epilepsy surgery; Surgery failure; Reoperation; Postoperative outcome	ICTAL SCALP EEG; HIPPOCAMPAL SCLEROSIS; SURGICAL-TREATMENT; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; SEIZURE RECURRENCE; RESECTION; PREDICTORS; LOBECTOMY; MEMORY	Purpose: Epilepsy surgery is the most efficacious therapeutic modality for patients with medically refractory focal epilepsies, but surgical failures remain a challenge to the epilepsy treatment team. The aim of present study was to evaluate the postoperative outcome of patients who underwent reoperation after a failed epilepsy surgery on the temporal lobe. Methods: We systematically analyzed the results of comprehensive preoperative evaluations before the first surgery, and before and after reoperation in 17 patients with drug resistant temporal lobe epilepsies. Results: Overall, 13 of 17 patients (76.5%) improved after reoperation: five patients (29.4%) were completely seizure free after reoperation (median duration 60 months, range 12-72); six patients (35.3%) were seizure free at least 12 month before observation points (median duration 120.5 months, range 35-155) and two patients (11.8%) had a decrease in seizure frequency. Four patients (23.5%) remained unchanged with respect to seizure frequency and severity. There was no correlation between the improvement in seizure outcome after reoperation and other clinical data except of the history of traumatic brain injury (TBI). The patients who had no history of TBI improved after reoperation, compared to patients with TBI (p = 0.044). The postoperative seizure outcome of patients with incongruent Video-EEG results before the first surgery (p = 0.116) and before reoperation (p = 0.622) was not poorer compared to patients with congruent Video-EEG results. Conclusions: Reoperation can considerably improve the operative outcome of the first failed epilepsy surgery in patients with drug resistant temporal lobe epilepsies. Epilepsy centres should be encouraged to report the results of failed epilepsy surgeries. (C) 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Jung, Rebekka; Aull-Watschinger, Susanne; Moser, Doris; Bonelli-Nauer, Sivlia; Pataraia, Ekaterina] Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; [Czech, Thomas] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Baumgartner, Christoph] Gen Hosp Hietzing, Neurol Ctr Rosenhugel, Dept Neurol 2, Vienna, Austria	Pataraia, E (corresponding author), Med Univ Vienna, Dept Neurol, Spitalgasse 23, A-1090 Vienna, Austria.	ekaterina.pataraia@meduniwien.ac.at		Bonelli, Silvia/0000-0002-6346-8474			Aull-Watschinger S, 2008, EPILEPSIA, V49, P1308, DOI 10.1111/j.1528-1167.2008.01732.x; CHUNG MY, 1991, EPILEPSIA, V32, P195, DOI 10.1111/j.1528-1157.1991.tb05244.x; Commission on neuroimaging of the international league against epilepsy, 1998, EPILEPSIA, V39, P1375; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Helmstaedter C, 2008, EPILEPSIA, V49, P88, DOI 10.1111/j.1528-1167.2007.01386.x; Hennessy MJ, 2000, BRAIN, V123, P2445, DOI 10.1093/brain/123.12.2445; Hennessy MJ, 2001, ACTA NEUROL SCAND, V103, P344, DOI 10.1034/j.1600-0404.2001.103006344.x; Jehi LE, 2010, J NEUROSURG, V113, P1186, DOI 10.3171/2010.8.JNS10180; Loddenkemper T, 2005, EPILEPSY BEHAV, V7, P1, DOI 10.1016/j.yebeh.2005.04.004; Lowe AJ, 2004, EPILEPSIA, V45, P237, DOI 10.1111/j.0013-9580.2004.35903.x; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Paglioli E, 2006, J NEUROSURG, V104, P70, DOI 10.3171/jns.2006.104.1.70; Pataraia E, 1998, EPILEPSIA, V39, P608, DOI 10.1111/j.1528-1157.1998.tb01429.x; Ramos E, 2009, J NEUROSURG, V110, P1127, DOI 10.3171/2009.1.JNS08638; Ryvlin P, 2005, CURR OPIN NEUROL, V18, P125, DOI 10.1097/01.wco.0000162852.22026.6f; Salanova V, 2005, ACTA NEUROL SCAND, V111, P126, DOI 10.1111/j.1600-0404.2005.00371.x; Schulz R, 2011, NEUROSURGERY, V68, P89, DOI 10.1227/NEU.0b013e3181fdf8f8; Schwartz TH, 2001, J NEUROSURG, V95, P615, DOI 10.3171/jns.2001.95.4.0615; Siegel AM, 2004, NEUROLOGY, V63, P2298, DOI 10.1212/01.WNL.0000147476.86575.A7; STEINHOFF BJ, 1995, NEUROLOGY, V45, P889, DOI 10.1212/WNL.45.5.889; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; WIESER HG, 1982, SURG NEUROL, V17, P445, DOI 10.1016/S0090-3019(82)80016-5; Zachenhofer I, 2011, ACTA NEUROCHIR, V153, P239, DOI 10.1007/s00701-010-0802-7	25	15	16	0	6	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311			SEIZURE-EUR J EPILEP	Seizure	SEP	2013	22	7					502	506		10.1016/j.seizure.2012.11.011			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	204JV	WOS:000323362500002	23273881	Bronze			2021-06-18	
J	Koo, HM; Lee, SM; Kim, MH				Koo, Hyun Mo; Lee, Sun Min; Kim, Min Hee			Spontaneous Wheel Running Exercise Induces Brain Recovery via Neurotrophin-3 Expression Following Experimental Traumatic Brain Injury in Rats	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Neurotrophin-3; Traumatic brain injury; Wheel running exercise	CLOSED-HEAD INJURY; PROTEIN; PLASTICITY; MOTOR; BDNF	[Purpose] The aim of the present study was to investigate the expression of neurotrophin-3 (NT-3) after applying spontaneous wheel running exercises (SWR) after experimental traumatic brain injury (TBI). [Subjects and Methods] Thirty male Sprague-Dawley rats were divided into 3 groups; 20 rats were subjected to controlled cortical impact for TBI, and then, animals were randomly collected from the SWR group and subjected to wheel running exercise for 3 weeks. Ten rats were not subjected to any injury or running exercise to compare with the effect of TBI and SWR. Immunohistochemistry, Western blotting, skilled ladder rung walking test, and 2,3,5-triphenyltetrazolium chloride staining analysis for the evaluation of NT-3 expression were used to assess brain damage and recovery. [Results] The TBI-induced decrease in NT-3 expression was recovered by wheel running exercise. Moreover, decreased ischemic volume and progressive neurobehavioral outcome were observed in the SWR group. [Conclusion] Spontaneous running exercise promotes brain recovery and motor function through an increase in expression of NT-3.	[Koo, Hyun Mo] Kyungsung Univ, Coll Sci, Dept Phys Therapy, Gyeonggi 461713, South Korea; [Lee, Sun Min] Dongju Univ, Dept Occupat Therapy, Gyeonggi 461713, South Korea; [Kim, Min Hee] Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Gyeonggi 461713, South Korea	Kim, MH (corresponding author), Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Gyeonggi 461713, South Korea.	kmh12@eulji.ac.kr			Kyungsung University	This research was supported by Kyungsung University Research Grants in 2013.	Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Emerick AJ, 2004, BEHAV BRAIN RES, V152, P315, DOI 10.1016/j.bbr.2003.10.010; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gwag BJ, 2003, ANTIOXID REDOX SIGN, V5, P621, DOI 10.1089/152308603770310284; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Jackson R.G.M., 2002, CURR ANAESTHESIA CRI, V13, P343; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Newcomb JK, 1999, J NEUROTRAUM, V16, P1, DOI 10.1089/neu.1999.16.1; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; WOODSIDE B, 1995, BRAIN RES, V690, P48, DOI 10.1016/0006-8993(95)00586-F	23	15	16	0	2	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	SEP	2013	25	9					1103	1107					5	Rehabilitation	Rehabilitation	246QT	WOS:000326554900012	24259924	Bronze, Green Published			2021-06-18	
J	Li, AH; Zou, FH; Fu, HR; Cui, G; Yan, YH; Wu, QY; Gu, XX				Li, Aihong; Zou, Feihui; Fu, Hongran; Cui, Gang; Yan, Yaohua; Wu, Qiyun; Gu, Xingxing			Upregulation of CRM1 Relates to Neuronal Apoptosis after Traumatic Brain Injury in Adult Rats	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						CRM1; P27(Kip1); Traumatic brain injury; Apoptosis; Rat	NUCLEAR EXPORT; GROWTH-FACTOR; S-PHASE; P27(KIP1); DEGRADATION; PHOSPHORYLATION; BINDING; SKP2; EXPRESSION; INHIBITORS	Traumatic brain injury (TBI) initiates a complex series of neurochemical and signaling changes that leads to neuronal dysfunction and over-reactive astrocytes. There is increasing evidence that CRM1 mediated P27(Kip1), which is a potent inhibitor of G1 cyclin-dependent kinases complexes, nuclear export-dependent or -independent Jab1/CSN5, and cytoplasmic degradation in cells. Up to now, the function of CRM1 in central nervous system (CNS) is still with limited acquaintance. In our study, to investigate whether CRM1 is involved in CNS lesion, we performed a TBI model in adult rats. Western blot and RT-PCR analysis revealed that the level of protein and mRNA of CRM1 increased in ipsilateral brain cortex in comparison to the contralateral. Immunohistochemistry and immunofluorescence double labeling indicated that CRM1 was shutting into nucleus around the wound, and increased CRM1 co-localized with P27(Kip1). Terminal deoxynucleotidyl transferase deoxy-UTP-nick end labeling (TUNEL) staining suggested that CRM1 was involved in neuronal apoptosis after brain injury. We also investigated co-localization of CRM1 and active-caspase-3 in the ipsilateral brain cortex. In addition, the expression patterns of Bax and active-caspase-3 were parallel with that of CRM1. Based on our data, we suggested that CRM1 might play an important role in neuronal apoptosis following TBI, and might provide a basis for the further study on its role in regulating the expression of P27(Kip1) and cell cycle re-entry in TBI.	[Li, Aihong; Zou, Feihui; Fu, Hongran; Cui, Gang; Yan, Yaohua] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Wu, Qiyun; Gu, Xingxing] Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China	Wu, QY (corresponding author), Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China.	zoufeihui666@gmail.com; xiaofu6666@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31071288]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 31071288) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Atasheva S, 2010, J VIROL, V84, P4158, DOI 10.1128/JVI.02554-09; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; de Late PL, 2010, J BIOL CHEM, V285, P5594, DOI 10.1074/jbc.M109.068346; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Foster JS, 2003, J BIOL CHEM, V278, P41355, DOI 10.1074/jbc.M302830200; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Holloway RG, 2010, NEW ENGL J MED, V362, P1757, DOI 10.1056/NEJMp0907808; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Johnson EA, 2004, J NEUROTRAUM, V21, P1183, DOI 10.1089/neu.2004.21.1183; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LOGAN A, 1992, J NEUROSCI, V12, P3828; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Mock C, 2005, J TRAUMA, V59, P1243, DOI 10.1097/01.ta.0000197290.02807.de; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Muller D, 2000, EMBO J, V19, P2168, DOI 10.1093/emboj/19.10.2168; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shen AG, 2009, NEUROSURGERY, V65, P153, DOI 10.1227/01.NEU.0000348550.47441.4B; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Swanson C, 2000, P NATL ACAD SCI USA, V97, P7796, DOI 10.1073/pnas.97.14.7796; Tomoda K, 1999, NATURE, V398, P160; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wu XJ, 2012, J MOL NEUROSCI, V46, P184, DOI 10.1007/s12031-011-9572-9; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zou FH, 2013, J MOL NEUROSCI, V49, P395, DOI 10.1007/s12031-012-9906-2	49	15	15	0	13	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2013	51	1					208	218		10.1007/s12031-013-9994-7			11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	211PJ	WOS:000323921000022	23494640				2021-06-18	
J	Micarelli, A; Jacobsson, H; Larsson, SA; Jonsson, C; Pagani, M				Micarelli, A.; Jacobsson, H.; Larsson, S. A.; Jonsson, C.; Pagani, M.			Neurobiological insight into hyperbaric hyperoxia	ACTA PHYSIOLOGICA			English	Article						attention system; hyperbaric hyperoxia; posterior cingulated cortex; rCBF; SPECT	CEREBRAL-BLOOD-FLOW; ACUTE HYPOBARIC HYPOXIA; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; OXYGEN-CONSUMPTION; 30-PERCENT OXYGEN; DEFAULT NETWORK; ACTIVATION; CORTEX; LEVEL	Aim: Hyperbaric hyperoxia (HBO) is known to modulate aerobic metabolism, vasoreactivity and blood flow in the brain. Nevertheless, mechanisms underlying its therapeutic effects, especially in traumatic brain injury (TBI) and stroke patients, are debated. The present study aimed at investigating regional cerebral blood flow (rCBF) distribution during acute HBO exposure. Methods: Regional cerebral blood flow response was investigated in seven healthy subjects exposed to either normobaric normoxia or HBO with ambient pressure/inspired oxygen pressure of 101/21 and 250/250 kPa respectively. After 40 min at the desired pressure, they were injected a perfusion tracer and subsequently underwent brain single photon emission computed tomography. rCBF distribution changes in the whole brain were assessed by Statistical Parametric Mapping. Results: During HBO, an increased relative rCBF distribution was found in sensory-motor, premotor, visual and posterior cingulate cortices as well as in superior frontal gyrus, middle/inferior temporal and angular gyrus and cerebellum, mainly in the dominant hemisphere. During normobaric normoxia, a higher 99m Tc-HMPAO distribution in the right insula and subcortical structures as well as in bilateral hippocampi and anterior cingulated cortex was found. Conclusions: The present study firstly confirmed the rCBF distribution increase during HBO in sensory-motor and visual cortices, and it showed for the first time a higher perfusion tracer distribution in areas encompassed in dorsal attention system and in default mode network. These findings unfold both the externally directed cognition performance improvement related to the HBO and the internally directed cognition states during resting-state conditions, suggesting possible beneficial effects in TBI and stroke patients.	[Micarelli, A.] Univ Roma Tor Vergata, Dept Med Sci & Translat Med, Rome, Italy; [Jacobsson, H.; Larsson, S. A.; Jonsson, C.; Pagani, M.] Karolinska Univ Hosp, Dept Nucl Med, Stockholm, Sweden; [Pagani, M.] CNR, Inst Cognit Sci & Technol, Rome, Italy	Micarelli, A (corresponding author), Univ Roma Tor Vergata, Dept Med Sci & Translat Med, Viale Oxford 81, Rome, Italy.	alessandromicarelli@yahoo.it	pagani, marco/AAV-9176-2020				ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; Belda FJ, 2005, JAMA-J AM MED ASSOC, V294, P2035, DOI 10.1001/jama.294.16.2035; BERGOFSKY EH, 1966, J APPL PHYSIOL, V21, P567; Boakye M, 2002, NEUROSCI LETT, V321, P5, DOI 10.1016/S0304-3940(01)02406-5; Brett M, 2001, NEUROIMAGE, V13, pS85; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Choi MH, 2010, NEUROSCI LETT, V471, P70, DOI 10.1016/j.neulet.2010.01.013; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Chung SC, 2004, BRAIN COGNITION, V56, P279, DOI 10.1016/j.bandc.2004.07.005; Chung SC, 2006, INT J PSYCHOPHYSIOL, V62, P103, DOI 10.1016/j.ijpsycho.2006.02.006; Chung SC, 2009, NEUROSCI LETT, V453, P175, DOI 10.1016/j.neulet.2009.02.050; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2012, DEV PSYCHOBIOL, V54, P239, DOI 10.1002/dev.20507; Di Piero V, 2002, EUR J NEUROL, V9, P419, DOI 10.1046/j.1468-1331.2002.00436.x; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; INGVAR DH, 1960, ACTA PHYSIOL SCAND, V48, P373, DOI 10.1111/j.1748-1716.1960.tb01870.x; Ishii K, 1998, Ann Nucl Med, V12, P29; Ishii K, 1996, J NUCL MED, V37, P1086; Ito H, 2000, J CEREBR BLOOD F MET, V20, P1264, DOI 10.1097/00004647-200008000-00011; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; Kanno I., 1996, J CEREB BLOOD FLOW M, V17, pS646; Kashikura K, 2001, NEUROSCI LETT, V299, P53, DOI 10.1016/S0304-3940(00)01781-X; Kashikura K, 2000, NEUROREPORT, V11, P903, DOI 10.1097/00001756-200004070-00001; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kolbitsch C, 2002, MAGN RESON IMAGING, V20, P535, DOI 10.1016/S0730-725X(02)00534-9; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Liu WW, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-13; Macey PM, 2007, PLOS MED, V4, P828, DOI 10.1371/journal.pmed.0040173; Mathieu D., 2006, HDB HYPERBARIC MED, P103; Mazard A, 2002, J COGNITIVE NEUROSCI, V14, P172, DOI 10.1162/089892902317236821; Melsom MN, 1999, ACTA PHYSIOL SCAND, V166, P151; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Omae T, 1998, STROKE, V29, P94, DOI 10.1161/01.STR.29.1.94; Pagani M, 2011, ACTA PHYSIOL, V202, P203, DOI 10.1111/j.1748-1716.2011.02264.x; Pagani M, 2000, ACTA PHYSIOL SCAND, V168, P377; Pagani M, 2012, J AUTISM DEV DISORD, V42, P313, DOI 10.1007/s10803-011-1240-y; Papo D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00045; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85, DOI 10.1113/jphysiol.1993.sp019503; Regli F, 1970, STROKE, V1, P314, DOI 10.1161/01.STR.1.5.314; Ren H, 2001, Chin J Traumatol, V4, P239; Rousseau A, 2005, ACTA PHYSIOL SCAND, V183, P231, DOI 10.1111/j.1365-201X.2005.01405.x; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Schellart NAM, 2011, CANCER-AM CANCER SOC, V117, P3434, DOI 10.1002/cncr.25874; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zeyu Xie, 2007, Neural Regeneration Research, V2, P314; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	51	15	16	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	SEP	2013	209	1					69	76		10.1111/apha.12116			8	Physiology	Physiology	198VK	WOS:000322950400011	23692702				2021-06-18	
J	Rangarajan, P; Eng-Ang, L; Dheen, ST				Rangarajan, Parakalan; Eng-Ang, Ling; Dheen, S. Thameem			Potential Drugs Targeting Microglia: Current Knowledge and Future Prospects	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Microglia; inflammation; brain injury; neurodegeneration; retinoic acid; glucocorticoids; minocycline; miRNA; epigenetics	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; PERIVENTRICULAR WHITE-MATTER; ACTIVATED RAT MICROGLIA; SPHINGOSINE KINASE 1; RETINOIC ACID; PROINFLAMMATORY CYTOKINES; MULTIPLE-SCLEROSIS; AMEBOID MICROGLIA; HIV-1 INFECTION	Inflammation in the central nervous system (CNS) may occur as a result of trauma, infection or neurodegenerative stimuli and is characterized by activation of microglia, the resident immune cells of the CNS. Activated microglia proliferate rapidly, migrate to the site of injury or infection and elicit immune response by phagocytosis of cell debris, production of cytokines, chemokines and reactive oxygen species, and presentation of antigens to other immune cells. In addition, microglia participate in tissue repair by producing neurotrophic factors. However, when microglia are chronically activated, they become neurotoxic to the surrounding CNS parenchyma. Chronic activation of microglia has been shown to augment neurodegeneration in Parkinson's disease (PD), Alzheimer's disease (AD), brain injury and number of other CNS pathologies. Identification of factors that control microglial activation, therefore, has become the major focus of recent research. A number of herbal and chemical compounds have been shown to attenuate microglial activation. However, these compounds exhibit non-specificity and produce unpleasant side-effects. Here, we provide a comprehensive review on some of the currently available drugs known to reduce microglial activation, their molecular targets and the subcellular signaling networks on which they act. We also review some of the newly emerging therapeutic avenues such as 'epidrugs' and finally emphasize on the importance of targeted drug delivery systems for alleviating microglia-mediated neurotoxicity.	[Rangarajan, Parakalan; Eng-Ang, Ling; Dheen, S. Thameem] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore	Dheen, ST (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Md10,4 Med Dr, Singapore 117597, Singapore.	thameem_dheen@nuhs.edu.sg	Dheen, S. Thameem/AAU-8627-2020	Dheen, S. Thameem/0000-0001-9600-6789	National Medical Research Council, SingaporeNational Medical Research Council, Singapore [NMRC/EDG/1039/2011, R-181-000-139-275]	The authors would like to acknowledge the National Medical Research Council, Singapore for the NMRC Exploratory/Developmental Grant (NMRC/EDG/1039/2011; R-181-000-139-275).	Baud O, 2004, BRAIN PATHOL, V14, P1; Bladh LG, 2005, MOL PHARMACOL, V67, P815, DOI 10.1124/mol.104.005801; Boillee S, 2008, J CLIN INVEST, V118, P474, DOI [10.1172/JC134613, 10.1172/JCI34613]; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Brooke SM, 2002, EXP NEUROL, V177, P151, DOI 10.1006/exnr.2002.7956; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Choi J., 2009, ENV HLTH PERSPECT, V118; Cucchiarini M, 2003, GENE THER, V10, P657, DOI 10.1038/sj.gt.3301925; Deng YY, 2008, BRAIN PATHOL, V18, P387, DOI 10.1111/j.1750-3639.2008.00138.x; Dheen ST, 2005, GLIA, V50, P21, DOI 10.1002/glia.20153; Diab A, 2004, J NEUROIMMUNOL, V148, P116, DOI 10.1016/j.jneuroim.2003.11.010; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Drager Ursula C, 2006, Sci STKE, V2006, ppe10, DOI 10.1126/stke.3242006pe10; Enderlin V, 1997, NEUROSCI LETT, V229, P125, DOI 10.1016/S0304-3940(97)00424-2; Giorgini F, 2008, J BIOL CHEM, V283, P7390, DOI 10.1074/jbc.M708192200; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; Hutter E, 2010, ACS NANO, V4, P2595, DOI 10.1021/nn901869f; INNOCENTI GM, 1983, DEV BRAIN RES, V11, P55, DOI 10.1016/0165-3806(83)90201-8; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; KAUR C, 1994, ARCH HISTOL CYTOL, V57, P449, DOI 10.1679/aohc.57.449; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Keller AF, 2011, EXP NEUROL, V228, P69, DOI 10.1016/j.expneurol.2010.12.010; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Koedel U, 1999, BRAIN PATHOL, V9, P57; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Li H, 1996, NEUROPATH APPL NEURO, V22, P207; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Lieb K, 2003, NEUROCHEM INT, V42, P131, DOI 10.1016/S0197-0186(02)00076-1; Lin HY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-13; Ling E A, 2001, Prog Brain Res, V132, P61; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Luo X.-G., 2010, BIOMED CENTRAL; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mallat M, 2005, CURR OPIN NEUROBIOL, V15, P101, DOI 10.1016/j.conb.2005.01.006; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Murugan M, 2011, GLIA, V59, P521, DOI 10.1002/glia.21121; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nair A, 2006, J NEUROIMMUNOL, V171, P72, DOI 10.1016/j.jneuroim.2005.09.012; Nau R, 2002, TRENDS NEUROSCI, V25, P38, DOI 10.1016/S0166-2236(00)02024-5; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Orlowski D, 2003, INT J DEV NEUROSCI, V21, P445, DOI 10.1016/j.ijdevneu.2003.09.001; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Persidsky Y, 2003, J LEUKOCYTE BIOL, V74, P691, DOI 10.1189/jlb.0503205; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Rayan Nirmala Arul, 2011, Front Biosci (Elite Ed), V3, P1079; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Ros-Bernal F, 2011, P NATL ACAD SCI USA, V108, P6632, DOI 10.1073/pnas.1017820108; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schildknecht S, 2011, J BIOL CHEM, V286, P4991, DOI 10.1074/jbc.M110.169565; Sen CK, 2011, PHYSIOL GENOMICS, V43, P517, DOI 10.1152/physiolgenomics.00037.2011; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Vallat-Decouvelaere AV, 2003, J NEUROPATH EXP NEUR, V62, P475, DOI 10.1093/jnen/62.5.475; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WOOD PL, 1995, NEUROL RES, V17, P242, DOI 10.1080/01616412.1995.11740321; Xu HH, 2006, J NEUROIMMUNOL, V171, P135, DOI 10.1016/j.jneuroim.2005.10.004; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	90	15	15	1	30	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	SEP	2013	12	6					799	806		10.2174/18715273113126660175			8	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	263HD	WOS:000327797200012	24047522				2021-06-18	
J	Sundaram, NK; Geer, EB; Greenwald, BD				Sundaram, Nina K.; Geer, Eliza B.; Greenwald, Brian D.			The Impact of Traumatic Brain Injury on Pituitary Function	ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Hypopituitarism; Hormone replacement therapy; Screening; Diagnosis; Pathophysiology; Neurocognitive impairment; Outcome	GROWTH-HORMONE GH; QUALITY-OF-LIFE; BONE-MINERAL DENSITY; ADRENOCORTICOTROPIN STIMULATION TEST; ANEURYSMAL SUBARACHNOID HEMORRHAGE; INSULIN TOLERANCE-TEST; REPLACEMENT THERAPY; LONG-TERM; BODY-COMPOSITION; DEFICIENT PATIENTS	It is paramount that clinicians who care for patients with traumatic brain injury (TBI) at any point in time, including neurosurgeons, rehabilitation physicians, internists, neurologists, and endocrinologists, are aware of the prevalence of posttraumatic hypopituitarism and its impacts on acute and long-term recovery. This article reviews the natural history, pathophysiology, and presenting features of hypopituitarism occurring after TBI. Proposed methodologies for screening, diagnosis, and initiation of treatment are discussed, as well as the effect of hormone replacement therapy on clinical outcomes.	[Sundaram, Nina K.; Geer, Eliza B.] Mt Sinai Hosp, Med Ctr, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Greenwald, Brian D.] JFK Johnson Rehabil Ctr Head Injuries, Edison, NJ 08818 USA; [Greenwald, Brian D.] UMDNJ Robert Wood Johnson Med Sch, JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ 08818 USA	Geer, EB (corresponding author), Mt Sinai Hosp, Med Ctr, Div Endocrinol Diabet & Bone Dis, 1 Gustave L Levy Pl,Box 1055, New York, NY 10029 USA.	eliza.geer@mssm.edu					Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Alexander GM, 1998, HORM BEHAV, V33, P85, DOI 10.1006/hbeh.1998.1439; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Amory JK, 2004, J CLIN ENDOCR METAB, V89, P503, DOI 10.1210/jc.2003-031110; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arwert LI, 2006, NEUROENDOCRINOLOGY, V83, P12, DOI 10.1159/000093337; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P1600, DOI 10.1210/jc.87.4.1600; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P3368, DOI 10.1210/jc.87.7.3368; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Behre HM, 1997, J CLIN ENDOCR METAB, V82, P2386, DOI 10.1210/jc.82.8.2386; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Biller BMK, 2000, J CLIN ENDOCR METAB, V85, P970, DOI 10.1210/jc.85.3.970; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; BISTRITZER T, 1981, AM J DIS CHILD, V135, P966, DOI 10.1001/archpedi.1981.02130340070022; Bleicken B, 2010, CLIN ENDOCRINOL, V72, P297, DOI 10.1111/j.1365-2265.2009.03596.x; Bollerslev J, 2006, EUR J ENDOCRINOL, V154, P537, DOI 10.1530/eje.1.02125; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Cherrier MM, 2003, J ANDROL, V24, P568; Chou YC, 2009, BRAIN INJURY, V23, P1095, DOI 10.3109/02699050903379396; Christophidis LJ, 2009, GROWTH HORM IGF RES, V19, P497, DOI 10.1016/j.ghir.2009.05.001; Cleemann L, 2009, EUR J ENDOCRINOL, V161, P251, DOI 10.1530/EJE-09-0020; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Cyran E, 1918, DEUT MED WOCHENSCHR, V44, P1261; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dokmetas HS, 2000, J CLIN ENDOCR METAB, V85, P3713, DOI 10.1210/jc.85.10.3713; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; EDWARDS OM, 1986, MEDICINE, V65, P281; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Gotherstrom G, 2007, EUR J ENDOCRINOL, V156, P55, DOI 10.1530/eje.1.02317; Gotherstrom G, 2009, J CLIN ENDOCR METAB, V94, P809, DOI 10.1210/jc.2008-1538; Greenwald BD, 2009, MED MANAGEMENT ADULT, P363; Hana V, 2002, EUR J ENDOCRINOL, V147, P333, DOI 10.1530/eje.0.1470333; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; Institute of Medicine, 2009, GULF WAR HLTH, V7; Ives JC, 2007, J ATHL TRAINING, V42, P431; Jacobs DM, 1998, NEUROLOGY, V50, P368, DOI 10.1212/WNL.50.2.368; JANOWSKY JS, 1994, BEHAV NEUROSCI, V108, P325, DOI 10.1037/0735-7044.108.2.325; Janowsky JS, 2000, J COGNITIVE NEUROSCI, V12, P407, DOI 10.1162/089892900562228; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khastgir G, 2003, J BONE MINER RES, V18, P925, DOI 10.1359/jbmr.2003.18.5.925; KLINGBEIL GEG, 1985, ARCH PHYS MED REHAB, V66, P44; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langenheim J, 2013, HORM METAB RES, V45, P96, DOI 10.1055/s-0032-1316293; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maison P, 2003, CIRCULATION, V108, P2648, DOI 10.1161/01.CIR.0000100720.01867.1D; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Maruff P, 2005, HORM RES, V64, P100, DOI 10.1159/000089325; McAllister TW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1034; Miller KJ, 2006, INT J NEUROSCI, V116, P895, DOI 10.1080/00207450600550154; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Murray RD, 1999, CLIN ENDOCRINOL, V51, P565, DOI 10.1046/j.1365-2265.1999.00838.x; Napoli R, 2003, J CLIN ENDOCR METAB, V88, P2817, DOI 10.1210/jc.2003-030144; Oertel H, 2004, PSYCHONEUROENDOCRINO, V29, P839, DOI 10.1016/S0306-4530(03)00151-3; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poomthavorn P, 2007, EUR J PEDIATR, V166, P1163, DOI 10.1007/s00431-006-0406-7; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Rosano GMC, 2006, ANN NY ACAD SCI, V1092, P341, DOI 10.1196/annals.1365.031; Rosario ER, 2012, J HEAD TRAUMA REHAB, V28, P1; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; Ross JL, 2000, NEUROLOGY, V54, P164, DOI 10.1212/WNL.54.1.164; Ross JL, 1998, J CLIN ENDOCR METAB, V83, P3198, DOI 10.1210/jc.83.9.3198; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Samuels MH, 2007, THYROID, V17, P249, DOI 10.1089/thy.2006.0252; Sathiavageeswaran M, 2007, EUR J ENDOCRINOL, V156, P439, DOI 10.1530/eje.1.02346; Scheepens A, 2000, J PEDIATR ENDOCR MET, V13, P1483; Schmidt IL, 2003, J CLIN ENDOCR METAB, V88, P4193, DOI 10.1210/jc.2002-021897; Schmidt R, 1996, J AM GERIATR SOC, V44, P1307, DOI 10.1111/j.1532-5415.1996.tb01400.x; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Shalet SM, 2003, J CLIN ENDOCR METAB, V88, P4124, DOI 10.1210/jc.2003-030126; SHERWIN BB, 1994, ANN NY ACAD SCI, V743, P213, DOI 10.1111/j.1749-6632.1994.tb55794.x; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Silha JV, 2005, CLIN ENDOCRINOL, V63, P79, DOI 10.1111/j.1365-2265.2005.02303.x; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Soares CD, 2001, ARCH GEN PSYCHIAT, V58, P529; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Streeten DHP, 1996, J CLIN ENDOCR METAB, V81, P285, DOI 10.1210/jc.81.1.285; Takala RSK, 2006, NEUROCRIT CARE, V4, P21, DOI 10.1385/NCC:4:1:021; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Tuchelt H, 2000, CLIN ENDOCRINOL, V53, P301, DOI 10.1046/j.1365-2265.2000.01089.x; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Widdowson WM, 2008, J CLIN ENDOCR METAB, V93, P4413, DOI 10.1210/jc.2008-1239; Wiren L, 1998, CLIN ENDOCRINOL, V48, P613, DOI 10.1046/j.1365-2265.1998.00462.x; Woodhouse LJ, 1999, J CLIN ENDOCR METAB, V84, P4570, DOI 10.1210/jc.84.12.4570; Ye P, 1999, ENDOCRINOLOGY, V140, P3063, DOI 10.1210/en.140.7.3063; Ye P, 2002, J NEUROSCI, V22, P6041; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426; Zhong J, 2005, J NEUROSCI RES, V80, P481, DOI 10.1002/jnr.20490; Zweifel JE, 1997, PSYCHONEUROENDOCRINO, V22, P189, DOI 10.1016/S0306-4530(96)00034-0	134	15	15	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8529	1558-4410		ENDOCRIN METAB CLIN	Endocrinol. Metabol. Clin. North Amer.	SEP	2013	42	3					565	+		10.1016/j.ecl.2013.05.003			20	Endocrinology & Metabolism	Endocrinology & Metabolism	228MO	WOS:000325191100011	24011887				2021-06-18	
J	Abdel-Rahman, N; Siman-Tov, M; Peleg, K				Abdel-Rahman, Nura; Siman-Tov, Maya; Peleg, Kobi		Israel Trauma Grp	Ethnicity and road traffic injuries: differences between Jewish and Arab children in Israel	ETHNICITY & HEALTH			English	Article						ethnic groups; road traffic injury; children; trauma; minority and majority population	MORTALITY	Objective. To examine the differences and characteristics of road traffic injuries (RTIs) among Jewish and Arab children, ages 0-17 years, in Israel. Design. A retrospective study based on data from the Israeli National Trauma Registry between 2001 and 2010. This study relates specifically to traffic-related hospitalizations among children ages 0-17 years. Data include demographic, injury, and hospitalization characteristics. Descriptive statistics and adjusted logistic regression were used to examine the differences of RTIs between the two ethnic groups. Results. A total of 18,884 children were included, of which Arab children comprised 38.2% of the total and 44.1% of the severely injured. Among Arab children 41.8% were pedestrians compared to 33.4% among Jewish children (p<0.0001). Arab children were younger, had more severe injuries and more traumatic brain injury (TBI) compared to Jewish children. Adjusted logistic regression analysis shows that the probability of an Arab child, relative to a Jewish child, to undergo surgical procedures was 1.2 (p<0.0001), to be hospitalized in intensive care units (ICUs) was 0.8 (p=0.003), and to be transferred to rehabilitation was 0.5 (p<0.0001). There was no significant difference in inpatient mortality between the two ethnic groups. Conclusions. Arab children in Israel are more likely to be hospitalized due to road accidents in comparison to Jewish children. Intervention programs should focus on Arab children and their unique characteristics.	[Abdel-Rahman, Nura; Siman-Tov, Maya; Peleg, Kobi] Gertner Inst Epidemiol & Publ Hlth Policy, Israel Natl Ctr Trauma & Emergency Med, Ramat Gan, Israel; [Peleg, Kobi] Tel Aviv Univ, Sch Publ Hlth, Dept Disaster Management, IL-69978 Tel Aviv, Israel	Peleg, K (corresponding author), Gertner Inst Epidemiol & Publ Hlth Policy, Israel Natl Ctr Trauma & Emergency Med, Ramat Gan, Israel.	kobip@gertner.health.gov.il					Abu-Asbah K., 2009, MASSAR I PUBLICATION, V1058; Baron-Epel O., 2007, CHARACTERIZATION KNO; Campos-Outcalt D, 2003, INJURY PREV, V9, P251, DOI 10.1136/ip.9.3.251; CBS, 2010, JER STAT ABSTR ISR 6; CBS, 2010, 3 CBS SOC ISR; CBS, 2011, JERUSALEM; CBS, 2010, ROAD ACC CAS SPEC SE; Central Bureau of Statistics (CBS), 2009, LIC DRIV; Champion HR, 1995, TRAUMA, P53; Gitelman V., 2010, ACCID ANAL PREV, V44, P63, DOI [10.1016/j.aap.2010.11.01722062338, DOI 10.1016/J.AAP.2010.11.01722062338]; Gofin R, 2002, INT J EPIDEMIOL, V31, P593, DOI 10.1093/ije/31.3.593; Gofin R, 2007, ISRAEL MED ASSOC J, V9, P724; Laflamme L, 2000, Inj Prev, V6, P293, DOI 10.1136/ip.6.4.293; Lavancovsky M., 2011, BETERMEN SAFE KIDS I, V1072; MACKELLAR A, 1995, MED J AUSTRALIA, V162, P238, DOI 10.5694/j.1326-5377.1995.tb139875.x; Moran M, 2010, TRANSPORT RES F-TRAF, V13, P377, DOI 10.1016/j.trf.2010.07.001; Naeem Z., 2010, INT J HLTH SCI QASSI, V4, pV; National Road Safety Authority in Israel (RSA), 2003, CHAR CAUS CAR ACC AR; Peleg K., 2005, EQUALITY AVAILABILIT; Savitsky B, 2007, ETHNIC HEALTH, V12, P129, DOI 10.1080/13557850601002171; Steinbach R, 2010, HEALTH PLACE, V16, P34, DOI 10.1016/j.healthplace.2009.08.002; Stirbu I, 2006, J EPIDEMIOL COMMUN H, V60, P249, DOI 10.1136/jech.2005.037325; World Health Organization, 2009, GLOB STAT REP ROAD S	23	15	15	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-7858	1465-3419		ETHNIC HEALTH	Ethn. Health	AUG 1	2013	18	4					391	401		10.1080/13557858.2012.754405			11	Ethnic Studies; Public, Environmental & Occupational Health	Ethnic Studies; Public, Environmental & Occupational Health	188RO	WOS:000322211500004	23289984				2021-06-18	
J	Prodam, F; Gasco, V; Caputo, M; Zavattaro, M; Pagano, L; Marzullo, P; Belcastro, S; Busti, A; Perino, C; Grottoli, S; Ghigo, E; Aimaretti, G				Prodam, F.; Gasco, V.; Caputo, M.; Zavattaro, M.; Pagano, L.; Marzullo, P.; Belcastro, S.; Busti, A.; Perino, C.; Grottoli, S.; Ghigo, E.; Aimaretti, G.			Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism	GROWTH HORMONE & IGF RESEARCH			English	Article						Hypopituitarism; Traumatic brain injury; Glucose metabolism; Lipids	GROWTH-HORMONE DEFICIENCY; BODY-COMPOSITION; PREVALENCE; RISK; ADULTS; DYSFUNCTION; DISEASE; PROFILE	Objective: Hypopituitarism is associated with metabolic alterations but in TBI-induced hypopituitarism data are scanty. The aim of our study was to evaluate the prevalence of naive hypertension, dyslipidemia, and altered glucose metabolism in TBI-induced hypopituitarism patients. Design: Cross-sectional retrospective study in a tertiary care endocrinology center. 54 adult patients encountering a moderate or severe TBI were evaluated in the chronic phase (at least 12 months after injury) after-trauma. Presence of hypopituitarism, BMI, hypertension, fasting blood glucose and insulin levels, oral glucose tolerance test (if available) and a lipid profile were evaluated. Results: The 27.8% of patients showed various degrees of hypopituitarism. In particular, 9.3% had total, 7.4% multiple and 11.1% isolated hypopituitarism. GHD was present in 22.2% of patients. BMI was similar between the two groups. Hypopituitaric patients presented a higher prevalence of dyslipidemia (p < 0.01) and altered glucose metabolism (p < 0.005) with respect to non hypopituitaric patients. In particular, triglycerides (p < 0.05) and HOMA-IR (p < 0.02) were higher in hypopituitaric TB! patients. Conclusions: We showed that long-lasting TBI patients who develop hypopituitarism frequently present metabolic alterations, in particular altered glucose levels, insulin resistance and hypertriglyceridemia. In view of the risk of premature cardiovascular death in hypopituitaric patients, major attention has to been paid in those who encountered a TBI, because they suffer from the same comorbidities and may present other deterioration factors due to complex pharmacological treatments and restriction in participation in life activities and healthy lifestyle. (C) 2013 Elsevier Ltd. All rights reserved.	[Prodam, F.; Caputo, M.; Zavattaro, M.; Pagano, L.; Marzullo, P.; Belcastro, S.; Busti, A.; Aimaretti, G.] Univ Piemonte Orientale Amedeo Avogadro, Dept Translat Med, I-28100 Novara, Italy; [Prodam, F.] Univ Piemonte Orientale, Dept Hlth Sci, SCDU Pediat, I-28100 Novara, Italy; [Prodam, F.] Univ Piemonte Orientale, ICSO, I-28100 Novara, Italy; [Gasco, V.; Grottoli, S.; Ghigo, E.] Univ Turin, I-10124 Turin, Italy; [Perino, C.] Don Gnocchi Rehabil Ctr, Turin, Italy	Aimaretti, G (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dept Translat Med, Via Solaroli 17, I-28100 Novara, Italy.	gianluca.aimaretti@med.unipmn.it	pagano, livio/J-3020-2018; Marzullo, Paolo/K-6371-2016	pagano, livio/0000-0001-8287-928X; Marzullo, Paolo/0000-0003-3215-5747; Prodam, Flavia/0000-0001-9660-5335	Regione PiemonteRegione Piemonte [2827]; University of Eastern Piedmont, Ministero dell'Universita e della Ricerca Scientifica [20082P8CCE]	This study was supported by Regione Piemonte (grant no. 2827, 2008), and University of Eastern Piedmont, Ministero dell'Universita e della Ricerca Scientifica (grant no. 20082P8CCE, 2008).	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Attanasio AF, 2010, J CLIN ENDOCR METAB, V95, P74, DOI 10.1210/jc.2009-1326; Barter P, 2011, ATHEROSCLEROSIS SUPP, V12, P265, DOI [10.1016/S1567-5688(11)00035-3, DOI 10.1016/S1567-5688(11)00035-3]; Cannavo S, 2011, J ENDOCRINOL INVEST, V34, P32, DOI [10.1007/BF03346692, 10.3275/7076]; Colao A, 2013, CLIN ENDOCRINOL, V79, P211, DOI 10.1111/cen.12122; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Evans LM, 1999, CLIN ENDOCRINOL, V50, P457; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Lauer MS, 2001, JAMA-J AM MED ASSOC, V285, P2508, DOI 10.1001/jama.285.19.2508; Leonsson M, 2002, CLIN ENDOCRINOL, V57, P751, DOI 10.1046/j.1365-2265.2002.01663.x; Lombardi G, 2012, J ENDOCRINOL INVEST, V35, P1021, DOI 10.3275/8717; Luque RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015767; MARKUSSIS V, 1992, LANCET, V340, P1188, DOI 10.1016/0140-6736(92)92892-J; Mersebach H, 2003, CLIN ENDOCRINOL, V58, P65, DOI 10.1046/j.1365-2265.2003.01675.x; Murray RD, 2010, CLIN ENDOCRINOL, V73, P508, DOI 10.1111/j.1365-2265.2009.03754.x; Nyenwe EA, 2009, AM J MED SCI, V338, P190, DOI 10.1097/MAJ.0b013e3181a84bde; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Sesmilo G, 2001, J CLIN ENDOCR METAB, V86, P5774, DOI 10.1210/jc.86.12.5774; Srinivasan S, 2004, J CLIN ENDOCR METAB, V89, P81, DOI 10.1210/jc.2003-030442; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; TEASDALE G, 1974, LANCET, V2, P81; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Verhelst J, 2011, EUR J ENDOCRINOL, V165, P881, DOI 10.1530/EJE-11-0599; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291	29	15	15	0	10	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1096-6374	1532-2238		GROWTH HORM IGF RES	Growth Horm. IGF Res.	AUG	2013	23	4					109	113		10.1016/j.ghir.2013.04.001			5	Cell Biology; Endocrinology & Metabolism	Cell Biology; Endocrinology & Metabolism	174KT	WOS:000321155000004	23660372				2021-06-18	
J	Wing, R; James, C				Wing, Robyn; James, Catherine			Pediatric Head Injury and Concussion	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Head injury; Concussion; Mild traumatic brain injury; Return to play; Postconcussive syndrome; Abusive head trauma; Pediatric	TRAUMATIC BRAIN-INJURY; CRANIAL COMPUTED-TOMOGRAPHY; SPORT-RELATED CONCUSSION; COLLEGIATE FOOTBALL PLAYERS; RAPID-SEQUENCE INTUBATION; GLASGOW COMA SCALE; HIGH-SCHOOL; STANDARDIZED ASSESSMENT; INTRACRANIAL-PRESSURE; SKULL FRACTURES	Children with head injuries frequently present to emergency departments. Even though most of these children have minor injuries, head injury is the most common cause of traumatic deaths in pediatric patients. The pediatric GCS and decision rules for obtaining head CT imaging help the provider evaluate head-injured infants and children. The provider must be vigilant to diagnose those who have life-threatening intracranial injuries or are victims of abusive head trauma. The goal of the emergency physician is to diagnose and treat the consequences of the primary injury and to limit or prevent secondary injury.	[Wing, Robyn; James, Catherine] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA; [James, Catherine] UMass Mem Med Ctr, Worcester, MA 01655 USA	James, C (corresponding author), UMass Mem Med Ctr, 55 Lake Ave North, Worcester, MA 01655 USA.	Catherine.james@umassmemorial.org		James, Catherine/0000-0002-3237-2699			Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; [Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Bean A, 2007, EMERG MED J, V24, P361, DOI 10.1136/emj.2007.048512; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Boston University, 2012, CAS STUD; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; de Louw A, 1994, Ned Tijdschr Geneeskd, V138, P2197; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Fastle RK, 2004, PEDIATR EMERG CARE, V20, P651, DOI 10.1097/01.pec.0000142947.35394.81; Faul M, 2012, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY; Gordon KE, 2010, PEDIATR NEUROL, V43, P253, DOI 10.1016/j.pediatrneurol.2010.05.012; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Injury Prevention and Control Program, 2012, SPORTS REL CONC HEAD; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; JENNETT B, 1976, LANCET, V1, P1031; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C, 2007, PEDIATRICS, V119, P1232, DOI 10.1542/peds.2007-0883; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Karpas A, 2013, PEDIATR EMERG CARE, V29, P30, DOI 10.1097/PEC.0b013e31827b5090; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly JP, 1997, NEUROLOGY, V48, P581; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lee LK, 2011, J PEDIATR-US, V158, P1003, DOI 10.1016/j.jpeds.2010.11.036; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Luu JL, 2011, PEDIATR EMERG CARE, V27, P1113, DOI 10.1097/PEC.0b013e31823aff59; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Nigrovic LE, 2013, ANN EMERG MED, V61, P389, DOI 10.1016/j.annemergmed.2012.08.030; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Nowinski C, 2011, HEAD GAMES FOOTBALLS; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Parri N, 2013, J EMERG MED, V44, P135, DOI 10.1016/j.jemermed.2012.02.038; Patricios J, 2012, BRIT J SPORT MED, V46, P198, DOI 10.1136/bjsports-2011-090386; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Ramirez-Schrempp D, 2011, PEDIATR EMERG CARE, V27, P312, DOI 10.1097/PEC.0b013e3182131579; Robinson N, 2001, EMERG MED J, V18, P453, DOI 10.1136/emj.18.6.453; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Salhi B, 2007, ANN EMERG MED, V49, P84, DOI 10.1016/j.annemergmed.2006.09.003; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schunk JE, 2012, PEDIATR REV, V33, P398, DOI 10.1542/pir.33-9-398; Section on Radiology, 2009, PEDIATRICS, V123, P1430, DOI DOI 10.1542/PEDS.2009-0558; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sturm JJ, 2013, AM J EMERG MED, V31, P166, DOI 10.1016/j.ajem.2012.07.002; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; United States Department of Health & Human Services, 2012, CHILD MALTR 2011; Upshaw JE, 2012, PEDIATR EMERG CARE, V28, P926, DOI 10.1097/PEC.0b013e318267f674; Vaillancourt C, 2007, ANN EMERG MED, V49, P86, DOI 10.1016/j.annemergmed.2006.09.002; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	122	15	17	0	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	AUG	2013	31	3					653	+		10.1016/j.emc.2013.05.007			25	Emergency Medicine	Emergency Medicine	207TQ	WOS:000323627700006	23915598				2021-06-18	
J	Strauss, KI; Gruzdev, A; Zeldin, DC				Strauss, Kenneth I.; Gruzdev, Artiom; Zeldin, Darryl C.			Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: Effects of traumatic brain injury	PROSTAGLANDINS & OTHER LIPID MEDIATORS			English	Article						Brain injury recovery; Behavior; Cytochrome P450 eicosanoids; Arachidonic acid metabolism	EPOXYEICOSATRIENOIC ACIDS; ARACHIDONIC-ACID; FUNCTIONAL HYPEREMIA; RAT; EPOXYGENASE; MODEL; CYTOCHROME-P-450; PHOSPHOLIPIDS; METABOLITES; INHIBITORS	After traumatic brain injury (TBI), arachidonic acid (ArA) is released from damaged cell membranes and metabolized to many bioactive eicosanoids, including several epoxyeicosatrienoic acids (EETs). Soluble epoxide hydrolase (Ephx2, sEH) appears to be the predominant pathway for EET metabolism to less active dihydroxyeicosatrienoates (DHETs). Prior studies indicate that brain levels of EETs increase transiently after TBI and EETs have antiinflammatory and neuroprotective activities which may benefit the injured brain. If the net effect of increased EET levels in the injured brain is beneficial to recovery, then Ephx2 gene disruption would be expected to enhance elevated EET levels and improve recovery in the injured brain. Thus, Ephx2-KO (Ephx2(-/-) bred onto pure C57Bl/6 background) mice were compared to wild-type controls in a unilateral controlled cortical impact model of TBI. Before injury, animals behaved comparably in open field activity and neurologic reflexes. Interestingly, the Ephx2-KO mice showed improved motor coordination on a beam walk task, yet showed indications of defective learning in a test of working spatial memory. After surgery, brain-injured Ephx2-KO mice again had less of a deficit in the beam walk than wild-type, and the difference in latency (post - pre) showed a trend of protection for Ephx2-KO mice after TBI. Brain-injured mice showed no genotype differences in working memory. Surprisingly, sham-operated Ephx2-KO mice exhibited an injured phenotype for working memory, compared to sham-operated wild-type mice. Brain eicosanoid levels were measured using liquid chromatography with tandem mass spectrometry. Of the 20 eicosanoids evaluated, only 8,9-EET was elevated in the Ephx2-KO cerebral cortex (37 d post-surgery, in both sham and injured). Tissue DHET levels were below the limit of quantification. These results reflect a significant contribution of sEH deficiency in coordination of ambulatory movements and working spatial memory in the mouse. Further investigation of differential sEH expression and EET levels at earlier time points and across other brain regions may shed light on these behavioral differences. (C) 2012 Published by Elsevier Inc.	[Strauss, Kenneth I.] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA; [Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	Strauss, KI (corresponding author), Michigan State Univ, Coll Human Med, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	kenneth.strauss@hc.msu.edu; artiom.gruzdev@nih.gov; zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS054890]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ZICES102425, ZIAES025034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054890] Funding Source: NIH RePORTER	This work was funded in part by NINDS Grant NS054890 (KIS). The authors would like to thank Laura Miller, J. Alyce Bradbury and Joan P. Graves for managing the animal colony, confirming genotypes and coordinating shipments. Thanks also to Analise Sauro and Jaimie Pineda for excellent technical assistance in the completion of this work.	Alkayed NJ, 1996, STROKE, V27, P971, DOI 10.1161/01.STR.27.5.971; BREZINSKI ME, 1990, P NATL ACAD SCI USA, V87, P6248, DOI 10.1073/pnas.87.16.6248; Campbell WB, 2000, TRENDS PHARMACOL SCI, V21, P125, DOI 10.1016/S0165-6147(00)01472-3; CAPDEVILA JH, 1987, BIOCHEM BIOPH RES CO, V146, P638, DOI 10.1016/0006-291X(87)90576-6; CHACOS N, 1983, ARCH BIOCHEM BIOPHYS, V223, P639, DOI 10.1016/0003-9861(83)90628-8; Christie MJ, 1999, INFLAMM RES, V48, P1, DOI 10.1007/s000110050367; Cronin A, 2011, J LIPID RES, V52, P712, DOI 10.1194/jlr.M009639; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hampson AJ, 2002, J NEUROSCI, V22, P257, DOI 10.1523/JNEUROSCI.22-01-00257.2002; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Higashimori H, 2010, AM J PHYSIOL-CELL PH, V299, pC1068, DOI 10.1152/ajpcell.00225.2010; Iliff JJ, 2009, AM J PHYSIOL-HEART C, V296, pH1352, DOI 10.1152/ajpheart.00950.2008; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004; Inceoglu B, 2011, P NATL ACAD SCI USA, V108, P5093, DOI 10.1073/pnas.1101073108; KARARA A, 1991, J BIOL CHEM, V266, P7561; Koerner IP, 2007, J NEUROSCI, V27, P4642, DOI 10.1523/JNEUROSCI.0056-07.2007; Kozak W, 2000, AM J PHYSIOL-REG I, V279, pR455; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Marowsky A, 2009, NEUROSCIENCE, V163, P646, DOI 10.1016/j.neuroscience.2009.06.033; McAuliffe JJ, 2006, BRAIN RES, V1118, P208, DOI 10.1016/j.brainres.2006.08.030; Morisseau C, 2012, BIOCHEM BIOPH RES CO, V419, P796, DOI 10.1016/j.bbrc.2012.02.108; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakashima T, 1996, AM J PHYSIOL-REG I, V271, pR1274; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Peng XQ, 2002, AM J PHYSIOL-HEART C, V283, pH2029, DOI 10.1152/ajpheart.01130.2000; Revermann M, 2010, ARTERIOSCL THROM VAS, V30, P909, DOI 10.1161/ATVBAHA.110.204099; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Yue HF, 2007, J PHARMACEUT BIOMED, V43, P1122, DOI 10.1016/j.jpba.2006.10.009; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325	36	15	15	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1098-8823	2212-196X		PROSTAG OTH LIPID M	Prostaglandins Other Lipid Mediat.	JUL-AUG	2013	104				SI		18	24		10.1016/j.prostaglandins.2012.07.005			7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	183GM	WOS:000321802500004	22922090	Green Accepted			2021-06-18	
J	Okahashi, S; Seki, K; Nagano, A; Luo, ZW; Kojima, M; Futaki, T				Okahashi, Sayaka; Seki, Keiko; Nagano, Akinori; Luo, Zhiwei; Kojima, Maki; Futaki, Toshiko			A virtual shopping test for realistic assessment of cognitive function	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Virtual reality; Cognitive function; Realistic assessment; Development; Brain injury	SIMULATED NATURALISTIC ENVIRONMENT; CONTINUOUS PERFORMANCE-TEST; TRAUMATIC BRAIN-INJURY; PROSPECTIVE MEMORY; ECOLOGICAL VALIDITY; EXECUTIVE FUNCTION; REALITY; REHABILITATION; DISTRACTION; RELIABILITY	Background: Cognitive dysfunction caused by brain injury often prevents a patient from achieving a healthy and high quality of life. By now, each cognitive function is assessed precisely by neuropsychological tests. However, it is also important to provide an overall assessment of the patients' ability in their everyday life. We have developed a Virtual Shopping Test (VST) using virtual reality technology. The objective of this study was to clarify 1) the significance of VST by comparing VST with other conventional tests, 2) the applicability of VST to brain-damaged patients, and 3) the performance of VST in relation to age differences. Methods: The participants included 10 patients with brain damage, 10 age-matched healthy subjects for controls, 10 old healthy subjects, and 10 young healthy subjects. VST and neuropsychological tests/questionnaires about attention, memory and executive function were conducted on the patients, while VST and the Mini-Mental State Examination (MMSE) were conducted on the controls and healthy subjects. Within the VST, the participants were asked to buy four items in the virtual shopping mall quickly in a rational way. The score for evaluation included the number of items bought correctly, the number of times to refer to hints, the number of movements between shops, and the total time spent to complete the shopping. Results: Some variables on VST correlated with the scores of conventional assessment about attention and everyday memory. The mean number of times referring to hints and the mean number of movements were significantly larger for the patients with brain damage, and the mean total time was significantly longer for the patients than for the controls. In addition, the mean total time was significantly longer for the old than for the young. Conclusions: The results suggest that VST is able to evaluate the ability of attention and everyday memory in patients with brain damage. The time of VST is increased by age.	[Okahashi, Sayaka; Futaki, Toshiko] Kyoto Univ, Div Occupat Therapy, Dept Human Hlth Sci, Grad Sch Med, Kyoto, Japan; [Okahashi, Sayaka; Nagano, Akinori; Luo, Zhiwei] Kobe Univ, Dept Computat Sci, Grad Sch Syst Informat, Kobe, Hyogo 657, Japan; [Seki, Keiko] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Kobe, Hyogo 657, Japan; [Kojima, Maki] Nishiyamato Rehabil Hosp, Dept Rehabil Med, Nara, Japan	Okahashi, S (corresponding author), Kyoto Univ, Div Occupat Therapy, Dept Human Hlth Sci, Grad Sch Med, Kyoto, Japan.	okahashi.sayaka.7c@kyoto-u.ac.jp	Kojima, Maki/V-9473-2019	Okahashi, Sayaka/0000-0001-9200-0259	KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21240019, 23800029]	The authors would like to thank all the volunteers, and especially those patients who participated in this study. Furthermore, we are grateful to Rumi Tanemura, PhD OT, Ho Kenneth Hung Lit, PhD, Motomi Toichi, PhD MD, Hiromi Sakai, PhD OT, Yuki Yamanaka, MSc, Tatsuo Oshiumi, MSc, Shin-ichi Nagai, MSc, Tomoko Tanaka, MSc OT, Hiromi Endo, MSc OT, Masumi Sawa, MSc SLP. This research was supported by KAKENHI; Grant-in-Aid for Scientific Research (A) (21240019) and Grant-in-Aid for Research Activity Start-up (23800029).	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; AMANO S, 2000, LEXICAL PROPERTIES J; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Clark JM, 2004, BEHAV RES METH INS C, V36, P371, DOI 10.3758/BF03195584; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Ishiai S., 1999, BEHAV INATTENTION TE; Kang YJ, 2008, CYBERPSYCHOL BEHAV, V11, P329, DOI 10.1089/cpb.2007.0116; Kazui H, 2006, J GERIATR PSYCH NEUR, V19, P3, DOI 10.1177/0891988705277543; Kazui Hiroaki, 2003, No To Shinkei, V55, P317; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2008, INT PSYCHOGERIATR, V20, P124, DOI 10.1017/S1041610207005923; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Mani TM, 2005, ARCH CLIN NEUROPSYCH, V20, P575, DOI 10.1016/j.acn.2004.12.008; Morganti F, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-26; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rand D, 2007, DISABIL REHABIL, V29, P1710, DOI 10.1080/09638280601107450; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Smith A., 1982, SYMBOL DIGIT MODALIT; Titov N, 2000, BRAIN INJURY, V14, P877; Titov N, 2005, BRAIN INJURY, V19, P315, DOI 10.1080/02699050400013725; Uttl B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001568; Vincelli F, 2001, STUD HEALTH TECHNOL, V81, P551; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson B., 1987, BEHAV INATTENTION TE; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1996, J GERIATR PSYCH NEUR; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	38	15	17	0	23	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	JUN 18	2013	10								59	10.1186/1743-0003-10-59			13	Engineering, Biomedical; Neurosciences; Rehabilitation	Engineering; Neurosciences & Neurology; Rehabilitation	171JP	WOS:000320923100001	23777412	DOAJ Gold, Green Published			2021-06-18	
J	Gurkoff, GG; Feng, JF; Van, KC; Izadi, A; Ghiasvand, R; Shahlaie, K; Song, M; Lowe, DA; Zhou, J; Lyeth, BG				Gurkoff, Gene G.; Feng, Jun-Feng; Van, Ken C.; Izadi, All; Ghiasvand, Rahil; Shahlaie, Kiarash; Song, Minsoo; Lowe, David A.; Zhou, Jia; Lyeth, Bruce G.			NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia	BRAIN RESEARCH			English	Article						Traumatic brain injury (TBI); Hypoxia; Excitotoxicity; N-acetylaspartylglutamate (NAAG); Behavior; Pre-clinical	TRAUMATIC BRAIN-INJURY; N-ACETYLASPARTYLGLUTAMATE NAAG; METABOTROPIC GLUTAMATE RECEPTORS; FLUID PERCUSSION INJURY; EXCITATORY AMINO-ACIDS; EXTRACELLULAR GLUTAMATE; CELL-DEATH; HYPOTENSION; RAT; RELEASE	Immediately following traumatic brain injury (TBI) and TBI with hypoxia, there is a rapid and pathophysiological increase in extracellular glutamate, subsequent neuronal damage and ultimately diminished motor and Cognitive function. N-acetyl-aspartyl glutamate (NAAG), a prevalent neuropeptide in the CNS, is co-released with glutamate, binds to the presynaptic group II metabotropic glutamate receptor subtype 3 (mGluR3) and suppresses glutamate release. However, the catalytic enzyme glutamate carboxypeptidase II (GCP II) rapidly hydrolyzes NAAG into NAA and glutamate. Inhibition of the GCP II enzyme with NAAG peptidase inhibitors reduces the concentration of glutamate both by increasing the duration of NAAG activity on mGluR3 and by reducing degradation into NAA and glutamate resulting in reduced cell death in models of TB! and TBI with hypoxia. In the following study, rats were administered the NAAG peptidase inhibitor PGI-02776 (10 mg/kg) 30 min following TBI combined with a hypoxic second insult Over the two weeks following injury, PGI-02776-treated rats had significantly improved motor function as measured by increased duration on the rota-rod and a trend toward improved performance on the beam walk. Furthermore, two weeks post-injury, PGI-02776-treated animals had a significant decrease in latency to find the target platform in the Morris water maze as compared to vehicle-treated animals. These findings demonstrate that the application of NAAG peptidase inhibitors can reduce the deleterious motor and cognitive effects of TBI combined with a second hypoxic insult in the weeks following injury. (C) 2013 Elsevier B.V. All rights reserved.	[Gurkoff, Gene G.; Feng, Jun-Feng; Van, Ken C.; Izadi, All; Ghiasvand, Rahil; Shahlaie, Kiarash; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophon & Sci Technol, Sacramento, CA 95817 USA; [Feng, Jun-Feng] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200027, Peoples R China; [Song, Minsoo; Lowe, David A.] PsychoGen Inc, Tarrytown, NY 10591 USA; [Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS61352, NS29995]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, R43NS061352] Funding Source: NIH RePORTER	This research was supported by NIH NS61352 (JZ & BGL) and NIH NS29995 (BGL).	Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bauman RA, 2005, BEHAV BRAIN RES, V160, P25, DOI 10.1016/j.bbr.2004.11.031; Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bzdega T, 2004, J NEUROCHEM, V89, P627, DOI 10.1111/j.1471-4159.2004.02361.x; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feng JF, 2012, BRAIN RES, V1469, P144, DOI 10.1016/j.brainres.2012.06.021; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Feng JF, 2011, BRAIN RES, V1395, P62, DOI 10.1016/j.brainres.2011.04.022; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kochanek PM, 1997, ACT NEUR S, V70, P109; Koura SS, 1998, ACT NEUR S, V71, P244; Luthi-Carter R, 1998, BRAIN RES, V795, P341, DOI 10.1016/S0006-8993(98)00244-3; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McSwain NE, 2004, J TRAUMA, V57, P8; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Olszewski RT, 2004, J NEUROCHEM, V89, P876, DOI 10.1111/j.1471-4159.2004.02358.x; Orlando LR, 1997, NEUROSCI LETT, V236, P91, DOI 10.1016/S0304-3940(97)00769-6; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Sanabria ERG, 2004, J NEUROPHYSIOL, V91, P182, DOI 10.1152/jn.00465.2003; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; Schweitzer C, 2000, NEUROPHARMACOLOGY, V39, P1700, DOI 10.1016/S0028-3908(99)00265-8; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Wroblewska B, 2006, ADV EXP MED BIOL, V576, P317; Wroblewska B, 1998, GLIA, V24, P172, DOI 10.1002/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6; Xi ZX, 2002, J PHARMACOL EXP THER, V300, P162, DOI 10.1124/jpet.300.1.162; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	63	15	15	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 17	2013	1515						98	107		10.1016/j.brainres.2013.03.043			10	Neurosciences	Neurosciences & Neurology	176QP	WOS:000321319500011	23562458	Green Accepted			2021-06-18	
J	Lippa, SM; Hawes, S; Jokic, E; Caroselli, JS				Lippa, Sara M.; Hawes, Samuel; Jokic, Emily; Caroselli, Jerome S.			Sensitivity of the RBANS to acute traumatic brain injury and length of post-traumatic amnesia	BRAIN INJURY			English	Article						Traumatic brain injury; head injury; RBANS; post-traumatic amnesia	NEUROPSYCHOLOGICAL STATUS RBANS; REPEATABLE BATTERY; GALVESTON ORIENTATION; SCREENING-TEST; VALIDITY; SCHIZOPHRENIA; RELIABILITY; CONSTRUCT; DISEASE	Objective: Although the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) has been shown to be a useful tool in evaluating the cognitive status of patients with dementia, stroke, schizophrenia and post-acute traumatic brain injury (TBI), no studies have examined its utility in an acute TBI setting. The current study investigates the RBANS' sensitivity to acute TBI, hypothesizing that the presence and severity of injury is predictive of worse RBANS performance. Method: Neuropsychological testing was conducted an average of 6.1 days after emergence from post-traumatic amnesia (PTA). RBANS results were evaluated based on a normative basis, pre-injury estimates, and brain injury severity. Results: In this sample of acute TBI patients (n = 51), the mean index scores on the RBANS ranged from 1.59-2.36 SD below the mean of the standardization sample. Each WRAT-4 Reading sub-test score was above the corresponding RBANS Total Scale Index score (t(31) 10.32, p<0.001). Regression analyses revealed that Delayed Memory (beta = - 0.365, p<0.007) and Total Score (beta = -0.297, p<0.023) indices were significantly predicted by PTA length after controlling for age and education.	[Lippa, Sara M.; Hawes, Samuel; Jokic, Emily; Caroselli, Jerome S.] TIRR Mem Hermann Hosp, Dept Psychol Neuropsychol, Houston, TX 77030 USA; [Lippa, Sara M.; Caroselli, Jerome S.] Univ Houston, Dept Psychol, Houston, TX USA; [Hawes, Samuel] Sam Houston State Univ, Dept Psychol, Houston, TX USA; [Caroselli, Jerome S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA	Caroselli, JS (corresponding author), TIRR Mem Hermann Hosp, Dept Psychol Neuropsychol, 1333 Moursund St, Houston, TX 77030 USA.	jerome.caroselli@memorialhermann.org					Beatty WW, 2003, ARCH CLIN NEUROPSYCH, V18, P509, DOI 10.1016/S0887-6177(02)00148-8; Beglinger LJ, 2010, J CLIN EXP NEUROPSYC, V32, P573, DOI 10.1080/13803390903313564; BENTON AL, 1974, REVISED BENTON VISUA; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Freilich BM, 2007, PSYCHOL REP, V101, P119, DOI 10.2466/PR0.101.1.119-129; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Gontkovsky ST, 2002, PSYCHOL REP, V90, P858, DOI 10.2466/PR0.90.3.858-860; Hobart MP, 1999, AM J PSYCHIAT, V156, P1951; Hobson VL, 2010, INT J GERIATR PSYCH, V25, P525, DOI 10.1002/gps.2382; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; Jennett B, 1975, Ciba Found Symp, P309; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Larson EB, 2005, J CLIN EXP NEUROPSYC, V27, P16, DOI 10.1080/138033990513564; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Pachet AK, 2007, CLIN NEUROPSYCHOL, V21, P286, DOI 10.1080/13854040500376823; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Stellton D., 2006, DISS ABSTR INT B, V67, P1200; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilde MC, 2006, CLIN NEUROPSYCHOL, V20, P702, DOI 10.1080/13854040500246901; Wilde MC, 2010, CLIN NEUROPSYCHOL, V24, P57, DOI 10.1080/13854040902984505; Wilk CM, 2004, SCHIZOPHR RES, V70, P175, DOI 10.1016/j.schres.2003.10.009; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th	32	15	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					689	695		10.3109/02699052.2013.771793			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500008	23672444				2021-06-18	
J	Purohit, MP; Wells, RE; Zafonte, R; Davis, RB; Yeh, GY; Phillips, RS				Purohit, Maulik P.; Wells, Rebecca Erwin; Zafonte, Ross; Davis, Roger B.; Yeh, Gloria Y.; Phillips, Russell S.			Neuropsychiatric Symptoms and the Use of Mind-Body Therapies	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							ALTERNATIVE MEDICINE USE; STRESS REDUCTION; COMPLEMENTARY; ADULTS; ASSOCIATION; DEPRESSION; MIGRAINE	Objective: Neuropsychiatric symptoms affect 37% of US adults and present in many important diagnoses including posttraumatic stress disorder, traumatic brain injury, and chronic pain. However, these symptoms are difficult to treat with standard treatments, and patients may seek alternative options. In this study, we examined the use of mind-body therapies by adults with neuropsychiatric symptoms. Method: We compared mind-body therapy use (biofeedback, energy healing, meditation, guided imagery, yoga, deep-breathing exercises, hypnosis, progressive relaxation therapy, qigong, and tai chi) between adults with and without neuropsychiatric symptoms (anxiety, depression, insomnia, headaches, memory deficits, attention deficits, and excessive daytime sleepiness) in the 2007 National Health Interview Survey (N = 23,393). Use of >= 1 of these therapies in the prior 12 months was the primary outcome of interest. We also examined prevalence and reasons for mind-body therapy use in adults with neuropsychiatric symptoms. We performed logistic regression to examine the association between neuropsychiatric symptoms and mind-body therapy use to adjust for sociodemographic and clinical factors. Results: Adults with >= 1 neuropsychiatric symptom used mind-body therapies more than adults without symptoms (25.3% vs 15.0%, P<.001). Prevalence increased with increasing number of symptoms (21.5% for 1 symptom, 32.4% for >= 3 symptoms, P<.001); differences persisted after adjustment for potential confounders (odds ratios, 1.39 [95% CI, 1.26-1.53] and 2.48 [95% CI, 2.18-2.82]). Reasons for mind-body therapy use among adults with >= 1 symptom included the ineffectiveness or expense of conventional medicine (30.2%). Most adults (nearly 70%) with >= 1 symptom did not discuss their mind-body therapy use with a conventional provider. Conclusions: Adults with >= 1 neuropsychiatric symptom use mind-body therapies frequently; more symptoms are associated with increased use. Future research is needed to understand the efficacy of these therapies.	[Purohit, Maulik P.; Zafonte, Ross] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Purohit, Maulik P.; Zafonte, Ross] Harvard Univ, Spaulding Rehabil Hosp, Sch Med, Boston, MA USA; [Purohit, Maulik P.; Davis, Roger B.; Yeh, Gloria Y.; Phillips, Russell S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Wells, Rebecca Erwin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Wells, Rebecca Erwin] Harvard Univ, Faulkner Hosp, Sch Med, Boston, MA USA; [Phillips, Russell S.] Harvard Univ, Ctr Primary Care, Sch Med, Boston, MA USA	Purohit, MP (corresponding author), Spaulding Rehabil Hosp Network, 125 Nashua St,720, Boston, MA 02114 USA.	mpurohit1@partners.org			institutional National Research Service Award from the National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health [T32AT000051]; American Headache Society; National Institute of Child Health and Human Development Investigator Award [5R24HD065688-02]; Spaulding-Harvard Spinal Cord Injury Model System, US Department of Education, National Institute on Disability and Rehabilitation Research, Traumatic Brain Injury Model Systems grant [H133N110010]; Department of Defense InsightUnited States Department of Defense; Harvard Clinical Consortium PTSD/TBI study site (INTRuST), Department of Defense, US Army Medical Research and Materiel Command grant [W81XWH-08-2-0159]; Mid-Career Investigator Award from NCCAM, National Institutes of Health [K24AT000589]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [K24AT000589] Funding Source: NIH RePORTER; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT000051] Funding Source: NIH RePORTER	Drs Purohit and Wells were supported by an institutional National Research Service Award Number T32AT000051 from the National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health. Dr Wells was supported by a headache fellowship from the American Headache Society. Dr Zafonte was supported by National Institute of Child Health and Human Development Investigator Award 5R24HD065688-02; Spaulding-Harvard Spinal Cord Injury Model System, US Department of Education, National Institute on Disability and Rehabilitation Research, Traumatic Brain Injury Model Systems grant H133N110010; Department of Defense Insight; and Harvard Clinical Consortium PTSD/TBI study site (INTRuST), Department of Defense, US Army Medical Research and Materiel Command grant W81XWH-08-2-0159. Drs Phillips and Davis were supported by Mid-Career Investigator Award K24AT000589 from NCCAM, National Institutes of Health.	[Anonymous], WHAT IS COMPL ALT ME; [Anonymous], NHIS 2007 SURV DESCR; Bertisch SM, 2008, OBESITY, V16, P1610, DOI 10.1038/oby.2008.239; Bertisch SM, 2009, J PSYCHOSOM RES, V66, P511, DOI 10.1016/j.jpsychores.2008.12.003; Carlson MJ, 2006, DISABIL REHABIL, V28, P505, DOI 10.1080/09638280500212062; Geoffroy PA, 2012, PRESSE MED, V41, P455, DOI 10.1016/j.lpm.2011.08.008; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Gross CR, 2011, EXPLORE-NY, V7, P76, DOI 10.1016/j.explore.2010.12.003; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hetrick SE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007316.pub2; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Joo HM, 2010, J KOREAN NEUROSURG S, V47, P345, DOI 10.3340/jkns.2010.47.5.345; Kurth T, 2012, LANCET NEUROL, V11, P92, DOI 10.1016/S1474-4422(11)70266-6; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Plantinga L, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110244; Purohit MP, 2013, PM&R, V5, P24, DOI 10.1016/j.pmrj.2012.06.012; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Schurks M, 2011, CEPHALALGIA, V31, P1301, DOI 10.1177/0333102411415879; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vollestad J, 2011, BEHAV RES THER, V49, P281, DOI 10.1016/j.brat.2011.01.007; Wang CC, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-23; Wells RE, 2011, HEADACHE, V51, P1087, DOI 10.1111/j.1526-4610.2011.01917.x; Wells RE, 2011, NEUROEPIDEMIOLOGY, V36, P46, DOI 10.1159/000322949; Wells RE, 2010, J NEUROL, V257, P1822, DOI 10.1007/s00415-010-5616-2	26	15	15	1	43	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	JUN	2013	74	6					E520	+		10.4088/JCP.12m08246			11	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	AA5DE	WOS:000331115200001	23842021	Green Accepted			2021-06-18	
J	Reynolds, JC; Rittenberger, JC; Callaway, CW				Reynolds, Joshua C.; Rittenberger, Jon C.; Callaway, Clifton W.			Methylphenidate and amantadine to stimulate reawakening in comatose patients resuscitated from cardiac arrest	RESUSCITATION			English	Article						Cardiac arrest; Resuscitation; Coma; Methylphenidate; Amantadine	TRAUMATIC BRAIN-INJURY; AMERICAN-HEART-ASSOCIATION; EMERGENCY CARDIOVASCULAR CARE; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; CONTROLLED-TRIAL; ISCHEMIA; NEUROPROTECTION; CONSCIOUSNESS; HYPOTHERMIA	Background: Despite critical-care packages including therapeutic hypothermia (TH), neurologic injury is common after cardiac arrest (CA) resuscitation. Methylphenidate and amantadine have treated coma in traumatically-brain-injured patients with mixed success, but have not been explored in post-arrest patients. Objective: Compare the outcome of comatose post-arrest patients treated with neurostimulants to a matched cohort. Methods: Retrospective cohort study from 6/2008 to 12/2011 in a tertiary university hospital. We included adult patients treated with methylphenidate or amantadine after resuscitation from in-hospital or out-of-hospital CA (OHCA) of any rhythm, excluding patients with traumatic/surgical etiology of arrest, terminal re-arrest within 6 h, or withdrawal of care by family within 6 h. Primary outcome was following commands; secondary outcomes included survival to hospital discharge, cerebral performance category (CPC), and modified Rankin scale (mRS). We compared characteristics and outcomes to a control cohort matched on TH and 72 h FOUR score +/- 1. Results: Of 588 patients, 8 received methylphenidate, 6 received amantadine, and 2 both. Most were female suffering OHCA with median age 61 years. All received TH and a multi-modal neurological evaluation. Initial exam revealed median GCS 6 and FOUR 7, which was unchanged at 72 h. Six patients (38%) followed commands prior to discharge at median 2.5 days (range: 1-18 days) after treatment. Patients receiving neurostimulants trended toward improved rate of following commands, survival to hospital discharge, and distribution of CPC and mRS scores. Conclusions: Neurostimulants may be considered to stimulate wakefulness in selected post-cardiac arrest patients, but a prospective trial is needed to evaluate this therapy. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Reynolds, Joshua C.; Rittenberger, Jon C.; Callaway, Clifton W.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA	Reynolds, JC (corresponding author), Iroquois Bldg,Suite 400 A,3600 Forbes Ave, Pittsburgh, PA 15261 USA.	reynoldsjc@upmc.edu		Reynolds, Joshua/0000-0002-5482-3569; Callaway, Clifton/0000-0002-3309-1573	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [2 U01 HL07787-07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL007787] Funding Source: NIH RePORTER	Dr. Callaway is supported in part by 2 U01 HL07787-07 from the National Heart, Lung, and Blood Institute.	Castro CC, 2012, BRAIN RES, V1474, P82, DOI 10.1016/j.brainres.2012.07.025; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; Donnino MW, 2011, RESUSCITATION, V82, P974, DOI 10.1016/j.resuscitation.2011.03.021; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Hughes S, 2005, BRAIN INJURY, V19, P1197, DOI 10.1080/02699050500309296; Kelley MH, 2011, NEUROPHARMACOLOGY, V61, P724, DOI 10.1016/j.neuropharm.2011.05.017; Knapp J, 2011, RESUSCITATION, V82, P1076, DOI 10.1016/j.resuscitation.2011.03.038; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Reynolds JC, 2012, J EMERG MED; Rittenberger JC, 2012, NEUROCRIT CARE, V16, P114, DOI 10.1007/s12028-011-9565-0; Rittenberger JC, 2011, RESUSCITATION, V82, P1399, DOI 10.1016/j.resuscitation.2011.06.024; Rittenberger JC, 2010, RESUSCITATION, V81, P1128, DOI 10.1016/j.resuscitation.2010.05.011; Rittenberger JC, 2008, RESUSCITATION, V79, P198, DOI 10.1016/j.resuscitation.2008.08.014; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Taguchi N, 2012, RESUSCITATION, V83, P652, DOI 10.1016/j.resuscitation.2011.11.004; TEASDALE G, 1974, LANCET, V2, P81; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wu O, 2009, RADIOLOGY, V252, P173, DOI 10.1148/radiol.2521081232; Yang ZJ, 2011, NEUROBIOL DIS, V43, P446, DOI 10.1016/j.nbd.2011.04.018	34	15	17	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	JUN	2013	84	6					818	824		10.1016/j.resuscitation.2012.11.014			7	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	172IV	WOS:000320996800033	23178867				2021-06-18	
J	Soble, JR; Spanierman, LB; Smith, JF				Soble, Jason R.; Spanierman, Lisa B.; Smith, Julie Fitzgerald			Neuropsychological functioning of combat veterans with posttraumatic stress disorder and mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychological assessment; Operation Enduring Freedom; Operation Iraqi Freedom combat veterans; Mild traumatic brain injury; Posttraumatic stress disorder	VERBAL-LEARNING TEST; POSTCONCUSSIVE SYMPTOMS; WAR VETERANS; HEAD-INJURY; IRAQ-WAR; MEMORY; AFGHANISTAN; ATTENTION; BLAST; PTSD	This study examined the neuropsychological performance of 125 outpatient Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with posttraumatic stress disorder (PTSD) and nonacute mild traumatic brain injury (TBI) (n=66) and PTSD (n=59) across multiple cognitive domains to determine whether mild TBI results in greater impairment among those with PTSD. Profile analyses revealed that veterans with PTSD and mild TBI did not differ significantly from those with just PTSD across domains, suggesting that comorbid mild TBI does not result in an additive effect. A norms-based comparison also revealed that neither group demonstrated impaired performance on any of the objective neuropsychological measures examined. However, both groups endorsed moderately elevated symptoms of depression and anxiety, indicating that comorbid psychopathology may contribute to subjective cognitive complaints.	[Soble, Jason R.] Univ Illinois, Dept Educ Psychol, Champaign, IL 61820 USA; [Spanierman, Lisa B.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Smith, Julie Fitzgerald] VA Illiana Healthcare Syst, Mental Hlth Serv, Danville, IL USA	Soble, JR (corresponding author), James A Haley VA Hosp, Dept Mental Hlth & Behav Sci Psychol 116B, 13000 N Bruce B Downs Blvd, Tampa, FL 33612 USA.	Jason.Soble@va.gov		Spanierman, Lisa/0000-0003-4878-9787			American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT., 1996, BECK DEPRESSION INVE, V2; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carlozzi NE, 2011, STRESS HEALTH, V27, pE287, DOI 10.1002/smi.1355; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU; DIKMEN S, 2009, NEUROPSYCHOLOGICAL A, P597; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gurvits TV, 2002, PSYCHIAT RES, V112, P263, DOI 10.1016/S0165-1781(02)00234-2; Hannay H.J., 2004, NEUROPSYCHOLOGICAL A, P133; Heaton R., 1993, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnson R.A., 2007, APPL MULTIVARIATE ST, V6th ed; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Koso M, 2006, EUR PSYCHIAT, V21, P167, DOI 10.1016/j.eurpsy.2005.06.004; Kramer J. H., 2007, HUMAN FRONTAL LOBES, P279; LARRABEE GJ, 2005, FORENSIC NEUROPSYCHO, P115; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lorber W, 2010, PSYCHOTHERAPY, V47, P296, DOI 10.1037/a0021161; McCrae M. A., 2008, MILD TRAUMATIC BRAIN; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; MEEHL PE, 1950, J CONSULT PSYCHOL, V14, P165, DOI DOI 10.1037/H0058049; Meyers J., 1995, REY COMPLEX FIGURE T; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Roca V, 2001, AM J PSYCHIAT, V158, P1738, DOI 10.1176/appi.ajp.158.10.1738-a; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff R.M., 1996, RUFF 2 7 SELECTIVE A; Sachinvala N, 2000, J NERV MENT DIS, V188, P818, DOI 10.1097/00005053-200012000-00005; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Slone L. B., 2008, WAR ZONE PRACTICAL G; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Tanielian T., 2008, INVISIBLE WOUNDS WAR, P431; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh TN, 1996, TEST MEMORY MALINGER; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wechsler D., 1999, MANUAL WECHSLER ABBR; Wechsler D., 1997, ADM SCORING MANUAL W; Wolfson D., 1993, HALSTEAD REITAN NEUR; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137	73	15	16	1	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN 1	2013	35	5					551	561		10.1080/13803395.2013.798398			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	161GJ	WOS:000320180200011	23672579				2021-06-18	
J	Sebastian, V; Diallo, A; Ling, DSF; Serrano, PA				Sebastian, Veronica; Diallo, Aissatou; Ling, Douglas S. F.; Serrano, Peter A.			Robust training attenuates TBI-induced deficits in reference and working memory on the radial 8-arm maze	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						traumatic brain injury; radial arm maze; working memory; reference memory; robust training	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; TERM COGNITIVE DEFICITS; MORRIS WATER MAZE; SPATIAL MEMORY; PREFRONTAL CORTEX; ENVIRONMENTAL ENRICHMENT; CELL-DEATH; RAT; HIPPOCAMPAL	Globally, it is estimated that nearly 10 million people sustain severe brain injuries leading to hospitalization and/or death every year. Amongst survivors, traumatic brain injury (TBI) results in a wide variety of physical, emotional and cognitive deficits. The most common cognitive deficit associated with TBI is memory loss, involving impairments in spatial reference and working memory. However, the majority of research thus far has characterized the deficits associated with TBI on either reference or working memory systems separately, without investigating how they interact within a single task. Thus, we examined the effects of TBI on short-term working and long-term reference memory using the radial 8-arm maze (RAM) with a sequence of four baited and four unbaited arms. Subjects were given 10 daily trials for 6 days followed by a memory retrieval test 2 weeks after training. Multiple training trials not only provide robust training, but also test the subjects' ability to frequently update short-term memory while learning the reference rules of the task. Our results show that TBI significantly impaired short-term working memory function on previously acquired spatial information but has little effect on long-term reference memory. Additionally, TBI significantly increased working memory errors during acquisition and reference memory errors during retention testing 2 weeks later. With a longer recovery period after TBI, the robust RAM training mitigated the reference memory deficit in retention but not the short-term working memory deficit during acquisition. These results identify the resiliency and vulnerabilities of short-term working and long-term reference memory to TBI in the context of robust training. The data highlight the role of cognitive training and other behavioral remediation strategies implicated in attenuating deficits associated with TBI.	[Sebastian, Veronica; Diallo, Aissatou; Serrano, Peter A.] CUNY Hunter Coll, Dept Psychol, New York, NY 10065 USA; [Ling, Douglas S. F.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Ling, Douglas S. F.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Serrano, Peter A.] CUNY, Grad Ctr, Dept Psychol, New York, NY USA	Serrano, PA (corresponding author), CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10065 USA.	serrano@genectr.hunter.cuny.edu			RCMI from the National Center for Research Resources (NCRR) [RR003037]; Department of DefenseUnited States Department of Defense [W81XWH-08-1-0243]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS080686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R24DA012136] Funding Source: NIH RePORTER	This study was funded in part by the RCMI grant number RR003037 from the National Center for Research Resources (NCRR) and the Department of Defense W81XWH-08-1-0243 to Peter A. Serrano.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Baddeley A. D., 1994, Neuropsychology, V8, P485, DOI [10.1037/0894-4105.8.4.485., 10.1037/0894-4105.8.4.485]; BEATTY WW, 1985, NEUROBIOL AGING, V6, P219, DOI 10.1016/0197-4580(85)90053-3; Bimonte HA, 2003, NEUROBIOL AGING, V24, P37, DOI 10.1016/S0197-4580(02)00015-5; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Chen M. F., 2012, J PHYSL, V591, P985; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; DASH PK, 1995, J NEUROSCI, V15, P2030; Daumas S, 2008, LEARN MEMORY, V15, P625, DOI 10.1101/lm.990208; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Floresco SB, 1997, J NEUROSCI, V17, P1880; Gong QZ, 1999, J NEUROTRAUM, V16, P893, DOI 10.1089/neu.1999.16.893; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Honig WK, 1978, COGNITIVE PROCESS, P213; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; JARRARD LE, 1978, J COMP PHYSIOL PSYCH, V92, P1119, DOI 10.1037/h0077516; Joel D, 1997, BRAIN RES, V765, P37, DOI 10.1016/S0006-8993(97)00334-X; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; KOLB B, 1982, BEHAV BRAIN RES, V6, P365, DOI 10.1016/0166-4328(82)90018-3; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Monaco C. M, 2013, EXP NEUROL, DOI [10.1016/j.expneurol.2013.01.007, DOI 10.1016/J.EXPNEUR0L.2013.01.007.[]; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schrott LM, 2008, BRAIN RES, V1198, P132, DOI 10.1016/j.brainres.2008.01.020; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; STEWART J, 1989, NEUROBIOL AGING, V10, P669, DOI 10.1016/0197-4580(89)90003-1; Tyagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057945; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; WALLACE JE, 1980, J GERONTOL, V35, P355, DOI 10.1093/geronj/35.3.355; Whiting MD, 2008, BRAIN RES, V1213, P69, DOI 10.1016/j.brainres.2008.01.107; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xia XW, 2012, WORLD NEUROSURG, V78, P689, DOI 10.1016/j.wneu.2011.07.042; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Ying Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052998; Yoshihara T, 2004, NEUROSCIENCE, V129, P1, DOI 10.1016/j.neuroscience.2004.07.030; Zhang M, 2011, J NEUROSCI, V31, P10174, DOI 10.1523/JNEUROSCI.0009-11.2011; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	67	15	15	0	16	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	MAY 3	2013	7								38	10.3389/fnbeh.2013.00038			9	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	136BV	WOS:000318335400001	23653600	DOAJ Gold, Green Published			2021-06-18	
J	Billiard, M; Podesta, C				Billiard, Michel; Podesta, Claudio			Recurrent hypersomnia following traumatic brain injury	SLEEP MEDICINE			English	Article						Recurrent hypersomnia; Traumatic brain injury; Post-traumatic recurrent hypersomnia; Kleine-Levin syndrome	KLEINE-LEVIN-SYNDROME; HEAD TRAUMA; GIRL	Background: Recurrent hypersomnia (RH) following a traumatic brain injury (TBI) is a rare form of RH. According to the International Classification of Sleep Disorders, 2nd edition (ICSD-2), RH must be considered in the differential diagnosis as secondary to an organic insult of the central nervous system and not as the clinical subtype of RH, Kleine-Levin syndrome (KLS). The aim of our study was to investigate if cases of RH following TBI should be considered in the differential diagnosis of RH as indicated by the International Classification of Sleep Disorders, 2nd edition or as genuine, or indicated by ICSD-2, RH must cases of KLS. Methods: Twelve cases of RH developed after TBI were collected and analyzed for circumstance at onset, severity of TBI, delay between TBI and occurrence of first episode of RH, symptoms of RH, duration and cycle length of episodes of hypersomnia, physical signs, and brain morphological imaging at the time of hypersomnia episodes. Results: Factors such as the delay between TBI and the first episode of RH, the presence of other triggering factors and potential genetic factors, the degree of the severity of TBI, the presence or absence of any consistent brain imaging abnormality, provided the following results: (1) two of the cases could be considered as symptomatic of the underlying pathological brain process, (2) eight of the cases could be considered as simply triggered by TBI in patients at risk for KLS, and (3) two cases could be considered neither symptomatic nor triggered by TBI, due to the long delay between TBI and occurrence of symptoms. Conclusion: Cases of RH following TBI do not present under a single mechanism. Clinical assessment and laboratory tests are necessary to correctly classify them. (c) 2013 Published by Elsevier B.V.	[Billiard, Michel] Gui de Chauliac Hosp, Dept Neurol, F-34090 Montpellier, France; [Podesta, Claudio] FLENI, Dept Neurol, Sleep Lab, Buenos Aires, DF, Argentina	Billiard, M (corresponding author), Gui de Chauliac Hosp, Dept Neurol, 70 Allee James Anderson, F-34090 Montpellier, France.	mbilliard@wanadoo.fr					American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Arnulf I, 2012, LANCET NEUROL, V11, P918, DOI 10.1016/S1474-4422(12)70187-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Billiard M, 2011, SLEEP MED REV, V15, P247, DOI 10.1016/j.smrv.2010.08.001; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cheung G, 2006, GEN HOSP PSYCHIAT, V28, P443, DOI 10.1016/j.genhosppsych.2006.03.011; CHIU HFK, 1989, AUST NZ J PSYCHIAT, V23, P425, DOI 10.3109/00048678909068302; Critchley M, 1962, BRAIN, V85, P41; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Janicki S, 2001, PSYCHOSOMATICS, V42, P350, DOI 10.1176/appi.psy.42.4.350; Kostic VS, 1998, BEHAV NEUROL, V11, P105, DOI 10.1155/1998/413989; Nose I, 2002, PSYCHIAT CLIN NEUROS, V56, P277, DOI 10.1046/j.1440-1819.2002.00979.x; Pelin Z, 2004, EUR PSYCHIAT, V19, P521, DOI 10.1016/j.eurpsy.2004.06.005; Podesta C, 2006, SLEEP MED, V7, P649, DOI 10.1016/j.sleep.2006.07.003; Ramnath B, 2008, INDIAN PEDIATR, V45, P1007; Smolik P, 1988, ACTA U CAROLINAE PRA, VXXXVIII; WILL RG, 1988, BRIT J PSYCHIAT, V152, P410, DOI 10.1192/bjp.152.3.410	18	15	15	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457			SLEEP MED	Sleep Med.	MAY	2013	14	5					462	465		10.1016/j.sleep.2013.01.009			4	Clinical Neurology	Neurosciences & Neurology	139VC	WOS:000318612100013	23499199				2021-06-18	
J	Khan, F; Amatya, B				Khan, Fary; Amatya, Bhasker			USE OF THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH (ICF) TO DESCRIBE PATIENT-REPORTED DISABILITY IN PRIMARY BRAIN TUMOUR IN AN AUSTRALIAN COMMUNITY COHORT	JOURNAL OF REHABILITATION MEDICINE			English	Article						ICF; disability; brain tumour; outcome assessment; environmental factors	GUILLAIN-BARRE-SYNDROME; QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; CORE SET; INPATIENT REHABILITATION; COGNITIVE DEFICITS; NECK-CANCER; OUTCOMES; PERSPECTIVE; DISEASE	Objective: To describe patient-reported disability in primary brain tumours using the International Classification of Functioning, Disability and Health (ICF); and comparison with categories within the core sets for stroke and traumatic brain injury. Method: A prospective community cross-sectional survey (n=106) following definitive treatment for primary brain tumours. Problems reported by participants were linked with ICF categories using 'linkage' rules. Participants rated 'activities and participation' and 'environmental factor' components of ICF checklist (using qualifiers); and responses compared with categories within core sets for stroke and traumatic brain injury. Results: Participant mean age 51 years, median time since diagnosis 2 years; over a third had high grade tumours. Participants considered 44 categories in 'activities and participation' and 16 categories (barriers) in 'environmental factors' as relevant (>= 10% response) using checklist. Reported problems included: Mobility, Domestic life, General tasks/demands; and Human made changes to environment. Although the linked categories for brain tumour survivors were similar to those in the core sets for stroke and traumatic brain injury, there was more commonality with the traumatic brain injury core set. Conclusion: The existing comprehensive stroke and traumatic brain injury core sets incorporate issues relevant to brain tumour survivors in post-acute settings. Findings from this report will assist in defining a future core set for brain tumour; the possibility however, of using a single core set relevant to most long-term neurological conditions needs to be explored.	[Khan, Fary; Amatya, Bhasker] Royal Melbourne Hosp, Dept Rehabil Med, Melbourne, Vic 3052, Australia; [Khan, Fary] Univ Melbourne, Dept Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Khan, Fary] Monash Univ, Sch Publ Hlth & Preventat Med, Melbourne, Vic 3004, Australia	Khan, F (corresponding author), Royal Melbourne Hosp, Dept Rehabil Med, 34-54 Poplar Rd, Melbourne, Vic 3052, Australia.	fary.khan@mh.org.au	Amatya, Bhasker/E-1062-2017	Amatya, Bhasker/0000-0003-4793-1104	Victorian Cancer Agency	F. Khan received the Clinical Research Fellowship granted by Victorian Cancer Agency. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organisation with which the authors are associated.	Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Arber A, 2010, INT J PALLIAT NURS, V16, P24, DOI 10.12968/ijpn.2010.16.1.46180; Bartolo M, 2012, J NEURO-ONCOL, V107, P537, DOI 10.1007/s11060-011-0772-5; Bernsen RAJAM, 1997, J NEUROL NEUROSUR PS, V62, P637, DOI 10.1136/jnnp.62.6.637; Brain Foundation, 2011, BRAIN TUM BRAIN CANC; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2009, J CLIN EPIDEMIOL, V62, P912, DOI 10.1016/j.jclinepi.2008.04.011; Coenen M, 2011, J NEUROL, V258, P1477, DOI 10.1007/s00415-011-5963-7; Flowers A, 2000, Cancer Control, V7, P523; Franklin Deborah Julie, 2007, Phys Med Rehabil Clin N Am, V18, P899, DOI 10.1016/j.pmr.2007.07.007; Fu JB, 2010, AM J PHYS MED REHAB, V89, P205, DOI 10.1097/PHM.0b013e3181ca2306; Gabanelli P, 2005, NEUROL SCI, V26, pS51, DOI 10.1007/s10072-005-0408-7; Gehring K, 2008, LANCET NEUROL, V7, P548, DOI 10.1016/S1474-4422(08)70111-X; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Huang ME, 2011, PM&R, V3, P746, DOI 10.1016/j.pmrj.2011.05.020; Huang ME, 2001, BRAIN INJURY, V15, P843; International Classification of Functioning Disability and Health (ICF), 2012, COMPR ICF COR SET TR; Khan F, 2007, DISABIL REHABIL, V29, P205, DOI 10.1080/09638280600756141; Khan F, 2012, J REHABIL MED, V44, P570, DOI 10.2340/16501977-0972; Khan F, 2011, J REHABIL MED, V43, P638, DOI 10.2340/16501977-0826; Khan F, 2010, J REHABIL MED, V42, P708, DOI 10.2340/16501977-0592; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Leonardi M, 2009, DISABIL REHABIL, V31, pS88, DOI 10.3109/09638280903317732; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; Ng L, 2012, DISABIL REHABIL, V34, P295, DOI 10.3109/09638288.2011.606345; Ownsworth T, 2009, DISABIL REHABIL, V31, P1038, DOI 10.1080/09638280802509538; Parkin DM, 2005, CANC INCIDENCE 5 CON, V7; Patton MQ., 1990, QUALITATIVE EVALUATI; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Rooney A, 2010, COCHRANE DB SYST REV, V3; Stier-Jarmer M, 2005, DISABIL REHABIL, V27, P389, DOI 10.1080/09638280400014022; Sveen U, 2012, DISABIL REHABIL; Tang V, 2008, J NEUROL, V255, P820, DOI 10.1007/s00415-008-0695-z; Tschiesner U, 2011, INT J REHABIL RES, V34, P121, DOI 10.1097/MRR.0b013e328343d4bc; Tschiesner U, 2009, LARYNGOSCOPE, V119, P915, DOI 10.1002/lary.20211; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; Weigl M, 2003, OSTEOARTHR CARTILAGE, V11, P519, DOI 10.1016/S1063-4584(03)00086-4; Weitzner MA, 1999, CANCER INVEST, V17, P285, DOI 10.3109/07357909909040599; *WHO, 2001, ICF CHECKL VERS 2 1A; World Health Organization, 2001, INT CLASS FUNCT DIS	40	15	15	0	17	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2013	45	5					434	445		10.2340/16501977-1132			12	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	163OB	WOS:000320345700004	23584801	DOAJ Gold			2021-06-18	
J	Beseoglu, K; Roussaint, N; Steiger, HJ; Hanggi, D				Beseoglu, Kerim; Roussaint, Nina; Steiger, Hans-Jakob; Haenggi, Daniel			Quality of life and socio-professional reintegration after mild traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						employment; epidemiology; mild traumatic brain injury; quality of life; short form 36	HEAD-INJURY; PSYCHOSOCIAL OUTCOMES; HEMORRHAGE PATIENTS; HEALTH; CT; CLASSIFICATION; SYMPTOMS; DISORDER; MODERATE	Background. Controversy exists about the influence of intracranial injuries in mild traumatic brain injury (mTBI) on quality of life (QoL). Some patients do not fully recover from mTBI and experience neurocognitive impairment and reduction in quality of life. We evaluated the influence of structural brain damage on QoL and employment status (ES) after mTBI. Methods. In a partially prospective design we evaluated QoL using Short-Form-36 (SF36) and current ES three years after trauma in 36 patients with mTBI in a matched pair design with two groups of 18 patients each with and without structural brain damage. Results. Both groups showed a reduction in physical (Physical Functioning, Role Physical, Bodily Pain and General Health) and emotional parameters (Vitality, Social Functioning, Role Emotional and Mental Health) without significant difference between both groups (p = 0.305, p = 0.406, p = 0.624, p = 0.720, p = 0.934, p = 0.282, p = 0.811 and p = 0.270 respectively). ES was independent of structural brain damage and an influential factor for QoL. Conclusion. MTBI specific QoL assessment including focus on ES is necessary to identify patients at risk for impaired recovery. Structural brain injury as seen on CT scan is not useful as a prognostic tool to predict QoL or ES after mTBI.	[Beseoglu, Kerim; Roussaint, Nina; Steiger, Hans-Jakob; Haenggi, Daniel] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany	Beseoglu, K (corresponding author), Univ Dusseldorf, Dept Neurosurg, Univ Klin Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany.	beseoglu@med.uni-duesseldorf.de	Steiger, Hans-Jakob/AAN-8307-2021	Steiger, Hans-Jakob/0000-0002-8249-2998			Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cantor JB, 2008, J HEAD TRAUMA REHAB, P2341; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; Ellert U, 1999, Gesundheitswesen, V61 Spec No, pS184; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kim JS, 2009, J KOREAN NEUROSURG S, V46, P459, DOI 10.3340/jkns.2009.46.5.459; Kurth BM, 2002, SOZ PRAVENTIV MED, V47, P266, DOI 10.1007/s00038-002-8217-8; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Merritta C, 2009, INT J REHABIL RES; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Noble AJ, 2008, NEUROSURGERY, V63, P1095, DOI 10.1227/01.NEU.0000327580.91345.78; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Pickard JD, 2004, J ROY SOC MED, V97, P384, DOI 10.1258/jrsm.97.8.384; Pritchard C, 2004, BRIT J NEUROSURG, V18, P347, DOI 10.1080/02688690400004993; Pritchard C, 2004, SURG NEUROL, V62, P7, DOI 10.1016/j.surneu.2004.01.018; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Uchino Y, 2001, ACTA NEUROCHIR, V143, P1031, DOI 10.1007/s007010170008; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zhang SR, 2009, J REHABIL MED, V41, P1062, DOI 10.2340/16501977-0462	32	15	15	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	APR	2013	27	2					202	206		10.3109/02688697.2012.717984			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	117LK	WOS:000316954700013	22938593				2021-06-18	
J	Dijkers, MP; Zanca, JM				Dijkers, Marcel P.; Zanca, Jeanne M.			Factors Complicating Treatment Sessions in Spinal Cord Injury Rehabilitation: Nature, Frequency, and Consequences	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Allied health personnel; Comorbidity; Health services; Health services research; Hospitals; Patient participation; Rehabilitation; Spinal cord injuries	SCIREHAB PROJECT SERIES; TRAUMATIC BRAIN-INJURY; LENGTH-OF-STAY; INPATIENT REHABILITATION; RISK-FACTORS; MEDICAL COMPLICATIONS; STROKE REHABILITATION; THERAPY TAXONOMY; PHYSICAL-THERAPY; ACUTE-CARE	Objective: To describe therapist-reported factors affecting therapy sessions in spinal cord injury (SCI) inpatient rehabilitation and explore their impact on the patient's rehabilitation program. Design: Prospective observational longitudinal cohort design. Data were obtained from systematic recordings of interventions by clinicians and from medical record abstraction. Setting: Six inpatient rehabilitation programs. Participants: Patients (N=1376) with traumatic SCI admitted for initial rehabilitation. Interventions: Not applicable. Main Outcome Measures: Factors recorded as impacting the objective or content of treatment sessions by physical therapy, occupational therapy, speech therapy, and therapeutic recreation, patients' participation in treatment as rated using a modified Pittsburgh Rehabilitation Participation Scale (PRPS), length of stay (LOS), medical morbidity measured using the Comprehensive Severity Index, hours of therapy per week, and missed therapy minutes. Results: Patients received 151,172 treatment sessions from 483 therapists. Pain, fatigue, and spasticity were commonly reported factors; other medical, behavioral, and logistical factors were also frequent, with 30% of sessions being affected by at least 1 factor. The number of factors was correlated with missed therapy minutes and with the PRPS score. Patients with more reported factors, overall or per average session, had a longer LOS and fewer hours of treatment per week. Conclusions: Medical and other factors complicating therapy are common. Those who need a longer stay because of their injury level or for other reasons have more opportunity to have sessions affected, but having many treatment sessions impacted by 1 or more factors also is likely to increase LOS. The nature of these factors and their impact on rehabilitation processes and outcomes deserve further study. Archives of Physical Medicine and Rehabilitation 2013;94(4 Suppl 2):S115-24 (C) 2013 by the American Congress of Rehabilitation Medicine	[Dijkers, Marcel P.; Zanca, Jeanne M.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA	Dijkers, MP (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1 Gustave L Levy Pl, New York, NY 10029 USA.	marcel.dijkers@mssm.edu		Dijkers, Marcel/0000-0002-8362-5596	Craig Hospital [H133A060103]; National Institute on Disability and Rehabilitation Research, Office of Special Education Services, Department of Education [H133N060027]	Supported in part by Craig Hospital (grant no. H133A060103) and the National Institute on Disability and Rehabilitation Research, Office of Special Education Services, Department of Education (grant no. H133N060027).	Abeyta N, 2009, J SPINAL CORD MED, V32, P336, DOI 10.1080/10790268.2009.11760787; Aito S, 2003, SPINAL CORD, V41, P629, DOI 10.1038/sj.sc.3101513; Alam E, 2008, ARCH PHYS MED REHAB, V89, P1284, DOI 10.1016/j.apmr.2008.01.014; Burnett DM, 2000, J NEUROTRAUM, V17, P765, DOI 10.1089/neu.2000.17.765; Cahow C, 2009, J SPINAL CORD MED, V32, P298, DOI 10.1080/10790268.2009.11760783; Chen D, 1999, ARCH PHYS MED REHAB, V80, P1397, DOI 10.1016/S0003-9993(99)90250-2; CREIGHTON C, 1995, AM J OCCUP THER, V49, P311, DOI 10.5014/ajot.49.4.311; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Evans CT, 2008, INFECT CONT HOSP EP, V29, P234, DOI 10.1086/527509; Frisbie JH, 2005, J SPINAL CORD MED, V28, P60, DOI 10.1080/10790268.2005.11753799; Gassaway J, 2009, J SPINAL CORD MED, V32, P260, DOI 10.1080/10790268.2009.11760780; Gordan W, 2009, J SPINAL CORD MED, V32, P307, DOI 10.1080/10790268.2009.11760784; Haisma J, 2007, CLIN REHABIL, V21, P932, DOI 10.1177/0269215507079134; Haisma JA, 2007, ARCH PHYS MED REHAB, V88, P1694, DOI 10.1016/j.apmr.2007.07.044; Haisma JA, 2007, J REHABIL MED, V39, P393, DOI 10.2340/16501977-0067; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS106, DOI 10.1016/j.apmr.2012.12.023; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS98, DOI 10.1016/j.apmr.2012.11.051; Horn SD, 2013, ARCH PHYS MED REHAB, V94, pS75, DOI 10.1016/j.apmr.2012.10.036; Irwin ZN, 2004, SPINE, V29, P796, DOI 10.1097/01.BRS.0000119400.92204.B5; Johnson K, 2009, J SPINAL CORD MED, V32, P329, DOI 10.1080/10790268.2009.11760786; JUDD FK, 1989, BRIT J PSYCHIAT, V154, P668, DOI 10.1192/bjp.154.5.668; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; McKinley W, 2006, J SPINAL CORD MED, V29, P501, DOI 10.1080/10790268.2006.11753899; McKinley William O, 2002, J Spinal Cord Med, V25, P88; Meikle B, 2002, ARCH PHYS MED REHAB, V83, P1222, DOI 10.1053/apmr.2002.33657; Nair KPS, 2005, SPINAL CORD, V43, P558, DOI 10.1038/sj.sc.3101752; Natale A, 2009, J SPINAL CORD MED, V32, P270, DOI 10.1080/10790268.2009.11760781; Ozelie R, 2009, J SPINAL CORD MED, V32, P283, DOI 10.1080/10790268.2009.11760782; PAYTON OD, 1985, PHYS THER, V65, P924, DOI 10.1093/ptj/65.6.924; Ploumis A, 2011, SPINAL CORD, V49, P411, DOI 10.1038/sc.2010.132; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P712, DOI 10.1016/S0003-9993(03)04850-5; Suyama T, 2001, J PHYS THER SCI, V13, P59; Unsal-Delialioglu S, 2010, J SPINAL CORD MED, V33, P243, DOI 10.1080/10790268.2010.11689701; Waring WP, 2010, J SPINAL CORD MED, V33, P346, DOI 10.1080/10790268.2010.11689712; Whiteneck G, 2009, J SPINAL CORD MED, V32, P251, DOI 10.1080/10790268.2009.11760779; Whiteneck GG, 2013, ARCH PHYS MED REHAB, V94, pS67, DOI 10.1016/j.apmr.2012.12.022; Wilson C, 2009, J SPINAL CORD MED, V32, P319, DOI 10.1080/10790268.2009.11760785; Yokoyama O, 2006, ARCH PHYS MED REHAB, V87, P1189, DOI 10.1016/j.apmr.2006.05.017	42	15	15	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2013	94	4		2			S115	S124		10.1016/j.apmr.2012.11.047			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	120LP	WOS:000317172100007	23465468				2021-06-18	
J	Fox, WC; Park, MS; Belverud, S; Klugh, A; Rivet, D; Tomlin, JM				Fox, W. Christopher; Park, Min S.; Belverud, Shawn; Klugh, Arnett; Rivet, Dennis; Tomlin, Jeffrey M.			Contemporary imaging of mild TBI: the journey toward diffusion tensor imaging to assess neuronal damage	NEUROLOGICAL RESEARCH			English	Article						Diffusion tensor imaging; Mild traumatic brain injury; Neuroimaging; Non-invasive assessment	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; WHITE-MATTER ABNORMALITIES; CT HEAD RULE; COMPUTED-TOMOGRAPHY; OUTCOME PREDICTION; GLUCOSE-METABOLISM; MEAN DIFFUSIVITY; UNITED-STATES; AXONAL INJURY	Objectives: To follow the progression of neuroimaging as a means of non-invasive evaluation of mild traumatic brain injury (mTBI) in order to provide recommendations based on reproducible, defined imaging findings. Methods: A comprehensive literature review and analysis of contemporary published articles was performed to study the progression of neuroimaging findings as a non-invasive 'biomarker' for mTBI. Results: Multiple imaging modalities exist to support the evaluation of patients with mTBI, including ultrasound (US), computed tomography (CT), single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI). These techniques continue to evolve with the development of fractional anisotropy (FA), fiber tractography (FT), and diffusion tensor imaging (DTI). Discussion: Modern imaging techniques, when applied in the appropriate clinical setting, may serve as a valuable tool for diagnosis and management of patients with mTBI. An understanding of modern neuroanatomical imaging will enhance our ability to analyse injury and recognize the manifestations of mTBI.	[Fox, W. Christopher; Park, Min S.; Belverud, Shawn; Klugh, Arnett; Tomlin, Jeffrey M.] USN, San Diego Med Ctr, Dept Neurosurg, San Diego, CA 92134 USA; [Rivet, Dennis] USN, Med Ctr Portsmouth, Dept Neurosurg, Portsmouth, VA USA; [Tomlin, Jeffrey M.] NATO Role III Multinatl Med Unit, Kandahar, Afghanistan	Fox, WC (corresponding author), USN, San Diego Med Ctr, Dept Neurosurg, San Diego, CA 92134 USA.	chrisfox26@gmail.com		Fox, W Christopher/0000-0002-7762-9902			Abu-Judeh HH, 1998, J NUCL MED, V39, P1357; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bigler ED, 2010, PSYCHOL INJ LAW, V3, P36, DOI 10.1007/s12207-010-9064-1; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Davis PC BJ, 2008, EXPERT PANEL NEUROLO; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Goldberg-Zimring D, 2005, J NEUROIMAGING, V15, p68S, DOI 10.1177/1051228405283363; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hattori N, 2009, J NUCL MED, V50, P1054, DOI 10.2967/jnumed.108.060368; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hricak H, 2011, RADIOLOGY, V258, P889, DOI 10.1148/radiol.10101157; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koizumi H, 2010, J CEREBR BLOOD F MET, V30, P1673, DOI 10.1038/jcbfm.2010.75; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lochner C, 2012, J PSYCHIATR NEUROSCI, V37, P193, DOI 10.1503/jpn.110059; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Moshel YA, 2009, J NEUROSURG-PEDIATR, V4, P495, DOI 10.3171/2009.7.PEDS09128; Naismith RT, 2012, ARCH NEUROL-CHICAGO, V69, P65, DOI 10.1001/archneurol.2011.243; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Shin YB, 2006, BRAIN INJURY, V20, P661, DOI 10.1080/02699050600677071; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; SILVERMAN IE, 1993, J NUCL MED, V34, P1447; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yamaki T, 1996, J TRAUMA, V40, P50, DOI 10.1097/00005373-199601000-00010; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	79	15	17	0	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2013	35	3					223	232		10.1179/1743132813Y.0000000162			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	104QW	WOS:000316010700002	23485049				2021-06-18	
J	Hanten, G; Li, XQ; Ibarra, A; Wilde, EA; Barnes, A; McCauley, SR; McCarthy, J; Hoxhaj, S; Mendez, D; Hunter, JV; Levin, HS; Smith, DH				Hanten, Gerri; Li, Xiaoqi; Ibarra, Alyssa; Wilde, Elisabeth A.; Barnes, Amanda; McCauley, Stephen R.; McCarthy, James; Hoxhaj, Shkelzen; Mendez, Donna; Hunter, Jill V.; Levin, Harvey S.; Smith, Douglas H.			Updating Memory after Mild Traumatic Brain Injury and Orthopedic Injuries	JOURNAL OF NEUROTRAUMA			English	Article						cognition; executive function, mild traumatic brain injury; memory	HEAD-INJURY; SYMPTOMS; MODERATE; CONCUSSION; IMPACT; TIME	Few studies have examined the trajectory of recovery of executive function (EF) after mild TBI (mTBI). Therefore, consensus has not been reached on the incidence and extent of EF impairment after mTBI. The present study investigated trajectory of change in executive memory over 3 months after mTBI on 59 right-handed participants with mTBI, as defined by Centers for Disease Control criteria, ages 14-30 years, recruited within 96 hours post-injury and tested < 1 week (baseline), 1 month, and 3 months after injury. Also included were 58 participants with orthopedic injury (OI) and 27 typically developing (TD) non-injured participants with similar age, socioeconomic status, sex, and ethnicity. MRI data were acquired at baseline and 3 months. Although criteria included a normal CT scan, lesions were detected by MRI in 19 mTBI patients. Participants completed the KeepTrack task, a verbal recall task placing demands on goal maintenance, semantic memory, and memory updating. Scores reflected items recalled and semantic categories maintained. The mTBI group was divided into two groups: high (score >= 12) or low (score < 12) symptoms based on the Rivermead Post-Concussion Symptoms Questionnaire (RPQ). Mixed model analyses revealed the trajectory of change in mTBI patients (high and low RPQ), OI patients, and TD subjects were similar over time (although the TD group differed from other groups at baseline), suggesting no recovery from mTBI up to 90 days. For categories maintained, differences in trajectory of recovery were discovered, with the OI comparison group surprisingly performing similar to those in the mTBI group with high RPQ symptoms, and different from low RPQ and the TD groups, bringing up questions about utility of OIs as a comparison group for mTBI. Patients with frontal lesions (on MRI) were also found to perform worse than those without lesions, a pattern that became more pronounced with time.	[Hanten, Gerri; Li, Xiaoqi; Wilde, Elisabeth A.; Barnes, Amanda; McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hoxhaj, Shkelzen] Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA; [Mendez, Donna] Baylor Coll Med, Dept Pediat Emergency Med, Houston, TX 77030 USA; [Hanten, Gerri] Rice Univ, Dept Psychol, Houston, TX 77251 USA; [Wilde, Elisabeth A.; McCauley, Stephen R.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Neurorehabil Neurons Networks Ctr TBI Rehabil Res, Houston, TX USA; [McCarthy, James] Texas Med Ctr, Mem Hermann Hosp, Houston, TX USA; [McCarthy, James] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX USA; [Hoxhaj, Shkelzen] Ben Taub Gen Hosp, Dept Med, Houston, TX 77030 USA; [Mendez, Donna] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Hunter, Jill V.] Texas Childrens Hosp, Houston, TX 77030 USA; [Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Ibarra, Alyssa] Univ Rochester, Dept Psychol, Rochester, NY 14627 USA	Hanten, G (corresponding author), Baylor Coll Med, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	ghanten@bcm.edu			NINDS grant [5 P01 NS056202]; DoD grant [W81XWH-08-2-0133 PT074693P2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, P01NS056202] Funding Source: NIH RePORTER	The authors gratefully acknowledge support from the following grants: NINDS grant 5 P01 NS056202 and DoD grant W81XWH-08-2-0133 PT074693P2.	Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; JENNETT B, 1975, LANCET, V1, P480; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Singer J.D., 2003, APPL LONGITUDINAL DA; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; YNTEMA DB, 1967, ACTA PSYCHOL, V27, P325, DOI 10.1016/0001-6918(67)90075-3	24	15	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2013	30	8			SI		618	624		10.1089/neu.2012.2392			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	133PO	WOS:000318151500003	23227898	Green Published			2021-06-18	
J	Lu, XCM; Mountney, A; Chen, ZY; Wei, G; Cao, Y; Leung, LY; Khatri, V; Cunningham, T; Tortella, FC				Lu, Xi-Chun May; Mountney, Andrea; Chen, Zhiyong; Wei, Guo; Cao, Ying; Leung, Lai Yee; Khatri, Vivek; Cunningham, Tracy; Tortella, Frank C.			Similarities and Differences of Acute Nonconvulsive Seizures and Other Epileptic Activities following Penetrating and Ischemic Brain Injuries in Rats	JOURNAL OF NEUROTRAUMA			English	Article						EEG rat; MCAO; NCS; PBBI	INTENSIVE-CARE-UNIT; FOCAL CEREBRAL-ISCHEMIA; PERIODIC EEG PATTERNS; TRANSHEMISPHERIC DIASCHISIS; CLINICAL-SIGNIFICANCE; GLYPROMATE ANALOG; CRITICALLY-ILL; DISCHARGES; MODEL; STROKE	The similarities and differences between acute nonconvulsive seizures (NCS) and other epileptic events, for example, periodic epileptiform discharges (PED) and intermittent rhythmic delta activities (IRDA), were characterized in rat models of penetrating and ischemic brain injuries. The NCS were spontaneously induced by either unilateral frontal penetrating ballistic-like brain injury (PBBI) or permanent middle cerebral artery occlusion (pMCAO), and were detected by continuous electroencephalogram (EEG) monitoring begun immediately after the injury and continued for 72 h or 24 h, respectively. Analysis of NCS profiles (incidence, frequency, duration, and time distribution) revealed a high NCS incidence in both injury models. The EEG waveform expressions of NCS and PED exhibited intrinsic variations that resembled human electrographic manifestations of post-traumatic and post-ischemic ictal and inter-ictal events, but these waveform variations were not distinguishable between the two types of brain injury. However, the NCS after pMCAO occurred more acutely and intensely (latency = 0.6 h, frequency = 25 episodes/rat) compared with the PBBI-induced NCS (latency = 24 h, frequency = 10 episodes/rat), such that the most salient features differentiating post-traumatic and post-ischemic NCS were the intensity and time distribution of the NCS profiles. After pMCAO, nearly 50% of the seizures occurred within the first 2 h of injury, whereas after PBBI, NCS occurred sporadically (0-5%/h) throughout the 72 h recording period. The PED were episodically associated with NCS. By contrast, the IRDA appeared to be independent of other epileptic events. This study provided comprehensive comparisons of post-traumatic and post-ischemic epileptic profiles. The identification of the similarities and differences across a broad spectrum of epileptic events may lead to differential strategies for post-traumatic and post-stroke seizure interventions.	[Lu, Xi-Chun May; Mountney, Andrea; Chen, Zhiyong; Wei, Guo; Cao, Ying; Leung, Lai Yee; Khatri, Vivek; Cunningham, Tracy; Tortella, Frank C.] Walter Reed Army Inst Res, Branch Brain Trauma Neuroprotect & Neurorestorat, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA	Lu, XCM (corresponding author), Walter Reed Army Inst Res, Branch Brain Trauma Neuroprotect & Neurorestorat, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	may.lu@us.army.mil	Leung, Lai Yee/H-8204-2013				ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Baykan B, 2000, SEIZURE-EUR J EPILEP, V9, P402, DOI 10.1053/seiz.2000.0435; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; BRENNER RP, 1990, J CLIN NEUROPHYSIOL, V7, P249, DOI 10.1097/00004691-199004000-00007; Brigo F, 2011, EPILEPSY BEHAV, V20, P254, DOI 10.1016/j.yebeh.2010.11.009; Carrera E, 2006, NEUROLOGY, V67, P99, DOI 10.1212/01.wnl.0000223361.90278.ca; CHATRIAN GE, 1964, ELECTROEN CLIN NEURO, V17, P177, DOI 10.1016/0013-4694(64)90149-X; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; COBB WA, 1945, J NEUROL NEUROSUR PS, V8, P65, DOI 10.1136/jnnp.8.3-4.65; Andraus MEC, 2012, ARQ NEURO-PSIQUIAT, V70, P145, DOI 10.1590/S0004-282X2012000200014; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; DELAPAZ D, 1981, ARCH NEUROL-CHICAGO, V38, P713, DOI 10.1001/archneur.1981.00510110073012; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Fitzpatrick W, 2007, CAN J NEUROL SCI, V34, P443, DOI 10.1017/S0317167100007332; Garcia-Morales I, 2002, J CLIN NEUROPHYSIOL, V19, P172, DOI 10.1097/00004691-200203000-00009; Garzon E, 2001, NEUROLOGY, V57, P1175, DOI 10.1212/WNL.57.7.1175; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Juhasz C, 1997, ACTA NEUROL SCAND, V96, P397; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Luckl J, 2008, BRAIN RES, V1191, P157, DOI 10.1016/j.brainres.2007.11.037; Mecarelli O, 2011, CEREBROVASC DIS, V31, P191, DOI 10.1159/000321872; Niedzielska K, 2000, Neurol Neurochir Pol, V34, P467; Niedzielska K, 2001, Neurol Neurochir Pol, V35, P595; Orta DS, 2009, ARCH NEUROL-CHICAGO, V66, P985, DOI 10.1001/archneurol.2009.137; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; SCHRAEDER PL, 1980, EPILEPSIA, V21, P647, DOI 10.1111/j.1528-1157.1980.tb04318.x; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Yemisci M, 2003, SEIZURE-EUR J EPILEP, V12, P465, DOI 10.1016/S1059-1311(02)00351-5; Zweckberger K, 2010, NEUROSCI LETT, V470, P150, DOI 10.1016/j.neulet.2009.12.075	43	15	15	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2013	30	7					580	590		10.1089/neu.2012.2641			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	133PD	WOS:000318150300009	23234254				2021-06-18	
J	Roberson, CJ; Boone, KB; Goldberg, H; Miora, D; Cottingham, M; Victor, T; Ziegler, E; Zeller, M; Wright, M				Roberson, Cedria J.; Boone, Kyle Brauer; Goldberg, Hope; Miora, Deborah; Cottingham, Maria; Victor, Tara; Ziegler, Elizabeth; Zeller, Michelle; Wright, Matthew			Cross Validation of the b Test in a Large Known Groups Sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						b Test; Malingering; Cognitive symptom validity	SUSPECT EFFORT; RECOGNITION TRIAL; RESPONSE BIAS; SENSITIVITY; SPECIFICITY; SCORES; PERFORMANCE	The b Test (Boone, Lu, & Herzberg, 2002a) is a measure of cognitive performance validity originally validated on 91 non-credible participants and 7 credible clinical comparison groups (total n=161). The purpose of the current study was to provide cross-validation data for the b Test on a known groups sample of non-credible participants (n=212) and credible heterogeneous neuropsychological clinic patients (n=103). The new data showed that while the original E-score cut-off of 155 achieved excellent specificity (99%), it was associated with relatively poor sensitivity (41%). However, the cut-off could be substantially lowered to 82, while still maintaining adequate specificity (90%) and raising sensitivity to 68%. Examination of non-credible subgroups revealed that b Test sensitivity in feigned mild traumatic brain injury (mTBI) was 58%, whereas in non-credible patients claiming depression and psychosis, cut-off sensitivity was 76% and 67%, respectively. These data suggest that the b Test may have a particular role in detection of non-credible cognitive symptoms associated with feigned psychiatric symptoms, and that fabricated deficits in processing speed and vigilance/visual scanning, detected by the b Test, are more prominent in feigned psychiatric presentations than in feigned mTBI. Further, b Test failures in patients with somatoform disorders were common, indicating that the b Test may have a specific use in detection of non-consciously created cognitive dysfunction associated with somatoform conditions.	[Roberson, Cedria J.; Boone, Kyle Brauer; Miora, Deborah] Alliant Int Univ, Calif Sch Forens Studies, Torrance, CA USA; [Goldberg, Hope] Olive View UCLA Med Ctr, Dept Psychiat, Sylmar, CA 91342 USA; [Cottingham, Maria] Henry M Jackson Fdn Adv Mil Med, Def & Vet Brain Injury Ctr, Camp Pendleton, CA USA; [Victor, Tara] Calif State Univ Dominguez Hills, Dept Psychol, Carson, CA 90747 USA; [Ziegler, Elizabeth] Spokane Vet Adm, Spokane, WA USA; [Zeller, Michelle] West Los Angeles Vet Adm, Los Angeles, CA USA; [Wright, Matthew] Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA; [Wright, Matthew] Los Angeles Biomed Inst, Torrance, CA USA	Roberson, CJ (corresponding author), Alliant Int Univ, Calif Sch Forens Studies, 1000 S Fremont, Alhambra, CA 91803 USA.	croberson@alliant.edu	Victor, Tara/K-6581-2019				Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Back C., 1996, ASSESSMENT, V3, P449, DOI [10.1177/107319119600300411, DOI 10.1177/107319119600300411, DOI 10.1016/S0887-6177(01)00166-4]; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P461, DOI 10.1076/clin.15.4.461.1890; Boone K., 2002, B TEST MANUAL; Boone K. B., 2002, DOT COUNTING TEST MA; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Jasinski LJ, 2011, CLIN NEUROPSYCHOL, V25, P1415, DOI 10.1080/13854046.2011.630024; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Shandera AL, 2010, PSYCHOL ASSESSMENT, V22, P50, DOI 10.1037/a0016585; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T, 1997, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Vilar-Lopez R, 2008, J CLIN EXP NEUROPSYC, V30, P710, DOI 10.1080/13803390701684562; Vilar-Lopez R, 2007, ARCH CLIN NEUROPSYCH, V22, P379, DOI 10.1016/j.acn.2007.01.012	24	15	15	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	APR 1	2013	27	3					495	508		10.1080/13854046.2012.737027			14	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	129JK	WOS:000317835100012	23157695				2021-06-18	
J	Tyagi, E; Agrawal, R; Zhuang, YM; Abad, C; Waschek, JA; Gomez-Pinilla, F				Tyagi, Ethika; Agrawal, Rahul; Zhuang, Yumei; Abad, Catalina; Waschek, James A.; Gomez-Pinilla, Fernando			Vulnerability Imposed by Diet and Brain Trauma for Anxiety-Like Phenotype: Implications for Post-Traumatic Stress Disorders	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; CHRONIC DISEASES; ANIMAL-MODELS; BDNF FUNCTION; DEPRESSION; INJURY; EXPRESSION; COGNITION; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION	Mild traumatic brain injury (mTBI, cerebral concussion) is a risk factor for the development of psychiatric illness such as posttraumatic stress disorder (PTSD). We sought to evaluate how omega-3 fatty acids during brain maturation can influence challenges incurred during adulthood (transitioning to unhealthy diet and mTBI) and predispose the brain to a PTSD-like pathobiology. Rats exposed to diets enriched or deficient in omega-3 fatty acids (n-3) during their brain maturation period, were transitioned to a western diet (WD) when becoming adult and then subjected to mTBI. TBI resulted in an increase in anxiety-like behavior and its molecular counterpart NPY1R, a hallmark of PTSD, but these effects were more pronounced in the animals exposed to n-3 deficient diet and switched to WD. The n-3 deficiency followed by WD disrupted BDNF signaling and the activation of elements of BDNF signaling pathway (TrkB, CaMKII, Akt and CREB) in frontal cortex. TBI worsened these effects and more prominently in combination with the n-3 deficiency condition. Moreover, the n-3 deficiency primed the immune system to the challenges imposed by the WD and brain trauma as evidenced by results showing that the WD or mTBI affected brain IL1b levels and peripheral Th17 and Treg subsets only in animals previously conditioned to the n-3 deficient diet. These results provide novel evidence for the capacity of maladaptive dietary habits to lower the threshold for neurological disorders in response to challenges.	[Tyagi, Ethika; Agrawal, Rahul; Zhuang, Yumei; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Abad, Catalina; Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724; Abad, Catalina/0000-0001-9144-9310	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050465, NS056413]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465, R01NS056413] Funding Source: NIH RePORTER	This work was supported by National Institute of Health Grants NS050465 and NS056413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Bazarian JJ, 2012, J HEAD TRAUMA REHABI; Bowen A, 2010, ANXIETY STRESS COPIN, V23, P449, DOI 10.1080/10615800903414315; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chapkin RS, 2007, J NUTR, V137, p200S, DOI 10.1093/jn/137.1.200S; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Freeman MP, 2010, AM J PSYCHIAT, V167, P244, DOI 10.1176/appi.ajp.2009.09121746; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Issazadeh-Navikas S, 2012, MOL MED, V18, P95, DOI 10.2119/molmed.2011.00311; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Lewis MD, 2011, J CLIN PSYCHIAT, V72, P1585, DOI 10.4088/JCP.11m06879; MacConmara MP, 2006, ANN SURG, V244, P514, DOI 10.1097/01.sla.0000239031.06906.1f; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Neylan TC, 2011, BRAIN BEHAV IMMUN, V25, P524, DOI 10.1016/j.bbi.2010.12.001; Pandey SC, 2006, J NEUROSCI, V26, P8320, DOI 10.1523/JNEUROSCI.4988-05.2006; Primeaux SD, 2005, NEUROPSYCHOPHARMACOL, V30, P1589, DOI 10.1038/sj.npp.1300705; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rices D, 2000, ENVIRON HEALTH PERSP, V108, P511; Robidoux J, 2000, ENDOCRINOLOGY, V141, P2795, DOI 10.1210/en.141.8.2795; Sah R, 2009, BIOL PSYCHIAT, V66, P705, DOI 10.1016/j.biopsych.2009.04.037; Segman RH, 2005, MOL PSYCHIATR, V10, P514, DOI [10.1038/sj.mp.4001636, 10.1038/sj.mp.4001654]; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Stahl LA, 2008, CURR OPIN INVEST DR, V9, P57; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872	39	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57945	10.1371/journal.pone.0057945			12	Multidisciplinary Sciences	Science & Technology - Other Topics	117EP	WOS:000316936100059	23483949	DOAJ Gold, Green Published			2021-06-18	
J	Chen, Y; Huang, W; Constantini, S				Chen, Yun; Huang, Wei; Constantini, Shlomi			Concepts and Strategies for Clinical Management of Blast-Induced Traumatic Brain Injury and Posttraumatic Stress Disorder	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							OIF/OEF SERVICE MEMBERS; SUBARACHNOID HEMORRHAGE; EMOTION DYSREGULATION; MENTAL-DISORDERS; MILD TBI; THERAPY; IMPACT; HEALTH; DEPRESSION; SYMPTOMS	After exposure of the human body to blast, kinetic energy of the blast shock waves might be transferred into hydraulic energy in the cardiovascular system to cause a rapid physical movement or displacement of blood (a volumetric blood surge). The volumetric blood surge moves through blood vessels from the high-pressure body cavity to the low-pressure cranial cavity, causing damage to tiny cerebral blood vessels and the blood-brain barrier (BBB). Large-scale cerebrovascular insults and BBB damage that occur globally throughout the brain may be the main causes of non-impact, blast-induced brain injuries, including the spectrum of traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD). The volumetric blood surge may be a major contributor not only to blast-induced brain injuries resulting from physical trauma, but may also be the trigger to psychiatric disorders resulting from emotional and psychological trauma. Clinical imaging technologies, which are able to detect tiny cerebrovascular insults, changes in blood flow, and cerebral edema, may help diagnose both TBI and PTSD in the victims exposed to blasts. Potentially, prompt medical treatment aiming at prevention of secondary neuronal damage may slow down or even block the cascade of events that lead to progressive neuronal damage and subsequent long-term neurological and psychiatric impairment.	[Chen, Yun] BrightstarTech Inc, Clarksburg, MD USA; [Huang, Wei] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Constantini, Shlomi] Tel Aviv Univ, Tel Aviv Med Ctr, Dana Childrens Hosp, Dept Pediat Neurosurg, IL-69978 Tel Aviv, Israel	Chen, Y (corresponding author), BrightstarTech Inc, Pleasanton, CA USA.	yun.chen@brightstartechinc.com					American Association of Neurological Surgeons, 2011, TRAUM BRAIN INJ; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Baker DG, 2009, MIL MED, V174, P773; Baschnagel JS, 2009, J ANXIETY DISORD, V23, P915, DOI 10.1016/j.janxdis.2009.05.005; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bhardwaj A, 2007, CURR NEUROL NEUROSCI, V7, P513, DOI 10.1007/s11910-007-0079-2; Bleich A, 2005, AM J GERIAT PSYCHIAT, V13, P705; Bodvarsdottir I, 2004, SCAND J PSYCHOL, V45, P3, DOI 10.1111/j.1467-9450.2004.00373.x; Bradley B, 2011, J CLIN PSYCHIAT, V72, P685, DOI 10.4088/JCP.10m06409blu; Breslau J, 2011, ACTA PSYCHIAT SCAND, V124, P474, DOI 10.1111/j.1600-0447.2011.01712.x; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Collombet JM, 2011, BEHAV BRAIN RES, V221, P261, DOI 10.1016/j.bbr.2011.03.006; Davis A E, 2000, Crit Care Nurs Clin North Am, V12, P447; De Deyn PP, 1999, PHARMACOPSYCHIATRY, V32, P17, DOI 10.1055/s-2007-979232; DeKosky ST, 2003, J AM GERIATR SOC, V51, pS314, DOI 10.1046/j.1532-5415.5157.x; DiGiovanni Cleto Jr, 2003, Prehosp Disaster Med, V18, P253; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Flaherty ML, 2010, SEMIN NEUROL, V30, P565, DOI 10.1055/s-0030-1268866; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fosse Gunilla Klensmeden, 2006, Eat Behav, V7, P404, DOI 10.1016/j.eatbeh.2005.12.006; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; FUJITA N, 1994, AM J NEURORADIOL, V15, P335; Gomes JA, 2005, CRIT CARE MED, V33, P1214, DOI 10.1097/01.CCM.0000166389.85273.38; Granacher RP, 2007, TRAUMATIC BRAIN INJU, P26; Hall KM, 2011, ASS PRESS       0523; Hoge C. W., 2008, US ARMY MED DEP J; Hoozemans JJM, 2003, CURR DRUG TARGETS, V4, P461, DOI 10.2174/1389450033490902; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johannesson KB, 2011, J NERV MENT DIS, V199, P162, DOI 10.1097/NMD.0b013e31820c73d1; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kamran M, 2010, NEURORADIOLOGY, V52, P319, DOI 10.1007/s00234-009-0609-5; Katsuki H, 2010, J PHARMACOL SCI, V114, P366, DOI 10.1254/jphs.10R05CR; Kehle SM, 2011, J PSYCHIATR RES, V45, P126, DOI 10.1016/j.jpsychires.2010.05.013; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kim H, 2005, NEUROL RES, V27, P287, DOI 10.1179/016164105X25234; Kline NS, 1951, AM J MENT DEF, V56, P547; KOOPMAN C, 1995, J TRAUMA STRESS, V8, P29, DOI 10.1007/BF02105405; Kwako Laura E, 2011, J Am Psychiatr Nurses Assoc, V17, P237, DOI 10.1177/1078390311402498; Lesaca T, 1996, PSYCHIAT SERV, V47, P424; Lescot T, 2008, CURR OPIN CRIT CARE, V14, P129, DOI 10.1097/MCC.0b013e3282f63c51; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Lim S, 2008, J APPL PSYCHOL, V93, P95, DOI 10.1037/0021-9010.93.1.95; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu YQ, 1990, J TRAUMA, V6, P16; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mansdorf IJ, 2008, BRIT MED BULL, V88, P7, DOI 10.1093/bmb/ldn041; Marion DW, 2003, INTENSIVE CARE IN NEUROSURGERY, P47; Martin E.M, 2008, J TRAUMA NURS, V15, P100; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Papangelou A, 2009, CURR TREAT OPTION NE, V11, P64, DOI 10.1007/s11940-009-0009-5; Petty MA, 2001, BRAIN RES REV, V36, P23, DOI 10.1016/S0165-0173(01)00062-5; PLUTA R, 1989, J CEREBR BLOOD F MET, V9, P163, DOI 10.1038/jcbfm.1989.24; Qureshi AI, 2007, NEUROCRIT CARE, V6, P56, DOI 10.1385/NCC:6:1:56; Rasanen HT, 1999, STROKE, V30, P827, DOI 10.1161/01.STR.30.4.827; Rees S, 2011, JAMA-J AM MED ASSOC, V306, P513, DOI 10.1001/jama.2011.1098; Roy MJ, 2010, ANN NY ACAD SCI, V1208, P142, DOI 10.1111/j.1749-6632.2010.05689.x; Salcioglu E, 2008, WORLD J PEDIATR, V4, P165, DOI 10.1007/s12519-008-0032-8; Santillan A, 2011, NEUROSURGERY, V69, P102; Santillan A, 2011, NEUROSURGERY, V69, P95, DOI 10.1227/NEU.0b013e31821424f9; Scalea TM, 2005, NEUROTRAUMA EVIDENCE, P3; Schneider B, 2011, PSYCHIAT RES, V190, P265, DOI 10.1016/j.psychres.2011.07.037; Scott J, 1998, ADDICT BEHAV, V23, P919, DOI 10.1016/S0306-4603(98)00074-4; Shields A, 2001, J CLIN CHILD PSYCHOL, V30, P349, DOI 10.1207/S15374424JCCP3003_7; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100108-02, 10.3928/02793695-20100107-01]; Steiner T, 2001, NEUROLOGY, V57, pS61, DOI 10.1212/WNL.57.suppl_2.S61; Stuhmiller JH, 2008, BIQPJHSCH10 ARM MED; Suk K, 2005, NEUROSIGNALS, V14, P23, DOI 10.1159/000085383; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Summerall EL, 2007, TRAUMATIC BRAIN INJU; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TIKOFSKY RS, 1991, SEMIN NUCL MED, V21, P40, DOI 10.1016/S0001-2998(05)80078-9; TrilloPazos G, 1997, GENITOURIN MED, V73, P343; Ullman JS, 1996, CRIT CARE CLIN, V12, P697, DOI 10.1016/S0749-0704(05)70273-6; Veenema Tener Goodwin, 2002, J Pediatr Health Care, V16, P235; Vinkers DJ, 2011, CRIM BEHAV MENT HEAL, V21, P307, DOI 10.1002/cbm.819; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; WAKADE AR, 1986, J NEUROSCI, V6, P2625; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Waterloo K, 2001, J NEUROL, V248, P595, DOI 10.1007/s004150170138; Weant KA, 2010, PHARMACOTHERAPY, V30, P405, DOI 10.1592/phco.30.4.405; Wieland D, 2010, PA NURSE, P12; Wieland Diane, 2010, Pa Nurse, V65, P4; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004	88	15	15	0	2	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2013	25	2					103	110					8	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	156FX	WOS:000319808300042	23686026				2021-06-18	
J	Drummond, M; Douglas, J; Olver, J				Drummond, Melanie; Douglas, Jacinta; Olver, John			'If I haven't got any smell ... I'm out of work': Consequences of olfactory impairment following traumatic brain injury	BRAIN INJURY			English	Article						Post-traumatic anosmia; acquired brain injury; rehabilitation	PENNSYLVANIA SMELL; DYSFUNCTION; ANOSMIA; SECONDARY; DEFICITS; IMPACT	Primary objective: Although estimates of the incidence of post-traumatic olfactory dysfunction range from 10-66.8%, there has been little research into its functional implications. The objective of this study was to describe the impact of olfactory impairment on daily activities and social participation from the perspective of adults who are living with the impairment. Research design: A qualitative research design based on a constructivist grounded theory approach. Methods and procedures: Purposive sampling of five participants with severe traumatic brain injury (TBI) who reported post-injury changes in their olfactory function was utilized. No participant had a pre-injury history of olfactory disturbance. The presence of olfactory disturbance was confirmed using the University of Pennsylvania Smell Identification Test (UPSIT). A semi-structured interview was employed to ascertain the participants' experiences. All interviews were transcribed verbatim and thematic analyses applied. Conclusions: The themes that emerged demonstrated olfactory dysfunction has significant impact on a range of activities and social roles.	[Drummond, Melanie; Olver, John] Epworth Monash Rehabil Med Unit, Richmond, Vic, Australia; [Drummond, Melanie; Olver, John] Epworth Rehabil, Richmond, Vic, Australia; [Drummond, Melanie; Douglas, Jacinta] La Trobe Univ, Dept Human Commun Sci, Bundoora, Vic, Australia	Drummond, M (corresponding author), Epworth Rehabil, 50 Burwood Rd, Hawthorn, Vic 3122, Australia.	melanie.drummond@epworth.org.au		Olver, John/0000-0001-7069-1191; Douglas, Jacinta/0000-0003-0940-6624			[Anonymous], MOSB MED DICT; Brewer WJ, 1996, BIOL PSYCHIAT, V40, P1021, DOI 10.1016/0006-3223(95)00594-3; Bromley S, 2000, AM FAM PHYSICIAN, V1, P15; Browne J., 2004, HDB RES METHODS NURS, P624; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Charmaz K, 2006, CONSTRUCTING GROUNDE; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; DAVIDSON TM, 1995, POSTGRAD MED, V98, P107; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; DOTY RL, 1989, LARYNGOSCOPE, V99, P402, DOI 10.1288/00005537-198904000-00008; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 1995, SMELL IDENTIFICATION; Drummond M., 2007, BRAIN IMPAIR, V8, P31; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Henkin RI, 1982, LOOSELEAF SERIES OTO, P1; Hirsh A, 2003, TASTE SMELL; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Holbrook Eric H, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P54, DOI 10.1097/00020840-200302000-00012; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; MATTES RD, 1990, AM J CLIN NUTR, V51, P233; MATTES RD, 1994, J AM DIET ASSOC, V94, P50, DOI 10.1016/0002-8223(94)92041-9; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Schiffman S, 1990, FIGHTING LOSS SMELL; Sensonics Inc., POCK SMELL TEST; Solomon GS, 1998, J NEUROPSYCH CLIN N, V10, P64, DOI 10.1176/jnp.10.1.64; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; World Health Organization, 2000, INT CLASS FUNCT DIS; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	44	15	15	0	26	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2013	27	3					332	345		10.3109/02699052.2012.750743			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400011	23438353				2021-06-18	
J	Grottke, O; Frietsch, T; Maas, M; Lier, H; Rossaint, R				Grottke, O.; Frietsch, T.; Maas, M.; Lier, H.; Rossaint, R.			Dealing with massive bleeding and associated perioperative coagulopathy. Recommendations for action of the German Society of Anaesthesiology and Intensive Care Medicine	ANAESTHESIST			German	Article						Trauma; Blood transfusion; Coagulopathy; Damage control surgery; Resuscitation	PROTHROMBIN COMPLEX CONCENTRATE; FRESH-FROZEN PLASMA; ACTIVATED FACTOR-VII; LIFE-THREATENING HEMORRHAGE; RECOMBINANT-FACTOR-VIIA; TRAUMATIC BRAIN-INJURY; DILUTIONAL COAGULOPATHY; FIBRINOGEN CONCENTRATE; TRANSFUSION PROTOCOL; MAJOR TRAUMA	Massive bleeding with coagulopathy and hemorrhagic shock poses a potential threat to life in numerous clinical settings. Optimal treatment including the prevention of exsanguination necessitates a standardized and interdisciplinary approach. Several studies have shown the importance of massive transfusion protocols and standardized coagulation algorithms to improve survival of severely bleeding patients and to avoid secondary complications. Thus, the Helsinki declaration for patient safety in anesthesiology demands the implementation of clinical practice guidelines for the treatment of patients requiring massive transfusion. This paper introduces a standardized algorithm for the treatment of patients with massive bleeding which was developed in consensus with the German Society of Anaesthesiology and Intensive Care Medicine (DGAI).	[Grottke, O.; Rossaint, R.] Univ Klinikum Aachen, Anasthesiol Klin, D-52074 Aachen, Germany; [Frietsch, T.] Robert Bosch Klinikum Schillerhohe, Gerlingen, Germany; [Maas, M.] Univ Klinikum Munster, Klin Anasthesiol Operat Intens Med & Schmerzthera, Munster, Germany; [Lier, H.] Univ Klinikum Koln, Klin Anasthesiol & Operat Intens Med, Cologne, Germany	Grottke, O (corresponding author), Univ Klinikum Aachen, Anasthesiol Klin, Pauwelsstr 30, D-52074 Aachen, Germany.	ogrottke@ukaachen.de	Grottke, Oliver/F-1508-2018; Lier, Heiko/J-3005-2019	Lier, Heiko/0000-0001-7374-4324; Maas, Matthias/0000-0001-8981-0939; Grottke, Oliver/0000-0002-0722-3122			Adam S, 2010, CLIN APPL THROMB-HEM, V16, P454, DOI 10.1177/1076029609336855; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bruce D, 2008, CRIT CARE, V12, DOI 10.1186/cc6987; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Cap AP, 2011, J TRAUMA, V71, pS9, DOI 10.1097/TA.0b013e31822114af; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub2; Carless PA, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001884.PUB2; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Dente CJ, 2009, J TRAUMA, V66, P1616, DOI 10.1097/TA.0b013e3181a59ad5; Desmurs-Clavel H, 2009, THROMB RES, V123, P796, DOI 10.1016/j.thromres.2008.07.007; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2008, ANESTH ANALG, V106, P1070, DOI 10.1213/ane.0b013e318165dfbb; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Engstrom M, 2006, J TRAUMA, V61, P624, DOI 10.1097/01.ta.0000226739.30655.75; Franchini M, 2010, CLIN OBSTET GYNECOL, V53, P219, DOI 10.1097/GRF.0b013e3181cc4378; Fries D, 2005, BRIT J ANAESTH, V95, P172, DOI 10.1093/bja/aei160; Fries D, 2009, CURR OPIN ANESTHESIO, V22, P267, DOI 10.1097/ACO.0b013e32832678d9; Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0b013e318168b367; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grottke O, 2011, BLOOD, V118, P1943, DOI 10.1182/blood-2011-03-343046; Grottke O, 2010, BEST PRACT RES-CLIN, V24, P95, DOI 10.1016/j.bpa.2009.09.005; Grottke O, 2010, CRIT CARE, V14, DOI 10.1186/cc8960; Hanke AA, 2010, ANAESTHESIA, V65, P688, DOI 10.1111/j.1365-2044.2010.06367.x; Hardy JF, 2006, CAN J ANAESTH, V53, pS40, DOI 10.1007/BF03022251; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hedner Ulla, 2003, Clin Adv Hematol Oncol, V1, P112; Henrich W, 2008, J PERINAT MED, V36, P467, DOI 10.1515/JPM.2008.093; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Honickel M, 2011, THROMB HAEMOSTASIS, V106, P724, DOI 10.1160/TH11-02-0101; Inaba K, 2010, ARCH SURG-CHICAGO, V145, P899, DOI 10.1001/archsurg.2010.175; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; Johansson PI, 2010, TRANSFUSION, V50, P701, DOI 10.1111/j.1537-2995.2009.02458.x; Kalina U, 2008, INT J CLIN PRACT, V62, P1614, DOI 10.1111/j.1742-1241.2008.01859.x; Kozek-Langenecker S, 2011, CRIT CARE, V15, DOI 10.1186/cc10488; Kozek-Langenecker SA, 2010, BEST PRACT RES-CLIN, V24, P27, DOI 10.1016/j.bpa.2009.09.009; Levi M, 2011, VOX SANG, V101, P154, DOI 10.1111/j.1423-0410.2011.01472.x; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Lier H, 2008, J TRAUMA, V65, P951, DOI 10.1097/TA.0b013e318187e15b; Lier H, 2011, INTENS CARE MED, V37, P572, DOI 10.1007/s00134-011-2139-y; Liesenfeld KH, 2006, BRIT J CLIN PHARMACO, V62, P527, DOI 10.1111/j.1365-2125.2006.02667.x; Lissauer ME, 2011, AM J SURG, V202, P53, DOI 10.1016/j.amjsurg.2010.05.002; Maegele M, 2011, VOX SANG, V100, P231, DOI 10.1111/j.1423-0410.2010.01387.x; Mellin-Olsen J, 2010, EUR J ANAESTH, V27, P592, DOI 10.1097/EJA.0b013e32833b1adf; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Mitterlechner T, 2011, J THROMB HAEMOST, V9, P729, DOI 10.1111/j.1538-7836.2011.04211.x; Morrison LJ, 2011, J CRIT CARE, V26, P363, DOI 10.1016/j.jcrc.2010.08.021; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Nunez TC, 2010, J TRAUMA, V68, P1498, DOI 10.1097/TA.0b013e3181d3cc25; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; O'Keeffe T, 2008, ARCH SURG-CHICAGO, V143, P686, DOI 10.1001/archsurg.143.7.686; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; Schick KS, 2009, CRIT CARE, V13, DOI 10.1186/cc8186; Schochl H, 2012, HAMOSTASEOLOGIE, V32, P22, DOI 10.5482/ha-1178; Schochl H, 2010, ANAESTHESIA, V65, P199, DOI 10.1111/j.1365-2044.2009.06188.x; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Schreiber MA, 2004, CRIT CARE CLIN, V20, P101, DOI 10.1016/S0749-0704(03)00095-2; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shanwell A, 2009, VOX SANG, V96, P316, DOI 10.1111/j.1423-0410.2009.01167.x; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Spahn DR, 2005, BRIT J ANAESTH, V95, P130, DOI 10.1093/bja/aei169; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stanworth SJ, 2004, BRIT J HAEMATOL, V126, P139, DOI 10.1111/j.1365-2141.2004.04973.x; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; van den Elsen MJLJ, 2010, CURR OPIN ANESTHESIO, V23, P269, DOI 10.1097/ACO.0b013e328336b8d0; Velik-Salchner C, 2007, J THROMB HAEMOST, V5, P1019, DOI 10.1111/j.1538-7836.2007.02481.x; Vincent JL, 2006, CRIT CARE, V10, DOI 10.1186/cc5026; VINCENT JL, 1983, CRIT CARE MED, V11, P449, DOI 10.1097/00003246-198306000-00012; Vivien B, 2005, CRIT CARE MED, V33, P1946, DOI 10.1097/01.CCM.0000171840.01892.36; Weber CF, 2012, ANESTHESIOLOGY, V117, P531, DOI 10.1097/ALN.0b013e318264c644; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004; Yucel N, 2006, J TRAUMA, V60, P1228, DOI 10.1097/01.ta.0000220386.84012.bf; Zander R, 2010, WIEN KLIN WOCHENSCHR, V122, pS6	88	15	16	0	14	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	MAR	2013	62	3					213	+		10.1007/s00101-012-2136-8			10	Anesthesiology	Anesthesiology	130EC	WOS:000317894500009	23407716				2021-06-18	
J	Pavawalla, SP; Salazar, R; Cimino, C; Belanger, HG; Vanderploeg, RD				Pavawalla, Shital P.; Salazar, Robert; Cimino, Cynthia; Belanger, Heather G.; Vanderploeg, Rodney D.			An Exploration of Diagnosis Threat and Group Identification Following Concussion Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Head injury; Memory; Expectations; Stereotype threat; Neuropsychological tests; Gender	STEREOTYPE THREAT; COGNITIVE PERFORMANCE; SYMPTOMS; MATH	Cognitive performance can be impacted by many non-neurological factors, including preexisting expectations. The phenomenon of stereotype threat, or reduced cognitive performance due to preexisting beliefs, can apply to individuals following neurological injury (i.e., "diagnosis threat''). We examined the effect of diagnosis threat on cognitive performance and symptom reporting following concussions while accounting for group identification (i.e., extent to which one's identity is tied to being concussed). We also examined gender stereotype threat (i.e., women and math ability) to understand how these two related threat effects compare. Participants with a history of concussion were randomly assigned to one of three instructional sets emphasizing concussion history or gender, or neutral instructions. Individuals without a history of concussion served as a comparison group. Results revealed an effect of diagnosis threat on cognitive performance after group identification was taken into account, but only in male participants. In contrast, an underlying gender stereotype threat was observed in females across conditions, which was counteracted in the gender stereotype condition (i.e., stereotype reactance effect) due to the type of threat cues used. Also, controls exhibited greater symptom reporting than individuals with a concussion. Our findings highlight the importance of considering non-neurological factors impacting cognitive performance. (JINS, 2013, 19, 305-313)	[Pavawalla, Shital P.] George Washington Med Fac Associates, Adventist Med Grp, Washington, DC USA; [Pavawalla, Shital P.; Belanger, Heather G.; Vanderploeg, Rodney D.] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Salazar, Robert; Cimino, Cynthia; Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Salazar, Robert] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Cimino, Cynthia] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA	Pavawalla, SP (corresponding author), Adventist Rehabil Hosp, 9909 Med Ctr Dr, Rockville, MD 20850 USA.	spavawal@adventisthealthcare.com			Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Health Administration (VHA)US Department of Veterans Affairs; Tampa VA Medical Center	This research received no specific grant from any funding agency, commercial or not-for-profit sectors. No financial relationships exist that could be interpreted as a conflict of interest affecting this manuscript. The research was supported by the Department of Veterans Affairs and Veterans Health Administration (VHA). Further support was provided by the Tampa VA Medical Center. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. We gratefully acknowledge the contributions of London Butterfield and Samantha Oliveira for their support in data collection. Unless otherwise indicated, the information in this manuscript and the manuscript itself is new and original, is not currently under review by any other publication, and has never been published either electronically or in print.	Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; KATZ I, 1965, J PERS SOC PSYCHOL, V2, P53, DOI 10.1037/h0022080; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keller J, 2003, PERS SOC PSYCHOL B, V29, P371, DOI 10.1177/0146167202250218; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; McKay PF, 2002, J APPL SOC PSYCHOL, V32, P767, DOI 10.1111/j.1559-1816.2002.tb00241.x; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nguyen HHD, 2008, J APPL PSYCHOL, V93, P1314, DOI 10.1037/a0012702; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed	22	15	15	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2013	19	3					305	313		10.1017/S135561771200135X			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	107DV	WOS:000316195900008	23298459				2021-06-18	
J	Dettmer, M; Pourmoghaddam, A; O'Connor, DP; Layne, CS				Dettmer, Marius; Pourmoghaddam, Amir; O'Connor, Daniel P.; Layne, Charles S.			Interaction of support surface stability and Achilles tendon vibration during a postural adaptation task	HUMAN MOVEMENT SCIENCE			English	Article						Learning; Sensory adaptation; Proprioception	HEALTHY-YOUNG ADULTS; HUMAN UPRIGHT STANCE; LOW-BACK-PAIN; APPROXIMATE ENTROPY; MUSCLE VIBRATION; CEREBRAL CONCUSSION; PARKINSONS-DISEASE; CONTROL MODEL; TIME-SERIES; RESPONSES	Orchestration of sensory-motor information and adaptation to internal or external, acute or chronic changes is one of the fundamental features of human postural control. The postural control system is challenged on a daily basis, and displays a remarkable ability to adapt to both long and short term challenges. To explore the interaction between support surface stability and Achilles tendon vibration during a period of adaptation we used both a linear measure and a non-linear measure derived from center-of-pressure (COP) data. An equilibrium score (ES), based upon peak amplitude of anterior-posterior sway towards theoretical limits of stability was the linear measure used to assess postural performance. We observed early effects of vibration on postural stability, depending on support characteristics. Participants were able to decrease sway with extended practice over days, independent of support surface stability. Approximate entropy analysis of COP data provided additional information about control adaptation processes. (C) 2013 Elsevier B.V. All rights reserved.	Univ Houston, Dept Hlth & Human Performance, Houston, TX 77204 USA; Ctr Neuromotor & Biomech Res, Houston, TX 77021 USA	Dettmer, M (corresponding author), 3855 Holman St,104C GAR, Houston, TX 77204 USA.	madettmer@uh.edu					Almeida GL, 2006, GAIT POSTURE, V23, P17, DOI 10.1016/j.gaitpost.2004.11.020; Barbieri G, 2008, EXP BRAIN RES, V185, P545, DOI 10.1007/s00221-007-1177-8; Benjuya N, 2004, J GERONTOL A-BIOL, V59, P166; Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Bove M, 2003, J PHYSIOL-LONDON, V550, P617, DOI 10.1113/jphysiol.2003.043331; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; Carver S, 2006, BIOL CYBERN, V95, P123, DOI 10.1007/s00422-006-0069-5; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Ceyte H, 2007, NEUROSCI LETT, V416, P71, DOI 10.1016/j.neulet.2007.01.044; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Dusing SC, 2009, PHYS THER, V89, P1354, DOI 10.2522/ptj.20080361; Fransson PA, 2003, IEEE T BIO-MED ENG, V50, P1310, DOI 10.1109/TBME.2003.819851; Fransson PA, 2003, IEEE ENG MED BIOL, V22, P53, DOI 10.1109/MEMB.2003.1195696; Fransson PA, 2000, GAIT POSTURE, V12, P14, DOI 10.1016/S0966-6362(00)00052-7; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Gurfinkel' V. S., 1996, Fiziologiya Cheloveka, V22, P83; Haran F J, 2008, J Neurol Phys Ther, V32, P186, DOI 10.1097/NPT.0b013e31818dee39; Hatzitaki V, 2004, EXP BRAIN RES, V154, P345, DOI 10.1007/s00221-003-1661-8; Hong SL, 2007, NEUROSCI LETT, V423, P104, DOI 10.1016/j.neulet.2007.06.043; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Isableu B, 2010, NEUROSCIENCE, V169, P1199, DOI 10.1016/j.neuroscience.2010.05.072; Ivanenko YP, 1999, EUR J NEUROSCI, V11, P647, DOI 10.1046/j.1460-9568.1999.00471.x; Ivanenko YP, 2000, NEUROSCI LETT, V292, P103, DOI 10.1016/S0304-3940(00)01438-5; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Leitner C, 2009, J ELECTROMYOGR KINES, V19, P380, DOI 10.1016/j.jelekin.2007.09.007; MATTHEWS PBC, 1986, J PHYSIOL-LONDON, V374, P73, DOI 10.1113/jphysiol.1986.sp016066; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; Mergner T, 2003, PROG BRAIN RES, V142, P189; Mergner T, 2002, ADV EXP MED BIOL, V508, P147; NASHNER LM, 1982, J NEUROSCI, V2, P536; NeuroCom, 1991, EQ SYST DAT INT MAN; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1993, AM J PHYSIOL, V264, pR638; Polonyova A, 2001, PHYSIOL RES, V50, P405; Radhakrishnan SM, 2011, EXP BRAIN RES, V213, P423, DOI 10.1007/s00221-011-2792-y; Ribot-Ciscar E, 1998, NEUROSCI LETT, V258, P147, DOI 10.1016/S0304-3940(98)00732-0; Roberts-Warrior D, 2000, BRAIN, V123, P2141, DOI 10.1093/brain/123.10.2141; Roll J P, 1993, J Vestib Res, V3, P259; ROLL JP, 1989, PROG BRAIN RES, V80, P113; Stergiou N., 2004, INNOVATIVE ANAL HUMA; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Termoz N, 2008, GAIT POSTURE, V27, P463, DOI 10.1016/j.gaitpost.2007.05.015; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thompson C, 2007, CLIN NEUROPHYSIOL, V118, P2456, DOI 10.1016/j.clinph.2007.08.013; Thompson C, 2011, HUM MOVEMENT SCI, V30, P153, DOI 10.1016/j.humov.2010.04.002; Tjernstrom F, 2005, J VESTIBUL RES-EQUIL, V15, P31; Tjernstrom F, 2002, GAIT POSTURE, V15, P75, DOI 10.1016/S0966-6362(01)00175-8; Tjernstrom F, 2010, J VESTIBUL RES-EQUIL, V20, P407, DOI 10.3233/VES-2010-0391; Turnock MJE, 2010, J MOTOR BEHAV, V42, P61, DOI 10.1080/00222890903397103; Vuillerme N, 2007, EXP BRAIN RES, V183, P323, DOI 10.1007/s00221-007-1047-4; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Yardley L, 1998, J NEUROL NEUROSUR PS, V65, P679, DOI 10.1136/jnnp.65.5.679	60	15	15	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	FEB	2013	32	1					214	227		10.1016/j.humov.2012.12.002			14	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	133MC	WOS:000318141500017	23465726				2021-06-18	
J	Ennis, SK; Rivara, FP; Mangione-Smith, R; Konodi, MA; MacKenzie, EJ; Jaffe, KM				Ennis, Stephanie K.; Rivara, Frederick P.; Mangione-Smith, Rita; Konodi, Mark A.; MacKenzie, Ellen J.; Jaffe, Kenneth M.			Variations in the quality of inpatient rehabilitation care to facilitate school re-entry and cognitive and communication function for children with TBI	BRAIN INJURY			English	Article						Rehabilitation; return to school; cognition	TRAUMATIC BRAIN-INJURY; LONG-TERM NEEDS; OF-CARE; SOCIAL-PARTICIPATION; AGE-CHILDREN; INDICATORS; SERVICES; ADOLESCENTS; SEVERITY; STUDENTS	Objective: To examine variations in processes of paediatric inpatient rehabilitation care related to school re-entry and management of cognitive and communication impairments after traumatic brain injury. Design: Retrospective cohort study. Methods: Adherence to care processes recommended for children (aged 0-17) with moderate-to-severe traumatic brain injury and admitted for inpatient rehabilitation was assessed. Quality-of-care indicators for processes supporting school re-entry and cognitive and communication rehabilitation were applied to measure variations in care delivered to 174 children across nine facilities using medical record review. Main outcomes and results: Adherence rates (the number of times recommended care was delivered or attempted divided by the number of times care was indicated) were calculated, revealing substantial variations in care within and between facilities. Overall, children received 51.3% (95% CI 31.9-70.7) and 72.3% (95% CI 61.1-83.5), of the care recommended for school re-entry and cognitive and communication rehabilitation, respectively. Conclusion: Substantial variations exist in the delivery of paediatric inpatient rehabilitation care processes for managing school re-entry and cognitive and communication impairments after traumatic brain injury. Measures of association of these care processes with patient outcomes are necessary. Reduction in this variation is essential to improving quality of care.	[Ennis, Stephanie K.; Rivara, Frederick P.; Konodi, Mark A.; Jaffe, Kenneth M.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Ennis, Stephanie K.; Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Rivara, Frederick P.; Mangione-Smith, Rita] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.; Mangione-Smith, Rita] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [MacKenzie, Ellen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [MacKenzie, Ellen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA	Ennis, SK (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490,1959 NE Pacific St, Seattle, WA 98195 USA.	sakays@uw.edu			Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD059049-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD059049] Funding Source: NIH RePORTER	This work was supported by Grant number R21 HD059049-01A1 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The authors have no conflicts of interest and no financial disclosures.	American Academy of Pediatrics Committee on Standards of Child Health, 1977, PREV CHILD HLTH CAR; American Speech Language and Hearing Association (ASHA) Rockville MD, 2009, TREATM EFF SUMM COGN, P1; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BROOK RH, 1994, METHODOLOGICAL PERSP; Carney N, 1999, Evid Rep Technol Assess (Summ), P1; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Commission on Accreditation of Rehabilitation Facilities. (CARF), 2009, MED REH STAND MAN; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Greenspan AI, 2000, BRAIN INJURY, V14, P417; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Janus PL, 1997, NEUROREHABILITATION, V9, P133, DOI 10.3233/NRE-1997-9205; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Min LC, 2007, MED CARE, V45, P480, DOI 10.1097/MLR.0b013e318030fff9; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Savage RC, 2001, NEUROREHABILITATION, V16, P49; Savage RC, 1997, J HEAD TRAUMA REHAB, V12, P11, DOI 10.1097/00001199-199704000-00003; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Shrout PE, 1979, INTRACLASS CORRELATI, V2, P420; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	36	15	15	1	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2013	27	2					179	188		10.3109/02699052.2012.729291			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500006	23384215				2021-06-18	
J	Matsumoto, M; Imura, T; Fukazawa, T; Sun, Y; Takeda, M; Kajiume, T; Kawahara, Y; Yuge, L				Matsumoto, Masaya; Imura, Takeshi; Fukazawa, Takahiro; Sun, Yanan; Takeda, Masaaki; Kajiume, Teruyuki; Kawahara, Yumi; Yuge, Louis			Electrical stimulation enhances neurogenin2 expression through beta-catenin signaling pathway of mouse bone marrow stromal cells and intensifies the effect of cell transplantation on brain injury	NEUROSCIENCE LETTERS			English	Article						Bone marrow stromal cells; Neural differentiation; Electrical stimulation; Neurogenin2; beta-catenin	STEM-CELLS; GENE-EXPRESSION; RAT; DIFFERENTIATION	Bone marrow stromal cells (BMSCs) have received significant attention for its use in neural regeneration. However, neural replacement by transplanted BMSCs was not very effective. Recently, the gene transfection method has improved the capability of cell transplantation; however, this method results in canceration and immune rejection. We induced the differentiation of mouse BMSCs into neural cells using electrical stimulation and transplanted the cells into traumatic brain injury (TBI) model mice. We found that the electrically stimulated cells have good potential to differentiate into neural cells and contribute to recovery from TBI without differentiating into astrocytes. In addition, we found that electrical stimulation enhanced neurogenin2 (Ngn2) expression. Ngn2 is involved in neural differentiation and inhibits astrocytic differentiation during cell growth. Furthermore, we found that this enhancement of Ngn2 expression occurred through beta-catenin signaling pathway. This study may contribute to the use of BMSCs for neural replacement in central nervous system diseases. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Matsumoto, Masaya; Imura, Takeshi; Fukazawa, Takahiro; Sun, Yanan; Yuge, Louis] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Bioenvironm Adaptat Sci, Hiroshima 7348551, Japan; [Takeda, Masaaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima 7348551, Japan; [Kajiume, Teruyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima 7348551, Japan; [Kawahara, Yumi; Yuge, Louis] Space Biolabs Co Ltd, Hiroshima, Japan	Yuge, L (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Bioenvironm Adaptat Sci, Hiroshima 7348551, Japan.	ryuge@hiroshima-u.ac.jp	Imura, Takeshi/A-7157-2018		Japanese Physical Therapy Association; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23300201, 23592127] Funding Source: KAKEN	The authors thank Dr. Masaru Okabe at Osaka University for kindly providing GFP mice and Hiroyuki Uwatoko and Kyosuke Nakata at the Division of Bio-Environmental Adaptation Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University for technical support. The work was supported by a grant from the Japanese Physical Therapy Association in 2012.	Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hong GM, 2012, TOXICOL SCI, V129, P146, DOI 10.1093/toxsci/kfs186; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kimura K, 1998, J BIOTECHNOL, V63, P55, DOI 10.1016/S0168-1656(98)00075-3; Kondo T, 2011, STEM CELLS, V29, P836, DOI 10.1002/stem.624; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Yamada M, 2007, STEM CELLS, V25, P562, DOI 10.1634/stemcells.2006-0011; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Zhao L, 2007, CELL BIOL INT, V31, P916, DOI 10.1016/j.cellbi.2007.02.006	14	15	16	0	19	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 15	2013	533						71	76		10.1016/j.neulet.2012.10.023			6	Neurosciences	Neurosciences & Neurology	077GN	WOS:000314016000014	23142721				2021-06-18	
J	Matsuoka, Y; Nishi, D; Yonemoto, N; Hamazaki, K; Matsumura, K; Noguchi, H; Hashimoto, K; Hamazaki, T				Matsuoka, Yutaka; Nishi, Daisuke; Yonemoto, Naohiro; Hamazaki, Kei; Matsumura, Kenta; Noguchi, Hiroko; Hashimoto, Kenji; Hamazaki, Tomohito			Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial	BMC PSYCHIATRY			English	Article						Fish oil; Omega-3 fatty acid; Docosahexaenoic acid; Eicosapentaenoic acid; Posttraumatic stress disorder; Accidental injury; Prevention	TRAUMATIC BRAIN-INJURY; FOOD FREQUENCY QUESTIONNAIRE; DOCOSAHEXAENOIC ACID; ACCIDENTAL INJURY; JAPANESE VERSION; PSYCHIATRIC MORBIDITY; DOUBLE-BLIND; SECONDARY PREVENTION; SEAFOOD CONSUMPTION; HEALTH SURVEY	Background: Preclinical and clinical studies suggest that supplementation with omega-3 fatty acids after trauma might reduce subsequent posttraumatic stress disorder (PTSD). To date, we have shown in an open trial that PTSD symptoms in critically injured patients can be reduced by taking omega-3 fatty acids, hypothesized to stimulate hippocampal neurogenesis. The primary aim of the present randomized controlled trial is to examine the efficacy of omega-3 fatty acid supplementation in the secondary prevention of PTSD following accidental injury, as compared with placebo. This paper describes the rationale and protocol of this trial. Methods/design: The Tachikawa Project for Prevention of Posttraumatic Stress Disorder with Polyunsaturated Fatty Acid (TPOP) is a double-blinded, parallel group, randomized controlled trial to assess whether omega-3 fatty acid supplementation can prevent PTSD symptoms among accident-injured patients consecutively admitted to an intensive care unit. We plan to recruit accident-injured patients and follow them prospectively for 12 weeks. Enrolled patients will be randomized to either the omega-3 fatty acid supplement group (1,470 mg docosahexaenoic acid and 147 mg eicosapentaenoic acid daily) or placebo group. Primary outcome is score on the Clinician-Administered PTSD Scale (CAPS). We will need to randomize 140 injured patients to have 90% power to detect a 10-point difference in mean CAPS scores with omega-3 fatty acid supplementation compared with placebo. Secondary measures are diagnosis of PTSD and major depressive disorder, depressive symptoms, physiologic response in the experiment using script-driven imagery and acoustic stimulation, serum brain-derived neurotrophic factor, health-related quality of life, resilience, and aggression. Analyses will be by intent to treat. The trial was initiated on December 13 2008, with 104 subjects randomized by November 30 2012. Discussion: This study promises to be the first trial to provide a novel prevention strategy for PTSD among traumatized people.	[Matsuoka, Yutaka; Nishi, Daisuke] Natl Disaster Med Ctr, Dept Psychiat, Tachikawa, Tokyo 1900014, Japan; [Matsuoka, Yutaka; Yonemoto, Naohiro; Noguchi, Hiroko] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Epidemiol, Kodaira, Tokyo 1878551, Japan; [Matsuoka, Yutaka; Nishi, Daisuke; Matsumura, Kenta; Noguchi, Hiroko] Natl Ctr Neurol & Psychiat, NIMH, Kodaira, Tokyo 1878553, Japan; [Matsuoka, Yutaka; Nishi, Daisuke; Yonemoto, Naohiro; Hamazaki, Kei; Matsumura, Kenta; Noguchi, Hiroko; Hashimoto, Kenji; Hamazaki, Tomohito] Japan Sci & Technol Agcy, CREST, Tachikawa, Tokyo 1900014, Japan; [Hamazaki, Kei] Toyama Univ, Fac Med, Dept Publ Hlth, Toyama 9300194, Japan; [Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chuo Ku, Chiba 2608670, Japan; [Hamazaki, Tomohito] Toyama Univ, Inst Nat Med, Dept Clin Sci, Toyama 9300194, Japan	Matsuoka, Y (corresponding author), Natl Disaster Med Ctr, Dept Psychiat, 3256 Midoricho, Tachikawa, Tokyo 1900014, Japan.	yutaka@ncnp.go.jp	Matsuoka, Yutaka/N-1588-2019; Nishi, Daisuke/AAH-7211-2019; Naohiro, Yonemoto/Y-3761-2019; Matsumura, Kenta/ABH-9288-2020; Hashimoto, Kenji/I-5800-2015	Matsuoka, Yutaka/0000-0002-8690-8129; Nishi, Daisuke/0000-0001-9349-3294; Matsumura, Kenta/0000-0002-4271-1543; Hashimoto, Kenji/0000-0002-8892-0439	CREST, the Japan Science and Technology AgencyJapan Science & Technology Agency (JST); Japan Science and Technology Agency, CRESTJapan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST); Ministry of Health, Labor, and Welfare of JapanMinistry of Health, Labour and Welfare, Japan; Suntory Wellness Ltd; Eli Lilly Japan KKEli Lilly; Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical; Toray Industries, Inc.Toray Industries, Inc.; Foundation for Total Health PromotionFoundation for Total Health Promotion; Qol Co., Ltd; DHA & EPA Association; NTT DoCoMo, Inc.; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; NCNP; Tamura Foundation for Promotion of Science and Technology; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Polyene Project, Inc.; Open Research Center for Lipid Nutrition (Kinjo Gakuin University); Nippon Suisan Kaisha, Ltd.; Mochida Pharmaceutical Co., Ltd.; Meiji Yasuda Life Foundation of Health and WelfareMeiji Yasuda Life Foundation of Health and Welfare	This study was supported by CREST, the Japan Science and Technology Agency (YM). The funding body peer reviewed proposal documents which included digest version of this study protocol as part of the selection process. All of the supplements used in the study were supplied by Kentech Co, Ltd., Toyama, Japan. They had no role in the study design and conduct, in the collection, analysis and interpretation of the data, or in the preparation, review, and approval of the manuscript.; Dr. Matsuoka has received research support from the Japan Science and Technology Agency, CREST and the Ministry of Health, Labor, and Welfare of Japan, an Intramural Research Grant for Neurological and Psychiatric Disorders from NCNP and lecture fees from Suntory Wellness Ltd, Eli Lilly Japan KK, and Otsuka Pharmaceutical Co., Ltd. Dr. Nishi has received research support from Toray Industries, Inc. and the Foundation for Total Health Promotion, and lecture fees from Qol Co., Ltd, DHA & EPA Association, and NTT DoCoMo, Inc. Dr. K. Hamazaki has received research support from the Japan Society for the Promotion of Science, an Intramural Research Grant for Neurological and Psychiatric Disorders from NCNP, the Tamura Foundation for Promotion of Science and Technology, and the Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care, and consultant fees from Polyene Project, Inc. and Otsuka Pharmaceutical Co., Ltd., and lecture fees from Nippon Suisan Kaisha, Ltd. Dr. T. Hamazaki has received research support from the Japan Society for the Promotion of Science, Open Research Center for Lipid Nutrition (Kinjo Gakuin University), and Nippon Suisan Kaisha, Ltd., and consultant fees from Polyene Project, Inc. and Otsuka Pharmaceutical Co., Ltd., and lecture fees from Mochida Pharmaceutical Co., Ltd. Dr. Matsumura has received research support from the Japan Society for the Promotion of Science and the 26th Research Grant in Medical and Health Science from Meiji Yasuda Life Foundation of Health and Welfare. All other authors declare that they have no competing interests with this work.	Ando A, 1999, JPN J PSYCHOL, V70, P384, DOI 10.4992/jjpsy.70.384; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Asukai N., 2003, JAP J TRAUM STRESS, V1, P47; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Beltz BS, 2007, NEUROSCI LETT, V415, P154, DOI 10.1016/j.neulet.2007.01.010; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Ehlers A, 2003, ARCH GEN PSYCHIAT, V60, P1024, DOI 10.1001/archpsyc.60.10.1024; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954, DOI 10.4088/JCP.v67n1217; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Hamanaka S, 2006, GEN HOSP PSYCHIAT, V28, P234, DOI 10.1016/j.genhosppsych.2006.02.007; Hamazaki T, 1996, J CLIN INVEST, V97, P1129, DOI 10.1172/JCI118507; Hepp U, 2008, BRIT J PSYCHIAT, V192, P376, DOI 10.1192/bjp.bp.106.030569; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hibbeln JR, 2002, J AFFECT DISORDERS, V69, P15, DOI 10.1016/S0165-0327(01)00374-3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Itomura M, 2008, IN VIVO, V22, P131; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kobayashi M, 2003, J EPIDEMIOL, V13, pS64; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kugaya A, 1998, JPN J CLIN ONCOL, V28, P333, DOI 10.1093/jjco/28.5.333; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Martins JG, 2012, MOL PSYCHIATR, V17, P1144, DOI 10.1038/mp.2012.25; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Matsumura K., 2012, GLOBAL J HLTH SCI, V4, P3, DOI [10.5539/gjhs.v4n1p3, DOI 10.5539/GJHS.V4N1P3]; Matsuoka Y, 2009, SOC PSYCH PSYCH EPID, V44, P341; Matsuoka Y, 2008, CRIT CARE MED, V36, P74, DOI 10.1097/01.CCM.0000291650.70816.D6; Matsuoka Y, 2011, PSYCHOTHER PSYCHOSOM, V80, P310, DOI 10.1159/000322980; Matsuoka Y, 2011, BIOPSYCHOSOC MED, V5, DOI 10.1186/1751-0759-5-3; Matsuoka Y, 2010, J CLIN PSYCHOPHARM, V30, P217, DOI 10.1097/JCP.0b013e3181d48830; Matsuoka Y, 2010, PSYCHOTHER PSYCHOSOM, V79, P56, DOI 10.1159/000259418; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nishi D, 2006, EMERG MED J, V23, P468, DOI 10.1136/emj.2005.029769; Nishi D, 2009, GEN HOSP PSYCHIAT, V31, P75, DOI 10.1016/j.genhosppsych.2008.09.002; Noaghiul S, 2003, AM J PSYCHIAT, V160, P2222, DOI 10.1176/appi.ajp.160.12.2222; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; PITMAN RK, 1987, ARCH GEN PSYCHIAT, V44, P970; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Sawazaki S, 1999, J NUTR SCI VITAMINOL, V45, P655, DOI 10.3177/jnsv.45.655; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Schnyder U, 2001, AM J RESP CRIT CARE, V164, P653, DOI 10.1164/ajrccm.164.4.2008087; Schnyder U, 2008, PSYCHOTHER PSYCHOSOM, V77, P111, DOI 10.1159/000112888; SCOTT J, 1976, PAIN, V2, P175, DOI 10.1016/0304-3959(76)90113-5; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SQUIRE LR, 1987, MEMORY BRAIN; Sublette ME, 2011, J CLIN PSYCHIAT, V72, P1577, DOI 10.4088/JCP.10m06634; Suzuki S, 2004, BRIT J CANCER, V90, P787, DOI 10.1038/sj.bjc.6601621; Takahashi N, 2004, HUM PSYCHOPHARM CLIN, V19, P187, DOI 10.1002/hup.576; TEASDALE G, 1974, LANCET, V2, P81; Tsubono Y, 1996, J Epidemiol, V6, P45; Tsugane S, 2003, J EPIDEMIOL, V13, pS2; Tucker PM, 2007, AM J PSYCHIAT, V164, P230, DOI 10.1176/appi.ajp.164.2.230; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Venna VR, 2009, PSYCHONEUROENDOCRINO, V34, P199, DOI 10.1016/j.psyneuen.2008.08.025; Verger P, 2004, AM J PSYCHIAT, V161, P1384, DOI 10.1176/appi.ajp.161.8.1384; Ware JE., 1993, SF 36 HLTH SURVEY MA; Weiss DS., 2007, CROSS CULTURAL ASSES, P219; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	79	15	15	0	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-244X		BMC PSYCHIATRY	BMC Psychiatry	JAN 5	2013	13								8	10.1186/1471-244X-13-8			13	Psychiatry	Psychiatry	099VE	WOS:000315649900001	23289548	DOAJ Gold, Green Published			2021-06-18	
J	Baek, SO; Kim, OL; Kim, SH; Kim, MS; Son, SM; Cho, YW; Byun, WM; Jang, SH				Baek, Seung Ok; Kim, Oh Lyong; Kim, Seong Ho; Kim, Min Soo; Son, Su Min; Cho, Yoon Woo; Byun, Woo Mok; Jang, Sung Ho			Relation between cingulum injury and cognition in chronic patients with traumatic brain injury; diffusion tensor tractography study	NEUROREHABILITATION			English	Article						Cognition; memory; traumatic brain injury; cingulum; diffusion tensor imaging	RHESUS-MONKEY; CORTEX; ANTERIOR; TRACTS; PATHWAYS; CHILDREN; NUCLEUS; BUNDLES; MEMORY	OBJECTIVES: Many diffusion tensor imaging (DTI) studies have reported an association between cingulum injury and cognition in patients with traumatic brain injury (TBI) using DTI parameters. In this study, we attempted to investigate the relation between cingulum injury and cognition in chronic patients with TBI, using the integrity of the cingulum as well as DTI parameters. METHOD: Thirty five consecutive chronic patients with TBI were recruited. The intelligence quotient (IQ) of the Wechsler Intelligence Scale and Memory Assessment Scale (MAS) was used for assessment of cognition. The patients were classified into three groups, according to continuity to the lower portion of the genu of the corpus callosum: type A-both sides of the cingulum showed intact continuity, type B-either cingulum showed a discontinuation, and, type C-both cingulums showed discontinuation. We measured the fractional anisotropy (FA), apparent diffusion coefficient (ADC), and voxel number of both cingulums. RESULTS: The IQ and MAS scores of type A and B were significantly higher than those of type C, respectively (p < 0.05), however, we did not observe a significant difference between type A and type B (p > 0.05). A positive correlation was observed between the FA value of the cingulum, and IQ and MAS, respectively (IQ r = 0.373, p < 0.05, MAS r = 0.357, p < 0.05), and between the voxel number and MAS (r = 0.500, p < 0.05). By contrast, we observed a negative correlation between the ADC value and IQ (r = -0.353, p < 0.05). CONCLUSION: In terms of integrity to the basal forebrain and DTI parameters of the injured cingulum, DTI findings showed a close association with whole cognition and memory in chronic patients with TBI.	[Baek, Seung Ok; Son, Su Min; Cho, Yoon Woo; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Oh Lyong; Kim, Seong Ho; Kim, Min Soo] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea; [Byun, Woo Mok] Yeungnam Univ, Coll Med, Dept Diagnost Radiol, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			National Research Foundation of Korea(NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A0 1001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A0 1001873).	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Baev K. V., 1998, BIOL NEURAL NETWORKS, Vxxxvii; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; FitzGerald M. J. T., 2011, CLIN NEUROANATOMY NE, Vxi; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hong JH, 2010, BRAIN RES, V1346, P190, DOI 10.1016/j.brainres.2010.05.088; Jung YJ, 2012, AM J NEURORADIOL, V33, P1775, DOI 10.3174/ajnr.A3027; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Mesulam MM, 2004, PROG BRAIN RES, V145, P67, DOI 10.1016/S0079-6123(03)45004-8; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Nieuwenhuys R, 2008, HUMAN CENTRAL NERVOU, Vxiv; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pagani E, 2007, MAGN RESON MED, V58, P527, DOI 10.1002/mrm.21346; Paxinos G, 2004, RAT NERVOUS SYSTEM, Vxvii; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Williams J. M., 1991, MEMORY ASSESSMENT SC, Viv; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeo SS, 2012, NEUROREHABILITATION, V31, P143, DOI 10.3233/NRE-2012-0783	36	15	15	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	33	3					465	471		10.3233/NRE-130979			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	252DY	WOS:000326986400013	23949082				2021-06-18	
S	Cummings, L		Capone, A; LoPiparo, F; Carapezza, M		Cummings, Louise			Clinical Pragmatics and Theory of Mind	PERSPECTIVES ON LINGUISTIC PRAGMATICS	Perspectives in Pragmatics Philosophy and Psychology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; FRAGILE-X-SYNDROME; HIGH-FUNCTIONING AUTISM; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHILDRENS COMMUNICATION CHECKLIST; DEFICIT HYPERACTIVITY DISORDER; RIGHT-HEMISPHERE; LANGUAGE IMPAIRMENT; PARKINSONS-DISEASE; ASPERGER-SYNDROME	Theory of mind (ToM) describes the cognitive ability to attribute mental states both to one's own mind and to the minds of others. In recent years, ToM has been credited with playing a significant role in developmental and acquired pragmatic disorders. In this way, ToM deficits have been linked to pragmatic deficits in individuals with autism spectrum disorders (e. g. Martin and McDonald, Journal of Autism and Developmental Disorders, 34, 311-328, 2004), emotional and behavioural disorders (e. g. Buitelaar et al., Development and Psychopathology, 11, 39-58, 1999), intellectual disability (e. g. Cornish et al., Journal of Intellectual Disability Research, 49, 372-378, 2005), right-hemisphere damage (e. g. Winner et al., Brain and Language, 62, 89-106, 1998), schizophrenia (e. g. Brune and Bodenstein, Schizophrenia Research, 75, 233-239, 2005), traumatic brain injury (e. g. McDonald and Flanagan, Neuropsychology, 18, 572-579, 2004) and neurodegenerative disorders such as Alzheimer's disease (e. g. Cuerva et al., Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 14, 153-158, 2001). In this chapter, I examine the central role of ToM reasoning in utterance interpretation. The chapter addresses what is known about ToM development during childhood and adolescence as well as changes in ToM skills as part of the aging process. The role of ToM in developmental and acquired pragmatic disorders is discussed. The contribution of ToM research into pragmatic disorders is critically evaluated. Finally, several ToM theories are examined. The question is addressed of which, if any, of these theories is able to capture the pragmatic features of utterance interpretation.	[Cummings, Louise] Nottingham Trent Univ, Nottingham, England	Cummings, L (corresponding author), Nottingham Trent Univ, Nottingham, England.	louise.cummings@ntu.ac.uk		Cummings, Louise/0000-0002-8947-8195			Abbecluto L, 2008, AM J MENT RETARD, V113, P214, DOI 10.1352/0895-8017(2008)113[214:SNOLAC]2.0.CO;2; Abbeduto L, 2004, J INTELL DISABIL RES, V48, P150, DOI 10.1111/j.1365-2788.2004.00524.x; Abbeduto L, 2001, Downs Syndr Res Pract, V7, P9, DOI 10.3104/reports.109; Abbeduto L, 2006, AM J MENT RETARD, V111, P170, DOI 10.1352/0895-8017(2006)111[170:CIRCCO]2.0.CO;2; Adachi T, 2004, BRAIN DEV-JPN, V26, P301, DOI 10.1016/S0387-7604(03)00170-0; Adams C, 2009, INT J LANG COMM DIS, V44, P301, DOI 10.1080/13682820802051788; Adrian JE, 2007, CHILD DEV, V78, P1052, DOI 10.1111/j.1467-8624.2007.01052.x; Annaz D, 2009, INT J LANG COMM DIS, V44, P962, DOI 10.3109/13682820802525005; Armstrong K, 2012, SCHIZOPHRENIA BULL, V38, P622, DOI 10.1093/schbul/sbq145; Averbeck BB, 2011, SCHIZOPHR RES, V127, P115, DOI 10.1016/j.schres.2010.08.009; Bach LJ, 2006, BRAIN COGNITION, V60, P196; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S, 2000, UNDERSTANDING OTHER, V2, P3, DOI DOI 10.1093/ACPROF:OSO/9780199692972.001.0001; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Beeke S, 2003, CLIN LINGUIST PHONET, V17, P291, DOI 10.1080/0269920031000080055; Berthiaume KS, 2010, J ATTEN DISORD, V14, P31, DOI 10.1177/1087054709347197; Bignell S, 2007, BRIT J DEV PSYCHOL, V25, P499, DOI 10.1348/026151006X171343; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; Bishop DVM, 2000, DEV PSYCHOPATHOL, V12, P177, DOI 10.1017/S0954579400002042; Bishop DVM, 2001, DEV MED CHILD NEUROL, V43, P809, DOI 10.1017/S0012162201001475; Blake ML, 2006, AM J SPEECH-LANG PAT, V15, P255; Bodden ME, 2010, PARKINSONISM RELAT D, V16, P466, DOI 10.1016/j.parkreldis.2010.04.014; Borod JC, 2000, NEUROPSYCHOLOGY, V14, P112, DOI 10.1037/0894-4105.14.1.112; Bosco FM, 2006, COGNITIVE DEV, V21, P3, DOI 10.1016/j.cogdev.2005.09.006; Botting N, 2005, INT J LANG COMM DIS, V40, P49, DOI 10.1080/13682820410001723390; Brownell H, 1999, BRAIN LANG, V68, P442, DOI 10.1006/brln.1999.2122; BRUNDAGE S, 1996, CLIN APHASIOLOGY, V24, P215; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Buitelaar JK, 1999, DEV PSYCHOPATHOL, V11, P39, DOI 10.1017/S0954579499001947; Carlomagno S, 2005, CORTEX, V41, P520, DOI 10.1016/S0010-9452(08)70192-8; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Carlson SM, 2004, J EXP CHILD PSYCHOL, V87, P299, DOI 10.1016/j.jecp.2004.01.002; Carruthers Peter, 1996, THEORIES THEORIES MI, P1; Castelli I, 2011, AGING MENT HEALTH, V15, P157, DOI 10.1080/13607863.2010.513038; Chapman SB, 1997, APHASIOLOGY, V11, P337, DOI 10.1080/02687039708248475; Charman T, 2000, COGNITIVE DEV, V15, P481, DOI 10.1016/S0885-2014(01)00037-5; Cheang HS, 2006, CLIN LINGUIST PHONET, V20, P447, DOI 10.1080/02699200500135684; Coelho C, 2003, APHASIOLOGY, V17, P173, DOI 10.1080/729255216; Coelho C. A., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Colle L, 2008, J AUTISM DEV DISORD, V38, P28, DOI 10.1007/s10803-007-0357-5; Corcoran Rhiannon, 2003, Cogn Neuropsychiatry, V8, P223, DOI 10.1080/13546800244000319; Cornish K, 2005, J INTELL DISABIL RES, V49, P372, DOI 10.1111/j.1365-2788.2005.00678.x; Cuerva AG, 2001, NEUROPSY NEUROPSY BE, V14, P153; Cummings L, 2009, CLINICAL PRAGMATICS, P1; Cummings L, 2014, CAMBRIDGE HDB COMMUN, P559, DOI [10.1017/cbo9781139108683.036, DOI 10.1017/CBO9781139108683.036]; Cummings L., 2012, HDB PRAGMATICS, V4, P291; Cummings L., 2010, ROUTLEDGE PRAGMATICS, P40; Cummings L., 2014, COMMUNICATION DISORD; Cummings L., 2012, WHAT IS CONTEXT LING, P55, DOI DOI 10.1075/LA.196.06CUM; Cummings L., 2014, OXFORD HDB PRAGMATIC; Cummings L, 2007, LANG COMMUN, V27, P396, DOI 10.1016/j.langcom.2007.06.001; Cummings L, 2011, PRAGMAT SOC, V2, P17, DOI 10.1075/ps.2.1.02cum; Cummings Louise, 2007, SEMINARS SPEECH LANG, V28, P98; Cummings Louise, 2005, PRAGMATICS MULTIDISC; Cummings Louise, 2008, CLIN LINGUISTICS; Cutica I, 2006, BRAIN LANG, V98, P12, DOI 10.1016/j.bandl.2006.01.001; David N, 2010, J AUTISM DEV DISORD, V40, P290, DOI 10.1007/s10803-009-0867-4; de Marchena A, 2010, AUTISM RES, V3, P311, DOI 10.1002/aur.159; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Donno R, 2010, BRIT J PSYCHIAT, V196, P282, DOI 10.1192/bjp.bp.108.061341; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Farrant BM, 2006, CHILD DEV, V77, P1842, DOI 10.1111/j.1467-8624.2006.00977.x; Fernandez-Duque D, 2009, J CLIN EXP NEUROPSYC, V31, P489, DOI 10.1080/13803390802282688; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Feyereisen P, 2007, INT J LANG COMM DIS, V42, P1, DOI 10.1080/13682820600624216; Fodor J, 1983, MODULARITY MIND ESSA; Frith R C, 1996, Cogn Neuropsychiatry, V1, P305, DOI 10.1080/135468096396460; FRYE D, 2000, CHILDRENS REASONING, P149; Geurts HM, 2008, J AUTISM DEV DISORD, V38, P1931, DOI 10.1007/s10803-008-0587-1; Gibbons ZC, 2007, NEUROPSYCHOLOGIA, V45, P1196, DOI 10.1016/j.neuropsychologia.2006.10.008; Gilmour J, 2004, J CHILD PSYCHOL PSYC, V45, P967, DOI 10.1111/j.1469-7610.2004.t01-1-00289.x; Girardi A, 2011, NEUROPSYCHOLOGY, V25, P53, DOI 10.1037/a0020357; Golan O, 2008, J AUTISM DEV DISORD, V38, P1534, DOI 10.1007/s10803-007-0533-7; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Gold R, 2010, BRAIN LANG, V113, P124, DOI [10.1016/j.band1.2010.03.002, 10.1016/j.bandl.2010.03.002]; GOLDMAN AI, 1993, BEHAV BRAIN SCI, V16, P15, DOI 10.1017/S0140525X00028648; Gopnik A, 2000, UNDERSTANDING OTHER, P50; Gordon R.M., 1986, MIND LANG, V1, P158, DOI [DOI 10.1111/J.1468-0017.1986.TB00324.X, 10.1111/j.1468-0017.1986.tb00324.x]; Gordon R.M., 1996, THEORIES THEORIES MI, P11, DOI DOI 10.1017/CB09780511597985.003; Grant CM, 2007, J ABNORM CHILD PSYCH, V35, P17, DOI 10.1007/s10802-006-9077-0; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Griffin R, 2006, LATERALITY, V11, P195, DOI 10.1080/13576500500450552; Hale CM, 2005, AUTISM, V9, P157, DOI 10.1177/1362361305051395; Hamilton AFD, 2009, COGNITION, V113, P37, DOI 10.1016/j.cognition.2009.07.007; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Holtgraves T, 2010, J CLIN EXP NEUROPSYC, V32, P388, DOI 10.1080/13803390903130729; Hughes C, 2005, CHILD DEV, V76, P356, DOI 10.1111/j.1467-8624.2005.00850_a.x; JENKINS JM, 1995, INFANT BEHAV DEV, V18, P273, DOI 10.1016/0163-6383(95)90016-0; John AE, 2009, AJIDD-AM J INTELLECT, V114, P85, DOI 10.1352/2009.114.85-99; Johnston JR, 2001, INT J LANG COMM DIS, V36, P349, DOI 10.1080/13682820110045838; Jones CD, 2009, J AUTISM DEV DISORD, V39, P432, DOI 10.1007/s10803-008-0642-y; Kasher A, 1999, BRAIN LANG, V68, P566, DOI 10.1006/brln.1999.2129; Kertesz A, 2010, ARCH NEUROL-CHICAGO, V67, P483, DOI 10.1001/archneurol.2010.55; Kleinman J, 2001, J AUTISM DEV DISORD, V31, P29, DOI 10.1023/A:1005657512379; Kuperberg GR, 2000, PSYCHOL MED, V30, P345, DOI 10.1017/S0033291700001744; Langdon R, 2002, PSYCHOL MED, V32, P1273, DOI 10.1017/S0033291702006396; Laws G, 2004, INT J LANG COMM DIS, V39, P45, DOI 10.1080/13682820310001615797; Lind SE, 2010, J AUTISM DEV DISORD, V40, P479, DOI 10.1007/s10803-009-0889-y; Losh M, 2003, J AUTISM DEV DISORD, V33, P239, DOI 10.1023/A:1024446215446; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Loukusa S, 2007, J AUTISM DEV DISORD, V37, P1049, DOI 10.1007/s10803-006-0247-2; MacLennan D. L., 2002, PREMIER OUTLOOK, V3, P38; Marini A, 2005, BRAIN LANG, V93, P46, DOI 10.1016/j.bandl.2004.08.002; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Martin I, 2004, J AUTISM DEV DISORD, V34, P311, DOI 10.1023/B:JADD.0000029553.52889.15; Marton I, 2009, J ABNORM CHILD PSYCH, V37, P107, DOI 10.1007/s10802-008-9262-4; Maylor EA, 2002, BRIT J PSYCHOL, V93, P465, DOI 10.1348/000712602761381358; Mazza M, 2008, PSYCHOPATHOLOGY, V41, P254, DOI 10.1159/000128324; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McInnes A, 2003, J ABNORM CHILD PSYCH, V31, P427, DOI 10.1023/A:1023895602957; McNamara P, 2003, BRAIN LANG, V84, P414, DOI 10.1016/S0093-934X(02)00558-8; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Miller CA, 2004, INT J LANG COMM DIS, V39, P191, DOI 10.1080/13682820310001616994; Miller CA, 2001, J COMMUN DISORD, V34, P73, DOI 10.1016/S0021-9924(00)00042-3; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Monetta L, 2007, BRAIN LANG, V101, P80, DOI 10.1016/j.bandl.2006.06.007; Monetta L, 2009, CORTEX, V45, P972, DOI 10.1016/j.cortex.2009.02.021; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Murphy MM, 2007, J INTELL DISABIL RES, V51, P387, DOI 10.1111/j.1365-2788.2006.00888.x; Mutter B, 2006, PERCEPT MOTOR SKILL, V102, P819, DOI 10.2466/PMS.102.3.819-835; Myers Penelope S., 1979, CLIN APHASIOLOGY C P, P38; Nelson PB, 2008, DEVELOPMENTAL SCI, V11, P847, DOI 10.1111/j.1467-7687.2008.00733.x; Nettle, 2006, J CULTURAL EVOLUTION, V4, P231, DOI [10.1556/JCEP.4.2006.3-4.3, DOI 10.1556/JCEP.4.2006.3-4.3]; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; Papagno C, 2001, BRAIN, V124, P1450, DOI 10.1093/brain/124.7.1450; Papagno C, 2001, J INT NEUROPSYCH SOC, V7, P516, DOI 10.1017/S1355617701744086; Papagno C, 2006, NEUROPSYCHOLOGY, V20, P598, DOI 10.1037/0894-4105.20.5.598; Pardini M, 2009, EXP AGING RES, V35, P98, DOI 10.1080/03610730802545259; Pelc K, 2006, PEDIATR NEUROL, V35, P93, DOI 10.1016/j.pediatrneurol.2006.01.014; Rinaldi W, 2000, INT J LANG COMM DIS, V35, P1, DOI 10.1080/136828200247223; Ripich DN, 2000, INT J LANG COMM DIS, V35, P49; Roncone R, 2004, NEUROPSYCHOL REHABIL, V14, P421, DOI 10.1080/09602010343000291; Rousseaux M, 2010, NEUROPSYCHOLOGIA, V48, P3884, DOI 10.1016/j.neuropsychologia.2010.09.026; Ruffman T, 1998, DEV PSYCHOL, V34, P161, DOI 10.1037/0012-1649.34.1.161; Ruffman T, 2002, CHILD DEV, V73, P734, DOI 10.1111/1467-8624.00435; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Ryder N, 2008, INT J LANG COMM DIS, V43, P427, DOI 10.1080/13682820701633207; Saldert C, 2010, INT J LANG COMM DIS, V45, P656, DOI 10.3109/13682820903494742; Saltzman J, 2000, J INT NEUROPSYCH SOC, V6, P781, DOI 10.1017/S1355617700677056; Scholl BJ, 1999, MIND LANG, V14, P131, DOI 10.1111/1468-0017.00106; Siegal M, 2006, SOC NEUROSCI-UK, V1, P167, DOI 10.1080/17470910600985597; Spanoudis G, 2007, INT J LANG COMM DIS, V42, P487, DOI 10.1080/13682820601010027; Speechley WJ, 2010, EUR PSYCHIAT, V25, P80, DOI 10.1016/j.eurpsy.2009.05.012; Spek AA, 2010, J AUTISM DEV DISORD, V40, P280, DOI 10.1007/s10803-009-0860-y; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Sudhalter V, 2001, AM J MENT RETARD, V106, P389, DOI 10.1352/0895-8017(2001)106<0389:CCOCWF>2.0.CO;2; Sullivan K, 1999, AM J MENT RETARD, V104, P523, DOI 10.1352/0895-8017(1999)104<0523:SBAIWS>2.0.CO;2; Sullivan K, 2003, DEV NEUROPSYCHOL, V23, P85, DOI 10.1207/S15326942DN231&2_5; Sullivan S, 2004, BRIT J PSYCHOL, V95, P1, DOI 10.1348/000712604322779424; Surian L, 2001, BRAIN LANG, V78, P224, DOI 10.1006/brln.2001.2465; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; Swettenham J, 2000, UNDERSTANDING OTHER, P442; Symons D, 1997, J EXP CHILD PSYCHOL, V67, P423, DOI 10.1006/jecp.1997.2416; Tager-Flusberg H., 2000, UNDERSTANDING OTHER, P124; Tavano A, 2008, SCHIZOPHR RES, V102, P53, DOI 10.1016/j.schres.2008.02.008; Taylor M, 1997, CHILD DEV, V68, P436, DOI 10.1111/j.1467-8624.1997.tb01950.x; Tenyi T, 2002, PSYCHOPATHOLOGY, V35, P25, DOI 10.1159/000056212; Titone D, 2004, SCHIZOPHR RES, V68, P235, DOI 10.1016/s0920-9964(03)00152-x; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Varley R, 2000, CURR BIOL, V10, P723, DOI 10.1016/S0960-9822(00)00538-8; Varley R, 2001, NEUROCASE, V7, P489, DOI 10.1093/neucas/7.6.489; Watson AC, 2001, J COGN DEV, V2, P449, DOI 10.1207/S15327647JCD0204_5; Weed E, 2010, BRAIN LANG, V113, P65, DOI 10.1016/j.bandl.2010.01.009; Weed E, 2008, INT J SPEECH-LANG PA, V10, P414, DOI 10.1080/17549500802455429; Wellman H. M., 2000, UNDERSTANDING OTHER, P21; Williams D, 2010, DEVELOPMENTAL SCI, V13, P307, DOI 10.1111/j.1467-7687.2009.00885.x; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Yirmiya N, 1996, J CHILD PSYCHOL PSYC, V37, P1003, DOI 10.1111/j.1469-7610.1996.tb01497.x	175	15	15	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2214-3807		978-3-319-01014-4; 978-3-319-01013-7	PERSP PRAGMAT PHILO			2013	2						23	56		10.1007/978-3-319-01014-4_2	10.1007/978-3-319-01014-4		34	Linguistics; Language & Linguistics; Philosophy	Linguistics; Philosophy	BG4AT	WOS:000388560000004					2021-06-18	
J	Ehinger, KHJ; Hansson, MJ; Sjovall, F; Elmer, E				Ehinger, Karl Henrik Johannes; Hansson, Magnus Joakim; Sjovall, Fredrik; Elmer, Eskil			Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor (R) EL	CLINICAL DRUG INVESTIGATION			English	Article							TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL PERMEABILITY TRANSITION; ANAPHYLACTIC REACTION; MICROEMULSION FORMULATION; DIETHYLHEXYL PHTHALATE; AFRICAN-AMERICAN; PHARMACOKINETICS; PROPOFOL; DIAZEPAM; BIOAVAILABILITY	Background Ciclosporin is used as an immunosuppressant in current clinical practice but recent research implies novel indications for the drug, such as neuro-and cardio-protection. The intravenous formulation currently on the market, Sandimmune (R) Injection (Sandimmune (R)), uses Cremophor (R) EL as emulsifying excipient. Cremophor (R) EL is known to cause hypersensitivity reactions in some patients, ranging from skin reactions to potentially fatal anaphylactic shock. Objectives The primary objective was to assess if CicloMulsion (R), a Cremophor (R) EL-free lipid emulsion of ciclosporin for intravenous administration, is bioequivalent to Sandimmune (R), and the secondary objective was to compare the tolerability profiles of the two preparations. Methods This was a single-centre, open-label, subject-blind, laboratory-blind, single-dose, randomized, two-treatment, two-period, two-sequence crossover study of the pharmacokinetics of two formulations of intravenous ciclosporin. Fifty-two healthy volunteer subjects were administered 5 mg/kg of each of the two formulations of ciclosporin as a 4-h intravenous infusion. The last blood sample was acquired 48 h after the end of the infusion. Bioequivalence assessments according to current guidelines were performed. Results The geometric mean ratios for CicloMulsion (R)/Sandimmune (R) (90 % confidence interval [CI]) were 0.90 (0.88, 0.92) for AUC(0-last) (area under the blood concentration-time curve from time zero to time of last measurable concentration) and 0.95 (0.92, 0.97) for C-max (maximum blood concentration). For all additional variables analysed, the 90 % CIs were also within the accepted bioequivalence range of 0.80-1.25. One anaphylactoid and one anaphylactic reaction, both classified as serious adverse events, were reported after treatment with Sandimmune (R). No serious adverse events were recorded after treatment with CicloMulsion (R). Conclusion We have assessed the pharmacokinetics and tolerability of a new Cremophor (R) EL-free lipid emulsion of ciclosporin, CicloMulsion (R), compared to Sandimmune (R). The proportion of adverse events was significantly higher for the Cremophor (R) EL-based product Sandimmune (R). We conclude that CicloMulsion (R) is bioequivalent to Sandimmune (R) and exhibits fewer adverse reactions.	[Ehinger, Karl Henrik Johannes; Hansson, Magnus Joakim; Sjovall, Fredrik; Elmer, Eskil] NeuroVive Pharmaceut AB Publ, Medicon Village, S-22381 Lund, Sweden; [Ehinger, Karl Henrik Johannes; Hansson, Magnus Joakim; Sjovall, Fredrik; Elmer, Eskil] Lund Univ, Dept Clin Sci, Mitochondrial Pathophysiol Unit, Lund, Sweden	Ehinger, KHJ (corresponding author), NeuroVive Pharmaceut AB Publ, Medicon Village, S-22381 Lund, Sweden.	johannes.ehinger@neurovive.com	Hansson, Magnus/G-4486-2014; Ehinger, Johannes/D-7120-2013; Elmer, Eskil/F-9341-2014	Hansson, Magnus/0000-0002-0201-0638; Ehinger, Johannes/0000-0002-2417-5767; Elmer, Eskil/0000-0001-7901-1826; Sjovall, Fredrik/0000-0001-5612-0325	NeuroVive Pharmaceutical AB (publ)	All authors receive salary support from, and are stockholders of, NeuroVive Pharmaceutical AB (publ). In addition, Eskil Elmer is co-founder and officer of Maas Biolab, LLC, and NeuroVive Pharmaceutical AB, which hold intellectual property rights and develop cyclophilin-D-inhibiting ciclosporins primarily for the treatment of acute brain injury and reperfusion injury in myocardial infarction. There are no other conflicts of interest to disclose. The authors are grateful to Marcus F. Keep, Daniel Wermeling and Torben Balchen for extensive input on the clinical trial protocol.	Baker MT, 2005, ANESTHESIOLOGY, V103, P860, DOI 10.1097/00000542-200510000-00026; BOWERS VD, 1991, TRANSPLANTATION, V51, P847, DOI 10.1097/00007890-199104000-00021; BRIGGS LP, 1982, ANAESTHESIA, V37, P1099, DOI 10.1111/j.1365-2044.1982.tb01753.x; CHAPUIS B, 1985, NEW ENGL J MED, V312, P1259; Christians U, 2000, THER DRUG MONIT, V22, P330, DOI 10.1097/00007691-200006000-00017; Christians Uwe, 2005, Expert Opin Drug Metab Toxicol, V1, P641, DOI 10.1517/17425255.1.4.641; Christians U, 2010, KIDNEY INT, V77, pS1, DOI 10.1038/ki.2009.504; Cook AM, 2009, EXPERT OPIN DRUG SAF, V8, P411, DOI 10.1517/14740330903066742; DILETTI E, 1992, INT J CLIN PHARM TH, V30, pS51; Dorr R T, 1994, Ann Pharmacother, V28, pS11; Dutta S, 1997, J PHARM SCI-US, V86, P967, DOI 10.1021/js970118m; DYE D, 1980, BRIT MED J, V280, P1353, DOI 10.1136/bmj.280.6228.1353; EMA, 2001, NOT GUID INV BIOAV B; FEE JPH, 1986, ACTA ANAESTH SCAND, V30, P337, DOI 10.1111/j.1399-6576.1986.tb02426.x; FEE JPH, 1984, LANCET, V2, P813; FRIEDMAN LS, 1985, AM J MED, V78, P343, DOI 10.1016/0002-9343(85)90447-4; Fritsche L, 2004, TRANSPLANT P, V36, p130S, DOI 10.1016/j.transproceed.2003.12.038; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; Gotardo MA, 2005, J PHARMACEUT BIOMED, V38, P709, DOI 10.1016/j.jpba.2005.02.005; Griveas I, 2010, ARTIF ORGANS, V34, P234, DOI 10.1111/j.1525-1594.2009.00838.x; GUPTA SK, 1990, J CLIN PHARMACOL, V30, P643, DOI 10.1002/j.1552-4604.1990.tb01868.x; Hijnen DJ, 2007, J EUR ACAD DERMATOL, V21, P85, DOI 10.1111/j.1468-3083.2006.01877.x; HOWRIE DL, 1985, DRUG INTEL CLIN PHAR, V19, P425, DOI 10.1177/106002808501900603; HUTTEL MS, 1980, BRIT J ANAESTH, V52, P77, DOI 10.1093/bja/52.1.77; Kacmaz RO, 2010, OPHTHALMOLOGY, V117, P576, DOI 10.1016/j.ophtha.2009.08.010; KAHAN BD, 1995, TRANSPLANTATION, V59, P505; KAHAN BD, 1984, LANCET, V1, P52; KANTO JH, 1988, INT J CLIN PHARM TH, V26, P41; Kees F, 2007, N-S ARCH PHARMACOL, V375, P393, DOI 10.1007/s00210-007-0169-3; Kloover JS, 2004, BRIT J CANCER, V90, P304, DOI 10.1038/sj.bjc.6601303; KOVARIK JM, 1994, TRANSPLANTATION, V58, P658; Lee M, 2001, J CLIN PHARMACOL, V41, P317, DOI 10.1177/00912700122010131; LEUNISSEN KML, 1985, LANCET, V1, P636; LiauChu M, 1997, ANN PHARMACOTHER, V31, P1287, DOI 10.1177/106002809703101101; Mackie F E, 2000, Pediatr Transplant, V4, P35, DOI 10.1034/j.1399-3046.2000.00081.x; MATTILA MAK, 1981, BRIT J ANAESTH, V53, P1265, DOI 10.1093/bja/53.12.1265; Micha JP, 2006, GYNECOL ONCOL, V100, P437, DOI 10.1016/j.ygyno.2005.09.012; Min DI, 2000, CLIN PHARMACOL THER, V68, P478, DOI 10.1067/mcp.2000.111255; MONERETVAUTRIN DA, 1983, BRIT J ANAESTH, V55, P469, DOI 10.1093/bja/55.5.469; MORGAN M, 1985, ANAESTHESIA, V40, P121; Naganuma M, 2011, J GASTROENTEROL, V46, P129, DOI 10.1007/s00535-010-0352-z; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Sanchez H, 2000, J MOL CELL CARDIOL, V32, P323, DOI 10.1006/jmcc.1999.1078; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Storb R, 2010, BIOL BLOOD MARROW TR, V16, pS18, DOI 10.1016/j.bbmt.2009.10.016; THEIS JGW, 1995, J CLIN ONCOL, V13, P2508, DOI 10.1200/JCO.1995.13.10.2508; THIEL G, 1986, CLIN NEPHROL, V25, pS40; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; U.S. Department of Health and Human Services Food and Drug Administration Research CfDE, 2001, GUID IND STAT APPR E; US Department of Health and Human Services US FDA 28 Center for Drug Evaluation and Research Center for Veterinary Medicine, 2001, GUID IND BIOAN METH; VANHOOFF JP, 1987, LANCET, V2, P1456; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; VENKATARAMANAN R, 1986, AM J HOSP PHARM, V43, P2800, DOI 10.1093/ajhp/43.11.2800; VERANI R, 1986, CLIN NEPHROL, V25, pS9; Volcheck GW, 1998, ANN ALLERG ASTHMA IM, V80, P159, DOI 10.1016/S1081-1206(10)62949-3; Warren RB, 2008, CLIN DERMATOL, V26, P438, DOI 10.1016/j.clindermatol.2007.11.006; WINDEBANK AJ, 1994, J PHARMACOL EXP THER, V268, P1051	60	15	17	0	6	ADIS INT LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW ZEALAND	1173-2563			CLIN DRUG INVEST	Clin. Drug Invest.		2013	33	1					25	34		10.1007/s40261-012-0029-x			10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	109ZQ	WOS:000316411300003	23179472	Green Published, Other Gold			2021-06-18	
J	Karpas, A; Finkelstein, M; Reid, S				Karpas, Anna; Finkelstein, Marsha; Reid, Samuel			Which Management Strategy Do Parents Prefer for Their Head-Injured Child Immediate Computed Tomography Scan or Observation?	PEDIATRIC EMERGENCY CARE			English	Article						head injury; computed tomography; observation	TRAUMATIC BRAIN-INJURY; RADIATION-EXPOSURE; UNITED-STATES; CT SCANS; RISKS; PATIENT; TRENDS; DEATH	Objective: The objectives of this study were to determine which method of head injury evaluation, immediate computed tomography (CT) or observation, parents would prefer for their child when given the opportunity to make an informed decision and to determine factors influencing preference. Methods: Parents of head-injured children 2 years or older who presented to a pediatric emergency department were eligible. After triage evaluation, and before physician assessment, research assistants presented educational materials regarding the method, risks, and benefits of both immediate CT and observation. Parents then completed a survey asking them their preference, reasons for preference, details of their child's injury, and demographic information. Results: One hundred thirty-four parents participated. After reviewing the educational materials, 53 (40%) preferred immediate CT; 77 (57%) preferred observation; 4 (3%) did not indicate a preference. Of those parents who preferred immediate CT, the leading reason given was, "I need to be 100% sure there is no bleeding in my child's brain." Of those parents who preferred observation, the 2 leading reasons given were, "I don't want my child to have a test unless he/she absolutely has to" and "I am concerned about the possibility of radiation causing a brain tumor." Injury mechanism, time between injury and presentation, time of day, child's age, worst symptom, previous CT, and demographic markers were not statistically associated with preference. Conclusions: When given the opportunity to make an informed decision regarding the evaluation of their head-injured child, parents were divided as to their preference. A small majority preferred observation.	[Finkelstein, Marsha] Childrens Hosp & Clin Minnesota, Res Program, Minneapolis, MN USA; [Finkelstein, Marsha] Childrens Hosp & Clin Minnesota, Sponsored Program, Minneapolis, MN USA	Reid, S (corresponding author), Childrens Hosp & Clin Minnesota, 345 N Smith Ave, St Paul, MN 55102 USA.	sam.reid@childrensmn.org			Children's Hospital and Clinics of Minnesota Internal Research Grant Program	This work was supported by a grant from the Children's Hospital and Clinics of Minnesota Internal Research Grant Program.	af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Baerlocher MO, 2010, JAMA-J AM MED ASSOC, V304, P2170, DOI 10.1001/jama.2010.1591; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Keays G, 2010, CAN J PUBLIC HEALTH, V101, P115, DOI 10.1007/BF03404354; Krahn M, 2008, JAMA-J AM MED ASSOC, V300, P436, DOI 10.1001/jama.300.4.436; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Larson DB, 2007, AM J ROENTGENOL, V189, P271, DOI 10.2214/AJR.07.2248; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MAYER T, 1981, Journal of the American Medical Association, V245, P719, DOI 10.1001/jama.245.7.719; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954	22	15	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2013	29	1					30	35		10.1097/PEC.0b013e31827b5090			6	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	064FY	WOS:000313059600007	23283259				2021-06-18	
J	Kozlowski, DA; Leasure, JL; Schallert, T				Kozlowski, Dorothy A.; Leasure, J. Leigh; Schallert, Timothy			The Control of Movement Following Traumatic Brain Injury	COMPREHENSIVE PHYSIOLOGY			English	Article							CONSTRAINT-INDUCED MOVEMENT; UNILATERAL SENSORIMOTOR CORTEX; LESS-AFFECTED FORELIMB; USE-DEPENDENT EXAGGERATION; CORTICAL CONTUSION INJURY; ENVIRONMENTAL ENRICHMENT; VOLUNTARY EXERCISE; MOTOR CORTEX; NEUROTROPHIC FACTOR; ADULT-RATS	Traumatic brain injury (TBI) results in a variety of impairments in cognition, mood, sensation, and movement, depending upon the location and severity of injury. Although not as extensively studied as cognitive impairments, motor impairments are common, especially in moderately to severely injured patients. The recovery of these deficits is not usually complete; however, extensive effort is put into the rehabilitation of motor skills to enhance independence and quality of life. Understanding the motor recovery process and how it can be influenced by rehabilitation has been extensively studied in animal models of stroke and focal lesions, albeit to a lesser extent following animal models of TBI. Injury-induced neural plasticity is intricately involved in motor recovery and influenced by behavioral compensation and rehabilitation following stroke and focal lesions. New studies in animal models of TBI indicate that neural plasticity and the processes of motor recovery and rehabilitation following brain injury may not mirror those processes shown to occur following stroke. Further examination of motor recovery, rehabilitation, and plasticity in animal models of TBI as well as in individuals with TBI will be necessary to fully understand the control of movement following brain injury. (C) 2013 American Physiological Society. Compr Physiol 3:121-139, 2013.	[Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Leasure, J. Leigh] Univ Houston, Dept Psychol, Houston, TX USA; [Leasure, J. Leigh] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Schallert, Timothy] Univ Texas Austin, Inst Neurosci, Dept Psychol, Austin, TX 78712 USA	Kozlowski, DA (corresponding author), Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA.	dkozlows@depaul.edu		Leasure, J. Leigh/0000-0002-9014-2525			Adkins DL, 2004, NEUROSCIENCE, V128, P473, DOI 10.1016/j.neuroscience.2004.07.019; Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Alessio HM, 2005, PHYSIOL BEHAV, V84, P65, DOI 10.1016/j.physbeh.2004.10.010; Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Allred RP, 2010, BEHAV NEUROSCI, V124, P124, DOI 10.1037/a0018457; Allred RP, 2005, RESTOR NEUROL NEUROS, V23, P297; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Bell K, 2007, BRAIN INJURY MED, P605; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Bland ST, 1999, NEUROSCI LETT, V277, P119, DOI 10.1016/S0304-3940(99)00855-1; Brene S, 2007, PHYSIOL BEHAV, V92, P136, DOI 10.1016/j.physbeh.2007.05.015; Brooks V, 1981, NERVOUS SYSTEM MOT 1, P1480; Brooks VB, 1981, NERVOUS SYSTEM MOT 2; Bury SD, 2000, NEUROPHARMACOLOGY, V39, P743, DOI 10.1016/S0028-3908(99)00272-5; Bury SD, 2002, J NEUROSCI, V22, P8597; Bury SD, 2000, NEUROSCI LETT, V287, P85, DOI 10.1016/S0304-3940(00)01138-1; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; Devine JM, 2009, PM&R, V1, P560, DOI 10.1016/j.pmrj.2009.03.015; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Dixon CE, 1996, NEUROTRAUMA, P1337; DOD, 2007, POL GUID TRAUM BRAIN; Dromerick AW, 2009, NEUROLOGY, V73, P195, DOI 10.1212/WNL.0b013e3181ab2b27; DVBIC, 2010, TBI NUMB; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P483, DOI 10.1053/apmr.2002.31203; Fang PC, 2010, STROKE, V41, P544, DOI 10.1161/STROKEAHA.109.572073; Faul M, 2010, TRAUMATIC BRAIN INJU, P74; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feeney DM, 1997, ADV NEUROL, V73, P383; Ferguson L, 2010, NAT NEUR SOC M; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Goldstein Larry B, 2006, NeuroRx, V3, P451, DOI 10.1016/j.nurx.2006.07.010; Goldstein Larry B, 2003, Phys Med Rehabil Clin N Am, V14, pS125, DOI 10.1016/S1047-9651(02)00060-8; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Greenwald BND, 2009, MT SINAI J MED, V76, P182, DOI 10.1002/msj.20103; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hansson AC, 2006, J NEUROENDOCRINOL, V18, P104, DOI 10.1111/j.1365-2826.2005.01390.x; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Hoffman JM, PM R, V2, P911; Hsu JE, 2006, EXP NEUROL, V201, P479, DOI 10.1016/j.expneurol.2006.05.003; Hsu JE, 2005, EUR J NEUROSCI, V22, P2069, DOI 10.1111/j.1460-9568.2005.04370.x; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Jang SH, 2011, NEUROREHABILITATION, V29, P339, DOI 10.3233/NRE-2011-0710; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82; Jones TA, 1999, J NEUROSCI, V19, P10153; Jones TA, 1999, J COMP NEUROL, V414, P57; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Jones TA, 2003, ILAR J, V44, P144, DOI 10.1093/ilar.44.2.144; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Jones TA, 2011, DEV PSYCHOBIOL, V53, P466, DOI 10.1002/dev.20557; KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 2004, J NEUROTRAUM, V21, P513, DOI 10.1089/089771504774129856; KOZLOWSKI DA, 1994, RESTOR NEUROL NEUROS, V7, P119, DOI 10.3233/RNN-1994-7207; Kozlowski DA, 1996, ABSTR SOC NEUR; Kozlowski DA, 1997, ABSTR SOC NEUR; KRAUSS J, 2007, BRAIN INJURY MED PRI, P469; Krauss JK, 1996, NEUROLOGY, V47, P1488, DOI 10.1212/WNL.47.6.1488; Krauss JK, 1997, MOVEMENT DISORD, V12, P428, DOI 10.1002/mds.870120326; KRAUSS JK, 1995, NEUROL RES, V17, P409, DOI 10.1080/01616412.1995.11740353; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Leasure JL, 2004, BEHAV BRAIN RES, V150, P83, DOI 10.1016/S0166-4328(03)00254-7; Leunissen I, 2012, HUM BRAIN MAPP; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lotze M, 2006, NEUROREHAB NEURAL RE, V20, P14, DOI 10.1177/1545968305282919; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Luke LM, 2004, SYNAPSE, V54, P187, DOI 10.1002/syn.20080; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mark VW, 2004, RESTOR NEUROL NEUROS, V22, P317; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; Mayer NH, 2007, BRAIN INJURY MED, P615; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Mohammed AH, 2002, PROG BRAIN RES, V138, P109, DOI 10.1016/S0079-6123(02)38074-9; Mumford N, 2012, BRAIN INJURY, V26, P166, DOI 10.3109/02699052.2011.648706; NATIV A, 1991, PHYS THER, V71, P48, DOI 10.1093/ptj/71.1.48; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Nudo RJ, 2010, BRAIN INJURY MED PRI, P913; Oostra KM, 2012, ARCH PHYS MED REHAB, V93, P828, DOI 10.1016/j.apmr.2011.11.018; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Phillips JP, 2003, J HEAD TRAUMA REHAB, V18, P342, DOI 10.1097/00001199-200307000-00005; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Povlishock JT, 1996, NEUROTRAUMA; Purves D.=, 2008, NEUROSCIENCE, V4th ed., P857; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Quinn B, 2000, BRAIN INJURY, V14, P1063; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sacco K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00146; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; SCHALLERT T, 1993, J NEURAL TRANSP PLAS, V4, P193, DOI 10.1155/NP.1993.193; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1983, BEHAV NEUROSCI, V97, P159, DOI 10.1037/0735-7044.97.1.159; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stevens MC, 2012, BRAIN IMAGING BEHAV; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Taub E, 2006, NEUROREHABILITATION, V21, P93; TEITELBA.P, 1969, J COMP PHYSIOL PSYCH, V67, P430, DOI 10.1037/h0027288; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; van Praag H, 1999, NAT NEUROSCI, V2, P266; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Voorhies AC, 2002, BEHAV BRAIN RES, V133, P237, DOI 10.1016/S0166-4328(02)00029-3; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Whishaw IQ, 2004, J NEUROTRAUM, V21, P1584, DOI 10.1089/neu.2004.21.1584; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	160	15	15	1	41	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2040-4603			COMPR PHYSIOL	Compr. Physiol.	JAN	2013	3	1					121	139		10.1002/cphy.c110005			19	Physiology	Physiology	086AH	WOS:000314654900003	23720282				2021-06-18	
J	Lesko, MM; Jenks, T; O'Brien, SJ; Childs, C; Bouamra, O; Woodford, M; Lecky, F				Lesko, Mehdi Moazzez; Jenks, Tom; O'Brien, Sara J.; Childs, Charmaine; Bouamra, Omar; Woodford, Maralyn; Lecky, Fiona			Comparing Model Performance for Survival Prediction Using Total Glasgow Coma Scale and Its Components in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						GCS; Glasgow Coma Scale; outcome; prognosis; traumatic brain injury	ADMISSION CHARACTERISTICS; RELIABILITY; VALIDATION; SCORES; IMPACT; CARE	The Glasgow Coma Scale (GCS) score is used in clinical practice for patient assessment and communication among clinicians and also in outcome prediction models such as the Trauma and Injury Severity Score (TRIS). The objective of this study is to determine which GCS subscore is best associated with outcome, taking time of assessment into account. Records of patients with brain injury who presented after 1989 were extracted from the Trauma Audit and Research Network (TARN) database. Using logistic regression, a baseline model was derived with age, Injury Severity Score (ISS), and year of injury as covariates and survival at discharge as the dependent variable. Total GCS, its subscores, and their combinations at various time points were separately added to the baseline model to compare their effect on model performance. The dataset contained 21,657 cases. The total GCS score at scene and its subscores had significantly lower predictive power compared with those recorded on arrival at the Emergency Department (ED) (scene total GCS: Area Under the Curve-AUC: 0.89; 95% confidence interval [CI]: 0.89-0.90) and Nagelkerke R-2 of 0.55, admission total GCS: AUC of 0.91; 95% CI: 0.91-0.91, and Nagelkerke R-2 of 0.59). Eye and verbal subscores had significantly lower performances compared with total GCS, motor subscore, and various combinations of subscores. Motor subscore and total GCS appeared to have similar predictive performance (admission total and motor GCS both had AUC of 0.91 (95% CI: 0.91-0.92) and Nagelkerke R-2 of 0.59 and 0.58, respectively). Motor subscore contains most of the predictive power of the total score. GCS on arrival is a significantly better predictor of outcome than that recorded at scene.	[Lesko, Mehdi Moazzez; Jenks, Tom; Bouamra, Omar; Woodford, Maralyn; Lecky, Fiona] Salford Royal Hosp, TARN, Salford M6 8HD, Lancs, England; [O'Brien, Sara J.] Univ Liverpool, Inst Infect & Global Hlth, Natl Ctr Zoonosis Res, Neston, England; [Childs, Charmaine] Natl Univ Singapore, Yong Loo Lin Sch Med, Alice Lee Ctr Nursing Studies, Clin Res Ctr, Singapore 117595, Singapore	Lesko, MM (corresponding author), Salford Royal Hosp, TARN, Clin Sci Bldg Eccles Old Rd, Salford M6 8HD, Lancs, England.	mehdimlesko@gmail.com		bouamra, omar/0000-0002-3155-4634; O'Brien, Sarah Jane/0000-0003-2896-8999	Trauma Audit and Research Network (TARN); Overseas Research Students (ORS) Award Scheme, University of Manchester	We would like to thank TARN members of staff and participating hospitals for the collection and submission of the data. This work was in part funded by the Trauma Audit and Research Network (TARN) and Overseas Research Students (ORS) Award Scheme, University of Manchester.	Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; *ASS ADV AUT MED, 2001, ABBR INJ SCAL; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; David W, 2000, APPL LOGISTIC REGRES; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Intercollegiate Group of Trauma Standards, 2009, REG TRAUM SYST INT G; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81	20	15	17	0	7	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	2013	30	1					17	22		10.1089/neu.2012.2438			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	061GU	WOS:000312837300004	22931390				2021-06-18	
J	Preece, MHW; Geffen, GM; Horswill, MS				Preece, Megan H. W.; Geffen, Gina M.; Horswill, Mark S.			Return-to-driving expectations following mild traumatic brain injury	BRAIN INJURY			English	Article						Brain concussion; mild head injury; fitness-to-drive; automobile driving; motor vehicles; attitudes	EMERGENCY-DEPARTMENT ASSESSMENT; HAZARD PERCEPTION; HEAD-INJURY; OLDER DRIVERS; CONCUSSION; PREDICTION; KNOWLEDGE; ATTITUDES; SYMPTOMS	Aim: Although individuals recovering from mild traumatic brain injury (MTBI) could pose a risk to road safety, little is known about their intentions regarding return-to-driving. Reported are the expectations of a sample of emergency department patients with MTBI regarding their recovery and return-to-driving. Method: Eighty-one patients with MTBI were recruited from an emergency department. Participants completed an 11-item questionnaire measuring expectations regarding recovery from injury; five of the items addressed return-to-driving. Results: Only 48% of the sample intended to reduce their driving following their injury. However, those that did intend to reduce their driving nominated a mean duration of 16.59 days (SD = 31.68) of reduced exposure. A logistic regression found that previous head injury experience and an interaction between pain and previous head injury experience predicted intentions to reduce driving. Similarly, a multiple regression revealed that pain level contributed significantly to the variance in time estimates of return-to-driving. Conclusion: The finding that half the individuals recovering from MTBI do not intend to moderate their driving exposure post-injury is cause for concern, as another study has shown that driving performance is compromised in this group immediately after injury.	[Preece, Megan H. W.] Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4122, Australia; [Preece, Megan H. W.; Geffen, Gina M.; Horswill, Mark S.] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia	Preece, MHW (corresponding author), Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4122, Australia.	megan.preece@griffithuni.edu.au	Horswill, Mark/J-9029-2019; Preece, Megan/A-7186-2013	Horswill, Mark/0000-0002-0286-6292; Preece, Megan/0000-0003-4852-8712			Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Darby P, 2009, SAFETY SCI, V47, P436, DOI 10.1016/j.ssci.2008.05.004; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Horswill MS, 2011, ACCIDENT ANAL PREV, V43, P2121, DOI 10.1016/j.aap.2011.05.035; Horswill MS, 2010, J INT NEUROPSYCH SOC, V16, P939, DOI 10.1017/S135561771000055X; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Linden MA, 2006, ARCH CLIN NEUROPSYCH, V21, P763, DOI 10.1016/j.acn.2006.08.010; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; McKenna F.P., 1999, IATSS RES, V23, P26; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Smith SS, 2009, ACCIDENT ANAL PREV, V41, P729, DOI 10.1016/j.aap.2009.03.016; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Wechsler D, 1981, WESCHLER ADULT INTEL; Wells P, 2008, STUDY LEARNER NEW DR	25	15	15	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2013	27	1					83	91		10.3109/02699052.2012.722260			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	059IY	WOS:000312699300009	23252439	Green Published			2021-06-18	
J	Qureshi, JS; Ohm, R; Rajala, H; Mabedi, C; Sadr-Azodi, O; Andren-Sandberg, A; Charles, AG				Qureshi, Javeria S.; Ohm, Rebecka; Rajala, Henrik; Mabedi, Charles; Sadr-Azodi, Omid; Andren-Sandberg, Ake; Charles, Anthony G.			Head injury triage in a sub Saharan African urban population	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Head injury; Traumatic brain injury; Glasgow Coma Score; Malawi; Africa	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; PRACTICAL SCALE; CARE; IMPACT; COUNTRIES; UGANDA; MALAWI; MODEL	Background: Injuries are the ninth leading cause of death in the world and disproportionately affect low- and middle-income countries. Head injury is the leading cause of trauma death. This study examines the epidemiology and outcomes of traumatic head injury presenting to a tertiary hospital in Malawi, in order to determine effective triage in a resource limited setting. Methods: The study was conducted at Kamuzu Central Hospital (KCH) in Lilongwe Malawi during a three-month period. Vital signs and Glasgow Coma Score (GCS) were prospectively collected for all patients that presented to the casualty department secondary to head injury. All head injury admissions were followed until death or discharge. Results: During the three-month study period, 4411 patients presented to KCH secondary to trauma and 841 (19%) had a head injury. A multivariate logistic regression model revealed that GCS and heart rate changes correlated strongly with mortality. There is a four-fold increase in the odds of mortality in moderate versus mild head injury based on GCS. Conclusion: In a resource limited setting, basic trauma tools such as GCS and heart rate can effectively triage head injury patients, who comprise the most critically ill trauma patients. Improvements in head injury outcome require multifaceted efforts including the development of a trauma system to improve pre-hospital care. (C) 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.	[Qureshi, Javeria S.; Charles, Anthony G.] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [Qureshi, Javeria S.; Mabedi, Charles] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi; [Ohm, Rebecka; Rajala, Henrik; Sadr-Azodi, Omid; Andren-Sandberg, Ake] Karolinska Univ Hosp, Dept Surg, Stockholm, Sweden	Qureshi, JS (corresponding author), Univ N Carolina, Dept Surg, 4001 Burnett Womack Bldg,CB 7050, Chapel Hill, NC 27599 USA.	jsquresh@gmail.com		Sadr Azodi, Omid/0000-0001-8093-7685	North Carolina Jaycee Burn Center; North Carolina TRACS grant	North Carolina Jaycee Burn Center.; North Carolina TRACS grant.	Ackaah W, 2010, TRAFFIC INJ PREV, V11, P522, DOI 10.1080/15389588.2010.489198; Alexander T, 2009, S AFR J SURG, V47, P120; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; Hyder AA, 2007, ASIA-PAC J PUBLIC HE, V19, P16, DOI 10.1177/10105395070190020401; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Jayaraman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006955; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; Kobusingye OC, 2000, J TRAUMA, V48, P498, DOI 10.1097/00005373-200003000-00022; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; MacLeod JBA, 2003, EUR J TRAUMA, V29, P392, DOI DOI 10.1007/s00068-003-1277-5; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mock C, 2004, GUIDELIENS ESSENTIAL; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; MOCK CN, 1993, J TRAUMA, V35, P518, DOI 10.1097/00005373-199310000-00004; Murray CJL., 1996, GLOBAL HLTH STAT COM; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; Oginni Fadekemi O, 2007, Traffic Inj Prev, V8, P137, DOI 10.1080/15389580601058472; Oluwadiya KS, 2009, ACCIDENT ANAL PREV, V41, P294, DOI 10.1016/j.aap.2008.12.002; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Samuel JC, 2010, TROP DOCT, V40, P98, DOI 10.1258/td.2009.090009; Samuel JC, 2009, WORLD J SURG, V33, P1836, DOI 10.1007/s00268-009-0113-4; Solagberu Babatunde A, 2002, West Afr J Med, V21, P230; Stewart de Ramirez S, 2011, ANN REV PUBLIC HLTH; TEASDALE G, 1974, LANCET, V2, P81; Tiska MA, 2004, EMERG MED J, V21, P237, DOI 10.1136/emj.2002.002097; Trauma ACoSCo, 1976, RES OPT CAR INJ PAT; World Health Organization, 2009, WHO COUNTR COOP STRA; 2001, AM J PREV MED S4, V21, P16	36	15	15	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191			INT J SURG	Int. J. Surg.		2013	11	3					265	269		10.1016/j.ijsu.2013.01.011			5	Surgery	Surgery	117FF	WOS:000316938200014	23380244	Bronze			2021-06-18	
S	Shi, YJ; Kim, D; Caldwell, M; Sun, DD		Annunziato, L		Shi, Yejie; Kim, Dong; Caldwell, Marie; Sun, Dandan			The Role of Na+/H+ Exchanger Isoform 1 in Inflammatory Responses: Maintaining H+ Homeostasis of Immune Cells	SODIUM CALCIUM EXCHANGE: A GROWING SPECTRUM OF PATHOPHYSIOLOGICAL IMPLICATIONS	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	6th International Conference on Sodium Calcium Exchange	OCT 01-05, 2011	Lacco Ameno, ITALY			Na+/H+ exchange; Na+/Ca2+ exchange; Inflammation; H+ homeostasis	CENTRAL-NERVOUS-SYSTEM; DENDRITIC CELLS; HUMAN-NEUTROPHILS; INTERFERON-GAMMA; NADPH OXIDASES; RAT MYOCARDIUM; UP-REGULATION; MICROGLIA; ACTIVATION; STROKE	The Na+/H+ exchangers (NHEs) are a family of membrane transporter proteins which catalyze the electroneutral exchange of one Na+ for one H+ and thus regulate intracellular pH (pH(i)) and cell volume. It is shown that Na+/H+ exchanger isoform 1 (NHE-1), but not other isoforms, is the important mechanism in extruding H+ and regulating pH(i) in the immune system. Immune cells, such as monocytes and neutrophils, generate reactive oxygen species (ROS) and cytokines in response to various stimuli and provide the first line of defense in the immune system. NHE-1 is activated during this respiratory burst and required to maintain an optimal pH(i) for the immune cells. In the central nervous system, NHE-1 is important for microglial (macrophage) activation and participates in the inflammatory response under pathological conditions including cerebral ischemia and traumatic brain injury. NHE-1 also affects Ca2+ homeostasis in microglia and contributes to the increase of [Ca2+](i) by coupling to the Na+/Ca2+ exchanger (NCX) stimulation, thus regulating immune cell function and participating in ischemic cell death. A better understanding of the function of NHE-1 in inflammatory responses will provide insight into its role in brain damage under disease conditions.	[Shi, Yejie; Kim, Dong; Caldwell, Marie; Sun, Dandan] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA	Sun, DD (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, S-598 South Biomed Sci Tower BST,3500 Terrace St, Pittsburgh, PA 15213 USA.	sund@upmc.edu	Shi, Yejie/C-2355-2018	Shi, Yejie/0000-0001-7502-9201	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS 48216, R01NS 38118]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038118, R01NS048216] Funding Source: NIH RePORTER	This work was supported by NIH grants R01NS 48216 and R01NS 38118 (D. Sun). We would like to thank Douglas B. Kintner for his critical comments of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bennett CL, 2012, TRENDS IMMUNOL, V33, P8, DOI 10.1016/j.it.2011.09.008; Bernardes-Silva M, 2001, J CEREBR BLOOD F MET, V21, P1115, DOI 10.1097/00004647-200109000-00009; Bhandaru M, 2012, PFLUG ARCH EUR J PHY, V463, P355, DOI 10.1007/s00424-011-1015-5; BIEMESDERFER D, 1992, AM J PHYSIOL, V263, pF833; Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; De Vito P, 2006, CELL IMMUNOL, V240, P69, DOI 10.1016/j.cellimm.2006.07.001; Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218; Felger JC, 2010, BRAIN BEHAV IMMUN, V24, P724, DOI 10.1016/j.bbi.2009.11.002; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Fukushima T, 1996, J CELL BIOL, V132, P1037, DOI 10.1083/jcb.132.6.1037; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; Harrigan TJ, 2008, J NEUROCHEM, V106, P2449, DOI 10.1111/j.1471-4159.2008.05553.x; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; Hsu C Y, 2000, J Stroke Cerebrovasc Dis, V9, P24, DOI 10.1053/jscd.2000.19318; Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; Luo J, 2007, CURR NEUROVASC RES, V4, P205; Martins PS, 2003, SHOCK, V20, P208, DOI 10.1097/01.shk.0000079425.52617.db; Matsuda T, 2006, J PHARMACOL SCI, V102, P22, DOI 10.1254/jphs.FMJ06002X4; Moor AN, 2001, J BIOL CHEM, V276, P16113, DOI 10.1074/jbc.M100519200; Nagano T, 2004, J NEUROCHEM, V90, P784, DOI 10.1111/j.1471-4159.2004.02511.x; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Petrecca K, 1999, AM J PHYSIOL-HEART C, V276, pH709; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Reichmann G, 2002, J NEUROIMMUNOL, V129, P125, DOI 10.1016/S0165-5728(02)00184-4; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158; Rotte A, 2010, CELL PHYSIOL BIOCHEM, V26, P553, DOI 10.1159/000322323; Rotte A, 2010, PFLUG ARCH EUR J PHY, V460, P1087, DOI 10.1007/s00424-010-0879-0; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Soeiro-Pereira PV, 2012, BRIT J PHARMACOL, V166, P1617, DOI 10.1111/j.1476-5381.2011.01764.x; SWALLOW CJ, 1993, J CELL PHYSIOL, V157, P453, DOI 10.1002/jcp.1041570304; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Zhang L, 2003, STROKE, V34, P1790, DOI 10.1161/01.STR.0000077016.55891.2E; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	43	15	17	0	4	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	0065-2598		978-1-4614-4756-6	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2013	961						411	418		10.1007/978-1-4614-4756-6_35			8	Medicine, Research & Experimental; Physiology	Research & Experimental Medicine; Physiology	BA3PQ	WOS:000334582100036	23224899				2021-06-18	
J	Sreenivasan, S; Garrick, T; McGuire, J; Smee, DE; Dow, D; Woehl, D				Sreenivasan, Shoba; Garrick, Thomas; McGuire, James; Smee, Daniel E.; Dow, Daniel; Woehl, Daniel			Critical Concerns in Iraq/Afghanistan War Veteran-Forensic Interface: Combat-Related Postdeployment Criminal Violence	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							AFGHANISTAN; IRAQ	Identifying whether there is a nexus between Iraq and Afghanistan combat injuries and civilian violence on return from deployment is complicated by differences in reactions of individuals to combat exposure, the overlapping effects of traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD), and the low base rate of civilian violence after combat exposure. Moreover, the overall prevalence of violence among returning Iraq and Afghanistan combat war veterans has not been well documented. Malingered symptoms and either exaggeration or outright fabrication of war zone exposure are challenges to rendering forensic opinions, with the risk reduced by accessing military documents that corroborate war zone duties and exposure. This article serves as a first step toward understanding what may potentiate violence among returning Iraq and Afghanistan veterans. We offer a systematic approach toward the purpose of forensic case formulation that addresses whether combat duty/war zone exposure and associated clinical conditions are linked to criminal violence on return to civilian life.	[Sreenivasan, Shoba] Greater Angeles VA Healthcare Syst Forens Outreac, Los Angeles, CA USA; [Sreenivasan, Shoba] USC Keck Sch Med, Los Angeles, CA USA; [Garrick, Thomas] UCLA David Geffen Sch Med, Los Angeles, CA USA; [Garrick, Thomas] Gen Hosp Psychiat, Greater Angeles VA Healthcare Syst Med Ctr, Los Angeles, CA USA; [McGuire, James] Vet Justice Programs, VHA, Los Angeles, CA USA; [Smee, Daniel E.] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA	Garrick, T (corresponding author), GLA VA Med Ctr, 11301 Wilshire Blvd,116-AC, Los Angeles, CA 90073 USA.	thomas.garrick@va.gov					American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; Burchett K, 2008, NEWSLETTER SECTION 7, P13; Daniel DL, 2008, POSTTRAUMATIC STRESS; DiLulio JJ, 2008, WEEKLY STANDARD; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Grover EM, 2008, PACE L REV, V594; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook JG, 2010, WIDENER LAW SCH L 10, V43, P1; Howell T, 2012, MILITARY        0306; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kolb RK, 2006, VETERANS FOREIGN WAR, P12; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Miller L, 2012, AGGRESS VIOLENT BEH, V17, P354, DOI 10.1016/j.avb.2012.03.007; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Mumola CJ, 1996, PUBLICATION NCJ, V178888; Nidiffer FD, 2007, BRAIN INJURY, V4, P26; Noonan ME, 2007, 217199 NCJ US DEP JU; Pitman R. K., 1998, PTSD RES Q, V9, P1; Sontag Deborah, 2008, NY TIMES; Sparr L F, 1987, Bull Am Acad Psychiatry Law, V15, P141; Tanielian T, 2008, INVISIBLE WOUNDS WAR; US Army, 2012, ARM 2020 GEN HLTH DI; Walter Reed Army Institute of Research Land, BATTL TRAIN; Walter Reed Army Institute of Research (WRAIR), 2005, BATTL TRAIN; Walter Reed Army Institute of Research (WRAIR), 2005, BATTL TRAIN; Ziejewski M., 2007, BRAIN INJ PROF, V4, P10	29	15	15	0	20	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2013	41	2					263	273					11	Law; Psychiatry	Government & Law; Psychiatry	185CJ	WOS:000321942500012	23771940				2021-06-18	
J	Hoffmann, M; Lehmann, W; Rueger, JM; Lefering, R				Hoffmann, Michael; Lehmann, Wolfgang; Rueger, Johannes M.; Lefering, Rolf		Trauma Registry German Soc Trauma	Introduction of a novel trauma score	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Glasgow Coma Scale; pupil size; pupil reactivity; outcome; traumatic brain injury	GLASGOW COMA SCALE; HEAD-INJURED PATIENTS; BRAIN-INJURY; MORTALITY; PREDICTION; ADMISSION; SEVERITY; CARE	BACKGROUND: Early diagnosis of traumatic brain injury (TBI) and reliable prediction of outcome are essential for determining treatment strategies and allocating resources. This study introduces the Eppendorf-Cologne Scale (ECS) and evaluated its predictive accuracy for outcome and TBI presence compared with those of the Glasgow Coma Scale (GCS). METHODS: A retrospective cohort analysis of severely injured trauma patients registered in the Trauma Registry of the German Society for Trauma Surgery from 1993 to 2010 was conducted. Only directly admitted patients alive on admission and with complete data on GCS, pupil reactivity, and size were included. The ECS was modeled using pupil reactivity, size, and a modified GCS motor component. The unadjusted predictive role of each component was evaluated using multivariable regression analysis. The predictive power regarding the presence of TBI and outcome of the ECS and the GCS was modeled using area under the receiver operating characteristic (AUROC) curve analyses. RESULTS: A total of 28,305 patients fulfilled the study inclusion criteria. The ECS outmatched the predictive accuracy of the GCS for outcome (AUROC, 0.824; 95% confidence interval [95% CI], 0.817-0.831; and AUROC, 0.811; 95% CI, 0.804-0.818, respectively; r(s) = 0.887, p < 0.001) and TBI presence (AUROC, 0.813; 95% CI, 0.805-0.822; and AUROC, 0.777; 95% CI, 0.768-0.786, respectively; r(s) = 0.889, p < 0.001). Patients with TBI were five times more often unconscious at the scene and showed a 3.5-fold increased in-hospital mortality. An ECS score of 8 was associated with a 20-fold higher mortality compared with an ECS score of 0. The ECS differentiates patients with a fourfold higher mortality within the GCS 3 collective. CONCLUSION: The ECS shows a significantly higher accuracy for prediction of outcome and TBI presence compared with the GCS and provides a simple, yet reliable, stratification tool for early decision making. (J Trauma Acute Care Surg. 2012;73: 1607-1613. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Hoffmann, Michael; Lehmann, Wolfgang; Rueger, Johannes M.] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, D-20246 Hamburg, Germany; [Lefering, Rolf] Univ Witten Herdecke, Cologne Merheim Med Ctr, Inst Res Operat Med, Cologne, Germany	Hoffmann, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Martinistr 52D, D-20246 Hamburg, Germany.	mi.hoffmann@web.de	Lehmann, Wolfgang/H-3555-2012				Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Crossman J, 1998, INJURY, V29, P435, DOI 10.1016/S0020-1383(98)00079-5; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hoffmann M, 2011, BR J SURG S1, V99, P122; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Juarez V J, 1995, J Neurosci Nurs, V27, P283; Kung WM, 2011, INJURY, V42, P940, DOI 10.1016/j.injury.2010.09.019; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Namiki J, 2011, CLIN NEUROL NEUROSUR, V113, P393, DOI 10.1016/j.clineuro.2011.01.001; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Rehn M, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-17; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	25	15	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2012	73	6					1607	1613		10.1097/TA.0b013e318270d572			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	058FV	WOS:000312620400039	23188250				2021-06-18	
J	Lindgren, C; Nordh, E; Naredi, S; Olivecrona, M				Lindgren, Cecilia; Nordh, Erik; Naredi, Silvana; Olivecrona, Magnus			Frequency of Non-convulsive Seizures and Non-convulsive Status Epilepticus in Subarachnoid Hemorrhage Patients in Need of Controlled Ventilation and Sedation	NEUROCRITICAL CARE			English	Article						Epilepsy; Seizures; Non-convulsive seizures; Continuous electroencephalogram; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; CONTINUOUS EEG; ANTICONVULSANT PROPHYLAXIS; ELECTROGRAPHIC SEIZURES; INTRACRANIAL ANEURYSMS; EPILEPSY; MANAGEMENT; VASOSPASM	Background Non-convulsive seizures (NCSZ) can be more prevalent than previously recognized among comatose neuro-intensive care patients. The aim of this study was to evaluate the frequency of NCSZ and non-convulsive status epilepticus (NCSE) in sedated and ventilated subarachnoid hemorrhage (SAH) patients. Methods Retrospective study at a university hospital neuro-intensive care unit, from January 2008 until June 2010. Patients were treated according to a local protocol, and were initially sedated with midazolam or propofol or combinations of these sedative agents. Thiopental was added for treatment of intracranial hypertension. No wake-up tests were performed. Using NicoletOne(A (R)) equipment (VIASYS Healthcare Inc., USA), continuous EEG recordings based on four electrodes and a reference electrode was inspected at full length both in a two electrode bipolar and a four-channel referential montage. Results Approximately 5,500 h of continuous EEG were registered in 28 SAH patients (33 % of the patients eligible for inclusion). The median Glasgow Coma scale was 8 (range 3-14) and the median Hunt and Hess score was 4 (range 1-4). During EEG registration, no clinical seizures were observed. In none of the patients inter ictal epileptiform activity was seen. EEG seizures were recorded only in 2/28 (7 %) patients. One of the patients experienced 4 min of an NCSZ and one had a 5 h episode of an NCSE. Conclusion Continuous EEG monitoring is important in detecting NCSZ in sedated patients. Continuous sedation, without wake-up tests, was associated with a low frequency of subclinical seizures in SAH patients in need of controlled ventilation.	[Lindgren, Cecilia; Naredi, Silvana] Umea Univ, Div Anaesthesiol & Intens Care, Dept Surg & Perioperat Sci, S-90187 Umea, Sweden; [Nordh, Erik] Umea Univ, Div Clin Neurophysiol, Dept Pharmacol & Clin Neurosci, S-90187 Umea, Sweden; [Olivecrona, Magnus] Umea Univ, Div Neurosurg, Dept Pharmacol & Clin Neurosci, S-90187 Umea, Sweden	Lindgren, C (corresponding author), Umea Univ, Div Anaesthesiol & Intens Care, Dept Surg & Perioperat Sci, S-90187 Umea, Sweden.	cecilia.lindgren@anestesi.umu.se; erik.nordh@neuro.umu.se; silvana.naredi@anestesi.umu.se; magnus.olivecrona@neuro.umu.se	Viani, Rafael/V-1196-2018	Lindgren, Cecilia/0000-0002-4903-9374; Naredi, Silvana/0000-0002-4409-6089	Swedish Society of Medicine; Faculty of Medicine at Umea University	The kind cooperation and assistance of staff at the ICU, Umea University Hospital and at the Department of Neurophysiology in performing this study is gratefully acknowledged. This study was supported by grants from The Swedish Society of Medicine, and from the Faculty of Medicine at Umea University. A visiting professorship at the Rehabilitation Research Chair, King Saud University, Riyadh, Saudi Arabia, to author E.N. is gratefully acknowledged.	BAKER CJ, 1995, NEUROSURGERY, V37, P863, DOI 10.1227/00006123-199511000-00003; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Cascino GD, 2009, NEUROLOGY, V72, P1718, DOI 10.1212/WNL.0b013e3181a4e465; Chaisewikul R, 2001, COCHRANE DB SYST REV; Choi KS, 2009, J KOREAN NEUROSURG S, V46, P93, DOI 10.3340/jkns.2009.46.2.93; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2007, NEUROSURGERY, V61, P4; Claassen J, 2007, NEUROSURGERY, V61, P60, DOI 10.1227/01.neu.0000279724.05898.e7; DEFALCO FA, 1992, EPILEPSIA, V33, P343; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; DRAKE CG, 1988, J NEUROSURG, V68, P985; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gilmore E, 2010, NEUROLOGIST, V16, P165, DOI 10.1097/NRL.0b013e3181c7cd0b; Hanggi D, 2011, NEUROCRIT CARE, V15, P318, DOI 10.1007/s12028-011-9583-y; HART RG, 1981, NEUROSURGERY, V8, P417, DOI 10.1227/00006123-198104000-00002; Hart Y, 2011, J NEUROSURG, V115, P1159, DOI 10.3171/2011.6.JNS101836; Hirsch LJ, 2008, EPILEPSIA, V49, P968, DOI 10.1111/j.1528-1167.2007.01481.x; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; KASSELL NF, 1982, NEUROSURGERY, V11, P337, DOI 10.1227/00006123-198209000-00001; Kriz J, 2003, EPILEPSY RES, V52, P215, DOI 10.1016/S0920-1211(02)00213-9; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; LARKIN JG, 1991, EPILEPSY RES, V9, P71, DOI 10.1016/0920-1211(91)90049-L; Lin CL, 2003, J NEUROSURG, V99, P978, DOI 10.3171/jns.2003.99.6.0978; Little AS, 2007, J NEUROSURG, V106, P805, DOI 10.3171/jns.2007.106.5.805; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; MEYER FB, 1990, EPILEPSIA, V31, P68, DOI 10.1111/j.1528-1157.1990.tb05362.x; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Pinto AN, 1996, J NEUROL, V243, P161, DOI 10.1007/BF02444009; Rathakrishnan R, 2011, NEUROCRIT CARE, V14, P152, DOI 10.1007/s12028-010-9495-2; Rhoney DH, 2000, NEUROLOGY, V55, P258, DOI 10.1212/WNL.55.2.258; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Sakowitz OW, 2006, NEUROSURGERY, V58, P137, DOI 10.1227/01.NEU.0000194532.47239.7C; Schmidt JM, 2011, NEUROCRIT CARE, V14, P149, DOI 10.1007/s12028-011-9519-6; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Stuart RM, 2010, NEUROCRIT CARE, V13, P355, DOI 10.1007/s12028-010-9414-6; SUNDARAM MBM, 1986, CAN J NEUROL SCI, V13, P229, DOI 10.1017/S0317167100036325; TEASDALE G, 1974, LANCET, V2, P81; Theilen HJ, 2000, CRIT CARE MED, V28, P3522, DOI 10.1097/00003246-200010000-00029; Tomycz Luke, 2011, Surg Neurol Int, V2, P90, DOI 10.4103/2152-7806.82372; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Zapater P, 1998, BRAIN RES, V796, P311, DOI 10.1016/S0006-8993(98)00352-7; Zubkov Alexander Y, 2008, Rev Neurol Dis, V5, P178	50	15	15	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2012	17	3					367	373		10.1007/s12028-012-9771-4			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	050QP	WOS:000312069400009	22932991				2021-06-18	
J	Peters, M; Trembovler, V; Alexandrovich, A; Parnas, M; Birnbaumer, L; Minke, B; Shohami, E				Peters, Maximilian; Trembovler, Victoria; Alexandrovich, Alexander; Parnas, Moshe; Birnbaumer, Lutz; Minke, Baruch; Shohami, Esther			Carvacrol Together with TRPC1 Elimination Improve Functional Recovery after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						head trauma; neuronal cell death; TBI	NF-KAPPA-B; CHANNELS; NEUROPROTECTION; OVEREXPRESSION; ACTIVATION; APOPTOSIS; STROKE	Death of Central Nervous System (CNS) neurons following traumatic brain injury (TBI) is a complex process arising from a combination of factors, many of which are still unknown. It has been found that inhibition of transient receptor potential (TRP) channels constitutes an effective strategy for preventing death of CNS neurons following TBI. TRP channels are classified into seven related subfamilies, most of which are Ca2+ permeable and involved in many cellular functions, including neuronal cell death. We hypothesized that TRP channels of the TRPC subfamily may be involved in post-TBI pathophysiology and that the compound 5-isopropyl-2-methylphenol (carvacrol), by inhibition of TRP channels, may exert neuroprotective effect after TBI. To test these suppositions, carvacrol was given to mice after TBI and its effect on their functional recovery was followed for several weeks. Our results show that neurological recovery after TBI was significantly enhanced by application of carvacrol. To better define the type of the specific channel involved, the effect of carvacrol on the extent and speed of recovery after TBI was compared among mice lacking TRPC1, TRPC3, or TRPC5, relative to wild type controls. We found that neurological recovery after TBI was significantly enhanced by combining carvacrol with TRPC1 elimination, but not by the absence of TRPC3 or TRPC5, showing a synergistic effect between carvacrol application and TRPC1 elimination. We conclude that TRPC1-sensitive mechanisms are involved in TBI pathology, and that inhibition of this channel by carvacrol enhances recovery and should be considered for further studies in animal models and humans.	[Trembovler, Victoria; Alexandrovich, Alexander; Shohami, Esther] Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, Inst Drug Res,Sch Pharm, IL-91120 Jerusalem, Israel; [Peters, Maximilian; Parnas, Moshe; Minke, Baruch] IMRIC, Dept Med Neurobiol, Jerusalem, Israel; [Peters, Maximilian; Parnas, Moshe; Minke, Baruch] Edmond & Lily Safra Ctr Brain Sci ELSC, Jerusalem, Israel; [Birnbaumer, Lutz] NIEHS, Neurobiol Lab, NIH, Res Triangle Pk, NC 27709 USA	Shohami, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, Inst Drug Res,Sch Pharm, IL-91120 Jerusalem, Israel.	esty.shohami@mail.huji.ac.il	Peters, Maximilian/AAA-3509-2020; Peters, Maximilian/B-7406-2008	Parnas, Moshe/0000-0001-9726-1511	Rosetrees TrustRosetrees Trust; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z01-ES-101684]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01ES101684, ZIAES101684] Funding Source: NIH RePORTER	This study was approved by the Institutional Animal Care Committee of the Hebrew University. We thank Ben Katz for critical reading of the manuscript. This research was supported by grants from the Rosetrees Trust (to Dr. Minke) and by the Intramural Research Program of the National Institutes of Health (NIH) (project Z01-ES-101684 to Dr. Lutz Birnbaumer).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Andersen A, 2006, INT J TOXICOL, V25, P1, DOI [10.1080/10915810600716570, 10.1080/10915810600716653, 10.1080/10915910600716612]; Beni SM, 2006, J CEREBR BLOOD F MET, V26, P478, DOI 10.1038/sj.jcbfm.9600209; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Dadon D, 2010, INT J BIOCHEM CELL B, V42, P1430, DOI 10.1016/j.biocel.2010.04.006; De Vincenzi M, 2004, FITOTERAPIA, V75, P801, DOI 10.1016/j.fitote.2004.05.002; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Marasa BS, 2006, BIOCHEM J, V397, P77, DOI 10.1042/BJ20060124; Metna-Laurent M, 2012, J NEUROSCI, V32, P7109, DOI 10.1523/JNEUROSCI.1054-12.2012; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; Narayanan KL, 2008, NEUROSCI LETT, V446, P117, DOI 10.1016/j.neulet.2008.09.034; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nishida M, 2006, MICROCIRCULATION, V13, P535, DOI 10.1080/10739680600885111; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Parnas M, 2011, COMPREHENSIVE BIOPHYSICS, VOL 6: CHANNELS, P68, DOI 10.1016/B978-0-12-374920-8.00617-2; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; Shan D, 2008, AM J PHYSIOL-CELL PH, V294, pC833, DOI 10.1152/ajpcell.00313.2007; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Yu H., 2012, PLOS ONE, V7; Yuan JP, 2012, ACTA PHYSIOL, V204, P238, DOI 10.1111/j.1748-1716.2011.02319.x; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784	33	15	16	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2012	29	18					2831	2834		10.1089/neu.2012.2575			4	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	050ZE	WOS:000312092800013	22994850	Green Published			2021-06-18	
J	Yu, ZQ; Zha, JH				Yu, Zheng-Quan; Zha, Ji-Hui			Genetic Ablation of Toll-Like Receptor 2 Reduces Secondary Brain Injury Caused by Cortical Contusion in Mice	ANNALS OF CLINICAL AND LABORATORY SCIENCE			English	Article						Traumatic brain injury; Cerebral inflammation; Toll-like receptor 2	RAT MODEL; ACTIVATION; PROGESTERONE; INFLAMMATION; HEMORRHAGE; EXPRESSION; CYTOKINES	Previous studies have shown that Toll-like receptor 2 (TLR2) was up-regulated after traumatic brain injury (TBI), but the potential contribution of TLR2 to TBI still remains unclear. The present study investigated the role of TLR2 in modulating TBI-induced secondary brain injury in mice. Wild-type TLR2(+/+) and TLR2(-/-)-deficient mice were subjected to a moderately severe weight-drop impact head injury. Brain samples were extracted at 24 hours after trauma. We measured TLR2 by western blot; motor function by Grip test; brain edema by wet/dry method; cortical apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) method; and IL-1 beta, TNF-alpha and IL-6 by enzyme-linked immunosorbent assay (ELISA). We found the absence of TLR2 function in mice resulted in ameliorating brain injury as shown by the reduced severity of neurological deficit, apoptosis, and brain edema at 24 hours after TBI, which was associated with the decreased expression of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6), compared with their wild-type counterparts after TBI. In combination, these results suggest that TLR2 might play an important aggravating role in the pathogenesis of TBI-induced secondary brain injury, possibly by regulating inflammatory cytokines in the cortex.	[Yu, Zheng-Quan] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Jiangsu, Peoples R China; [Zha, Ji-Hui] Xuzhou Med Coll, Dept Neurosurg, Xuzhou 221002, Jiangsu, Peoples R China	Yu, ZQ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Jiangsu, Peoples R China.	yuzhengquan1964@gmail.com					Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen G, 2009, CYTOKINE, V45, P162, DOI 10.1016/j.cyto.2008.11.015; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Johnson Pauline, 2009, Crit Rev Immunol, V29, P347; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Lee Sung Joong, 2002, Current Drug Targets - Inflammation and Allergy, V1, P181; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Mallard C, 2009, CLIN PERINATOL, V36, P763, DOI 10.1016/j.clp.2009.07.009; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Palsson-McDermott EM, 2007, IRISH J MED SCI, V176, P253, DOI 10.1007/s11845-007-0103-1; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Sen O, 2011, TURK NEUROSURG, V21, P203, DOI 10.5137/1019-5149.JTN.3646-10.1; Yuan TM, 2010, J NEUROIMMUNOL, V229, P16, DOI 10.1016/j.jneuroim.2010.08.008	23	15	15	1	9	ASSOC CLINICAL SCIENTISTS	MIDDLEBURY	PO BOX 1287, MIDDLEBURY, VT 05753 USA	0091-7370	1550-8080		ANN CLIN LAB SCI	Ann. Clin. Lab. Sci.	WIN	2012	42	1					26	33					8	Medical Laboratory Technology	Medical Laboratory Technology	980SR	WOS:000306913900005	22371907				2021-06-18	
J	Sherman, MD; Perlick, DA; Straits-Troster, K				Sherman, Michelle D.; Perlick, Deborah A.; Straits-Troester, Kristy			Adapting the Multifamily Group Model for Treating Veterans With Posttraumatic Stress Disorder	PSYCHOLOGICAL SERVICES			English	Article						multifamily groups; family psychoeducation; PTSD; veterans; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; MALE VIETNAM VETERANS; FAMILY PSYCHOEDUCATION; MILITARY FAMILIES; SOCIAL SUPPORT; SAFE PROGRAM; RISK-FACTORS; THERAPY; IRAQ	The Department of Veterans Affairs (VA) health care system's leadership has endorsed family involvement in veterans' mental health care as an important component of treatment. Both veterans and families describe family participation as highly desirable, and research has documented that having healthy social support is a strong protective factor for posttraumatic stress disorder (PTSD). Family psychoeducation has been shown to be effective in preventing relapse among severely mentally ill, and preliminary evidence suggests that family interventions for PTSD may improve veteran and family outcomes. The multifamily group (MFG) treatment model incorporates psychoeducation, communication training, and problem-solving skill building, and it increases social support through its group format. This article describes the rationale for further adaptation of the MFG model for PTSD, and it reviews issues related to its implementation as a promising adjunctive treatment as part of the continuum of PTSD services available in VA.	[Sherman, Michelle D.] Oklahoma City VA Med Ctr, Oklahoma City, OK 73104 USA; [Perlick, Deborah A.] VISN 3 Mental Illness Res Educ & Clin Ctr, Bronx, NY USA; [Perlick, Deborah A.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Straits-Troester, Kristy] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27706 USA	Sherman, MD (corresponding author), Oklahoma City VA Med Ctr, 921 NE 13th St 116A, Oklahoma City, OK 73104 USA.	michelle.sherman@va.gov		Sherman, Michelle/0000-0003-1055-9433			Batten SV, 2009, PSYCHOL SERV, V6, P184, DOI 10.1037/a0015392; Breitborde NJK, 2009, PSYCHIAT SERV, V60, P1477, DOI 10.1176/appi.ps.60.11.1477; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Carter Center, 2003, PRES NEW FREED COMM; Christianson A., 2000, RECONCILABLE DIFFERE; Erbes CR, 2009, PSYCHOL SERV, V6, P175, DOI 10.1037/a0016662; Garcia HA, 2011, PSYCHOL SERV, V8, P1, DOI 10.1037/a0022705; Gewirtz AH, 2011, PROF PSYCHOL-RES PR, V42, P56, DOI 10.1037/a0022345; Glynn SM, 1999, J CONSULT CLIN PSYCH, V67, P243, DOI 10.1037/0022-006X.67.2.243; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horrell SCV, 2011, PROF PSYCHOL-RES PR, V42, P79, DOI 10.1037/a0022297; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; Lee TC, 2006, PSYCHIAT CLIN NEUROS, V60, P546, DOI 10.1111/j.1440-1819.2006.01556.x; Lester P, 2011, MIL MED, V176, P19, DOI 10.7205/MILMED-D-10-00122; Makin-Byrd K, 2011, PROF PSYCHOL-RES PR, V42, P47, DOI 10.1037/a0022292; McFarlane W.R., 2002, MULTIFAMILY GROUPS T; McFarlane WR, 2003, J MARITAL FAM THER, V29, P223, DOI 10.1111/j.1752-0606.2003.tb01202.x; Miklowitz DJ, 2008, ARCH GEN PSYCHIAT, V65, P1053, DOI 10.1001/archpsyc.65.9.1053; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; Mueser KT, 1999, BEHAV FAMILY THERAPY; Nezu A. M., 2007, SOLVING LIFES PROBLE; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Perlick DA, 2011, PROF PSYCHOL-RES PR, V42, P70, DOI 10.1037/a0022319; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sherman M. D., 2011, NAT VA MENT HLTH C W; Sherman MD, 2005, PROF PSYCHOL-RES PR, V36, P626, DOI 10.1037/0735-7028.36.6.626; Sherman MD, 2005, PSYCHIAT SERV, V56, P1624, DOI 10.1176/appi.ps.56.12.1624; Sherman MD, 2005, PSYCHIAT SERV, V56, P1150, DOI 10.1176/appi.ps.56.9.1150; Sherman MD, 2005, COMMUNITY MENT HLT J, V41, P115, DOI 10.1007/s10597-005-2647-8; Sherman MD, 2003, PROF PSYCHOL-RES PR, V34, P42, DOI 10.1037/0735-7028.34.1.42; SHERMAN MD, 2008, SAFE PROGRAM SUPPORT; Sherman MD, 2008, PROF PSYCHOL-RES PR, V39, P443, DOI 10.1037/0735-7028.39.4.443; Sherman MD, 2006, COMMUNITY MENT HLT J, V42, P213, DOI 10.1007/s10597-005-9018-3; Sherman MD, 2009, PROF PSYCHOL-RES PR, V40, P593, DOI 10.1037/a0016333; Sherman MD, 2009, PSYCHIAT SERV, V60, P254, DOI 10.1176/appi.ps.60.2.254; Straits-Troster K., 2011, BRAIN IMPAIR, V12, P15; Substance Abuse and Mental Health Services Administration, 2011, HHS PUBL; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Yalom I. D., 2005, THEORY PRACTICE GROU	47	15	15	0	17	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	NOV	2012	9	4			SI		349	360		10.1037/a0028963			12	Psychology, Clinical	Psychology	036ZP	WOS:000311071100003	22731838				2021-06-18	
J	Chew, BG; Spearman, CM; Quigley, MR; Wilberger, JE				Chew, Brandon G.; Spearman, Christopher M.; Quigley, Matthew R.; Wilberger, James E.			The prognostic significance of traumatic brainstem injury detected on T2-weighted MRI Clinical article	JOURNAL OF NEUROSURGERY			English	Article						trauma; brainstem injury; MRI; volumetric analysis; outcome; traumatic brain injury	SEVERE HEAD-INJURY; GLASGOW COMA SCALE; MAGNETIC-RESONANCE; DATA-BANK; CLASSIFICATION; TOMOGRAPHY; MECHANISM; SEVERITY; LESIONS; SCORE	Object. Magnetic resonance imaging is frequently used to evaluate patients with traumatic brain injury in the acute and subacute setting, and it can detect injuries to the brainstem, which are often associated with poor outcomes. This study was undertaken to determine which MRI and clinical factors provide prognostic information in patients with traumatic brainstem injuries. Methods. The authors performed a retrospective analysis of cases involving patients admitted to a Level I trauma center who were identified in a prospective database as having suffered traumatic brainstem injury identified on MRI. Patient outcomes were dichotomized to dead/vegetative versus functional groups. Standard demographic data, admission Glasgow Coma Scale (GCS) scores, results of the motor component of the GCS examination at admission and 24 hours later, CT scan findings, and peak intracranial pressure were collected from medical records. Volumetric analysis of each patient's injuries was performed with T2-weighted and gradient echo sequences. The T2-weighted MRI sequence for each patient was reviewed to determine the anatomical location of injury within the brainstem and whether the injury crossed the midline. Results. Thirty-six patients who met the study inclusion criteria were identified. At 6-month follow-up, 53% of these patients had poor outcomes and 47% had recovered. Patients with injuries to the medulla or deep bilateral injuries to the pons did not recover. The T2 volumes were found superior to gradient echo sequences in regard to predicting survival (ROC/AUC 0.67, p = 0.07 vs 0.60, p = 0.29, respectively), but neither reached statistical significance. The timing of MR image acquisition did not influence the findings. The time from admission to MRI did not differ significantly between the recovered group and the poor-outcome group (p = 0.52, Mann-Whitney test), and lesion size as measured by T2 volume did not vary with time to scan (R-2 = 0.03, p = 0.3, linear regression). Performing a stepwise logistic regression with all the variables yielded the following factors related to recovery: crossing midline, p = 0.0156, OR 0.075; and 24-hour GCS motor score, p = 0.0045, OR = 2.25, c-statistic 0.913. Further examination of these 2 factors disclosed the following: none of 15 patients with midline-crossing lesions and a 24-hour GCS motor score of 4 or less recovered; conversely, 12 of 13 patients with lesions that did not cross midline recovered, regardless of GCS motor score. Conclusions. Bilateral injury to the pons and medulla as detected on T2-weighted MRI sequences was associated with poor outcome in patients with brainstem injuries; T2 volumes were found superior to gradient echo sequences in regard to predicting survival, but neither reached statistical significance. When MRI findings were coupled with clinical examination findings, a strong correlation existed between poor outcome and the combination of bilateral brainstem injury and a motor GCS score of 4 or less 24 hours after admission. (http://thejns.org/doi/abs/10.3171/2012.6.JNS111736)	[Chew, Brandon G.; Spearman, Christopher M.; Quigley, Matthew R.; Wilberger, James E.] Allegheny Gen Hosp, Dept Neurosurg, Pittsburgh, PA 15212 USA	Chew, BG (corresponding author), Allegheny Gen Hosp, Dept Neurosurg, 420 East North Ave,Suite 302, Pittsburgh, PA 15212 USA.	bgcneuromd@gmail.com					CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Lagares A, 2006, NEUROCIRUGIA, V17, P105; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z	23	15	15	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2012	117	4					722	728		10.3171/2012.6.JNS111736			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	015YZ	WOS:000309485600021	22860606				2021-06-18	
J	Auxemery, Y				Auxemery, Y.			Mild traumatic brain injury and postconcussive syndrome: A re-emergent questioning	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						Postconcussive syndrome; Mild traumatic brain injury; Blast injuries; Physiopathology; Psychopathology; Comorbidities; Post traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; SYMPTOMS; POPULATION; CONCUSSION; MECHANISMS; IRAQ	Introduction. - Blast injuries are psychologically and physically devastating. Notably, primary blast injury occurs as a direct effect of changes in atmospheric pressure caused by a blast wave. The combat-related traumatic brain injuries (TBI) resulting from exposure to explosions is highly prevalent among military personnel who have served in current wars. Traumatic brain injury is a common cause of neurological damage and disability among civilians and servicemen. Most patients with TBI suffer a mild traumatic brain injury with transient loss of consciousness. A controversial issue in the field of head injury is the outcome of concussion. Literature findings. - Most individuals with such injuries are not admitted to emergency units and receive a variable degree of medical attention. Nevertheless, cranial traumas vary in their mechanisms (blast, fall, road accident, bullet-induced craniocerebral injury) and in their gravity (from minor to severe). The majority of subjects suffering concussion have been exposed to explosion or blast injuries, which have caused minor cranial trauma. Although some authors refuse to accept the reality of post-concussion syndrome (PCS) and confuse it with masked depression, somatic illnesses or post-traumatic stress, we have raised the question again of its existence, without denying the intricate links with other psychiatric or neurological disorders. Although the mortality rate is negligible, the traumatic sequel after mild traumatic brain injury is clear. A difference in initial somatic severity is noted between the serious somatic consequences of a severe cranial trauma compared with the apparently benign consequences of a minor cranial trauma. However, the long-term consequences of the two types of impacts are far from negligible: PCS is a source of morbidity. The prognosis for minor cranial traumas is benign at vital level but a number of patients will develop long-term complaints, which contrast with the negativity of the clinical examination and complementary explorations. The origin of these symptoms questions their organic and psychological aetiologies, which are potentially associated or intricately linked. After a cerebral concussion patients report a cluster of symptoms referred to as postconcussive. Clinical findings. - Post-concussion syndrome lies within the confines of somatic symptoms (headaches, dizziness, and fatigue), cognitive symptoms (memory and concentration problems) and affective symptoms (irritability, emotional lability, depression, anxiety, trouble sleeping). The nosographical entity of post-concussion syndrome is still in the process of elaboration following the input of new research intended to determine a cluster of specific symptoms. The persistent post-concussion syndrome is believed to be due to the psychological effects of the injury, biological factors, or a combination of both. Considered in isolation, the symptoms of post-concussion syndrome are non-specific and come together with other diagnostic frameworks such as characterised depressive episodes and post-traumatic stress. Post-concussion syndrome is not specific to concussion but can be present in subjects without any previous cranial trauma. Discussion. Blast trauma can thus be understood as experiencing a shockwave on the brain and as a psycho-traumatic event. The major methodological problem of the studies is the quantification of the functional symptoms present in different nosographical frameworks, which are often co-morbid. Post-traumatic stress disorder is one of several psychiatric disorders that may increase suffering and disability among people with mild traumatic brain injury; in addition mood disorders also seem to be frequent psychiatric complications among these patients. Psychotic disorders after TBI have been associated with several brain regions. The establishment of a causative relationship between TBI and psychiatric disorders is interesting in terms of our understanding of these possible sequelae of TBI. The grey substance of the grey nuclei of the base can also be altered by a scissoring mechanism of the perforating arteries. A cortical contusion through impression of the cortex on the contours of the cranium is frequent. The most common type of injury is traumatic axonal injury. Cerebral lesions that are secondary to TBI associate cell deaths through the mechanisms of apoptosis and necrosis concerning the nerve and glial cells. The scientific objective is to discover an anatomoclinical correlation between the symptoms of post-concussion syndrome and objectifiable brain damage. The predictive value of serum concentrations of the specific serum markers S-100B and neurone specific enolase has been established. Conclusion. - Cerebral imaging will allow the mechanisms concerned in cranial trauma to be better understood and thus may allow these mechanisms to be linked with co-morbid post-traumatic psychiatric disorders such as depression. The pyschopathological approach provides supplementary enlightenment where neuroimaging studies struggle to establish precise anatomoclinical correlations between neurotraumatic lesions, state of post-traumatic stress, and PCS. Moving away from a purely scientific view to focus on subjectivity, PCS can establish itself in subjects with no history of head trauma thus showing purely psychic suffering. Is the former name of "subjective post-head injury syndrome" no longer pertinent since the neurobiological affections can be objectified? Yet, the tatter does not necessarily explain the somatic symptoms. Beyond any opposition of a psychic or somatic causality, it shows the complexity of this interaction. Admittedly, looking for a neuropathological affection is particularly cardinal to propose an aetiological model and objectify the lesions, which should be documented using a forensic approach. However, within the context of treatment, this theoretical division of the brain and the mind becomes less operative: the psychotherapeutic support will on the contrary back the indivisibility of the subject, he/she, who faced the "clatter". (C) L'Encephale, Paris, 2011.	Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, F-57070 Metz 3, France	Auxemery, Y (corresponding author), Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, 27 Ave Plantieres,BP 90001, F-57070 Metz 3, France.	yann.auxemery@hotmail.fr					American Psychiatric Association, 2000, DSM 4 TR MAN DIAGN S; [Anonymous], 1993, ARCH PHYS MED REHAB, V74, pS8; [Anonymous], 2006, CLIN PRACTICE GUIDEL; Auxemery Y, 2011, ENCEPHALE IN PRESS, DOI [10.1016/j.encep.2011.12.001, DOI 10.1016/J.ENCEP.2011.12.001]; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Engel CC, 2000, PSYCHOSOM MED, V62, P739, DOI 10.1097/00006842-200011000-00001; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kemp S, 2005, BRAIN INJURY, V19, P1269, DOI 10.1080/02699050500309353; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; *ORG MOND SANT, 1993, CLASS INT TROUBL MEN; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taber KH, 2007, J NEUROPSYCH CLIN N, V19, P100; Tagay S, 2005, J PSYCHOSOM RES, V58, P439, DOI 10.1016/j.jpsychores.2004.09.007; Tanelian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Waddington A, 2003, ENCEPHALE, V29, P20; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	38	15	15	0	53	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	SEP	2012	38	4					329	335		10.1016/j.encep.2011.07.003			7	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	028EL	WOS:000310405500008	22980474				2021-06-18	
J	Velez-Ruiz, NJ; Klein, JP				Velez-Ruiz, Naymee J.; Klein, Joshua P.			Neuroimaging in the Evaluation of Epilepsy	SEMINARS IN NEUROLOGY			English	Article						epilepsy; hippocampal sclerosis; cortical malformation; brain tumor; cavernous angioma; neurocutaneous disorder; traumatic brain injury	TEMPORAL-LOBE EPILEPSY; FOCAL CORTICAL DYSPLASIA; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; CEREBRAL GLUCOSE-METABOLISM; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL ATROPHY; TUBEROUS SCLEROSIS; SURGICAL-TREATMENT; INTRACRANIAL MENINGIOMAS; CAVERNOUS MALFORMATIONS	Neuroimaging has provided extraordinary insight into the pathologic substrate of epilepsy. The excellent spatial resolution and soft tissue contrast of magnetic resonance imaging (MRI) allows identification of a substantial number of pathologies including hippocampal sclerosis, malformations of cortical development, low grade tumors, and vascular abnormalities, among others. Complementary imaging modalities such as positron emission tomography, single photon emission computed tomography, and magnetoencephalography can be diagnostically helpful as well. Identification of a pathologic substrate is particularly important in patients with medically refractory epilepsy who are undergoing evaluation for surgery, and essential in determining the likelihood of seizure freedom after surgical intervention. This article reviews current and emerging neuroimaging techniques in the field of epilepsy.	[Velez-Ruiz, Naymee J.] Emory Univ Hosp, Dept Neurol, Div Epilepsy, Atlanta, GA 30322 USA; [Velez-Ruiz, Naymee J.] Emory Univ, Sch Med, Atlanta, GA USA; [Klein, Joshua P.] Brigham & Womens Hosp, Dept Neurol, Div Hosp Neurol, Boston, MA 02115 USA; [Klein, Joshua P.] Harvard Univ, Sch Med, Boston, MA USA	Velez-Ruiz, NJ (corresponding author), Emory Clin A, 1365 Clifton Rd, Atlanta, GA 30322 USA.	naymeejeannette@gmail.com					Alberstone CD, 2000, J NEUROSURG, V92, P79, DOI 10.3171/jns.2000.92.1.0079; Andrade CS, 2011, ARQ NEURO-PSIQUIAT, V69, P130, DOI 10.1590/S0004-282X2011000100024; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; AWAD IA, 1993, NEUROSURGERY, V33, P179, DOI 10.1227/00006123-199308000-00001; Bajic D, 2009, EUR RADIOL, V19, P2544, DOI 10.1007/s00330-009-1438-y; Barkovich AJ, 1997, NEUROLOGY, V49, P1148, DOI 10.1212/WNL.49.4.1148; Barkovich AJ, 2004, NEUROIMAG CLIN N AM, V14, P401, DOI 10.1016/j.nic.2004.04.003; Barry E., 2001, TREATMENT EPILEPSY P, P609; Baumann CR, 2006, EPILEPSIA, V47, P563, DOI 10.1111/j.1528-1167.2006.00468.x; Blum DE, 1998, EPILEPSIA, V39, P651, DOI 10.1111/j.1528-1157.1998.tb01434.x; Bruggemann JM, 2009, J CLIN NEUROSCI, V16, P780, DOI 10.1016/j.jocn.2008.08.025; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; CAVANAGH JB, 1956, BRIT MED J, V2, P1403, DOI 10.1136/bmj.2.5006.1403; Chang BS, 2003, EPILEPSY BEHAV, V4, P618, DOI 10.1016/j.yebeh.2003.09.006; Chapman K, 2005, J NEUROL NEUROSUR PS, V76, P710, DOI 10.1136/jnnp.2003.026757; Colombo N, 2003, EPILEPTIC DISORD, V5, pS67; Colombo N, 2003, AM J NEURORADIOL, V24, P724; CONNELLY A, 1994, NEUROLOGY, V44, P1411, DOI 10.1212/WNL.44.8.1411; DAUMASDUPORT C, 1988, NEUROSURGERY, V23, P545, DOI 10.1227/00006123-198811000-00002; Demir MK, 2006, EUR J RADIOL, V60, P48, DOI 10.1016/j.ejrad.2006.06.002; Detre JA, 1998, NEUROLOGY, V50, P926, DOI 10.1212/WNL.50.4.926; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Englot DJ, 2011, J NEUROSURG, V115, P1169, DOI 10.3171/2011.7.JNS11536; Eriksson SH, 2001, BRAIN, V124, P617, DOI 10.1093/brain/124.3.617; Farid N, 2012, RADIOLOGY, V264, P542, DOI 10.1148/radiol.12112638; Foldvary N, 1999, EPILEPSIA, V40, P26, DOI 10.1111/j.1528-1157.1999.tb01984.x; FRANCESCHI M, 1995, J NEUROL NEUROSUR PS, V59, P427, DOI 10.1136/jnnp.59.4.427; Funke ME, 2011, EPILEPSIA, V52, P10, DOI 10.1111/j.1528-1167.2011.03144.x; GAILLARD WD, 1995, EPILEPSY RES, V20, P77, DOI 10.1016/0920-1211(94)00065-5; GARCIA PA, 1995, MAGN RESON IMAGING, V13, P1181, DOI 10.1016/0730-725X(95)02030-W; GASTAUT H, 1976, EPILEPSIA, V17, P337, DOI 10.1111/j.1528-1157.1976.tb03412.x; Ginat DT, 2012, RADIOGRAPHICS, V32, P499, DOI 10.1148/rg.322105761; Golby AJ, 2002, EPILEPSIA, V43, P855, DOI 10.1046/j.1528-1157.2002.20501.x; Griffiths PD, 1996, NEUROPEDIATRICS, V27, P284, DOI 10.1055/s-2007-973796; Gross BA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1165; Grossman RI, 2003, NEURORADIOLOGY REQUI, P231; Grossman RI, 2003, NEURORADIOLOGY REQUI, P243; Grossman RI., 2003, NEURORADIOLOGY REQUI, V2nd ed.; Grossman RI, 2003, NEURORADIOLOGY REQUI, P98; Guerrini R, 2003, EPILEPTIC DISORD, V5, pS9; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; Hakyemez B, 2006, NEURORADIOLOGY, V48, P513, DOI 10.1007/s00234-006-0094-z; Hammen T, 2007, SEIZURE-EUR J EPILEP, V16, P248, DOI 10.1016/j.seizure.2007.01.001; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Henry TR, 2011, RADIOLOGY, V261, P199, DOI 10.1148/radiol.11101651; JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869; Jansen A, 2009, CLIN NEUROL NEUROSUR, V111, P57, DOI 10.1016/j.clineuro.2008.08.005; JOHANNSSON JH, 1981, J NEUROSURG, V54, P58, DOI 10.3171/jns.1981.54.1.0058; Kahlenberg CA, 2012, SEIZURE-EUR J EPILEP, V21, P540, DOI 10.1016/j.seizure.2012.05.014; Kamimura T, 2006, EPILEPSIA, V47, P991, DOI 10.1111/j.1528-1167.2006.00511.x; Kim Sunhee, 2011, Int J Mol Imaging, V2011, P813028, DOI 10.1155/2011/813028; Kim YH, 2011, EPILEPSIA, V52, P722, DOI 10.1111/j.1528-1167.2010.02950.x; KING D, 1995, EPILEPSIA, V36, P905, DOI 10.1111/j.1528-1157.1995.tb01634.x; Knake S, 2006, EPILEPSY RES, V69, P80, DOI 10.1016/j.eplepsyres.2006.01.001; Knowlton RC, 2006, ANN NEUROL, V59, P835, DOI 10.1002/ana.20857; KOELLER KK, 1992, AM J NEURORADIOL, V13, P1319; Koh S, 2000, EPILEPSIA, V41, P1206, DOI 10.1111/j.1528-1157.2000.tb00327.x; Kotagal P., 2001, TREATMENT EPILEPSY P, P627; KUZNIECKY R, 1993, ARCH NEUROL-CHICAGO, V50, P65, DOI 10.1001/archneur.1993.00540010059018; LEVESQUE MF, 1991, J NEUROSURG, V75, P364, DOI 10.3171/jns.1991.75.3.0364; Lieu AS, 2000, EPILEPSY RES, V38, P45; Lim CCT, 2005, AM J NEURORADIOL, V26, P61; Lippitz B, 1996, Acta Neurochir Suppl, V65, P108; Madan N, 2009, EPILEPSIA, V50, P9, DOI 10.1111/j.1528-1167.2009.02292.x; MANNO EM, 1994, NEUROLOGY, V44, P2331; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; Mathern GW, 2009, EPILEPSIA, V50, P45, DOI 10.1111/j.1528-1167.2009.02294.x; MCMURDO SK, 1987, AM J ROENTGENOL, V148, P791, DOI 10.2214/ajr.148.4.791; MEINERS LC, 1994, AM J NEURORADIOL, V15, P1547; Morris HH, 2001, TREATMENT EPILEPSIES, P615; Nagar VA, 2008, AM J NEURORADIOL, V29, P1147, DOI 10.3174/ajnr.A0996; OBrien TJ, 1997, EPILEPSIA, V38, P74, DOI 10.1111/j.1528-1157.1997.tb01080.x; Okada YC, 1997, ELECTROEN CLIN NEURO, V103, P474, DOI 10.1016/S0013-4694(97)00043-6; ORMSON MJ, 1986, RADIOLOGY, V160, P215, DOI 10.1148/radiology.160.1.3086931; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; Phi JH, 2010, J NUCL MED, V51, P728, DOI 10.2967/jnumed.109.070920; PRAYSON RA, 1993, EPILEPSIA, V34, P609, DOI 10.1111/j.1528-1157.1993.tb00436.x; Rabin ML, 2004, BRAIN, V127, P2286, DOI 10.1093/brain/awh281; RAYMOND AA, 1994, NEUROLOGY, V44, P1841, DOI 10.1212/WNL.44.10.1841; RAYMOND AA, 1994, BRAIN, V117, P461, DOI 10.1093/brain/117.3.461; Reinsberger C, 2010, NEUROIMAGE, V52, P1238, DOI 10.1016/j.neuroimage.2010.04.264; Richardson MP, 2006, NEUROLOGY, V66, P699, DOI 10.1212/01.wnl.0000201186.07716.98; Riela A R, 1985, Pediatr Neurol, V1, P85, DOI 10.1016/0887-8994(85)90042-6; Ruggieri PM, 2004, NEUROLOGY, V62, pS27, DOI 10.1212/01.WNL.0000117581.46053.18; SACKELLARES JC, 1990, NEUROLOGY, V40, P1420, DOI 10.1212/WNL.40.9.1420; Sakamoto S, 2003, EPILEPSIA, V44, P1196, DOI 10.1046/j.1528-1157.2003.08603.x; Salamon N, 2008, NEUROLOGY, V71, P1594, DOI 10.1212/01.wnl.0000334752.41807.2f; Salamon N, 2006, BRAIN, V129, P352, DOI 10.1093/brain/awh681; Saloner D, 2010, J NEURO-ONCOL, V99, P333, DOI 10.1007/s11060-010-0367-6; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Schwartz ES, 2010, PEDIATR RADIOL, V40, P50, DOI 10.1007/s00247-009-1451-y; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shorvon SD, 2009, EPILEPSIA, V50, P39, DOI 10.1111/j.1528-1167.2009.02038.x; Simos PG, 1999, J NEUROSURG, V91, P787, DOI 10.3171/jns.1999.91.5.0787; Sisodiya SM, 2000, BRAIN, V123, P1075, DOI 10.1093/brain/123.6.1075; Spanaki MV, 1999, J NUCL MED, V40, P730; SPENCER SS, 1994, EPILEPSIA, V35, pS72, DOI 10.1111/j.1528-1157.1994.tb05990.x; SPENCER SS, 1993, NEUROLOGY, V43, P2117, DOI 10.1212/WNL.43.10.2117; Spencer SS, 2001, TREATMENT EPILEPSY P, P1077; Stavrou I, 2008, NEUROSURGERY, V63, P888, DOI 10.1227/01.NEU.0000327881.72964.6E; Stufflebeam SM, 2011, NEUROSURG CLIN N AM, V22, P153, DOI 10.1016/j.nec.2010.11.006; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; SZELIES B, 1983, J COMPUT ASSIST TOMO, V7, P946, DOI 10.1097/00004728-198312000-00002; Tassi L, 2005, BRAIN, V128, P321, DOI 10.1093/brain/awh357; Theodore WH, 1997, EPILEPSIA, V38, P81, DOI 10.1111/j.1528-1157.1997.tb01081.x; Thiele EA, 2010, EPILEPSIA, V51, P90, DOI 10.1111/j.1528-1167.2009.02458.x; Velasco TR, 2011, NEUROSURGERY, V68, P431, DOI 10.1227/NEU.0b013e318201c293; von Oertzen J, 2002, NEUROLOGY, V58, P257, DOI 10.1212/WNL.58.2.257; von Oertzen J, 2002, J NEUROL NEUROSUR PS, V73, P643, DOI 10.1136/jnnp.73.6.643; Wang A, 2012, EPILEPSY RES TREAT, V2012, DOI DOI 10.1155/2012/198183; Wennberg R, 2011, CLIN NEUROPHYSIOL, V122, P1295, DOI 10.1016/j.clinph.2010.11.019; Widdess-Walsh P, 2005, EPILEPSY RES, V67, P25, DOI 10.1016/j.eplepsyres.2005.07.013; Wong CYO, 1996, J NUCL MED, V37, P1094; Woo CLF, 2001, PEDIATR NEUROL, V25, P295, DOI 10.1016/S0887-8994(01)00318-6; ZENTNER J, 1994, J NEUROL NEUROSUR PS, V57, P1497, DOI 10.1136/jnnp.57.12.1497	118	15	17	0	14	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	SEP	2012	32	4					361	373		10.1055/s-0032-1331809			13	Clinical Neurology	Neurosciences & Neurology	077AD	WOS:000313999400007	23361482	Bronze			2021-06-18	
J	Matsukawa, H; Shinoda, M; Fuji, M; Takahashi, O; Murakata, A; Yamamoto, D; Sumiyoshi, S; Ishikawa, R				Matsukawa, Hidetoshi; Shinoda, Masaki; Fuji, Motoharu; Takahashi, Osamu; Murakata, Atsushi; Yamamoto, Daisuke; Sumiyoshi, Sosuke; Ishikawa, Ryoichi			Intraventricular hemorrhage on computed tomography and corpus callosum injury on magnetic resonance imaging in patients with isolated blunt traumatic brain injury Clinical article	JOURNAL OF NEUROSURGERY			English	Article						blunt traumatic brain injury; corpus callosum; diffuse axonal injury; intraventricular hemorrhage	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; GLASGOW OUTCOME SCALE; PROGNOSIS; FEATURES; LESIONS	Object. Intraventricular hemorrhage (IVH) is widely regarded as one element of a complex involving severe blunt traumatic brain injury (TBI); corpus callosum injury (CCI) is recently considered to be one factor associated with poor outcome in patients with TBI. Although postmortem studies have focused on the relationship between IVH and CCI, there have been few investigations of IVH evidenced on CT scans as a predictor of CCI evidenced on MRI. Methods. The authors retrospectively reviewed prospectively collected data from 371 patients with blunt TBI, without trauma to the face, chest, abdomen, extremities, or pelvic girdle, requiring immediate therapeutic intervention. Their aim was to investigate whether IVH found on CT predicts CCI on MRI. Clinical and radiological data were collected between June 2003 and February 2011. First, the authors classified patients into groups of those with CCI and those without CCI, and they compared clinical and radiological findings between them. Then, they investigated prognostic factors that were related to the development of disability at 6 months after injury. The outcomes at 6 months after injury were evaluated using the Extended Glasgow Outcome Scale (GOS-E). Finally, the authors evaluated the correlation between the severity of the IVH on CT and the number of CCI lesions on MRI. The severity of the IVH was defined by the number of ventricles in which IVH was seen, and the number of CCI lesions was counted on the MRI study. Results. On multivariate logistic regression analysis, Glasgow Coma Scale score less than 9 (OR 2.70 [95% CI 1.10-6.27]), traffic accident (OR 2.59 [95% CI 1.37-4.93]), and IVH on CT (OR 3.31 [95% CI 1.25-8.49]) were significantly related to CCI. Multivariate analysis also showed that older age (p = 0.0001), male sex (OR 3.26 [95% CI 1.46-8.08], p = 0.0065), Glasgow Coma Scale score less than 9 (OR 8.27 [95% Cl 3.39-21.4], p < 0.0001), evidence of IVH on CT (OR 4.09 [95% CI 1.45-11.9], p = 0.0081), and evidence of CCI on MRI (OR 8.32 [95% CI 3.89-18.8], p < 0.0001) were associated with future development of disability (GOS-E score <= 6). Furthermore, simple regression analysis revealed the existence of a strong correlation between the severity of IVH and the number of CCI lesions (r = 0.0668, p = 0.0022). Conclusions. The authors' results suggest that evidence of IVH on CT may indicate CCI, which can lead to disability in patients with isolated blunt TBI. (http://thejns.org/doi/abs/10.3171/2012.5.JNS112318)	[Matsukawa, Hidetoshi; Shinoda, Masaki; Fuji, Motoharu; Murakata, Atsushi; Yamamoto, Daisuke; Sumiyoshi, Sosuke; Ishikawa, Ryoichi] St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, Tokyo 1048560, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Div Gen Internal Med, Dept Med, Chuo Ku, Tokyo 1048560, Japan	Matsukawa, H (corresponding author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	mahide@luke.or.jp			General Insurance Association of Japan; Smoking Research Foundation; St. Luke's Life Science Institute Research Grant for Clinical Epidemiology Research	This study was supported by a medical research grant on traffic accidents from The General Insurance Association of Japan (2010), a grant from the Smoking Research Foundation (2011), and St. Luke's Life Science Institute Research Grant for Clinical Epidemiology Research (2011).	Abraszko RA, 1995, BRIT J NEUROSURG, V9, P769, DOI 10.1080/02688699550040747; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; BERRY K, 1994, AM J FOREN MED PATH, V15, P132, DOI 10.1097/00000433-199406000-00008; Caille S, 2005, NEUROSURGERY, V57, P50, DOI 10.1227/01.NEU.0000163089.31657.08; Christie M, 1988, Br J Neurosurg, V2, P343, DOI 10.3109/02688698809001005; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; FRENCH BN, 1977, SURG NEUROL, V7, P171; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; Gallo A, 2005, ARCH NEUROL-CHICAGO, V62, P803, DOI 10.1001/archneur.62.5.803; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Inamasu J, 2001, AM J EMERG MED, V19, P167, DOI 10.1053/ajem.2001.21335; JAYAKUMAR PN, 1990, ACTA NEUROCHIR, V106, P48, DOI 10.1007/BF01809332; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kerr P, 1985, Clin Exp Neurol, V21, P123; KOBAYASHI S, 1985, CHILD NERV SYST, V1, P18, DOI 10.1007/BF00706725; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LINDENBERG R, 1955, AM J PATHOL, V31, P297; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makino Y, 2004, J NEUROTRAUM, V21, P585, DOI 10.1089/089771504774129919; Matsukawa H, 2011, J NEUROSURG, V115, P1019, DOI 10.3171/2011.6.JNS11513; Matsukawa H, 2011, ACTA NEUROCHIR, V153, P1687, DOI 10.1007/s00701-011-1002-9; Maxeiner H., 2009, Legal Medicine, V11, P278, DOI 10.1016/j.legalmed.2009.08.005; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; OLIFF M, 1978, J COMPUT ASSIST TOMO, V2, P625, DOI 10.1097/00004728-197811000-00020; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; PIEK J, 1986, ACTA NEUROCHIR, V83, P105, DOI 10.1007/BF01402386; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Ryberg C, 2007, NEUROBIOL AGING, V28, P955, DOI 10.1016/j.neurobiolaging.2006.04.008; SATO M, 1987, ACTA NEUROCHIR, V88, P95, DOI 10.1007/BF01404144; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; TSAI FY, 1978, J COMPUT ASSIST TOMO, V2, P323, DOI 10.1097/00004728-197807000-00018; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZUCCARELLO M, 1981, ACTA NEUROCHIR, V55, P283, DOI 10.1007/BF01808444	40	15	16	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2012	117	2					334	339		10.3171/2012.5.JNS112318			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	978ST	WOS:000306766800026	22702486				2021-06-18	
J	Moojen, VKM; Damiani-Neves, M; Bavaresco, DV; Pescador, BB; Comim, CM; Quevedo, J; Boeck, CR				Moojen, Vania K. M.; Damiani-Neves, Marcela; Bavaresco, Daniela V.; Pescador, Bruna B.; Comim, Clarissa M.; Quevedo, Joao; Boeck, Carina R.			NMDA preconditioning prevents object recognition memory impairment and increases brain viability in mice exposed to traumatic brain injury	BRAIN RESEARCH			English	Article						NMDA preconditioning; Memory; Cellular viability; Traumatic brain injury	METHYL-D-ASPARTATE; CEREBELLAR GRANULE CELLS; GLUTAMATE NEUROTOXICITY; SIGNALING PATHWAYS; QUINOLINIC ACID; HIPPOCAMPUS; NEURONS; RAT; RECEPTORS; ACTIVATION	Recent studies have focused on the role of N-methyl-D-aspartate (NMDA) in brain injury. The present study is aimed at verifying memory, anxiety/depression parameters, and cellular viability in the brain of mice preconditioned with NMDA and subjected to the model of mild traumatic brain injury. For this purpose, male albino CF-1 mice were pre-treated with NMDA (75 mg/kg) and subjected to brain trauma, and after 24 h submitted to memory tasks and anxiety and depression-like behavioral tests. The memory tests were evaluated at 1.5 h, 24 h, and 7 days after the training. In addition, the cellular viability was evaluated in the cerebral cortex and hippocampus 96 h after the trauma. It was observed that the cellular viability was reduced in the hippocampus of the mice subjected to trauma and the preconditioning with NMDA was able to protect this damage. All mice learnt the task in the habituation test, but in the object recognition task the mice preconditioned with NMDA were protected against impairment induced by TBI in both short and long-term memory. On the other hand, in the step-down inhibitory avoidance test, only the mice treated with NMDA showed impairment of long-term memory (7 days after training session). The evaluation of anxiety/depression behavior showed no changes after TBI. In conclusion, NMDA preconditioning induced impairment of the long-term memory; however, it was able to protect against the novel recognition memory impairment and increase the cellular survival in the hippocampus of mice exposed to traumatic brain injury. (c) 2012 Elsevier B.V. All rights reserved.	[Comim, Clarissa M.; Quevedo, Joao; Boeck, Carina R.] Univ Extremo S Catarinense UNESC, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Neurociencias,INCT TM, BR-88806000 Criciuma, SC, Brazil; [Moojen, Vania K. M.; Damiani-Neves, Marcela; Bavaresco, Daniela V.; Pescador, Bruna B.; Boeck, Carina R.] Univ Extremo S Catarinense UNESC, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Biol Celular & Mol,INCT TM, BR-88806000 Criciuma, SC, Brazil	Boeck, CR (corresponding author), Univ Extremo S Catarinense, UNASAU, PPGCS, Lab Neurociencias, BR-88806000 Criciuma, SC, Brazil.	cariboeck@hotmail.com	Boeck, Carina Rodrigues/E-9472-2011; Bavaresco, Daniela/I-4136-2018; Comim, Clarissa M/S-9007-2019; de Quevedo, Joao Luciano/N-1407-2019; de Quevedo, Joao Luciano/E-5491-2013; Comim, Clarissa M/C-4365-2014	Boeck, Carina Rodrigues/0000-0002-6828-5634; Bavaresco, Daniela/0000-0002-5533-8848; Comim, Clarissa M/0000-0003-4991-042X; de Quevedo, Joao Luciano/0000-0003-3114-6611; de Quevedo, Joao Luciano/0000-0003-3114-6611; 	Brazilian National Council Research: CNPq grants [484193/2010-4]; UNESC	This work was supported by funds from the Brazilian National Council Research: CNPq grants no. 484193/2010-4 and UNESC.	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Boeck CR, 2004, EPILEPSIA, V45, P745, DOI 10.1111/j.0013-9580.2004.65203.x; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; Conti AC, 1998, J NEUROSCI, V18, P5663; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; DAMSCHRODERWILLIAMS P, 1995, J NEUROCHEM, V65, P1069; Dickie BGM, 1996, NEUROSCIENCE, V72, P731, DOI 10.1016/0306-4522(95)00611-7; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Gidday JM, 2010, TRANSL STROKE RES, V1, P19, DOI 10.1007/s12975-010-0011-y; GIMENEZLLORT L, 1995, EUR J PHARMACOL, V275, P171, DOI 10.1016/0014-2999(94)00768-3; GOLD PE, 1986, BEHAV NEURAL BIOL, V46, P87, DOI 10.1016/S0163-1047(86)90927-1; Herculano BD, 2011, BEHAV BRAIN RES, V219, P92, DOI 10.1016/j.bbr.2010.12.025; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.0.CO;2-5; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Levin ED, 1998, BEHAV GENET, V28, P381, DOI 10.1023/A:1021673703129; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Love S, 1999, BRAIN PATHOL, V9, P119; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Ogita K, 2005, NEUROPHARMACOLOGY, V48, P810, DOI 10.1016/j.neuropharm.2004.12.018; Ogita K, 2003, J NEUROCHEM, V85, P1336, DOI 10.1046/j.1471-4159.2003.01778.x; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Sandhu R, 1996, CIRC RES, V78, P137, DOI 10.1161/01.RES.78.1.137; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tauskela JS, 1999, BRAIN RES, V827, P143, DOI 10.1016/S0006-8993(99)01322-0; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Willis C., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003986.PUB2; Xiong J, 2011, CHINESE MED J-PEKING, V124, P2209, DOI 10.3760/cma.j.issn.0366-6999.2011.14.023; Youssef FF, 2006, BRAIN RES, V1073, P183, DOI 10.1016/j.brainres.2005.12.008	55	15	15	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 23	2012	1466						82	90		10.1016/j.brainres.2012.05.041			9	Neurosciences	Neurosciences & Neurology	989ZH	WOS:000307600300008	22652305	Bronze			2021-06-18	
J	Nikitidou, L; Kanter-Schlifke, I; Dhondt, J; Carmeliet, P; Lambrechts, D; Kokaia, M				Nikitidou, Litsa; Kanter-Schlifke, Irene; Dhondt, Joke; Carmeliet, Peter; Lambrechts, Diether; Kokaia, Merab			VEGF Receptor-2 (Flk-1) Overexpression in Mice Counteracts Focal Epileptic Seizures	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; STIMULATES AXONAL OUTGROWTH; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; IN-VITRO; HIPPOCAMPAL NEUROGENESIS; CELL PROLIFERATION; GENE-EXPRESSION; SEX-DIFFERENCES; NERVOUS-SYSTEM	Vascular endothelial growth factor (VEGF) was first described as an angiogenic agent, but has recently also been shown to exert various neurotrophic and neuroprotective effects in the nervous system. These effects of VEGF are mainly mediated by its receptor, VEGFR-2, which is also referred to as the fetal liver kinase receptor 1 (Flk-1). VEGF is up-regulated in neurons and glial cells after epileptic seizures and counteracts seizure-induced neurodegeneration. In vitro, VEGF administration suppresses ictal and interictal epileptiform activity caused by AP4 and 0 Mg2+ via Flk-1 receptor. We therefore explored whether increased VEGF signaling through Flk-1 overexpression may regulate epileptogenesis and ictogenesis in vivo. To this extent, we used transgenic mice overexpressing Flk-1 postnatally in neurons. Intriguingly, Flk-1 overexpressing mice were characterized by an elevated threshold for seizure induction and a decreased duration of focal after discharges, indicating anti-ictal action. On the other hand, the kindling progression in these mice was similar to wild-type controls. No significant effects on blood vessels or glia cells, as assessed by Glut1 and GFAP immunohistochemistry, were detected. These results suggest that increased VEGF signaling via overexpression of Flk-1 receptors may directly affect seizure activity even without altering angiogenesis. Thus, Flk-1 could be considered as a novel target for developing future gene therapy strategies against ictal epileptic activity.	[Nikitidou, Litsa; Kanter-Schlifke, Irene; Kokaia, Merab] Univ Lund Hosp, Expt Epilepsy Grp, Wallenberg Neurosci Ctr, S-22185 Lund, Sweden; [Dhondt, Joke; Carmeliet, Peter; Lambrechts, Diether] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium; [Dhondt, Joke; Carmeliet, Peter; Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium	Nikitidou, L (corresponding author), Univ Lund Hosp, Expt Epilepsy Grp, Wallenberg Neurosci Ctr, BMC A-11, S-22185 Lund, Sweden.	Merab.Kokaia@med.lu.se	Verdrengh, Evelien/H-4571-2012; Lambrechts, Diether/AAJ-3167-2020; Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821; Lambrechts, Diether/0000-0002-3429-302X	Swedish Research CouncilSwedish Research CouncilEuropean Commission; EU commissionEuropean CommissionEuropean Commission Joint Research Centre [LSH-037315]; Segerfalk Foundation; Kock foundation; Crafoord Foundation; Long term Structural funding: Methusalem	This study was supported by grants from the Swedish Research Council, EU commission grant (LSH-037315), Segerfalk Foundation, Kock foundation, Crafoord Foundation and Long term Structural funding: Methusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boer K, 2008, ACTA NEUROPATHOL, V115, P683, DOI 10.1007/s00401-008-0354-6; Cammalleri M, 2011, EUR J NEUROSCI, V33, P482, DOI 10.1111/j.1460-9568.2010.07529.x; Cornford E M, 1999, Adv Neurol, V79, P845; Croll SD, 2004, ADV EXP MED BIOL, V548, P57; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; EBERT U, 1994, BRAIN RES, V638, P45, DOI 10.1016/0006-8993(94)90631-9; Edwards HE, 1999, BRAIN RES, V838, P136, DOI 10.1016/S0006-8993(99)01619-4; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fujiki M, 2010, EXP NEUROL, V225, P377, DOI 10.1016/j.expneurol.2010.07.010; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gotzsche CR, 2011, NEUROBIOL DIS; Gronlund KM, 1996, J NEUROPATH EXP NEUR, V55, P832, DOI 10.1097/00005072-199607000-00008; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lee Hyoshin, 2007, Plant Biology (Rockville), V2007, P156; LI J, 1995, J BIOL CHEM, V270, P308, DOI 10.1074/jbc.270.1.308; Matsuzaki H, 2001, FASEB J, V15, P1218; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Newton SS, 2003, J NEUROSCI, V23, P10841; Nicoletti JN, 2008, NEUROSCIENCE, V151, P232, DOI 10.1016/j.neuroscience.2007.09.083; Nicoletti JN, 2010, EPILEPSY BEHAV, V19, P272, DOI 10.1016/j.yebeh.2010.07.011; PAXINOS G, 1997, RAT BRAIN STEREOTAXI, V33; Peltola J, 2002, SEIZURE-EUR J EPILEP, V11, P44, DOI 10.1053/seiz.2001.0575; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shimakawa S, 2002, BRAIN RES, V956, P67, DOI 10.1016/S0006-8993(02)03482-0; Shimotake J, 2010, STROKE, V41, P343, DOI 10.1161/STROKEAHA.109.564229; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sun JQ, 2010, BIOCHEM BIOPH RES CO, V394, P146, DOI 10.1016/j.bbrc.2010.02.132; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170; Teskey GC, 1999, CEREB CORTEX, V9, P675, DOI 10.1093/cercor/9.7.675; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Woldbye DPD, 2010, BRAIN, V133, P2778, DOI 10.1093/brain/awq219; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com	49	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40535	10.1371/journal.pone.0040535			7	Multidisciplinary Sciences	Science & Technology - Other Topics	973NH	WOS:000306366400032	22808185	DOAJ Gold, Green Published			2021-06-18	
J	Moran, C; Kirk, C; Powell, E				Moran, Catherine; Kirk, Cecilia; Powell, Emma			Spoken Persuasive Discourse Abilities of Adolescents With Acquired Brain Injury	LANGUAGE SPEECH AND HEARING SERVICES IN SCHOOLS			English	Article						adolescents; brain injury; discourse analysis	CLOSED-HEAD-INJURY; SCHOOL-AGE-CHILDREN; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; EXPOSITORY DISCOURSE; CAPACITY THEORY; LANGUAGE; COMPREHENSION; NARRATIVES; ADULTS	Purpose: The aim of this study was to examine the performance of adolescents with acquired brain injury (ABI) during a spoken persuasive discourse task. Persuasive discourse is frequently used in social and academic settings and is of importance in the study of adolescent language. Method: Participants included 8 adolescents with ABI and 8 peers without ABI who were matched for age, gender, and education. A spoken persuasive discourse task requiring participants to express their opinion on a topic was administered, and the 2 groups were compared on measures of language productivity, syntactic complexity, and language content. In addition, the relationship between working memory and discourse production was explored. Results: There were no statistically significant group differences on measures of language productivity or syntactic complexity, with the exception of the use of mazes, which was more prevalent in the discourse of the group with ABI. However, there were significant differences in language content, with age-matched peers producing more than twice as many supporting reasons and far fewer tangentially related utterances than the adolescents with ABI. Conclusions: Persuasive discourse production was affected following ABI. Given the importance of persuasive discourse in social and academic situations, further investigations into factors that influence discourse production in adolescents with ABI are warranted.	[Moran, Catherine] Univ Canterbury, Christchurch 1, New Zealand; [Kirk, Cecilia] Univ Oregon, Eugene, OR 97403 USA; [Powell, Emma] Accident Compensat Corp New Zealand, Wellington, New Zealand	Moran, C (corresponding author), Univ Canterbury, Christchurch 1, New Zealand.	catherine.moran@canterbury.ac.nz					Accident Compensation Corporation, 2010, ACT REH SERV TRAUM B; Baddeley A.D, 1976, PSYCHOL MEMORY; Bartsch K, 2007, DEV PSYCHOL, V43, P111, DOI 10.1037/0012-1649.43.1.111; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Blosser J, 2003, PEDIAT TRAUMATIC BRA; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Chapman S. B., 1997, AM J SPEECH-LANG PAT, V6, P66; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; CLARK RA, 1976, CHILD DEV, V47, P1008, DOI 10.1111/j.1467-8624.1976.tb02281.x; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Crowhurst M., 1990, CANADIAN J ED, V15, P348, DOI DOI 10.2307/1495109; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dennis M., 1989, CLIN NEUROPSYCHOLOGY, P89; Devito J. A., 2003, ESSENTIAL ELEMENTS P; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Felton M, 2001, DISCOURSE PROCESS, V32, P135; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; Hagen C., 1998, RANCHO LEVELS COGNIT; HAMMILL DD, 1994, TEST ADOLESCENT ADUL; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); JORDAN F M, 1992, Brain Injury, V6, P39, DOI 10.3109/02699059209008120; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kellogg RT, 2004, AM J PSYCHOL, V117, P341, DOI 10.2307/4149005; Knudson R.E., 1992, CHILD STUDY J, V22, P167; KROLL BM, 1984, WRIT COMMUN, V1, P407; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LIGHT LL, 1985, J GERONTOL, V40, P737, DOI 10.1093/geronj/40.6.737; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; McCutchen D, 1996, EDUC PSYCHOL REV, V8, P299, DOI 10.1007/BF01464076; Miller J. F., 2010, SALT SYSTEMATIC ANAL; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A., 1999, MODELS WORKING MEMOR; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; New Zealand Qualifications Authority, 2007, LEV 1 ENGL EX PROD F; Nippold M. A., 2007, LATER LANGUAGE DEV S; Nippold MA, 2005, J SPEECH LANG HEAR R, V48, P1048, DOI 10.1044/1092-4388(2005/073); Nippold MA, 2005, LANG SPEECH HEAR SER, V36, P125, DOI 10.1044/0161-1461(2005/012); Nippold MA, 2010, CHILD LANG TEACH THE, V26, P238, DOI 10.1177/0265659009349979; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; Scott C.M., 2004, LANGUAGE DEV CHILDHO, P111; Scott CM, 2000, J SPEECH LANG HEAR R, V43, P324, DOI 10.1044/jslhr.4302.324; Semel W, 2003, CLIN EVALUATION LANG; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; YEKOVICH FR, 1990, PSYCHOL LEARN MOTIV, V25, P259, DOI DOI 10.1016/S0079-7421(08)60259-5; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	55	15	15	0	11	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	0161-1461	1558-9129		LANG SPEECH HEAR SER	Lang. Speech Hear. Serv. Sch.	JUL 1	2012	43	3					264	275		10.1044/0161-1461(2011/10-0114)			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	083YF	WOS:000314501600003	22269583				2021-06-18	
J	Niu, LJ; Xu, RX; Zhang, P; Du, MX; Jiang, XD				Niu, L. -J.; Xu, R. -X.; Zhang, P.; Du, M-X; Jiang, X. -D.			SUPPRESSION OF FRIZZLED-2-MEDIATED WNT/CA(2+) SIGNALING SIGNIFICANTLY ATTENUATES INTRACELLULAR CALCIUM ACCUMULATION IN VITRO AND IN A RAT MODEL OF TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						Wnt5a; Frizzled-2; Wnt/Ca2+ pathway; calcium; astrocytes; TBI	NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE; CELL-DEATH; FRIZZLED HOMOLOGS; CA2+ HOMEOSTASIS; WNT/BETA-CATENIN; NEURONAL CELLS; WNT; PATHWAY; TRANSDUCTION	Traumatic brain injury (TBI) can dramatically increase levels of intracellular calcium (Ca2+). The association between Wnt5a/Frizzled-2 (wingless-type mouse mammary tumor virus integration site family member 5a/Fzd2) signaling and Ca2+ cellular homeostasis in lower vertebrates has been well documented. However, little is known about Wnt5a/Fzd2 signaling in mammalian nerve cells, or whether Ca2+ accumulation after TBI is mediated through this pathway. We hypothesized that an activated Wnt5a/Fzd2 pathway following TBI may play a role in Ca2+ overloading. To elucidate the influence of Fzd2 and the Wnt5a signal transduction pathway on an increase in intracellular Ca2+, we assessed the expression of Wnt5a/Fzd2 in rat hippocampal cells both in vitro and in vivo. We found that transfection of the rat Fzd2 gene in rat neonatal hippocampal astrocytes significantly increased gene expressions of both Wnt5a and Frd2 by fourfold when compared to non-transfected cells (P < 0.01 in both cases). Expressions of the proteins Wnt5a and Fzd2 were significantly increased approximately two- and threefold, respectively, when compared to non-transfected control cells (P < 0.01 in both cases). Moreover, intracellular Ca2+, as manifested by the fluorescent intensity of the intracellular Ca2+ indicator Fluo-3/AM, was significantly increased by 1.75-fold (P < 0.01). The blocking of Fzd2 signaling using Stealth RNAi markedly inhibited the elevated gene and protein expression of Wnt5a in the transfected cells by two- and fourfold, respectively (P < 0.01), and suppressed intracellular Ca2+ by 1.5-fold (P < 0.01). Furthermore, in vivo, we demonstrated that TBI-induced dramatic upregulation of gene and protein expression of Wnt5a/Fzd2 by two- and five-fold (P < 0.01) in injured hippocampi, and intracellular Ca2+ increased in isolated injured hippocampal cells. Whereas, the in vivo blocking of Fzd2 signaling by hippocampal delivery of Stealth RNA1 and Invivofectamine significantly suppressed the increased gene and protein expression of Wnt5a and Fzd2 induced by TBI by 1- to 3.5-fold (P < 0.01) and also inhibited Ca(2+)accumulation by 1.5-fold (P < 0.01). These findings demonstrated that the Wnt5a/Fzd2 signaling pathway contributed to increasing intracellular Ca2+ in nerve cells under physiological and pathological conditions. Furthermore, our findings provide evidence that specifically expressed components of this signal pathway, such as Wnt5a and Fzd2, are potential therapeutic targets following brain trauma. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Niu, L. -J.; Xu, R. -X.] Mil Gen Hosp Beijing PLA, Affiliated Brain Hosp, Beijing 100041, Peoples R China; [Niu, L. -J.; Xu, R. -X.; Zhang, P.; Du, M-X; Jiang, X. -D.] So Med Univ, Inst Neurol, Zhujiang Hosp, Guangzhou 510282, Guangdong, Peoples R China; [Niu, L. -J.; Xu, R. -X.; Zhang, P.; Du, M-X; Jiang, X. -D.] Lab Brain Funct & Repair, Guangzhou 510282, Guangdong, Peoples R China	Xu, RX (corresponding author), Mil Gen Hosp Beijing PLA, Affiliated Brain Hosp, 5 S Gate, Beijing 100041, Peoples R China.	jz_xuruxiang@163.com					Alberdi E, 2005, CELL CALCIUM, V38, P417, DOI 10.1016/j.ceca.2005.06.020; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Conti AC, 1998, J NEUROSCI, V18, P5663; FARBER JL, 1981, LIFE SCI, V29, P1289, DOI 10.1016/0024-3205(81)90670-6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Liu M, 2006, EUR J NEUROSCI, V23, P2027, DOI 10.1111/j.1460-9568.2006.04724.x; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; MIYAKE T, 1992, BRAIN RES, V590, P300, DOI 10.1016/0006-8993(92)91109-R; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Racay P, 1996, GEN PHYSIOL BIOPHYS, V15, P273; Racay P, 1996, GEN PHYSIOL BIOPHYS, V15, P193; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; SCHUMANN MA, 1993, J BIOL CHEM, V268, P2134; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Verkhratsky A, 1998, PHYSIOL REV, V78, P99; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	33	15	19	0	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	JUN 28	2012	213						19	28		10.1016/j.neuroscience.2012.03.057			10	Neurosciences	Neurosciences & Neurology	960GM	WOS:000305376000002	22521824				2021-06-18	
J	Yang, RH; Wang, F; Hou, XH; Cao, ZP; Wang, B; Xu, XN; Hu, SJ				Yang, R. -H.; Wang, F.; Hou, X. -H.; Cao, Z. -P.; Wang, B.; Xu, X. -N.; Hu, S. -J.			DIETARY OMEGA-3 POLYUNSATURATED FATTY ACIDS IMPROVES LEARNING PERFORMANCE OF DIABETIC RATS BY REGULATING THE NEURON EXCITABILITY	NEUROSCIENCE			English	Article						fish oil; diabetes; learning and memory; hippocampal pyramidal neuron; excitability; potassium currents	HIPPOCAMPAL SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; POTASSIUM CHANNELS; DIFFERENTIAL EXPRESSION; MEMBRANE EXCITABILITY; ALZHEIMERS-DISEASE; DECLARATIVE MEMORY	Previous research has demonstrated that diabetes induced learning and memory deficits. However, the mechanism of memory impairment induced by diabetes is poorly understood. Dietary fatty acids, especially polyunsaturated fatty acids (PUFA), have been shown to enhance learning and memory and prevent memory deficits in various experimental conditions. Sprague-Dawley rats were used in the present study to investigate the effect of fish oil supplementation on spatial learning and memory of streptozotocin (STZ)-induced diabetic rats with the Morris Water Maze. The excitability of CA1 pyramidal neurons and the related ionic currents was also examined. Diabetes impaired spatial learning and memory of rats. Diabetes decreased the sodium currents and increased the potassium currents, and further led to the reduction of excitability of CA1 pyramidal neurons, effects which may contribute to the behavioral deficits. Fish oil dietary supplementation decreased the transient currents and Kv4.2 expression in the hippocampus and partially improved learning performance of diabetic rats. The results of the present study suggested that sodium and potassium currents contributed to the inhibitory effect of diabetes on neuron excitability, further influencing learning and memory processing. Dietary fish oil may modulate the membrane excitability and is a possible strategy for preventing the impairments of diabetes on hippocampal function. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Yang, R. -H.; Wang, F.; Hou, X. -H.; Cao, Z. -P.; Wang, B.; Xu, X. -N.] Fourth Mil Med Univ, Dept Nutr & Food Hyg, Minist Educ,Sch Publ Hlth, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Peoples R China; [Hu, S. -J.] Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China	Yang, RH (corresponding author), Fourth Mil Med Univ, Dept Nutr & Food Hyg, Minist Educ,Sch Publ Hlth, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Peoples R China.	fmmur.young@gmail.com; sjhu@fmmu.edu.cn			Program for Changjiang Scholars and Innovative Research Team in the University (PCSIRT)Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT); Science and Technology Program of Shaanxi Province [2011JM4002]	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in the University (PCSIRT). This work was supported by the Science and Technology Program of Shaanxi Province [2011JM4002].	Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Azouz R, 1999, J NEUROSCI, V19, P2209; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Baldi E, 2005, NEUROSCI LETT, V378, P176, DOI 10.1016/j.neulet.2004.12.029; Baydas G, 2003, LIFE SCI, V73, P1907, DOI 10.1016/S0024-3205(03)00561-7; Biessels Geert Jan, 2007, Prim Care Diabetes, V1, P187, DOI 10.1016/j.pcd.2007.10.002; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Brismar T, 2007, PSYCHONEUROENDOCRINO, V32, P1041, DOI 10.1016/j.psyneuen.2007.08.002; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Candy SM, 2000, BRAIN RES, V863, P298, DOI 10.1016/S0006-8993(00)02171-5; Candy SM, 2000, NEUROSCI LETT, V279, P105, DOI 10.1016/S0304-3940(99)00954-4; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Conquer JA, 2000, LIPIDS, V35, P1305, DOI 10.1007/s11745-000-0646-3; CRAWFORD SG, 1995, HEREDITAS, V122, P73, DOI 10.1111/j.1601-5223.1995.00073.x; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1999, BEHAV BRAIN RES, V103, P123, DOI 10.1016/S0166-4328(99)00044-3; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Fontani G, 2005, EUR J CLIN INVEST, V35, P691, DOI 10.1111/j.1365-2362.2005.01570.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Giese KP, 1998, LEARN MEMORY, V5, P257; Haag M, 2003, CAN J PSYCHIAT, V48, P195; Hasanein P, 2010, NEUROBIOL LEARN MEM, V93, P472, DOI 10.1016/j.nlm.2010.01.004; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Heng LJ, 2011, BEHAV BRAIN RES, V224, P250, DOI 10.1016/j.bbr.2011.05.043; Hu Yuan-yuan, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1336; Izumi Y, 2003, DIABETOLOGIA, V46, P1007, DOI 10.1007/s00125-003-1144-2; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Kawashima A, 2010, J NUTR BIOCHEM, V21, P268, DOI 10.1016/j.jnutbio.2008.12.015; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; McCarthy AM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e9; McGahon BM, 1999, NEUROSCIENCE, V94, P305, DOI 10.1016/S0306-4522(99)00219-5; Northam EA, 2006, NAT CLIN PRACT NEURO, V2, P78, DOI 10.1038/ncpneuro0097; Ristow M, 2004, J MOL MED, V82, P510, DOI 10.1007/s00109-004-0552-1; Seo S, 2011, NEUROSCIENCE, V192, P28, DOI 10.1016/j.neuroscience.2011.07.007; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Tiwari V, 2009, PHARMACOL BIOCHEM BE, V93, P183, DOI 10.1016/j.pbb.2009.05.009; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; Veigas JM, 2011, PHARMACOL RES, V63, P377, DOI 10.1016/j.phrs.2011.02.004; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Yang JJ, 2010, TOXICOL IN VITRO, V24, P397, DOI 10.1016/j.tiv.2009.10.019; Yang RH, 2008, BRAIN RES, V1230, P224, DOI 10.1016/j.brainres.2008.07.033; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Younga GS, 2005, REPROD NUTR DEV, V45, P549, DOI 10.1051/rnd:2005045	52	15	17	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 14	2012	212						93	103		10.1016/j.neuroscience.2012.04.005			11	Neurosciences	Neurosciences & Neurology	962NB	WOS:000305550700009	22516014				2021-06-18	
J	Murphy, A; Kaufman, MS; Molton, I; Coppel, DB; Benson, J; Herring, SA				Murphy, Ashley; Kaufman, Marla S.; Molton, Ivan; Coppel, David B.; Benson, John; Herring, Stanley A.			Concussion Evaluation Methods Among Washington State High School Football Coaches and Athletic Trainers	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; SENSITIVITY	Objective: To evaluate awareness of concussion assessment methods and to determine whether there are differences among Washington State high school football coaches and athletic trainers in urban versus rural school districts. Design: A Catalyst WebQ survey link was randomly sent by e-mail to varsity head football coaches, athletic trainers, and athletic directors in Washington State school districts. Participants: Survey participants were high school varsity head football coaches and athletic trainers from a total of 106 Washington State high schools. Methods: A 12-item questionnaire on Catalyst WebQ was distributed via e-mail. The survey inquired about use of the methods of concussion assessment, both on the field and for follow-up; participants' concussion education training; and familiarity with Washington State's Zackery Lystecit Law. Main Outcome Measurements: The survey examined differences in concussion management practices between rural and urban school districts and also between coaches and athletic trainers in Washington State, specifically regarding the use of the Standardized Concussion Assessment Tool 2 (SCAT2) and neurocognitive testing (NCT). Results: Twenty-seven of 48 respondents (56%) used the SCAT2 for on-the-field assessment; urban respondents were significantly more likely to use SCAT2 (P < .05). The difference between coaches and athletic trainers with respect to SCAT2 use was not significant (P = .08). NCT was used by 18 of 58 respondents (31%). This was more commonly used by those in urban districts (P < .01) and by athletic trainers (P < .01). Eleven of these 18 individuals (61%) reported that a neuropsychologist interpreted the results; the rest used other providers not specifically trained in neuropsychology. There was no statistically significant correlation between years of experience and use of the SCAT2, but those with more than 10 years of experience were less likely to use NCT (P < .01). All respondents reported being familiar with Washington State's Zackery Lystedt Law, but only 44.1% reported that the law changed their concussion management. Conclusions: There were statistically significant differences between SCAT2 and NCT use for respondents from urban and rural districts, and also between coaches and athletic trainers, as well as NCT use among respondents with varying years of experience. Further understanding and identification of barriers that limit identification and management of concussions in high school athletes are crucial to prevent serious permanent injury. Additional education is necessary to ensure that athletic trainers and coaches are aware of current recommendations within the medical literature for the evaluation and management of concussions. PM R 2012;4:4.19-426	[Kaufman, Marla S.; Herring, Stanley A.] Univ Washington, Med Ctr, Dept Rehabil Med, Dept Orthopaed & Sports Med,Dept Neurol Surg, Seattle, WA 98105 USA; [Murphy, Ashley] Univ Washington, Sch Med, Seattle, WA 98105 USA	Kaufman, MS (corresponding author), Univ Washington, Med Ctr, Dept Rehabil Med, Dept Orthopaed & Sports Med,Dept Neurol Surg, 4245 Roosevelt Way NE, Seattle, WA 98105 USA.	kaufman2@uw.edu			Medical Student Research Training Program, University of Washington School of Medicine, Seattle, WA	Research support: Medical Student Research Training Program, University of Washington School of Medicine, Seattle, WA	[Anonymous], 2009, SCAT2 SPORT CONC ASS; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Ferrara MS, 2001, J ATHL TRAINING, V36, P145; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; ImPACT, 2009, BEST APPR CONC MAN; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schootman M, 1999, BRAIN INJURY, V13, P995; Washington State Department of Health, 2008, GUID US RUR URB CLAS; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	24	15	15	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUN	2012	4	6					419	426		10.1016/j.pmrj.2012.03.013			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	969EO	WOS:000306038700005	22732154				2021-06-18	
J	Quigley, KS; McAndrew, LM; Almeida, L; D'Andrea, EA; Engel, CC; Hamtil, H; Ackerman, AJ				Quigley, Karen S.; McAndrew, Lisa M.; Almeida, Liliana; D'Andrea, Elizabeth A.; Engel, Charles C.; Hamtil, Heather; Ackerman, Adam J.			Prevalence of Environmental and Other Military Exposure Concerns in Operation Enduring Freedom and Operation Iraqi Freedom Veterans	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							GULF-WAR VETERANS; TRAUMATIC BRAIN-INJURY; PHYSICAL SYMPTOMS; HEALTH; CARE; SEEKING; ASSOCIATION; DEPLOYMENT; COMMUNITY; VALIDITY	Objective: This study examined the prevalence of self-reported exposures in returning Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) veterans and the relationship of exposure reports to current physical symptoms. Methods: Using self-reports obtained immediately after return from deployment in a cohort of 760 enlisted Army reserve component military personnel, we assessed prevalence rates of environmental and other exposures and the association of these exposures to severity of physical symptoms. Results: Reporting of environmental exposures was relatively low in veterans of OEF/OIF, but reporting more environmental and other exposures, in particular screening positive for a traumatic brain injury, was related to greater physical symptom severity immediately after deployment. Conclusions: Non-treatment-seeking, enlisted Army reserve component personnel reported relatively few exposures immediately after return from deployment; however, more exposures was modestly associated with greater severity of physical symptoms when controlling for predeployment symptoms, gender, and other deployment-related exposures.	[Quigley, Karen S.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Quigley, Karen S.] Edith Nourse Rogers Mem Vet Adm Hosp, Bedford, MA 01730 USA; [Quigley, Karen S.; McAndrew, Lisa M.; Almeida, Liliana; Hamtil, Heather; Ackerman, Adam J.] NJ WRIISC, Dept Vet Affairs New Jersey Healthcare Syst, E Orange, NJ USA; [Quigley, Karen S.; McAndrew, Lisa M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; [D'Andrea, Elizabeth A.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Engel, Charles C.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Engel, Charles C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Psychiat, Bethesda, MD 20814 USA; [Almeida, Liliana] Alliant Int Univ, CSPP, Los Angeles, CA USA; [Hamtil, Heather] Rutgers State Univ, Ctr Behav Hlth Serv & Criminal Justice Res, New Brunswick, NJ 08903 USA	Quigley, KS (corresponding author), Northeastern Univ, Dept Psychol, 125 Nightingale Hall, Boston, MA 02115 USA.	k.quigley@neu.edu	Quigley, Karen S./B-9003-2013; McAndrew, Lisa/H-7035-2017	Quigley, Karen S./0000-0001-8844-990X; McAndrew, Lisa/0000-0002-1350-8773	Department of Veterans AffairsUS Department of Veterans Affairs [IIR 02-296]; NJ WRIISC; Jersey Healthcare System at Department of Veterans Affairs; Deployment Health Clinical Center, Walter Reed Army Medical Center	This work was supported by a Department of Veterans Affairs, Health Services Research and Development grant (IIR 02-296) to Dr Quigley while she was employed. at the NJ WRIISC. Additional funds were provided by the NJ WRIISC and the Center for Healthcare Knowledge Management (NJ REAP; VA Health Services Research and Development) at the Department of Veterans Affairs Now Jersey Healthcare System, and by the Deployment Health Clinical Center, Walter Reed Army Medical Center.	[Anonymous], 2006, UPD PRE POSTDEPL HLT, P10; Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; Brewer NT, 2008, RISK ANAL, V28, P1737, DOI 10.1111/j.1539-6924.2008.01118.x; Brix Kelley, 2011, Mil Med, V176, P91; CAMERON L, 1995, PSYCHOSOM MED, V57, P37, DOI 10.1097/00006842-199501000-00006; CAMERON L, 1993, HEALTH PSYCHOL, V12, P171, DOI 10.1037/0278-6133.12.3.171; Cherry N, 2001, OCCUP ENVIRON MED, V58, P299, DOI 10.1136/oem.58.5.299; Department of Livestock Services, 2010, AFGH IR DOD SHOULD I, P1; Engel CC, 2000, PSYCHOSOM MED, V62, P739, DOI 10.1097/00006842-200011000-00001; Engel CC, 2006, PHILOS T R SOC B, V361, P707, DOI 10.1098/rstb.2006.1829; Engel CC, 2002, ENVIRON HEALTH PERSP, V110, P641, DOI 10.1289/ehp.02110s4641; Furlong CE, 2000, GENOME RES, V10, P153, DOI 10.1101/gr.10.2.153; Greenhill J, 2009, SENATORS HEAR GUARD; Institute of Medicine, 2009, VET AG OR UPD 2008; Interian A, 2006, PSYCHOSOMATICS, V47, P392, DOI 10.1176/appi.psy.47.5.392; King DW, 2003, MANUAL DEPLOYMENT RI; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Kroenke K, 1998, J OCCUP ENVIRON MED, V40, P520, DOI 10.1097/00043764-199806000-00004; Kroenke K, 1994, Arch Fam Med, V3, P774; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; LEVENTHAL H, 1992, COGNITIVE THER RES, V16, P143, DOI 10.1007/BF01173486; McAndrew LM, 2012, J OCCUP ENVIRON MED, V54, P665, DOI 10.1097/JOM.0b013e318255ba1b; McCauley LA, 2002, ARCH ENVIRON HEALTH, V57, P340, DOI 10.1080/00039890209601419; Murphy D, 2008, BRIT MED J, V337, P220; Office of Public Health and Environmental Hazards, 2010, OP END FREED OP IR F, V6, P1; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Richardson RD, 2004, NEUROLOGIST, V10, P18, DOI 10.1097/01.nrl.0000106921.76055.24; Riddle Mark, 2011, Mil Med, V176, P105; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Santos SL, 2012, J OCCUP ENVIRON MED, V54, P752, DOI 10.1097/JOM.0b013e31824fe11e; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Smith TC, 2003, AM J EPIDEMIOL, V158, P457, DOI 10.1093/aje/kwg178; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; US Army Public Health Command, 2010, HLTH ASS 2003 QARM A, P1; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wolfe J, 1998, AM J IND MED, V33, P104, DOI 10.1002/(SICI)1097-0274(199802)33:2<104::AID-AJIM2>3.0.CO;2-Y	40	15	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	JUN	2012	54	6			SI		659	664		10.1097/JOM.0b013e3182570506			6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	957MA	WOS:000305165900002	22588478				2021-06-18	
J	Sonig, A; Thakur, JD; Chittiboina, P; Khan, IS; Nanda, A				Sonig, Ashish; Thakur, Jai Deep; Chittiboina, Prashant; Khan, Imad Saeed; Nanda, Anil			Is posttraumatic cerebrospinal fluid fistula a predictor of posttraumatic meningitis? A US Nationwide Inpatient Sample database study	NEUROSURGICAL FOCUS			English	Article						cerebrospinal fluid fistula; meningitis; head injury	NOSOCOMIAL BACTERIAL-MENINGITIS; HIGH-RESOLUTION CT; ANTIBIOTIC-PROPHYLAXIS; HEAD-INJURY; ANTIMICROBIAL PROPHYLAXIS; RISK-FACTORS; CSF LEAKS; NEUROSURGERY; METAANALYSIS; RHINORRHEA	Object. Various factors have been reported in literature to be associated with the development of posttraumatic meningitis. There is a paucity of data regarding skull fractures and facial fractures leading to CSF leaks and their association with the development of meningitis. The primary objective of this study was to analyze the US Nationwide Inpatient Sample (NIS) database to elucidate the factors associated with the development of posttraumatic meningitis. A secondary goal was to analyze the overall hospitalization cost related to posttraumatic meningitis and factors associated with that cost. Methods. The NIS database was analyzed to identify patients admitted to hospitals with a diagnosis of head injury from 2005 through 2009. This data set was analyzed to assess the relationship of various clinical parameters that may affect the development of posttraumatic meningitis using binary logistic regression models. Additionally, the overall hospitalization cost for the head injury patients who did not undergo any neurosurgical intervention was further categorized into quartile groups, and a regression model was created to analyze various factors responsible for escalating the overall cost of the hospital stay. Results. A total of 382,267 inpatient admissions for head injury were analyzed for the 2005-2009 period. Meningitis was reported in 0.2% of these cases (708 cases). Closed skull base fractures, open skull base fractures, cranial vault fractures, and maxillofacial fractures were reported in 20,524 (5.4%), 1089 (0.3%), 5064 (1.3%), and 88,649 (23.2%) patients, respectively. Among these patients with fractures, meningitis was noted in 0.17%, 0.18%, 0.05%, and 0.10% admissions, respectively. Cerebrospinal fluid rhinorrhea was reported in 453 head injury patients (0.1%) and CSF otorrhea in 582 (0.2%). Of the patients reported to have CSF rhinorrhea, 35 (7.7%) developed meningitis, whereas in the cohort with CSF otorrhea, 15 patients (2.6%) developed meningitis. Cerebrospinal fluid rhinorrhea (p < 0.001, OR 22.8, 95% CI 15.6-33.3), CSF otorrhea (p < 0.001, OR 9.2, 95% CI 5.2-16.09), and major neurosurgical procedures (p < 0.001, OR 5.6, 95% CI 4.8-6.5) were independent predictors of meningitis. Further, CSF rhinorrhea (p < 0.001, OR 2.0, 95% CI 1.6-2.7), CSF otorrhea (p < 0.001, OR 2.3, 95% CI 1.9-2.7), and posttraumatic meningitis (p < 0.001, OR 3.1, 95% CI 2.5-3.8) were independent factors responsible for escalating the cost of head injury in cases not requiring any major neurosurgical intervention. Conclusions. Cerebrospinal fluid rhinorrhea and CSF otorrhea are independent predictors of posttraumatic meningitis. Furthermore, meningitis and CSF fistulas may independently lead to significantly increased cost of hospitalization in head injury patients not undergoing any major neurosurgical intervention. (http://thejns.org/doi/abs/10.3171/2012.5.FOCUS1269)	[Sonig, Ashish; Thakur, Jai Deep; Chittiboina, Prashant; Khan, Imad Saeed; Nanda, Anil] Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr Shreveport, Shreveport, LA 71130 USA	Nanda, A (corresponding author), Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr Shreveport, 1501 Kings Highway,POB 33932, Shreveport, LA 71130 USA.	ananda@lsuhsc.edu	Chittiboina, Prashant/T-7177-2017; Chittiboina, Prashant/AAE-3799-2020	Chittiboina, Prashant/0000-0001-9349-4756; Chittiboina, Prashant/0000-0001-9349-4756			APPELBAUM E, 1960, JAMA-J AM MED ASSOC, V173, P1818, DOI 10.1001/jama.1960.03020340036010; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; BROWN EM, 1994, LANCET, V344, P1547; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Choi D, 1996, BRIT J NEUROSURG, V10, P571, DOI 10.1080/02688699646880; COOPER MA, 1995, LANCET, V345, P515, DOI 10.1016/S0140-6736(95)90610-X; Dagi T F, 1983, Am J Emerg Med, V1, P295, DOI 10.1016/0735-6757(83)90109-2; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; ELJAMEL MS, 1993, BRIT J NEUROSURG, V7, P501, DOI 10.3109/02688699308995072; Friedman J A, 2000, Neurosurg Focus, V9, pe1, DOI 10.3171/foc.2000.9.1.1; HAND WL, 1970, ANN INTERN MED, V73, P862, DOI 10.7326/0003-4819-73-5-862; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; JONES SR, 1973, J TRAUMA, V13, P895, DOI 10.1097/00005373-197313100-00009; Kaufman B A, 1990, Infect Dis Clin North Am, V4, P677; Korinek AM, 2006, NEUROSURGERY, V59, P126, DOI 10.1227/01.NEU.0000220477.47323.92; La Fata V, 2008, AM J NEURORADIOL, V29, P536, DOI 10.3174/ajnr.A0885; LUI TN, 1989, PEDIATR NEUROSCI, V15, P85, DOI 10.1159/000120448; MACGEE EE, 1970, J NEUROSURG, V33, P312, DOI 10.3171/jns.1970.33.3.0312; Palabiyikoglu I, 2006, J HOSP INFECT, V62, P94, DOI 10.1016/j.jhin.2005.06.010; PAPPAS DG, 1993, CLIN INFECT DIS, V17, P364, DOI 10.1093/clinids/17.3.364; PARK JI, 1983, LARYNGOSCOPE, V93, P1294; Plaisier B. R., 2005, INTERNET J NEUROSURG, V2; Prosser JD, 2011, OTOLARYNG CLIN N AM, V44, P857, DOI 10.1016/j.otc.2011.06.007; Prosser JD, 2011, OTOLARYNGOL CLIN N A, V44, pvii; Ratilal BO, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004884, 10.1002/14651858.CD004884.pub3]; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SPONSEL C, 1994, POSTGRAD MED, V95, P109; Stone JA, 1999, AM J NEURORADIOL, V20, P706; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Weisfelt M, 2007, J HOSP INFECT, V66, P71, DOI 10.1016/j.jhin.2007.02.017; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3	33	15	15	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JUN	2012	32	6							E4	10.3171/2012.5.FOCUS1269			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	954DQ	WOS:000304927100006	22655693				2021-06-18	
J	Anderson, V; Eren, S; Dob, R; Le Brocque, R; Iselin, G; Davern, TJ; McKinlay, L; Kenardy, J				Anderson, Vicki; Eren, Senem; Dob, Rian; Le Brocque, Robyne; Iselin, Greg; Davern, Timothy J.; McKinlay, Lynne; Kenardy, Justin			Early Attention Impairment and Recovery Profiles After Childhood Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						child; traumatic brain injury; attention; recovery	PEDIATRIC HEAD-INJURY; CHILDREN; SKILLS; DEFICITS; PERFORMANCE; SAMPLE	Objectives: To examine recovery of attention from 3 to 6 months postinjury; to identify effects of injury severity and time since injury on performance; to explore whether complex attention skills (eg, shifting, divided attention, attentional control) are more vulnerable to traumatic brain injury (TBI), and slower to recover than simple attention skills (eg, attentional capacity, selective attention, sustained attention). Design: Prospective longitudinal investigation. Participants: A total of 205 school-aged children with TBI were divided into groups according to injury severity (mild = 63%, moderate = 27%, severe = 10%). Setting: Emergency departments of 3 metropolitan children's hospitals across Australia. Main Measures: Standardized clinical measures of both simple and complex attention were administered at 3 months and 6 months postinjury. Results: Attention skills were vulnerable to the impact of TBI. More severe injury affected attention skills most negatively. Significant recovery was observed over time. There were few interaction effects, with severity groups exhibiting similar levels of recovery over the 6 months post-TBI. No differences in recovery trajectories were detected for simple and complex attention. Conclusions: These findings have important clinical and educational implications, suggesting that children with TBI, and particularly those with more serious injuries, are most vulnerable to attention deficits in the acute stages postinjury. It is important that schools and families are aware of these limitations and structure expectations accordingly. For example, gradual return to school should be considered, and in the early stages of recovery, children should be provided with sufficient rest time, with reduced expectations for tasks such as homework.	[Anderson, Vicki; Eren, Senem] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki; Eren, Senem] Univ Melbourne, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic 3052, Australia; [Davern, Timothy J.] Monash Univ, Melbourne, Vic 3004, Australia; [Dob, Rian] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Le Brocque, Robyne; Iselin, Greg; Kenardy, Justin] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [McKinlay, Lynne] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Brisbane, Qld, Australia	Anderson, V (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Kenardy, Justin A/H-6603-2014; Kenardy, Justin/F-2085-2010; Le Brocque, Robyne/F-4848-2010	Kenardy, Justin A/0000-0001-9475-8450; Le Brocque, Robyne/0000-0002-4574-1254; McKinlay, Lynne/0000-0002-6677-0628			Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; COOLEY EL, 1990, DEV NEUROPSYCHOL, V6, P239, DOI 10.1080/87565649009540465; Crowe L, 2009, JPCH, V45, P345; Dennis M., 1995, TRAUMATIC HEAD INJUR, P165; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gioia G.A., 2000, BEHAV RATING INVENTO; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kraus J., 1995, TRAUMATIC HEAD INJUR, P117; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T., 1999, TEST EVERYDAY ATTENT; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McLennan W., 1997, AUSTR STANDARD CLASS; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner M, 1990, ANNU REV NEUROSCI, V15, P25; Sparrow S., 1984, VINELAND ADAPTIVE BE; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TAYLOR HG, 1990, NEW ENGL J MED, V323, P1657, DOI 10.1056/NEJM199012133232403; TEASDALE G, LANCET, V2, P81; Timmermans SR, 1991, COGNITIVE REHABILITA, V9, P26; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Vriezen ER, 2000, BRAIN COGNITION, V44, P67; WALSH K, 1978, NEUROPSYCHOLOGY CLIN; Warchausky S, 1996, ARCH CLIN NEUROPSYCH, V11, P147; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHLSER ABBREVIATED; Willmott C, 2000, DEV NEUROPSYCHOL, V17, P361, DOI 10.1207/S15326942DN1703_5; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	42	15	15	2	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2012	27	3					199	209		10.1097/HTR.0b013e31821a9d2b			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	941CV	WOS:000303941500008	21691214				2021-06-18	
J	Fleming, JC; Bailey, CS; Hundt, H; Gurr, KR; Bailey, SI; Cepinskas, G; Lawendy, AR; Badhwar, A				Fleming, Jennifer C.; Bailey, Christopher S.; Hundt, Hans; Gurr, Kevin R.; Bailey, Stewart I.; Cepinskas, Gediminas; Lawendy, Abdel-Rahman; Badhwar, Amit			Remote inflammatory response in liver is dependent on the segmental level of spinal cord injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Meeting of the Society-for-Neuroscience	OCT, 2009	Chicago, IL	Soc Neurosci		Leukocyte; liver; spinal cord injury; inflammation; intravital microscopy	SYMPATHETIC-NERVOUS-SYSTEM; TRAUMA PATIENTS; LEUKOCYTE MOBILIZATION; ISOFLURANE ANESTHESIA; COMPRESSION INJURY; INTEGRIN BLOCKADE; IMMUNE-SYSTEM; BRAIN; NEUTROPHILS; COMPLICATIONS	BACKGROUND: Traumatic spinal cord injury (SCI) triggers a systemic inflammatory response (SIR) that contributes to a high incidence of secondary organ complications, particularly after a cervical or high-level thoracic injury. Because liver plays a key role in initiating and propagating the SIR, the aim of this study was to assess the effects that SCI at differing segmental levels has on the intensity of the inflammatory response in the liver. METHODS: Using male Wistar rats, clip compression SCI was performed at the 4th thoracic (T4 SCI; high-level SCI) or the 12th thoracic (T12 SCI; low-level SCI) spinal cord segment. Sham-injured rats had a partial laminectomy, but no SCI. Leukocyte recruitment to the liver, hepatic blood flow, and hepatocellular injury/death were assessed using intravital microscopy and histology. Chemokine and cytokine concentrations were assessed in the liver. Outcomes were measured at 1.5 hours, 12 hours, and 24 hours after SCI. RESULTS: At 12 hours after injury, T4 SCI caused a threefold increase in hepatic leukocyte recruitment compared with T12 SCI (p < 0.05). T4 SCI induced 50% more hepatocyte injury than T12 SCI at 12 hours (p < 0.05). Hepatic blood flow decreased after SCI, but not after sham injury, and stayed decreased only after T4 SCI at 24 hours after injury. The T4 SCI-induced changes were accompanied by increases in the hepatic concentrations of interleukin-1 beta, leptin, interleukin 10, and cytokine-induced neutrophil chemoattractant-1 at 1.5 hours. CONCLUSIONS: Our findings indicate that traumatic SCI triggers an acute SIR that contributes to hepatocellular injury. SCI-induced remote injury/dysfunction to the liver appears to be transient and is more robust after an upper thoracic SCI compared with a lower thoracic SCI. (J Trauma. 2012; 72: 1194-1202. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Fleming, Jennifer C.; Bailey, Christopher S.; Hundt, Hans; Gurr, Kevin R.; Bailey, Stewart I.; Lawendy, Abdel-Rahman] Univ Western Ontario, Div Orthopaed, Dept Surg, London, ON N6A 4G5, Canada; [Fleming, Jennifer C.; Bailey, Christopher S.; Cepinskas, Gediminas; Lawendy, Abdel-Rahman; Badhwar, Amit] Victoria Hosp, Lawson Hlth Res Inst, Ctr Crit Care Illness Res, Victoria Res Labs,London Hlth Sci Ctr, London, ON N6A 4G5, Canada	Fleming, JC (corresponding author), Univ Western Ontario, Div Orthopaed, Dept Surg, Victoria Hosp,London Hlth Sci Ctr, E4-126A,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	Jennifer.Fleming@lhsc.on.ca	Urquhart, Jennifer/Q-7604-2016; Cepinskas, Gediminas/V-3810-2019; Bailey, Chris S/L-7522-2015	Urquhart, Jennifer/0000-0002-9393-814X; Bailey, Chris S/0000-0001-5508-8415; Cepinskas, Gediminas/0000-0002-0267-6659			Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Bao F, 2011, EXP NEUROL, V231, P272, DOI 10.1016/j.expneurol.2011.07.001; Bao F, 2009, EXP NEUROL, V215, P308, DOI 10.1016/j.expneurol.2008.10.022; Bedirli N, 2008, ANESTH ANALG, V106, P830, DOI 10.1213/ane.0b013e3181616fc9; Bloom K K, 1989, J Am Paraplegia Soc, V12, P11; Brock RW, 2001, AM J PHYSIOL-GASTR L, V280, pG279; Campagnolo DI, 2008, SPINAL CORD, V46, P477, DOI 10.1038/sc.2008.4; CAMPAGNOLO DI, 1994, AM J PHYS MED REHAB, V73, P387, DOI 10.1097/00002060-199411000-00003; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Deitch EA, 1999, J TRAUMA, V46, P781; DEVIVO MJ, 1989, ARCH INTERN MED, V149, P1761, DOI 10.1001/archinte.149.8.1761; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024; FLETCHER DJ, 1995, SPINE, V20, P1136, DOI 10.1097/00007632-199505150-00005; Furlan JC, 2006, SPINE, V31, P2674, DOI 10.1097/01.brs.0000244569.91204.01; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Hundt H, 2011, INJURY, V42, P691, DOI 10.1016/j.injury.2010.12.013; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Mayorov DN, 2001, J NEUROTRAUM, V18, P727, DOI 10.1089/089771501750357663; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McKinley W, 2007, J SPINAL CORD MED, V30, P215, DOI 10.1080/10790268.2007.11753929; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ogura H, 1999, J TRAUMA, V46, P774, DOI 10.1097/00005373-199905000-00004; Pfeifer R, 2011, J ORTHOP RES, V29, P270, DOI 10.1002/jor.21214; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Stein DM, 2010, NEUROCRIT CARE, V13, P29, DOI 10.1007/s12028-010-9359-9; TANAKA H, 1991, ANN SURG, V214, P187, DOI 10.1097/00000658-199108000-00014; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P506, DOI 10.1053/mr.2000.3848; Tiegs G, 1999, J NEUROIMMUNOL, V96, P131, DOI 10.1016/S0165-5728(99)00014-4; Weaver LC, 2001, J NEUROTRAUM, V18, P1107, DOI 10.1089/08977150152693782; Wunder C, 2004, MICROVASC RES, V68, P20, DOI 10.1016/j.mvr.2004.03.003; YANO H, 1994, CAN J ANAESTH, V41, P149, DOI 10.1007/BF03009810; Zimmer MB, 2007, J SPINAL CORD MED, V30, P319, DOI 10.1080/10790268.2007.11753947	41	15	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1194	1201		10.1097/TA.0b013e31824d68bd			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	944JD	WOS:000304195100017	22673245				2021-06-18	
J	Katsnelson, M; Mackenzie, L; Frangos, S; Oddo, M; Levine, JM; Pukenas, B; Faerber, J; Dong, CH; Kofke, WA; le Roux, PD				Katsnelson, Michael; Mackenzie, Larami; Frangos, Suzanne; Oddo, Mauro; Levine, Joshua M.; Pukenas, Bryan; Faerber, Jennifer; Dong, Chuanhui; Kofke, W. Andrew; le Roux, Peter D.			Are Initial Radiographic and Clinical Scales Associated With Subsequent Intracranial Pressure and Brain Oxygen Levels After Severe Traumatic Brain Injury?	NEUROSURGERY			English	Article						Acute Physiology and Chronic Health Evaluation; Brain tissue oxygen tension; Computed tomography; Glasgow Coma Scale; Injury Severity Score; Intracranial pressure; Marshall CT classification; Rotterdam CT Score; Traumatic brain injury	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; PULMONARY-ARTERY CATHETERS; TISSUE OXYGEN; INTENSIVE-CARE; SUBARACHNOID HEMORRHAGE; SECONDARY INSULTS; PROGNOSTIC VALUE; CONTROLLED TRIAL; APACHE-II	BACKGROUND: Prediction of clinical course and outcome after severe traumatic brain injury (TBI) is important. OBJECTIVE: To examine whether clinical scales (Glasgow Coma Scale [GCS], Injury Severity Score [ISS], and Acute Physiology and Chronic Health Evaluation II [APACHE II]) or radiographic scales based on admission computed tomography (Marshall and Rotterdam) were associated with intensive care unit (ICU) physiology (intracranial pressure [ICP], brain tissue oxygen tension [Pbto(2)]), and clinical outcome after severe TBI. METHODS: One hundred one patients (median age, 41.0 years; interquartile range [26-55]) with severe TBI who had ICP and Pbto(2) monitoring were identified. The relationship between admission GCS, ISS, APACHE II, Marshall and Rotterdam scores and ICP, Pbto(2), and outcome was examined by using mixed-effects models and logistic regression. RESULTS: Median (25%-75% interquartile range) admission GCS and APACHE II without GCS scores were 3.0 (3-7) and 11.0 (8-13), respectively. Marshall and Rotterdam scores were 3.0 (3-5) and 4.0 (4-5). Mean ICP and Pbto(2) during the patients' ICU course were 15.5 +/- 10.7 mm Hg and 29.9 +/- 10.8 mm Hg, respectively. Three-month mortality was 37.6%. Admission GCS was not associated with mortality. APACHE II (P = .003), APACHE-non-GCS (P = .004), Marshall (P < .001), and Rotterdam scores (P < .001) were associated with mortality. No relationship between GCS, ISS, Marshall, or Rotterdam scores and subsequent ICP or Pbto(2) was observed. The APACHE II score was inversely associated with median Pbto(2) (P = .03) and minimum Pbto(2) (P = .008) and had a stronger correlation with amount of time of reduced Pbto(2). CONCLUSION: Following severe TBI, factors associated with outcome may not always predict a patient's ICU course and, in particular, intracranial physiology.	[Mackenzie, Larami; Frangos, Suzanne; Oddo, Mauro; Levine, Joshua M.; Kofke, W. Andrew; le Roux, Peter D.] Univ Penn, Dept Neurosurg, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Katsnelson, Michael; Mackenzie, Larami; Levine, Joshua M.] Univ Penn, Dept Neurol, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Levine, Joshua M.; Kofke, W. Andrew] Univ Penn, Dept Anesthesiol & Crit Care, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Pukenas, Bryan] Univ Penn, Dept Radiol, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Faerber, Jennifer] Univ Penn, Dept Biostat, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Dong, Chuanhui] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	le Roux, PD (corresponding author), Univ Penn, Dept Neurosurg, Med Ctr, Ctr Clin Epidemiol & Biostat, 235 S 8th St,4th Floor, Philadelphia, PA 19106 USA.	lerouxp@uphs.upenn.edu	Oddo, Mauro/R-3370-2016	Oddo, Mauro/0000-0002-6155-2525	Integra Foundation; Integra Neurosciences; Mary Elisabeth Groff Surgical and Medical Research Trust	Dr le Roux was supported in part by research grants from the Integra Foundation, Integra Neurosciences, and the Mary Elisabeth Groff Surgical and Medical Research Trust. Dr le Roux is a member of the Integra Speaker's Bureau. All other authors have no financial disclosures to report.	American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP C; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Brain Trauma Foundation, 2000, GUID MAN PROGN SEV T; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clinical Trials Unit, CLIN RAND ANT SIGN H; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Grmec S, 2001, CRIT CARE, V5, P19; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2005, INTENS CARE MED, V31, P799, DOI 10.1007/s00134-005-2628-y; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nangunoori RM, 2010, NEUROSURGERY; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Richard C, 2003, JAMA-J AM MED ASSOC, V290, P2713, DOI 10.1001/jama.290.20.2713; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, V4, P5103; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2000, NEUROSURGERY, V46, P70; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Tbi Impact, INT MISS PROGN AN CL; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278	83	15	15	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAY	2012	70	5					1095	1105		10.1227/NEU.0b013e318240c1ed			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	933VA	WOS:000303390400021	22076531				2021-06-18	
J	Namdari, S; Alosh, H; Baldwin, K; Mehta, S; Keenan, MA				Namdari, Surena; Alosh, Hassan; Baldwin, Keith; Mehta, Samir; Keenan, Mary Ann			Outcomes of tendon fractional lengthenings to improve shoulder function in patients with spastic hemiparesis	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Tendon lengthening; spasticity; hemiparesis	UPPER-LIMB SPASTICITY; BRAIN-INJURED ADULTS; DYNAMIC ELECTROMYOGRAPHY; ORTHOPEDIC MANAGEMENT; SURGICAL-TREATMENT; BOTULINUM TOXIN; STROKE; DEFORMITY; CONTRACTURE; REDUCTION	Background: Patients with spastic hemiparesis after upper motor neuron (UMN) injury often exhibit limited shoulder movement. We evaluated the outcomes of shoulder tendon fractional lengthenings in patients with spasticity and preserved volitional control. Methods: A consecutive series of 34 adults with spastic hemiparesis from UMN injury (23 post-stroke, 11 post-traumatic brain injury) and limited shoulder movement with preserved volitional motor control who underwent shoulder tendon fractional lengthenings (pectoralis major, latissimus dorsi, teres major) were evaluated. Active and passive shoulder motion, spasticity, pain, and satisfaction were considered pre- and postoperatively. Results: There were 15 males and 19 females with a mean age of 44.1 years. Mean follow-up was 12.2 months. Mean Modified Ashworth spasticity score was 2.4 preoperatively compared to 1.9 postoperatively (P = .001). Active flexion, abduction, and external rotation improved compared to the normal contralateral side (P < .001) with most dramatic gains in external rotation. Similarly, passive extension, flexion, abduction, and external rotation improved compared to the normal contralateral side (P < .01). Ninety-four percent (15/16) with preoperative pain had improved pain relief postoperatively with 14 (88%) being pain-free. Thirty-one (92%) were satisfied with the outcome. Conclusion: Shoulder tendon lengthenings can be an effective means of pain-relief, improved motion, enhanced active motor function, and decreased spasticity in patients with spastic hemiparesis from UMN injury. (c) 2012 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Namdari, Surena; Alosh, Hassan; Baldwin, Keith; Mehta, Samir; Keenan, Mary Ann] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	Keenan, MA (corresponding author), Hosp Univ Penn, Dept Orthopaed Surg, 2 Silverstein,3400 Spruce St, Philadelphia, PA 19104 USA.	MaryAnn.Keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				Aldwell C B, 1969, Clin Orthop Relat Res, V63, P69; Bertelli JA, 2009, J BONE JOINT SURG BR, V91B, P943, DOI 10.1302/0301-620X.91B7.21795; Bhakta BB, 1996, J NEUROL NEUROSUR PS, V61, P30, DOI 10.1136/jnnp.61.1.30; Botte M J, 1988, Orthop Rev, V17, P891; BOTTE MJ, 1988, J HAND SURG-AM, V13A, P147, DOI 10.1016/0363-5023(88)90220-1; BRAUN RM, 1971, J BONE JOINT SURG AM, VA 53, P1307, DOI 10.2106/00004623-197153070-00006; Braun RM, 1999, CLIN ORTHOP RELAT R, P54; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; KAPLAN PE, 1977, ARCH PHYS MED REHAB, V58, P415; Keenan MA, 2010, GREENS OPERATIVE HAN, P1178; Keenan MAE, 2004, J HEAD TRAUMA REHAB, V19, P143, DOI 10.1097/00001199-200403000-00006; Keenan MAE, 2002, CUR CLIN NEUROL, P197; KOZIN SH, 1993, CLIN ORTHOP RELAT R, P109; Namdari S, 2011, J SHOULDER ELB SURG, V20, P802, DOI 10.1016/j.jse.2010.10.023; Namdari S, 2010, J BONE JOINT SURG AM, V92A, P2589, DOI 10.2106/JBJS.I.01390; PILL SG, 2008, SPASTICITY OTHER FOR, P119; PINZUR MS, 1993, CLIN ORTHOP RELAT R, P118; Posteraro F, 2010, J REHABIL MED, V42, P279, DOI 10.2340/16501977-0500; RHOADES ME, 1978, CLIN ORTHOP RELAT R, P104; Shaw L, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14260; van der Sluijs JA, 2004, J PEDIATR ORTHOP B, V13, P218, DOI 10.1097/00009957-200405000-00015; Waters PM, 2009, J BONE JOINT SURG AM, V91A, P213, DOI 10.2106/JBJS.I.00501; Yelnik A. P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P746, DOI 10.1016/j.rehab.2009.09.005	23	15	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	MAY	2012	21	5					691	698		10.1016/j.jse.2011.03.026			8	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	944HU	WOS:000304190700024	21719314				2021-06-18	
J	Taft, CT; Kachadourian, LK; Suvak, MK; Pinto, LA; Miller, MM; Knight, JA; Marx, BP				Taft, Casey T.; Kachadourian, Lorig K.; Suvak, Michael K.; Pinto, Lavinia A.; Miller, Mark M.; Knight, Jeffrey A.; Marx, Brian P.			Examining Impelling and Disinhibiting Factors for Intimate Partner Violence in Veterans	JOURNAL OF FAMILY PSYCHOLOGY			English	Article						trauma; veterans; violence; aggression; head injury	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; AGGRESSION; PERPETRATION; PERSONALITY; VALIDITY; SCALE	We examined correlates of intimate partner violence (IPV) in a military Veteran sample (N = 129) using Finkel's (2007) framework for understanding the interactions between impelling and disinhibiting risk factors. Correlates investigated included head contact events (HCEs), posttraumatic stress disorder (PTSD) symptoms, and antisocial features. Results indicated that antisocial features were significantly associated with IPV at the bivariate level. PTSD symptoms also were associated with IPV, but this association was marginally significant. Tests of moderation provided support for the expectation that HCEs would potentiate associations between antisocial features and IPV. HCEs also moderated the association between PTSD symptoms and IPV. However, contrary to expectations, the opposite pattern emerged such that PTSD symptoms were associated with a higher rate of IPV for those without a history of HCEs. Study findings have potentially important implications for furthering our understanding of the complex etiology of IPV in this population.	[Taft, Casey T.; Kachadourian, Lorig K.; Miller, Mark M.; Knight, Jeffrey A.; Marx, Brian P.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Taft, Casey T.; Kachadourian, Lorig K.; Miller, Mark M.; Knight, Jeffrey A.; Marx, Brian P.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Suvak, Michael K.] Suffolk Univ, Dept Psychol, Boston, MA USA; [Pinto, Lavinia A.] Kent State Univ, Dept Psychol, Kent, OH USA	Taft, CT (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD, 150 S Huntington Ave 116B-4, Boston, MA 02130 USA.	Casey.Taft@va.gov	Miller, Mark Webber/G-7322-2011; Marx, Brian/AAK-5072-2020	Miller, Mark Webber/0000-0001-6393-8563; 	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH079806, K08 MH7311701A2] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH073117, R01MH079806] Funding Source: NIH RePORTER		Blake D. D., 1990, BEHAV THER, V13, P187; Butcher J.N., 1990, DEV USE MMPI 2 CONTE; Chemtob CM, 1997, J TRAUMA STRESS, V10, P17, DOI 10.1023/A:1024852228908; Cohen J., 2003, APPL MULTIPLE CORREL; Cohen R A, 1999, Violence Vict, V14, P397; Finkel EJ, 2007, REV GEN PSYCHOL, V11, P193, DOI 10.1037/1089-2680.11.2.193; Gagnon DR, 2008, J TRAUMA STRESS, V21, P448, DOI 10.1002/jts.20359; Greve KW, 2001, BRAIN INJURY, V15, P255; Hamberger L. K., 2007, INT HDB PSYCHOPATHIC, V1, P497; Harenski CL, 2010, BRIT J PSYCHOL, V101, P401, DOI 10.1348/000712609X471067; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI DOI 10.1037/1040-3590.1.1.53; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Lilienfeld SO, 1996, PSYCHOL ASSESSMENT, V8, P281, DOI 10.1037/1040-3590.8.3.281; Miller M. W., RESILIENCE IN PRESS, P56; Miller MW, 2003, CLIN PSYCHOL-SCI PR, V10, P373, DOI 10.1093/clipsy/bpg040; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Neumann CS, 2008, J CONSULT CLIN PSYCH, V76, P893, DOI 10.1037/0022-006X.76.5.893; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Taft C. T., 2010, US MILITARY FAMILIES; Taft CT, 2009, AM J ORTHOPSYCHIAT, V79, P461, DOI 10.1037/a0016657	23	15	15	1	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0893-3200			J FAM PSYCHOL	J. Fam. Psychol.	APR	2012	26	2					285	289		10.1037/a0027424			5	Psychology, Clinical; Family Studies	Psychology; Family Studies	921RU	WOS:000302495800014	22369461	Green Accepted			2021-06-18	
J	Farinelli, M; Heitz, FD; Grewe, BF; Tyagarajan, SK; Helmchen, F; Mansuy, IM				Farinelli, Melissa; Heitz, Fabrice D.; Grewe, Benjamin F.; Tyagarajan, Shiva K.; Helmchen, Fritjof; Mansuy, Isabelle M.			Selective Regulation of NR2B by Protein Phosphatase-1 for the Control of the NMDA Receptor in Neuroprotection	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; ORGANOTYPIC HIPPOCAMPAL CULTURES; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; KINASE-II; ISCHEMIC BRAIN; CELL-DEATH; CA-2+-INDEPENDENT ACTIVITY; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY	An imbalance between pro-survival and pro-death pathways in brain cells can lead to neuronal cell death and neurodegeneration. While such imbalance is known to be associated with alterations in glutamatergic and Ca2+ signaling, the underlying mechanisms remain undefined. We identified the protein Ser/Thr phosphatase protein phosphatase-1 (PP1), an enzyme associated with glutamate receptors, as a key trigger of survival pathways that can prevent neuronal death and neurodegeneration in the adult hippocampus. We show that PP1 alpha overexpression in hippocampal neurons limits NMDA receptor overactivation and Ca2+ overload during an excitotoxic event, while PP1 inhibition favors Ca2+ overload and cell death. The protective effect of PP1 is associated with a selective dephosphorylation on a residue phosphorylated by CaMKII alpha on the NMDA receptor subunit NR2B, which promotes pro-survival pathways and associated transcriptional programs. These results reveal a novel contributor to the mechanisms of neuroprotection and underscore the importance of PP1-dependent dephosphorylation in these mechanisms. They provide a new target for the development of potential therapeutic treatment of neurodegeneration.	[Farinelli, Melissa; Heitz, Fabrice D.; Grewe, Benjamin F.; Helmchen, Fritjof; Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Farinelli, Melissa; Heitz, Fabrice D.; Mansuy, Isabelle M.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Tyagarajan, Shiva K.] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	Farinelli, M (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	mansuy@hifo.uzh.ch	Tyagarajan, Shiva/P-3135-2015; Grewe, Benjamin/E-7044-2017; Mansuy, Isabelle M/N-3042-2015; Helmchen, Fritjof/A-6255-2008	Tyagarajan, Shiva/0000-0003-0074-1805; Grewe, Benjamin/0000-0001-8560-2120; Mansuy, Isabelle M/0000-0001-7785-5371; Helmchen, Fritjof/0000-0002-8867-9569	National Center for Competence in Research "Neural Plasticity and Repair''; University of Zurich; Swiss Federal Institute of Technology; Human Frontier Science ProgramHuman Frontier Science Program; Swiss National FoundationSwiss National Science Foundation (SNSF); Slack-Gyr Foundation; Bitterlin Foundation	Funding by the National Center for Competence in Research "Neural Plasticity and Repair'', the University of Zurich, the Swiss Federal Institute of Technology, The Human Frontier Science Program, The Swiss National Foundation, Slack-Gyr Foundation, and Bitterlin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Camacho A, 2007, NEUROSCIENCE, V145, P873, DOI 10.1016/j.neuroscience.2006.12.069; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fields RD, 2005, CELL CALCIUM, V37, P433, DOI 10.1016/j.ceca.2005.01.011; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gee CE, 2006, EUR J NEUROSCI, V23, P2595, DOI 10.1111/j.1460-9568.2006.04786.x; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hedou GF, 2008, J NEUROSCI, V28, P154, DOI 10.1523/JNEUROSCI.4109-07.2008; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Kollen M, 2008, NEUROSCIENCE, V154, P1308, DOI 10.1016/j.neuroscience.2008.04.045; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lennmyr F, 2004, ACTA NEUROL SCAND, V110, P175, DOI 10.1111/j.1600-0404.2004.00306.x; Liao GY, 2001, MOL PHARMACOL, V59, P960; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lipton P, 1999, PHYSIOL REV, V79, P1431; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Martel MA, 2008, NEUROSCIENCE; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; NEWELL DW, 1995, J NEUROSCI, V15, P7702; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schubert P, 1994, J Neural Transm Suppl, V44, P73; SCHWORER H, 1988, BRIT J PHARMACOL, V93, P715, DOI 10.1111/j.1476-5381.1988.tb10330.x; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Strack S, 1997, J NEUROCHEM, V68, P2119; STRASSER U, 1995, J NEUROSCI METH, V57, P177, DOI 10.1016/0165-0270(94)00147-9; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tu W, CELL, V140, P222; Walton M, 1996, MOL BRAIN RES, V43, P21, DOI 10.1016/S0169-328X(96)00144-1; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	62	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34047	10.1371/journal.pone.0034047			11	Multidisciplinary Sciences	Science & Technology - Other Topics	959UC	WOS:000305339100108	22479519	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Csokay, A; Emelifeonwu, JA; Fugedi, L; Valalik, I; Lang, J				Csokay, Andras; Emelifeonwu, John Amaechi; Fuegedi, Laszlo; Valalik, Istvan; Lang, Jozsef			The importance of very early decompressive craniectomy as a prevention to avoid the sudden increase of intracranial pressure in children with severe traumatic brain swelling (retrospective case series)	CHILDS NERVOUS SYSTEM			English	Article						Decompressive craniectomy; Traumatic brain swelling; Vascular tunnel	HEAD-INJURY	The purpose of the retrospective case series of eight consecutive patients is to call our attention to the optimal timing of decompressive craniectomy (DC) in children. We report the outcomes of eight children under the age of 12 with severe head injuries. DC was performed at different intracranial pressure (ICP; 20 and 25 mmHg) levels. Our results suggest that above 20 mmHg, very fast progression of ICP (within15min) can occur, which may limit the time available to plan and perform DC with a successful patient outcome. Considering the anamnestic data, it could be useful to perform DC at 20-22 mmHg ICP in young patients in order to prevent the potential of very fast brain swelling if there is no possibility to perform durotomy within 20 min after the onset of raising the ICP. It is especially considerable in poor countries where the emergency route could be less organized because of locations of building and extreme load of the staff. Further controlled trials are necessary to evaluate the indication and standardization of early decompressive craniectomy as a standard preventive therapy in pediatric severe traumatic brain swelling.	[Csokay, Andras; Fuegedi, Laszlo; Valalik, Istvan; Lang, Jozsef] BAZ Cty Hosp, Dept Neurosurg, H-3501 Miskolc, Hungary; [Emelifeonwu, John Amaechi; Lang, Jozsef] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales	Csokay, A (corresponding author), BAZ Cty Hosp, Dept Neurosurg, 72-76 Szentpeteri Kapu 76, H-3501 Miskolc, Hungary.	csokaya@gmail.com					Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Csokay A, 2011, NEUROL RES, V33, P747, DOI 10.1179/1743132811Y.0000000001; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Munch E, 2000, NEUROSURGERY, V47, P315; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Sahuquillo J, 2009, COCHRANE DATABASE SY; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	15	15	16	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2012	28	3					441	444		10.1007/s00381-011-1661-0			4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	897OY	WOS:000300663300018	22207401				2021-06-18	
J	Mikkonen, K; Pekkala, N; Pokka, T; Romner, B; Uhari, M; Rantala, H				Mikkonen, Kirsi; Pekkala, Niina; Pokka, Tytti; Romner, Bertil; Uhari, Matti; Rantala, Heikki			S100B proteins in febrile seizures	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						S100B; Febrile seizure; Children	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; BLOOD	S100B protein concentrations correlate with the severity and outcome of brain damage after brain injuries, and have been shown to be markers of blood-brain barrier damage. In children elevated Si 008 values are seen as a marker of damage to astrocytes even after mild head injuries. S100B proteins may also give an indication of an ongoing pathological process in the brain with respect to febrile seizures (FS) and the likelihood of their recurrence. To evaluate this, we measured S100B protein concentrations in serum and cerebrospinal fluid from 103 children after their first FS. 33 children with acute infection without FS served as controls for the serum concentrations. In the FS patients the mean S100B concentration in the cerebrospinal fluid samples was 0.21 mu g/L and that in the serum samples 0.12 mu g/L. The mean serum concentration in the controls was 0.11 mu g/L (difference 0.01 mu g/L, 95% confidence interval -0.02 to 0.04 mu g/L, P = 0.46). There was a correlation between age and serum S100B concentration (r= -0.28, P = 0.008) in children under four years, but S100B concentrations did not predict the clinical severity of the FS nor their recurrence. There was no correlation between time of arrival at the hospital after FS and S100B concentration in serum (r = -0.130, P = 0.28) or in cerebrospinal fluid samples (r = -0.091, P = 0.52). Our findings indicate that FS does not cause significant blood-brain barrier openings, and increase the evidence that these seizures are relatively harmless for the developing brain. (C) 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Mikkonen, Kirsi; Pekkala, Niina; Pokka, Tytti; Uhari, Matti; Rantala, Heikki] Univ Oulu, Dept Pediat, FIN-90014 Oulu, Finland; [Romner, Bertil] Rigshosp, Dept Neurosurg, DK-2100 Copenhagen, Denmark	Mikkonen, K (corresponding author), Univ Oulu, Dept Pediat, POB 5000, FIN-90014 Oulu, Finland.	kirsi.mikkonen@oulu.fi			Special State Grants for Health Research in the Department of Pediatrics and Adolescence, Oulu University Hospital, Finland	This study was supported by Special State Grants for Health Research in the Department of Pediatrics and Adolescence, Oulu University Hospital, Finland.	[Anonymous], 1989, EPILEPSIA, V30, P389; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Burgess DL, 2005, EPILEPSIA, V46, P51, DOI 10.1111/j.1528-1167.2005.00359.x; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Heizmann CW, 2005, J PEDIATR-US, V147, P731, DOI 10.1016/j.jpeds.2005.08.046; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2011, CARDIOVASC PSYCHIAT, V2011; NELSON KB, 1978, PEDIATRICS, V61, P720; Palmio J, 2001, J NEUROL SCI, V183, P27, DOI 10.1016/S0022-510X(00)00478-0; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Schulpis KH, 2006, SCAND J CLIN LAB INV, V66, P733, DOI 10.1080/00365510600977737; Strengell T, 2009, ARCH PEDIAT ADOL MED, V163, P799, DOI 10.1001/archpediatrics.2009.137; Tomkins O, 2011, CARDIOVASC PSYCHIAT, V2011	15	15	17	0	5	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311			SEIZURE-EUR J EPILEP	Seizure	MAR	2012	21	2					144	146		10.1016/j.seizure.2011.10.006			3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	900ER	WOS:000300869900013	22130006				2021-06-18	
J	Reeves, RR; Laizer, JT				Reeves, Roy R.; Laizer, Janet T.			Traumatic Brain Injury and Suicide	JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; BEHAVIOR; ASSOCIATION; POPULATION; PEOPLE; POSTINJURY; SYMPTOMS; VETERANS	A number of psychiatric and neurological problems may occur following traumatic brain injury (TBI). Anxiety and depression are common. There is evidence that there may be a correlation between TBI and increased risk of suicide. This article will explore current literature on the risk of suicidal behavior in people who have experienced TBI. Risk factors for suicide, recognition and assessment of suicidal behavior, and treatment issues will be discussed.	[Reeves, Roy R.; Laizer, Janet T.] GV Sonny Montgomery Vet Affairs Med Ctr, Jackson, MS 39216 USA; [Reeves, Roy R.; Laizer, Janet T.] Univ Mississippi, Sch Med, Jackson, MS 39216 USA	Reeves, RR (corresponding author), GV Sonny Montgomery Vet Affairs Med Ctr, 1500 E Woodrow Wilson Dr, Jackson, MS 39216 USA.	roy.reeves@va.gov					Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J CLIN PSYCHOL MED S, V18, P116, DOI 10.1007/s10880-011-9240-9; Breshears RE, 2010, J PERS ASSESS, V92, P349, DOI 10.1080/00223891.2010.482011; Bryan C, 2011, J CLIN PSYCHOL, V67, P856, DOI 10.1002/jclp.20808; Coco K, 2011, J NEUROSCI NURS, V43, P337, DOI 10.1097/JNN.0b013e318234ea0b; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Morey L.C., 2004, COMPREHENSIVE HDB PS, V2, P15; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Oquendo MA, 2003, AM J PSYCHIAT, V160, P580, DOI 10.1176/appi.ajp.160.3.580; Reeves RR, 2009, TERROR HOT SPOTS CON, P105; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2003, J HEAD TRAUMA REHAB, V18, P445, DOI 10.1097/00001199-200309000-00006; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thibault JM, 2004, AM FAM PHYSICIAN, V70, P1101; TREVENA L, 2004, CLIN PRACTICE GUIDEL; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	35	15	16	0	8	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0279-3695			J PSYCHOSOC NURS MEN	J. Psychosoc. Nurs. Ment. Health Serv.	MAR	2012	50	3					32	38		10.3928/02793695-20120207-02			7	Nursing	Nursing	905VA	WOS:000301302800011	22329620				2021-06-18	
J	Sturm, JJ; Pierzchala, A; Simon, HK; Hirsh, DA				Sturm, Jesse J.; Pierzchala, Amanda; Simon, Harold K.; Hirsh, Daniel A.			Ondansetron Use in the Pediatric Emergency Room for Diagnoses Other Than Acute Gastroenteritis	PEDIATRIC EMERGENCY CARE			English	Article						gastroenteritis; vomiting; ondansetron	RANDOMIZED CONTROLLED-TRIAL; ORAL ONDANSETRON; CHILDREN; PLACEBO	Background: Ondansetron is widely used in the pediatric emergency department (PED) for vomiting and acute gastroenteritis (GE). Little is known about the spectrum of its use in diagnoses other than acute GE. Objective: The objective of this study was to evaluate the spectrum of diagnoses for which ondansetron is used in the PED. Methods: Medical records from 2 tertiary care PEDs from January 2006 to December 2008 were retrospectively reviewed. Patients 3 months to 18 years of age given ondansetron in the PED were identified. Patients without a primary discharge diagnosis (based on International Classification of Diseases, Ninth Revision code) of vomiting or GE were defined as non-GE. Patient age, initial triage level (1 = lowest acuity, 5 = highest), route of administration (enteral vs parenteral), primary diagnosis, disposition, and prescription for ondansetron at discharge were recorded; GE and non-GE patients were compared based on age and triage acuity. Results: There were 32,971 patients who received ondansetron in the PED; 12,620 (38%) were non-GE patients. Non-GE patients were older (8.3 vs 4.3 years, P < 0.001) and of higher average initial triage level (2.95 vs 2.33, P < 0.001) compared with GE patients. Within non-GE patients, 79% received ondansetron enterally, 71% were discharged, and 37% of those discharged received an ondansetron prescription. The most common primary diagnoses for non-GE discharged patients were fever (15%), abdominal pain/tenderness (13%), head injury/concussion (7%), pharyngitis (6%), viral infection (6%), migraine variants (5%), and otitis media (5%). The most common diagnoses of patients admitted were appendicitis (11%), asthma (6%), pneumonia (4%), and diabetes (4%). Conclusions: Although ondansetron is a widely accepted treatment for GE in children, this study identifies a broader spectrum of primary diagnoses for which ondansetron is being used.	[Sturm, Jesse J.; Pierzchala, Amanda; Simon, Harold K.; Hirsh, Daniel A.] Emory Univ, Childrens Healthcare Atlanta, Atlanta, GA 30307 USA	Sturm, JJ (corresponding author), Emory Univ, Childrens Healthcare Atlanta, 1784 Delaware Ave NE, Atlanta, GA 30307 USA.	jesse.sturm@gmail.com					[Anonymous], 2009, DRUG TOPICS, V155, P24; Freedman SB, 2006, NEW ENGL J MED, V354, P1698, DOI 10.1056/NEJMoa055119; Garra G, 2009, ANN EMERG MED, V53, P528, DOI 10.1016/j.annemergmed.2008.06.003; Langston WT, 2008, ANN EMERG MED, V52, P30, DOI 10.1016/j.annemergmed.2008.01.326; Leung Alexander K C, 2007, Paediatr Drugs, V9, P175, DOI 10.2165/00148581-200709030-00006; PDR Editorial Staff, 2004, RED BOOK UPD; Ramsook C, 2002, ANN EMERG MED, V39, P397, DOI 10.1067/mem.2002.122706; Reeves JJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e62; Roslund G, 2008, ANN EMERG MED, V52, P22, DOI 10.1016/j.annemergmed.2007.09.010; Steel R, 1997, PRINCIPLES PROCEDURE, P520; Stork CM, 2006, ACAD EMERG MED, V13, P1027, DOI 10.1197/j.aem.2006.05.018; Sturm JJ, 2010, ANN EMERG MED, V55, P415, DOI 10.1016/j.annemergmed.2009.11.011; Szajewska H, 2007, ALIMENT PHARM THER, V25, P393, DOI 10.1111/j.1365-2036.2006.03231.x	13	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2012	28	3					247	250		10.1097/PEC.0b013e3182494d87			4	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	905JN	WOS:000301268500007	22344213				2021-06-18	
J	Tate, R; Simpson, G; Lane-Brown, A; Soo, C; de Wolf, A; Whiting, D				Tate, Robyn; Simpson, Grahame; Lane-Brown, Amanda; Soo, Cheryl; de Wolf, Annelies; Whiting, Diane			Sydney Psychosocial Reintegration Scale (SPRS-2): Meeting the Challenge of Measuring Participation in Neurological Conditions	AUSTRALIAN PSYCHOLOGIST			English	Article						assessment; brain injuries; community integration; participation; psychometric properties; Sydney Psychosocial Reintegration Scale	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION MEASURE; PSYCHOMETRIC PROPERTIES; INTERNATIONAL CLASSIFICATION; OUTCOMES; REHABILITATION; DISABILITY; RECOVERY; HEALTH; ADULTS	This three-part article presents: (1) a review of the construct of participation; (2) an overview of the 12-item Sydney Psychosocial Reintegration Scale (SPRS) as a measure of participation and as a description of new developments resulting in its revision (SPRS-2); and (3) as an application in different neurological groups. Psychometrically, the SPRS performs very well. There are no significant floor or ceiling effects, and both Form A (change since injury) and Form B (current status) show excellent inter-rater and testretest reliability. There is also substantial evidence for its validity (concurrent, discriminant, and convergent/divergent), and it shows good fit to a Rasch model, providing evidence for its construct validity. Rasch logit scores are used to provide reliable change index values to determine whether an individual patient's scores have improved or deteriorated. In Part 3, three samples were compared: traumatic brain injury (TBI; n = 130), primary brain tumour (PBT; n = 54), and spinal cord injury (SCI; n = 50) on the SPRS-2 Form B. The TBI sample performed more poorly than the PBT and SCI samples on the interpersonal relationships and occupational activity domains. On the living skills domain, the TBI and SCI groups both performed more poorly than the PBT sample. These data demonstrate the differential levels of participation observed in different neurological groups.	[Tate, Robyn; Simpson, Grahame; Lane-Brown, Amanda; de Wolf, Annelies] Univ Sydney, Rehabil Studies Unit, Sydney Med Sch, No Clin Sch, Sydney, NSW 1680, Australia; [Tate, Robyn] Royal Rehabil Ctr Sydney, Sydney, NSW, Australia; [Simpson, Grahame; Whiting, Diane] Liverpool Hosp, Brain Injury Rehabilitat Unit, Liverpool, Merseyside, England; [Soo, Cheryl] Royal Childrens Hosp, Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic, Australia	Tate, R (corresponding author), Univ Sydney, Rehabil Studies Unit, Sydney Med Sch, No Clin Sch, POB 6, Sydney, NSW 1680, Australia.	rtate@med.usyd.edu.au	Simpson, Grahame K/W-1074-2019; Whiting, Diane/AAN-2522-2021	Simpson, Grahame K/0000-0001-8156-9060; Whiting, Diane/0000-0003-1912-6626			Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cameron I. D., 2007, MOTOR ACCIDENT AUTHO; Cameron ID, 2010, DISABIL REHABIL, V32, P1051, DOI 10.3109/09638281003672377; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; De Wolf A., 2008, J REHABILITATION S47, V40, P106; De Wolf A, 2010, QUAL LIFE RES, V19, P1185, DOI 10.1007/s11136-010-9685-6; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fleming J, 2009, DISABIL REHABIL, V31, P1666, DOI 10.1080/09638280902738425; Fleming J, 2009, BRAIN IMPAIR, V10, P34, DOI 10.1375/brim.10.1.34; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Kervick RB, 2005, BRAIN INJURY, V19, P881, DOI 10.1080/02699050400025273; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Ley P., 1972, QUANTITATIVE ASPECTS; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Long E, 2008, BRAIN IMPAIR, V9, P274, DOI 10.1375/brim.9.3.274; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Magasi S, 2010, ARCH PHYS MED REHAB, V91, pS17, DOI 10.1016/j.apmr.2010.07.011; Magasi S, 2009, J REHABIL MED, V41, P936, DOI 10.2340/16501977-0450; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; OWNSWORTH T, 2004, BRAIN IMPAIR, V5, P53, DOI DOI 10.1375/BRIM.5.1.53.35407; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Perdices M, 2005, BRAIN IMPAIR, V6, DOI [10.1375/brim.2005.6.3.219, DOI 10.1375/brim.2005.6.3.219]; Perenboom RJM, 2003, DISABIL REHABIL, V25, P577, DOI 10.1080/0963828031000137081; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Simpson G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.67.35401, DOI 10.1375/BRIM.5.1.67.35401]; Simpson G. K, 2010, BRAIN IMPAIR, V11, P50; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; Tate R, TRAUMATIC B IN PRESS; Tate R. L., 2010, COMPENDIUM TESTS SCA; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whiting D., 2010, NSWOG NEUROONCOLOGY; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; World Health Organization, 2001, INT CLASS FUNCT DIS	62	15	15	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	MAR	2012	47	1			SI		20	32		10.1111/j.1742-9544.2011.00060.x			13	Psychology, Multidisciplinary	Psychology	879MQ	WOS:000299334300004					2021-06-18	
J	Zhu, L; Ji, XJ; Wang, HD; Pan, H; Chen, M; Lu, TJ				Zhu, Lin; Ji, Xiang-jun; Wang, Han-dong; Pan, Hao; Chen, Min; Lu, Ting-jia			Zinc neurotoxicity to hippocampal neurons in vitro induces ubiquitin conjugation that requires p38 activation	BRAIN RESEARCH			English	Article						Neuron; Ubiquitin; Zinc; Traumatic brain injury; p38	TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; 12-LIPOXYGENASE ACTIVATION; PROTEASOME SYSTEM; CORTICAL-NEURONS; DEATH; DEGRADATION; ERYTHROPOIETIN; EXPRESSION; RECEPTOR	There is increasing evidence showing that zinc plays a key role in inducing neuronal death during central nervous system injury. However, the underlying mechanisms are poorly understood. Here we assessed the effect of zinc on ubiquitin conjugation and subsequent neurodegeneration using cultured hippocampal cells. We report that cultured neurons are vulnerable to increased level of extracellular Zn2+. Zn2+-induced poly-ubiquitination in cultured neurons is in a concentration- and time-dependent manner. Furthermore our data demonstrated that Zn2+-induced ubiquitination requires p38 activation. These findings indicate that excessive zinc could impair the protein degradation pathway and may be a crucial factor mediating neuronal death following traumatic brain injury. Crown Copyright (C) 2012 Published by Elsevier B.V. All rights reserved.	[Zhu, Lin; Ji, Xiang-jun; Wang, Han-dong; Pan, Hao] Nanjing Univ, Dept Neurosurg, Jinling Hosp, Sch Med, Nanjing 210002, Jiangsu, Peoples R China; [Chen, Min; Lu, Ting-jia] Chinese Acad Sci, Inst Neurosci State, Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Wang, HD (corresponding author), Nanjing Univ, Dept Neurosurg, Jinling Hosp, Sch Med, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	wanghandong61@126.com	Chen, Min/A-1134-2014		Jinling Hospital of Nanjing [2008033]; Postdoctoral Foundation of Jiangsu Province, China [1002049C]; Postdoctoral Science FoundationChina Postdoctoral Science Foundation [201150M1572]	The authors gratefully acknowledge Professor Zhi-Qi Xiong (Institute of Neuroscience State, Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China) for technical assistance. This work was financially supported by grants of the Jinling Hospital of Nanjing (Grant No 2008033), the Postdoctoral Foundation of Jiangsu Province (Grant No 1002049C) the China Postdoctoral Science Foundation (Grant No 201150M1572). We declare that there is no conflict of interest. The authors declare no conflict of interest.	Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Daniels WMU, 2004, METAB BRAIN DIS, V19, P79, DOI 10.1023/B:MEBR.0000027419.79032.bd; Figueiredo-Pereira ME, 1999, MOL BIOL REP, V26, P65, DOI 10.1023/A:1006909918866; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; He K, 2010, J NEUROCHEM, V114, P452, DOI 10.1111/j.1471-4159.2010.06762.x; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; Ide T, 1999, J CEREBR BLOOD F MET, V19, P750, DOI 10.1097/00004647-199907000-00004; Kim I, 2004, EXP CELL RES, V298, P229, DOI 10.1016/j.yexcr.2004.04.017; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Kiss P, 2005, BIOCHEM J, V391, P301, DOI 10.1042/BJ20050523; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Li SH, 2000, J BIOL CHEM, V275, P13386, DOI 10.1074/jbc.275.18.13386; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Mittal S, 2010, NEUROSCI RES, V68, P159, DOI 10.1016/j.neures.2010.08.002; Mizukami K, 2002, ACTA NEUROPATHOL, V103, P453, DOI 10.1007/s00401-001-0489-1; Morimoto T, 1996, AM J PATHOL, V148, P249; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 2004, CURR MOL MED, V4, P87, DOI 10.2174/1566524043479211; Song SM, 2004, TRENDS MOL MED, V10, P565, DOI 10.1016/j.molmed.2004.09.005; Stefanidou M, 2006, ARCH TOXICOL, V80, P1, DOI 10.1007/s00204-005-0009-5; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tomoda K, 1999, NATURE, V398, P160; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weber A, 2005, NEUROBIOL DIS, V20, P594, DOI 10.1016/j.nbd.2005.04.016; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Yamamoto Y, 2008, CARDIOVASC RES, V79, P89, DOI 10.1093/cvr/cvn076; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; Zhang YM, 2004, J NEUROSCI, V24, P10616, DOI 10.1523/JNEUROSCI.2469-04.2004; Zhang Y, 2007, MOL MED, V13, P350, DOI 10.2119/2007-00042.Zhang; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015	46	15	15	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 15	2012	1438						1	7		10.1016/j.brainres.2011.12.031			7	Neurosciences	Neurosciences & Neurology	913IB	WOS:000301869500001	22261248				2021-06-18	
J	Meierhans, R; Brandi, G; Fasshauer, M; Sommerfeld, J; Schupbach, R; Bechir, M; Stover, JF				Meierhans, R.; Brandi, G.; Fasshauer, M.; Sommerfeld, J.; Schuepbach, R.; Bechir, M.; Stover, J. F.			Arterial lactate above 2 mM is associated with increased brain lactate and decreased brain glucose in patients with severe traumatic brain injury	MINERVA ANESTESIOLOGICA			English	Article						Critical care; Microdialysis; Lactic acid	NUCLEAR-MAGNETIC-RESONANCE; ENERGY-METABOLISM; RAT-BRAIN; COGNITIVE DEFICITS; BLOOD LACTATE; TRANSPORT; MICRODIALYSIS; HYPERGLYCEMIA; DEPRIVATION; ASTROCYTES	Background. Lactate fuels cerebral energy-consuming processes and it is neuroprotective. The impact of arterial lactate on brain metabolism determined by microdialysis was investigated retrospectively in patients with severe traumatic brain injury (FBI). Methods. Cerebral microdialysis (glucose, lactate), neuromonitoring (ICP, CPP, ptiO(2), SjvO(2)) and blood gas data collected in 20 patients during pharmacologic coma were grouped within predefined arterial lactate clusters (<1, 1-2, >2 mM). Microdialysis samples were only taken from time points characterized by normoventilation (paCO(2) 34.5-42 mmHg), sufficient oxygenation (paO(2)>75 mmHg) and hematocrit (>= 24%) to exclude confounding influences. Results. Elevated arterial lactate >= 2 mM was associated with significantly increased brain lactate which coincided with markedly decreased brain glucose despite significantly increased arterial glucose levels and sufficient cerebral perfusion indirectly determined by normal SjvO(2) and ptiO(2) values. At elevated arterial lactate levels signs of significantly increased cerebral lactate uptake coincided with markedly decreased cerebral glucose uptake. Infused lactate above 50 mM per 24 hours was associated with significantly decreased cerebral glucose. Conclusion. Increased arterial lactate levels were associated with increased cerebral lactate uptake and elevated brain lactate. At the same time brain glucose uptake and brain glucose were significantly reduced. It remains unclear whether arterial lactate is the driving force for the increased cerebral lactate levels or if the reduced glucose uptake also contributed to the increased cerebral lactate levels. Further studies are required to assess the impact of lactate infusion under clinical conditions. (Minerva Anestesiol 2012;78:185-93)	[Meierhans, R.; Brandi, G.; Fasshauer, M.; Sommerfeld, J.; Schuepbach, R.; Bechir, M.; Stover, J. F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Brandi, G.] Fdn IRCCS Osped Maggiore Policlin Mangiag & Regin, Neurosurg Intens Care Unit, Dept Anesthesia, Milan, Italy; [Brandi, G.] Fdn IRCCS Osped Maggiore Policlin Mangiag & Regin, Crit Care Med, Milan, Italy	Stover, JF (corresponding author), Univ Spital Zurich, Chirurg Intensivmed, Zurich, Switzerland.	john.stover@access.uzh.ch	Schuepbach, Reto A/J-9737-2012; Schuepbach, Reto/AAO-6360-2020	Schuepbach, Reto A/0000-0002-7058-4377; Schuepbach, Reto/0000-0002-7058-4377	Swiss National Science Foundation (SNP)Swiss National Science Foundation (SNSF); SUVA	The help of the nursing staff in collecting and analyzing cerebral microdialysis samples is gratefully acknowledged. The study was supported by grants from the Swiss National Science Foundation (SNP) and the SUVA Fonds to JFS.	Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Bechir M, 2010, MINERVA ANESTESIOL, V76, P896; Bhatia A, 2007, INTENS CARE MED, V33, P1322, DOI 10.1007/s00134-007-0660-9; Bliss TM, 2004, J NEUROSCI, V24, P6202, DOI 10.1523/JNEUROSCI.0805-04.2004; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Canis M, 2009, BRAIN RES, V1257, P32, DOI 10.1016/j.brainres.2008.12.005; Cater HL, 2003, J NEUROCHEM, V87, P1381, DOI 10.1046/j.1471-4159.2003.02100.x; Cater HL, 2001, J PHYSIOL-LONDON, V531, P459, DOI 10.1111/j.1469-7793.2001.0459i.x; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Clemmesen Otto, 2004, Curr Opin Crit Care, V10, P152, DOI 10.1097/00075198-200404000-00012; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cureton EL, 2010, J SURG RES, V159, P468, DOI 10.1016/j.jss.2009.04.020; EDLUND GL, 1988, BIOCHEM J, V249, P117, DOI 10.1042/bj2490117; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; LARRABEE MG, 1995, J NEUROCHEM, V64, P1734; Levy B, 2006, CURR OPIN CRIT CARE, V12, P315, DOI 10.1097/01.ccx.0000235208.77450.15; Llompart-Pou JA, 2007, J ENDOCRINOL INVEST, V30, P393, DOI 10.1007/BF03346316; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Mason GF, 2006, DIABETES, V55, P929, DOI 10.2337/diabetes.55.04.06.db05-1325; Maurer MH, 2004, NEUROSCI LETT, V355, P105, DOI 10.1016/j.neulet.2003.10.056; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; NEIMOTO EM, 1974, STROKE, V5, P81; NEMOTO EM, 1974, STROKE, V5, P48, DOI 10.1161/01.STR.5.1.48; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Schurr A, 1999, J NEUROSCI, V19, P34; Schurr A, 2001, J NEUROSCI RES, V66, P782, DOI 10.1002/jnr.10065; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; Schurr A, 1997, BRAIN RES, V744, P105, DOI 10.1016/S0006-8993(96)01106-7; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; TILDON JT, 1993, NEUROCHEM RES, V18, P177, DOI 10.1007/BF01474682; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35	41	15	15	0	5	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	FEB	2012	78	2					185	193					9	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	912BI	WOS:000301768200010	21971438				2021-06-18	
J	Ragan, DK; McKinstry, R; Benzinger, T; Leonard, J; Pineda, JA				Ragan, Dustin K.; McKinstry, Robert; Benzinger, Tammie; Leonard, Jeffrey; Pineda, Jose A.			Depression of whole-brain oxygen extraction fraction is associated with poor outcome in pediatric traumatic brain injury	PEDIATRIC RESEARCH			English	Article							CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; MITOCHONDRIAL DYSFUNCTION; MAGNETIC-SUSCEPTIBILITY; METABOLIC-RATE; HEAD-INJURY; O-15 PET; ISCHEMIA; CHILDREN; MRI	INTRODUCTION: Traumatic brain injury (TBI) is a leading cause of death and disability in children. Metabolic failure is an integral component of the pathological aftermath of TBI. The oxygen extraction fraction (OEF) is a valuable parameter for characterization and description of metabolic abnormalities; however, OEF measurement has required either invasive procedures or the use of ionizing radiation, which significantly limits its use in pediatric research. RESULTS: Patients with TBI had depressed OEF levels that correlated with the severity of injury. In addition, the OEF measured within 2 weeks of injury was predictive of patient outcome at 3 mo after injury. In pediatric TBI patients, low OEF-a marker of metabolic dysfunction-correlates with the severity of injury and outcome. DISCUSSION: Our findings support previous literature on the role of metabolic dysfunction after TBI. METHODS: Using a recently developed magnetic resonance (MR) technique for the measurement of oxygen saturation, we determined the whole-brain OEF in both pediatric TBI patients and in healthy controls. Injury and outcome were classified using pediatric versions of the Glasgow Coma Scale (GCS) and Glasgow Outcome Scale-Extended (GOS-E), respectively.	[Ragan, Dustin K.; Pineda, Jose A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [McKinstry, Robert; Benzinger, Tammie] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Leonard, Jeffrey] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA	Pineda, JA (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	Pineda_j@kids.wustl.edu	Benzinger, Tammie L. S./ABA-8534-2020; Pineda, Jose/W-2806-2019; Benzinger, Tammie/L-6104-2013	Benzinger, Tammie L. S./0000-0002-8114-0552; 	Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); Washington University Institute of Clinical and Translational Sciences [KL2 RR024994, UL1 RR024992]; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HDO62171]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD062171] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024994, UL1RR024992] Funding Source: NIH RePORTER	Financial support for this study was received from the Robert Wood Johnson Foundation, the Washington University Institute of Clinical and Translational Sciences (KL2 RR024994 and UL1 RR024992), and the Eunice Kennedy Shriver National Institute of Child Health & Human Development (P30HDO62171).	An HY, 2000, J CEREBR BLOOD F MET, V20, P1225, DOI 10.1097/00004647-200008000-00008; Barker SJ, 2008, CURR OPIN ANESTHESIO, V21, P805, DOI 10.1097/ACO.0b013e328316bb6f; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bremmer JP, 2011, MOL IMAGING BIOL, V13, P759, DOI 10.1007/s11307-010-0382-1; Centers for Disease Control and Prevention, TRAUM BRAIN INJ US E; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Coles JP, 2006, J CEREBR BLOOD F MET, V26, P48, DOI 10.1038/sj.jcbfm.9600179; Dave KR, 2001, J CEREBR BLOOD F MET, V21, P1401, DOI 10.1097/00004647-200112000-00004; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; He X, 2007, MAGN RESON MED, V57, P115, DOI 10.1002/mrm.21108; HOFFMAN WE, 1986, ANESTH ANALG, V65, P729; HOFFMAN WE, 1986, ANESTH ANALG, V65, P639; Ito H, 2005, ANN NUCL MED, V19, P65, DOI 10.1007/BF03027383; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; LANIER WL, 1985, ANESTHESIOLOGY, V63, P589, DOI 10.1097/00000542-198512000-00007; Lu HZ, 2008, MAGN RESON MED, V60, P357, DOI 10.1002/mrm.21627; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Mellon EA, 2009, J NEUROSCI METH, V179, P29, DOI 10.1016/j.jneumeth.2009.01.008; MICHENFELDER JD, 1971, BRIT J ANAESTH, V43, P630, DOI 10.1093/bja/43.7.630; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Patel SC, 2008, NEUROSCIENCE MED, P147; Pearson ES, 1931, J AM STAT ASSOC, V26, P128, DOI 10.2307/2277761; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sedlacilk J, 2009, Z MED PHYS, V19, P48, DOI 10.1016/j.zemedi.2008.07.005; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; Zhan RZ, 2002, ANESTHESIOLOGY, V97, P896, DOI 10.1097/00000542-200210000-00022; Zhao JM, 2007, MAGN RESON MED, V58, P592, DOI 10.1002/mrm.21342	45	15	15	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	FEB	2012	71	2					199	204		10.1038/pr.2011.31			6	Pediatrics	Pediatrics	934OZ	WOS:000303455000011	22258132	Bronze, Green Published			2021-06-18	
J	Schultz, S; DeSilva, M; Gu, TT; Qiang, M; Whang, K				Schultz, Stephen; DeSilva, Mauris; Gu, Ting Ting; Qiang, Mei; Whang, Kyumin			Effects of the Analgesic Acetaminophen (Paracetamol) and its para-Aminophenol Metabolite on Viability of Mouse-Cultured Cortical Neurons	BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY			English	Article							ENDOCANNABINOID SYSTEM; PHARMACOKINETICS; AUTISM; PLASMA	Acetaminophen has been used as an analgesic for more than a hundred years, but its mechanism of action has remained elusive. Recently, it has been shown that acetaminophen produces analgesia by the activation of the brain endocannabinoid receptor CB1 through its para-aminophenol (p-aminophenol) metabolite. The objective of this study was to determine whether p-aminophenol could be toxic for in vitro developing mouse cortical neurons as a first step in establishing a link between acetaminophen use and neuronal apoptosis. We exposed developing mouse cortical neurons to various concentrations of drugs for 24 hr in vitro. Acetaminophen itself was not toxic to developing mouse cortical neurons at therapeutic concentrations of 10-250 mu g/ml. However, concentrations of p-aminophenol from 1 to 100 mu g/ml produced significant (p < 0.05) loss of mouse cortical neuron viability at 24 hr compared to the controls. The naturally occurring endocannabinoid anandamide also caused similar 24-hr loss of cell viability in developing mouse cortical neurons at concentrations from 1 to 100 mu g/ml, which indicates the mechanism of cell death could be through the cannabinoid receptors. The results of our experiments have shown a detrimental effect of the acetaminophen metabolite p-aminophenol on in vitro developing cortical neuron viability which could act through CB1 receptors of the endocannabinoid system. These results could be especially important in recommending an analgesic for children or individuals with traumatic brain injury who have developing cortical neurons.	[Schultz, Stephen; DeSilva, Mauris] USA, Med Res Unit San Antonio, Ft Sam Houston, TX 78234 USA; [Gu, Ting Ting; Qiang, Mei; Whang, Kyumin] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Schultz, S (corresponding author), USA, Med Res Unit San Antonio, 3650 Chambers Pass, Ft Sam Houston, TX 78234 USA.	stephen.t.schultz@amedd.army.mil	Whang, Kyumin/AAT-7006-2020		Naval Medical Research Unit San Antonio [G1008]	This project was funded by work unit number G1008 from the Naval Medical Research Unit San Antonio.	ALBERT KS, 1974, J PHARMACOKINET BIOP, V2, P381, DOI 10.1007/BF01071309; Anavi-Goffer S, 2009, CHEMBIOCHEM, V10, P1591, DOI 10.1002/cbic.200800827; Anderson BJ, 1998, BRIT J CLIN PHARMACO, V46, P237, DOI 10.1046/j.1365-2125.1998.00780.x; Becker KG, 2010, MED HYPOTHESES, V74, P7, DOI 10.1016/j.mehy.2009.08.033; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; Bessems JGM, 2001, CRIT REV TOXICOL, V31, P55, DOI 10.1080/20014091111677; Campolongo P, 2009, INT REV NEUROBIOL, V85, P117, DOI 10.1016/S0074-7742(09)85009-5; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Douglas DR, 1996, ACAD EMERG MED, V3, P740, DOI 10.1111/j.1553-2712.1996.tb03508.x; GAZZARD BG, 1973, J PHARM PHARMACOL, V25, P964, DOI 10.1111/j.2042-7158.1973.tb09987.x; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Jager Gerry, 2008, Curr Drug Abuse Rev, V1, P114; Mallet C, 2008, PAIN, V139, P190, DOI 10.1016/j.pain.2008.03.030; Pasquariello N, 2009, J BIOL CHEM, V284, P29413, DOI 10.1074/jbc.M109.044412; Qiang M, 2005, MOL PHARMACOL, V67, P2115, DOI 10.1124/mol.104.010751; Schultz ST, 2008, AUTISM, V12, P293, DOI 10.1177/1362361307089518; Schultz ST, 2010, ACTA NEUROBIOL EXP, V70, P227; Shelov SP, 1998, CARING YOUR BABY YOU	18	15	16	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1742-7835			BASIC CLIN PHARMACOL	Basic Clin. Pharmacol. Toxicol.	FEB	2012	110	2					141	144		10.1111/j.1742-7843.2011.00767.x			4	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	907RD	WOS:000301434200005	21771276	Bronze			2021-06-18	
J	Servia, L; Badia, M; Baeza, I; Montserrat, N; Justes, M; Cabre, X; Valdres, P; Trujillano, J				Servia, Luis; Badia, Mariona; Baeza, Ignacio; Montserrat, Neus; Justes, Margarida; Cabre, Xavier; Valdres, Pedro; Trujillano, Javier			Time spent in the emergency department and mortality rates in severely injured patients admitted to the intensive care unit: An observational study	JOURNAL OF CRITICAL CARE			English	Article						Multiple traumas; Intensive care; Emergency department; Time management	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL; RESUSCITATION; MANAGEMENT; SYSTEM; CENTERS; PROGRAM; IMPACT	Purpose: The aim of this study was to identify the determinants of a shorter emergency department time (EDt) in patients with severe trauma (STPs) admitted to the intensive care unit and determine whether EDt influences mortality. Patients and Methods: A prospective observational study of STPs (2005-2007) was conducted. With the variables available from the ED, 2 multiple logistic regression models (MLRM) were created: one for the factors associated with EDt less than or equal to median and the other with mortality. Results: A total of 243 patients were included. The mean age was 43 years; 76% were male. The overall mortality rate was 20%. The median EDt was 120 minutes. The independent factors that were associated with the MLRM for an EDt of 120 minutes or less included age less than 60 years, mechanical ventilation, severe traumatic brain injury, and a trauma and injury severity score of 20 or higher. The MLRM for mortality was age greater than 60 years, mechanical ventilation, traumatic brain injury and shock. An EDt of 120 minutes or less was associated with an increased risk of death in the univariate analysis but not in the MLRM. Conclusions: Patients in the ED with indicators of high trauma severity have a reduced EDt but a higher mortality rate. Advanced age increases both mortality and EDt. With the factors included in the model, EDt was not an independent factor for mortality in STPs. (C) 2012 Elsevier Inc. All rights reserved.	[Servia, Luis; Badia, Mariona; Baeza, Ignacio; Montserrat, Neus; Justes, Margarida; Trujillano, Javier] Hosp Arnau Vilanova, Intens Care Unit, Lleida 25198, Spain; [Cabre, Xavier; Valdres, Pedro] Hosp Arnau Vilanova, Emergency Dept, Lleida 25198, Spain; [Trujillano, Javier] Univ Lleida, Dept Ciencias Med Basicas, IRBLLEIDA, Lleida 25198, Spain	Trujillano, J (corresponding author), Hosp Arnau Vilanova, Intens Care Unit, Lleida 25198, Spain.	jtruji@cmb.udl.es	Montserrat, Nuria/F-3136-2016; Goixart, Lluis Servia/C-6561-2011; Trujillano, Javier/A-4325-2010; Badia, Mariona/AAB-5513-2020; Valdres, Pedro/AAP-1201-2021	Montserrat, Nuria/0000-0002-1603-1755; Goixart, Lluis Servia/0000-0001-9513-1465; Trujillano, Javier/0000-0001-8071-7711; Badia, Mariona/0000-0002-0923-1417; 			*AM COLL SURG COMM, 2000, AM RES OPT CAR INJ P; Bernhard M, 2007, RESUSCITATION, V73, P362, DOI 10.1016/j.resuscitation.2006.09.014; Brooks A, 2004, INJURY, V35, P407, DOI 10.1016/S0020-1383(03)00219-5; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Cowan RM, 2005, CRIT CARE, V9, P291, DOI 10.1186/cc2981; COWLEY RA, 1973, J TRAUMA, V13, P1029, DOI 10.1097/00005373-197312000-00001; DAVIS JW, 1992, J TRAUMA, V32, P660, DOI 10.1097/00005373-199205000-00020; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Di Bartolomeo S, 2004, INJURY, V35, P391, DOI 10.1016/S0020-1383(03)00246-8; Di Bartolomeo S, 2007, INJURY, V38, P305, DOI 10.1016/j.injury.2006.10.005; Eastes LS, 2001, J TRAUMA, V50, P908, DOI 10.1097/00005373-200105000-00022; Haas B, 2008, CRIT CARE, V12, DOI 10.1186/cc6980; Henzler D, 2007, CRIT CARE MED, V35, P1027, DOI 10.1097/01.CCM.0000259526.45894.08; LOWE DK, 1991, J TRAUMA, V31, P1265, DOI 10.1097/00005373-199109000-00011; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Richardson JD, 2009, J AM COLL SURGEONS, V208, P671, DOI 10.1016/j.jamcollsurg.2008.11.018; Ruchholtz S, 2002, INTENS CARE MED, V28, P1395, DOI 10.1007/s00134-002-1446-8; Santora RJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8008; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Theodorou D, 2009, RESUSCITATION, V80, P350, DOI 10.1016/j.resuscitation.2008.10.015; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; van Olden GDJ, 2003, INJURY, V34, P191, DOI 10.1016/S0020-1383(02)00202-4; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wurmb TE, 2008, EUR J EMERG MED, V15, P311, DOI 10.1097/MEJ.0b013e3283036ce6	30	15	15	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2012	27	1					58	65		10.1016/j.jcrc.2011.07.001			8	Critical Care Medicine	General & Internal Medicine	898VX	WOS:000300771600010	21958981				2021-06-18	
J	Veech, RL; Valeri, CR; VanItallie, TB				Veech, Richard L.; Valeri, C. Robert; VanItallie, Theodore B.			The mitochondrial permeability transition pore provides a key to the diagnosis and treatment of traumatic brain injury	IUBMB LIFE			English	Article						TBI; ketone bodies; mPTP; cyclosporine A; brain energetics	CYCLOSPORINE-A; METABOLISM; GLUCOSE; PYROPHOSPHATE; DYSFUNCTION; APOPTOSIS; DAMAGE	The pathological consequences of traumatic head injury result largely from the opening of the mitochondrial permeability transition pore (mPTP). The mPTP opens due to a decrease in brain phosphorylation energy resulting in a further decrease in brain ATP production and a measurable increase in brain heat generation and temperature. The increase in brain temperature can be measured transcranially by near infrared spectroscopy which can be used to diagnose traumatic brain injury (TBI) and to monitor treatment. Effective therapy of TBI can be achieved by closure of the mPTP by administration of cyclosporine A or by oral administration of ketone body esters. While ketosis has previously been known to prevent damage from TBI, the availability of oral ketone esters presents the first practical modality of achieving therapeutic levels of ketone bodies. (c) 2012 IUBMB Life, 2012	[Veech, Richard L.] NIAAA, Lab Metab Control, NIH, Rockville, MD 20852 USA; [Valeri, C. Robert] Naval Blood Res Lab Inc, Boston, MA USA; [VanItallie, Theodore B.] Columbia Univ, Dept Med, St Lukes Roosevelt Hosp Ctr, Coll Phys & Surg, New York, NY USA	Veech, RL (corresponding author), NIAAA, Lab Metab Control, NIH, Rockville, MD 20852 USA.	rveech@mail.nih.gov			Defense Research Project Administration, DARPA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIDAA000112, ZIAAA000110] Funding Source: NIH RePORTER	Support for development of the ketone ester from the Defense Research Project Administration, DARPA, is gratefully acknowledged.	Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Kashiwaya Y, 2010, J BIOL CHEM, V285, P25950, DOI 10.1074/jbc.M110.138198; Kelly J. J., 1995, SPIE, V2389, P818; Li L, 2009, TRENDS ENDOCRIN MET, V20, P429, DOI 10.1016/j.tem.2009.06.004; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; SATO K, 1995, FASEB J, V9, P651; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Veech R L, 1986, Adv Exp Med Biol, V194, P617; VEECH RL, 1980, FEBS LETT, V117, pK65, DOI 10.1016/0014-5793(80)80571-0; Veech RL, 2002, IUBMB LIFE, V54, P241, DOI 10.1080/15216540215678; YAMADA T, 1988, J BIOCHEM-TOKYO, V104, P847, DOI 10.1093/oxfordjournals.jbchem.a122561; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	25	15	17	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1521-6543			IUBMB LIFE	IUBMB Life	FEB	2012	64	2					203	207		10.1002/iub.590			5	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	875OE	WOS:000299039800013	22241645	Green Accepted, Bronze			2021-06-18	
J	Rosi, S; Ferguson, R; Fishman, K; Allen, A; Raber, J; Fike, JR				Rosi, Susanna; Ferguson, Ryan; Fishman, Kelly; Allen, Antino; Raber, Jacob; Fike, John R.			The Polyamine Inhibitor Alpha-Difluoromethylornithine Modulates Hippocampus-Dependent Function after Single and Combined Injuries	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR-SUPEROXIDE DISMUTASE; NEURAL PRECURSOR CELLS; LONG-TERM-MEMORY; EARLY GENE ARC; ORNITHINE-DECARBOXYLASE; CRANIAL IRRADIATION; ADULT NEUROGENESIS; DENTATE GYRUS	Exposure to uncontrolled irradiation in a radiologic terrorism scenario, a natural disaster or a nuclear battlefield, will likely be concomitantly superimposed on other types of injury, such as trauma. In the central nervous system, radiation combined injury (RCI) involving irradiation and traumatic brain injury may have a multifaceted character. This may entail cellular and molecular changes that are associated with cognitive performance, including changes in neurogenesis and the expression of the plasticity-related immediate early gene Arc. Because traumatic stimuli initiate a characteristic early increase in polyamine metabolism, we hypothesized that treatment with the polyamine inhibitor alpha-difluoromethylornithine (DFMO) would reduce the adverse effects of single or combined injury on hippocampus structure and function. Hippocampal dependent cognitive impairments were quantified with the Morris water maze and showed that DFMO effectively reversed cognitive impairments after all injuries, particularly traumatic brain injury. Similar results were seen with respect to the expression of Arc protein, but not neurogenesis. Given that polyamines have been found to modulate inflammatory responses in the brain we also assessed the numbers of total and newly born activated microglia, and found reduced numbers of newly born cells. While the mechanisms responsible for the improvement in cognition after DFMO treatment are not yet clear, the present study provides new and compelling data regarding the potential use of DFMO as a potential countermeasure against the adverse effects of single or combined injury.	[Rosi, Susanna; Ferguson, Ryan; Fishman, Kelly; Allen, Antino; Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Rosi, Susanna; Ferguson, Ryan] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna; Ferguson, Ryan; Fishman, Kelly; Allen, Antino; Fike, John R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr ONPRC, Portland, OR 97201 USA	Rosi, S (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	john.fike@ucsf.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R33 AI080531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R33AI080531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) grant R33 AI080531. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; COFFINO P, 1991, J CELL BIOCHEM, V45, P54, DOI 10.1002/jcb.240450112; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; FIKE JR, 1994, RADIAT RES, V138, P99, DOI 10.2307/3578852; FIKE JR, 1995, INT J RADIAT ONCOL, V32, P1035, DOI 10.1016/0360-3016(95)00030-3; GERRISH KE, 1993, LIFE SCI, V52, P1101, DOI 10.1016/0024-3205(93)90431-2; Gilad GM, 2007, J NEUROSCI RES, V85, P594, DOI 10.1002/jnr.21152; Gilad GM, 2003, CELL MOL NEUROBIOL, V23, P637, DOI 10.1023/A:1025036532672; GOBBEL GT, 1991, RADIAT RES, V128, P306, DOI 10.2307/3578054; Gupta N, 2009, NEUROSCIENCE, V161, P691, DOI 10.1016/j.neuroscience.2009.03.075; Gupta N, 2012, PHARMACOL BIOCHEM BE, V100, P464, DOI 10.1016/j.pbb.2011.10.011; Gupta S, 2000, CANCER RES, V60, P5125; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Kilpelainen P, 2000, J NEUROSCI RES, V62, P675, DOI 10.1002/1097-4547(20001201)62:5<675::AID-JNR6>3.0.CO;2-S; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malaterre J, 2004, EUR J NEUROSCI, V20, P317, DOI 10.1111/j.1460-9568.2004.03498.x; MANETTA A, 1988, European Journal of Gynaecological Oncology, V9, P222; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris R., 1984, J NEUROSCI METHODS, V11; Nakagawa M, 1996, INT J RADIAT ONCOL, V36, P113, DOI 10.1016/S0360-3016(96)00239-8; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rola R, 2005, RADIAT RES, V164, P556, DOI 10.1667/RR3412.1; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2008, RADIAT RES, V169, P626, DOI 10.1667/RR1263.1; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rosi S., 2010, HIPPOCAMPUS; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shinohara C, 1997, CANCER RES, V57, P2694; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Soulet D, 2003, J CELL BIOL, V162, P257, DOI 10.1083/jcb.200301097; Sparapani M, 1996, EXP BRAIN RES, V108, P433; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Temiz C, 2005, J CLIN NEUROSCI, V12, P449, DOI 10.1016/j.jocn.2004.05.019; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Villasana L, 2006, RADIAT RES, V166, P883, DOI 10.1667/RR0642.1; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Wheeler DL, 2003, CANCER RES, V63, P3037; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097	68	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31094	10.1371/journal.pone.0031094			10	Multidisciplinary Sciences	Science & Technology - Other Topics	911GB	WOS:000301704200060	22299052	DOAJ Gold, Green Published			2021-06-18	
J	Liu, EH; Li, CM; Govindasamy, M; Neo, HJ; Lee, TL; Low, CM; Tachibana, S				Liu, Eugene H.; Li, Chunmei; Govindasamy, Malathi; Neo, Hong Jye; Lee, Tat Leang; Low, Chian Ming; Tachibana, Shinro			Elevated prepronociceptin, nociceptin/orphanin FQ and nocistatin concentrations in rat chronic constriction nerve injury and diabetic neuropathic pain models	NEUROSCIENCE LETTERS			English	Article						Nociceptin/orphanin FQ; Nocistatin; Prepronociceptin; Chronic constriction nerve injury; Diabetic neuropathic pain	RECEPTOR; PROTEIN; SYSTEM	Nociceptin/orphanin FQ(N/OFQ) and nocistatin are derived from the same precursor peptide, prepronociceptin. N/OFQ and nocistatin have been postulated to participate in pain modulation. In this study, we investigated whether the prepronociceptin, N/OFQ and nocistatin concentrations in the brain and spinal cord would be altered in chronic constriction injury and diabetic rat neuropathic pain models. Total brain and spinal cord lysates as well as serum from rats that had undergone chronic constriction injury and streptozocin-induced diabetic neuropathy were used to determine the concentrations of three peptides using competitive radioimmunoassay. We found that N/OFQ and prepronociceptin concentrations were significantly raised in both rat neuropathic pain models. Nocistatin was raised in the brains of post traumatic neuropathy pain rats. Overall, our data have demonstrated for the first time that prepronociceptin. N/OFQ and nocistatin concentrations are significantly altered at different tissues of two rat neuropathy pain models. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Liu, Eugene H.; Li, Chunmei; Govindasamy, Malathi; Neo, Hong Jye; Lee, Tat Leang; Low, Chian Ming; Tachibana, Shinro] Natl Univ Hlth Syst, Dept Anaesthesia, Yong Loo Lin Sch Med, Singapore 119074, Singapore; [Low, Chian Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	Liu, EH (corresponding author), Natl Univ Hlth Syst, Dept Anaesthesia, Yong Loo Lin Sch Med, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.	Eugene_Liu_HC@nuhs.edu.sg	Neo, Harvey/AAH-8483-2019; Low, Chian-Ming/V-9271-2017	Low, Chian-Ming/0000-0002-1154-4842	National Medical Research Council in SingaporeNational Medical Research Council, Singapore	This work was supported by a grant from the National Medical Research Council in Singapore.	Bridges D, 2001, BRIT J ANAESTH, V87, P12, DOI 10.1093/bja/87.1.12; COURTEIX C, 1993, PAIN, V53, P81, DOI 10.1016/0304-3959(93)90059-X; Fantin M, 2007, BRIT J PHARMACOL, V152, P549, DOI 10.1038/sj.bjp.0707377; Fioravanti B, 2008, CURR TOP MED CHEM, V8, P1442, DOI 10.2174/156802608786264227; Fu X, 2006, BRAIN RES, V1078, P212, DOI 10.1016/j.brainres.2006.01.026; Gavioli EC, 2008, PEPTIDES, V29, P1404, DOI 10.1016/j.peptides.2008.04.004; Himukashi S, 2005, ACTA ANAESTH SCAND, V49, P771, DOI 10.1111/j.1399-6576.2005.00723.x; Joseph T, 2007, PEPTIDES, V28, P1433, DOI 10.1016/j.peptides.2007.05.009; Liu EHC, 2006, NEUROSCI LETT, V397, P59, DOI 10.1016/j.neulet.2005.11.060; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Muth-Selbach U, 2004, ANESTHESIOLOGY, V101, P753, DOI 10.1097/00000542-200409000-00025; Okuda-Ashitaka E, 1998, NATURE, V392, P286; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Rizzi A, 2006, PAIN, V124, P100, DOI 10.1016/j.pain.2006.03.021; Sandnini M, 2005, EUR J PHARMACOL, V507, P43, DOI 10.1016/j.ejphar.2004.11.030	15	15	15	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JAN 6	2012	506	1					104	106		10.1016/j.neulet.2011.10.059			3	Neurosciences	Neurosciences & Neurology	891GK	WOS:000300205000021	22075222				2021-06-18	
J	Radley, E; Akram, A; Grubb, BD; Gibson, CL				Radley, Elizabeth; Akram, Asha; Grubb, Blair D.; Gibson, Claire L.			Investigation of the mechanisms of progesterone protection following oxygen-glucose deprivation in organotypic hippocampal slice cultures	NEUROSCIENCE LETTERS			English	Article						Oxygen-glucose deprivation; Progesterone; Allopregnanolone; Neuroprotection; Hippocampal cultures	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; NEUROACTIVE STEROIDS; RAT; NEUROPROTECTION; ALLOPREGNANOLONE; NEUROSTEROIDS; ISCHEMIA; RECEPTOR; STROKE	This study aimed to test the hypothesis that progesterone is neuroprotective against oxygen-glucose deprivation (OGD) through its conversion to the active metabolite allopregnanolone (AlloP) and the potentiation of GABA(A) receptors. Organotypic hippocampal cultures were exposed to 2 h of OGD and the resulting cell death was quantified 24 h later using combined propidium iodide and Hoechst immunostaining. Initially, we confirmed, that both progesterone and AlloP were protective in terms of reducing cell death following OGD in hippocampal cultures and for both, the optimal level of protection was observed at a concentration of 0.1 mu M. However, the protective effect of progesterone was absent in the presence of finasteride (10 mu M) which inhibits the metabolism of progesterone to active metabolites, including AlloP. In addition, the concurrent application of picrotoxin (100 mu M), a potent GABA(A) receptor antagonist, prevented the protection previously seen by either progesterone or AlloP alone. These results indicate that progesterone protects hippocampal cultures from cell death following OGD largely due to its conversion to AlloP and that GABA(A) receptors are important mediators of the protective effects of both progesterone and AlloP. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Radley, Elizabeth; Akram, Asha; Gibson, Claire L.] Univ Leicester, Sch Psychol, Leicester LE1 9HN, Leics, England; [Grubb, Blair D.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	Gibson, CL (corresponding author), Univ Leicester, Sch Psychol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	cg95@le.ac.uk		Gibson, Claire/0000-0002-3358-7341; Radley, Elizabeth/0000-0002-8156-1381	Nuffield Foundation [URB/39341]; School of Psychology Research Committee	This study was supported by funds from the Nuffield Foundation (URB/39341 to CLG) and the School of Psychology Research Committee. The authors would like to thank Dr Lucia Pinon for help and advice regarding preparation of the hippocampal slices. Dr Gibson thanks the University of Leicester for granting a period of study leave which enabled the completion of this piece of work.	Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GEE KW, 1988, MOL NEUROBIOL, V2, P291, DOI 10.1007/BF02935636; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Izumi Y, 2007, EUR J NEUROSCI, V26, P1881, DOI 10.1111/j.1460-9568.2007.05809.x; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; KOKATE TG, 1994, J PHARMACOL EXP THER, V270, P1223; Lipski J, 2007, NEUROSCIENCE, V146, P617, DOI 10.1016/j.neuroscience.2007.02.003; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Lockhart EM, 2002, NEUROSCI LETT, V328, P33, DOI 10.1016/S0304-3940(02)00448-2; Lyden P, 2002, STROKE, V33, P122, DOI 10.1161/hs0102.101478; Lyden PD, 1997, INT REV NEUROBIOL, V40, P233; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; PAUL SM, 1992, FASEB J, V6, P2311; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; SMITH SS, 1994, PROG NEUROBIOL, V44, P55, DOI 10.1016/0301-0082(94)90057-4; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932	31	15	15	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JAN 6	2012	506	1					131	135		10.1016/j.neulet.2011.10.065			5	Neurosciences	Neurosciences & Neurology	891GK	WOS:000300205000027	22079341				2021-06-18	
J	Bailey, BM; Liesemer, K; Statler, KD; Riva-Cambrin, J; Bratton, SL				Bailey, Beau M.; Liesemer, Kate; Statler, Kimberly D.; Riva-Cambrin, Jay; Bratton, Susan L.			Monitoring and prediction of intracranial hypertension in pediatric traumatic brain injury: Clinical factors and initial head computed tomography	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; pediatrics; Marshall score; coma; intracranial hypertension; cerebral perfusion pressure	PRESSURE MONITORS; HEMORRHAGIC COMPLICATIONS; SCAN CHARACTERISTICS; LINEAR RELATIONSHIP; YOUNG-CHILDREN; RISK-FACTORS; CLASSIFICATION; HYPOTENSION; ICP	BACKGROUND: Control of intracranial hypertension (ICH) in patients with traumatic brain injury (TBI) is standard care. However, predicting risk for ICH is essential to balance risks and benefits of intracranial pressure (ICP) monitoring. Current recommendations for ICP monitoring in pediatric trauma patients are extrapolated from adult studies. METHODS: This retrospective study evaluated 299 children admitted to Primary Children's Medical Center with moderate to severe TBI. ICP monitors were used in 120. Demographic, injury, and admission computed tomography (CT) scan characteristics were compared with determine factors associated with monitoring among those with less severe head CT findings. Among all monitored patients, clinical and radiographic features were compared for early ICH defined as any sustained ICP >= 20 mm Hg in the first 24 hours. RESULTS: Factors independently associated with monitoring children with Marshall I or II scores included presence of intraventricular hemorrhage (odds ratio [OR], 21.4; 95% confidence interval [CI], 4.0-114.7) and greater injury severity scores (ISS) (OR, 9.5 [95% CI, 2.9-31.1] for ISS 21 to 29 and OR, 14.3 [95% CI, 4.3-50.5] for ISS >29 compared with ISS <21). Among those with a normal head CT, 9 of 68 had an ICP monitor placed because of the inability to localize pain. Of these, 78% (7 of 9) had early ICH. Among monitored patients radiologic and clinical features of injury severity were not useful to distinguish risk for early ICH. CONCLUSIONS: Among children with severe TBI, a normal head CT does not exclude ICH. Need for ICP monitoring should be determined by depth of coma in addition to radiographic imaging. J Trauma. 2012;72: 263-270. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Liesemer, Kate; Statler, Kimberly D.; Bratton, Susan L.] Univ Utah, Sch Med, Dept Pediat, Div Crit Care Med, Salt Lake City, UT 84118 USA; [Riva-Cambrin, Jay] Univ Utah, Sch Med, Dept Neurosurg, Div Pediat Neurosurg, Salt Lake City, UT 84118 USA; [Bratton, Susan L.] Primary Childrens Med Ctr, Dept Pediat, Div Crit Care Med, Salt Lake City, UT 84103 USA; [Bailey, Beau M.] Univ Utah, Sch Med, Kaysville, UT USA	Bratton, SL (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Crit Care Med, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84118 USA.	Susan.Bratton@hsc.utah.edu		Bratton, Susan/0000-0002-4605-8078	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC1NS068943-01]; Neurosurgery Research and Education Foundation (AANS); Hydrocephalus Association Mentored Young Investigator Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC1NS068943] Funding Source: NIH RePORTER	Grant received from National Institute of Neurological Disorders and Stroke, grant number 1RC1NS068943-01, Neurosurgery Research and Education Foundation (AANS), Hydrocephalus Association Mentored Young Investigator Award.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Blaha M, 2005, J NEUROL NEUROSUR PS, V76, P147, DOI 10.1136/jnnp.2003.030817; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; Bratton S. L., 2007, J NEUROTRAUMA S1, V24, pS37; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK WC, 1989, NEUROSURGERY, V25, P20; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; Marmarou A, 2005, ACT NEUR S, V95, P277; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1992, J NEUROTRAUM, V9, pS317; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Wang D, 2004, J TRAUMA, V56, P972; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	26	15	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2012	72	1					263	270		10.1097/TA.0b013e31822a9512			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	898IF	WOS:000300734800048	21841509				2021-06-18	
B	Bodin, D; Yeates, KO; Klamar, K		Apps, JN; Walter, KD		Bodin, Doug; Yeates, Keith Owen; Klamar, Karl			Definition and Classification of Concussion	PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; POSTCONCUSSIONAL-SYNDROME; INTERNATIONAL-CONFERENCE; CHILDREN; MANAGEMENT; SYMPTOMS; STATEMENT; ADOLESCENTS; AGREEMENT		[Bodin, Doug; Yeates, Keith Owen] Ohio State Univ, Dept Psychol, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Yeates, Keith Owen] Ohio State Univ, Ctr Biobehav Hlth, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Klamar, Karl] Ohio State Univ, Med Ctr, Nationwide Childrens Hosp, Columbus, OH 43210 USA	Bodin, D (corresponding author), Ohio State Univ, Dept Psychol, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA.	doug.bodin@NationwideChildrens.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; [Anonymous], 1966, CLIN NEUROSURG, V12, P386; Ashwal S., 2010, PEDIAT TRAUMATIC BRA; Bergman DA, 1999, PEDIATRICS, V104, P1407; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Bodin D., 2010, TXB PEDIAT PSYCHOSOM; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2006, NEUROSURG FOCUS, V21, P1, DOI [DOI 10.3171/FOC.2006.21.4.4, 10.3171/foc.2006.21.4.4]; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; *CO MED SOC, 1991, REP SPORTS MED COMM; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Falk AC, 2005, CHILD NERV SYST, V21, P430, DOI 10.1007/s00381-005-1142-4; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Matz P. G., 2003, SEM NEUROSURGERY, V14, P125; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Ruff RM, 1999, BRAIN INJURY, V13, P943; Slobounov S., 2008, INJURIES ATHLETICS C, P399; Tator CH, 2009, CAN J NEUROL SCI, V36, P405, DOI 10.1017/S031716710000771X; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1992, ICD 10 CLASS MENT BE; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	47	15	16	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-89544-4				2012							9	19		10.1007/978-0-387-89545-1_2	10.1007/978-0-387-89545-1		11	Psychology, Clinical; Clinical Neurology; Pediatrics	Psychology; Neurosciences & Neurology; Pediatrics	BZV30	WOS:000303027500002					2021-06-18	
J	Brown, SB; Colantonio, A; Kim, H				Brown, Stephanie B.; Colantonio, Angela; Kim, Hwan			Gender Differences in Discharge Destination Among Older Adults Following Traumatic Brain Injury	HEALTH CARE FOR WOMEN INTERNATIONAL			English	Article							SEVERITY SCORE; OUTCOMES; EPIDEMIOLOGY; CARE; TBI; SEX	Traumatic brain injury (TBI) is a leading cause of death and disability, and the highest in-patient admission rates are among older adults. We identified that gender independently influences discharge destination following TBI in older adults. In this cross-sectional study, we examined discharge destinations of patients admitted to acute care over a 4-year period, as captured by the Ontario Trauma Registry (n = 3,480). Following TBI, women were significantly more likely than men to be sent to long term care facilities rather than home settings (p < .05), controlling for age, injury severity, mechanism of injury, and comorbidities.	[Colantonio, Angela; Kim, Hwan] Toronto Rehabil Inst UHN, Toronto, ON M5G 1V7, Canada; [Brown, Stephanie B.] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada	Colantonio, A (corresponding author), Toronto Rehabil Inst UHN, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [200603MOP] Funding Source: Medline		Aras MD, 2004, INT J REHABIL RES, V27, P257, DOI 10.1097/00004356-200412000-00001; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Colantonio A., 2003, ONT NEUR FDN IN PROV; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Holroyd-Leduc JM, 2000, STROKE, V31, P1833, DOI 10.1161/01.STR.31.8.1833; Kim H, 2006, CAN J NEUROL SCI, V33, P48, DOI 10.1017/S0317167100004686; Neale Rachel, 2003, Emerg Med (Fremantle), V15, P38, DOI 10.1046/j.1442-2026.2003.00406.x; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Sorensen EA, 2009, HEART LUNG, V38, P306, DOI 10.1016/j.hrtlng.2008.10.009; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662	20	15	15	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	0739-9332			HEALTH CARE WOMEN IN	Health Care Women Int.		2012	33	10					896	904		10.1080/07399332.2012.673654			9	Public, Environmental & Occupational Health; Women's Studies	Public, Environmental & Occupational Health; Women's Studies	001FD	WOS:000308444900003	22946592				2021-06-18	
J	Chiu, CYP; Tlustos, SJ; Walz, NC; Holland, SK; Eliassen, JC; Bernard, L; Wade, SL				Chiu, C. -Y. Peter; Tlustos, Sarah J.; Walz, Nicolay Chertkoff; Holland, Scott K.; Eliassen, James C.; Bernard, Lori; Wade, Shari L.			Neural Correlates of Risky Decision Making in Adolescents With and Without Traumatic Brain Injury Using the Balloon Analog Risk Task	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							BART	We studied risky decision making (RDM) in 8 healthy adolescents (TC) and 11 adolescents with mild to moderate traumatic brain injuries (TBI) using the Balloon Analog Risk Task (BART) and functional magnetic resonance imaging (fMRI). Participants inflated simulated balloons (with more points awarded to bigger balloons), which might burst at any time. Increasing brain activation levels were associated with increasing balloon size in a largely bilateral network, including cerebellar, inferior parietal, limbic, and frontal areas. Both groups performed similarly and activated similar networks.	[Chiu, C. -Y. Peter; Tlustos, Sarah J.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp, Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, Cincinnati, OH USA; [Holland, Scott K.] Cincinnati Childrens Hosp, Med Ctr, Commun Sci Res Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Eliassen, James C.] Univ Cincinnati, Coll Med, Ctr Imaging Res, Cincinnati, OH 45221 USA; [Bernard, Lori; Wade, Shari L.] Cincinnati Childrens Hosp, Med Ctr, Div Phys Med & Rehabil, Dept Pediat, Cincinnati, OH USA	Chiu, CYP (corresponding author), Univ Cincinnati, Dept Psychol, ML0376, Cincinnati, OH 45221 USA.	peter.chiu@uc.edu		Holland, Scott/0000-0003-3719-0875	NIH from the National Institute of Mental Health [RO1-MH073764]; National Institute on Disability and Rehabilitation Research in the Department of Education [H133G050239]; Ohio Department of Public Safety; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by (1) NIH grant RO1-MH073764 from the National Institute of Mental Health (to S. Wade); (2) H133G050239 from the National Institute on Disability and Rehabilitation Research in the Department of Education (to S. Wade); and (3) EMS/Trauma grant from the Ohio Department of Public Safety (to S. Wade).	Bornovalova MA, 2009, PHARMACOL BIOCHEM BE, V93, P258, DOI 10.1016/j.pbb.2008.10.023; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038	8	15	15	1	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		2012	37	2					176	183		10.1080/87565641.2011.632796			8	Psychology, Developmental; Psychology; Psychology, Experimental	Psychology	912LK	WOS:000301799300005	22339229	Green Accepted			2021-06-18	
J	Mohammad-Gharibani, P; Tiraihi, T; Mesbah-Namin, SA; Arabkheradmand, J; Kazemi, H				Mohammad-Gharibani, Payam; Tiraihi, Taki; Mesbah-Namin, Seyed Alireza; Arabkheradmand, Jalil; Kazemi, Hadi			Induction of bone marrow stromal cells into GABAergic neuronal phenotype using creatine as inducer	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						BMSCs; GABAergic-like neurons; induction; creatine	IN-VITRO DIFFERENTIATION; EMBRYONIC STEM-CELLS; TRAUMATIC BRAIN-INJURY; NEURAL STEM; SUBTYPE SPECIFICATION; HUNTINGTON-DISEASE; SURVIVAL; PRECURSORS; GENERATION; RAT	Purpose: Deficits involving GABAergic neurons have been reported in aging, central nervous trauma and neurodegenerative disorders; bone marrow stromal cells (BMSCs) have been proposed as a feasible source of donor cells in replacement cell therapy. In this study, the effects of creatine on transdifferentiating BMSCs into GABAergic-like neurons were evaluated in vitro. Methods: The BMSCs were isolated from adult rats, preinduced by beta-mercaptoethanol (BME) and retinoic acid (RA), and then induced by creatine into GABAergic-like neurons. The cells were characterized using different differentiation markers. The functionality of the differentiated cells was evaluated using FM1-43. Results: The isolated cells expressed Oct-4 and were immunoreactive to fibronectin and CD44. The highest percentages of cells immunoreactive to nestin and neurofilament-68 were found at the second day of preinduction. At the induction stage, there were increases in the number of cells immunoreactive to neurofilament-200, MAP-2, synapsin I, synaptophysin, and NeuN. The percentages of the immunoreactive cells to GABAergic neuron markers increased. The optimal induction dose was 5 mM. The dose of 10mM showed a decline in the expression of most of these markers. The functionality test indicated that the synaptic vesicles were released upon stimulation. Conclusion: Creatine can induce the differentiation of BMSCs to the GABAergic neuronal phenotype within one week.	[Tiraihi, Taki] Tarbiat Modares Univ, Fac Med Sci, Dept Anat Sci, Tehran 14115111, Iran; [Mohammad-Gharibani, Payam; Arabkheradmand, Jalil; Kazemi, Hadi] Univ Tehran, Khatam Al Anbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Mesbah-Namin, Seyed Alireza] Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, Tehran 14115111, Iran; [Mohammad-Gharibani, Payam] Tarbiat Modares, Dept Anat Sci, Fac Med Sci, Tehran, Iran	Tiraihi, T (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Anat Sci, Tehran 14115111, Iran.	takialtr@modares.ac.ir		Gharibani, Payam/0000-0002-4546-0890	Shefa Neurosciences Research Center at Khatam Al-Anbia Hospital, Tehran, Iran [86-N-105]; Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran	The project was funded by Shefa Neurosciences Research Center at Khatam Al-Anbia Hospital, Tehran, Iran (Grant # 86-N-105). We are also grateful for the support of the Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. We express deep gratitude to Professor Dr Howard Prentice (Department of Biomedical Science, Charles E Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, United States of America) and Mrs H. AliAkbar for editing the manuscript.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Adhihetty PJ, 2008, NEUROMOL MED, V10, P275, DOI 10.1007/s12017-008-8053-y; Andres RH, 2005, CELL TRANSPLANT, V14, P537, DOI 10.3727/000000005783982756; Andres RH, 2005, J NEUROCHEM, V95, P33, DOI 10.1111/j.1471-4159.2005.03337.x; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Arlotta P, 2003, ANN NY ACAD SCI, V991, P229; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Bosch M, 2004, EXP NEUROL, V190, P42, DOI 10.1016/j.expneurol.2004.06.027; Brewer GJ, 2000, J NEUROCHEM, V74, P1968, DOI 10.1046/j.1471-4159.2000.0741968.x; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020; COCHARD P, 1984, J NEUROSCI, V4, P2080; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Cousin M., 2003, CURR PROT NEUROSCI, P261; Croft AP, 2004, STEM CELLS DEV, V13, P409, DOI 10.1089/scd.2004.13.409; Deldicque L, 2008, J APPL PHYSIOL, V104, P371, DOI 10.1152/japplphysiol.00873.2007; Dubois-Dauphin ML, 2010, BIOMATERIALS, V31, P7032, DOI 10.1016/j.biomaterials.2010.06.017; Ducray A, 2006, NEUROSCI LETT, V395, P57, DOI 10.1016/j.neulet.2005.10.051; Ducray AD, 2007, J NEUROSCI RES, V85, P1863, DOI 10.1002/jnr.21337; Ducray AD, 2007, BRAIN RES, V1137, P50, DOI 10.1016/j.brainres.2006.12.038; Flames N, 2005, NEURON, V46, P377, DOI 10.1016/j.neuron.2005.04.020; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gavalda N, 2004, MOL CELL NEUROSCI, V25, P460, DOI 10.1016/j.mcn.2003.11.012; Gharibani PM, 2010, RESTOR NEUROL NEUROS, V28, P367, DOI 10.3233/RNN-2010-0539; Goldman SA, 2007, CLIN PHARMACOL THER, V82, P453, DOI 10.1038/sj.clpt.6100337; Gualano B, 2010, AM J KIDNEY DIS, V55, pE7, DOI 10.1053/j.ajkd.2009.10.053; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, STEM CELLS, V24, P949, DOI 10.1634/stemcells.2005-0192; Horn M, 1999, CARDIOVASC RES, V43, P117, DOI 10.1016/S0008-6363(99)00075-9; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; Juravleva E, 2005, J NEUROSCI RES, V79, P224, DOI 10.1002/jnr.20291; Kilic G, 2002, BIOPHYS J, V83, P849, DOI 10.1016/S0006-3495(02)75213-2; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Maisano X, 2009, NEUROTHERAPEUTICS, V6, P263, DOI 10.1016/j.nurt.2009.01.011; Mathew SS, 2008, J NEUROSCI, V28, P725, DOI 10.1523/JNEUROSCI.3625-07.2008; Matthews RT, 1998, J NEUROSCI, V18, P156; McLeish MJ, 2005, CRIT REV BIOCHEM MOL, V40, P1, DOI 10.1080/10409230590918577; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; Mohammad-Gharibani Payam, 2009, IRANIAN BIOMEDICAL JOURNAL, V13, P137; Murashov AK, 2004, FASEB J, V18, P252, DOI 10.1096/fj.04-2251fje; Naghdi M, 2009, CYTOTHERAPY, V11, P137, DOI 10.1080/14653240802716582; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Pavan B, 2011, DRUG DISCOV TODAY, V16, P520, DOI 10.1016/j.drudis.2011.03.010; Pena-Altamira E, 2005, BRAIN RES, V1058, P183, DOI 10.1016/j.brainres.2005.07.011; Persky AM, 2003, J CLIN PHARMACOL, V43, P29, DOI 10.1177/0091270002239703; Rawson ES, 2011, NUTRITION, V27, P451, DOI 10.1016/j.nut.2010.04.001; ROMAND R, 1988, BRAIN RES, V462, P167, DOI 10.1016/0006-8993(88)90601-4; Roybon L, 2010, CEREB CORTEX, V20, P1234, DOI 10.1093/cercor/bhp187; Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001; Shin E, 2012, STEM CELL REV REP, V8, P513, DOI 10.1007/s12015-011-9290-2; Tabrizi SJ, 2005, NEUROLOGY, V64, P1655, DOI 10.1212/01.WNL.0000160388.96242.77; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; Tewarie RSN, 2009, J SPINAL CORD MED, V32, P105; Thompson K, 2009, NEUROTHERAPEUTICS, V6, P284, DOI 10.1016/j.nurt.2009.01.016; Undamatla J, 2001, CELL MOTIL CYTOSKEL, V49, P16, DOI 10.1002/cm.1017; Wang N, 2011, FOOD CHEM TOXICOL, V49, P2975, DOI 10.1016/j.fct.2011.06.080; Westmoreland JJ, 2001, BIOCHEM BIOPH RES CO, V284, P674, DOI 10.1006/bbrc.2001.5031; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu Yongchao, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P488; WUARIN L, 1991, DEV BIOL, V144, P429, DOI 10.1016/0012-1606(91)90435-6; Zhang SF, 2011, NEURODEGENER DIS, V8, P194, DOI 10.1159/000321681; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhong JY, 2011, DEVELOPMENT, V138, P409, DOI 10.1242/dev.061051	72	15	19	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	6					511	525		10.3233/RNN-2012-100155			15	Neurosciences	Neurosciences & Neurology	030MU	WOS:000310575600006	22903159				2021-06-18	
J	Romesser, J; Booth, J; Benge, J; Pastorek, N; Helmer, D				Romesser, Jennifer; Booth, Jane; Benge, Jared; Pastorek, Nicholas; Helmer, Drew			Mild traumatic brain injury and pain in Operation Iraqi Freedom/Operation Enduring Freedom veterans	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						back pain; headaches; loss of consciousness; mental health treatment; mild traumatic brain injury; OIF/OEF veterans; pain; pain interference; polytrauma; posttraumatic stress disorder; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; COMORBID CHRONIC PAIN; PREVALENCE; AFGHANISTAN; DEPRESSION; POLYTRAUMA; SEVERITY; HEALTH	The purpose of this study was to describe the pain experience in Operation Iraqi Freedom/Operation Enduring Freedom veterans with and without a history of mild traumatic brain injury (mTBI) who present to polytrauma clinics for evaluation and management. We sought to evaluate the relationship between a veteran's history of mTBI and posttraumatic stress (PTS) on axial pain, head/headache pain, and pain interference. We performed retrospective chart reviews of 529 Iraq/Afghanistan veterans referred for evaluation at two Department of Veterans Affairs medical centers. Problems with head/headache, low back, and neck pain were frequently endorsed. Subjective pain interference was reported in 21% of patients without a history of mTBI, 31.9% of patients with a history of mTBI with disorientation only, and 36.1% of patients with a history of mTBI with loss of consciousness. Statistically significant differences existed between the mTBI groups on PTS symptom endorsement, and PTS was predictive of pain experience and interference. A history of mTBI with loss of consciousness predicted head/headache pain, but otherwise did not predict pain or pain interference. PT'S was strongly related to the pain experience. Pain is common in polytrauma patients. PTS severity is strongly associated with both pain report and pain interference, with head/headache pain showing a unique association with a history of mTBI. Implications for evaluation and management of pain in this complex population are discussed.	[Romesser, Jennifer] George E Wahlen Dept Veteran Affairs VA Med Ctr, Salt Lake City, UT USA; [Romesser, Jennifer] Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA; [Booth, Jane; Pastorek, Nicholas] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Booth, Jane] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Benge, Jared] Jack C Montgomery VA Med Ctr, Dept Phys Med & Rehabil, Muskogee, OK USA; [Pastorek, Nicholas] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Helmer, Drew] Michael E DeBakey Veteran Affairs Med Ctr, Neurorehabil Neurons Networks VA Rehabil Res & De, Houston, TX USA; [Helmer, Drew] Baylor Coll Med, Dept Med, Div Gen Med, Houston, TX 77030 USA	Romesser, J (corresponding author), George E Wahlen Dept Veteran Affairs Med Ctr, 500 Foothill Dr,116B OPMH, Salt Lake City, UT 84148 USA.	jennifer.romesser@va.gov		Benge, Jared/0000-0001-6201-3278			American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Belmont PJ, 2011, J TRAUMA, V71, pE1, DOI 10.1097/TA.0b013e3181edebed; *DVVIS WORK GROUP, CLIN PRACT GUID LIN, P64349; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hauret KG, 2010, AM J PREV MED, V38, pS61, DOI 10.1016/j.amepre.2009.10.021; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kalra R, 2008, FED PRACT, V25, P36; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCrea M, 2008, MILD TRAUMATIC BRAIN; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ohayon MM, 2004, J CLIN PSYCHIAT, V65, P5; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherbourne CD, 2009, J GEN INTERN MED, V24, P620, DOI 10.1007/s11606-009-0956-2; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Tunks ER, 2008, CAN J PSYCHIAT, V53, P224; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; VonKorff M, 1996, BRIT J PSYCHIAT, V168, P101, DOI 10.1192/S0007125000298474	27	15	15	0	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1127	1135		10.1682/JRRD.2010.12.0238			9	Rehabilitation	Rehabilitation	149EZ	WOS:000319303100014	23341284	Bronze			2021-06-18	
J	Strangman, GE; O'Neil-Pirozzi, TM; Supelana, C; Goldstein, R; Katz, DI; Glenn, MB				Strangman, Gary E.; O'Neil-Pirozzi, Therese M.; Supelana, Christina; Goldstein, Richard; Katz, Douglas I.; Glenn, Mel B.			Fractional anisotropy helps predicts memory rehabilitation outcome after traumatic brain injury	NEUROREHABILITATION			English	Article						Cognitive rehabilitation; memory; diffusion tensor imaging; behavioral neurology; semantic clustering; brain trauma; structural neuroimaging	DIFFUSE AXONAL INJURY; WHITE-MATTER; COGNITIVE REHABILITATION; CORPUS-CALLOSUM; WORKING-MEMORY; MOTOR AREAS; HEAD-INJURY; TENSOR; MODERATE; RECOVERY	Traumatic brain injury (TBI) commonly results in residual memory difficulties. Such deficits are amenable to cognitive rehabilitation, but optimal selection of rehabilitation interventions remains a challenge. We hypothesized that diffusion tensor imaging (DTI) could be used to predict which individuals were likely to benefit from a specific memory rehabilitation intervention. Thirty-seven individuals with TBI, of all severities, first underwent DTI scanning, along with 18 matched controls. Participants with TBI then attended a 12-session memory intervention emphasizing internal memory strategies (I-MEMS). Primary outcome measures (HVLT, RBMT) were collected at the time of DTI scanning, and both immediately and one month post-therapy. In contrast to typical neuroimaging analysis, fractional anisotropy (FA) was used to predict long-term outcome scores, adjusting for typical predictors (injury severity, age, education, time since injury, pretest score). FA of the parahippocampal white matter was a significant negative predictor of HVLT, while the anterior corpus callosum, left anterior internal capsule, and right anterior corona radiata were negative predictors of RBMT outcome. The importance of these predictors rivaled those of pretest scores. Thus, FA measures may provide substantial predictive value for other cognitive interventions as well. The reason why higher FA was associated with less successful response to cognitive intervention remains unclear and will require further study.	[Strangman, Gary E.] Harvard Univ, Dept Psychiat, Sch Med, Neural Syst Grp, Charlestown, MA 02129 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Glenn, Mel B.] Harvard Univ, Dept Phys Med & Rehabil, Sch Med, Charlestown, MA 02129 USA	Strangman, GE (corresponding author), Harvard Univ, Dept Psychiat, Sch Med, Neural Syst Grp, 149 13th St,Suite 2651, Charlestown, MA 02129 USA.	strang@nmr.mgh.harvard.edu		Strangman, Gary/0000-0001-8896-2164; Katz, Douglas/0000-0002-7502-8505	National Institute on Disability and Rehabilitation Research, Department of Education [H133A020513]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS: K25-NS046554]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K25NS046554] Funding Source: NIH RePORTER	We would like to thank Dana Christina, Kalika Kelkar, the Statewide Head Injury Program, and Community Rehabilitation Care for their help and support. The contents of this publication were developed under a grant from the National Institute on Disability and Rehabilitation Research, Department of Education (H133A020513). However, those contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government. Support for this project also came from the NIH (NINDS: K25-NS046554).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Brandt J., 2001, HOPKINS VERBAL LEARN; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; COUGHLAN AK, 1979, J NEUROL NEUROSUR PS, V42, P914, DOI 10.1136/jnnp.42.10.914; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Faust M, 2008, BRAIN LANG, V105, P220, DOI 10.1016/j.bandl.2007.12.002; Filley CM, 2005, ANN NY ACAD SCI, V1064, P162, DOI 10.1196/annals.1340.028; Filley CM, 2005, PSYCHIAT CLIN N AM, V28, P685, DOI 10.1016/j.psc.2005.05.008; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Giles GM, 2001, BRAIN DAM B, P231; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Han BS, 2007, NEUROREHABILITATION, V22, P151; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Nair DG, 2007, NEUROIMAGE, V34, P253, DOI 10.1016/j.neuroimage.2006.09.010; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Strangman Gary E, 2009, Front Neuroinform, V3, P12; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang JY, 2011, NEUROIMAGE; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Wei CW, 2008, ARCH PHYS MED REHAB, V89, pS85, DOI 10.1016/j.apmr.2008.07.005; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wilson B, 2003, RIVERMEAD BEHAV M S2; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yin X, 2011, HUM BRAIN MAPP	78	15	15	0	13	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	3					295	310		10.3233/NRE-2012-0797			16	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	028QC	WOS:000310436200006	23093456	Bronze			2021-06-18	
J	Vakil, E				Vakil, Eli			Neuropsychological assessment: Principles, rationale, and challenges	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychological; Assessment; Review	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; FRONTAL-LOBE DAMAGE; SEVERE HEAD-INJURY; PREMORBID INTELLIGENCE; COMPUTERIZED ASSESSMENT; ECOLOGICAL VALIDITY; EXECUTIVE FUNCTION; VIRTUAL-REALITY; EVERYDAY MEMORY	Neuropsychological assessments are increasingly in demand for a wide range of patients. This paper offers a survey of the basic aspects of neuropsychological assessment that are of greatest importance for professionals (e. g., psychologists, psychiatrists, social workers, and lawyers) who are not trained in neuropsychological testing, but who refer clients for neuropsychological assessment. This survey could also serve neuropsychologists in their early stages of training, by addressing some of the major issues related to the assessment process. The range of goals that neuropsychological assessment may attain is first outlined. Next, a model is presented that explains the rationale enabling generalization from assessment to real-world functions that are the focus of interest and the target of prediction. Issues that need to be considered before deciding to conduct a neuropsychological evaluation are then introduced, and sources of information available to the assessor are described. A description is provided of what a neuropsychological assessment includes, with an emphasis on its cognitive aspects. Finally, mention is made of some of the difficulties and challenges that must be confronted in the course of a neuropsychological assessment.	[Vakil, Eli] Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; [Vakil, Eli] Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, IL-52900 Ramat Gan, Israel	Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	vakile@mail.biu.ac.il					ADAMS KM, 1985, J CONSULT CLIN PSYCH, V53, P790, DOI 10.1037/0022-006X.53.6.790; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; *AM PSYCH ASS, 1986, GUID COMP BAS TESTS; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baade LE, 2004, ARCH CLIN NEUROPSYCH, V19, P227, DOI 10.1016/S0887-6177(03)00092-1; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Bilder RM, 2011, J INT NEUROPSYCH SOC, V17, P7, DOI 10.1017/S1355617710001396; Bond M. R., 1986, NEUROPSYCHOLOGICAL A; BRANDT J, 1988, CLIN ASSESSMENT MALI; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bruner J. S., 1957, CONT APPROACHES COGN, P41; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Christensen AL, 1979, LURIAS NEUROPSYCHOLO; de Jager CA, 2003, PSYCHOL MED, V33, P1039, DOI 10.1017/S0033291703008031; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Farah MJ, 2003, CLIN NEUROPSYCHOLOGY, P146; Feldstein SN, 1999, CLIN NEUROPSYCHOL, V13, P303, DOI 10.1076/clin.13.3.303.1744; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Golden C. J., 1976, LURIA NEBRASKA NEURO; Greiffenstein M., 2008, CLIN NEUROPSYCHOL, V22, P1; Greiffenstein MF, 2002, PSYCHOL ASSESSMENT, V14, P202, DOI 10.1037//1040-3590.14.2.202; Handler J., 1994, HANDB NEUR, P125; Hoofien D, 2000, J CLIN EXP NEUROPSYC, V22, P305, DOI 10.1076/1380-3395(200006)22:3;1-V;FT305; Jagaroo V, 2009, NEUROINFORMATICS FOR NEUROPSYCHOLOGY, P1, DOI 10.1007/978-1-4419-0060-9_1; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; Kaplan E.F., 1988, CLIN NEUROPSYCHOLOGY; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lehrner J., 2008, EUROPEAN J GERIATRIC, V10, P59; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Luciana M, 2003, J CHILD PSYCHOL PSYC, V44, P649, DOI 10.1111/1469-7610.00152; Luis CA, 2011, INT J ALZHEIMERS DIS, V2011; Luria A. R., 1966, HIGHER CORTICAL FUNC; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nelson AP, 2008, CNS SPECTRUMS, V13, P56, DOI 10.1017/S1092852900016163; Parkin AJ, 1997, MEMORY AMNESIA INTRO; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Quraishi S, 2002, J AFFECT DISORDERS, V72, P209, DOI 10.1016/S0165-0327(02)00091-5; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reitan R M, 1989, Arch Clin Neuropsychol, V4, P385, DOI 10.1016/0887-6177(89)90029-2; Reitan RM, 2000, ARCH CLIN NEUROPSYCH, V15, P433, DOI 10.1016/S0887-6177(99)00038-4; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; RUSSELL EW, 1995, NEUROPSYCHOL REV, V5, P1, DOI 10.1007/BF02214929; Sbordone R. J., 1996, ECOLOGICAL VALIDITY, P15; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schlegel RE, 2007, ARCH CLIN NEUROPSYCH, V22, pS49, DOI 10.1016/j.acn.2006.10.005; Schulenberg SE, 2004, COMPUT HUM BEHAV, V20, P477, DOI 10.1016/j.chb.2003.10.006; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; SCHWARTZ AF, 1989, CORTEX, V25, P665, DOI 10.1016/S0010-9452(89)80026-7; Selverstein SM, 2007, BEHAV RES METHODS, V39, P940, DOI 10.3758/BF03192989; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T., 1990, NEUROPSYCHOLOGY MENT; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Teng E, 2009, DEMENT GERIATR COGN, V28, P168, DOI 10.1159/000235732; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Vakil E, 1997, CLIN NEUROPSYCHOL, V11, P356, DOI 10.1080/13854049708400464; Vakil E., 2006, QUANTIFIED PROCESS A; Vakil E, 2010, CLIN NEUROPSYCHOL, V24, P662, DOI 10.1080/13854040903493522; Wechsler D., 1997, WESCHSLER ADULT INTE; WELSH MC, 1990, CHILD DEV, V61, P1697, DOI 10.1111/j.1467-8624.1990.tb03560.x; Wieshmann UC, 1999, LANCET, V353, P1242, DOI 10.1016/S0140-6736(99)00248-2; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson B., 1987, BEHAV INATTENTION TE; Wilson B. A., 1993, APPL PREV PSYCHOL, V2, P209, DOI [DOI 10.1016/S0962-1849(05)80091-5, 10.1016/S0962-1849(05)80091-5]; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wilson B.A., 1991, NEUROPSYCHOL REHABIL, V1, P117, DOI [https://doi.org/10.1080/09602019108401386, DOI 10.1080/09602019108401386]; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; WILSON BA, 1991, NEUROPSYCHOLOGY, V5, P281; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wolfson D., 1993, HALSTEAD REITAN NEUR	90	15	18	0	37	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	2					135	150		10.1080/13803395.2011.623121			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	916EC	WOS:000302079900003	22087572				2021-06-18	
J	Wallenquist, U; Holmqvist, K; Hanell, A; Marklund, N; Hillered, L; Forsberg-Nilsson, K				Wallenquist, U.; Holmqvist, K.; Hanell, A.; Marklund, N.; Hillered, L.; Forsberg-Nilsson, K.			Ibuprofen attenuates the inflammatory response and allows formation of migratory neuroblasts from grafted stem cells after traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Neural stem cell; regeneration; transplantation; controlled cortical impact; eGFP	CONTROLLED CORTICAL IMPACT; GENE-EXPRESSION; FORM NEURONS; MICE; RATS; CYCLOOXYGENASE-2; RECOVERY; NEURODEGENERATION; TRANSPLANTATION; INTEGRATION	Purpose: There is hope for neural stem and progenitor cells (NSPC) to enhance regeneration when transplanted to the injured brain after traumatic brain injury (TBI). So far, the therapeutic effects of NSPC transplantation have been hampered mainly by the notable death of the transplanted cells. Neuroinflammation may lead to additional cell death after TBI and we hypothesized that survival of grafted NSPC could be enhanced by anti-inflammatory treatment. Methods: Mice that were subjected to controlled cortical impact TBI and grafted with NSPC, were treated with the non-steroidal anti-inflammatory drug ibuprofen. Results: Ibuprofen was found to down-regulate the TBI-induced inflammatory response. In addition, migrating neuroblasts from transplanted cells were observed near the contusion and in the ipsilateral hippocampus in ibuprofen-treated animals only, suggesting that the anti-inflammatory treatment had beneficial effects on graft survival and/or differentiation. However, Morris Water Maze performance or TBI-induced tissue loss was not influenced by ibuprofen treatment. Conclusions: Our data suggests that anti-inflammatory strategies may be a complement to enhance the outcome for the cell transplants following TBI.	[Wallenquist, U.; Forsberg-Nilsson, K.] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; [Wallenquist, U.; Hanell, A.; Marklund, N.; Hillered, L.] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden; [Holmqvist, K.] MSD, N-3011 Drammen, Norway	Forsberg-Nilsson, K (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.	karin.nilsson@igp.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Hanell, Anders/E-4776-2011	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Hanell, Anders/0000-0001-9369-3886; Marklund, Niklas/0000-0002-9797-5626; Hillered, Lars/0000-0002-2808-9292	Swedish Research Council MedicineSwedish Research Council; Uppsala University Hospital	This study was supported by grants from the Swedish Research Council Medicine (LH and KFN) and Uppsala University Hospital (LH). The authors would like to thank the animal facility personnel for excellent assistance with animal care.	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Antezana DF, 2003, J NEUROSURG, V98, P860, DOI 10.3171/jns.2003.98.4.0860; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Brannvall K, 2006, NEUROREPORT, V17, P623; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Casper D, 2000, NEUROSCI LETT, V289, P201, DOI 10.1016/S0304-3940(00)01294-5; Clark RSB, 1999, FASEB J, V13, P813; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; COLE DJ, 1993, J PHARMACOL EXP THER, V266, P1713; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kudo C, 2003, BIOCHEM PHARMACOL, V66, P289, DOI 10.1016/S0006-2952(03)00235-1; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Magge SN, 2009, J NEUROSCI RES, V87, P1547, DOI 10.1002/jnr.21983; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481	43	15	18	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	1					9	19		10.3233/RNN-2011-0606			11	Neurosciences	Neurosciences & Neurology	901HN	WOS:000300955300002	22377906				2021-06-18	
J	Zlotnik, A; Klin, Y; Gruenbaum, BF; Gruenbaum, SE; Ohayon, S; Leibowitz, A; Kotz, R; Dubilet, M; Boyko, M; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Klin, Yael; Gruenbaum, Benjamin Fredrick; Gruenbaum, Shaun Evan; Ohayon, Sharon; Leibowitz, Akiva; Kotz, Ruslan; Dubilet, Michael; Boyko, Matthew; Shapira, Yoram; Teichberg, Vivian I.			beta 2 Adrenergic-mediated Reduction of Blood Glutamate Levels and Improved Neurological Outcome After Traumatic Brain Injury in Rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						beta 2 adrenergic receptors; glutamate; recovery; traumatic brain injury	TRANSIENT FOREBRAIN ISCHEMIA; EXCITATORY AMINO-ACIDS; CLOSED-HEAD-INJURY; CEREBROSPINAL-FLUID; CEREBRAL-ISCHEMIA; PROVIDES NEUROPROTECTION; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; INFARCT SIZE; IN-VITRO	Background: Isoflurane-anesthetized rats subjected to traumatic brain injury (TBI) show a transient reduction in blood L-glutamate levels. Having previously observed that isoproterenol produces a sustained decrease in blood glutamate levels in naive rats, we investigated the possible effects of nonselective and selective beta 1 and beta 2 adrenergic agonists and antagonists both on blood glutamate levels and on the neurological outcomes of rats subjected to TBI. Methods: Rats received either 10mL/kg of isotonic saline 1 hour after TBI, 50 mu g/kg of isoproterenol pretreatment 30 minutes before TBI, 10mg/kg of propranolol pretreatment 60 minutes before TBI, 10mg/kg of metoprolol pretreatment 60 minutes before TBI, or 10mg/kg of butaxamine pretreatment 40 minutes before TBI and 10 minutes before pretreatment with 50 mu g/kg isoproterenol or 10 mg/kg of propranolol 60 minutes after TBI. A neurological severity score (NSS) was measured at 1, 24, and 48 hours after TBI. Blood glutamate, blood glucose, mean arterial blood pressure, and heart rate were measured at the time of drug injection, at the time of TBI, 60 minutes after TBI, and 90 minutes after TBI. Results: Blood glutamate levels decreased spontaneously by 60 minutes after TBI in the control group (P< 0.05), reverting to baseline levels by 90 minutes after TBI. A pretreatment with either 10mg/kg of metoprolol 60 minutes before TBI or with 50 mu g/kg of isoproterenol 30 minutes before TBI also reduced blood glutamate levels (P< 0.05) both at 90 minutes after TBI and improved the NSS measured 24 and 48 hours after TBI in comparison with the control saline-treated group. However, a 10-mg/kg butoxamine pretreatment 40 minutes before TBI and 10 minutes before pretreatment with 50 mu g/kg of isoproterenol or 10mg/kg of propranolol 60 minutes before TBI neither affected blood glutamate levels across time after TBI nor caused any significant change in the NSS measured 24 and 48 hours after TBI in comparison with the control saline-treated group. A strong correlation (r(2) = 0.73) was demonstrated between the percent decrease in blood glutamate levels at 90 minutes after TBI and the percent improvement of NSS measured 24 hours after TBI. Conclusions: The results suggest that the transient blood glutamate reduction seen after TBI is the result of a stress response and of the activation of the sympathetic nervous system through the beta 2 adrenergic receptors, causing an increase of the brain-to-blood efflux of glutamate observed with excess brain glutamate levels after a brain insult. This strongly correlates with the neurological improvement observed 24 hours after TBI.	[Zlotnik, Alexander] Soroka Med Ctr, Dept Anesthesiol & Crit Care, Div Anesthesiol, IL-84105 Beer Sheva, Israel; [Zlotnik, Alexander; Gruenbaum, Benjamin Fredrick; Ohayon, Sharon; Leibowitz, Akiva; Kotz, Ruslan; Dubilet, Michael; Boyko, Matthew; Shapira, Yoram] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Gruenbaum, Shaun Evan] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA	Zlotnik, A (corresponding author), Soroka Med Ctr, Dept Anesthesiol & Crit Care, Div Anesthesiol, POB 151, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	Leibowitz, Akiva/F-1397-2012	Leibowitz, Akiva/0000-0003-4244-1915; Boyko, Matthew/0000-0003-3116-1643	Nella and Leon Benoziyo Center for Neurological Diseases; Braintact Ltd; Irwin Green Fund for Studying the Development of the Brain; Carl and Micaela Einhorn-Dominic Institute for Brain Research	The authors gratefully acknowledge the help of Valeria Frishman, lab assistant at the Department of Clinical Biochemistry, Soroka Medical Center, Ben-Gurion University of the Negev, for her outstanding help with the biochemical analysis. This work was supported in part by grants to VIT from the Nella and Leon Benoziyo Center for Neurological Diseases; Braintact Ltd, the Irwin Green Fund for Studying the Development of the Brain, the Carl and Micaela Einhorn-Dominic Institute for Brain Research. The data obtained are part of A.Z's PhD thesis. VIT is the incumbent of the Louis and Florence Katz-Cohen Chair of Neuropharmacology.	Berger C, 2008, EXP NEUROL, V210, P543, DOI 10.1016/j.expneurol.2007.12.002; Brown DR, 2004, ANESTH ANALG, V99, P1427, DOI 10.1213/01.ANE.0000135638.60722.E3; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Culmsee C, 2004, STROKE, V35, P1197, DOI 10.1161/01.STR.0000125855.17686.6d; Culmsee C, 1999, NEUROCHEM INT, V35, P47, DOI 10.1016/S0197-0186(99)00032-7; Culmsee C, 2007, EUR J PHARMACOL, V575, P57, DOI 10.1016/j.ejphar.2007.07.066; Culmsee C, 2009, ANESTH ANALG, V108, P3, DOI 10.1213/ane.0b013e31818db6f6; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Goyagi T, 2006, ANESTH ANALG, V103, P658, DOI 10.1213/01.ane.0000228859.95126.69; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Han F, 2008, NEUROSCI LETT, V430, P275, DOI 10.1016/j.neulet.2007.11.021; Iwata M, 2010, ANESTH ANALG, V110, P1126, DOI 10.1213/ANE.0b013e3181d278f7; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Junker V, 2002, EUR J PHARMACOL, V446, P25, DOI 10.1016/S0014-2999(02)01814-9; KEENAN D, 1995, CIRC RES, V77, P973, DOI 10.1161/01.RES.77.5.973; Koura SS, 1998, ACT NEUR S, V71, P244; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Laurer HL, 2000, EUR J TRAUMA, V26, P95, DOI DOI 10.1007/S000680050007; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Martin SW, 1999, CAN J PHYSIOL PHARM, V77, P156, DOI 10.1139/cjpp-77-3-156; MOTOMURA S, 1990, AM HEART J, V119, P608, DOI 10.1016/S0002-8703(05)80284-4; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneider AM, 2000, BEHAV NEUROSCI, V114, P1256; Semkova I, 1996, BRAIN RES, V717, P44, DOI 10.1016/0006-8993(95)01567-1; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Sharma AB, 2008, RESUSCITATION, V76, P108, DOI 10.1016/j.resuscitation.2007.04.028; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Stoffel M, 2002, J NEUROTRAUM, V19, P467, DOI 10.1089/08977150252932415; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zhu Y, 1998, J CEREBR BLOOD F MET, V18, P1032; Zhu Y, 2001, NEUROSCIENCE, V107, P593, DOI 10.1016/S0306-4522(01)00357-8; Zhu Y, 1999, NEUROSCIENCE, V90, P1255, DOI 10.1016/S0306-4522(98)00564-8; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2011, NEUROCHEM RES, V36, P732, DOI 10.1007/s11064-010-0388-8; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	52	15	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2012	24	1					30	38		10.1097/ANA.0b013e318232deaa			9	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	863EB	WOS:000298144500007	21979171				2021-06-18	
J	Eckner, JT; Chandran, S; Richardson, JK				Eckner, James T.; Chandran, SriKrishna; Richardson, James K.			Investigating the Role of Feedback and Motivation in Clinical Reaction Time Assessment	PM&R			English	Article							COMMUNITY-DWELLING WOMEN; TRAUMATIC BRAIN-INJURY; OLDER-PEOPLE; SENSORIMOTOR FUNCTION; PERFORMANCE; CONCUSSION; FALLS; KNOWLEDGE; ASSOCIATION; STATEMENT	Objective: To investigate the influence of performance feedback and motivation during 2 tests of simple visuomotor reaction time (RT). Design: Cross-sectional, observational study. Setting: Outpatient academic physiatry clinic. Participants: Thirty-one healthy adults (mean [SD], 54 +/- 15 years). Methods: Participants completed a clinical test of RT (RTclin) and a computerized test of RT with and without performance feedback (RTcompFB and RTcompNoFB, respectively) in randomly assigned order. They then ranked their degree of motivation during each test. RTclin measured the time required to catch a suspended vertical shaft by hand closure after release of the shaft by the examiner. RTcompFB and RTcompNoFB both measured the time required to press a computer key in response to a visual cue displayed on a computer monitor. Performance feedback (visual display of the previous trial and summary results) was provided for RTcompFB, but not for RTcompNoFB. Main Outcome Measurements: Means and standard deviations of RTclin, RTcompFB, and RTcompNoFB and participants' self-reported motivation on a 5-point Likert scale for each test. Results: There were significant differences in both the means and standard deviations of RTclin, RTcompFB, and RTcompNoFB (F-2,F-60 = 81.66, P < .0001; F-2,F-60 = 32.46, P < .0001, respectively), with RTclin being both the fastest and least variable of the RT measurements. RTclin was more strongly correlated with RTcompFB = 0.449, P = .0011) than with RTcompNoFB (r = 0.314, P = .086). The participants reported similar levels of motivation between RTclin and RTcompFB both of which were reported to be more motivating than RTcompNoFB. Conclusions: The stronger correlation between RTclin and RTcompFB as well as the higher reported motivation during RTclin and RTcompFB testing suggest that performance feedback ;is a positive motivating factor that is inherent to RTclin testing. RTclin is a simple, inexpensive technique for measuring RT and appears to be an intrinsically motivating task. This motivation may promote faster, more consistent RT performance compared with currently available computerized programs, which do not typically provide performance feedback. PM R 2011;3:1092-1097	[Eckner, James T.; Richardson, James K.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Chandran, SriKrishna] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA	Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			University of Michigan Patent application; Foundation for Physical Medicine and Rehabilitation; University of Michigan Bone and Joint Injury Prevention and Rehabilitation Center (pilot grant); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [k-12/RMSTP]; University of Michigan Biostatistics Core [UL1RR024986]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024986] Funding Source: NIH RePORTER	4A, University of Michigan Patent application; 8A, Foundation for Physical Medicine and Rehabilitation (2007 New Investigator Award) and the University of Michigan Bone and Joint Injury Prevention and Rehabilitation Center (pilot grant), k-12/RMSTP Fellowship (NIH funded).; The authors thank the University of Michigan Biostatistics Core (UL1RR024986 CTSA funded) for statistical advice.	Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bulmash EL, 2006, J AFFECT DISORDERS, V93, P213, DOI 10.1016/j.jad.2006.01.015; Callisaya ML, 2009, AGE AGEING, V38, P290, DOI 10.1093/ageing/afp017; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chudler EH, 2007, NEUROSCIENCE KIDS RE; CHURCH RM, 1965, AM J PSYCHOL, V78, P102, DOI 10.2307/1421087; Collie A, 2005, SPORTS NEUROPSYCHOLO, P240; CRABTREE DA, 1988, PERCEPT MOTOR SKILL, V66, P363, DOI 10.2466/pms.1988.66.2.363; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Eckner JT, 2011, J ATHL TRAI IN PRESS, V46, P415; FERRIS S, 1976, J AM GERIATR SOC, V24, P529, DOI 10.1111/j.1532-5415.1976.tb03277.x; Gorus E, 2007, J CLIN PSYCHOPHARM, V27, P182, DOI 10.1097/JCP.0b013e318032eadb; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; LOCKE EA, 1968, AM J PSYCHOL, V81, P566, DOI 10.2307/1421061; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; Lord SR, 1996, AGE AGEING, V25, P292, DOI 10.1093/ageing/25.4.292; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; MCCORMACK P D, 1963, Percept Mot Skills, V17, P279; MCCORMACK P D, 1963, Percept Mot Skills, V17, P565; MCCORMACK PD, 1962, PERCEPT MOTOR SKILL, V14, P367; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Menz HB, 2004, ARCH PHYS MED REHAB, V85, P245, DOI 10.1016/j.apmr.2003.06.015; Miscio G, 2006, NEUROL SCI, V26, P402, DOI 10.1007/s10072-005-0523-0; O'Neill WM, 2000, PAIN, V85, P209, DOI 10.1016/S0304-3959(99)00274-2; ODENHEIMER GL, 1994, J GERONTOL, V49, pM153, DOI 10.1093/geronj/49.4.M153; PERETTI PO, 1970, PERCEPT MOTOR SKILL, V30, P838, DOI 10.2466/pms.1970.30.3.838; Pichel F, 2006, RESP MED, V100, P1020, DOI 10.1016/j.rmed.2005.09.036; REBOK GW, 1994, ALZ DIS ASSOC DIS, V8, P228, DOI 10.1097/00002093-199408040-00002; Rebok GW, 1995, MOVEMENT DISORD, V10, P778, DOI 10.1002/mds.870100611; Richerson SJ, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-12; Smeesters C, 2001, J BIOMECH, V34, P589, DOI 10.1016/S0021-9290(01)00005-7; Tiedemann AC, 2007, J GERONTOL A-BIOL, V62, P1259, DOI 10.1093/gerona/62.11.1259; Turner C, 2006, J PSYCHOPHARMACOL, V20, P506, DOI 10.1177/0269881106059804; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wood JM, 2008, J AM GERIATR SOC, V56, P986, DOI 10.1111/j.1532-5415.2008.01709.x	43	15	17	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	DEC	2011	3	12					1092	1097		10.1016/j.pmrj.2011.04.022			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	966YG	WOS:000305872700003	21852221	Green Published, Green Accepted			2021-06-18	
J	Wade, SL; Oberjohn, K; Conaway, K; Osinska, P; Bangert, L				Wade, Shari L.; Oberjohn, Karen; Conaway, Kathryn; Osinska, Paulina; Bangert, Lauren			Live Coaching of Parenting Skills Using the Internet: Implications for Clinical Practice	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						acquired brain injury; parenting; telehealth; parent-child interaction; therapeutic alliance	TRAUMATIC BRAIN-INJURY; BEHAVIORAL FAMILY INTERVENTION; CHILD INTERACTION THERAPY; YOUNG-CHILDREN; SHORT-TERM; OUTCOMES; PROGRAM; CAREGIVERS; EFFICACY; AREAS	Many parents who would benefit from parenting skills training via live coaching do not receive it due to barriers such as time, distance, and the unavailability of skilled providers. This report describes an innovative web-based parenting skills program for families of young children with traumatic brain injury (TBI)-Internet-Based Interacting Together Everyday, Recovery After Childhood TBI (I-InTERACT). I-InTERACT is a web-based parenting skills program of 10-14 sessions that combines self-guided web modules with live coaching via videoconferencing. We describe the feasibility and utility of this approach, as well as the unique nature of the therapeutic process, detailing the perspectives of 13 parents of children with TBI who participated in the program and 6 therapists who delivered the program. Nine of 13 parents preferred the web-based coaching to traditional treatment; they cited its ease of use and the comfort of doing it at home. Therapists uniformly liked coaching over the web despite the need to address boundaries and troubleshoot technological difficulties. Therapeutic alliance was comparable to traditional therapy with nearly all families expressing a strong connection to the therapist. Individuals with less computer experience particularly liked the program because it gave them access to the web and a sense of empowerment. These preliminary findings support the utility of web-based parenting skills training for families from diverse backgrounds, while underscoring the potential for clinical use with other underserved populations.	[Wade, Shari L.; Oberjohn, Karen; Osinska, Paulina; Bangert, Lauren] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Cincinnati, OH 45221 USA	Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org					Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Bauer WM, 2003, J REHABIL, V69, P18; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Connell S, 1997, BEHAV MODIF, V21, P379, DOI 10.1177/01454455970214001; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Eyberg S., 1988, CHILD FAM BEHAV THER, V10, P33, DOI [DOI 10.1300/J019V10N01_04, 10.1300/J019v10n01_04]; EYBERG SM, 1995, PSYCHOPHARMACOL BULL, V31, P83; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Gilkey SL, 2009, FAM SOC, V90, P37, DOI 10.1606/1044-3894.3843; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Mayheu M. M, 2011, SKYPE HIPAA WHAT ARE; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thomas R, 2007, J ABNORM CHILD PSYCH, V35, P475, DOI 10.1007/s10802-007-9104-9; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2006, J CONSULT CLIN PSYCH, V51, P178; Webster-Stratton C., 2010, EVIDENCE BASED PSYCH; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	25	15	15	0	17	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	DEC	2011	42	6			SI		487	493		10.1037/a0025222			7	Psychology, Multidisciplinary	Psychology	860CI	WOS:000297924400012					2021-06-18	
J	Guskiewicz, KM; Broglio, SP				Guskiewicz, Kevin M.; Broglio, Steven P.			Sport-Related Concussion: On-Field and Sideline Assessment	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Mild traumatic brain injury; Symptom assessment; Balance and postural control; Neuropsychological function; Emergency action plan	COLLEGIATE FOOTBALL PLAYERS; ERROR SCORING SYSTEM; HIGH-SCHOOL; NEUROPSYCHOLOGICAL PERFORMANCE; INTERNATIONAL-CONFERENCE; POSTURAL STABILITY; SYMPTOMS; EPIDEMIOLOGY; STATEMENT; PREVENTION	The careful and well-planned sideline assessment of concussion can be the difference between a good and bad outcome when managing sport-related concussion. In most cases, the sideline assessment serves as a triage for determining if an injury, such as a concussion, has actually occurred, and if so, establishes a benchmark for determining whether a more serious and potentially catastrophic condition could be developing. Concussions can evolve into something more serious if signs and symptoms go undetected or are ignored. Although these are very rare events, they must always be at the forefront of the clinician's mind.	[Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	Guskiewicz, KM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Hall,CB 8700,South Rd, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Guskiewicz, Kevin/0000-0002-8682-2130			Agel J, 2007, J ATHL TRAINING, V42, P249; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Broglio S. P., J NEUROTRAU IN PRESS; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Broglio SP, 2009, J SCI MED SPORT, V12, P388, DOI 10.1016/j.jsams.2007.12.010; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Patel AV, 2007, J ATHL TRAINING, V42, P66; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Romberg MH, 1853, MANUAL NERVOUS DIS M; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; SANDERS MJ, 2001, HEAD FACIAL TRAUMA M, P624; Susco TM, 2004, J ATHL TRAINING, V39, P241; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	38	15	15	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					603	+		10.1016/j.pmr.2011.08.003			16	Rehabilitation	Rehabilitation	858SI	WOS:000297822600004	22050938				2021-06-18	
J	Zgaljardic, DJ; Yancy, S; Temple, RO; Watford, MF; Miller, R				Zgaljardic, Dennis J.; Yancy, Sybil; Temple, Richard O.; Watford, Monica F.; Miller, Rebekah			Ecological Validity of the Screening Module and the Daily Living Tests of the Neuropsychological Assessment Battery Using the Mayo-Portland Adaptability Inventory-4 in Postacute Brain Injury Rehabilitation	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; neuropsychological assessment; ecological validity; outcomes assessment; postacute brain injury rehabilitation	ALZHEIMERS-DISEASE; DRIVING ABILITY; NAB; DEMENTIA; PERFORMANCE; MODERATE; SAMPLE; STROKE; SKILLS; ATTENTION	Purpose: The assessment of ecological validity of neuropsychological measures is an area of growing interest, particuliuly in the postacute brain injury rehabilitation (PABIR) setting, as there is an increasing demand for clinicians to address functional and real-world outcomes. In the current study, we assessed the predictive value of the Screening module and the Daily Living tests of the Neuropsychological Assessment Battery (NAB) using clinician ratings from the Mayo-Portland Adaptability Inventory-4 (MPAI-4) in patients with moderate to severe traumatic brain injury. Method: Forty-seven individuals were each administered the NAB Screening module (NAB-SM) and the NAB Daily Living (NAB-DL) tests following admission to a residential PABIR program. MPAI-4 ratings were also obtained at admission. Linear regression analysis was used to examine the association between these functional and neuropsychological assessment measures. Results: We replicated prior work (Temple at al., 2009) and expanded evidence for the ecological validity of the NAB-SM. Furthermore, our findings support the ecological validity of the NAB-DL Bill Payment, Judgment, and Map Reading tests with regards to functional skills and real-world activities. Conclusions: The current study supports prior work from our lab assessing the predictive value of the NAB-SM, as well as provides evidence for the ecological validity for select NAB-DL tests in patients with moderate to severe traumatic brain injury admitted to a residential PABIR program.	[Zgaljardic, Dennis J.; Miller, Rebekah] Transit Learning Ctr, Dept Neuropsychol, Galveston, TX 77550 USA; [Zgaljardic, Dennis J.; Watford, Monica F.] Univ Texas Med Branch, Sch Hlth Profess, Dept Rehabil Sci, Galveston, TX 77555 USA; [Zgaljardic, Dennis J.] Univ Texas Med Branch, Sch Hlth Profess, Dept Neurol, Galveston, TX 77555 USA; [Yancy, Sybil] Transit Learning Ctr, Dept Occupat Therapy, Galveston, TX 77550 USA; [Temple, Richard O.] CORE Hlth Care, Dripping Springs, TX USA	Zgaljardic, DJ (corresponding author), Transit Learning Ctr, Dept Neuropsychol, 1528 Postoff St, Galveston, TX 77550 USA.	dzgaljardic@tlc-galveston.org					Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; Cahn-Weiner DA, 2009, EPILEPTIC DISORD, V11, P222, DOI 10.1684/epd.2009.0265; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Duchek JM, 1997, ALZ DIS ASSOC DIS, V11, P48, DOI 10.1097/00002093-199706001-00011; Duchek JM, 1998, J GERONTOL B-PSYCHOL, V53, P130; Fischer J. S., 2004, NEUROPSYCHOLOGICAL A, P729; Fong KNK, 2001, BRAIN INJURY, V15, P443, DOI 10.1080/02699050010005940; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Gavett BE, 2009, J INT NEUROPSYCH SOC, V15, P121, DOI 10.1017/S1355617708090176; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; Iverson GL, 2007, APPL NEUROPSYCHOL, V14, P178, DOI 10.1080/09084280701508952; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; LEONBERGER FT, 1989, PROF PSYCHOL-RES PR, V20, P411, DOI 10.1037/0735-7028.20.6.411; Long C. J., 1996, ECOLOGICAL VALIDITY, P15; Lynch WJ, 2004, J HEAD TRAUMA REHAB, V19, P180, DOI 10.1097/00001199-200403000-00009; Malec J. F., 2003, MANUAL MAYO PORTLAND; Ott BR, 2003, J GERIATR PSYCH NEUR, V16, P151, DOI 10.1177/0891988703255688; PARASURAMAN R, 1991, HUM FACTORS, V33, P539; Rabin LA, 2007, CLIN NEUROPSYCHOL, V21, P727, DOI 10.1080/13854040600888776; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Silva MT, 2009, REV ASSOC MED BRAS, V55, P484, DOI 10.1590/S0104-42302009000400027; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; State University of New York at Buffalo, 1997, GUID UN DAT SET MED; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Tate R. L., 2010, COMPENDIUM TESTS SCA, P643; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; White T., 2003, NEUROPSYCHOLOGICAL A; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yantz CL, 2010, NEUROPSYCHOL REHABIL, V20, P725, DOI 10.1080/09602011003765690; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P283, DOI 10.1080/09084282.2010.525118; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909	36	15	16	0	16	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2011	56	4					359	365		10.1037/a0025466			7	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	862AQ	WOS:000298062600009	21928919				2021-06-18	
J	Bouilleret, V; Cardamone, L; Liu, C; Koe, AS; Fang, K; Williams, JP; Myers, DE; O'Brien, TJ; Jones, NC				Bouilleret, Viviane; Cardamone, Lisa; Liu, Cyril; Koe, Amelia S.; Fang, Ke; Williams, John P.; Myers, Damian E.; O'Brien, Terence J.; Jones, Nigel C.			Confounding Neurodegenerative Effects of Manganese for In Vivo MR Imaging in Rat Models of Brain Insults	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						manganese-enhanced MRI; traumatic brain injury; neurodegeneration; manganese toxicity	MN-ENHANCED MRI; HIPPOCAMPAL VOLUMETRICS; POSTTRAUMATIC EPILEPSY; MAJOR DEPRESSION; INJURY; MEMRI; NEUROTOXICITY; ACTIVATION; TOXICITY; STRESS	Purpose: To examine the long-term consequences of manganese exposure due to the use of manganese-enhanced magnetic resonance imaging (MEMRI) in a model of closed head injury, the fluid-percussion injury (FPI) model. Materials and Methods: Two groups of adult male Wistar rats (n = 72) were studied with either MEMRI, whereby rats receive MnCl2 (100 mg/kg intraperitoneally) 24 hours prior to scanning, or standard MRI (sMRI) with no contrast agent. Rats from both groups underwent FPI or sham injury and were longitudinally assessed for 6 months for neurological toxicity using behavioral tests, EEG recording, and MRI scanning. Results: Regardless of whether they received FPI. MEMRI animals showed progressive signs of cerebral toxicity compared with sMRI rats, including significantly reduced weight gain, progressive brain volume decrease, and increased anxiety and depressive-like behaviors. Conclusion: Long-term structural and functional consequences of using manganese as a contrast agent for MRI can confound experimental outcomes and must be taken into account when designing longitudinal imaging studies using manganese-enhanced MRI.	[Bouilleret, Viviane; Cardamone, Lisa; Liu, Cyril; Koe, Amelia S.; Williams, John P.; Myers, Damian E.; O'Brien, Terence J.; Jones, Nigel C.] Univ Melbourne, Dept Med RMH, Parkville, Vic 3052, Australia; [Bouilleret, Viviane] CHU Bicetre, ApHp, Dept Neurophysiol & Epilepsy, Paris, France; [Fang, Ke] Florey Neurosci Inst, Small Anim MRI Facil, Parkville, Vic, Australia	Jones, NC (corresponding author), Univ Melbourne, Dept Med RMH, Parkville, Vic 3052, Australia.	ncjones@unimelb.edu.au	Jones, Nigel C/K-7773-2012; Myers, Damian E/L-5302-2013; Bouilleret, viviane/AAQ-5878-2021; O'Brien, Terence J/L-8102-2013	Jones, Nigel/0000-0002-1080-8439; Myers, Damian/0000-0002-7569-9907; O'Brien, Terence/0000-0002-7198-8621	Victorian Neurotrauma Initiative	Contract grant sponsor: Victorian Neurotrauma Initiative grant.	Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Aoki I, 2004, NMR BIOMED, V17, P569, DOI 10.1002/nbm.941; Aoki I, 2003, MAGNET RESON MED, V50, P7, DOI 10.1002/mrm.10528; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; Association AP, 2000, DIAGN STAT MAN MENT; Bock NA, 2008, NMR BIOMED, V21, P473, DOI 10.1002/nbm.1211; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Bouilleret V, 2009, NEUROIMAGE, V45, P267, DOI 10.1016/j.neuroimage.2008.12.019; Brown JS, 2002, ENV CHEM TOXINS PSYC; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brurok H, 1999, BIOCHEM BIOPH RES CO, V254, P768, DOI 10.1006/bbrc.1998.0131; CHANDRA SV, 1976, ARCH TOXICOL, V35, P319, DOI 10.1007/BF00570272; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Erikson KM, 2004, SCI TOTAL ENVIRON, V334, P409, DOI 10.1016/j.scitotenv.2004.04.044; Erikson KM, 2003, NEUROCHEM INT, V43, P475, DOI 10.1016/S0197-0186(03)00037-8; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Geuze E, 2005, MOL PSYCHIATR, V10, P160, DOI 10.1038/sj.mp.4001579; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hsu YH, 2007, BRAIN, V130, P3124, DOI 10.1093/brain/awm207; Itoh K, 2008, NEUROSCIENCE, V154, P732, DOI 10.1016/j.neuroscience.2008.03.080; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; KLAASSEN CD, 1974, TOXICOL APPL PHARM, V29, P458, DOI 10.1016/0041-008X(74)90117-3; Lee Bruce, 2005, NeuroRx, V2, P372; Lee JH, 2005, MAGN RESON MED, V53, P640, DOI 10.1002/mrm.20368; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMillan DE, 1999, NEUROTOXICOLOGY, V20, P499; MEIRI U, 1972, SCIENCE, V176, P308, DOI 10.1126/science.176.4032.308; Murayama Y, 2006, MAGN RESON IMAGING, V24, P349, DOI 10.1016/j.mri.2005.12.031; Nairismagi J, 2006, NEUROIMAGE, V30, P130, DOI 10.1016/j.neuroimage.2005.09.007; Neumeister A, 2005, BIOL PSYCHIAT, V57, P935, DOI 10.1016/j.biopsych.2005.01.016; Obenaus A, 2007, EPILEPSIA, V48, P11, DOI 10.1111/j.1528-1167.2007.01237.x; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Racette BA, 2005, MOVEMENT DISORD, V20, P492, DOI 10.1002/mds.20381; Rosen JB, 2006, BIOL PSYCHOL, V73, P49, DOI 10.1016/j.biopsycho.2006.01.007; Serrano F, 2008, MAGN RESON MED, V60, P169, DOI 10.1002/mrm.21648; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2008, SCHIZOPHRENIA BULL, V34, P595, DOI 10.1093/schbul/sbn056; Silva AC, 2008, J NEUROSCI METH, V167, P246, DOI 10.1016/j.jneumeth.2007.08.020; SLOOT WN, 1994, BRAIN RES, V657, P124, DOI 10.1016/0006-8993(94)90959-8; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Takeda A, 1998, BRAIN RES BULL, V45, P149, DOI 10.1016/S0361-9230(97)00330-4; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thuen M, 2005, J MAGN RESON IMAGING, V22, P492, DOI 10.1002/jmri.20400; Van der Linden A, 2004, NMR BIOMED, V17, P602, DOI 10.1002/nbm.936; van Raay L, 2009, J NEUROSCI METH, V179, P184, DOI 10.1016/j.jneumeth.2009.01.024; Watanabe T, 2006, MAGN RESON IMAGING, V24, P209, DOI 10.1016/j.mri.2005.10.034; Watanabe T, 2004, NMR BIOMED, V17, P554, DOI 10.1002/nbm.937; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WOLF GL, 1983, AM J ROENTGENOL, V141, P193, DOI 10.2214/ajr.141.1.193; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477	59	15	15	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	OCT	2011	34	4					774	784		10.1002/jmri.22669			11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	826ZP	WOS:000295394400005	21769969				2021-06-18	
J	Ham, HY; Lee, JK; Jang, JW; Seo, BR; Kim, JH; Choi, JW				Ham, Hyung-Yong; Lee, Jung-Kil; Jang, Jae-Won; Seo, Bo-Ra; Kim, Jae-Hyoo; Choi, Jeong-Wook			Post-Traumatic Cerebral Infarction: Outcome after Decompressive Hemicraniectomy for the Treatment of Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain trauma; Cerebral infarction; Decompressive craniectomy	CLINICAL-COURSE; CRANIECTOMY; PREDICTORS; SECONDARY; SURGERY; CT	Objective : Posttraumatic cerebral infarction (PTCI), an infarction in well-defined arterial distributions after head trauma, is a known complication in patients with severe head trauma. The primary aims of this study were to evaluate the clinical and radiographic characteristics of PTCI, and to assess the effect on outcome of decompressive hemicraniectomy (DHC) in patients with PTCI. Methods : We present a retrospective analysis of 20 patients with PTO who were treated between January 2003 and August 2005. Twelve patients among them showed malignant PTO, which is defined as PTCI including the territory of Middle Cerebral Artery (MCA). Medical records and radiologic imaging studies of patients were reviewed. Results : Infarction of posterior cerebral artery distribution was the most common site of PTCI. Fourteen patients underwent DHC an average of 16 hours after trauma. The overall mortality rate was 75%. Glasgow outcome scale (GOS) of survivors showed that one patient was remained in a persistent vegetative state, two patients were severely disabled and only two patients were moderately disabled at the time of discharge. Despite aggressive treatments, all patients with malignant PTO had died. Malignant PTCI was the indicator of poor clinical outcome. Furthermore, Glasgow coma scale (GCS) at the admission was the most valuable prognostic factor. Significant correlation was observed between a GCS less than 5 on admission and high mortality (p<0.05). Conclusion : In patients who developed non-malignant PTCI and GCS higher than 5 after head injury, early DHC and duroplasty should be considered, before occurrence of irreversible ischemic brain damage. High mortality rate was observed in patients with malignant PTCI or PTCI with a GCS of 3-5 at the admission. A large prospective randomized controlled study will be required to justify for aggressive treatments including DHC and medical treatment in these patients.	[Ham, Hyung-Yong; Lee, Jung-Kil; Jang, Jae-Won; Seo, Bo-Ra; Kim, Jae-Hyoo] Chonnam Natl Univ, Sch Med, Dept Neurosurg, Kwangju 501757, South Korea; [Ham, Hyung-Yong; Lee, Jung-Kil; Jang, Jae-Won; Seo, Bo-Ra; Kim, Jae-Hyoo] Res Inst Med Sci, Kwangju 501757, South Korea; [Choi, Jeong-Wook] GwangJu Woori Hosp, Dept Neurosurg, Kwangju, South Korea	Lee, JK (corresponding author), Chonnam Natl Univ, Sch Med, Dept Neurosurg, Kwangju 501757, South Korea.	jkl@chonnam.ac.kr					Doerfler A, 2001, STROKE, V32, P813, DOI 10.1161/01.STR.32.3.813; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Harscher S, 2006, ACTA NEUROCHIR, V148, P31, DOI 10.1007/s00701-005-0617-0; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Inamasu J, 2002, CHILD NERV SYST, V18, P175, DOI 10.1007/s003810100506; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; KEANE JR, 1980, ANN NEUROL, V8, P186, DOI 10.1002/ana.410080209; Krieger DW, 1999, STROKE, V30, P287, DOI 10.1161/01.STR.30.2.287; LAINE FJ, 1995, AM J ROENTGENOL, V165, P967, DOI 10.2214/ajr.165.4.7677003; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Mori K, 2001, ACTA NEUROCHIR, V143, P483, DOI 10.1007/s007010170078; Mori K, 2001, ACTA NEUROCHIR, V143, P491; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; Robertson SC, 2004, NEUROSURGERY, V55, P55, DOI 10.1227/01.NEU.0000126875.02630.36; ROTHFUS WE, 1987, AM J NEURORADIOL, V8, P1073; SATO M, 1986, NEUROSURGERY, V18, P300, DOI 10.1227/00006123-198603000-00007; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Server A, 2001, ACTA RADIOL, V42, P254; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; WEISBERG LA, 1979, COMPUT TOMOGR, V3, P15, DOI 10.1016/0363-8235(75)90004-6	29	15	19	0	8	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	OCT	2011	50	4					370	376		10.3340/jkns.2011.50.4.370			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	843NF	WOS:000296678000015	22200021	DOAJ Gold, Green Published			2021-06-18	
J	Kovarsky, D; Schiemer, C; Murray, A				Kovarsky, Dana; Schiemer, Christine; Murray, Allison			Humor, Rapport, and Uncomfortable Moments in Interactions With Adults With Traumatic Brain Injury	TOPICS IN LANGUAGE DISORDERS			English	Article						communication disorders; interaction; rapport; traumatic brain injury	ENGAGEMENT; THERAPY; TALK	We examined uncomfortable moments that damaged rapport during group interactions between college students in training to become speech-language pathologists and adults with traumatic brain injury. The students worked as staff in a community-based program affiliated with a university training program that functioned as a recreational gathering place for any adult with traumatic brain injury who wished to attend. Analysis revealed the interactional difficulties experienced by the student staff as they tried to manage offensive humor produced by an individual with traumatic brain injury without interfering with rapport. Nevertheless, successive instances of sexually explicit humor resulted in rapport being damaged to such an extent that it eventually derailed the entire interaction. Results are discussed in terms of those aspects of context outside the communicative intentions of any of the interactants that contributed to this breach in rapport.	[Kovarsky, Dana; Schiemer, Christine; Murray, Allison] Univ Rhode Isl, Dept Communicat Disorders, Kingston, RI 02881 USA	Kovarsky, D (corresponding author), Univ Rhode Isl, Dept Communicat Disorders, Kingston, RI 02881 USA.	danakovarsky5@gmail.com					Brown Penelope, 1987, POLITENESS SOME UNIV, DOI [10.1017/CBO9780511813085, DOI 10.2307/3587263]; Glenn Philip, 2003, LAUGHTER INTERACTION; Hagen C., 1998, RANCHO LEVELS COGNIT; Kinsman RA, 2008, J CLIN NURS, V17, P1088, DOI 10.1111/j.1365-2702.2007.02090.x; Kovarsky Dana, 2009, Seminars in Speech and Language, V30, P27, DOI 10.1055/s-0028-1104532; Scollon R., 1995, INTERCULTURAL COMMUN; Shultz, 1982, COUNSELOR GATEKEEPER; Simmons-Mackie N, 2003, APHASIOLOGY, V17, P751, DOI 10.1080/02687030344000229; Simmons-Mackie Nina, 2009, Seminars in Speech and Language, V30, P18, DOI 10.1055/s-0028-1104531; Spencer-Oatey H, 2002, J PRAGMATICS, V34, P529, DOI 10.1016/S0378-2166(01)00039-X; Spencer-Oatey H., 2005, J POLITENESS RES LAN, V1, P95, DOI DOI 10.1515/JPLR.2005.1.1.95; Straehle C., 1993, Framing in Discourse, P210; Tennant K F, 1990, J Gerontol Nurs, V16, P11; Walsh IP, 2007, TOP LANG DISORD, V27, P24, DOI 10.1097/00011363-200701000-00004; Walsh Irene P., 2009, Seminars in Speech and Language, V30, P37, DOI 10.1055/s-0028-1104533; Wooten P., 1993, PULMONARY REHABILITA, P422; ZAJDMAN A, 1995, J PRAGMATICS, V23, P325, DOI 10.1016/0378-2166(94)00038-G	17	15	15	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	OCT-DEC	2011	31	4					325	335		10.1097/TLD.0b013e3182358e98			11	Linguistics; Rehabilitation	Linguistics; Rehabilitation	846PG	WOS:000296915100005					2021-06-18	
J	McDevitt, JK; Tierney, RT; Mansell, JL; Driban, JB; Higgins, M; Toone, N; Mishra, A; Krynetskiy, E				McDevitt, Jane K.; Tierney, Ryan T.; Mansell, Jamie L.; Driban, Jeffrey B.; Higgins, Michael; Toone, Nieka; Mishra, Anarug; Krynetskiy, Evgeny			Neuronal structural protein polymorphism and concussion in college athletes	BRAIN INJURY			English	Article						Single nucleotide polymorphism; neurofilament heavy; MTBI	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E; UNITED-STATES; APOE PROMOTER; EPIDEMIOLOGY; ALLELE; MILD	Objective: To examine the association between a neuronal structural protein polymorphism and the frequency and severity of concussions in college athletes. Methods: Forty-eight athletes with previous self-reported history of a concussion were matched with 48 controls that did not report a history of concussion. Each group was genotyped for neurofilament heavy (NEFH) polymorphism rs# 165602 in this retrospective case-control study. Results: There was no significant association (chi(2) = 0.487, p = 0.485) between carrying the NEFH rare allele and a history of one or more concussions due to small effect sizes. A Fisher's exact test revealed no significant association (p = 1.00, phi = -0.03) between the presence of NEFH rare allele and a history of multiple concussions. The independent t-tests revealed no significant differences in duration of signs and symptoms (t = 1.41, p = 0.17, d = 0.48) or return to play (t = 0.23, p = 0.82, d = 0.08) between NEFH rare allele carrier and non-carriers. Conclusions: Among college athletes, carrying the rare allele assessed may not influence an athlete's susceptibility to sustaining a concussion or return to play duration following a concussion.	[McDevitt, Jane K.; Tierney, Ryan T.; Driban, Jeffrey B.; Toone, Nieka] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Mansell, Jamie L.] Lincoln Univ, Dept Hlth Phys Educ & Recreat, Chester Cty, PA USA; [Higgins, Michael] Towson Univ, Dept Kinesiol, Towson, MD USA; [Mishra, Anarug; Krynetskiy, Evgeny] Temple Sch Pharm, Philadelphia, PA USA	McDevitt, JK (corresponding author), 139 Pearson Hall,Broad St & Montgomery Ave, Philadelphia, PA 19122 USA.	jane.mcdevitt@temple.edu	Driban, Jeffrey/H-3486-2019	Driban, Jeffrey/0000-0001-6098-4273	Jayne Haines Center for Pharmacogenomics and Drug Safety of Temple University School of Pharmacy	This work was supported by the Jayne Haines Center for Pharmacogenomics and Drug Safety of Temple University School of Pharmacy.	Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Caselli RJ, 2004, NEUROLOGY, V62, P1990, DOI 10.1212/01.WNL.0000129533.26544.BF; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Fabrizi GM, 2007, BRAIN, V130, P394, DOI 10.1093/brain/awl284; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GELEHRTER T, 1998, PRINCIPLES MEDICAL G; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; GODSEL LM, 2007, CELL, V18, P28; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; HISANAGA S, 1988, J MOL BIOL, V202, P297, DOI 10.1016/0022-2836(88)90459-7; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LASEK RJ, 1988, STUDYING INTRINSIC D, P1; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Nawashiro H, 2000, J CEREBR BLOOD F MET, V20, P1040, DOI 10.1097/00004647-200007000-00003; ROTH S, 2007, GENETICS PRIMER EXER, P37; SALADIN K, 2007, ANATOMY PHYSL UNITY, P83; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sosin DM, 1996, BRAIN INJURY, V10, P47; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Thurman DJ, 2001, HEAD TRAUMA THERAPEU; Wagner OI, 2007, EXP CELL RES, V313, P2228, DOI 10.1016/j.yexcr.2007.04.025	30	15	15	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2011	25	11					1108	1113		10.3109/02699052.2011.607790			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	829WC	WOS:000295614900009	21902461				2021-06-18	
J	McDonald, S; Rushby, J; Li, S; de Sousa, A; Dimoska, A; James, C; Tate, R; Togher, L				McDonald, Skye; Rushby, Jacqueline; Li, Sophie; de Sousa, Arielle; Dimoska, Aneta; James, Charlotte; Tate, Robyn; Togher, Leanne			The influence of attention and arousal on emotion perception in adults with severe traumatic brain injury	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Traumatic brain injury; Emotion perception; Arousal; Attention	EVOKED CARDIAC RESPONSE; CLOSED-HEAD-INJURY; FACIAL EXPRESSIONS; ORIENTING REFLEX; GENDER-DIFFERENCES; SOCIAL-BEHAVIOR; SKIN-CONDUCTANCE; HABITUATION; RECOGNITION; ACTIVATION	Many people with traumatic brain injury (TIN) have poor emotion recognition, with negative emotions more frequently impaired. They can also display abnormal affective responses to emotionally charged material, however, the mechanisms underpinning such deficits are unclear. This study examined whether affective responsivity can be improved by focusing attention and whether responsivity is associated with perception accuracy. Eighteen adults with moderate-to-severe TBI and 18 control participants viewed facial expressions while skin conductance (SCR) and evoked cardiac deceleration (ECD) (used as indices of orientation) and skin conductance levels (SCL) (used as an index of phasic arousal) were monitored. They viewed two blocks of faces (8 angry and 8 happy per block), passively in the first block and with the instruction to identify the emotional expression in the second. No differences between conditions, emotions or groups were found using SCR. Both groups demonstrated increasing ECD for the attend condition relative to the passive condition. For the passive task the control group showed increasing SCL (sensitisation) over trials when viewing angry faces and decreasing SCL (habituation) to happy faces. No differences between emotions were shown for the TBI group who rapidly habituated to both expressions. For the attend task, there was no evidence of habituation for either expression for either the control or TBI participants. Physiological measures did not correlate to accuracy in recognising emotions. The results suggest that increasing attentional demands improves orientation and emotional engagement (arousal) to emotional faces following TBI. However, the relationship to this and emotion perception accuracy remains unclear. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.	[McDonald, Skye; Rushby, Jacqueline; Li, Sophie; de Sousa, Arielle; Dimoska, Aneta; James, Charlotte] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Tate, Robyn] Univ Sydney, Dept Med, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia	McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Rushby, Jacqueline/D-1820-2010; Togher, Leanne/AAC-7083-2019; McDonald, Skye/G-4118-2014	Rushby, Jacqueline/0000-0002-5018-638X; McDonald, Skye/0000-0003-0723-6094; Togher, Leanne/0000-0002-4518-6748	Australian National Medical and Health Research CouncilNational Health and Medical Research Council of Australia	This research was funded by a grant from the Australian National Medical and Health Research Council. We are grateful to the Ryde, Westmead and Liverpool Brain Injury Units in Sydney, Australia, for their assistance with recruitment. We are indebted to the people with traumatic brain injuries and their families, as well as our volunteers from the general community, who gave willingly of their time to make this research possible.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Andersson S, 1999, J PSYCHOPHYSIOL, V13, P109, DOI 10.1027//0269-8803.13.2.109; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; BARRY RJ, 1984, PHYSIOL PSYCHOL, V12, P35, DOI 10.3758/BF03332162; Barry RJ, 2005, CLIN NEUROPHYSIOL, V116, P2693, DOI 10.1016/j.clinph.2005.08.008; BARRY RJ, 1993, INT J PSYCHOPHYSIOL, V15, P39, DOI 10.1016/0167-8760(93)90093-5; Barry RJ, 2004, INTEGR PHYS BEH SCI, V39, P166, DOI 10.1007/BF02734437; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Codispoti M, 2006, BRAIN RES, V1068, P213, DOI 10.1016/j.brainres.2005.11.009; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; CONNOLLY JF, 1978, PHYSIOL BEHAV, V21, P511, DOI 10.1016/0031-9384(78)90121-X; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1017/S0048577200990759; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hoffman M. L., 1984, EMOTIONS COGNITION B, P103; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; IACONO WG, 1983, PSYCHOPHYSIOLOGY, V20, P71, DOI 10.1111/j.1469-8986.1983.tb00905.x; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; LACEY BC, 1978, AM PSYCHOL, V33, P99, DOI 10.1037/0003-066X.33.2.99; LACEY BC, 1980, PSYCHOPHYSIOLOGY, V17, P209, DOI 10.1111/j.1469-8986.1980.tb00137.x; Lacey J. I., 1967, PSYCHOL STRESS ISSUE, P14; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lang P.J., 1999, A4 U FLOR CTR RES PS; Lawrence CA, 2009, ACTA NEUROBIOL EXP, V69, P552; Lipps T, 1907, PSYCHOL UNTERSUCHUNG, V1; Luria A. R, 1973, WORKING BRAIN; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; MALMO RB, 1959, PSYCHOL REV, V66, P367, DOI 10.1037/h0047858; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; MERCKELBACH H, 1989, BEHAV RES THER, V27, P289, DOI 10.1016/0005-7967(89)90048-X; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Pavlov I. P., 1927, CONDITIONED REFLEXES; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/pms.1991.73.3f.1139; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Rushby JA, 2005, CLIN NEUROPHYSIOL, V116, P2363, DOI 10.1016/j.clinph.2005.06.008; Rushby JA, 2007, BIOL PSYCHOL, V75, P248, DOI 10.1016/j.biopsycho.2007.03.003; Rushby JA, 2009, INT J PSYCHOPHYSIOL, V74, P120, DOI 10.1016/j.ijpsycho.2009.08.003; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Sokolov E.N., 1963, PERCEPTION CONDITION; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; VaezMousavi SM, 2007, ACTA NEUROBIOL EXP, V67, P461; VaezMousavi SM, 2007, ACTA NEUROBIOL EXP, V67, P179; Vrana SR, 2004, BIOL PSYCHOL, V66, P63, DOI 10.1016/j.biopsycho.2003.07.004; Watson Sr R. I., 1978, GREAT PSYCHOL; WEBSTER WR, 1965, SCIENCE, V148, P654, DOI 10.1126/science.148.3670.654; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6	75	15	15	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2011	82	1			SI		124	131		10.1016/j.ijpsycho.2011.01.014			8	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	859PZ	WOS:000297889600014	21315778				2021-06-18	
J	Sozda, CN; Larson, MJ; Kaufman, DAS; Schmalfuss, IM; Perlstein, WM				Sozda, Christopher N.; Larson, Michael J.; Kaufman, David A. S.; Schmalfuss, Ilona M.; Perlstein, William M.			Error-related processing following severe traumatic brain injury: An event-related functional magnetic resonance imaging (fMRI) study	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Traumatic brain injury; TBI; Cognitive control; Performance monitoring; Anterior cingulate cortex; ACC	ANTERIOR CINGULATE CORTEX; WORKING-MEMORY LOAD; CLOSED-HEAD INJURY; COGNITIVE CONTROL; PREFRONTAL CORTEX; SEVERE TBI; POSTTRAUMATIC AMNESIA; CONFLICT DETECTION; NEURONAL-ACTIVITY; NEURAL ACTIVITY	Continuous monitoring of one's performance is invaluable for guiding behavior towards successful goal attainment by identifying deficits and strategically adjusting responses when performance is inadequate. In the present study, we exploited the advantages of event-related functional magnetic resonance imaging (fMRI) to examine brain activity associated with error-related processing after severe traumatic brain injury (sTBI). fMRI and behavioral data were acquired while 10 sTBI participants and 12 neurologically-healthy controls performed a task-switching cued-Stroop task. fMRI data were analyzed using a random-effects whole-brain voxel-wise general linear model and planned linear contrasts. Behaviorally, sTBI patients showed greater error-rate interference than neurologically-normal controls. fMRI data revealed that, compared to controls, sTBI patients showed greater magnitude error-related activation in the anterior cingulate cortex (ACC) and an increase in the overall spatial extent of error-related activation across cortical and subcortical regions. Implications for future research and potential limitations in conducting fMRI research in neurologically-impaired populations are discussed, as well as some potential benefits of employing multimodal imaging (e.g., fMRI and event-related potentials) of cognitive control processes in TBI. (C) 2011 Elsevier B.V. All rights reserved.	[Sozda, Christopher N.; Larson, Michael J.; Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA; [Schmalfuss, Ilona M.] Univ Florida, Dept Med, Gainesville, FL USA; [Perlstein, William M.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Perlstein, William M.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Kaufman, David A. S.] St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; [Schmalfuss, Ilona M.] N Florida S Georgia Vet Adm Hosp, Gainesville, FL USA	Perlstein, WM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, HSC Box 100165, Gainesville, FL 32610 USA.	wmp@phhp.ufl.edu	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01-MH01857, R21-MH073076]; Evelyn F. McKnight Brain Research Grant Program; Florida Brain and Spinal Cord Injury Research Trust; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH001857, R21MH073076] Funding Source: NIH RePORTER	This original research manuscript, or parts of it, have not been and will not be submitted elsewhere for publication. This work was supported by NIH grants K01-MH01857 and R21-MH073076, and by grants from the Evelyn F. McKnight Brain Research Grant Program, and the Florida Brain and Spinal Cord Injury Research Trust Fund awarded to WMP. The work was submitted by the first author in partial fulfillment of requirements for the Master of Science degree. We extend our appreciation to Ashley Carroll, Neha Dixit, Cortney Mauer, Megan McIntyre, Drew Nagle, Paul Seignourel, Floris Singletary, Allen Sirizi, and Raechel Steckley for their assistance in participant recruitment and data acquisition.	Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Donamayor N, 2012, HUM BRAIN MAPP, V33, P1621, DOI 10.1002/hbm.21305; Easdon C, 2004, BRAIN COGNITION, V54, P136; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hayes JP, 2009, PSYCHIAT RES-NEUROIM, V172, P7, DOI 10.1016/j.pscychresns.2008.05.005; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; Horn L.J., 1999, PHYSICAL MED REHABIL, P1281; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Larson K.J., INT J PSYCH IN PRESS; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Larson MJ, 2009, NEUROREPORT, V20, P1486, DOI 10.1097/WNR.0b013e32833283fe; Larson MJ, 2009, NEUROPSYCHOLOGY, V23, P433, DOI 10.1037/a0015723; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lovell Mark R., 1994, P133; Luck S.J., 2005, **DROPPED REF**; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Spielberger C.D., 1970, STATE TRAIT ANXIETY; Spreen O., 1991, COMPENDIUM NEUROPSYC; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Talairach J, 1988, COPLANAR STEROTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; van Veen V, 2006, CURR DIR PSYCHOL SCI, V15, P237, DOI 10.1111/j.1467-8721.2006.00443.x; Wechsler, 1981, WAIS R MANUAL; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X	67	15	15	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760			INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2011	82	1			SI		97	106		10.1016/j.ijpsycho.2011.06.019			10	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	859PZ	WOS:000297889600011	21756946	Green Accepted			2021-06-18	
J	Tsitsopoulos, PP; Tobieson, L; Enblad, P; Marklund, N				Tsitsopoulos, Parmenion P.; Tobieson, Lovisa; Enblad, Per; Marklund, Niklas			Surgical treatment of patients with unilateral cerebellar infarcts: clinical outcome and prognostic factors	ACTA NEUROCHIRURGICA			English	Article						Cerebellar infarct; External ventricular drainage; Surgical decompression; Modified Rankin Scale; Outcome; Age	ENDOSCOPIC 3RD VENTRICULOSTOMY; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; OCCLUSIVE HYDROCEPHALUS; OBSTRUCTIVE HYDROCEPHALUS; POSTERIOR-FOSSA; MANAGEMENT; HEMORRHAGE; CRANIECTOMY; EXPERIENCE	There are limited data on the long-term outcome and on factors influencing the prognosis in patients with cerebellar infarcts treated with surgical decompression. Thirty-two patients (age 64.3 +/- 9.9 years) with expansive unilateral cerebellar infarcts were retrospectively evaluated. All patients were treated with ventriculostomy, suboccipital decompressive craniectomy and removal of the necrotic tissue. The Glasgow Coma Scale (GCS) and the Reaction Level Scale (RLS) scores evaluated the level of consciousness during hospitalization, while the modified Rankin Scale (mRS) was used for the 6-month and long-term outcome. Predicting factors were analyzed using a univariate logistic regression model. The median time from ictus to surgery was 48.4 h (range 8-120 h). Before surgery, the median GCS score was 9 (3-13). At discharge, the GCS score improved to 13.6 (7-15) (p < 0.05 compared to preoperative scores). At the long-term follow-up (median 67.5 months), ten patients were dead, and 77% of survivors had a good outcome (mRS score of a parts per thousand currency sign2). The number of days on a ventilator and the GCS score prior to surgery and at discharge were strong predictors of clinical outcome (p < 0.05), although one third of patients with a GCS a parts per thousand currency signaEuro parts per thousand 8 at the time of surgery had a good long-term outcome. In patients a parts per thousand yen70 years old, 50% had a good long-term outcome, and advanced age was not associated with a bad result (p > 0.05). Our results imply that surgical evacuation of significant cerebellar infarctions may be considered also in patients with advanced age and/or a decreased level of consciousness.	[Marklund, Niklas] Univ Uppsala Hosp, Dept Neurosurg, SE-75185 Uppsala, Sweden; [Tsitsopoulos, Parmenion P.; Tobieson, Lovisa; Enblad, Per; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg Sect, Uppsala, Sweden	Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, SE-75185 Uppsala, Sweden.	niklas.marklund@neurokir.uu.se		Marklund, Niklas/0000-0002-9797-5626	Uppsala University; Swedish Brain Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission	The authors wish to acknowledge the NCC staff of Uppsala University Hospital and Marten Melbius, Department of Neuroradiology at Uppsala University Hospital, for their valuable assistance in gathering the data, and Associate Professor Anders Wanhainen for statistical discussion. The study was financially supported by Uppsala University, the Swedish Brain Foundation and the Swedish Research Council.	AUER LM, 1986, ACTA NEUROCHIR, V79, P74, DOI 10.1007/BF01407448; Baldauf J, 2006, NEUROSURGERY, V59, P539, DOI 10.1227/01.NEU.0000228681.45125.E9; BERTALANFFY H, 1992, CLIN NEUROL NEUROSUR, V94, P19, DOI 10.1016/0303-8467(92)90113-H; CHEN HJ, 1992, STROKE, V23, P957, DOI 10.1161/01.STR.23.7.957; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; FAIRBURN B, 1956, BMJ-BRIT MED J, V1, P1335, DOI 10.1136/bmj.1.4979.1335; FEELY MP, 1979, NEUROSURGERY, V4, P7, DOI 10.1227/00006123-197901000-00003; Gurol ME, 2008, CURR TREAT OPTION NE, V10, P138, DOI 10.1007/s11940-008-0015-z; HEROS RC, 1982, STROKE, V13, P106, DOI 10.1161/01.STR.13.1.106; HEROS RC, 1992, STROKE, V23, P937, DOI 10.1161/01.STR.23.7.937; HORNIG CR, 1994, STROKE, V25, P372, DOI 10.1161/01.STR.25.2.372; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jauss M, 1999, J NEUROL, V246, P257, DOI 10.1007/s004150050344; Juttler E, 2009, STROKE, V40, P3060, DOI 10.1161/STROKEAHA.109.550913; KASE CS, 1993, STROKE, V24, P76, DOI 10.1161/01.STR.24.1.76; Khaja AM, 2007, LANCET, V369, P319, DOI 10.1016/S0140-6736(07)60154-8; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; KRIEGER D, 1993, ELECTROEN CLIN NEURO, V88, P261, DOI 10.1016/0168-5597(93)90050-Y; Kudo Hiroshi, 2007, J Stroke Cerebrovasc Dis, V16, P259, DOI 10.1016/j.jstrokecerebrovasdis.2007.09.001; LAUN A, 1984, ACTA NEUROCHIR, V71, P295, DOI 10.1007/BF01401324; LINDGREN SO, 1956, J NEUROSURG, V13, P575, DOI 10.3171/jns.1956.13.6.0575; Mohsenipour I, 1999, ZBL NEUROCHIR, V60, P68; Pfefferkorn T, 2009, STROKE, V40, P3045, DOI 10.1161/STROKEAHA.109.550871; Raco A, 2003, NEUROSURGERY, V53, P1061, DOI 10.1227/01.NEU.0000088766.34559.3E; RIEKE K, 1993, CEREBROVASC DIS, V3, P45, DOI 10.1159/000108670; SHENKIN HA, 1982, LANCET, V2, P429; TANEDA M, 1982, J NEUROSURG, V57, P83, DOI 10.3171/jns.1982.57.1.0083; Tatu L, 1996, NEUROLOGY, V47, P1125, DOI 10.1212/WNL.47.5.1125; TEASDALE G, 1974, LANCET, V2, P81; Tsitsopoulos PP, 2011, ACTA NEUROL SCAND, V123, P345, DOI 10.1111/j.1600-0404.2010.01404.x; Weimar C, 2002, J NEUROL, V249, P888, DOI 10.1007/s00415-002-0755-8; WEISBERG LA, 1986, NEUROLOGY, V36, P858, DOI 10.1212/WNL.36.6.858; Weisscher N, 2008, J NEUROL, V255, P867, DOI 10.1007/s00415-008-0796-8; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; WOOD MW, 1969, J NEUROSURG, V30, P260, DOI 10.3171/jns.1969.30.3part1.0260; Yoshimura K, 2007, MINIM INVAS NEUROSUR, V50, P270, DOI 10.1055/s-2007-990293	37	15	18	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	OCT	2011	153	10					2075	2083		10.1007/s00701-011-1120-4			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	818WU	WOS:000294787400024	21833781				2021-06-18	
J	Zurek, J; Fedora, M				Zurek, Jiri; Fedora, Michal			Dynamics of Glial Fibrillary Acidic Protein During Traumatic Brain Injury in Children	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Glial fibrillary acidic protein; brain injury; outcome; children	PRACTICAL SCALE; DAMAGE; BIOMARKERS; DIAGNOSIS; SERUM; GFAP	Backgrounds: Glial fibrillary acidic protein (GFAP) is a monomeric intermediate filament protein found in the astroglial cytoskeleton and is not found outside the central nervous system. It is a brain-specific protein that is released after traumatic brain injury (TBI). Methods: This prospective study enrolled 59 children who had TBI, as verified by computed tomography. Daily GFAP measurement began at admission (< 12 hours after trauma) and continued for 6 days. Blood samples were analyzed for GFAP by enzyme-linked immunosorbent assay. Outcome was assessed using the Glasgow Outcome Scale (GOS) at 6 months after injury. Results: The median serum levels of GFAP at admission were 7.47 ng/mL in patients who died, compared with 0.12 ng/mL in patients who survived (p = 0.002). GFAP levels were significantly higher in patients who had a poor outcome 6 months after injury than in those who were alive or had good outcome (p < 0.001). The area under the receiver operating characteristic curve for GFAP was 0.833 for day 0 and 0.884 for day 2. Conclusions: These results suggest that determination of serum levels of GFAP may add to the clinical assessment of the primary damage and prediction of outcome after severe TBI.	[Zurek, Jiri; Fedora, Michal] Univ Childrens Hosp, Dept Anesthesia & Intens Care, Brno 62500, Czech Republic	Zurek, J (corresponding author), Univ Childrens Hosp, Dept Anesthesia & Intens Care, Cernopolni 9, Brno 62500, Czech Republic.	jzurek@fnbrno.cz		Zurek, Jiri/0000-0002-6409-2560			Brenner M, 2001, NAT GENET, V27, P117; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; GALEA E, 1995, J NEUROSCI RES, V41, P452, DOI 10.1002/jnr.490410404; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; JENNETT B, 1975, LANCET, V1, P480; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; KRAUS JF, 1996, NEUROTRAUMA, P13; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4	17	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2011	71	4					854	859		10.1097/TA.0b013e3182140c8c			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	833ZT	WOS:000295925700020	21986734				2021-06-18	
J	Denes, Z; Barsi, P; Szel, I; Boros, E; Fazekas, G				Denes, Zoltan; Barsi, Peter; Szel, Istvan; Boros, Erzsebet; Fazekas, Gabor			Complication during postacute rehabilitation: patients with posttraumatic hydrocephalus	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						hydrocephalus; rehabilitation; traumatic brain injury		The objective of this study was to determine the incidence of posttraumatic hydrocephalus (PTH) among patients in our rehabilitation unit for traumatic brain injury. Furthermore, we aimed to assess the effect of shunt implantation and to identify the postoperative complication rate. This is a retrospective cohort study, in which between 2000 and 2009, data were collected from inpatients with traumatic brain injury complicated by PTH. During this period, 55 patients in our unit presented with PTH; all of these patients underwent ventricular shunt implantation. The incidence of PTH treated with shunt implantation was 4.8%. The mean age of the patients was 32 years (range 14-75 years). In 22 cases, the hydrocephalus was diagnosed in our rehabilitation unit (40%). Other patients were diagnosed and shunted before being transferred to our department. The median time of shunting was 80 days (range 20-270 days) after brain trauma. On the basis of scores of the functional independence measure, improvement could be observed in 43 cases (78%), the mean score improvement was 40 (2-81). Postoperative complications were seen in 10 patients (18%): four due to infections and six due to shunt failure. Revision was necessary in all 10 cases. Almost half of the diagnoses of PTH were established in the postacute rehabilitation unit, and all complications after shunt implantation were also recognized there. Precise clinical observation is necessary for diagnosis of PTH. Early diagnosis and treatment are important to prevent secondary complications. Teamwork and good cooperation between acute and postacute care are necessary for successful rehabilitation of patients with traumatic brain injury.	[Denes, Zoltan; Szel, Istvan; Boros, Erzsebet; Fazekas, Gabor] Natl Inst Med Rehabil, H-1121 Budapest, Hungary; [Barsi, Peter] Semmelweis Univ, Janos Szentagothai Ctr, MRI Res Unit, H-1085 Budapest, Hungary	Denes, Z (corresponding author), Natl Inst Med Rehabil, Szanatorium Str 19th, H-1121 Budapest, Hungary.	z.denes@rehabint.hu					ADAMS RD, 2005, PRINCIPLES NEUROLOGY, P529; Dandy WE, 1914, AM J DIS CHILD, V8, P406; Groswasser Z, 1988, Brain Inj, V2, P267, DOI 10.3109/02699058809150897; Guyot LL, 2000, NEUROL RES, V22, P25; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; KATZ RT, 1989, AM J PHYS MED REHAB, V68, P91, DOI 10.1097/00002060-198904000-00009; Kim Seok Won, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P211; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MORI K, 1995, BRAIN DEV-JPN, V17, P338, DOI 10.1016/0387-7604(95)00070-R; Paoletti P, 1983, J Neurosurg Sci, V27, P171; STREGE JR, 2004, GERMAN MED SCI; Tribl G, 2000, BRAIN INJURY, V14, P345	12	15	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	2011	34	3					222	226		10.1097/MRR.0b013e328346e87d			5	Rehabilitation	Rehabilitation	805MS	WOS:000293731700006	21555949				2021-06-18	
J	Dinocourt, C; Aungst, S; Yang, K; Thompson, SM				Dinocourt, Celine; Aungst, Stephanie; Yang, Kun; Thompson, Scott M.			Homeostatic increase in excitability in area CA1 after Schaffer collateral transection in vivo	EPILEPSIA			English	Article						Traumatic brain injury; Axonal injury; Hippocampus; Lesion; Plasticity	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; PARVALBUMIN-IMMUNOREACTIVE NEURONS; SPONTANEOUS RECURRENT SEIZURES; GABA-MEDIATED INHIBITION; POSTTRAUMATIC EPILEPSY; RAT HIPPOCAMPUS; PILOCARPINE MODEL; PYRAMIDAL NEURONS; DENTATE GYRUS	Purpose: Epilepsy is a significant long-term consequence of traumatic brain injury (TBI) and is likely to result from multiple mechanisms. One feature that is common to many forms of TBI is denervation. We asked whether chronic partial denervation in vivo would lead to a homeostatic increase in the excitability of a denervated cell population. Methods: To answer this question, we took advantage of the unique anatomy of the hippocampus where the input to the CA1 neurons, the Schaffer collaterals, could be transected in vivo with preservation of their outputs and only minor cell death. Key Findings: We observed a delayed increase in neuronal excitability, as apparent in extracellular recordings from hippocampal brain slices prepared 14 days (but not 3 days) post lesion. Although population spikes in slices from control and lesioned animals were comparable under resting conditions, application of solutions that were mildly proconvulsive (high K(+), low Mg(2+), low concentrations of bicuculline) produced increases in the number of population spikes in slices from lesioned rats, but not in slices from unlesioned sham controls. Denervation did not produce changes in several markers of c-aminobutyric acid (GABA)ergic synaptic inhibition, including the number of GABAergic neurons, alpha 1 GABA(A) receptor subunits, the vesicular GABA transporter, or miniature inhibitory postsynaptic currents. Significance: We conclude that chronic partial denervation does lead to a delayed homeostatic increase in neuronal excitability, and may, therefore, contribute to the long-term neurologic consequences of TBI.	[Dinocourt, Celine; Aungst, Stephanie; Yang, Kun; Thompson, Scott M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Aungst, Stephanie; Thompson, Scott M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Thompson, Scott M/K-8921-2015		Epilepsy Foundation of America; CURE Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS40388]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040338] Funding Source: NIH RePORTER	Supported with a postdoctoral fellowship to CD from the Epilepsy Foundation of America, and funds from the CURE Foundation (SMT), and the National Institutes of Health (SMT, NS40388). We thank Sandra Naumann for technical assistance.	Abdulla FA, 2001, J NEUROPHYSIOL, V85, P630; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060.abs; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BEST N, 1993, NEUROSCI LETT, V155, P1, DOI 10.1016/0304-3940(93)90660-D; BEST N, 1994, ACTA NEUROPATHOL, V87, P187; Bouilleret V, 2000, HIPPOCAMPUS, V10, P305; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cai X, 2007, J NEUROSCI, V27, P59, DOI 10.1523/JNEUROSCI.4502-06.2007; Cannon WB., 1949, SUPERSENSITIVITY DEN; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Desai NS, 1999, NAT NEUROSCI, V2, P515; Dinocourt C, 2003, J COMP NEUROL, V459, P407, DOI 10.1002/cne.10622; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; GRAFSTEIN B, 1957, ELECTROEN CLIN NEURO, V9, P723, DOI 10.1016/0013-4694(57)90096-2; Hagemann G, 2000, J NEUROPHYSIOL, V84, P600; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; Jacobs KM, 1996, CEREB CORTEX, V6, P514, DOI 10.1093/cercor/6.3.514; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LU WX, 1992, BRAIN RES, V578, P155, DOI 10.1016/0006-8993(92)90243-3; Luhmann H J, 1996, Epilepsy Res Suppl, V12, P119; MAJKOWSKI J, 1990, COMPREHENSIVE EPILEP, P281; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCBAIN CJ, 1994, J NEUROPHYSIOL, V72, P2853; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Morin F, 1998, EPILEPSY RES, V32, P363, DOI 10.1016/S0920-1211(98)00033-3; Mun-Bryce S, 2004, BRAIN RES, V1026, P218, DOI 10.1016/j.brainres.2004.08.023; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; RUTECKI PA, 1985, J NEUROPHYSIOL, V54, P1363; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; THOMSON AM, 1986, NEUROSCIENCE, V19, P1161, DOI 10.1016/0306-4522(86)90130-2; Toth Z, 1997, J NEUROSCI, V17, P8106; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Waldbaum S, 2009, EPILEPSIA, V50, P904, DOI 10.1111/j.1528-1167.2008.01939.x; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828	54	15	15	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0013-9580			EPILEPSIA	Epilepsia	SEP	2011	52	9					1656	1665		10.1111/j.1528-1167.2011.03113.x			10	Clinical Neurology	Neurosciences & Neurology	821KK	WOS:000294973700019	21635239	Green Accepted			2021-06-18	
J	Huang, YH; Lee, TC; Chen, WF; Wang, YM				Huang, Yu-Hua; Lee, Tao-Chen; Chen, Wu-Fu; Wang, Yi-Ming			Safety of the Nonabsorbable Dural Substitute in Decompressive Craniectomy for Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Dural substitute; Neuro-Patch; Complications; Decompressive craniectomy	ADHESION PREVENTIVE MATERIAL; SITE INFECTIONS; COMPLICATIONS; CRANIOTOMY; CLOSURE	Background: Artificial dural substitutes are increasingly being used in decompressive craniectomy to prevent peridural fibrosis and facilitate cranioplasty for patients with head injury. The safety of the dural substitute should be systemically evaluated. We focus on Neuro-Patch (B. Braun, Boulogne, France), a nonabsorbable substitute and commonly used by neurosurgeons. Methods: In this retrospective study, 132 patients undergoing 135 craniectomies and cranioplasties for traumatic brain injury were enrolled. We subdivided the operations into two groups on the basis of whether Neuro-Patch was used (N = 50) or not (N = 85). Risk factors of neurosurgical site infection were assessed first. Then, we compared the occurrence of infective, hemorrhagic, and hydrodynamic morbidities after craniectomy and cranioplasty between the two groups. Results: The incidence of neurosurgical site infection after craniectomy or cranioplasty showed no intergroup difference (p = 1.000). Postoperatively, extra-axial hematoma, which consists of subdural or epidural hematoma, occurred in 9 of 50 craniectomies (18.00%) with Neuro-Patch and 3 of 85 craniectomies (3.53%) without Neuro-patch, which was significantly different (p = 0.009). The rates of hydrodynamic morbidities (subdural hygroma or cerebrospinal fluid leakage) after the procedures were similar between the two groups. Conclusions: The use of Neuro-Patch does not increase the incidence of neurosurgical site infection and hydrodynamic complications, including subdural hygroma and cerebrospinal fluid leakage, after decompressive craniectomy or cranioplasty for severe traumatic brain injury. However, extra-axial hematoma at the site of craniectomy is more often encountered in patients with Neuro-Patch and forms a compressive lesion on the adjacent brain.	[Huang, Yu-Hua; Lee, Tao-Chen; Chen, Wu-Fu; Wang, Yi-Ming] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Chang Gung Mem Hosp,Dept Neurosurg, Kaohsiung, Taiwan	Huang, YH (corresponding author), Chang Gung Mem Hosp, Dept Neurosurg, 123 Ta Pei Rd, Niao Sung Hsiang 800, Kaohsiung Hsien, Taiwan.	newlupin2001@yahoo.com.tw					Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; CARVI Y, 2006, NEUROL RES, V28, P139, DOI DOI 10.1179/016164106X98008; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; Gouda JJ, 1997, NEUROSURGERY, V41, P943, DOI 10.1097/00006123-199710000-00033; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; JACCARD E, 1983, NEUROCHIRURGIE, V29, P333; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Kawaguchi T, 2003, NEUROL MED-CHIR, V43, P320, DOI 10.2176/nmc.43.320; Korinek AM, 1997, NEUROSURGERY, V41, P1073, DOI 10.1097/00006123-199711000-00010; Lee CH, 2007, CLIN NEUROL NEUROSUR, V109, P667, DOI 10.1016/j.clineuro.2007.05.015; Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A; Robertson SC, 1997, NEUROSURGERY, V40, P201, DOI 10.1097/00006123-199701000-00046; TANAKA Y, 1987, SURG NEUROL, V27, P353, DOI 10.1016/0090-3019(87)90010-3; THOMPSON D, 1994, J NEUROL NEUROSUR PS, V57, P646, DOI 10.1136/jnnp.57.5.646; Vakis A, 2006, CLIN NEUROL NEUROSUR, V108, P798, DOI 10.1016/j.clineuro.2005.11.026; Verheggen R, 1997, ACTA NEUROCHIR, V139, P1074, DOI 10.1007/BF01411563; von Wild KRH, 1999, SURG NEUROL, V52, P418, DOI 10.1016/S0090-3019(99)00125-1; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	21	15	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2011	71	3					533	537		10.1097/TA.0b013e318203208a			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	818MX	WOS:000294756900007	21768912				2021-06-18	
J	Jin, W; Wu, J; Wang, HD; Kong, J; Ni, HB; Liang, WB				Jin, Wei; Wu, Jun; Wang, Handong; Kong, Jie; Ni, Hongbin; Liang, Weibang			Erythropoietin Administration Modulates Pulmonary Nrf2 Signaling Pathway After Traumatic Brain Injury in Mice	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Erythropoietin; Traumatic brain injury; Nuclear factor erythroid 2-related factor 2; Acute lung injury	ACUTE LUNG INJURY; HEME OXYGENASE-1 EXPRESSION; CLOSED-HEAD INJURY; RAT MODEL; NEURONAL APOPTOSIS; OXIDATIVE STRESS; INFLAMMATION; MECHANISM; PERMEABILITY; ISCHEMIA	Background: In our previous studies, antioxidant transcription factor, nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway has been shown to play an important role in protecting traumatic brain injury (TBI)-induced acute lung injury (ALI). This study was designed to explore whether recombinant human erythropoietin (rhEPO) administration modulates pulmonary Nrf2 signaling pathway in a murine TBI model. Methods: Closed head injury was made by Hall's weight-dropping method. The rhEPO was administered at a dose of 5,000 IU/kg 30 minutes after TBI. Pulmonary capillary permeability, wet or dry weight ratio, apoptosis, Nrf2 and its downstream cytoprotective enzymes including NAD(P) H: quinone oxidoreductase 1, and glutathione S-transferase were investigated at 24 hours after TBI. Results: We found that treatment with rhEPO markedly ameliorated TBI-induced ALI, as characterized by decreased pulmonary capillary permeability, wet or dry weight ratio, and alveolar cells apoptosis. Administration of rhEPO also significantly upregulated the mRNA expressions and activities of Nrf2 signaling pathway-related agents, including Nrf2, NAD(P) H: quinone oxidoreductase 1, and glutathione S-transferase. Conclusions: The results of this study suggest that post-TBI rhEPO administration may induce Nrf2-mediated cytoprotective response in the lung, and this may be a mechanism whereby rhEPO reduces TBI-induced ALI.	[Jin, Wei; Wu, Jun; Kong, Jie; Ni, Hongbin; Liang, Weibang] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Handong] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China	Liang, WB (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	njneurosurgery@yahoo.com.cn			Drum Tower Hospital	Supported by grants from Drum Tower Hospital.	Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; DETTBARN CL, 1989, HEART LUNG, V18, P583; Genc K, 2010, CELL BIOCHEM FUNCT, V28, P197, DOI 10.1002/cbf.1639; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jin W, 2009, EXP BIOL MED, V234, P181, DOI 10.3181/0807-RM-232; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Katavetin P, 2007, BIOCHEM BIOPH RES CO, V359, P928, DOI 10.1016/j.bbrc.2007.05.207; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kumral A, 2005, BIOL NEONATE, V87, P15, DOI 10.1159/000080490; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lv R, 2005, ANN CLIN LAB SCI, V35, P174; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Mikrogianakis A, 2007, J NEUROTRAUM, V24, P338, DOI 10.1089/neu.2006.003615; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Tascilar O, 2007, WORLD J GASTROENTERO, V13, P6172, DOI 10.3748/wjg.13.6172; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Ware LB, 2005, EUR RESPIR J, V26, P101, DOI 10.1183/09031936.05.00106604; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu HW, 2006, EUR J CARDIO-THORAC, V29, P902, DOI 10.1016/j.ejcts.2006.02.036; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yoshimi M, 2008, RESPIROLOGY, V13, P639, DOI 10.1111/j.1440-1843.2008.01324.x; Zhu L, 2009, J TRAUMA, V66, P730, DOI 10.1097/TA.0b013e318184b4db	33	15	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2011	71	3					680	686		10.1097/TA.0b013e3181f6b984			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	818MX	WOS:000294756900034	21394044				2021-06-18	
J	Krpan, KM; Stuss, DT; Anderson, ND				Krpan, Katherine M.; Stuss, Donald T.; Anderson, Nicole D.			Coping behaviour following traumatic brain injury: What makes a planner plan and an avoider avoid?	BRAIN INJURY			English	Article						Traumatic brain injury; coping; stress; neuropsychology; behaviour; autonomic response	PERFORMANCE; DYSFUNCTION; PREDICTORS; STRATEGIES; HEALTH; DAMAGE; LIFE	Primary objective: Avoidant coping has consistently been related to negative outcomes following traumatic brain injury (TBI), although the mechanisms of this relationship are not clear. A recent study demonstrated that people with moderate-to-severe TBI engaged in more avoidant than planful coping behaviour during a psychosocial stress test, while their matched healthy counterparts engaged in the opposite pattern. The purpose of the current study was to evaluate the neuropsychological, physiological and psychological differences between planners and avoiders with TBI. Methods and procedures: Eighteen people with moderate-to-severe TBI completed the Baycrest Psychosocial Stress Test (BPST) where coping behaviour was evaluated and physiological measures recorded. Participants also completed a series of questionnaires and a neuropsychological test battery. Main outcomes and results: Compared to avoiders, planners had better executive function, were more psychologically and physiologically reactive and performed better on the BPST. Dysfunction on tests assessing executive abilities was the best predictor of avoidant coping, while physiological and psychological reactivity were the best predictors of planful coping. Conclusions: This study is the first to document differences between planners and avoiders with TBI. Understanding the determinants of coping following TBI will allow for more sophisticated and targeted rehabilitative intervention.	[Stuss, Donald T.; Anderson, Nicole D.] Baycrest, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Krpan, Katherine M.; Stuss, Donald T.; Anderson, Nicole D.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Krpan, Katherine M.; Anderson, Nicole D.] Baycrest, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; [Stuss, Donald T.] Univ Toronto, Fac Med Neurol Rehabil Sci, Toronto, ON M5S 1A1, Canada; [Anderson, Nicole D.] Univ Toronto, Fac Med Psychiat, Toronto, ON M5S 1A1, Canada	Anderson, ND (corresponding author), Baycrest, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	nanderson@klaru-baycrest.on.ca	Anderson, Nicole D/E-9101-2011	Anderson, Nicole D/0000-0002-5979-2220	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CIHRCanadian Institutes of Health Research (CIHR); Ontario Research Coalition; Toronto Rehabilitation InstituteUniversity of Toronto; Max and Ruth Wiseman Award; Mary Gertrude l'Anson Scholarship	The authors report no conflicts of interest. This work was supported by an NSERC grant to N. D. Anderson. K. M. Krpan was a doctoral student in the Department of Psychology at the University of Toronto during the project and was funded by CIHR Doctoral Fellowship, Ontario Research Coalition, Toronto Rehabilitation Institute, Max and Ruth Wiseman Award and the Mary Gertrude l'Anson Scholarship.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Army Individual Test Battery, 1944, MAN DIR SCOR; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck A. T., 1996, BECK DEPRESSION INVE; BENDIG AW, 1956, EDUC PSYCHOL MEAS, V16, P516, DOI 10.1177/001316445601600410; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; COHEN RA, 1985, NEUROPSYCHOLOGIA, V23, P243, DOI 10.1016/0028-3932(85)90108-3; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; CRAIK FIM, 1990, ADV NEUROL, V51, P210; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Dawson M. E., 1990, PRINCIPLES PSYCHOPHY, P295; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Finset A, 2000, BRAIN INJURY, V14, P887; Folkman S., 1988, WAYS COPING QUESTION; FREEDMAN M, 1990, BRAIN COGNITION, V14, P134, DOI 10.1016/0278-2626(90)90025-J; Frydenberg E., 1996, COPING SCALE ADULTS; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; KENDALL E, 2001, BRAIN IMPAIR, V2, P81; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; SOSNOWSKI T, 1991, PSYCHOPHYSIOLOGY, V28, P665, DOI 10.1111/j.1469-8986.1991.tb01011.x; Spielberger CD, 1983, STATE TRAIT ANXIETY; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2008, COGNITIVE NEUROREHAB, P39; STUSS DT, 1991, AWARENESS DEFICIT BR; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; ZACHARY RA, 1982, SHIPLEY I LIVING SCA	58	15	15	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2011	25	10					989	996		10.3109/02699052.2011.597045			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800009	21749191				2021-06-18	
J	Kung, WM; Tsai, SH; Chiu, WT; Hung, KS; Wang, SP; Lin, JW; Lin, MS				Kung, Woon-Man; Tsai, Shin-Han; Chiu, Wen-Ta; Hung, Kuo-Sheng; Wang, Shin-Ping; Lin, Jia-Wei; Lin, Muh-Shi			Correlation between Glasgow coma score components and survival in patients with traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury (TBI); Glasgow coma scale (GCS); Eye; Motor; Verbal combinations; Survival prediction	SCALE SCORE; HEAD-INJURY; SEVERITY; OUTCOMES	Background: The Glasgow coma scale (GCS) score is used in the initial evaluation of patients with traumatic brain injury (TBI); however, the determination of an accurate score is not possible in all clinical situations. Our aim is to determine if the individual components of the GCS score, or combinations of them, are useful in predicting mortality in patients with TBI. Methods: The components of the GCS score and the receiver-operating characteristic (ROC) curves were analyzed from 27,625 cases of TBI in Taiwan. Results: The relationship between the survival rate and certain eye (E), motor (M) and verbal (V) score combinations for GCS scores of 6, 11, 12 and 13 were statistically significant. The areas under ROC curve of E + V, M + V and M alone were 0.904, 0.903 and 0.900, respectively, representing the 3 most precise combinations for predicting mortality. The area under the ROC curve for the complete GCS score (E + M + V) was 0.885. Patients with lower E, M and V score respectively, and lower complete GCS scores had higher hazard of death than those with the highest scores. Conclusion: The results of this study indicate that the 3 fundamental elements comprising the Glasgow coma scale, E, M, and V individually, and in certain combinations are predictive of the survival of TBI patients. This observation is clinically useful when evaluating TBI patients in whom a complete GCS score cannot be obtained. (C) 2010 Elsevier Ltd. All rights reserved.	[Kung, Woon-Man; Tsai, Shin-Han; Chiu, Wen-Ta; Hung, Kuo-Sheng; Lin, Jia-Wei; Lin, Muh-Shi] Taipei Med Univ, Dept Neurosurg, Wan Fang Hosp, Taipei, Taiwan; [Lin, Muh-Shi] Taipei Cty Hosp, Dept Neurosurg, Taipei, Taiwan; [Tsai, Shin-Han; Chiu, Wen-Ta; Hung, Kuo-Sheng; Wang, Shin-Ping] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chiu, Wen-Ta; Lin, Jia-Wei; Lin, Muh-Shi] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Kung, Woon-Man] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan; [Kung, Woon-Man] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Lin, Muh-Shi] Taipei City Hosp, Dept Neurosurg, Xiao Branch, Taipei, Taiwan; [Lin, Muh-Shi] Taipei Med, Dept Surg, Sch Med, Taipei, Taiwan; [Kung, Woon-Man] Chang Bing Show Chwan Mem Hosp, Dept Neurosurg, Changhua, Taiwan	Lin, MS (corresponding author), Taipei Med Univ, Dept Neurosurg, Wan Fang Hosp, 111,Sect 3,Hsing Long Rd, Taipei, Taiwan.	neurosurgery2005@yahoo.com.tw	LLM, 林牧熹 醫學博士 法學碩士 Muh-Shi Lin MD PhD/U-7004-2019; Kung, Woon-Man/Q-3012-2019	LLM, 林牧熹 醫學博士 法學碩士 Muh-Shi Lin MD PhD/0000-0002-9798-8160; Kung, Woon-Man/0000-0001-8311-2902	National Health Research Institute, TaiwanNational Health Research Institutes - Taiwan [NHRI-EX99-9707PI]; Department of Health, Executive Yuan, Taiwan [DOH99-TD-B-111-003]	The author(s) disclosed receipt of the following financial support for the research and/or authorship of this article: National Health Research Institute, Taiwan (Grant No. NHRI-EX99-9707PI); Department of Health, Executive Yuan, Taiwan (Grant No. DOH99-TD-B-111-003).	Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; MCNETT M, 2007, J NEUROSCI NURS, V39, P668; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Nijboer JMM, 2010, INJURY, V41, P52, DOI 10.1016/j.injury.2009.05.030; PARKINSON D, 1985, CAN J SURG, V28, P79; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109	16	15	18	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	SEP	2011	42	9					940	944		10.1016/j.injury.2010.09.019			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	811IP	WOS:000294202400018	21067749				2021-06-18	
J	Moran, LM; Taylor, HG; Rusin, J; Bangert, B; Dietrich, A; Nuss, KE; Wright, M; Yeates, KO				Moran, Lisa M.; Taylor, H. Gerry; Rusin, Jerome; Bangert, Barbara; Dietrich, Ann; Nuss, Kathryn E.; Wright, Martha; Yeates, Keith Owen			Do Postconcussive Symptoms Discriminate Injury Severity in Pediatric Mild Traumatic Brain Injury?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; child; postconcussion symptoms	POST-CONCUSSIVE SYMPTOMS; CLOSED-HEAD INJURIES; NEUROBEHAVIORAL SYMPTOMS; UNITED-STATES; CHILDREN; MANAGEMENT; STABILITY	Objectives: To assess whether postconcussive symptoms (PCS) can be used to discriminate injury severity among children with mild traumatic brain injury (TBI). Participants: One hundred eighty-six children with mild TBI, divided into high and low injury severity depending on whether the injury was associated with a loss of consciousness (LOC), and a comparison group of 99 children with orthopedic injuries (OI), all aged 8 to 15 years at the time of injury. Main Measures: Parent-rated frequency and severity of PCS at initial assessment within 2 weeks postinjury and again at 3 and 12 months postinjury. Results: Ratings of PCS obtained at the initial and 3-month assessments differentiated children with mild TBI from OI, although only ratings at the initial assessment discriminated among all 3 groups. Somatic PCS accounted for most of the discriminatory power. Conclusions: Overall, the accuracy of group classification was relatively modest, with a large proportion of misclassifications of children in the mild-TBI groups. Although children with mild TBI have more PCS than children with OI, PCS do not permit sufficiently accurate discrimination of mild TBI and injury severity to warrant diagnostic decisions at this time.	[Moran, Lisa M.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Dietrich, Ann; Nuss, Kathryn E.; Yeates, Keith Owen] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Rusin, Jerome] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH USA; [Dietrich, Ann; Nuss, Kathryn E.] Nationwide Childrens Hosp, Dept Emergency Med, Columbus, OH USA; [Moran, Lisa M.; Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Taylor, H. Gerry; Wright, Martha] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Wright, Martha] Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Radiol, Cleveland, OH USA; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Neurosurg, Cleveland, OH USA	Yeates, KO (corresponding author), Nationwide Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH USA.	keith.yeates@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Nuss, Kathryn/0000-0003-2185-7364; Yeates, Keith/0000-0001-7680-2892	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD44099, HD39834]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD039834, K02HD044099] Funding Source: NIH RePORTER	This work was supported by grants HD44099 and HD39834 from the National Institutes of Health to the senior author (K.O.Y.).	Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Kelly JP, 1997, NEUROLOGY, V48, P581; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Lahat E, 1996, PEDIATR NEUROL, V15, P299, DOI 10.1016/S0887-8994(96)00221-4; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W., 1997, CLIN NEUROPSYCHOL, V11, P305; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; World Health Organization, 1992, ICD 10 CLASS MENT BE; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	34	15	15	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2011	26	5					348	354		10.1097/HTR.0b013e3181f8d32e			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	814VO	WOS:000294485500003	21900857	Green Accepted			2021-06-18	
J	Shichinohe, H; Kuroda, S; Sugiyama, T; Ito, M; Kawabori, M; Nishio, M; Takeda, Y; Koike, T; Houkin, K				Shichinohe, Hideo; Kuroda, Satoshi; Sugiyama, Taku; Ito, Masaki; Kawabori, Masahito; Nishio, Mitsufumi; Takeda, Yukari; Koike, Takao; Houkin, Kiyohiro			Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium-Safety and Efficacy of Clinical Use for Neurotransplantation	TRANSLATIONAL STROKE RESEARCH			English	Article						Bone marrow stromal cells; Platelet lysate; Cell culture; Neurotransplantation; Autologous graft; Central nervous system disorders	MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN INJURY; SERUM-FREE MEDIUM; INTRACEREBRAL TRANSPLANTATION; CEREBRAL-ISCHEMIA; TGF-BETA; DIFFERENTIATE; EXPANSION; RATS; EXPRESSION	The donor cell culture in animal serum-free medium is quite important for the clinical application of cell transplantation therapy. This study was aimed to test the hypothesis that the human bone marrow stromal cells (hBMSC) expanded with fetal calf serum (FCS)-free, platelet lysate (PL)-containing medium retain their biological features favoring central nervous system regeneration. The hBMSC were cultured with 5% PL or 10% FCS. Their phenotypes were analyzed with flow cytometry, and their production of growth factors was quantified with enzyme-linked immunosorbent assay. Their capacity of neural differentiation was verified by immunocytochemistry. There was no significant difference in morphology and cell surface marker between the hBMSC-FCS and hBMSC-PL. Both of them were positive for CD44, CD90, CD105, and CD166 and were negative for CD34, CD45, and CD271. The production of human brain-derived neurotrophic factor, human hepatocyte growth factor, human beta-nerve growth factor, and human platelet-derived growth factor-BB did not differ between the two groups, although the hBMSC-PL produced significantly more amount of TGF-beta 1 than the hBMSC-FCS. There was no significant difference in their in vitro differentiation into the neurons and astrocytes between the two groups. The hBMSC expanded with PL-containing medium retain their biological capacity of neural differentiation and neuroprotection. The PL may be a clinically valuable and safe substitute for FCS in expanding the hBMSC for cell therapy.	[Shichinohe, Hideo; Kuroda, Satoshi; Sugiyama, Taku; Ito, Masaki; Kawabori, Masahito; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Nishio, Mitsufumi; Takeda, Yukari; Koike, Takao] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido 0608638, Japan	Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	skuroda@med.hokudai.ac.jp	Shichinohe, Hideo/G-5367-2012; Houkin, Kiyohiro/G-5364-2012; Kawabori, Masahito/AAH-7117-2020; Sugiyama, Taku/U-9482-2018	Kawabori, Masahito/0000-0002-3574-8380; Sugiyama, Taku/0000-0003-0398-225X	Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19390371, 20390377, 20591701, 21390400]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21390400, 23390342] Funding Source: KAKEN	This study was supported by grant-in-aids from the Ministry of Education, Science and Culture of Japan (nos. 19390371, 20390377, 20591701, and 21390400).	Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Chiba Y, 2009, NEUROSURGERY, V64, P991, DOI 10.1227/01.NEU.0000341905.57162.1D; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Gu Y, 2010, J MOL NEUROSCI, V40, P332, DOI 10.1007/s12031-009-9304-6; He XY, 2011, CYTOTHERAPY, V13, P46, DOI 10.3109/14653249.2010.510505; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Hokari M, 2009, CYTOKINE, V46, P260, DOI 10.1016/j.cyto.2009.02.008; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Lee PH, 2008, CLIN PHARMACOL THER, V83, P723, DOI 10.1038/sj.clpt.6100386; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Maruichi K, 2009, NEUROPATHOLOGY, V29, P422, DOI 10.1111/j.1440-1789.2008.00995.x; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reger Roxanne L., 2008, V449, P93, DOI 10.1007/978-1-60327-169-1_7; Rezaee F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009690; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2008, NEUROREHAB NEURAL RE, V22, P447, DOI 10.1177/1545968308315596; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2010, NEUROPATHOLOGY, V30, P113, DOI 10.1111/j.1440-1789.2009.01050.x; Sugiyama T, 2011, NEUROSURGERY, V68, P1733, DOI 10.1227/NEU.0b013e31820edd63; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wolfe Margaret, 2008, V449, P3, DOI 10.1007/978-1-60327-169-1_1; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yano S, 2005, J NEUROTRAUM, V22, P907, DOI 10.1089/neu.2005.22.907	49	15	15	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	SEP	2011	2	3					307	315		10.1007/s12975-011-0088-y			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	943YH	WOS:000304163500010	24323651				2021-06-18	
J	Eide, PK; Bakken, A				Eide, Per K.; Bakken, Andre			The baseline pressure of intracranial pressure (ICP) sensors can be altered by electrostatic discharges	BIOMEDICAL ENGINEERING ONLINE			English	Article							TRAUMATIC BRAIN-INJURY; CLINICAL-EVALUATION; CODMAN MICROSENSOR; TECHNICAL REPORT; EPIDURAL SPACE; COMPLICATIONS; DEVICE; SAFETY; HYDROCEPHALUS; TRANSDUCERS	Background: The monitoring of intracranial pressure (ICP) has a crucial role in the surveillance of patients with brain injury. During long-term monitoring of ICP, we have seen spontaneous shifts in baseline pressure (ICP sensor zero point), which are of technical and not physiological origin. The aim of the present study was to explore whether or not baseline pressures of ICP sensors can be affected by electrostatics discharges (ESD's), when ESD's are delivered at clinically relevant magnitudes. Methods: We performed bench-testing of a set of commercial ICP sensors. In our experimental setup, the ICP sensor was placed in a container with 0.9% NaCl solution. A test person was charged 0.5 - 10 kV, and then delivered ESD's to the sensor by touching a metal rod that was located in the container. The continuous pressure signals were recorded continuously before/after the ESD's, and the pressure readings were stored digitally using a computerized system Results: A total of 57 sensors were tested, including 25 Codman ICP sensors and 32 Raumedic sensors. When charging the test person in the range 0.5-10 kV, typically ESD's in the range 0.5 - 5 kV peak pulse were delivered to the ICP sensor. Alterations in baseline pressure >= 2 mmHg was seen in 24 of 25 (96%) Codman sensors and in 17 of 32 (53%) Raumedic sensors. Lasting changes in baseline pressure > 10 mmHg that in the clinical setting would affect patient management, were seen frequently for both sensor types. The changes in baseline pressure were either characterized by sudden shifts or gradual drifts in baseline pressure. Conclusions: The baseline pressures of commercial solid ICP sensors can be altered by ESD's at discharge magnitudes that are clinically relevant. Shifts in baseline pressure change the ICP levels visualised to the physician on the monitor screen, and thereby reveal wrong ICP values, which likely represent a severe risk to the patient.	[Eide, Per K.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurosurg, N-0027 Oslo, Norway; [Eide, Per K.] Univ Oslo, Fac Med, Oslo, Norway; [Bakken, Andre] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Clin & Biomed Engn, N-0027 Oslo, Norway	Eide, PK (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurosurg, N-0027 Oslo, Norway.	per.kristian.eide@ous-hf.no					Abenstein JP, 2007, MAYO CLIN PROC, V82, P276; ALLEN R, 1986, J MED ENG TECHNOL, V10, P299, DOI 10.3109/03091908609022923; Allin D, 2008, NEUROSURGERY, V62, P1158, DOI 10.1227/01.neu.0000325878.67752.eb; BRUNER J M R, 1972, JAAMI Journal of the Association for the Advancement of Medical Instrumentation, V6, P222; BRUNER JMR, 1967, ANESTHESIOLOGY, V28, P396, DOI 10.1097/00000542-196703000-00023; Citerio G, 2004, ACTA NEUROCHIR, V146, P1221, DOI 10.1007/s00701-004-0351-z; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; Eide PK, 2010, J NEUROSURG, V112, P616, DOI 10.3171/2009.7.JNS081593; Eide PK, 2008, MED ENG PHYS, V30, P34, DOI 10.1016/j.medengphy.2007.01.005; Eide PK, 2006, MED ENG PHYS, V28, P542, DOI 10.1016/j.medengphy.2005.09.003; Eide PK, 2010, J NEUROSURG, V113, P1317, DOI 10.3171/2010.7.JNS10483; Fernandes HM, 1998, ACT NEUR S, V71, P44; GAMBARDELLA G, 1992, NEUROSURGERY, V31, P918, DOI 10.1227/00006123-199211000-00014; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gray WP, 1996, NEUROSURGERY, V39, P927, DOI 10.1097/00006123-199611000-00008; Guyot LL, 1998, ACT NEUR S, V71, P47; HOLDSTOCK P, 1996, FOS FSD S, P356; Janny P, 1950, THESIS; Kathirgamanathan P, 2000, J ELECTROSTAT, V49, P51, DOI 10.1016/S0304-3886(00)00003-6; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lang JM, 2003, NEUROSURGERY, V52, P1455, DOI 10.1227/01.NEU.0000065136.70455.6F; LEONARD PF, 1972, ANESTH ANAL CURR RES, V51, P797; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Morgalla MH, 2002, ACTA NEUROCHIR, V144, P57, DOI 10.1007/s701-002-8274-2; Morgalla MH, 1999, J MED ENG TECHNOL, V23, P144; Morgalla MH, 2001, J NEUROSURG, V95, P529, DOI 10.3171/jns.2001.95.3.0529; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Piper I, 2001, NEUROSURGERY, V49, P1158, DOI 10.1097/00006123-200111000-00026; PIPER IR, 1995, NEUROSURGERY, V36, P1142, DOI 10.1227/00006123-199506000-00012; Poca MA, 2008, J NEUROSURG, V108, P934, DOI 10.3171/JNS/2008/108/5/0934; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Rossi S, 1998, ACT NEUR S, V71, P91; Signorini DF, 1998, BRIT J NEUROSURG, V12, P223; Smallwood J, 2005, J ELECTROSTAT, V63, P501, DOI 10.1016/j.elstat.2005.03.009; Stendel R, 2003, ACTA NEUROCHIR, V145, P185, DOI 10.1007/s00701-002-1052-0; WEIBELL FJ, 1974, ANN BIOMED ENG, V2, P126, DOI 10.1007/BF02368486; Yau YH, 2000, J NEUROSURG, V93, P1072, DOI 10.3171/jns.2000.93.6.1072; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	41	15	15	1	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-925X			BIOMED ENG ONLINE	Biomed. Eng. Online	AUG 22	2011	10								75	10.1186/1475-925X-10-75			16	Engineering, Biomedical	Engineering	824RX	WOS:000295220900001	21859487	DOAJ Gold, Green Published			2021-06-18	
J	Zhang, Y; Su, YY; Ye, H; Xiao, SY; Chen, WB; Zhao, JW				Zhang, Yan; Su, Ying Ying; Ye, Hong; Xiao, Shu Ying; Chen, Wei Bi; Zhao, Jing Wei			Predicting comatose patients with acute stroke outcome using middle-latency somatosensory evoked potentials	CLINICAL NEUROPHYSIOLOGY			English	Article						Middle-latency somatosensory evoked potentials; Severe stroke; Glasgow Coma Scale; Outcome prediction	CEREBRAL-ARTERY INFARCTION; TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; POSTANOXIC COMA; PROGNOSIS; RESPONSES; SURVIVORS; CORTEX; SCALE	Objective: To evaluate the prognostic value of middle-latency somatosensory evoked potential (MLSEP) in comatose patients with acute severe supratentorial stroke, considering both unfavourable outcome and death. Methods: Eighty-eight patients with acute severe supratentorial stroke underwent MLSEP, short-latency somatosensory evoked potential (SLSEP), Glasgow Coma Scale (GCS) and cerebral computed tomography (CCT) within 1 week from onset. MLSEP and SLSEP were recorded in 25 normal controls. All patients were evaluated with two criteria of outcome as unfavourable outcome (modified Rankin Scale 4-6) and death 6 months after onset. N60 of MLSEP predictive value was compared with N20 of SLSEP, GCS and CCT. Results: Sixty-seven patients (76.1%) suffered from cerebral infarction; and 21 patients (23.9%) suffered from intracerebral haemorrhage. Seventy-one patients (80.7%) had unfavourable outcomes and 39 patients (44.3%) died. The peak latencies of MLSEP were prolonged and some waves of MLSEP were absent in stroke patients, and the proportion of absent waves in lesion-ipsilateral MLSEP was higher than in contralateral MLSEP. By using the prognostic authenticity analysis of predictors, the lesion-ipsilateral absence of N60 showed the highest sensitivity for unfavourable outcome (97.2%, confidence interval (CI): 89.3-99.5%) and death (100%, CI: 88.8-100%), which was superior to GCS, CCT and N20. Bilateral absence of N60 showed a high specificity of 100% for unfavourable outcome, which was as good as bilateral absence of N20. However, it showed a specificity of 89.8% (CI: 77.0-96.2%) for death, not as good as bilateral absence of N20 (98%, CI: 87.8-99.9%). The false positive rate of lesion-ipsilateral absence of N60 for unfavourable outcome and death was 12.7% (CI: 6.6-22.5%) and 50.6% (CI: 39.2-62.0%), respectively, and that of bilateral absence of N60 was 0 (CI: 0-12.3%) and 14.3% (CI: 5.4-31.0%), respectively. Conclusions: We confirm the high predictive value of MLSEP in severe stroke. MLSEP showed higher sensitivity than SLSEP for predicting unfavourable outcome and death. Combined MLSEP with SLSEP results produced even greater predictive value. Significance: The combination of MLSEP and SLSEP would increase the sensitivity and maintain the high specificity not only for predicting outcome in coma after cardiopulmonary resuscitation but also after severe stroke. (C) 2011 Published by Elsevier Ireland Ltd. on behalf of International Federation of Clinical Neurophysiology.	[Zhang, Yan; Su, Ying Ying; Ye, Hong; Xiao, Shu Ying; Chen, Wei Bi; Zhao, Jing Wei] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing 100053, Peoples R China	Su, YY (corresponding author), Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.	tangsuyingying@sina.com			Capital Developing Medical Research Fund, China (CDMRF) [2007-1043]	The study was sponsored by the Capital Developing Medical Research Fund, China (CDMRF, 2007-1043). We received helpful comments from Prof. Y.C. Ding.	Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Barba C, 2002, CLIN NEUROPHYSIOL, V113, P981, DOI 10.1016/S1388-2457(02)00104-9; BATES D, 1991, J NEUROL NEUROSUR PS, V54, P569, DOI 10.1136/jnnp.54.7.569; CHIANG T-R, 1989, Taiwan yixuehui zazhi, V88, P778; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; Forss N, 1999, BRAIN, V122, P1889, DOI 10.1093/brain/122.10.1889; Frot M, 1999, CEREB CORTEX, V9, P854, DOI 10.1093/cercor/9.8.854; GARRAGHTY PE, 1990, BRAIN RES, V528, P165, DOI 10.1016/0006-8993(90)90213-U; Gendo A, 2001, INTENS CARE MED, V27, P1305, DOI 10.1007/s001340101008; Haring HP, 1999, STROKE, V30, P1076, DOI 10.1161/01.STR.30.5.1076; Hofmeijer J, 2008, CEREBROVASC DIS, V25, P176, DOI 10.1159/000113736; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI 10.1097/01.PHM.0000043771.90606.81; Madl C, 2000, CRIT CARE MED, V28, P721, DOI 10.1097/00003246-200003000-00020; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; Navarrete-Navarro P, 2003, INTENS CARE MED, V29, P1237, DOI 10.1007/s00134-003-1755-6; PONS TP, 1988, P NATL ACAD SCI USA, V85, P5279, DOI 10.1073/pnas.85.14.5279; Reid JM, 2010, AGE AGEING, V39, P360, DOI 10.1093/ageing/afq027; SACCO RL, 1990, ARCH NEUROL-CHICAGO, V47, P1181, DOI 10.1001/archneur.1990.00530110035013; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Sherman AL, 2000, NEUROLOGY, V54, P889, DOI 10.1212/WNL.54.4.889; Su YY, 2010, J CLIN NEUROPHYSIOL, V27, P25, DOI 10.1097/WNP.0b013e3181cb4282; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; TEASDALE G, 1974, LANCET, V2, P81; vonKummer R, 1996, AM J NEURORADIOL, V17, P1743; Wang YL, 2007, INT J STROKE, V2, P211, DOI 10.1111/j.1747-4949.2007.00142.x; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Young GB, 2005, NEUROCRIT CARE, V2, P159, DOI 10.1385/NCC:2:2:159; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	34	15	17	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	AUG	2011	122	8					1645	1649		10.1016/j.clinph.2010.11.016			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	791AX	WOS:000292633300025	21317029				2021-06-18	
J	Evans, K; Hux, K				Evans, Kelli; Hux, Karen			Comprehension of indirect requests by adults with severe traumatic brain injury: Contributions of gestural and verbal information	BRAIN INJURY			English	Article						TBI; inferencing; non-verbal cues	SOCIAL-PERCEPTION; HEAD-INJURY; RECOGNITION; DEFICITS; EMOTION; NEUROPRAGMATICS; COMMUNICATION; IMPAIRMENT; DISCOURSE; COGNITION	Purpose: The researchers sought to determine the extent to which individuals with and without traumatic brain injury (TBI) integrate gestural and verbal information when interpreting indirect requests. Method: Eighteen adults with cognitive-communication impairments secondary to severe TBI and 18 neurologically-intact adults viewed video vignettes depicting actors conversing in everyday contexts and concluding with indirect requests. Indirect requests were presented in three conditions: verbal information only (VO), gestural information only (GO) and combined verbal and gestural information (VG). Following each vignette, participants answered prediction and interpretation probes. Results: Statistical analysis revealed comparable performance patterns across participant groups, with significantly better performance in the VG condition than either the VO or GO conditions; however, neurologically-intact participants performed significantly better than participants with TBI in all conditions. Further analysis involved categorization of incorrect responses to determine the basis for participant errors. Conclusion: Overall, results suggest that individuals with brain injury benefit from a combination of gestural and verbal information when interpreting indirect requests; however, interpretations by individuals with brain injury are less accurate than interpretations made by neurologically-intact individuals. Incorrect responses tend to be abstract rather than literal and inaccurate with regard to a speaker's intended meaning.	[Evans, Kelli] Univ S Alabama, Dept Speech Pathol & Audiol, Mobile, AL 36688 USA; [Hux, Karen] Univ Nebraska, Barkley Mem Ctr, Lincoln, NE USA	Evans, K (corresponding author), Univ S Alabama, Dept Speech Pathol & Audiol, 5721 USA Dr N,HAHN 1119, Mobile, AL 36688 USA.	kellievans@usouthal.edu	Hux, Karen/AAQ-2078-2020				Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Bavelas J., 1994, RES LANG SOC INTERAC, V27, P201, DOI DOI 10.1207/S15327973RLSI2703_3; BAVELAS JB, 1992, DISCOURSE PROCESS, V15, P469, DOI 10.1080/01638539209544823; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Cassell Justine, 1999, PRAGMAT COGN, V7, P1, DOI [10.1075/pc.7.1.03cas., DOI 10.1075/PC.7.1.03CAS]; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Crisp R., 1993, DISABILITY HANDICAP, V8, P393, DOI [DOI 10.1080/02674649366780371, 10.1080/02674649366780371]; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Delis DC, 2001, DELISKAPLAN EXECUTIV; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hagen C, 2000, TBI REH MAN CAR ENV; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Holler J, 2003, GESTURE, V3, P127, DOI DOI 10.1075/GEST.3.2.02HOL; Hux K, 2008, J MED SPEECH-LANG PA, V16, P83; Jacobs N, 2007, J MEM LANG, V56, P291, DOI 10.1016/j.jml.2006.07.011; Kelly SD, 1999, J MEM LANG, V40, P577, DOI 10.1006/jmla.1999.2634; Kertesz A., 1982, W APHASIA BATTERY WA; Kertesz A., 2007, W APHASIA BATTERY RE; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McNeill D., 2005, GESTURE THOUGHT; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059	36	15	15	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					767	776		10.3109/02699052.2011.576307			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600013	21561291				2021-06-18	
J	Giannantoni, A; Silvestro, D; Siracusano, S; Azicnuda, E; D'Ippolito, M; Rigon, J; Sabatini, U; Bini, V; Formisano, R				Giannantoni, Antonella; Silvestro, Daniela; Siracusano, Salvatore; Azicnuda, Eva; D'Ippolito, Mariagrazia; Rigon, Jessica; Sabatini, Umberto; Bini, Vittorio; Formisano, Rita			Urologic Dysfunction and Neurologic Outcome in Coma Survivors After Severe Traumatic Brain Injury in the Postacute and Chronic Phase	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Coma; Rehabilitation; Urinary bladder disorder; neurogenic	URINARY-INCONTINENCE; DAMAGE	Giannantoni A, Silvestro D, Siracusano S, Azicnuda E, D'Ippolito M, Rigon J, Sabatini U, Bini V, Formisano R. Urologic dysfunction and neurologic outcome in coma survivors after severe traumatic brain injury in the postacute and chronic phase. Arch Phys Med Rehabil 2011;92:1134-8. Objectives: To investigate voiding dysfunction and upper urinary tract status in survivors of coma resulting from traumatic brain injury (TBI), and to compare clinical and urodynamic results with neurologic and psychological features as well as functional outcomes. Design: Observational study focused on urologic dysfunction and neurologic outcome in coma survivors after traumatic brain injury in the postacute and chronic phase. Setting: A postcoma unit in a rehabilitation hospital. Participants: Consecutive patients (N=57) who recovered from coma of traumatic etiology and who were admitted during a 1-year period to a postcoma unit of a rehabilitation hospital. Interventions: Patients underwent clinical urologic assessment, urodynamics with the assessment of the Schafer nomogram and the projected isovolumetric detrusor pressure to evaluate detrusor contractility, ultrasound assessment of the lower and upper urinary tract and voiding cystourethrography, routinely performed, according to the International Continence Society Standards. Neurologic variables assessed were brain injury and disability severity, and neuropsychological status. Neuroimaging identified the site of cerebral lesions. Main Outcome Measures: Urinary symptoms, disability by means of the Glasgow Outcome Scale (GOS), and neuropsychological status by means of the Neurobehavioral Rating Scale (NBRS), and the relationships among them. Results: Of the 57 patients studied, 30 had overactive bladder (urge incontinence) symptoms, 28 had detrusor overactivity, and 18 had detrusor underactivity with associated pseudodyssynergia in 15 of these patients. Eleven patients had hypertrophic bladder; 3, bilateral pyelectasia; and 2, vesicoureteral reflux. Disability measured by GOS was severe in 8 patients and moderate in 27, while recovery was good in 22 patients. The mean NBRS total score indicated a mild cognitive impairment. Neuroimaging showed diffuse brain injury in all patients. Statistically significant relationships were found between urge incontinence, detrusor overactivity, and poor neurologic functional outcome, between detrusor overactivity and right hemisphere damage (P=.0001), and between impaired detrusor contractility and left hemisphere injuries (P=.0001). Conclusions: Most patients who recovered from coma resulting from TBI have symptoms of overactive bladder syndrome and voiding difficulties. These urinary problems correlate with cerebral involvement and neurologic functional outcome.	[Giannantoni, Antonella; Bini, Vittorio] Univ Perugia, Osped S Maria della Misericordia, Dept Urol & Androl, I-06100 Perugia, Italy; [Silvestro, Daniela; Azicnuda, Eva; D'Ippolito, Mariagrazia; Formisano, Rita] Santa Lucia Fdn, Post Coma Unit, Rome, Italy; [Sabatini, Umberto] Santa Lucia Fdn, Dept Radiol, Rome, Italy; [Siracusano, Salvatore] Univ Trieste, Osped Gattinara, Dept Urol, Trieste, Italy; [Rigon, Jessica] San Camillo Hosp, Lido Venice, Italy	Giannantoni, A (corresponding author), Univ Perugia, Osped S Maria della Misericordia, Dept Urol & Androl, I-06100 Perugia, Italy.	agianton@libero.it	D'Ippolito, Mariagrazia/K-4010-2016; Bini, Vittorio/F-5134-2010; Azicnuda, Eva/K-9010-2016; Bini, Vittorio/AAA-1104-2019; Sabatini, Umberto/K-4659-2016	D'Ippolito, Mariagrazia/0000-0001-7818-7352; Bini, Vittorio/0000-0001-8404-2918; Bini, Vittorio/0000-0001-8404-2918; Sabatini, Umberto/0000-0001-5321-8626; Siracusano, Salvatore/0000-0002-1709-9823			ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Arena M G, 1992, Funct Neurol, V7, P47; AUERBACK ALFRED, 1952, CALIFORNIA MED, V76, P23; CARDOZO L, 2009, INCONTINENCE INT CON; Chase J, 2010, J UROLOGY, V183, P1296, DOI 10.1016/j.juro.2009.12.059; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Damasio H., 1989, LESION ANAL NEUROPSY; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Griffiths DJ, 2004, SCAND J UROL NEPHROL, V38, P93, DOI 10.1080/03008880410015426; JENNETT B, 1975, LANCET, V1, P480; Krimchansky BZ, 1999, BRAIN INJURY, V13, P899; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Marinkovic SP, 2001, J UROLOGY, V165, P359, DOI 10.1097/00005392-200102000-00003; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Moiyadi AV, 2007, NEUROREHABILITATION, V22, P93; Nour S, 2000, BRAIN, V123, P781, DOI 10.1093/brain/123.4.781; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SCHAFER W, 1990, UROL CLIN N AM, V17, P553; Stohrer M, 2009, EUR UROL, V56, P81, DOI 10.1016/j.eururo.2009.04.028; TEASDALE G, 1974, LANCET, V2, P81; Wong SYS, 2006, J AFFECT DISORDERS, V96, P83, DOI 10.1016/j.jad.2006.05.013; WYNDAELE JJ, 1990, NEUROUROL URODYNAM, V9, P43, DOI 10.1002/nau.1930090106	27	15	15	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2011	92	7					1134	1138		10.1016/j.apmr.2011.02.013			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	790UU	WOS:000292615900017	21704794				2021-06-18	
J	Kerr, K; Oram, J; Tinson, H; Shum, D				Kerr, Katelyn; Oram, Joanne; Tinson, Helen; Shum, David			The correlates of aggression in people with acquired brain injury: A preliminary retrospective study	BRAIN INJURY			English	Article						Activities of daily living; aggression; violence; head injury; length of stay; traumatic brain injury	LONG-TERM SURVIVORS; IMPULSIVE AGGRESSION; VIOLENCE; BEHAVIOR; SETTINGS; ASSAULT; PATIENT; WARDS	Primary objective: To identify correlates of aggressive behaviours in patients with acquired brain injury (ABI). Methods and procedures: During a 16 month period, patients who had ABI and who had been aggressive during hospitalization (n = 32) were identified by hospital staff. A comprehensive chart review of these patients was completed. Results were compared against results of a matched patient sample who had not been aggressive (32). Main outcomes and results: Five variables which were significantly correlated with aggression were entered into a standard logistic regression. The model explained 61.4% of the total variance and successfully predicted 87.5% of the non-aggressive group and 78.1% of the aggressive group. The overall correct prediction rate was 82.8%. Of the five variables, four were found to significantly contribute to the predictive ability of the model: An education of 10 years or less, a history of aggression, dependence on staff for assistance with activities of daily living and a hospitalization period of 51 days or more. Conclusions: The results highlight some variables related to aggression by patients with ABI in the hospital environment and can be utilized in staff education and training programmes to increase the awareness of risk factors.	[Kerr, Katelyn; Shum, David] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Kerr, Katelyn; Oram, Joanne; Tinson, Helen] Princess Alexandra Hosp, Dept Psychol, Brisbane, Qld 4102, Australia; [Shum, David] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Kerr, Katelyn] Toowong Private Hosp, Brisbane, Qld, Australia	Kerr, K (corresponding author), Toowong Private Hosp, 496 Milton Rd, Milton, Qld 4066, Australia.	katelyn01@hotmail.com	Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262	Commonwealth Government	The authors wish to acknowledge the staff of the two hospital wards that participated in the study for their assistance and support. The writing of this article was supported through a writing bursary obtained through the Griffith University Primary Health Care Research Evaluation and Development (PHCRED) program, funded by the Commonwealth Government.	Alderman N, 2002, BRAIN INJURY, V16, P469, DOI 10.1080/02699050110118458; Arnetz JE, 2000, J ADV NURS, V31, P668, DOI 10.1046/j.1365-2648.2000.01322.x; Bandura A., 1973, AGGRESSION SOCIAL LE; BERKOWITZ L, 1981, J PERS SOC PSYCHOL, V40, P687, DOI 10.1037/0022-3514.40.4.687; BOWIE V, 1989, COPING VIOLENCE GUID; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Carter R, 2000, HIGH RISK VIOLENCE N, V6, P5; COMBS AW, 1952, J ABNORM SOC PSYCH, V47, P420, DOI 10.1037/h0057196; Dollard J., 1939, FRUSTRATION AGGRESSI; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Farrell GA, 1999, J ADV NURS, V29, P532, DOI 10.1046/j.1365-2648.1999.00920.x; Ferguson T. J., 1983, AGGRESSION THEORETIC, V1, P41; FORRESTER K, 1995, EMERGENCE OFFICIAL N, V1, P5; Geen R.G., 1977, ADV EXPT SOCIAL PSYC, P1, DOI DOI 10.1016/S0065-2601(08)60353-6; Greve KW, 2002, PERS INDIV DIFFER, V32, P639, DOI 10.1016/S0191-8869(01)00066-6; Greve KW, 2001, BRAIN INJURY, V15, P255; HIRSCHI T, 1977, AM SOCIOL REV, V42, P571, DOI 10.2307/2094556; Holden R J, 1985, Aust Nurses J, V15, P44; HUESMANN LR, 1984, DEV PSYCHOL, V46, P1071; Institute of Medicine, 2005, IMPR QUAL HLTH CAR M; Kozlowska K, 1997, AUST NZ J PSYCHIAT, V31, P641, DOI 10.3109/00048679709062676; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Lyneham J, 2000, Aust J Adv Nurs, V18, P8; McKenna BG, 2003, INT J MENT HEALTH NU, V12, P56, DOI 10.1046/j.1440-0979.2003.00269.x; Minium EW, 1993, STAT REASONING PSYCH; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nijman HLI, 1999, PSYCHIATR SERV, V50, P832, DOI 10.1176/ps.50.6.832; O'Connell B, 2000, J CLIN NURS, V9, P602, DOI 10.1046/j.1365-2702.2000.00401.x; Owen C, 1998, PSYCHIATR SERV, V49, P1452, DOI 10.1176/ps.49.11.1452; Pallant J., 2005, SPSS SURVIVOR MANUAL; Pescosolido BA, 1999, AM J PUBLIC HEALTH, V89, P1339, DOI 10.2105/AJPH.89.9.1339; Poster EC, 1996, ARCH PSYCHIAT NURS, V10, P365, DOI 10.1016/S0883-9417(96)80050-1; *REH I CHIC, 1992, REH I CHIC FUNCT ASS; *ROYAL COLL PSYCH, 1998, OP41 ROYAL COLL PSYC; SANDEL EM, 1996, ARCH PHYS MED REHAB, V77, P617; SILVER JM, 1987, PSYCHIAT ANN, V17, P375, DOI 10.3928/0048-5713-19870601-08; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Sommargren C E, 1994, AACN Clin Issues Crit Care Nurs, V5, P516; *SPSS INC, 2005, STAT PACK SOC SCI WI; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Wen X, 1997, DEFINITION PREVALENC; Whittington R, 1996, J ADV NURS, V24, P326, DOI 10.1046/j.1365-2648.1996.18114.x; Winstanley S, 2002, ACTA PSYCHIAT SCAND, V106, P144, DOI 10.1034/j.1600-0447.106.s412.31.x; WOOD RL, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P153; Zernike W, 1998, Int J Nurs Pract, V4, P126, DOI 10.1046/j.1440-172X.1998.00073.x	45	15	15	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					729	741		10.3109/02699052.2011.580315			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600009	21561292				2021-06-18	
J	O'Connor, C; Robertson, IH; Levine, B				O'Connor, Charlene; Robertson, Ian H.; Levine, Brian			The Prosthetics of Vigilant Attention: Random Cuing Cuts Processing Demands	NEUROPSYCHOLOGY			English	Article						fMRI; alerting tones; SART; DLPFC; sustained attention; arousal	TRAUMATIC BRAIN-INJURY; EVENT-RELATED FMRI; SUSTAINED ATTENTION; PREFRONTAL CORTEX; RESPONSE-INHIBITION; GOAL MANAGEMENT; FRONTOPARIETAL NETWORK; INTRINSIC ALERTNESS; EXECUTIVE FUNCTIONS; VISUAL-ATTENTION	Objective: Engagement in tasks requiring vigilant attention is susceptible to modulation by exogenous stimulation, reflected in changes in performance accuracy and speed. The shift from endogenous to exogenous control may be observed not only when the external cue is meaningful to the task, but also when it holds no information about the task or performance. The purpose of this study was to examine how the shift to exogenous engagement is reflected in changes to the well-documented, right-lateralized, frontal-parietal-thalamic vigilant attention network. Method: Using functional magnetic resonance imaging, healthy participants were scanned as they performed the Sustained Attention to Response Task (SART) in 60-s blocks, some of which were presented with brief, random, auditory tones. The SART requires participants to overcome the tendency to respond in an automatic, task-driven manner in response to infrequent no-go stimuli. Results: Despite no overall effect on performance, and only a transient increase in response times immediately following the tones, the SART with alerting tones was associated with a diminished pattern of activation in key nodes of the network. The pattern of right-lateralized activity observed with the SART was attenuated with the tones, and activity in the right middle frontal gyrus was significantly diminished, as revealed by region-of-interest analyses. Conclusions: Alerting tones provided the stimulation to cue the maintenance of the goal-state, reducing reliance on prefrontal control mechanisms and demonstrating the shift from endogenous top-down control to exogenous control. These findings suggest a neural mechanism for the facilitatory effects of exogenous engagement for patients with damaged top-down attentional brain systems.	[O'Connor, Charlene; Levine, Brian] Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [O'Connor, Charlene; Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [O'Connor, Charlene] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5S 1A1, Canada; [Levine, Brian] Univ Toronto, Dept Med Neurol, Toronto, ON M5S 1A1, Canada; [Robertson, Ian H.] Trinity Coll Dublin, Dept Psychol, Dublin, Ireland; [Robertson, Ian H.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland	Levine, B (corresponding author), Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	blevine@rotman-baycreston.ca	Levine, Brian/G-4328-2010; Levine, Brian/O-2725-2019	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Robertson, Ian H/0000-0001-8637-561X	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD42385-01]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-202037]; Heart and Stroke Foundation of Ontario Centre for Stroke RecoveryHeart & Stroke Foundation of Ontario; Ontario Neurotrauma Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042385] Funding Source: NIH RePORTER	This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant HD42385-01, Canadian Institutes of Health Research Grant MOP-202037, the Heart and Stroke Foundation of Ontario Centre for Stroke Recovery; and the Ontario Neurotrauma Foundation Studentship Grant.	COHEN RM, 1988, NEUROPSY NEUROPSY BE, V1, P3; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; De Pisapia N, 2006, NEUROCOMPUTING, V69, P1322, DOI 10.1016/j.neucom.2005.12.100; Dockree PM, 2005, NEUROIMAGE, V27, P587, DOI 10.1016/j.neuroimage.2005.05.044; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Dodds CM, 2008, NEUROPSYCHOLOGY, V22, P545, DOI 10.1037/0894-4105.22.4.545; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fassbender C, 2006, J PSYCHOPHYSIOL, V20, P286, DOI 10.1027/0269-8803.20.4.286; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gobbele R, 2000, EXP BRAIN RES, V133, P506, DOI 10.1007/s002210000435; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; Hager F, 1998, EUR ARCH PSY CLIN N, V248, P161; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kelly AMC, 2004, EUR J NEUROSCI, V19, P3105, DOI 10.1111/j.0953-816X.2004.03429.x; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kubler A, 2006, J COGNITIVE NEUROSCI, V18, P1331, DOI 10.1162/jocn.2006.18.8.1331; LaBerge D, 2005, BRAIN RES REV, V50, P86, DOI 10.1016/j.brainresrev.2005.04.004; Laberge D, 1990, J Cogn Neurosci, V2, P358, DOI 10.1162/jocn.1990.2.4.358; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; LEVINE B, 2011, REHABILITATION UNPUB; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Liddle PF, 2001, HUM BRAIN MAPP, V12, P100, DOI 10.1002/1097-0193(200102)12:2<100::AID-HBM1007>3.0.CO;2-6; Manly T, 2005, NEUROPSYCHOLOGIA, V43, P1721, DOI 10.1016/j.neuropsychologia.2005.02.009; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; MANLY T, 1997, METHODOLOGY FRONTAL, P135; Marklund P, 2007, CORTEX, V43, P22, DOI 10.1016/S0010-9452(08)70443-X; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Mottaghy FM, 2006, NEUROIMAGE, V29, P225, DOI 10.1016/j.neuroimage.2005.07.034; NORMAN DA, 1986, CONSCIOUSNESS SELF R, V4, P4; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Parasuraman R, 1998, ATTENTIVE BRAIN, P221; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Portas CM, 1998, J NEUROSCI, V18, P8979; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Romanski LM, 1997, J COMP NEUROL, V379, P313; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Rueckert L, 1998, NEUROPSYCHOLOGIA, V36, P653, DOI 10.1016/S0028-3932(97)00150-4; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schneider W., 2001, E PRIME USERS GUIDE; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smith A, 1996, NATURE, V380, P291, DOI 10.1038/380291a0; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Talairach J., 1988, COPLANAR STEREOTAXIC; WHITEHEAD R, 1991, J COGNITIVE NEUROSCI, V3, P329, DOI 10.1162/jocn.1991.3.4.329; Zordan L, 2008, BRAIN COGNITION, V66, P57, DOI 10.1016/j.bandc.2007.05.005	65	15	15	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JUL	2011	25	4					535	543		10.1037/a0022767			9	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	787WQ	WOS:000292407800011	21463046				2021-06-18	
J	Smith, CM; Adelson, PD; Chang, YF; Brown, SD; Kochanek, PM; Clark, RSB; Bayir, H; Hinchberger, J; Bell, MJ				Smith, Craig M.; Adelson, P. David; Chang, Yue-Fang; Brown, S. Danielle; Kochanek, Patrick M.; Clark, Robert S. B.; Bayir, Huelya; Hinchberger, Jessica; Bell, Michael J.			Brain-systemic temperature gradient is temperature-dependent in children with severe traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						pediatric; brain injury; temperature; hypothermia; TBI	TISSUE OXYGEN-TENSION; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; RECTAL TEMPERATURES; UNITED-STATES; CARE; HYPERTHERMIA; MANAGEMENT; BLADDER; IMPACT	Objectives: To understand the gradient between rectal and brain temperature in children after severe traumatic brain injury. We hypothesized that the rectal temperature and brain temperature gradient will be influenced by the child's body surface area and that this relationship will persist over physiologic temperature ranges. Design: Retrospective review of a prospectively collected pediatric neurotrauma registry. Setting: Academic, university-based pediatric neurotrauma program. Patients: Consecutive children (n = 40) with severe traumatic brain injury (Glasgow coma scale of <8) who underwent brain temperature monitoring (July 2003 to December 2008) were studied after informed consent was obtained. A subset of children (n = 24) were concurrently enrolled in a randomized, controlled clinical trial of early-moderate hypothermia for neuroprotection. Interventions: Data extraction of multiple clinical variables, including demographic data, body surface area, and rectal and brain temperature at recorded at hourly intervals. Measurements and Main Results: Paired brain and rectal temperature measurements (in degrees Celsius, n = 4369) were collected hourly and compared by using Pearson correlations. Patients were stratified according to body surface area (<1.0 m(2), 1.0-1.99 m(2), 2.0-2.99 m(2), and >3.0 m(2)) and based on brain temperature (<= 34.0, 34.1-36.0; 36.1-38, >= 38.1). Body surface area and brain temperature were compared between groups by using Pearson correlations with correction for repeated measures. Mean brain temperature-rectal temperature difference was calculated for stratified brain temperature ranges. Overall, brain and rectal temperatures were highly correlated (r = .86, p < .001). During brain hyperthermia, brain temperature-rectal temperature was similar to that reported in previous studies with brain temperature higher than rectal temperature (1.75 +/- 0.4; r = .54). Surprisingly, this relationship was reversed during brain hypothermia (brain temperature-rectal temperature = -1.87 +/- 0.8; r = .37), indicating a reversal of the brain-systemic temperature gradient. When stratified for body surface area, the correlation between rectal temperature and brain temperature remained strong (r = .78, 0.91, 0.79 and 0.95, respectively, p < .001). However, the correlation between brain temperature and rectal temperature was substantially decreased when stratified for brain temperature (r = .37, 0.58, 0.48, 0.54, p < .001). In particular, during moderate brain hypothermia (brain temperature < 34), the correlation between brain temperature and rectal temperature was weakest, indicating the greatest variability during this condition which is often targeted for therapeutic trials. Conclusions: Brain temperature and rectal temperature are generally well-correlated in children with traumatic brain injury. This relationship is different at the extremes of the physiologic temperature range, with the temperature gradient reversed during brain hypothermia and hyperthermia. Given that studies showing neuroprotection from hypothermia in animal models of brain injury generally target brain temperature, our data suggest the possibility that, if brain temperature were the therapeutic target in clinical trials, this would result in somewhat higher systemic temperature and potentially fewer side effects. This relationship may be exploited in future clinical trials to maintain brain hypothermia (for neurologic protection) at slightly higher systemic temperatures (and potentially fewer systemic side effects). (Pediatr Crit Care Med 2011; 12:449-454)	[Smith, Craig M.; Kochanek, Patrick M.; Clark, Robert S. B.; Bayir, Huelya; Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Chang, Yue-Fang; Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA USA; [Hinchberger, Jessica] Univ Pittsburgh, Sch Med, Dept Nursing, Pittsburgh, PA USA; [Kochanek, Patrick M.; Clark, Robert S. B.; Bayir, Huelya; Bell, Michael J.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kochanek, Patrick M.; Clark, Robert S. B.; Bayir, Huelya; Bell, Michael J.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Adelson, P. David; Brown, S. Danielle] Phoenix Childrens Hosp, Dept Neurosurg, Phoenix, AZ USA	Smith, CM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	smithcm3@upmc.edu	Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	National Institutes of Health, Bethesda, MDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HD40686, NS30318]; Cyberomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318, P01NS030318] Funding Source: NIH RePORTER	Supported, in part, by the National Institutes of Health, Bethesda, MD (T32HD40686) (CMS) and NS30318 (PMK). Dr. Adelson consulted for Traumic and received honoraria/speaking fees from Cyberomics. The remaining authors have not disclosed potential conflicts of interest.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Ao HS, 2000, RESUSCITATION, V45, P111, DOI 10.1016/S0300-9572(00)00154-4; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 2008, BRIT J NEUROSURG, V22, P486, DOI 10.1080/02688690802245541; Childs C, 2008, BRAIN INJURY, V22, P603, DOI 10.1080/02699050802189719; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Fountas KN, 2003, J NEUROSURG ANESTH, V15, P87, DOI 10.1097/00008506-200304000-00004; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/NCC:3:3:260; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jaeger M, 2005, ACT NEUR S, V95, P117; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Latorre JGS, 2009, NEUROLOGIST, V15, P193, DOI 10.1097/NRL.0b013e31819f956a; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; WEISEND MP, 1994, J NEUROSURG, V80, P120, DOI 10.3171/jns.1994.80.1.0120; 2000, J NEUROTRAUMA, V17, P457	41	15	15	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2011	12	4					449	454		10.1097/PCC.0b013e3181f390dd			6	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	788ME	WOS:000292448200018	20711083	Green Accepted			2021-06-18	
J	Schonberger, M; Ponsford, J; Reutens, D; Beare, R; Clarke, D; O'Sullivan, R				Schoenberger, Michael; Ponsford, Jennie; Reutens, David; Beare, Richard; Clarke, David; O'Sullivan, Richard			The relationship between mood disorders and MRI findings following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; depression; magnetic resonance imaging	II PSYCHIATRIC-DISORDERS; AXIS-I; DEPRESSION; ANXIETY; SYMPTOMS	Background: High rates of depression have been reported in individuals with traumatic brain injury (TBI). The purpose of the current study was to investigate the relationship between structural MRI findings and the development of novel cases of post-injury depression in this population Methods: The study has a cross-sectional design. Assessments were conducted on average 2.2 years post-injury. Participants were 54 individuals (76% male, mean age 35 years, median PTA duration 16 days) who had sustained a TBI. Depression was assessed with the Structured Clinical Interview for DSM-IV (SCID-IV). Structural MRI scans were performed with a 1.5 Tesla machine. Results: The presence of lesions in the frontal, temporal, parietal and the sublobar regions was not related to depression. However, an imbalance of left vs right frontal and parietal viable brain volumes was related to the development of depression. Discussion: These findings are in support of Heller's model of emotion processing, but should be replicated using larger samples. Potential clinical implications are discussed in the manuscript.	[Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol, D-79106 Freiburg, Germany; [Schoenberger, Michael; Ponsford, Jennie; Clarke, David] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Schoenberger, Michael; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Reutens, David; Beare, Richard] Monash Univ, Dept Med, Monash Med Ctr, Melbourne, Vic 3004, Australia; [Reutens, David] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Beare, Richard] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Schonberger, M (corresponding author), Univ Freiburg, Inst Psychol, Dept Rehabil Psychol, Engelberger Str 41, D-79106 Freiburg, Germany.	michael.schoenberger@psychologie.uni-freiburg.de	Reutens, David/C-7226-2018	Reutens, David/0000-0002-1652-9369; Beare, Richard/0000-0002-7530-5664			Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Deb S, 1999, AM J PSYCHIAT, V156, P374; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Heller W, 1998, COGNITION EMOTION, V12, P421; Heller W., 1993, NEUROPSYCHOLOGY, V7, P476, DOI [10.1037/0894-4105.7.4.476, DOI 10.1037/0894-4105.7.4.476]; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Keller J, 2000, J ABNORM PSYCHOL, V109, P3, DOI 10.1037/0021-843X.109.1.3; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Larsen R. J., 1992, EMOTION, V13, P25; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	37	15	15	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2011	25	6					543	550		10.3109/02699052.2011.565013			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300001	21534732				2021-06-18	
J	Shindler, KS; Chatterjee, D; Biswas, K; Goyal, A; Dutt, M; Nassrallah, M; Khan, RS; Das Sarma, J				Shindler, Kenneth S.; Chatterjee, Dhriti; Biswas, Kaushiki; Goyal, Ashish; Dutt, Mahasweta; Nassrallah, Mayssa; Khan, Reas S.; Das Sarma, Jayasri			Macrophage-Mediated Optic Neuritis Induced by Retrograde Axonal Transport of Spike Gene Recombinant Mouse Hepatitis Virus	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Axonal transport; Demyelination; Mouse hepatitis virus; Multiple sclerosis; Optic neuritis; Spike glycoprotein	CD8(+) T-CELLS; GLYCOPROTEIN-E; CORONAVIRUS; DEMYELINATION; SPREAD; INFECTION; DAMAGE; MODEL; MICE; PROTEINS	After intracranial inoculation, neurovirulent mouse hepatitis virus (MHV) strains induce acute inflammation, demyelination, and axonal loss in the central nervous system. Prior studies using recombinant MHV strains that differ only in the spike gene, which encodes a glycoprotein involved in virus-host cell attachment, demonstrated that spike mediates anterograde axonal transport of virus to the spinal cord. A demyelinating MHV strain induces optic neuritis, but whether this is due to the retrograde axonal transport of viral particles to the retina or due to traumatic disruption of retinal ganglion cell axons during intracranial inoculation is not known. Using recombinant isogenic MHV strains, we examined the ability of recombinant MHV to induce optic neuritis by retrograde spread from the brain through the optic nerve into the eye after intracranial inoculation. Recombinant demyelinating MHV induced macrophage infiltration of optic nerves, demyelination, and axonal loss, whereas optic neuritis and axonal injury were minimal in mice infected with the nondemyelinating MHV strain that differs in the spike gene. Thus, optic neuritis was dependent on a spike glycoprotein-mediated mechanism of viral antigen transport along retinal ganglion cell axons. These data indicate that MHV spreads by retrograde axonal transport to the eye and that targeting spike protein interactions with axonal transport machinery is a potential therapeutic strategy for central nervous system viral infections and associated diseases.	[Chatterjee, Dhriti; Biswas, Kaushiki; Goyal, Ashish; Das Sarma, Jayasri] Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata, India; [Shindler, Kenneth S.; Dutt, Mahasweta; Nassrallah, Mayssa; Khan, Reas S.] Univ Penn, Scheie Eye Inst, Philadelphia, PA USA; [Shindler, Kenneth S.; Dutt, Mahasweta; Nassrallah, Mayssa; Khan, Reas S.] Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA USA	Das Sarma, J (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata, India.	dassarmaj@iiserkol.ac.in	Sarma, Jayasri Das/AAS-3837-2020	majumder, dhriti/0000-0001-9292-6430	Du Pre Foundation; Indian Institute of Science Education and Research-Kolkata; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG3774A2/1]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY015098, EY019014]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); University Grant Commission, IndiaUniversity Grants Commission, India; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY019014, K08EY015098] Funding Source: NIH RePORTER	The authors thank the Du Pre Foundation for support of AG.; This work was supported by the Indian Institute of Science Education and Research-Kolkata's startup money, by a research grant from the National Multiple Sclerosis Society to JDS (RG3774A2/1), and by National Institutes of Health grants (EY015098 and EY019014) and Career Development Award from Research to Prevent Blindness to KSS. DC and KB are supported by University Grant Commission, India.	BENNUN A, 1982, J IMMUNOL, V129, P303; Cunningham AL, 2006, J INFECT DIS, V194, pS11, DOI 10.1086/505359; Dandekar AA, 2001, J VIROL, V75, P6115, DOI 10.1128/JVI.75.13.6115-6120.2001; Das Sarma J, 2000, J VIROL, V74, P9206, DOI 10.1128/JVI.74.19.9206-9213.2000; Das Sarma J, 2002, J NEUROVIROL, V8, P381, DOI 10.1080/13550280290100815; Das Sarma J, 2001, J NEUROVIROL, V7, P432; Das Sarma J, 2001, EXP MOL PATHOL, V71, P1; Das Sarma J, 2010, INTERDISCIP PERSPECT, V2010; Das Sarma J, 2008, J VIROL, V82, P5519, DOI 10.1128/JVI.01488-07; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Jin YH, 2009, J VIROL, V83, P10981, DOI 10.1128/JVI.01398-09; Klingen Y, 2008, J VIROL, V82, P237, DOI 10.1128/JVI.01342-07; Lancaster KZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000791; LAVI E, 1986, LAB ANIM SCI, V36, P130; McGraw HM, 2009, J VIROL, V83, P8315, DOI 10.1128/JVI.00633-09; McGraw HM, 2009, J VIROL, V83, P4791, DOI 10.1128/JVI.02341-08; Navas S, 2001, J VIROL, V75, P2452, DOI 10.1128/JVI.75.5.2452-2457.2001; PASICK JMM, 1994, J VIROL, V68, P2915, DOI 10.1128/JVI.68.5.2915-2928.1994; PERLMAN S, 1990, J EXP MED, V172, P1127, DOI 10.1084/jem.172.4.1127; Shindler KS, 2008, EXP EYE RES, V87, P208, DOI 10.1016/j.exer.2008.05.017; Shindler KS, 2008, J VIROL, V82, P8882, DOI 10.1128/JVI.00920-08; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; van Rossum D, 2008, GLIA, V56, P271, DOI 10.1002/glia.20611; Vaughan JC, 2009, BIOPHYS J, V97, P1647, DOI 10.1016/j.bpj.2009.07.011; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001	32	15	16	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2011	70	6					470	480		10.1097/NEN.0b013e31821da499			11	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	766AV	WOS:000290751700006	21572336	Bronze, Green Published, Green Accepted			2021-06-18	
J	Johnson, LSM				Johnson, L. Syd M.			Concussion in youth ice hockey: It's time to break the cycle	CANADIAN MEDICAL ASSOCIATION JOURNAL			English	Article							SPORT-RELATED CONCUSSION; BODY-CHECKING; INJURY; BODYCHECKING; CHILDHOOD; PLAYERS; RATES		Dalhousie Univ, Halifax, NS, Canada	Johnson, LSM (corresponding author), Dalhousie Univ, Halifax, NS, Canada.	syd.johnson@dal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 77670]; Therapeutic Hopes and Ethical Concerns: Clinical research in the neurosciences; States of Mind: Emerging issues in neuroethics [NNF 80045]	Research funded by Canadian Institutes of Health Research, MOP 77670, Therapeutic Hopes and Ethical Concerns: Clinical research in the neurosciences, and NNF 80045, States of Mind: Emerging issues in neuroethics.	American Academy of Pediatrics. Committee on Sports Medicine and Fitness, 2000, PEDIATRICS, V105, P657; Bey T, 2009, WEST J EMERG MED, V10, P6; *BOST U CTR STUD T, 2009, 18 YEAR OLD HIGH SCH; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cusimano Michael D, 2011, Open Med, V5, pe57; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; GULLI C, 2011, MACLEANS        0204, P50; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hicks B, 2009, HARD TIMES AHEAD NAT; *HOCKEYCANADA, 2011, BACKGR CHECK; KALCHMAN L, 2003, MAKING NHL VERY LONG; Kissick J, 2007, CANADIAN ACAD SPORT; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Molsa J, 2003, AM J SPORT MED, V31, P751; Montelparel WJ, 2004, AM SOC TEST MATER, V1446, P70, DOI 10.1520/STP11610S; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; *NHL, 2011, NHL CONC RIS ACC HIT; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; rosen D., 2011, NEW CONCUSSION PROTO; ROSEN D, 2010, CAN CONCUSSED PLAYER; RUTHERFORD K, 2009, QUEB HOCK BUCK TREND; *US HOCK, HOCK US BOD RUL PROP; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	33	15	15	0	7	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 3Y6, CANADA	0820-3946			CAN MED ASSOC J	Can. Med. Assoc. J.	MAY 17	2011	183	8					921	924		10.1503/cmaj.110282			4	Medicine, General & Internal	General & Internal Medicine	762AZ	WOS:000290446000058	21502353	Bronze, Green Published			2021-06-18	
J	Domowicz, MS; Henry, JG; Wadlington, N; Navarro, A; Kraig, RP; Schwartz, NB				Domowicz, Miriam S.; Henry, Judith G.; Wadlington, Natasha; Navarro, Antonia; Kraig, Richard P.; Schwartz, Nancy B.			Astrocyte precursor response to embryonic brain injury	BRAIN RESEARCH			English	Article						Astrocyte precursor; Gliogenesis; Brain stab-wound injury; Ventricular zone; Optic tectum	PERINATAL WHITE-MATTER; OLIGODENDROCYTE LINEAGE MATURATION; DEVELOPING NERVOUS-SYSTEM; DEVELOPING SPINAL-CORD; DEVELOPING RAT-BRAIN; CHICK OPTIC TECTUM; PERIVENTRICULAR LEUKOMALACIA; DEVELOPMENTAL NEUROPATHOLOGY; INTRAUTERINE ENVIRONMENT; CORTICAL GLIOGENESIS	Penetrating traumatic insult during pregnancy is a leading cause of human fetal demise; in particular, trauma to the brain may lead to devastating long-term cognitive sequelae. Perinatal brain injury involves glial precursors, but the neural mechanisms controlling astrocyte ontogeny after injury remain incompletely understood, partly due to a lack of appropriate markers and animal models. We analyzed astrocyte precursor response to injury at the beginning (E11) and peak (E15) of gliogenesis in an avian tectal model of penetrating embryonic brain trauma, without confounding maternal and sibling effects. At both ages, lateral ventricular dilatation, necrotic foci, periventricular cysts and intraventricular hemorrhages were observed distal to stab wounds two days after a unilateral stab injury to optic tecta. Neuronal (TUBB3) and oligodendrocyte precursor (PLP) markers were down-regulated, even far-removed from the wound site. In contrast, the mature astrocyte marker, GFAP, was up-regulated at the wound site, around necrotic areas and cysts, plus in usual areas of GFAP expression. Increased inflammatory response and apoptotic cell death were also confirmed in the injured tecta. Increased expression of NFIA, SOX9 and GLAST at the wound site and in the ventricular zone (VZ) of the injured tecta indicated an astroglial precursor response. However, cell division increased in the VZ only in early (Ell) injury, but not later (E15), indicating that in late injury the astrogliogenesis occurring after acute injury is predominantly due to precursor differentiation rather than precursor proliferation. The inability to replenish the glial precursor pool during the critical period of vulnerability to injury may be an important cause of subsequent developmental abnormalities. (C) 2011 Elsevier B.V. All rights reserved.	[Domowicz, Miriam S.; Henry, Judith G.; Wadlington, Natasha; Navarro, Antonia; Schwartz, Nancy B.] Univ Chicago, Med Ctr, Dept Pediat, Chicago, IL 60637 USA; [Kraig, Richard P.] Univ Chicago, Med Ctr, Dept Neurol, Chicago, IL 60637 USA; [Schwartz, Nancy B.] Univ Chicago, Med Ctr, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Domowicz, MS (corresponding author), Univ Chicago, Med Ctr, Dept Pediat, 5481 S Maryland Ave,MC 5058, Chicago, IL 60637 USA.	mdxx@uchicago.edu		Wadlington, Natasha/0000-0002-4380-7838; Domowicz, Miriam/0000-0001-7860-4427; Kraig, Richard/0000-0003-4584-1017	National Institute of Child Health and Human Disorders [HD 09402, P30 HD054275]; National Institute of General Medical ScienceUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25 GM066522-06]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-19108]; White Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD009402] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD054275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM066522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019108] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute of Child Health and Human Disorders (HD 09402; P30 HD054275), the National Institute of General Medical Science (R25 GM066522-06), the National Institute of Neurological Disorders and Stroke (NS-19108), and the White Foundation.	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Billiards SS, 2006, J COMP NEUROL, V497, P199, DOI 10.1002/cne.20991; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; Caggiano AO, 1996, J COMP NEUROL, V376, P447, DOI 10.1002/(SICI)1096-9861(19961216)376:3<447::AID-CNE7>3.0.CO;2-2; CEPKO CL, 1997, MOL CELLULAR APPROAC, P391; Chapman SB, 2003, PEDIATR NEUROL, V29, P34, DOI 10.1016/S0887-8994(03)00012-2; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Cuadros MA, 1997, J COMP NEUROL, V389, P390; Cuadros MA, 2000, J COMP NEUROL, V423, P659, DOI 10.1002/1096-9861(20000807)423:4<659::AID-CNE10>3.0.CO;2-S; DAMBSKA M, 1989, J CHILD NEUROL, V4, P291, DOI 10.1177/088307388900400408; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Domowicz MS, 2009, DEV BIOL, V329, P242, DOI 10.1016/j.ydbio.2009.02.024; Dornowicz MS, 2008, DEV BIOL, V315, P114, DOI 10.1016/j.ydbio.2007.12.014; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Folkerth RD, 2005, J CHILD NEUROL, V20, P940, DOI 10.1177/08830738050200120301; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; JAWORSKI DM, 1995, J NEUROSCI, V15, P1352; Johnston MV, 2002, NEUROSCIENTIST, V8, P212, DOI 10.1177/1073858402008003007; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; Kim DW, 2006, BRAIN RES, V1076, P16, DOI 10.1016/j.brainres.2006.01.010; King LA, 2009, J NEUROSCI METH, V177, P30, DOI 10.1016/j.jneumeth.2008.09.019; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Laflamme N, 1999, J NEUROSCI, V19, P10923; LAVAIL JH, 1971, BRAIN RES, V28, P421; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; LAWSON LJ, 1995, EUR J NEUROSCI, V7, P1584, DOI 10.1111/j.1460-9568.1995.tb01154.x; Lea PM, 2001, MENT RETARD DEV D R, V7, P235, DOI 10.1002/mrdd.1033; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Leviton A, 2007, TRENDS NEUROSCI, V30, P473, DOI 10.1016/j.tins.2007.05.009; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Marin-Padilla M, 1999, J NEUROPATH EXP NEUR, V58, P407, DOI 10.1097/00005072-199905000-00001; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; McClure MM, 2008, J CEREBR BLOOD F MET, V28, P995, DOI 10.1038/sj.jcbfm.9600597; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; MILLIGAN CE, 1991, J COMP NEUROL, V314, P136, DOI 10.1002/cne.903140113; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Moses P, 2002, DEV PSYCHOBIOL, V40, P266, DOI 10.1002/dev.10031; NAKAMURA Y, 1994, J NEUROPATH EXP NEUR, V53, P582, DOI 10.1097/00005072-199411000-00005; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Petrone P, 2011, INJURY, V42, P47, DOI 10.1016/j.injury.2010.06.026; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; PRICE J, 1988, DEVELOPMENT, V104, P473; REDDY P, 1986, CELL, V46, P53, DOI 10.1016/0092-8674(86)90859-7; Rees S, 2004, NEUROSCI LETT, V361, P111, DOI 10.1016/j.neulet.2004.02.002; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; Robinson S, 2005, NEUROBIOL DIS, V18, P568, DOI 10.1016/j.nbd.2004.10.024; Rodricks CL, 2008, INT J DEV NEUROSCI, V26, P113, DOI 10.1016/j.ijdevneu.2007.08.006; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Sent E, 2006, MENT RETARD DEV D R, V12, P97, DOI 10.1002/mrdd.20106; Seo J.H., 2008, NEUROCHEM RES; Shibata T, 1997, J NEUROSCI, V17, P9212; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P237, DOI 10.1207/S15326942DN1802_5; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Svedin P, 2005, J CHILD NEUROL, V20, P960, DOI 10.1177/08830738050200120501; Tan S, 2005, J CHILD NEUROL, V20, P972, DOI 10.1177/08830738050200120801; Vardeh D, 2009, J CLIN INVEST, V119, P287, DOI 10.1172/JCI37098; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wang XB, 2008, BIOCHEM BIOPH RES CO, V371, P283, DOI 10.1016/j.bbrc.2008.04.055; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; WIGGINS RC, 1986, NEUROTOXICOLOGY, V7, P103; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yakovlev AG, 2001, J NEUROSCI, V21, P7439; Yamagata M, 2006, MOL CELL NEUROSCI, V33, P296, DOI 10.1016/j.mcn.2006.08.001	85	15	15	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 10	2011	1389						35	49		10.1016/j.brainres.2011.03.006			15	Neurosciences	Neurosciences & Neurology	767VK	WOS:000290886300005	21396923	Green Accepted			2021-06-18	
J	Bulger, EM				Bulger, Eileen M.			7.5% Saline and 7.5% Saline/6% Dextran for Hypovolemic Shock	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	US Army-Institute-of-Surgical-Research Prehospital Fluid Conference	JAN 08-09, 2010	Ft Worth, TX	USArmy Inst Surg Res & Casual Care Res, US Army Med Res Mat Command			RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; HYPERTONIC RESUSCITATION; HEMORRHAGIC-SHOCK; INFLAMMATORY RESPONSE; MULTICENTER TRIAL; SODIUM-CHLORIDE; HYPOTENSION; EFFICACY		Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA	Bulger, EM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Surg, Box 359796,325 9th Ave, Seattle, WA 98104 USA.	ebulger@u.washington.edu			NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL073233, R01 HL073233-01] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM076101-01A1, R01 GM076101] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL073233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM076101] Funding Source: NIH RePORTER		Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; Gurfinkel V, 2003, J TRAUMA, V54, P1137, DOI 10.1097/01.TA.0000064452.37534.29; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Rizoli SB, 1999, J SURG RES, V83, P130, DOI 10.1006/jsre.1999.5581; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rizoli SB, 1998, J IMMUNOL, V161, P6288; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Wade C, 1997, Acta Anaesthesiol Scand Suppl, V110, P77; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; YOUNES RN, 1992, SURGERY, V111, P380	20	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2011	70	5		S			S27	S29		10.1097/TA.0b013e31821a559a			3	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	762RU	WOS:000290499200010	21666775	Green Accepted			2021-06-18	
J	Barr, TL; Alexander, S; Conley, Y				Barr, Taura L.; Alexander, Sheila; Conley, Yvette			Gene Expression Profiling for Discovery of Novel Targets in Human Traumatic Brain Injury	BIOLOGICAL RESEARCH FOR NURSING			English	Article						traumatic brain injury; gene expression profiling; genomics; biomarkers	BLOOD MONONUCLEAR-CELLS; MULTIPLE-SCLEROSIS PATIENTS; ACUTE ISCHEMIC-STROKE; CONTROL MAQC PROJECT; SUBSTANTIA-NIGRA; MICROARRAY ANALYSIS; PARKINSONS-DISEASE; GENOMIC RESPONSES; OLIGONUCLEOTIDE ARRAYS; ALZHEIMERS-DISEASE	Several clinical trials have failed to demonstrate a significant effect on outcome following human traumatic brain injury (TBI) despite promising results obtained in preclinical animal studies. These failures may be due in part to a misinterpretation of the findings obtained in preclinical animal models of TBI, a misunderstanding of the complexity of the human response to TBI, limited knowledge about the biological pathways that interact to contribute to good and bad outcomes after brain injury, and the effects of genomic variability and environment on individual recovery. Recent publications suggest that data obtained from gene expression profiling studies of complex neurological diseases such as stroke, multiple sclerosis (MS), Alzheimer's and Parkinson's may contribute to a more informed understanding of what affects outcome following TBI. These data may help to bridge the gap between successful preclinical studies and negative clinical trials in humans to reveal novel targets for therapy. Gene expression profiling has the capability to identify biomarkers associated with response to TBI, elucidate complex genetic interactions that may play a role in outcome following TBI, and reveal biological pathways related to brain health. This review highlights the current state of the literature on gene expression profiling for neurological disease and discusses its ability to aid in unraveling the variable human response to TBI and the potential for it to offer treatment strategies in an area where we currently have limited therapeutic options primarily based on supportive care.	[Barr, Taura L.] W Virginia Univ, Sch Nursing, Morgantown, WV 26506 USA; [Barr, Taura L.] W Virginia Univ, Ctr Neurosci, Morgantown, WV 26506 USA; [Alexander, Sheila; Conley, Yvette] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA	Barr, TL (corresponding author), W Virginia Univ, Sch Nursing, Biomed Res Bldg,1 Med Ctr Dr,Off 313,POB 9303, Morgantown, WV 26506 USA.	tbarr@hsc.wvu.edu		Conley, Yvette/0000-0002-1784-6067	predoctoral Intramural Research Training Award via the Graduate Partnerships Program through the National Institute of Nursing Research, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)	The author(s) disclosed receipt of the following financial support for the research and/or authorship of this article: A predoctoral Intramural Research Training Award via the Graduate Partnerships Program through the National Institute of Nursing Research, National Institutes of Health.	Achiron A, 2006, AUTOIMMUN REV, V5, P517, DOI 10.1016/j.autrev.2006.02.009; Achiron A, 2004, ANN NEUROL, V55, P410, DOI 10.1002/ana.20008; Achiron A, 2007, ANN NY ACAD SCI, V1107, P155, DOI 10.1196/annals.1381.017; Andersson A, 2007, LEUKEMIA, V21, P1198, DOI 10.1038/sj.leu.2404688; Arthur AT, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-17; Baird AE, 2006, PHARMACOGENOMICS, V7, P141, DOI 10.2217/14622416.7.2.141; Baker J, 2007, PHARMACOGENOMICS, V8, P397, DOI 10.2217/14622416.8.4.397; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Basso G, 2007, BLOOD CELL MOL DIS, V39, P164, DOI 10.1016/j.bcmd.2007.05.004; Becker KG, 1997, J NEUROIMMUNOL, V77, P27, DOI 10.1016/S0165-5728(97)00045-3; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chacon Marcus R, 2008, Curr Cardiol Rep, V10, P37, DOI 10.1007/s11886-008-0008-2; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; DeRisi J, 1996, NAT GENET, V14, P457; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; *EXP AN, 2007, EXPR PROF WHOL BLOOD; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A; Goertsches R, 2007, Int MS J, V14, P98; Grond-Ginsbach C, 2008, J NEUROL, V255, P723, DOI 10.1007/s00415-008-0784-z; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Grunblatt E, 2001, J NEUROCHEM, V78, P1, DOI 10.1046/j.1471-4159.2001.00397.x; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hershey AD, 2004, HEADACHE, V44, P994, DOI 10.1111/j.1526-4610.2004.04193.x; Hong J, 2004, J NEUROIMMUNOL, V152, P126, DOI 10.1016/j.jneuroim.2004.03.004; Iglesias AH, 2004, J NEUROIMMUNOL, V150, P163, DOI 10.1016/j.jneuroim.2004.01.017; JERNE NK, 1985, EMBO J, V4, P847, DOI 10.1002/j.1460-2075.1985.tb03709.x; Kalman J, 2005, PSYCHIAT GENET, V15, P1; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Koike F, 2003, J NEUROIMMUNOL, V139, P109, DOI 10.1016/S0165-5728(03)00155-3; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Lindberg RLP, 2006, EXPERT REV MOL DIAGN, V6, P843, DOI 10.1586/14737159.6.6.843; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Maouche S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-302; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Miller Renee M, 2006, NeuroRx, V3, P319, DOI 10.1016/j.nurx.2006.05.008; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Miller RM, 2005, NEUROBIOL AGING, V26, P765, DOI 10.1016/j.neurobiolaging.2004.12.002; Miller RM, 2004, J NEUROSCI, V24, P7445, DOI 10.1523/JNEUROSCI.4204-03.2004; Moore DF, 2005, CIRCULATION, V111, P212, DOI 10.1161/01.CIR.0000152105.79665.C6; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Paintlia AS, 2004, J NEUROSCI RES, V77, P63, DOI 10.1002/jnr.20130; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Ramanathan M, 2001, J NEUROIMMUNOL, V116, P213, DOI 10.1016/S0165-5728(01)00308-3; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Satoh J, 2006, J NEUROIMMUNOL, V174, P108, DOI 10.1016/j.jneuroim.2006.02.004; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Sharp FR, 2007, STROKE, V38, P691, DOI 10.1161/01.STR.0000247940.27518.38; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Sharp FR, 2006, EPILEPSIA, V47, P1603, DOI 10.1111/j.1528-1167.2006.00809.x; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Tajouri L, 2007, CURR GENOMICS, V8, P181, DOI 10.2174/138920207780833829; Tang Y, 2005, ARCH NEUROL-CHICAGO, V62, P210, DOI 10.1001/archneur.62.2.210; Tang Y, 2004, ANN NEUROL, V56, P808, DOI 10.1002/ana.20291; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Tang Y, 2001, ANN NEUROL, V50, P699, DOI 10.1002/ana.10042; Tang Y, 2003, J CEREBR BLOOD F MET, V23, P310, DOI 10.1097/01.WCB.0000048518.34839.DE; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Whitney LW, 1999, ANN NEUROL, V46, P425; Whitney LW, 2001, J NEUROIMMUNOL, V121, P40, DOI 10.1016/S0165-5728(01)00438-6; Woo Yong, 2004, J Biomol Tech, V15, P276; Yang T, 2004, MOL BRAIN RES, V132, P155, DOI 10.1016/j.molbrainres.2003.10.014; Zhou Yi-wu, 2002, Fa Yi Xue Za Zhi, V18, P146; 2006, MICROARRAY PLATFORM	85	15	16	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	APR	2011	13	2					140	153		10.1177/1099800410385671			14	Nursing	Nursing	735ZP	WOS:000288459600004	21112922				2021-06-18	
J	Brougham, R; David, DS; Adornato, V; Gordan, W; Dale, B; Georgeadis, AC; Gassaway, J				Brougham, Rebecca; David, Dana Spivak; Adornato, Viki; Gordan, Wendy; Dale, Beverly; Georgeadis, Amy C.; Gassaway, Julie			Speech-language pathology treatment time during inpatient spinal cord injury rehabilitation: the SCIRehab project	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injuries; traumatic; Tetraplegia; Paraplegia; Brain injury; traumatic; Rehabilitation; Health services research; Outcomes research; Speech-language pathology; Cognitive therapy; Communication disorders; Dysphagia; Practice-based evidence	TRAUMATIC BRAIN-INJURY; OUTCOMES; DYSPHAGIA; SEVERITY; ILLNESS	Background/objective: Following spinal cord injury (SCI), speech-language pathologists (SLPs) perform assessments and provide treatment for swallowing, motor speech, voice, and cognitive-communication disorders that result from the SCI and/or co-occurring brain injuries. This paper describes the nature and distribution of speech-language pathology (SLP) activities delivered during inpatient SCI rehabilitation and discusses predictors (patient and injury characteristics) of the amount of time spent in specific SLP treatment activities. Methods: Six rehabilitation centers enrolled 600 patients with traumatic SCI for an observational study of acute inpatient rehabilitation treatment (SCIRehab). SLPs documented the details of assessment and treatment and time spent on each of a set of specific SLP activities during each patient encounter. Patterns of time use are described for all patients by neurological injury category. Ordinary least squares stepwise regression models are used to identify patient and injury characteristics predictive of treatment time in the specific SLP activities identified. Results: SLP consults were requested for 40% of SCIRehab patients. Fifty-seven percent of these patients received intense therapy (defined as more than five sessions during the rehabilitation stay); the remainder received primarily evaluation or less intense services (one to five sessions). The patients who participated in intense treatment received a mean total of 16.1 hours (range 2.5-105.2 hours, standard deviation (SD) 16.5, median 9.7 hours) of SLP; significant differences were seen in the amount of time spent in each activity among neurological injury groups. Cognitive-communication and swallowing therapy were the most common SLP activities. Patients with motor levels of injury at C1-C4 spent the highest percentage of their therapy time working on swallowing therapy while patients with low tetraplegia and paraplegia, and those classified as AIS D (regardless of motor level of injury) focused the greatest percentage of time on cognitive-communication work. Patient and injury characteristics explained a portion of the variation in time spent on cognitive-communication therapy but did not explain the variation in time spent on swallowing and other SLP treatment activities. Conclusion: The need for swallowing and cognitive treatment by SLP is common during inpatient rehabilitation due to dysfunction resulting from use of artificial airways and feeding approaches, as well as secondary brain injuries. The large amount of variability seen in SLP treatment time, which is not explained well by patient and injury characteristics, sets the stage for future analyses to associate treatments with outcomes.	[Gassaway, Julie] Inst Clin Outcomes Res, Salt Lake City, UT 84102 USA; [Brougham, Rebecca] Shepherd Ctr, Atlanta, GA USA; [David, Dana Spivak] Mt Sinai Med Ctr, New York, NY 10029 USA; [Adornato, Viki] Carolina Rehabil, Charlotte, NC USA; [Gordan, Wendy] Craig Hosp, Englewood, CO USA; [Dale, Beverly] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Georgeadis, Amy C.] Natl Rehabil Hosp, Washington, DC USA	Gassaway, J (corresponding author), Inst Clin Outcomes Res, 699 E South Temple, Salt Lake City, UT 84102 USA.	jgassaway@isiscor.com			National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of Education, NIDRRUS Department of Education [H133A060103, H133N060005, H133N060028, H133N060009, H133N060027, H133N060014]; Craig Hospital	The contents of this paper were developed under grants from the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of Education, NIDRR grant numbers H133A060103 and H133N060005 to Craig Hospital, H133N060028 to National Rehabilitation Hospital, H133N060009 to Shepherd Center, H133N060027 to The Mount Sinai School of Medicine, H133N060014 to Rehabilitation Institute of Chicago, and to Carolinas Rehabilitation by subcontract from Craig Hospital. The contents of this manuscript do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	AVERILL RF, 1992, HEALTH SERV RES, V27, P587; BRADY S, 2004, APPL RES CLIN EXP TH, V4, P1; Clemmer TP, 1999, CRIT CARE MED, V27, P1768, DOI 10.1097/00003246-199909000-00011; DAHLBERG C, 1997, TOP SPINAL CORD INJ, V2, P41; Fiedler R.C., 1996, FUNCTIONAL EVALUATIO, P75; Fiedler RC, 2000, AM J PHYS MED REHAB, V79, P184, DOI 10.1097/00002060-200003000-00012; Frempong-Boadu A, 2002, J SPINAL DISORD TECH, V15, P362, DOI 10.1097/00024720-200210000-00004; Gassaway J, 2009, J SPINAL CORD MED, V32, P260, DOI 10.1080/10790268.2009.11760780; Gordan W, 2009, J SPINAL CORD MED, V32, P307, DOI 10.1080/10790268.2009.11760784; HOIT JD, 1990, J SPEECH HEAR RES, V33, P798, DOI 10.1044/jshr.3304.798; HORN S, 1997, ONCOL ISSUES, V12, P16; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; HORN SD, 1991, MED CARE, V29, P305, DOI 10.1097/00005650-199104000-00001; Logemann J. A., 1998, EVALUATION TREATMENT; MacBean N, 2006, J MED SPEECH-LANG PA, V14, P167; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Marino R, 2003, REFERENCE MANUAL INT; Martin RE, 1997, DYSPHAGIA, V12, P2, DOI 10.1007/PL00009513; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Stevens J., 1999, INTERMEDIATE STAT MO, V2nd ed.; Stevens J., 2003, PARTIAL SEMIPARTIAL; Tervonen H, 2007, J NEUROSURG-SPINE, V7, P124, DOI 10.3171/SPI-07/08/124; Whiteneck G., 2011, J SPINAL CORD MED, V34, P135; Whiteneck G, 2009, J SPINAL CORD MED, V32, P251, DOI 10.1080/10790268.2009.11760779; Winslow CP, 1999, AM J OTOLARYNG, V20, P16, DOI 10.1016/S0196-0709(99)90046-7	27	15	15	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	MAR	2011	34	2					186	195		10.1179/107902611X12971826988174			10	Clinical Neurology	Neurosciences & Neurology	744FR	WOS:000289080800007	21675357	Green Published			2021-06-18	
J	Shi, W; Zhao, W; Shen, A; Shao, B; Wu, XJ; Yang, J; Ni, LC; Wu, QY; Chen, JA				Shi, Wei; Zhao, Wei; Shen, Aiguo; Shao, Bai; Wu, Xiujie; Yang, Jiao; Ni, Lanchun; Wu, Qiyun; Chen, Jian			Traumatic Brain Injury Induces an Up-Regulation of Hs1-Associated Protein X-1 (Hax-1) in Rat Brain Cortex	NEUROCHEMICAL RESEARCH			English	Article						Hax-1; Traumatic brain injury; Rats; Neurons	CELL-DEATH; APOPTOSIS; MECHANISMS; CASPASE-3; IDENTIFICATION; INHIBITION; EXPRESSION; INTERACTS; CLEAVAGE; NEURONS	HS1-associated protein X-1 (Hax-1) is an intracellular protein with anti-apoptotic properties that, in addition to suppressing cell death by inhibiting the activation of initiator caspase-9 and death caspase-3, is involved in an increasing number of signaling cascades. However, its expression and function in the central nervous system lesion are still unclear. In this study, we performed a traumatic brain injury (TBI) model in adult rats and investigated the dynamic changes of Hax-1 expression in the brain cortex. Western blot and immunohistochemistry analysis revealed that Hax-1 was present in normal brain. It gradually increased, reached a peak at day 3 after TBI, and then declined during the following days. Double immunofluorescence staining showed that Hax-1 immunoreactivity (IR) was found in neurons, but not astrocytes and microglia. Moreover, the 3rd day post injury was the apoptotic peak implied by the alteration of caspase-3, Bcl-2 and TUNEL. All these results suggested that Hax-1 may be involved in the pathophysiology of TBI and further research is needed to have a good understanding of its function and mechanism.	[Shi, Wei; Zhao, Wei; Shen, Aiguo; Wu, Xiujie; Yang, Jiao; Ni, Lanchun; Wu, Qiyun; Chen, Jian] Nantong Univ, Coll Med, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Peoples R China; [Shao, Bai] Nantong Univ, Affiliated Dongtai Hosp, Dept Neurosurg, Yancheng 224200, Peoples R China	Wu, QY (corresponding author), Nantong Univ, Coll Med, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Peoples R China.	ntwuqiyun@163.com.cn; chenjian9079@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770488, 30870320, 31070723, 81070275]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009157, BK2009161]; Nature Science Foundation of JiangsuNatural Science Foundation of Jiangsu Province [09KJB320011]	This work was supported by the National Natural Science Foundation of China (No. 30770488, No. 30870320, No. 31070723 and No. 81070275); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009157 and No. BK2009161); Nature Science Foundation of Jiangsu Colleges and Universities Grant (09KJB320011).	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Erhardt L, 1996, EUR HEART J, V17, P1781; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; Grzybowska EA, 2006, GENE, V371, P84, DOI 10.1016/j.gene.2005.11.035; Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5; Hippe A, 2006, GENE, V379, P116, DOI 10.1016/j.gene.2006.04.027; Kang YJ, 2010, BIOCHEM BIOPH RES CO, V393, P794, DOI 10.1016/j.bbrc.2010.02.084; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee AY, 2008, MOL CELLS, V25, P86; LOGAN A, 1992, J NEUROSCI, V12, P3828; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; Marshall L F, 2000, Clin Neurosurg, V46, P105; Mirmohammadsadegh A, 2003, J INVEST DERMATOL, V120, P1045, DOI 10.1046/j.1523-1747.2003.12247.x; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Patel T, 1996, FASEB J, V10, P587; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Vafiadaki E, 2007, J MOL BIOL, V367, P65, DOI 10.1016/j.jmb.2006.10.057; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587	31	15	15	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2011	36	3					375	382		10.1007/s11064-010-0332-y			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	716RB	WOS:000286990100003	21136158				2021-06-18	
J	Sulaiman, AM; Denman, N; Buchanan, S; Porter, N; Vesi, S; Sharpe, R; Graham, DI; Maxwell, WL				Sulaiman, Ahmed Mohammed; Denman, Nicola; Buchanan, Shaun; Porter, Nicola; Vesi, Sauparnika; Sharpe, Rachel; Graham, David I.; Maxwell, William L.			Stereology and Ultrastructure of Chronic Phase Axonal and Cell Soma Pathology in Stretch-Injured Central Nerve Fibers	JOURNAL OF NEUROTRAUMA			English	Article						programmed cell death; retinal ganglion cell; secondary axotomy	TRAUMATIC BRAIN-INJURY; RETINAL GANGLION-CELLS; SITU DNA FRAGMENTATION; OPTIC-NERVE; WHITE-MATTER; WALLERIAN DEGENERATION; QUANTITATIVE-ANALYSIS; CYTOSKELETAL CHANGES; LONGITUDINAL CHANGES; PROGRESSIVE ATROPHY	Magnetic resonance imaging (MRI) suggests that with survival after human traumatic brain injury (TBI), there is ongoing loss of white and grey matter from the injured brain during the chronic phase. However; direct quantitative experimental evidence in support of this observation is lacking. Using the guinea pig stretch-injury optic nerve model, quantitative evidence by stereology of damage to the optic nerve and retina was sought. Stretch injury was applied to the right optic nerve of 15 adult male guinea pigs. Three animals each at 1, 2, 3, 8, or 12 weeks' survival were killed and prepared for transmission electron microscopy (TEM). The estimated number of intact and injured axons within bins of transverse diameters 0-0.5, 0.51-1.0, 1.01-1.5, 1.51-2.0, 2.01-2.5, and 2.51-3.0 mu m in the middle segment of each injured optic nerve and from 5 control animals were compared across all survival time points. The estimated numbers of intact and pyknotic retinal ganglion cells from the same animals were also compared. Loss of myelinated fibers continued throughout the experimental period. The most rapid loss was of the largest fibers; loss of intermediate-sized fibers continued, but the numbers of the smallest fibers increased from 3 weeks onward. There was hypertrophy and proliferation of glial cells within the surrounding neuropil. A relatively low-grade loss of retinal ganglion cells occurred throughout the experiment, with about 60% remaining at 12 weeks' survival. We provide quantitative evidence that after traumatic axonal injury (TAI) there is a continuing loss of nerve fibers and their cell bodies from a CNS tract over a 3-month post-traumatic interval.	[Maxwell, William L.] Univ Glasgow, Dept Anat, Sch Med Vet Med & Life Sci MVLS, Coll Med Vet Med & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Maxwell, William L.] Univ Glasgow, Dept Human Anat, Coll Med Vet Med & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Graham, David I.] So Gen Hosp, Univ Div Neuropathol, Glasgow G51 4TF, Lanark, Scotland	Maxwell, WL (corresponding author), Univ Glasgow, Dept Anat, Sch Med Vet Med & Life Sci MVLS, Coll Med Vet Med & Life Sci, Thomson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	William.Maxwell@gla.ac.uk					Agudo M, 2008, MOL VIS, V14, P1050; BARRON KD, 1986, J NEUROCYTOL, V15, P345, DOI 10.1007/BF01611437; BAUR PS, 1977, J MICROSC-OXFORD, V109, P315, DOI 10.1111/j.1365-2818.1977.tb01145.x; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BIGLER ED, 2011, BRAIN IMAGI IN PRESS; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Butt AM, 2004, EYE, V18, P1110, DOI 10.1038/sj.eye.6701595; CELLERINO A, 2000, J NEUROSCI, V20, P1; COE R, 2002, EFFECT SIZE CALCULAT; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Couto LA, 2004, J NEUROSCI RES, V77, P410, DOI 10.1002/jnr.20170; CRAGG BG, 1961, J PHYSIOL-LONDON, V157, P315, DOI 10.1113/jphysiol.1961.sp006724; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; FRIEDE RL, 1986, ACTA NEUROPATHOL, V72, P74, DOI 10.1007/BF00687950; FRIEDE RL, 1967, J COMP NEUROL; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; JAFARI SS, 1998, THESIS U GLASGOW; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KREUTZBERG GW, 1971, ACTA NEUROPATHOL, V17, P220, DOI 10.1007/BF00685055; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; Marques SA, 2003, BRAIN RES, V969, P1, DOI 10.1016/S0006-8993(02)03834-9; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; MAXWELL WL, 1994, J NEUROCYTOL, V23, P379, DOI 10.1007/BF01666527; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Narciso MS, 2001, AN ACAD BRAS CIENC, V73, P231, DOI 10.1590/S0001-37652001000200008; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; RICHARDSON PM, 1982, J NEUROCYTOL, V11, P949, DOI 10.1007/BF01148310; RINK A, 1995, AM J PATHOL, V147, P1575; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rosenberg LJ, 1997, J NEUROTRAUM, V14, P823, DOI 10.1089/neu.1997.14.823; SAATMAN KE, 2009, HDB NEUROCHEMISTRY M, P344; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Staal JA, 2009, J NEUROTRAUM, V26, P781, DOI 10.1089/neu.2008.0669; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; SULAMAIN MA, 2005, THESIS U GLASGOW GLA; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; WEGNER JE, 1976, BIOL GUINEA PIG; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Wilson S, 2004, J NEUROTRAUM, V21, P239, DOI 10.1089/089771504322972031; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029	73	15	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2011	28	3					383	400		10.1089/neu.2010.1707			18	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	734WD	WOS:000288370600005	21190396				2021-06-18	
J	Tume, LN; Baines, PB; Lisboa, PJG				Tume, Lyvonne N.; Baines, Paul B.; Lisboa, Paulo J. G.			The effect of nursing interventions on the intracranial pressure in paediatric traumatic brain injury	NURSING IN CRITICAL CARE			English	Article						Head injuries; Intensive care nursing; Paediatric intensive care	INTRA-CRANICAL PRESSURE; HEAD-INJURY; INTENSIVE-CARE; HYPERVENTILATION; CHILDREN; ADULTS; EPIDEMIOLOGY; STIMULATION; SCALE; ICP	Aims and objectives: The aim of this research was to investigate the effect of five selected intensive care nursing interventions on the intracranial pressure (ICP) of moderate to severe traumatic brain-injured children in intensive care. Background: The physiological effects of many nursing interventions in paediatric intensive care (PIC) are not known. This results in the lack of an evidence base for many PIC nursing practices. Design: Prospective observational cohort study conducted over 3 years in a single tertiary referral paediatric intensive care unit (PICU) in the North West of England. Methods: Five selected commonly performed nursing interventions were studied: endotracheal suctioning and manual ventilation (ETSMV), turning via a log-rolling (LR) approach, eye care, oral care and washing. These were studied in the first 72 h after injury. Results: A total of 25 children with moderate to severe traumatic brain injury and intraparenchymal ICP monitoring in intensive care (aged 2-17 years) were enrolled. Both ETSMV and LR were associated with clinically and statistically significant changes in ICP from baseline to maximal ICP (p = 0.001 ETSMV; p = < 0.001 LR) and from maximal post-ICP (p = < 0.001 ETSMV; p = < 0.001 LR). Eye care, oral care or washing did not cause any clinically significant change in ICP from baseline. After decompressive craniectomy, none of the interventions caused significant changes in ICP. Conclusions: Only two of the five nursing interventions, endotracheal suctioning and LR, caused intracranial hypertension in moderate to severe traumatic brain-injured children, and after craniectomy, no care interventions caused any significant change in ICP. Relevance to clinical practice: Knowledge about the physiological effects of many intensive care nursing interventions is lacking and this is magnified in paediatrics. This study provides a significant addition to the evidence base in this area and allows intensive care nurses to plan, implement and evaluate more effectively their nursing care for brain-injured children.	[Tume, Lyvonne N.] Liverpool John Moores Univ, Alder Hey Childrens NHS Fdn Trust, PICU, Liverpool L3 5UX, Merseyside, England	Tume, LN (corresponding author), Liverpool John Moores Univ, Alder Hey Childrens NHS Fdn Trust, PICU, Liverpool L3 5UX, Merseyside, England.	lyvonne.tume@alderhey.nhs.uk					ADELSON D, 2003, PEDIAT CRITICAL CA S, V4, pS28; AMBUEL B, 1992, J PEDIATR PSYCHOL, V17, P95, DOI 10.1093/jpepsy/17.1.95; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brucia J, 1996, HEART LUNG, V25, P295, DOI 10.1016/S0147-9563(96)80065-3; CAMPBELL V, 1991, RES BRIEFS, V4, P138; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Crosby L J, 1992, J Neurosci Nurs, V24, P40; ERSSON U, 1990, ACTA ANAESTH SCAND, V34, P99, DOI 10.1111/j.1399-6576.1990.tb03051.x; FISHER DM, 1982, ANESTHESIOLOGY, V57, P416, DOI 10.1097/00000542-198211000-00013; Garradd J, 1986, Aust J Physiother, V32, P107, DOI 10.1016/S0004-9514(14)60647-4; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; Hobdell E F, 1989, Crit Care Nurse, V9, P75; JENNETT B, 1975, LANCET, V1, P480; JONES B, 1995, AUSTR J ADV NURSING, V12, P32; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kerr M E, 1998, Am J Crit Care, V7, P205; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; LEE ST, 1989, HEART LUNG, V18, P411; MACKWAYJONES K, 2005, ADV PAEDIAT LIFE SUP, pCH22; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; MITCHELL PH, 1981, NURS RES, V30, P212; Paratz Jennifer, 1993, Physiotherapy Theory and Practice, V9, P3, DOI 10.3109/09593989309036480; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; PARSONS C, 1984, NURS RES, V33, P68; PARSONS LC, 1985, RES NURS HEALTH, V8, P173, DOI 10.1002/nur.4770080211; PARSONS LC, 1984, HEART LUNG, V13, P372; Prendergast V, 2009, AM J CRIT CARE, V18, P368, DOI 10.4037/ajcc2009621; RUDY EB, 1991, HEART LUNG, V20, P667; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; TUME L, 2008, BRIT J INTENSIVE AUT, P84; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Yanko J R, 2001, Crit Care Nurs Q, V23, P1	34	15	15	1	8	WILEY PERIODICALS, INC	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN, MA 02148-529 USA	1362-1017			NURS CRIT CARE	Nurs. Crit. Care	MAR-APR	2011	16	2					77	84		10.1111/j.1478-5153.2010.00412.x			8	Nursing	Nursing	796SZ	WOS:000293073800006	21299760				2021-06-18	
J	Petridis, AK; Doukas, A; Barth, H; Mehdorn, M				Petridis, A. K.; Doukas, A.; Barth, H.; Mehdorn, M.			Outcome of Craniocerebral Gunshot Injuries in the Civilian Population. Prognostic Factors and Treatment Options	CENTRAL EUROPEAN NEUROSURGERY			English	Article						gunshot; cranial injury; handgun; brain edema	HEAD-INJURY; WOUNDS; BRAIN; WAR	Aim: Gunshot wounds to the head are rare in Europe. They may be inflicted by low-velocity handguns, captive bolt guns and tear gas cartridges and mostly result from suicide attempts. The experience of neurosurgeons with this kind of traumatic injury is decreasing; the aim of this study was therefore to analyse prognostic factors which help to decide whether or not to operate and to discuss treatment options. Methods: Thirty patients with gunshot head injuries treated in our hospital from 1993 to 2008 were retrospectively evaluated. Glasgow Coma Scale (GCS) score, pupil reactivity, lesion localisation, number of bone fragments, intracranial pressure (ICP), midline shift, hypotension, and dural penetration were analysed for their prognostic value. Surgically and non-surgically treated patients were evaluated separately. Complications were registered. Results: A low GCS of 3-8, fixed pupils, > 2 bone fragments, bilobar or posterior fossa/brainstem lesions and ICP > 45 mmHg were indicators of a poor prognosis. Conclusion: Patients with a GCS of 3-8 and two non-reactive pupils should not be operated. If one or both of the pupils are reactive, surgery should be performed irrespective of the GCS score, except in patients with translobar/transventricular wounds. Even if there are no clear contraindications to surgery, the outcome is expected to be poor in patients with a low GCS score, midline shift > 10 mm, > 2 bone fragments in the brain, and a bilobar, posterior fossa/brainstem or ventricular lesion and ICP > 45 mmHg. When surgery is performed the wound and the missile or bone track should be debrided meticulously, the wound and dura should be closed in a watertight fashion and antibiotic prophylaxis as well as tetanus serum should be given.	[Petridis, A. K.; Doukas, A.; Barth, H.; Mehdorn, M.] Univ Kiel, D-24106 Kiel, Germany	Petridis, AK (corresponding author), Univ Kiel, Schittenhelmstr 10, D-24106 Kiel, Germany.	opticdisc@aol.com	Mehdorn, Maximilian/D-2495-2010				AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Aarabi Bizhan, 2001, Journal of Trauma Injury Infection and Critical Care, V51, pS1; ASKENASY JJM, 1989, ACTA NEUROL SCAND, V79, P47, DOI 10.1111/j.1600-0404.1989.tb03708.x; BRANDT F, 1983, NEUROCHIRURGIA, V26, P164; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Crevenna Richard, 2003, Wien Med Wochenschr, V153, P37, DOI 10.1046/j.1563-258X.2003.02050.x; Doctor Vishal S, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P213, DOI 10.1097/MOO.0b013e3281fbd3ef; Dosoglu M, 1999, NEUROCHIRURGIE, V45, P201; Gajdos M, 1997, Rozhl Chir, V76, P518; Giese A, 2002, SURG NEUROL, V57, P268, DOI 10.1016/S0090-3019(02)00643-2; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; Harat M, 2000, Neurol Neurochir Pol, V34, P487; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; Kohlmeier RE, 2001, AM J FOREN MED PATH, V22, P337, DOI 10.1097/00000433-200112000-00001; Kon T, 2002, NEUROL SURG TOKYO, V30, P517; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; MOSDAL C, 1985, ACTA NEUROCHIR, V74, P31, DOI 10.1007/BF01413273; Murano T, 2005, AM SURGEON, V71, P1009; Reiss M, 1998, Praxis (Bern 1994), V87, P832; Rosenfeld JV, 2002, J CLIN NEUROSCI, V9, P9, DOI 10.1054/jocn.2001.0949; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; STONE JL, 1995, J TRAUMA, V38, P851, DOI 10.1097/00005373-199506000-00002; SUDDABY L, 1987, CAN J NEUROL SCI, V14, P268, DOI 10.1017/S0317167100026597; Tsuei Yuang-Seng, 2005, J Chin Med Assoc, V68, P126, DOI 10.1016/S1726-4901(09)70233-3; Vrankovic D, 1998, INJURY, V29, P369, DOI 10.1016/S0020-1383(98)00054-0	30	15	15	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			CENT EUR NEUROSURG	Cent. Eur. Neurosurg.	FEB	2011	72	1					5	14		10.1055/s-0029-1241850			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	722PM	WOS:000287446800002	20309801				2021-06-18	
J	Rice, AC; Chiou, VL; Zuckoff, SB; Shapiro, SM				Rice, Ann C.; Chiou, Victoria L.; Zuckoff, Sarah B.; Shapiro, Steven M.			Profile of minocycline neuroprotection in bilirubin-induced auditory system dysfunction	BRAIN RESEARCH			English	Article						Brainstem auditory evoked potentials; Neonates; Gunn rats	JAUNDICED GUNN-RATS; EVOKED-POTENTIAL ABNORMALITIES; TRAUMATIC BRAIN-INJURY; INDUCED NEURONAL LOSS; NEUROLOGICAL DYSFUNCTION; GLUCURONYL TRANSFERASE; MICROGLIAL ACTIVATION; ACUTE HYPOGLYCEMIA; COCHLEAR NUCLEUS; STEM RESPONSE	Excessive hyperbilirubinemia in human neonates can cause permanent dysfunction of the auditory system, as assessed with brainstem auditory evoked potentials (BAEPs). Jaundiced Gunn rat pups (jjs) exhibit similar BAEP abnormalities as hyperbilirubinemic neonates. Sulfadimethoxine (sulfa) administration to jjs, which displaces bilirubin from serum albumin into tissues including brain, exacerbates acute toxicity. Minocycline administered prior to sulfa in jjs protects against BAEP abnormalities. This study evaluates the neuroprotective capabilities of minocycline HCl (50 mg/kg) administered 30 or 120 min after sulfa (200 mg/kg) in 16 days old jjs. BAEPs are recorded at 6 or 24 h post-sulfa. Abnormal BAEP waves exhibit increased latency and decreased amplitude. The sulfa/saline treated jjs exhibited a significantly increased interwave interval between waves I and II (I-II IWI) and significantly decreased amplitudes of waves II and III compared to the saline/saline jjs. The minocycline 30 min post-sulfa (sulfa/mino + 30) group was not significantly different from the saline/saline control group, indicating neuroprotection. The minocycline 120 min post-sulfa (sulfa/mino + 120) group had a significantly decreased amplitude of wave III at both 6 and 24 h. These studies indicate that minocycline has a graded neuroprotective effect when administered after acute bilirubin neurotoxicity. (C) 2010 Elsevier B.V. All rights reserved.	[Rice, Ann C.; Chiou, Victoria L.; Zuckoff, Sarah B.; Shapiro, Steven M.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA	Rice, AC (corresponding author), Virginia Commonwealth Univ, Dept Neurol, Box 980599, Richmond, VA 23298 USA.	acrice@vcu.edu; vchiou@wfubmc.edu; sarah.zuckoff@grnail.com; sshapiro@vcu.edu			NIH R01United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DC000369]; ADWilliams memorial trust; Jeffress memorial trust; Child Neurology Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000369] Funding Source: NIH RePORTER	These studies were supported by NIH R01 grant DC000369 and ADWilliams memorial trust to SMS, Jeffress memorial trust to ACR and Child Neurology Foundation Medical Scholarship to VC. We greatly appreciate the assistance of Dr. Robert J. Hamm with the statistical analyses.	Bhutani VK, 2004, SEMIN PERINATOL, V28, P319, DOI 10.1053/j.semperi.2004.09.006; BUCHWALD JS, 1975, SCIENCE, V189, P382, DOI 10.1126/science.1145206; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005; Firat Y, 2008, AM J OTOLARYNG, V29, P339, DOI 10.1016/j.amjoto.2008.02.001; Fruehwald-Schultes B, 2000, DIABETES CARE, V23, P1059, DOI 10.2337/diacare.23.8.1059; FULLERTON BC, 1990, HEARING RES, V49, P363, DOI 10.1016/0378-5955(90)90114-5; Galbraith G, 2006, J NEUROSCI METH, V153, P214, DOI 10.1016/j.jneumeth.2005.10.017; Geiger AS, 2007, NEONATOLOGY, V92, P219, DOI 10.1159/000103740; Giordano P, 2006, Acta Otorhinolaryngol Ital, V26, P198; Hoi-Hansen T, 2009, J RENIN-ANGIO-ALDO S, V10, P216, DOI 10.1177/1470320309343007; HUANG C, 1980, BRAIN RES, V184, P215, DOI 10.1016/0006-8993(80)90601-0; Husain K, 2004, HEARING RES, V191, P110, DOI 10.1016/j.heares.2004.01.011; Jacob RJ, 1999, DIABETES, V48, P141, DOI 10.2337/diabetes.48.1.141; Johnson L, 2009, J PERINATOL, V29, pS25, DOI 10.1038/jp.2008.211; JOHNSON L, 1959, AMA J DIS CHILD, V97, P591, DOI 10.1001/archpedi.1959.02070010593009; JOHNSON L, 1961, AM J DIS CHILD, V101, P322, DOI 10.1001/archpedi.1961.04020040050007; Kaplan M, 2004, CLIN PERINATOL, V31, P555, DOI 10.1016/j.clp.2004.05.001; KERN W, 1994, J NEUROPHYSIOL, V72, P678; LARROCHE JCL, 1968, KERNICTERUS HDB CLIN, P491; Lin SZ, 2005, EUR J NEUROSCI, V22, P21, DOI 10.1111/j.1460-9568.2005.04182.x; Maier K, 2007, NEUROBIOL DIS, V25, P514, DOI 10.1016/j.nbd.2006.10.022; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maisels MJ, 2000, MG CLIN PED, P139; MARKAND ON, 1994, J CLIN NEUROPHYSIOL, V11, P319, DOI 10.1097/00004691-199405000-00004; Mejia ROS, 2001, NEUROSURGERY, V48, P1393; Meli DN, 2006, INFECT IMMUN, V74, P3890, DOI 10.1128/IAI.01949-05; MOLLER AR, 1994, J CLIN NEUROPHYSIOL, V11, P284, DOI 10.1097/00004691-199405000-00002; MUNTE TF, 1995, NEUROREPORT, V6, P1509; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; Perlstein M. A., 1960, PEDIATR CLIN N AM, V7, P665; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Ping JL, 2007, J NEUROSCI METH, V161, P11, DOI 10.1016/j.jneumeth.2006.10.001; Popelar J, 2006, NEUROBIOL AGING, V27, P490, DOI 10.1016/j.neurobiolaging.2005.03.001; Quintero EM, 2006, BRAIN RES, V1093, P198, DOI 10.1016/j.brainres.2006.03.104; Rice AC, 2008, PEDIATR RES, V64, P265, DOI 10.1203/PDR.0b013e31817d9be0; Rice AC, 2006, BRAIN RES, V1107, P215, DOI 10.1016/j.brainres.2006.06.005; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Shaia WT, 2002, HEARING RES, V173, P82, DOI 10.1016/S0378-5955(02)00631-7; SHAPIRO SM, 1988, DEV BRAIN RES, V41, P147, DOI 10.1016/0165-3806(88)90178-2; SHAPIRO SM, 1989, ANN OTO RHINOL LARYN, V98, P308, DOI 10.1177/000348948909800414; SHAPIRO SM, 1991, HEARING RES, V57, P16; SHAPIRO SM, 1988, PEDIATR RES, V23, P306, DOI 10.1203/00006450-198803000-00015; SHAPIRO SM, 1993, PEDIATR RES, V34, P629, DOI 10.1203/00006450-199311000-00014; Shapiro SM, 2007, NEONATOLOGY, V92, P248, DOI 10.1159/000103743; Shapiro Steven M, 2005, J Perinatol, V25, P54, DOI 10.1038/sj.jp.7211157; Stevenson David K, 2004, Adv Pediatr, V51, P263; Strachan MWJ, 2003, DIABETOLOGIA, V46, P97, DOI 10.1007/s00125-002-0950-2; STREBEL L, 1971, PEDIATR RES, V5, P548, DOI 10.1203/00006450-197110000-00007; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; VOLPE JJ, 2001, BILIRUBIN BRAIN INJU, P490; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; ZAAROOR M, 1991, ELECTROEN CLIN NEURO, V80, P436, DOI 10.1016/0168-5597(91)90092-C; ZAAROOR M, 1991, ELECTROEN CLIN NEURO, V80, P422, DOI 10.1016/0168-5597(91)90091-B	55	15	17	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JAN 12	2011	1368						290	298		10.1016/j.brainres.2010.10.052			9	Neurosciences	Neurosciences & Neurology	714ZJ	WOS:000286849900031	20971088	Green Accepted			2021-06-18	
J	Amdur, D; Batres, A; Belisle, J; Brown, JH; Cornis-Pop, M; Mathewson-Chapman, M; Harms, G; Hunt, SC; Kennedy, P				Amdur, Deborah; Batres, Alfonso; Belisle, Janet; Brown, John H., Jr.; Cornis-Pop, Micaela; Mathewson-Chapman, Marianne; Harms, Gregory; Hunt, Stephen C.; Kennedy, Peggy			VA Integrated Post-Combat Care: A Systemic Approach to Caring for Returning Combat Veterans	SOCIAL WORK IN HEALTH CARE			English	Article						veteran; post-combat care; continuum of care; reintegration	TRAUMATIC BRAIN-INJURY; POLYTRAUMA REHABILITATION; AFGHANISTAN; IRAQ; HEALTH; WAR; RISK; PAIN	The Department of Veterans Affairs (VA's) mission is to care for those who have borne the battle. As medical technology has advanced, more and more of our returning combat Veterans survive what would have been fatal wounds in previous conflicts (Gawande, 2004). But survival is only the immediate goal-our job is to restore Veterans to the greatest level of health, independence, and quality of life that is medically possible. The VA is achieving this goal through close collaboration with the Department of Defense (DoD) to facilitate a smooth transition and continuum of care that ensures Veterans and Service Members receive the care they deserve. This article describes VA's system of Veteran-centered, post-combat care programs that rely on significant involvement of social workers to support Service Members, Veterans and their families through recovery, rehabilitation, and re-integration into their home communities.	[Batres, Alfonso; Harms, Gregory] Dept Vet Affairs, Readjustment Counseling Serv, Washington, DC USA; [Amdur, Deborah] Off Care Management & Social Work, Dept Vet Affairs, Washington, DC 20420 USA; [Belisle, Janet] Off Care Management & Social Work Serv, Dept Vet Affairs Cent Off, Dept Vet Affairs, Washington, DC USA; [Brown, John H., Jr.] VHA OEF OIF Outreach Off, Dept Vet Affairs, Washington, DC USA; [Cornis-Pop, Micaela] Off Rehabil Serv, Dept Vet Affairs, Richmond, VA USA; [Hunt, Stephen C.] Puget Sound Healthcare Syst, Post Deployment Integrated Care Initiat, Seattle, WA USA	Amdur, D (corresponding author), Off Care Management & Social Work, Dept VA, 810 Vermont Ave NW,Room 475C, Washington, DC 20420 USA.	Deborah.Amdur@va.gov					Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Helmer DA, 2007, J OCCUP ENVIRON MED, V49, P475, DOI 10.1097/JOM.0b013e318042d682; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; McFarlane AC, 2009, CURR OPIN PSYCHIATR, V22, P369, DOI 10.1097/YCO.0b013e32832c9064; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907	12	15	15	0	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0098-1389			SOC WORK HEALTH CARE	Soc. Work Health Care		2011	50	7			SI		564	575		10.1080/00981389.2011.554275			12	Social Work	Social Work	888PI	WOS:000300015600007	21846255				2021-06-18	
J	Jones, HN; Story, TJ; Collins, TA; Dejoy, D; Edwards, CL				Jones, Harrison N.; Story, Tyler J.; Collins, Timothy A.; DeJoy, Daniel; Edwards, Christopher L.			Multidisciplinary assessment and diagnosis of conversion disorder in a patient with foreign accent syndrome	BEHAVIOURAL NEUROLOGY			English	Article						Foreign accent syndrome; conversion disorder; neuropsychological assessment; case study; speech disorders	ARTICULATION; SIGN	Multiple reports have described patients with disordered articulation and prosody, often following acute aphasia, dysarthria, or apraxia of speech, which results in the perception by listeners of a foreign-like accent. These features led to the term foreign accent syndrome (FAS), a speech disorder with perceptual features that suggest an indistinct, non-native speaking accent. Also correctly known as psuedoforeign accent, the speech does not typically match a specific foreign accent, but is rather a constellation of speech features that result in the perception of a foreign accent by listeners. The primary etiologies of FAS are cerebrovascular accidents or traumatic brain injuries which affect cortical and subcortical regions critical to expressive speech and language production. Far fewer cases of FAS associated with psychiatric conditions have been reported. We will present the clinical history, neurological examination, neuropsychological assessment, cognitive-behavioral and biofeedback assessments, and motor speech examination of a patient with FAS without a known vascular, traumatic, or infectious precipitant. Repeated multidisciplinary examinations of this patient provided convergent evidence in support of FAS secondary to conversion disorder. We discuss these findings and their implications for evaluation and treatment of rare neurological and psychiatric conditions.	[Jones, Harrison N.] Duke Univ, Med Ctr, Dept Surg, Div Speech Pathol & Audiol, Durham, NC 27710 USA; [Story, Tyler J.; Collins, Timothy A.] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA; [Story, Tyler J.; DeJoy, Daniel] Duke Univ, Med Ctr, N Carolina State Univ, Dept Commun, Durham, NC 27710 USA; [Edwards, Christopher L.] Duke Univ, Med Ctr, Dept Psychiat, Div Med Psychol, Durham, NC 27710 USA; [Edwards, Christopher L.] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA	Jones, HN (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Speech Pathol & Audiol, 155 Baker Hose,Trent Dr,DUMC 3887, Durham, NC 27710 USA.	harrison.jones@duke.edu					Abel TJ, 2009, CLIN NEUROL NEUROSUR, V111, P97, DOI 10.1016/j.clineuro.2008.07.014; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Aronson A. E., 1990, CLIN VOICE DISORDERS; Avila C, 2004, NEUROREPORT, V15, P2267, DOI 10.1097/00001756-200410050-00025; Bakker JI, 2004, CAN J NEUROL SCI, V31, P271, DOI 10.1017/S0317167100053956; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A., 1994, MULTILINGUAL APHASIA; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; Briggs S. R, 1989, PERSONALITY PSYCHOL, P246; Butcher, 1989, MINNESOTA MULTIPHASI; Carbary TJ, 2000, BRAIN COGNITION, V43, P78; CHEN HI, 1989, J APPL PHYSIOL, V66, P943; Christoph DH, 2004, EUR NEUROL, V52, P198, DOI 10.1159/000082035; Costa P. T, 1985, NEO PERSONALITY INVE; Coughlan T, 2004, J ROY SOC MED, V97, P242, DOI 10.1258/jrsm.97.5.242; Crow HC, 1996, J GERONTOL A-BIOL, V51, pM247, DOI 10.1093/gerona/51A.5.M247; Delis DC, 2000, CALIFORNIA VERBAL LE; Derogatis LR, 1983, SCL 90 R ADM SCORING; Duffy JR, 2019, MOTOR SPEECH DISORDE; Edwards CL., 2005, CIENCIAS CONDUCTA, V20, P89; EDWARDS RJ, 2000, EUR NEUROL, V53, P87; Flipsen P, 2003, J SPEECH LANG HEAR R, V46, P724, DOI 10.1044/1092-4388(2003/058); FORD CV, 1985, PSYCHOSOMATICS, V26, P371, DOI 10.1016/S0033-3182(85)72845-9; Fridriksson J, 2005, NEUROCASE, V11, P319, DOI 10.1080/13554790591006302; GOLDEN GJ, 1978, STROOP COLOR WORD TE; Goldman-Eisler F., 1968, PSYCHOLINGUISTICS EX; Gonzalez-Alvarez J, 2003, REV NEUROLOGIA, V36, P227, DOI 10.33588/rn.3603.2002306; Green P., 2005, GREENS WORD MEMORY T; Gurd JM, 2001, CORTEX, V37, P715, DOI 10.1016/S0010-9452(08)70622-1; Haley KL, 2010, J NEUROLINGUIST, V23, P28, DOI 10.1016/j.jneuroling.2009.08.001; Hayes MW, 1999, MOVEMENT DISORD, V14, P914, DOI 10.1002/1531-8257(199911)14:6<914::AID-MDS1002>3.0.CO;2-B; Hem Erlend, 2006, Tidsskr Nor Laegeforen, V126, P3311; Kaplan E., 1983, BOSTON NAMING TEST; Keefe F. J., 1997, SEMINARS ANESTHESIA, V16, P117; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; Lindblom B., 1983, PRODUCTION SPEECH, P217, DOI DOI 10.1007/978-1-4613-8202-7_10; Lippert-Gruener M, 2005, BRAIN INJURY, V19, P955, DOI 10.1080/02699050500109506; Luzzi S, 2008, J NEUROL NEUROSUR PS, V79, P79, DOI 10.1136/jnnp.2006.113365; Mace CJ, 1996, BRIT J PSYCHIAT, V169, P282, DOI 10.1192/bjp.169.3.282; Marien P, 2007, FOLIA PHONIATR LOGO, V59, P210, DOI 10.1159/000102933; Marien P, 2006, CLIN NEUROL NEUROSUR, V108, P518, DOI 10.1016/j.clineuro.2005.06.006; Munson Patrick D, 2005, S D J Med, V58, P187; Okun MS, 2007, NEUROLOGIST, V13, P87, DOI 10.1097/01.nrl.0000256358.52613.cc; Poulin Stephane, 2007, Ann Gen Psychiatry, V6, P1, DOI 10.1186/1744-859X-6-1; Reeves RR, 2007, J NEUROPSYCH CLIN N, V19, P70, DOI 10.1176/appi.neuropsych.19.1.70; Reeves RR, 2001, NEUROPSY NEUROPSY BE, V14, P135; Reitan R. M., 1992, TRAIL MAKING TEST MA; Roth EJ, 1997, ARCH PHYS MED REHAB, V78, P550, DOI 10.1016/S0003-9993(97)90176-3; Ruff R. M., 1988, RUFF FIGURAL FLUENCY; Ryalls J, 2006, CLIN LINGUIST PHONET, V20, P157, DOI 10.1080/02699200400026900; SELIGER GM, 1992, STROKE, V23, P1655, DOI 10.1161/01.STR.23.11.1655; Spielberger C.D., 1970, STATE TRAIT ANXIETY; Stone J, 2003, AM J PSYCHIAT, V160, P391, DOI 10.1176/appi.ajp.160.2.391; TAKAYAMA Y, 1993, NEUROLOGY, V43, P1361, DOI 10.1212/WNL.43.7.1361; Tombaugh TN, 1996, TEST MEMORY MALINGER; Tsao YC, 1997, J SPEECH LANG HEAR R, V40, P858, DOI 10.1044/jslhr.4004.858; Van Borsel J, 2005, J COMMUN DISORD, V38, P421, DOI 10.1016/j.jcomdis.2005.03.004; Verhoeven J, 2005, BEHAV NEUROL, V16, P225, DOI 10.1155/2005/989602; Villaverde-Gonzalez R, 2003, REV NEUROLOGIA, V36, P1035, DOI 10.33588/rn.3611.2002609; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; WILKERSON G, 1993, WIDE RANGE ACHIEVEME, V3	64	15	16	1	18	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2011	24	3					245	255		10.1155/2011/786560			11	Clinical Neurology	Neurosciences & Neurology	834NC	WOS:000295967200007	21876264	DOAJ Gold, Green Published			2021-06-18	
J	Liddle, J; Fleming, J; McKenna, K; Turpin, M; Whitelaw, P; Allen, S				Liddle, Jacki; Fleming, Jennifer; McKenna, Kryss; Turpin, Merrill; Whitelaw, Penny; Allen, Shelley			Driving and driving cessation after traumatic brain injury: processes and key times of need	DISABILITY AND REHABILITATION			English	Article						Brain injury; driving; occupational therapy	COMMUNITY INTEGRATION; OLDER DRIVERS; REINTEGRATION; CONSTRUCTION; TRANSITION; OUTCOMES; SUPPORT; RETURN	Purpose. The ability to drive safely is commonly affected by traumatic brain injury (TBI). Driving is a role and activity that is highly valued and also associated with successful community reintegration after TBI. Relatively little is understood about the processes of interruption to driving and potential return to driving that can be experienced by people with TBI and their family members (FMs). Exploring the way in which driving interruption, return to driving and permanent cessation of driving happen for people with TBI, their FMs and health professionals (HPs) who work with them can enable a fuller understanding of the experiences and needs and enhance the rehabilitation approaches in this situation. Method. A descriptive phenomenological approach was used to explore the experience with the aim of improving services for people with TBI. Semi-structured interviews about driving and driving cessation were conducted with 15 people with TBI, 10 FMs and 10 HPs who had experience in driving and driving cessation issues. Results. The findings reveal experiences of the process of driving and driving cessation contextualised within experiences of the accident and treatment process. Participants identified key times of need in relation to driving: being told about driving restrictions, understanding driving restrictions, the 'on hold' period, and returning to driving. Conclusions. The processes surrounding driving and driving cessation after TBI are complex. Informational, support and practical needs differ at the different times. There are key times where people may need further support to improve rehabilitation outcomes. Rehabilitation approaches may particularly need to provide clear, consistent information about driving restrictions, and the process required for returning to driving. While recovery time appears necessary for allowing a safe return to driving, active support for continued involvement in the community using alternative transport may reduce the frustration and disengagement experienced by people in the 'on hold' period.	[Liddle, Jacki; Fleming, Jennifer; McKenna, Kryss; Turpin, Merrill; Whitelaw, Penny; Allen, Shelley] Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld, Australia	Liddle, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia.	j.liddle@uq.edu.au	; Liddle, Jacki/F-6872-2010	Turpin, Merrill/0000-0001-7946-0883; Liddle, Jacki/0000-0002-6336-9898	School of Health and Rehabilitation Motor Accident Insurance Commission (MAIC)	This project was funded by a School of Health and Rehabilitation Motor Accident Insurance Commission (MAIC) Rehabilitation Research Grant. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Austroads, 2003, ASS FITN DRIV; Brooks N, 2005, BRAIN INJURY, V19, P165, DOI 10.1080/02699050410001720004; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Hakamies-Blomqvist L, 1998, ACCIDENT ANAL PREV, V30, P305, DOI 10.1016/S0001-4575(97)00106-1; HakamiesBlomqvist L, 1996, J AM GERIATR SOC, V44, P650, DOI 10.1111/j.1532-5415.1996.tb01826.x; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Langdridge D., 2007, PHENOMENOLOGICAL PSY; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Liddle J, 2004, QUAL HEALTH RES, V14, P1396, DOI 10.1177/1049732304268793; Liddle J, 2007, AUST OCCUP THER J, V54, P303, DOI 10.1111/j.1440-1630.2006-00614.x; Liddle J, 2009, BRAIN IMPAIR, V10, P271, DOI 10.1375/brim.10.3.271; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Mezuk B, 2008, J GERONTOL B-PSYCHOL, V63, pS298, DOI 10.1093/geronb/63.5.S298; MOLNAR LJ, 2008, PROMISING APPROACHES; Novack TA, 2000, BRAIN INJURY, V14, P987; Patton M.Q., 2002, QUALITATIVE RES EVAL; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Qualitative Solutions and Research, 1999, NVIVO REF GUID SOFTW; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Verburg G, 2003, NEUROREHABILITATION, V18, P113	30	15	16	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2011	33	25-26					2574	2586		10.3109/09638288.2011.582922			13	Rehabilitation	Rehabilitation	851RO	WOS:000297288800019	21671828				2021-06-18	
J	Donaldson, RI; Hung, YW; Shanovich, P; Hasoon, T; Evans, G				Donaldson, Ross I.; Hung, Yuen Wai; Shanovich, Patrick; Hasoon, Tariq; Evans, Gerald			Injury Burden During an Insurgency: The Untold Trauma of Infrastructure Breakdown in Baghdad, Iraq	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Conflict; Injury; Iraq; War	HEALTH-CARE; MORTALITY; VIOLENCE; EPIDEMIOLOGY; PATTERNS; DARFUR; CONGO	Background: Injuries as a result of the ongoing violence in Iraq have been a topic of both lay and academic interest. However, to date, attempts to quantify injuries in the country have focused primarily on direct mortality, which represents only a small portion of overall injury burden and ignores those injuries indirectly resulting from the conflict-induced breakdown of Iraqi infrastructure. Methods: We performed a cross-sectional household survey from October to November, 2009, within the Baghdad Governorate of central Iraq. Using two-stage cluster-sampling with a proportional-to-size methodology, we randomized a total of 60 clusters to Baghdad's five governmental districts. Within each cluster, we interviewed heads of households regarding all injuries during the last 3 months. Results: We surveyed 1,172 households, gathering information regarding 7,396 individuals. Only 8.4% of injuries were intentional, and fatalities represented only a small fraction (1.7%) of overall injury burden. The well-publicized intentional explosions in Baghdad, although accounting for close to half (44%) of all intentional injuries, made up only 4% of the total. Other injuries at least partially attributable to the conflict-induced breakdown of Iraqi infrastructure proved a much larger burden, for example, those from electric shock, unintentional explosions, unintentional gunshot wounds, and falls. Conclusions: Past and current fighting in Baghdad continues to adversely affect the Iraqi populace, where the indirect effects of infrastructure breakdown are likely the primary source of injury. When measuring the burden of large-scale violence, health researchers should account for the full injury burden, including both injury morbidity and indirect injuries.	[Donaldson, Ross I.; Shanovich, Patrick] Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Dept Emergency Med, Los Angeles, CA 90095 USA; [Donaldson, Ross I.; Hung, Yuen Wai; Shanovich, Patrick; Hasoon, Tariq; Evans, Gerald] Int Med Corps, Baghdad, Iraq	Donaldson, RI (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Box 21, Torrance, CA 90509 USA.	ross@rossdonaldson.com			Australian Agency for International Development (AusAID)Australian Aid (AusAID); Iraqi Ministry of Health; International Medical Corps	Supported by Australian Agency for International Development (AusAID), Iraqi Ministry of Health, and International Medical Corps.	Aboutanos MB, 1997, J TRAUMA, V43, P719, DOI 10.1097/00005373-199710000-00031; Ahoua L, 2006, Glob Public Health, V1, P195, DOI 10.1080/17441690600681869; Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; Awqati NA, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-40; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Cardona M, 2008, INJURY PREV, V14, P232, DOI 10.1136/ip.2007.018259; *CENTR ORG STAT IN, 2008, TAB REP IR HOUS SOC; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Count Iraq Body, DOC CIV DEATHS VIOL; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Fatmi Z, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-152; HICKS MH, N ENGL J MED, V360, P1585; Hyder AA, 2009, J TRAUMA, V66, P888, DOI 10.1097/TA.0b013e3181627614; *INT ORG MIGR, IR DISPL RET 2008 MI; Kobusingye O, 2001, Inj Prev, V7, P46, DOI 10.1136/ip.7.1.46; Maziak W, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-63; Olawale OA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-246; Rezapur-Shahkolai F, 2009, PUBLIC HEALTH, V123, P384, DOI 10.1016/j.puhe.2009.03.010; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Siegler A, 2008, PREHOSP DISASTER MED, V23, P369, DOI 10.1017/S1049023X00006026; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Tercero F, 2006, PUBLIC HEALTH, V120, P106, DOI 10.1016/j.puhe.2005.07.005; *UN OFF COORD HUM, 2009, BAGHD GOV PROF; Van Herp M, 2003, DISASTERS, V27, P141, DOI 10.1111/1467-7717.00225; WHO, 2004, GUID COND COMM SURV	26	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2010	69	6					1379	1385		10.1097/TA.0b013e318203190f			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	695RT	WOS:000285391000022	21150518				2021-06-18	
J	Nathanson, AT; Baird, J; Mello, M				Nathanson, Andrew T.; Baird, Janette; Mello, Michael			Sailing Injury and Illness: Results of an Online Survey	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						sailing; injury; illness; injury prevention	OLYMPIC CLASS SAILORS; EPIDEMIOLOGY; PERFORMANCE; PATTERNS; MEDICINE; INTERNET; WORLD	Objective.-The purpose of this study was to describe the relative frequency, patterns, and mechanisms of sailing-related injuries in dinghies and keelboats. Data were also collected on risky and risk-averse behaviors of sailors, as well as on sailing-related illnesses. Methods.-A web-based, logic-driven, multiple-choice survey was developed and links were posted on sailing-related websites. Data were collected from March through November 2006 on any injuries or illnesses sailors sustained over the prior 12 months. Results.-From 1188 respondents, a total of 1715 injuries and 559 illnesses was reported. The top 3 injuries for keel boats were leg contusions (11%), hand lacerations (8%), and arm contusions (6%), and in dinghies they were leg contusions (13%), knee contusions (6%), and leg lacerations (6%). The most common mechanisms of injury were "trip/fall," "hit by object," and "caught in lines." Tacking, heavy weather, and jibing were the most common factors contributing to injury. The rates of injury and severe injury in this internet-based survey were 4.6 and 0.57 per 1000 days of sailing, respectively. Of the 70 severe injuries, 25% were fractures, 16% were torn tendons or cartilage, 14% were concussions, and 8% were dislocations. The median rate of lifejacket use was 30%, and median rate of sunscreen use was 80%. Sixteen percent of sailors reported sunburn over the prior 12 months. Seven percent of sailors reported use of alcohol within the 2 hours preceding injury. Conclusions.-The most common injuries in both keel boats and dinghies are soft-tissue injuries to the extremities. Severe injuries and illnesses in sailing are uncommon in this study population.	[Nathanson, Andrew T.] Rhode Isl Hosp, Dept Emergency Med, Injury Prevent Ctr, Providence, RI 02903 USA; Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA	Nathanson, AT (corresponding author), Rhode Isl Hosp, Dept Emergency Med, Injury Prevent Ctr, 593 Eddy St, Providence, RI 02903 USA.	Anathanson@lifespan.org			Bonnell Cove Foundation	Funding was obtained from the Bonnell Cove Foundation.	Aagaard P, 1998, SCAND J MED SCI SPOR, V8, P138; Allen JB, 2006, BRIT J SPORT MED, V40, P587, DOI 10.1136/bjsm.2002.001669; Allen J B, 1999, Phys Med Rehabil Clin N Am, V10, P49; Allen J.B., 2005, NZ J SPORTS MED, V33, P43; Branth S, 1996, MED SCI SPORT EXER, V28, P1272, DOI 10.1097/00005768-199610000-00010; Howland J, 2001, ACCIDENT ANAL PREV, V33, P257, DOI 10.1016/S0001-4575(00)00040-3; Jacobs M. E., 2007, WILDERNESS MED, P1780; Legg S, 1999, J SPORT MED PHYS FIT, V39, P315; Legg SJ, 1997, J SPORT MED PHYS FIT, V37, P41; Legg SJ, 1997, J SPORT MED PHYS FIT, V37, P213; McCormick D P, 1988, Br J Sports Med, V22, P95; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nathanson AT, 2008, WILD ENVIRON MED, V19, P129, DOI 10.1580/07-WEME-BR-1471.1; Nathanson AT, 1999, WILD ENVIRON MED, V10, P218, DOI 10.1580/1080-6032(1999)010[0218:WIROAP]2.3.CO;2; Neville V, 2009, SPORTS MED, V39, P129, DOI 10.2165/00007256-200939020-00003; Neville VJ, 2006, BRIT J SPORT MED, V40, P304, DOI 10.1136/bjsm.2005.021477; NEWTON F, 1989, PRACTITIONER, V233, P1032; Price CJS, 2002, BRIT J SPORT MED, V36, P457, DOI 10.1136/bjsm.36.6.457; Reimers S, 2007, ARCH SEX BEHAV, V36, P147, DOI 10.1007/s10508-006-9143-2; Schaefer O, 2000, SPORTVERLETZ SPORTSC, V14, P25, DOI 10.1055/s-2000-3819; Shephard RJ, 1997, SPORTS MED, V23, P350, DOI 10.2165/00007256-199723060-00002; Shoveller J A, 2001, Chronic Dis Can, V22, P83; 2007, RECREATIONAL BOATING; 2007, NATL LIFE JACKET WEA	24	15	16	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1080-6032			WILD ENVIRON MED	Wildern. Environ. Med.	WIN	2010	21	4					291	297		10.1016/j.wem.2010.06.006			7	Public, Environmental & Occupational Health; Sport Sciences	Public, Environmental & Occupational Health; Sport Sciences	700AE	WOS:000285703700003	21168780	Bronze			2021-06-18	
J	Sankhyan, N; Raju, KNV; Sharma, S; Gulati, S				Sankhyan, Naveen; Raju, K. N. Vykunta; Sharma, Suvasini; Gulati, Sheffali			Management of Raised Intracranial Pressure	INDIAN JOURNAL OF PEDIATRICS			English	Article						Coma; Critically ill child; Intracranial hypertension; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; HYPERTONIC SALINE; DECOMPRESSIVE CRANIECTOMY; CRITICAL-CARE; HYPOTHERMIA; THERAPY; TRIAL; EDEMA; FUROSEMIDE	Appropriate management of raised intracranial pressure begins with stabilization of the patient and simultaneous assessment of the level of sensorium and the cause of raised intracranial pressure. Stabilization is initiated with securing the airway, ventilation and circulatory function. The identification of surgically remediable conditions is a priority. Emergent use of external ventricular drain or ventriculo-peritoneal shunt may be lifesaving in selected patients. In children with severe coma, signs of herniation or acutely elevated intracranial pressure, treatment should be started prior to imaging or invasive monitoring. Emergent use of hyperventilation and mannitol are life saving in such situations. Medical management involves careful use of head elevation, osmotic agents, and avoiding hypotonic fluids. Appropriate care also includes avoidance of aggravating factors. For refractory intracranial hypertension, barbiturate coma, hypothermia, or decompressive craniectomy should be considered.	[Sankhyan, Naveen; Raju, K. N. Vykunta; Sharma, Suvasini; Gulati, Sheffali] All India Inst Med Sci, Dept Pediat, Child Neurol Div, New Delhi 110029, India	Gulati, S (corresponding author), All India Inst Med Sci, Dept Pediat, Child Neurol Div, New Delhi 110029, India.	sheffaligulati@gmail.com	SANKHYAN, NAVEEN/AAP-6531-2021				Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Berger C, 2005, STROKE, V36, pE4, DOI 10.1161/01.STR.0000151328.70519.e9; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; Bilotta F, 2008, NEUROCRIT CARE, V8, P241, DOI 10.1007/s12028-007-9012-4; Biousse V, 2003, AM J OPHTHALMOL, V135, P437, DOI 10.1016/S0002-9394(02)02062-7; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Edwards P, 2005, LANCET, V365, P1957; Feigin VL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004583.pub2; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; FRENCH L A, 1964, Clin Neurosurg, V10, P212; GOLDSTEIN B, 2008, ROGERS TXB PEDIAT IN; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; HOFFMAN SL, 1988, J INFECT DIS, V158, P325, DOI 10.1093/infdis/158.2.325; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Larive LL, 2004, NEUROCRIT CARE, V1, P435, DOI 10.1385/NCC:1:4:435; LAYON JA, 2004, TXB NEUROINTENSIVE C, P709; Marcoux KK, 2005, AACN ADV CRIT CARE, V16, P212, DOI 10.1097/00044067-200504000-00012; MARSH ML, 1977, ANESTHESIOLOGY, V47, P149, DOI 10.1097/00000542-197708000-00006; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; MILLER JD, 1992, J NEUROTRAUM, V9, pS317; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SCHALEN W, 1992, ACTA NEUROCHIR, V117, P153, DOI 10.1007/BF01400613; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Suarez Jose I, 2004, Cleve Clin J Med, V71 Suppl 1, pS9; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thenuwara K, 2002, ANESTHESIOLOGY, V96, P416, DOI 10.1097/00000542-200202000-00029; TORNHEIM PA, 1979, NEUROSURGERY, V4, P48, DOI 10.1227/00006123-197901000-00009; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	39	15	16	0	3	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0019-5456	0973-7693		INDIAN J PEDIATR	Indian J. Pediatr.	DEC	2010	77	12					1409	1416		10.1007/s12098-010-0190-2			8	Pediatrics	Pediatrics	693EI	WOS:000285207000007	20821277				2021-06-18	
J	Winkler, D; Farnworth, L; Sloan, S; Brown, T; Callaway, L				Winkler, Dianne; Farnworth, Louise; Sloan, Sue; Brown, Ted; Callaway, Libby			Comparison of People With ABI Living in Two Accommodation Settings: Shared Supported Accommodation and Residential Aged Care	BRAIN IMPAIRMENT			English	Article						community participation; social inclusion	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; COMMUNITY INTEGRATION; NEEDS SCALE; REHABILITATION; OUTCOMES; PARTICIPATION; POSTDISCHARGE; INDIVIDUALS; PREDICTION	Background: People with severe acquired brain injury (AB!) often require high and ongoing levels of paid support, which is sometimes provided within a shared supported accommodation service (SSA). In Victoria there are more than 140 people with severe ABI living in shared supported accommodation services who have a similar level of disability as young people with ABI in residential aged care (RAC). Objectives: The aims of this article are twofold: (1) to describe the characteristics, support needs and level of community inclusion of people with an ABI living in shared SSA in Victoria and (2) to compare the characteristics, support needs, social contact, community integration and leisure participation of this group with a group of people with ABI under 50 years old living in RAC reported in a previous study. Participants: Information was obtained from SSA managers on 128 residents with an ABI, aged under 60 years, who were living in shared supported accommodation. Measures: Questionnaires were used to obtain information about the characteristics, support needs and occupational participation of participants. Support needs were measured utilising the Care and Needs Scale (CANS). Method: Questionnaires were sent to and completed by SSA managers. Results: Of the 39 SSA managers contacted, 32 provided information about the characteristics of 128 residents with ABI living in their facilities. While 72% of SSA residents accessed the community almost everyday or more often, 40% of this sample received a visit from a friend less often than once per year. Results of the CANS indicated that the SSA group required a similar level of support to the comparison group of people with ABI living in RAC, but went outside, participated in community based leisure activities, and visited friends significantly more often. There was no significant difference between the two groups in the frequency of visits to the facility from relatives or friends. Conclusion: Although the relationship between client outcomes and accommodation is a complex one, this study suggests that the type of accommodation and support has a significant impact on the frequency of community participation experienced people with ABI and high care needs.	[Winkler, Dianne] Monash Univ, Melbourne, Vic 3004, Australia; [Winkler, Dianne] Summer Fdn, Melbourne, Vic, Australia; [Farnworth, Louise; Brown, Ted; Callaway, Libby] Monash Univ Frankston, Dept Occupat Therapy, Frankston, Vic, Australia; [Sloan, Sue] Osborn Sloan & Associates, Melbourne, Vic, Australia	Winkler, D (corresponding author), POB 208, Blackburn, Vic 3130, Australia.	di.winkler@summerfoundation.org.au		Winkler, Di/0000-0003-3899-6248; Brown, Ted/0000-0001-9403-5877			*AUSTR I HLTH WELF, 2007, AIHW B, V67; *AUSTR I HLTH WELF, 2003, DAT GUID DAT IT DEF; *AUSTR I HLTH WELF, 2010, YOUNG PEOPL DIS RES; Baguley I, 2000, BRAIN INJURY, V14, P505; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cameron C, 2001, AUST NZ J PUBL HEAL, V25, P261, DOI 10.1111/j.1467-842X.2001.tb00574.x; Colantonio A, 2010, BRAIN IMPAIR, V11, P31, DOI 10.1375/brim.11.1.31; *COMM DEP HLTH AG, 2002, INF YOUNG PEOPL DIS; *DEP FAM HOUS COMM, 2009, YOUNG PEOPL DIS RES; *DEP HLTH HUM SERV, 2001, ACQ BRAIN INJ STRAT; *DEP HLTH HUM SERV, 2005, CREAT NEW OPP RESP N; Dillman D.A., 2000, MAIL INTERNET SURVEY; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Emerson E, 1996, J INTELLECT DEV DIS, V21, P17, DOI 10.1080/13668259600033021; Felce D., 1996, DEINSTITUTIONALISATI, P81; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; Fyffe C, 2003, YOUNG PEOPLE ABI LES; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Kim S, 2001, J INTELLECT DEV DIS, V26, P35, DOI 10.1080/13668250020032750; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Mansell J., 1996, DEINSTITUTIONALISATI, P242; Matthews S., 1983, AGEING SOC, V3, P141; McMillan TM, 2004, CLIN REHABIL, V18, P132, DOI 10.1191/0269215504cr712oa; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PAPASTRAT LA, 1992, J HEAD TRAUMA REHAB, V7, P11; Ponsford J., 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Senate Community Affairs References Committee, 2005, COMM AFF REF COMM QU; SLOAN S, 2007, BRAIN IMPAIR, V8, P251, DOI DOI 10.1375/BRIM.8.3.251; Social Inclusion Unit, 2009, AUSTR PUBL SERV SOC; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; *SPSS, 2007, SPSS VERS 16 0 BAS; Strettles B, 2005, ACCOMMODATION NSW AD; Stringer K, 1999, STUDY ACCOMMODATION; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; TATE RL, 2003, 26 ANN BRAIN IMP C S; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Willer B., 1993, J HEAD TRAUMA REHABI, V8, P11; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler D., 2007, YOUNGER PEOPLE RESID; Winkler Dianne, 2006, Aust Health Rev, V30, P100; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; WISEMAN JP, 1986, J SOC PERS RELAT, V3, P191, DOI 10.1177/0265407586032005; World Health Organization, 2001, INT CLASS FUNCT DIS; Young L, 2001, J INTELLECT DEV DIS, V26, P51, DOI 10.1080/13668250020032769; Young L, 1998, J INTELLECT DEV DIS, V23, P155, DOI 10.1080/13668259800033661	54	15	15	1	5	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2010	11	3					313	325		10.1375/brim.11.3.313			13	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	710VJ	WOS:000286544800007					2021-06-18	
J	Kondo, K; Maruishi, M; Ueno, H; Sawada, K; Hashimoto, Y; Ohshita, T; Takahashi, T; Ohtsuki, T; Matsumoto, M				Kondo, Keita; Maruishi, Masaharu; Ueno, Hiroki; Sawada, Kozue; Hashimoto, Yukari; Ohshita, Tomohiko; Takahashi, Tetsuya; Ohtsuki, Toshiho; Matsumoto, Masayasu			The pathophysiology of prospective memory failure after diffuse axonal injury - Lesion-symptom analysis using diffusion tensor imaging	BMC NEUROSCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; EVENT; COMPONENTS; ANISOTROPY; REGIONS; TIME	Background: Prospective memory (PM) is one of the most important cognitive domains in everyday life. The neuronal basis of PM has been examined by a large number of neuroimaging and neuropsychological studies, and it has been suggested that several cerebral domains contribute to PM. For these activation studies, a constellation of experimental PM trials was developed and adopted to healthy subjects. In the present study, we used a widely used clinical PM assessment battery to determine the lesions attributable to PM failure, with the hypothesis that lesion-symptom analysis using diffusion tensor imaging (DTI) in subjects with diffuse axonal injury (DAI) can reveal the neuronal basis of PM in everyday life. Results: Fourteen DAI patients (age: range of 18-36, median 24) participated in this study. PM failure was scored in the range of 0-6 using three sub-tests of the Rivermead Behavioural Memory Test. The PM scores of DAI patients were in the range of 2-6 (median 4.5, inter-quartile range 2.25). The severity of axonal injury following DAI was examined using fractional anisotropy (FA), one of the DTI parameters, at voxel level in each subject. We then obtained clusters correlated with PM failure by conducting voxel-based regression analysis between FA values and PM scores. Three clusters exhibited significant positive correlation with PM score, the left parahippocampal gyrus, left inferior parietal lobe, and left anterior cingulate. Conclusions: This is the first lesion-symptom study to reveal the neuronal basis of PM using DTI on subjects with DAI. Our findings suggest that the neuronal basis of PM is in the left parahippocampal gyrus, left inferior parietal lobe, and/or left anterior cingulate. These findings are similar to those of previous activation studies with loading experimental PM tasks.	[Kondo, Keita; Ueno, Hiroki; Ohshita, Tomohiko; Takahashi, Tetsuya; Ohtsuki, Toshiho; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, Hiroshima, Japan; [Kondo, Keita; Maruishi, Masaharu; Ueno, Hiroki; Sawada, Kozue; Hashimoto, Yukari] Hiroshima Prefectural Rehabil Ctr, Hiroshima Higher Brain Funct Ctr, Higashihiroshima, Japan; [Hashimoto, Yukari] Fukuyama Univ, Dept Psychol, Fukuyama, Hiroshima, Japan; [Maruishi, Masaharu] Hiroshima Prefectural Coll Hlth Sci, Dept Commun Sci & Disorders, Hiroshima, Japan	Takahashi, T (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan.	tetakaha@mac.com			General Insurance Association of Japan; Ministry of Health, Labour, and Welfare of JapanMinistry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21700563] Funding Source: KAKEN	We thank the entire staff of the Hiroshima Higher Brain Function Center for assistance in subject recruitment and testing. This research was supported in part by grants from the General Insurance Association of Japan and from the Ministry of Health, Labour, and Welfare of Japan.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ardekani BA, 2003, NEUROREPORT, V14, P2025, DOI 10.1097/00001756-200311140-00004; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Asari T, 2005, NEUROIMAGE, V26, P694, DOI 10.1016/j.neuroimage.2004.12.063; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; Cockburn J, 1996, J CLIN EXP NEUROPSYC, V18, P304, DOI 10.1080/01688639608408284; Einstein, 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; EVANS RW, 1992, NEUROL CLIN, V10, pR11; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; McDaniel M. A., 2007, PROSPECTIVE MEMORY O, P171; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NARAYAN RK, 1989, TXB HEAD INJURY, P23; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; Wieshmann UC, 1999, LANCET, V353, P1242, DOI 10.1016/S0140-6736(99)00248-2; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa	39	15	16	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	NOV 20	2010	11								147	10.1186/1471-2202-11-147			7	Neurosciences	Neurosciences & Neurology	691CD	WOS:000285057000001	21092119	DOAJ Gold, Green Published			2021-06-18	
J	Meade, AJ; Meloni, BP; Mastaglia, FL; Watt, PM; Knuckey, NW				Meade, Amanda J.; Meloni, Bruno P.; Mastaglia, Frank L.; Watt, Paul M.; Knuckey, Neville W.			AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid	BRAIN RESEARCH			English	Article						Neuroprotection; Excitotoxicity; Phylomer peptide; TAT; c-Jun; JNKI	N-TERMINAL KINASE; ADULT-RAT BRAIN; C-JUN; INDUCED SEIZURE; CLUSTAL-W; KAINATE; EXCITOTOXICITY; ACTIVATION; ISCHEMIA; EXPRESSION	This study has assessed the neuroprotective efficacy of five AP-1 inhibitory peptides in an in vitro excitotoxicity model. The five AP-1 inhibitory peptides and controls of the INK inhibitor peptide (JNKI-1D-TAT) and TAT cell-penetrating-peptide were administered to primary cortical neuronal cultures prior to kainic acid exposure. All five AP-1 inhibitory peptides and JNKI-1D-TAT provided significant neuroprotection from kainic acid induced neuronal cell death. Kainic acid exposure induced caspase and calpain activation in neuronal cultures, with caspase-induced cleavage of a-fodrin reduced by administration of the AP-1 inhibitory peptides. Sequence analysis of the AP-1 inhibitory peptides did not reveal the presence of any secondary structures; however two peptides shared 66% amino-acid sequence homology. As a result, truncated sequences were designed and synthesised to identify the active region of the peptides. All truncated peptides were significantly neuroprotective following kainic acid and glutamate exposure. We have shown for the first time the neuroprotective efficacy of full-length and truncated AP-1 inhibitory peptides in kainic acid and glutamate neuronal excitotoxicity models. The identification of therapeutic targets, such as the AP-1 complex, is an important step for the development of pharmaceuticals to reduce neuronal loss in disorders with a prevalence of excitotoxic cell death such as epilepsy, cerebral ischaemia, and traumatic brain injury. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.	[Meade, Amanda J.; Meloni, Bruno P.; Mastaglia, Frank L.; Knuckey, Neville W.] QEII Med Ctr, Australian Neuromuscular Res Inst, Nedlands, WA 6009, Australia; [Meade, Amanda J.; Meloni, Bruno P.; Mastaglia, Frank L.; Knuckey, Neville W.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia; [Meloni, Bruno P.; Knuckey, Neville W.] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia; [Watt, Paul M.] Univ Western Australia, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia	Meloni, BP (corresponding author), QEII Med Ctr, Australian Neuromuscular Res Inst, A Block,4th Floor,Verdun St, Nedlands, WA 6009, Australia.	meloni@cyllene.uwa.edu.au	Craig, Amanda/F-6699-2013	Craig, Amanda/0000-0002-7197-4369	Neurotrauma Research Project Grant; University of Western Australia; Phylogica Ltd.	The authors would like to thank Dr Nadia Milech, Ms Kate Thomas, Ms Joanne Chieng and Mr Tom Hamilton for their technical support and Dr Kym Campbell for expert editing. This work was supported by a Neurotrauma Research Project Grant, The University of Western Australia and Phylogica Ltd.	Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Bi XN, 1996, BRAIN RES, V726, P98, DOI 10.1016/0006-8993(95)01360-1; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340; CHOI DW, 1987, J NEUROSCI, V7, P357; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Fahrig T, 2005, MOL PHARMACOL, V67, P1544, DOI 10.1124/mol.104.008177; Fernandez M, 2005, J NEUROSCI RES, V82, P115, DOI 10.1002/jnr.20608; Gill MB, 2008, NEUROCHEM RES, V33, P2379, DOI 10.1007/s11064-008-9649-1; Gillardon F, 1997, MOL BRAIN RES, V50, P16, DOI 10.1016/S0169-328X(97)00162-9; Hoyt KR, 1998, J PHYSIOL-LONDON, V509, P103, DOI 10.1111/j.1469-7793.1998.103bo.x; Jeon SH, 2000, EXP MOL MED, V32, P227, DOI 10.1038/emm.2000.37; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu W, 2001, BRAIN RES, V916, P239, DOI 10.1016/S0006-8993(01)03006-2; Manno A, 2007, NEUROREPORT, V18, P373; Meade AJ, 2010, J NEUROCHEM, V112, P258, DOI 10.1111/j.1471-4159.2009.06459.x; Meloni BP, 2001, NEUROSCIENCE, V108, P17, DOI 10.1016/S0306-4522(01)00396-7; Mielke K, 1999, NEUROSCIENCE, V91, P471, DOI 10.1016/S0306-4522(98)00667-8; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; NADLER JV, 1981, LIFE SCI, V29, P2031; Niebauer M, 1999, NEUROPHARMACOLOGY, V38, P1343, DOI 10.1016/S0028-3908(99)00059-3; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Pugazhenthi S, 2006, FREE RADICAL BIO MED, V40, P21, DOI 10.1016/j.freeradbiomed.2005.08.023; Schauwecker PE, 2000, BRAIN RES, V884, P116, DOI 10.1016/S0006-8993(00)02888-2; SMEAL T, 1989, GENE DEV, V3, P2091, DOI 10.1101/gad.3.12b.2091; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troy CM, 2001, J NEUROCHEM, V77, P157, DOI 10.1046/j.1471-4159.2001.t01-1-00218.x; Vaslin A, 2009, NEUROTOX RES, V15, P123, DOI 10.1007/s12640-009-9012-6; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang L, 2008, J NEUROSURG ANESTH, V20, P124, DOI 10.1097/ANA.0b013e3181667c27; Xu W, 2008, NEUROSCIENTIST, V14, P409, DOI 10.1177/1073858407309762	34	15	16	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 11	2010	1360						8	16		10.1016/j.brainres.2010.09.007			9	Neurosciences	Neurosciences & Neurology	680RR	WOS:000284252600002	20833150				2021-06-18	
J	Feeney, TJ				Feeney, Timothy J.			Structured Flexibility: The Use of Context-Sensitive Self-regulatory Scripts to Support Young Persons with Acquired Brain Injury and Behavioral Difficulties	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavior disorders; cognitive-behavioral intervention; ecological validity; functional assessment; multicomponent intervention; pediatric rehabilitation; positive behavior support; school-based treatment; traumatic brain injury	PSYCHIATRIC-DISORDERS; CHILDREN; TBI; INTERVENTIONS; ADOLESCENTS; CORTEX	Objective: This study investigated the effects of a cognitive-behavioral intervention on the escalating behavior problems observed in 2 children with severe traumatic brain injury. Design: Multiple baseline designs were used to document the effects of an intervention package that integrated cognitive and executive function interventions to address severe challenging behaviors in public school settings. Main outcomes and results: The results suggested that the intervention reduced the frequency and intensity of challenging behaviors and increased the quantity of work completed. Conclusions: These 2 successful single-subject experiments expand the findings of previous studies on the use of a support-oriented intervention that uses context-sensitive, flexible cognitive/behavioral scripts combined with positive behavior interventions and supports to reduce challenging behaviors.	Sch & Community Support Inc, Latham, NY 12110 USA	Feeney, TJ (corresponding author), Sch & Community Support Inc, 17 British Amer Blvd, Latham, NY 12110 USA.	tim@positivesupport.org	Berger, Emily/N-7268-2017	Berger, Emily/0000-0001-5550-807X			Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BARLOW D, 1991, SINGLE CASE EXPT DES, P47; BIJOU SW, 1968, J APPL BEHAV ANAL, V1, P175, DOI 10.1901/jaba.1968.1-175; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bronson MB, 2000, SELF-REGULATION IN EARLY CHILDHOOD, P1; Carr EG, 2002, J POSIT BEHAV INTERV, V4, P4, DOI 10.1177/109830070200400102; COSTEFF H, 1985, SCAND J REHABIL MED, P10; DURAND VM, 1991, J APPL BEHAV ANAL, V24, P251, DOI 10.1901/jaba.1991.24-251; DURAND VM, 1992, MOTIVATION ASSESSMEN; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; FEENEY TJ, TXB TRAUMAT IN PRESS; Glesne C., 1992, BECOMING QUALITATIVE; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; McDonald S., 2005, BRAIN IMPAIR, V6, P56, DOI DOI 10.1375/BRIM.6.1.56.65481; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Singh N. N., 1994, ABERRANT BEHAV CHECK; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2008, EXECUTIVE FUNCTIONS, P409; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker M, 2009, DEV NEUROREHABIL, V12, P370, DOI 10.3109/17518420903087533; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	28	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2010	25	6					416	425		10.1097/HTR.0b013e3181fbc0a2			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	679HA	WOS:000284151300003	21076242				2021-06-18	
J	Friedman, DE; Tobias, RS; Akman, CI; Smith, EO; Levin, HS				Friedman, David E.; Tobias, Ronnie S.; Akman, Cigdem I.; Smith, E. O'Brian; Levin, Harvey S.			Recurrent seizure-related injuries in people with epilepsy at a tertiary epilepsy center: A 2-year longitudinal study	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Seizure; Injury; Head injury	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; HEAD-INJURY; DYSFUNCTION; HISTORY	Though seizure-related injuries (SRIs) among people with epilepsy (PWE) have recently gained much attention in the literature, most studies are retrospective and data are gathered indirectly through questionnaires or medical record documentation. We investigated SRIs and their associated risks in PWE attending a tertiary care center with direct and systematic inquiries during routine clinic follow-up visits over a 2-year period (N=306). Past SRIs occurred in 54% of all patients, and 24% experienced recurrent SRIs during the study period. On multiple regression analyses, past SRI was associated with tonic-clonic seizures (TCSs) (3.2, 95% CI = 1.7-5.8) and cognitive handicap (4.3, 95% CI 1.5-16.1), and recurrent SRI was associated with TCSs (3.5, 95% CI=1.6-7.9). Most recurrent SRIs (72%) involved head injury. SRIs are common when assessed systematically in a tertiary care setting, and TCSs represent a risk factor for recurrent SRIs. The potential clinical impact of recurrent SRIs on PWE requires further study. (C) 2010 Elsevier Inc. All rights reserved.	[Friedman, David E.; Tobias, Ronnie S.; Akman, Cigdem I.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Smith, E. O'Brian] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Friedman, DE (corresponding author), 1 Baylor Plaza,NB 302, Houston, TX 77030 USA.	defriedm@bcm.tmc.edu					Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1989, EPILEPSIA, V30, P348, DOI 10.1111/j.1528-1157.1989.tb05308.x; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Beghi E, 2002, EPILEPSIA, V43, P1076, DOI 10.1046/j.1528-1157.2002.18701.x; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLUME WT, 1973, BRAIN, V96, P289, DOI 10.1093/brain/96.2.289; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DESAI BT, 1983, ANN EMERG MED, V12, P543, DOI 10.1016/S0196-0644(83)80294-7; Duncan JS, 2003, ANN NEUROL, V54, P421, DOI 10.1002/ana.10710; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Friedman DE, 2010, EPILEPSIA, V51, P43, DOI 10.1111/j.1528-1167.2009.02170.x; Hermann BP, 2006, ANN NEUROL, V60, P80, DOI 10.1002/ana.20872; Krauss GL, 1999, NEUROLOGY, V52, P1324, DOI 10.1212/WNL.52.7.1324; Lawn ND, 2004, NEUROLOGY, V63, P1565, DOI 10.1212/01.WNL.0000142991.14507.B5; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Motamedi G, 2003, EPILEPSY BEHAV, V4, pS25, DOI 10.1016/j.yebeh.2003.07.004; NAKKEN KO, 1993, EPILEPSIA, V34, P836, DOI 10.1111/j.1528-1157.1993.tb02099.x; Neufeld MY, 1999, EPILEPSY RES, V34, P123, DOI 10.1016/S0920-1211(98)00105-3; Pellock JM, 2000, MENT RETARD DEV D R, V6, P309, DOI 10.1002/1098-2779(2000)6:4<309::AID-MRDD10>3.0.CO;2-I; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELLJONES DL, 1989, J NEUROL NEUROSUR PS, V52, P659, DOI 10.1136/jnnp.52.5.659; Sherrard J, 2002, J INTELL DISABIL RES, V46, P6, DOI 10.1046/j.1365-2788.2002.00346.x; SPITZ MC, 1994, EPILEPSIA, V35, P764, DOI 10.1111/j.1528-1157.1994.tb02508.x; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Thompson PJ, 2005, EPILEPSIA, V46, P1780, DOI 10.1111/j.1528-1167.2005.00279.x; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	30	15	16	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	NOV	2010	19	3					400	404		10.1016/j.yebeh.2010.07.029			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	696OV	WOS:000285451600033	20851687				2021-06-18	
J	Glang, A; Todis, B; Sublette, P; Brown, BE; Vaccaro, M				Glang, Ann; Todis, Bonnie; Sublette, Patricia; Brown, Brenda Eagan; Vaccaro, Monica			Professional Development in TBI for Educators: The Importance of Context	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; education; in-service training; pediatrics; schools; staff development; students; teaching	TRAUMATIC BRAIN-INJURY; TREATMENT INTEGRITY; PEDIATRIC TBI; STUDENTS; OUTCOMES; CONSULTATION; IMPLEMENTATION; MATHEMATICS; KNOWLEDGE; BEHAVIOR	Effective instructional and behavioral support strategies implemented by trained educators can help mitigate the academic and behavioral challenges associated with childhood brain injury. However, the training provided by university teacher preparation programs is clearly inadequate, a problem that cuts across the professions that work with school-aged students. Educators need training in methods validated for students with traumatic brain injury (TBI) and in adapting strategies validated for students with other disabilities. Almost 10 years after Ylvisaker and colleagues proposed a research and professional development agenda in the area of teacher training, students with TBI continue to be underserved and underidentified for educational supports. Effective staff development practices for educators must include training in evidence-based interventions, supervised practice with new skills, and continued mentoring, feedback, and consultation in the school setting. Two models currently in use-the TBI Consulting Team and BrainSTARS models-incorporate those features. Preliminary evidence suggests that these models help teachers feel more prepared and knowledgeable in working with students with TBI. Given the urgent needs of students with TBI, validating these promising practices should be a high priority for the field of pediatric brain injury.	[Glang, Ann; Todis, Bonnie; Sublette, Patricia] Western Oregon Univ, Teaching Res Inst, Eugene, OR 97401 USA; [Brown, Brenda Eagan; Vaccaro, Monica] Brain Injury Assoc Penn, Carlisle, PA USA	Glang, A (corresponding author), Western Oregon Univ, Teaching Res Inst, 99 W 10th Ave,Ste 370, Eugene, OR 97401 USA.	glanga@wou.edu			Oregon Department of Education [8700]; Pennsylvania Department of Health	This work was supported in part by grant 8700 from the Oregon Department of Education to Teaching Research Institute, Western Oregon University, and by a grant from the Pennsylvania Department of Health to the Brain Injury Association of Pennsylvania. The authors thank Cathy Thomas and Laura Beck for their assistance in the preparation of this manuscript.	Benedict EA, 2007, TOP EARLY CHILD SPEC, V27, P174, DOI 10.1177/02711214070270030801; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; Borko H., 2004, EDUC RESEARCHER, V33, P3, DOI [DOI 10.3102/0013189X033008003, 10.3102/0013189X033008003]; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; CARPENTER TP, 1989, AM EDUC RES J, V26, P499, DOI 10.2307/1162862; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Chapman J. K., 2005, PHYS DISABILITIES ED, V21, P17; Chapman J. K., 2000, RURAL SPECIAL ED Q, V19, P3; Darling-Hammond L, 2009, EDUC LEADERSHIP, V66, P46; Davis AS, 2004, J SCHOOL PSYCHOL, V42, P87, DOI 10.1016/j.jsp.2003.11.001; Dise-Lewis JE, 2009, J HEAD TRAUMA REHAB, V24, P166, DOI 10.1097/HTR.0b013e3181a7ecb0; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Fixsen D. L., 2005, IMPLEMENTATION RES S; FUCHS LS, 1992, EXCEPT CHILDREN, V58, P436; Fullan M., 2007, LEARNING PROFESSIONA, V28, P35; FUNK P, 1996, PHYS DISABILITIES ED, V15, P49; Garet MS, 2001, AM EDUC RES J, V38, P915, DOI 10.3102/00028312038004915; Gersten R, 2009, REV EDUC RES, V79, P1202, DOI 10.3102/0034654309334431; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Glang A, 2004, NEUROREHABILITATION, V19, P219; GLANG A, 1994, LEARNING DISABILITIE, V9, P226; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2006, J HEAD TRAUMA REHAB, V21, P411, DOI 10.1097/00001199-200609000-00013; Glang A, 2008, NEUROREHABILITATION, V23, P477; Grant SG, 1996, AM EDUC RES J, V33, P509; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Grossman P, 2001, TEACH COLL REC, V103, P942, DOI 10.1111/0161-4681.00140; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Jones HA, 2008, PSYCHOL SCHOOLS, V45, P918, DOI 10.1002/pits.20342; Joyce B, 2002, STUDENT ACHIEVEMENT; Lerman DC, 2008, J APPL BEHAV ANAL, V41, P243, DOI 10.1901/jaba.2008.41-243; Lewis TJ, 2002, CHILD FAM BEHAV THER, V24, P165, DOI 10.1300/J019v24n01_11; Little JW, 2002, TEACH TEACH EDUC, V18, P917; McCutchen D, 2002, J LEARN DISABIL-US, V35, P69, DOI 10.1177/002221940203500106; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Noell GH, 1997, SCHOOL PSYCHOL QUART, V12, P77, DOI 10.1037/h0088949; Odom SL, 2009, TOP EARLY CHILD SPEC, V29, P53, DOI 10.1177/0271121408329171; Penuel WR, 2007, AM EDUC RES J, V44, P921, DOI 10.3102/0002831207308221; Reynolds CR., 2002, CLIN GUIDE BEHAV ASS; Sailors M, 2010, ELEM SCHOOL J, V110, P301, DOI 10.1086/648980; SALEND SJ, 1984, BEHAV MODIF, V8, P211, DOI 10.1177/01454455840082004; Sterling-Turner HE, 2002, SCHOOL PSYCHOL QUART, V17, P47, DOI 10.1521/scpq.17.1.47.19906; Sterling-Turner HE, 2001, SCHOOL PSYCHOL QUART, V16, P56, DOI 10.1521/scpq.16.1.56.19157; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TODIS B, J HEAD TRAU IN PRESS; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Turnbull HR, 2004, EXCEPTIONAL LIVES SP; TYLER JS, 1997, CHILDREN ACQUIRED BR, P323; U.S. Department of Education, 2001, NO CHILD LEFT; Wagner M., 2006, 20063004 NCSER; WALD PJ, 2000, ED LEARNERS CREATING; Walker NW, 1999, CHILD NEUROPSYCHOL, V5, P137, DOI 10.1076/chin.5.2.137.3168; Watson T. S., 1995, J BEHAV EDUC, V3, P281, DOI DOI 10.1007/bf02110316; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Yoon K.S., 2007, REV EVIDENCE TEACHER	58	15	15	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2010	25	6					426	432		10.1097/HTR.0b013e3181fb8f45			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	679HA	WOS:000284151300004	21076243				2021-06-18	
J	Almosnino, S; Pelland, L; Stevenson, JM				Almosnino, Sivan; Pelland, Lucie; Stevenson, Joan M.			Retest Reliability of Force-Time Variables of Neck Muscles Under Isometric Conditions	JOURNAL OF ATHLETIC TRAINING			English	Article						injuries; concussions; muscle strength; sports	INTRACLASS CORRELATIONS; CERVICAL STRENGTH; REPRODUCIBILITY; EXTENSION; FLEXION; WOMEN	Context: Proper conditioning of the neck muscles may play a role in reducing the risk of neck injury and, possibly, concussions in contact sports. However, the ability to reliably measure the force-time-based variables that might be relevant for this purpose has not been addressed. Objective: To assess the between-days reliability of discrete force-time based variables of neck muscles during maximal voluntary isometric contractions in 5 directions. Design: Cohort study. Setting: University research center. Patients or Other Participants: Twenty-six highly physically active men (age = 21.6 +/- 2.1 years, height = 1.85 +/- 0.09 m, mass = 81.6 +/- 9.9 kg, head circumference = 0.58 +/- 0.01 m, neck circumference = 0.39 +/- 0.02 m). Intervention(s): We used a custom-built testing apparatus to measure maximal voluntary isometric contractions of the neck muscles in 5 directions (extension, flexion, protraction, left lateral bending, and right lateral bending) on 2 separate occasions separated by 7 to 8 days. Main Outcome Measure(s): Variables measured were peak force (PF), rate of force development (RFD), and time to 50% of PF (T50PF). Reliability indices calculated for each variable comprised the difference in scores between the testing sessions, with corresponding 95% confidence intervals, the coefficient of variation of the typical error of measurement (CVTE), and intraclass correlation coefficients (ICC [3,3]). Results: No evidence of systematic bias was detected for the dependent measures across any movement direction; retest differences in measurements were between 1.8% and 2.7%, with corresponding 95% confidence interval ranges of less than 10% and overlapping zero. The CVTE was lowest for PF (range, 2.4%-6.3%) across all testing directions, followed by RFD (range, 4.8%-9.0%) and T50PF (range, 7.1%-9.3%). The ICC score range for all dependent measures was 0.90 to 0.99. Conclusions: Discrete variables representative of the force-generating capacity of neck muscles under isometric conditions can be measured with an acceptable degree of reliability. This finding has possible applications for investigating the role of neck muscle strength-training programs in reducing the risk of injuries in sport settings.	[Pelland, Lucie; Stevenson, Joan M.] Queens Univ, Sch Rehabil Therapy, Kingston, ON K7L 3N6, Canada; [Almosnino, Sivan; Stevenson, Joan M.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON K7L 3N6, Canada; [Almosnino, Sivan; Pelland, Lucie] Kingston Gen Hosp, Human Mobil Res Ctr, Kingston, ON, Canada	Pelland, L (corresponding author), Queens Univ, Sch Rehabil Therapy, Louise D Acton Bldg,31 George St, Kingston, ON K7L 3N6, Canada.	Lucie.Pelland@queensu.ca			Ontario Neurotrauma Foundation; Queen's University Advisory Research Council	Funding was provided by the Ontario Neurotrauma Foundation and the Queen's University Advisory Research Council (Dr Pelland). We thank Sam Pedlow and Alexis Twiddy for their contributions.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; AMUNDSEN LR, 1990, MUSCLE STRENGTH TEST, P89; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Barry BK, 2005, EXP BRAIN RES, V162, P122, DOI 10.1007/s00221-004-2127-3; Burnett Angus F, 2005, Work, V25, P205; Cagnie B, 2007, ARCH PHYS MED REHAB, V88, P1441, DOI 10.1016/j.apmr.2007.06.776; Conley MS, 1997, EUR J APPL PHYSIOL, V75, P443, DOI 10.1007/s004210050186; Dvir Z, 2003, ISOKINET EXERC SCI, V11, P49, DOI 10.3233/IES-2003-0109; Dvir Z, 2008, J MANIP PHYSIOL THER, V31, P518, DOI 10.1016/j.jmpt.2008.08.008; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Geertsen SS, 2008, J APPL PHYSIOL, V105, P915, DOI 10.1152/japplphysiol.01155.2007; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, NEW VIEW STAT; Hunter JP, 2004, MED SCI SPORT EXER, V36, P850, DOI 10.1249/01.MSS.0000126467.58091.38; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; Kumar S, 2001, CLIN BIOMECH, V16, P380, DOI 10.1016/S0268-0033(01)00023-7; LEVOSKA S, 1992, CLIN BIOMECH, V7, P33, DOI 10.1016/0268-0033(92)90005-O; Olivier PE, 2008, J SCI MED SPORT, V11, P96, DOI 10.1016/j.jsams.2007.01.009; Ordway NR, 1999, SPINE, V24, P240, DOI 10.1097/00007632-199902010-00008; Portero P, 2001, EUR J APPL PHYSIOL, V84, P540, DOI 10.1007/s004210100399; Seng KY, 2002, CLIN BIOMECH, V17, P545, DOI 10.1016/S0268-0033(02)00067-0; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sommerich CM, 2000, J ELECTROMYOGR KINES, V10, P377, DOI 10.1016/S1050-6411(00)00033-X; STONE MH, 2008, PRINCIPLES PRACTICE, P225; Strimpakos N, 2004, ARCH PHYS MED REHAB, V85, P1309, DOI 10.1016/j.apmr.2003.08.104; Strimpakos N., 2001, PHYS THER REV, V6, P39; Symons TB, 2005, J GERONTOL A-BIOL, V60, P114, DOI 10.1093/gerona/60.1.114; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Valkeinen H, 2002, EUR J APPL PHYSIOL, V88, P247, DOI 10.1007/s00421-002-0709-y; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Walmsley RP, 1996, ISOKINET EXERC SCI, V6, P117, DOI 10.3233/IES-1996-6207; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Ylinen JJ, 1999, CLIN BIOMECH, V14, P217, DOI 10.1016/S0268-0033(98)00063-1	34	15	16	0	6	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2010	45	5					453	458		10.4085/1062-6050-45.5.453			6	Sport Sciences	Sport Sciences	654GZ	WOS:000282157800003	20831389	Green Published			2021-06-18	
J	Aydin, S; Overwater, E; Saltzherr, TP; Jin, PHPFK; van Exter, P; Ponsen, KJ; Luitse, JSK; Goslings, JC				Aydin, Sema; Overwater, Eline; Saltzherr, Teun Peter; Jin, P. H. Ping Fung Kon; van Exter, Pieternel; Ponsen, Kees Jan; Luitse, Jan S. K.; Goslings, J. Carel			The Association of Mobile Medical Team Involvement on On-Scene Times and Mortality in Trauma Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Trauma; Mobile medical team; On-scene time; Mortality; Prehospital care	ENDOTRACHEAL INTUBATION; SERVICES EMS; SURVIVAL; IMPACT; CARE; INJURY; SCOOP; SCORE; LIFE	Objectives: Mobile medical teams (MMTs) provide specialized care on-scene with the purpose to improve outcome. However, this additional care could prolong the on-scene time (OST), which is related to mortality. The purpose of this study was to assess the effects of MMT involvement on the mortality rate and on the OST, in a Dutch consecutive cohort of Level I trauma patients. Methods: All patients who required presentation in the trauma resuscitation room in an urban Level I trauma center were included in this prospective study during the period of November 2005 till November 2007. For data collection, we used both pre- and in-hospital registration systems. Outcome measures were 30-day mortality and OST. Results: In total, 1,054 patients were analyzed. In 172 (16%) patients, the MMT was involved. Mortality was significantly higher in the MMT group compared with patients treated without MMT involvement; 9.9% versus 2.7%, respectively (p < 0.001). Significantly higher Injury Severity Scores, intervention rates, and a significantly lower Triage Revised Trauma Score were found in patients treated by MMT. After adjustment for patient and injury characteristics, no association could be found between MMT involvement and higher mortality (95% CI, 0.581-3.979; p = 0.394). In patients with severe traumatic brain injury (GCS score <= 8) in whom a MMT was involved, the mortality was 25.5%, compared with 32.7% in those without MMT involvement (p = 0.442). The mean OST was prolonged (2.7 minutes) when MMT was involved (26.1 vs. 23.4 minutes; p = 0.003). Conclusions: In this study, OSTs were long compared with PHTLS recommendations. MMT involvement slightly prolonged the OST. Trauma patients with MMT involvement had a high mortality, but after correction for patient and injury characteristics, the mortality rate did not significantly differ from patients without MMT involvement.	[Aydin, Sema; Overwater, Eline; Saltzherr, Teun Peter; Jin, P. H. Ping Fung Kon; Ponsen, Kees Jan; Luitse, Jan S. K.; Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Trauma Unit, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [van Exter, Pieternel] Reg Ambulance Serv RAVAA, Amsterdam, Netherlands	Saltzherr, TP (corresponding author), Univ Amsterdam, Acad Med Ctr, Trauma Unit, Dept Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.p.saltzherr@amc.uva.nl		Overwater, Eline/0000-0002-0993-5035			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Birk Hans O, 2002, Prehosp Disaster Med, V17, P167; BORDER JR, 1983, J TRAUMA, V23, P708, DOI 10.1097/00005373-198308000-00005; BOYD DR, 1983, WORLD J SURG, V7, P149, DOI 10.1007/BF01655923; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cornwell EE, 2000, ARCH SURG-CHICAGO, V135, P315, DOI 10.1001/archsurg.135.3.315; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; FEERO S, 1995, AM J EMERG MED, V13, P133, DOI 10.1016/0735-6757(95)90078-0; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; GOLD CR, 1987, ANN EMERG MED, V16, P797, DOI 10.1016/S0196-0644(87)80578-4; Gonzalez RP, 2006, J TRAUMA, V61, P404, DOI 10.1097/01.ta.0000229816.16305.94; Lemson J, 2008, Ned Tijdschr Geneeskd, V152, P1106; McSwain NE, 2006, PREHOSPITAL TRAUMA L; Oppe S, 2001, ACCIDENT ANAL PREV, V33, P129, DOI 10.1016/S0001-4575(00)00023-3; Petri R W, 1995, Prehosp Disaster Med, V10, P24; Ringburg AN, 2007, J TRAUMA, V63, P258, DOI 10.1097/01.ta.0000240449.23201.57; Roorda J, 1996, INJURY, V27, P163, DOI 10.1016/0020-1383(95)00218-9; Sampalis J S, 1994, Prehosp Disaster Med, V9, P178; SAMPALIS JS, 1993, J TRAUMA, V34, P252, DOI 10.1097/00005373-199302000-00014; Spaite DW, 2003, ANN EMERG MED, V42, P729, DOI 10.1016/S0196-0644(03)00822-9; van Olden GDJ, 2003, INJURY, V34, P191, DOI 10.1016/S0020-1383(02)00202-4; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Zink BJ, 2004, ANN EMERG MED, V44, P451, DOI 10.1016/j.annemergmed.2004.05.001	23	15	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2010	69	3					589	593		10.1097/TA.0b013e3181e74858			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	649HX	WOS:000281760800023	20838130				2021-06-18	
J	Bouzat, P; Francony, G; Brun, J; Lavagne, P; Picard, J; Broux, C; Declety, P; Jacquot, C; Albaladejo, P; Payen, JF				Bouzat, Pierre; Francony, Gilles; Brun, Julien; Lavagne, Pierre; Picard, Julien; Broux, Christophe; Declety, Philippe; Jacquot, Claude; Albaladejo, Pierre; Payen, Jean-Francois			Detecting traumatic internal carotid artery dissection using transcranial Doppler in head-injured patients	INTENSIVE CARE MEDICINE			English	Article						Transcranial Doppler; Trauma; Carotid dissection; Internal carotid	EARLY-DIAGNOSIS; ULTRASOUND; ANGIOGRAPHY; TOMOGRAPHY; STENOSIS; CRITERIA; IMPROVES; THERAPY	The early diagnosis of traumatic internal carotid artery dissection (TICAD) is essential for initiating appropriate treatment and improving outcome. We searched for criteria from transcranial Doppler (TCD) measurements on admission that could be associated with subsequent TICAD diagnosis in patients with traumatic brain injury (TBI). We conducted a retrospective 1:4 matched (age, mean arterial blood pressure) cohort study of 11 TBI patients with TICAD and absent or mild brain lesions on initial CT scan, 22 TBI controls with comparable brain CT scan lesions (controls 1), and 22 TBI controls with more severe brain CT scan lesions (controls 2) on admission. TCD measurements were obtained on admission from both middle cerebral arteries (MCA). All patients had subsequent CT angiography to diagnose TICAD. A > 25% asymmetry in the systolic blood flow velocity between the two MCA was found in 9/11 patients with TICAD versus 0/22 in controls 1 and 5/22 in controls 2 (p < 0.01). The combination of this asymmetry with an ipsilateral pulsatility index a parts per thousand currency sign0.80 was found in 9/11 patients with TICAD versus none in the two groups of controls (p < 0.01). Our results suggest that significant asymmetry in the systolic blood flow velocity between the MCAs and a reduced ipsilateral pulsatility index could be criteria from TCD measurements associated with the occurrence of TICAD in head-injured patients. If prospectively validated, these findings could be incorporated in screening protocols for TICAD in patients with TBI.	[Payen, Jean-Francois] Hop Albert Michallon, F-38043 Grenoble, France; [Bouzat, Pierre; Francony, Gilles; Brun, Julien; Lavagne, Pierre; Picard, Julien; Broux, Christophe; Declety, Philippe; Jacquot, Claude; Albaladejo, Pierre; Payen, Jean-Francois] Albert Michallon Hosp, Dept Anesthesiol & Crit Care, F-38000 Grenoble, France	Payen, JF (corresponding author), Hop Albert Michallon, BP 217, F-38043 Grenoble, France.	jfpayen@ujf-grenoble.fr	albaladejo, pierre/M-6901-2014; Bouzat, Pierre/AAC-4105-2019; Payen, Jean-Francois/L-6667-2014; Bouzat, Pierre/L-6881-2014	Bouzat, Pierre/0000-0003-4667-6738; 			ACHTEREEKTE HAM, 1994, SURG NEUROL, V42, P240, DOI 10.1016/0090-3019(94)90270-4; Arthurs ZM, 2008, INJURY, V39, P1232, DOI 10.1016/j.injury.2008.02.042; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Can U, 1997, STROKE, V28, P1966, DOI 10.1161/01.STR.28.10.1966; DuBose J, 2008, J TRAUMA, V65, P1561, DOI 10.1097/TA.0b013e31817fd954; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Hartmann A, 2000, CEREBROVASC DIS, V10, P33, DOI 10.1159/000016022; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; KRAJEWSKI LP, 1980, ANN SURG, V191, P341, DOI 10.1097/00000658-198003000-00014; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menon RK, 2008, ANN NY ACAD SCI, V1142, P200, DOI 10.1196/annals.1444.015; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Moppett IK, 2004, BRIT J ANAESTH, V93, P710, DOI 10.1093/bja/aeh205; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; ROMNER B, 1994, ACTA NEUROCHIR, V126, P185, DOI 10.1007/BF01476431; SCHNEIDER PA, 1988, STROKE, V19, P589, DOI 10.1161/01.STR.19.5.589; Shafe M, 2004, ACAD EMERG MED, V11, P774, DOI 10.1197/j.aem.2004.02.518; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Srinivasan J, 1996, STROKE, V27, P1226, DOI 10.1161/01.STR.27.7.1226; Yang ST, 2006, J CLIN NEUROSCI, V13, P123, DOI 10.1016/j.jocn.2005.02.016	24	15	15	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	SEP	2010	36	9					1514	1520		10.1007/s00134-010-1919-0			7	Critical Care Medicine	General & Internal Medicine	638PV	WOS:000280908000009	20490780				2021-06-18	
J	Giannotti, M; Al-Sahab, B; McFaull, S; Tamim, H				Giannotti, Maria; Al-Sahab, Ban; McFaull, Steve; Tamim, Hala			Epidemiology of acute head injuries in Canadian children and youth soccer players	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Soccer; Canada; Head injury; Youth; Children; Sport	US EMERGENCY-DEPARTMENTS; MEDICAL-RESEARCH PROGRAM; BALL PROPERTIES; UNITED-STATES; BRAIN-INJURY; EYE INJURIES; RISK-FACTORS; FOOTBALL; MECHANISMS; PREVENTION	Background: Limited studies have been done to assess head injury characteristics for children and youth soccer players in Canada. Objectives: To describe acute head injury characteristics in children and youth soccer players and identify the characteristics of patients who required hospital admission. Methods: Analysis was based on the Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP). Soccer-related head injuries amongst 5-19 year old children presenting at 16 hospital emergency departments during 1994-2004 were selected in the study. All head injury-related variables (nature of injury, mechanism of injury, location of play, soccer type and season of play) were stratified by age and sex. A logistic regression model, consisting of the injury-related variables, sex and age as the independent variables, was performed to examine the characteristics of those head-injured patients who required hospital admission. Results: Overall, there were 4720 head injury cases identified (15% of all soccer-related emergency department visits). The highest proportion of head injuries was amongst males (70%) and children aged 10-14 years (50%). Of head injury cases, 35% were superficial and/or open wounds, 28% minor head injuries, 11% concussions, 9% eye injuries and 5% fractures. The total number of cases that required hospital admission was 164 (3.5%). Based on logistic regression analysis, head-injured youth aged 15-19 years were almost two times more likely to be admitted to hospital than their younger counterparts (OR = 2.2, 95% CI: 1.3-3.6). Compared to ball contact injuries, contact with structures/surfaces, other players/persons and other unspecified objects increased the odds of hospital admission at least by two-folds. Moreover, those who played unorganised soccer were significantly more likely to be admitted to the hospital as compared to those who played organised soccer (OR = 1.7, 95% CI: 1.2-2.6). Finally, playing in the non-winter seasons had increased likelihood of hospital admissions. Conclusions: Head injuries constituted a significant proportion of soccer-related injuries presenting to emergency departments. Future studies need to evaluate the nature and safety of the playing surfaces/turf and other structures on or around the field of play. (C) 2009 Elsevier Ltd. All rights reserved.	[Giannotti, Maria; Al-Sahab, Ban; Tamim, Hala] York Univ, Bethune Coll, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [McFaull, Steve] Publ Hlth Agcy Canada, Injury & Child Maltreatment Sect, Ottawa, ON, Canada	Tamim, H (corresponding author), York Univ, Bethune Coll, Sch Kinesiol & Hlth Sci, 4700 Keele St, Toronto, ON M3J 2R7, Canada.	htamim@yorku.ca	Al-Sahab, Ban/AAG-4430-2021				Adams AL, 2006, ACAD EMERG MED, V13, P571, DOI [10.1111/j.1553-2712.2006.tb01010.x, 10.1197/j.aem.2005.12.015]; Adams J, 2007, CLIN J SPORT MED, V17, P304, DOI 10.1097/JSM.0b013e31803202c8; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Anderson SJ, 2000, PEDIATRICS, V105, P659, DOI 10.1542/peds.105.3.640; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Blond L, 1999, BRIT J SPORT MED, V33, P110, DOI 10.1136/bjsm.33.2.110; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; *CAN SOCC ASS, 2007, 2006 DEM REP, P1; Cerulli G, 2002, J CRANIOFAC SURG, V13, P627, DOI 10.1097/00001665-200209000-00006; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delilbasi C, 2004, ORAL SURG ORAL MED O, V97, P23, DOI 10.1016/j.tripleo.2003.10.008; DEMARCO J, 1994, JAMA-J AM MED ASSOC, V271, P1233; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Federation Internationale de Football Association (FIFA), FIFA BIG COUNT 2006; Filipe JAC, 2003, ARCH OPHTHALMOL-CHIC, V121, P687; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Hawkins RD, 2001, BRIT J SPORT MED, V35, P43, DOI 10.1136/bjsm.35.1.43; Health Canada, 2006, CAN HOSP INJ REP PRE; Horn EP, 2000, RETINA-J RET VIT DIS, V20, P604, DOI 10.1097/00006982-200011000-00003; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Kent JS, 2007, CAN J OPHTHALMOL, V42, P605, DOI 10.3129/canjophthalmol-i07-093; Kinnear P., 2008, SPSS 15 MADE SIMPLE; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kontos AP, 2004, J PEDIATR PSYCHOL, V29, P447, DOI 10.1093/jpepsy/jsh048; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Mackenzie S G, 1999, Inj Prev, V5, P208; Papakosta V, 2008, DENT TRAUMATOL, V24, P193, DOI 10.1111/j.1600-9657.2007.00536.x; Peterson L, 2000, AM J SPORT MED, V28, pS51; Pickett W, 2005, BRIT J SPORT MED, V39, P226, DOI 10.1136/bjsm.2004.013169; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Price RJ, 2004, BRIT J SPORT MED, V38, P466, DOI 10.1136/bjsm.2003.005165; *PUBL HLTH AG CAN, 2005, INV INJ DAT SOURC SU; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI33, DOI 10.1136/bjsm.2005.019059; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Vinger PF, 2004, BRIT J OPHTHALMOL, V88, P167, DOI 10.1136/bjo.2003.026229	40	15	15	1	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2010	41	9					907	912		10.1016/j.injury.2009.09.040			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	634SL	WOS:000280605500006	19878944				2021-06-18	
J	Hart, T; Sherer, M; Temkin, N; Whyte, J; Dikmen, S; Heinemann, AW; Bell, K				Hart, Tessa; Sherer, Mark; Temkin, Nancy; Whyte, John; Dikmen, Sureyya; Heinemann, Allen W.; Bell, Kathleen			Participant-Proxy Agreement on Objective and Subjective Aspects of Societal Participation Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						participation; proxy report; traumatic brain injury	COMMUNITY INTEGRATION; PRACTICAL SCALE; HEAD-INJURY; OUTCOMES; REHABILITATION; AWARENESS; CONCORDANCE; ORIENTATION; RELATIVES; MODERATE	Objective: To examine congruence between participant (P) and significant other (SO) reports on societal participation in 3 objective domains (economic, community, and social activities) and subjective satisfaction with participation at 1 year after traumatic brain injury (TBI). Participants: Ninety-seven persons with moderate to severe TBI and their SOs (27 spouses/partners, 47 parents, 23 other relatives/friends). Main outcome measure: Community Participation Indicators questionnaire, divided into Objective (Economic, Community, Social) and Subjective (Satisfaction) subscales. Design: Prospective correlational study. Results: P-SO congruence differed by domain of participation, with Economic and Community indicators showing higher agreement than Social and Satisfaction items. Congruence was not affected by P-SO relationship or whether the pair lived together. However, pairs who spent at least daily time together had significantly higher agreement on Satisfaction items than pairs who were together less often. Congruence was not predicted by SOs' self-reported degree of awareness of Ps' concerns. Severity of TBI, within the range represented in this sample, had no effect on P-SO congruence in any domain. Conclusion: In research on participation after TBI, proxy report may be an acceptable substitute for missing participant report on productivity and community activity outcomes. However, proxy responses should be used with caution for questions about social activities and degree of satisfaction with participation.	[Hart, Tessa; Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Temkin, Nancy; Dikmen, Sureyya; Bell, Kathleen] Univ Washington, Seattle, WA 98195 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Hart, T (corresponding author), Moss Rehabil Res Inst, 60 E Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu	Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326; Bell, Kathleen/0000-0002-0928-2046; Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research [H133A040004, H133A070040, H133B040032, H133A02051, H133A020514]	This work was funded by grants H133A040004, H133A070040, H133B040032, H133A02051, and H133A020514 from the National Institute on Disability and Rehabilitation Research. The authors thank Jason Barber for database development and Kelly Bognar, Caron Morita, Rebecca Hardin, Leslie Kempthorne, Aaron Scrol, and Ashley Swearingen for data collection and data management. Mary Czerniak assisted with the manuscript preparation.	Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dawson DR, 2005, J HEAD TRAUMA REHAB, V20, P426, DOI 10.1097/00001199-200509000-00004; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC27; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; HEINEMANN AW, MEASURING P IN PRESS; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Johnston MV, 2006, BRAIN INJURY, V20, P391, DOI 10.1080/02699050500487795; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Magasi SR, 2008, J SPINAL CORD MED, V31, P145, DOI 10.1080/10790268.2008.11760705; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; TEASDALE G, 1974, LANCET, V2, P81; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091	33	15	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2010	25	5					339	348		10.1097/HTR.0b013e3181c7e60b			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	649JR	WOS:000281765400006	20042981				2021-06-18	
J	Serin, GM; Derinsu, U; Sari, M; Gergin, O; Ciprut, A; Akdas, F; Batman, C				Serin, Gediz Murat; Derinsu, Ufuk; Sari, Murat; Gergin, Oezguel; Ciprut, Ayca; Akdas, Ferda; Batman, Caglar			Cochlear implantation in patients with bilateral cochlear trauma	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article							TEMPORAL BONE-FRACTURES	Purpose: Temporal bone fracture, which involves the otic capsule, can lead to complete loss of auditory and vestibular functions, whereas the patients without fractures may experience profound sensorineural hearing loss due to cochlear concussion. Cochlear implant is indicated in profound sensorineural hearing loss due to cochlear trauma but who still have an intact auditory nerve. Material and methods: This is a retrospective review study. We report 5 cases of postlingually deafened patients caused by cochlear trauma, who underwent cochlear implantation. Preoperative and postoperative hearing performance will be presented. These patients are cochlear implanted after the cochlear trauma in our department between 2001 and 2006. Results: All patients performed very well with their implants, obtained open-set speech understanding. They all became good telephone users after implantation. Their performance in speech understanding was comparable to standard postlingual adult patients implanted. Conclusion: Cochlear implantation is an effective aural rehabilitation in profound sensorineural hearing loss caused by temporal bone trauma. Preoperative temporal bone computed tomography, magnetic resonance imaging, and promontorium stimulation testing are necessary to make decision for the surgery and to determine the side to be implanted. Surgery could be challenging and complicated because of anatomical irregularity. Moreover, fibrosis and partial or total ossification within the cochlea must be expected. (C) 2010 Published by Elsevier Inc.	[Serin, Gediz Murat; Sari, Murat; Gergin, Oezguel; Batman, Caglar] Marmara Univ, Dept Otorhinolaryngol, Sch Med, Istanbul, Turkey; [Derinsu, Ufuk; Ciprut, Ayca; Akdas, Ferda] Marmara Univ, Dept Audiol, Sch Med, Istanbul, Turkey	Serin, GM (corresponding author), Marmara Univ Hastanesi KBB ABD, Tophanelioglu Cad 13-15, TR-34662 Istanbul, Turkey.	gedizserin@yahoo.com	Ciprut, Ayca/AAI-6358-2020; Derinsu, Ufuk/M-3912-2014	Derinsu, Ufuk/0000-0003-0438-0074			Camilleri AE, 1999, J LARYNGOL OTOL, V113, P454, DOI 10.1017/S0022215100144202; GRAEME C, 2003, COCHLEAR IMPLANTS FU; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Moody-Antonio S, 2005, OTOL NEUROTOL, V26, P649, DOI 10.1097/01.mao.0000178124.13118.76; MORGAN WE, 1994, LARYNGOSCOPE, V104, P426; Simons JP, 2005, OTOLARYNG HEAD NECK, V132, P809, DOI 10.1016/j.otohns.2004.06.711; Teoh SW, 2004, LARYNGOSCOPE, V114, P1714, DOI 10.1097/00005537-200410000-00007	7	15	15	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709			AM J OTOLARYNG	Am. J. Otolaryngol.	SEP-OCT	2010	31	5					350	355		10.1016/j.amjoto.2009.04.008			6	Otorhinolaryngology	Otorhinolaryngology	648SY	WOS:000281715600008	20015779				2021-06-18	
J	Hallen, M; Karlsson, M; Carlhed, R; Hallgren, T; Bergenheim, M				Hallen, Magnus; Karlsson, Mathias; Carlhed, Rickard; Hallgren, Thomas; Bergenheim, Mikael			S-100B in Serum and Urine After Traumatic Head Injury in Children	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						S-100B; Head trauma; Children	BRAIN-INJURY; S100B LEVELS; PROTEIN MEASUREMENTS; COMPUTED-TOMOGRAPHY; MULTICENTER; ELIMINATION; S-100-BETA; FAMILY; DAMAGE	Background: Children with head trauma are frequently seen in many emergency units. The clinical evaluation of these patients is difficult for a number of reasons and improved diagnostic tools are needed. S-100B, a protein found in glial cells, has previously been shown to be a sensible marker for brain damage after head injury in adults, but few studies have focused on its use in children. Methods: In this study, 111 children with head trauma were included and venous blood and urine samples were taken at arrival (S1 and U1) and 6 hours later (S2 and U2). S-100B levels were analyzed. Clinical and radiologic evaluations were performed according to hospital routine. Two groups were identified-group 1: no computed tomography (CT) scan performed or a CT scan without any sign of trauma-related intracranial pathology (n = 105). Group 2: A CT scan with signs of trauma-related intracranial pathology (n = 6). Results: In group 1, the median (inter quartile range) serum S-100B value in S1-samples was 0.111 mu g/L (0.086-0.153), and in group 2, it was 0.282 mu g/L (0.195-1.44) (p < 0.01). Also, S2 values significantly differed between the two groups. Urine values were, however, not significantly differing between the groups. Conclusions: Serum S-100B values within 6 hours after head trauma in children were significantly higher in patients with intracranial pathology compared with those without intracranial complications. Identification of these high-risk patients already in the emergency department is of major importance, and we suggest that S-100B could be a valuable diagnostic tool in addition to those used in clinical practice today.	[Hallen, Magnus; Hallgren, Thomas; Bergenheim, Mikael] Cent Hosp Karlstad, Dept Surg, S-65185 Karlstad, Sweden; [Karlsson, Mathias] Stockholm Soder Hosp, Karolinska Inst, Dept Clin Sci & Educ, Karlstad, Sweden; [Karlsson, Mathias] Dept Clin Res, Karlstad, Sweden; [Carlhed, Rickard] Cent Hosp Karlstad, Dept Lab Med, S-65185 Karlstad, Sweden	Bergenheim, M (corresponding author), Cent Hosp Karlstad, Dept Surg, S-65185 Karlstad, Sweden.	mikael.bergenheim@liv.se			Center of Clinical Research, County Council of Varmland, Sweden	Supported by The Center of Clinical Research, County Council of Varmland, Sweden.	Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; Astrand R, 2006, ACTA NEUROL SCAND, V113, P262, DOI 10.1111/j.1600-0404.2005.00573.x; BAUDIER J, 1984, BIOCHIM BIOPHYS ACTA, V790, P164, DOI 10.1016/0167-4838(84)90220-6; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; FANO G, 1995, PROG NEUROBIOL, V46, P71, DOI 10.1016/0301-0082(94)00062-M; Hallen M, 2008, CLIN CHEM LAB MED, V46, P1025, DOI 10.1515/CCLM.2008.190; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; JENSEN R, 1985, J NEUROCHEM, V45, P700, DOI 10.1111/j.1471-4159.1985.tb04048.x; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Oh EJ, 2007, J CLIN LAB ANAL, V21, P387, DOI 10.1002/jcla.20201; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Ucar T, 2004, J TRAUMA, V57, P95, DOI 10.1097/01.TA.0000071352.95491.75; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; Unden J, 2004, SCAND J INFECT DIS, V36, P10, DOI 10.1080/00365540310017294; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	27	15	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2010	69	2					284	289		10.1097/TA.0b013e3181ca060b			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	638JN	WOS:000280890800007	20734463				2021-06-18	
J	Mozer, AB; Whittemore, SR; Benton, RL				Mozer, Anthony B.; Whittemore, Scott R.; Benton, Richard L.			Spinal Microvascular Expression of PV-1 is Associated with Inflammation, Perivascular Astrocyte Loss, and Diminished EC Glucose Transport Potential in Acute SCI	CURRENT NEUROVASCULAR RESEARCH			English	Article						Caveolae; inflammation; MECA-32; microvessels; neurovascular unit; NVU; PAL-E; PLVAP	BLOOD-BRAIN-BARRIER; VESICLE-ASSOCIATED PROTEIN-1; CORD-INJURY; NEUROVASCULAR UNIT; IN-VITRO; MOUSE; MARKER; PERMEABILITY; MODULATION; DIAPHRAGMS	The endothelial-specific expression of plasmalemmal vesicle associated protein-1 (PV-1) is typical of fenestrated endothelium observed in pulmonary capillaries and some endocrine organs. In the central nervous system (CNS) it is expressed during development but disappears concomitant with maturation of the blood-CNS barrier [1]. Consistent with observations made in models of stroke, Alzheimer's disease, and tumorigenesis, we show PV-1 expression in the spinal cord specifically upregulated by pathologically-activated endothelial cells (ECs) in response to traumatic spinal cord injury (SCI). Adult female C57B1/6 mice received a moderate T9/10 contusive SCI. PV-1 assessed by qRT-PCR and immunohistochemistry 3 hours to 14 days post-injury showed expression as early as 1 day post-SCI, with levels decreasing by 14 days. This expression was associated with microvessels in the injury epicenter and penumbral zone, with the time course and distribution correlated with progressing peripheral inflammatory cell infiltration. PV-1-immunoreactive ECs were angiogenic as demonstrated by intravascular binding of Griffonia simplicifolia isolectin B4 (IB4). ECs expressing high levels of PV-1 were anatomically and physiologically abnormal with altered/absent immunostaining for occludin and zonula occludens-1 (ZO-1), and decreased expression of glial fibrillary acidic protein (GFAP) and aquaporin-4 (AQP4). Glucose transporter type I (Glut-1) expression decreased in affected, PV-1 positive microvessels with little colocalization of PV-1 and Glut-1 apparent by 7 days post-SCI. These data suggest that upregulation of microvascular expression of PV-1 post-SCI may promote major components of secondary injury including extravasation of cellular and acellular mediators of inflammation and may accelerate loss of neuropil and decline in the functional and anatomical integrity of the neurovascular unit (NVU).	[Mozer, Anthony B.; Whittemore, Scott R.; Benton, Richard L.] Univ Louisville, Sch Med, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Whittemore, Scott R.; Benton, Richard L.] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Mozer, Anthony B.; Whittemore, Scott R.; Benton, Richard L.] Univ Louisville, Sch Med, Dept Neurol Surg, Louisville, KY 40292 USA; [Mozer, Anthony B.] Univ Louisville, Sch Med, MD Program, Louisville, KY 40292 USA	Benton, RL (corresponding author), Univ Louisville, Sch Med, Kentucky Spinal Cord Injury Res Ctr, 511 S Floyd St,MDR 616, Louisville, KY 40292 USA.	rlbent01@louisville.edu			Kentucky Spinal Cord and Head Injury Research Trust; Commonwealth of Kentucky Challenge for Excellence;  [RR15576];  [NS045734]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR015576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045734] Funding Source: NIH RePORTER	The authors wish to thank Ms. Christine Nunn and Mrs. Kim Fentress for superb surgical support and perioperative care of experimental animals. Thanks also to Ms. Darlene Burke for assistance with statistical analyses, to Mr. Mark Gruenthal for assistance in developing analytical methods using the Nikon Elements software, and to Mrs. Melissa Maddie and Mrs. Amanda Ribble for immunohistochemical and tissue harvesting expertise. This research was supported by RR15576, NS045734, and the Kentucky Spinal Cord and Head Injury Research Trust (SRW, RLB), and the Commonwealth of Kentucky Challenge for Excellence (SRW). The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Baba T, 2009, INVEST OPHTH VIS SCI, V50, P3503, DOI 10.1167/iovs.08-2614; Benton RL, 2008, J CEREBR BLOOD F MET, V28, P1771, DOI 10.1038/jcbfm.2008.76; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Ciofi P, 2009, ENDOCRINOLOGY, V150, P5509, DOI 10.1210/en.2009-0584; Coisne C, 2005, LAB INVEST, V85, P734, DOI 10.1038/labinvest.3700281; del Zoppo GJ, 2009, NEUROSCIENCE, V158, P972, DOI 10.1016/j.neuroscience.2008.08.028; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Hamm S, 2004, CELL TISSUE RES, V315, P157, DOI 10.1007/s00441-003-0825-y; Han HS, 2005, CURR NEUROVASC RES, V2, P409, DOI 10.2174/156720205774962647; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hnasko R, 2002, J ENDOCRINOL, V175, P649, DOI 10.1677/joe.0.1750649; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Keuschnigg J, 2009, BLOOD, V114, P478, DOI 10.1182/blood-2008-11-188763; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Lutty GA, 2010, EYE, V24, P408, DOI 10.1038/eye.2009.318; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Noble LJ, 1996, J COMP NEUROL, V376, P542; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Noble LJ, 2002, J NEUROSCI, V22, P7526; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Reiss Y, 1998, EUR J IMMUNOL, V28, P3086, DOI 10.1002/(SICI)1521-4141(199810)28:10<3086::AID-IMMU3086>3.3.CO;2-Q; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Saville LR, 2004, J NEUROIMMUNOL, V156, P42, DOI 10.1016/j.jneuroim.2004.07.002; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Simard M, 2003, J NEUROSCI, V23, P9254; Stan RV, 2007, J CELL MOL MED, V11, P621, DOI 10.1111/j.1582-4934.2007.00075.x; Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189; Stan RV, 2001, GENOMICS, V72, P304, DOI 10.1006/geno.2000.6489; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Takigawa T, 2010, J NEUROTRAUM, V27, P739, DOI 10.1089/neu.2009.1111; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Yamamoto I, 2007, AM J TRANSPLANT, V7, P1954, DOI 10.1111/j.1600-6143.2007.01876.x; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Yuan J, 2010, AM J PHYSIOL-RENAL, V299, pF265, DOI 10.1152/ajprenal.00071.2010; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	47	15	15	1	5	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	AUG	2010	7	3					238	250					13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	633MG	WOS:000280506500007	20590523				2021-06-18	
J	Chieregato, A; Martino, C; Pransani, V; Nori, G; Russo, E; Noto, A; Simini, B				Chieregato, A.; Martino, C.; Pransani, V.; Nori, G.; Russo, E.; Noto, A.; Simini, B.			Classification of a traumatic brain injury: the Glasgow Coma scale is not enough	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							SEVERE HEAD-INJURY; MODERATE; IMPACT	Background Classifying the severity of a traumatic brain injury (TBI) solely by means of the Glasgow Coma scale (GCS) is under scrutiny, because it overlooks other important clinical signs. Clinicians treating patients with acute TBI are well placed to suggest which variables, in addition to the GCS, should concur in a new classification of TBI. Methods In Italy, acute TBI patients are treated by anaesthetists, and so we asked them, in a questionnaire survey, to rate the weight they give to the GCS and to other clinical variables in their approach to TBI. Because sedation may underestimate GCS scores, we also inquired whether anaesthetists select sedatives that allow drug-free GCS scores. The questionnaire was distributed to 1334 anaesthetists attending courses on neurotrauma; the response rate was 63%. Results Two thirds of the respondents believe that the definition of severe TBI should include, in addition to GCS scores, pupil reactivity to light and computer tomogram (CT) findings, the variables that guide Italian anaesthetists in TBI management. Most respondents (68.2%) administer sedation which allows prompt neurological evaluation and reliable GCS scoring. A minority of respondents (9.3%) withhold or antagonize sedation, delay tracheal intubation or allow patient-ventilator asynchrony. Conclusions Italian anaesthetists would welcome a definition of TBI severity that includes CT findings and pupil reactivity in addition to the GCS.	[Chieregato, A.; Martino, C.; Pransani, V.; Nori, G.; Russo, E.] Osped Bufalini, UO Anestesia & Rianimaz, Cesena, Italy; [Noto, A.] Univ Messina, Osped G Martino, Unita Cardiovasc & Torac, Messina, Italy; [Simini, B.] Osped Gen Prov, UO Anestesia Rianimaz & Terapia Antalg, Lucca, Italy	Chieregato, A (corresponding author), Osped Gen Provinciale M Bufalini, UO Anestesia & Rianimaz, Viale Ghirotti 286, I-47023 Cesena, Italy.	achiere@ausl-cesena.emr.it	Russo, Emanuele/AAP-5645-2020; Noto, Alberto/G-6468-2012	Russo, Emanuele/0000-0002-6531-5527; Martino, Costanza/0000-0002-2691-0059; Noto, Alberto/0000-0002-1490-9317			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Burmeister LF, 2003, ANESTHESIOLOGY, V99, P1251; BURNS KE, 2008, CAN MED ASSOC J, V29, P245; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENNETT B, 1977, LANCET, V1, P878; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SHAPIRO HM, 1975, ANESTHESIOLOGY, V43, P445, DOI 10.1097/00000542-197510000-00010; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1974, LANCET, V2, P81; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569	18	15	15	0	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	JUL	2010	54	6					696	702		10.1111/j.1399-6576.2010.02234.x			7	Anesthesiology	Anesthesiology	604QA	WOS:000278292400005	20397980				2021-06-18	
J	Fariniuk, LF; de Sousa, MH; Westphalen, VPD; Carneiro, E; Neto, UXS; Roskamp, L; Cavali, AE				Fariniuk, Luiz Fernando; de Sousa, Maria Helena; Dietzel Westphalen, Vania Portela; Carneiro, Everdan; Silva Neto, Ulisses X.; Roskamp, Liliane; Cavali, Ana Egide			Evaluation of care of dentoalveolar trauma	JOURNAL OF APPLIED ORAL SCIENCE			English	Article						Tooth injury; Dentoalveolar trauma; Examination; Prevalence	DENTAL INJURIES; UNIVERSITY; PROGNOSIS; CHILDREN; TEETH; AGE	Objectives: The aim of this study was to evaluate cases of dental trauma treated at the specialized center of Pontifical Catholic University of Parana, Curitiba, Brazil, during a period of 2 years. Material and methods: A total of 647 patients were evaluated and treated between 2003 and 2005. Data obtained from each patient were tabulated and analyzed as to gender, age, etiology, time elapsed after the injury, diagnosis (type of trauma), and affected teeth. Results: The results revealed that male individuals aged 7 to 13 years presented the highest prevalence of injury, and falling was the main causal factor. In most cases, the time elapsed between the accident and the first care ranged from 4 to 24 h. A total of 1,747 teeth were affected, with higher incidence of concussion/subluxation and coronal fracture, followed by lateral luxation and avulsion. The permanent maxillary central incisors were the most commonly affected teeth. Conclusion: The frequency and causes of dentoalveolar trauma should be investigated for identification of risk groups, treatment demands and costs in order to allow for the establishment of effective preventive measures that can reduce the treatment duration and costs for both patients and oral health services.	[Fariniuk, Luiz Fernando; de Sousa, Maria Helena; Dietzel Westphalen, Vania Portela; Carneiro, Everdan; Silva Neto, Ulisses X.; Cavali, Ana Egide] Pontif Catholic Univ Parana, Dept Dent, Curitiba, Parana, Brazil	Fariniuk, LF (corresponding author), Rua Imaculada Conceicao 1115, BR-80215000 Curitiba, Parana, Brazil.	fariniuk@uol.com.br	Fariniuk, Luiz F/C-1678-2014; da Silva Neto, Ulisses Xavier/G-7484-2012; ROSKAMP, LILIANE/H-9282-2012; Carneiro, Everdan/I-3924-2016; Carneiro, Everdan/B-5881-2013; Westphalen, Vania Portela Ditzel/G-7318-2012; da Silva Neto, Ulisses Xavier/C-3170-2017	Fariniuk, Luiz F/0000-0003-0731-9893; ROSKAMP, LILIANE/0000-0002-2331-0090; Carneiro, Everdan/0000-0002-7883-5396; Westphalen, Vania Portela Ditzel/0000-0003-2313-7117; da Silva Neto, Ulisses Xavier/0000-0002-9143-2671			Al-Jundi SH, 2004, DENT TRAUMATOL, V20, P1, DOI 10.1111/j.1600-4469.2004.00218.x; Andreasen J O, 1970, Scand J Dent Res, V78, P329; Andreasen JO, 2002, DENT TRAUMATOL, V18, P116, DOI 10.1034/j.1600-9657.2002.00079.x; ANDREASEN JO, 1990, ENDOD DENT TRAUMATOL, V6, P78; De Rossi Moara, 2009, Braz. Dent. J., V20, P259, DOI 10.1590/S0103-64402009000300016; Garcia-Ballesta C, 2003, RCOE, V8, P131; Grimm S, 2004, DENT TRAUMATOL, V20, P134, DOI 10.1111/j.1600-4469.2004.00238.x; Haavikko K, 1976, Proc Finn Dent Soc, V72, P152; Jackson NG, 2006, DENT TRAUMATOL, V22, P179, DOI 10.1111/j.1600-9657.2006.00369.x; Kramer PF, 2003, DENT TRAUMATOL, V19, P299, DOI 10.1046/j.1600-4469.2003.00203.x; Panzarini Sônia Regina, 2008, Braz. oral res., V22, P229; Rocha MJD, 2001, DENT TRAUMATOL, V17, P245; RODRIGUEZ JG, 2004, ACTA ODONTOL VENEZ, V42, P209; Roskamp L, 2009, J PERIODONTOL, V80, P1121, DOI 10.1902/jop.2009.090019; Sakai Vivien Thiemy, 2005, J. Appl. Oral Sci., V13, P340, DOI 10.1590/S1678-77572005000400005; Sandalli N, 2005, DENT TRAUMATOL, V21, P188, DOI 10.1111/j.1600-9657.2005.00309.x; Scariot R, 2009, J APPL ORAL SCI, V17, P195, DOI 10.1590/S1678-77572009000300012; SHINYA K, 1993, ANN PLAS SURG, V30, P417, DOI 10.1097/00000637-199305000-00005; Silva AC, 2004, DENT TRAUMATOL, V20, P6	19	15	17	1	7	UNIV SAO PAULO FAC ODONTOLOGIA BAURU	BAURU-SP	AL DR OCTAVIO PINHEIRO BRISOLLA, 9-75, BAURU-SP, 17012-901, BRAZIL	1678-7757			J APPL ORAL SCI	J. Appl. Oral Sci.	JUL-AUG	2010	18	4					343	345		10.1590/S1678-77572010000400004			3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	648KK	WOS:000281692300004	20835567	DOAJ Gold, Green Published			2021-06-18	
J	Goverover, Y; Chiaravalloti, N; DeLuca, J				Goverover, Yael; Chiaravalloti, Nancy; DeLuca, John			Pilot Study to Examine the Use of Self-Generation to Improve Learning and Memory in People With Traumatic Brain Injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activities of daily living; brain injuries; executive function; learning; memory; retention (psychology)	MULTIPLE-SCLEROSIS; COGNITIVE OPERATIONS; SEMANTIC-MEMORY; ALZHEIMER-TYPE; DEMENTIA; WORDS; REHABILITATION	People with traumatic brain injury (TBI) experience memory and learning difficulties Difficulty in the initial acquisition of information is a primary reason people with TBI experience difficulties in learning and memory Treatment focusing on improving the acquisition of information will likely improve both recall and recognition performance In the "generation effect," items self-generated are remembered better than items read or otherwise provided The purpose of this study was to examine the application of the generation effect in improving memory for functional activities The study used a within-subiects design and included 10 participants with TBI and 15 healthy control participants Results demonstrated that material learned under the generated learning conditions was recalled better than when generated under provided learning conditions This finding was true in both the TBI and the control groups These results provide initial evidence supporting the use of self-generation to improve new learning of functional tasks for people with TBI	[Goverover, Yael] NYU, Dept Occupat Therapy, Steinhardt Sch Culture Educ & Human Dev, New York, NY 10012 USA; [Chiaravalloti, Nancy] Kessler Fdn Res Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ USA; [Chiaravalloti, Nancy; DeLuca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	Goverover, Y (corresponding author), NYU, Dept Occupat Therapy, Steinhardt Sch Culture Educ & Human Dev, 35 W 4th St,11th Floor, New York, NY 10012 USA.						Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Barrett AM, 2000, NEUROLOGY, V54, P1258, DOI 10.1212/WNL.54.6.1258; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P63, DOI 10.1080/13803390601186957; Basso MR, 2006, J INT NEUROPSYCH SOC, V12, P640, DOI 10.1017/S1355617706060759; Beatty W W, 1990, J Geriatr Psychiatry Neurol, V3, P163, DOI 10.1177/089198879000300308; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; CRUTCHER RJ, 1989, J EXP PSYCHOL LEARN, V15, P669, DOI 10.1037/0278-7393.15.4.669; DELIS DC, 2000, DELISKAPLAN EXECUTIV; Delis DC, 1987, CALIFORNIA VERBAL LE; Delis DC, 2001, DELISKAPLAN EXECUTIV; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DICK MB, 1989, BRAIN COGNITION, V9, P88, DOI 10.1016/0278-2626(89)90046-8; FISHER AG, 2001, ASSESSMENT MOTOR PRO; GARDINER JM, 1984, MEM COGNITION, V12, P443, DOI 10.3758/BF03198305; Goverover Y, 2008, ARCH PHYS MED REHAB, V89, P1514, DOI 10.1016/j.apmr.2007.11.059; Hsieh S, 1999, PERCEPT MOTOR SKILL, V89, P355, DOI 10.2466/PMS.89.6.355-367; JOHNSON MK, 1981, AM J PSYCHOL, V94, P37, DOI 10.2307/1422342; Jurica PJ, 1999, MEM COGNITION, V27, P648, DOI 10.3758/BF03211558; Kinjo H, 2000, AM J PSYCHOL, V113, P95, DOI 10.2307/1423462; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; MCELROY LA, 1982, J VERB LEARN VERB BE, V21, P249, DOI 10.1016/S0022-5371(82)90593-X; MITCHELL DB, 1986, J GERONTOL, V41, P79, DOI 10.1093/geronj/41.1.79; Mulligan NW, 2006, J EXP PSYCHOL LEARN, V32, P836, DOI 10.1037/0278-7393.32.4.836; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; SLAMECKA NJ, 1983, J VERB LEARN VERB BE, V22, P153, DOI 10.1016/S0022-5371(83)90112-3; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith ML, 1996, NEUROPSYCHOLOGIA, V34, P553, DOI 10.1016/0028-3932(95)00139-5; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wilkinson G.S., 1993, WRAT 3 WIDE RANGE AC; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020	34	15	16	0	3	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2010	64	4					540	546		10.5014/ajot.2010.09020			7	Rehabilitation	Rehabilitation	633NS	WOS:000280510400003	20825124				2021-06-18	
J	Lunney, M; McGuire, M; Endozo, N; McIntosh-Waddy, D				Lunney, Margaret; McGuire, Maria; Endozo, Nancy; McIntosh-Waddy, Dorothy			Consensus-Validation Study Identifies Relevant Nursing Diagnoses, Nursing Interventions, and Health Outcomes for People with Traumatic Brain Injuries	REHABILITATION NURSING			English	Article						health outcomes; nursing diagnosis; nursing interventions; rehabilitation; standards of care; traumatic brain injury	REHABILITATION; CLIENTS	A consensus-validation study used action research methods to identify relevant nursing diagnoses, nursing interventions, and patient outcomes for a population of adults with traumatic brain injury (TBI) in long-term care. In meetings totaling 159 hours to reach 100% consensus through group discussions, the three classifications of NANDA International's (NANDA-I's) approved nursing diagnoses, the Nursing Interventions Classification (NIC), and the Nursing Outcomes Classification (NOC) were used as the basis for three nurses experienced in working with adults with TBI to select the elements of nursing care. Among almost 200 NANDA-I nursing diagnoses, 29 were identified as relevant for comprehensive nursing care of this population. Each nursing diagnosis was associated with 3-11 of the more than 500 NIC interventions and 1-13 of more than 300 NOC outcomes. The nurses became aware of the complexity and the need for critical thinking. The findings were used to refine the facility's nursing standards of care, which were to be combined with the interdisciplinary plan of care and included in future electronic health records.	[Lunney, Margaret] CUNY Coll Staten Isl, Staten Isl, NY USA; [McGuire, Maria; Endozo, Nancy; McIntosh-Waddy, Dorothy] Sea View Hosp Rehabil Ctr & Home, Staten Isl, NY USA	Lunney, M (corresponding author), CUNY Coll Staten Isl, Staten Isl, NY USA.	margaret.lunney@gmail.com	da Cruz, Dina Monteiro/C-3639-2012	da Cruz, Dina Monteiro/0000-0003-1373-409X			Alverzo Joan, 2004, Rehabil Nurs, V29, P85; *AM ASS NEUR NURS, 2004, AANN COR CURR NEUR N; *AM NURS ASS, 2003, NURS SOC POL STAT; American Nurses Association, 2004, NURS SCOP STAND PRAC; *ASS REH NURS, ROL DESCR REH STAFF; Baum F, 2006, J EPIDEMIOL COMMUN H, V60, P854, DOI 10.1136/jech.2004.028662; BROADWAY JO, 2009, REHABILITATION NURSI, V34, P9; Bulechek G., 2008, NURSING INTERVENTION; CARLSON J, 2006, NANDA NIC NOC C PHIL; Casey D, 2007, NURS HEALTH SCI, V9, P5, DOI 10.1111/j.1442-2018.2007.00297.x; *CDCP, 2006, FACTS TRAUM BRAIN IN; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cruz DM, 2009, J CONTIN EDUC NURS, V40, P121, DOI 10.3928/00220124-20090301-05; FITZWATER E, 2004, REHABILITATION NURSI, V29, P13; Fitzwater Evelyn, 2004, Rehabil Nurs, V29, P13; Holley UA, 2007, REHABIL NURS, V32, P51, DOI 10.1002/j.2048-7940.2007.tb00152.x; Jacelon CS, 2007, REHABIL NURS, V32, P23, DOI 10.1002/j.2048-7940.2007.tb00145.x; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lunney M, 2005, J NURS ADMIN, V35, P1; Lunney M., 2001, CRITICAL THINKING NU; Lunney M., 2009, CRITICAL THINKING AC; Moorhead S., 2008, NURSING OUTCOMES CLA, V5; Mullins Maria, 2005, Rehabil Nurs, V30, P92; NANDA-International, 2009, NURS DIAGN DEF CLASS; *NY STAT OFF PROF, 2009, ED LAW ART 139 DEF N; Pesut D.J., 1999, CLIN REASONING ART S; Reitzel E, 2009, REHABIL NURS, V34, P52; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Stringer E., 2007, ACTION RES; Yu F, 2008, REHABIL NURS, V33, P124, DOI 10.1002/j.2048-7940.2008.tb00216.x	30	15	17	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	JUL-AUG	2010	35	4					161	166		10.1002/j.2048-7940.2010.tb00042.x			6	Nursing; Rehabilitation	Nursing; Rehabilitation	616CG	WOS:000279185100006	20681391				2021-06-18	
J	Edvardsson, B; Persson, S				Edvardsson, Bengt; Persson, Staffan			Reversible cerebral vasoconstriction syndrome associated with autonomic dysreflexia	JOURNAL OF HEADACHE AND PAIN			English	Article						Reversible cerebral vasoconstriction syndrome; Autonomic dysreflexia; Cerebral infarct; Thunderclap headache; Hypertension; Reversible posterior leukoencephalopathy syndrome	THUNDERCLAP HEADACHE; POSTERIOR LEUKOENCEPHALOPATHY; ANGIOPATHY; PATIENT	A 32-year-old man with a residual spastic quadriparesis from a traumatic C5-C6 fracture experienced a severe thunderclap headache. The medical history revealed an episode of autonomic dysreflexia (AD) due to neurogenic bladder/urinary tract infection (UTI). Blood pressure monitoring at admission revealed hypertension; blood pressure reaching 160/100 mmHg (average blood pressure in these patients and also in this patient being 90/60 mmHg). CT scan of the head, cerebrospinal fluid examination, CT angiography and MR angiography of the brain vessels were normal. Another UTI and a subsequent spell of AD were diagnosed. The patient continued to experience recurrent thunderclap headaches. Selective catheter cerebral angiography revealed multiple calibre changes in the intracranial blood vessels. A diagnosis of reversible cerebral vasoconstriction syndrome (RCVS) due to AD was considered. A magnetic resonance imaging (MRI) of the brain after 2 weeks revealed ischaemic changes in the left hemisphere. Follow-up brain MRI after 3 weeks showed reduction in size of the ischaemic changes, and catheter angiography after 6 weeks demonstrated improvement/normalization. A diagnosis of RCVS could be established. Repeated MRI/CT of the brain after 6 months demonstrated a large infarction in the left hemisphere. RCVS has been reported to occur in various clinical settings. It can occur in the setting of AD in patients with traumatic cervical cord injury. Prompt recognition of RCVS may be of vital importance to avoid further morbidity in patients with spinal cord injury.	[Edvardsson, Bengt; Persson, Staffan] Univ Lund Hosp, Fac Neurol, Dept Neurol, S-22185 Lund, Sweden	Edvardsson, B (corresponding author), Univ Lund Hosp, Fac Neurol, Dept Neurol, S-22185 Lund, Sweden.	Bengt.Edvardsson@med.lu.se					Calabrese LH, 2007, ANN INTERN MED, V146, P34, DOI 10.7326/0003-4819-146-1-200701020-00007; CALL GK, 1988, STROKE, V19, P1159, DOI 10.1161/01.STR.19.9.1159; Chaves CJ, 2008, SPINAL CORD, V46, P760, DOI 10.1038/sc.2008.38; Chen SP, 2006, NEUROLOGY, V67, P2164, DOI 10.1212/01.wnl.0000249115.63436.6d; Chen SP, 2008, ANN NEUROL, V63, P751, DOI 10.1002/ana.21384; Chen SP, 2006, CEPHALALGIA, V26, P530, DOI 10.1111/j.1468-2982.2005.01063.x; Dodick DW, 2002, J NEUROL NEUROSUR PS, V72, P6, DOI 10.1136/jnnp.72.1.6; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Ducros Anne, 2009, Pract Neurol, V9, P256, DOI 10.1136/jnnp.2009.187856; Elstner M, 2009, CEPHALALGIA, V29, P677, DOI 10.1111/j.1468-2982.2008.01768.x; Gerretsen P, 2007, CAN J NEUROL SCI, V34, P467, DOI 10.1017/S0317167100007381; Gerretsen P, 2009, CURR NEUROL NEUROSCI, V9, P108, DOI 10.1007/s11910-009-0018-5; Koopman K, 2008, J HEADACHE PAIN, V9, P389, DOI 10.1007/s10194-008-0068-0; McClain WA, 1999, AM J EMERG MED, V17, P238, DOI 10.1016/S0735-6757(99)90113-4; Schwedt TJ, 2006, LANCET NEUROL, V5, P621, DOI 10.1016/S1474-4422(06)70497-5; Singhal AB, 2004, ARCH NEUROL-CHICAGO, V61, P411, DOI 10.1001/archneur.61.3.411; Valles M, 2005, SPINAL CORD, V43, P738, DOI 10.1038/sj.sc.3101780; Warlow C, 2008, STROKE PRACTICAL MAN; YARKONY GM, 1986, ARCH PHYS MED REHAB, V67, P834	19	15	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1129-2369			J HEADACHE PAIN	J. Headache Pain	JUN	2010	11	3					277	280		10.1007/s10194-010-0196-1			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	593JO	WOS:000277450200013	20186562	Bronze, Green Published			2021-06-18	
J	Honeybul, S; Ho, KM; Lind, CRP; Gillett, GR				Honeybul, Stephen; Ho, Kwok M.; Lind, Christopher R. P.; Gillett, Grant R.			Decompressive craniectomy for neurotrauma: the limitations of applying an outcome prediction model	ACTA NEUROCHIRURGICA			English	Article						Decompressive craniectomy; Complications; Outcome; Neurotrauma	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; COMPLICATIONS; VALIDATION; MANAGEMENT	There is currently much interest in the use of decompressive craniectomy for patients with severe head injury. A number of studies have demonstrated that not only can the technique lower intracranial pressure but can also improve outcome. Whilst many patients who would otherwise have died or had a poor outcome now go on to make a good recovery, there is little doubt that complications can have a very significant impact on long term outcome. By using the corticosteroid randomisation after significant head injury (CRASH) collaborators outcome prediction model, three patients were selected who had a similar outcome prediction. All three patients developed intracranial hypertension following trauma and had a decompressive craniectomy. Despite having a similar outcome prediction only one patient made an uneventful recovery. The remaining two patients suffered significant complications. This report illustrates the potential clinical applications and limitations of an outcome prediction model and demonstrates the impact that complications can have on eventual outcome.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Lind, Christopher R. P.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand	Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Lind, Christopher/K-3629-2012; Ho, Kwok M./E-3546-2010	Lind, Christopher/0000-0001-9991-1725; Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GILLETT GR, 2001, NZ MED J, V1130, P188; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2009, J CLIN NEUROSCI, V16, P727, DOI 10.1016/j.jocn.2008.06.015; HONEYBUL S, 2009, J CLIN NEUR IN PRESS; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tokoro K, 1989, Neurol Med Chir (Tokyo), V29, P196, DOI 10.2176/nmc.29.196; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	30	15	17	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2010	152	6					959	964		10.1007/s00701-010-0626-5			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	597TA	WOS:000277783300005	20349359				2021-06-18	
J	Miller, R; Miller, M				Miller, Rubin; Miller, Marvin			Overrepresentation of Males in Traumatic Brain Injury of Infancy and in Infants With Macrocephaly Further Evidence That Questions the Existence of Shaken Baby Syndrome	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						forensic science; shaken baby syndrome; traumatic brain injury of infancy; increased extra-axial fluid spaces; macrocephaly; subdural hematoma; retinal hemorrhages; male gender	NONACCIDENTAL HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; EXTRACEREBRAL FLUID COLLECTIONS; PERIMACULAR RETINAL FOLDS; EXTERNAL HYDROCEPHALUS; BENIGN ENLARGEMENT; NATURAL-HISTORY; INTRACRANIAL HEMORRHAGE; SUBARACHNOID SPACES; SURGICAL-TREATMENT	Shaken baby syndrome (SBS) has been thought to be caused by violent shaking of an infant and is characterized by the triad of findings: subdural hematoma (SDH), retinal hemorrhages, and neurologic abnormalities. The triad is not specific for SBS and can be seen in accidental trauma and in certain medical conditions. Recent observations, however, question whether SBS exists. Herein, we review the gender differences in 3 groups of infants with traumatic brain injury: (1) neonates with SDH from birth trauma, (2) infants with SDH from accidental trauma, and (3) infants with SDH from SBS. Gender differences are also presented in a fourth group of infants with macrocephaly related to increased extra-axial fluid spaces (IEAFS). Compared with the expected male frequency of 51.4% in newborns, there was a statistically significant overrepresentation of males in each of the 4 groups-65.3%, 62.2%, 62.6%, and 68.8%, respectively. We believe that the most likely explanation for these findings relates to the larger head size of the male compared with the female which has several relevant consequences. First, the larger head circumference of a male newborn compared with a female newborn may increase the likelihood that a male newborn will incur a small SDH from the minor trauma of the birthing process that can later rebleed and present with a symptomatic SDH that could be misdiagnosed as SBS and child abuse. Second, a short fall would have a greater likelihood of causing a SDH in a male infant than a female infant who could subsequently become symptomatic from hours to weeks later and could thus present as an unexplained SDH. Third, infants with macrocephaly related to IEAFS may be at increased risk for developing a SDH from the larger head size and greater tautness of the bridging vessels in the extra-axial fluid spaces. We believe that many infants who have been diagnosed with SBS have been given incorrect diagnoses of child abuse. Rather, their SDH may occur as a result of a small SDH from the birthing process that enlarges during early infancy, a short fall, or from macrocephaly with IEAFS.	[Miller, Rubin; Miller, Marvin] Wright State Univ, Dept Pediat Ob Gyn & Biomed Engn, Boonshoft Sch Med, Dayton, OH 45435 USA	Miller, M (corresponding author), Childrens Med Ctr, Dept Med Genet, 1 Childrens Plaza, Dayton, OH 45404 USA.	srmmem@aol.com					ALVAREZ LA, 1986, PEDIATRICS, V77, P901; AOKI N, 1994, J NEUROSURG, V81, P20, DOI 10.3171/jns.1994.81.1.0020; AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; ASCH AJ, 1976, PEDIATRICS, V57, P535; AVERY GB, 1994, NEONATOLOGY, P1146; BERGSTROM M, 1977, J COMPUT ASSIST TOMO, V1, P449, DOI 10.1097/00004728-197710000-00011; BRAY GL, 1987, AM J DIS CHILD, V141, P1215, DOI 10.1001/archpedi.1987.04460110085030; Brousseau TJ, 2005, J EMERG MED, V29, P283, DOI 10.1016/j.jemermed.2005.02.009; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAROLAN PL, 1986, PEDIATR NEUROSCI, V12, P140; Cho Jun Beom, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P273; COLE TRP, 1991, AM J MED GENET, V41, P115, DOI 10.1002/ajmg.1320410128; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Datta S, 2005, ARCH DIS CHILD, V90, P947, DOI 10.1136/adc.2002.021154; DAY RE, 1979, ARCH DIS CHILD, V54, P512, DOI 10.1136/adc.54.7.512; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Donohoe M, 2003, AM J FOREN MED PATH, V24, P239, DOI 10.1097/01.paf.0000083635.85457.97; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ersahin Y, 1997, CHILD NERV SYST, V13, P526, DOI 10.1007/s003810050131; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Fenton S, 1999, ARCH OPHTHALMOL-CHIC, V117, P1432; Fung ELW, 2002, PEDIATR INT, V44, P37, DOI 10.1046/j.1442-200X.2002.01500.x; Gago LC, 2003, RETINA-J RET VIT DIS, V23, P724, DOI 10.1097/00006982-200310000-00027; Gardner HB, 2004, NEUROPATH APPL NEURO, V30, P192, DOI 10.1111/j.1365-2990.2003.00503.x; Geddes JF, 2004, BMJ-BRIT MED J, V328, P719, DOI 10.1136/bmj.328.7442.719; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Golden N, 2005, J CLIN NEUROSCI, V12, P235, DOI 10.1016/j.jocn.2004.11.001; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Grech V, 2003, J EPIDEMIOL COMMUN H, V57, P612, DOI 10.1136/jech.57.8.612; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; HAMZA M, 1987, PEDIATR NEUROL, V3, P218, DOI 10.1016/0887-8994(87)90021-X; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; HOFFMAN J, 1998, NY TIMES        0330; HOWARD MA, 1993, BRIT J NEUROSURG, V7, P355, DOI 10.3109/02688699309103489; Hwang SK, 2000, CHILD NERV SYST, V16, P590, DOI 10.1007/s003810000312; HYMEL KP, 2004, CHILD MALTREATMENT, V7, P329; IKEDA A, 1987, CHILD NERV SYST, V3, P19, DOI 10.1007/BF00707188; ITO H, 1978, J NEUROSURG, V48, P197, DOI 10.3171/jns.1978.48.2.0197; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kairys SW, 2001, PEDIATRICS, V108, P206; Kaler S G, 1994, Adv Pediatr, V41, P263; Kayser K, 1987, HEIGHT WEIGHT HUMAN; KELLY P, 2004, NZJM, V117, P1201; King WJ, 2003, CAN MED ASSOC J, V168, P155; KUKARNI R, 1999, J PEDIAT HEMATOL ONC, V21, P289; Lantz P, 2006, 58 ANN SCI M AM AC F; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; LAUBSCHER B, 1990, EUR J PEDIATR, V149, P502, DOI 10.1007/BF01959405; Le Fanu J, 2005, J ROY SOC MED, V98, P249, DOI 10.1258/jrsm.98.6.249; Lee A. C. W., 1999, Hong Kong Medical Journal, V5, P337; Leestma J. E., 2006, J AM PHYS SURG, V11, P14; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; Leo RA, 1998, J CRIM LAW CRIM, V88, P429, DOI 10.2307/1144288; Loh JK, 2002, SURG NEUROL, V58, P218, DOI 10.1016/S0090-3019(02)00830-3; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Medina LS, 2001, AM J NEURORADIOL, V22, P564; Miller M, 2003, JAMA-J AM MED ASSOC, V290, P2542, DOI 10.1001/jama.290.19.2542-b; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; MORI K, 1980, J COMPUT ASSIST TOMO, V4, P466, DOI 10.1097/00004728-198008000-00009; MULLER PJ, 1974, J NEUROSURG, V41, P160, DOI 10.3171/jns.1974.41.2.0160; NATELSON SE, 1973, PEDIATRICS, V51, P169; NICKEL RE, 1987, DEV MED CHILD NEUROL, V29, P181; ODITA JC, 1992, CHILD NERV SYST, V8, P36, DOI 10.1007/BF00316560; Ofshe RJ, 1997, DENVER U LAW REV, V74, P979; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; Perrin RG, 1997, NEUROSURGERY, V40, P1190, DOI 10.1097/00006123-199706000-00016; Piatt J H Jr, 1999, Neurosurg Focus, V7, pe4; Pierre-Kahn V, 2003, OPHTHALMOLOGY, V110, P1718, DOI 10.1016/S0161-6420(03)00581-5; PIERREKAHN A, 1986, CHILD NERV SYST, V2, P191, DOI 10.1007/BF00706809; Pittman T, 2003, PEDIATR NEUROSURG, V39, P57, DOI 10.1159/000071315; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; ROBERTSON WC, 1979, J PEDIATR-US, V94, P382, DOI 10.1016/S0022-3476(79)80575-2; ROMODANOV AP, 1987, SURG NEUROL, V28, P253, DOI 10.1016/0090-3019(87)90302-8; Rooms L, 2003, PEDIATRICS, V111, pE636, DOI 10.1542/peds.111.5.e636; Roshan K, 1998, J TROP PEDIATRICS, V44, P153, DOI 10.1093/tropej/44.3.153; Rutty GN, 1999, AM J FOREN MED PATH, V20, P48, DOI 10.1097/00000433-199903000-00012; SAUNDERS C, 1948, BRIT J OBSTET GYNAEC, V55, P55; SCHIPKE R, 1954, PEDIATRICS, V14, P468; SCHULZ DM, 1962, ARCH PATHOL, V74, P244; Shen W C, 1986, Acta Radiol Suppl, V369, P689; Sherwood D, 1930, AM J DIS CHILD, V39, P980; SPARACIO RR, 1971, NEW YORK STATE J MED, V71, P212; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Sun DTF, 2006, CHILD NERV SYST, V22, P593, DOI 10.1007/s00381-006-0094-7; TAKAGI T, 1982, CHILD BRAIN, V9, P102; Takitani K, 2002, PEDIATR INT, V44, P680, DOI 10.1046/j.1442-200X.2002.01620.x; Tolias C, 2000, PEDIATR NEUROSURG, V33, P194, DOI 10.1159/000055952; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; Uscinski RH, 2004, J NEUROSURG, V100, P574; Uscinski Ronald, 2004, J AM PHYS SURG, V9, P76; Van Calenbergh F, 2000, CHILD NERV SYST, V16, P429, DOI 10.1007/PL00007287; Vinchon M, 2004, J NEUROSURG, V101, P44, DOI 10.3171/ped.2004.101.2.0044; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Wells RG, 2002, ARCH PEDIAT ADOL MED, V156, P252, DOI 10.1001/archpedi.156.3.252; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; WILMS G, 1993, AM J NEURORADIOL, V14, P855; Wygnanski-Jaffe T, 2006, AM J OPHTHALMOL, V142, P233, DOI 10.1016/j.ajo.2006.03.038; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687; Zou KH, 2003, RADIOLOGY, V226, P609, DOI 10.1148/radiol.2263011500; Zouros A, 2004, J NEUROSURG, V100, P512, DOI 10.3171/ped.2004.100.5.0512; 2000 GROWTH CHARTS	116	15	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	2010	31	2					165	173		10.1097/PAF.0b013e3181d96a8e			9	Medicine, Legal; Pathology	Legal Medicine; Pathology	603KI	WOS:000278207100014	20308871				2021-06-18	
J	Roberta, A; Rossella, B				Roberta, Albertini; Rossella, Bianchi			Aquaporins and Glia	CURRENT NEUROPHARMACOLOGY			English	Article						Aquaporins; glial cells	WATER CHANNEL PROTEIN; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; CELL CHIP28 PROTEIN; SPINAL-CORD-INJURY; TRANSGENIC MICE; RAT-BRAIN; NEUROGLIAL ACTIVATION; FUNCTIONAL EXPRESSION	Glial cells coordinate the differentiation, metabolism, and excitability of neurons; they modulate synaptic transmission and integrate signals emanating from neurons and other glial cells. Several evidences underlying the relation between these pathways and the regulatory mechanisms of ion concentration, supporting the role of Aquaporins (AQPs) in these processes. The goal of this review is to summarize the localization of different isoforms of AQPs in relation to glial cells both in central and peripheral nervous system, underlying AQP involvement in physiological and in pathophysiological conditions such as brain edema, glioma and epilepsy.	[Roberta, Albertini] Univ Brescia, Dept Biomed Sci & Biotechnol, Div Human Anat, I-25123 Brescia, Italy; [Rossella, Bianchi] Univ Milan, Dept Human Morphol, Milan, Italy	Roberta, A (corresponding author), Univ Brescia, Dept Biomed Sci & Biotechnol, Div Human Anat, Vle Europa 11, I-25123 Brescia, Italy.	roberta_albertini@alice.it					AHLSEN G, 1993, BIOL PSYCHIAT, V33, P734, DOI 10.1016/0006-3223(93)90124-V; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; ARCURI C, 1995, J NEUROSCI RES, V40, P622, DOI 10.1002/jnr.490400507; Badaut J, 2000, J NEUROENDOCRINOL, V12, P960, DOI 10.1046/j.1365-2826.2000.00539.x; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Basaldella Luca, 2007, Neurosurg Focus, V22, pE4; Bauman M. L., 1994, NEUROBIOLOGY AUTISM, P19; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Borsani E, 2009, NEUROSCI LETT, V449, P183, DOI 10.1016/j.neulet.2008.11.014; Buffoli B, 2009, J ANAT, V215, P498, DOI 10.1111/j.1469-7580.2009.01143.x; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Carulli D, 2004, PROG NEUROBIOL, V72, P373, DOI 10.1016/j.pneurobio.2004.03.007; CHEBABO SR, 1995, BRAIN RES, V695, P203, DOI 10.1016/0006-8993(95)00778-O; Chen CH, 2007, NEUROCRIT CARE, V7, P92, DOI 10.1007/s12028-007-0033-9; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; DUDEK FE, 1990, NEUROSCI LETT, V120, P267, DOI 10.1016/0304-3940(90)90056-F; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Evans A, 2002, Curr Probl Diagn Radiol, V31, P79; Fatemi SH, 2008, SYNAPSE, V62, P501, DOI 10.1002/syn.20519; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; FATEMI SH, 2002, INT J NEUROPSYCHOPH, V5, P153; FISCHBARG J, 1990, P NATL ACAD SCI USA, V87, P3244, DOI 10.1073/pnas.87.8.3244; Gao HW, 2006, GLIA, V53, P783, DOI 10.1002/glia.20336; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; He Q, 1997, J NEUROSCI, V17, P3515; Ishibashi K, 1997, BIOCHEM BIOPH RES CO, V237, P714, DOI 10.1006/bbrc.1997.7219; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; KANDEL ER, 1991, PRINCIPLES NEURAL SC, P18; KRUGER L, 1993, J COMP NEUROL, V333, P417, DOI 10.1002/cne.903330308; Kwon TH, 2001, SEMIN NEPHROL, V21, P231, DOI 10.1053/snep.2001.21647; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; Lee TS, 2004, ACTA NEUROPATHOL, V108, P493, DOI 10.1007/s00401-004-0910-7; Lehmann GL, 2004, CURR NEUROVASC RES, V1, P293, DOI 10.2174/1567202043362081; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Li X, 2009, NEUROSCIENCE, V162, P67, DOI 10.1016/j.neuroscience.2009.04.044; Longatti P, 2006, NEUROSCI LETT, V392, P178, DOI 10.1016/j.neulet.2005.09.083; MANGIARDI JR, 1990, NEUROSURGERY, V26, P1, DOI 10.1227/00006123-199001000-00001; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; Masseguin C, 2000, J APPL PHYSIOL, V88, P843; Meng SZ, 2004, EUR J NEUROSCI, V19, P2261, DOI 10.1111/j.0953-816X.2004.03315.x; Merves M, 2000, LARYNGOSCOPE, V110, P1925, DOI 10.1097/00005537-200011000-00030; Mobasheri A, 2005, J MOL HISTOL, V36, P1, DOI 10.1007/s10735-004-2633-4; Mosbasheri A, 2004, AM J PHYSIOL-CELL PH, V286, pC529, DOI 10.1152/ajpcell.00408.2003; Nagahama M, 2006, NEUROSCI LETT, V395, P206, DOI 10.1016/j.neulet.2005.10.092; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nandasena BGTL, 2007, BRAIN RES, V1157, P32, DOI 10.1016/j.brainres.2007.04.033; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Newman Eric A., 1995, P717; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Nicchia GP, 2001, J HISTOCHEM CYTOCHEM, V49, P1547, DOI 10.1177/002215540104901208; Nielsen S, 1997, J NEUROSCI, V17, P171; Oshio K, 2005, NEUROSURGERY, V56, P375, DOI 10.1227/01.NEU.0000148904.57841.6B; Oshio K, 2006, BIOCHEM BIOPH RES CO, V341, P1022, DOI 10.1016/j.bbrc.2006.01.062; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Oshio K, 2004, NEUROSCIENCE, V127, P685, DOI 10.1016/j.neuroscience.2004.03.016; Pan EH, 1996, NEUROSCI LETT, V207, P9, DOI 10.1016/0304-3940(96)12477-0; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Perez E, 2007, BRAIN RES, V1128, P164, DOI 10.1016/j.brainres.2006.09.109; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; QUAGLIARELLO VJ, 1986, J CLIN INVEST, V77, P1084, DOI 10.1172/JCI112407; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; Rodriguez A, 2006, ACTA NEUROPATHOL, V112, P573, DOI 10.1007/s00401-006-0117-1; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; SAADOUN S, 2002, J ANAT, V200, P528; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Schwartzkroin PA, 1998, EPILEPSY RES, V32, P275, DOI 10.1016/S0920-1211(98)00058-8; Shields SD, 2007, PAIN, V131, P8, DOI 10.1016/j.pain.2006.11.018; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Solenov EI, 2002, J NEUROSCI METH, V113, P85, DOI 10.1016/S0165-0270(01)00481-2; Speake T, 2003, BBA-BIOMEMBRANES, V1609, P80, DOI 10.1016/S0005-2736(02)00658-2; St Hillaire C, 2005, J NEUROVIROL, V11, P535, DOI 10.1080/13550280500385203; Stevens AL, 2000, AM J PHYSIOL-CELL PH, V278, pC791; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tan G, 2008, J INT MED RES, V36, P777, DOI 10.1177/147323000803600420; Tomas-Camardiel M, 2004, J NEUROCHEM, V91, P891, DOI 10.1111/j.1471-4159.2004.02759.x; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Verkman AS, 2006, SEMIN NEPHROL, V26, P200, DOI 10.1016/j.semnephrol.2006.02.002; WALZ W, 1987, CAN J PHYSIOL PHARM, V65, P1051, DOI 10.1139/y87-166; WALZ W, 1992, NEUROSCI LETT, V135, P243, DOI 10.1016/0304-3940(92)90446-E; Warth A, 2005, ACTA NEUROPATHOL, V109, P418, DOI 10.1007/s00401-005-0984-x; Warth A, 2004, ACTA NEUROPATHOL, V107, P311, DOI 10.1007/s00401-003-0812-0; Warth A, 2007, J NEUROSCI RES, V85, P1336, DOI 10.1002/jnr.21224; Warth A, 2007, APPL IMMUNOHISTO M M, V15, P193, DOI 10.1097/01.pai.0000213110.05108.e9; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P624, DOI 10.1111/j.1440-1681.2007.04619.x; Yamamoto N, 2002, MOL BRAIN RES, V104, P96, DOI 10.1016/S0169-328X(02)00322-4; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhang D, 2002, J GEN PHYSIOL, V119, P561, DOI 10.1085/jgp.20028597; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	111	15	17	0	1	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1570-159X	1875-6190		CURR NEUROPHARMACOL	Curr. Neuropharmacol.	JUN	2010	8	2					84	91		10.2174/157015910791233178			8	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	599KE	WOS:000277910000002	21119878	Green Published			2021-06-18	
J	Capizzani, AR; Drongowski, R; Ehrlich, PF				Capizzani, Anthony R.; Drongowski, Robert; Ehrlich, Peter F.			Assessment of termination of trauma resuscitation guidelines: are children small adults?	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	41st Annual Meeting of the Canadian-Association-of-Paediatric-Surgeons	OCT 01-03, 2009	Halifax, CANADA	Canadian Assoc Paediat Surg		Pediatric trauma; Prehospital traumatic cardiopulmonary arrest; Resuscitation	CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; SURVIVAL; CPR	Background: Guidelines for termination of resuscitation in prehospital traumatic cardiopulmonary arrest (TCPA) have recently been published for adults. Clinical criteria for termination of care include absent pulse, unorganized electrocardiogram (ECG), fixed pupils (all at the scene), and cardiopulmonary resuscitation (CPR) greater than 15 minutes. The goal of this study was to evaluate these guidelines in a pediatric trauma population. Methods: Pediatric trauma patients with documented arrest were included in the study. Data assessed were duration of CPR, ECG rhythm, pulse assessment, pupil response, transport times, and standard injury criteria (eg, mechanism of injury). Survivors were compared to nonsurvivors using descriptive statistics, chi(2), and Pearson correlation. Results: Between 2000 and 2009, 30 patients were identified as having had a TCPA. Of the 30 with a prehospital TCPA, there were 9 females and 21 males (0.2-18 years old). The average (SD) injury severity score was 35.4 (20.6). Twenty-four patients (80%) did not survive. Severe traumatic brain injury was associated with nonsurvivors in 78%. One-way analysis of variances demonstrated that CPR greater than 15 minutes (P = .011) and fixed pupils (P = .022) were significant variables to distinguish between survivors and nonsurvivors, whereas ECG rhythm (P = .34) and absent pulse (P = .056) did not, 42 +/- 28 minutes for nonsurvivors and 7 +/- 3 minutes for survivors. Conclusion: Criteria for termination of resuscitation correctly predicted 100% of those who died when all the criteria were met. More importantly, no survivors would have had resuscitation stopped. Duration of CPR seems to be a strong predictor of mortality in this study. (C) 2010 Elsevier Inc. All rights reserved.	[Ehrlich, Peter F.] Univ Michigan, Sch Med, Pediat Surg Sect, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA	Ehrlich, PF (corresponding author), Univ Michigan, Sch Med, Pediat Surg Sect, Dept Surg, Ann Arbor, MI 48109 USA.	pehrlich@med.umich.edu					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CAUKINS CM, 2002, J PEDIATR SURG, V37, P180; Committee on Trauma of the American College of Surgeons, 2006, RES OPT CAR INJ PAT; Cone David C, 2005, Prehosp Emerg Care, V9, P276, DOI 10.1080/10903120590961996; Fisher B, 1999, PEDIATR EMERG CARE, V15, P274; HAZINSKI MF, 1994, ANN EMERG MED, V23, P1229, DOI 10.1016/S0196-0644(94)70346-9; Hopson Laura R, 2003, Prehosp Emerg Care, V7, P141, DOI 10.1080/10903120390937274; HOPSON LR, 2003, J AM COLL SURGEONS, V1, P112; Li GH, 1999, J TRAUMA, V47, P1, DOI 10.1097/00005373-199907000-00001; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; O'Brien E, 2008, PREHOSP EMERG CARE, V12, P57, DOI 10.1080/10903120701707989; Peden M, 2008, WORLD REPORT CHILD I, P1; Pickens JJ, 2005, J TRAUMA, V58, P951, DOI 10.1097/01.TA.0000162174.06448.5A; SAKLAYEN M, 1995, MEDICINE, V74, P163, DOI 10.1097/00005792-199507000-00001; SAS, 2004, SAS STAT SOFTW VERS; SHIMAZU S, 1983, J TRAUMA, V23, P213, DOI 10.1097/00005373-198303000-00006; Stockinger ZT, 2004, J AM COLL SURGEONS, V198, P227, DOI 10.1016/j.jamcollsurg.2003.10.012; Stratton SJ, 1998, J TRAUMA, V45, P96, DOI 10.1097/00005373-199807000-00021; Suominen P, 1998, RESUSCITATION, V36, P9, DOI 10.1016/S0300-9572(97)00088-9	21	15	15	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAY	2010	45	5					903	907		10.1016/j.jpedsurg.2010.02.014			5	Pediatrics; Surgery	Pediatrics; Surgery	590RI	WOS:000277244600011	20438923				2021-06-18	
J	Olivecrona, M; Wildemyr, Z; Koskinen, LOD				Olivecrona, Magnus; Wildemyr, Zandra; Koskinen, Lars-Owe D.			The apolipoprotein E epsilon 4 allele and outcome in severe traumatic brain injury treated by an intracranial pressure-targeted therapy	JOURNAL OF NEUROSURGERY			English	Article						apolipoprotein E; epsilon 4 allele; severe traumatic brain injury; outcome; prediction	E-DEFICIENT MICE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; E GENOTYPE; E POLYMORPHISM; APOE-EPSILON-4 ALLELE; APOE GENOTYPE; ASSOCIATION; REGENERATION	Object. In this paper, the authors' goal was to study the influence of the apolipoprotein E epsilon 4 allele on the clinical outcome in patients treated for severe traumatic brain injury (TBI) with an intracranial pressure (ICP)-targeted therapy based on the Lund concept. Methods. The authors conducted a prospective double-blinded randomized trial in which they examined patients with severe TBI. Inclusion criteria consisted of a Glasgow Coma Scale (GCS) score <= 8 at the time of intubation and sedation, patient age between 15 and 70 years, an initial cerebral perfusion pressure > 10 mm Hg, and arrival to the hospital < 24 hours after trauma. Blood samples for the analysis of apolipoprotein E allele types were collected. Independent staff members evaluated outcomes by obtaining Glasgow Outcome Scale (GOS) scores at 3, 12, and 24 months. Results. The occurrence of the epsilon 4 allele was analyzed in 46 patients (mean age 35 +/- 2.2 years with a median GCS score of 6 [range 3-8]). The epsilon 4 allele was present in 39.1% of the patients. The ICP, cerebral perfusion pressure, and injury severity score were not statistically significantly different between the groups. The median GOS score at 3 months was 3.5, and at 12 and 24 months was 4 (range 1-5). Except for the GOS score at 3 months, which was dichotomized as favorable (GOS Score 4 or 5) and unfavorable (GOS Scores 1-3), no statistically significant differences in outcome, irrespective of GOS dichotomization used, were found between the patients with the epsilon 4 allele and those without. The presence of the epsilon 4 allele did not predict for clinical outcome, but GCS and ICP did. Conclusions. The presence of epsilon 4 is not associated with long-term clinical outcome in patients with severe TBI treated with an ICP targeted therapy, based on the Lund concept. (DOI: 10.3171/2009.8.JNS09636)	[Olivecrona, Magnus; Wildemyr, Zandra; Koskinen, Lars-Owe D.] Umea Univ Hosp, Dept Pharmacol & Clin Neurosci, S-90185 Umea, Sweden; [Wildemyr, Zandra] Univ Uppsala Hosp, Dept Neurosurg, Uppsala, Sweden	Olivecrona, M (corresponding author), Univ Hosp, Dept Neurosurg, SE-90185 Umea, Sweden.	magnus.olivecrona@vll.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502	foundation for clinical neurosciences at Umea University; Kempe Foundation; Tore Nilsson's Fund; Capio Research Fund	This study was financially supported by the foundation for clinical neurosciences at Umea University, the Kempe Foundation, Tore Nilsson's Fund, and Capio Research Fund.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chapman J, 2001, NEUROLOGY, V56, P312, DOI 10.1212/WNL.56.3.312; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Fontanella M, 2007, J NEUROSURG, V106, P245, DOI 10.3171/jns.2007.106.2.245; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Horsburgh K, 1999, NEUROREPORT, V10, P837, DOI 10.1097/00001756-199903170-00031; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; JENNETT B, 1975, LANCET, V1, P480; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Kerr ME, 2003, CRIT CARE MED, V31, P2371, DOI 10.1097/01.CCM.0000080484.72004.C4; Lanterna LA, 2005, NEUROLOGY, V64, P1238, DOI 10.1212/01.WNL.0000156523.77347.B4; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Leung CHS, 2002, STROKE, V33, P548, DOI 10.1161/hs0202.102326; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; McCarron MO, 2003, ACTA NEUROL SCAND, V107, P106, DOI 10.1034/j.1600-0404.2003.01365.x; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; OLIVECRONA M, 2009, J NEUROTRAUMA; OLIVECRONA M, 2008, EUR J ANAESTH, V25, P4; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; PITAS RE, 1987, J BIOL CHEM, V262, P14352; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZANNIS VI, 1982, J LIPID RES, V23, P911	42	15	16	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAY	2010	112	5					1113	1119		10.3171/2009.8.JNS09636			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	591BW	WOS:000277273600030	19747047				2021-06-18	
J	Jung, GO; Yoon, MR; Kim, SJ; Sin, MJ; Kim, EY; Moon, JI; Kim, JM; Choi, GS; Kwon, CHD; Cho, JW; Lee, SK				Jung, G. O.; Yoon, M. R.; Kim, S. -J.; Sin, M. J.; Kim, E. Y.; Moon, J. I.; Kim, J. M.; Choi, G. -S.; Kwon, C. H. D.; Cho, J. -W.; Lee, S. K.			The Risk Factors of Delayed Graft Function and Comparison of Clinical Outcomes After Deceased Donor Kidney Transplantation: Single-Center Study	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	11th Congress of the Asian-Society-of-Transplantation	OCT 01-04, 2009	Beirut, LEBANON	Asian Soc Transplantat			CADAVERIC RENAL-TRANSPLANTATION; OF-WISCONSIN SOLUTION; LONG-TERM SURVIVAL; ALLOGRAFT SURVIVAL; MULTIORGAN DONORS; ACUTE REJECTION; PRESERVATION; IMPACT	Introduction. The aim of this study was to analyze risk factors for delayed graft function (DGF) after deceased donor kidney transplantation and to compare the clinical outcomes of non-DGF versus DGF recipients. Patients and methods. From January 2004 to June 2008, 75/154 kidneys were transplanted into 74 recipients. We classified the recipients into two groups: group 1 (n = 61) without DGF and group 2 (n = 13) with DGF. Results. On univariate analysis, recipient age (P = .048) cause of brain death (traumatic brain injury vs disease, P = .016), blood urea nitrogen (P = .002), serum creatinine (P = .001), arterial pH (P = .019), and serum sodium level (P = .012) just before organ procurement showed significant differences. On multivariate analysis, the cause of brain death (P = .015, hazard ratio [HR]: 7.086), the terminal serum creatinine >= 1.5 mg/dL before organ procurement (P = .007, HR: 10.132), and recipient age over >= 50 years (P = .021, HR: 7.767) were independent risk factors for the development of DGF. Graft failures occurred among 5/74 recipients with 5-year graft survivals between group 1 and group 2 of 91.7% and 84.6%, respectively. Patient death occurred in five cases, most by due to infection. The 5-year patient survival between groups 1 and 2 were 93.9% and 84.6%, respectively (P = .106). Conclusion. The independent risk factors for DGF were the cause of brain death, the terminal creatinine level, and the recipient age. In deceased donor kidney transplantation, DGF may have less effect on long-term patient and graft survivals.	[Jung, G. O.; Kim, S. -J.; Moon, J. I.; Kim, J. M.; Choi, G. -S.; Kwon, C. H. D.; Cho, J. -W.; Lee, S. K.] Sungkyunkwan Univ, Sch Med, Div Transplantat, Dept Surg,Samsung Med Ctr, Seoul 135710, South Korea	Kim, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Div Transplantat, Dept Surg,Samsung Med Ctr, Ilwondong 50, Seoul 135710, South Korea.	kmhyj111@skku.edu	Kwon, Choon Hyuck David/H-7263-2019; kim, jm/O-5935-2014; Kim, Sung Joo/C-9604-2011; Kim, Jong Man/AAH-5295-2020	Kwon, Choon Hyuck David/0000-0002-1082-3321; 			ALMOND PS, 1991, TRANSPLANT P, V23, P1304; Boom H, 2000, KIDNEY INT, V58, P859, DOI 10.1046/j.1523-1755.2000.00235.x; Bronzatto EJM, 2009, TRANSPL P, V41, P849, DOI 10.1016/j.transproceed.2009.02.004; Chatziantoniou C, 2008, CURR OPIN NEPHROL HY, V17, P76, DOI 10.1097/MNH.0b013e3282f1bb69; Giral-Classe M, 1998, KIDNEY INT, V54, P972, DOI 10.1046/j.1523-1755.1998.00071.x; Hetzel GR, 2002, TRANSPL INT, V15, P10, DOI 10.1007/s00147-001-0368-7; Humar A, 2002, CLIN TRANSPLANT, V16, P425, DOI 10.1034/j.1399-0012.2002.02055.x; Koning OHJ, 1997, TRANSPLANTATION, V63, P1620, DOI 10.1097/00007890-199706150-00015; KONING OHJ, 1995, TRANSPLANT P, V27, P752; Marcen R, 1998, TRANSPLANTATION, V66, P461, DOI 10.1097/00007890-199808270-00008; Marshall R, 1996, SURGERY, V120, P663, DOI 10.1016/S0039-6060(96)80014-6; McLaren AJ, 1999, CLIN TRANSPLANT, V13, P266, DOI 10.1034/j.1399-0012.1999.130308.x; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Patel SJ, 2008, TRANSPLANTATION, V86, P313, DOI 10.1097/TP.0b013e31817ef190; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pfaff WW, 1998, TRANSPLANTATION, V65, P219; Quiroga I, 2006, NEPHROL DIAL TRANSPL, V21, P1689, DOI 10.1093/ndt/gfl042; Rodrigo E, 2004, AM J TRANSPLANT, V4, P1163, DOI 10.1111/j.1600-6143.2004.00488.x; ROSENTHAL JT, 1991, TRANSPLANTATION, V51, P1115; Sellers MT, 2000, CLIN TRANSPLANT, V14, P543, DOI 10.1034/j.1399-0012.2000.140605.x; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	22	15	15	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2010	42	3					705	709		10.1016/j.transproceed.2010.02.063			5	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	588VV	WOS:000277103500009	20430152				2021-06-18	
J	Cheng, BH; Yang, XX; Chen, CC; Cheng, DF; Xu, XD; Zhang, XW				Cheng, Baohua; Yang, Xinxin; Chen, Chengchun; Cheng, Danfu; Xu, Xudong; Zhang, Xuewen			D-beta-Hydroxybutyrate Prevents MPP plus -Induced Neurotoxicity in PC12 Cells	NEUROCHEMICAL RESEARCH			English	Article						Parkinson's disease; D-beta-Hydroxybutyrate; Apoptosis; MPP; PC12	TRAUMATIC BRAIN-INJURY; ION-INDUCED APOPTOSIS; KETOGENIC DIET; KAINIC ACID; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; KETONE-BODIES; RAT-BRAIN; COMPLEX-I	Numerous studies show that D-beta-Hydroxybutyrate (D beta HB) is neuroprotective. The present study was to explore the neuroprotective effects of D beta HB against the cell death and apoptosis induced by 1-methyl-4-phenylpyridinium ion (MPP+) in PC12 cells. PC12 cells were pretreated with D beta HB and followed by MPP+ exposure. The cell viability was determined by MTT assay. The morphological characteristics of apoptosis was observed by Acridine Orange (AO) staining and apoptotic rates were measured by flow cytometer. The product of lipid peroxidation, malondialdehyde (MDA), was measured using thiobarbituric acid method. The mitochondrial membrane potential (MMP), intracellular ROS and total glutathione were detected by microplate reader. In PC12 cells, pretreatment with D beta HB significantly reduced MPP+-induced the decrease of cell viability. AO staining and flow cytometric analysis found D beta HB inhibited MPP+-induced apoptosis. The measurement of MDA formation showed that D beta HB alleviated lipid peroxidation induced by MPP+. The loss of MMP induced by MPP+ was preventive by D beta HB. The changes of intracellular ROS and total glutathione induced by MPP+ were reversed by D beta HB. D beta HB protected PC12 cells against MPP+-induced death and apoptosis.	[Cheng, Baohua; Yang, Xinxin; Xu, Xudong; Zhang, Xuewen] Jining Med Univ, Jining, Shandong, Peoples R China; [Yang, Xinxin; Cheng, Danfu] Rizhao Peoples Hosp, Rizhao, Shandong, Peoples R China; [Chen, Chengchun] Wenzhou Med Coll, Wenzhou, Zhejiang, Peoples R China	Cheng, BH (corresponding author), Jining Med Univ, Jining, Shandong, Peoples R China.	apple9red@yahoo.com.cn					Bharath S, 2002, BIOCHEM PHARMACOL, V64, P1037, DOI 10.1016/S0006-2952(02)01174-7; Bo J, 2005, NEUROSCI RES, V53, P183, DOI 10.1016/j.neures.2005.06.014; Chalimoniuk M, 2006, CELL MOL NEUROBIOL, V26, P1153, DOI 10.1007/s10571-006-9078-0; Chen J, 2006, APOPTOSIS, V11, P943, DOI 10.1007/s10495-006-6715-5; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; CHIBA K, 1984, BIOCHEM BIOPH RES CO, V120, P574, DOI 10.1016/0006-291X(84)91293-2; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Eberhardt O, 2003, TOXICOL LETT, V139, P135, DOI 10.1016/S0378-4274(02)00428-9; Freeman JM, 1998, PEDIATRICS, V102, P1358, DOI 10.1542/peds.102.6.1358; GO KG, 1988, METAB BRAIN DIS, V3, P257, DOI 10.1007/BF00999535; Guzman M, 2001, TRENDS ENDOCRIN MET, V12, P169, DOI 10.1016/S1043-2760(00)00370-2; HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409; HAWKINS RA, 1986, AM J PHYSIOL, V250, pE169; HEIKKILA RE, 1989, MOL CHEM NEUROPATHOL, V10, P171, DOI 10.1007/BF03159727; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Imamura K, 2006, J NEUROSCI RES, V84, P1376, DOI 10.1002/jnr.21021; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Jellinger KA, 2000, J NEURAL TRANSM, V107, P1, DOI 10.1007/s007020050001; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jin BK, 1998, NEUROSCI LETT, V245, P61, DOI 10.1016/S0304-3940(98)00170-0; Kang XG, 2007, TOXICOL IN VITRO, V21, P1003, DOI 10.1016/j.tiv.2007.02.004; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; KINSMAN SL, 1992, EPILEPSIA, V33, P1132, DOI 10.1111/j.1528-1157.1992.tb01770.x; KIRSCH JR, 1984, STROKE, V15, P319, DOI 10.1161/01.STR.15.2.319; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; Lee CS, 2005, EUR J PHARMACOL, V527, P23, DOI 10.1016/j.ejphar.2005.10.008; Lee CS, 2003, NEUROCHEM RES, V28, P1833, DOI 10.1023/A:1026119708124; Liang LP, 2007, J NEUROSCI, V27, P4326, DOI 10.1523/JNEUROSCI.0019-07.2007; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; Mejia-Toiber J, 2006, NEUROCHEM RES, V31, P1399, DOI 10.1007/s11064-006-9189-5; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; Nakamura S, 2003, INVEST OPHTH VIS SCI, V44, P4682, DOI 10.1167/iovs.03-0198; Nehlig A, 1996, DEV NEUROSCI-BASEL, V18, P426, DOI 10.1159/000111437; Noh HS, 2006, J NEUROSCI RES, V84, P1829, DOI 10.1002/jnr.21057; Noh HS, 2003, EPILEPSY RES, V53, P119, DOI 10.1016/S0920-1211(02)00262-0; Noh HS, 2005, EPILEPSY RES, V65, P153, DOI 10.1016/j.eplepsyres.2005.05.008; Noh HS, 2006, NEUROSCI LETT, V395, P87, DOI 10.1016/j.neulet.2005.10.073; Noh HS, 2005, BRAIN RES, V1042, P114, DOI 10.1016/j.brainres.2005.01.097; Oida Y, 2006, BRAIN RES, V1082, P196, DOI 10.1016/j.brainres.2006.01.116; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Perkins CL, 2000, CANCER RES, V60, P1645; POLLAY M, 1980, J NEUROSCI RES, V5, P163, DOI 10.1002/jnr.490050208; Przedborski S, 2005, PARKINSONISM RELAT D, V11, pS3, DOI 10.1016/j.parkreldis.2004.10.012; Roucou X, 2001, CELL DEATH DIFFER, V8, P875, DOI 10.1038/sj.cdd.4400910; Sawada H, 2002, NEUROPHARMACOLOGY, V42, P1056, DOI 10.1016/S0028-3908(02)00049-7; Segura-Aguilara J, 2004, NEUROTOX RES, V6, P615, DOI 10.1007/BF03033456; Seyfried J, 2000, NEUROCHEM INT, V36, P489, DOI 10.1016/S0197-0186(99)00156-4; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Takata MK, 2005, J BIOSCI BIOENG, V100, P511, DOI 10.1263/jbb.100.511; Tatton WG, 1999, PARKINSONISM RELAT D, V5, P221, DOI 10.1016/S1353-8020(99)00041-3; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Troy CM, 2002, J NEUROSCI RES, V69, P145, DOI 10.1002/jnr.10294; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004	66	15	16	1	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2010	35	3					444	451		10.1007/s11064-009-0078-6			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	553YV	WOS:000274403600012	19851865				2021-06-18	
J	Kean, S				Kean, Susanne			The experience of ambiguous loss in families of brain injured ICU patients	NURSING IN CRITICAL CARE			English	Article						Family care in critical care; Family-centred care; Family nursing; Interview/focus group techniques; Qualitative research		Background: Advances in medical technology have led to increased survival rates for critically ill patients, resulting in the survival of patients with serious traumatic brain injury. These patients may suffer some permanent brain damage leading to an ambiguous loss in families. Ambiguous loss has two dimensions: (1) a loss that relates to the physical absence but psychological presence of the family member and (2) a loss that refers to the psychological absence but physical presence of the family member. Aim: The overall study aimed at exploring families' experiences with critical illness in intensive care and nurses' perception of families. This article presents findings of one specific aspect, namely, families who experienced an ambiguous loss following the patient's brain injury which resulted in permanent brain damage. Design and method: Constructivist grounded theory that used focus groups as the method of choice. Reported data originate from nine family interviews (12 adults, 12 children/young people). Data analysis: Interviews were recorded, transcribed verbatim and imported into NVivo for data management and analysis. The principle approach in grounded theory, the constant comparative method, was followed. Results: The findings suggest that 'the emergence of ambiguous loss' reflects the families' experiences with the second type of ambiguous loss, namely a loss that relates to a family member who was physically present but psychologically absent. 'Mapping the future' is a further dimension of this theme which underlines the impact of an ambiguous loss on everyday family life. Conclusion: Families where the patient had suffered permanent brain damage experience an ambiguous loss. In this situation a caring scenario emerged which had a fundamental impact on the family's future. The dimension of 'mapping the future' draws out these implications for different family members. Relevance to clinical practice: Nurses need to be aware of the implications an ambiguous loss can have on families.	Univ Edinburgh, Sch Med, Sch Hlth Social Sci, Edinburgh EH8 9AG, Midlothian, Scotland	Kean, S (corresponding author), Univ Edinburgh, Sch Med, Sch Hlth Social Sci, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	susanne.kean@ed.ac.uk		Kean, Susanne/0000-0002-3717-9740	Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/F029179/1] Funding Source: researchfish		ALLMOND BA, 1999, FAMILY IS PATIENT; Anspach ReneeR., 1997, DECIDING WHO LIVES F; Bernardes Jon, 1997, FAMILY STUDIES INTRO; Bloor M., 2001, FOCUS GROUPS SOCIAL; Bosk CL., 1979, FORGIVE REMEMBER MAN; Boss P, 2002, LANCET, V360, pS39, DOI 10.1016/S0140-6736(02)11815-0; Boss P., 2006, LOSS TRAUMA RESILIEN; Boss P., 1999, AMBIGUOUS LOSS LEARN; Boss PG, 2002, FAM PROCESS, V41, P14, DOI 10.1111/j.1545-5300.2002.40102000014.x; Carey M., 1994, CRITICAL ISSUES QUAL; Cavallo MM, 2005, TXB TRAUMATIC BRAIN; CHARMAZ K, 1990, SOC SCI MED, V30, P1161, DOI 10.1016/0277-9536(90)90256-R; Charmaz K., 2002, HDB INTERVIEW RES CO, V2nd; Charmaz K, 2006, CONSTRUCTING GROUNDE; Charmaz K., 2000, HDB QUALITATIVE RES; Charmaz K., 1991, GOOD DAYS BAD DAYS S; Chesla C A, 1996, Image J Nurs Sch, V28, P199, DOI 10.1111/j.1547-5069.1996.tb00352.x; DALE BJ, 2006, HDB FAMILIES HEALTH; DAVIS F, 1960, AM J SOCIOL, V66, P41, DOI 10.1086/222821; Davis Fred., 1963, PASSAGE CRISIS POLIO; DeYoung R, 2003, OMEGA-J DEATH DYING, V47, P343, DOI 10.2190/QYTT-GC1X-MNLX-6WLU; GLASER B., 1992, EMERGENCE VS FORCING; Glaser B, 1978, THEORETICAL SENSITIV; Glaser B. G., 1967, DISCOVERY GROUNDED T; Greenstein T. N., 2006, METHODS FAMILY RES; Gubrium J.F., 1990, WHAT IS FAMILY; Hess Robert D., 1959, FAMILY WORLDS PSYCHO; Jones D.W, 2002, MYTHS MADNESS FAMILY; Kean S, 2008, THESIS U EDINBURGH E; Kean S, 2010, J CLIN NURS, V19, P266, DOI 10.1111/j.1365-2702.2009.02837.x; KEENAN S, 2004, SURVIVING INTENSIVE; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI DOI 10.1037/1091-7527.26.1.69; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; LEWISFRAVEL D, 1992, QUALITATIVE METHODS; Lindeke L L, 2000, J Pediatr Nurs, V15, P99, DOI 10.1053/jpdn.2000.5447; McGoldrick M., 2003, NORMAL FAMILY PROCES; McKie L, 2004, SOCIOLOGY, V38, P593, DOI 10.1177/0038038504043220; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; Morgan DHJ, 1996, FAMILY CONNECTIONS I; Morgan DL., 1997, FOCUS GROUPS QUALITA; MUNCIE J, 1997, UNDERSTANDING FAMILY; Risman B.J., 1998, GENDER VERTIGO AM FA; Strauss A., 1998, BASICS QUALITATIVE R; Thayer-Bacon B. J., 2003, RELATIONAL EPISTEMOL; Timmermans Stefan., 1999, SUDDEN DEATH MYTH CP; Vogler C, 1999, SOCIOLOGY FAMILY REA; Wasoff F., 2000, FAMILY POLICY; WILLIAMS J, 1991, HEAD INJURY FAMILY M; Wright L, 2005, NURSES FAMILIES GUID; Zussman R., 1994, INTENSIVE CARE MED E	51	15	16	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1362-1017	1478-5153		NURS CRIT CARE	Nurs. Crit. Care	MAR-APR	2010	15	2					66	75		10.1111/j.1478-5153.2010.00379.x			10	Nursing	Nursing	796QB	WOS:000293065600005	20236433				2021-06-18	
J	Figaji, AA; Kent, SJ				Figaji, Anthony A.; Kent, Samuel J.			Brain Tissue Oxygenation in Children Diagnosed With Brain Death	NEUROCRITICAL CARE			English	Article						MeSH-brain tissue oxygenation; Children; Brain death; Traumatic brain injury	CEREBRAL OXYGENATION; DELIVERY; TENSION; CARE	Background Diagnosing brain death in children is challenging. Guidelines recommend using confirmatory testing to provide ancillary information to support the diagnosis. Brain tissue oxygenation (PbtO(2)) is being increasingly used in the adult neurocritical care for continuous monitoring of the adequacy of brain oxygenation; however, data in pediatrics is limited. Evidence from adult studies suggests that persistent PbtO(2) of 0 mmHg is associated with brain death, but this relationship has not yet been demonstrated in children; therefore, we examined our experience with PbtO(2) monitoring and brain death in children with acute neurological pathology. Methods We retrospectively reviewed patient records from a prospectively maintained database of 85 children who were ventilated for coma due to acute neurological injury and who received intracerebral monitoring. Results We identified five children who had suffered brain death while being monitored. PbtO(2) had decreased to 0 mmHg in all five children at the time of brain death diagnosis. In contrast, PbtO(2) in patients, who did not develop brain death, never decreased to 0 mmHg. We review the benefits and drawbacks of using brain tissue oxygenation as ancillary information in diagnosing brain death in children. Conclusions Preliminary data from this study suggest that PbtO(2) decreases to 0 mmHg when brain death occurs in children. Further study is needed to determine the limitations, and the sensitivity and specificity of this finding in a larger group of children.	[Kent, Samuel J.] Univ Aberdeen, Aberdeen, Scotland; [Figaji, Anthony A.] Univ Cape Town, ZA-7925 Cape Town, South Africa	Kent, SJ (corresponding author), Univ Aberdeen, Aberdeen, Scotland.	s.kent.02@aberdeen.ac.uk		Figaji, Anthony/0000-0002-3357-6490			*AC MED ROYAL COLL, 1998, COD PRACT DIAGN BRAI; Academy of Medical Royal Colleges, 2008, COD PRACT DIAGN CONF; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; *AUSTR NZ INT CAR, 1998, REC BRAIN DEATH ORG; BAINES P, 2005, CURR PAEDIAT, V15, P301; Bell MDD, 2004, BRIT J ANAESTH, V92, P633, DOI 10.1093/bja/aeh108; BLEND MJ, 1986, NEUROPEDIATRICS, V17, P168, DOI 10.1055/s-2008-1052521; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Doppenberg EMR, 1997, J NEUROSURG, V87, P809, DOI 10.3171/jns.1997.87.6.0809; DRAKE B, 1986, PEDIATRICS, V78, P107; FIGAJI AA, 2009, BRAIN TISSUE OXYGE 1; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; GREEN JB, 1972, J NEUROL NEUROSUR PS, V35, P103, DOI 10.1136/jnnp.35.1.103; Heran MKS, 2008, CAN J NEUROL SCI, V35, P409, DOI 10.1017/S0317167100009069; KOHRMAN MH, 1990, PEDIATR NEUROL, V6, P47, DOI 10.1016/0887-8994(90)90078-F; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Monteiro LM, 2006, INTENS CARE MED, V32, P1937, DOI 10.1007/s00134-006-0353-9; MONTES JE, 1980, CAN ANAESTH SOC J, V27, P172, DOI 10.1007/BF03007783; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Palmer S, 2005, NEUROCRIT CARE, V2, P17, DOI 10.1385/NCC:2:1:017; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Scheufler KM, 2002, ANESTH ANALG, V95, P1042, DOI 10.1097/00000539-200210000-00046; Shemie SD, 2007, LANCET NEUROL, V6, P87, DOI 10.1016/S1474-4422(06)70680-9; Smith ML, 2007, NEUROL RES, V29, P755, DOI 10.1179/016164107X208121; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Task Force for the Determination of Brain Death in Children, 1987, ARCH NEUROL-CHICAGO, V44, P587; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20	32	15	16	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2010	12	1					56	61		10.1007/s12028-009-9298-5			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	571HL	WOS:000275742800010	19847675				2021-06-18	
J	Namdari, S; Pill, SG; Makani, A; Keenan, MA				Namdari, Surena; Pill, Stephan G.; Makani, Amun; Keenan, Mary Ann			Rectus Femoris to Gracilis Muscle Transfer With Fractional Lengthening of the Vastus Muscles: A Treatment for Adults With Stiff Knee Gait	PHYSICAL THERAPY			English	Article							CEREBRAL-PALSY; CHILDREN; SURGERY; RELEASE; MOTION	Background. Stiff knee gait, which may be seen in patients With upper motor neuron injury, describes a gait pattern with a relative loss of sagittal knee motion. It interferes with foot clearance during swing, often leading to inefficient compensatory mechanisms and ambulatory dysfunction. Distal rectus femoris Muscle transfers and fractional lengthening of the vastus Muscles have been performed in adult patients. Objective. The purpose of this study was to describe a unique Surgical technique and report on initial outcomes. Design. A retrospective case-series study design was used. Methods. The patients were adults with stiff knee gait Clue to stroke or traumatic brain injury who underwent distal rectus femoris muscle transfer with fractional lengthening of the vastus muscles. The patients (19 men and 18 women) had an average age of 51 years at the time of Surgery. Lower-extremity examinations, clinical gait analyses, and satisfaction levels were recorded preoperatively and postoperatively. Results. At a mean follow-up time of 10 months, 36 (97%) of the 37 patients were satisfied with their clinical and functional results, and the average Viosca score improved from 3.1 to 3.5. Limitations. Limitations of the study include use of a retrospective design, lack of a control group, and quantitative measures of gait. Conclusion. Distal rectus femoris muscle transfer and fractional lengthening of the vastus muscles were found to be a possible treatment for adults With stiff-knee gait caused by stroke or traumatic brain injury.	[Keenan, Mary Ann] Hosp Univ Penn, Neuroorthopaed Program, Philadelphia, PA 19104 USA; [Namdari, Surena; Pill, Stephan G.; Makani, Amun; Keenan, Mary Ann] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	Keenan, MA (corresponding author), Hosp Univ Penn, Neuroorthopaed Program, 3400 Spruce St,2 Silverstein, Philadelphia, PA 19104 USA.	maryann.keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				BAUMANN JU, 1980, INT ORTHOP, V3, P305; Chambers H, 1998, J PEDIATR ORTHOPED, V18, P703, DOI 10.1097/00004694-199811000-00003; COTTRELL GW, 1963, J BONE JOINT SURG AM, V45, P1556; DUNCAN WR, 1955, J BONE JOINT SURG AM, V37, P634; GAGE JR, 1987, DEV MED CHILD NEUROL, V29, P159; GAGE JR, 1990, CLIN ORTHOP RELAT R, V253, P45; Goldberg SR, 2006, J BIOMECH, V39, P689, DOI 10.1016/j.jbiomech.2005.01.015; OUNPUU S, 1993, J PEDIATR ORTHOPED, V13, P331, DOI 10.1097/01241398-199305000-00011; OUNPUU S, 1993, J PEDIATR ORTHOPED, V13, P325, DOI 10.1097/01241398-199305000-00010; PERRY J, 1987, DEV MED CHILD NEUROL, V29, P153; PERRY J, 1985, ATLAS ORTHOTICS BIOM, P223; Reinbolt JA, 2008, J BIOMECH, V41, P2362, DOI 10.1016/j.jbiomech.2008.05.030; SUTHERLAND DH, 1990, J PEDIATR ORTHOPED, V10, P433; SUTHERLAND DH, 1975, DEV MED CHILD NEUROL, V17, P26; Viosca E, 2005, ARCH PHYS MED REHAB, V86, P1234, DOI 10.1016/j.apmr.2004.11.016; WATERS RL, 1979, J BONE JOINT SURG AM, V61, P927, DOI 10.2106/00004623-197961060-00022	16	15	16	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	FEB	2010	90	2					261	268		10.2522/ptj.20090151			8	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	550LT	WOS:000274130000015	20023004	Bronze			2021-06-18	
J	Hou, QH; Ling, L; Wang, F; Xing, SH; Pei, Z; Zeng, JS				Hou, Qinghua; Ling, Li; Wang, Fang; Xing, Shihui; Pei, Zhong; Zeng, Jinsheng			Endostatin expression in neurons during the early stage of cerebral ischemia is associated with neuronal apoptotic cell death in adult hypertensive rat model of stroke	BRAIN RESEARCH			English	Article						Endostatin; Apoptosis; Cathepsin B; Cerebral infarction	ANGIOGENESIS INHIBITOR ENDOSTATIN; TRAUMATIC BRAIN-INJURY; ENDOTHELIAL-CELLS; IN-VIVO; CATHEPSIN; XVIII; GENERATION; OCCLUSION; GROWTH; DOMAIN	Endostatin (ES) has been recognized as a potent anti-angiogenic factor We here investigated the expression of ES in ischemic brain and the consequence of cells expressing ES after stroke in adult stroke-prone renovascular hypertensive rats A single dose of Ca-074ME, a membrane-permeable cathepsin B (CB) specific inhibitor, or vehicle was given by intraperitoneal injection immediately after distal middle cerebral artery occlusion (dMCAO), ES expression was evaluated using fluorescent immunohistochemistry staining, and CB enzyme activity was tested by measuring the free 7-amino-4-methylcoumarin (AMC) released by CB from its' specific substrate, the Z-Arg-Arg-7-amido-4-methylcoumarin ES immunoreactivity (IR) was significantly up-regulated as early as 6 h and returned to baseline level at 3 days in pen-infarct area following dMCAO Double-staining experiment revealed that the majority of ischemia-induced ES positive cells were neurons Furthermore, ES was co-labeled with CB and Cleaved Caspase-3(Asp175) whereas treatment with Ca-074ME reduced up-regulation of ES expression and attenuated apoptosis in pen-infarct neurons Collectively, our data suggest that pen-infarct neurons express ES during the early stage of cerebral ischemia and treatment with Ca-074ME attenuates ES expression and apoptosis in pen-infarct neurons (C) 2009 Elsevier B V All rights reserved	[Hou, Qinghua; Ling, Li; Xing, Shihui; Pei, Zhong; Zeng, Jinsheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China; [Hou, Qinghua; Ling, Li; Xing, Shihui; Pei, Zhong; Zeng, Jinsheng] Sun Yat Sen Univ, Affiliated Hosp 1, Stroke Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Hou, Qinghua] GuangZhou Med Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou 510260, Guangdong, Peoples R China; [Wang, Fang] Shenzhen Baoan Peoples Hosp, Dept Neurol, Shengzhen 518101, Peoples R China	Zeng, JS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.				Teaching and Research Award Program for Outstanding Young Teachers in Higher Education Institutions of the Ministry of Education, ChinaMinistry of Education, China; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [39940012, 30271485, 30770764]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [990065, 21906, 2003C30610]; China Medical Board of New York Inc [CMB00-730]; Fund for Priority Subjects in Clinical Medicine, Chinese Ministry of Health; Key and Scientific Project of the Natural Science Foundation of Guangdong Province, China [2003C30610, 2003B30303, 2003D30301]; Natural Science Foundation for Doctorial Research of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [5300761]; First Affiliated Hospital and Life Science Institute in Sun Yet-Sen University; Foundation for Scientific and technologic Project of Guangzhou City [2006 Z1-E0111, Z1-E0113]	This study was supported by the grants from the Teaching and Research Award Program for Outstanding Young Teachers in Higher Education Institutions of the Ministry of Education, China (2002), the National Natural Science Foundation of China (Nos 39940012, 30271485 and 30770764), the Natural Science Foundation of Guangdong Province, China (Nos. 990065, 21906, and 2003C30610), China Medical Board of New York Inc (No. CMB00-730), the Fund for Priority Subjects in Clinical Medicine, Chinese Ministry of Health (2004), the Key and Scientific Project of the Natural Science Foundation of Guangdong Province, China (Nos. 2003B30303,2003C30610 and 2003D30301), the Natural Science Foundation for Doctorial Research of Guangdong Province (No 5300761) and the fund on collaboration study for First Affiliated Hospital and Life Science Institute in Sun Yet-Sen University (2006), the Foundation for Scientific and technologic Project of Guangzhou City (Nos. 2006 Z1-E0111 and Z1-E0113).	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Deininger MH, 2006, J NEUROTRAUM, V23, P1103, DOI 10.1089/neu.2006.23.1103; Deininger MH, 2002, J NEUROSCI, V22, P10621; Deininger MH, 2002, J NEUROIMMUNOL, V131, P216, DOI 10.1016/S0165-5728(02)00276-X; FATIMA D, 2003, HUM GENE THER, V14, P997; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Hanai J, 2002, J BIOL CHEM, V277, P16464, DOI 10.1074/jbc.M112274200; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Ma DHK, 2007, INVEST OPHTH VIS SCI, V48, P644, DOI 10.1167/iovs.06-0884; MATSUSHITA K, 1994, HYPERTENSION, V23, P565, DOI 10.1161/01.HYP.23.5.565; Mihalik R, 2004, CELL DEATH DIFFER, V11, P1357, DOI 10.1038/sj.cdd.4401493; Miosge N, 2003, J HISTOCHEM CYTOCHEM, V51, P285, DOI 10.1177/002215540305100303; Miosge N, 1999, FASEB J, V13, P1743; Mueller CA, 2007, EXP NEUROL, V208, P228, DOI 10.1016/j.expneurol.2007.07.020; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Seyfried DM, 2001, BRAIN RES, V901, P94, DOI 10.1016/S0006-8993(01)02289-2; Skovseth DK, 2005, BLOOD, V105, P1044, DOI 10.1182/blood-2004-03-1164; Tian Heng-Li, 2007, Neurosci Bull, V23, P35, DOI 10.1007/s12264-007-0005-2; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Zeng JS, 1998, STROKE, V29, P1708, DOI 10.1161/01.STR.29.8.1708; Zeng JS, 1998, CHINESE MED J-PEKING, V111, P741	24	15	15	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 22	2010	1311						182	188		10.1016/j.brainres.2009.11.033			7	Neurosciences	Neurosciences & Neurology	554GY	WOS:000274424700018	19941836				2021-06-18	
J	Kave, G; Kukulansky-Segal, D; Avraham, A; Herzberg, O; Landa, J				Kave, Gitit; Kukulansky-Segal, Dorit; Avraham, Ayelet; Herzberg, Orly; Landa, Janna			Searching for the Right Word: Performance on Four Word-Retrieval Tasks Across Childhood	CHILD NEUROPSYCHOLOGY			English	Article						Word retrieval; Naming; Verbal fluency; Language; Executive lexical search	HOMOPHONE MEANING GENERATION; BOSTON NAMING TEST; TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; VERBAL FLUENCY TASKS; SCHOOL-AGED CHILDREN; EXECUTIVE FUNCTIONS; NORMATIVE DATA; SPEECH PRODUCTION; FRONTAL-LOBE	Word retrieval was assessed in 207 normally developing Hebrew-speaking children aged 8-17 through four tasks: picture naming, phonemic fluency, semantic fluency, and homophone meaning generation (HMGT). Scores on all tests correlated positively and significantly with participant age. Yet, age effects and the correlation between age and test scores were weakest for the naming test and strongest for the HMGT. We discuss the nature of the word search involved in each task and suggest that the more executive demands required by a test the steeper the slope of performance increase on this test.	[Kave, Gitit] Open Univ, Dept Educ & Psychol, IL-43107 Raanana, Israel; [Kukulansky-Segal, Dorit; Avraham, Ayelet; Herzberg, Orly; Landa, Janna] Safra Childrens Hosp, Dept Pediat Rehabil, Sheba Med Ctr, Ramat Gan, Israel; [Herzberg, Orly] Tel Aviv Univ, Dept Commun Disorders, IL-69978 Tel Aviv, Israel	Kave, G (corresponding author), Open Univ, Dept Educ & Psychol, Dorothy Rothschild Campus,1 Univ Rd,POB 808, IL-43107 Raanana, Israel.	gkave@012.net.il		Kave, Gitit/0000-0002-4950-5507; Herzberg, Osnat/0000-0003-2823-7627	Chief Scientist Office of the Israeli Ministry of Health, Israel [3000003639]; Open University of Israel [46310]	This work was partially supported by grant # 3000003639 from the Chief Scientist Office of the Israeli Ministry of Health, Israel, as well as by research fund # 46310 from the Open University of Israel. We wish to thank Suzy Bracha, Odelya Chiprot, Nilly Degany, Inbar Morag, Hadas Nagar-Turgeman, Adi Shaked, Shani Waidergorean, and Rivka Ziv for their help in data collection and preparation. There are no financial or other relationships that could be interpreted as a conflict of interests.	Ameel E, 2008, J MEM LANG, V58, P262, DOI 10.1016/j.jml.2007.01.006; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Biemiller A, 2006, J EDUC PSYCHOL, V98, P44, DOI 10.1037/0022-0663.98.1.44; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; Caramazza A, 2004, J EXP PSYCHOL LEARN, V30, P278, DOI 10.1037/0278-7393.30.1.278; Caramazza A, 2001, J EXP PSYCHOL LEARN, V27, P1430, DOI 10.1037//0278-7393.27.6.1430; Castner JE, 2008, J INT NEUROPSYCH SOC, V14, P890, DOI 10.1017/S1355617708081046; Cohen MJ, 1999, ARCH CLIN NEUROPSYCH, V14, P433, DOI 10.1016/S0887-6177(98)00038-9; Crawford JR, 2002, J INT NEUROPSYCH SOC, V8, P547, DOI 10.1017/S1355617702814291; Delis DC, 2001, DELISKAPLAN EXECUTIV; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Hurks PPM, 2006, J CLIN EXP NEUROPSYC, V28, P684, DOI 10.1080/13803390590954191; Jescheniak JD, 2003, J EXP PSYCHOL LEARN, V29, P432, DOI 10.1037/0278-7393.29.3.432; JESCHENIAK JD, 1994, J EXP PSYCHOL LEARN, V20, P824, DOI 10.1037/0278-7393.20.4.824; Kaplan E., 1983, BOSTON NAMING TEST; Kave G, 2006, DEV NEUROPSYCHOL, V29, P493, DOI 10.1207/s15326942dn2903_7; Kave G, 2005, J CLIN EXP NEUROPSYC, V27, P690, DOI 10.1080/13803390490918499; Kave G, 2005, BRAIN LANG, V92, P204, DOI 10.1016/j.bandl.2004.06.004; KAVE G, PSYCHOL AGI IN PRESS; Kave G, 2008, J CLIN EXP NEUROPSYC, V30, P349, DOI 10.1080/13803390701416197; Kave G, 2007, J INT NEUROPSYCH SOC, V13, P424, DOI 10.1017/S1355617707070622; Kim H, 2008, CLIN NEUROPSYCHOL, V22, P84, DOI 10.1080/13854040601064526; KINDLON D, 1984, BRAIN LANG, V21, P255, DOI 10.1016/0093-934X(84)90050-6; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Koren R, 2005, ARCH CLIN NEUROPSYCH, V20, P1087, DOI 10.1016/j.acn.2005.06.012; Korkman M, 2001, DEV NEUROPSYCHOL, V20, P331, DOI 10.1207/S15326942DN2001_2; Marien P, 1998, BRAIN LANG, V65, P447, DOI 10.1006/brln.1998.2000; Matute E, 2004, DEV NEUROPSYCHOL, V26, P647, DOI 10.1207/s15326942dn2602_7; McGregor KK, 2002, J SPEECH LANG HEAR R, V45, P332, DOI 10.1044/1092-4388(2002/026); Miozzo M, 2004, COGN NEUROPSYCHOL, V21, P840, DOI 10.1080/02643290342000573; Pineda D, 1998, INT J NEUROSCI, V96, P177, DOI 10.3109/00207459808986466; Prigatano GP, 2008, J INT NEUROPSYCH SOC, V14, P143, DOI 10.1017/S1355617708080089; Prigatano GP, 2008, BRAIN INJURY, V22, P491, DOI 10.1080/02699050802084902; Ravid D, 2002, J CHILD LANG, V29, P417, DOI 10.1017/S0305000902005111; Riva D, 2000, BRAIN LANG, V71, P267, DOI 10.1006/brln.1999.2166; Sauzeon H, 2004, BRAIN LANG, V89, P192, DOI 10.1016/S0093-934X(03)00367-5; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Storms G, 2004, BRAIN LANG, V91, P274, DOI 10.1016/j.bandl.2004.03.005; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Warrington EK, 2000, J INT NEUROPSYCH SOC, V6, P643, DOI 10.1017/S1355617700666018	45	15	15	1	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.		2010	16	6					549	563	PII 922984093	10.1080/09297049.2010.485124			15	Clinical Neurology	Neurosciences & Neurology	675XM	WOS:000283874300002	20544436				2021-06-18	
J	Labombarda, F; Deniselle, MCG; De Nicola, AF; Gonzalez, SL				Labombarda, Florencia; Gonzalez Deniselle, Maria Claudia; Federico De Nicola, Alejandro; Laura Gonzalez, Susana			Progesterone and the Spinal Cord: Good Friends in Bad Times	NEUROIMMUNOMODULATION			English	Article						Spinal cord injury; Progesterone; Brain-derived neurotrophic factor; Oligodendrocytes; Remyelination	NEUROTROPHIC FACTOR; NEUROPROTECTION; INJURY; EXPRESSION; RAT	In recent years, a growing list of publications point to the value of steroid hormones as an interesting option for the treatment of several type of lesions and diseases of the nervous system. Progesterone, well known for its role in pregnancy, has recently been shown to exert neuroprotective and promyelinating effects in both, the peripheral and central nervous system, including the injured spinal cord. Previous work from our laboratory has shown that progesterone actions in experimental models of spinal neurodegeneration or injury may involve the modulation of brain-derived neurotrophic factor, a neurotrophin with important implications in neuronal survival and axonal regeneration. The spinal cord is target for progesterone since neurons and glial cells express the intracellular receptors for this neuroactive steroid. However, the presence in the spinal cord of new membrane receptors and the enzymes involved in progesterone metabolism to its reduced derivatives, which modulate the activity of neurotransmitter receptors, suggest that progesterone actions involve pleiotropic mechanisms. Our recent data uncovering several molecular events may help to understand the protective and promyelinating actions of progesterone and further support the role of this steroid as a promising therapeutic agent for neurotrauma and/or neurodegenerative diseases. Copyright (C) 2010 S. Karger AG, Basel	[Labombarda, Florencia; Gonzalez Deniselle, Maria Claudia; Federico De Nicola, Alejandro; Laura Gonzalez, Susana] Consejo Nacl Invest Cient & Tecn, Lab Bioquim Neuroendocrina, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina	Gonzalez, SL (corresponding author), Univ Buenos Aires, Fac Med, Paraguay 2155,C1121ABG, Buenos Aires, DF, Argentina.	sugonza@dna.uba.ar			University of Buenos AiresUniversity of Buenos Aires [M808, M611]; National Research Council of ArgentinaConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 5542]; FONCYTFONCyT [00291]	The authors acknowledge the support of the University of Buenos Aires (M808, M611), the National Research Council of Argentina (CONICET, PIP 5542) and FONCYT (BID 1728 OC AR/PICT 2006 No. 00291).	Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Gonzalez SL, 2009, CELL MOL NEUROBIOL, V29, P27, DOI 10.1007/s10571-008-9291-0; Jodhka PK, 2009, ENDOCRINOLOGY, V150, P3162, DOI 10.1210/en.2008-1247; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2002, J NEUROTRAUM, V19, P343, DOI 10.1089/089771502753594918; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; NACIMIENTO W, 1995, ACTA NEUROPATHOL, V90, P552	10	15	18	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2010	17	3					146	149		10.1159/000258709			4	Endocrinology & Metabolism; Immunology; Neurosciences	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	552VS	WOS:000274322300004	20134188				2021-06-18	
J	Nielssen, O; Elliott, G; Large, M				Nielssen, Olav; Elliott, Gordon; Large, Matthew			The Reliability of Evidence About Psychiatric Diagnosis After Serious Crime: Part I. Agreement Between Experts	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							FIELD TRIALS; INJURY	The purpose of this study was to assess the extent of agreement on psychiatric diagnosis in written evidence provided by experts in serious criminal matters in Australia. We found good or very good inter-rater agreement on the diagnoses of acquired brain injury, schizophrenia-spectrum psychosis, substance-induced psychotic disorder, and intellectual disability. There was moderate agreement on the diagnosis of depressive and personality disorders. Agreement on anxiety disorders, in particular post-traumatic stress disorder, was poor. Agreement on the principal Axis I diagnosis was moderate, and there was a similar probability of agreement within pairs of experts engaged by the same side and those engaged by opposite sides. Concern about bias in expert psychiatric opinion in criminal cases appears to have been overstated. There was little evidence to suggest that experts' adversarial roles influenced their opinions on psychiatric diagnosis.	[Nielssen, Olav; Large, Matthew] Univ New S Wales, Sydney, NSW, Australia; [Nielssen, Olav; Elliott, Gordon] St Vincents Hosp, Sydney, NSW 2010, Australia; [Elliott, Gordon] New S Wales Justice Hlth, Sydney, NSW, Australia; [Large, Matthew] Prince Wales Hosp, Sydney, NSW, Australia	Large, M (corresponding author), Prince Wales Hosp, Euroa Ctr, Randwick, NSW 2031, Australia.	mmbl@bigpond.com		Nielssen, Olav/0000-0001-5172-2781			American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BECK AT, 1962, AM J PSYCHIAT, V119, P210, DOI 10.1176/ajp.119.3.210; Beck M, 1994, Mo Med, V91, P179; Bourget D, 2004, CAN PSYCHIAT ASS B, V9, P6; FAUST D, 1988, SCIENCE, V241, P31, DOI 10.1126/science.3291114; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Fleiss JL, 1981, STAT METHODS RATES P, V2nd; KILPATRICK DG, 1998, EMPHASIS CRITERION A, V4, P303; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Large M, 2001, AUST NZ J PSYCHIAT, V35, P535, DOI 10.1046/j.1440-1614.2001.00939.x; Large M, 2009, AUST NZ J PSYCHIAT, V43, P446, DOI 10.1080/00048670902817745; Large MM, 2008, J AM ACAD PSYCHIATRY, V36, P515; LEESHALEY PR, 1990, J TRAUMA STRESS, V3, P315; MEZZICH JE, 1981, J PSYCHIAT RES, V16, P29, DOI 10.1016/0022-3956(81)90011-X; Miller PR, 2001, PSYCHIAT RES, V105, P265, DOI 10.1016/S0165-1781(01)00318-3; Mossman D, 1999, J AM ACAD PSYCHIATRY, V27, P414; Nielssen O, 2005, AUST NZ J PSYCHIAT, V39, P453, DOI 10.1111/j.1440-1614.2005.01603.x; Nielssen O, 2008, BRIT J PSYCHIAT, V192, P394, DOI 10.1192/bjp.192.5.394a; Rosen GM, 2008, BRIT J PSYCHIAT, V192, P3, DOI 10.1192/bjp.bp.107.043083; Rosenman SJ, 1997, J PSYCHIAT RES, V31, P581, DOI 10.1016/S0022-3956(97)00032-0; SARTORIUS N, 1995, AM J PSYCHIAT, V152, P1427; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Sim J, 2005, PHYS THER, V85, P257; SPITZER RL, 1979, AM J PSYCHIAT, V136, P815; SPITZER RL, 1974, BRIT J PSYCHIAT, V125, P341, DOI 10.1192/bjp.125.4.341; EXPERT WITNESS CODE	26	15	15	0	5	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2010	38	4					516	523					8	Law; Psychiatry	Government & Law; Psychiatry	712WL	WOS:000286696900010	21156911				2021-06-18	
J	Rekha, J; Chakravarthy, S; Veena, LR; Kalai, VP; Choudhury, R; Halahalli, HN; Alladi, PA; Dhanushkodi, A; Nirmala, M; Swamilingiah, GM; Agrahari, M; Raju, TR; Panicker, MM; Kutty, BM				Rekha, J.; Chakravarthy, Sridhara; Veena, L. R.; Kalai, Vani P.; Choudhury, Rupam; Halahalli, Harsha N.; Alladi, Phalguni Anand; Dhanushkodi, Anandh; Nirmala, M.; Swamilingiah, Geetha M.; Agrahari, Maulishree; Raju, T. R.; Panicker, M. M.; Kutty, Bindu M.			Transplantation of Hippocampal Cell Lines Restore Spatial Learning in Rats With Ventral Subicular Lesions	BEHAVIORAL NEUROSCIENCE			English	Article						brain lesion; neurodegeneration; learning impairment; hippocampal transplants; trophic factors; functional recovery	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; NERVE GROWTH-FACTOR; MORRIS WATER MAZE; ENTORHINAL CORTEX; FUNCTIONAL RECOVERY; IBOTENATE LESIONS; IN-VIVO; SUBVENTRICULAR ZONE; BEHAVIORAL RECOVERY	We have demonstrated in our previous studies that ventral subicular lesion induces neurodegeneration of the hippocampus and produces cognitive impairment in rats; In die present study, the efficacy of transplanted green fluorescent protein (GFP)-labeled hippocampal cell line (H3-GFP) cells in establishing functional recovery in ventral subicular lesioned rats has been evaluated. The survival of H3-GFP transplants and their ability to express trophic factors in vivo were also Investigated Adult male Wistar rats were subjected to selective lesioning of ventral subiculum and were transplanted with H3-GFP cells into die cornu ammonis 1 (CA1) hippocampus. The transplants sealed mainly in the dentate gyrus and expressed neurotrophic factors. brain-derived neurotrophic factor (BDNF), and basic fibroblast growth factor (bFGF) The ventral subicular lesioned (VSL) Rats with H3-GFP transplants showed enhanced expression of BDNF in the hippocampus and performed well in eight-arm radial maze and Moms water maze The VSL rats without hippocampal transplants continued to show cognitive impairments In task learning. The present study demonstrated the H3-GFP transplants mediated recovery of cognitive functions in VSL, rats. Our study supports the notion of graft meditated host regeneration and functional recovery through trophic support. although these mechanisms require further investigation	[Rekha, J.; Veena, L. R.; Kalai, Vani P.; Halahalli, Harsha N.; Alladi, Phalguni Anand; Dhanushkodi, Anandh; Nirmala, M.; Raju, T. R.; Kutty, Bindu M.] NIMHANS Deemed Univ, Natl Inst Mental Hlth & Neurosci, Dept Neurophysiol, Bangalore 560029, Karnataka, India; [Chakravarthy, Sridhara; Choudhury, Rupam; Swamilingiah, Geetha M.; Panicker, M. M.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Agrahari, Maulishree] Peoples Educ Soc Inst Technol, Dept Biotechnol, Bangalore, Karnataka, India	Kutty, BM (corresponding author), NIMHANS Deemed Univ, Natl Inst Mental Hlth & Neurosci, Dept Neurophysiol, Bangalore 560029, Karnataka, India.		Halahalli, Harsha/ABE-2908-2020; Halahalli, Harsha/I-1564-2015; Alladi, Phalguni/AAY-6912-2020	Halahalli, Harsha/0000-0003-3400-4395; Panicker, Mitradas/0000-0002-0782-6222; Alladi, Phalguni/0000-0002-2876-3478	Department of Biotechnology DBT New DelhiDepartment of Biotechnology (DBT) India [BT/PR 6567/Med/14/849/2005]; NIMHANS, Bangalore; NCBS, Bangalore	The authors greatly acknowledge the Department of Biotechnology (DBT New Delhi. for providing financial support to carry Out the research Study (project No. BT/PR 6567/Med/14/849/2005) Studies have been carried out at NIMHANS, Bangalore, and at NCBS, Bangalore	ANANDH D, 2007, BEHAV NEUROSCI, V121, P191; Barde YA, 1987, PROG BRAIN RES <D>, V71, P185; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Bindu B, 2005, BRAIN RES, V1063, P121, DOI 10.1016/j.brainres.2005.09.044; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Brodhun M, 2004, EXP TOXICOL PATHOL, V56, P103, DOI 10.1016/j.etp.2004.04.004; CHAKRAVARTHY S, 2001, THESIS MANIPAL ACAD; CHO YH, 1995, NEUROBIOL LEARN MEM, V64, P285, DOI 10.1006/nlme.1995.0011; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Corti S, 2002, EXP NEUROL, V177, P443, DOI 10.1006/exnr.2002.8004; DANIEL HL, 1996, J NEUROSCI, V16, P1759; DASILVA FHL, 1990, PHYSIOL REV, V70, P453; Deng YB, 2003, CHINESE MED J-PEKING, V116, P1649; Devi L, 2003, BRAIN RES, V960, P9, DOI 10.1016/S0006-8993(02)03699-5; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Eaton MJ, 1997, PAIN, V72, P59, DOI 10.1016/S0304-3959(97)00015-8; Floresco SB, 1996, BEHAV BRAIN RES, V81, P163, DOI 10.1016/S0166-4328(96)00058-7; Galani R, 1997, NEUROBIOL LEARN MEM, V67, P43, DOI 10.1006/nlme.1996.3745; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; GOVINDAIAH RBS, 1997, BRAIN RES, V745, P121; Herzog D, 2002, J HIST SEXUALITY, V11, P3, DOI 10.1353/sex.2002.0007; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hodges H, 2000, NEUROSCIENCE, V101, P945, DOI 10.1016/S0306-4522(00)00408-5; JARRARD LE, 1978, J COMP PHYSIOL PSYCH, V92, P1119, DOI 10.1037/h0077516; JARRARD LE, 1984, PHARMACOL BIOCHEM BE, V21, P273, DOI 10.1016/0091-3057(84)90226-0; JARRARD LE, 1986, HIPPOCAMPUS, P93; JAT PS, 1991, P NATL ACAD SCI USA, V92, P8935; Kerr DA, 2003, J NEUROSCI, V23, P5131; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Laxmi TR, 1999, BRAIN RES, V816, P245, DOI 10.1016/S0006-8993(98)01187-1; Laxmi TR, 2000, BRAIN RES, V869, P236, DOI 10.1016/S0006-8993(00)02368-4; LINDSAY RM, 1984, NEUROSCIENCE, V12, P45, DOI 10.1016/0306-4522(84)90136-2; LUNBERG C, 1997, EXPT NEUROLOGY, V145, P342; Modo M, 2002, STROKE, V33, P2270, DOI 10.1161/01.STR.0000027693.50675.C5; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nutan K S, 1998, Indian J Physiol Pharmacol, V42, P460; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Oswald CJP, 2000, BEHAV NEUROSCI, V114, P211, DOI 10.1037/0735-7044.114.1.211; Paxinos G., 1982, RAT BRAIN; Rao MS, 2006, NEUROBIOL DIS, V21, P276, DOI 10.1016/j.nbd.2005.07.009; RAWLINS JNP, 1983, BEHAV BRAIN RES, V10, P233, DOI 10.1016/0166-4328(83)90033-5; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Riegert C, 2004, BEHAV BRAIN RES, V152, P23, DOI 10.1016/j.bbr.2003.09.011; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; SCHENK F, 1985, EXP BRAIN RES, V58, P11; SHANKARANARAYAN.RB, 2001, NEUROSCIENCE, V102, P319; Sharp PE, 1999, HIPPOCAMPUS, V9, P158; SHARP PE, 1990, J NEUROSCI, V10, P3093; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shobha K, 2007, J NEUROL SCI, V254, P9, DOI 10.1016/j.jns.2006.12.004; SINDEN JD, 1995, BEHAV BRAIN SCI, V18, P10, DOI 10.1017/S0140525X00037249; Sinden JD, 1997, NEUROSCIENCE, V81, P599, DOI 10.1016/S0306-4522(97)00330-8; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; STRUBLE RG, 1991, J NEUROPATH EXP NEUR, V50, P82, DOI 10.1097/00005072-199101000-00007; SWANSON LW, 1979, J COMP NEUROL, V186, P621, DOI 10.1002/cne.901860408; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; TAUBE JS, 1992, BEHAV NEURAL BIOL, V57, P131, DOI 10.1016/0163-1047(92)90629-I; Tobias CA, 2001, J NEUROTRAUM, V18, P287, DOI 10.1089/08977150151070937; Toda H, 2001, NEUROSCI LETT, V316, P9, DOI 10.1016/S0304-3940(01)02331-X; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Virley D, 1999, BRAIN, V122, P2321, DOI 10.1093/brain/122.12.2321; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Wong AM, 2005, BRAIN RES, V1063, P140, DOI 10.1016/j.brainres.2005.09.049; Yuan QJ, 2000, NEUROREPORT, V11, P2237, DOI 10.1097/00001756-200007140-00035; Zaman V, 2003, HIPPOCAMPUS, V13, P618, DOI 10.1002/hipo.10091; Zigova T, 2000, EXP NEUROL, V163, P31, DOI 10.1006/exnr.2000.7344	71	15	16	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7044	1939-0084		BEHAV NEUROSCI	Behav. Neurosci.	DEC	2009	123	6					1197	1217		10.1037/a0017655			21	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	532HP	WOS:000272738100006	20001104	Green Published			2021-06-18	
J	Shields, BJ; Smith, GA				Shields, Brenda J.; Smith, Gary A.			Epidemiology of Cheerleading Fall-Related Injuries in the United States	JOURNAL OF ATHLETIC TRAINING			English	Article						injury surveillance; athletic injuries; elite athletes; collegiate athletes; high school athletes; youth athletes	RISK-FACTORS; PLAYGROUND EQUIPMENT; ARM FRACTURE; CHILDREN; SURFACE	Context. Over the past several decades, cheerleaders have been performing fewer basic maneuvers and more gymnastic tumbling runs and stunts. As the difficulty of these maneuvers has increased, cheerleading injuries have also increased. Objective: To describe the epidemiology of cheerleading fall-related injuries by type of cheerleading team and event. Design: Prospective injury surveillance study. Setting: Participant exposure and injury data were collected from US cheerleading teams via the Cheerleading RIO (Reporting Information Online) surveillance tool. Patients or Other Participants: Athletes from 412 enrolled cheerleading teams who participated in official, organized cheerleading practices, pep rallies, athletic events, or cheerleading competitions. Main Outcome Measure(s): The numbers and rates of cheerleading fall-related injuries during a 1-year period (20062007) are reported. Results: A total of 79 fall-related injuries were reported during the 1-year period. Most occurred during practice (85%, 67/79) and were sustained by high school cheerleaders (51%, 40/79). A stunt or pyramid was being attempted in 89% (70/79) of cases. Fall heights ranged from 1 to 11 ft (0.30-3.35 m) (mean = 4.7 +/- 2.0 ft [1.43 +/- 0.61 m]). Strains and sprains were the most common injuries (54%, 43/79), and 6% (5/79) of the injuries were concussions or closed head injuries. Of the 15 most serious injuries (concussions or closed head injuries, dislocations, fractures, and anterior cruciate ligament tears), 87% (13/15) were sustained while the cheerleader was performing on artificial turf, grass, a traditional foam floor, or a wood floor. The fall height ranged from 4 to 11 ft (1.22-1.52 m) for 87% of these cases (13/15). Conclusions: Cheerleading-related falls may result in severe injuries and even death, although we report no deaths in the present study. The risk for serious injury increases as fall height increases or as the impact-absorbing capacity of the surfacing material decreases (or both).	[Shields, Brenda J.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	Shields, BJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.shields@nationwidechildrens.org			Research Institute at Nationwide Children's HospitalOhio State University	Funding for this study was provided by the Research Institute at Nationwide Children's Hospital. Debbie Bracewell, from the National Council for Spirit Safety and Education, Lisa Thompson, from Cheer Ltd, and Steve Wedge, from Cheerleaders of America, Inc, helped to categorize the cheerleading maneuvers.	ASTM, 2004, F129204 ASTM; Bertocci GE, 2004, INJURY, V35, P417, DOI 10.1016/S0020-1383(03)00062-7; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; *CBS BROADC INC, 2006, CHEERL INJ FALL COUR; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Chiu J, 1998, J BIOMECH, V31, P1169, DOI 10.1016/S0021-9290(98)00137-7; Cory CZ, 2006, FORENSIC SCI INT, V163, P102, DOI 10.1016/j.forsciint.2005.11.014; Giannone L., 2006, AM ASS CHEERLEADING, P1; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; Macarthur C, 2000, ACCIDENT ANAL PREV, V32, P377, DOI 10.1016/S0001-4575(99)00079-2; MUELLER FO, 2008, 25 NAT CTR CAT SPORT; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Sherker S, 2005, INJURY PREV, V11, P120, DOI 10.1136/ip.2004.007310; Sherker S, 2004, MED J AUSTRALIA, V180, P562, DOI 10.5694/j.1326-5377.2004.tb06092.x; Sherker S, 2003, INJURY PREV, V9, P279, DOI 10.1136/ip.9.3.279; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2009, J ATHL TRAINING, V44, P595, DOI 10.4085/1062-6050-44.6.595; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567	22	15	15	2	19	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2009	44	6					578	585		10.4085/1062-6050-44.6.578			8	Sport Sciences	Sport Sciences	522OU	WOS:000272008400003	19911083	Green Published			2021-06-18	
J	McQuay, N; Cipolla, J; Franges, EZ; Thompson, GE				McQuay, Nathaniel, Jr.; Cipolla, James; Franges, Eleanor Z.; Thompson, Gregory E.			The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial? Clinical article	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; recombinant activated factor VIIa; emergency craniectomy	CLOSED-HEAD-INJURY; EPIDEMIOLOGY; HEMOPHILIA; CIRRHOSIS; REVERSAL; DEATHS	Object. The role of recombinant activated factor VII (rFVIIa) in traumatic brain injury (TBI) has not been well established. This study evaluates the outcomes of using rFVIIa as first-line therapy in patients with a severe TBI requiring emergent craniotomy that are coagulopathic. Methods. The authors retrospectively reviewed patients admitted between 2003 and 2006 to a Level I trauma center with a severe TBI requiring an emergency craniotomy. Eighteen patients with coagulopathy that was corrected using rFVIIa were identified. Variables evaluated included age, injury severity score, head abbreviated injury score, Glasgow Coma Scale score, international normalized ratio, time to operation, operative procedure, thromboembolic events, and death. Results. The cohort consisted of 18 patients, predominantly male (55.6%) with a mean age of 80.5 years. The most common mechanism of injury was a fall. Coagulopathy was due to premorbid anticoagulants in 50% of the cohort. Time from admission to operation was 130 minutes. Coagulopathy reversal was complete in all 18 cases (100%). A high mortality rate (55.6%) was attributed to a high incidence of withdrawal of care (50%). The incidence of thromboembolic events was low (5.6%). Survivors, when compared with nonsurvivors, had a >3-fold increase in postoperative Glasgow Coma Scale score for similar preoperative scores. A good functional outcome was achieved in 75% of survivors with a mean follow-up period of 4.2 months. Conclusions. The use of rFVIIa in the correction of coagulopathy in patients having sustained severe TBI requiring emergency craniotomy appears to be safe and effective even among the elderly. This allows a shorter transit time to craniotomy. Its effects on mortality and long-term neurological outcome requires further investigation prospectively. (DOI: 10.3171/2009.4.JNS081611)	[McQuay, Nathaniel, Jr.; Cipolla, James] Univ Penn Hlth Syst, Dept Surg, Trauma Crit Div, St Lukes Hosp, Bethlehem, PA USA; [Franges, Eleanor Z.; Thompson, Gregory E.] St Lukes Hosp, Dept Neurosurg, Bethlehem, PA USA	McQuay, N (corresponding author), 801 Ostrum St, Bethlehem, PA 18015 USA.	mcquayn@slhn.org					Bosch J, 2004, GASTROENTEROLOGY, V127, P1123, DOI 10.1053/j.gastro.2004.07.015; Bosch J, 2008, HEPATOLOGY, V47, P1604, DOI 10.1002/hep.22216; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Dager WE, 2006, PHARMACOTHERAPY, V26, P1091, DOI 10.1592/phco.26.8.1091; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Hsia CC, 2008, ANN SURG, V248, P61, DOI 10.1097/SLA.0b013e318176c4ec; Johansson PI, 2008, VOX SANG, V94, P113, DOI 10.1111/j.1423-0410.2007.01011.x; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; May AK, 1997, AM SURGEON, V63, P233; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Morenski JD, 2003, J NEUROSURG, V98, P611, DOI 10.3171/jns.2003.98.3.0611; NESBITT L, 2006, ACAD EMERG MED, V13, pS72; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Powner DJ, 2005, NEUROSURGERY, V57, P823, DOI 10.1227/01.NEU.0000179915.74429.b2; Rizoli SB, 2006, J TRAUMA, V61, P1419, DOI 10.1097/01.ta.0000243045.56579.74; Roitberg B, 2005, NEUROSURGERY, V57, P832, DOI 10.1227/01.NEU.0000180816.80626.C2; Sachs B, 2007, SPINE, V32, P2285, DOI 10.1097/BRS.0b013e3181557d45; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stephens JM, 2007, EXPERT OPIN PHARMACO, V8, P1127, DOI 10.1517/14656566.8.8.1127; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Yusim Y, 2006, J CLIN ANESTH, V18, P545, DOI 10.1016/j.jclinane.2006.02.012	29	15	16	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2009	111	4					666	671		10.3171/2009.4.JNS081611			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	503PL	WOS:000270550000007	19425887				2021-06-18	
J	Rochette, LM; Conner, KA; Smith, GA				Rochette, Lynne M.; Conner, Kristen A.; Smith, Gary A.			The contribution of traumatic brain injury to the medical and economic outcomes of motor vehicle-related injuries in Ohio	JOURNAL OF SAFETY RESEARCH			English	Article						Injury; Brain; Traumatic; Traffic accidents; Trauma; Drinking; Alcohol; Protective devices; Prevention	UNITED-STATES; HOSPITALIZATION; HELMET; CARE; GUIDELINES; MORTALITY; ALCOHOL	Objective: To describe traumatic brain injury (TBI) among injured roadway users. Aim I assessed the association of age, gender, alcohol/drug use, safety equipment use, type of roadway user, metropolitan area, and primary payer with motor vehicle-related TBI outcome. Aim 2 assessed the relationship of motor vehicle-related TBI and risk/protective factors with medical and economic outcomes. Methods: Population-level hospital and trauma databases from the Ohio Hospital Association and Ohio Department of Public Safety, respectively, were probabilistically linked for 2003 through 2006. Injured roadway users (motor vehicle occupants, motorcyclists, bicyclists, pedestrians, and others) were assessed for TBI, ventilator use, intensive care unit (ICU) admission, injury severity score (ISS), need for rehabilitation, death, and total hospital charges. Results: The odds of a motor vehicle-related TBI were greater among those not using safety equipment (OR = 1.56). The interactions of alcohol/drug use by gender and of alcohol/drug use by location were significant. Sustaining a TBI increased the odds of requiring ventilation (OR = 3.66), being admitted to the ICU (OR = 2.51), having a high ISS (OR = 4.24), requiring rehabilitation (OR = 2.22), or death (OR = 2.52). When compared with a non-TBI, total hospital charges increased by a factor of 1.35 for a TBI. Hospital charges were $46,441 on average for individuals who sustained a TBI, whereas mean hospital charges were $32,614 for patients with a non-TBL Conclusions: Among injured roadway users, individuals who sustain a TBI are more likely to require extensive medical care and have injuries resulting in death. Impact on industry: Prevention strategies aimed at reducing alcohol use and increasing safety device use should be encouraged to reduce the burden of TBL (C) 2009 National Safety Council and Elsevier Ltd. All rights reserved.	[Rochette, Lynne M.; Conner, Kristen A.; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA	Rochette, LM (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	lynne.rochette@nationwidechildrens.org					Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; BUTLER MA, 1994, RURAL URBAN CONTINUU; *CDCP TASK FORC CO, 2005, GUID COMM PREV SERV; Coben JH, 2007, ACCIDENT ANAL PREV, V39, P190, DOI 10.1016/j.aap.2006.06.018; Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; GABELLA B, 1995, ACCIDENT ANAL PREV, V27, P363, DOI 10.1016/0001-4575(94)00079-2; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Hillary FG, 2002, BRAIN INJURY, V16, P729, DOI 10.1080/02699050110119844; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Langlois JA, 2006, TRAUMATIC BRAIN INJU; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGlincy MH, 2004, ASA P JOINT STAT M, P4001; Peden M., 2004, WHOEDMPAR20045, P31; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sosin DM, 1996, BRAIN INJURY, V10, P47; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X	26	15	17	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	OCT	2009	40	5					353	358		10.1016/j.jsr.2009.08.003			6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	532PC	WOS:000272760900003	19932315				2021-06-18	
J	Neal, MD; Cushieri, J; Rosengart, MR; Alarcon, LH; Moore, EE; Maier, RV; Minei, JP; Billiar, TR; Peitzman, AB; Sperry, JL				Neal, Matthew D.; Cushieri, Joseph; Rosengart, Matthew R.; Alarcon, Louis H.; Moore, Ernest E.; Maier, Ronald V.; Minei, Joseph P.; Billiar, Timothy R.; Peitzman, Andrew B.; Sperry, Jason L.		Inflammation & Host Response Injur	Preinjury Statin Use Is Associated With a Higher Risk of Multiple Organ Failure After Injury: A Propensity Score Adjusted Analysis	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	22nd Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 13-17, 2009	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Preinjury statin use; Multiple organ failure; Cox proportional hazard regression	SCALE COLLABORATIVE PROJECT; ORIENTED RESEARCH CORE; STANDARD OPERATING PROCEDURES; IMPROVES ENDOTHELIAL FUNCTION; PERIOPERATIVE BETA-BLOCKER; ACUTE CORONARY SYNDROMES; CLINICAL CARE; HOST RESPONSE; PREEXISTING CONDITIONS; TRAUMA PATIENTS	Background: Recent studies suggest that statin use may improve outcome in critically ill patients. This has been attributed to the pleiomorphic effect and modulation of inflammatory mediators that occurs with statin use. We sought to determine whether preinjury statin (PIS) use was associated with improved outcome in severely injured blunt trauma patients. Methods: Data were obtained from a multicenter prospective cohort study evaluating outcomes in blunt injured adults with hemorrhagic shock. Patients aged 55 years and older were analyzed. Those with isolated traumatic brain injury, cervical cord injury, and those who survived <24 hours were excluded. A propensity score predicting statin use was created using logistic regression. Cox proportional hazard regression was then used to evaluate the effects of PIS use oil mortality and the development of multiple organ failure (MOF, multiple organ dysfunction syndrome >5) and nosocomial infection (NI) after adjusting for important injury characteristics and the propensity of taking PISs. Results: Overall mortality and MOF rates for the study cohort (n = 295) were 21% and 50%, respectively. Over 24% of patients (n = 71) reported PIS use. Kaplan-Meier analysis revealed no difference in NI or mortality over time but did show a significant higher incidence of MOF in those with PIS use (p = 0.04). Regression analysis verified PIS was independently associated with an 80% higher risk of MOF (hazard ratio: 1.8; 95% confidence interval, 1.1-2.9) and was found to be one of the strongest independent risk factors for the development of MOF. Conclusion: PIS use was independently associated with a higher risk of MOF postinjury. These results are contrary to previous analyses. The protective effect of statins may be lost in the severely injured, and modulation of the inflammatory response may result in higher morbidity. Further studies are required to better understand the impact and potential therapeutic utility of this commonly prescribed medication both before and after injury.	[Neal, Matthew D.; Rosengart, Matthew R.; Alarcon, Louis H.; Billiar, Timothy R.; Peitzman, Andrew B.; Sperry, Jason L.] Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, Pittsburgh, PA 15213 USA; [Cushieri, Joseph; Maier, Ronald V.] Univ Washington, Harborview Med Ctr, Div Gen Surg & Trauma, Seattle, WA 98104 USA; [Cushieri, Joseph; Maier, Ronald V.] Univ Washington, Dept Surg, Washington, DC USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burn, Dallas, TX 75390 USA	Sperry, JL (corresponding author), Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, 200 Lothrop St, Pittsburgh, PA 15213 USA.	sperryjl@upmc.edu		Alarcon, Louis/0000-0001-6994-8412	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM062119] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR024154, KL2 RR024154-03] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54 GM062119, U54 GM062119-1] Funding Source: Medline		Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Brandt C A, 2003, AMIA Annu Symp Proc, P794; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Chiu W, 2007, J TRAUMA, V63, P510; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Cuschieri J, 2008, J TRAUMA, V65, P944, DOI 10.1097/TA.0b013e3181826df7; Daumerie G, 2008, CURR OPIN ANESTHESIO, V21, P60, DOI 10.1097/ACO.0b013e3282f35ea5; Davis K, 2008, J TRAUMA, V64, P73; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; Efron DT, 2008, J TRAUMA, V64, P66, DOI 10.1097/TA.0b013e31815b842a; Enderson BL, 2007, J TRAUMA, V62, P33; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Harbrecht BG, 2007, J TRAUMA, V63, P703, DOI 10.1097/TA.0b013e31811eadea; Heeschen C, 2002, CIRCULATION, V105, P1446, DOI 10.1161/01.CIR.0000012530.68333.C8; Hollis S, 2006, J TRAUMA, V61, P1255, DOI 10.1097/01.ta.0000243889.07090.da; Huggins GS, 1998, CIRCULATION, V98, P1291, DOI 10.1161/01.CIR.98.13.1291; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Kruger Peter S, 2006, Crit Care Resusc, V8, P223; Le Manach Y, 2007, ANESTH ANALG, V104, P1326, DOI 10.1213/01.ane.0000263029.72643.10; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lee TH, 1999, NEW ENGL J MED, V341, P1838, DOI 10.1056/NEJM199912093412410; Li JJ, 2006, MED HYPOTHESES, V66, P1199, DOI 10.1016/j.mehy.2005.06.035; Li JJ, 2006, CLIN CHIM ACTA, V366, P269, DOI 10.1016/j.cca.2005.10.021; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Maier RV, 2005, J TRAUMA, V59, P762, DOI 10.1097/01.ta.0000177656.85206.cd; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Marshall JC, 1999, EUR J SURG, V163, P62; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Moore FA, 2006, J TRAUMA, V61, P82, DOI 10.1097/01.ta.0000225933.08478.65; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Nathens AB, 2005, J TRAUMA, V59, P764, DOI 10.1097/01.ta.0000177759.17704.35; Neideen T, 2008, J TRAUMA, V65, P1016, DOI 10.1097/TA.0b013e3181897eac; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Osamah H, 1997, BRIT J CLIN PHARMACO, V44, P77, DOI 10.1046/j.1365-2125.1997.00625.x; Pryor JP, 2007, J TRAUMA, V62, P61; Ridker PM, 1998, CIRCULATION, V97, P1671, DOI 10.1161/01.CIR.97.17.1671; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Schouten O, 2007, AM J CARDIOL, V100, P316, DOI 10.1016/j.amjcard.2007.02.093; Shepherd J, 2006, J INTERN MED, V260, P305, DOI 10.1111/j.1365-2796.2006.01700.x; Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006; Stevenson Judy, 2004, J Perianesth Nurs, V19, P392; Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; West MA, 2006, J TRAUMA, V61, P436, DOI 10.1097/01.ta.0000232517.83039.c4; Westphal S, 2008, ANGIOLOGY, V59, P613, DOI 10.1177/0003319708316005; Williams TM, 2008, ANN SURG, V247, P30, DOI 10.1097/SLA.0b013e3181492c0d	58	15	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2009	67	3					476	484		10.1097/TA.0b013e3181ad66bb			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	493IL	WOS:000269729900008	19741387	Green Accepted			2021-06-18	
J	Ball, CG; Rozycki, GS; Feliciano, DV				Ball, Chad G.; Rozycki, Grace S.; Feliciano, David V.			Upper Extremity Amputations After Motor Vehicle Rollovers	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Motor vehicle collision; Amputation; Rollover	MANAGEMENT; TRAUMA	Background: The upper extremity is vulnerable to injury during a rollover motor vehicle crash (MVC). There is some concern that positioning one's arm oil a vehicle door/window eliminates the benefit of maintaining containment within a protective structure. Mangled extremities with associated vascular injuries have an amputation rate exceeding 40%. The primary goal was to describe the care process and outcome of patients requiring an emergent upper extremity amputation after a rollover MVC. Methods: All patients requiring an upper extremity amputation after a rollover MVC (2000-2008) were included. Patient demographics, injuries, and outcomes were analyzed. Results: Seventeen patients required an upper extremity amputation after a rollover MVC (mean injury severity score = 23; hemodynamic instability at presentation 29%). Injuries occurred on the side ipsilateral to the occupant vehicle position in 88% of cases. Most (76%) amputations occurred between May I and August I of their respective years, with 11 (65%) in the past 24 months. All amputations except one (replantation attempt) were completed within 24 hours. Concurrent operative procedures were performed in six (35%) patients, including three diagnostic peritoneal lavages, two laparotomies (splenectomies), one craniotomy, and one thoracotomy (atrial rupture). Mortality (12%) was a direct result of traumatic brain injuries. Temporary intravascular shunts were used before amputation in four (24%) patients. The majority (65%) of amputations were above the elbow joint. Conclusions: Blunt mangled upper extremities requiring completion amputations are most often caused by MVC rollovers. The risk of this injury is strongly associated with summer days and seems to be increasing in frequency.	[Ball, Chad G.; Rozycki, Grace S.; Feliciano, David V.] Emory Univ, Dept Surg, Grady Mem Hosp, Atlanta, GA 30322 USA	Ball, CG (corresponding author), Dept Surg, Grady Mem Hosp Campus,Glenn Mem Bldg,Room 302,69, Atlanta, GA 30303 USA.	ball.chad@gmail.com					Chang James, 2004, Tech Hand Up Extrem Surg, V8, P161, DOI 10.1097/01.bth.0000134711.75677.3b; Chapman M W, 1982, Instr Course Lect, V31, P75; Dente CJ, 2004, AM SURGEON, V70, P1088; Durham RM, 1996, AM J SURG, V172, P569, DOI 10.1016/S0002-9610(96)00245-0; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; Hunt JP, 2008, TRAUMA, V17, P105; JOHANSEN K, 1990, J TRAUMA, V30, P568, DOI 10.1097/00005373-199005000-00007; PETERSON SL, 2008, TRAUMA, P871; Rozycki GS, 2003, J TRAUMA, V55, P814, DOI 10.1097/01.TA.0000087807.44105.AE; Sane AD, 2007, CHIR MAIN, V26, P221, DOI 10.1016/j.main.2007.08.001; VANWIJNGAARDEN M, 1993, SURG GYNECOL OBSTET, V1777, P41	11	15	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2009	67	2					410	412		10.1097/TA.0b013e3181adf4eb			3	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	482OL	WOS:000268898500040	19667899				2021-06-18	
J	Seyfried, DM; Han, Y; Yang, D; Ding, J; Chopp, M				Seyfried, D. M.; Han, Y.; Yang, D.; Ding, J.; Chopp, M.			Erythropoietin promotes neurological recovery after intracerebral haemorrhage in rats	INTERNATIONAL JOURNAL OF STROKE			English	Article						erythropoietin; intracerebral haemorrhage; neural regeneration	TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; CARBAMYLATED ERYTHROPOIETIN; ENHANCES NEUROGENESIS; CEREBRAL-ISCHEMIA; MIGRATION; STROKE; ANGIOGENESIS; MEMORY; MOTOR	Background Attention has turned to neurorestorative therapies, including erythropoietin, for experimental ischaemic stroke and head injury. Treatments for intracerebral haemorrhage need to be developed, as this represents a particularly devastating and common form of neurological injury. Aim The aim of this study is to investigate the therapeutic potential of erythropoietin after intracerebral haemorrhage in rats and to measure its effects on mechanisms of recovery and neurogenesis. Methods Intracerebral haemorrhage was induced in 24 Wistar male rats by intrastriatal infusion of autologous blood. Recombinant human erythropoietin (5000 or 10 000 U/kg BW/day) or saline was administered starting 1 day after intracerebral haemorrhage and continued daily for 1 week (n=8 for each group). To label proliferating cells, 5'-bromo-2' deoxyuridine was injected daily for 13 days after intracerebral haemorrhage. All animals survived for 2 weeks after intracerebral haemorrhage. Functional outcome, area of tissue loss and immunohistochemical staining were measured at 14 days after intracerebral haemorrhage. Global test or anova was used to test the erythropoietin dose effect. Results Rats receiving recombinant human erythropoietin after intracerebral haemorrhage exhibited significant improvement in modified neurological severity score and corner test at 14 days (P < 0 center dot 05). Increased expression of phenotypes of synaptogenesis and proliferating immature neurons were shown by immunohistochemical staining. Only the group receiving a lower dose of recombinant human erythropoietin had significantly less tissue loss compared with the control group (P < 0 center dot 05). In rats treated with recombinant human erythropoietin, double staining for 5'-bromo-2' deoxyuridine and TUJ1 revealed a subpopulation of cells that express an immature neuronal marker while still dividing. Conclusions Erythropoietin improves neurological outcome and increases histochemical parameters of neurogenesis when given after intracerebral haemorrhage in rats. Intriguingly, only the lower dose of recombinant human erythropoietin was effective in reducing tissue loss in the region of intracerebral haemorrhage.	[Seyfried, D. M.; Han, Y.; Yang, D.; Ding, J.] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, M.] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA	Seyfried, DM (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsdos@neuro.hfh.edu			Internal (Departmental) Funds and National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NSO58581]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058581] Funding Source: NIH RePORTER	Special thanks to Susan MacPhee-Gray for editorial assistance. This work was supported by Internal (Departmental) Funds and National Institutes of Health grant NSO58581.	Bartesaghi S, 2005, NEUROTOXICOLOGY, V26, P923, DOI 10.1016/j.neuro.2005.01.016; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Coleman TR, 2006, P NATL ACAD SCI USA, V103, P5965, DOI 10.1073/pnas.0601377103; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Fernandes HM, 2000, ACT NEUR S, V76, P463; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; Kellert BA, 2007, PEDIATR RES, V61, P451, DOI 10.1203/pdr.0b013e3180332cec; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Schallert T, 1997, ADV NEUROL, V73, P229; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Torup L, 2007, BRIT J PHARMACOL, V151, P1141, DOI 10.1038/sj.bjp.0707287; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007	25	15	15	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	AUG	2009	4	4					250	256		10.1111/j.1747-4949.2009.00292.x			7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	482YP	WOS:000268927000006	19689750	Green Accepted			2021-06-18	
J	Hanten, G; Li, XQ; Newsome, MR; Swank, P; Chapman, SB; Dennis, M; Barnes, M; Ewing-Cobbs, L; Levin, HS				Hanten, Gerri; Li, Xiaoqi; Newsome, Mary R.; Swank, Paul; Chapman, Sandra B.; Dennis, Maureen; Barnes, Marcia; Ewing-Cobbs, Linda; Levin, Harvey S.			Oral Reading and Expressive Language After Childhood Traumatic Brain Injury Trajectory and Correlates of Change Over Time	TOPICS IN LANGUAGE DISORDERS			English	Article						childhood TBI; cognition; expressive language; outcome; reading	CLOSED-HEAD INJURY; WORKING-MEMORY; CHILDREN	Oral reading and expressive language skills were examined in 2 cohorts of children aged 5-15 years, who had mild, moderate, or severe traumatic brain injury. Children recruited prospectively from time of injury were assessed on 5 occasions over 2 years in a longitudinal study of change in reading skills, using the Gray Oral Reading Test-3rd Edition, and in expressive language, using the Formulated Sentences subtest of the Clinical Evaluation of Language Fundamentals-3rd Edition. Contributions of related cognitive-linguistic skills were also examined. Children recruited retrospectively were studied on a single occasion in a cross-sectional design investigating the contribution of age-related variables to the reading and sentence formulation scores. Similar to previous studies of childhood traumatic brain injury, children injured when younger initially showed a more rapid rate of recovery but poorer overall performance on outcome measures than did children injured when older. Socioeconomic status strongly predicted outcome for both reading and expressive language.	[Hanten, Gerri; Li, Xiaoqi; Newsome, Mary R.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA; [Swank, Paul; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr, Dept Pediat, Houston, TX USA; [Barnes, Marcia] Univ Texas Houston Hlth Sci Ctr, Dept Pediat, Childrens Learning Inst, Houston, TX USA; [Chapman, Sandra B.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [Dennis, Maureen] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Hanten, G (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, 1709 Dryden Rd,Ste 725, Houston, TX 77030 USA.	ghanten@bcm.edu					Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DENCKLA M B, 1974, Cortex, V10, P186; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; HANTEN G, 2008, COGNITIVE NEUROREHAB, P487; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Semel E. M., 1995, CLIN EVALUATION LANG; STALLINGS GA, 1995, INT NEUR ASS 23 ANN; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1991, WECHSLER INTELLIGENC; WEIDERHOLT JL, 1992, GRAY ORAL READING TE; Wolf M, 2000, J LEARN DISABIL-US, V33, P387, DOI 10.1177/002221940003300409; WOODCOCK R, 1989, W JOHNSON TESTS ACHI; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	20	15	15	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-8294			TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2009	29	3					236	248		10.1097/TLD.0b013e3181b531f0			13	Linguistics; Rehabilitation	Linguistics; Rehabilitation	488HT	WOS:000269340700005					2021-06-18	
J	Joosse, P; Smit, G; Arendshorst, RJ; Soedarmo, S; Ponsen, KJ; Goslings, JC				Joosse, P.; Smit, G.; Arendshorst, R. J.; Soedarmo, S.; Ponsen, K. -J.; Goslings, J. C.			Outcome and prognostic factors of traumatic brain injury: a prospective evaluation in a Jakarta University hospital	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Developing countries; Prognostic factors; Trauma and injury severity score; Traumatic brain injury	SEVERE HEAD-INJURY; SEVERITY; MORTALITY; SCALE; TRISS; CARE	The aim of the study was to report management and outcome of traumatic brain injury (TBI) in a Jakarta University hospital, and to determine prognostic factors. All consecutive patients with an Abbreviated Injury Score (AIS) head of >= 4 or an AIS head score of >= 3 combined with an AIS score of _> 2 in any other body region were analyzed on patient characteristics and outcome. Prognostic factors evaluated were Glasgow Coma Scale (GCS) score, pupil reactions and probability of survival based on the Trauma and Injury Severity Score (TRISS) method. A total of 49 patients were included; overall mortality was 37%. The GCS and abnormal pupil reactions were associated with mortality with an odds ratio of 0.78 and 6.90, respectively. Thus, TBI has a poor prognosis in the population under study. The TRISS has limitations in evaluating trauma care for this selected group of patients. GCS and pupil reactions are valuable and simple for usage as prognostic factors. (C) 2008 Elsevier Ltd. All rights reserved.	[Joosse, P.] Sint Lucas Andreas Hosp, Dept Surg, NL-1061 AE Amsterdam, Netherlands; [Smit, G.] Katholieke Univ Nijmegen, Radboud Hosp, Dept Gen Practice, Nijmegen, Netherlands; [Arendshorst, R. J.] Vrije Univ Amsterdam, VU Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Soedarmo, S.] Univ Kristen Indonesia, UKI Hosp, Dept Surg, Jakarta, Indonesia; [Ponsen, K. -J.; Goslings, J. C.] Univ Amsterdam, Acad Med Ctr, Dept Surg, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands	Joosse, P (corresponding author), Sint Lucas Andreas Hosp, Dept Surg, Jan Tooropstr 164, NL-1061 AE Amsterdam, Netherlands.	pieterjoosse@hotmail.com					Ahmad FU, 2006, NEUROL INDIA, V54, P73; *AM COLL SURG COMM, 1997, ADV TRAUM LIF SUPP D; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHAMPION HR, 1983, WORLD J SURG, V7, P4, DOI 10.1007/BF01655906; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; HARTONO B, 2007, INDONESIA HLTH PROFI; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1979, Acta Neurochir Suppl (Wien), V28, P149; Joosse P, 2001, J TRAUMA, V51, P134, DOI 10.1097/00005373-200107000-00021; KRAUS JF, 1995, J NEUROTRAUM, V12, P873, DOI 10.1089/neu.1995.12.873; MARKLE J, 1992, J TRAUMA, V33, P326, DOI 10.1097/00005373-199208000-00025; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Raja IA, 2001, WORLD J SURG, V25, P1230; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P597, DOI [10.1089/neu.2000.17.597, DOI 10.1089/NEU.2000.17.597]; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P583; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J Neurotrauma, V17, P563, DOI 10.1089/neu.2000.17.563; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009	23	15	16	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2009	16	7					925	928		10.1016/j.jocn.2008.06.014			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	451YJ	WOS:000266506500014	19269829				2021-06-18	
